Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" OR11H12 ENSG00000257115 "Olfactory receptor family 11 subfamily H member 12" B2RN74 14 18601045-18602129 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047370 Uncertain NA NA "HPA047370: AB_2680016" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POTEM "ACT, P704P, POTE14beta" ENSG00000222036 "POTE ankyrin domain family member M" A6NI47 14 18967434-19003752 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "prostate: 18.7" "Cell type enhanced" "Detected in single" "Langerhans cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.2;K-562: 4.2;U-2 OS: 7.4" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 71: Testis - DNA repair" "Cluster 9: U-2 OS - Unknown function" "Cluster 10: Non-specific - Unknown function" "unprognostic (6.16e-2)" 0.1 0.2 0.7 0.2 0.3 0.2 0.3 0.4 0.8 0.2 0.0 0.1 0.2 0.2 0.2 0.1 0.2 0.2 0.3 0.3 0.5 0.1 0.0 0.2 0.2 0.4 0.1 0.3 0.2 0.1 0.0 0.4 0.4 18.7 0.1 1.1 0.3 0.1 0.2 0.5 0.1 0.1 0.0 0.3 0.2 4.1 0.3 0.1 0.6 0.1 0.1 0.1 0.0 0.9 0.7 0.7 0.3 0.6 0.1 0.1 3.2 0.3 0.1 0.1 0.1 0.6 0.1 0.4 0.4 0.1 0.4 0.2 0.1 0.2 0.1 0.1 0.2 0.3 1.0 1.0 0.0 0.3 0.8 0.1 0.2 0.4 0.0 0.2 0.1 0.1 4.2 1.8 0.2 0.7 0.4 0.3 0.8 0.0 0.5 0.3 0.3 0.8 0.2 0.2 0.2 1.1 0.3 1.7 0.1 0.9 2.1 0.2 0.5 0.3 7.4 0.4 0.3 0.8 1.5 0.1 0.2 0.3 0.4 0.7 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.7 0.3 0.4 0.8 0.3 0.5 0.4 0.1 0.4 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 POTEG "A26C2, CT104.4, POTE-14, POTE14, POTE14alpha" ENSG00000187537 "POTE ankyrin domain family member G" Q6S5H5 14 19402486-19434341 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "prostate: 1.1" "Cell type enhanced" "Detected in single" "Spermatocytes: 1.1" "Cancer enhanced" "Detected in single" "prostate cancer: 0.5" "Not detected" "Not detected" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 71: Testis - DNA repair" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (4.01e-1)" "unprognostic (1.51e-1)" "unprognostic (6.00e-2)" "unprognostic (1.17e-1)" "unprognostic (2.02e-1)" "unprognostic (2.69e-2)" "unprognostic (1.05e-1)" "unprognostic (2.05e-3)" "unprognostic (1.06e-1)" "unprognostic (1.29e-1)" "unprognostic (2.50e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 7.6 15.0 4.7 11.1 3.5 2.9 4.1 4.5 10.6 2.7 3.1 5.0 7.6 3.7 11.3 2.9 7.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 OR11H2 "C14orf15, OR11H2P, OR11H8P" ENSG00000258453 "Olfactory receptor family 11 subfamily H member 2" Q8NH07 14 19712904-19714332 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047370 Uncertain NA NA "HPA047370: AB_2680016" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4N2 ENSG00000176294 "Olfactory receptor family 4 subfamily N member 2" Q8NGD1 14 19719015-19830253 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "testis: 3.8" "Group enriched" "Detected in some" 18 "Early spermatids: 30.9;Late spermatids: 12.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 2.0" "Not detected" "Not detected" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 9: U-2 OS - Unknown function" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (2.80e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4Q3 "C14orf13, OR4Q4" ENSG00000182652 "Olfactory receptor family 4 subfamily Q member 3" 14 19743571-19749469 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049924 Uncertain NA NA "HPA049924: AB_2680955" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4M1 ENSG00000176299 "Olfactory receptor family 4 subfamily M member 1" Q8NGD0 14 19773504-19783696 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "Early spermatids: 48.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058889 Uncertain NA NA "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA058889: AB_2683845" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4K2 ENSG00000165762 "Olfactory receptor family 4 subfamily K member 2" Q8NGD2 14 19875142-19883932 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4K5 ENSG00000176281 "Olfactory receptor family 4 subfamily K member 5" Q8NGD3 14 19920582-19921659 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4K1 ENSG00000155249 "Olfactory receptor family 4 subfamily K member 1" Q8NGD4 14 19930917-19936757 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA028877 Uncertain NA NA "HPA028877: AB_10600923" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4K15 OR4K15Q ENSG00000169488 "Olfactory receptor family 4 subfamily K member 15" Q8NH41 14 19975444-19976659 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055732 Uncertain NA NA "HPA055732: AB_2682900" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4K14 ENSG00000169484 "Olfactory receptor family 4 subfamily K member 14" Q8NGD5 14 20014143-20019307 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4K13 ENSG00000176253 "Olfactory receptor family 4 subfamily K member 13" Q8NH42 14 20029399-20036038 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4L1 OR4L2P ENSG00000176246 "Olfactory receptor family 4 subfamily L member 1" Q8NH43 14 20060045-20060983 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4K17 ENSG00000176230 "Olfactory receptor family 4 subfamily K member 17" Q8NGC6 14 20110739-20122199 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 2.2;liver: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "cerebellum: 1.8;cerebral cortex: 1.0;white matter: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "Cluster 18: Basophils - Vesicular transport" 0.2 0.3 0.2 0.4 0.1 2.2 0.1 1.8 1.0 0.0 0.0 0.1 0.6 0.2 0.3 0.2 0.1 0.3 0.2 0.2 0.2 0.4 4.6 0.2 0.5 0.2 0.0 0.2 0.1 0.0 0.2 0.2 0.3 0.1 1.4 0.4 0.0 1.0 0.6 0.3 0.1 0.0 0.4 0.3 0.4 0.0 0.1 0.3 0.0 0.1 0.1 1.5 0.2 0.3 0.3 0.3 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.3 0.4 0.5 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.5 0.2 0.6 0.5 0.1 0.0 0.6 0.4 0.1 0.1 0.1 0.1 0.2 0.0 0.5 0.5 0.5 0.0 0.4 0.3 0.7 0.4 0.4 0.2 0.2 0.3 0.3 0.0 0.4 0.3 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.2 0.3 0.1 0.3 0.2 0.5 0.3 0.6 0.3 0.3 0.1 0.6 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.2 0.2 0.1 0.1 0.0 0.2 0.1 1.8 1.0 0.2 0.2 0.2 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4N5 ENSG00000184394 "Olfactory receptor family 4 subfamily N member 5" Q8IXE1 14 20138820-20145471 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 60 "HEL: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 36: HEL - Hemostasis" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR11G2 ENSG00000196832 "Olfactory receptor family 11 subfamily G member 2" Q8NGC1 14 20190894-20201075 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 4.8;Club cells: 3.1;granulocytes: 6.3;Respiratory ciliated cells: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 5 "neutrophil: 2.2" "Lineage enriched" "Detected in single" 14 "granulocytes: 2.2" "Cell line enriched" "Detected in single" 15 "HEL: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 36: HEL - Hemostasis" "Cluster 11: Alveolar cells - Smell perception" 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 4.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 3.1 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 6.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 OR11H6 ENSG00000176219 "Olfactory receptor family 11 subfamily H member 6" Q8NGC7 14 20223710-20224702 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR11H4 ENSG00000176198 "Olfactory receptor family 11 subfamily H member 4" Q8NGC9 14 20239286-20244349 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA052790 Uncertain NA NA "HPA052790: AB_2681950" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TTC5 Strap ENSG00000136319 "Tetratricopeptide repeat domain 5" Q8N0Z6 14 20256558-20305960 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045008, HPA054198" Approved Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "HPA045008: AB_10960209, HPA054198: AB_2682414" "unprognostic (2.19e-3)" "unprognostic (1.00e-1)" "unprognostic (1.94e-1)" "unprognostic (1.47e-1)" "unprognostic (1.39e-2)" "unprognostic (6.48e-2)" "unprognostic (8.15e-2)" "unprognostic (6.82e-2)" "unprognostic (4.68e-2)" "unprognostic (1.03e-1)" "unprognostic (8.32e-2)" "unprognostic (3.29e-1)" "prognostic favorable (8.54e-4)" "unprognostic (3.01e-1)" "unprognostic (1.77e-1)" "unprognostic (1.10e-1)" "unprognostic (5.07e-2)" 2.1 2.8 2.8 1.8 2.8 2.9 3.8 2.2 3.1 3.1 4.8 2.2 2.1 3.1 3.2 2.2 5.7 2.2 1.8 2.6 3.1 3.5 1.4 2.5 3.2 2.1 2.7 3.0 1.9 6.1 2.1 2.4 2.1 3.8 2.3 2.6 2.3 3.0 0.7 3.4 1.6 2.9 2.1 2.4 2.4 2.5 4.3 2.6 4.9 2.3 3.1 2.3 1.7 2.2 3.4 5.4 6.5 0.7 4.7 6.8 3.5 4.3 5.0 6.4 6.6 2.4 7.6 7.2 2.7 4.5 3.3 2.8 6.4 3.0 9.8 6.3 2.4 5.9 2.2 4.3 4.8 11.0 3.5 4.2 6.7 5.6 7.2 5.8 6.3 5.1 4.3 3.5 6.3 4.6 6.5 4.6 5.5 5.6 5.2 3.4 4.8 5.2 5.6 3.5 2.2 4.3 4.9 5.1 3.0 2.6 4.0 5.3 6.6 2.5 4.1 3.4 2.3 5.0 4.7 8.9 2.0 4.6 6.0 1.3 2.0 2.9 2.7 2.0 2.3 2.7 2.0 2.2 2.2 3.0 2.1 2.5 0.8 3.0 2.9 1.6 2.7 2.0 2.8 2.8 2.2 3.1 2.6 3.1 2.1 2.7 2.1 2.1 4.3 2.2 13.9 12.8 7.2 6.5 15.2 6.4 9.4 21.5 13.6 15.5 9.4 12.8 4.3 12.8 9.8 18.4 16.7 20.4 12.2 2.3 11.7 10.6 1.6 27.7 13.4 12.3 9.0 6.7 18.2 6.5 12.4 12.5 8.6 7.9 12.0 16.0 10.8 6.4 15.4 5.0 12.4 6.9 18.3 11.2 6.8 3.4 10.2 10.5 7.2 6.5 11.5 12.4 19.6 11.6 8.7 6.4 5.0 9.8 7.8 4.6 8.6 13.1 32.8 19.4 6.6 14.1 11.6 26.6 36.1 8.8 8.7 4.7 12.7 14.6 8.3 5.3 CCNB1IP1 "C14orf18, HEI10" ENSG00000100814 "Cyclin B1 interacting protein 1" Q9NPC3 14 20311368-20333312 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Meiosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 381.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 1: Thyroid gland - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "unprognostic (4.79e-2)" "unprognostic (1.35e-1)" "unprognostic (1.29e-1)" "unprognostic (9.37e-2)" "unprognostic (5.46e-3)" "unprognostic (2.79e-2)" "unprognostic (8.43e-2)" "unprognostic (5.88e-2)" "unprognostic (1.56e-1)" "unprognostic (1.88e-2)" "unprognostic (4.87e-2)" "unprognostic (4.77e-2)" "prognostic favorable (5.18e-6)" "unprognostic (2.12e-1)" "unprognostic (1.54e-2)" "unprognostic (4.43e-1)" "unprognostic (1.52e-1)" 31.3 20.0 31.7 10.6 32.8 35.5 58.1 31.8 44.3 52.6 38.4 35.3 21.3 43.0 48.4 27.3 53.2 20.8 74.7 31.1 35.3 66.4 74.9 36.9 25.3 34.7 32.7 99.4 45.3 51.3 22.2 31.3 34.9 38.1 30.1 21.2 29.6 24.4 52.2 35.5 24.7 29.9 32.7 20.4 31.0 23.3 31.8 32.0 57.4 63.4 30.7 40.0 41.7 34.4 30.8 24.7 137.5 133.3 68.9 94.1 110.3 37.0 73.6 55.5 72.8 83.2 33.4 106.2 23.9 27.1 55.6 53.8 96.6 69.9 74.3 30.9 82.0 63.1 22.6 79.7 201.7 117.5 56.6 128.8 114.6 39.6 381.3 67.3 42.6 125.7 77.7 82.1 37.0 48.9 68.5 79.3 83.2 66.5 46.6 82.9 67.9 45.5 58.7 44.6 109.0 113.6 25.5 58.5 170.7 75.8 18.7 84.5 18.4 31.6 40.1 38.4 48.8 38.3 51.0 72.6 10.6 97.3 37.1 6.3 4.2 0.1 8.2 1.4 10.9 11.6 9.0 10.3 17.7 9.8 9.2 13.0 0.6 6.0 1.6 18.2 13.3 3.8 31.7 32.8 31.8 44.3 31.1 35.3 34.7 32.7 34.9 32.7 31.8 34.4 22.2 28.9 27.2 16.3 35.5 58.1 74.0 45.5 113.3 4.2 57.0 71.9 30.9 58.6 21.0 23.9 20.9 41.2 27.7 15.1 103.7 31.8 64.2 13.0 37.6 24.9 41.3 34.7 22.2 38.2 70.6 34.5 23.0 20.2 34.9 76.7 20.0 35.3 17.8 1.7 28.5 40.1 28.5 23.3 26.5 92.8 51.6 22.4 51.6 7.5 17.8 46.9 30.9 15.1 19.7 29.3 18.8 44.0 17.4 63.5 21.0 86.5 5.2 17.6 46.0 36.6 31.6 101.0 77.5 67.0 40.1 34.1 28.7 61.1 44.3 51.3 PARP2 "ADPRTL2, ARTD2" ENSG00000129484 "Poly(ADP-ribose) polymerase 2" Q9UGN5 14 20343615-20357904 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052003 Approved Supported Nucleoplasm,Nucleoli NA Yes "Cluster 16: MAIT-cells - Unknown function" "Cluster 54: Non-specific - Microtubule organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Nucleoli "HPA052003: AB_2681689" "unprognostic (3.93e-1)" "unprognostic (7.92e-2)" "unprognostic (4.12e-1)" "unprognostic (1.24e-1)" "unprognostic (3.40e-2)" "unprognostic (7.30e-2)" "prognostic unfavorable (6.48e-4)" "unprognostic (1.97e-2)" "unprognostic (4.43e-2)" "unprognostic (9.35e-3)" "unprognostic (1.44e-2)" "unprognostic (1.42e-2)" "unprognostic (3.37e-3)" "unprognostic (2.83e-1)" "unprognostic (9.19e-2)" "unprognostic (1.91e-1)" "unprognostic (2.89e-2)" 17.7 21.1 21.1 10.7 22.0 26.8 17.5 21.4 31.4 18.1 16.4 19.3 12.8 20.9 17.8 14.6 17.5 10.0 17.1 22.5 21.0 15.5 17.2 13.5 14.5 19.5 18.9 22.9 17.9 11.1 21.0 12.9 19.8 13.9 14.0 26.4 14.2 13.4 32.4 19.2 14.2 15.8 19.0 16.5 16.3 23.8 19.8 11.9 16.7 27.1 17.9 13.8 15.3 22.1 55.5 39.5 59.7 45.3 19.4 18.4 43.4 60.2 32.5 74.8 91.8 36.8 51.3 40.4 26.5 19.0 64.8 50.1 78.3 27.5 87.8 32.4 38.3 37.2 46.6 63.3 17.3 77.9 20.4 12.5 23.0 45.5 51.1 20.5 38.5 48.0 39.2 53.4 52.3 33.5 40.1 33.0 33.0 62.8 60.0 49.7 79.7 26.5 30.0 28.2 41.3 28.3 65.3 36.8 17.9 37.4 34.2 25.8 26.6 45.3 68.1 31.5 48.1 49.3 67.7 53.4 19.0 33.3 51.4 1.9 5.0 0.5 8.9 4.8 11.7 6.8 8.4 7.9 5.5 4.1 9.0 8.6 0.1 7.6 2.6 5.6 5.3 4.8 21.1 22.0 21.4 31.4 22.5 21.0 19.5 18.9 19.8 19.0 19.8 22.1 12.1 25.6 6.5 7.2 9.5 6.5 10.5 16.1 18.8 29.2 7.4 10.0 14.0 5.7 19.9 7.3 12.5 25.8 10.2 4.5 7.9 12.8 9.3 9.9 13.3 11.0 4.8 30.3 17.6 8.7 22.2 11.6 7.7 11.3 8.2 18.4 6.8 10.1 11.9 30.3 15.5 5.0 14.2 4.6 5.1 9.8 11.5 6.6 8.8 9.4 4.2 20.7 6.2 6.0 9.3 10.1 4.5 17.0 19.1 4.5 5.3 7.4 28.0 23.2 6.6 9.8 18.5 20.9 41.5 11.3 4.8 14.9 6.2 16.7 7.4 7.0 TEP1 "p240, TLP1, TP1, TROVE1, VAULT2" ENSG00000129566 "Telomerase associated protein 1" Q99973 14 20365667-20413501 "Plasma proteins, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 23.9;Gastric mucus-secreting cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029206 Supported Nucleoplasm,Vesicles NA NA "Cluster 17: Basophils - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 21: OE19 - Mitochondria" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm Vesicles "HPA029206: AB_10601271" "unprognostic (4.53e-2)" "unprognostic (2.81e-2)" "unprognostic (1.26e-1)" "prognostic favorable (9.58e-4)" "unprognostic (2.27e-1)" "unprognostic (2.76e-1)" "unprognostic (2.66e-2)" "unprognostic (1.43e-1)" "unprognostic (6.81e-2)" "unprognostic (1.42e-2)" "unprognostic (1.92e-1)" "unprognostic (1.05e-1)" "unprognostic (1.46e-1)" "unprognostic (1.10e-1)" "unprognostic (2.18e-1)" "unprognostic (6.18e-2)" "unprognostic (3.00e-1)" 9.4 7.8 3.4 12.1 4.1 5.1 8.7 3.2 4.0 7.8 6.0 17.4 28.0 6.9 7.3 6.8 7.2 10.7 6.8 3.3 4.3 6.5 6.5 11.0 15.0 6.0 5.3 6.2 6.2 13.7 5.7 6.6 5.1 7.9 17.9 5.0 8.3 6.3 10.3 7.9 15.5 9.7 3.8 14.8 9.6 2.3 5.8 10.2 8.1 5.1 15.1 7.5 7.8 5.2 9.2 4.2 4.1 4.5 26.1 9.9 7.3 6.8 6.0 4.0 5.1 8.7 10.2 8.1 4.2 17.0 7.3 9.3 3.5 13.6 6.8 7.8 3.5 9.5 9.4 5.7 7.5 8.0 16.1 14.1 11.8 6.5 5.2 17.1 15.2 6.7 3.1 5.8 14.0 5.4 4.7 5.8 1.8 28.4 3.6 12.2 10.2 2.8 13.2 13.8 1.2 1.9 5.4 12.8 4.2 11.8 6.5 4.9 20.1 15.5 10.6 4.9 1.9 12.9 6.9 5.1 3.7 6.9 5.5 3.6 2.3 0.0 1.0 2.8 1.0 1.7 0.5 1.0 0.8 2.4 0.5 0.6 4.5 0.5 2.9 5.4 0.6 0.3 3.4 4.1 3.2 4.0 3.3 4.3 6.0 5.3 5.1 3.8 5.8 5.2 3.7 9.6 14.1 13.1 8.4 2.8 4.8 3.1 2.8 0.3 3.2 2.8 3.2 8.6 5.6 1.8 2.1 2.0 14.3 23.9 1.9 4.8 0.2 2.9 4.2 5.8 4.2 2.1 1.9 5.1 2.5 3.4 25.5 4.2 10.8 2.6 8.2 4.9 6.4 0.0 2.1 12.8 0.0 10.4 4.6 1.3 5.0 10.2 5.4 16.9 12.9 2.6 7.2 4.5 3.9 6.0 12.8 3.8 8.4 5.1 21.8 3.8 12.2 2.6 0.0 5.1 6.1 0.0 0.6 2.4 1.4 1.9 5.0 2.2 8.3 4.9 KLHL33 ENSG00000185271 "Kelch like family member 33" A6NCF5 14 20425852-20436166 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 29 "skeletal muscle: 73.3;tongue: 20.2" "Cell type enriched" "Detected in some" 19 "Cardiomyocytes: 27.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 21 "plasmacytoid DC: 5.8" "Lineage enriched" "Detected in single" 21 "dendritic cells: 5.8" "Cell line enriched" "Detected in single" 9 "REH: 4.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA049985, HPA056560" Enhanced NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 14: REH - Unknown function" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA049985: , HPA056560: AB_2683174" "unprognostic (6.92e-2)" "unprognostic (6.39e-2)" "unprognostic (2.07e-1)" "unprognostic (4.81e-1)" "unprognostic (2.43e-1)" "unprognostic (2.26e-1)" "unprognostic (2.38e-3)" "unprognostic (1.60e-1)" "unprognostic (9.77e-2)" "unprognostic (1.25e-1)" "unprognostic (7.39e-2)" "unprognostic (4.15e-2)" "unprognostic (4.60e-2)" "unprognostic (7.43e-3)" "unprognostic (4.88e-3)" "unprognostic (3.32e-5)" "unprognostic (2.32e-1)" 0.9 0.3 0.5 0.2 0.5 0.2 0.6 1.5 0.6 1.2 0.3 0.8 0.3 1.4 1.0 0.9 0.8 0.8 1.0 0.4 0.5 0.5 0.1 0.4 0.6 0.4 0.6 1.2 0.2 0.5 0.2 0.2 0.4 1.0 0.3 0.3 0.5 1.0 73.3 0.1 0.5 0.5 0.1 0.6 0.3 0.4 0.6 1.0 0.4 20.2 0.6 0.5 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.0 0.0 5.8 0.0 0.1 0.5 0.5 1.5 0.6 0.4 0.5 0.4 0.6 0.4 0.1 0.6 0.7 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 27.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 OSGEP "GCPL1, KAE1, OSGEP1, PRSMG1, TCS3" ENSG00000092094 "O-sialoglycoprotein endopeptidase" Q9NPF4 14 20446401-20455089 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Acyltransferase, Transferase" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039751 Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 52: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 57: B-cells - Immune response" Nucleoplasm "Plasma membrane" "HPA039751: AB_10794754" "prognostic favorable (1.48e-4)" "unprognostic (4.15e-3)" "unprognostic (1.29e-1)" "unprognostic (4.33e-3)" "unprognostic (1.54e-2)" "unprognostic (3.95e-2)" "unprognostic (5.54e-3)" "unprognostic (2.80e-3)" "unprognostic (2.98e-1)" "unprognostic (1.05e-1)" "unprognostic (3.35e-3)" "unprognostic (1.22e-1)" "prognostic unfavorable (4.64e-6)" "unprognostic (4.83e-2)" "unprognostic (1.86e-2)" "unprognostic (2.53e-2)" "unprognostic (9.91e-2)" 5.7 6.3 6.1 3.8 6.2 6.1 7.0 6.4 7.3 6.8 6.8 7.6 3.8 6.4 8.5 6.0 6.1 6.6 8.1 6.0 6.3 5.8 11.1 6.2 9.3 6.4 6.1 5.3 5.6 7.4 5.2 6.7 6.4 4.9 7.0 4.1 5.3 8.3 10.5 4.7 6.2 5.6 6.5 8.4 6.4 2.4 6.3 9.9 7.6 9.9 10.1 8.2 4.9 6.9 10.3 17.2 5.6 16.2 9.9 6.6 17.6 8.0 11.3 21.1 20.1 21.5 12.3 21.1 10.3 11.0 9.0 8.6 17.9 17.6 14.1 16.8 19.1 14.8 12.2 32.1 7.4 24.3 19.7 5.3 5.2 26.1 14.0 4.6 14.3 18.8 14.0 12.1 17.6 21.0 25.0 11.8 9.1 31.5 31.8 35.3 10.3 12.4 12.8 11.7 21.3 4.2 15.4 16.0 11.9 3.3 9.7 23.7 6.1 8.7 21.2 11.3 10.7 3.4 18.0 31.7 5.0 36.1 11.0 9.3 29.2 38.5 18.8 27.9 17.4 28.7 19.7 17.2 44.5 38.1 15.9 17.4 13.8 20.9 23.3 16.9 19.2 24.6 6.1 6.2 6.4 7.3 6.0 6.3 6.4 6.1 6.4 6.5 6.3 6.9 27.1 35.3 34.9 16.3 46.0 11.5 20.9 26.2 14.2 37.8 24.0 25.1 17.2 15.7 29.1 23.9 37.5 66.3 31.8 22.5 35.2 24.7 3.1 19.2 18.3 24.1 26.9 19.6 23.0 29.8 47.0 23.4 28.1 16.3 25.9 24.6 25.7 19.3 65.8 10.1 24.1 24.2 22.4 30.7 32.8 3.0 19.3 34.2 21.4 7.5 28.4 31.0 32.0 16.6 17.0 20.0 30.6 21.4 26.2 10.9 42.2 39.7 25.5 51.5 13.1 24.6 23.9 7.8 16.9 22.0 11.5 46.1 26.8 37.3 31.6 17.4 APEX1 "APE, APE-1, APEN, APEX, APX, HAP1, REF-1, REF1" ENSG00000100823 "Apurinic/apyrimidinic endodeoxyribonuclease 1" P27695 14 20455191-20457772 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Activator, DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000956, HPA002564, CAB004294, CAB047307" Supported Supported Nucleoplasm Yes No 330000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 32: Non-specific - Translation" Nucleoplasm "CAB004294: AB_626685, CAB047307: , HPA000956: AB_2666158, HPA002564: AB_1078174" "unprognostic (2.80e-3)" "unprognostic (1.39e-1)" "unprognostic (1.55e-2)" "unprognostic (4.74e-3)" "unprognostic (1.97e-2)" "unprognostic (5.88e-2)" "prognostic unfavorable (7.82e-5)" "unprognostic (4.21e-2)" "unprognostic (3.14e-2)" "unprognostic (2.46e-2)" "unprognostic (2.42e-2)" "unprognostic (1.68e-1)" "unprognostic (1.38e-1)" "unprognostic (1.22e-1)" "unprognostic (1.83e-2)" "unprognostic (2.54e-1)" "unprognostic (7.08e-2)" 83.9 103.6 56.9 82.8 58.1 154.9 103.2 60.0 67.5 80.4 57.9 89.1 107.5 97.2 66.5 80.5 99.1 79.7 76.6 57.5 60.3 82.8 104.6 61.0 112.4 58.9 58.3 146.3 92.2 88.3 39.3 57.3 59.5 69.3 92.7 52.9 66.0 80.2 102.9 83.4 73.0 95.7 59.5 68.9 85.4 21.5 60.1 125.0 93.2 71.9 121.2 103.8 65.8 62.6 249.3 296.8 267.8 247.2 180.9 259.3 226.5 227.3 245.7 333.3 287.4 216.9 240.7 477.9 198.4 176.4 178.1 262.5 317.5 242.1 304.8 214.7 135.9 195.5 162.8 368.9 189.5 623.1 193.2 270.6 261.6 217.6 212.6 267.2 282.3 193.9 228.4 153.6 270.7 240.0 404.7 264.7 260.3 282.4 269.5 441.5 297.7 200.8 281.7 327.1 315.2 201.8 248.5 305.2 253.1 185.0 186.4 276.7 186.0 175.0 292.8 177.9 216.6 203.1 375.8 327.7 77.8 390.7 224.7 0.9 106.7 7.5 79.6 93.4 108.4 154.8 98.9 95.4 208.6 140.5 133.1 117.7 6.8 97.6 60.1 235.6 65.8 200.3 56.9 58.1 60.0 67.5 57.5 60.3 58.9 58.3 59.5 59.5 60.1 62.6 63.8 64.1 57.6 11.8 120.3 106.4 101.1 192.9 136.1 57.5 131.3 136.8 50.1 111.5 117.1 68.0 41.7 200.1 114.1 32.4 150.6 152.7 19.9 65.0 161.1 75.6 120.0 135.6 20.6 104.5 212.6 88.7 72.9 82.0 81.6 165.5 42.1 70.8 175.6 28.6 19.5 85.4 138.4 96.7 89.4 5.8 80.5 95.2 64.0 11.2 121.9 77.4 75.2 22.6 19.4 78.2 73.1 64.3 71.1 60.4 66.2 170.1 64.6 51.6 52.6 87.5 174.2 8.5 43.0 106.4 97.0 101.5 75.1 198.4 157.6 76.8 PIP4P1 "C14orf9, MGC26684, TMEM55B" ENSG00000165782 "Phosphatidylinositol-4,5-bisphosphate 4-phosphatase 1" Q86T03 14 20457681-20461465 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 78.4;Hofbauer cells: 54.9;Syncytiotrophoblasts: 167.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048528 Approved NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "HPA048528: AB_2680427" "unprognostic (1.84e-1)" "unprognostic (6.23e-2)" "unprognostic (1.81e-1)" "unprognostic (7.07e-2)" "unprognostic (2.04e-1)" "unprognostic (8.51e-2)" "unprognostic (1.71e-2)" "unprognostic (3.37e-3)" "unprognostic (4.94e-2)" "unprognostic (1.33e-1)" "unprognostic (7.78e-3)" "unprognostic (1.85e-1)" "prognostic favorable (1.01e-4)" "unprognostic (4.80e-2)" "unprognostic (1.47e-1)" "unprognostic (7.53e-2)" "unprognostic (1.96e-1)" 23.6 27.3 37.2 13.6 38.3 49.0 22.4 36.5 38.6 22.2 32.1 25.4 17.8 21.6 27.0 25.5 21.6 13.4 22.9 38.2 38.8 27.4 25.1 23.9 18.8 38.3 37.8 20.9 24.4 30.6 28.3 16.6 40.4 23.6 15.6 26.1 23.5 15.4 35.1 33.6 28.7 15.9 36.0 31.3 27.8 21.2 38.2 16.9 22.5 22.6 21.1 24.2 21.3 36.5 21.1 32.4 21.3 25.1 32.7 20.2 39.5 19.6 38.1 26.2 31.5 19.3 33.2 18.8 16.5 24.6 75.9 21.6 26.3 21.5 22.9 24.9 19.7 13.5 15.5 28.6 44.6 25.2 26.7 26.3 28.9 30.2 30.5 23.8 24.5 28.7 11.5 37.1 21.9 24.2 34.3 22.1 14.3 32.9 44.5 25.1 20.7 12.6 24.6 46.6 30.7 23.0 20.1 32.6 25.8 18.3 16.4 23.6 17.2 23.8 30.1 36.0 17.6 42.0 58.0 27.6 16.5 19.2 26.5 1.3 3.2 7.3 4.2 2.3 3.5 12.4 5.2 4.8 4.1 10.3 5.8 6.1 4.1 4.4 2.0 10.4 4.5 2.5 37.2 38.3 36.5 38.6 38.2 38.8 38.3 37.8 40.4 36.0 38.2 36.5 23.5 9.6 12.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 29.8 22.7 0.0 0.0 3.1 22.0 0.0 78.4 23.8 0.0 19.6 36.8 0.0 19.1 13.5 9.1 0.0 0.0 0.0 40.0 35.0 8.2 0.0 24.3 3.8 15.6 0.0 0.0 54.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.0 12.9 0.0 0.0 0.0 0.0 36.9 0.0 0.0 7.6 0.0 0.0 20.4 5.1 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 167.2 9.9 18.4 0.0 0.0 PNP "NP, PUNP" ENSG00000198805 "Purine nucleoside phosphorylase" P00491 14 20468954-20477089 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Purine salvage" "Glycosyltransferase, Transferase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 333.9;epididymis: 594.8" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 360.6;Erythroid cells: 227.3;Syncytiotrophoblasts: 646.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 531.3;U-937: 593.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001625 Enhanced Supported Cytosol NA NA 58000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 47: Cytotrophoblasts - Unknown function" Cytosol "HPA001625: AB_1854577" "unprognostic (1.20e-3)" "unprognostic (2.68e-2)" "unprognostic (1.04e-2)" "unprognostic (1.70e-1)" "unprognostic (3.10e-1)" "unprognostic (7.06e-2)" "prognostic unfavorable (4.43e-4)" "unprognostic (4.94e-3)" "unprognostic (3.87e-2)" "unprognostic (7.45e-2)" "unprognostic (1.85e-2)" "unprognostic (2.21e-1)" "prognostic favorable (2.24e-4)" "unprognostic (1.69e-1)" "unprognostic (7.54e-2)" "unprognostic (2.46e-1)" "unprognostic (1.64e-3)" 78.6 24.8 16.1 46.8 16.6 333.9 34.6 22.6 22.7 25.3 18.9 52.2 120.3 14.2 594.8 87.4 18.2 56.8 29.0 17.7 19.6 206.8 98.0 48.6 46.7 20.3 18.1 5.0 23.2 32.0 19.8 132.6 20.1 15.0 61.8 27.1 22.6 27.4 7.3 29.6 60.3 38.7 23.1 44.5 50.6 7.4 21.1 33.5 17.8 10.0 64.4 100.4 41.5 20.1 86.1 113.4 24.0 53.9 26.0 21.0 71.8 85.2 40.3 68.2 67.0 66.1 76.5 227.1 96.8 45.5 81.5 89.9 125.2 159.8 89.5 75.0 109.6 189.1 89.9 109.3 24.2 531.3 94.7 14.4 57.4 206.0 91.0 37.8 295.9 141.0 95.4 137.4 86.7 79.1 157.6 311.3 67.5 215.7 186.1 130.2 35.9 88.3 243.7 79.6 101.9 22.6 163.4 205.0 13.2 32.6 75.5 92.5 240.0 46.1 62.6 105.1 148.4 63.1 113.3 258.9 39.3 593.0 4.6 12.0 30.6 10.3 39.8 27.3 73.6 25.7 44.2 45.0 48.1 28.8 27.6 35.9 3.7 38.5 26.6 27.3 16.7 31.1 16.1 16.6 22.6 22.7 17.7 19.6 20.3 18.1 20.1 23.1 21.1 20.1 149.6 0.0 23.5 5.9 50.3 84.6 67.4 12.6 112.7 4.7 56.3 62.6 3.5 27.1 13.4 82.8 14.6 360.6 45.2 61.1 39.2 43.2 1.3 36.0 12.7 139.4 46.4 227.3 0.6 51.5 41.8 32.4 106.5 65.3 57.7 5.0 24.3 30.6 70.9 16.8 1.1 51.3 18.3 18.1 58.4 0.8 0.3 83.3 30.2 3.7 13.2 78.8 29.9 3.0 0.9 130.8 83.9 0.7 88.6 27.5 41.2 118.9 10.5 18.1 0.0 23.9 41.3 0.4 0.7 114.7 63.9 646.2 62.3 3.1 51.4 77.1 RNASE10 "RAH1, RNASE9" ENSG00000182545 "Ribonuclease A family member 10 (inactive)" Q5GAN6 14 20505537-20511169 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Fertilization" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 5.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "head and neck cancer: 2.0;testis cancer: 1.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SiHa: 7.2;U-2 OS: 10.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA052593 Uncertain "Secreted - unknown location" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 9: U-2 OS - Unknown function" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "HPA052593: AB_2681878" "unprognostic (2.48e-3)" "unprognostic (2.22e-1)" "unprognostic (2.46e-2)" "unprognostic (1.17e-1)" "unprognostic (1.74e-1)" "unprognostic (5.91e-3)" "unprognostic (5.03e-3)" "unprognostic (5.58e-3)" "unprognostic (4.20e-2)" "unprognostic (3.04e-1)" "unprognostic (1.98e-3)" "unprognostic (1.11e-1)" "unprognostic (7.88e-4)" "unprognostic (1.58e-1)" "unprognostic (3.62e-1)" "unprognostic (8.76e-2)" "unprognostic (2.58e-1)" 2.1 1.8 3.2 1.6 3.0 1.1 0.4 2.8 4.3 0.5 2.8 0.7 1.6 2.0 1.1 1.1 1.1 0.6 0.4 3.2 2.4 0.9 0.8 1.6 0.8 3.8 3.0 1.1 0.4 0.4 0.5 0.8 3.2 1.2 0.4 0.5 0.9 0.7 2.0 2.5 1.7 0.5 1.8 1.3 1.1 1.9 3.1 0.5 0.7 0.2 0.4 0.7 0.5 5.2 4.4 2.0 0.9 1.9 0.2 0.4 2.8 0.2 0.4 0.1 0.3 0.9 1.2 0.5 1.3 0.5 0.6 2.3 0.0 0.3 0.1 1.7 0.7 0.0 1.5 0.6 0.5 0.1 2.0 0.7 1.5 0.1 2.3 0.4 1.0 0.7 1.0 2.3 0.0 1.2 0.7 1.1 0.5 0.6 0.2 3.3 0.3 2.6 0.7 1.8 1.1 1.4 7.2 1.7 0.9 0.9 1.6 0.7 0.4 0.7 10.8 0.9 0.8 2.2 0.9 0.2 0.8 0.6 0.9 1.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.3 0.3 0.0 0.0 3.2 3.0 2.8 4.3 3.2 2.4 3.8 3.0 3.2 1.8 3.1 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 RNASE9 "h461, RAK1" ENSG00000188655 "Ribonuclease A family member 9 (inactive)" P60153 14 20556093-20560931 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 985 "epididymis: 98.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL163195.3 ENSG00000259060 "Novel protein" 14 20582892-20609795 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "epididymis: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 68: Epididymis - Unknown function" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 RNASE11 "C14orf6, RAJ1" ENSG00000173464 "Ribonuclease A family member 11 (inactive)" Q8TAA1 14 20583559-20609884 "Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "epididymis: 444.4" "Group enriched" "Detected in some" 63 "Early spermatids: 32.1;Late spermatids: 57.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA003724 Uncertain "Secreted in male reproductive system" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" "HPA003724: AB_1079817" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 444.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 57.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNASE12 RAI1 ENSG00000258436 "Ribonuclease A family member 12 (inactive)" Q5GAN4 14 20590193-20590823 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 300 "epididymis: 862.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044175, HPA059465" Enhanced "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "HPA044175: AB_10960390, HPA059465: AB_2732638" 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 862.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6S1 OR6S1Q ENSG00000181803 "Olfactory receptor family 6 subfamily S member 1" Q8NH40 14 20640696-20641691 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.62e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANG "RAA1, RNASE5" ENSG00000214274 Angiogenin P03950 14 20684177-20698971 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Angiogenesis, Differentiation, Stress response" "Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 52 "liver: 3018.1" "Cell type enriched" "Detected in many" 24 "Hepatocytes: 4816.3" "Cancer enriched" "Detected in all" 17 "liver cancer: 279.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 24.5;myeloid DC: 14.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Hep G2: 152.2;OE19: 116.1" "Low region specificity" "Detected in all" HPA055896 Approved "Nucleoli,Nucleoli rim,Mitotic chromosome,Actin filaments" "Secreted to blood" Yes No 308000000 410000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "Nucleoli, Nucleoli rim, Mitotic chromosome" "Actin filaments" "HPA055896: " "unprognostic (2.50e-2)" "unprognostic (1.82e-1)" "unprognostic (9.77e-2)" "prognostic favorable (6.85e-4)" "unprognostic (5.71e-3)" "unprognostic (6.99e-2)" "prognostic favorable (7.83e-5)" "unprognostic (1.16e-1)" "unprognostic (3.20e-3)" "unprognostic (9.19e-3)" "unprognostic (1.31e-1)" "unprognostic (3.69e-1)" "unprognostic (6.65e-2)" "unprognostic (1.03e-1)" "unprognostic (3.39e-1)" "unprognostic (2.00e-1)" "unprognostic (3.09e-1)" 37.6 3.0 3.6 6.0 3.5 1.0 37.8 3.5 4.9 38.2 5.6 32.6 23.2 23.4 17.9 9.8 30.5 28.5 16.9 3.6 4.9 18.4 3018.1 18.5 3.5 4.5 4.2 58.1 30.8 5.3 5.0 3.8 4.3 32.7 45.7 2.2 52.6 13.3 6.2 27.4 27.1 10.4 4.5 7.4 58.2 10.2 3.7 1.5 8.8 10.5 4.1 24.8 31.4 4.8 3.7 9.9 2.3 0.0 23.9 27.8 0.3 4.8 8.8 1.1 4.0 5.9 5.1 0.4 1.5 12.0 8.0 3.8 2.8 3.1 1.3 18.4 3.8 0.9 5.1 152.2 5.0 4.0 0.5 22.2 2.5 1.5 5.1 11.8 5.7 4.2 0.2 27.0 3.5 0.7 0.9 1.2 0.7 116.1 10.7 0.7 3.9 11.3 2.3 2.9 0.0 0.4 4.6 1.7 6.5 5.1 4.0 0.7 6.0 1.9 2.8 1.7 0.7 5.9 4.8 0.5 3.2 2.0 5.0 0.0 24.5 0.0 0.6 2.9 0.4 5.8 1.2 1.1 14.5 4.9 0.3 0.2 0.4 0.0 0.1 2.3 0.8 7.1 3.6 3.5 3.5 4.9 3.6 4.9 4.5 4.2 4.3 4.5 3.7 4.8 9.7 28.9 17.7 0.0 9.7 27.1 43.3 39.2 14.2 0.1 33.8 24.8 0.8 194.5 24.6 11.0 0.0 1.6 0.7 32.5 11.7 40.0 1.0 6.2 9.7 11.0 71.0 27.8 0.0 31.6 5.3 48.8 56.1 24.9 0.0 10.7 62.4 4816.3 15.9 0.0 0.0 171.9 12.2 95.9 18.7 2.9 71.1 13.8 23.2 0.0 4.9 10.1 0.0 0.0 0.0 21.6 33.3 24.0 11.7 43.7 91.3 61.2 76.5 0.6 13.1 29.7 17.7 1.0 1.3 9.4 52.4 9.3 5.6 0.5 51.6 39.2 RNASE4 RAB1 ENSG00000258818 "Ribonuclease A family member 4" P34096 14 20684560-20701216 "Plasma proteins, Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 478.8" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 67.3;Gastric mucus-secreting cells: 47.4;Hepatocytes: 55.8;Intestinal goblet cells: 110.0" "Cancer enhanced" "Detected in many" "liver cancer: 6.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 24.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 92.6;ASC TERT1: 107.2;Hep G2: 136.9;HSkMC: 63.1;OE19: 92.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 61000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 27: Mucus-secreting cells - Mucin production" "unprognostic (1.07e-1)" "unprognostic (3.46e-1)" "unprognostic (5.21e-2)" "unprognostic (3.18e-4)" "unprognostic (1.20e-1)" "unprognostic (7.05e-2)" "prognostic favorable (9.62e-5)" "unprognostic (1.43e-1)" "unprognostic (2.22e-2)" "unprognostic (6.88e-2)" "unprognostic (3.71e-2)" "unprognostic (1.29e-1)" "unprognostic (3.46e-1)" "unprognostic (2.54e-2)" "unprognostic (1.57e-1)" "unprognostic (9.16e-2)" "unprognostic (4.27e-2)" 106.4 7.8 5.5 8.9 5.7 1.2 96.6 5.4 8.3 95.6 8.5 56.5 22.0 59.2 37.0 20.1 77.3 55.6 44.1 5.5 8.1 40.3 478.8 40.3 12.2 6.9 6.6 111.7 41.0 14.7 12.5 5.7 6.9 76.7 65.2 4.7 74.8 45.8 14.1 47.4 41.9 25.9 6.7 11.8 84.7 10.6 5.3 5.8 26.5 31.5 10.6 65.3 75.9 7.8 2.7 12.1 2.6 0.1 92.6 107.2 0.5 10.5 23.8 1.4 4.5 3.4 4.1 0.1 2.9 24.6 6.2 2.5 1.4 2.6 1.7 17.2 1.8 0.3 2.9 136.9 10.2 1.3 0.6 63.1 5.8 1.6 10.3 34.6 12.6 4.2 0.1 12.2 6.9 1.5 1.0 0.2 0.5 92.3 10.3 0.6 2.1 3.6 2.9 2.4 0.1 0.5 5.0 2.3 2.6 4.2 3.4 0.2 13.3 3.0 1.7 4.1 0.3 2.6 3.5 0.4 4.7 1.3 2.7 0.2 24.1 0.1 0.8 1.2 1.0 5.3 1.5 0.6 13.8 4.9 0.3 0.6 0.6 0.6 0.1 3.3 3.3 8.4 5.5 5.7 5.4 8.3 5.5 8.1 6.9 6.6 6.9 6.7 5.3 7.8 1.8 38.5 19.1 2.0 3.4 2.8 1.7 2.5 11.4 0.0 9.9 2.5 0.2 28.6 4.7 3.7 0.0 0.2 0.3 30.4 0.0 34.4 0.2 0.1 0.8 4.0 67.3 8.4 0.1 22.2 0.4 39.2 47.4 0.8 1.3 0.3 5.0 55.8 1.6 0.0 0.2 110.0 2.0 6.2 4.0 0.3 12.5 3.6 3.6 1.9 2.7 1.3 1.0 0.0 0.9 12.8 33.2 4.1 5.9 1.7 41.7 10.2 11.6 0.3 0.0 2.6 8.1 0.2 0.1 10.2 4.1 0.4 0.8 0.1 39.6 1.5 AL163636.1 ENSG00000259171 "Novel protein, ANG-RNASE4 readthrough" 14 20684587-20700576 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 115.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "liver cancer: 0.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 9.9;memory B-cell: 3.6;myeloid DC: 5.8" "Group enriched" "Detected in many" 12 "B-cells: 3.6;dendritic cells: 5.8;monocytes: 9.9" "Cell line enhanced" "Detected in many" "ASC diff: 17.2;ASC TERT1: 38.5;Hep G2: 26.0;HSkMC: 16.9;OE19: 75.0" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 21: OE19 - Mitochondria" "unprognostic (1.88e-1)" "unprognostic (3.10e-2)" "unprognostic (1.34e-1)" "unprognostic (1.08e-2)" "unprognostic (1.33e-2)" "unprognostic (2.81e-3)" "unprognostic (1.93e-1)" "unprognostic (1.27e-1)" "unprognostic (2.60e-1)" "unprognostic (8.66e-2)" "unprognostic (6.61e-2)" "unprognostic (6.87e-3)" "unprognostic (8.58e-3)" "unprognostic (2.88e-1)" "unprognostic (2.53e-2)" "unprognostic (5.11e-2)" 45.2 5.8 1.0 6.8 0.7 0.1 34.7 0.6 1.6 31.7 1.5 29.5 26.5 25.1 10.6 11.8 27.3 48.0 14.9 0.8 1.5 15.6 115.1 23.7 5.4 1.2 0.9 69.7 19.4 3.3 3.1 2.6 1.1 41.4 35.1 0.3 35.1 16.5 6.7 17.9 31.7 17.9 1.3 3.6 58.4 7.1 0.8 1.5 8.2 14.6 5.1 24.7 25.7 1.6 2.6 0.8 2.0 0.0 17.2 38.5 0.0 2.4 6.4 0.0 1.7 0.0 2.7 0.0 0.0 10.2 2.7 0.8 0.6 0.2 0.0 6.4 0.4 0.4 0.0 26.0 1.3 0.0 0.0 16.9 1.4 0.0 0.9 12.1 0.5 1.8 0.0 11.6 2.9 0.0 0.2 0.5 0.0 75.0 0.3 0.3 1.4 2.1 0.1 0.9 0.0 0.2 4.0 1.6 2.0 0.0 1.9 0.2 1.8 3.3 0.6 2.0 0.4 2.2 1.6 0.0 3.2 0.4 3.8 0.0 9.9 0.0 0.0 0.5 0.3 3.6 0.4 0.2 5.8 1.2 0.2 0.0 0.1 0.0 0.0 1.0 0.5 2.4 1.0 0.7 0.6 1.6 0.8 1.5 1.2 0.9 1.1 1.3 0.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EDDM3A "FAM12A, HE3-ALPHA" ENSG00000181562 "Epididymal protein 3A" Q14507 14 20745887-20748380 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "epididymis: 636.1" "Cell type enriched" "Detected in some" 26 "Collecting duct cells: 29.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049952 Approved "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA049952: AB_2680970" "unprognostic (1.42e-1)" "unprognostic (9.88e-2)" "unprognostic (8.56e-3)" "unprognostic (2.10e-1)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 636.1 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 35.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 29.5 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 EDDM3B "FAM12B, HE3-BETA" ENSG00000181552 "Epididymal protein 3B" P56851 14 20768404-20770948 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 279 "epididymis: 2563.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.3;NB-4: 2.6" "Not detected" "Not detected" HPA001323 Enhanced "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 24: NB-4 - Immune response" "Cluster 35: Glandular cells - Unknown function" "HPA001323: AB_1848377" "unprognostic (2.40e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2563.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNASE6 "RAD1, RNaseK6, RNS6" ENSG00000169413 "Ribonuclease A family member k6" Q93091 14 20781268-20782467 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 110.5" "Cell type enhanced" "Detected in many" "B-cells: 108.0;dendritic cells: 221.7;Hofbauer cells: 207.9;Kupffer cells: 551.2;Langerhans cells: 198.4;Macrophages: 270.3;monocytes: 115.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 1238.8" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 7 "RPMI-8226: 65.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA000698 Approved "Secreted to blood" NA NA 2600000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 16: Immune cells - Immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 41: Macrophages - Immune response" "HPA000698: AB_2181340" "unprognostic (5.04e-2)" "unprognostic (5.21e-3)" "unprognostic (3.59e-2)" "unprognostic (4.05e-2)" "unprognostic (1.74e-1)" "unprognostic (7.31e-2)" "unprognostic (7.91e-2)" "unprognostic (2.29e-1)" "unprognostic (4.45e-1)" "unprognostic (1.65e-1)" "unprognostic (2.04e-1)" "unprognostic (2.73e-1)" "unprognostic (2.85e-3)" "unprognostic (9.62e-2)" "unprognostic (5.60e-3)" "unprognostic (3.46e-2)" "unprognostic (5.54e-2)" 25.2 29.5 8.0 59.6 7.5 27.5 24.0 7.8 13.6 31.6 10.0 27.7 17.3 10.6 78.4 16.0 11.3 47.7 11.7 7.3 10.9 12.2 21.1 29.6 110.5 13.6 10.1 9.9 8.4 9.0 4.3 44.8 11.9 7.9 34.0 1.8 11.2 17.2 2.0 8.6 33.4 23.6 10.8 62.1 14.9 4.5 12.6 43.8 5.5 6.0 84.5 43.3 5.1 19.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 2.1 2.1 0.0 0.0 0.0 0.0 0.0 1.7 4.7 0.6 0.2 0.0 0.0 1.9 4.6 0.0 0.0 0.0 0.2 0.0 65.6 1.1 0.7 0.0 0.1 0.0 0.0 0.1 0.1 0.0 8.1 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.7 0.0 441.1 537.3 12.8 5.3 124.8 12.0 324.7 13.6 5.6 513.3 410.3 6.4 1.0 199.0 36.7 2.0 1238.8 1.1 329.8 8.0 7.5 7.8 13.6 7.3 10.9 13.6 10.1 11.9 10.8 12.6 19.5 1.6 6.4 7.5 0.0 108.0 4.5 0.2 0.0 1.8 0.0 1.4 2.8 0.6 14.3 1.2 0.0 0.0 1.1 221.7 2.6 0.0 0.0 0.8 0.1 0.0 3.8 0.0 12.0 0.0 0.0 1.6 1.4 1.1 0.2 0.0 0.0 8.6 3.3 207.9 0.0 0.0 0.5 2.0 551.2 198.4 4.8 2.8 270.3 21.4 1.9 115.8 0.0 9.2 0.0 0.0 0.0 12.6 0.7 52.4 0.2 0.4 0.5 0.2 0.4 13.1 0.6 0.6 0.1 0.7 0.6 3.8 2.2 7.8 0.0 3.4 1.2 RNASE1 "RAC1, RNS1" ENSG00000129538 "Ribonuclease A family member 1, pancreatic" P07998 14 20801228-20802855 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Endonuclease, Hydrolase, Lyase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "pancreas: 9121.6" "Cell type enhanced" "Detected in many" "Adipocytes: 826.6;Alveolar cells type 1: 929.5;Alveolar cells type 2: 818.4;Gastric mucus-secreting cells: 821.1;Hepatic stellate cells: 650.3;Hofbauer cells: 1583.4;Intestinal goblet cells: 663.8;Macrophages: 632.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 9.7;myeloid DC: 20.3" "Group enriched" "Detected in many" 9 "dendritic cells: 20.3;monocytes: 9.7" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 286.8;OE19: 67.4;RT4: 114.2;TIME: 179.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001140 Enhanced Approved Nucleoplasm,Vesicles "Secreted to digestive system" NA NA 1100000000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 4: Macrophages - Innate immune response" Vesicles Nucleoplasm "HPA001140: AB_1079816" "unprognostic (2.32e-2)" "unprognostic (3.16e-2)" "unprognostic (9.51e-3)" "unprognostic (7.77e-2)" "unprognostic (6.93e-2)" "unprognostic (1.28e-1)" "unprognostic (3.42e-3)" "unprognostic (6.59e-3)" "unprognostic (4.69e-2)" "unprognostic (7.92e-2)" "unprognostic (6.32e-2)" "unprognostic (3.56e-2)" "unprognostic (5.14e-3)" "unprognostic (1.11e-2)" "unprognostic (1.47e-1)" "unprognostic (2.43e-2)" "unprognostic (1.67e-1)" 694.2 501.3 336.6 131.3 466.1 6.2 353.3 404.4 556.1 203.9 294.9 378.4 176.7 139.4 112.0 194.0 232.0 406.4 377.7 351.3 380.9 253.0 54.5 775.9 187.8 438.9 408.3 190.6 9121.6 60.6 43.9 897.4 403.7 83.9 425.2 3.1 168.0 149.7 127.6 118.1 201.8 285.6 357.3 353.1 1003.5 977.5 465.4 177.6 119.7 280.6 68.8 374.7 107.9 533.7 0.0 1.4 0.5 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 6.7 0.0 0.3 1.7 0.0 2.2 0.6 0.0 1.4 0.0 0.1 0.1 5.3 0.1 0.8 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 286.8 0.0 31.4 0.4 0.0 0.0 0.3 2.0 1.2 67.4 0.0 0.2 0.1 1.5 0.2 114.2 1.2 1.4 0.0 0.8 0.3 2.0 0.3 0.1 179.3 0.0 2.7 1.8 0.3 0.6 0.1 0.1 4.6 0.1 3.8 1.6 9.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 20.3 0.1 0.0 0.0 0.1 0.0 0.0 5.0 0.0 2.4 336.6 466.1 404.4 556.1 351.3 380.9 438.9 408.3 403.7 357.3 465.4 533.7 826.6 929.5 818.4 1.6 11.1 35.6 1.0 1.9 15.9 0.1 6.2 11.7 59.8 27.1 174.0 16.5 0.0 12.9 5.7 261.8 0.0 8.8 20.0 3.8 1.9 581.7 48.7 28.0 0.5 315.2 14.6 58.4 821.1 3.4 25.2 103.8 650.3 7.9 1583.4 1.7 0.8 663.8 8.2 267.9 197.5 57.1 32.0 632.8 40.9 36.5 3.4 0.8 0.0 1.0 232.3 286.8 246.7 10.9 7.5 1.4 81.7 0.9 34.9 2.7 98.6 20.7 31.4 16.4 6.6 16.6 28.1 25.9 10.6 392.8 162.9 3.8 RNASE3 "ECP, RAF1, RNS3" ENSG00000169397 "Ribonuclease A family member 3" P12724 14 20891399-20892348 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 95 "bone marrow: 934.3" "Cell type enhanced" "Detected in some" "Early spermatids: 22.9;Erythroid cells: 5.9;Kupffer cells: 4.5;Late spermatids: 10.9;Macrophages: 3.0;Rod photoreceptor cells: 3.5" "Cancer enriched" "Detected in single" 8 "glioma: 2.0" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 22 "eosinophil: 304.6" "Lineage enriched" "Detected in many" 22 "granulocytes: 304.6" "Cell line enhanced" "Detected in some" "HL-60: 150.4;NB-4: 51.1;THP-1: 63.6;U-937: 301.8" HPA056183 Enhanced "Secreted to blood" NA NA 4200000 "Cluster 49: Eosinophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA056183: AB_2683059" "unprognostic (2.54e-2)" "unprognostic (6.61e-2)" "unprognostic (1.84e-1)" "unprognostic (2.50e-1)" "unprognostic (1.37e-2)" "unprognostic (8.21e-2)" "unprognostic (6.45e-2)" "unprognostic (9.20e-3)" "unprognostic (1.20e-1)" "unprognostic (9.21e-2)" "unprognostic (8.62e-7)" "unprognostic (6.29e-2)" "unprognostic (1.03e-1)" "unprognostic (1.70e-1)" "unprognostic (2.37e-1)" 0.4 0.4 0.5 0.5 0.5 934.3 0.1 0.5 1.2 0.1 0.3 0.2 0.0 0.1 0.3 0.1 0.3 0.3 0.2 0.5 1.0 0.2 2.0 2.7 0.7 1.1 0.7 0.2 0.1 0.0 0.3 0.6 0.9 0.2 0.1 3.8 1.2 0.1 0.1 1.7 0.1 1.0 1.0 9.8 0.1 1.8 0.5 9.4 0.1 0.0 0.0 0.3 0.1 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 150.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 63.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 301.8 0.0 11.3 8.8 304.6 0.0 1.2 0.1 0.0 0.0 0.0 14.1 0.0 0.0 0.0 4.3 0.0 0.5 1.6 0.0 4.4 0.5 0.5 0.5 1.2 0.5 1.0 1.1 0.7 0.9 1.0 0.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.1 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.5 0.0 10.9 0.3 3.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 RNASE2 "EDN, RAF3, RNS2" ENSG00000169385 "Ribonuclease A family member 2" P10153 14 20955487-20956436 "Enzymes, Plasma proteins, Predicted secreted proteins" Chemotaxis "Endonuclease, Hydrolase, Lyase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 49 "bone marrow: 1713.7" "Cell type enhanced" "Detected in some" "Erythroid cells: 30.7;Kupffer cells: 174.3;Macrophages: 82.2;monocytes: 54.6" "Cancer enriched" "Detected in many" 7 "glioma: 14.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 457.5;eosinophil: 1352.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 1352.6" "Group enriched" "Detected in some" 303 "HL-60: 539.0;NB-4: 539.8;THP-1: 1405.4;U-937: 1295.9" HPA044983 Enhanced "Secreted to blood" NA NA 200000000 "Cluster 49: Eosinophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "HPA044983: AB_10963689" "unprognostic (6.66e-2)" "unprognostic (3.00e-1)" "unprognostic (6.85e-2)" "unprognostic (7.68e-2)" "unprognostic (2.73e-2)" "unprognostic (9.26e-2)" "unprognostic (4.94e-3)" "unprognostic (6.77e-2)" "unprognostic (9.54e-2)" "unprognostic (3.24e-2)" "unprognostic (3.25e-2)" "unprognostic (3.45e-1)" "prognostic unfavorable (3.28e-13)" "unprognostic (2.27e-2)" "unprognostic (7.14e-3)" "unprognostic (5.33e-2)" "unprognostic (1.50e-1)" 7.1 6.0 3.0 9.1 2.8 1713.7 1.7 2.9 5.5 2.3 4.4 2.2 0.2 2.1 0.3 0.9 5.7 2.6 4.0 2.8 4.2 1.7 4.6 12.2 1.9 5.4 4.1 1.5 1.7 0.5 1.7 1.8 4.4 1.7 0.7 1.7 1.9 0.2 0.7 2.9 1.4 9.7 4.5 35.1 2.1 0.7 4.2 14.8 0.9 0.6 0.6 5.2 1.4 6.3 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 3.1 0.0 539.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 539.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.0 1405.4 0.0 0.0 0.1 0.0 1.2 0.0 0.2 0.7 0.0 1295.9 0.0 457.5 109.0 1352.6 0.4 19.3 0.8 0.3 0.4 0.0 191.8 0.4 0.4 0.4 9.8 0.1 2.8 2.6 0.1 39.9 3.0 2.8 2.9 5.5 2.8 4.2 5.4 4.1 4.4 4.5 4.2 6.3 0.2 3.2 0.5 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 1.4 0.0 1.9 0.0 0.5 0.0 0.0 1.3 0.0 30.7 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 1.4 2.2 13.0 0.0 0.0 0.0 0.0 174.3 0.7 1.7 0.3 82.2 0.0 0.0 54.6 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 19.7 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 METTL17 "FLJ20859, METT11D1" ENSG00000165792 "Methyltransferase like 17" Q9H7H0 14 20989973-20997035 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002955, HPA059802" Uncertain Enhanced Nucleoplasm "Intracellular and membrane" No No "Cluster 44: Non-specific - Transcription" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA002955: AB_2144183, HPA059802: AB_2684129" "unprognostic (1.90e-2)" "unprognostic (1.21e-1)" "unprognostic (2.17e-1)" "unprognostic (2.53e-1)" "unprognostic (2.88e-1)" "unprognostic (1.28e-1)" "unprognostic (1.00e-2)" "unprognostic (2.23e-3)" "unprognostic (1.90e-1)" "unprognostic (1.33e-1)" "unprognostic (1.39e-1)" "unprognostic (4.02e-2)" "unprognostic (3.06e-2)" "unprognostic (1.39e-2)" "unprognostic (1.35e-1)" "unprognostic (2.11e-1)" "unprognostic (3.29e-2)" 11.9 32.2 11.0 11.1 11.5 26.6 12.2 12.3 16.1 14.1 13.2 20.6 17.6 12.8 11.2 22.4 13.0 10.3 23.7 10.7 11.1 20.0 19.7 11.7 18.0 12.0 10.9 13.8 18.8 19.4 9.6 12.2 11.6 12.3 21.7 8.0 15.6 13.8 21.3 16.1 21.5 14.2 12.0 23.3 17.6 18.6 12.0 21.7 13.6 29.2 19.3 12.2 14.6 12.3 37.5 48.0 41.8 16.1 25.3 12.2 32.0 22.3 32.8 69.1 58.2 34.3 44.9 85.8 24.4 29.1 43.7 54.0 57.5 48.5 49.6 32.5 44.7 41.8 27.5 56.6 31.5 71.5 42.8 23.4 41.7 35.1 27.8 23.0 27.9 70.5 40.4 38.6 33.8 24.9 48.9 72.2 49.6 62.7 56.2 56.8 42.9 48.2 37.5 34.4 30.2 36.5 30.0 43.9 24.8 31.1 29.4 60.0 15.5 22.4 72.0 25.1 30.2 28.7 49.8 62.1 15.5 46.0 29.3 28.8 8.1 8.6 11.7 9.8 7.0 13.9 12.7 13.2 16.8 10.8 12.4 11.7 0.1 10.7 5.5 11.1 11.5 6.9 11.0 11.5 12.3 16.1 10.7 11.1 12.0 10.9 11.6 12.0 12.0 12.3 11.2 9.6 17.7 21.9 33.6 18.9 17.9 21.2 46.1 37.5 16.5 16.4 5.4 21.5 17.9 11.0 43.8 30.8 23.0 19.3 5.9 20.4 49.2 11.8 16.2 13.5 12.2 26.9 9.7 15.4 17.4 17.7 36.2 11.1 29.7 22.0 11.7 24.2 18.1 21.9 9.3 24.0 16.2 11.3 12.4 10.2 33.5 16.3 3.6 6.5 19.8 23.4 26.8 8.5 11.0 13.8 32.5 21.4 33.6 11.0 27.9 18.0 21.4 53.1 13.1 14.6 17.0 23.4 17.3 40.6 17.8 12.7 27.6 29.0 35.6 24.8 SLC39A2 ZIP2 ENSG00000165794 "Solute carrier family 39 member 2" Q9NP94 14 20999255-21001871 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 18.8;seminal vesicle: 33.2;skin 1: 37.5" "Cell type enhanced" "Detected in some" "Muller glia cells: 22.3;Squamous epithelial cells: 12.0;Suprabasal keratinocytes: 6.0;Urothelial cells: 4.4" "Group enriched" "Detected in many" 4 "cervical cancer: 5.1;colorectal cancer: 3.3;head and neck cancer: 6.1;melanoma: 1.9;urothelial cancer: 6.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 71 "HaCaT: 23.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA030489, HPA073231" Uncertain Approved "Plasma membrane,Cytoplasmic bodies" NA NA "Cluster 31: Skin - Epidermis development" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 5: Muller glia cells - Visual perception" "Plasma membrane" "Cytoplasmic bodies" "HPA030489: AB_10601488, HPA073231: " "unprognostic (2.76e-2)" "unprognostic (4.86e-2)" "unprognostic (9.72e-2)" "unprognostic (2.37e-1)" "unprognostic (2.46e-1)" "unprognostic (2.71e-1)" "unprognostic (3.42e-1)" "unprognostic (1.70e-1)" "unprognostic (4.43e-1)" "unprognostic (6.20e-3)" "unprognostic (3.31e-1)" "unprognostic (2.80e-1)" "unprognostic (3.62e-2)" "unprognostic (1.91e-1)" "unprognostic (5.80e-2)" "unprognostic (3.71e-1)" "unprognostic (2.30e-3)" 0.1 0.0 0.2 0.1 0.2 0.0 1.9 0.3 0.3 8.0 0.2 1.9 0.0 0.3 0.1 18.8 0.5 0.4 0.2 0.2 0.2 0.0 0.1 0.1 0.0 0.2 0.3 0.0 0.0 2.3 0.1 0.3 0.2 12.2 1.3 3.7 4.1 33.2 0.2 37.5 0.1 0.2 0.3 0.0 0.0 0.1 0.3 2.8 0.0 0.0 2.7 0.3 14.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 23.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.3 0.2 0.2 0.2 0.3 0.2 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.8 1.1 0.9 0.0 0.2 0.8 0.3 0.4 0.0 0.7 0.0 2.1 0.1 0.0 0.5 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 22.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.8 0.2 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 12.0 6.0 0.3 0.0 0.0 1.4 4.4 NDRG2 "KIAA1248, SYLD" ENSG00000165795 "NDRG family member 2" Q9UN36 14 21016763-21070872 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis, Wnt signaling pathway" "Developmental protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 1885.3;salivary gland: 2081.6;skeletal muscle: 1828.7" "Cell type enhanced" "Detected in many" "Astrocytes: 379.0;Distal tubular cells: 485.2;Muller glia cells: 548.0;Sertoli cells: 598.2" "Cancer enhanced" "Detected in all" "glioma: 78.5" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 11 "myeloid DC: 204.4" "Lineage enriched" "Detected in all" 11 "dendritic cells: 204.4" "Cell line enhanced" "Detected in many" "Hep G2: 57.0;HMC-1: 39.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002896, HPA003590, CAB017491" Enhanced Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA 460000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 5: Muller glia cells - Visual perception" "Centriolar satellite" "Nucleoplasm, Cytosol" "CAB017491: AB_2298331, HPA002896: AB_1079459, HPA003590: AB_1079458" "unprognostic (9.27e-3)" "unprognostic (2.97e-3)" "unprognostic (1.26e-2)" "unprognostic (5.09e-3)" "unprognostic (2.00e-2)" "unprognostic (2.92e-2)" "prognostic favorable (6.71e-4)" "unprognostic (1.85e-3)" "unprognostic (5.57e-2)" "unprognostic (3.46e-2)" "unprognostic (1.69e-1)" "unprognostic (5.10e-2)" "prognostic favorable (1.43e-12)" "unprognostic (1.46e-1)" "unprognostic (5.56e-2)" "unprognostic (6.11e-2)" "unprognostic (4.19e-2)" 192.0 400.6 1613.1 27.4 1885.3 2.8 321.6 1623.2 1666.4 395.4 1189.8 198.3 72.1 229.7 260.3 229.5 305.0 130.7 327.2 1551.7 1590.0 150.1 544.4 115.5 48.6 1690.6 1686.1 476.1 93.7 278.5 88.5 45.3 1581.9 171.3 111.0 134.1 2081.6 208.0 1828.7 220.3 125.4 127.7 1584.5 152.0 130.9 33.3 1752.7 40.1 99.9 1591.4 100.4 158.0 265.8 1597.9 10.9 2.3 6.8 12.6 1.1 0.0 1.0 0.2 4.5 3.9 2.2 15.1 20.0 0.6 4.0 0.3 6.2 17.6 30.3 6.3 5.4 0.1 10.9 14.3 2.2 57.0 1.3 1.3 39.0 11.8 13.1 0.9 1.9 6.3 0.0 12.6 29.0 1.2 0.6 9.4 5.0 4.0 17.9 35.2 0.8 14.6 0.7 3.7 7.6 27.4 0.1 19.4 3.0 3.3 14.4 17.3 26.6 8.2 0.0 1.2 20.8 0.4 0.4 6.1 4.8 0.3 1.8 0.3 4.7 0.0 6.5 0.7 8.3 1.5 11.4 6.4 12.6 11.9 204.4 4.4 18.7 14.0 1.4 3.0 0.1 7.0 9.4 15.3 1613.1 1885.3 1623.2 1666.4 1551.7 1590.0 1690.6 1686.1 1581.9 1584.5 1752.7 1597.9 98.0 0.0 11.9 379.0 6.7 28.7 83.7 86.4 12.0 6.3 240.7 201.2 180.2 151.5 110.9 40.5 10.4 11.5 9.1 81.4 485.2 104.9 6.3 33.3 11.0 53.9 33.5 8.4 1.1 21.7 0.7 62.3 18.8 40.2 48.8 79.0 164.2 214.9 20.7 3.3 3.9 77.4 57.0 30.8 137.6 14.4 348.6 30.4 321.9 47.8 8.7 548.0 1.0 42.7 71.0 16.3 37.9 166.3 1.2 68.5 18.5 41.3 70.8 15.5 598.2 167.7 162.8 1.7 5.5 21.6 30.4 21.6 11.9 66.8 118.9 155.9 TPPP2 "C14orf8, CT152, p18, p25beta" ENSG00000179636 "Tubulin polymerization promoting protein family member 2" P59282 14 21024109-21036276 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 254.8" "Cell type enriched" "Detected in some" 4 "Late spermatids: 9161.6" "Cancer enhanced" "Detected in single" "liver cancer: 0.5" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA004120 Enhanced NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 25: Spermatids - Spermatogenesis" "HPA004120: AB_2303582" "unprognostic (2.91e-2)" "unprognostic (2.49e-3)" "unprognostic (2.54e-1)" "unprognostic (1.66e-2)" "unprognostic (2.14e-2)" "unprognostic (2.57e-3)" "unprognostic (4.63e-4)" "unprognostic (3.83e-1)" "unprognostic (3.16e-1)" "unprognostic (1.09e-1)" "unprognostic (4.64e-4)" "unprognostic (2.51e-4)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (3.21e-1)" 0.1 0.4 0.8 0.1 0.9 0.0 0.5 0.8 1.1 0.2 1.3 0.1 0.1 0.2 3.4 0.0 0.2 0.3 0.6 0.8 0.8 0.9 13.3 0.1 0.0 0.9 0.8 0.8 0.2 0.2 0.1 0.0 0.9 0.4 0.3 0.3 1.4 0.2 3.2 0.1 0.3 0.0 0.9 0.1 0.1 254.8 0.9 0.0 0.1 4.7 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.8 1.1 0.8 0.8 0.9 0.8 0.9 0.9 0.9 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 1.9 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.1 1897.4 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 5.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 9161.6 47.5 2.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 35.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 52.0 30.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 RNASE13 RAL1 ENSG00000206150 "Ribonuclease A family member 13 (inactive)" Q5GAN3 14 21032818-21034807 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 102 "epididymis: 306.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 43: Cardiomyocytes - Nuclear processes" "unprognostic (2.54e-1)" "unprognostic (2.52e-1)" "unprognostic (2.86e-1)" "unprognostic (8.40e-2)" "unprognostic (1.93e-1)" "unprognostic (7.15e-2)" "unprognostic (1.63e-3)" "unprognostic (5.20e-4)" "unprognostic (1.47e-2)" 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 306.9 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.0 0.1 0.3 0.3 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNASE7 RAE1 ENSG00000165799 "Ribonuclease A family member 7" Q9H1E1 14 21042316-21044234 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 74.9;lymphoid tissue: 24.1;skin 1: 27.9" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 30.2;Cholangiocytes: 8.6;Prostatic glandular cells: 7.3;Urothelial cells: 27.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 17.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 24.7;hTCEpi: 10.3;hTERT-HME1: 53.3" "HPA005690, CAB062560, CAB068225" Enhanced "Secreted in other tissues" NA NA 280000 "Cluster 84: Esophagus - Epithelial cell function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" "CAB062560: AB_2665595, CAB068225: AB_2665594, HPA005690: AB_1079819" "unprognostic (1.13e-2)" "unprognostic (3.21e-1)" "unprognostic (5.84e-2)" "unprognostic (2.53e-1)" "unprognostic (1.71e-1)" "unprognostic (8.27e-2)" "unprognostic (7.80e-2)" "unprognostic (8.73e-2)" "unprognostic (3.28e-1)" "unprognostic (1.15e-1)" "unprognostic (2.25e-2)" "unprognostic (1.94e-1)" "unprognostic (2.17e-2)" "unprognostic (1.74e-1)" "unprognostic (8.23e-2)" "unprognostic (3.24e-1)" "unprognostic (3.42e-1)" 0.1 0.1 0.0 0.0 0.0 0.0 3.0 0.0 0.0 2.5 0.0 0.2 0.0 0.0 0.0 74.9 0.0 6.6 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.3 0.5 0.0 4.7 0.5 0.3 27.9 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.0 0.0 0.0 24.1 0.2 9.3 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 24.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.1 53.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 30.2 1.5 0.0 0.0 0.1 2.4 0.5 8.6 0.4 0.0 0.0 1.5 0.0 0.1 0.0 4.5 0.9 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.0 0.0 0.3 5.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 7.3 0.0 0.0 2.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 5.3 0.3 0.0 0.2 27.2 RNASE8 RAE2 ENSG00000173431 "Ribonuclease A family member 8" Q8TDE3 14 21057822-21058455 "Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 229 "salivary gland: 54.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to digestive system" NA NA "Cluster 24: Salivary gland - Salivary secretion" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 54.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARHGEF40 "FLJ10357, solo" ENSG00000165801 "Rho guanine nucleotide exchange factor 40" Q8TER5 14 21070273-21090248 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 6.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 6.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030745, HPA030746, HPA030757" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Plasma membrane, Cytosol" "HPA030745: , HPA030746: AB_10599613, HPA030757: AB_10600203" "unprognostic (6.30e-2)" "unprognostic (1.94e-1)" "unprognostic (2.36e-1)" "unprognostic (5.91e-2)" "unprognostic (2.55e-1)" "unprognostic (8.16e-3)" "unprognostic (1.27e-2)" "unprognostic (9.84e-3)" "unprognostic (1.33e-1)" "unprognostic (8.80e-2)" "unprognostic (1.64e-2)" "unprognostic (2.53e-1)" "unprognostic (6.01e-3)" "unprognostic (1.14e-2)" "unprognostic (1.38e-2)" "unprognostic (2.33e-1)" "unprognostic (8.95e-2)" 21.0 47.2 9.6 5.3 11.1 1.6 18.5 10.0 9.2 24.8 6.2 14.5 3.7 18.9 12.2 3.5 13.2 14.8 12.3 8.9 11.1 10.1 26.9 14.2 2.3 13.5 10.5 19.3 24.0 10.7 9.0 6.5 10.5 12.3 6.2 2.8 20.2 18.6 10.5 7.4 7.9 9.7 10.1 27.8 9.5 4.3 12.1 3.1 15.8 6.1 1.7 13.8 13.3 12.1 3.3 2.9 30.8 5.8 24.5 37.1 1.1 11.4 28.1 12.1 9.4 1.4 7.5 0.0 1.8 20.9 12.2 5.0 2.6 3.7 4.3 6.6 1.1 4.6 3.4 9.0 3.5 3.0 16.5 15.5 2.4 10.3 3.1 22.6 0.0 0.0 1.4 1.3 9.6 0.3 0.0 8.6 8.1 0.8 0.5 1.0 23.2 1.4 7.6 4.1 0.7 11.6 6.4 0.6 8.9 6.0 2.7 10.1 5.9 25.4 17.5 11.9 5.9 2.6 0.0 0.0 8.8 4.2 7.5 0.0 1.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 6.2 0.1 0.0 0.1 0.0 0.4 9.6 11.1 10.0 9.2 8.9 11.1 13.5 10.5 10.5 10.1 12.1 12.1 12.7 6.4 5.0 32.0 2.5 4.8 8.0 5.8 1.8 9.2 6.6 11.3 13.4 47.1 3.2 14.7 0.0 1.4 0.5 10.0 19.6 21.2 1.0 17.6 13.1 11.0 7.8 1.7 0.3 10.2 0.9 20.4 18.3 3.5 38.0 11.6 8.2 31.5 14.1 5.0 6.2 9.1 4.1 46.9 14.6 2.3 24.2 22.0 23.2 17.8 23.6 24.6 1.0 21.1 8.9 16.4 6.6 24.0 3.1 6.3 1.0 7.1 1.7 6.8 26.3 18.6 21.9 3.1 2.8 0.6 4.4 1.2 3.5 14.6 18.7 6.1 ZNF219 ENSG00000165804 "Zinc finger protein 219" Q9P2Y4 14 21090077-21104722 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030761, HPA056168" Approved Supported Nucleoplasm NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA030761: AB_2673598, HPA056168: AB_2683052" "unprognostic (9.82e-3)" "unprognostic (4.50e-3)" "unprognostic (3.35e-1)" "unprognostic (1.11e-3)" "unprognostic (4.49e-2)" "unprognostic (1.96e-1)" "unprognostic (2.54e-1)" "unprognostic (6.79e-2)" "unprognostic (2.62e-2)" "unprognostic (1.70e-1)" "unprognostic (6.02e-2)" "unprognostic (1.30e-1)" "unprognostic (1.80e-3)" "unprognostic (6.28e-2)" "unprognostic (1.92e-1)" "unprognostic (2.56e-2)" "unprognostic (2.35e-2)" 44.2 77.1 15.2 7.4 10.7 4.5 35.5 32.0 17.9 33.9 14.3 83.3 22.4 41.6 9.4 49.2 29.6 5.4 42.0 22.0 14.8 20.6 17.1 32.8 2.5 20.7 25.7 30.7 24.7 12.4 23.5 6.5 20.3 38.3 10.3 11.0 28.2 21.7 34.0 45.6 33.1 9.3 13.6 13.1 33.3 11.9 17.8 10.9 32.3 5.9 3.6 44.7 36.1 9.1 8.1 26.6 33.6 49.5 4.5 4.3 48.1 9.8 15.0 4.9 7.7 15.5 17.7 12.0 7.2 3.7 5.4 59.1 10.8 31.4 3.4 24.6 11.5 7.1 42.2 32.7 2.8 1.5 10.9 6.6 25.9 8.0 14.7 6.5 6.0 11.0 6.9 3.5 2.7 22.4 16.2 11.3 47.5 15.3 5.7 33.7 5.6 3.1 3.8 44.0 38.2 34.4 13.5 7.9 7.8 6.7 9.5 4.2 1.2 6.0 26.4 14.7 4.0 6.1 4.2 2.7 3.8 6.0 11.8 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.6 0.1 0.0 0.4 0.0 0.0 15.2 10.7 32.0 17.9 22.0 14.8 20.7 25.7 20.3 13.6 17.8 9.1 5.6 3.2 10.7 12.7 1.8 14.8 13.3 13.5 11.4 36.6 14.4 19.6 7.6 10.0 4.3 3.7 27.1 9.6 3.4 33.0 1.9 10.3 9.2 2.5 1.9 6.3 7.8 8.2 3.5 11.3 1.0 6.0 5.1 4.6 14.7 35.1 9.3 8.0 7.4 11.8 4.9 17.4 10.2 7.5 11.8 5.6 9.9 5.9 8.8 7.5 0.8 33.0 1.0 13.6 2.5 7.8 10.0 12.4 3.9 12.0 23.6 6.8 4.3 27.4 13.1 9.3 14.7 8.9 8.7 13.5 15.6 12.4 5.2 6.3 26.6 12.7 TMEM253 "C14orf176, C14orf95, NCRNA00220" ENSG00000232070 "Transmembrane protein 253" P0C7T8 14 21098811-21103724 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in many" 14 "intestine: 97.3" "Cell type enriched" "Detected in some" 4 "Proximal enterocytes: 201.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA052329, HPA065092" Enhanced NA NA "Cluster 56: Intestine - Transmembrane transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 45: Enterocytes - Digestion" "HPA052329: AB_2681791, HPA065092: AB_2685420" "unprognostic (7.48e-3)" "unprognostic (1.33e-2)" "unprognostic (7.19e-2)" "unprognostic (3.84e-2)" "unprognostic (1.41e-2)" "unprognostic (1.50e-2)" "unprognostic (2.07e-1)" "unprognostic (2.90e-2)" "unprognostic (2.04e-1)" "unprognostic (1.40e-1)" "unprognostic (1.28e-2)" "unprognostic (5.46e-2)" "unprognostic (9.93e-2)" "unprognostic (3.59e-1)" "unprognostic (1.80e-1)" "unprognostic (2.20e-2)" "unprognostic (1.04e-1)" 0.7 2.4 0.7 0.8 0.8 0.1 0.6 0.9 1.6 0.7 0.8 15.0 97.3 0.4 1.6 1.5 0.5 0.9 0.4 0.8 0.8 1.0 1.1 0.5 0.1 0.8 0.9 0.5 1.3 0.4 0.6 0.4 0.8 0.7 12.8 0.2 6.9 1.3 0.1 1.3 88.8 0.8 0.8 0.5 0.7 0.4 0.8 0.4 5.7 0.0 0.3 0.5 1.0 0.8 0.1 0.4 0.7 0.9 0.7 0.0 1.7 0.4 0.7 0.1 0.4 0.9 0.5 1.5 0.2 0.0 0.0 1.7 0.3 1.4 0.0 0.9 0.1 0.7 1.4 1.0 0.0 0.0 0.0 0.2 1.0 0.2 0.9 0.6 0.1 0.5 0.5 0.0 0.3 0.0 0.0 0.1 0.6 1.6 0.0 0.3 0.2 0.8 0.7 0.6 0.3 0.6 0.5 0.3 0.8 0.5 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.9 1.6 0.8 0.8 0.8 0.9 0.8 0.8 0.8 0.8 0.0 0.0 0.0 2.0 0.5 0.8 1.0 1.3 2.2 0.9 0.7 1.3 0.2 1.5 0.3 0.0 0.0 1.1 0.1 45.3 0.0 0.3 0.1 0.0 0.2 0.4 3.6 0.0 0.1 0.0 0.2 0.2 2.0 0.2 0.0 0.6 0.0 0.2 0.2 0.0 0.2 11.2 0.0 0.3 0.3 0.0 0.0 0.2 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.1 8.8 0.0 0.1 0.2 201.8 0.7 0.1 0.5 0.0 0.4 0.4 0.0 0.3 1.6 0.6 1.0 0.1 0.2 23.4 0.8 OR5AU1 ENSG00000169327 "Olfactory receptor family 5 subfamily AU member 1" Q8NGC0 14 21148370-21159060 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 1.5;Glandular and luminal cells: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 44: Endometrium - Transcription" 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.4 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 HNRNPC HNRPC ENSG00000092199 "Heterogeneous nuclear ribonucleoprotein C" P07910 14 21209136-21269494 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005223, HPA051075, CAB075755, CAB075756" Supported Enhanced Nucleoplasm NA NA 1200000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "CAB005223: AB_2117508, CAB075755: AB_2665761, CAB075756: AB_2665762, HPA051075: AB_2681335" "unprognostic (1.92e-3)" "unprognostic (1.02e-2)" "unprognostic (1.43e-1)" "unprognostic (2.44e-1)" "unprognostic (1.42e-2)" "unprognostic (5.21e-3)" "prognostic unfavorable (7.72e-5)" "unprognostic (8.66e-3)" "unprognostic (5.96e-3)" "prognostic favorable (1.19e-4)" "unprognostic (3.31e-3)" "unprognostic (5.30e-3)" "prognostic unfavorable (7.29e-5)" "unprognostic (7.36e-2)" "unprognostic (3.73e-3)" "unprognostic (2.28e-3)" "unprognostic (5.42e-2)" 286.9 309.2 274.1 319.5 290.1 540.3 328.5 283.9 332.6 307.8 248.8 266.7 232.3 318.9 311.9 318.3 328.5 246.4 269.5 275.3 289.2 372.9 334.4 251.8 497.7 287.2 275.4 427.3 237.7 257.8 237.7 342.0 299.0 249.6 290.9 407.3 225.9 247.9 288.2 260.1 255.2 265.9 295.2 306.5 232.3 193.7 276.6 557.8 259.2 244.0 496.0 374.6 278.6 327.1 1076.2 832.7 1277.7 748.5 754.8 704.7 910.2 673.2 764.3 1034.3 900.6 799.4 787.6 1935.6 414.1 772.1 656.8 775.6 1611.4 1035.4 1389.0 1236.1 918.1 992.8 614.2 1241.4 920.6 1495.2 762.6 731.8 854.2 756.5 1781.1 897.8 1078.4 957.7 1483.6 787.1 829.5 1020.0 1713.7 1435.2 1351.4 990.3 770.1 1375.0 1073.9 925.3 1159.7 956.9 699.0 665.5 838.5 760.9 786.4 1057.3 725.2 1332.6 783.1 388.9 698.2 473.8 972.8 708.8 1144.4 1873.6 370.6 1215.3 794.1 480.2 515.1 516.9 419.0 450.9 544.5 531.4 494.0 451.2 716.3 467.0 552.1 478.2 810.8 471.0 439.4 460.5 575.7 1220.5 274.1 290.1 283.9 332.6 275.3 289.2 287.2 275.4 299.0 295.2 276.6 327.1 172.7 153.8 233.9 69.5 307.2 536.2 583.9 512.2 331.8 169.8 259.9 191.5 137.9 173.0 393.2 275.8 198.1 612.6 309.4 134.0 283.7 315.0 169.0 365.1 352.2 257.5 224.0 389.9 74.3 216.6 746.8 287.1 197.2 555.6 415.9 281.3 174.2 233.9 388.5 116.1 79.2 276.0 260.4 293.8 500.1 76.5 270.0 325.7 208.1 99.3 341.9 157.9 227.6 97.5 112.2 210.7 151.1 230.9 293.6 531.5 135.0 370.8 381.9 296.1 151.2 285.1 282.6 391.5 249.0 315.5 539.9 874.9 339.1 311.8 318.0 590.3 RPGRIP1 "CORD13, LCA6, RGI1, RPGRIP" ENSG00000092200 "RPGR interacting protein 1" Q96KN7 14 21280083-21351301 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Ciliopathy, Cone-rod dystrophy, Disease variant, Glaucoma, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 80 "retina: 185.3;testis: 59.6" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 231.4;Early spermatids: 177.3;Late spermatids: 108.9;Rod photoreceptor cells: 117.5;Spermatocytes: 51.7" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.0" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "neutrophil: 8.8" "Group enriched" "Detected in many" 18 "dendritic cells: 3.3;granulocytes: 8.8;monocytes: 3.7" "Cell line enhanced" "Detected in some" "RT4: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA042955, HPA060190" Supported Supported NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 77: Retina - Visual perception" "Cluster 15: RT4 - Unknown function" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA042955: AB_2678239, HPA060190: AB_2684218" "unprognostic (9.02e-4)" "unprognostic (3.64e-2)" "unprognostic (1.89e-1)" "unprognostic (1.86e-1)" "unprognostic (7.35e-2)" "unprognostic (1.82e-2)" "unprognostic (2.99e-2)" "unprognostic (1.14e-1)" "unprognostic (2.92e-1)" "unprognostic (1.99e-1)" "unprognostic (3.94e-3)" "unprognostic (2.33e-1)" "unprognostic (7.31e-3)" "unprognostic (2.86e-2)" "unprognostic (2.87e-1)" "unprognostic (3.13e-1)" "unprognostic (1.83e-2)" 0.2 0.1 0.5 0.7 0.3 1.2 0.6 0.8 0.6 0.3 0.4 0.5 0.9 0.2 0.0 0.2 0.1 0.3 0.2 0.4 0.3 0.2 0.8 0.5 0.5 0.4 0.2 0.1 0.1 0.2 0.1 1.2 0.6 0.4 0.6 185.3 0.1 0.1 0.1 0.5 0.8 0.0 0.1 1.5 0.2 59.6 0.5 0.1 0.3 0.2 0.3 0.5 0.1 0.3 0.3 0.8 0.8 0.4 0.0 0.0 1.1 0.3 0.0 0.0 0.4 0.5 0.5 1.1 0.2 0.0 0.4 0.2 0.3 0.0 0.0 0.2 0.5 0.4 0.8 0.2 0.0 0.9 0.3 0.4 0.0 0.0 0.0 0.4 0.0 0.8 0.7 0.1 0.0 0.3 0.3 0.5 1.2 0.5 0.3 0.4 0.7 0.9 0.0 3.8 0.6 0.5 0.7 0.8 0.2 0.6 0.3 0.5 0.3 0.2 0.2 0.8 0.6 0.9 0.9 1.0 0.4 0.6 0.2 0.7 3.7 0.0 0.0 1.7 0.1 0.0 0.0 0.0 3.3 0.1 0.1 0.0 8.8 0.3 0.0 0.0 0.0 1.0 0.5 0.3 0.8 0.6 0.4 0.3 0.4 0.2 0.6 0.1 0.5 0.3 0.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.2 0.3 1.0 0.0 0.0 0.0 231.4 0.9 0.0 0.0 0.0 0.0 177.3 0.1 0.1 0.6 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.9 0.0 1.2 0.0 0.0 2.7 0.9 108.9 1.8 0.8 0.0 1.0 0.5 4.8 0.0 0.0 0.9 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.7 117.5 0.0 0.1 0.1 51.7 2.2 0.0 0.1 1.5 0.1 0.1 0.0 0.1 SUPT16H "CDC68, FACT, FACTP140, FLJ10857, FLJ14010, SPT16/CDC68" ENSG00000092201 "SPT16 homolog, facilitates chromatin remodeling subunit" Q9Y5B9 14 21351476-21384019 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022551, HPA049787" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA 27000 "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Nucleoli fibrillar center" "CAB022551: , HPA049787: AB_2680881" "unprognostic (1.65e-1)" "unprognostic (2.22e-1)" "unprognostic (3.52e-2)" "unprognostic (7.12e-2)" "unprognostic (7.32e-2)" "unprognostic (1.22e-2)" "unprognostic (1.38e-3)" "unprognostic (1.86e-1)" "unprognostic (7.65e-2)" "unprognostic (4.91e-2)" "unprognostic (1.09e-1)" "unprognostic (1.26e-1)" "unprognostic (6.48e-3)" "unprognostic (1.02e-1)" "unprognostic (7.58e-3)" "unprognostic (9.05e-2)" "unprognostic (5.87e-3)" 29.3 24.8 9.7 36.6 11.1 42.3 35.9 18.8 13.9 34.2 8.2 30.6 23.1 41.1 19.5 29.0 32.0 24.1 24.1 9.7 15.6 28.6 22.4 26.3 51.2 11.3 12.0 43.6 22.6 46.2 13.5 32.1 12.0 29.9 35.1 44.4 20.9 32.6 21.8 28.9 25.9 36.6 10.7 32.9 26.3 43.3 12.1 56.8 33.3 24.6 51.8 35.6 20.1 12.3 147.8 136.9 185.5 136.6 85.5 81.7 131.4 130.3 103.2 155.5 145.4 133.9 129.5 311.3 48.5 96.5 99.7 153.9 237.2 118.9 234.0 99.8 100.9 188.7 121.9 195.1 87.0 270.1 134.7 73.4 72.6 131.0 146.3 75.4 107.7 174.2 158.1 129.4 131.3 99.9 253.6 85.8 207.1 136.2 134.1 270.3 210.6 168.0 63.9 160.8 183.8 157.2 209.8 125.3 81.1 118.7 69.2 127.9 91.1 135.0 113.4 85.0 143.3 128.8 230.2 306.7 49.9 158.0 104.9 35.6 18.3 28.2 29.6 23.9 34.7 31.2 27.9 33.2 23.7 27.4 31.3 32.2 15.0 34.0 31.1 22.2 28.4 25.2 9.7 11.1 18.8 13.9 9.7 15.6 11.3 12.0 12.0 10.7 12.1 12.3 41.5 64.1 55.9 24.2 51.6 35.6 44.3 51.5 45.5 48.9 46.3 49.7 64.2 22.8 50.3 53.3 47.9 65.1 73.6 28.4 25.4 71.0 142.5 52.0 124.3 46.9 23.4 74.6 27.4 61.1 63.9 61.1 29.6 61.7 84.2 73.4 29.3 32.0 41.9 55.5 30.1 31.2 40.7 34.9 25.2 96.1 59.7 40.7 17.8 20.6 90.9 53.3 64.9 16.1 25.2 68.9 15.2 59.8 39.5 46.1 16.5 30.4 40.2 41.1 19.7 78.5 69.5 128.9 152.8 45.1 41.5 45.6 56.3 61.6 43.0 35.7 CHD8 "DUPLIN, HELSNF1, KIAA1564" ENSG00000100888 "Chromodomain helicase DNA binding protein 8" Q9HCK8 14 21385194-21456126 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Repressor" "Autism, Autism spectrum disorder, Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052186, HPA076133" Enhanced Nucleoplasm NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA052186: AB_2681754, HPA076133: " "unprognostic (3.45e-1)" "unprognostic (9.71e-2)" "unprognostic (3.31e-1)" "unprognostic (2.67e-1)" "unprognostic (1.14e-1)" "unprognostic (3.43e-1)" "prognostic unfavorable (4.94e-4)" "unprognostic (7.31e-2)" "unprognostic (9.22e-2)" "prognostic favorable (8.35e-4)" "unprognostic (1.64e-1)" "unprognostic (2.63e-2)" "unprognostic (2.54e-3)" "unprognostic (2.88e-1)" "unprognostic (9.24e-2)" "unprognostic (2.51e-1)" "unprognostic (8.07e-3)" 12.5 11.9 11.2 13.5 12.5 35.3 14.8 16.3 13.2 12.4 10.5 14.0 9.4 14.8 11.1 14.9 12.9 10.1 12.0 11.1 12.2 11.7 9.6 13.7 18.0 11.4 11.6 17.1 13.6 22.3 13.1 11.7 11.1 13.2 12.3 14.8 13.6 12.1 15.7 22.3 14.7 14.8 11.5 15.8 14.2 12.9 12.5 25.4 14.8 12.7 17.5 12.8 12.9 13.6 31.2 39.6 43.6 20.7 27.7 23.6 24.9 24.4 28.4 36.5 35.4 35.0 26.3 51.4 14.8 33.1 28.4 37.2 54.9 35.1 46.0 39.3 24.2 46.3 27.6 43.5 25.7 64.6 40.4 32.8 27.2 40.9 29.7 28.6 33.4 40.2 32.4 26.7 28.0 33.9 46.1 26.0 33.4 30.9 34.3 42.0 32.9 17.4 27.3 57.9 30.9 30.7 37.5 29.8 21.8 39.7 20.7 30.5 36.4 29.2 23.0 17.8 29.1 30.3 38.4 50.3 12.1 23.2 29.6 9.1 3.8 9.8 5.5 3.8 6.4 4.2 4.9 5.6 2.7 11.2 5.0 4.4 7.9 7.8 6.7 6.1 4.7 2.7 11.2 12.5 16.3 13.2 11.1 12.2 11.4 11.6 11.1 11.5 12.5 13.6 27.6 38.5 56.3 27.4 32.2 12.6 11.3 15.9 23.3 33.3 21.9 22.6 19.6 24.3 32.6 33.1 27.1 14.7 40.0 16.8 1.9 21.8 3.4 32.5 37.9 25.5 27.1 27.8 41.0 23.6 12.3 24.0 27.5 39.5 28.4 41.7 13.9 14.9 17.5 23.5 40.2 16.0 8.2 20.1 9.3 4.1 16.1 25.3 10.6 20.6 27.1 18.9 32.0 29.7 33.1 26.5 13.9 17.7 32.4 16.1 12.0 7.4 28.8 24.3 0.0 32.1 26.2 29.2 25.1 24.6 16.6 12.3 31.4 34.1 16.8 12.7 RAB2B FLJ14824 ENSG00000129472 "RAB2B, member RAS oncogene family" Q8WUD1 14 21459020-21476960 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050292 Uncertain NA NA "Cluster 44: Non-specific - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 24: Non-specific - Transcription regulation" "HPA050292: AB_2681076" "unprognostic (7.56e-2)" "unprognostic (4.61e-2)" "unprognostic (2.98e-2)" "unprognostic (3.05e-3)" "unprognostic (1.75e-2)" "unprognostic (6.69e-2)" "unprognostic (8.86e-2)" "unprognostic (1.38e-2)" "unprognostic (1.64e-1)" "unprognostic (2.50e-2)" "unprognostic (1.13e-1)" "unprognostic (1.66e-1)" "unprognostic (5.22e-3)" "unprognostic (1.49e-1)" "unprognostic (3.47e-1)" "unprognostic (3.21e-1)" "unprognostic (1.63e-1)" 11.7 11.6 15.8 7.5 17.2 18.8 12.1 17.9 20.0 11.9 14.5 12.4 7.8 10.7 14.8 8.8 11.3 8.4 10.4 15.7 19.1 10.4 13.0 11.0 9.4 18.4 18.8 13.8 11.5 10.5 14.2 9.7 19.4 13.7 8.3 17.9 10.0 9.9 6.9 11.6 11.2 10.4 16.7 12.3 10.1 10.2 18.6 10.6 14.5 8.2 10.2 10.7 10.5 20.4 6.1 9.5 20.2 14.2 15.1 16.5 10.8 12.5 15.2 12.1 16.5 5.1 11.7 8.8 9.1 13.4 13.5 8.4 12.9 7.8 17.0 22.2 6.3 10.4 6.3 17.0 18.7 14.8 18.8 17.0 11.7 14.9 12.8 17.5 17.8 15.6 6.7 12.4 18.3 4.6 11.3 11.3 11.0 8.9 11.4 14.2 19.8 5.1 12.8 6.9 14.6 17.6 17.9 6.7 14.2 18.9 5.5 6.0 19.9 12.0 10.8 9.4 7.4 15.6 17.4 12.6 5.3 5.1 16.7 12.1 2.9 7.8 6.0 3.8 6.8 5.4 6.5 6.5 3.6 4.8 5.0 6.7 3.2 6.1 5.4 10.6 7.1 3.5 15.8 17.2 17.9 20.0 15.7 19.1 18.4 18.8 19.4 16.7 18.6 20.4 16.5 9.6 15.0 12.1 15.7 19.8 14.4 11.2 22.2 11.8 16.9 11.4 8.3 7.2 8.3 12.9 25.0 10.0 22.5 11.6 1.9 6.6 32.1 10.6 11.1 14.6 21.4 17.0 13.1 5.1 8.8 12.5 10.7 13.6 19.0 13.5 15.4 24.1 11.4 20.2 13.0 8.5 12.2 22.7 16.6 54.5 10.2 12.5 26.6 12.2 13.1 8.2 12.3 16.1 19.6 6.4 5.7 10.9 27.1 14.8 9.9 9.9 9.2 15.0 0.0 13.3 12.0 16.7 14.9 14.9 18.2 15.7 17.6 9.4 7.3 12.6 TOX4 "C14orf92, KIAA0737, LCP1" ENSG00000092203 "TOX high mobility group box family member 4" O94842 14 21476597-21499175 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 265.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017880, HPA027551" Approved Approved Nucleoplasm,Nucleoli,Vesicles NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm "Nucleoli, Vesicles" "HPA017880: AB_1845573, HPA027551: AB_10601701" "unprognostic (9.56e-2)" "unprognostic (2.54e-2)" "unprognostic (2.81e-1)" "unprognostic (7.46e-2)" "unprognostic (9.30e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (3.46e-4)" "unprognostic (8.05e-3)" "unprognostic (2.58e-1)" "unprognostic (5.00e-2)" "unprognostic (3.23e-2)" "unprognostic (2.94e-1)" "prognostic favorable (8.38e-5)" "unprognostic (1.84e-1)" "unprognostic (2.48e-1)" "unprognostic (9.03e-2)" "unprognostic (2.48e-3)" 16.7 14.6 17.3 14.1 17.6 21.4 16.3 17.9 20.1 18.0 14.8 18.5 12.6 15.4 15.1 21.1 14.7 12.2 21.9 17.5 17.7 15.0 15.7 15.9 15.1 17.1 18.7 15.9 15.8 20.4 13.6 15.5 17.5 14.7 15.2 16.1 14.8 17.4 55.5 21.5 14.8 19.7 16.8 13.7 16.9 14.3 18.3 26.1 17.1 25.8 21.3 17.4 16.0 19.5 27.1 27.4 22.7 21.5 32.1 30.6 30.3 25.3 49.6 52.7 50.3 27.0 31.6 16.2 17.5 41.5 42.0 31.5 37.4 38.8 66.8 28.6 15.1 18.1 17.7 37.8 41.5 33.6 28.7 40.0 39.8 41.7 39.4 35.9 38.0 30.1 22.6 27.4 37.9 22.8 33.4 19.3 12.8 39.5 43.2 29.7 23.7 18.6 24.5 33.4 20.9 21.5 25.0 26.3 21.3 29.8 24.8 12.6 25.0 27.2 24.9 24.1 22.5 35.1 41.7 36.9 12.8 16.4 28.7 40.9 27.4 40.0 23.1 29.2 25.0 24.0 20.5 22.2 26.0 24.9 21.3 24.4 48.6 29.2 27.5 33.7 31.7 28.9 17.3 17.6 17.9 20.1 17.5 17.7 17.1 18.7 17.5 16.8 18.3 19.5 60.0 67.3 64.0 0.0 43.3 87.3 63.9 81.3 58.1 75.0 50.4 42.0 51.8 42.9 64.4 46.0 29.2 73.5 69.3 51.0 62.6 47.3 76.1 42.6 46.9 53.4 68.9 48.8 0.0 51.4 64.1 48.4 40.8 50.4 61.4 41.4 37.9 43.1 43.8 42.1 0.0 45.4 52.9 41.3 61.6 36.5 48.7 46.1 39.2 0.0 55.3 40.4 46.4 0.0 0.0 51.4 51.9 44.0 44.4 59.0 91.4 64.0 57.4 54.5 32.9 54.1 58.6 131.9 66.8 50.5 88.8 265.8 62.0 55.5 43.8 70.0 METTL3 "M6A, MT-A70, Spo8" ENSG00000165819 "Methyltransferase like 3" Q86U44 14 21498133-21511342 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Differentiation, DNA damage, Immunity, Innate immunity, Oogenesis, Spermatogenesis" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Early spermatids: 188.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 23: Testis - Cell cycle regulation" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (1.62e-1)" "unprognostic (1.65e-1)" "unprognostic (5.75e-2)" "unprognostic (1.70e-1)" "unprognostic (1.22e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.19e-5)" "unprognostic (1.02e-3)" "unprognostic (1.85e-1)" "prognostic favorable (2.78e-4)" "prognostic favorable (2.72e-4)" "unprognostic (4.52e-2)" "unprognostic (4.64e-3)" "unprognostic (2.98e-2)" "unprognostic (7.14e-2)" "unprognostic (5.36e-2)" "unprognostic (1.22e-1)" 12.1 18.5 12.1 11.3 13.0 5.8 16.0 12.6 13.1 12.9 12.5 11.9 7.6 13.2 18.1 11.7 18.8 9.8 16.7 12.5 12.9 14.1 11.7 12.9 19.0 14.1 13.1 15.0 11.5 19.0 13.0 15.2 13.7 17.3 12.9 8.6 14.2 16.7 16.8 16.5 10.6 16.3 13.1 13.9 11.2 19.8 13.4 17.8 16.8 18.6 21.2 14.4 12.4 13.7 39.6 57.7 55.0 22.2 40.5 33.4 27.5 35.9 26.0 41.7 48.5 22.0 46.4 40.8 22.6 22.3 54.2 41.6 66.4 35.2 65.7 39.1 39.8 25.9 31.9 88.1 16.6 34.8 28.2 25.0 30.3 26.0 30.2 18.6 54.8 20.8 32.0 23.5 55.9 29.1 31.0 28.6 46.4 66.1 70.7 30.7 42.6 36.5 38.8 26.6 33.4 36.6 38.7 50.6 37.5 42.7 39.8 22.8 36.6 15.0 24.8 27.6 24.9 24.9 32.5 29.0 18.2 27.7 32.0 6.5 8.9 8.9 8.0 11.5 12.4 14.3 10.0 9.4 10.9 10.8 10.3 9.3 0.9 15.7 9.6 13.0 15.5 8.4 12.1 13.0 12.6 13.1 12.5 12.9 14.1 13.1 13.7 13.1 13.4 13.7 12.5 12.8 20.1 15.7 16.2 14.9 23.3 21.2 21.1 23.4 15.1 16.5 30.6 12.8 13.6 12.9 14.6 31.1 16.2 5.4 3.9 14.5 188.2 11.7 11.4 14.7 10.8 20.4 15.0 10.0 15.7 15.3 7.1 10.0 8.8 20.4 9.7 9.5 16.6 21.9 13.7 8.7 14.2 10.0 9.9 24.3 17.1 10.8 16.0 10.3 17.9 14.9 15.5 19.1 21.7 10.8 6.5 19.9 14.9 18.8 5.5 9.1 15.3 21.0 32.9 16.4 17.5 42.4 20.3 12.4 12.4 25.3 13.2 13.2 13.4 19.0 SALL2 "Hsal2, KIAA0360, ZNF795" ENSG00000165821 "Spalt like transcription factor 2" Q9Y467 14 21521080-21537216 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.1" "Cell type enhanced" "Detected in many" "Astrocytes: 13.4;Bipolar cells: 13.9;Horizontal cells: 13.5;Muller glia cells: 11.2;Oligodendrocyte precursor cells: 10.6" "Cancer enhanced" "Detected in many" "glioma: 16.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD8 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 109.2;NTERA-2: 85.7;SuSa: 36.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004162 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 32: T-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 12: NES - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" Vesicles Nucleoplasm "HPA004162: AB_2667155" "unprognostic (5.73e-2)" "unprognostic (7.88e-2)" "unprognostic (3.21e-2)" "prognostic unfavorable (3.97e-4)" "unprognostic (1.24e-1)" "unprognostic (1.03e-1)" "unprognostic (5.53e-2)" "unprognostic (4.58e-3)" "unprognostic (1.03e-1)" "unprognostic (1.15e-1)" "prognostic favorable (1.23e-4)" "unprognostic (7.98e-2)" "unprognostic (2.09e-1)" "unprognostic (5.28e-3)" "unprognostic (2.03e-1)" "unprognostic (3.75e-2)" "unprognostic (1.86e-1)" 3.9 5.4 40.2 1.4 37.7 0.2 5.5 43.2 31.0 13.1 16.6 13.3 1.7 13.5 6.3 2.9 12.7 3.2 5.4 29.4 43.7 6.2 0.9 4.5 1.7 41.3 45.2 17.2 4.3 20.6 27.0 1.2 36.9 7.0 2.1 16.9 3.1 9.2 1.5 2.6 6.7 9.5 39.2 2.8 6.0 1.6 49.1 6.5 10.5 2.8 1.7 8.7 6.3 28.7 0.1 2.4 109.2 24.2 1.9 1.6 0.0 2.1 2.7 7.1 7.2 2.3 1.2 0.1 2.2 3.2 3.1 0.2 24.5 2.7 10.0 2.0 12.5 0.0 0.7 2.2 3.2 0.0 0.1 7.3 0.9 3.4 0.0 18.4 2.2 10.9 16.6 0.0 6.2 2.1 16.0 0.1 85.7 0.1 0.5 14.3 2.3 0.0 8.3 11.6 30.4 17.3 0.0 0.6 0.3 36.2 9.2 0.2 0.0 0.9 11.5 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.5 1.1 0.0 0.1 0.0 0.5 0.5 0.1 40.2 37.7 43.2 31.0 29.4 43.7 41.3 45.2 36.9 39.2 49.1 28.7 0.8 3.2 3.6 13.4 0.0 0.6 0.6 1.1 8.0 13.9 3.4 2.8 0.9 2.8 1.5 5.5 8.4 0.1 0.2 0.0 1.9 1.8 0.3 0.5 3.2 1.0 0.0 0.4 2.5 0.0 0.1 3.9 0.0 0.4 0.0 7.2 2.5 0.1 0.1 13.5 9.3 0.0 4.1 0.0 0.3 0.7 5.0 0.2 0.0 0.0 0.0 11.2 0.0 10.6 2.6 0.3 0.0 6.0 0.2 0.4 0.0 0.8 0.0 2.8 0.0 3.9 3.0 0.0 0.5 1.0 0.6 0.1 0.8 3.9 0.0 0.1 OR10G3 ENSG00000169208 "Olfactory receptor family 10 subfamily G member 3" Q8NGC4 14 21568520-21580076 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Alveolar cells type 2: 11.7;Club cells: 2.5;granulocytes: 2.5;T-cells: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA019766 Uncertain NA NA "Cluster 11: Alveolar cells - Smell perception" "HPA019766: AB_1854780" 0.0 0.0 0.2 0.0 0.7 0.1 0.0 0.3 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.7 0.3 0.3 0.1 0.3 0.1 0.3 0.1 0.0 0.3 0.3 0.1 6.4 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 TRAV1-1 "TCRAV1S1, TCRAV7S1, TRAV11" ENSG00000255569 "T cell receptor alpha variable 1-1" A0A0B4J248 14 21621838-21622567 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "lymphoid tissue: 17.9" "Cell type enriched" "Detected in single" 10 "T-cells: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 18 "MAIT T-cell: 26.0;memory CD4 T-cell: 11.8;memory CD8 T-cell: 27.1;naive CD4 T-cell: 17.7;naive CD8 T-cell: 25.7;T-reg: 30.6" "Lineage enriched" "Detected in many" 23 "T-cells: 30.6" "Cell line enriched" "Detected in single" 160 "MOLT-4: 30.7" NA NA "Cluster 13: T-cells - Unknown function" "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.56e-1)" "unprognostic (6.87e-2)" "unprognostic (5.07e-1)" "unprognostic (6.72e-4)" "unprognostic (2.62e-3)" "unprognostic (6.08e-3)" "unprognostic (2.29e-1)" "unprognostic (6.56e-2)" "unprognostic (4.69e-2)" "unprognostic (2.96e-1)" "unprognostic (9.40e-5)" "unprognostic (3.51e-2)" "unprognostic (3.14e-1)" "unprognostic (1.40e-1)" 0.2 0.0 0.0 2.7 0.0 0.7 0.1 0.0 0.1 0.6 0.0 0.6 0.6 0.2 0.0 0.2 0.1 1.1 0.0 0.0 0.0 0.1 0.1 0.2 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.1 1.1 0.0 0.0 1.9 1.3 0.1 0.0 17.9 0.1 0.0 3.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 26.0 0.0 11.8 27.1 0.2 0.0 17.7 25.7 0.0 0.0 0.0 0.0 30.6 6.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 OR10G2 ENSG00000255582 "Olfactory receptor family 10 subfamily G member 2" Q8NGC3 14 21633836-21634940 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.80e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAV1-2 ENSG00000256553 "T cell receptor alpha variable 1-2" A0A0B4J238 14 21642889-21643578 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "lymphoid tissue: 19.3" "Cell type enriched" "Detected in single" 6 "T-cells: 4.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 7 "MAIT T-cell: 2027.8" "Lineage enriched" "Detected in many" 507 "T-cells: 2027.8" "Not detected" "Not detected" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.19e-3)" "unprognostic (1.29e-3)" "unprognostic (1.59e-2)" "unprognostic (1.84e-3)" "unprognostic (5.87e-3)" "unprognostic (1.55e-3)" "unprognostic (3.56e-2)" "unprognostic (8.90e-2)" "unprognostic (6.50e-4)" "unprognostic (3.16e-1)" "unprognostic (1.68e-1)" "unprognostic (1.13e-2)" "unprognostic (2.15e-1)" "unprognostic (1.43e-1)" "unprognostic (8.99e-2)" "unprognostic (8.30e-2)" 0.3 0.7 0.0 4.5 0.0 1.3 0.4 0.0 0.4 0.6 0.0 1.2 1.6 0.3 0.3 0.5 0.7 3.1 0.1 0.0 0.0 0.2 1.1 2.0 7.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.8 1.1 0.0 0.3 0.0 0.0 0.4 1.3 0.3 0.1 4.6 1.5 0.1 0.0 19.3 0.5 0.0 7.2 2.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.3 0.7 1.0 0.6 2027.8 0.4 44.9 311.2 0.8 0.2 40.9 70.0 3.9 0.3 1.3 1.7 79.5 40.4 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 OR4E2 ENSG00000221977 "Olfactory receptor family 4 subfamily E member 2" Q8NGC2 14 21653835-21667642 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4E1 OR4E1P ENSG00000276240 "Olfactory receptor family 4 subfamily E member 1" P0C645 14 21667940-21673818 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 67: Proximal tubular cells - Tubular reabsorption" 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAV2 ENSG00000211776 "T cell receptor alpha variable 2" A0A0B4J234 14 21712321-21712843 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 21 "lymphoid tissue: 56.3" "Cell type enriched" "Detected in single" 5 "T-cells: 2.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 40.9" "Lineage enriched" "Detected in single" 124 "T-cells: 40.9" "Cell line enriched" "Detected in single" 21 "Daudi: 2.1" NA NA "Cluster 13: T-cells - Unknown function" "Cluster 63: T-cells - Adaptive immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.38e-2)" "unprognostic (6.44e-3)" "unprognostic (7.50e-2)" "unprognostic (1.93e-2)" "unprognostic (1.86e-3)" "unprognostic (3.64e-2)" "unprognostic (4.45e-2)" "unprognostic (2.00e-2)" "unprognostic (1.06e-2)" "unprognostic (1.24e-1)" "unprognostic (5.84e-2)" "unprognostic (9.93e-5)" "unprognostic (1.92e-1)" "unprognostic (4.86e-2)" "unprognostic (1.15e-1)" "unprognostic (3.45e-2)" 0.4 0.2 0.0 8.2 0.0 2.5 0.3 0.0 0.5 0.3 0.0 2.0 0.8 0.0 0.0 0.9 0.3 0.9 0.3 0.0 0.0 0.2 0.3 1.6 19.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.8 0.0 0.2 0.0 0.0 0.1 1.7 0.0 0.0 3.3 2.7 0.2 0.0 56.3 0.2 0.0 13.2 2.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 31.3 0.0 31.5 9.9 0.0 0.0 24.5 9.6 0.1 0.0 0.0 0.3 40.9 5.7 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 TRAV3 ENSG00000211777 "T cell receptor alpha variable 3" A0A0B4J244 14 21723713-21724321 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 10.1" "Cell type enriched" "Detected in some" 4 "T-cells: 6.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "memory CD4 T-cell: 48.8;memory CD8 T-cell: 33.6;naive CD4 T-cell: 51.2;naive CD8 T-cell: 47.8;T-reg: 112.7" "Lineage enriched" "Detected in single" 144 "T-cells: 112.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 3: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (2.32e-3)" "unprognostic (4.61e-4)" "unprognostic (2.50e-1)" "unprognostic (6.25e-3)" "unprognostic (7.75e-2)" "unprognostic (8.35e-4)" "unprognostic (8.65e-3)" "unprognostic (4.31e-3)" "unprognostic (2.88e-3)" "unprognostic (4.24e-3)" "unprognostic (5.27e-2)" "unprognostic (3.35e-1)" "unprognostic (1.91e-4)" "unprognostic (1.67e-1)" "unprognostic (6.61e-2)" "unprognostic (9.32e-2)" "unprognostic (1.08e-1)" 0.2 0.2 0.0 2.9 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.5 0.1 0.2 0.6 0.5 0.0 0.0 0.1 0.2 0.8 7.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.8 0.0 0.2 0.0 0.0 0.3 1.3 0.0 0.0 2.0 1.0 0.3 0.4 10.1 0.1 0.1 5.7 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 14.3 0.0 48.8 33.6 0.1 0.1 51.2 47.8 0.7 0.1 0.0 0.0 112.7 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.5 0.0 0.0 0.0 6.7 0.0 0.0 0.0 TRAV4 "TCRAV20S1, TCRAV4S1" ENSG00000211778 "T cell receptor alpha variable 4" A0A0B4J268 14 21736152-21736982 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "lymphoid tissue: 37.9" "Cell type enriched" "Detected in some" 8 "T-cells: 8.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 70 "MAIT T-cell: 66.1;memory CD4 T-cell: 81.9;memory CD8 T-cell: 124.0;naive CD4 T-cell: 77.1;naive CD8 T-cell: 81.0;T-reg: 167.9" "Lineage enriched" "Detected in many" 118 "T-cells: 167.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 3: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.13e-2)" "unprognostic (4.08e-3)" "unprognostic (1.02e-1)" "unprognostic (2.39e-4)" "unprognostic (5.20e-3)" "unprognostic (1.18e-4)" "unprognostic (1.34e-2)" "unprognostic (5.48e-2)" "unprognostic (7.19e-3)" "unprognostic (2.48e-3)" "unprognostic (8.68e-2)" "unprognostic (2.82e-1)" "unprognostic (1.37e-4)" "unprognostic (1.65e-1)" "unprognostic (3.23e-1)" "unprognostic (2.89e-1)" "unprognostic (6.49e-2)" 0.4 0.3 0.0 7.7 0.0 1.3 1.1 0.0 0.4 1.1 0.0 1.8 1.7 0.3 0.0 1.1 0.6 2.8 0.5 0.1 0.0 0.2 0.6 2.4 17.4 0.3 0.4 0.2 0.5 0.1 0.0 0.1 0.2 1.2 2.1 0.0 0.8 0.1 0.0 0.4 3.3 0.4 0.1 5.4 2.4 0.3 0.2 37.9 0.3 0.0 14.2 2.8 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.1 0.6 0.1 66.1 0.1 81.9 124.0 0.1 0.1 77.1 81.0 1.4 0.4 0.5 0.4 167.9 25.2 0.0 0.0 0.0 0.4 0.1 0.0 0.3 0.4 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 TRAV5 ENSG00000211779 "T cell receptor alpha variable 5" A0A0B4J249 14 21749178-21749705 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 12.9" "Cell type enriched" "Detected in some" 5 "T-cells: 7.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 52 "MAIT T-cell: 24.7;memory CD4 T-cell: 49.5;memory CD8 T-cell: 77.3;naive CD4 T-cell: 39.9;naive CD8 T-cell: 74.0;T-reg: 81.4" "Lineage enriched" "Detected in many" 73 "T-cells: 81.4" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.04e-3)" "unprognostic (2.62e-3)" "unprognostic (1.33e-1)" "unprognostic (1.69e-2)" "unprognostic (6.26e-5)" "unprognostic (3.58e-1)" "unprognostic (8.15e-2)" "unprognostic (5.82e-2)" "unprognostic (1.22e-2)" "unprognostic (1.12e-1)" "unprognostic (3.11e-2)" "unprognostic (8.38e-6)" "unprognostic (2.28e-1)" "unprognostic (1.62e-1)" "unprognostic (1.78e-1)" "unprognostic (1.70e-2)" 0.1 0.4 0.0 3.6 0.0 0.5 0.7 0.0 0.2 0.3 0.5 1.0 0.5 0.7 0.0 0.3 0.1 2.7 0.2 0.1 0.0 0.2 0.8 1.1 12.9 0.3 0.2 0.3 0.6 0.0 0.0 0.0 0.1 2.1 1.6 0.0 2.6 0.3 0.0 0.0 2.7 0.8 0.0 4.6 1.8 0.1 0.1 11.5 0.8 0.8 7.6 0.7 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 1.0 0.5 24.7 0.2 49.5 77.3 0.1 0.1 39.9 74.0 1.1 0.0 0.2 0.3 81.4 17.9 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.2 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.7 0.0 0.0 0.0 TRAV6 TCRAV5S1 ENSG00000211780 "T cell receptor alpha variable 6" A0A075B6T7 14 21768489-21769080 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 11.2" "Group enriched" "Detected in some" 7 "Gastric mucus-secreting cells: 1.1;T-cells: 3.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Group enriched" "Detected in many" 70 "MAIT T-cell: 17.1;memory CD4 T-cell: 33.7;memory CD8 T-cell: 19.0;naive CD4 T-cell: 26.3;naive CD8 T-cell: 16.2;T-reg: 59.6" "Lineage enriched" "Detected in single" 146 "T-cells: 59.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 3: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.44e-2)" "unprognostic (1.53e-1)" "unprognostic (5.19e-2)" "unprognostic (1.78e-1)" "unprognostic (3.49e-4)" "unprognostic (3.25e-1)" "unprognostic (2.49e-2)" "unprognostic (2.79e-1)" "unprognostic (8.90e-3)" "unprognostic (2.05e-1)" "unprognostic (1.81e-1)" "unprognostic (2.87e-5)" "unprognostic (1.32e-1)" "unprognostic (2.95e-2)" "unprognostic (3.59e-1)" "unprognostic (1.24e-2)" 0.1 0.0 0.0 2.4 0.0 0.6 0.5 0.0 0.0 0.1 0.0 1.0 0.3 0.1 0.6 0.6 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.8 5.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.7 0.0 0.2 0.2 0.0 0.0 2.3 0.0 0.0 2.7 0.8 0.1 0.4 11.2 0.1 0.0 4.4 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 17.1 0.2 33.7 19.0 0.0 0.1 26.3 16.2 0.4 0.0 0.0 0.0 59.6 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 TRAV7 ENSG00000211781 "T cell receptor alpha variable 7" A0A075B6U4 14 21782993-21783503 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 4: T-regs - Cell cycle regulation" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAV8-1 ENSG00000211782 "T cell receptor alpha variable 8-1" A0A0A6YYK1 14 21797287-21797886 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 11.8" "Cell type enriched" "Detected in single" 9 "T-cells: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 43 "MAIT T-cell: 14.2;memory CD4 T-cell: 39.5;memory CD8 T-cell: 20.6;naive CD4 T-cell: 37.6;naive CD8 T-cell: 16.3;T-reg: 54.4" "Lineage enriched" "Detected in single" 77 "T-cells: 54.4" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (8.53e-3)" "unprognostic (1.98e-2)" "unprognostic (5.44e-2)" "unprognostic (1.34e-2)" "unprognostic (4.86e-4)" "unprognostic (2.84e-3)" "unprognostic (8.19e-3)" "unprognostic (1.90e-2)" "unprognostic (6.27e-3)" "unprognostic (1.08e-1)" "unprognostic (1.36e-1)" "unprognostic (6.54e-5)" "unprognostic (2.60e-1)" "unprognostic (2.31e-1)" "unprognostic (3.86e-1)" "unprognostic (5.72e-2)" 0.1 0.0 0.0 3.7 0.0 0.4 0.2 0.0 0.2 0.0 0.0 0.7 0.6 0.2 0.2 0.7 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.8 6.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.6 0.0 0.1 0.2 0.7 0.0 0.0 1.7 0.5 0.2 0.0 11.8 0.0 0.0 4.7 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.2 14.2 0.0 39.5 20.6 0.1 0.1 37.6 16.3 0.7 0.0 0.0 0.1 54.4 8.5 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 TRAV9-1 ENSG00000211783 "T cell receptor alpha variable 9-1" A0A075B6T8 14 21811502-21811977 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 16: MAIT-cells - Unknown function" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAV10 "TCRAV10S1, TCRAV24S1" ENSG00000211784 "T cell receptor alpha variable 10" A0A0B4J240 14 21825472-21826075 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 16 "lymphoid tissue: 16.2" "Cell type enriched" "Detected in single" 6 "T-cells: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 64 "MAIT T-cell: 24.7;memory CD4 T-cell: 38.3;memory CD8 T-cell: 43.3;naive CD4 T-cell: 42.5;naive CD8 T-cell: 25.0;T-reg: 59.4" "Lineage enriched" "Detected in single" 156 "T-cells: 59.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (2.58e-3)" "unprognostic (1.27e-3)" "unprognostic (1.74e-2)" "unprognostic (5.74e-4)" "unprognostic (3.80e-4)" "unprognostic (2.97e-3)" "unprognostic (1.91e-1)" "unprognostic (5.63e-2)" "unprognostic (7.70e-2)" "unprognostic (2.78e-1)" "unprognostic (4.67e-5)" "unprognostic (2.49e-1)" "unprognostic (1.91e-2)" "unprognostic (1.66e-1)" 0.2 0.2 0.0 3.5 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.6 0.1 0.2 0.0 0.3 0.1 0.9 0.0 0.0 0.0 0.1 0.2 0.9 5.8 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 1.8 0.7 0.0 0.0 16.2 0.1 0.0 5.3 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 24.7 0.1 38.3 43.3 0.0 0.1 42.5 25.0 0.3 0.0 0.2 0.3 59.4 14.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 TRAV12-1 ENSG00000211785 "T cell receptor alpha variable 12-1" A0A0B4J245 14 21841240-21841774 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 21.1" "Cell type enhanced" "Detected in some" "Gastric mucus-secreting cells: 4.1;Plasma cells: 1.4;T-cells: 6.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 72 "MAIT T-cell: 128.5;memory CD4 T-cell: 205.2;memory CD8 T-cell: 199.7;naive CD4 T-cell: 138.6;naive CD8 T-cell: 251.7;T-reg: 193.9" "Lineage enriched" "Detected in many" 97 "T-cells: 251.7" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (4.83e-3)" "unprognostic (9.56e-5)" "unprognostic (2.18e-2)" "unprognostic (3.33e-3)" "unprognostic (8.05e-2)" "unprognostic (2.99e-4)" "unprognostic (3.16e-4)" "unprognostic (3.23e-2)" "unprognostic (1.77e-3)" "unprognostic (1.15e-1)" "unprognostic (6.92e-2)" "unprognostic (3.97e-4)" "unprognostic (1.39e-1)" "unprognostic (7.99e-2)" "unprognostic (2.14e-1)" "unprognostic (2.92e-2)" 0.5 0.0 0.0 6.5 0.0 1.2 1.3 0.0 0.2 0.6 0.0 1.3 2.8 0.4 0.8 0.7 0.4 2.5 0.1 0.0 0.0 0.1 0.5 1.3 13.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 2.5 0.0 0.2 0.0 0.4 0.0 2.3 1.2 0.0 4.9 1.9 0.1 0.0 21.1 0.2 0.2 14.3 2.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.8 0.9 1.9 0.4 128.5 0.2 205.2 199.7 0.3 0.6 138.6 251.7 2.6 0.3 1.0 0.2 193.9 100.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 TRAV8-2 ENSG00000211786 "T cell receptor alpha variable 8-2" A0A0B4J237 14 21846537-21847221 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "lymphoid tissue: 24.1" "Cell type enriched" "Detected in some" 9 "T-cells: 10.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 99 "MAIT T-cell: 59.1;memory CD4 T-cell: 143.4;memory CD8 T-cell: 81.1;naive CD4 T-cell: 143.2;naive CD8 T-cell: 80.1;T-reg: 190.6" "Lineage enriched" "Detected in many" 184 "T-cells: 190.6" "Cell line enriched" "Detected in single" 6 "JURKAT: 1.9" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (5.88e-3)" "unprognostic (9.98e-4)" "unprognostic (2.31e-2)" "unprognostic (2.23e-2)" "unprognostic (9.88e-5)" "unprognostic (1.94e-3)" "unprognostic (7.22e-3)" "unprognostic (9.30e-3)" "unprognostic (2.82e-3)" "unprognostic (1.39e-1)" "unprognostic (1.69e-1)" "unprognostic (7.57e-5)" "unprognostic (1.86e-1)" "unprognostic (5.00e-2)" "unprognostic (6.66e-2)" "unprognostic (1.02e-1)" 0.3 0.1 0.0 3.2 0.0 1.9 0.2 0.0 0.0 0.2 0.0 0.7 1.1 0.2 1.6 0.5 0.2 1.4 0.1 0.0 0.0 2.7 0.2 1.2 14.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.1 0.0 0.4 0.0 0.0 0.4 1.3 0.1 0.0 4.1 1.3 0.3 0.0 24.1 0.3 0.0 6.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 1.0 1.1 0.1 59.1 0.2 143.4 81.1 0.3 0.3 143.2 80.1 0.7 0.2 0.2 0.1 190.6 40.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.7 0.0 0.0 0.0 TRAV8-3 ENSG00000211787 "T cell receptor alpha variable 8-3" A0A0A6YYJ7 14 21852558-21853006 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 71.1" "Cell type enriched" "Detected in single" 7 "T-cells: 3.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 1.2" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 138.2;T-reg: 153.1" "Lineage enriched" "Detected in many" 47 "T-cells: 153.1" "Cell line enriched" "Detected in single" 6 "JURKAT: 2.9" "Low region specificity" "Detected in single" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (7.74e-4)" "unprognostic (5.25e-5)" "unprognostic (8.88e-4)" "unprognostic (1.12e-2)" "unprognostic (2.69e-1)" "unprognostic (9.64e-5)" "unprognostic (8.20e-2)" "unprognostic (1.25e-2)" "unprognostic (1.38e-2)" "unprognostic (6.44e-2)" "unprognostic (2.13e-2)" "unprognostic (1.46e-1)" "unprognostic (2.66e-5)" "unprognostic (2.99e-1)" "unprognostic (4.17e-2)" "unprognostic (1.04e-1)" "unprognostic (1.26e-2)" 0.6 0.0 0.2 6.5 0.3 3.8 2.9 0.0 1.2 2.3 0.0 3.0 2.4 0.8 16.8 1.6 8.9 5.7 0.4 0.3 0.0 0.7 1.2 3.8 40.2 0.0 0.0 0.5 0.0 0.1 0.0 0.6 0.0 1.9 4.7 0.0 2.0 0.7 0.3 0.8 2.7 1.0 0.0 9.1 2.7 3.1 0.0 71.1 0.9 1.1 30.2 6.8 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.4 1.2 0.1 29.7 0.1 106.6 48.4 0.3 0.6 138.2 77.0 3.2 0.2 0.3 0.9 153.1 34.6 0.2 0.3 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 TRAV13-1 ENSG00000211788 "T cell receptor alpha variable 13-1" A0A0B4J241 14 21868839-21869365 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "lymphoid tissue: 62.5" "Cell type enriched" "Detected in single" 26 "T-cells: 15.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 329.3" "Lineage enriched" "Detected in many" 28 "T-cells: 329.3" "Cell line enriched" "Detected in single" 20 "JURKAT: 1.9" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.10e-3)" "unprognostic (9.80e-3)" "unprognostic (1.60e-2)" "unprognostic (3.04e-3)" "unprognostic (5.71e-2)" "unprognostic (3.30e-5)" "unprognostic (7.68e-2)" "unprognostic (2.44e-2)" "unprognostic (1.55e-2)" "unprognostic (6.67e-3)" "unprognostic (3.30e-2)" "unprognostic (1.15e-1)" "unprognostic (7.16e-5)" "unprognostic (1.03e-1)" "unprognostic (4.95e-2)" "unprognostic (1.20e-2)" "unprognostic (5.59e-2)" 1.1 0.3 0.0 13.7 0.1 2.2 1.1 0.0 0.2 0.2 0.0 3.7 3.6 0.7 0.3 0.8 0.9 3.7 0.5 0.0 0.0 0.4 1.0 4.4 29.2 0.2 0.0 0.4 0.5 0.0 0.0 0.0 0.0 1.1 3.0 0.0 1.2 0.4 0.2 0.2 7.5 0.4 0.0 8.4 3.8 0.2 0.0 62.5 0.6 0.7 29.9 5.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.7 0.4 1.4 0.4 62.6 0.4 203.8 179.6 0.5 0.6 232.3 292.5 6.2 0.5 0.5 0.9 329.3 80.2 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 15.6 0.0 0.0 0.0 TRAV12-2 ENSG00000211789 "T cell receptor alpha variable 12-2" A0A075B6T6 14 21887857-21888502 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 22.4" "Cell type enriched" "Detected in some" 6 "T-cells: 6.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 17 "memory CD4 T-cell: 101.9;memory CD8 T-cell: 87.7;naive CD4 T-cell: 90.3;naive CD8 T-cell: 65.2;T-reg: 143.3" "Lineage enriched" "Detected in many" 77 "T-cells: 143.3" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.73e-3)" "unprognostic (6.86e-3)" "unprognostic (1.74e-2)" "unprognostic (4.98e-3)" "unprognostic (4.75e-2)" "unprognostic (2.41e-4)" "unprognostic (2.22e-2)" "unprognostic (7.44e-2)" "unprognostic (5.23e-4)" "unprognostic (1.73e-3)" "unprognostic (1.74e-1)" "unprognostic (1.43e-1)" "unprognostic (1.03e-3)" "unprognostic (3.69e-1)" "unprognostic (3.34e-3)" "unprognostic (9.87e-2)" "unprognostic (3.01e-2)" 0.8 0.8 0.0 7.5 0.0 0.9 1.0 0.0 0.1 1.0 0.0 1.6 4.1 0.8 0.5 0.8 1.2 2.5 0.3 0.0 0.0 0.3 0.6 2.5 15.7 0.1 0.0 0.8 0.0 0.2 0.0 0.0 0.2 0.8 2.1 0.0 1.7 0.1 0.2 0.5 2.9 0.5 0.0 5.9 2.3 0.0 0.0 22.4 0.6 0.0 13.5 3.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.5 1.2 0.0 5.7 0.1 101.9 87.7 0.2 0.1 90.3 65.2 1.8 0.1 0.2 0.1 143.3 27.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 TRAV8-4 ENSG00000211790 "T cell receptor alpha variable 8-4" P01737 14 21894433-21895030 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "lymphoid tissue: 20.8" "Cell type enriched" "Detected in single" 15 "T-cells: 4.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 184.9;memory CD8 T-cell: 101.6;naive CD4 T-cell: 154.6;naive CD8 T-cell: 74.5;T-reg: 235.1" "Lineage enriched" "Detected in many" 49 "T-cells: 235.1" "Cell line enriched" "Detected in single" 1440 "JURKAT: 405.7" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (3.41e-4)" "unprognostic (1.74e-3)" "unprognostic (2.29e-2)" "unprognostic (1.14e-4)" "unprognostic (3.47e-4)" "unprognostic (5.06e-2)" "unprognostic (1.42e-2)" "unprognostic (5.10e-4)" "unprognostic (4.24e-3)" "unprognostic (1.41e-2)" "unprognostic (1.82e-1)" "unprognostic (2.51e-3)" "unprognostic (1.42e-1)" "unprognostic (3.80e-2)" "unprognostic (2.60e-1)" "unprognostic (5.58e-2)" 0.3 0.0 0.0 6.5 0.0 0.6 0.5 0.0 0.1 0.3 0.3 1.0 0.8 0.0 0.2 0.1 0.2 0.8 0.2 0.0 0.0 0.2 0.3 0.8 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.5 0.0 0.3 0.1 0.1 0.6 1.7 0.3 0.0 2.9 1.5 0.2 0.0 20.8 0.2 0.1 7.6 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 405.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.1 1.4 0.2 24.1 1.9 184.9 101.6 0.1 0.2 154.6 74.5 4.7 0.3 0.3 0.3 235.1 45.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.7 0.0 0.0 0.0 TRAV13-2 ENSG00000211791 "T cell receptor alpha variable 13-2" A0A0B4J235 14 21918188-21918756 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 24 "lymphoid tissue: 51.7" "Group enriched" "Detected in some" 4 "NK-cells: 4.1;T-cells: 5.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 38 "MAIT T-cell: 32.9;memory CD4 T-cell: 94.0;memory CD8 T-cell: 57.3;naive CD4 T-cell: 101.8;naive CD8 T-cell: 114.1;T-reg: 114.8" "Lineage enriched" "Detected in many" 53 "T-cells: 114.8" "Cell line enriched" "Detected in some" 4 "JURKAT: 6.1" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (6.15e-3)" "unprognostic (1.47e-2)" "unprognostic (2.07e-2)" "unprognostic (1.26e-3)" "unprognostic (5.58e-1)" "unprognostic (4.38e-4)" "unprognostic (1.08e-1)" "unprognostic (6.47e-2)" "unprognostic (2.85e-2)" "unprognostic (4.16e-2)" "unprognostic (2.12e-1)" "unprognostic (2.99e-1)" "unprognostic (3.66e-4)" "unprognostic (1.52e-1)" "unprognostic (9.38e-2)" "unprognostic (2.62e-1)" "unprognostic (1.77e-2)" 0.3 0.0 0.0 6.6 0.0 1.4 0.9 0.0 0.2 0.4 0.0 1.3 2.1 0.2 1.2 0.7 0.3 1.4 0.2 0.0 0.0 0.2 0.4 1.6 14.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 1.0 0.0 0.5 0.1 0.1 0.5 1.6 0.5 0.1 4.6 1.9 0.2 0.0 51.7 0.2 0.0 10.0 1.9 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 6.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.2 0.1 2.2 0.2 32.9 0.4 94.0 57.3 0.1 0.2 101.8 114.1 2.1 0.6 0.2 0.3 114.8 40.6 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 5.7 0.0 0.0 0.0 TRAV14DV4 "hADV14S1, TCRAV6S1-hDV104S1, TRAV14/DV4" ENSG00000211792 "T cell receptor alpha variable 14/delta variable 4" A0A0A6YYC5 14 21924063-21924651 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "lymphoid tissue: 25.7" "Cell type enriched" "Detected in single" 12 "T-cells: 6.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 38.2;memory CD8 T-cell: 78.1;naive CD4 T-cell: 30.7;naive CD8 T-cell: 122.3;T-reg: 42.6" "Lineage enriched" "Detected in single" 176 "T-cells: 122.3" "Cell line enhanced" "Detected in single" "JURKAT: 1.6" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (6.82e-3)" "unprognostic (1.00e-2)" "unprognostic (1.43e-1)" "unprognostic (3.06e-3)" "unprognostic (3.00e-5)" "unprognostic (2.52e-1)" "unprognostic (7.61e-4)" "unprognostic (3.77e-1)" "unprognostic (2.82e-2)" "unprognostic (1.76e-1)" "unprognostic (1.40e-1)" "unprognostic (2.62e-5)" "unprognostic (3.01e-1)" "unprognostic (4.17e-2)" "unprognostic (2.90e-1)" "unprognostic (1.60e-2)" 0.6 0.1 0.0 4.2 0.0 1.5 0.6 0.0 0.1 0.5 0.0 0.8 2.0 0.3 0.0 0.6 0.6 1.6 0.2 0.0 0.0 0.2 1.1 2.5 12.7 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 1.2 0.0 0.2 0.1 0.0 0.2 1.7 0.1 0.0 3.4 1.3 0.0 0.0 25.7 0.2 0.0 8.0 1.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.2 9.9 0.1 38.2 78.1 0.0 0.2 30.7 122.3 0.3 0.4 0.3 0.0 42.6 21.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 TRAV9-2 ENSG00000211793 "T cell receptor alpha variable 9-2" A0A087WT02 14 21941128-21941657 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "lymphoid tissue: 27.8" "Cell type enriched" "Detected in single" 6 "T-cells: 5.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 178.3;naive CD4 T-cell: 172.2;T-reg: 350.8" "Lineage enriched" "Detected in many" 78 "T-cells: 350.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (2.02e-3)" "unprognostic (2.04e-3)" "unprognostic (1.06e-1)" "unprognostic (1.25e-4)" "unprognostic (1.14e-5)" "unprognostic (1.37e-2)" "unprognostic (2.23e-2)" "unprognostic (5.98e-4)" "unprognostic (9.53e-3)" "unprognostic (1.92e-1)" "unprognostic (2.51e-1)" "unprognostic (9.00e-4)" "unprognostic (2.49e-1)" "unprognostic (4.28e-2)" "unprognostic (3.38e-1)" "unprognostic (2.56e-2)" 0.2 0.0 0.0 5.6 0.0 0.1 0.3 0.0 0.2 0.7 0.0 1.8 0.8 0.2 0.0 0.4 0.4 1.7 0.2 0.0 0.0 0.2 1.1 1.8 18.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.4 0.0 0.1 0.4 0.2 0.2 2.0 0.5 0.0 5.0 3.1 0.1 0.0 27.8 0.2 0.2 16.3 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.2 0.8 0.0 14.3 0.6 178.3 43.4 0.2 0.3 172.2 42.5 4.4 0.3 0.2 1.1 350.8 40.8 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 TRAV12-3 "TCRAV12S3, TCRAV2S2, TRAV123" ENSG00000211794 "T cell receptor alpha variable 12-3" A0A0B4J271 14 21965451-21966061 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "lymphoid tissue: 60.3" "Group enriched" "Detected in some" 4 "Erythroid cells: 1.7;T-cells: 6.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory CD4 T-cell: 186.5;T-reg: 256.6" "Lineage enriched" "Detected in many" 23 "T-cells: 256.6" "Cell line enriched" "Detected in single" 43 "JURKAT: 4.5" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.62e-4)" "unprognostic (7.68e-4)" "unprognostic (5.17e-2)" "unprognostic (1.33e-3)" "unprognostic (2.32e-1)" "unprognostic (1.80e-3)" "unprognostic (2.50e-2)" "unprognostic (1.17e-1)" "unprognostic (7.55e-4)" "unprognostic (9.00e-3)" "unprognostic (1.03e-1)" "unprognostic (1.20e-1)" "unprognostic (4.52e-5)" "unprognostic (3.75e-1)" "unprognostic (4.98e-2)" "unprognostic (5.80e-2)" "unprognostic (1.68e-2)" 0.5 0.1 0.0 9.3 0.0 1.5 1.1 0.0 0.1 1.7 0.0 2.1 2.2 0.6 0.9 0.4 0.6 6.1 0.5 0.0 0.0 0.3 0.4 2.8 18.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.6 3.2 0.0 0.3 0.2 0.1 0.4 2.7 0.5 0.0 4.6 1.9 0.1 0.0 60.3 0.2 0.0 17.4 3.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.5 0.2 0.4 0.2 12.7 0.4 186.5 57.4 0.4 1.8 119.7 153.3 4.6 0.9 0.7 0.5 256.6 48.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 TRAV8-6 ENSG00000211795 "T cell receptor alpha variable 8-6" A0A0B4J262 14 21978459-21979120 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "lymphoid tissue: 24.7" "Group enriched" "Detected in some" 19 "Spermatocytes: 1.2;Spermatogonia: 1.5;T-cells: 3.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 89.3;memory CD8 T-cell: 64.2;naive CD4 T-cell: 92.6;naive CD8 T-cell: 38.7;T-reg: 125.0" "Lineage enriched" "Detected in many" 45 "T-cells: 125.0" "Cell line enriched" "Detected in single" 97 "JURKAT: 9.6" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.42e-2)" "unprognostic (9.23e-4)" "unprognostic (5.47e-3)" "unprognostic (1.27e-3)" "unprognostic (7.80e-2)" "unprognostic (7.74e-5)" "unprognostic (2.88e-3)" "unprognostic (5.41e-3)" "unprognostic (2.59e-3)" "unprognostic (2.24e-2)" "unprognostic (9.25e-2)" "unprognostic (2.92e-1)" "unprognostic (9.78e-5)" "unprognostic (4.65e-1)" "unprognostic (2.80e-2)" "unprognostic (1.94e-1)" "unprognostic (1.61e-3)" 0.2 0.0 0.0 3.0 0.0 0.8 0.8 0.0 0.0 0.4 0.0 0.9 0.7 0.3 0.7 0.3 0.3 2.0 0.2 0.0 0.0 0.3 0.3 1.4 10.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.2 0.1 0.1 0.2 1.3 0.4 0.1 2.9 1.5 0.4 0.0 24.7 0.1 0.1 8.2 1.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.3 0.1 17.9 0.2 89.3 64.2 0.1 0.1 92.6 38.7 2.8 0.1 0.1 0.2 125.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.5 0.0 0.0 0.0 3.2 0.0 0.0 0.0 TRAV16 "TCRAV16S1, TCRAV9S1" ENSG00000211796 "T cell receptor alpha variable 16" A0A0A6YYK6 14 21990496-21990938 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "lymphoid tissue: 39.8" "Cell type enhanced" "Detected in some" "Erythroid cells: 1.3;Gastric mucus-secreting cells: 3.1;T-cells: 5.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 48.0;T-reg: 58.0" "Lineage enriched" "Detected in single" 164 "T-cells: 58.0" "Cell line enriched" "Detected in single" 184 "JURKAT: 18.3" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (2.93e-2)" "unprognostic (1.06e-4)" "unprognostic (6.22e-3)" "unprognostic (3.67e-3)" "unprognostic (1.01e-4)" "unprognostic (1.01e-1)" "unprognostic (4.08e-2)" "unprognostic (2.79e-2)" "unprognostic (6.94e-4)" "unprognostic (5.25e-2)" "unprognostic (2.33e-1)" "unprognostic (5.27e-5)" "unprognostic (1.55e-1)" "unprognostic (3.91e-2)" "unprognostic (4.01e-1)" "unprognostic (2.07e-3)" 0.2 0.0 0.0 5.7 0.0 0.8 0.8 0.0 0.3 0.5 0.0 1.5 1.9 0.2 1.3 0.5 0.2 2.6 0.1 0.0 0.0 0.6 0.2 1.8 16.6 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.4 1.7 0.0 0.6 0.1 0.0 0.6 1.6 0.0 0.0 2.8 1.7 0.1 0.1 39.8 0.3 0.0 10.1 3.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 11.9 0.0 45.6 18.2 0.0 0.1 48.0 22.4 0.3 0.0 0.0 0.0 58.0 10.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 TRAV17 "TCRAV17S1, TCRAV3S1" ENSG00000211797 "T cell receptor alpha variable 17" A0A0B4J275 14 21997539-21998168 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "lymphoid tissue: 27.8" "Cell type enriched" "Detected in some" 5 "T-cells: 6.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 19 "memory CD4 T-cell: 81.4;memory CD8 T-cell: 63.7;naive CD4 T-cell: 61.8;naive CD8 T-cell: 53.2;T-reg: 116.3" "Lineage enriched" "Detected in single" 226 "T-cells: 116.3" "Cell line enriched" "Detected in single" 221 "JURKAT: 22.0" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (8.22e-4)" "unprognostic (4.50e-3)" "unprognostic (1.37e-3)" "unprognostic (2.06e-2)" "unprognostic (2.72e-6)" "unprognostic (6.44e-2)" "unprognostic (7.45e-2)" "unprognostic (1.28e-2)" "unprognostic (1.67e-3)" "unprognostic (8.23e-2)" "unprognostic (1.50e-1)" "unprognostic (1.58e-5)" "unprognostic (1.73e-1)" "unprognostic (8.43e-3)" "unprognostic (8.53e-2)" "unprognostic (2.21e-1)" 0.2 0.0 0.0 5.9 0.0 0.5 0.2 0.0 0.2 0.5 0.0 1.2 1.8 0.3 0.8 0.6 0.6 1.4 0.1 0.0 0.0 0.2 0.4 1.4 13.2 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.6 1.6 0.0 0.1 0.0 0.0 0.1 1.5 0.3 0.0 3.3 2.2 0.1 0.0 27.8 0.3 0.0 10.2 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.7 0.0 3.9 0.2 81.4 63.7 0.0 0.2 61.8 53.2 0.5 0.1 0.1 0.3 116.3 22.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 TRAV18 TCRAV18S1 ENSG00000211798 "T cell receptor alpha variable 18" A0A075B6X5 14 22003106-22003673 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "lymphoid tissue: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 5.6;memory CD8 T-cell: 6.3;naive CD4 T-cell: 12.4;naive CD8 T-cell: 7.9;T-reg: 5.1" "Lineage enriched" "Detected in single" 124 "T-cells: 12.4" "Cell line enriched" "Detected in some" 7 "JURKAT: 36.2" "Not detected" "Not detected" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.30e-2)" "unprognostic (6.59e-3)" "unprognostic (2.94e-2)" "unprognostic (1.31e-1)" "unprognostic (1.92e-1)" "unprognostic (2.67e-1)" "unprognostic (9.94e-2)" "unprognostic (1.02e-2)" "unprognostic (7.00e-2)" "unprognostic (1.92e-1)" "unprognostic (5.61e-4)" 0.0 0.0 0.0 0.7 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.4 3.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 1.0 0.8 0.4 0.0 9.8 0.2 0.5 2.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.2 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 5.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 5.6 6.3 0.0 0.0 12.4 7.9 0.0 0.0 0.0 0.0 5.1 3.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 TRAV19 "TCRAV12S1, TCRAV19S1" ENSG00000211799 "T cell receptor alpha variable 19" A0A0A6YYK7 14 22007512-22008181 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "lymphoid tissue: 36.8" "Cell type enhanced" "Detected in single" "T-cells: 2.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 10 "memory CD4 T-cell: 17.8;memory CD8 T-cell: 45.6;naive CD4 T-cell: 23.2;naive CD8 T-cell: 24.5;T-reg: 23.9" "Lineage enriched" "Detected in single" 173 "T-cells: 45.6" "Cell line enriched" "Detected in some" 19 "JURKAT: 26.2" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (5.04e-3)" "unprognostic (2.11e-2)" "unprognostic (2.19e-2)" "unprognostic (1.04e-3)" "unprognostic (1.52e-1)" "unprognostic (2.95e-4)" "unprognostic (2.15e-3)" "unprognostic (1.50e-1)" "unprognostic (4.92e-2)" "unprognostic (2.99e-3)" "unprognostic (1.15e-1)" "unprognostic (3.41e-1)" "unprognostic (3.79e-2)" "unprognostic (1.22e-1)" "unprognostic (7.40e-2)" "unprognostic (1.18e-1)" "unprognostic (4.33e-3)" 0.4 0.4 0.0 6.1 0.0 1.2 0.9 0.0 0.0 0.7 0.0 1.3 2.7 0.5 0.4 1.0 0.3 2.4 0.7 0.0 0.1 0.5 0.6 3.2 18.2 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.5 3.1 0.0 1.2 0.4 0.0 0.3 2.3 0.6 0.1 6.5 3.7 0.8 0.0 36.8 0.4 0.3 12.7 3.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 2.6 0.0 17.8 45.6 0.0 0.0 23.2 24.5 0.2 0.0 0.0 0.0 23.9 8.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 2.7 0.0 0.0 0.0 TRAV20 ENSG00000211800 "T cell receptor alpha variable 20" A0A0B4J274 14 22040594-22041153 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "lymphoid tissue: 14.6" "Cell type enriched" "Detected in single" 6 "T-cells: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 8 "memory CD4 T-cell: 124.2;memory CD8 T-cell: 94.6;naive CD4 T-cell: 124.6;naive CD8 T-cell: 98.0;T-reg: 152.3" "Lineage enriched" "Detected in many" 60 "T-cells: 152.3" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.70e-2)" "unprognostic (3.31e-3)" "unprognostic (6.84e-2)" "unprognostic (2.90e-3)" "unprognostic (1.14e-2)" "unprognostic (1.93e-3)" "unprognostic (2.21e-2)" "unprognostic (4.70e-2)" "unprognostic (8.88e-2)" "unprognostic (7.00e-2)" "unprognostic (3.95e-2)" "unprognostic (1.16e-4)" "unprognostic (1.80e-1)" "unprognostic (3.26e-2)" "unprognostic (1.64e-1)" "unprognostic (2.11e-2)" 0.1 0.1 0.0 3.3 0.0 0.2 0.3 0.0 0.1 0.5 0.0 0.7 0.4 0.2 0.0 0.2 0.1 1.7 0.1 0.0 0.0 0.1 0.6 1.4 9.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.7 0.0 0.6 0.2 0.1 0.0 0.8 0.5 0.0 2.4 0.8 0.0 0.0 14.6 0.3 0.0 7.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.5 0.1 15.6 1.6 124.2 94.6 0.0 0.1 124.6 98.0 2.5 0.2 0.4 0.4 152.3 40.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 TRAV21 ENSG00000211801 "T cell receptor alpha variable 21" A0A0B4J279 14 22052514-22053056 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "lymphoid tissue: 63.2" "Group enriched" "Detected in some" 12 "Gastric mucus-secreting cells: 6.1;T-cells: 23.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 14 "memory CD4 T-cell: 220.5;memory CD8 T-cell: 233.5;naive CD4 T-cell: 198.6;naive CD8 T-cell: 204.8;T-reg: 391.9" "Lineage enriched" "Detected in many" 76 "T-cells: 391.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (2.53e-4)" "unprognostic (1.03e-2)" "unprognostic (3.94e-3)" "unprognostic (3.69e-4)" "unprognostic (1.74e-1)" "unprognostic (1.22e-3)" "unprognostic (4.86e-3)" "unprognostic (2.47e-2)" "unprognostic (1.13e-1)" "unprognostic (2.87e-3)" "unprognostic (4.20e-2)" "unprognostic (9.80e-2)" "unprognostic (4.53e-3)" "unprognostic (3.13e-1)" "unprognostic (2.96e-2)" "unprognostic (1.51e-1)" "unprognostic (2.41e-1)" 0.4 0.1 0.0 5.9 0.0 0.8 1.4 0.0 0.1 1.1 0.0 1.8 2.0 0.1 1.7 0.9 0.7 1.7 0.1 0.0 0.1 0.7 0.5 2.7 14.2 0.2 0.0 0.4 0.0 0.1 0.0 0.3 0.1 0.7 2.7 0.0 1.0 0.1 0.4 0.3 2.6 0.7 0.1 5.4 2.4 0.1 0.0 63.2 3.8 0.0 17.0 2.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.9 1.7 0.2 17.4 0.5 220.5 233.5 0.9 0.8 198.6 204.8 5.1 0.4 0.7 0.6 391.9 73.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 23.0 0.0 0.0 0.0 TRAV22 "TCRAV13S1, TCRAV22S1" ENSG00000211802 "T cell receptor alpha variable 22" A0A0B4J277 14 22070557-22071208 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "lymphoid tissue: 22.8" "Group enriched" "Detected in some" 4 "NK-cells: 1.0;T-cells: 3.8" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 59.6" "Lineage enriched" "Detected in many" 6 "T-cells: 59.6" "Cell line enriched" "Detected in single" 5 "U-266/70: 2.7" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.18e-2)" "unprognostic (6.03e-2)" "unprognostic (3.52e-2)" "unprognostic (1.82e-3)" "unprognostic (3.00e-5)" "unprognostic (4.27e-1)" "unprognostic (3.45e-2)" "unprognostic (2.51e-2)" "unprognostic (1.40e-2)" "unprognostic (4.79e-2)" "unprognostic (2.93e-2)" "unprognostic (2.63e-5)" "unprognostic (6.15e-2)" "unprognostic (1.12e-2)" "unprognostic (7.56e-3)" "unprognostic (3.15e-2)" 0.1 0.0 0.0 1.9 0.0 0.4 0.2 0.0 0.0 0.3 0.0 0.6 0.6 0.5 0.0 0.6 0.4 0.6 0.6 0.0 0.0 0.4 0.2 1.0 5.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.2 1.1 0.0 0.2 0.1 0.1 0.1 0.8 0.1 0.1 2.3 0.6 0.1 0.0 22.8 0.2 0.4 4.5 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 6.0 0.0 2.9 0.0 35.2 18.3 0.0 0.1 31.3 18.7 0.1 3.8 0.1 10.3 59.6 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 TRAV23DV6 "TCRAV17S1, TRAV23/DV6" ENSG00000211803 "T cell receptor alpha variable 23/delta variable 6" A0A075B6W5 14 22086407-22086961 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "lymphoid tissue: 26.3" "Cell type enriched" "Detected in single" 20 "T-cells: 4.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory CD4 T-cell: 79.3;naive CD4 T-cell: 85.6;T-reg: 65.6" "Lineage enriched" "Detected in many" 56 "T-cells: 85.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (7.79e-3)" "unprognostic (2.91e-2)" "unprognostic (2.01e-1)" "unprognostic (2.69e-1)" "unprognostic (2.66e-2)" "unprognostic (2.20e-2)" "unprognostic (1.19e-3)" "unprognostic (3.91e-2)" "unprognostic (1.04e-2)" "unprognostic (1.79e-1)" "unprognostic (2.24e-2)" "unprognostic (4.56e-3)" "unprognostic (1.34e-1)" "unprognostic (4.47e-2)" "unprognostic (7.44e-2)" "unprognostic (1.33e-1)" 0.5 0.1 0.0 6.4 0.0 1.1 0.5 0.0 0.0 0.5 0.0 1.2 2.1 0.2 0.0 1.0 0.5 1.3 0.3 0.0 0.0 0.1 0.5 1.8 10.3 0.0 0.1 1.3 0.0 0.1 0.0 0.0 0.0 0.6 1.8 0.0 0.5 0.1 0.1 0.1 1.0 0.5 0.0 3.3 2.2 0.0 0.0 26.3 0.6 0.0 10.8 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 2.0 0.0 3.2 0.0 79.3 19.6 0.0 0.1 85.6 21.4 1.5 0.1 0.0 0.0 65.6 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 TRDV1 hDV101S1 ENSG00000211804 "T cell receptor delta variable 1" A0A1B0GX56 14 22096032-22096619 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "lymphoid tissue: 75.3" "Group enriched" "Detected in some" 8 "Plasma cells: 2.1;T-cells: 7.9" "Cancer enhanced" "Detected in some" "testis cancer: 2.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 21 "gdT-cell: 1071.6" "Lineage enriched" "Detected in many" 198 "T-cells: 1071.6" "Not detected" "Not detected" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 63: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.59e-4)" "unprognostic (2.31e-3)" "unprognostic (1.49e-1)" "unprognostic (3.09e-3)" "unprognostic (3.18e-3)" "unprognostic (1.51e-2)" "unprognostic (4.21e-5)" "unprognostic (6.57e-2)" "unprognostic (1.83e-4)" "unprognostic (3.39e-1)" "unprognostic (2.21e-1)" "unprognostic (3.20e-3)" "unprognostic (1.04e-1)" "unprognostic (1.69e-1)" "unprognostic (2.01e-2)" "unprognostic (4.69e-2)" 0.3 0.2 0.0 2.1 0.0 1.0 0.3 0.0 0.0 0.5 0.0 4.6 0.5 0.2 0.0 0.1 0.3 2.6 0.0 0.0 0.0 0.3 0.8 3.4 10.3 0.1 0.0 1.3 0.0 0.0 0.0 0.1 0.1 0.2 2.6 0.0 0.3 0.6 0.3 0.1 0.7 0.1 0.0 20.0 1.8 1.3 0.0 75.3 1.1 0.0 5.6 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.6 0.4 1071.6 0.6 3.3 1.4 26.0 27.4 0.0 0.3 23.8 51.7 5.4 0.1 1.1 1.2 43.5 55.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 TRAV24 ENSG00000211805 "T cell receptor alpha variable 24" A0A0B4J272 14 22105343-22105846 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "lymphoid tissue: 21.4" "Cell type enriched" "Detected in single" 11 "T-cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 24 "memory CD4 T-cell: 24.4;memory CD8 T-cell: 47.5;naive CD4 T-cell: 22.4;naive CD8 T-cell: 66.5;T-reg: 40.9" "Lineage enriched" "Detected in single" 244 "T-cells: 66.5" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.96e-3)" "unprognostic (2.05e-3)" "unprognostic (3.76e-2)" "unprognostic (1.79e-4)" "unprognostic (5.42e-2)" "unprognostic (1.04e-1)" "unprognostic (7.79e-3)" "unprognostic (3.31e-1)" "unprognostic (1.05e-1)" "unprognostic (2.47e-5)" "unprognostic (3.62e-2)" "unprognostic (3.91e-2)" "unprognostic (1.44e-2)" 0.2 0.0 0.0 3.8 0.3 0.4 0.2 0.0 0.3 0.2 0.0 0.6 1.0 0.2 0.0 0.0 0.6 0.9 0.0 0.0 0.2 0.0 1.0 1.4 7.4 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.0 0.0 0.6 0.0 0.0 0.0 1.2 0.7 0.0 2.3 1.7 0.0 0.6 21.4 0.1 0.5 4.5 1.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.7 0.1 24.4 47.5 0.0 0.0 22.4 66.5 0.2 0.0 0.1 0.2 40.9 10.0 0.0 0.3 0.0 0.3 0.0 0.2 0.2 0.5 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 TRAV25 "TCRAV25S1, TCRAV32S1" ENSG00000211806 "T cell receptor alpha variable 25" A0A0B4J276 14 22112347-22113031 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "lymphoid tissue: 15.2" "Cell type enriched" "Detected in single" 6 "T-cells: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 63 "memory CD4 T-cell: 33.5;memory CD8 T-cell: 20.9;naive CD4 T-cell: 32.6;naive CD8 T-cell: 22.5;T-reg: 49.4" "Lineage enriched" "Detected in single" 404 "T-cells: 49.4" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (9.50e-3)" "unprognostic (1.49e-2)" "unprognostic (7.22e-2)" "unprognostic (2.89e-5)" "unprognostic (6.65e-3)" "unprognostic (7.53e-3)" "unprognostic (7.30e-3)" "unprognostic (1.69e-1)" "unprognostic (2.04e-1)" "unprognostic (3.52e-3)" "unprognostic (9.55e-2)" "unprognostic (4.17e-2)" "unprognostic (1.17e-1)" "unprognostic (3.74e-1)" 0.1 0.0 0.0 2.7 0.1 0.3 0.5 0.0 0.2 0.1 0.0 0.8 0.8 0.3 0.6 0.2 0.2 0.5 0.0 0.0 0.1 0.2 0.1 1.5 8.7 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.0 0.0 0.0 0.0 0.2 0.1 0.7 0.3 0.0 2.3 1.7 0.0 0.1 15.2 0.1 0.0 7.7 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 33.5 20.9 0.0 0.0 32.6 22.5 0.1 0.0 0.0 0.0 49.4 7.4 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 TRAV26-1 ENSG00000211807 "T cell receptor alpha variable 26-1" A0A087WT03 14 22123318-22124285 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "lymphoid tissue: 14.0" "Cell type enriched" "Detected in single" 5 "T-cells: 3.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory CD4 T-cell: 37.4;naive CD4 T-cell: 39.7;T-reg: 55.8" "Lineage enriched" "Detected in single" 69 "T-cells: 55.8" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.36e-3)" "unprognostic (1.33e-5)" "unprognostic (1.21e-2)" "unprognostic (3.60e-2)" "unprognostic (1.50e-3)" "unprognostic (1.08e-2)" "unprognostic (4.89e-2)" "unprognostic (1.99e-1)" "unprognostic (4.67e-4)" "unprognostic (3.93e-3)" "unprognostic (3.28e-1)" "unprognostic (4.01e-5)" "unprognostic (1.63e-1)" "unprognostic (1.75e-2)" "unprognostic (1.74e-1)" "unprognostic (1.73e-2)" 0.1 0.1 0.0 2.9 0.0 0.3 0.4 0.0 0.1 0.0 0.0 0.8 0.5 0.1 0.0 0.4 0.1 0.9 0.0 0.0 0.0 0.1 0.2 1.0 8.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.2 0.0 0.0 0.1 1.1 0.0 0.0 2.6 1.6 0.0 0.0 14.0 0.1 0.0 6.2 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.0 1.2 0.0 37.4 9.6 0.0 0.0 39.7 12.5 0.4 0.0 0.1 0.0 55.8 7.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 TRAV8-7 ENSG00000211808 "T cell receptor alpha variable 8-7 (pseudogene)" 14 22132553-22133034 "Predicted intracellular proteins, T-cell receptor genes" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAV27 ENSG00000211809 "T cell receptor alpha variable 27" A0A087WT01 14 22147995-22148633 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "lymphoid tissue: 19.8" "Cell type enriched" "Detected in some" 4 "T-cells: 4.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 19 "memory CD4 T-cell: 51.6;memory CD8 T-cell: 58.9;naive CD4 T-cell: 60.4;naive CD8 T-cell: 59.1;T-reg: 81.9" "Lineage enriched" "Detected in many" 63 "T-cells: 81.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (3.86e-3)" "unprognostic (1.66e-2)" "unprognostic (4.15e-2)" "unprognostic (2.78e-4)" "unprognostic (1.61e-1)" "unprognostic (2.21e-3)" "unprognostic (3.13e-1)" "unprognostic (8.30e-2)" "unprognostic (1.12e-2)" "unprognostic (2.07e-2)" "unprognostic (6.61e-2)" "unprognostic (2.14e-1)" "unprognostic (1.75e-4)" "unprognostic (3.45e-1)" "unprognostic (3.91e-2)" "unprognostic (1.68e-1)" "unprognostic (3.12e-3)" 0.1 0.0 0.0 2.3 0.0 0.4 0.1 0.0 0.0 0.6 0.0 0.6 0.3 0.2 0.0 0.4 0.3 0.2 0.1 0.0 0.0 0.1 0.1 0.7 5.0 0.1 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.2 1.5 0.0 0.2 0.0 0.2 0.2 0.7 0.0 0.0 1.7 0.9 0.0 0.1 19.8 0.1 0.0 5.6 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.5 0.0 3.2 0.2 51.6 58.9 0.0 0.0 60.4 59.1 1.0 1.3 0.1 0.3 81.9 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 TRAV29DV5 TRAV29/DV5 ENSG00000211810 "T cell receptor alpha variable 29/delta variable 5" P04437 14 22163238-22163870 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "lymphoid tissue: 26.6" "Cell type enriched" "Detected in some" 5 "T-cells: 13.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 20 "memory CD4 T-cell: 99.2;memory CD8 T-cell: 126.3;naive CD4 T-cell: 105.5;naive CD8 T-cell: 66.4;T-reg: 123.9" "Lineage enriched" "Detected in single" 129 "T-cells: 126.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (7.25e-4)" "unprognostic (3.20e-3)" "unprognostic (4.50e-2)" "unprognostic (8.49e-4)" "unprognostic (3.24e-3)" "unprognostic (9.16e-2)" "unprognostic (2.73e-1)" "unprognostic (4.17e-3)" "unprognostic (4.47e-2)" "unprognostic (3.81e-1)" "unprognostic (1.03e-1)" "unprognostic (5.11e-4)" "unprognostic (7.53e-2)" "unprognostic (4.69e-2)" "unprognostic (9.86e-2)" "unprognostic (7.28e-2)" 0.2 0.0 0.0 4.7 0.0 0.8 0.3 0.0 0.1 0.2 0.0 1.3 1.7 0.1 0.4 0.8 0.5 0.9 0.3 0.0 0.0 0.2 0.5 1.3 11.8 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.3 0.2 0.0 0.0 1.8 0.2 0.0 4.7 2.0 0.1 0.1 26.6 0.1 0.0 11.7 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 5.1 0.2 2.5 0.1 99.2 126.3 0.1 0.2 105.5 66.4 0.9 0.2 0.2 0.2 123.9 35.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 TRAV30 ENSG00000259092 "T cell receptor alpha variable 30" A0A087WSZ9 14 22168429-22168988 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "lymphoid tissue: 13.7" "Cell type enriched" "Detected in single" 11 "T-cells: 2.2" "Cancer enriched" "Detected in many" 6 "renal cancer: 11.4" "Not detected" "Not detected" "Group enriched" "Detected in many" 19 "memory CD4 T-cell: 23.4;memory CD8 T-cell: 21.4;naive CD4 T-cell: 35.5;naive CD8 T-cell: 22.8;T-reg: 42.3" "Lineage enriched" "Detected in many" 28 "T-cells: 42.3" "Group enriched" "Detected in some" 14 "HDLM-2: 13.7;HHSteC: 11.4" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.98e-2)" "unprognostic (1.18e-1)" "unprognostic (2.34e-2)" "unprognostic (2.37e-2)" "unprognostic (3.75e-3)" "unprognostic (3.51e-1)" "unprognostic (2.35e-2)" "unprognostic (3.56e-2)" "unprognostic (2.29e-1)" "unprognostic (1.16e-1)" "unprognostic (1.57e-1)" "unprognostic (4.17e-2)" "unprognostic (3.85e-3)" "unprognostic (8.04e-3)" 0.1 0.0 0.0 1.5 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.8 1.4 0.8 0.0 0.2 1.7 0.4 0.0 0.1 0.0 2.1 2.0 0.9 6.4 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.4 0.8 0.0 0.0 1.1 0.0 0.0 1.6 0.5 0.0 0.1 13.7 0.0 0.3 3.7 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.5 1.1 0.0 0.8 0.0 23.4 21.4 0.2 0.0 35.5 22.8 1.4 0.0 0.0 0.2 42.3 11.6 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 TRAV26-2 "TCRAV26S2, TCRAV4S1, TRAV262" ENSG00000211812 "T cell receptor alpha variable 26-2" A0A0B4J265 14 22202583-22203368 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 30 "lymphoid tissue: 41.5" "Cell type enriched" "Detected in single" 11 "T-cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 35 "memory CD4 T-cell: 52.8;memory CD8 T-cell: 80.5;naive CD4 T-cell: 50.9;naive CD8 T-cell: 36.8;T-reg: 66.3" "Lineage enriched" "Detected in single" 121 "T-cells: 80.5" "Cell line enriched" "Detected in single" 122 "HDLM-2: 12.2" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (7.57e-5)" "unprognostic (1.82e-1)" "unprognostic (2.19e-1)" "unprognostic (6.76e-4)" "unprognostic (8.84e-5)" "unprognostic (4.51e-2)" "unprognostic (2.10e-2)" "unprognostic (8.91e-3)" "unprognostic (9.24e-2)" "unprognostic (2.61e-1)" "unprognostic (1.66e-2)" "unprognostic (1.42e-1)" "unprognostic (7.76e-3)" "unprognostic (3.41e-1)" "unprognostic (5.19e-2)" 0.1 0.0 0.1 4.6 0.0 0.3 0.2 0.0 0.1 0.0 0.0 1.1 0.6 0.0 0.0 0.5 0.1 1.0 0.0 0.1 0.0 0.1 0.9 1.3 9.9 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.3 0.1 0.0 0.0 0.8 0.3 0.0 1.9 1.0 0.1 0.2 41.5 0.1 0.6 7.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.6 0.1 0.9 0.0 52.8 80.5 0.0 0.1 50.9 36.8 0.6 0.0 0.1 0.0 66.3 18.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 TRAV34 "TCRAV26S1, TCRAV34S1" ENSG00000211813 "T cell receptor alpha variable 34" A0A0B4J273 14 22207522-22208129 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 19 "lymphoid tissue: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 71 "memory CD4 T-cell: 9.9;memory CD8 T-cell: 4.5;naive CD4 T-cell: 14.0;naive CD8 T-cell: 5.0;T-reg: 16.9" "Lineage enriched" "Detected in single" 169 "T-cells: 16.9" "Cell line enriched" "Detected in single" 111 "HDLM-2: 59.2" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (3.61e-2)" "unprognostic (2.36e-4)" "unprognostic (1.24e-3)" "unprognostic (5.78e-2)" "unprognostic (1.18e-1)" "unprognostic (3.68e-2)" 0.0 0.0 0.1 0.9 0.0 0.0 0.2 0.1 0.1 0.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 2.9 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.5 0.0 0.3 13.3 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.9 4.5 0.0 0.0 14.0 5.0 0.0 0.0 0.0 0.0 16.9 2.6 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 TRAV36DV7 TRAV36/DV7 ENSG00000211815 "T cell receptor alpha variable 36/delta variable 7" A0A075B6V5 14 22226746-22227254 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 18 "lymphoid tissue: 27.5" "Cell type enriched" "Detected in single" 4 "T-cells: 2.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 8 "memory CD4 T-cell: 29.2;memory CD8 T-cell: 21.9;naive CD4 T-cell: 37.6;naive CD8 T-cell: 23.0;T-reg: 50.1" "Lineage enriched" "Detected in many" 13 "T-cells: 50.1" "Group enriched" "Detected in some" 11 "Daudi: 1.4;HL-60: 3.3" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (3.67e-3)" "unprognostic (1.25e-2)" "unprognostic (1.81e-2)" "unprognostic (2.74e-2)" "unprognostic (7.69e-2)" "unprognostic (2.39e-6)" "unprognostic (8.10e-2)" "unprognostic (9.54e-2)" "unprognostic (3.13e-1)" "unprognostic (2.44e-2)" "unprognostic (1.36e-1)" "unprognostic (2.45e-1)" "unprognostic (4.62e-5)" "unprognostic (1.52e-1)" "unprognostic (2.91e-2)" "unprognostic (1.11e-1)" "unprognostic (4.17e-4)" 0.2 0.0 0.0 2.1 0.0 1.3 0.0 0.1 0.0 0.2 0.0 0.8 0.3 0.0 0.0 0.3 0.2 1.0 0.4 0.0 0.0 0.0 0.1 1.5 10.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 1.6 0.6 0.1 0.1 27.5 0.1 0.0 5.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.9 1.6 0.0 0.0 1.4 29.2 21.9 0.0 0.1 37.6 23.0 0.3 0.0 0.0 0.0 50.1 9.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 TRAV38-1 "TCRAV14S2, TCRAV38S1, TRAV381" ENSG00000211816 "T cell receptor alpha variable 38-1" A0A0B4J264 14 22271968-22272563 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "lymphoid tissue: 13.9" "Group enriched" "Detected in some" 13 "Gastric mucus-secreting cells: 1.1;T-cells: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 31 "memory CD4 T-cell: 41.2;memory CD8 T-cell: 21.9;naive CD4 T-cell: 46.4;naive CD8 T-cell: 29.2;T-reg: 71.5" "Lineage enriched" "Detected in single" 218 "T-cells: 71.5" "Cell line enriched" "Detected in single" 15 "HDLM-2: 6.1" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (5.06e-3)" "unprognostic (1.04e-2)" "unprognostic (1.03e-1)" "unprognostic (2.99e-3)" "unprognostic (7.49e-2)" "unprognostic (1.21e-1)" "unprognostic (1.14e-1)" "unprognostic (5.75e-1)" "unprognostic (1.25e-2)" "unprognostic (2.46e-1)" "unprognostic (2.76e-2)" "unprognostic (2.26e-1)" 0.2 0.0 0.0 3.0 0.0 0.3 0.2 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.7 13.9 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.2 0.0 0.2 0.1 0.7 0.0 0.0 2.1 1.1 0.1 0.1 13.7 0.0 0.0 7.4 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.8 0.1 41.2 21.9 0.0 0.0 46.4 29.2 0.3 0.0 0.2 0.2 71.5 15.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 TRAV38-2DV8 "hADV38S2, TCRAV14S1, TRAV38-2/DV8, TRAV382DV8" ENSG00000211817 "T cell receptor alpha variable 38-2/delta variable 8" A0JD32 14 22281105-22281748 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "lymphoid tissue: 34.2" "Group enriched" "Detected in some" 4 "Gastric mucus-secreting cells: 3.1;T-cells: 3.8" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.3" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 182.9;memory CD8 T-cell: 113.3;naive CD4 T-cell: 152.6;naive CD8 T-cell: 96.6;T-reg: 227.6" "Lineage enriched" "Detected in many" 9 "T-cells: 227.6" "Cell line enriched" "Detected in single" 16 "HDLM-2: 1.6" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 58: T-cells - T-cell receptor" 0.4 0.4 0.2 4.2 0.2 0.7 0.6 0.1 0.3 0.8 0.0 1.1 1.5 0.5 0.0 0.4 0.5 1.5 0.1 0.2 0.1 0.5 0.8 1.3 12.4 0.2 1.3 0.1 0.0 0.1 0.0 0.2 0.3 1.2 1.9 0.0 0.4 0.3 0.0 0.1 1.2 0.1 0.1 2.9 1.4 0.2 0.3 34.2 0.2 0.6 8.0 3.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.1 33.2 0.1 0.2 0.3 182.9 113.3 0.2 0.3 152.6 96.6 2.4 0.2 0.4 24.5 227.6 57.7 0.2 0.2 0.1 0.3 0.2 0.1 0.2 1.3 0.3 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 TRAV39 "TCRAV27S1, TCRAV39S1" ENSG00000211818 "T cell receptor alpha variable 39" A0A0B4J263 14 22304054-22304553 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 16 "lymphoid tissue: 65.2" "Cell type enhanced" "Detected in single" "T-cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 33.2;memory CD8 T-cell: 27.1;naive CD4 T-cell: 35.8;naive CD8 T-cell: 23.6;T-reg: 36.7" "Lineage enriched" "Detected in many" 7 "T-cells: 36.7" "Cell line enhanced" "Detected in single" "MCF7: 1.1" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 58: T-cells - T-cell receptor" "unprognostic (9.69e-3)" "unprognostic (4.53e-3)" "unprognostic (8.90e-2)" "unprognostic (6.16e-2)" "unprognostic (2.21e-1)" "unprognostic (1.22e-2)" "unprognostic (5.71e-2)" "unprognostic (8.03e-3)" "unprognostic (3.17e-1)" "unprognostic (8.97e-2)" "unprognostic (8.96e-2)" "unprognostic (2.29e-1)" "unprognostic (6.55e-8)" "unprognostic (7.91e-2)" "unprognostic (5.25e-2)" "unprognostic (4.51e-2)" "unprognostic (3.56e-1)" 0.6 0.3 0.3 2.8 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.5 1.0 0.7 0.0 0.1 0.2 0.5 0.6 0.6 0.2 1.8 0.0 3.9 7.7 0.2 0.2 0.3 0.0 0.0 0.0 0.2 0.2 0.8 1.2 0.0 0.1 0.6 0.0 0.2 0.4 0.3 0.2 1.9 0.7 1.3 0.3 65.2 0.0 0.6 6.0 1.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.2 33.2 27.1 0.0 0.0 35.8 23.6 0.0 0.0 0.0 5.3 36.7 8.6 0.3 0.2 0.2 0.2 0.6 0.2 0.2 0.2 0.2 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 TRAV40 "TCRAV31S1, TCRAV40S1" ENSG00000211819 "T cell receptor alpha variable 40" A0A0B4J280 14 22314490-22314919 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 24 "lymphoid tissue: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "memory CD4 T-cell: 5.4;memory CD8 T-cell: 3.2;naive CD4 T-cell: 4.8;naive CD8 T-cell: 4.4;T-reg: 6.4" "Lineage enriched" "Detected in single" 64 "T-cells: 6.4" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 9.3 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 5.4 3.2 0.0 0.0 4.8 4.4 0.0 0.0 0.0 0.0 6.4 1.4 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TRAV41 "TCRAV19S1, TCRAV41S1" ENSG00000211820 "T cell receptor alpha variable 41" A0A0B4J266 14 22320188-22320691 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 39 "lymphoid tissue: 107.8" "Cell type enriched" "Detected in single" 7 "T-cells: 2.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "memory CD4 T-cell: 77.1;naive CD4 T-cell: 74.1;T-reg: 71.1" "Lineage enriched" "Detected in many" 46 "T-cells: 77.1" "Cell line enriched" "Detected in some" 60 "HDLM-2: 136.5" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.25e-3)" "unprognostic (1.98e-2)" "unprognostic (1.17e-1)" "unprognostic (2.30e-1)" "unprognostic (1.94e-1)" "unprognostic (8.89e-3)" "unprognostic (1.56e-1)" "unprognostic (6.27e-2)" "unprognostic (2.22e-1)" "unprognostic (1.99e-2)" "unprognostic (6.89e-3)" "unprognostic (3.33e-2)" "unprognostic (1.49e-3)" "unprognostic (1.24e-1)" "unprognostic (3.37e-2)" "unprognostic (8.34e-3)" "unprognostic (1.45e-1)" 0.1 0.0 0.7 5.7 1.1 0.4 0.4 0.7 1.8 0.1 0.6 1.0 1.0 0.5 0.0 0.7 0.1 1.3 0.0 0.9 0.8 0.0 0.3 2.7 16.1 1.2 0.9 0.0 0.0 0.1 0.0 0.0 0.9 0.3 1.6 0.0 0.0 0.1 0.3 0.1 0.8 0.7 0.7 4.1 1.2 0.1 0.8 107.8 0.2 0.0 12.6 1.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 136.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 3.3 0.8 0.3 0.0 77.1 19.1 0.0 0.0 74.1 31.0 1.6 0.1 0.1 0.0 71.1 18.1 0.7 1.1 0.7 1.8 0.9 0.8 1.2 0.9 0.9 0.7 0.8 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 TRDV2 "hDV102S1, MGC117421" ENSG00000211821 "T cell receptor delta variable 2" A0JD36 14 22422371-22423042 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 1.2;lymphoid tissue: 3.4" "Cell type enriched" "Detected in some" 7 "T-cells: 24.5" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 218 "gdT-cell: 3222.2" "Lineage enriched" "Detected in all" 575 "T-cells: 3222.2" "Cell line enriched" "Detected in single" 25 "REH: 7.3" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 3: T-cells - Adaptive immune response" "Cluster 14: REH - Unknown function" "Cluster 58: T-cells - T-cell receptor" 0.1 0.0 0.0 1.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.2 0.0 0.1 0.6 0.1 0.0 0.0 0.1 0.3 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 2.2 0.1 0.0 0.0 3.4 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 3.9 3222.2 4.4 1.6 2.1 1.9 14.7 5.6 0.4 1.7 4.2 5.1 1.3 0.8 2.3 5.9 384.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.6 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.5 0.0 0.0 0.0 TRDD1 ENSG00000223997 "T cell receptor delta diversity 1" P0DPR3 14 22438547-22438554 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRDD2 ENSG00000237235 "T cell receptor delta diversity 2" 14 22439007-22439015 "Predicted intracellular proteins, T-cell receptor genes" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRDD3 ENSG00000228985 "T cell receptor delta diversity 3" 14 22449113-22449125 "Predicted intracellular proteins, T-cell receptor genes" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRDJ1 ENSG00000211825 "T cell receptor delta joining 1" A0A075B706 14 22450089-22450139 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 54.0;lymphoid tissue: 78.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 77 "gdT-cell: 13481.1;NK-cell: 5148.7" "Group enriched" "Detected in all" 101 "NK-cells: 5148.7;T-cells: 13481.1" "Cell line enriched" "Detected in some" 15 "NB-4: 522.3" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 24: NB-4 - Immune response" 21.1 0.0 2.0 10.6 1.5 54.0 3.7 0.6 2.5 3.7 0.5 6.3 9.9 22.4 0.0 2.3 4.6 4.5 4.6 3.5 1.1 1.0 15.8 24.9 18.8 1.5 0.7 2.2 0.0 2.4 0.0 3.2 0.9 2.4 13.2 0.0 2.8 0.0 0.0 0.0 5.8 1.3 0.4 56.1 2.0 3.4 1.0 78.4 2.0 7.6 21.2 3.1 0.0 2.0 0.0 0.0 34.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 522.3 3.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 2.6 13.6 6.1 13481.1 20.3 9.7 15.9 27.1 86.2 20.6 4.7 30.5 120.9 92.1 5148.7 11.2 16.9 62.4 2899.6 2.0 1.5 0.6 2.5 3.5 1.1 1.5 0.7 0.9 0.4 1.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRDJ4 ENSG00000211826 "T cell receptor delta joining 4" 14 22455249-22455296 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 5.9;lymphoid tissue: 13.2" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 10 "ovarian cancer: 2.9" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 45 "gdT-cell: 123.0;NK-cell: 281.9" "Group enriched" "Detected in many" 362 "NK-cells: 281.9;T-cells: 123.0" "Cell line enriched" "Detected in some" 16 "NB-4: 38.7" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" 0.9 0.0 0.2 0.0 0.3 0.9 1.7 0.5 2.3 0.0 2.5 1.4 5.9 2.4 0.0 0.0 0.3 0.0 0.0 0.3 0.2 0.0 0.0 1.2 1.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.1 0.4 13.2 1.3 0.1 0.7 4.4 0.0 0.0 2.0 0.0 0.0 0.8 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 123.0 0.0 0.3 0.2 1.9 0.6 0.3 0.0 1.5 4.5 0.0 281.9 0.5 0.0 3.0 13.1 0.2 0.3 0.5 2.3 0.3 0.2 0.4 0.2 0.6 0.4 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRDJ2 ENSG00000211827 "T cell receptor delta joining 2" 14 22456689-22456742 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 37.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "thyroid cancer: 1.0" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 89 "gdT-cell: 953.4;NK-cell: 2991.2" "Group enriched" "Detected in all" 279 "NK-cells: 2991.2;T-cells: 953.4" "Cell line enriched" "Detected in some" 17 "NB-4: 104.6" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 24: NB-4 - Immune response" 3.0 0.0 0.5 3.7 0.3 4.8 0.8 0.2 0.9 0.0 0.0 3.3 0.0 4.8 0.0 0.0 1.6 0.0 0.0 0.8 0.4 1.2 0.0 7.6 6.4 0.7 0.2 1.7 0.0 0.0 0.0 1.8 0.4 0.0 2.9 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 26.2 1.4 0.7 0.8 37.0 0.0 0.0 2.9 0.5 0.0 1.9 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 6.3 0.4 0.0 953.4 2.0 3.3 0.8 22.0 14.7 3.9 1.7 17.6 14.4 7.0 2991.2 2.2 1.4 19.2 206.2 0.5 0.3 0.2 0.9 0.8 0.4 0.7 0.2 0.4 0.0 0.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRDJ3 ENSG00000211828 "T cell receptor delta joining 3" 14 22459098-22459156 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 19 "lymphoid tissue: 99.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in many" 4 "gdT-cell: 2218.4" "Lineage enriched" "Detected in all" 4 "T-cells: 2218.4" "Cell line enriched" "Detected in some" 49 "NB-4: 148.4" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 63: T-cells - Adaptive immune response" "Cluster 24: NB-4 - Immune response" 1.5 0.0 0.8 4.7 0.3 3.3 0.0 0.6 0.8 0.0 0.3 1.6 5.1 2.0 0.0 0.0 0.0 0.5 0.0 1.7 0.3 0.0 0.0 1.6 4.1 1.2 0.6 0.0 0.0 0.0 0.0 2.6 0.9 0.0 2.6 0.0 1.6 0.0 4.0 0.0 1.9 0.0 0.1 22.0 0.0 0.1 0.6 99.4 0.0 0.0 3.8 0.0 0.0 1.5 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 148.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.1 2218.4 1.1 1.1 1.0 4.4 15.1 5.5 0.3 8.2 8.0 6.7 525.7 0.8 2.8 12.9 120.0 0.8 0.3 0.6 0.8 1.7 0.3 1.2 0.6 0.9 0.1 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRDC ENSG00000211829 "T cell receptor delta constant" 14 22462932-22465787 "Predicted membrane proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 15 "lymphoid tissue: 404.4" "Cell type enriched" "Detected in some" 4 "NK-cells: 746.6" "Cancer enhanced" "Detected in all" "thyroid cancer: 19.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 87 "gdT-cell: 5873.4;NK-cell: 2243.9" "Group enriched" "Detected in all" 150 "NK-cells: 2243.9;T-cells: 5873.4" "Cell line enriched" "Detected in some" 38 "NB-4: 356.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 63: T-cells - Adaptive immune response" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "unprognostic (1.21e-3)" "unprognostic (8.15e-3)" "unprognostic (7.03e-2)" "prognostic favorable (8.25e-4)" "unprognostic (2.53e-1)" "unprognostic (2.42e-3)" "unprognostic (2.19e-1)" "prognostic favorable (6.13e-4)" "unprognostic (2.76e-2)" "unprognostic (2.19e-2)" "unprognostic (4.94e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (7.67e-5)" "unprognostic (1.25e-1)" "unprognostic (2.38e-1)" "unprognostic (1.22e-2)" "unprognostic (1.99e-2)" 13.4 0.4 1.3 7.8 1.0 26.2 3.8 1.4 1.4 2.9 0.6 8.9 3.9 7.6 2.1 2.0 4.1 7.9 2.7 2.0 0.9 1.1 11.1 11.6 22.7 0.9 1.2 1.9 0.2 0.4 0.7 2.8 0.8 1.0 7.5 0.0 4.6 1.2 1.6 1.3 5.6 2.2 0.7 54.2 2.0 2.7 0.9 404.4 1.8 1.3 18.3 4.6 0.9 1.3 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 356.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.2 0.0 3.1 0.9 1.4 0.0 0.0 0.1 3.2 4.8 2.3 5873.4 7.9 3.8 5.7 16.7 31.7 9.2 1.9 16.2 46.6 27.0 2243.9 5.5 7.1 27.5 1292.0 1.3 1.0 1.4 1.4 2.0 0.9 0.9 1.2 0.8 0.7 0.9 1.3 1.1 3.2 5.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.0 0.6 0.0 0.0 0.0 165.7 0.3 0.0 0.5 0.0 0.9 0.8 0.7 0.0 1.3 0.0 0.0 0.0 1.3 0.0 1.0 0.0 0.0 4.2 0.5 0.5 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.9 0.0 0.0 5.7 0.0 746.6 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 123.5 0.0 0.0 0.0 TRDV3 hDV103S1 ENSG00000256590 "T cell receptor delta variable 3" A0JD37 14 22469041-22469698 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "epididymis: 12.5;lymphoid tissue: 9.2" "Cell type enhanced" "Detected in some" "Fibroblasts: 1.8;NK-cells: 1.0;T-cells: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 10 "gdT-cell: 63.4" "Lineage enriched" "Detected in single" 303 "T-cells: 63.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.31e-2)" "unprognostic (6.56e-2)" "unprognostic (1.43e-1)" 0.4 0.0 0.3 0.1 0.5 0.0 0.0 0.3 0.4 0.0 0.1 0.5 0.0 0.0 12.5 0.0 0.0 0.3 0.0 0.5 0.3 0.0 0.0 0.1 1.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.2 2.1 0.1 0.0 0.5 9.2 0.0 0.0 0.9 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 63.4 0.0 0.0 0.2 0.7 0.7 0.0 0.1 1.0 6.1 0.0 0.1 0.0 0.0 2.7 1.8 0.3 0.5 0.3 0.4 0.5 0.3 0.4 0.3 0.3 0.2 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 TRAJ61 ENSG00000211831 "T cell receptor alpha joining 61 (non-functional)" 14 22475316-22475375 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 49 "brain: 3.1;lymphoid tissue: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 3.1" "Group enriched" "Detected in many" 8 "gdT-cell: 4.1;memory CD4 T-cell: 4.8;memory CD8 T-cell: 4.8;naive CD4 T-cell: 7.9;naive CD8 T-cell: 4.1;NK-cell: 4.3;T-reg: 7.6" "Group enriched" "Detected in many" 9 "NK-cells: 4.3;T-cells: 7.9" "Cell line enriched" "Detected in single" 23 "U-266/84: 2.3" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 16: U-266 - Nucleosome" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 4.7 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.8 7.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.6 0.2 0.0 4.8 4.8 0.0 0.0 7.9 4.1 0.0 4.3 0.0 0.0 7.6 0.7 0.0 0.3 3.1 0.6 0.4 0.5 0.6 0.5 0.9 0.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ59 ENSG00000211832 "T cell receptor alpha joining 59 (non-functional)" 14 22476553-22476606 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.8;gallbladder: 1.6;lymphoid tissue: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 3.8" "Immune cell enhanced" "Detected in some" "gdT-cell: 3.9;naive CD8 T-cell: 5.2" "Lineage enriched" "Detected in single" 7 "T-cells: 5.2" "Cell line enriched" "Detected in single" 13 "U-698: 1.3" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" 0.0 0.0 0.2 1.9 0.7 0.0 0.0 3.8 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 1.6 0.0 0.4 0.4 0.0 0.0 0.0 1.9 1.1 0.7 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.5 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 2.0 1.7 0.0 0.0 2.0 5.2 0.8 0.1 0.0 0.0 0.9 0.2 0.2 0.7 3.8 0.4 0.4 0.4 1.1 0.7 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ58 ENSG00000211833 "T cell receptor alpha joining 58 (non-functional)" 14 22477707-22477769 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 3.8;lymphoid tissue: 7.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 14 "memory CD4 T-cell: 58.2;memory CD8 T-cell: 40.9;naive CD4 T-cell: 63.7;naive CD8 T-cell: 20.7;T-reg: 57.3" "Lineage enriched" "Detected in many" 42 "T-cells: 63.7" "Group enriched" "Detected in some" 21 "Daudi: 2.4;U-266/84: 2.5;U-698: 1.3" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 16: U-266 - Nucleosome" 0.0 0.0 0.3 7.7 0.3 0.0 0.0 3.8 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.2 1.1 0.3 0.0 0.6 6.9 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.2 2.1 1.2 0.0 0.4 7.5 0.0 0.0 0.7 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.4 58.2 40.9 0.0 0.4 63.7 20.7 1.5 1.4 0.0 0.3 57.3 16.8 0.3 0.3 3.8 0.6 0.2 1.1 0.6 0.6 0.9 0.2 0.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ57 ENSG00000211834 "T cell receptor alpha joining 57" 14 22478872-22478934 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 3.4;intestine: 5.4;lymphoid tissue: 10.5;salivary gland: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 26 "memory CD4 T-cell: 80.9;memory CD8 T-cell: 74.8;naive CD4 T-cell: 92.2;naive CD8 T-cell: 44.9;T-reg: 155.8" "Lineage enriched" "Detected in many" 46 "T-cells: 155.8" "Group enriched" "Detected in some" 46 "HAP1: 3.1;U-266/84: 2.4;U-698: 8.2" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" 0.0 0.0 0.3 10.5 0.4 1.1 0.0 3.4 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.3 0.0 0.0 1.5 3.6 1.2 1.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.7 0.6 7.4 0.0 0.0 0.0 5.4 0.0 0.3 4.0 1.1 0.0 0.8 3.4 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 8.2 0.0 0.0 0.0 0.4 0.1 0.0 1.4 0.2 0.3 3.4 80.9 74.8 0.0 0.0 92.2 44.9 1.7 0.3 0.1 0.0 155.8 23.3 0.3 0.4 3.4 0.8 0.4 0.3 1.2 1.4 0.9 0.3 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ56 ENSG00000211835 "T cell receptor alpha joining 56" 14 22479521-22479582 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 4.5;intestine: 3.2;lymphoid tissue: 4.9;stomach 1: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 4.5" "Group enriched" "Detected in many" 40 "memory CD4 T-cell: 49.8;memory CD8 T-cell: 52.1;naive CD4 T-cell: 47.3;naive CD8 T-cell: 20.4;T-reg: 49.2" "Lineage enriched" "Detected in single" 59 "T-cells: 52.1" "Cell line enhanced" "Detected in some" "NB-4: 3.1;U-266/84: 2.5" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" 0.0 0.0 0.4 0.0 0.3 0.0 0.0 4.5 1.2 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.5 4.9 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.3 0.0 0.0 0.0 0.7 3.2 0.0 0.8 4.0 1.2 0.4 1.0 1.1 0.0 0.0 2.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.1 1.0 0.0 49.8 52.1 0.0 0.0 47.3 20.4 0.0 0.1 0.2 0.0 49.2 13.5 0.4 0.3 4.5 1.2 0.5 0.9 1.1 0.4 0.8 0.8 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ54 ENSG00000211836 "T cell receptor alpha joining 54" 14 22482287-22482346 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 2.9;brain: 2.7;intestine: 4.2;lymphoid tissue: 8.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 162.6;memory CD8 T-cell: 115.0;naive CD4 T-cell: 186.3;naive CD8 T-cell: 82.2;T-reg: 172.9" "Lineage enriched" "Detected in many" 7 "T-cells: 186.3" "Cell line enhanced" "Detected in some" "NB-4: 3.0;U-266/84: 13.2;U-698: 4.7" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 16: Immune cells - Immune response" "Cluster 16: U-266 - Nucleosome" "Cluster 22: Epithelial cell types - Mixed function" 0.0 0.0 0.2 2.3 0.4 2.9 0.0 2.7 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.6 0.0 0.4 8.7 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.1 1.8 0.0 0.0 0.0 4.2 0.0 0.4 3.6 0.0 0.0 0.7 1.7 0.0 0.0 1.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 4.7 0.0 0.0 0.0 0.3 0.3 0.0 28.1 0.0 1.5 1.6 162.6 115.0 0.1 0.1 186.3 82.2 5.0 26.8 0.5 0.1 172.9 42.4 0.2 0.4 2.7 1.1 0.2 0.6 0.7 0.4 0.6 0.4 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 TRAJ53 ENSG00000211837 "T cell receptor alpha joining 53" 14 22483004-22483069 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "lymphoid tissue: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 17 "memory CD4 T-cell: 78.9;memory CD8 T-cell: 38.5;naive CD4 T-cell: 94.2;naive CD8 T-cell: 38.9;T-reg: 146.9" "Lineage enriched" "Detected in many" 48 "T-cells: 146.9" "Group enriched" "Detected in some" 5 "Karpas-707: 4.6;U-698: 7.1" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" 0.5 0.0 0.3 2.7 0.4 2.3 0.0 1.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.6 0.8 0.3 0.0 0.0 10.9 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.3 5.3 2.7 0.0 0.4 0.7 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 7.1 0.0 0.0 0.0 0.2 0.3 0.0 4.7 0.0 0.3 3.0 78.9 38.5 0.8 1.9 94.2 38.9 0.8 1.6 0.4 0.0 146.9 18.3 0.3 0.4 1.0 0.4 0.6 0.8 0.3 0.5 0.7 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ52 ENSG00000211838 "T cell receptor alpha joining 52" 14 22486228-22486296 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 9.1;stomach 1: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 128.1;T-reg: 167.0" "Lineage enriched" "Detected in many" 157 "T-cells: 167.0" "Cell line enriched" "Detected in single" 14 "U-698: 1.4" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" 0.0 0.0 0.4 9.1 0.4 2.4 0.0 1.8 0.8 0.0 0.1 0.4 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.7 0.0 1.3 1.6 4.2 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.9 5.0 0.1 1.0 3.5 0.0 0.0 4.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.3 27.5 0.1 3.0 0.6 95.4 59.7 0.0 0.2 128.1 63.8 0.5 1.0 0.2 0.4 167.0 33.5 0.4 0.4 1.8 0.8 0.3 0.7 0.5 0.8 0.7 0.4 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ50 ENSG00000211839 "T cell receptor alpha joining 50" 14 22488593-22488652 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 1.9;lymphoid tissue: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "T-reg: 72.4" "Lineage enriched" "Detected in many" 22 "T-cells: 72.4" "Group enriched" "Detected in some" 12 "U-266/84: 1.1;U-698: 1.2" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 16: U-266 - Nucleosome" 0.0 0.0 0.2 0.0 0.6 0.0 0.0 1.9 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.4 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.5 1.5 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.2 0.0 0.0 0.0 3.3 0.0 0.0 2.7 0.0 0.4 0.0 32.6 12.3 0.0 0.1 31.2 24.3 1.0 0.1 0.0 0.0 72.4 12.9 0.2 0.6 1.9 0.5 0.3 0.3 1.2 0.9 0.6 0.1 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ49 ENSG00000211840 "T cell receptor alpha joining 49" 14 22489488-22489543 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 38 "retina: 406.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 9 "gdT-cell: 257.1;memory CD4 T-cell: 196.1;memory CD8 T-cell: 121.1;naive CD4 T-cell: 200.3;naive CD8 T-cell: 146.4;NK-cell: 104.2;T-reg: 361.0" "Group enriched" "Detected in all" 10 "NK-cells: 104.2;T-cells: 361.0" "Cell line enhanced" "Detected in some" "RH-30: 3.2;SH-SY5Y: 5.0;U-266/84: 15.4;U-698: 3.7" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 79: Retina - Phototransduction" "Cluster 16: U-266 - Nucleosome" 0.0 0.0 0.4 10.5 0.6 2.8 0.0 1.7 1.7 0.0 0.7 4.5 4.6 0.0 0.0 0.0 0.0 0.0 5.0 0.4 0.6 0.0 0.8 0.8 3.6 2.3 4.1 0.0 0.0 0.0 0.0 0.0 2.3 0.8 2.8 406.5 0.0 0.0 0.0 0.0 3.5 0.0 0.2 8.1 7.6 0.4 0.8 3.7 0.0 0.0 3.0 0.5 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 3.7 0.0 0.0 0.0 0.7 2.5 0.2 257.1 0.2 1.1 23.2 196.1 121.1 0.3 2.0 200.3 146.4 3.3 104.2 1.8 1.8 361.0 73.9 0.4 0.6 1.7 1.7 0.4 0.6 2.3 4.1 2.3 0.2 0.8 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ48 ENSG00000211841 "T cell receptor alpha joining 48" 14 22490491-22490553 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 7.7;retina: 27.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "memory B-cell: 37.7;memory CD4 T-cell: 80.7;memory CD8 T-cell: 71.3;naive CD4 T-cell: 100.1;naive CD8 T-cell: 78.2;T-reg: 149.4" "Group enriched" "Detected in many" 14 "B-cells: 37.7;T-cells: 149.4" "Group enriched" "Detected in some" 9 "HDLM-2: 22.6;U-266/84: 18.4;U-698: 16.2" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 16: U-266 - Nucleosome" 0.0 0.0 0.6 7.7 0.8 3.4 0.0 2.8 1.0 1.2 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.0 6.6 2.7 1.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.5 27.8 0.0 0.0 0.0 0.0 4.7 0.0 0.6 2.1 2.3 0.2 1.7 3.4 0.0 0.0 6.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 16.2 0.0 2.0 0.0 0.2 1.6 0.2 10.8 0.1 0.6 37.7 80.7 71.3 0.0 19.6 100.1 78.2 2.5 6.5 0.4 0.2 149.4 27.4 0.6 0.8 2.8 1.0 1.2 0.6 2.7 1.5 1.2 0.6 1.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ47 ENSG00000211842 "T cell receptor alpha joining 47" 14 22492851-22492907 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 6.3;retina: 13.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 13 "gdT-cell: 40.2;memory CD4 T-cell: 106.3;memory CD8 T-cell: 87.1;naive CD4 T-cell: 76.4;naive CD8 T-cell: 50.5;T-reg: 133.1" "Lineage enriched" "Detected in many" 21 "T-cells: 133.1" "Cell line enhanced" "Detected in some" "HDLM-2: 7.7;U-266/84: 37.9;U-698: 12.8" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 16: U-266 - Nucleosome" 1.3 0.0 0.9 6.3 0.9 2.7 0.0 2.6 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.6 0.0 0.0 2.3 4.0 1.0 1.0 0.9 0.0 0.0 0.0 0.0 0.9 0.0 0.9 13.6 0.0 0.0 0.0 1.2 0.0 0.0 0.6 1.7 1.0 0.0 1.0 3.7 0.0 0.0 0.8 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.9 12.8 0.0 0.0 0.0 0.5 0.6 0.0 40.2 0.5 3.2 6.1 106.3 87.1 0.1 0.1 76.4 50.5 2.9 1.2 0.0 0.7 133.1 37.0 0.9 0.9 2.6 0.8 0.6 0.6 1.0 1.0 0.9 0.6 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ46 ENSG00000211843 "T cell receptor alpha joining 46" 14 22493403-22493465 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "retina: 12.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "gdT-cell: 86.3" "Lineage enriched" "Detected in many" 9 "T-cells: 86.3" "Group enriched" "Detected in some" 59 "U-266/84: 8.5;U-698: 3.3" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 77: Retina - Visual perception" "Cluster 16: U-266 - Nucleosome" 0.9 0.0 0.9 0.0 1.5 0.0 0.0 2.5 0.7 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 1.7 1.5 1.9 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.7 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 1.0 0.9 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 3.3 0.0 0.0 0.0 0.4 0.0 0.1 86.3 0.0 0.3 1.2 24.3 10.9 0.0 9.4 22.6 13.6 0.9 2.2 0.2 0.0 18.9 9.5 0.9 1.5 2.5 0.7 0.5 0.6 1.5 1.9 1.1 0.4 1.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ45 ENSG00000211844 "T cell receptor alpha joining 45" 14 22493925-22493990 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 13.6;retina: 21.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "gdT-cell: 318.6;memory CD4 T-cell: 130.7;memory CD8 T-cell: 151.2;naive CD4 T-cell: 134.8;naive CD8 T-cell: 138.6;T-reg: 206.9" "Lineage enriched" "Detected in many" 7 "T-cells: 318.6" "Cell line enriched" "Detected in some" 7 "HDLM-2: 479.4" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 44: HDLM-2 - Immune response" 0.0 0.0 0.7 8.1 1.0 0.8 0.0 2.8 0.7 0.0 1.5 0.2 4.3 0.5 0.0 0.0 2.0 0.5 0.0 0.4 0.8 0.0 0.7 0.6 13.6 2.6 1.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 2.3 21.4 2.0 0.0 0.0 0.0 0.0 0.0 1.1 11.2 5.5 0.0 0.9 3.5 0.4 0.0 4.0 1.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 479.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.5 5.4 0.0 3.1 0.0 1.2 0.2 0.1 318.6 0.8 2.7 2.1 130.7 151.2 0.2 0.8 134.8 138.6 3.6 44.0 0.4 1.3 206.9 66.0 0.7 1.0 2.8 0.7 0.4 0.8 2.6 1.3 1.6 1.1 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ44 ENSG00000211845 "T cell receptor alpha joining 44" 14 22494821-22494883 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "lymphoid tissue: 26.2;retina: 20.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 18 "gdT-cell: 215.7;memory CD4 T-cell: 214.5;memory CD8 T-cell: 64.3;naive CD4 T-cell: 161.2;naive CD8 T-cell: 80.8;T-reg: 192.8" "Lineage enriched" "Detected in many" 25 "T-cells: 215.7" "Group enriched" "Detected in some" 8 "HDLM-2: 77.1;U-266/84: 35.5" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 44: HDLM-2 - Immune response" 0.9 0.0 0.7 26.2 0.6 1.7 0.7 1.7 1.0 0.0 0.2 1.1 0.0 0.0 0.0 0.6 0.0 0.5 2.6 0.7 0.4 0.3 0.0 1.9 16.6 0.9 1.1 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.0 20.6 0.0 0.0 3.8 0.0 2.1 0.0 0.4 5.5 2.2 0.1 0.7 2.6 0.0 0.0 8.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 77.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.5 7.5 0.0 0.0 0.0 0.3 1.1 0.3 215.7 0.3 3.9 0.8 214.5 64.3 0.7 1.0 161.2 80.8 2.0 8.6 0.5 0.6 192.8 49.0 0.7 0.6 1.7 1.0 0.7 0.4 0.9 1.1 1.2 0.4 0.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ43 ENSG00000211846 "T cell receptor alpha joining 43" 14 22495913-22495966 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 5.7;retina: 13.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 10 "gdT-cell: 162.3;memory CD4 T-cell: 178.6;memory CD8 T-cell: 245.5;naive CD4 T-cell: 195.9;naive CD8 T-cell: 234.5;T-reg: 263.9" "Lineage enriched" "Detected in all" 30 "T-cells: 263.9" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" 1.1 0.0 1.2 5.7 0.7 2.7 0.0 2.6 0.7 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.7 0.0 0.0 0.3 3.0 1.8 1.4 0.0 0.0 0.0 0.0 0.0 1.5 0.8 0.0 13.7 0.0 0.0 0.0 0.0 1.7 0.0 2.1 2.4 0.0 0.0 0.9 3.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 1.0 0.6 162.3 0.3 22.4 2.0 178.6 245.5 0.7 1.6 195.9 234.5 8.8 2.1 0.7 1.5 263.9 73.8 1.2 0.7 2.6 0.7 0.7 0.7 1.8 1.4 1.5 2.1 0.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ42 ENSG00000211847 "T cell receptor alpha joining 42" A0A075B6Y9 14 22496887-22496952 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 12.9;retina: 22.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "memory CD4 T-cell: 151.8;memory CD8 T-cell: 100.2;naive CD4 T-cell: 129.7;naive CD8 T-cell: 91.1;T-reg: 203.6" "Lineage enriched" "Detected in many" 73 "T-cells: 203.6" "Cell line enriched" "Detected in some" 7 "HDLM-2: 101.1" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 44: HDLM-2 - Immune response" 0.0 0.0 0.9 12.9 0.6 4.0 0.5 1.8 2.1 0.0 1.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 1.2 11.2 4.6 0.8 0.0 0.0 0.0 0.0 0.4 1.4 1.1 1.5 22.8 0.0 0.0 0.0 3.0 1.8 0.0 1.1 3.7 2.2 0.1 0.8 4.3 0.6 0.0 5.2 0.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 101.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 13.7 3.2 0.0 0.0 0.0 1.1 0.3 0.6 31.9 0.0 4.3 2.4 151.8 100.2 0.0 0.3 129.7 91.1 2.7 1.8 1.5 0.5 203.6 39.5 0.9 0.6 1.8 2.1 0.8 0.5 4.6 0.8 1.4 1.1 0.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ41 ENSG00000211848 "T cell receptor alpha joining 41" 14 22497657-22497718 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.2;retina: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 95.0;memory CD8 T-cell: 77.7;naive CD4 T-cell: 96.3;naive CD8 T-cell: 304.6;T-reg: 90.4" "Lineage enriched" "Detected in many" 139 "T-cells: 304.6" "Cell line enriched" "Detected in single" 32 "NB-4: 3.1" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 58: T-cells - T-cell receptor" 0.0 0.0 0.6 2.4 0.4 1.0 0.0 0.9 0.9 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.3 0.0 0.0 2.3 2.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 2.6 11.6 0.0 0.0 0.0 0.7 2.5 0.0 0.4 1.1 1.1 0.0 0.9 3.2 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 1.1 24.0 0.4 5.1 0.1 95.0 77.7 0.0 0.6 96.3 304.6 2.1 1.6 1.4 0.4 90.4 96.7 0.6 0.4 0.9 0.9 0.1 0.3 1.0 1.0 1.5 0.4 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ40 ENSG00000211849 "T cell receptor alpha joining 40" 14 22499689-22499749 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 5.3;retina: 20.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 131.7;memory CD8 T-cell: 93.0;naive CD4 T-cell: 137.3;naive CD8 T-cell: 86.2;T-reg: 244.3" "Lineage enriched" "Detected in many" 25 "T-cells: 244.3" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" 0.9 0.0 0.5 2.4 0.5 1.0 0.0 2.6 0.9 0.0 0.2 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.1 0.8 0.0 0.0 1.2 2.3 2.2 1.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 3.7 1.2 0.0 1.1 5.3 0.0 0.0 3.9 0.5 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.1 0.5 23.0 0.1 11.2 1.1 131.7 93.0 0.1 0.2 137.3 86.2 9.8 0.6 0.7 0.0 244.3 38.9 0.5 0.5 2.6 0.9 1.1 0.8 2.2 1.2 1.8 1.3 1.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ39 ENSG00000211850 "T cell receptor alpha joining 39" 14 22501601-22501663 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 22.7;heart muscle: 15.2;lymphoid tissue: 18.7;retina: 26.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "memory CD4 T-cell: 204.6;T-reg: 158.0" "Lineage enriched" "Detected in many" 58 "T-cells: 204.6" "Cell line enriched" "Detected in some" 4 "U-266/84: 18.2" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.88e-2)" 7.2 3.9 0.9 13.8 5.0 0.0 3.0 2.8 2.8 0.0 0.4 2.7 10.9 0.0 22.7 0.0 0.0 0.0 15.2 0.7 0.6 1.7 0.0 0.3 18.7 2.6 2.9 0.0 0.0 0.0 0.0 0.0 2.0 1.1 1.7 26.5 0.0 0.0 9.8 2.9 4.2 0.0 1.8 7.0 5.8 0.0 0.8 7.0 0.0 0.0 8.0 1.0 0.0 0.9 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.2 0.4 0.0 34.4 0.2 19.0 0.3 204.6 78.0 1.5 0.3 126.9 80.2 3.5 0.5 0.5 0.0 158.0 51.1 0.9 5.0 2.8 2.8 0.7 0.6 2.6 2.9 2.0 1.8 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TRAJ38 ENSG00000211851 "T cell receptor alpha joining 38" 14 22502231-22502292 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 11.5;lymphoid tissue: 9.7;retina: 22.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 124.3" "Lineage enriched" "Detected in many" 25 "T-cells: 124.3" "Group enriched" "Detected in some" 68 "HDLM-2: 9.0;JURKAT: 6.5;U-266/84: 4.8" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 44: HDLM-2 - Immune response" 0.0 1.9 1.0 5.4 4.3 0.8 2.2 2.7 1.0 0.0 1.1 0.8 0.0 0.0 11.5 0.0 0.7 0.0 1.1 1.3 1.0 0.9 0.0 2.8 5.7 2.3 2.7 0.0 0.0 0.0 0.0 0.0 2.1 2.5 0.0 22.7 0.0 0.0 0.0 0.7 1.6 0.0 2.2 7.2 1.2 0.0 1.5 5.7 0.0 0.0 9.7 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 56.5 0.6 22.0 0.0 88.2 74.8 1.0 0.1 124.3 59.9 5.0 0.2 0.2 0.4 115.7 19.1 1.0 4.3 2.7 1.0 1.3 1.0 2.3 2.7 2.1 2.2 1.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ37 ENSG00000278661 "T cell receptor alpha joining 37" 14 22503750-22503814 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 22.7;retina: 27.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 201.9;memory CD8 T-cell: 72.3;naive CD4 T-cell: 140.8;naive CD8 T-cell: 79.5;T-reg: 183.9" "Lineage enriched" "Detected in many" 90 "T-cells: 201.9" "Cell line enhanced" "Detected in some" "AN3-CA: 2.9;JURKAT: 2.4;U-266/84: 1.1" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "unprognostic (5.96e-2)" 0.0 4.0 1.1 20.7 1.6 2.0 0.0 1.6 1.1 0.0 0.4 2.0 4.4 0.0 7.4 0.0 0.6 0.0 0.0 0.7 1.1 0.5 0.0 1.9 22.7 1.2 1.4 0.0 0.0 0.0 0.0 0.4 1.0 1.9 0.7 27.8 4.0 0.0 0.0 0.7 4.2 1.1 0.9 5.8 6.1 0.4 0.9 5.8 0.0 0.0 8.3 0.0 0.0 0.9 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 0.0 0.0 0.0 1.4 0.0 0.3 10.2 0.1 23.5 0.4 201.9 72.3 1.0 0.2 140.8 79.5 2.2 1.6 0.5 0.0 183.9 34.7 1.1 1.6 1.6 1.1 0.7 1.1 1.2 1.4 1.0 0.9 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ36 ENSG00000276699 "T cell receptor alpha joining 36" 14 22505110-22505167 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "retina: 26.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "stomach cancer: 0.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 24 "memory CD4 T-cell: 61.3;memory CD8 T-cell: 53.5;naive CD4 T-cell: 64.1;naive CD8 T-cell: 46.3;T-reg: 116.9" "Lineage enriched" "Detected in single" 135 "T-cells: 116.9" "Cell line enhanced" "Detected in some" "JURKAT: 6.4;SCLC-21H: 2.2;U-698: 1.2" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 77: Retina - Visual perception" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "unprognostic (8.03e-3)" 0.0 0.0 0.9 2.2 3.1 3.7 0.6 2.2 1.6 0.0 1.2 0.4 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.9 0.6 0.4 0.0 0.0 3.2 2.6 1.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.9 26.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 3.5 0.0 0.0 1.0 2.0 0.0 0.0 5.6 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.5 0.0 2.7 0.0 2.5 0.4 61.3 53.5 0.0 0.1 64.1 46.3 0.8 0.1 0.0 0.0 116.9 24.1 0.9 3.1 2.2 1.6 0.9 0.6 2.6 1.1 1.5 1.3 1.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ35 ENSG00000211854 "T cell receptor alpha joining 35 (non-functional)" 14 22506644-22506702 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "lymphoid tissue: 6.7;retina: 14.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "stomach cancer: 0.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 17 "gdT-cell: 39.7;MAIT T-cell: 28.6;memory CD4 T-cell: 56.7;memory CD8 T-cell: 41.6;naive CD4 T-cell: 71.1;naive CD8 T-cell: 47.3;T-reg: 73.5" "Lineage enriched" "Detected in many" 24 "T-cells: 73.5" "Group enriched" "Detected in some" 7 "AF22: 9.5;U-266/84: 35.6" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 16: U-266 - Nucleosome" "unprognostic (1.05e-1)" 0.0 0.0 0.6 0.0 0.7 0.0 0.0 1.3 0.7 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.6 0.8 2.4 0.0 0.4 3.3 1.3 1.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.8 14.2 1.6 0.0 0.0 0.0 0.0 1.3 0.6 0.0 1.3 0.0 1.1 6.7 0.0 0.0 3.1 0.1 0.0 0.7 1.9 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.6 3.1 0.0 0.0 0.0 0.3 0.4 0.1 39.7 0.0 28.6 0.4 56.7 41.6 0.4 0.3 71.1 47.3 3.0 0.0 0.6 0.1 73.5 19.7 0.6 0.7 1.3 0.7 0.6 0.8 1.3 1.5 1.1 0.6 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ34 ENSG00000211855 "T cell receptor alpha joining 34" 14 22507666-22507723 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "choroid plexus: 5.2;intestine: 4.9;lymphoid tissue: 8.1;retina: 17.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 134.5;memory CD8 T-cell: 94.4;naive CD4 T-cell: 118.9;naive CD8 T-cell: 93.3;T-reg: 203.0" "Lineage enriched" "Detected in many" 181 "T-cells: 203.0" "Group enriched" "Detected in some" 41 "HDLM-2: 4.0;NTERA-2: 3.0;THP-1: 3.7;U-266/84: 5.3" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 44: HDLM-2 - Immune response" "unprognostic (3.40e-1)" 0.6 0.0 1.6 0.0 2.2 2.8 0.0 1.6 2.2 0.0 5.2 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 1.2 8.1 1.6 0.9 0.0 0.0 0.0 0.0 0.0 1.5 0.6 3.5 17.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.7 1.0 0.0 0.7 5.1 0.0 0.0 5.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.3 1.1 0.7 7.4 0.2 26.1 0.8 134.5 94.4 0.6 0.1 118.9 93.3 0.6 0.8 0.3 0.0 203.0 35.6 1.6 2.2 1.6 2.2 0.9 0.7 1.6 0.9 1.5 1.3 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ33 ENSG00000211856 "T cell receptor alpha joining 33" 14 22508602-22508658 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "intestine: 8.7;lymphoid tissue: 15.5;retina: 18.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 5 "MAIT T-cell: 2136.5" "Lineage enriched" "Detected in all" 464 "T-cells: 2136.5" "Group enriched" "Detected in some" 8 "MOLT-4: 64.5;U-698: 52.8" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" 0.0 0.0 1.2 15.5 2.6 3.1 0.8 1.7 1.0 0.0 1.8 0.9 8.7 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.6 1.5 0.3 1.3 4.1 1.6 0.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.8 18.8 0.0 0.0 0.0 0.8 6.5 0.0 1.3 3.1 0.0 0.6 1.7 6.4 0.0 0.0 10.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 52.8 0.0 0.0 0.0 3.0 1.5 1.0 14.7 0.5 2136.5 4.6 104.9 398.8 0.3 1.3 131.6 120.2 2.5 3.4 1.1 1.2 158.4 50.3 1.2 2.6 1.7 1.0 0.3 0.6 1.6 0.7 1.0 1.3 1.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ32 ENSG00000211857 "T cell receptor alpha joining 32" 14 22509341-22509406 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 15.6;retina: 12.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "MAIT T-cell: 353.6;memory CD4 T-cell: 152.5;memory CD8 T-cell: 130.4;naive CD4 T-cell: 177.0;naive CD8 T-cell: 133.0;T-reg: 187.8" "Lineage enriched" "Detected in many" 67 "T-cells: 353.6" "Cell line enhanced" "Detected in some" "AF22: 104.2;HDLM-2: 17.5;U-266/84: 44.5;U-698: 61.7" NA NA "Cluster 13: T-cells - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 12: NES - Nervous system development" 0.0 2.4 0.4 7.4 2.1 1.6 0.0 2.6 2.5 0.0 1.6 0.4 5.1 0.5 0.0 0.5 0.6 1.7 0.0 0.4 0.4 1.2 0.0 2.7 15.6 3.0 2.2 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 12.6 0.0 0.0 0.0 0.0 2.5 0.0 1.2 3.0 4.9 0.0 0.9 7.5 0.0 0.0 11.4 0.0 0.0 1.9 0.0 0.0 104.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.5 61.7 0.0 0.0 0.0 0.7 0.5 0.2 35.0 0.1 353.6 5.3 152.5 130.4 0.1 0.4 177.0 133.0 5.1 1.0 0.8 0.4 187.8 35.9 0.4 2.1 2.6 2.5 0.4 0.4 3.0 2.2 2.2 1.2 0.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ31 ENSG00000211858 "T cell receptor alpha joining 31" A0A075B700 14 22510968-22511024 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.2;lymphoid tissue: 15.7;retina: 17.4" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 7 "stomach cancer: 2.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 147.2;memory CD8 T-cell: 73.7;naive CD4 T-cell: 121.4;naive CD8 T-cell: 84.3;T-reg: 170.1" "Lineage enriched" "Detected in many" 103 "T-cells: 170.1" "Group enriched" "Detected in some" 11 "JURKAT: 1.1;U-266/84: 1.0" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 16: U-266 - Nucleosome" "unprognostic (6.41e-2)" 0.0 0.0 1.0 6.3 2.6 1.8 2.2 3.3 7.2 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.0 1.1 15.7 2.0 2.1 0.0 0.0 0.0 0.0 0.6 1.7 1.2 3.6 17.4 0.0 0.0 0.0 0.0 1.8 1.4 1.1 4.8 0.0 0.0 1.6 7.2 0.0 0.0 7.7 1.6 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.6 24.7 0.0 147.2 73.7 0.9 0.0 121.4 84.3 1.6 0.4 0.6 0.0 170.1 35.6 1.0 2.6 3.3 7.2 0.5 1.3 2.0 2.1 1.7 1.1 1.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ30 ENSG00000211859 "T cell receptor alpha joining 30" 14 22512852-22512908 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 8.5;retina: 11.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "memory CD4 T-cell: 79.6;memory CD8 T-cell: 129.8;naive CD4 T-cell: 121.6;naive CD8 T-cell: 114.9;T-reg: 136.0" "Lineage enriched" "Detected in many" 73 "T-cells: 136.0" "Cell line enriched" "Detected in single" 12 "U-698: 1.2" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" 0.0 0.0 0.7 8.5 2.0 2.1 0.0 3.2 1.1 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 1.2 0.0 0.0 6.9 2.4 1.0 0.0 0.0 0.0 0.0 0.0 1.6 0.4 0.0 11.1 0.0 0.0 0.0 0.8 2.1 0.0 0.9 2.5 0.0 3.4 2.0 4.8 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 1.9 0.8 16.5 0.7 79.6 129.8 0.1 0.1 121.6 114.9 1.8 0.2 0.0 0.2 136.0 31.6 0.7 2.0 3.2 1.1 0.5 0.7 2.4 1.0 1.6 0.9 2.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ29 ENSG00000211860 "T cell receptor alpha joining 29" 14 22513939-22513998 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.9;retina: 11.6;stomach 1: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 106.7;memory CD8 T-cell: 130.3;naive CD4 T-cell: 99.3;naive CD8 T-cell: 78.7;T-reg: 187.1" "Lineage enriched" "Detected in many" 61 "T-cells: 187.1" "Cell line enriched" "Detected in single" 23 "U-266/84: 2.3" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 16: U-266 - Nucleosome" 0.0 0.0 0.8 2.5 2.8 1.2 0.0 3.4 1.3 0.0 0.6 1.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.0 1.9 1.8 1.7 1.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.3 3.7 3.4 1.2 3.9 0.7 0.0 3.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.9 0.0 19.0 2.4 106.7 130.3 0.2 0.1 99.3 78.7 3.0 0.2 0.0 0.7 187.1 38.9 0.8 2.8 3.4 1.3 0.7 1.1 1.7 1.3 1.7 1.0 1.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ28 ENSG00000211861 "T cell receptor alpha joining 28" 14 22515623-22515688 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 11.0;retina: 14.7;stomach 1: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "T-reg: 138.5" "Lineage enriched" "Detected in many" 20 "T-cells: 138.5" "Cell line enriched" "Detected in single" 35 "U-266/84: 3.5" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 16: U-266 - Nucleosome" 0.0 0.0 0.9 10.2 1.9 3.4 0.5 1.7 1.4 0.0 1.8 0.4 4.3 0.0 0.0 0.0 0.0 1.2 0.0 0.8 1.1 0.0 0.0 1.8 11.0 2.4 1.1 0.0 0.0 0.0 0.0 0.3 1.8 0.0 0.0 14.7 2.1 0.0 0.0 0.0 1.6 0.0 0.9 2.7 6.5 0.0 1.0 2.7 0.0 0.0 2.6 1.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.5 0.3 0.0 7.4 0.1 28.5 0.0 84.7 72.8 0.0 0.1 76.0 80.2 0.5 6.9 0.2 0.7 138.5 32.4 0.9 1.9 1.7 1.4 0.8 1.1 2.4 1.1 1.8 0.9 1.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ27 ENSG00000211862 "T cell receptor alpha joining 27" 14 22516273-22516331 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 12.1;retina: 14.8;testis: 17.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 10 "MAIT T-cell: 213.3;memory CD4 T-cell: 141.9;memory CD8 T-cell: 105.6;naive CD4 T-cell: 107.7;naive CD8 T-cell: 87.8;T-reg: 157.3" "Lineage enriched" "Detected in many" 50 "T-cells: 213.3" "Cell line enhanced" "Detected in some" "NB-4: 3.0;REH: 14.4;U-266/84: 5.8;U-698: 5.5" NA NA "Cluster 13: T-cells - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 14: REH - Unknown function" 0.0 0.0 0.8 12.1 2.6 3.2 0.0 4.5 2.2 3.2 1.4 0.9 4.2 0.0 0.0 0.0 0.0 1.2 0.0 0.8 0.7 1.0 0.0 1.9 11.6 2.1 1.5 0.0 0.0 0.0 0.0 0.0 2.6 0.7 1.8 14.8 0.0 0.9 6.1 0.0 8.4 2.6 2.0 1.8 3.2 17.3 1.2 5.8 0.0 0.0 6.8 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.5 0.0 0.0 0.0 0.0 0.6 0.7 14.1 0.1 213.3 0.3 141.9 105.6 0.0 0.2 107.7 87.8 3.2 4.2 1.1 0.9 157.3 35.4 0.8 2.6 4.5 2.2 0.8 0.7 2.1 1.5 2.6 2.0 1.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ26 ENSG00000211863 "T cell receptor alpha joining 26" 14 22518446-22518505 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "cervix: 4.4;lymphoid tissue: 3.7;retina: 10.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "memory CD4 T-cell: 80.4;memory CD8 T-cell: 77.1;naive CD4 T-cell: 88.1;naive CD8 T-cell: 94.8;T-reg: 151.7" "Lineage enriched" "Detected in many" 90 "T-cells: 151.7" "Cell line enriched" "Detected in single" 44 "HDLM-2: 4.3" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 44: HDLM-2 - Immune response" 0.0 0.0 0.6 2.5 2.5 0.0 0.0 2.2 0.8 4.4 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 1.1 1.1 0.0 1.3 3.7 2.8 2.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.8 10.7 0.0 0.0 0.0 0.0 1.8 0.0 2.8 1.8 1.1 0.2 1.4 3.2 0.0 0.0 3.0 0.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 3.0 0.1 22.7 0.0 80.4 77.1 0.0 0.4 88.1 94.8 0.6 0.3 0.2 0.1 151.7 21.1 0.6 2.5 2.2 0.8 0.7 1.1 2.8 2.3 1.9 2.8 1.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ25 ENSG00000211864 "T cell receptor alpha joining 25 (non-functional)" 14 22518812-22518871 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 4.2;retina: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "MAIT T-cell: 4.6;memory CD4 T-cell: 5.0;memory CD8 T-cell: 5.5;naive CD4 T-cell: 6.1;naive CD8 T-cell: 2.0;T-reg: 7.6" "Lineage enriched" "Detected in single" 16 "T-cells: 7.6" "Not detected" "Not detected" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" 0.0 0.0 0.5 0.0 1.5 0.9 0.0 0.9 0.9 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 1.7 0.3 0.0 0.3 0.4 0.8 1.1 1.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 1.2 4.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.0 4.6 0.0 5.0 5.5 0.0 0.0 6.1 2.0 0.0 0.0 0.0 0.0 7.6 1.4 0.5 1.5 0.9 0.9 0.3 1.7 0.8 1.1 1.0 0.7 1.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ24 ENSG00000211865 "T cell receptor alpha joining 24" 14 22519969-22520031 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 8.9;lymphoid tissue: 5.3;retina: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 139 "MAIT T-cell: 28.5;memory CD4 T-cell: 51.9;memory CD8 T-cell: 64.8;naive CD4 T-cell: 49.3;naive CD8 T-cell: 60.4;T-reg: 95.6" "Lineage enriched" "Detected in single" 288 "T-cells: 95.6" "Cell line enhanced" "Detected in some" "Daudi: 2.4;MOLT-4: 8.1;U-698: 1.6" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 58: Brain - Synaptic function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" 0.0 0.0 0.6 2.5 2.8 1.1 2.0 0.9 8.9 0.0 1.2 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.6 0.0 1.3 0.5 5.3 2.3 1.3 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.8 8.4 0.0 0.0 0.0 0.0 0.0 1.2 1.4 1.7 0.0 0.5 1.4 4.7 0.0 0.0 0.8 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.3 0.0 0.4 0.0 28.5 0.1 51.9 64.8 0.1 0.2 49.3 60.4 0.1 0.0 0.1 0.3 95.6 15.9 0.6 2.8 0.9 8.9 0.8 0.6 2.3 1.3 4.4 1.4 1.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ23 ENSG00000211866 "T cell receptor alpha joining 23" 14 22520416-22520478 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 7.7;retina: 12.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "T-reg: 181.7" "Lineage enriched" "Detected in many" 65 "T-cells: 181.7" "Group enriched" "Detected in some" 4 "NB-4: 7.0;U-266/84: 3.6" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 24: NB-4 - Immune response" "unprognostic (2.03e-1)" 0.0 1.9 1.0 7.7 3.5 0.0 0.6 1.7 2.4 0.0 1.2 1.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.9 1.7 0.3 0.0 0.0 5.1 3.2 1.2 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.8 12.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 5.4 0.0 0.4 0.9 6.8 0.0 0.0 3.5 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 1.3 0.0 0.0 0.0 2.8 0.3 0.0 4.2 0.4 32.6 0.1 105.8 96.9 0.0 0.3 110.9 98.5 1.9 0.5 0.1 0.1 181.7 35.0 1.0 3.5 1.7 2.4 0.9 1.7 3.2 1.2 2.9 1.0 0.9 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ22 ENSG00000211867 "T cell receptor alpha joining 22" 14 22522040-22522102 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 5.4;epididymis: 3.7;lymphoid tissue: 11.0;retina: 12.9;stomach 1: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory CD4 T-cell: 149.8;T-reg: 192.2" "Lineage enriched" "Detected in many" 87 "T-cells: 192.2" "Group enriched" "Detected in some" 35 "MOLT-4: 4.3;U-698: 2.6" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" 0.0 0.0 3.7 11.0 5.4 0.0 0.0 2.6 2.7 0.0 1.7 0.2 0.0 0.0 3.7 0.6 0.0 0.0 0.0 1.1 1.3 0.3 0.0 0.9 10.5 2.9 1.6 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.8 12.9 0.0 0.0 0.0 0.0 0.0 0.0 2.0 3.5 6.9 0.0 1.6 5.8 0.2 0.0 2.9 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 1.0 0.4 0.3 4.0 0.0 32.7 0.0 149.8 43.9 0.6 0.6 139.6 89.4 2.1 1.0 0.5 0.4 192.2 39.2 3.7 5.4 2.6 2.7 1.1 1.3 2.9 1.6 3.2 2.0 1.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ21 ENSG00000211868 "T cell receptor alpha joining 21" 14 22523600-22523654 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 5.4;choroid plexus: 9.4;intestine: 7.0;lymphoid tissue: 10.7;retina: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "T-reg: 108.7" "Lineage enriched" "Detected in many" 71 "T-cells: 108.7" "Group enriched" "Detected in some" 23 "U-266/84: 2.2;U-698: 2.3" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 16: U-266 - Nucleosome" 1.4 0.0 3.1 0.0 5.4 1.9 0.0 2.2 1.2 0.0 9.4 0.5 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.8 0.2 2.2 0.3 7.7 2.1 1.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.9 12.1 0.0 0.0 0.0 0.0 7.0 1.4 1.8 10.7 0.9 0.0 1.2 3.9 0.0 0.0 1.5 1.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 24.8 0.2 65.7 49.4 0.0 0.2 67.7 41.8 1.5 0.7 0.0 0.0 108.7 15.0 3.1 5.4 2.2 1.2 0.9 0.8 2.1 1.4 2.0 1.8 1.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ20 ENSG00000211869 "T cell receptor alpha joining 20" 14 22524325-22524381 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 8.2;lymphoid tissue: 16.9;retina: 11.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 25 "MAIT T-cell: 190.9;memory CD4 T-cell: 124.6;memory CD8 T-cell: 193.7;naive CD4 T-cell: 138.5;naive CD8 T-cell: 140.1;T-reg: 225.0" "Lineage enriched" "Detected in single" 280 "T-cells: 225.0" "Not detected" "Not detected" NA NA "Cluster 13: T-cells - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" 0.0 0.0 2.3 16.9 3.7 0.0 0.0 1.9 2.4 0.0 1.2 1.0 0.0 0.0 8.2 0.0 0.0 1.4 0.0 1.0 0.3 0.0 0.9 0.0 6.1 2.3 1.0 0.0 0.0 0.0 0.0 0.0 2.1 0.4 0.0 11.3 0.0 0.0 0.0 0.9 4.3 0.0 0.8 5.5 2.0 0.0 1.0 6.2 0.0 0.0 3.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 6.7 0.5 190.9 0.5 124.6 193.7 0.3 0.3 138.5 140.1 0.8 0.3 0.5 0.3 225.0 50.8 2.3 3.7 1.9 2.4 1.0 0.3 2.3 1.0 2.1 0.8 1.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ19 ENSG00000211870 "T cell receptor alpha joining 19 (non-functional)" 14 22525263-22525322 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 7.5;retina: 20.7" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "stomach cancer: 1.0" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 1.7;memory CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Group enriched" "Detected in some" 22 "U-266/84: 2.3;U-698: 2.0" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 16: U-266 - Nucleosome" "unprognostic (2.39e-2)" 0.0 2.2 4.7 2.4 3.9 1.9 1.3 2.8 2.4 0.0 1.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.3 0.0 1.0 7.5 2.9 1.4 0.0 0.0 0.0 0.0 1.0 2.9 0.4 0.8 20.7 0.0 0.0 0.0 3.4 0.0 1.3 0.9 1.9 3.3 0.6 1.3 7.0 0.4 0.0 0.0 1.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.9 1.7 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.3 4.7 3.9 2.8 2.4 0.7 0.7 2.9 1.4 2.9 0.9 1.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ18 ENSG00000211871 "T cell receptor alpha joining 18" 14 22525650-22525715 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 28.0;retina: 15.9" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "memory CD4 T-cell: 66.1;memory CD8 T-cell: 37.7;naive CD4 T-cell: 96.4;naive CD8 T-cell: 82.7;T-reg: 105.0" "Lineage enriched" "Detected in many" 6 "T-cells: 105.0" "Group enriched" "Detected in some" 5 "HDLM-2: 13.1;U-266/84: 9.2" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 44: HDLM-2 - Immune response" "unprognostic (1.82e-1)" 0.0 0.0 4.2 18.0 3.7 2.6 0.5 1.6 1.5 0.0 1.6 0.6 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.9 0.7 0.6 0.7 0.9 10.7 2.2 1.6 0.0 0.0 0.0 0.0 0.0 1.6 0.4 1.4 15.9 2.0 0.0 0.0 1.5 4.1 0.0 1.0 5.9 3.7 1.0 0.7 9.8 0.0 0.0 28.0 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 2.4 0.0 0.0 0.0 0.0 0.2 1.0 9.1 0.1 14.4 17.3 66.1 37.7 0.0 1.8 96.4 82.7 1.4 0.4 0.0 0.0 105.0 36.3 4.2 3.7 1.6 1.5 0.9 0.7 2.2 1.6 1.6 1.0 0.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ17 ENSG00000211872 "T cell receptor alpha joining 17" 14 22526844-22526906 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 7.3;retina: 15.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "T-reg: 148.3" "Lineage enriched" "Detected in many" 31 "T-cells: 148.3" "Cell line enhanced" "Detected in some" "MOLT-4: 3.8;NB-4: 7.0;U-266/84: 2.4;U-698: 1.3" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 24: NB-4 - Immune response" 0.0 0.0 1.7 5.0 2.8 2.5 1.2 1.3 1.6 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.6 0.3 0.0 0.0 0.3 3.2 1.7 1.7 0.0 0.0 0.0 0.0 0.0 2.3 0.9 2.5 15.9 3.4 0.0 0.0 0.6 2.1 1.2 1.1 6.0 1.1 0.5 1.5 7.3 0.0 0.0 3.6 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 26.5 0.0 97.2 71.2 0.7 0.3 86.6 57.5 4.7 0.0 0.5 0.0 148.3 29.9 1.7 2.8 1.3 1.6 0.6 0.3 1.7 1.7 2.3 1.1 1.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ16 ENSG00000211873 "T cell receptor alpha joining 16" 14 22528527-22528586 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 5.7;lymphoid tissue: 8.3;retina: 17.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 33 "MAIT T-cell: 39.0;memory CD4 T-cell: 55.6;memory CD8 T-cell: 52.5;naive CD4 T-cell: 44.3;naive CD8 T-cell: 37.4;T-reg: 60.2" "Lineage enriched" "Detected in many" 41 "T-cells: 60.2" "Cell line enriched" "Detected in some" 7 "HDLM-2: 8.7" NA NA "Cluster 13: T-cells - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 44: HDLM-2 - Immune response" 0.0 0.0 2.2 2.5 3.2 2.3 0.0 1.7 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.6 0.9 2.3 4.5 1.8 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.8 17.5 0.0 0.0 0.0 0.0 5.7 0.0 1.1 2.8 1.1 0.6 0.8 8.3 0.0 2.0 5.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 39.0 0.4 55.6 52.5 0.3 0.1 44.3 37.4 1.4 0.1 0.3 0.0 60.2 18.2 2.2 3.2 1.7 1.7 0.8 1.0 1.8 1.2 1.3 1.1 0.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ14 ENSG00000211875 "T cell receptor alpha joining 14" 14 22530327-22530378 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 8.6;retina: 21.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 10 "MAIT T-cell: 5.3;memory CD4 T-cell: 7.6;memory CD8 T-cell: 10.1;naive CD4 T-cell: 6.1;naive CD8 T-cell: 3.9;T-reg: 13.7" "Lineage enriched" "Detected in single" 138 "T-cells: 13.7" "Not detected" "Not detected" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 20: Retina & Lymphoid tissues - Unknown function" 0.0 0.0 2.2 0.0 2.6 1.0 0.0 1.4 1.7 0.0 0.5 0.7 3.3 0.0 0.0 0.0 0.0 2.0 0.0 0.8 2.8 0.0 0.0 0.0 1.0 2.7 1.9 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.2 0.0 0.0 2.1 8.6 0.0 0.0 2.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 5.3 0.0 7.6 10.1 0.0 0.0 6.1 3.9 0.0 0.0 0.0 0.0 13.7 0.0 2.2 2.6 1.4 1.7 0.8 2.8 2.7 1.9 1.8 0.7 2.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ13 ENSG00000211876 "T cell receptor alpha joining 13" 14 22531076-22531138 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 15.5;retina: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 82.8;memory CD8 T-cell: 58.8;naive CD4 T-cell: 85.6;naive CD8 T-cell: 48.0;T-reg: 126.3" "Lineage enriched" "Detected in many" 88 "T-cells: 126.3" "Group enriched" "Detected in some" 6 "MOLT-4: 8.1;U-698: 7.1" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" 0.9 2.4 1.3 5.5 3.1 3.6 1.2 1.8 1.6 0.0 2.9 0.1 0.0 0.5 0.0 0.0 0.6 1.9 0.0 1.0 1.1 0.6 0.0 0.4 15.5 2.4 1.2 0.0 0.0 0.0 0.0 0.0 2.4 0.4 1.7 28.0 0.0 0.0 0.0 0.0 4.2 0.0 0.9 6.2 4.6 0.0 0.8 5.4 0.6 0.0 5.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 7.1 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.0 13.1 0.8 82.8 58.8 0.0 0.0 85.6 48.0 1.4 0.3 0.0 1.1 126.3 27.1 1.3 3.1 1.8 1.6 1.0 1.1 2.4 1.2 2.4 0.9 0.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ12 ENSG00000211877 "T cell receptor alpha joining 12" 14 22531939-22531998 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "lymphoid tissue: 30.4;retina: 31.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 319.7" "Group enriched" "Detected in all" 110 "B-cells: 196.9;T-cells: 319.7" "Group enriched" "Detected in some" 13 "Daudi: 12.1;MOLT-4: 7.9;U-698: 30.7" NA NA "Cluster 13: T-cells - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" 0.0 1.7 2.8 30.4 2.5 0.9 0.0 2.4 2.0 0.0 2.4 0.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.1 1.0 0.5 0.0 3.4 15.6 3.3 1.3 0.0 0.0 0.0 0.0 1.0 1.4 0.4 1.7 31.2 1.8 0.0 0.0 0.0 2.0 1.3 1.5 11.2 3.3 0.5 1.3 15.0 0.0 0.0 25.1 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 30.7 0.0 0.0 0.0 1.9 0.4 2.3 26.0 0.5 319.7 160.3 104.9 135.2 0.4 196.9 98.6 79.1 0.0 1.1 1.1 1.1 265.9 53.8 2.8 2.5 2.4 2.0 1.1 1.0 3.3 1.3 1.4 1.5 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ11 ENSG00000211878 "T cell receptor alpha joining 11" 14 22532502-22532561 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 9.7;retina: 28.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "T-reg: 139.0" "Lineage enriched" "Detected in single" 152 "T-cells: 139.0" "Group enriched" "Detected in some" 31 "MOLT-4: 3.9;RT4: 1.8;U-266/84: 3.5" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 16: U-266 - Nucleosome" 0.0 0.0 1.5 9.7 3.1 3.8 0.0 1.3 2.0 0.0 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 1.4 0.6 1.2 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 28.1 0.0 0.0 0.0 0.0 1.8 0.0 0.6 2.4 2.4 1.4 1.1 8.5 0.0 0.0 6.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.1 29.1 0.9 80.4 55.1 0.1 0.5 62.5 37.0 0.5 0.0 0.3 0.1 139.0 27.5 1.5 3.1 1.3 2.0 1.3 0.5 1.3 0.8 0.8 0.6 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ10 ENSG00000211879 "T cell receptor alpha joining 10" 14 22533497-22533560 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 22.0;retina: 31.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 156.3;memory CD8 T-cell: 239.5;naive CD4 T-cell: 141.1;naive CD8 T-cell: 425.6;T-reg: 229.4" "Lineage enriched" "Detected in many" 23 "T-cells: 425.6" "Group enriched" "Detected in some" 4 "HDLM-2: 9.0;MOLT-4: 28.5" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "unprognostic (7.94e-2)" 0.6 2.4 1.1 15.9 2.1 1.6 0.0 0.3 1.8 2.5 0.6 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.8 0.0 0.0 2.0 22.0 1.9 0.8 0.0 0.0 0.0 0.0 0.6 1.1 0.4 0.8 31.8 2.0 0.0 0.0 0.6 6.7 0.0 0.5 13.7 4.5 2.9 0.7 9.5 0.0 0.0 13.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 4.6 0.0 0.0 0.0 18.2 0.4 0.3 6.8 0.2 48.5 11.3 156.3 239.5 1.1 13.4 141.1 425.6 0.7 1.2 0.8 0.4 229.4 77.6 1.1 2.1 0.3 1.8 0.5 0.8 1.9 0.8 1.1 0.5 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ9 ENSG00000211880 "T cell receptor alpha joining 9" 14 22535554-22535614 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 22.2;retina: 30.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 137.3;memory CD8 T-cell: 150.2;naive CD4 T-cell: 118.6;naive CD8 T-cell: 188.1;T-reg: 297.5" "Lineage enriched" "Detected in many" 59 "T-cells: 297.5" "Cell line enriched" "Detected in some" 6 "MOLT-4: 7.5" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" 0.0 0.0 2.0 22.2 2.9 1.8 0.5 0.7 1.1 0.0 0.9 2.1 4.4 0.0 0.0 0.0 0.2 0.5 0.0 0.6 0.6 0.0 0.3 2.6 12.8 0.9 1.1 1.0 0.0 0.0 0.0 0.0 1.1 0.8 6.9 30.5 0.0 0.0 3.9 0.0 6.4 0.0 1.2 10.5 3.5 0.1 0.6 12.5 1.4 0.0 11.0 0.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.2 0.0 0.0 0.0 0.6 0.1 2.2 2.7 0.5 32.7 0.7 137.3 150.2 0.0 3.3 118.6 188.1 5.0 0.9 0.0 0.1 297.5 51.5 2.0 2.9 0.7 1.1 0.6 0.6 0.9 1.1 1.1 1.2 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ7 ENSG00000211882 "T cell receptor alpha joining 7" 14 22537622-22537680 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 15.2;retina: 42.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 48 "MAIT T-cell: 26.9;memory CD4 T-cell: 44.2;memory CD8 T-cell: 28.6;naive CD4 T-cell: 54.8;naive CD8 T-cell: 31.2;T-reg: 87.6" "Lineage enriched" "Detected in single" 92 "T-cells: 87.6" "Group enriched" "Detected in some" 71 "MOLT-4: 10.7;U-266/84: 3.3" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" 0.0 0.0 2.4 9.3 5.7 3.9 0.0 1.6 1.5 0.0 1.9 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.5 0.6 2.6 2.6 6.9 2.3 1.5 0.0 0.0 0.0 0.0 0.0 2.9 0.8 2.6 42.2 0.0 2.5 0.0 0.0 1.5 0.0 1.9 2.2 2.4 0.1 1.1 15.2 0.0 0.0 4.4 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 26.9 0.0 44.2 28.6 0.1 0.0 54.8 31.2 0.3 0.0 0.0 0.9 87.6 14.8 2.4 5.7 1.6 1.5 0.8 1.5 2.3 1.5 2.9 1.9 1.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ6 ENSG00000211883 "T cell receptor alpha joining 6" 14 22539073-22539134 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 15.2;retina: 56.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 28 "MAIT T-cell: 137.1;memory CD4 T-cell: 135.0;memory CD8 T-cell: 142.8;naive CD4 T-cell: 138.2;naive CD8 T-cell: 76.2;T-reg: 264.4" "Lineage enriched" "Detected in many" 192 "T-cells: 264.4" "Cell line enhanced" "Detected in some" "HL-60: 3.3;MOLT-4: 8.6;NB-4: 13.3" NA NA "Cluster 13: T-cells - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 24: NB-4 - Immune response" "unprognostic (8.83e-2)" 0.0 0.0 2.5 12.3 2.8 2.1 0.0 1.4 1.0 0.0 1.4 1.4 0.0 0.9 0.0 0.0 0.7 1.9 1.6 0.6 0.6 0.0 0.0 3.8 15.2 1.6 1.2 0.0 0.0 0.0 0.0 0.0 1.9 0.4 2.5 56.6 0.0 0.0 0.0 4.9 3.7 0.0 2.0 14.8 6.8 0.5 0.8 12.3 0.0 0.0 5.8 2.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 5.3 0.1 137.1 0.1 135.0 142.8 0.5 0.2 138.2 76.2 1.3 0.4 0.2 0.5 264.4 54.6 2.5 2.8 1.4 1.0 0.6 0.6 1.6 1.2 1.9 2.0 0.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ5 ENSG00000211884 "T cell receptor alpha joining 5" 14 22540247-22540306 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 9.7;lymphoid tissue: 12.4;retina: 44.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 62 "MAIT T-cell: 63.0;memory CD4 T-cell: 156.5;memory CD8 T-cell: 124.4;naive CD4 T-cell: 110.4;naive CD8 T-cell: 113.2;T-reg: 244.8" "Lineage enriched" "Detected in many" 113 "T-cells: 244.8" "Group enriched" "Detected in some" 27 "JURKAT: 1.3;MOLT-4: 3.6;NB-4: 3.0" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "unprognostic (3.52e-1)" 0.6 0.0 1.4 7.2 2.1 2.2 0.6 1.4 2.6 0.0 0.0 0.6 9.7 0.0 0.0 0.0 0.0 1.7 0.0 0.9 0.8 0.0 0.0 2.5 10.8 2.1 1.6 1.0 0.0 0.0 0.0 0.0 1.5 0.5 4.3 44.0 0.0 0.0 3.9 0.0 3.0 0.0 0.7 9.8 0.0 0.9 0.9 12.4 0.0 0.0 11.3 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.6 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.1 0.9 63.0 0.5 156.5 124.4 0.1 0.3 110.4 113.2 2.1 0.5 0.0 0.4 244.8 56.9 1.4 2.1 1.4 2.6 0.9 0.8 2.1 1.6 1.5 0.7 0.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ4 ENSG00000211885 "T cell receptor alpha joining 4" 14 22542199-22542261 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 18.0;retina: 56.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 36 "MAIT T-cell: 78.6;memory CD4 T-cell: 222.6;memory CD8 T-cell: 164.4;naive CD4 T-cell: 175.6;naive CD8 T-cell: 107.2;T-reg: 273.2" "Lineage enriched" "Detected in many" 91 "T-cells: 273.2" "Group enriched" "Detected in some" 70 "MOLT-4: 7.7;NB-4: 6.2" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 24: NB-4 - Immune response" "unprognostic (7.36e-2)" 0.0 0.0 2.3 7.7 2.7 5.0 3.5 1.6 2.6 0.0 0.7 1.8 5.4 0.0 0.0 0.0 0.7 3.5 0.0 0.9 0.5 1.3 1.0 5.9 15.0 2.5 2.2 0.0 0.0 0.0 0.0 0.6 1.2 0.3 5.8 56.0 1.9 0.0 0.0 2.2 1.6 0.0 1.5 11.3 3.4 0.1 0.9 18.0 0.2 0.0 10.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 4.7 0.7 78.6 0.2 222.6 164.4 0.3 0.9 175.6 107.2 2.9 0.3 0.2 0.4 273.2 46.2 2.3 2.7 1.6 2.6 0.9 0.5 2.5 2.2 1.2 1.5 0.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ3 ENSG00000211886 "T cell receptor alpha joining 3" A0A075B6Y3 14 22543179-22543240 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "retina: 89.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 18 "MAIT T-cell: 139.0;memory CD4 T-cell: 200.3;memory CD8 T-cell: 172.4;naive CD4 T-cell: 186.6;naive CD8 T-cell: 293.9;T-reg: 198.9" "Lineage enriched" "Detected in many" 146 "T-cells: 293.9" "Cell line enriched" "Detected in some" 14 "JURKAT: 181.0" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "unprognostic (1.21e-1)" "unprognostic (3.50e-1)" 0.9 0.0 1.8 13.1 3.2 3.7 0.0 1.5 1.8 2.7 0.1 2.4 0.0 0.0 3.8 0.0 0.0 2.1 0.0 1.1 1.0 1.3 0.0 6.0 18.4 1.7 1.1 0.0 0.0 0.0 0.0 0.4 2.1 0.0 4.2 89.2 1.9 0.0 0.0 1.4 14.5 0.0 1.2 9.1 4.9 0.6 1.1 17.2 0.0 0.0 17.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 181.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.6 11.2 0.2 139.0 0.8 200.3 172.4 0.2 0.8 186.6 293.9 2.0 0.3 0.8 1.0 198.9 56.6 1.8 3.2 1.5 1.8 1.1 1.0 1.7 1.1 2.1 1.2 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ2 ENSG00000211887 "T cell receptor alpha joining 2 (non-functional)" 14 22544071-22544136 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "retina: 73.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "stomach cancer: 0.7" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 1.7;memory CD8 T-cell: 2.6" "Lineage enriched" "Detected in single" 27 "T-cells: 2.6" "Cell line enriched" "Detected in some" 9 "JURKAT: 73.0" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "unprognostic (1.43e-1)" 0.0 0.0 0.4 7.4 0.9 2.2 0.0 0.6 1.4 2.3 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 4.9 10.0 1.3 0.7 0.0 0.0 0.0 0.0 0.6 0.5 0.7 4.5 73.1 0.0 0.0 0.0 0.0 8.0 0.0 0.7 15.4 6.7 0.1 0.4 12.9 0.0 0.0 2.7 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 73.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.7 2.6 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.9 0.6 1.4 0.3 0.1 1.3 0.7 0.5 0.7 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ1 ENSG00000211888 "T cell receptor alpha joining 1 (non-functional)" 14 22545037-22545098 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 28.1;retina: 94.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "memory CD8 T-cell: 3.6" "Lineage enriched" "Detected in single" 37 "T-cells: 3.6" "Cell line enriched" "Detected in some" 6 "JURKAT: 28.3" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "unprognostic (1.02e-1)" 2.5 0.0 2.2 7.8 2.8 6.6 3.2 1.0 2.9 2.6 0.2 1.5 0.0 0.0 11.5 0.7 0.0 0.5 0.0 0.8 0.0 0.6 0.8 3.8 17.2 1.2 0.8 0.0 0.0 0.0 0.0 0.0 1.1 0.0 4.2 94.0 1.9 0.0 0.0 0.7 0.0 1.2 0.4 12.6 3.6 0.1 0.8 28.1 0.0 0.0 14.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 3.8 3.1 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 2.4 0.0 2.7 3.6 0.0 0.0 2.3 0.8 0.0 0.0 0.0 0.0 0.8 0.1 2.2 2.8 1.0 2.9 0.8 0.0 1.2 0.8 1.1 0.4 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAC ENSG00000277734 "T cell receptor alpha constant" 14 22547506-22552156 "Predicted membrane proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 7 "lymphoid tissue: 787.9" "Cell type enhanced" "Detected in many" "dendritic cells: 166.3;Rod photoreceptor cells: 75.9;T-cells: 428.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "MAIT T-cell: 2123.1;memory CD4 T-cell: 2939.7;memory CD8 T-cell: 2508.6;naive CD4 T-cell: 2671.8;naive CD8 T-cell: 2388.0;T-reg: 4379.2" "Lineage enriched" "Detected in all" 41 "T-cells: 4379.2" "Cell line enhanced" "Detected in many" "HDLM-2: 127.0;JURKAT: 294.7;NB-4: 83.1;U-266/84: 126.2;U-698: 62.1" "Low region specificity" "Detected in all" NA NA "Cluster 13: T-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "prognostic favorable (3.21e-4)" "prognostic favorable (4.87e-6)" "unprognostic (9.92e-3)" "prognostic favorable (4.15e-6)" "unprognostic (3.71e-2)" "prognostic favorable (5.25e-5)" "unprognostic (2.83e-2)" "unprognostic (9.81e-3)" "unprognostic (2.51e-3)" "unprognostic (1.00e-2)" "unprognostic (1.01e-1)" "unprognostic (4.99e-1)" "prognostic unfavorable (3.40e-5)" "unprognostic (2.13e-1)" "unprognostic (6.35e-2)" "unprognostic (1.33e-1)" "unprognostic (2.75e-2)" 17.5 7.7 5.4 157.5 14.8 29.5 16.9 6.9 3.9 12.0 2.4 33.6 46.6 9.3 39.3 17.2 10.0 42.2 45.3 2.0 2.0 10.5 16.5 47.0 394.3 3.4 8.2 7.3 3.3 1.9 11.4 2.3 4.0 15.3 43.4 112.7 25.8 5.5 3.3 19.5 78.3 10.4 2.5 134.1 54.9 7.2 2.2 787.9 12.2 2.7 287.6 58.4 9.7 2.3 0.3 0.0 11.6 0.0 0.0 0.0 0.2 0.1 0.4 0.3 0.4 1.8 0.0 11.4 1.5 0.0 0.2 0.0 0.2 0.1 1.1 127.0 0.0 0.2 0.0 0.0 0.0 16.4 0.8 0.0 0.0 4.3 0.2 0.0 3.1 294.7 0.4 0.1 1.2 0.0 45.7 83.1 3.1 0.1 0.6 22.9 2.8 0.2 0.7 0.0 0.0 0.2 0.0 0.0 1.1 1.7 0.0 1.6 8.3 3.4 0.7 0.3 1.0 2.7 126.2 62.1 1.0 0.5 0.1 24.5 10.2 9.8 520.5 6.7 2123.1 105.6 2939.7 2508.6 7.9 94.6 2671.8 2388.0 57.7 89.7 11.0 11.8 4379.2 2965.8 5.4 14.8 6.9 3.9 2.0 2.0 3.4 8.2 4.0 2.5 2.2 2.3 9.0 3.2 25.6 0.0 46.3 0.0 1.0 0.0 5.7 9.0 4.9 8.5 35.7 0.0 6.2 0.0 12.5 0.2 166.3 0.9 17.6 0.7 46.2 0.9 0.6 3.3 0.0 16.4 0.0 0.0 0.2 15.9 4.1 0.5 10.1 0.0 9.3 1.4 1.3 0.0 0.0 0.9 0.0 8.1 0.0 4.8 1.8 12.2 0.0 0.0 20.2 11.8 44.3 0.0 0.0 0.1 1.2 5.3 25.4 0.2 0.5 4.6 0.0 75.9 0.0 2.6 4.7 2.2 0.8 5.4 0.0 0.3 428.0 0.0 0.7 0.2 DAD1 OST2 ENSG00000129562 "Defender against cell death 1" P61803 14 22564907-22589224 "Cancer-related genes, Metabolic proteins, Predicted membrane proteins, Transporters" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028882 Uncertain Uncertain "Endoplasmic reticulum,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 68: Epididymis - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 55: Plasma cells - Humoral immune response" Cytosol "Endoplasmic reticulum" "HPA028882: AB_10602214" "unprognostic (2.76e-1)" "unprognostic (1.21e-1)" "unprognostic (1.15e-1)" "unprognostic (1.97e-2)" "unprognostic (2.02e-1)" "unprognostic (1.18e-3)" "prognostic unfavorable (7.73e-4)" "unprognostic (9.43e-3)" "unprognostic (3.06e-2)" "unprognostic (6.09e-2)" "unprognostic (1.99e-2)" "unprognostic (9.64e-2)" "unprognostic (6.62e-3)" "unprognostic (1.19e-1)" "unprognostic (3.08e-1)" "unprognostic (1.93e-1)" "unprognostic (1.37e-3)" 204.0 229.3 209.2 159.1 224.4 129.0 224.0 236.2 259.4 229.6 252.2 197.7 165.8 184.3 473.8 187.0 230.5 190.8 202.6 211.4 238.0 296.8 275.7 183.4 169.6 240.2 218.7 174.5 200.2 254.1 201.6 141.8 238.7 145.5 209.9 86.2 286.3 205.5 156.6 137.2 173.8 206.6 237.2 165.3 197.0 150.7 219.2 211.6 272.8 197.5 191.0 200.0 163.4 252.0 373.3 344.7 274.6 375.8 740.2 529.9 238.3 387.0 473.0 340.5 478.1 219.6 520.1 233.7 242.1 453.1 381.4 330.0 291.1 375.7 543.3 319.8 265.1 228.5 180.9 886.0 514.5 321.2 315.8 395.8 498.7 356.0 454.4 383.1 506.2 220.9 176.4 532.1 509.9 459.3 153.6 391.4 169.7 816.1 557.8 211.7 232.4 306.7 503.2 306.1 211.5 263.4 294.9 416.1 445.9 328.7 251.4 323.1 381.1 291.8 232.2 358.2 248.3 391.2 502.6 308.5 263.8 225.5 431.0 532.4 421.9 460.9 528.4 371.9 518.9 527.2 543.8 501.4 401.0 477.1 564.8 497.6 481.5 437.2 332.3 783.9 560.3 941.8 209.2 224.4 236.2 259.4 211.4 238.0 240.2 218.7 238.7 237.2 219.2 252.0 357.9 160.3 161.7 15.0 183.9 198.3 188.3 581.8 149.7 25.1 201.0 274.6 173.8 187.3 315.2 255.6 27.1 260.9 204.6 174.8 215.2 525.4 196.8 270.3 242.9 267.8 135.7 130.2 10.6 415.2 383.1 276.5 145.2 255.6 302.6 150.8 187.7 231.9 350.3 21.9 11.0 242.3 360.1 146.2 224.8 101.5 214.3 166.8 330.8 8.4 217.3 216.8 198.8 18.1 42.5 396.8 160.7 199.0 408.6 172.5 244.8 420.8 393.7 42.6 151.2 141.5 291.0 300.3 128.1 179.6 215.8 289.0 211.7 266.6 183.8 174.4 ABHD4 FLJ12816 ENSG00000100439 "Abhydrolase domain containing 4, N-acyl phospholipase B" Q8TB40 14 22598237-22613215 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 35.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 35.4" "Cell line enhanced" "Detected in many" "ASC diff: 121.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000600 Uncertain Approved Nucleoplasm NA NA "Cluster 38: Basophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA000600: AB_1078081" "unprognostic (5.04e-2)" "unprognostic (5.15e-2)" "unprognostic (2.68e-3)" "unprognostic (8.17e-2)" "unprognostic (1.17e-1)" "unprognostic (5.24e-2)" "unprognostic (1.19e-3)" "unprognostic (3.69e-2)" "unprognostic (1.28e-1)" "unprognostic (5.72e-2)" "unprognostic (1.32e-3)" "unprognostic (3.73e-1)" "unprognostic (1.56e-2)" "unprognostic (5.18e-2)" "unprognostic (1.37e-1)" "unprognostic (4.51e-2)" "unprognostic (1.03e-2)" 22.8 28.7 21.6 7.3 23.6 12.6 17.5 22.3 22.4 25.9 27.7 19.2 15.0 26.3 27.4 38.3 15.4 24.7 20.5 21.0 24.5 25.3 22.6 17.6 8.0 27.8 24.5 15.9 14.5 22.8 12.8 17.9 23.3 19.3 13.8 21.7 16.5 33.7 25.5 18.9 17.9 24.5 22.5 14.8 24.9 36.8 24.2 10.1 21.6 27.2 14.8 24.8 26.2 26.0 23.4 38.5 15.5 14.2 121.8 44.0 14.9 10.3 52.2 25.3 46.8 23.5 36.4 2.2 26.7 45.2 27.2 44.5 9.9 26.6 20.6 17.3 3.5 8.7 28.1 77.9 55.6 1.4 30.3 56.1 20.6 33.2 28.2 52.7 26.4 16.0 6.5 41.1 23.5 12.8 0.7 1.3 18.8 94.4 27.7 6.5 13.8 9.8 29.6 24.6 1.0 3.1 69.1 24.3 27.2 30.6 9.5 2.6 18.8 11.0 14.9 18.0 4.1 44.1 25.3 0.8 8.2 1.8 8.9 35.4 6.3 10.2 8.2 4.7 6.8 5.5 5.4 5.5 4.2 3.1 1.7 3.5 25.7 7.3 4.6 0.6 3.4 5.6 21.6 23.6 22.3 22.4 21.0 24.5 27.8 24.5 23.3 22.5 24.2 26.0 5.0 12.8 5.6 2.6 4.7 3.2 7.0 5.2 7.4 3.5 6.2 6.6 6.7 11.5 3.4 3.7 4.2 6.1 4.8 9.8 9.8 13.3 3.1 8.3 6.0 6.5 6.0 4.4 1.1 11.7 2.3 5.2 16.3 12.5 5.1 5.2 9.3 10.3 7.8 8.4 1.2 6.8 4.1 6.9 1.7 4.7 5.6 4.6 1.8 1.0 9.4 6.9 5.2 4.0 3.7 9.8 9.3 8.2 12.4 9.5 13.3 4.7 2.6 3.2 6.6 3.1 6.0 0.7 0.5 13.2 2.7 26.8 5.0 9.7 3.3 11.7 OR6J1 "OR6J1P, OR6J2" ENSG00000255804 "Olfactory receptor family 6 subfamily J member 1" Q8NGC5 14 22630929-22644352 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.2" "Cell type enhanced" "Detected in single" "granulocytes: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 60: Granulocytes - Receptor signaling" 0.0 0.1 0.5 0.2 0.5 0.6 0.1 1.2 0.7 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.6 0.4 0.1 0.0 0.1 0.1 0.5 0.3 0.1 0.2 0.0 0.0 0.1 0.5 0.1 0.0 0.8 0.2 0.0 0.3 0.3 0.1 0.0 0.1 0.2 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.5 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.1 0.1 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.8 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.6 0.2 0.1 0.1 0.1 0.1 0.5 0.5 1.2 0.7 0.6 0.4 0.5 0.3 0.5 0.1 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OXA1L "MGC133129, OXA1" ENSG00000155463 "OXA1L mitochondrial inner membrane protein" Q15070 14 22766522-22773042 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003531 Approved Supported Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 32: Non-specific - Translation" Mitochondria "HPA003531: AB_1079539" "unprognostic (4.04e-3)" "unprognostic (2.41e-2)" "unprognostic (3.39e-1)" "unprognostic (2.24e-2)" "unprognostic (7.25e-2)" "unprognostic (1.42e-2)" "unprognostic (1.08e-2)" "unprognostic (1.06e-2)" "unprognostic (1.92e-1)" "unprognostic (1.01e-1)" "unprognostic (1.78e-1)" "unprognostic (1.78e-1)" "prognostic favorable (4.82e-4)" "unprognostic (8.35e-2)" "unprognostic (1.62e-1)" "unprognostic (4.37e-2)" "unprognostic (1.15e-3)" 77.7 90.7 27.6 40.8 28.5 71.9 67.6 31.4 28.8 59.4 47.1 72.9 66.3 55.0 48.1 76.6 55.8 49.6 147.2 27.5 29.6 70.8 108.6 54.8 70.0 31.3 29.1 71.2 98.0 105.3 27.5 38.0 31.1 45.0 57.7 41.9 64.2 44.8 234.9 69.3 58.9 46.1 29.1 62.3 83.9 25.0 31.6 63.6 54.9 272.5 75.5 61.3 60.4 31.1 89.3 121.3 48.8 82.1 146.7 217.4 94.4 64.0 138.1 94.3 107.9 91.1 96.4 167.0 86.4 75.0 73.0 121.0 103.0 126.3 90.0 67.6 65.4 79.1 73.2 329.7 165.5 150.9 88.4 211.0 137.6 75.4 114.9 114.7 273.3 93.8 62.2 124.0 103.4 130.0 91.8 51.3 53.2 118.5 150.0 92.9 87.2 128.3 117.9 103.4 35.1 67.0 94.6 205.7 129.7 58.4 89.2 122.7 86.2 52.7 62.2 98.5 75.4 94.0 84.7 78.1 41.6 83.6 60.0 11.9 68.1 18.5 29.5 71.6 36.0 51.0 42.5 37.4 95.1 54.4 47.4 35.6 15.1 41.7 58.5 26.9 55.8 53.7 27.6 28.5 31.4 28.8 27.5 29.6 31.3 29.1 31.1 29.1 31.6 31.1 30.6 48.1 44.0 7.8 83.7 69.5 61.1 89.0 92.8 31.0 52.1 46.5 118.0 72.9 62.1 29.5 10.4 72.8 32.5 48.9 74.3 85.2 10.2 20.4 40.3 58.6 40.7 64.3 6.8 161.3 113.0 47.6 66.8 23.1 80.4 56.5 64.2 102.9 143.4 18.5 7.5 75.3 38.7 148.1 76.8 13.3 57.2 85.6 51.6 3.7 133.4 22.9 74.2 4.5 8.0 86.3 69.7 36.9 84.2 45.6 101.4 116.0 42.6 38.3 39.5 39.4 43.0 31.8 28.4 112.9 67.3 57.2 57.9 70.6 112.1 74.9 SLC7A7 "LPI, y+LAT-1" ENSG00000155465 "Solute carrier family 7 member 7" Q9UM01 14 22773222-22829820 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 131.6;kidney: 300.6" "Group enriched" "Detected in many" 4 "Hofbauer cells: 216.5;Kupffer cells: 410.6;Macrophages: 146.2;monocytes: 164.0;Proximal enterocytes: 423.1;Proximal tubular cells: 327.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 299.9;intermediate monocyte: 410.0;non-classical monocyte: 457.1" "Lineage enriched" "Detected in many" 5 "monocytes: 457.1" "Group enriched" "Detected in many" 4 "BEWO: 217.2;CACO-2: 385.7;OE19: 329.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA036227 Enhanced NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA036227: AB_10696653" "unprognostic (1.34e-1)" "unprognostic (7.65e-2)" "unprognostic (4.25e-2)" "unprognostic (2.52e-1)" "unprognostic (6.12e-2)" "unprognostic (3.69e-2)" "unprognostic (7.84e-3)" "unprognostic (1.47e-1)" "unprognostic (2.88e-2)" "unprognostic (1.73e-2)" "unprognostic (2.60e-3)" "unprognostic (7.15e-2)" "prognostic unfavorable (6.28e-6)" "unprognostic (2.68e-3)" "unprognostic (1.86e-2)" "unprognostic (2.61e-1)" "unprognostic (1.12e-1)" 15.1 9.0 3.1 37.4 3.2 19.7 6.8 3.8 7.5 7.3 4.3 13.8 107.0 5.3 2.0 3.7 7.8 17.0 5.1 2.8 3.8 300.6 16.4 54.1 29.1 6.9 4.7 2.1 5.2 78.4 1.4 18.2 6.4 3.5 15.0 1.0 5.4 2.8 2.0 3.2 131.6 15.6 5.1 56.8 8.6 32.8 7.1 9.6 4.6 2.8 25.2 14.7 4.1 8.1 0.2 11.2 1.2 0.5 1.9 3.7 217.2 2.2 16.3 0.4 1.4 385.7 34.4 17.0 72.2 1.4 1.2 13.3 0.1 0.0 0.6 0.6 0.2 0.9 0.4 3.7 9.1 1.9 1.6 7.1 1.0 1.0 0.5 1.8 25.3 1.5 0.1 12.8 2.9 0.6 0.4 1.7 3.6 329.0 0.1 2.9 35.5 9.8 0.8 1.3 0.4 0.8 0.6 0.5 2.5 9.4 0.4 8.3 1.3 0.8 1.7 0.6 0.5 2.7 0.9 8.9 0.9 0.8 0.2 0.2 299.9 1.1 0.5 410.0 0.4 19.1 0.2 0.2 99.5 13.8 0.7 0.4 36.5 0.3 457.1 3.4 0.9 155.1 3.1 3.2 3.8 7.5 2.8 3.8 6.9 4.7 6.4 5.1 7.1 8.1 5.3 12.8 7.1 2.0 14.3 1.0 0.2 6.7 1.8 0.2 0.5 1.7 0.9 67.2 5.6 3.7 0.0 1.2 5.7 3.0 11.7 8.2 61.1 1.7 1.2 5.0 1.2 0.0 0.6 6.4 5.2 4.4 2.6 0.4 1.3 0.7 16.1 3.0 216.5 0.0 1.4 7.2 2.0 410.6 16.8 11.8 3.7 146.2 5.4 20.6 164.0 0.4 4.1 0.0 0.8 8.9 12.5 0.0 20.1 0.1 423.1 327.6 9.2 1.3 6.6 0.8 1.4 17.8 2.2 0.4 0.4 1.8 2.7 38.8 6.4 0.1 MRPL52 ENSG00000172590 "Mitochondrial ribosomal protein L52" Q86TS9 14 22829879-22835037 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 549.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012319 Approved Supported Nucleoplasm,Mitochondria Yes No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 7: Non-specific - Mitochondria" Mitochondria Nucleoplasm "HPA012319: AB_1854118" "unprognostic (8.98e-2)" "unprognostic (9.07e-2)" "unprognostic (1.36e-1)" "unprognostic (3.18e-1)" "unprognostic (1.36e-1)" "unprognostic (4.74e-2)" "unprognostic (4.01e-3)" "unprognostic (1.29e-1)" "unprognostic (6.52e-2)" "unprognostic (8.05e-3)" "unprognostic (8.07e-2)" "unprognostic (2.87e-1)" "unprognostic (7.46e-2)" "unprognostic (2.19e-1)" "unprognostic (1.40e-1)" "unprognostic (3.16e-1)" "unprognostic (1.41e-1)" 76.5 105.6 106.9 53.7 109.6 51.9 72.4 113.6 130.8 66.5 109.4 88.3 70.0 72.8 30.8 141.6 61.0 20.6 193.7 107.7 110.4 130.8 154.2 73.5 41.7 113.4 109.8 59.9 108.7 70.6 70.1 32.9 113.6 83.5 33.9 15.2 79.6 35.6 155.2 96.6 77.7 25.6 111.5 96.3 113.4 67.7 112.0 62.0 83.2 55.4 41.3 85.0 78.2 112.9 237.5 181.4 97.4 121.4 59.3 69.1 236.8 161.2 115.0 140.8 133.4 224.1 321.9 178.8 172.5 111.3 143.4 210.8 79.8 223.4 105.6 190.8 132.6 133.6 65.6 518.5 180.3 211.9 183.6 104.8 150.4 182.7 154.5 111.2 226.6 222.7 139.4 172.8 104.6 329.2 172.5 320.0 180.1 292.5 397.5 210.2 121.5 210.4 149.9 138.7 96.8 125.1 124.5 120.6 178.3 68.9 116.0 198.9 176.5 146.4 172.0 185.1 249.2 169.4 219.1 228.0 133.3 143.3 239.6 101.5 111.2 60.2 74.5 128.9 69.5 140.9 82.2 68.2 159.1 111.6 75.9 74.2 19.1 74.5 96.4 131.3 100.7 98.5 106.9 109.6 113.6 130.8 107.7 110.4 113.4 109.8 113.6 111.5 112.0 112.9 105.5 73.7 85.4 5.2 132.5 121.2 88.0 169.2 98.4 23.2 131.2 145.2 103.4 167.3 118.0 136.1 18.8 177.3 82.5 220.9 277.8 245.2 72.4 106.5 89.8 104.4 138.0 112.5 5.7 314.5 287.7 65.8 165.1 116.3 123.0 70.5 106.4 291.0 236.2 20.2 6.2 268.0 107.8 140.2 125.1 58.3 55.9 120.1 124.5 6.5 221.5 80.4 107.1 5.5 9.1 396.9 215.6 49.2 156.4 111.8 313.7 549.8 99.9 33.7 65.7 70.7 147.7 135.4 105.3 190.8 149.2 126.0 85.0 80.3 233.8 98.8 MMP14 MT1-MMP ENSG00000157227 "Matrix metallopeptidase 14" P50281 14 22836560-22849041 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 244.0;Pancreatic endocrine cells: 144.7;Syncytiotrophoblasts: 122.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 923.8;HHSteC: 794.2;HSkMC: 887.0;hTERT-RPE1: 925.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009918, HPA051432" Approved Approved "Intermediate filaments,Cytosol" No No 1400000 "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 38: Extravillous trophoblasts - Unknown function" Cytosol "Intermediate filaments" "CAB009918: AB_2250767, HPA051432: AB_2681484" "unprognostic (1.34e-1)" "unprognostic (1.37e-1)" "unprognostic (1.11e-2)" "unprognostic (2.81e-1)" "unprognostic (4.28e-2)" "unprognostic (1.12e-2)" "unprognostic (3.05e-3)" "unprognostic (5.91e-3)" "unprognostic (1.95e-1)" "prognostic unfavorable (9.48e-4)" "unprognostic (3.82e-3)" "unprognostic (7.31e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (5.02e-2)" "unprognostic (6.69e-2)" "unprognostic (1.00e-2)" "unprognostic (3.41e-3)" 151.5 31.7 5.6 59.9 5.0 1.6 101.5 5.7 7.5 181.3 61.8 77.2 39.5 167.3 19.0 92.1 82.1 148.2 41.3 6.6 7.2 35.9 13.2 91.8 24.8 11.9 8.4 90.2 36.0 65.3 14.2 118.9 9.2 59.9 36.6 9.6 78.1 45.5 18.8 127.5 69.4 106.0 7.3 30.8 57.7 11.7 13.2 13.0 50.0 16.1 30.8 103.9 111.1 10.6 90.6 1.2 26.3 2.0 923.8 651.6 455.9 270.1 606.4 93.3 158.5 21.3 337.4 0.9 146.4 301.9 24.6 216.3 0.3 262.2 99.7 1.1 0.6 37.2 1.7 5.0 794.2 0.4 1.3 887.0 148.7 334.7 288.3 925.5 492.9 0.6 0.8 2.1 185.1 0.7 0.4 79.4 14.7 17.7 52.4 2.1 96.0 0.2 61.4 148.1 0.3 0.6 187.3 0.3 574.2 104.4 1.0 79.5 436.8 724.9 53.7 198.2 329.6 0.8 1.6 1.1 410.9 0.6 396.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 5.0 5.7 7.5 6.6 7.2 11.9 8.4 9.2 7.3 13.2 10.6 13.9 12.8 3.0 2.0 3.4 34.0 23.4 105.4 39.3 0.0 14.1 17.5 4.7 50.1 42.2 7.3 0.0 105.6 0.3 19.9 11.7 63.0 0.4 16.1 81.6 35.2 7.8 0.0 0.0 28.7 244.0 84.0 25.5 14.8 3.8 9.3 32.9 2.7 89.5 0.0 0.0 24.5 34.6 20.2 32.7 2.4 72.1 38.0 37.4 4.7 21.5 14.3 0.0 0.5 0.1 144.7 33.0 54.9 0.3 21.8 19.9 11.7 46.8 0.8 39.5 11.1 73.9 0.8 0.8 33.7 34.2 122.7 2.5 15.6 18.6 37.9 LRP10 "DKFZP564C1940, LRP9, MGC8675, MST087, MSTP087" ENSG00000197324 "LDL receptor related protein 10" Q7Z4F1 14 22871740-22881713 "Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 367.2;Pancreatic endocrine cells: 314.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 59.1" "Lineage enriched" "Detected in all" 5 "granulocytes: 59.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000932 Approved Nucleoplasm,Nucleoli NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Nucleoli "HPA000932: AB_2281523" "unprognostic (1.08e-1)" "unprognostic (1.52e-2)" "unprognostic (3.72e-2)" "unprognostic (4.59e-2)" "unprognostic (1.72e-1)" "unprognostic (5.01e-2)" "prognostic unfavorable (3.54e-7)" "prognostic unfavorable (9.17e-4)" "unprognostic (8.32e-2)" "unprognostic (1.48e-2)" "unprognostic (1.97e-2)" "unprognostic (4.55e-2)" "prognostic favorable (6.31e-5)" "unprognostic (3.06e-2)" "unprognostic (8.81e-2)" "unprognostic (2.27e-1)" "unprognostic (4.14e-2)" 81.8 48.7 27.3 67.4 34.1 80.3 74.9 30.6 25.4 87.1 53.5 111.1 94.8 100.3 26.5 173.4 76.0 108.7 68.1 24.1 33.2 79.2 45.1 79.9 49.7 53.8 33.0 76.8 74.6 87.7 28.8 57.0 35.2 70.0 55.9 10.4 95.2 95.1 45.7 94.6 91.3 76.1 36.9 62.5 99.8 15.5 35.1 38.9 63.3 36.0 53.8 104.7 100.0 38.8 78.9 94.3 20.4 53.4 269.9 155.4 68.6 121.6 228.6 75.1 103.4 29.1 272.4 41.2 59.5 275.8 85.9 109.8 13.3 139.2 29.5 67.5 14.3 14.4 48.4 20.5 120.0 33.0 125.4 170.8 159.4 112.7 57.9 207.3 138.8 18.7 17.9 153.8 102.8 90.3 9.3 10.0 4.4 75.8 125.6 20.8 20.6 41.5 79.1 137.8 1.8 22.1 67.3 127.5 52.4 15.2 67.1 23.5 146.3 114.9 32.5 60.4 51.1 71.6 45.6 18.7 59.6 13.2 50.2 15.3 4.7 34.6 9.7 4.7 9.5 7.3 11.9 11.3 4.6 4.9 10.1 5.8 59.1 5.4 5.5 3.8 12.4 7.3 27.3 34.1 30.6 25.4 24.1 33.2 53.8 33.0 35.2 36.9 35.1 38.8 78.4 105.8 60.9 13.1 60.5 38.5 95.8 69.1 40.9 2.3 68.0 51.7 30.4 115.8 100.4 82.8 0.0 67.9 60.7 367.2 9.8 173.3 14.1 45.5 35.3 64.2 66.5 69.7 0.2 238.5 96.5 71.8 86.6 80.6 34.9 40.2 81.4 43.2 58.7 0.0 0.2 125.4 57.0 55.0 46.8 16.5 56.8 44.1 55.2 10.3 82.2 91.4 127.7 3.5 7.3 314.0 289.6 73.0 89.8 127.3 259.8 47.6 85.8 8.8 65.7 38.8 70.4 5.4 7.9 74.6 47.5 132.4 58.2 24.6 109.1 154.1 REM2 FLJ38964 ENSG00000139890 "RRAD and GEM like GTPase 2" Q8IYK8 14 22883222-22887678 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 9.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 12.8;Early spermatids: 29.2;Endometrial ciliated cells: 10.9;Late spermatids: 9.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 3.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 3.1" "Region enhanced" "Detected in all" "basal ganglia: 44.8" "Group enriched" "Detected in some" 5 "basal ganglia: 8.3;cerebellum: 4.6;hippocampal formation: 3.2;midbrain: 2.2" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 12: NES - Nervous system development" "Cluster 29: Early spermatids - Spermatogenesis" "unprognostic (4.56e-3)" "unprognostic (1.89e-2)" "unprognostic (1.47e-1)" "unprognostic (3.95e-1)" "unprognostic (1.49e-1)" "unprognostic (9.50e-2)" "unprognostic (1.11e-1)" "unprognostic (1.21e-2)" "unprognostic (1.54e-1)" "unprognostic (1.66e-3)" "unprognostic (1.49e-5)" "unprognostic (9.40e-2)" "unprognostic (4.63e-5)" "unprognostic (3.56e-1)" "unprognostic (2.72e-1)" "unprognostic (9.93e-2)" "unprognostic (2.49e-2)" 0.7 0.4 1.0 0.9 3.3 9.9 0.7 1.4 2.1 1.2 2.0 1.3 0.3 0.8 0.4 0.7 2.6 0.3 0.4 1.3 1.6 1.6 0.6 2.3 0.9 1.1 1.2 1.1 0.6 1.3 5.8 0.2 0.8 1.5 0.1 0.5 0.8 0.3 0.8 2.2 2.0 0.3 0.8 5.8 0.9 4.8 2.2 0.6 1.0 0.3 0.5 1.0 0.9 0.8 0.7 0.3 3.1 0.1 0.3 0.4 0.4 0.0 0.2 0.0 0.2 0.3 1.0 0.3 0.1 0.0 0.1 1.3 0.0 0.1 0.2 0.5 0.7 0.1 1.5 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.1 1.3 0.2 1.0 0.0 0.3 0.1 0.3 0.6 0.0 0.1 0.3 0.1 0.1 0.4 1.5 0.3 0.4 0.5 0.1 0.5 0.2 0.0 0.0 0.7 0.0 0.1 1.2 0.5 0.8 0.1 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.3 0.6 0.2 0.3 0.0 0.9 0.4 0.5 3.7 0.0 0.4 0.2 0.2 0.1 1.0 3.3 1.4 2.1 1.3 1.6 1.1 1.2 0.8 0.8 2.2 0.8 1.6 12.8 2.4 0.0 4.0 2.8 0.9 1.2 4.0 0.1 4.7 4.3 1.7 1.5 1.9 1.8 0.0 0.5 3.5 1.4 0.0 0.7 29.2 10.9 1.3 1.1 6.6 0.4 0.2 0.0 0.3 0.7 1.5 4.7 0.0 0.6 0.4 0.0 0.4 0.0 0.1 1.9 0.0 0.6 1.0 9.6 1.2 0.6 3.6 0.0 1.3 0.7 0.0 0.0 0.1 0.4 0.2 1.2 3.1 0.9 0.4 0.5 4.6 0.9 0.0 0.4 0.9 0.8 0.8 4.5 3.0 0.4 1.7 0.3 1.2 1.3 RBM23 "CAPERbeta, FLJ10482, RNPC4" ENSG00000100461 "RNA binding motif protein 23" Q86U06 14 22893204-22919182 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" HPA004144 Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Intermediate filaments" Nucleoplasm "HPA004144: AB_1079747" "unprognostic (5.93e-2)" "unprognostic (1.47e-1)" "unprognostic (1.48e-1)" "unprognostic (7.11e-2)" "unprognostic (1.11e-1)" "unprognostic (1.41e-2)" "unprognostic (2.14e-2)" "unprognostic (1.06e-1)" "unprognostic (4.27e-2)" "unprognostic (4.70e-2)" "unprognostic (3.73e-3)" "unprognostic (2.29e-1)" "prognostic favorable (8.06e-9)" "unprognostic (4.41e-2)" "unprognostic (3.06e-1)" "unprognostic (5.05e-2)" "unprognostic (1.81e-1)" 31.8 37.9 35.8 34.1 38.5 53.2 40.7 55.0 42.0 46.0 48.4 38.3 30.7 53.4 39.3 39.6 59.4 39.1 33.6 35.8 42.9 44.2 40.7 42.0 44.8 38.6 38.5 57.9 39.2 83.2 40.6 46.7 37.0 39.0 41.7 52.2 38.0 40.1 29.1 36.3 37.3 45.9 37.7 45.4 39.2 31.3 43.4 57.9 54.5 40.7 50.6 43.5 37.7 45.0 55.9 86.3 86.6 45.4 46.5 39.6 36.1 59.9 81.3 114.0 88.8 39.6 66.6 93.0 45.8 55.8 54.8 77.3 98.3 50.3 92.2 73.1 81.2 43.7 65.8 2.8 72.9 84.6 68.9 51.0 68.3 65.8 43.4 63.4 64.4 45.5 56.5 58.3 56.6 71.1 93.8 38.0 38.7 84.8 80.3 80.1 71.8 56.6 44.0 78.0 59.5 66.3 89.8 68.8 38.6 56.6 50.8 49.6 59.8 19.3 33.3 47.5 56.1 55.1 77.0 87.6 32.4 48.2 71.7 40.1 47.7 50.7 37.1 37.0 25.1 29.3 26.3 32.2 49.5 34.7 31.5 28.2 136.6 59.7 49.7 24.6 30.0 32.0 35.8 38.5 55.0 42.0 35.8 42.9 38.6 38.5 37.0 37.7 43.4 45.0 36.8 44.8 48.3 12.1 82.3 18.4 44.7 28.4 27.9 66.4 38.7 35.9 24.3 68.6 42.7 33.1 116.7 53.0 53.8 48.8 45.0 36.3 9.5 55.1 36.8 39.5 65.4 54.1 13.5 33.5 48.0 32.0 36.7 41.4 70.9 27.2 53.2 37.2 31.5 50.5 16.1 39.3 20.3 54.9 33.6 11.9 35.4 40.4 16.0 19.7 70.8 52.4 102.0 18.6 15.3 39.7 55.1 28.2 42.2 29.1 57.3 33.1 64.0 164.2 32.9 47.8 32.1 52.0 64.3 22.0 21.0 101.4 64.0 28.1 42.3 27.8 PRMT5 "HRMT1L5, SKB1, SKB1Hs" ENSG00000100462 "Protein arginine methyltransferase 5" O14744 14 22920525-22929408 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Pancreatic endocrine cells: 92.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005525, CAB012459, HPA064708" Approved Supported Nucleoplasm,Cytosol NA NA 45000 "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Nucleoplasm, Cytosol" "CAB012459: , HPA005525: AB_1079679, HPA064708: AB_2685330" "unprognostic (8.34e-2)" "unprognostic (5.14e-3)" "unprognostic (1.19e-2)" "unprognostic (2.19e-1)" "unprognostic (4.56e-3)" "prognostic unfavorable (1.82e-4)" "prognostic unfavorable (4.77e-5)" "unprognostic (3.64e-2)" "unprognostic (6.80e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (2.61e-4)" "unprognostic (4.69e-2)" "unprognostic (1.99e-3)" "unprognostic (1.21e-1)" "unprognostic (7.04e-2)" "unprognostic (6.28e-2)" "prognostic unfavorable (1.04e-4)" 27.6 31.0 19.9 27.9 21.6 21.7 34.9 21.0 25.9 33.3 24.4 38.4 24.0 36.9 30.6 49.0 44.6 19.4 35.1 20.9 21.8 37.0 28.3 23.2 26.6 20.2 22.2 45.3 32.9 47.3 24.5 30.6 22.0 27.9 35.6 30.8 27.7 33.3 65.8 34.4 23.3 35.5 20.4 26.3 29.2 30.3 21.6 33.1 37.9 42.1 34.3 31.4 33.5 22.8 161.7 169.2 114.2 112.9 62.3 67.7 125.6 104.1 91.6 192.7 156.6 159.2 160.1 171.3 83.2 88.5 108.3 135.8 246.4 212.8 213.9 98.5 119.3 104.5 108.3 256.3 111.4 221.7 85.7 69.3 113.2 143.1 264.8 72.7 91.0 128.5 160.0 91.7 108.5 171.4 151.3 102.9 103.1 160.8 221.8 176.0 140.3 122.7 98.8 110.7 126.0 79.8 125.7 132.3 65.5 94.3 91.3 82.6 70.9 75.1 103.1 103.0 145.9 116.6 246.0 207.2 46.1 109.2 116.0 3.0 31.3 0.4 14.2 31.7 22.9 30.6 19.0 23.0 42.8 27.9 24.4 20.4 7.7 19.8 25.1 25.9 17.6 29.1 19.9 21.6 21.0 25.9 20.9 21.8 20.2 22.2 22.0 20.4 21.6 22.8 8.5 19.2 15.1 5.5 11.4 26.5 26.5 33.8 15.4 10.8 13.9 15.4 1.1 28.6 19.4 7.3 8.4 41.7 8.6 11.1 23.5 32.0 2.3 18.5 21.4 12.3 6.1 24.4 6.1 27.0 33.4 16.7 12.8 12.6 7.0 21.9 10.4 15.1 19.6 16.8 5.8 17.5 20.3 4.4 11.7 3.7 16.4 8.0 26.6 0.0 11.8 18.2 3.1 5.5 4.0 92.8 12.7 21.1 12.4 23.6 7.4 24.6 31.1 11.2 6.6 25.9 19.5 43.1 47.3 20.3 27.8 33.4 8.2 27.5 21.1 17.9 HAUS4 "C14orf94, FLJ20424" ENSG00000092036 "HAUS augmin like complex subunit 4" Q9H6D7 14 22946228-22957161 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029803 Approved NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 50: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "HPA029803: AB_10601428" "unprognostic (8.47e-3)" "unprognostic (3.52e-1)" "unprognostic (6.47e-2)" "unprognostic (7.59e-2)" "unprognostic (3.08e-2)" "unprognostic (1.73e-1)" "unprognostic (7.54e-2)" "unprognostic (4.32e-3)" "unprognostic (2.92e-2)" "unprognostic (2.87e-2)" "unprognostic (7.70e-2)" "unprognostic (8.66e-2)" "unprognostic (3.00e-2)" "unprognostic (6.94e-2)" "unprognostic (3.16e-1)" "unprognostic (1.96e-1)" "prognostic unfavorable (2.24e-4)" 29.3 24.8 12.8 29.2 13.8 63.5 39.7 12.9 15.6 33.7 14.4 32.3 28.1 26.2 22.2 30.5 31.0 26.4 26.5 11.8 13.6 26.0 32.2 31.7 40.7 15.2 14.2 52.8 45.2 27.6 14.5 22.4 15.0 26.1 30.2 10.4 33.2 26.4 19.1 39.3 30.6 24.3 13.9 37.7 32.0 12.9 13.8 30.8 27.7 22.9 36.7 29.0 31.7 15.6 77.0 51.2 55.5 56.9 42.0 50.4 86.6 36.5 48.2 39.3 56.1 37.0 88.5 146.2 17.2 22.3 29.2 75.5 31.2 44.9 34.5 39.8 23.0 48.1 35.8 90.2 37.7 63.3 77.8 35.7 84.7 17.5 50.9 48.2 71.1 82.0 35.8 71.2 41.6 58.1 69.8 56.7 29.9 59.3 50.9 66.3 68.8 57.0 35.2 40.7 22.5 37.1 52.7 54.0 34.0 24.1 47.8 50.2 39.3 36.2 46.3 26.3 33.6 74.6 67.9 67.1 16.7 70.6 20.9 8.7 79.5 17.7 15.7 54.1 20.8 38.2 29.1 22.2 101.3 33.0 40.2 32.0 100.8 23.7 34.7 28.5 43.2 46.0 12.8 13.8 12.9 15.6 11.8 13.6 15.2 14.2 15.0 13.9 13.8 15.6 4.9 22.4 6.8 16.0 13.4 12.4 5.9 8.7 29.6 1.0 13.7 11.0 1.3 11.5 7.5 1.8 0.0 12.4 3.4 9.6 5.9 17.6 0.6 2.3 3.9 7.5 7.8 42.2 3.7 27.3 13.8 8.3 16.3 3.7 3.8 4.9 8.9 4.4 17.3 0.0 6.1 20.9 2.0 29.1 13.0 0.5 5.6 17.3 5.4 15.9 33.4 6.2 3.1 7.5 8.9 18.4 18.7 4.1 21.5 3.4 26.3 8.0 9.6 0.5 0.0 3.3 6.2 3.1 6.1 32.0 11.1 8.2 10.9 1.2 35.2 5.9 AL132780.3 ENSG00000259132 "Novel protein" 14 22946270-22982258 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in single" 32 "Alveolar cells type 1: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 38.9;MCF7: 23.7" HPA029803 Approved NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 22: Non-specific - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 11: Alveolar cells - Smell perception" "HPA029803: AB_10601428" 3.0 4.8 9.5 2.8 9.6 4.7 2.5 9.1 13.9 4.0 9.0 5.6 3.9 2.6 6.8 4.2 4.7 4.2 8.1 9.6 9.4 7.7 6.9 4.0 6.4 10.1 9.4 6.9 12.8 2.3 3.1 2.8 9.9 4.7 4.0 2.0 3.7 2.1 5.8 6.1 4.2 1.8 9.5 10.2 5.4 3.4 9.8 4.7 3.4 1.5 2.6 3.5 3.0 10.2 4.0 13.0 4.4 0.8 7.1 7.1 6.1 0.0 5.6 3.7 4.1 2.9 0.0 0.0 1.9 9.4 1.3 0.6 2.9 3.9 2.1 0.0 1.6 0.0 7.7 38.9 4.1 4.2 0.1 4.3 8.1 3.5 8.3 8.5 6.9 12.7 0.0 5.6 3.4 23.7 6.2 16.8 2.2 6.4 5.1 5.7 3.9 4.4 14.1 10.8 4.4 1.9 0.0 2.8 1.4 4.7 4.6 7.9 0.1 5.4 2.6 0.6 4.4 4.7 9.4 7.1 0.4 1.7 3.1 0.3 2.8 1.2 1.7 2.5 0.6 1.6 1.0 1.0 2.8 2.3 1.8 1.0 5.8 0.5 1.6 1.4 2.4 1.5 9.5 9.6 9.1 13.9 9.6 9.4 10.1 9.4 9.9 9.5 9.8 10.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AJUBA "JUB, MGC15563" ENSG00000129474 "Ajuba LIM protein" Q96IF1 14 22971177-22982551 "Cancer-related genes, Predicted intracellular proteins" "Cell adhesion, Cell cycle, RNA-mediated gene silencing, Transcription, Transcription regulation" Repressor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 61.7" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 47.5;Basal squamous epithelial cells: 35.3;Pancreatic endocrine cells: 33.8;Prostatic glandular cells: 34.2;Sertoli cells: 32.9;Suprabasal keratinocytes: 49.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 217.0;hTCEpi: 222.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA006171 Approved Approved "Nucleoplasm,Golgi apparatus" NA Yes "Cluster 11: Basophils - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Golgi apparatus" "HPA006171: AB_1852044" "unprognostic (1.15e-1)" "unprognostic (2.99e-2)" "unprognostic (2.39e-1)" "unprognostic (1.24e-3)" "unprognostic (9.81e-2)" "unprognostic (1.49e-1)" "unprognostic (1.80e-3)" "unprognostic (2.73e-1)" "unprognostic (1.39e-1)" "unprognostic (1.86e-1)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.47e-1)" "unprognostic (3.19e-3)" "unprognostic (2.94e-1)" "unprognostic (2.68e-1)" "unprognostic (9.35e-3)" "unprognostic (2.07e-1)" 4.8 3.0 2.3 1.4 1.8 0.5 6.7 2.0 2.2 14.4 9.2 3.2 1.5 12.1 8.5 18.3 7.5 4.9 6.3 2.2 1.5 17.7 43.4 15.2 2.6 2.5 2.1 12.2 11.6 7.2 2.0 19.3 1.6 10.6 2.5 3.7 8.2 15.9 1.9 61.7 1.9 8.4 2.2 3.8 4.2 5.5 1.9 8.2 10.9 2.3 5.5 7.6 15.5 2.7 46.9 54.1 71.0 27.6 6.8 12.2 57.4 44.9 58.5 102.6 91.4 116.0 47.3 1.2 45.5 92.9 70.8 146.2 54.9 217.0 124.6 4.5 5.0 3.5 90.8 131.4 78.9 4.9 3.1 38.9 222.3 42.9 164.3 72.7 40.0 8.3 1.9 2.8 96.2 37.3 4.5 5.7 4.5 86.6 73.9 12.7 59.0 1.2 103.9 71.3 0.2 6.2 135.5 39.4 8.8 57.4 55.3 4.5 36.1 44.2 88.4 7.3 43.6 0.4 1.3 0.5 7.0 4.2 20.6 0.7 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.5 0.1 0.2 0.3 0.2 0.5 0.5 0.2 0.2 0.0 0.1 2.3 1.8 2.0 2.2 2.2 1.5 2.5 2.1 1.6 2.2 1.9 2.7 2.1 19.2 6.4 0.7 0.0 47.5 13.0 27.6 35.3 0.1 3.7 9.7 4.5 20.0 10.2 7.3 0.0 10.0 0.1 0.3 5.9 14.3 5.8 13.0 2.5 4.0 0.0 0.0 0.0 14.9 9.8 3.4 0.0 4.4 0.0 12.8 2.5 17.1 1.7 0.0 0.0 0.4 2.0 0.0 2.2 5.0 3.7 0.6 3.6 0.0 0.0 8.1 0.0 0.5 0.0 33.8 0.1 0.7 1.2 34.2 0.3 21.0 8.3 0.2 32.9 2.7 14.0 7.0 2.7 14.2 49.6 4.0 0.5 1.6 0.8 18.0 C14orf93 "FLJ12154, RTFC" ENSG00000100802 "Chromosome 14 open reading frame 93" Q9H972 14 22985894-23010166 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002569 Approved Approved "Nucleoplasm,Plasma membrane" "Secreted to blood" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 57: B-cells - Immune response" "Nucleoplasm, Plasma membrane" "HPA002569: AB_1078334" "prognostic favorable (5.05e-4)" "unprognostic (1.31e-2)" "unprognostic (2.97e-2)" "unprognostic (2.23e-3)" "unprognostic (2.30e-2)" "unprognostic (1.30e-1)" "unprognostic (1.24e-2)" "unprognostic (1.02e-1)" "unprognostic (1.88e-1)" "unprognostic (1.29e-1)" "unprognostic (4.86e-3)" "unprognostic (7.45e-2)" "unprognostic (2.01e-3)" "unprognostic (1.10e-1)" "unprognostic (2.49e-1)" "unprognostic (2.14e-1)" "unprognostic (7.11e-2)" 8.3 4.8 6.5 5.7 7.7 12.6 8.2 6.7 7.0 11.2 8.5 8.8 7.4 8.7 11.4 7.4 9.5 9.2 5.6 6.2 7.3 11.1 8.9 6.7 10.1 7.7 7.2 10.3 9.6 8.3 6.5 5.0 7.5 9.6 9.6 4.4 8.0 5.7 6.7 18.3 8.1 6.8 6.7 10.6 8.3 4.0 7.2 15.7 11.5 7.9 10.5 8.6 8.3 9.5 5.7 10.5 8.8 12.3 13.9 30.8 12.2 6.6 10.2 5.1 6.7 6.6 16.5 16.0 6.1 6.0 7.2 11.8 5.4 16.6 4.7 6.3 3.8 10.1 14.0 15.3 12.1 7.4 8.3 22.4 12.8 7.6 9.6 18.5 9.6 10.1 11.1 3.4 5.3 16.3 9.5 13.6 3.0 12.3 7.3 15.1 8.4 9.8 6.7 8.6 31.8 13.8 8.8 8.4 9.0 9.4 13.0 12.8 5.5 9.6 12.7 4.3 6.7 11.9 3.6 11.0 6.6 9.1 10.0 12.2 7.7 22.9 8.1 7.4 7.2 10.4 6.5 8.5 9.1 10.0 9.8 9.4 11.2 10.4 13.0 6.3 13.4 7.1 6.5 7.7 6.7 7.0 6.2 7.3 7.7 7.2 7.5 6.7 7.2 9.5 3.1 9.6 1.1 14.7 8.7 3.1 4.1 4.6 10.2 1.4 4.0 4.1 3.3 1.5 2.6 0.0 4.2 4.3 7.8 3.7 7.9 3.9 0.8 3.3 2.6 3.3 15.7 6.5 3.4 3.0 5.7 3.9 7.7 3.0 7.0 4.7 1.4 1.5 3.8 0.0 3.4 6.3 4.1 5.5 2.5 1.5 4.4 3.4 5.4 9.4 1.9 4.1 7.2 7.1 9.9 3.1 7.3 4.1 5.2 1.9 4.6 3.6 4.6 2.0 6.6 3.8 3.7 2.9 8.2 5.3 1.6 3.0 5.2 4.1 5.1 2.5 PSMB5 MB1 ENSG00000100804 "Proteasome 20S subunit beta 5" P28074 14 23016543-23035230 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 1146.8" "Low region specificity" "Detected in all" "HPA049518, HPA061796" Approved Supported Nucleoplasm,Centrosome NA NA 6200000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Centrosome" "HPA049518: AB_2680802, HPA061796: AB_2684612" "unprognostic (3.03e-1)" "unprognostic (1.99e-2)" "unprognostic (8.35e-2)" "unprognostic (6.13e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (2.85e-4)" "prognostic unfavorable (2.90e-5)" "unprognostic (2.55e-2)" "unprognostic (9.95e-2)" "prognostic favorable (1.08e-4)" "unprognostic (2.06e-1)" "unprognostic (1.19e-1)" "unprognostic (5.30e-2)" "unprognostic (1.75e-1)" "unprognostic (1.95e-1)" "unprognostic (4.95e-2)" "prognostic unfavorable (4.73e-4)" 84.0 116.0 129.1 58.7 134.2 32.0 81.0 141.4 134.3 71.3 141.1 80.8 61.1 71.0 129.5 102.3 93.3 61.0 136.8 136.4 141.1 98.5 119.1 64.7 49.0 137.9 138.4 61.6 80.9 143.5 80.1 90.1 145.2 76.8 88.7 59.7 73.5 78.6 332.4 76.0 53.0 103.4 141.3 50.3 81.0 57.8 136.5 79.5 72.3 274.1 68.6 92.1 68.4 146.5 181.0 398.9 250.6 245.5 360.4 318.9 261.8 252.0 307.3 446.1 376.1 329.2 282.2 228.0 228.1 352.1 298.4 239.7 428.4 320.2 401.9 139.9 311.4 146.9 260.3 1146.8 287.3 170.2 162.1 354.2 292.0 331.8 264.1 289.7 475.5 190.5 218.6 121.5 376.0 557.2 97.6 218.4 285.7 341.6 631.4 133.8 197.7 150.7 349.9 256.6 336.0 251.0 179.9 354.8 245.4 322.2 175.0 217.7 254.1 212.4 210.1 197.3 247.8 99.7 218.4 158.8 164.9 140.8 274.6 97.8 127.6 58.0 89.4 125.6 103.5 103.8 101.1 85.1 137.6 99.7 135.0 102.5 48.1 67.4 92.7 172.4 91.3 147.8 129.1 134.2 141.4 134.3 136.4 141.1 137.9 138.4 145.2 141.3 136.5 146.5 94.2 76.9 69.2 16.0 47.3 140.2 174.1 461.5 100.7 61.0 130.4 135.5 157.6 112.9 240.4 95.6 29.2 400.1 40.2 75.0 275.9 277.7 93.0 149.0 109.5 150.0 154.6 82.5 17.6 231.3 435.2 139.9 73.9 88.0 31.0 162.6 89.6 171.6 221.6 70.7 18.0 109.2 329.6 57.5 80.9 106.4 118.7 64.0 115.6 15.9 138.2 170.8 25.7 11.6 29.4 285.7 88.0 122.2 78.2 185.1 81.2 437.8 268.9 71.8 98.6 87.1 355.1 174.4 81.6 144.7 157.1 430.2 43.4 215.7 148.9 215.3 PSMB11 beta5t ENSG00000222028 "Proteasome subunit beta 11" A5LHX3 14 23042212-23044060 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 93 "lymphoid tissue: 30.6" "Group enriched" "Detected in some" 10 "Early spermatids: 2.4;Late spermatids: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "olfactory bulb: 1.9" "Not detected" "Not detected" "HPA028967, HPA056970" Enhanced NA NA "Cluster 63: T-cells - Adaptive immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA028967: AB_2732444, HPA056970: AB_2683293" "unprognostic (7.96e-2)" "unprognostic (2.77e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 30.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDH24 CDH11L ENSG00000139880 "Cadherin 24" Q86UP0 14 23047062-23057538 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 11.7;Astrocytes: 9.1;Bipolar cells: 8.2;Endothelial cells: 8.8;Enteroendocrine cells: 10.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 52.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074551 Approved Vesicles,Cytosol NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol Vesicles "HPA074551: " "unprognostic (2.30e-1)" "unprognostic (3.06e-2)" "unprognostic (4.15e-3)" "unprognostic (6.21e-2)" "unprognostic (1.27e-1)" "unprognostic (9.18e-2)" "unprognostic (6.68e-3)" "unprognostic (2.71e-2)" "unprognostic (5.97e-3)" "unprognostic (3.55e-1)" "unprognostic (4.18e-2)" "unprognostic (5.97e-2)" "prognostic unfavorable (1.15e-4)" "unprognostic (1.27e-1)" "unprognostic (1.43e-1)" "unprognostic (1.37e-2)" "unprognostic (8.85e-2)" 4.3 2.4 4.9 1.2 3.8 1.2 3.6 3.8 4.7 5.9 1.7 2.7 1.1 8.6 1.1 4.0 4.3 4.2 2.0 9.4 4.3 2.9 0.5 3.3 1.3 4.0 3.9 2.4 2.1 2.2 1.9 1.6 3.9 3.1 1.7 1.7 3.1 1.6 0.7 2.9 2.4 4.0 2.3 2.4 2.0 1.7 3.8 3.7 4.6 0.5 0.9 2.6 4.1 5.3 4.6 4.5 18.3 20.9 4.4 2.2 10.1 8.4 5.4 7.0 9.0 5.7 6.1 0.3 6.7 9.2 1.8 25.8 8.0 7.1 5.6 7.1 6.7 1.0 12.7 1.9 4.9 13.2 0.3 17.3 2.3 7.6 5.0 8.5 11.5 4.2 2.9 11.0 6.1 12.9 1.0 8.8 4.6 4.7 10.2 22.9 6.1 8.4 2.0 3.8 52.9 14.2 19.7 10.4 1.1 5.0 9.3 1.9 10.7 6.9 26.0 2.8 6.3 3.5 1.1 0.3 7.2 3.8 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 3.8 3.8 4.7 9.4 4.3 4.0 3.9 3.9 2.3 3.8 5.3 11.7 0.0 0.0 9.1 0.3 1.5 0.8 0.5 3.4 8.2 2.1 1.1 2.0 0.0 0.5 1.8 0.0 2.3 0.9 1.9 1.9 0.5 0.4 0.6 2.1 8.8 10.7 0.0 2.6 0.5 2.5 1.7 1.1 1.0 0.0 4.3 2.5 0.0 0.6 0.0 1.7 1.7 0.0 0.0 0.3 1.0 0.0 0.1 1.8 2.8 0.1 4.4 0.0 5.5 0.2 0.6 0.3 0.0 0.3 0.8 0.2 0.5 0.5 0.8 0.0 0.2 1.5 1.1 2.5 2.0 2.3 1.9 0.7 2.5 2.1 0.9 ACIN1 "ACINUS, fSAP152, KIAA0670" ENSG00000100813 "Apoptotic chromatin condensation inducer 1" Q9UKV3 14 23058564-23095614 "Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000657 Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 30000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 60: Granulocytes - Receptor signaling" Nucleoplasm "Plasma membrane, Cytosol" "HPA000657: AB_1078091" "unprognostic (2.54e-3)" "unprognostic (1.99e-1)" "unprognostic (1.38e-2)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (4.89e-3)" "prognostic unfavorable (4.88e-5)" "unprognostic (1.49e-3)" "unprognostic (9.70e-2)" "unprognostic (4.11e-2)" "unprognostic (1.00e-2)" "unprognostic (6.64e-3)" "unprognostic (1.35e-3)" "unprognostic (4.34e-2)" "unprognostic (2.78e-2)" "unprognostic (2.28e-2)" "unprognostic (7.33e-2)" 41.5 57.7 58.3 35.0 60.2 66.7 36.6 64.3 64.6 46.1 62.7 42.6 28.6 41.5 30.1 50.9 39.3 24.3 44.1 57.5 63.4 51.3 47.5 33.8 45.2 60.9 60.6 48.7 45.1 41.4 48.5 37.2 59.9 45.8 33.2 39.0 39.1 27.8 53.0 39.5 46.0 38.9 55.7 66.4 45.3 47.6 61.6 52.8 47.1 36.5 47.4 41.9 41.3 64.4 77.1 77.6 120.0 97.7 73.3 58.5 120.2 83.8 58.8 98.9 80.0 103.8 87.8 141.8 48.4 69.7 65.0 82.6 167.4 95.6 100.7 100.2 74.3 124.5 82.9 144.8 41.8 136.6 106.4 69.0 58.0 101.5 84.8 81.0 87.9 103.4 117.2 55.1 75.7 96.5 156.1 134.6 135.1 84.6 73.3 139.7 93.0 75.8 82.9 133.3 79.7 58.6 111.2 71.7 69.1 86.7 59.2 109.0 90.7 67.3 67.3 64.7 78.5 57.9 70.2 144.0 59.9 101.8 74.8 5.3 4.0 5.1 4.2 3.5 3.2 3.8 2.9 3.2 3.4 5.4 3.8 3.7 10.8 7.5 3.2 5.5 3.5 2.6 58.3 60.2 64.3 64.6 57.5 63.4 60.9 60.6 59.9 55.7 61.6 64.4 49.8 70.5 123.0 44.4 61.6 37.3 30.2 52.7 64.9 38.1 43.4 40.8 67.9 32.9 67.2 35.0 27.1 58.0 65.0 64.4 17.6 53.4 42.5 70.5 97.6 55.5 58.3 76.2 41.0 49.3 66.8 60.3 85.1 90.1 130.6 79.4 35.0 28.8 47.1 15.2 43.6 50.1 42.7 38.1 40.8 10.9 46.0 52.5 26.6 44.0 53.4 26.1 54.6 45.8 65.6 59.4 49.7 38.4 65.4 43.5 37.7 21.6 82.6 43.3 6.6 52.4 66.9 42.1 39.2 58.5 46.5 69.2 65.2 86.1 55.8 38.4 C14orf119 FLJ20671 ENSG00000179933 "Chromosome 14 open reading frame 119" Q9NWQ9 14 23095505-23100456 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003638 Uncertain Supported Mitochondria,Cytosol NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Mitochondria Cytosol "HPA003638: AB_2243669" "unprognostic (2.10e-2)" "unprognostic (4.29e-2)" "unprognostic (5.89e-3)" "unprognostic (2.91e-1)" "unprognostic (2.33e-2)" "unprognostic (5.26e-3)" "prognostic unfavorable (5.42e-5)" "unprognostic (1.23e-1)" "unprognostic (3.36e-2)" "unprognostic (1.65e-2)" "unprognostic (4.08e-3)" "unprognostic (1.25e-1)" "unprognostic (5.54e-2)" "unprognostic (2.06e-2)" "unprognostic (3.61e-2)" "prognostic favorable (3.30e-5)" "unprognostic (1.63e-1)" 41.5 49.2 26.7 34.3 28.6 15.5 46.9 30.3 32.0 41.1 34.7 42.8 33.6 40.1 42.3 45.6 33.2 27.5 36.6 26.8 29.7 49.4 37.2 38.1 34.2 30.3 29.6 33.6 31.6 35.3 38.4 33.7 30.6 30.6 51.3 25.5 36.2 38.5 32.9 30.9 41.2 48.8 29.7 47.1 41.0 25.2 31.5 40.4 33.9 31.1 50.8 47.5 33.9 32.2 53.9 52.5 77.4 47.2 166.8 144.3 62.1 88.5 129.9 114.1 134.6 41.9 81.3 40.9 44.8 144.2 138.0 89.9 74.6 117.4 157.6 65.2 36.5 61.6 41.4 180.8 130.7 93.2 91.9 177.0 104.1 96.3 70.5 104.0 126.6 72.7 41.9 44.4 127.2 77.8 44.3 72.1 48.7 124.5 79.2 38.6 57.5 47.0 130.8 85.9 37.1 33.8 73.7 68.6 81.0 85.5 46.4 53.2 103.0 54.0 47.0 81.6 40.6 41.5 52.6 50.5 49.4 58.3 49.2 317.0 160.8 302.7 122.6 106.0 140.9 143.9 138.9 137.3 150.7 121.0 144.0 142.6 94.5 131.0 74.4 102.2 188.7 203.2 26.7 28.6 30.3 32.0 26.8 29.7 30.3 29.6 30.6 29.7 31.5 32.2 50.9 48.1 47.7 4.2 41.9 26.5 89.0 144.5 23.9 28.6 41.9 50.5 23.7 34.3 75.9 31.3 8.4 89.0 53.5 44.1 129.1 95.9 22.6 39.0 45.2 56.2 28.3 65.4 3.8 84.3 105.5 42.9 30.5 33.2 54.4 39.6 46.4 29.6 107.8 20.2 4.4 57.4 81.4 38.9 32.1 15.1 64.0 53.1 48.0 5.6 93.2 36.1 58.7 2.0 11.5 97.0 42.4 48.5 31.4 59.8 61.5 100.3 48.3 21.5 32.9 18.6 47.1 52.7 25.6 33.5 34.0 143.1 46.5 81.3 51.7 83.2 LMLN2 ENSG00000283654 "Leishmanolysin like peptidase 2" A0A1B0GTW7 14 23099062-23104989 "Enzymes, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "HSkMC: 2.5" "Not detected" "Not detected" NA NA "Cluster 34: Mesenchymal cell lines - ECM organization" 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.2 0.3 0.0 0.5 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.3 0.1 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.2 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.3 0.1 0.2 0.3 0.3 0.3 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CEBPE CRP1 ENSG00000092067 "CCAAT enhancer binding protein epsilon" Q15744 14 23117306-23119255 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "bone marrow: 51.8" "Cell type enhanced" "Detected in some" "Hofbauer cells: 6.6;Kupffer cells: 1.4;Macrophages: 2.3;monocytes: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 218 "eosinophil: 750.4" "Lineage enriched" "Detected in many" 250 "granulocytes: 750.4" "Group enriched" "Detected in some" 4 "HL-60: 233.8;NB-4: 122.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002928, CAB005113" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 4: Macrophages - Innate immune response" Nucleoplasm "Plasma membrane, Cytosol" "CAB005113: AB_631240, HPA002928: AB_1078494" "unprognostic (1.33e-2)" "unprognostic (4.76e-2)" "unprognostic (4.19e-2)" "unprognostic (2.04e-1)" "unprognostic (5.01e-2)" "unprognostic (1.66e-3)" "unprognostic (2.84e-1)" "unprognostic (1.49e-2)" "unprognostic (3.33e-2)" "unprognostic (5.69e-2)" "unprognostic (9.03e-2)" "unprognostic (2.22e-1)" "unprognostic (3.80e-3)" "unprognostic (1.42e-1)" "unprognostic (1.12e-2)" "unprognostic (2.57e-2)" "unprognostic (8.19e-2)" 0.1 0.0 0.1 1.6 0.1 51.8 0.0 0.0 0.2 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.5 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.1 3.2 0.3 0.1 3.4 0.8 0.0 0.3 0.5 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 233.8 39.6 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.9 122.5 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 26.3 0.0 0.5 3.0 750.4 0.0 0.6 0.1 0.5 1.0 0.4 1.5 0.5 1.8 1.5 3.4 0.0 0.3 1.5 0.0 1.8 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 6.6 0.0 0.0 0.0 0.0 1.4 0.6 0.1 0.0 2.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.6 0.1 0.0 0.0 SLC7A8 "LAT2, LPI-PC1" ENSG00000092068 "Solute carrier family 7 member 8" Q9UHI5 14 23125295-23183674 "Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 331.1" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 74.1;Kupffer cells: 90.0;Proximal tubular cells: 144.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 9.3;eosinophil: 14.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 14.0" "Cell line enhanced" "Detected in many" "ASC diff: 68.8;BEWO: 110.6;K-562: 136.9;NTERA-2: 64.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046015, HPA051950, HPA060672" Enhanced NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 1: K-562 - Erythropoiesis" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "CAB046015: AB_2239464, HPA051950: AB_2681670, HPA060672: AB_2684340" "unprognostic (1.50e-1)" "unprognostic (1.52e-1)" "unprognostic (2.88e-1)" "unprognostic (1.03e-2)" "unprognostic (1.12e-2)" "unprognostic (3.03e-2)" "prognostic unfavorable (1.97e-4)" "prognostic favorable (3.15e-4)" "unprognostic (1.24e-1)" "unprognostic (2.37e-1)" "unprognostic (1.39e-3)" "unprognostic (9.44e-2)" "unprognostic (7.00e-2)" "unprognostic (2.96e-2)" "unprognostic (8.56e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (1.52e-4)" 27.6 15.2 1.2 7.0 7.1 1.6 27.7 5.5 7.6 31.3 42.8 12.5 36.3 43.6 4.8 37.5 45.9 18.6 7.9 3.4 6.5 119.3 6.9 15.4 4.5 3.4 3.1 67.5 19.9 331.1 15.8 16.0 5.8 39.2 13.7 13.9 23.8 35.5 49.4 31.6 24.2 20.9 0.0 18.5 63.4 21.2 6.7 4.9 23.7 15.4 9.0 29.9 37.5 1.4 1.6 0.0 52.9 0.1 68.8 8.5 110.6 6.0 26.3 0.3 2.0 60.4 3.6 0.4 0.8 13.9 5.4 11.7 8.5 3.5 0.3 0.0 5.2 0.6 0.3 0.0 25.5 0.2 35.8 54.1 33.2 0.9 0.9 11.6 5.2 5.4 136.9 0.3 1.5 1.2 0.3 0.8 64.0 12.9 47.4 0.1 0.9 12.5 0.7 21.4 8.2 0.3 0.2 12.0 32.3 60.1 42.8 0.6 0.5 2.3 1.8 0.7 0.0 0.3 15.9 0.2 6.9 0.0 0.4 9.3 0.1 14.0 0.0 0.1 1.1 0.1 0.9 0.1 0.0 0.0 0.9 3.3 0.4 0.0 0.1 0.0 0.5 2.3 1.2 7.1 5.5 7.6 3.4 6.5 3.4 3.1 5.8 0.0 6.7 1.4 0.5 16.0 15.0 2.3 1.8 3.1 28.8 6.4 29.0 26.4 31.6 15.2 5.7 0.0 9.0 16.5 0.0 18.7 0.5 8.3 5.9 1.9 2.2 13.6 74.1 2.1 33.0 0.0 24.8 2.4 4.4 15.5 53.5 18.4 5.1 27.3 66.4 1.3 59.2 26.9 53.5 33.7 4.1 90.0 3.3 3.1 9.6 15.3 19.6 15.9 0.5 39.3 0.0 4.0 2.6 3.0 6.5 7.9 1.6 26.4 27.3 144.8 1.0 4.4 0.0 2.8 4.7 1.1 1.3 25.3 3.0 41.3 2.9 3.4 18.5 32.3 RNF212B C14orf164 ENSG00000215277 "Ring finger protein 212B" A8MTL3 14 23185316-23273477 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "kidney: 27.1" "Group enriched" "Detected in some" 5 "Early spermatids: 42.9;Proximal tubular cells: 44.9;Spermatocytes: 94.6;Spermatogonia: 24.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;Daudi: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053574 Uncertain NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA053574: AB_2682195" "unprognostic (2.88e-1)" "unprognostic (2.17e-1)" "unprognostic (4.65e-1)" "unprognostic (8.54e-2)" "unprognostic (1.30e-1)" "unprognostic (4.79e-1)" "unprognostic (4.48e-2)" "unprognostic (2.98e-2)" "unprognostic (3.82e-1)" "unprognostic (1.83e-2)" "unprognostic (4.96e-3)" "unprognostic (4.45e-1)" "unprognostic (7.33e-5)" "unprognostic (9.60e-2)" "unprognostic (3.40e-1)" "unprognostic (7.56e-2)" "unprognostic (5.39e-3)" 0.1 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.1 27.1 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.4 5.9 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.7 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.6 0.0 0.0 0.0 3.9 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.1 0.1 0.0 0.0 1.8 2.1 0.0 0.0 0.0 0.0 0.2 42.9 0.2 0.2 0.1 0.0 0.0 3.5 0.2 0.2 0.1 0.0 0.3 0.0 0.1 0.0 0.7 0.0 0.0 2.2 0.5 0.0 0.0 0.0 9.5 0.9 3.2 0.0 0.0 1.6 0.2 0.0 0.5 1.6 0.1 0.0 0.4 0.1 0.0 1.0 44.9 0.0 0.3 0.0 0.1 0.1 94.6 24.8 0.0 0.0 0.0 0.2 0.0 0.1 0.0 HOMEZ KIAA1443 ENSG00000215271 "Homeobox and leucine zipper encoding" Q8IX15 14 23272422-23299447 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.4" "Group enriched" "Detected in all" 6 "Early spermatids: 309.7;Late spermatids: 78.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036316, HPA036317" Enhanced Supported Nucleoplasm,Nucleoli NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 23: Testis - Cell cycle regulation" "Cluster 15: RT4 - Unknown function" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Nucleoli" "HPA036316: AB_2675056, HPA036317: AB_10669787" "unprognostic (3.70e-2)" "unprognostic (7.58e-2)" "unprognostic (6.36e-2)" "unprognostic (3.93e-2)" "unprognostic (9.11e-2)" "unprognostic (5.23e-2)" "unprognostic (1.20e-2)" "unprognostic (1.59e-2)" "unprognostic (1.37e-1)" "prognostic favorable (2.41e-5)" "unprognostic (2.23e-1)" "unprognostic (1.77e-1)" "prognostic favorable (1.17e-11)" "unprognostic (2.62e-1)" "unprognostic (2.00e-1)" "prognostic favorable (1.75e-4)" "unprognostic (3.23e-1)" 6.1 4.9 4.6 4.7 6.2 1.5 6.7 5.9 5.8 6.5 4.0 6.7 7.3 5.3 8.0 9.8 7.0 5.2 7.8 4.8 5.5 9.4 6.2 6.1 4.6 6.8 5.5 9.9 7.8 8.8 3.6 5.7 6.3 6.5 6.2 6.0 7.0 9.6 9.0 7.7 5.0 7.2 4.9 5.6 7.8 34.4 6.7 9.4 7.3 14.9 7.9 10.9 5.7 6.4 7.0 7.2 13.0 12.3 19.8 8.7 14.8 7.2 9.4 6.8 8.7 3.3 14.6 15.2 6.1 7.1 16.0 23.3 17.3 18.0 8.5 8.4 6.6 5.2 6.0 14.1 25.8 7.6 4.4 13.5 17.7 5.4 11.8 15.1 13.1 17.0 15.6 6.0 11.8 16.1 5.9 5.2 5.3 21.3 4.1 9.2 9.7 6.7 12.5 28.5 4.2 5.2 6.9 19.3 7.8 19.7 12.0 8.9 14.6 4.7 2.1 5.9 3.3 25.1 11.3 5.0 2.5 5.5 7.2 2.9 5.0 7.3 3.5 4.5 2.8 2.6 3.0 2.9 4.8 2.3 3.2 3.9 0.8 2.4 3.4 2.9 4.1 2.9 4.6 6.2 5.9 5.8 4.8 5.5 6.8 5.5 6.3 4.9 6.7 6.4 3.7 6.4 7.0 4.6 5.6 2.8 18.4 19.9 9.1 5.8 7.0 5.7 6.9 12.8 14.4 23.9 6.2 6.9 4.6 6.8 13.7 11.0 309.7 4.4 4.2 5.7 3.6 5.0 1.9 10.9 6.6 5.2 13.7 6.9 3.8 8.2 5.3 6.9 8.7 10.1 2.0 9.2 8.2 6.1 5.1 78.9 6.8 5.8 3.6 6.5 15.1 6.9 5.2 3.0 6.8 9.1 5.5 7.5 6.1 16.3 8.6 19.8 12.9 3.7 6.6 4.7 4.7 15.2 5.3 10.1 5.1 9.3 4.2 3.8 7.9 29.1 PPP1R3E FLJ00089 ENSG00000235194 "Protein phosphatase 1 regulatory subunit 3E" Q9H7J1 14 23295652-23302859 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 47.0" "Cell type enhanced" "Detected in all" "Early spermatids: 111.9;Late spermatids: 62.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 41.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA061600 Approved Approved "Microtubules,Mitotic spindle,Mitochondria" Yes No "Cluster 51: Monocytes - Innate immune response" "Cluster 77: Retina - Visual perception" "Cluster 29: U-266 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Microtubules, Mitochondria" "Mitotic spindle" "HPA061600: AB_2684566" "unprognostic (3.45e-2)" "unprognostic (1.57e-2)" "prognostic unfavorable (6.89e-5)" "unprognostic (4.05e-1)" "unprognostic (2.85e-2)" "unprognostic (1.29e-2)" "unprognostic (7.12e-2)" "prognostic favorable (3.10e-4)" "unprognostic (1.73e-2)" "unprognostic (1.18e-1)" "unprognostic (1.77e-3)" "unprognostic (2.41e-1)" "unprognostic (8.67e-3)" "unprognostic (8.46e-2)" "unprognostic (2.88e-1)" "unprognostic (8.12e-2)" "unprognostic (5.46e-2)" 5.8 8.0 15.2 5.7 17.9 3.9 6.4 17.9 23.8 10.2 9.7 7.4 6.3 6.4 10.1 6.0 9.5 3.3 6.2 15.0 15.3 11.6 11.2 5.7 9.5 18.5 16.5 12.5 10.6 5.7 19.3 2.7 19.4 12.1 5.9 47.0 8.5 6.2 14.9 10.9 13.3 3.4 13.8 15.1 9.0 14.7 17.7 8.2 14.9 5.4 8.2 7.9 8.5 23.3 1.1 3.0 3.6 2.5 6.9 2.9 1.7 1.2 2.2 2.0 1.7 1.7 5.8 11.2 0.8 1.6 2.2 7.6 2.1 1.2 2.5 4.0 2.1 2.0 6.9 4.0 1.8 2.3 4.4 2.5 4.5 1.2 6.1 3.3 0.9 6.0 1.9 9.8 1.7 2.6 2.1 3.6 0.9 3.6 2.8 3.4 2.5 7.2 1.1 2.5 4.5 1.2 1.8 1.6 1.2 1.8 1.9 0.8 1.7 2.4 1.3 4.1 0.9 41.1 4.6 5.1 1.9 4.0 1.5 0.2 0.4 0.2 0.5 1.4 0.6 1.0 0.1 0.2 0.3 0.6 0.5 0.3 0.4 0.2 1.8 0.3 0.4 0.3 15.2 17.9 17.9 23.8 15.0 15.3 18.5 16.5 19.4 13.8 17.7 23.3 5.8 3.2 4.8 30.0 25.4 5.6 9.0 5.3 11.4 59.4 7.8 11.6 8.8 7.2 5.0 20.2 37.5 8.2 12.8 8.0 5.9 2.1 111.9 3.7 6.6 7.2 8.4 7.2 25.0 3.3 2.0 6.1 20.4 4.3 3.8 9.4 7.5 7.2 7.4 32.0 33.0 7.7 4.1 9.5 9.6 62.9 27.4 9.2 10.6 15.9 8.1 20.4 26.8 16.1 56.1 2.4 11.6 25.9 11.9 6.7 19.5 9.5 4.8 38.1 13.1 3.5 5.4 36.5 13.9 8.4 9.1 5.2 15.7 7.2 9.6 8.6 BCL2L2 "BCL-W, KIAA0271, PPP1R51" ENSG00000129473 "BCL2 like 2" Q92843 14 23298790-23311751 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB040539, HPA048740" Approved Uncertain Nucleoplasm NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 45: Intestine - Brush border" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "CAB040539: , HPA048740: " "unprognostic (8.23e-3)" "unprognostic (9.85e-2)" "unprognostic (1.71e-2)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (1.64e-1)" "unprognostic (3.47e-3)" "unprognostic (1.53e-2)" "unprognostic (1.78e-1)" "unprognostic (2.91e-3)" "unprognostic (1.50e-3)" "unprognostic (2.60e-1)" "prognostic favorable (1.99e-6)" "unprognostic (2.44e-1)" "unprognostic (2.00e-1)" "unprognostic (6.60e-2)" "unprognostic (5.38e-2)" 48.5 36.6 102.4 26.0 95.3 13.9 35.6 83.7 112.4 30.2 61.8 86.9 28.5 43.0 30.5 46.8 35.4 24.7 37.3 89.8 88.8 35.0 20.9 34.6 13.9 94.8 94.0 31.8 53.3 52.9 38.1 23.8 91.7 47.4 31.8 51.9 52.2 45.5 24.2 46.5 34.3 41.5 101.0 20.5 54.2 25.1 108.3 10.7 38.5 19.9 16.4 55.6 34.9 92.4 24.1 23.0 25.6 19.0 43.4 39.2 19.3 43.9 28.5 21.8 24.9 16.3 42.6 16.8 14.2 26.6 27.4 43.9 15.9 28.1 29.4 8.9 12.7 18.4 44.4 30.3 26.6 20.7 30.0 30.3 54.0 17.6 27.1 30.6 18.6 2.9 17.3 18.0 27.8 17.8 1.6 14.5 8.0 33.4 41.3 12.8 28.1 8.2 19.7 45.5 31.7 18.0 20.8 31.3 31.2 15.6 20.6 15.5 37.1 35.1 24.8 27.6 23.1 22.0 12.7 2.2 21.6 16.0 43.5 0.0 0.4 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.3 102.4 95.3 83.7 112.4 89.8 88.8 94.8 94.0 91.7 101.0 108.3 92.4 9.2 9.6 13.1 0.0 2.6 8.7 9.5 12.7 5.7 20.0 11.0 8.0 28.9 4.3 13.6 5.5 25.0 5.3 3.5 16.8 13.7 8.0 20.1 11.1 10.4 10.8 18.6 2.1 0.0 18.3 4.0 10.4 9.7 12.1 5.7 12.0 11.4 7.2 5.5 20.2 0.0 16.8 6.1 8.4 4.0 6.1 11.1 5.5 7.2 0.0 7.5 7.4 2.1 0.0 0.0 25.5 11.0 21.4 4.5 17.2 16.3 9.2 12.2 12.7 6.6 12.6 15.5 0.5 0.9 10.8 11.1 5.6 1.5 8.9 10.5 17.6 BCL2L2-PABPN1 ENSG00000258643 "BCL2L2-PABPN1 readthrough" Q92843 14 23306833-23326175 "Cancer-related genes, Predicted intracellular proteins, Transporters" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Astrocytes: 10.1;Excitatory neurons: 10.9;Inhibitory neurons: 14.4;Oligodendrocyte precursor cells: 16.6;Oligodendrocytes: 13.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000637, HPA048740" Approved Uncertain "Nucleoplasm,Nuclear speckles" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Nuclear speckles" "HPA000637: AB_1079553, HPA048740: " "unprognostic (1.32e-2)" "unprognostic (8.74e-2)" "unprognostic (1.21e-1)" "unprognostic (1.32e-3)" "unprognostic (9.82e-3)" "unprognostic (2.85e-2)" "unprognostic (1.05e-6)" "unprognostic (4.39e-2)" "unprognostic (1.67e-1)" "unprognostic (1.84e-3)" "unprognostic (7.61e-2)" "unprognostic (3.47e-2)" "unprognostic (1.72e-7)" "unprognostic (3.13e-2)" "unprognostic (8.77e-2)" "unprognostic (3.46e-3)" "unprognostic (4.95e-2)" 8.2 4.1 8.8 4.2 10.8 10.7 9.6 7.2 20.6 10.9 1.3 17.2 10.4 8.3 2.0 11.6 10.8 10.9 7.2 9.8 8.3 3.5 4.2 7.3 4.3 8.7 9.3 4.6 12.4 8.0 7.1 10.9 9.0 12.1 6.3 5.6 24.9 22.1 4.8 11.0 8.8 7.7 10.1 6.0 10.3 12.5 11.7 1.2 8.7 0.9 4.1 13.4 7.5 15.8 11.4 18.0 15.2 31.3 15.3 29.3 14.0 13.4 27.3 39.8 44.2 10.1 38.0 3.5 4.0 21.2 22.5 24.2 16.9 21.4 17.9 8.5 21.6 4.7 11.2 26.0 14.5 10.0 29.7 37.4 29.7 17.6 6.1 27.3 14.7 0.2 8.2 8.2 19.3 18.1 0.4 7.5 17.3 10.3 18.2 7.9 4.0 5.9 10.3 10.1 16.0 10.0 9.8 22.6 15.2 10.8 8.7 8.2 15.4 18.7 8.4 17.1 12.8 4.9 6.6 1.1 25.2 10.5 19.4 0.8 2.5 0.1 0.1 1.2 0.0 0.5 0.0 0.0 0.8 1.0 0.1 0.0 0.5 1.6 1.4 0.4 0.0 0.6 8.8 10.8 7.2 20.6 9.8 8.3 8.7 9.3 9.0 10.1 11.7 15.8 0.0 3.2 3.9 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 10.9 0.0 0.0 0.7 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.8 0.0 0.0 0.0 16.6 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 PABPN1 "OPMD, PAB2, PABP2" ENSG00000100836 "Poly(A) binding protein nuclear 1" Q86U42 14 23321289-23326185 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" HPA000637 Supported Approved "Nucleoplasm,Nuclear speckles" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 43: Testis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoplasm "Nuclear speckles" "HPA000637: AB_1079553" "unprognostic (5.11e-3)" "unprognostic (2.65e-2)" "unprognostic (7.20e-2)" "unprognostic (2.95e-2)" "unprognostic (1.05e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (3.55e-4)" "unprognostic (1.88e-2)" "unprognostic (1.47e-1)" "unprognostic (1.95e-3)" "prognostic favorable (9.66e-4)" "unprognostic (5.88e-2)" "prognostic unfavorable (2.41e-7)" "unprognostic (1.52e-2)" "unprognostic (1.31e-2)" "unprognostic (1.07e-1)" "unprognostic (8.25e-3)" 133.2 178.7 187.0 86.4 183.9 136.9 127.7 193.4 249.3 165.6 184.5 184.1 107.6 176.0 130.3 151.0 175.6 63.4 138.1 185.8 196.6 187.7 194.8 130.0 103.9 186.0 182.2 176.3 138.8 101.0 199.0 79.7 181.6 179.4 101.5 126.6 130.4 85.8 131.5 136.9 167.8 97.4 175.6 174.3 159.3 230.1 186.3 147.6 189.8 94.1 116.5 146.3 144.0 190.4 127.2 133.9 298.3 216.6 125.5 143.1 191.4 120.4 121.6 168.4 157.4 168.0 223.0 229.7 67.0 157.0 180.6 186.4 337.7 169.7 230.7 195.2 116.7 173.5 208.1 435.5 145.2 273.5 220.2 157.1 164.7 125.0 149.1 240.9 188.1 196.0 164.5 174.6 159.8 239.6 296.1 334.5 328.6 151.2 149.3 289.1 114.8 136.2 196.1 256.2 205.6 159.9 161.4 143.2 129.6 196.9 114.2 196.3 153.2 112.1 153.8 110.4 161.8 207.3 153.0 276.5 51.4 221.4 138.7 15.7 7.6 8.5 6.0 5.8 4.9 7.4 6.1 5.5 6.1 9.3 7.5 7.0 10.0 10.1 7.2 13.8 7.6 2.5 187.0 183.9 193.4 249.3 185.8 196.6 186.0 182.2 181.6 175.6 186.3 190.4 66.3 35.3 49.4 0.0 83.3 157.8 84.4 74.0 158.2 120.1 110.2 89.5 14.3 77.2 51.2 126.9 146.0 70.0 102.5 85.5 13.7 52.6 55.6 71.8 80.8 75.0 161.4 94.2 0.0 57.2 67.4 72.4 68.8 78.6 24.1 169.3 66.0 121.6 63.2 77.4 0.0 107.2 54.9 84.7 119.0 45.9 81.1 85.5 53.4 0.0 104.4 55.8 65.9 0.0 0.0 59.2 91.6 59.8 102.2 88.7 88.9 40.3 49.8 80.2 72.3 57.5 85.0 41.8 33.3 187.4 179.9 62.8 67.3 107.6 108.1 114.6 SLC22A17 "BOCT, BOIT, NGALR" ENSG00000092096 "Solute carrier family 22 member 17" Q8WUG5 14 23346306-23352912 "Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 304.0;choroid plexus: 372.6;pituitary gland: 149.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 71.4;Horizontal cells: 201.9;Inhibitory neurons: 111.1;Muller glia cells: 74.2;Oligodendrocyte precursor cells: 120.6" "Cancer enhanced" "Detected in all" "glioma: 51.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 20.7;AN3-CA: 31.4;ASC diff: 23.2;SH-SY5Y: 41.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002728 Uncertain NA NA "Cluster 32: T-cells - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" "HPA002728: AB_1079998" "unprognostic (9.34e-2)" "unprognostic (2.34e-1)" "unprognostic (2.31e-2)" "unprognostic (6.23e-3)" "unprognostic (2.85e-2)" "unprognostic (1.07e-1)" "unprognostic (2.31e-2)" "unprognostic (1.26e-2)" "unprognostic (4.23e-2)" "unprognostic (3.22e-1)" "prognostic favorable (1.73e-4)" "unprognostic (1.78e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (5.95e-4)" "unprognostic (3.50e-2)" "unprognostic (1.23e-2)" "unprognostic (3.87e-2)" 7.3 30.1 159.4 3.9 159.6 0.6 11.8 98.0 159.1 25.4 372.6 24.6 4.6 14.8 10.3 4.4 19.1 6.4 22.0 145.5 304.0 16.3 2.5 8.3 3.4 165.6 143.8 17.0 17.2 11.4 149.1 5.0 145.5 39.8 2.4 26.4 25.4 25.7 1.5 7.6 10.2 7.0 125.5 4.2 13.3 8.9 231.8 1.7 19.1 2.7 1.6 15.2 17.9 139.5 0.0 1.9 20.7 31.4 23.2 11.4 3.4 7.5 11.6 2.5 1.9 0.0 1.9 0.0 2.8 11.0 6.6 0.4 0.7 0.5 0.0 0.0 1.4 4.4 0.0 0.2 13.1 0.0 4.4 16.7 1.2 2.6 0.0 11.3 0.8 9.1 0.0 0.2 3.8 3.2 0.1 0.2 11.3 0.0 0.0 0.0 0.7 0.2 0.0 2.0 19.9 41.5 5.8 0.0 0.0 4.0 3.5 0.6 0.0 2.9 8.9 16.6 0.0 0.1 3.2 0.0 1.9 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 159.4 159.6 98.0 159.1 145.5 304.0 165.6 143.8 145.5 125.5 231.8 139.5 7.7 0.0 2.7 46.7 2.3 12.6 18.6 2.6 12.5 53.0 23.4 30.1 10.0 2.8 5.5 20.2 43.8 2.4 1.0 0.0 1.9 0.7 0.2 1.8 10.6 12.0 20.8 1.7 71.4 1.3 4.9 21.7 3.6 0.6 4.5 12.0 16.8 0.9 1.0 201.9 111.1 0.0 0.0 0.6 5.1 2.3 21.1 1.2 7.2 19.7 0.7 74.2 0.0 120.6 49.2 1.5 0.0 42.9 9.2 31.3 0.0 16.9 3.2 69.0 0.0 14.1 18.0 1.1 2.3 3.0 10.9 4.8 2.0 4.5 0.3 6.1 EFS "CASS3, EFS1, EFS2, HEFS, SIN" ENSG00000100842 "Embryonal Fyn-associated substrate" O43281 14 23356403-23365752 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 48.9;Squamous epithelial cells: 22.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 73.2;AN3-CA: 39.5;BEWO: 57.7;SH-SY5Y: 66.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001581, HPA001790" Approved Uncertain Nucleoplasm,Cytosol No NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 35: Glandular cells - Unknown function" Nucleoplasm Cytosol "HPA001581: AB_2666367, HPA001790: " "unprognostic (9.58e-3)" "unprognostic (1.10e-2)" "unprognostic (3.68e-2)" "unprognostic (1.78e-1)" "unprognostic (6.05e-2)" "unprognostic (5.76e-2)" "unprognostic (3.00e-1)" "unprognostic (3.85e-2)" "unprognostic (7.36e-2)" "unprognostic (2.15e-1)" "unprognostic (2.75e-1)" "unprognostic (1.00e-2)" "prognostic unfavorable (4.09e-5)" "unprognostic (3.44e-3)" "unprognostic (1.73e-1)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" 19.3 12.6 39.7 5.5 59.6 0.0 22.7 51.7 45.6 47.3 28.0 24.4 3.1 29.2 9.9 44.1 28.6 8.7 15.0 35.6 39.3 10.0 1.8 12.1 3.6 63.0 57.6 41.9 2.2 22.2 8.4 10.4 54.8 36.8 3.3 10.6 26.2 22.5 3.6 59.0 9.6 12.5 44.8 7.6 11.9 5.4 49.9 3.2 17.5 5.1 4.8 25.3 42.9 76.0 4.7 0.0 73.2 39.5 17.1 20.0 57.7 5.3 11.3 2.0 0.9 0.0 0.0 0.0 0.0 30.3 0.3 27.5 0.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 11.6 18.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 28.1 0.0 0.0 0.0 22.6 0.1 0.0 24.1 7.8 66.5 15.1 2.6 0.0 8.7 17.6 0.0 0.0 7.6 0.0 19.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.7 59.6 51.7 45.6 35.6 39.3 63.0 57.6 54.8 44.8 49.9 76.0 2.0 0.0 6.7 17.0 0.0 11.6 11.6 5.6 9.6 5.0 20.3 16.3 0.7 0.0 4.1 0.0 6.2 9.3 0.2 0.0 1.9 0.1 0.9 0.6 18.9 1.8 0.0 0.0 0.2 0.0 14.7 15.7 0.0 0.7 0.0 4.4 1.8 0.0 1.6 0.0 0.3 0.0 0.0 0.0 3.7 0.8 20.2 0.4 7.2 1.9 0.0 9.0 0.0 22.1 48.9 0.0 0.0 13.9 0.1 7.6 0.0 0.3 1.1 9.3 6.6 12.6 8.9 2.2 0.5 22.7 13.4 18.1 0.5 0.3 0.0 7.0 IL25 "IL-17E, IL-25, IL17E" ENSG00000166090 "Interleukin 25" Q9H293 14 23372809-23376403 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 22 "Cardiomyocytes: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB024864 Uncertain "Secreted to blood" NA NA 4230000 "Cluster 54: Cardiomyocytes - Muscle contraction" "CAB024864: " "unprognostic (1.49e-1)" "unprognostic (6.82e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CMTM5 "CKLFSF5, FLJ37521" ENSG00000166091 "CKLF like MARVEL transmembrane domain containing 5" Q96DZ9 14 23376773-23379772 "Predicted membrane proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 182.4;choroid plexus: 49.5" "Cell type enhanced" "Detected in some" "Macrophages: 93.7;Muller glia cells: 32.0;Oligodendrocyte precursor cells: 20.6;Oligodendrocytes: 106.2" "Group enriched" "Detected in some" 37 "glioma: 8.4;melanoma: 3.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "basophil: 20.8" "Lineage enriched" "Detected in many" 19 "granulocytes: 20.8" "Cell line enriched" "Detected in some" 7 "HEL: 91.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052338 Enhanced Approved "Golgi apparatus,Vesicles" NA NA 540000 "Cluster 34: Basophils - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 36: HEL - Hemostasis" "Cluster 51: Myeloid cells - Hemostasis" "Golgi apparatus, Vesicles" "HPA052338: AB_2681793" "unprognostic (2.73e-3)" "unprognostic (1.51e-1)" "unprognostic (5.24e-1)" "unprognostic (2.43e-3)" "unprognostic (2.63e-1)" "unprognostic (6.40e-2)" "unprognostic (8.34e-3)" "unprognostic (1.78e-1)" "unprognostic (2.27e-2)" "unprognostic (8.40e-2)" "unprognostic (6.24e-4)" "unprognostic (3.03e-3)" "unprognostic (1.97e-3)" "unprognostic (1.17e-1)" "unprognostic (1.93e-1)" "unprognostic (1.11e-2)" 1.1 1.0 75.6 0.5 119.1 8.2 0.9 123.8 101.7 2.8 49.5 5.8 0.5 0.8 1.1 1.2 1.2 2.1 22.7 73.9 85.2 0.5 0.3 1.5 0.2 150.9 106.2 0.8 0.2 0.1 0.6 0.7 135.2 2.1 0.8 2.3 2.2 3.2 3.1 0.7 1.7 0.8 113.4 2.8 1.4 0.1 110.2 0.1 0.5 0.9 0.0 1.2 2.6 182.4 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 91.8 0.0 0.0 0.2 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 2.2 20.8 0.7 0.9 0.1 0.4 0.0 0.1 0.2 0.0 0.3 0.1 0.0 0.0 4.2 0.0 0.0 1.0 0.4 30.0 75.6 119.1 123.8 101.7 73.9 85.2 150.9 106.2 135.2 113.4 110.2 182.4 0.5 0.0 0.0 6.5 0.4 1.0 0.1 0.0 1.2 0.2 1.3 5.5 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.1 1.3 0.0 0.0 0.0 0.0 3.3 0.0 0.1 0.0 0.2 0.0 0.0 1.3 0.4 0.0 0.0 93.7 5.4 0.0 1.5 32.0 0.0 20.6 106.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.6 3.4 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.1 MYH6 ENSG00000197616 "Myosin heavy chain 6" P13533 14 23381982-23408273 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Atrial septal defect, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 54 "heart muscle: 2882.7" "Cell type enriched" "Detected in some" 17 "Cardiomyocytes: 8051.1" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 23 "NTERA-2: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA001239, HPA001349, CAB075723, CAB075724, CAB075725" Enhanced Uncertain "Focal adhesion sites" NA NA 25000000 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 5: NTERA-2 - Transcription" "Cluster 54: Cardiomyocytes - Muscle contraction" "Focal adhesion sites" "CAB075723: AB_2665728, CAB075724: AB_2665729, CAB075725: AB_2665730, HPA001239: AB_1079438, HPA001349: AB_1079437" "unprognostic (2.09e-2)" "unprognostic (8.53e-4)" "unprognostic (1.80e-2)" "unprognostic (2.99e-1)" "unprognostic (1.66e-1)" "unprognostic (2.09e-1)" "unprognostic (1.66e-1)" "unprognostic (5.73e-2)" "unprognostic (1.44e-2)" "unprognostic (5.34e-3)" "unprognostic (6.90e-2)" "unprognostic (1.42e-1)" "unprognostic (1.85e-1)" "unprognostic (1.22e-2)" 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 2882.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.9 5.8 0.0 0.0 0.5 0.1 0.9 0.0 0.0 1.9 0.0 53.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 50.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8051.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 31.7 0.0 2.7 0.1 0.0 0.0 449.6 0.0 0.0 0.0 0.3 1.1 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.8 60.3 0.1 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 MYH7 "CMD1S, CMH1, MPD1" ENSG00000092054 "Myosin heavy chain 7" P12883 14 23412740-23435660 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 71 "heart muscle: 7569.2;skeletal muscle: 14554.3;tongue: 5378.8" "Cell type enriched" "Detected in some" 127 "Cardiomyocytes: 10295.8" "Group enriched" "Detected in some" 9 "head and neck cancer: 12.2;prostate cancer: 15.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 31 "HSkMC: 11.4" "Low region specificity" "Detected in many" "HPA001239, HPA001349, CAB015384" Enhanced Uncertain "Focal adhesion sites" NA NA 43000000 "Cluster 13: Striated muscle - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" "Focal adhesion sites" "CAB015384: AB_2147279, HPA001239: AB_1079438, HPA001349: AB_1079437" "unprognostic (6.49e-2)" "unprognostic (8.27e-5)" "unprognostic (1.56e-1)" "unprognostic (3.04e-3)" "unprognostic (4.30e-1)" "unprognostic (7.33e-3)" "unprognostic (8.60e-2)" "unprognostic (1.55e-1)" "unprognostic (1.31e-1)" "unprognostic (1.22e-1)" "unprognostic (3.79e-1)" "unprognostic (5.38e-3)" "unprognostic (2.32e-1)" "unprognostic (1.20e-1)" "unprognostic (1.41e-1)" "unprognostic (2.28e-2)" 2.0 1.3 1.4 0.0 1.9 0.1 2.5 0.1 1.1 0.3 1.4 1.2 0.5 0.4 0.0 129.2 0.1 1.1 7569.2 1.2 2.9 0.9 1.4 3.2 1.5 0.8 1.6 0.7 7.8 0.0 1.5 0.0 0.9 76.8 0.0 0.0 37.0 0.0 14554.3 4.8 0.9 0.0 0.9 0.5 0.9 1.4 3.2 0.1 1.8 5378.8 0.1 0.2 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.9 0.1 1.1 1.2 2.9 0.8 1.6 0.9 0.9 3.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10295.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 80.9 0.0 0.0 0.2 3.1 0.0 70.5 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.7 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 3.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 52.2 51.2 0.1 2.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 NGDN "C14orf120, CANu1, DKFZP564O092, LCP5, lpd-2, NGD" ENSG00000129460 Neuroguidin Q8NEJ9 14 23469689-23509862 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000944 Approved Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Mitochondria" Nucleoplasm "HPA000944: AB_1079483" "unprognostic (2.63e-3)" "unprognostic (7.65e-2)" "unprognostic (2.84e-1)" "unprognostic (4.16e-3)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" "unprognostic (8.87e-2)" "unprognostic (1.72e-3)" "unprognostic (5.64e-2)" "unprognostic (3.87e-3)" "unprognostic (7.10e-2)" "unprognostic (1.65e-1)" "unprognostic (6.36e-2)" "unprognostic (9.83e-2)" "unprognostic (2.29e-2)" "unprognostic (2.58e-1)" "unprognostic (1.70e-1)" 32.2 26.4 25.6 23.3 28.4 64.4 40.3 30.5 37.7 30.5 25.0 30.1 23.4 34.7 32.5 26.2 32.0 17.6 23.7 25.9 26.6 31.3 32.9 24.2 35.3 27.1 27.0 39.6 25.7 33.3 20.8 29.2 27.7 24.8 29.0 25.2 24.6 26.6 53.4 35.2 26.8 31.4 27.7 28.6 27.0 28.6 26.9 37.5 28.4 39.2 36.8 32.3 27.7 31.7 37.6 73.1 54.5 51.5 52.0 37.3 72.1 48.6 50.7 101.3 81.4 72.1 66.8 92.6 35.0 44.7 71.1 63.7 109.0 60.1 118.7 61.8 57.3 83.2 44.1 229.3 70.5 110.4 56.9 46.5 75.0 79.9 94.4 39.6 52.2 69.5 93.6 64.1 50.4 88.8 82.3 86.0 69.5 84.8 97.1 67.1 65.6 47.9 65.7 70.4 55.6 62.8 57.6 68.3 83.8 55.0 42.2 70.4 39.8 47.8 57.3 45.1 71.3 79.4 148.7 133.3 20.6 56.1 52.2 67.0 62.3 58.5 88.0 71.8 93.5 129.0 94.6 89.9 74.8 107.7 121.3 95.5 19.1 109.5 71.7 79.1 116.1 93.3 25.6 28.4 30.5 37.7 25.9 26.6 27.1 27.0 27.7 27.7 26.9 31.7 33.8 35.3 29.2 2.9 52.1 70.6 63.8 78.2 72.8 23.2 25.5 31.2 20.2 21.5 46.8 27.6 16.7 59.3 45.3 19.9 33.2 38.6 7.2 24.3 25.9 36.5 24.6 35.1 7.5 36.0 43.3 34.4 16.3 27.5 45.0 23.2 25.4 21.4 29.8 25.2 6.8 22.7 28.5 19.2 39.0 6.9 35.1 21.1 32.0 9.4 34.3 26.8 46.4 4.0 11.0 31.1 22.8 28.2 30.4 42.9 25.8 35.5 36.6 28.6 19.7 51.5 36.0 68.7 64.2 39.6 67.6 57.2 47.6 20.5 27.2 49.5 ZFHX2 "KIAA1056, KIAA1762, ZFH-5, ZNF409" ENSG00000136367 "Zinc finger homeobox 2" Q9C0A1 14 23520857-23556192 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.9;testis: 7.3" "Cell type enhanced" "Detected in many" "Astrocytes: 22.5;Early spermatids: 38.9;Excitatory neurons: 31.0;Inhibitory neurons: 20.0;Late spermatids: 19.1;Oligodendrocyte precursor cells: 27.2;Oligodendrocytes: 20.8;Spermatocytes: 16.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 11.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.8;SuSa: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000720, HPA005146" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" Yes No "Cluster 9: Neutrophils - Innate immune response" "Cluster 21: Non-specific - Transcription" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoli fibrillar center" Nucleoplasm "HPA000720: AB_10603462, HPA005146: AB_1859250" "unprognostic (7.54e-3)" "unprognostic (2.01e-1)" "unprognostic (1.53e-1)" "unprognostic (2.53e-1)" "unprognostic (2.61e-1)" "unprognostic (6.12e-3)" "unprognostic (1.40e-1)" "unprognostic (5.40e-2)" "unprognostic (3.94e-2)" "unprognostic (3.71e-2)" "unprognostic (5.08e-4)" "unprognostic (2.39e-1)" "unprognostic (5.33e-3)" "unprognostic (3.75e-1)" "unprognostic (7.35e-2)" "unprognostic (1.76e-1)" "unprognostic (1.90e-2)" 0.5 0.7 1.8 0.5 6.3 0.1 0.4 11.9 5.3 0.4 0.0 0.7 0.1 0.7 0.4 0.2 2.2 0.4 0.3 3.2 0.0 1.3 0.2 0.5 0.3 1.5 0.1 0.5 0.4 1.7 3.4 0.2 0.2 0.6 0.2 3.1 0.4 1.2 0.7 0.5 0.3 0.6 0.0 0.2 0.4 7.3 0.9 0.2 0.7 0.5 0.2 0.3 0.2 2.3 0.1 3.1 2.4 4.8 1.6 0.2 0.1 0.7 0.2 0.3 1.2 0.3 0.2 0.2 0.3 0.0 0.3 0.1 1.2 0.1 0.5 2.2 0.8 2.5 0.0 0.6 0.2 0.4 1.7 0.3 0.1 0.5 0.1 1.3 0.3 2.1 0.4 0.4 0.1 0.8 0.3 0.3 2.9 0.3 0.7 1.4 0.0 0.0 1.3 1.2 2.7 1.7 0.4 0.6 0.1 3.6 1.0 0.6 0.1 0.0 1.2 0.7 0.3 0.3 1.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.8 6.3 11.9 5.3 3.2 0.0 1.5 0.1 0.2 0.0 0.9 2.3 0.5 0.0 1.1 22.5 0.7 0.1 0.6 1.1 0.0 9.0 2.2 2.3 2.5 0.0 2.4 1.8 0.0 0.3 0.1 0.6 1.9 2.8 38.9 12.2 0.6 1.1 6.7 0.0 31.0 2.4 0.0 1.4 2.0 2.5 0.0 3.2 0.7 0.2 1.0 8.4 20.0 0.7 2.0 1.0 1.9 19.1 0.6 0.8 0.0 4.7 1.0 2.7 0.0 27.2 20.8 1.2 1.2 0.4 0.1 1.4 0.4 1.4 9.8 3.8 0.0 2.5 1.3 16.5 1.2 0.7 0.0 0.3 0.4 0.2 0.6 0.3 THTPA THTPASE ENSG00000259431 "Thiamine triphosphatase" Q9BU02 14 23555988-23560271 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 54.8;Spermatocytes: 57.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028876 Approved Uncertain Nucleoplasm,Nucleoli NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Nucleoli "HPA028876: AB_10600731" "unprognostic (3.50e-3)" "unprognostic (1.51e-1)" "unprognostic (1.20e-1)" "unprognostic (7.11e-2)" "unprognostic (2.25e-1)" "unprognostic (2.12e-1)" "unprognostic (4.13e-1)" "unprognostic (1.58e-3)" "unprognostic (1.98e-1)" "unprognostic (1.57e-1)" "unprognostic (4.47e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.70e-9)" "unprognostic (3.47e-2)" "unprognostic (2.32e-1)" "unprognostic (3.62e-2)" "unprognostic (5.40e-2)" 13.6 17.6 29.3 10.4 41.7 8.2 11.0 27.5 33.0 9.4 28.5 11.5 14.2 12.1 15.1 8.5 14.9 9.7 14.8 30.1 27.0 14.4 11.3 9.5 10.6 28.4 27.5 12.6 11.4 19.8 11.1 6.7 27.7 16.0 10.6 13.2 17.3 14.0 23.6 6.9 9.8 11.8 27.9 10.7 10.7 20.1 27.9 11.0 11.5 20.7 10.2 10.2 7.3 29.3 3.9 24.1 11.4 12.4 26.3 14.6 6.3 11.2 9.7 10.7 10.5 4.9 15.9 7.2 9.5 13.1 12.1 11.8 12.1 13.8 7.8 15.9 13.7 10.2 16.9 13.3 13.0 9.1 8.7 20.6 10.2 16.4 12.0 22.9 13.0 11.6 7.7 15.9 15.7 11.6 14.6 3.7 4.1 20.9 20.1 9.9 7.9 13.4 18.9 7.6 22.1 10.6 10.8 22.0 6.6 6.6 14.9 4.4 10.9 7.0 7.4 14.5 6.5 18.9 12.2 4.4 7.3 4.2 10.9 13.7 16.0 8.7 9.8 12.0 9.8 10.2 7.2 7.6 14.7 15.3 11.7 10.2 1.7 8.3 16.1 18.7 6.4 10.9 29.3 41.7 27.5 33.0 30.1 27.0 28.4 27.5 27.7 27.9 27.9 29.3 8.1 6.4 7.5 16.6 14.5 0.0 7.8 0.0 6.8 27.4 12.0 10.7 0.1 8.6 3.7 7.3 8.4 11.0 9.2 7.2 54.8 14.5 21.9 6.7 9.2 6.2 6.1 3.4 11.8 12.4 5.1 9.9 9.2 6.7 23.5 7.7 7.1 10.8 18.4 8.4 23.1 7.5 0.0 7.9 0.0 23.0 11.5 9.8 0.0 4.7 9.9 33.4 14.4 15.1 37.0 8.2 9.6 7.5 11.3 9.3 15.2 38.9 2.9 11.6 13.1 13.2 7.7 57.5 8.3 9.5 0.0 6.7 9.3 14.2 7.7 5.9 AP1G2 G2AD ENSG00000213983 "Adaptor related protein complex 1 subunit gamma 2" O75843 14 23559565-23568070 "Predicted intracellular proteins" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 108.3;RT4: 151.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA004106 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 15: RT4 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA004106: AB_1078172" "unprognostic (1.94e-3)" "unprognostic (2.49e-1)" "unprognostic (2.56e-2)" "unprognostic (2.73e-2)" "unprognostic (7.34e-2)" "unprognostic (6.61e-2)" "unprognostic (6.61e-2)" "unprognostic (6.28e-3)" "unprognostic (1.16e-1)" "unprognostic (8.65e-3)" "unprognostic (8.85e-2)" "unprognostic (8.40e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (1.30e-2)" "unprognostic (3.22e-1)" "unprognostic (2.06e-1)" "unprognostic (1.02e-3)" 15.3 18.0 31.3 23.3 35.5 30.5 20.0 34.0 40.5 22.5 27.8 27.2 28.7 11.7 14.3 35.5 19.8 18.2 6.1 32.8 30.7 26.7 15.1 18.9 39.1 29.7 28.7 23.0 36.2 24.9 67.4 12.9 29.9 33.8 23.0 9.8 29.7 15.9 2.2 45.2 37.5 10.3 27.5 45.7 35.2 7.5 30.2 30.1 27.2 1.6 42.9 26.3 26.2 30.1 29.1 30.4 0.8 3.1 4.5 7.2 45.5 3.5 8.3 10.3 13.5 28.6 64.8 53.8 15.6 2.8 0.1 53.5 16.2 45.4 7.0 30.0 9.2 20.8 14.5 67.7 16.9 31.6 108.3 20.9 66.0 7.0 24.1 11.2 6.1 37.5 9.2 22.3 4.4 70.8 26.3 28.8 6.9 59.2 11.1 38.9 0.2 16.7 41.3 151.2 8.2 11.5 15.0 68.0 5.6 17.9 40.4 7.8 5.3 2.7 20.2 2.6 0.2 16.2 9.2 21.3 1.2 21.3 3.3 40.6 25.4 43.8 29.5 35.2 28.0 30.7 31.5 31.5 42.5 28.1 25.4 24.8 10.2 38.7 37.0 22.2 42.2 35.6 31.3 35.5 34.0 40.5 32.8 30.7 29.7 28.7 29.9 27.5 30.2 30.1 9.1 19.2 21.7 6.2 31.4 13.5 18.9 33.1 29.0 31.1 23.7 21.8 0.5 17.2 38.2 12.9 2.1 22.8 23.7 38.7 5.9 30.4 1.1 9.7 4.7 9.7 32.4 9.9 21.5 29.4 24.1 7.1 64.2 15.6 31.7 22.0 6.4 2.5 15.2 72.3 15.7 29.4 42.7 15.2 21.0 1.2 9.3 15.1 10.6 6.5 27.5 8.6 12.3 4.0 4.7 26.6 53.1 6.0 14.0 11.0 33.1 9.6 24.3 6.2 0.0 1.6 5.0 5.8 3.9 16.4 9.8 24.5 30.9 13.9 34.6 23.3 JPH4 "JPHL1, KIAA1831" ENSG00000092051 "Junctophilin 4" Q96JJ6 14 23568035-23578790 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 126.2;pituitary gland: 66.5" "Group enriched" "Detected in some" 13 "Bipolar cells: 191.4;Horizontal cells: 410.5" "Cancer enhanced" "Detected in some" "glioma: 6.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 2.8;myeloid DC: 3.2" "Group enriched" "Detected in many" 8 "dendritic cells: 3.2;monocytes: 2.8" "Group enriched" "Detected in some" 6 "SCLC-21H: 14.2;SH-SY5Y: 35.4;U-2 OS: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045022 Approved Cytosol NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" Cytosol "HPA045022: " "unprognostic (3.30e-2)" "unprognostic (1.91e-3)" "unprognostic (5.05e-3)" "unprognostic (7.41e-2)" "unprognostic (2.04e-1)" "unprognostic (1.84e-1)" "unprognostic (3.77e-3)" "unprognostic (5.98e-4)" "unprognostic (1.58e-1)" "unprognostic (1.16e-1)" "unprognostic (3.89e-3)" "unprognostic (1.15e-2)" "unprognostic (3.15e-2)" "unprognostic (2.10e-2)" "unprognostic (1.91e-1)" "unprognostic (2.13e-2)" "unprognostic (4.96e-3)" 1.5 11.7 83.7 1.0 88.5 0.2 1.0 25.2 126.2 8.4 0.0 1.7 0.8 24.3 5.2 0.4 13.7 0.5 0.3 115.4 29.3 3.0 0.3 2.5 1.0 14.5 11.0 13.6 0.5 1.8 66.5 0.5 11.2 12.3 0.6 12.5 0.3 36.8 0.2 0.9 1.3 12.9 7.2 2.6 0.9 1.4 31.7 0.3 0.4 0.5 0.6 1.6 6.6 57.2 0.0 0.0 0.7 3.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 4.4 0.0 0.2 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.7 14.2 35.4 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 26.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.3 2.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 83.7 88.5 25.2 126.2 115.4 29.3 14.5 11.0 11.2 7.2 31.7 57.2 0.3 0.0 0.6 0.7 0.0 0.0 0.2 0.0 0.0 191.4 0.2 0.1 1.3 0.0 0.0 0.0 4.2 0.0 0.0 0.1 0.0 0.0 0.3 0.3 5.7 1.7 1.8 0.0 22.1 0.0 0.0 1.4 0.0 0.1 5.1 1.2 1.8 0.0 2.0 410.5 18.3 0.2 0.0 1.3 9.3 0.2 10.8 0.9 0.0 0.0 0.1 1.6 0.0 15.6 0.4 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 7.7 13.1 0.1 2.3 0.5 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.8 DHRS2 "HEP27, SDR25C1" ENSG00000100867 "Dehydrogenase/reductase 2" Q13268 14 23630115-23645639 "Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 336.3;urinary bladder: 392.6" "Cell type enhanced" "Detected in some" "Extravillous trophoblasts: 15.1;Syncytiotrophoblasts: 24.8;Theca cells: 12.6;Urothelial cells: 30.6" "Cancer enriched" "Detected in many" 6 "urothelial cancer: 141.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 719.8;RT4: 828.1;SK-BR-3: 4047.2;U-2 OS: 1286.3" "Region enriched" "Detected in single" 4 "cerebellum: 2.4" "HPA053915, HPA069551" Enhanced Supported Nucleoplasm,Mitochondria No NA "Cluster 46: Fibroblasts - ECM organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Mitochondria Nucleoplasm "HPA053915: AB_2682307, HPA069551: AB_2686150" "unprognostic (3.07e-1)" "unprognostic (4.91e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (9.97e-2)" "unprognostic (5.03e-3)" "unprognostic (5.62e-2)" "unprognostic (1.86e-1)" "unprognostic (4.08e-1)" "unprognostic (6.91e-2)" "unprognostic (6.66e-2)" "unprognostic (4.59e-2)" "prognostic unfavorable (3.75e-5)" "unprognostic (1.83e-1)" "unprognostic (1.46e-1)" "unprognostic (1.76e-1)" "prognostic favorable (6.45e-4)" 1.2 1.6 0.3 0.1 0.2 0.0 336.3 0.2 0.4 1.9 0.2 0.2 0.0 0.2 0.4 0.1 0.3 0.0 0.0 0.4 1.2 1.6 23.6 0.2 0.0 0.4 1.2 25.5 10.3 2.1 2.5 3.2 1.7 3.3 0.4 0.4 97.7 3.1 0.0 3.4 0.1 0.2 0.3 19.0 4.7 3.4 1.1 0.0 0.1 0.0 0.0 392.6 13.6 0.3 1.2 2.2 0.2 199.9 0.3 0.3 3.1 0.3 0.2 6.4 0.1 14.4 1.1 0.8 1.9 0.3 10.4 2.0 0.7 1.2 1.4 289.5 21.6 2.8 1.0 719.8 0.0 4.3 25.1 1.7 0.2 2.5 1.7 0.0 0.1 0.4 1.8 0.7 1.4 8.0 2.5 0.3 1.1 6.9 31.7 2.6 6.3 2.7 0.0 828.1 3.5 5.0 5.9 4047.2 4.9 0.7 3.9 1.0 0.0 2.4 1286.3 7.7 4.3 2.0 0.6 11.3 1.7 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.4 0.4 1.2 0.4 1.2 1.7 0.3 1.1 0.3 0.1 0.0 0.0 0.0 0.4 0.0 2.1 0.2 0.0 0.8 7.4 1.3 0.4 0.0 0.0 0.0 0.0 7.9 0.1 0.1 7.9 0.1 5.0 0.1 0.0 0.2 3.5 0.0 0.1 0.2 15.1 3.5 0.0 0.0 0.0 1.4 0.0 4.9 1.7 0.0 0.1 0.2 0.0 0.3 0.8 3.7 0.0 0.1 0.0 0.0 0.6 0.4 0.0 0.0 0.0 4.8 0.2 1.2 0.0 0.3 0.0 0.2 0.0 1.2 6.6 0.0 0.7 0.3 7.4 0.0 0.1 24.8 0.2 12.6 0.7 30.6 DHRS4 "FLJ11008, humNRDR, SCAD-SRL, SDR-SRL, SDR25C2" ENSG00000157326 "Dehydrogenase/reductase 4" Q9BTZ2 14 23953734-23969279 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 235.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA023972 Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles "Nuclear membrane" "HPA023972: AB_1854890" "unprognostic (1.21e-2)" "unprognostic (2.59e-1)" "unprognostic (3.46e-2)" "unprognostic (3.79e-3)" "unprognostic (1.97e-1)" "unprognostic (1.66e-1)" "unprognostic (7.35e-3)" "unprognostic (1.61e-3)" "unprognostic (2.66e-1)" "unprognostic (1.19e-2)" "unprognostic (1.06e-2)" "unprognostic (7.65e-2)" "prognostic favorable (4.55e-6)" "unprognostic (2.03e-2)" "unprognostic (1.48e-1)" "unprognostic (2.03e-1)" "unprognostic (5.68e-2)" 34.1 45.8 8.6 10.4 9.2 6.9 34.5 8.8 9.7 30.5 10.1 43.5 34.0 27.1 5.2 45.8 23.6 5.9 49.1 8.3 8.6 92.0 109.7 28.0 10.2 9.2 8.6 33.0 40.3 8.8 19.3 5.3 9.2 31.9 13.5 3.9 31.2 8.4 62.2 44.7 38.6 8.3 8.6 32.2 33.7 37.9 9.0 9.6 25.4 14.0 8.5 30.5 33.1 9.5 15.1 29.6 10.4 17.2 16.6 18.5 0.1 27.4 15.3 11.5 9.1 6.5 16.5 13.3 14.3 14.6 7.6 18.1 8.6 12.3 10.1 34.6 16.5 7.8 23.5 36.6 9.5 11.6 45.2 18.0 14.8 9.2 20.8 12.3 14.4 19.6 11.8 30.4 15.8 52.3 21.1 10.7 9.9 18.9 30.3 33.8 18.0 41.4 12.1 17.1 19.9 16.1 27.7 17.6 13.8 6.8 16.0 14.6 25.5 13.3 13.8 13.9 9.0 22.8 22.8 3.5 11.8 12.6 13.6 5.4 54.4 6.0 18.0 45.8 21.4 21.5 20.3 18.2 47.4 18.5 20.1 19.5 2.3 18.1 25.5 39.4 19.4 36.2 8.6 9.2 8.8 9.7 8.3 8.6 9.2 8.6 9.2 8.6 9.0 9.5 16.6 16.0 30.5 6.2 12.5 12.5 10.4 15.7 55.2 5.1 22.2 31.9 35.4 17.2 21.3 14.7 0.0 9.6 17.8 34.2 78.2 6.4 50.4 13.1 11.6 14.6 19.2 20.8 2.6 9.8 6.0 23.7 34.7 7.8 13.9 10.5 20.0 68.1 30.4 6.7 2.1 50.1 8.2 29.2 13.5 66.1 11.1 35.9 5.4 3.7 33.2 18.1 47.4 4.0 5.0 5.3 22.3 17.3 24.6 11.2 51.8 235.4 23.2 1.8 6.6 13.5 18.1 59.4 1.9 61.6 13.4 3.8 18.1 22.9 71.8 9.0 DHRS4L2 SDR25C3 ENSG00000187630 "Dehydrogenase/reductase 4 like 2" Q6PKH6 14 23969874-24006408 "Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 136.2" "Cell type enhanced" "Detected in all" "Hepatocytes: 204.2;Proximal enterocytes: 326.4;Proximal tubular cells: 581.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA023972 Uncertain Approved "Nuclear membrane,Vesicles" "Secreted - unknown location" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles "Nuclear membrane" "HPA023972: AB_1854890" "unprognostic (1.41e-2)" "unprognostic (2.83e-3)" "unprognostic (1.25e-1)" "unprognostic (2.68e-2)" "unprognostic (1.47e-1)" "unprognostic (2.53e-1)" "unprognostic (6.02e-2)" "unprognostic (3.97e-3)" "unprognostic (7.34e-2)" "prognostic favorable (3.21e-4)" "unprognostic (1.57e-2)" "unprognostic (1.46e-2)" "unprognostic (1.36e-3)" "unprognostic (6.00e-2)" "unprognostic (2.38e-1)" "unprognostic (2.00e-1)" "unprognostic (3.65e-2)" 27.2 39.5 28.8 14.6 29.6 11.5 30.5 28.3 38.4 26.9 30.8 34.7 34.4 19.7 12.8 38.4 18.6 10.6 45.9 28.5 27.8 122.5 136.2 22.5 14.6 29.3 28.7 25.2 34.0 24.5 16.7 10.0 28.7 32.5 26.6 6.7 24.7 20.7 50.7 37.1 42.0 18.4 28.6 29.3 27.9 41.4 29.4 16.9 21.5 28.5 16.5 26.0 26.1 29.9 18.7 29.0 4.9 24.4 46.2 47.9 0.6 17.3 34.3 24.8 18.4 8.4 22.5 12.6 11.5 35.3 16.0 20.6 22.3 29.1 20.6 43.3 13.3 3.1 24.8 52.4 34.0 15.3 47.9 50.0 36.4 16.3 23.7 17.0 29.5 40.0 10.1 44.9 26.7 61.5 40.4 16.5 9.7 45.9 31.8 64.9 19.9 38.2 35.6 23.7 26.0 15.7 24.5 21.5 15.0 10.3 25.2 24.5 20.8 12.9 13.4 15.4 8.8 25.5 21.1 3.8 11.1 23.7 18.8 4.8 56.3 6.9 19.4 47.2 20.1 21.9 20.9 22.2 45.4 17.4 21.0 19.1 2.6 17.2 29.3 37.4 21.8 33.6 28.8 29.6 28.3 38.4 28.5 27.8 29.3 28.7 28.7 28.6 29.4 29.9 39.3 16.0 29.6 10.4 17.8 27.8 46.1 56.8 27.9 9.9 45.5 54.4 17.2 47.1 34.3 25.8 2.1 21.2 22.9 37.9 127.2 40.0 20.7 20.6 20.1 32.0 37.3 24.2 7.3 55.7 7.3 36.4 13.3 16.5 17.7 31.8 50.0 204.2 146.1 11.8 6.7 61.7 42.7 55.9 42.8 35.4 43.8 41.9 51.6 10.3 65.0 79.5 35.0 10.1 8.5 30.4 54.9 37.2 10.8 32.5 326.4 581.7 28.6 8.3 32.9 24.2 32.7 17.2 1.7 42.1 40.2 13.0 21.3 37.5 78.1 42.4 CARMIL3 "BC008134, C14orf121, crml-1, LRRC16B" ENSG00000186648 "Capping protein regulator and myosin 1 linker 3" Q8ND23 14 24052009-24069729 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 3.6;pituitary gland: 8.1;skin 1: 3.9;testis: 2.2" "Cell type enhanced" "Detected in single" "Collecting duct cells: 1.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 5.5;HMC-1: 3.7;Karpas-707: 3.3;SCLC-21H: 5.4;SH-SY5Y: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030596 Uncertain NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "HPA030596: AB_10603012" "unprognostic (2.67e-2)" "unprognostic (2.07e-3)" "unprognostic (1.50e-1)" "unprognostic (3.09e-2)" "unprognostic (6.17e-2)" "unprognostic (1.29e-4)" "unprognostic (6.13e-2)" "unprognostic (8.92e-4)" "unprognostic (4.02e-1)" "unprognostic (7.08e-2)" "unprognostic (1.39e-4)" "unprognostic (4.49e-2)" "unprognostic (1.17e-1)" "unprognostic (7.01e-2)" "unprognostic (1.25e-2)" "unprognostic (4.19e-1)" "unprognostic (2.16e-1)" 0.1 0.3 2.0 0.3 1.5 0.2 0.3 3.6 2.1 0.3 0.0 0.5 0.5 0.2 0.0 0.6 0.1 0.3 0.1 1.9 1.3 0.7 0.2 0.3 0.3 2.0 1.4 0.1 0.7 0.0 8.1 0.0 2.0 0.3 0.1 1.0 0.6 0.0 0.0 3.9 0.7 0.0 0.5 0.5 0.3 2.2 1.9 0.1 0.5 0.0 0.4 0.1 0.5 1.8 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.9 0.0 0.1 0.1 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.3 0.0 0.2 0.8 0.0 0.3 0.1 0.1 0.4 0.0 0.0 0.0 0.0 5.4 2.6 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.5 3.6 2.1 1.9 1.3 2.0 1.4 2.0 0.5 1.9 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 CPNE6 ENSG00000100884 "Copine 6" O95741 14 24070837-24078100 "Plasma proteins, Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 54.3;retina: 16.4" "Cell type enhanced" "Detected in some" "Astrocytes: 15.3;Bipolar cells: 26.3;Horizontal cells: 32.0;Inhibitory neurons: 11.4;Late spermatids: 18.1" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/84: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031636, HPA076665" Enhanced NA NA "Cluster 65: Brain - Ion transport" "Cluster 16: U-266 - Nucleosome" "Cluster 62: Horizontal cells - Visual perception" "HPA031636: AB_10601203, HPA076665: " "unprognostic (1.02e-2)" "unprognostic (3.26e-4)" "unprognostic (1.64e-1)" "unprognostic (5.66e-5)" "unprognostic (3.51e-3)" "unprognostic (2.53e-2)" "unprognostic (2.49e-2)" "unprognostic (1.09e-3)" "unprognostic (1.71e-1)" "unprognostic (1.67e-1)" "unprognostic (2.30e-2)" "unprognostic (3.65e-2)" "unprognostic (1.32e-1)" "unprognostic (1.01e-2)" "unprognostic (5.79e-2)" "unprognostic (4.50e-2)" "unprognostic (2.71e-1)" 0.2 0.2 42.1 0.2 37.7 0.2 0.0 20.0 41.1 0.2 12.2 1.5 2.5 0.2 0.3 1.7 0.3 0.0 0.2 54.3 24.9 7.0 2.1 0.1 0.0 31.4 23.2 0.1 0.0 0.0 8.0 0.0 32.7 2.8 0.5 16.4 0.0 12.3 0.1 0.4 3.4 0.3 20.8 0.0 0.4 0.5 31.3 0.1 0.2 0.1 0.0 0.7 0.4 26.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.1 37.7 20.0 41.1 54.3 24.9 31.4 23.2 32.7 20.8 31.3 26.0 0.0 0.0 0.0 15.3 0.0 0.1 0.0 0.0 0.0 26.3 0.0 0.0 1.7 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.1 0.0 0.0 6.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.0 11.4 0.2 0.0 0.0 0.0 18.1 0.6 0.0 0.0 1.0 0.0 1.4 0.0 1.5 0.8 0.0 0.0 0.0 0.0 0.3 6.5 2.4 0.0 3.8 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 NRL "D14S46E, NRL-MAF, RP27" ENSG00000129535 "Neural retina leucine zipper" P54845 14 24078662-24115010 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 75 "retina: 317.3" "Cell type enriched" "Detected in many" 5 "Rod photoreceptor cells: 3720.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SuSa: 4.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB026066, HPA064599" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 79: Retina - Phototransduction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm Cytosol "CAB026066: , HPA064599: AB_2685295" "unprognostic (2.71e-2)" "unprognostic (8.17e-4)" "unprognostic (4.60e-2)" "unprognostic (1.80e-1)" "unprognostic (7.23e-2)" "unprognostic (1.99e-2)" "unprognostic (5.29e-2)" "unprognostic (1.88e-5)" "unprognostic (3.59e-2)" "unprognostic (7.84e-3)" "unprognostic (1.75e-3)" "unprognostic (3.49e-2)" "unprognostic (2.38e-5)" "unprognostic (2.56e-2)" "unprognostic (1.10e-1)" "unprognostic (1.73e-1)" "unprognostic (1.35e-3)" 0.8 2.5 1.7 0.5 1.5 0.5 1.0 2.3 2.2 1.1 0.6 0.9 1.1 1.1 0.7 1.1 1.0 0.9 2.2 1.5 1.5 3.1 3.6 1.0 1.0 2.3 1.8 1.2 1.7 1.9 2.4 0.3 1.7 1.5 0.3 317.3 1.0 0.7 2.5 0.7 1.3 0.3 1.7 2.1 1.2 4.2 1.6 1.2 2.7 1.4 0.7 1.1 0.8 1.7 0.3 1.2 1.6 1.6 0.3 0.2 0.4 0.3 0.3 0.5 0.3 0.7 0.5 1.2 0.4 0.5 1.0 0.5 0.6 0.3 0.2 0.6 0.5 0.7 0.6 2.2 0.6 1.4 1.6 0.4 0.5 0.2 0.7 0.7 0.5 2.2 0.7 1.2 0.3 0.9 1.2 0.6 1.8 1.8 0.9 1.2 1.5 0.0 0.4 1.3 1.7 1.2 0.8 0.7 0.8 4.8 0.9 1.5 0.4 1.1 0.5 0.1 0.7 3.6 1.9 1.5 0.3 0.9 1.1 0.2 0.3 1.3 0.2 0.4 0.1 1.0 0.2 0.4 0.3 0.7 0.8 0.6 0.1 0.5 0.3 0.4 0.2 0.3 1.7 1.5 2.3 2.2 1.5 1.5 2.3 1.8 1.7 1.7 1.6 1.7 1.4 0.0 0.5 5.5 6.2 0.8 1.6 0.1 1.2 434.4 2.0 1.9 2.1 0.0 0.7 7.3 431.6 1.4 3.2 1.5 13.7 0.6 2.7 1.3 0.7 24.1 1.8 3.2 1.8 1.1 0.9 0.7 2.6 1.0 0.0 0.7 0.7 3.3 2.0 250.7 2.6 1.7 0.0 1.3 0.4 4.2 1.2 1.4 1.8 0.0 1.1 636.4 5.2 2.0 4.4 0.3 5.3 1.9 1.7 2.0 5.6 6.7 0.1 3720.7 0.0 1.2 0.7 9.7 4.3 2.2 0.4 2.5 2.6 2.3 1.0 2.1 PCK2 "PEPCK, PEPCK2" ENSG00000100889 "Phosphoenolpyruvate carboxykinase 2, mitochondrial" Q16822 14 24094053-24110598 "Citric acid cycle related proteins, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Gluconeogenesis "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "intestine: 196.1;kidney: 99.1;liver: 374.1" "Group enriched" "Detected in many" 4 "Hepatocytes: 309.3;Proximal enterocytes: 752.6;Proximal tubular cells: 237.1" "Cancer enhanced" "Detected in all" "liver cancer: 91.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 104.7;hTCEpi: 104.7;SK-MEL-30: 103.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB018734, HPA051162, HPA053502" Enhanced Enhanced Mitochondria NA NA 3500000 "Cluster 51: Monocytes - Innate immune response" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 30: Epithelial cell lines - Translation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria "CAB018734: AB_2160168, HPA051162: AB_2681368, HPA053502: AB_2682171" "unprognostic (3.38e-2)" "unprognostic (1.13e-1)" "unprognostic (1.50e-2)" "unprognostic (4.07e-1)" "unprognostic (3.11e-1)" "unprognostic (2.10e-1)" "prognostic favorable (2.81e-4)" "unprognostic (3.91e-2)" "unprognostic (1.04e-1)" "unprognostic (2.18e-2)" "unprognostic (1.26e-1)" "unprognostic (3.67e-2)" "unprognostic (1.33e-2)" "unprognostic (2.81e-1)" "unprognostic (3.71e-1)" "unprognostic (2.82e-2)" "unprognostic (1.17e-1)" 25.5 10.7 3.2 8.0 3.9 4.5 21.1 3.8 3.3 6.8 3.4 44.8 196.1 5.8 3.1 20.0 5.9 4.5 5.8 3.1 3.9 99.1 374.1 16.5 8.7 4.6 4.2 3.0 34.8 17.4 8.0 2.8 4.1 9.1 19.2 2.7 18.6 7.1 2.6 12.6 136.3 3.8 4.0 21.7 16.0 19.7 3.9 3.7 18.9 1.2 7.5 10.8 10.0 4.3 17.6 9.8 2.7 18.1 11.0 10.5 46.0 21.5 25.6 17.4 28.4 16.1 19.9 44.6 2.6 33.4 5.6 25.4 18.0 28.1 13.8 22.8 0.8 8.0 5.0 84.2 104.7 15.8 33.4 12.9 104.7 10.6 26.5 5.0 14.0 50.6 23.4 79.3 6.4 74.6 4.0 7.6 3.1 39.4 13.0 8.7 10.5 26.0 5.3 26.7 11.3 18.2 16.5 21.2 103.9 2.6 28.5 24.1 2.7 3.8 19.7 5.6 6.0 53.2 18.6 11.0 10.6 24.5 9.6 0.3 11.6 3.5 4.0 21.6 4.1 11.4 4.5 4.5 15.3 7.3 2.7 2.5 1.3 2.2 22.0 2.5 9.1 6.1 3.2 3.9 3.8 3.3 3.1 3.9 4.6 4.2 4.1 4.0 3.9 4.3 4.8 12.8 28.5 1.3 17.9 3.3 10.2 12.3 5.7 4.7 8.6 5.2 1.8 18.6 8.0 18.4 0.0 4.7 4.3 91.2 35.2 18.9 60.1 1.6 5.2 5.6 9.1 24.4 0.5 76.3 14.3 7.4 16.8 4.5 1.3 1.6 13.2 309.3 63.8 0.0 0.9 60.8 18.3 25.8 5.7 30.8 3.4 16.4 7.2 1.0 22.9 5.8 7.2 0.0 0.1 29.0 87.8 3.0 13.3 7.6 752.6 237.1 4.8 5.5 0.0 3.4 18.7 19.8 1.0 9.1 4.8 3.0 7.6 6.8 72.0 15.0 DCAF11 "GL014, PRO2389, WDR23" ENSG00000100897 "DDB1 and CUL4 associated factor 11" Q8TEB1 14 24114195-24125242 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 201.2;Hepatocytes: 156.0;Proximal enterocytes: 147.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003583, HPA031157" Approved Enhanced Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 6: Erythroid cells - Oxygen transport" Nucleoplasm "HPA003583: AB_2667001, HPA031157: AB_10603002" "unprognostic (1.50e-1)" "unprognostic (4.72e-2)" "unprognostic (3.22e-1)" "unprognostic (8.45e-2)" "unprognostic (1.01e-1)" "unprognostic (9.58e-2)" "unprognostic (1.91e-3)" "unprognostic (1.48e-3)" "unprognostic (3.23e-2)" "unprognostic (4.08e-1)" "unprognostic (1.19e-1)" "unprognostic (2.01e-1)" "prognostic favorable (3.50e-13)" "unprognostic (2.58e-1)" "unprognostic (3.48e-1)" "unprognostic (6.80e-2)" "unprognostic (1.68e-1)" 15.4 41.6 21.5 13.4 21.7 39.5 17.1 19.7 23.0 15.4 19.9 24.5 29.3 17.1 23.2 29.8 15.6 13.6 38.1 22.3 19.9 35.8 107.2 17.5 15.6 21.0 20.3 23.1 59.7 28.2 25.6 9.2 19.8 23.6 16.6 17.6 25.9 17.5 62.3 20.1 37.5 11.7 19.2 28.9 34.3 16.5 22.0 19.0 26.4 50.0 16.1 20.3 16.2 21.1 12.5 18.3 12.3 10.9 10.7 8.8 16.6 9.1 10.7 16.0 19.5 12.0 21.3 19.4 10.3 12.2 13.3 16.1 15.8 9.6 7.4 23.1 9.5 15.6 19.7 67.3 14.3 27.7 31.0 5.3 23.1 6.7 16.7 13.1 12.3 31.6 15.0 23.0 9.7 39.2 23.7 28.5 7.2 35.0 17.0 25.1 16.0 28.2 12.2 28.1 22.1 17.0 5.3 29.9 13.4 12.7 15.4 19.6 5.1 12.5 10.0 13.6 13.2 38.6 36.2 25.3 6.0 17.7 10.9 14.0 13.8 20.5 13.8 15.8 11.7 12.1 12.5 13.5 17.1 11.5 12.2 11.4 11.7 23.0 13.9 8.6 16.7 15.2 21.5 21.7 19.7 23.0 22.3 19.9 21.0 20.3 19.8 19.2 22.0 21.1 18.2 28.9 45.4 10.4 30.5 8.8 22.2 18.7 31.3 34.1 34.8 20.7 41.2 44.3 23.9 38.6 47.9 34.6 34.2 76.1 46.9 41.6 19.3 22.0 10.8 15.2 28.9 201.2 9.2 46.2 31.5 14.1 29.0 22.5 12.6 26.5 22.1 156.0 37.4 16.8 6.9 40.7 20.3 27.0 12.8 26.6 9.0 24.1 17.8 9.4 39.2 38.8 55.6 7.1 9.7 31.9 34.6 14.7 26.6 25.0 147.9 56.0 22.3 29.4 26.3 15.9 14.5 23.7 12.4 32.6 11.4 50.5 31.2 60.7 49.0 22.7 AL136295.3 ENSG00000259371 "Novel protein" 14 24120956-24131829 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.38e-1)" "unprognostic (4.35e-3)" "unprognostic (4.81e-2)" "unprognostic (1.87e-2)" "unprognostic (6.61e-5)" "unprognostic (5.64e-2)" "unprognostic (1.61e-1)" "unprognostic (1.29e-1)" "unprognostic (1.78e-1)" "unprognostic (5.39e-2)" "unprognostic (1.53e-2)" "unprognostic (4.52e-4)" "unprognostic (2.37e-1)" "unprognostic (9.36e-2)" "unprognostic (2.23e-1)" 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.4 0.0 0.0 0.3 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FITM1 FIT1 ENSG00000139914 "Fat storage inducing transmembrane protein 1" A5D6W6 14 24130659-24132849 "Metabolic proteins, Predicted membrane proteins" "Lipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "heart muscle: 171.1;skeletal muscle: 224.1" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 281.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 2.0;HMC-1: 1.2;RH-30: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA019842 Uncertain NA NA "Cluster 38: Heart - Muscle contraction" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA019842: AB_1853025" "unprognostic (1.81e-2)" "unprognostic (4.29e-7)" "unprognostic (2.77e-1)" "unprognostic (2.02e-3)" "unprognostic (2.24e-2)" "unprognostic (6.68e-2)" "prognostic favorable (1.00e-3)" "unprognostic (1.20e-4)" "unprognostic (4.57e-1)" "unprognostic (2.12e-2)" "unprognostic (2.84e-2)" "unprognostic (3.68e-2)" "unprognostic (2.47e-1)" "unprognostic (2.86e-2)" "unprognostic (5.62e-1)" "unprognostic (1.96e-1)" "unprognostic (2.12e-3)" 1.0 7.3 0.7 0.2 0.8 1.7 1.2 1.1 1.1 0.9 0.6 1.3 0.9 0.8 0.5 1.3 0.8 0.2 171.1 0.6 0.7 1.8 27.0 1.4 0.5 0.8 0.7 1.4 15.5 0.1 1.5 0.1 0.8 3.3 0.3 0.8 7.4 0.4 224.1 1.6 2.3 0.0 0.6 10.2 1.3 2.2 0.7 0.4 2.0 1.7 0.2 0.7 0.9 1.0 0.0 0.0 0.1 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.3 0.3 0.1 0.2 2.0 0.2 0.0 1.2 0.2 0.2 0.0 0.2 0.0 0.0 0.7 0.0 0.3 0.2 0.2 0.2 0.6 0.0 0.0 0.3 0.3 2.0 0.0 0.1 0.3 0.2 0.3 0.1 0.2 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.2 0.0 0.5 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 1.1 1.1 0.6 0.7 0.8 0.7 0.8 0.6 0.7 1.0 2.7 0.0 0.0 0.0 0.6 0.1 0.3 0.4 0.0 1.8 1.3 0.9 281.6 1.5 0.2 0.0 0.0 0.2 1.1 1.9 0.0 1.0 2.2 0.5 0.3 5.0 1.2 0.0 0.3 3.0 0.2 12.2 1.1 0.9 0.0 0.6 1.1 37.4 0.2 0.0 0.2 1.1 0.0 0.8 0.3 3.9 0.0 0.4 0.0 0.0 0.9 0.9 2.1 0.0 0.4 0.8 0.3 0.7 0.2 0.3 3.8 0.6 0.3 0.7 0.0 56.8 7.5 1.5 0.3 0.7 0.6 0.7 0.8 12.3 0.9 0.2 PSME1 "IFI5111, PA28alpha" ENSG00000092010 "Proteasome activator subunit 1" Q06323 14 24136163-24138967 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006632 Approved Approved "Nuclear bodies,Cytosol" NA NA 7500000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "Nuclear bodies" "HPA006632: AB_1079686" "prognostic favorable (8.87e-5)" "unprognostic (1.02e-2)" "unprognostic (9.90e-2)" "unprognostic (2.84e-1)" "unprognostic (2.65e-1)" "unprognostic (1.97e-1)" "unprognostic (5.16e-1)" "unprognostic (7.04e-2)" "unprognostic (9.63e-3)" "unprognostic (5.06e-3)" "unprognostic (1.49e-2)" "unprognostic (1.38e-2)" "unprognostic (1.14e-2)" "unprognostic (1.45e-1)" "unprognostic (4.50e-1)" "prognostic favorable (4.60e-4)" "unprognostic (1.62e-3)" 163.2 231.2 36.4 102.1 37.3 120.3 157.1 37.1 47.1 159.0 36.4 182.2 133.9 128.6 85.0 177.6 139.6 68.3 145.2 35.7 38.9 224.5 219.7 184.1 156.8 40.5 37.6 154.3 131.0 84.6 115.0 72.4 39.0 146.3 119.9 24.5 151.6 85.9 140.7 142.9 211.6 79.8 39.6 272.6 160.4 30.7 38.2 129.1 150.6 67.3 150.7 135.2 157.1 40.3 98.6 79.0 59.8 115.9 127.6 146.0 91.6 61.5 199.0 193.2 274.8 51.9 233.5 252.1 44.8 102.7 101.7 139.1 86.8 127.3 128.7 211.2 52.5 112.9 34.9 289.6 280.0 144.8 137.6 128.2 80.4 87.4 76.3 182.6 147.4 158.1 17.5 218.5 76.3 249.3 376.0 175.1 5.8 162.3 135.9 293.2 123.4 182.9 246.8 259.8 37.7 67.3 78.0 200.7 124.6 35.5 131.9 139.5 85.1 52.8 61.0 60.6 92.7 201.8 224.5 120.9 71.9 128.0 86.6 394.8 441.9 552.3 484.5 570.1 484.8 399.4 448.4 463.2 425.0 370.1 318.6 395.7 653.9 515.6 575.2 408.3 537.9 978.6 36.4 37.3 37.1 47.1 35.7 38.9 40.5 37.6 39.0 39.6 38.2 40.3 305.5 208.3 172.7 7.5 353.8 156.4 241.6 570.7 199.2 28.2 159.6 169.2 59.6 248.8 296.5 283.3 10.4 393.3 406.7 347.8 318.9 500.0 3.5 171.4 250.5 228.0 189.7 244.9 1.4 549.8 293.2 184.8 138.6 223.9 240.1 124.7 242.4 266.6 313.7 6.7 1.9 397.6 280.8 295.3 294.2 16.5 189.2 275.4 188.5 4.7 930.4 98.3 620.0 3.0 6.6 373.6 461.2 124.8 422.0 280.6 754.3 700.5 236.3 23.5 105.2 121.4 283.6 3.5 24.9 200.0 156.0 304.4 424.6 243.6 406.6 301.3 EMC9 "C14orf122, CGI-112, FAM158A" ENSG00000100908 "ER membrane protein complex subunit 9" Q9Y3B6 14 24138959-24141591 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 155.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 63.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078254 Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 39: Non-specific - Basic cellular processes" "HPA078254: " "unprognostic (3.09e-2)" "unprognostic (4.23e-2)" "unprognostic (1.28e-1)" "unprognostic (3.39e-2)" "unprognostic (3.07e-1)" "unprognostic (2.51e-1)" "unprognostic (3.14e-2)" "unprognostic (5.71e-2)" "unprognostic (9.46e-2)" "prognostic favorable (2.43e-4)" "unprognostic (1.15e-2)" "unprognostic (2.74e-1)" "unprognostic (1.17e-2)" "unprognostic (1.81e-1)" "unprognostic (3.33e-1)" "unprognostic (1.29e-2)" "unprognostic (1.99e-1)" 10.4 30.2 9.5 2.7 9.5 6.0 10.4 9.7 10.9 11.4 11.7 14.9 9.9 11.0 4.8 14.5 11.5 2.5 17.6 9.5 10.4 22.2 26.8 10.1 4.2 9.9 9.1 13.3 20.8 5.0 31.9 3.0 10.1 19.5 3.4 12.5 14.4 5.2 39.6 16.6 14.4 3.1 8.8 17.3 13.8 16.3 9.6 6.1 14.4 18.4 3.6 13.2 11.9 9.1 14.1 32.6 9.0 25.0 4.7 2.5 8.3 8.7 7.0 12.5 12.5 14.2 10.5 11.6 7.5 7.0 9.7 12.6 7.4 13.8 7.4 9.3 18.0 2.7 13.2 63.3 5.8 10.3 5.7 3.4 5.6 6.8 11.9 10.0 14.1 16.3 2.7 14.9 9.9 33.0 10.2 8.8 10.4 14.3 23.7 6.4 22.3 12.1 9.8 16.7 15.7 12.7 16.3 28.9 7.7 4.4 16.1 5.2 7.1 5.4 15.0 8.0 14.7 18.7 17.7 13.5 8.4 4.4 8.8 0.8 4.2 3.5 3.7 2.3 4.2 4.6 5.1 5.0 4.3 4.8 2.5 3.4 0.4 3.4 2.1 10.2 7.5 3.5 9.5 9.5 9.7 10.9 9.5 10.4 9.9 9.1 10.1 8.8 9.6 9.1 14.1 0.0 7.0 3.9 17.3 18.1 10.4 24.7 24.5 46.4 23.3 23.1 19.7 17.2 15.5 23.9 18.8 33.0 17.3 22.1 56.7 17.6 83.3 12.6 12.3 12.3 21.0 32.6 6.1 11.7 24.2 16.6 6.1 12.9 5.1 24.2 8.6 26.1 30.5 11.8 6.6 29.6 24.4 14.0 19.6 155.7 11.5 11.4 16.0 3.7 15.4 21.2 9.2 4.0 3.2 9.7 14.0 21.8 21.6 17.9 75.9 61.0 18.6 54.4 13.1 15.5 18.5 20.9 5.6 18.1 23.9 24.5 13.4 32.0 30.9 10.3 PSME2 PA28beta ENSG00000100911 "Proteasome activator subunit 2" Q9UL46 14 24143362-24147570 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 1063.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062661 Approved Nucleoplasm NA NA 5900000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA062661: AB_2684825" "prognostic favorable (1.27e-4)" "unprognostic (7.55e-3)" "unprognostic (2.84e-1)" "unprognostic (8.72e-2)" "unprognostic (2.69e-1)" "unprognostic (1.50e-1)" "unprognostic (3.71e-1)" "unprognostic (1.02e-1)" "unprognostic (2.30e-2)" "unprognostic (2.90e-3)" "unprognostic (2.07e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (3.47e-5)" "unprognostic (3.09e-2)" "unprognostic (3.00e-1)" "unprognostic (6.43e-3)" "unprognostic (3.07e-3)" 81.3 204.5 25.7 86.6 26.0 42.8 79.7 25.5 40.1 93.7 28.8 104.6 165.9 68.6 48.6 112.5 75.0 30.6 105.3 25.7 28.2 142.0 228.1 107.9 89.6 30.7 26.5 71.7 102.1 27.7 123.7 30.7 27.5 94.1 79.2 18.1 84.0 33.8 63.7 72.6 152.9 44.0 28.1 204.6 101.6 56.9 28.7 52.1 92.2 26.6 80.2 74.0 80.6 27.8 95.2 93.2 59.5 140.6 42.8 59.9 85.6 47.7 108.4 145.7 182.4 72.7 183.9 111.0 30.7 59.8 166.5 79.1 32.1 92.0 87.6 198.6 28.9 75.2 45.8 277.1 135.9 103.4 100.1 61.2 26.3 115.1 44.1 65.6 79.3 78.2 37.2 165.2 61.5 188.6 204.2 140.0 19.8 142.3 112.1 189.2 93.2 119.2 108.9 209.4 36.8 47.7 101.6 168.8 70.3 31.0 89.0 110.7 63.4 80.7 75.1 38.2 102.5 143.7 215.1 140.7 52.9 110.0 99.7 110.3 605.5 217.5 421.1 1217.1 431.5 432.6 412.2 415.9 504.7 357.2 305.7 373.8 192.3 543.4 801.7 375.6 447.3 1562.7 25.7 26.0 25.5 40.1 25.7 28.2 30.7 26.5 27.5 28.1 28.7 27.8 185.3 51.3 113.7 5.2 198.5 154.9 174.3 754.8 126.3 39.7 104.5 120.8 69.5 140.2 287.7 117.7 22.9 296.6 223.6 316.1 299.3 370.5 12.6 113.0 147.3 159.7 98.0 74.2 1.7 567.1 296.6 128.6 132.5 109.9 141.5 83.4 69.7 236.6 332.1 28.6 2.2 288.5 319.4 143.7 224.9 15.5 74.0 237.8 136.9 2.8 763.7 69.8 326.5 2.5 1.3 303.1 324.5 77.8 389.3 282.8 1063.1 373.6 293.7 19.2 46.0 62.0 453.3 54.6 24.8 144.5 139.8 228.2 228.6 229.0 338.5 224.4 RNF31 "FLJ10111, FLJ23501, HOIP, Paul, ZIBRA" ENSG00000092098 "Ring finger protein 31" Q96EP0 14 24146683-24160660 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 16.0;Excitatory neurons: 8.8;Gastric mucus-secreting cells: 7.7;Inhibitory neurons: 8.2;Microglial cells: 10.3;Oligodendrocyte precursor cells: 9.5;Plasma cells: 8.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "CAB009063, HPA048745" Approved Approved Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 59: Non-specific - Transcription" Cytosol "CAB009063: AB_2127706, HPA048745: AB_2680509" "unprognostic (3.58e-2)" "unprognostic (5.22e-2)" "unprognostic (2.51e-2)" "unprognostic (9.05e-2)" "unprognostic (2.52e-1)" "unprognostic (6.24e-2)" "unprognostic (9.09e-3)" "unprognostic (1.55e-2)" "unprognostic (3.11e-3)" "unprognostic (1.96e-2)" "unprognostic (1.33e-1)" "unprognostic (2.46e-1)" "unprognostic (6.21e-3)" "unprognostic (1.15e-1)" "unprognostic (2.59e-1)" "unprognostic (1.41e-2)" "unprognostic (1.99e-1)" 14.3 18.5 4.9 9.1 4.8 9.5 14.3 4.2 6.6 16.7 3.6 15.0 7.1 18.2 6.9 16.2 14.8 6.9 19.6 4.6 4.1 17.5 15.8 14.9 10.4 5.3 4.4 17.8 23.9 10.4 18.7 6.9 4.5 16.6 6.6 4.1 16.9 7.1 41.5 19.3 15.9 9.6 4.5 26.1 17.9 16.4 4.8 11.7 16.5 17.9 9.6 15.1 14.0 4.4 6.1 10.8 10.5 14.8 6.1 6.3 23.2 9.9 15.1 18.2 15.6 10.2 13.5 10.9 6.9 11.8 10.2 7.6 5.4 11.8 9.7 13.2 4.2 11.0 9.5 32.5 12.8 17.5 18.8 12.3 10.4 7.2 12.9 9.6 12.0 7.9 5.9 12.9 7.7 17.3 17.6 8.6 5.3 9.9 12.7 10.1 9.8 6.8 8.9 20.8 9.9 12.7 8.6 25.6 12.5 9.2 7.4 13.3 11.1 12.6 10.2 8.8 8.9 21.4 21.2 11.5 4.4 6.1 13.6 0.0 0.8 0.8 0.6 1.7 1.8 0.4 0.9 0.6 0.5 0.4 0.6 0.4 1.7 1.7 1.0 1.8 1.1 0.4 4.9 4.8 4.2 6.6 4.6 4.1 5.3 4.4 4.5 4.5 4.8 4.4 0.9 0.0 4.6 16.0 5.2 0.6 0.3 0.0 4.6 0.6 1.0 0.3 0.3 0.0 3.1 0.0 0.0 0.6 1.0 0.8 0.0 0.3 0.1 1.0 1.3 1.3 0.0 3.8 8.8 0.0 0.5 1.3 7.7 0.9 0.0 1.1 0.4 0.8 0.4 0.0 8.2 0.3 2.0 0.6 1.5 0.4 0.3 2.7 0.0 10.3 0.5 0.3 3.1 9.5 7.3 0.2 0.2 0.0 8.7 0.2 0.5 0.2 0.8 0.8 0.0 1.4 1.2 1.6 0.8 5.7 0.9 0.5 4.3 0.8 0.1 0.3 IRF9 ISGF3G ENSG00000213928 "Interferon regulatory factor 9" Q00978 14 24161265-24166565 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 73.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 76.6;BJ hTERT+ SV40 Large T+ RasG12V: 58.9;GAMG: 48.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001862 Approved Supported Cytosol NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 64: Macrophages - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 52: Non-specific - Transcription" Cytosol "HPA001862: AB_1079153" "unprognostic (4.96e-3)" "unprognostic (4.91e-2)" "unprognostic (6.84e-3)" "unprognostic (8.17e-3)" "unprognostic (5.32e-2)" "unprognostic (2.51e-2)" "unprognostic (2.00e-1)" "unprognostic (1.77e-2)" "unprognostic (4.50e-1)" "unprognostic (9.10e-2)" "unprognostic (4.08e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (7.58e-8)" "unprognostic (1.56e-1)" "unprognostic (4.44e-2)" "unprognostic (4.40e-2)" "prognostic favorable (9.92e-4)" 25.2 27.1 16.0 25.0 17.4 25.4 22.5 16.3 15.9 31.6 13.3 29.3 17.6 27.7 13.1 21.8 25.0 24.2 19.1 14.7 17.9 29.1 25.9 28.2 25.2 22.0 17.9 25.0 14.1 11.6 22.1 12.8 17.5 22.1 9.9 3.6 36.4 12.7 9.0 20.7 26.8 17.6 22.2 48.5 25.3 8.3 18.0 22.7 22.8 8.8 20.4 27.0 22.5 21.2 3.9 2.4 2.5 0.9 15.9 17.6 1.6 7.3 37.5 76.6 58.9 5.2 22.5 5.0 7.7 20.3 48.5 6.0 1.6 1.5 19.3 24.3 0.0 11.6 2.1 6.1 25.3 1.1 14.2 17.2 5.3 9.1 1.9 15.1 8.3 1.0 1.7 32.6 10.0 4.5 2.0 4.8 0.4 2.8 7.4 0.8 2.5 3.0 17.2 2.6 0.4 2.6 6.6 3.5 38.9 5.1 1.1 9.7 16.1 8.1 5.7 4.8 1.7 32.4 24.9 4.7 9.4 1.8 7.3 197.2 80.5 112.3 73.4 103.1 58.1 93.3 72.4 62.0 61.7 88.7 64.0 58.4 202.8 74.8 103.9 75.1 103.0 103.4 16.0 17.4 16.3 15.9 14.7 17.9 22.0 17.9 17.5 22.2 18.0 21.2 37.9 25.6 15.1 21.2 22.8 2.3 8.6 6.1 6.2 6.6 8.0 10.3 0.2 10.0 9.7 5.5 8.4 1.5 32.0 6.1 0.0 4.9 0.2 9.0 19.4 21.0 1.8 7.4 5.0 5.5 21.9 14.8 20.9 9.4 24.6 42.0 11.0 1.7 7.0 8.4 4.9 5.3 10.2 8.2 8.0 1.0 12.8 13.4 5.4 26.2 13.4 11.2 73.2 32.2 9.5 6.2 10.9 6.8 13.2 8.4 21.8 2.6 32.3 4.3 13.1 33.7 15.1 1.3 1.7 3.7 2.7 1.6 26.1 24.9 4.9 12.4 REC8 "kleisin-alpha, REC8L1, Rec8p" ENSG00000100918 "REC8 meiotic recombination protein" O95072 14 24171853-24180257 "Plasma proteins, Predicted intracellular proteins" "Chromosome partition, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 68.9" "Cell type enhanced" "Detected in many" "Early spermatids: 150.6;Gastric mucus-secreting cells: 73.9;Late spermatids: 74.5;Respiratory ciliated cells: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 10.8;HHSteC: 8.7;MOLT-4: 11.7;SH-SY5Y: 47.4;SuSa: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031727, HPA031729" Approved Approved Nucleoplasm NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 43: Testis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "HPA031727: AB_10602920, HPA031729: AB_10669915" "prognostic favorable (2.19e-4)" "unprognostic (2.57e-2)" "unprognostic (2.15e-2)" "unprognostic (1.77e-2)" "unprognostic (2.00e-1)" "unprognostic (5.10e-3)" "unprognostic (1.00e-1)" "unprognostic (1.21e-2)" "unprognostic (3.16e-1)" "unprognostic (1.31e-1)" "prognostic favorable (5.57e-4)" "unprognostic (1.16e-1)" "prognostic unfavorable (1.41e-7)" "unprognostic (8.98e-2)" "unprognostic (2.12e-1)" "unprognostic (1.88e-2)" "unprognostic (6.40e-3)" 9.8 6.1 3.3 2.1 3.2 6.6 2.5 5.2 3.9 6.3 5.3 8.5 1.3 7.1 0.1 2.7 14.9 8.8 2.8 3.4 4.5 12.4 3.3 9.5 3.1 8.9 4.8 3.9 2.7 0.2 68.9 0.6 8.9 7.3 0.4 1.9 4.7 6.2 0.9 1.7 7.3 2.4 3.6 13.6 25.7 29.9 5.3 10.1 3.5 0.3 3.1 4.0 3.7 4.4 0.1 0.2 10.8 0.1 0.4 0.5 0.6 0.4 0.5 1.0 0.8 0.1 1.2 0.2 0.1 0.0 0.6 0.5 0.3 0.0 0.7 1.0 0.2 0.4 0.7 0.0 8.7 0.2 1.5 4.8 0.5 0.4 0.1 4.1 1.9 0.4 0.1 1.4 0.0 0.2 11.7 1.8 3.4 0.0 0.1 0.2 0.0 0.1 0.4 0.4 0.2 47.4 0.0 0.1 0.4 26.0 0.2 0.5 0.4 0.0 0.2 0.3 0.1 1.7 0.5 0.1 0.0 0.2 0.2 2.2 0.1 9.7 4.7 1.1 5.4 1.6 1.7 2.7 3.2 1.7 0.7 2.4 0.1 2.8 5.8 5.2 2.9 1.2 3.3 3.2 5.2 3.9 3.4 4.5 8.9 4.8 8.9 3.6 5.3 4.4 9.5 12.8 10.8 3.6 6.8 1.9 4.4 15.8 8.6 14.9 2.8 2.0 2.0 25.8 14.8 27.6 0.0 1.4 10.2 5.1 5.9 2.9 150.6 43.5 10.6 4.8 4.8 25.9 3.8 2.7 3.2 10.0 73.9 21.9 3.8 7.9 3.6 2.1 2.3 6.7 5.1 2.5 10.2 5.7 3.9 74.5 4.7 6.6 1.8 2.8 4.0 21.1 2.1 5.5 4.6 5.0 0.7 3.0 11.0 1.5 4.1 24.7 51.4 2.0 0.0 3.7 3.9 8.3 43.4 1.3 2.0 0.4 11.3 33.8 2.4 4.0 IPO4 "FLJ23338, Imp4" ENSG00000196497 "Importin 4" Q8TEX9 14 24180219-24188869 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 40.4" "Group enriched" "Detected in many" 4 "Early spermatids: 80.5;Late spermatids: 118.0;Spermatocytes: 52.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039043, HPA064572" Uncertain Approved Cytosol NA NA 17000 "Cluster 27: Non-specific - Gene expression" "Cluster 22: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" Cytosol "HPA039043: AB_10673233, HPA064572: AB_2685291" "unprognostic (2.43e-2)" "unprognostic (1.15e-1)" "unprognostic (6.03e-2)" "unprognostic (1.00e-1)" "unprognostic (1.64e-1)" "unprognostic (5.93e-2)" "prognostic unfavorable (8.08e-6)" "unprognostic (9.45e-2)" "unprognostic (2.60e-1)" "unprognostic (5.13e-2)" "unprognostic (6.75e-2)" "unprognostic (9.28e-2)" "prognostic unfavorable (3.20e-4)" "unprognostic (8.59e-4)" "unprognostic (5.45e-2)" "unprognostic (2.18e-1)" "unprognostic (2.15e-2)" 8.9 13.2 1.6 4.7 1.4 4.2 8.0 1.5 1.6 6.9 4.4 7.2 3.2 7.7 2.0 14.0 8.0 1.1 7.8 1.3 2.1 14.1 14.7 6.7 2.8 1.6 1.4 6.9 27.7 2.6 9.4 2.5 1.8 6.8 1.4 0.3 8.7 3.6 21.0 10.7 5.9 1.9 1.4 7.3 8.6 40.4 1.6 2.1 7.0 1.0 1.8 8.7 7.0 2.0 21.9 49.2 6.0 36.0 4.1 8.6 28.4 14.8 6.3 23.5 12.5 39.2 22.4 31.3 16.1 10.6 12.2 25.6 20.4 28.8 2.6 12.1 29.8 20.4 18.6 77.0 8.7 45.4 18.1 7.5 12.3 24.3 6.0 5.3 11.8 15.8 37.5 8.5 15.0 76.6 21.8 21.2 29.1 28.5 41.7 24.4 17.3 23.2 12.6 25.7 29.3 21.1 19.7 31.8 13.9 2.9 27.1 14.7 12.4 22.9 30.8 21.0 32.4 19.8 27.1 34.2 10.8 19.3 31.8 0.0 1.1 0.4 3.3 1.9 3.8 1.8 2.8 2.7 2.4 2.6 2.3 2.9 0.0 2.7 2.4 3.2 1.7 1.9 1.6 1.4 1.5 1.6 1.3 2.1 1.6 1.4 1.8 1.4 1.6 2.0 3.5 0.0 7.9 0.7 4.9 5.9 3.8 5.0 4.6 0.8 11.1 9.7 1.6 8.6 8.7 5.5 4.2 12.1 5.5 3.1 0.0 13.3 80.5 8.3 3.9 5.6 4.2 3.4 1.3 11.0 11.1 4.5 1.1 5.0 0.0 3.1 2.9 5.8 7.9 1.7 1.1 5.9 2.0 2.2 2.6 118.0 5.0 1.3 0.0 0.0 1.7 1.6 2.1 1.0 0.8 6.8 2.5 5.7 2.9 6.1 0.7 11.7 15.1 2.7 6.6 7.0 4.7 52.1 18.8 3.9 6.3 5.9 3.1 6.1 10.4 2.7 TM9SF1 "HMP70, MP70" ENSG00000100926 "Transmembrane 9 superfamily member 1" O15321 14 24189149-24195687 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA059249 Supported Approved "Golgi apparatus" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA059249: AB_2683959" "unprognostic (3.27e-1)" "prognostic unfavorable (8.94e-4)" "unprognostic (9.31e-2)" "unprognostic (1.48e-1)" "unprognostic (3.84e-2)" "unprognostic (1.19e-2)" "unprognostic (4.84e-3)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" "unprognostic (2.24e-1)" "unprognostic (1.23e-1)" "unprognostic (2.62e-3)" "unprognostic (2.44e-1)" "unprognostic (4.24e-1)" "unprognostic (2.20e-1)" "unprognostic (4.18e-3)" 28.0 35.2 7.5 10.5 7.6 3.7 25.6 7.9 7.9 29.2 18.2 23.9 12.7 31.1 31.3 25.4 27.9 17.5 21.7 7.4 7.7 25.1 34.6 26.7 7.7 8.8 9.4 24.8 46.8 36.6 20.0 18.1 8.4 23.4 15.5 5.9 35.6 21.3 19.5 24.2 21.4 18.1 8.5 19.4 29.4 20.2 8.3 8.3 30.7 11.1 12.4 23.8 23.6 8.4 22.0 45.1 17.7 18.0 59.4 40.4 22.4 37.6 55.4 53.7 60.5 19.1 49.0 12.5 25.2 50.3 30.7 50.5 14.9 29.7 39.3 18.4 15.4 9.4 21.3 56.2 41.8 18.5 22.8 41.3 56.1 36.9 50.5 42.3 32.3 7.9 11.2 30.7 43.6 51.2 12.1 15.7 8.4 62.1 39.2 15.6 22.1 24.7 42.5 37.9 16.3 18.6 39.0 44.3 24.5 16.8 28.8 14.1 26.0 47.5 21.2 23.1 28.1 31.0 25.5 7.4 18.1 11.5 39.5 33.4 20.5 25.0 14.1 18.1 15.3 15.0 14.6 12.6 23.4 16.3 13.0 12.9 28.3 23.1 18.5 39.2 17.2 13.5 7.5 7.6 7.9 7.9 7.4 7.7 8.8 9.4 8.4 8.5 8.3 8.4 5.5 16.0 5.3 8.8 11.2 3.3 6.1 7.3 18.8 4.4 6.1 5.0 1.5 7.2 7.6 1.8 14.6 9.8 5.0 4.0 0.0 8.2 13.9 5.2 7.4 8.7 1.8 5.5 6.6 4.9 10.4 14.9 13.7 6.3 2.5 5.3 5.0 4.8 4.1 0.0 7.1 3.5 6.1 2.5 4.5 6.2 5.3 5.6 1.8 4.7 5.3 5.4 4.1 9.0 7.3 5.3 6.1 4.5 54.3 7.7 3.5 3.0 30.0 7.6 6.6 10.1 7.4 7.0 5.4 19.5 4.7 11.9 9.1 5.7 4.1 3.8 AL136295.1 ENSG00000254692 "Novel protein" 14 24189157-24213473 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 6.4;granulocytes: 6.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SiHa: 8.1" HPA059249 Approved Approved "Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 43: THP-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "Golgi apparatus" "HPA059249: AB_2683959" "unprognostic (3.45e-2)" 1.7 3.0 0.6 2.1 0.7 2.0 0.8 0.7 1.5 1.2 0.5 1.3 2.5 1.0 0.2 0.8 1.1 0.4 1.7 0.6 0.8 1.7 0.8 1.1 1.4 0.8 0.6 0.9 1.4 0.5 0.5 0.7 0.7 0.8 0.9 1.3 0.8 0.6 1.9 1.3 2.2 0.6 0.5 0.8 1.3 1.0 0.8 1.6 0.8 0.0 0.4 0.8 0.7 0.7 1.5 1.4 2.4 0.9 2.2 1.3 1.9 1.4 2.0 1.0 2.2 1.0 5.1 1.5 0.2 1.8 2.9 1.5 1.5 0.8 3.2 2.4 0.0 0.9 0.8 1.2 0.4 4.3 2.5 0.5 0.8 1.2 0.0 3.5 0.7 1.3 0.1 4.3 1.7 1.2 1.1 0.0 2.1 0.7 0.0 1.7 1.9 0.0 1.9 1.1 0.2 1.0 8.1 2.7 3.4 2.8 2.0 3.4 4.4 0.2 1.0 1.3 2.1 3.4 2.6 3.6 0.5 0.9 0.8 0.0 0.1 0.5 0.2 0.3 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.2 0.0 0.3 0.0 0.3 0.1 0.6 0.7 0.7 1.5 0.6 0.8 0.8 0.6 0.7 0.5 0.8 0.7 0.0 6.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 TSSK4 "C14orf20, STK22E" ENSG00000139908 "Testis specific serine kinase 4" Q6SA08 14 24205696-24208362 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 38.1" "Cell type enriched" "Detected in some" 9 "Early spermatids: 253.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA060660, HPA077103" Approved Approved "Cell Junctions" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 83: Testis - Spermatogenesis" "Cluster 20: HeLa - Mitochondria" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Cell Junctions" "HPA060660: AB_2684339, HPA077103: AB_2732332" "unprognostic (1.95e-1)" "unprognostic (4.30e-2)" "unprognostic (1.52e-1)" "unprognostic (5.69e-2)" "unprognostic (2.36e-1)" "unprognostic (3.38e-5)" "unprognostic (1.06e-1)" "unprognostic (6.25e-3)" "unprognostic (1.64e-1)" "unprognostic (3.39e-1)" "unprognostic (7.03e-3)" "unprognostic (1.27e-3)" "unprognostic (3.42e-1)" "unprognostic (4.30e-2)" "unprognostic (6.28e-2)" "unprognostic (8.98e-2)" "unprognostic (7.26e-2)" 1.0 1.1 0.7 2.0 0.4 3.4 1.0 1.0 0.3 1.4 0.0 1.4 1.6 1.1 0.3 1.3 1.2 1.6 0.7 0.6 0.1 0.8 0.6 1.0 2.7 0.3 0.3 1.1 1.5 0.0 0.9 0.4 0.3 0.9 0.0 3.1 1.5 0.0 1.3 4.2 1.7 0.0 0.2 1.7 1.2 38.1 0.3 0.0 1.4 0.0 0.0 1.1 1.1 0.3 0.6 2.3 2.2 0.8 0.0 0.0 2.4 0.9 0.0 0.0 0.0 1.3 2.2 1.8 0.5 0.1 0.4 2.1 0.0 0.1 0.0 0.9 1.7 2.0 3.4 1.7 0.0 1.0 2.1 0.0 0.0 0.0 0.3 1.9 0.0 2.1 0.8 1.2 0.0 2.2 2.1 1.1 0.4 0.5 1.8 1.8 0.8 1.5 0.0 3.0 1.2 1.2 1.7 1.4 0.4 0.9 1.0 1.0 0.9 1.6 1.0 2.1 0.7 2.3 3.0 2.6 0.5 1.6 0.5 0.0 0.2 0.4 0.4 0.2 0.1 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.5 0.1 0.3 0.1 0.1 0.7 0.4 1.0 0.3 0.6 0.1 0.3 0.3 0.3 0.2 0.3 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 253.7 0.3 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 26.5 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.1 0.1 0.3 0.1 0.8 0.0 0.0 0.2 0.1 6.8 0.8 0.0 0.0 0.1 0.1 0.1 0.0 0.0 CHMP4A "C14orf123, HSPC134, VPS32A" ENSG00000254505 "Charged multivesicular body protein 4A" Q9BY43 14 24209615-24213830 "Metabolic proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068473 Approved NA NA 1400000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 63: NK-cells & T-cells - Immune response" "HPA068473: AB_2685994" "unprognostic (4.33e-3)" "unprognostic (3.76e-2)" "unprognostic (4.29e-2)" "unprognostic (5.45e-2)" "unprognostic (4.29e-1)" "unprognostic (1.25e-1)" "unprognostic (1.74e-4)" "unprognostic (2.02e-3)" "unprognostic (9.61e-2)" "unprognostic (1.76e-2)" "unprognostic (1.44e-2)" "unprognostic (1.57e-1)" "prognostic unfavorable (3.91e-8)" "unprognostic (3.30e-1)" "unprognostic (3.42e-1)" "unprognostic (7.37e-2)" "unprognostic (6.90e-2)" 58.8 39.5 73.9 49.3 77.3 38.5 51.4 74.2 109.3 39.1 68.5 59.2 39.4 33.6 79.0 50.5 45.2 35.8 46.9 71.2 73.4 52.4 53.5 36.1 72.6 76.6 75.6 30.8 42.5 72.9 23.0 33.9 76.5 51.0 64.5 15.5 31.5 60.6 20.1 51.6 43.6 51.6 76.8 51.5 45.8 16.5 78.1 70.4 43.4 27.4 84.9 47.7 32.0 77.7 48.7 100.5 43.8 49.1 75.4 67.9 59.7 52.9 62.6 53.0 60.7 46.6 114.9 79.0 48.5 80.6 49.8 56.4 47.5 84.7 58.8 142.6 25.6 64.7 91.6 207.4 131.8 101.1 69.9 69.1 121.6 43.9 168.4 60.8 72.3 84.6 68.2 119.7 107.1 136.1 98.0 93.5 29.0 123.3 83.0 71.9 37.5 86.7 99.3 128.4 28.4 34.3 112.7 101.8 73.8 49.8 65.7 90.2 49.4 33.0 40.0 42.7 47.2 117.1 133.2 86.4 31.2 71.7 71.3 144.3 152.2 103.4 123.4 195.6 132.9 182.8 131.8 138.5 179.9 169.3 101.6 109.9 42.6 138.4 193.6 190.0 185.2 171.6 73.9 77.3 74.2 109.3 71.2 73.4 76.6 75.6 76.5 76.8 78.1 77.7 74.2 16.0 33.3 13.4 78.6 52.6 76.0 154.8 18.8 31.8 66.7 65.7 2.1 92.9 86.3 62.5 64.6 93.4 111.4 50.0 97.8 116.0 11.0 49.1 52.5 58.8 39.2 53.7 14.3 82.3 84.0 39.3 25.5 53.2 76.5 41.1 67.5 73.1 162.5 25.2 12.6 69.9 99.7 94.8 90.3 19.1 66.8 80.1 69.4 11.2 202.6 64.7 178.2 12.1 15.5 76.0 66.7 48.5 44.8 76.1 144.9 159.3 72.2 24.2 98.6 40.6 58.1 20.4 18.3 32.3 78.8 120.7 102.8 43.8 79.7 70.4 MDP1 "FN6Pase, MGC5987" ENSG00000213920 "Magnesium dependent phosphatase 1" Q86V88 14 24213943-24216070 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003064, HPA070338" Uncertain Approved Nucleoplasm NA NA 29000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA003064: AB_10602350, HPA070338: AB_2686256" "unprognostic (2.70e-1)" "unprognostic (3.68e-1)" "unprognostic (2.51e-1)" "unprognostic (2.11e-1)" "unprognostic (3.09e-1)" "unprognostic (5.46e-2)" "unprognostic (5.48e-2)" "unprognostic (1.12e-1)" "unprognostic (6.27e-2)" "unprognostic (8.02e-2)" "unprognostic (2.00e-3)" "unprognostic (1.02e-1)" "prognostic favorable (5.96e-4)" "unprognostic (6.39e-2)" "unprognostic (1.32e-1)" "unprognostic (3.82e-1)" "unprognostic (3.19e-2)" 14.0 18.6 6.8 3.2 6.8 3.9 14.6 7.0 7.5 14.7 6.4 12.6 3.1 11.5 7.9 7.3 12.1 4.0 18.2 7.0 6.9 16.8 10.3 9.2 5.8 6.7 6.8 12.3 15.3 5.8 20.1 4.0 6.9 13.7 3.5 4.1 10.6 4.8 15.0 12.6 9.5 4.5 7.2 11.6 11.9 7.8 6.6 5.3 13.6 4.8 4.7 12.5 11.1 7.8 4.1 9.5 7.2 4.7 6.9 6.3 0.3 4.2 8.9 8.2 8.4 5.0 10.9 15.7 10.4 4.3 2.4 3.7 3.4 8.2 5.0 5.4 3.9 6.0 3.3 12.1 6.7 7.9 4.2 4.5 7.7 4.9 9.4 8.3 5.9 11.1 1.9 11.4 7.4 21.1 11.7 12.6 2.2 7.8 16.9 8.0 5.0 12.6 8.0 5.7 8.7 8.6 6.6 14.3 9.4 3.9 8.3 4.5 3.5 8.8 8.7 3.9 4.4 18.6 8.4 11.7 8.3 3.8 6.9 5.1 13.9 16.5 7.7 15.2 7.3 13.4 9.9 9.0 16.1 12.9 11.7 9.9 4.6 12.4 13.0 29.9 16.3 10.3 6.8 6.8 7.0 7.5 7.0 6.9 6.7 6.8 6.9 7.2 6.6 7.8 6.6 6.4 12.9 0.0 11.0 4.6 3.5 5.6 16.5 3.9 8.2 11.7 0.0 4.3 2.1 5.5 0.0 3.7 7.3 5.9 13.7 13.8 5.7 4.6 5.5 8.2 11.5 7.8 0.0 19.6 5.3 8.1 9.2 4.3 5.1 4.3 8.6 5.8 7.9 3.3 0.0 10.8 12.2 3.3 8.7 3.0 6.2 10.6 17.8 0.0 21.9 5.2 4.1 0.0 0.0 11.7 6.2 7.5 25.8 2.9 23.7 21.7 13.2 2.9 13.1 7.7 8.7 4.4 3.5 11.5 4.5 2.5 9.7 3.4 8.8 2.6 NEDD8-MDP1 ENSG00000255526 "NEDD8-MDP1 readthrough" 14 24213955-24232352 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 1.3;testis: 1.3" "Group enriched" "Detected in some" 11 "Alveolar cells type 2: 3.1;granulocytes: 1.3;Respiratory ciliated cells: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 1.5;MCF7: 1.5;MOLT-4: 2.3" "HPA003064, HPA060254" Uncertain Approved Nucleoplasm NA NA "Cluster 23: Testis - Cell cycle regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 11: Alveolar cells - Smell perception" Nucleoplasm "HPA003064: AB_10602350, HPA060254: AB_2732644" "unprognostic (2.72e-3)" "unprognostic (1.82e-1)" "unprognostic (3.64e-1)" "unprognostic (6.44e-2)" "unprognostic (2.64e-1)" "unprognostic (1.13e-1)" "unprognostic (6.04e-3)" "unprognostic (1.04e-1)" "unprognostic (1.92e-2)" "unprognostic (1.32e-3)" "unprognostic (2.33e-1)" "unprognostic (1.99e-2)" "unprognostic (1.64e-1)" "unprognostic (4.43e-2)" "unprognostic (2.60e-2)" "unprognostic (1.92e-1)" "unprognostic (1.83e-2)" 0.1 0.2 0.0 0.2 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.6 0.2 0.0 0.1 0.1 0.2 0.1 0.1 0.1 1.3 0.3 0.4 0.1 0.0 0.1 0.2 1.3 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 1.1 0.0 0.3 0.2 0.4 0.0 0.0 1.5 0.0 0.0 0.1 0.2 0.3 0.1 0.3 0.5 0.1 0.5 0.3 0.4 0.2 0.6 0.2 0.4 0.0 0.0 0.0 0.5 0.0 0.2 0.7 0.0 0.2 0.2 0.0 0.6 0.1 0.0 0.1 1.5 2.3 0.2 0.1 0.8 0.0 0.1 0.0 0.8 0.1 0.0 0.3 0.1 0.0 0.3 0.5 0.1 0.2 0.4 0.0 0.0 0.7 0.0 0.4 1.3 0.9 0.9 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 NEDD8 Nedd-8 ENSG00000129559 "NEDD8 ubiquitin like modifier" Q15843 14 24216857-24232367 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004082, HPA027583, HPA060254" Uncertain Enhanced Nucleoplasm,Cytosol NA NA 990000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 16: Pancreatic endocrine cells - Mixed function" Nucleoplasm Cytosol "CAB004082: AB_10695300, HPA027583: AB_2732439, HPA060254: AB_2732644" "unprognostic (1.26e-2)" "unprognostic (2.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.08e-1)" "unprognostic (1.69e-1)" "unprognostic (3.34e-3)" "unprognostic (1.83e-3)" "unprognostic (9.19e-2)" "unprognostic (4.66e-1)" "unprognostic (1.35e-2)" "unprognostic (2.66e-2)" "unprognostic (1.41e-1)" "unprognostic (1.78e-3)" "unprognostic (2.76e-2)" "unprognostic (1.31e-1)" "unprognostic (2.79e-2)" "unprognostic (5.25e-3)" 169.0 224.3 156.9 71.5 162.3 91.0 156.7 158.6 219.1 152.4 152.5 172.9 55.9 147.6 132.6 202.1 131.3 51.0 299.8 163.1 168.6 195.8 175.7 147.7 81.2 163.7 158.7 138.1 110.9 289.1 143.9 84.3 162.4 133.7 88.7 74.6 139.3 85.5 294.3 182.2 128.8 97.7 157.5 164.6 146.8 77.9 162.1 125.7 132.8 197.1 113.1 152.0 157.5 162.0 166.9 292.7 223.8 159.9 255.2 223.2 165.6 218.7 237.4 259.5 237.5 204.6 196.1 142.1 126.9 317.1 212.3 169.2 230.8 349.5 365.6 201.9 139.7 150.2 272.9 710.7 220.8 251.8 151.6 237.0 231.8 217.2 172.0 239.1 317.3 162.3 139.3 161.5 409.4 380.3 203.4 241.1 166.1 303.7 335.8 141.3 176.9 146.1 302.7 322.1 96.7 221.7 188.3 192.6 168.4 229.5 117.6 199.2 230.3 145.4 144.9 184.9 198.5 187.9 322.7 210.6 102.6 146.2 139.6 461.6 277.3 459.9 214.7 302.8 235.5 311.9 246.0 241.0 276.3 273.4 229.8 233.1 299.8 233.7 310.5 369.7 327.3 526.6 156.9 162.3 158.6 219.1 163.1 168.6 163.7 158.7 162.4 157.5 162.1 162.0 276.4 144.2 156.8 0.0 182.1 277.9 227.5 644.7 166.8 101.0 263.4 301.5 464.7 215.9 301.5 310.8 47.9 525.7 237.0 267.8 594.8 344.9 72.6 201.8 189.4 259.5 212.4 220.7 0.0 406.9 625.0 246.0 108.1 195.4 218.6 228.7 222.0 431.5 576.3 106.0 0.0 286.4 362.2 288.7 345.5 77.3 272.1 255.4 268.6 0.0 394.0 275.0 346.1 0.0 0.0 449.8 311.5 275.7 161.3 254.4 340.2 845.8 279.7 95.9 210.4 178.7 318.4 150.0 196.9 252.1 386.6 419.5 216.0 289.8 291.8 275.5 GMPR2 ENSG00000100938 "Guanosine monophosphate reductase 2" Q9P2T1 14 24232422-24239242 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Purine metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 123.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000904, HPA067884, HPA068782" Approved Approved Nucleoplasm,Nucleoli No No 50000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 1: Thyroid gland - Transcription" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Nucleoli "HPA000904: AB_1078998, HPA067884: AB_2685916, HPA068782: AB_2686032" "unprognostic (1.95e-2)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (1.03e-1)" "unprognostic (9.86e-2)" "unprognostic (5.98e-2)" "unprognostic (3.24e-1)" "unprognostic (5.21e-3)" "unprognostic (9.24e-2)" "unprognostic (3.08e-1)" "unprognostic (7.88e-2)" "unprognostic (1.16e-1)" "prognostic favorable (2.21e-5)" "unprognostic (2.30e-1)" "unprognostic (1.96e-1)" "unprognostic (2.29e-1)" "unprognostic (1.12e-2)" 45.0 92.1 24.5 19.7 25.7 19.3 44.3 25.8 30.2 44.7 28.2 44.2 30.9 38.2 29.9 38.7 44.9 32.0 39.6 24.8 25.7 70.1 56.0 38.8 26.9 26.2 25.6 51.2 49.0 67.7 48.1 22.7 26.8 41.7 25.5 18.8 41.8 26.3 40.6 35.2 45.8 21.2 26.0 55.9 50.7 21.9 26.1 28.4 58.4 19.8 27.3 43.1 40.3 26.2 27.1 34.2 29.0 26.7 50.9 74.7 40.0 32.1 59.2 47.3 55.7 38.8 24.6 34.7 22.5 49.8 25.5 43.6 42.4 69.2 69.5 19.0 25.5 24.3 25.0 159.1 46.8 53.7 51.4 72.2 54.9 23.6 47.7 61.1 69.7 52.3 12.5 33.3 46.6 51.8 50.1 57.1 34.3 39.5 37.3 33.5 24.2 22.6 69.1 52.7 22.0 36.2 16.9 45.8 52.6 39.5 38.6 41.1 36.2 23.0 15.8 32.0 20.6 59.4 63.1 21.8 16.6 38.9 20.2 24.3 34.2 15.0 19.7 27.5 21.6 13.7 21.5 23.7 35.9 15.9 19.3 20.2 56.0 14.9 27.9 15.8 31.5 26.5 24.5 25.7 25.8 30.2 24.8 25.7 26.2 25.6 26.8 26.0 26.1 26.2 25.2 25.6 18.7 10.7 23.2 11.0 44.5 49.9 27.3 19.6 24.8 32.9 12.5 38.6 35.7 53.3 4.2 67.2 22.6 35.6 101.8 43.6 18.3 29.6 16.6 26.3 10.3 20.6 7.8 33.0 48.5 18.8 17.9 20.0 31.7 29.7 16.8 24.8 50.0 18.5 8.0 19.8 30.5 46.6 14.6 10.5 28.9 32.5 21.4 9.4 32.1 43.3 25.7 7.5 11.7 33.7 32.1 25.2 21.2 19.0 50.2 123.1 43.2 19.7 26.3 16.0 24.5 19.8 10.3 20.7 10.7 49.3 24.6 51.3 28.4 30.5 TINF2 TIN2 ENSG00000092330 "TERF1 interacting nuclear factor 2" Q9BSI4 14 24239643-24242674 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 233.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059061, HPA069807" Enhanced "Nuclear bodies" "Intracellular and membrane" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nuclear bodies" "HPA059061: AB_2683895, HPA069807: AB_2686203" "prognostic favorable (4.96e-4)" "unprognostic (8.58e-2)" "unprognostic (1.53e-1)" "unprognostic (5.47e-2)" "unprognostic (3.20e-2)" "unprognostic (2.78e-2)" "unprognostic (4.75e-2)" "unprognostic (2.50e-1)" "unprognostic (4.70e-1)" "unprognostic (8.05e-2)" "unprognostic (1.05e-1)" "unprognostic (8.71e-2)" "unprognostic (9.59e-3)" "unprognostic (2.04e-3)" "unprognostic (2.17e-1)" "unprognostic (4.78e-2)" "unprognostic (7.44e-2)" 47.2 76.4 17.6 17.3 19.1 20.1 44.0 18.9 23.6 42.2 17.7 40.7 11.5 43.7 21.0 63.2 36.1 12.8 39.4 17.6 18.4 48.5 33.5 44.1 22.7 19.5 18.6 32.2 44.6 233.5 31.9 14.2 19.5 37.9 15.7 12.8 37.6 16.2 45.2 40.8 38.4 19.4 18.8 55.8 41.8 16.3 18.7 29.2 40.7 16.1 26.6 40.9 41.4 20.0 18.4 16.4 23.2 12.2 25.1 18.5 11.8 18.3 23.1 26.3 24.5 7.1 20.0 26.7 10.3 26.1 19.0 17.5 13.2 16.5 16.5 34.1 6.7 16.8 15.1 28.5 21.6 17.9 23.1 20.5 26.0 21.1 20.0 24.5 28.9 25.0 6.7 33.1 21.5 20.0 27.0 8.8 5.4 19.3 20.1 21.9 14.8 19.5 23.7 25.8 14.2 13.2 19.1 18.0 17.0 15.3 12.9 11.4 23.3 12.2 14.9 21.0 14.6 25.2 19.5 15.1 14.8 9.9 18.6 124.6 47.8 113.7 59.7 51.1 48.1 58.7 46.5 56.2 41.1 65.1 48.3 48.4 60.2 63.5 49.3 34.9 61.5 75.8 17.6 19.1 18.9 23.6 17.6 18.4 19.5 18.6 19.5 18.8 18.7 20.0 34.6 16.0 23.0 6.2 54.5 16.8 63.8 35.7 26.7 23.0 18.4 17.7 13.5 15.7 29.3 18.4 8.4 31.8 51.1 19.2 35.2 35.1 8.1 12.8 15.7 31.4 13.1 15.8 4.1 47.2 26.5 28.1 16.8 18.7 40.5 10.0 27.8 16.5 35.5 15.2 4.1 16.3 32.6 30.1 19.7 10.7 23.6 29.9 21.4 7.5 43.3 41.8 72.1 3.5 7.5 40.5 23.8 29.7 31.5 38.9 22.0 25.4 9.5 18.8 26.3 25.8 29.9 24.3 26.2 27.4 25.1 42.3 46.5 29.4 15.6 53.0 TGM1 "ICR2, LI, LI1, TGASE, TGK" ENSG00000092295 "Transglutaminase 1" P22735 14 24249114-24264432 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Keratinization "Acyltransferase, Transferase" "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "esophagus: 713.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 12.8;Basal respiratory cells: 63.6;Club cells: 18.8;Distal tubular cells: 29.4;Squamous epithelial cells: 34.7" "Group enriched" "Detected in many" 4 "cervical cancer: 30.8;head and neck cancer: 78.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 17.5;HaCaT: 24.2;HeLa: 16.2;MCF7: 17.5;SK-BR-3: 21.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB015159, HPA040171, HPA070372" Enhanced Approved "Vesicles,Plasma membrane" NA NA 530000 "Cluster 84: Esophagus - Epithelial cell function" "Cluster 28: BEWO - Transcription regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Vesicles, Plasma membrane" "CAB015159: AB_2202870, HPA040171: AB_2676869, HPA070372: " "unprognostic (2.95e-2)" "unprognostic (8.79e-2)" "unprognostic (2.92e-2)" "unprognostic (1.89e-2)" "unprognostic (2.36e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-2)" "unprognostic (1.12e-2)" "unprognostic (2.39e-1)" "unprognostic (3.01e-2)" "unprognostic (6.72e-2)" "unprognostic (2.15e-1)" "unprognostic (1.94e-7)" "unprognostic (7.11e-2)" "unprognostic (7.38e-2)" "unprognostic (2.22e-3)" "unprognostic (1.86e-2)" 25.7 1.3 0.6 0.9 0.8 0.7 2.2 3.7 2.0 78.7 0.8 1.4 0.8 1.0 1.6 713.5 4.4 0.6 5.1 0.5 0.6 2.5 1.7 5.3 1.5 1.5 0.9 3.0 3.2 0.2 3.3 1.2 1.4 4.1 0.9 1.7 89.7 4.4 1.1 73.2 1.9 0.5 0.4 2.6 1.8 2.9 0.9 1.3 2.7 0.3 40.4 1.3 144.2 0.9 1.1 2.0 1.1 1.0 0.0 0.8 17.5 0.4 0.2 1.0 1.6 1.2 1.7 1.0 2.3 1.3 0.3 24.2 2.8 2.0 0.6 2.0 3.3 1.4 16.2 5.7 0.8 0.9 1.5 1.5 9.3 0.5 2.0 0.5 0.7 3.4 1.0 1.0 0.7 17.5 0.7 1.9 0.3 1.1 2.2 1.1 0.1 1.1 0.6 2.1 1.2 1.6 0.2 21.7 0.1 1.4 1.5 1.1 0.8 1.1 4.8 2.0 0.9 1.5 1.8 0.3 0.4 2.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 3.7 2.0 0.5 0.6 1.5 0.9 1.4 0.4 0.9 0.9 0.2 12.8 1.1 2.0 0.0 0.3 4.6 63.6 4.0 0.9 1.1 0.8 0.8 5.7 18.8 0.0 0.0 1.4 0.3 0.2 29.4 2.0 0.1 0.3 0.2 0.2 0.0 0.0 1.5 0.9 0.8 3.9 0.0 0.6 4.5 0.7 0.0 0.2 0.4 0.0 1.7 0.1 6.1 0.6 0.3 0.0 0.6 0.4 0.0 1.0 0.4 0.2 0.0 1.0 1.0 2.6 0.0 0.4 0.1 7.4 0.1 0.2 2.1 0.6 0.0 0.1 1.0 0.0 0.6 34.7 1.8 1.2 0.6 1.2 0.3 6.2 RABGGTA PTAR3 ENSG00000100949 "Rab geranylgeranyltransferase subunit alpha" Q92696 14 24265538-24271611 "Enzymes, Predicted intracellular proteins" "Prenyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 59.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043488 Approved NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA043488: AB_10794887" "unprognostic (2.00e-1)" "unprognostic (8.37e-2)" "unprognostic (2.61e-3)" "unprognostic (1.13e-1)" "unprognostic (8.34e-2)" "unprognostic (1.39e-1)" "unprognostic (2.78e-1)" "unprognostic (5.78e-2)" "unprognostic (3.89e-2)" "unprognostic (7.11e-2)" "unprognostic (3.12e-2)" "unprognostic (1.12e-1)" "prognostic favorable (5.44e-4)" "unprognostic (1.77e-1)" "unprognostic (1.84e-1)" "prognostic favorable (1.51e-4)" "unprognostic (2.01e-1)" 11.3 14.7 6.9 7.7 7.0 10.0 11.3 7.6 9.4 14.7 6.1 12.2 11.0 9.3 10.0 59.2 12.1 9.2 16.3 7.5 8.5 13.7 14.8 13.9 9.8 8.3 7.7 10.6 17.7 16.9 15.2 7.8 8.2 12.2 8.5 3.1 20.1 8.3 19.1 19.9 13.1 6.9 7.4 17.1 16.3 11.8 7.9 9.0 11.9 12.5 12.4 10.0 19.4 8.1 10.6 13.0 6.8 10.6 8.9 17.4 31.9 15.2 12.8 21.4 19.4 12.2 17.4 13.1 11.8 16.3 9.5 20.4 7.0 33.2 9.2 20.8 14.4 8.6 11.0 45.9 17.9 18.8 36.3 19.9 35.9 11.4 13.5 11.6 19.7 16.4 9.0 16.1 16.3 41.0 12.5 10.1 2.3 14.0 19.2 9.3 6.2 14.5 20.5 15.6 16.9 9.7 10.5 29.9 12.8 9.4 12.5 13.7 14.5 11.2 7.8 6.1 10.5 17.2 13.9 8.7 9.5 11.5 17.6 11.9 25.7 17.1 16.0 46.8 13.3 16.3 15.3 12.4 32.0 10.4 12.8 10.0 7.3 16.9 33.1 5.4 18.1 18.4 6.9 7.0 7.6 9.4 7.5 8.5 8.3 7.7 8.2 7.4 7.9 8.1 9.3 9.6 11.6 4.6 18.0 17.7 19.6 61.6 35.9 7.7 13.8 14.0 12.4 15.7 28.1 5.5 6.2 38.0 14.4 25.0 15.6 23.4 3.3 9.7 5.8 9.3 13.1 7.8 5.1 27.1 31.1 10.1 23.4 11.9 36.2 8.3 9.7 7.1 26.5 11.8 4.3 14.5 26.4 17.9 10.4 7.7 9.0 18.3 16.0 3.7 18.8 9.0 12.3 4.0 3.7 39.3 23.7 7.2 20.3 15.4 27.7 20.4 15.5 5.3 6.6 5.8 12.0 3.3 34.2 36.9 12.4 57.3 16.8 10.3 18.0 20.9 DHRS1 "FLJ25430, MGC20204, SDR19C1" ENSG00000157379 "Dehydrogenase/reductase 1" Q96LJ7 14 24290598-24299780 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 68.9;liver: 61.2" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 178.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000599, HPA076886" Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" Nucleoplasm "Centrosome, Cytosol" "HPA000599: AB_1078655, HPA076886: " "unprognostic (2.08e-3)" "unprognostic (1.37e-1)" "unprognostic (2.26e-2)" "unprognostic (2.75e-1)" "unprognostic (3.57e-1)" "unprognostic (6.57e-2)" "prognostic favorable (1.18e-5)" "prognostic favorable (6.83e-4)" "unprognostic (3.66e-1)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (9.88e-2)" "unprognostic (2.25e-3)" "unprognostic (1.32e-2)" "unprognostic (1.58e-1)" "unprognostic (2.04e-1)" "unprognostic (2.08e-1)" 12.4 14.8 2.0 2.8 2.1 4.4 13.3 2.3 2.8 17.6 2.7 16.3 21.5 11.5 5.8 68.9 9.4 5.3 5.4 2.0 2.4 15.0 61.2 9.7 4.4 2.4 2.1 7.0 7.7 13.5 8.8 3.5 2.3 10.1 6.6 1.2 26.2 7.4 2.9 40.7 19.8 5.7 2.3 10.5 11.4 5.5 2.1 4.8 11.7 2.8 9.5 8.9 25.4 2.7 16.6 4.0 4.2 1.7 9.4 10.0 1.1 5.9 12.7 13.4 14.6 1.7 15.7 7.7 2.5 9.3 2.2 14.0 3.2 26.5 6.6 5.4 3.6 2.4 9.1 27.2 4.5 4.8 1.9 8.9 15.9 3.4 2.5 11.2 10.2 6.5 4.9 7.4 11.4 7.0 1.8 1.8 0.7 13.4 6.1 6.0 3.0 10.8 10.5 6.4 3.8 2.7 8.2 11.1 3.0 3.0 5.8 1.4 4.0 1.1 2.6 1.7 2.0 4.1 3.5 3.8 4.9 4.1 1.3 15.1 9.0 18.4 6.5 10.2 7.2 9.9 7.2 6.2 11.1 6.3 7.0 4.0 5.9 5.0 6.2 6.8 12.3 5.2 2.0 2.1 2.3 2.8 2.0 2.4 2.4 2.1 2.3 2.3 2.1 2.7 17.8 22.4 17.1 8.5 18.4 32.9 26.9 89.9 28.5 12.3 32.4 27.3 19.0 50.1 36.1 35.0 18.8 48.3 26.2 59.6 39.2 27.1 21.7 14.2 6.7 17.1 19.2 16.2 6.9 30.4 9.5 16.5 19.4 18.0 6.3 14.6 14.6 105.4 28.1 15.2 9.2 39.8 40.7 14.6 18.0 34.8 20.2 17.0 46.2 4.7 15.2 16.5 24.7 7.1 14.2 64.1 50.3 20.7 21.8 17.9 178.8 74.8 22.6 47.7 26.3 10.4 16.3 27.3 14.0 80.5 45.7 26.1 23.4 13.7 41.3 35.9 NOP9 C14orf21 ENSG00000196943 "NOP9 nucleolar protein" Q86U38 14 24299850-24309124 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000850 Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 20: HeLa - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "Nucleoli, Cytosol" "HPA000850: AB_1078287" "unprognostic (1.39e-1)" "unprognostic (4.64e-2)" "unprognostic (4.57e-3)" "unprognostic (1.85e-1)" "unprognostic (8.28e-2)" "unprognostic (3.54e-1)" "unprognostic (1.69e-2)" "unprognostic (9.37e-2)" "unprognostic (7.22e-2)" "unprognostic (1.40e-1)" "unprognostic (1.09e-1)" "unprognostic (6.77e-2)" "prognostic favorable (9.39e-6)" "unprognostic (7.03e-3)" "unprognostic (3.80e-1)" "unprognostic (1.95e-1)" "unprognostic (1.59e-2)" 9.9 13.0 6.3 5.5 6.7 7.0 9.3 6.2 6.1 8.6 4.6 11.1 7.8 9.9 3.5 16.1 9.5 3.3 13.2 5.8 6.3 8.6 13.8 8.7 6.2 6.7 6.5 11.7 12.6 6.7 7.9 4.1 6.4 9.0 5.5 7.4 10.6 4.4 27.2 12.6 11.4 4.9 6.9 17.3 10.6 7.7 6.8 5.9 8.6 11.2 6.7 9.8 9.3 6.3 6.5 12.8 10.2 12.8 8.7 7.3 9.8 11.4 8.5 13.2 10.2 9.7 11.3 16.7 6.3 10.5 10.7 16.6 20.4 14.2 13.7 10.6 7.8 12.3 18.3 22.4 7.0 28.4 13.5 7.4 10.9 9.7 8.9 7.0 12.4 9.3 10.6 8.0 9.3 11.3 13.2 10.7 4.6 22.9 16.2 16.0 6.1 10.6 8.1 14.8 10.2 7.8 16.1 18.4 3.5 7.3 6.9 7.4 12.8 8.7 7.2 6.9 10.9 11.1 10.6 12.2 4.8 12.7 7.1 0.3 0.6 0.5 0.4 0.7 0.4 0.3 0.3 0.2 0.5 0.4 0.2 0.2 0.1 0.1 1.2 0.3 0.3 0.4 6.3 6.7 6.2 6.1 5.8 6.3 6.7 6.5 6.4 6.9 6.8 6.3 4.0 3.2 3.3 2.6 6.2 12.5 3.2 4.9 6.2 8.1 5.3 3.9 1.2 7.2 8.5 9.2 8.4 6.3 6.7 15.2 0.0 7.3 3.1 5.2 4.8 5.6 10.7 9.9 3.6 10.3 5.8 4.5 6.1 5.0 1.3 9.6 6.1 18.1 7.3 6.7 4.3 7.6 0.0 10.7 6.3 1.3 6.5 5.8 0.0 1.0 7.6 5.5 2.1 3.0 5.0 11.6 8.5 4.5 5.5 5.2 12.5 6.6 7.7 8.0 6.6 5.4 5.4 4.6 5.7 8.1 13.5 6.4 4.9 5.5 14.3 4.6 CIDEB ENSG00000136305 "Cell death inducing DFFA like effector b" Q9UHD4 14 24305096-24311430 "Predicted intracellular proteins" "Apoptosis, Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 310.8" "Group enriched" "Detected in many" 5 "Hepatocytes: 258.9;Proximal enterocytes: 301.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 21.5;HEL: 11.0;Hep G2: 24.0;HL-60: 15.5;Karpas-707: 10.6;U-266/84: 14.8;U-937: 17.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA001272 Approved NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 85: Liver - Metabolism" "Cluster 32: U-937 - Innate immune response" "Cluster 2: Hepatocytes - Metabolism" "HPA001272: AB_2666255" "unprognostic (2.62e-2)" "unprognostic (6.55e-2)" "unprognostic (2.62e-3)" "unprognostic (9.35e-2)" "unprognostic (2.38e-3)" "unprognostic (1.83e-2)" "unprognostic (1.57e-1)" "unprognostic (8.48e-4)" "unprognostic (1.36e-1)" "unprognostic (3.06e-2)" "unprognostic (3.39e-3)" "unprognostic (2.36e-2)" "unprognostic (6.43e-2)" "unprognostic (6.04e-2)" "unprognostic (5.15e-2)" "unprognostic (2.09e-2)" "unprognostic (2.64e-1)" 13.2 37.2 1.6 5.6 1.6 12.3 11.6 2.3 2.2 17.3 2.2 10.7 70.6 8.6 4.4 35.5 12.9 3.8 7.5 1.5 2.2 31.1 310.8 10.5 4.8 2.0 2.0 25.3 19.3 1.9 12.2 2.0 1.9 11.2 3.5 0.2 14.2 4.8 2.5 22.6 58.1 4.0 1.9 88.9 8.0 2.2 2.6 3.6 7.6 1.3 7.2 8.6 20.1 1.9 0.0 0.0 0.0 0.0 1.4 0.6 0.2 0.4 0.1 0.2 0.1 1.4 0.5 0.0 0.0 0.6 0.0 2.0 0.0 0.2 0.0 21.5 0.0 11.0 0.0 24.0 0.1 15.5 0.0 0.5 0.0 0.0 0.0 0.0 4.8 0.0 0.0 10.6 0.0 0.0 0.1 7.3 0.0 5.6 0.0 1.8 0.1 5.5 0.0 0.7 4.5 0.0 5.9 0.1 0.0 0.1 0.0 5.3 0.2 0.0 0.0 0.0 0.0 8.4 14.8 0.1 0.0 17.9 0.0 0.9 5.2 6.9 3.4 1.8 3.2 0.5 2.2 2.1 5.2 0.4 1.4 1.7 2.9 5.2 0.9 1.3 1.3 2.0 1.6 1.6 2.3 2.2 1.5 2.2 2.0 2.0 1.9 1.9 2.6 1.9 8.8 0.0 1.7 0.0 6.9 7.0 6.4 5.6 29.6 0.4 4.6 5.6 0.0 11.5 3.3 1.8 2.1 0.1 15.0 14.4 9.8 1.5 0.1 4.3 2.0 7.0 1.8 13.0 0.0 9.6 0.2 4.0 5.1 1.2 8.8 0.3 12.5 258.9 7.9 0.0 0.1 11.7 8.2 30.5 2.6 0.5 6.2 13.2 5.4 1.0 8.8 0.6 21.6 0.0 0.1 15.4 24.4 3.0 7.2 0.7 301.5 51.6 10.5 0.6 0.0 0.9 2.8 0.2 2.3 33.4 6.1 0.3 11.1 3.6 8.6 1.8 LTB4R2 "BLT2, BLTR2, JULF2, NOP9" ENSG00000213906 "Leukotriene B4 receptor 2" Q9NPC1 14 24305734-24312053 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 37.7;skin 1: 46.4" "Group enriched" "Detected in some" 4 "Basal squamous epithelial cells: 18.2;Squamous epithelial cells: 15.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.1" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 15.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB022689, HPA029680, HPA072921" Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 59: Non-specific - Transcription" "Plasma membrane" Nucleoplasm "CAB022689: , HPA029680: AB_10603013, HPA072921: AB_2686557" "unprognostic (2.01e-1)" "unprognostic (1.04e-1)" "unprognostic (9.53e-2)" "unprognostic (8.82e-2)" "unprognostic (1.42e-1)" "unprognostic (1.12e-2)" "unprognostic (1.40e-1)" "unprognostic (7.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.37e-1)" "unprognostic (1.48e-3)" "unprognostic (7.18e-2)" "unprognostic (7.05e-11)" "unprognostic (1.84e-1)" "unprognostic (1.04e-1)" "unprognostic (4.23e-2)" "unprognostic (1.19e-1)" 5.1 5.8 0.4 2.1 0.5 5.4 4.7 0.5 0.4 15.8 0.4 2.7 2.6 3.0 0.8 37.7 4.0 0.9 2.2 0.3 0.3 2.8 4.0 4.7 2.0 1.2 0.4 4.9 4.7 0.2 3.9 1.0 0.5 5.0 0.5 2.1 11.7 1.2 3.0 46.4 5.1 0.5 0.5 13.5 2.7 4.2 0.6 1.7 3.9 0.1 3.2 2.7 21.6 0.8 2.4 3.9 1.6 1.7 0.3 0.5 7.1 0.8 0.4 1.2 0.7 3.1 1.3 2.9 1.4 0.5 1.6 15.0 1.1 2.5 0.8 3.7 4.4 2.0 3.7 1.5 0.4 3.4 3.7 0.5 3.1 1.7 2.0 1.0 0.5 5.3 2.6 3.3 0.5 4.4 1.8 3.5 0.9 0.1 4.7 7.4 1.5 1.7 0.3 2.8 3.1 1.5 1.5 1.8 1.3 1.7 3.4 2.5 1.5 2.3 2.8 3.6 1.3 7.1 2.1 4.7 0.5 5.5 1.8 0.0 0.5 0.3 0.6 0.3 0.3 0.0 0.5 0.5 0.5 0.0 0.3 0.2 0.2 0.2 0.2 0.1 0.1 0.3 0.4 0.5 0.5 0.4 0.3 0.3 1.2 0.4 0.5 0.5 0.6 0.8 2.3 0.0 0.0 0.0 0.7 0.3 3.4 0.1 18.2 0.4 0.6 1.3 0.0 0.0 0.0 1.8 0.0 0.2 1.2 0.5 0.0 0.2 0.0 1.9 0.2 1.6 1.8 2.1 0.0 1.4 0.1 0.5 1.5 0.4 0.0 0.2 1.1 1.0 0.7 3.3 0.0 0.4 0.0 1.9 0.0 0.0 0.3 1.8 0.0 0.0 0.2 0.2 1.0 0.0 0.0 0.4 1.2 0.0 3.0 0.4 1.1 0.3 0.7 0.5 0.0 0.3 0.2 0.9 0.2 15.7 0.1 0.3 2.3 0.3 0.8 0.8 LTB4R "BLTR, CMKRL1, GPR16, LTB4R1, P2RY7, P2Y7" ENSG00000213903 "Leukotriene B4 receptor" Q15722 14 24311450-24318036 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.1;skin 1: 110.1" "Cell type enhanced" "Detected in many" "Kupffer cells: 45.5;Macrophages: 28.0;Suprabasal keratinocytes: 47.0" "Cancer enhanced" "Detected in all" "head and neck cancer: 18.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 100.3" "Group enriched" "Detected in many" 6 "granulocytes: 100.3;monocytes: 38.4" "Cell line enhanced" "Detected in many" "HaCaT: 20.3;Karpas-707: 17.4" "Low region specificity" "Detected in single" HPA003873 Approved NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "HPA003873: AB_1078288" "unprognostic (4.07e-2)" "unprognostic (7.67e-2)" "unprognostic (3.67e-3)" "unprognostic (2.40e-3)" "unprognostic (4.90e-2)" "unprognostic (9.00e-3)" "unprognostic (1.15e-2)" "unprognostic (8.63e-2)" "unprognostic (3.68e-1)" "unprognostic (2.06e-1)" "prognostic favorable (1.85e-4)" "unprognostic (7.25e-2)" "prognostic unfavorable (3.44e-15)" "unprognostic (2.88e-1)" "unprognostic (2.97e-1)" "unprognostic (6.59e-2)" "unprognostic (7.45e-2)" 12.5 12.5 1.3 5.0 1.4 16.0 11.8 1.6 1.4 33.3 1.5 6.2 4.2 6.6 5.3 103.1 10.4 2.2 5.4 1.2 1.3 10.3 18.0 15.4 5.4 1.6 1.4 8.4 7.7 0.5 10.8 2.2 1.6 16.8 1.6 4.2 23.5 2.2 5.8 110.1 12.2 1.6 1.5 40.7 6.0 7.8 1.8 4.0 10.2 0.7 9.2 6.8 51.5 1.6 2.7 5.7 2.0 1.6 1.3 1.3 8.4 1.1 0.8 1.2 1.4 4.2 3.2 4.2 1.9 1.1 2.1 20.3 1.8 3.1 1.7 11.5 6.3 4.0 8.4 2.9 0.6 5.7 5.9 0.7 5.5 2.3 3.0 1.8 2.0 6.8 3.7 17.4 0.5 5.6 2.5 10.1 1.4 0.2 4.3 9.9 1.8 7.4 0.7 4.3 4.3 1.7 5.3 2.9 3.0 3.5 4.9 6.2 1.3 4.3 4.2 4.2 1.5 9.9 2.3 7.1 0.9 14.9 2.8 17.0 38.4 40.5 3.4 4.9 2.4 0.0 2.5 2.7 11.2 0.2 1.2 0.8 100.3 2.1 1.2 1.1 0.6 13.7 1.3 1.4 1.6 1.4 1.2 1.3 1.6 1.4 1.6 1.5 1.8 1.6 10.1 0.0 0.6 3.6 2.5 24.0 10.5 18.5 12.0 3.0 6.3 5.0 1.4 5.7 4.3 0.0 6.2 0.9 14.2 2.2 0.0 2.1 0.3 4.6 1.8 5.6 0.0 1.3 1.5 6.1 0.8 2.5 3.1 4.5 1.3 1.4 7.9 4.1 15.6 0.0 1.3 2.8 8.2 45.5 3.7 1.1 3.4 28.0 3.6 2.8 25.4 1.6 18.6 1.0 1.2 4.6 5.4 1.5 6.2 2.7 5.4 0.9 6.4 10.8 6.6 2.0 1.8 1.5 1.4 22.6 47.0 0.8 13.5 1.3 3.2 2.5 ADCY4 AC4 ENSG00000129467 "Adenylate cyclase 4" Q8NFM4 14 24318349-24335093 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Adipocytes: 90.9;Endothelial cells: 74.6;Hepatic stellate cells: 50.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 9 "basophil: 2.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 2.9" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 2.9;TIME: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB005070, HPA048344" Approved NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "CAB005070: AB_2273639, HPA048344: AB_2680366" "unprognostic (5.59e-2)" "unprognostic (1.34e-1)" "unprognostic (3.47e-4)" "prognostic favorable (8.20e-4)" "unprognostic (4.06e-1)" "unprognostic (2.82e-3)" "unprognostic (1.75e-4)" "unprognostic (8.58e-2)" "unprognostic (2.51e-2)" "unprognostic (7.88e-2)" "unprognostic (6.77e-2)" "unprognostic (7.87e-2)" "prognostic unfavorable (7.01e-4)" "unprognostic (8.02e-2)" "unprognostic (3.88e-2)" "unprognostic (1.57e-1)" "unprognostic (3.47e-2)" 18.0 2.6 2.8 2.3 2.2 0.0 16.1 2.2 2.8 9.2 2.0 3.9 0.9 8.8 0.5 3.7 8.2 2.9 16.9 2.0 2.1 10.2 1.4 9.9 1.6 2.7 2.5 2.4 2.3 1.0 1.7 9.9 2.6 5.3 0.7 0.0 3.7 1.4 4.3 4.7 4.5 1.9 2.4 9.9 3.7 1.1 3.0 0.4 7.7 2.8 0.8 5.9 6.7 2.3 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 5.1 0.1 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.8 2.2 2.2 2.8 2.0 2.1 2.7 2.5 2.6 2.4 3.0 2.3 90.9 0.0 1.8 0.3 1.0 3.6 0.4 0.3 3.4 0.0 1.5 1.5 10.6 0.0 0.9 1.8 0.0 0.2 1.6 2.9 0.0 1.2 1.3 0.5 1.1 74.6 1.2 0.4 0.2 3.1 0.1 4.7 7.1 0.6 1.3 0.0 50.3 0.2 1.4 1.7 0.2 7.9 0.0 5.0 3.1 6.9 0.0 1.5 7.2 12.2 2.5 0.9 1.0 0.0 0.0 2.1 3.8 0.0 1.4 0.4 2.4 0.0 1.1 0.2 6.6 1.7 5.7 0.3 0.8 0.6 2.8 0.0 1.6 0.5 2.1 0.2 RIPK3 RIP3 ENSG00000129465 "Receptor interacting serine/threonine kinase 3" Q9Y572 14 24336025-24340022 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Necrosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 38.5;Exocrine glandular cells: 35.2;Gastric mucus-secreting cells: 22.4;Paneth cells: 21.4;Proximal enterocytes: 22.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.0;HDLM-2: 4.1;OE19: 10.1;SK-BR-3: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 64: Macrophages - Immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "unprognostic (1.85e-2)" "unprognostic (1.66e-1)" "unprognostic (5.16e-3)" "unprognostic (1.12e-2)" "unprognostic (1.95e-1)" "unprognostic (1.29e-1)" "unprognostic (1.19e-1)" "unprognostic (2.32e-1)" "unprognostic (3.25e-1)" "unprognostic (2.02e-1)" "unprognostic (3.31e-2)" "unprognostic (1.11e-1)" "unprognostic (5.26e-3)" "unprognostic (9.58e-2)" "unprognostic (5.58e-2)" "unprognostic (1.08e-1)" "unprognostic (2.93e-2)" 8.6 1.7 0.7 5.6 0.7 4.9 8.0 0.7 1.4 6.4 0.8 15.2 10.2 3.2 1.4 11.9 3.8 5.4 4.1 0.7 0.7 6.2 1.7 8.1 7.7 1.2 0.8 0.7 7.9 0.8 1.2 3.2 1.1 3.4 11.0 0.0 8.9 1.5 1.5 6.5 18.3 2.1 0.8 18.6 10.6 1.1 1.1 3.5 10.7 1.3 7.6 5.4 7.5 1.1 0.0 0.0 0.0 0.0 2.4 2.7 0.0 0.6 3.4 0.0 0.0 0.1 7.0 0.1 1.7 0.3 0.0 1.6 0.0 0.1 0.0 4.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.2 1.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 10.1 0.0 0.0 0.0 1.2 1.2 0.0 0.0 0.0 0.0 11.1 0.0 0.0 1.9 2.9 1.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 0.0 1.7 3.3 4.2 3.7 5.1 3.9 2.1 3.1 3.7 3.3 2.4 1.6 2.3 1.9 2.7 6.0 1.6 6.1 2.9 0.7 0.7 0.7 1.4 0.7 0.7 1.2 0.8 1.1 0.8 1.1 1.1 5.5 3.2 9.1 0.0 5.7 1.5 1.4 5.8 1.8 0.0 2.0 0.9 0.7 2.8 4.7 3.7 0.0 0.3 9.6 38.5 3.9 8.1 0.1 3.2 0.8 4.2 6.1 1.3 0.0 35.2 0.4 1.9 22.4 5.4 12.6 0.0 0.7 0.0 12.7 0.0 0.0 14.4 4.1 9.5 1.6 0.3 0.0 7.7 3.6 1.9 11.6 0.0 10.3 0.0 0.0 17.8 21.4 0.0 5.5 0.5 22.5 0.1 3.7 0.0 0.0 0.2 1.0 0.0 0.3 3.9 1.4 0.3 8.3 0.1 8.0 3.3 NFATC4 NFAT3 ENSG00000100968 "Nuclear factor of activated T cells 4" Q14934 14 24365673-24379604 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 58.8;Endometrial stromal cells: 28.3;Fibroblasts: 22.8;Sertoli cells: 26.3;Smooth muscle cells: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 36.8;BJ hTERT+: 49.5;hTERT-RPE1: 42.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA031641, CAB032859, HPA076526" Uncertain Supported "Nuclear speckles,Cytosol" No No "Cluster 72: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "Nuclear speckles, Cytosol" "CAB032859: AB_1128521, HPA031641: AB_10600826, HPA076526: AB_2686805" "unprognostic (3.51e-1)" "unprognostic (5.61e-2)" "prognostic unfavorable (5.84e-4)" "unprognostic (8.08e-2)" "unprognostic (1.67e-1)" "unprognostic (6.57e-2)" "unprognostic (3.24e-2)" "unprognostic (1.15e-1)" "unprognostic (1.27e-1)" "unprognostic (4.18e-2)" "unprognostic (1.39e-1)" "unprognostic (9.11e-2)" "prognostic unfavorable (1.81e-6)" "unprognostic (1.47e-2)" "unprognostic (1.07e-1)" "unprognostic (1.35e-1)" "unprognostic (4.19e-2)" 48.4 54.9 9.1 6.0 9.4 0.6 47.2 8.6 10.5 126.0 9.0 71.9 4.5 82.1 13.7 22.2 82.6 17.8 30.2 9.0 9.3 35.5 5.6 30.2 4.8 10.3 9.4 142.7 13.8 9.0 37.9 18.2 8.8 51.5 5.0 2.8 20.5 16.2 9.0 25.0 29.9 18.8 8.2 17.7 35.5 42.7 9.7 1.7 50.4 2.5 3.6 66.2 65.9 8.5 0.0 0.1 17.8 0.0 25.4 36.8 0.1 17.3 49.5 23.0 20.0 0.0 14.6 14.9 0.5 25.0 1.6 0.0 7.1 0.3 13.9 0.0 0.6 11.3 20.6 0.0 12.3 0.0 0.0 26.8 0.3 13.9 0.1 42.5 18.2 4.7 3.7 0.0 4.5 0.8 0.0 1.7 2.3 1.0 0.1 1.1 1.6 2.0 0.0 0.2 2.9 11.9 0.0 3.3 5.7 8.7 10.3 4.5 10.3 21.3 4.4 20.5 0.0 10.4 1.6 11.0 4.4 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 9.4 8.6 10.5 9.0 9.3 10.3 9.4 8.8 8.2 9.7 8.5 4.1 3.2 8.1 58.8 1.1 4.5 0.9 1.9 0.6 1.3 3.3 2.8 7.8 0.0 4.8 0.0 0.0 0.6 0.0 0.8 0.0 2.8 4.4 2.5 28.3 4.6 7.7 0.0 0.1 0.2 0.6 22.8 3.6 6.4 0.0 4.1 1.4 0.2 0.6 0.0 0.2 3.4 10.2 0.0 6.8 6.5 17.4 0.4 7.2 13.1 0.0 7.6 0.0 1.0 0.2 0.6 0.3 7.5 0.2 0.8 0.4 0.2 2.1 1.5 26.3 4.3 27.1 12.5 2.9 1.0 3.4 0.5 0.9 6.0 1.6 2.3 NYNRIN "CGIN1, FLJ11811, KIAA1305" ENSG00000205978 "NYN domain and retroviral integrase containing" Q9P2P1 14 24399003-24419283 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 18.2;Squamous epithelial cells: 18.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.4;HEL: 14.7;HUVEC TERT2: 35.6;RT4: 29.8;TIME: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018945 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA018945: AB_1859538" "unprognostic (9.41e-3)" "unprognostic (3.96e-2)" "unprognostic (2.02e-1)" "unprognostic (4.49e-3)" "unprognostic (5.08e-2)" "unprognostic (1.14e-2)" "unprognostic (2.56e-1)" "unprognostic (2.65e-2)" "unprognostic (1.44e-3)" "unprognostic (4.21e-1)" "unprognostic (1.01e-1)" "unprognostic (4.51e-2)" "unprognostic (3.59e-2)" "unprognostic (2.39e-2)" "unprognostic (1.86e-1)" "unprognostic (3.39e-1)" "unprognostic (2.43e-1)" 8.7 3.7 4.3 3.1 3.9 0.4 6.3 16.3 4.6 16.8 5.4 7.6 4.0 11.5 28.0 11.6 16.9 8.6 7.5 3.2 6.6 6.3 4.5 8.1 1.9 5.8 5.4 35.1 3.8 5.8 5.8 12.8 6.3 7.5 5.5 1.8 7.4 14.9 3.8 13.3 5.3 10.5 3.2 4.4 6.0 5.1 7.8 4.5 7.8 4.2 2.9 9.5 14.0 2.8 0.2 0.1 4.6 0.0 6.3 13.0 0.3 2.2 2.3 1.5 1.6 3.3 14.4 0.4 0.6 8.6 0.2 0.0 7.5 0.2 1.5 0.0 0.8 14.7 2.0 0.3 4.7 0.0 0.0 13.3 0.6 1.0 0.0 2.6 35.6 0.1 2.4 0.0 0.2 0.6 0.0 0.8 2.7 1.0 0.0 1.9 0.0 0.0 0.0 29.8 0.6 10.0 0.0 1.3 0.2 11.2 2.5 2.1 17.4 0.1 8.2 0.0 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.3 3.9 16.3 4.6 3.2 6.6 5.8 5.4 6.3 3.2 7.8 2.8 15.2 3.2 1.7 4.9 0.1 4.6 3.9 9.5 15.4 0.5 1.8 3.6 3.1 8.6 15.6 9.2 0.0 1.1 1.6 2.7 0.0 4.1 0.8 1.4 10.8 15.0 5.4 3.6 1.0 3.0 1.0 10.1 10.7 1.7 0.0 12.0 18.2 2.7 10.7 0.0 3.9 9.0 4.1 9.0 1.4 0.2 2.5 1.4 3.6 3.7 0.7 5.4 0.0 0.5 0.1 4.8 5.1 0.4 1.2 1.2 1.0 0.3 10.8 0.2 0.0 1.2 7.3 0.3 1.2 18.0 3.8 1.1 0.3 1.5 8.8 4.5 CBLN3 ENSG00000139899 "Cerebellin 3 precursor" Q6UW01 14 24426545-24430954 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 93.9" "Cell type enhanced" "Detected in some" "dendritic cells: 3.0;Theca cells: 5.7" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 11 "cerebellum: 93.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 13.4;HDLM-2: 17.2;HSkMC: 23.3;Karpas-707: 18.3;U-266/70: 12.8" "Region enriched" "Detected in many" 25 "cerebellum: 429.5" "Region enriched" "Detected in many" 42 "cerebellum: 446.5" HPA041266 Enhanced Supported Approved Nucleoplasm "Secreted in brain" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 2: Karpas-707 - Immune response" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "HPA041266: AB_10674430" "unprognostic (5.02e-2)" "unprognostic (3.26e-1)" "unprognostic (1.43e-3)" "prognostic unfavorable (4.22e-4)" "unprognostic (4.39e-4)" "unprognostic (5.39e-3)" "unprognostic (1.60e-2)" "unprognostic (1.92e-2)" "unprognostic (2.16e-2)" "unprognostic (9.76e-2)" "unprognostic (6.20e-2)" "unprognostic (2.71e-2)" "prognostic unfavorable (6.20e-6)" "unprognostic (2.75e-2)" "unprognostic (2.63e-1)" "unprognostic (1.72e-1)" "unprognostic (9.02e-2)" 7.3 17.1 2.7 8.3 3.0 0.6 4.7 93.9 7.0 4.6 2.1 4.2 2.1 2.7 7.4 2.9 4.0 5.6 3.7 2.4 3.3 4.4 6.0 4.8 13.7 3.9 5.8 10.1 2.0 2.9 4.2 3.7 8.4 4.5 2.1 0.5 4.3 3.1 1.8 3.5 5.4 2.2 3.2 13.7 3.3 5.1 3.4 3.9 4.5 0.6 9.1 4.9 4.6 4.8 1.5 1.3 0.7 2.5 6.2 13.4 0.4 5.5 11.1 2.1 2.7 0.7 2.6 2.4 1.2 3.4 2.4 0.3 0.8 2.9 1.4 17.2 0.6 0.0 5.2 1.1 3.3 0.4 0.9 23.3 1.3 2.7 2.1 8.8 1.9 1.0 0.7 18.3 2.8 0.8 0.0 0.7 0.1 1.5 1.5 0.0 0.0 1.8 1.2 0.5 0.9 0.5 0.5 0.1 0.8 0.3 0.8 0.6 8.7 7.7 1.5 3.2 0.3 12.8 3.2 2.7 0.4 1.1 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.0 93.9 7.0 2.4 3.3 3.9 5.8 8.4 3.2 3.4 4.8 1.4 0.0 0.0 0.0 2.6 0.4 0.6 1.5 0.0 0.0 0.8 1.0 0.5 0.0 0.4 0.0 0.0 0.9 3.0 0.8 0.0 1.1 0.0 0.3 2.0 0.8 0.0 0.4 0.3 1.1 0.6 2.6 0.0 0.5 0.0 0.9 0.0 0.2 0.9 0.0 0.1 0.5 0.0 0.3 0.4 0.3 2.5 0.7 0.0 1.0 2.6 1.2 0.0 0.0 0.0 0.8 0.0 1.5 0.1 0.5 0.9 0.8 1.4 0.2 0.0 0.7 1.4 0.0 0.2 0.2 0.6 0.8 0.2 5.7 0.6 0.6 KHNYN KIAA0323 ENSG00000100441 "KH and NYN domain containing" O15037 14 24429286-24441843 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003402 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 24: B-cells - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 27: Mucus-secreting cells - Mucin production" Nucleoplasm Cytosol "HPA003402: AB_1079190" "unprognostic (2.95e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (1.03e-1)" "unprognostic (8.03e-2)" "prognostic unfavorable (5.10e-4)" "unprognostic (4.11e-2)" "unprognostic (1.65e-1)" "unprognostic (2.01e-1)" "unprognostic (1.28e-1)" "unprognostic (1.05e-2)" "unprognostic (5.75e-2)" "unprognostic (1.88e-1)" "unprognostic (1.47e-1)" "unprognostic (8.43e-2)" "unprognostic (1.41e-1)" "unprognostic (6.08e-2)" "unprognostic (2.73e-1)" 24.5 24.1 13.9 28.8 17.1 39.1 23.6 20.7 15.0 27.2 15.0 28.9 27.7 25.1 17.3 27.8 28.1 18.2 18.0 12.3 13.9 16.6 19.0 25.2 27.9 19.7 15.5 41.4 28.3 19.9 18.1 33.0 17.5 25.0 25.6 8.4 24.4 21.2 22.5 26.6 33.4 20.0 14.5 32.4 38.8 9.5 15.4 24.2 22.5 17.7 31.2 27.1 25.2 19.6 28.2 35.1 29.2 23.4 31.2 30.5 29.7 27.3 33.2 30.9 24.2 22.1 48.6 39.3 15.6 25.9 25.3 26.9 25.8 44.4 22.9 63.4 12.0 17.8 33.1 41.1 32.0 26.3 37.1 31.3 100.2 32.0 42.4 42.3 36.4 29.1 24.0 35.7 17.6 36.6 9.6 16.5 7.6 53.7 28.6 15.0 0.3 20.2 19.9 42.1 20.9 21.8 22.4 14.6 36.9 29.0 17.5 30.4 36.2 28.1 24.4 33.9 16.0 66.5 39.9 27.4 15.3 14.4 26.0 0.9 1.3 1.9 1.7 1.6 1.0 1.3 1.4 1.4 0.9 2.3 1.0 1.0 1.7 1.6 1.3 1.5 1.4 1.2 13.9 17.1 20.7 15.0 12.3 13.9 19.7 15.5 17.5 14.5 15.4 19.6 15.3 12.8 16.3 10.7 15.6 8.9 25.3 15.1 11.4 2.9 13.8 11.9 3.4 17.2 13.0 7.3 2.1 24.7 14.3 32.2 1.9 18.1 0.4 8.6 10.3 15.0 10.8 22.1 2.9 41.8 13.6 11.6 36.7 13.4 14.0 13.5 9.7 9.5 13.6 0.0 1.5 26.1 18.3 12.6 9.3 3.1 14.0 13.3 12.4 6.5 16.6 8.3 16.5 3.5 6.7 41.1 17.3 11.3 8.6 33.7 35.0 3.9 12.9 9.2 13.1 13.6 14.3 1.1 1.6 9.4 12.8 26.8 12.7 14.6 17.6 34.3 SDR39U1 "C14orf124, HCDI" ENSG00000100445 "Short chain dehydrogenase/reductase family 39U member 1" Q9NRG7 14 24439766-24442905 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 121.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044294, HPA075356" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 39: Non-specific - Mitochondria" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Cytosol" "HPA044294: AB_10961400, HPA075356: " "unprognostic (2.99e-2)" "unprognostic (1.21e-1)" "unprognostic (4.13e-2)" "unprognostic (2.42e-2)" "unprognostic (2.36e-1)" "unprognostic (6.28e-2)" "unprognostic (2.06e-2)" "unprognostic (1.67e-3)" "unprognostic (4.24e-1)" "unprognostic (2.87e-3)" "prognostic favorable (2.34e-4)" "unprognostic (9.13e-2)" "unprognostic (1.13e-3)" "unprognostic (7.47e-2)" "unprognostic (2.48e-1)" "unprognostic (1.63e-1)" "unprognostic (5.32e-2)" 41.5 73.9 55.4 14.8 56.9 28.9 44.6 59.7 65.1 40.4 53.4 43.3 16.9 33.5 17.7 35.1 35.8 11.6 83.7 54.0 55.7 60.2 57.9 35.1 22.6 56.7 57.9 47.2 50.1 22.7 58.1 14.4 56.6 47.2 9.3 37.9 38.0 23.1 96.7 40.1 42.1 11.6 57.4 57.7 47.5 34.7 58.5 27.8 38.7 72.5 14.1 41.1 33.4 57.3 20.1 35.4 25.5 30.0 34.8 26.5 24.4 11.5 16.3 26.4 30.2 27.4 26.0 28.4 30.0 13.4 19.6 37.1 22.8 29.2 11.5 38.2 39.5 25.3 26.1 74.1 16.9 23.7 23.4 29.7 34.6 19.0 27.2 26.9 28.5 65.5 23.1 24.5 26.3 36.2 40.2 39.2 24.1 31.3 32.6 50.9 13.2 20.9 47.5 27.1 43.8 36.8 30.3 55.4 28.3 15.1 38.1 34.9 14.2 8.0 25.5 23.7 15.3 38.3 26.9 35.7 21.1 30.6 21.2 39.1 38.3 23.8 40.3 23.7 39.2 49.7 30.7 32.3 43.7 49.7 43.2 45.2 11.4 58.4 20.3 60.7 40.2 33.0 55.4 56.9 59.7 65.1 54.0 55.7 56.7 57.9 56.6 57.4 58.5 57.3 34.9 28.9 21.7 10.1 35.0 26.5 40.8 40.1 21.6 37.2 44.2 47.2 0.2 45.8 36.5 40.5 12.5 48.4 41.6 19.7 121.3 29.1 16.9 16.9 15.9 27.3 27.6 35.3 12.2 19.9 24.3 24.8 13.3 17.8 36.1 28.4 21.0 38.6 30.2 28.6 12.6 25.8 38.7 19.3 19.6 26.3 32.9 21.6 42.7 12.2 22.9 63.4 37.0 11.1 17.0 15.7 17.7 31.6 34.4 24.9 21.3 71.7 26.8 47.4 0.0 25.5 24.0 67.1 22.6 21.0 27.3 56.1 28.6 27.0 22.5 29.8 CMA1 ENSG00000092009 "Chymase 1" P23946 14 24505353-24508265 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 18.5" "Cell type enriched" "Detected in some" 28 "granulocytes: 53.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB000363, HPA052634" Enhanced Supported "Cytosol,Cytoplasmic bodies" "Secreted to blood" NA NA 3000000 "Cluster 35: T-regs - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 60: Granulocytes - Receptor signaling" "Cytoplasmic bodies" Cytosol "CAB000363: AB_2083616, HPA052634: AB_2681892" "unprognostic (1.37e-1)" "unprognostic (2.27e-3)" "unprognostic (2.04e-1)" "unprognostic (7.07e-3)" "unprognostic (1.48e-2)" "unprognostic (1.19e-1)" "unprognostic (5.79e-2)" "unprognostic (2.21e-1)" "unprognostic (8.91e-3)" "unprognostic (4.19e-3)" "unprognostic (1.29e-4)" "unprognostic (2.52e-3)" "unprognostic (7.78e-2)" "unprognostic (7.37e-2)" "unprognostic (4.98e-3)" 9.0 0.0 0.2 3.7 0.1 0.2 18.5 0.0 0.2 4.6 0.3 8.7 0.6 3.1 4.3 10.2 0.9 7.3 1.6 0.1 0.2 0.2 0.5 1.5 1.8 0.5 0.3 0.1 1.6 0.6 0.2 0.1 0.3 1.0 8.3 0.0 4.7 1.3 0.9 9.0 5.8 2.2 0.3 0.2 1.5 0.9 0.2 3.0 0.4 3.0 2.4 11.1 0.9 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.2 0.1 0.2 0.5 0.3 0.3 0.3 0.2 0.2 0.0 0.0 1.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 53.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.1 0.0 CTSG CG ENSG00000100448 "Cathepsin G" P08311 14 24573518-24576250 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 154 "bone marrow: 5352.9" "Cell type enriched" "Detected in some" 16 "granulocytes: 534.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "THP-1: 8681.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000110, HPA047737" Enhanced "Intracellular and membrane" NA NA 330000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "CAB000110: , HPA047737: AB_2680140" "unprognostic (1.67e-1)" "unprognostic (2.57e-2)" "unprognostic (6.92e-2)" "unprognostic (1.08e-1)" "prognostic favorable (1.57e-4)" "unprognostic (4.05e-2)" "unprognostic (4.13e-2)" "unprognostic (3.06e-1)" "unprognostic (2.42e-1)" "unprognostic (2.60e-2)" "unprognostic (2.05e-2)" "unprognostic (1.63e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (8.91e-4)" 23.4 0.1 0.0 13.5 0.0 5352.9 25.4 0.0 0.0 16.6 0.0 25.5 5.8 9.6 10.2 22.1 2.7 25.9 3.7 0.0 0.0 2.3 3.6 11.6 6.5 0.0 0.0 0.5 3.5 1.5 1.0 2.9 0.0 3.7 25.5 0.0 11.5 4.8 1.8 28.0 18.1 7.7 0.0 16.9 4.9 3.2 0.0 26.0 0.8 7.6 6.0 34.8 4.1 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 303.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 33.2 0.0 0.1 0.0 0.0 3.6 41.5 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 1.2 0.0 3.6 0.0 0.0 8681.4 0.0 0.0 0.3 0.0 5.3 0.0 0.8 2.8 0.0 1287.5 0.1 0.0 6.0 0.0 1.1 1.0 0.0 0.0 0.9 3.4 5.4 0.0 0.0 1.7 7.3 5.0 0.0 6.5 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.8 33.3 0.0 0.2 6.4 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.3 0.0 0.0 2.4 0.0 1.3 0.0 0.0 0.1 1.0 0.0 0.0 534.9 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.6 11.1 9.1 0.0 1.5 5.4 0.0 1.8 0.0 2.1 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.7 0.0 0.0 0.2 1.3 0.3 1.7 0.0 4.0 0.0 5.1 0.0 0.4 0.0 GZMH "CCP-X, CGL-2, CSP-C, CTLA1, CTSGL2" ENSG00000100450 "Granzyme H" P20718 14 24606480-24609699 "Enzymes, Predicted secreted proteins" Cytolysis "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 33.9;lymphoid tissue: 25.2" "Group enriched" "Detected in many" 10 "dendritic cells: 575.2;NK-cells: 492.3;T-cells: 302.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "gdT-cell: 1678.5;memory CD4 T-cell: 490.7;memory CD8 T-cell: 1389.6;naive CD8 T-cell: 1214.0" "Lineage enriched" "Detected in all" 7 "T-cells: 1678.5" "Cell line enhanced" "Detected in single" "U-266/70: 1.0" "Low region specificity" "Detected in many" HPA029200 Enhanced "Secreted to blood" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 2: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "HPA029200: AB_10602908" "unprognostic (3.72e-3)" "unprognostic (1.47e-3)" "unprognostic (5.35e-2)" "prognostic favorable (2.00e-6)" "unprognostic (8.80e-2)" "unprognostic (1.65e-3)" "unprognostic (2.08e-3)" "unprognostic (1.13e-1)" "unprognostic (1.62e-2)" "unprognostic (4.41e-2)" "unprognostic (1.14e-1)" "unprognostic (2.68e-1)" "prognostic unfavorable (1.74e-6)" "unprognostic (1.23e-1)" "unprognostic (1.80e-1)" "unprognostic (3.35e-2)" "unprognostic (2.77e-3)" 3.4 5.2 1.2 3.1 1.3 33.9 4.6 1.3 2.4 2.6 1.6 2.7 2.4 2.0 5.0 3.6 3.5 7.0 2.5 1.1 1.3 1.2 6.7 15.9 25.2 2.0 1.2 2.8 0.8 0.7 2.4 1.6 1.5 1.4 2.5 0.0 7.9 2.1 1.9 0.6 2.8 3.4 1.3 24.4 4.7 0.8 1.4 3.8 1.5 0.6 4.5 7.5 1.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.2 31.6 3.4 1.7 1678.5 3.6 30.2 7.6 490.7 1389.6 3.3 4.6 155.1 1214.0 18.6 250.8 5.4 44.6 4.5 1436.5 1.2 1.3 1.3 2.4 1.1 1.3 2.0 1.2 1.5 1.3 1.4 1.3 2.9 0.0 4.6 0.0 3.3 1.1 0.1 0.0 0.0 0.0 1.7 1.5 1.4 8.6 0.0 0.0 0.0 0.1 575.2 0.0 0.0 0.1 0.1 0.3 0.3 1.5 0.0 8.6 0.0 0.0 0.0 1.2 1.1 0.4 1.3 0.0 7.5 1.2 0.1 0.0 0.0 0.0 0.0 9.3 3.4 0.2 0.0 4.5 3.6 1.9 3.1 0.0 492.3 0.0 0.1 0.0 0.0 0.0 43.7 0.2 0.0 2.6 0.7 0.0 0.0 1.9 1.3 0.1 0.0 0.4 1.8 0.0 302.2 0.0 0.1 0.1 GZMB "CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT" ENSG00000100453 "Granzyme B" P10144 14 24630954-24634267 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Cytolysis" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 68.2;lymphoid tissue: 37.1" "Group enriched" "Detected in many" 5 "dendritic cells: 2050.2;NK-cells: 1704.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "plasmacytoid DC: 6765.2" "Lineage enriched" "Detected in all" 5 "dendritic cells: 6765.2" "Cell line enriched" "Detected in some" 6 "HMC-1: 22.0" "CAB000376, HPA003418" Enhanced "Secreted to blood" NA NA 2170 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "CAB000376: AB_323716, HPA003418: AB_1079020" "prognostic favorable (7.27e-4)" "unprognostic (2.82e-3)" "unprognostic (8.54e-2)" "prognostic favorable (1.58e-5)" "unprognostic (2.07e-3)" "unprognostic (1.48e-3)" "unprognostic (4.43e-2)" "unprognostic (8.25e-2)" "unprognostic (3.70e-2)" "unprognostic (3.05e-3)" "unprognostic (4.26e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (1.10e-7)" "unprognostic (1.24e-1)" "unprognostic (1.48e-1)" "unprognostic (1.29e-1)" "unprognostic (2.71e-3)" 8.2 1.7 1.2 17.8 1.3 68.2 2.1 1.2 3.9 1.2 1.4 2.5 2.3 7.1 1.6 3.8 1.5 6.5 1.8 1.2 7.9 1.5 4.1 15.3 37.1 1.5 1.5 0.3 1.0 0.7 0.7 3.3 1.6 1.4 2.2 0.0 2.3 1.4 2.0 0.4 4.4 4.3 1.4 28.9 3.5 0.5 1.8 9.7 1.9 1.5 34.6 18.5 1.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 3.9 0.0 0.0 0.0 0.7 2.8 9.9 3.0 5.3 1338.5 4.0 16.0 7.0 95.2 641.6 6.3 3.1 29.1 607.5 43.1 507.8 6.0 6765.2 2.7 1607.1 1.2 1.3 1.2 3.9 1.2 7.9 1.5 1.5 1.6 1.4 1.8 1.3 4.3 6.4 36.0 0.0 15.9 2.8 0.3 0.0 0.0 0.0 0.9 0.8 1.1 4.3 7.4 0.0 0.0 0.4 2050.2 0.6 0.0 1.6 0.0 0.4 0.5 2.7 0.0 11.8 0.0 0.0 0.1 5.1 9.2 0.5 17.7 0.0 4.2 1.2 0.2 0.0 0.0 0.6 0.0 4.8 9.0 0.2 0.0 27.1 42.7 1.0 11.6 0.0 1704.4 0.0 0.1 0.1 2.3 0.0 86.8 0.2 0.6 3.1 4.4 0.0 0.0 1.3 1.3 0.0 0.1 0.4 4.1 0.3 373.8 0.0 0.6 0.1 STXBP6 "amisyn, HSPC156" ENSG00000168952 "Syntaxin binding protein 6" Q8NFX7 14 24809656-25050297 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 128.6;Inhibitory neurons: 180.6;Oligodendrocytes: 188.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "gdT-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 48.6;Daudi: 50.7;HBF TERT88: 64.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003552, HPA074869" Approved NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 22: Non-specific - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA003552: AB_10603343, HPA074869: " "unprognostic (1.52e-1)" "unprognostic (2.73e-1)" "unprognostic (2.54e-2)" "unprognostic (1.20e-2)" "unprognostic (9.01e-2)" "unprognostic (2.28e-2)" "unprognostic (1.05e-1)" "unprognostic (2.37e-2)" "unprognostic (1.69e-1)" "unprognostic (6.46e-3)" "unprognostic (1.51e-1)" "unprognostic (6.73e-3)" "unprognostic (5.10e-3)" "unprognostic (1.16e-1)" "unprognostic (1.43e-1)" "unprognostic (1.36e-1)" "unprognostic (1.48e-3)" 7.3 0.8 18.5 3.8 19.6 0.2 5.0 16.2 27.7 13.5 0.6 11.9 12.3 7.5 38.1 6.0 7.0 11.0 24.7 18.9 21.6 3.6 4.3 26.3 1.6 23.9 23.6 2.8 39.5 23.0 1.0 42.8 17.8 12.7 14.8 2.1 15.0 9.5 4.4 15.0 18.5 5.1 11.4 0.7 9.8 4.4 42.1 7.8 18.0 7.6 5.5 12.3 2.6 19.1 0.1 1.0 2.0 0.5 12.9 22.3 0.2 15.1 40.2 35.5 37.5 48.6 0.3 50.7 0.1 42.6 0.0 0.1 0.0 0.1 64.1 27.2 3.2 12.1 0.4 37.0 9.4 0.9 6.3 3.3 0.0 0.0 0.2 2.0 0.0 1.4 0.5 16.9 34.2 9.7 0.2 0.1 6.6 25.4 0.0 0.0 28.1 0.4 0.0 2.8 2.3 0.1 0.1 7.8 42.6 4.3 0.5 0.7 0.0 6.4 17.2 41.2 2.1 5.1 6.0 2.4 21.8 0.3 24.2 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.2 18.5 19.6 16.2 27.7 18.9 21.6 23.9 23.6 17.8 11.4 42.1 19.1 50.3 51.3 7.7 128.6 0.4 67.7 48.4 0.1 20.5 0.6 2.9 3.3 27.4 64.3 3.4 20.2 0.0 1.4 1.7 12.6 0.0 47.9 20.4 38.8 4.9 35.8 40.7 8.6 72.9 98.7 1.5 44.9 20.4 72.8 42.6 0.8 36.8 5.8 20.1 0.0 180.6 64.6 2.0 1.0 11.0 4.6 1.5 2.9 110.3 113.4 2.0 2.7 0.0 113.6 188.1 39.9 49.6 1.2 3.1 73.9 71.8 9.6 0.0 0.5 0.0 16.4 6.5 12.6 19.7 4.1 48.2 4.0 3.2 0.0 51.7 16.4 NOVA1 NOVA-1 ENSG00000139910 "NOVA alternative splicing regulator 1" P51513 14 26443090-26598033 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 85.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 222.9;Excitatory neurons: 414.9;Oligodendrocyte precursor cells: 1269.7;Oligodendrocytes: 319.5" "Cancer enriched" "Detected in many" 5 "glioma: 14.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 53.3;ASC diff: 25.6;HAP1: 23.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004155 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 70: Brain - Nervous system development" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Nucleoli Nucleoplasm "HPA004155: AB_1079497" "unprognostic (1.46e-1)" "unprognostic (4.43e-3)" "unprognostic (6.55e-3)" "unprognostic (4.00e-2)" "unprognostic (6.69e-3)" "unprognostic (4.29e-2)" "unprognostic (3.74e-3)" "unprognostic (2.41e-1)" "unprognostic (5.21e-1)" "unprognostic (4.32e-2)" "unprognostic (5.04e-4)" "unprognostic (2.40e-1)" "unprognostic (1.93e-3)" "unprognostic (9.27e-4)" "unprognostic (9.20e-2)" "unprognostic (5.62e-2)" "unprognostic (1.31e-4)" 23.4 5.4 44.0 2.4 39.7 0.1 28.9 85.4 56.3 12.1 18.9 11.6 1.4 8.5 4.9 2.9 6.7 4.8 3.3 38.8 65.3 6.1 0.9 1.4 3.4 50.3 51.2 5.0 1.2 2.4 19.3 0.1 48.5 5.6 5.1 13.4 2.7 15.9 4.3 4.7 3.6 9.5 49.2 0.9 3.3 8.8 71.1 1.2 3.4 8.7 4.5 5.9 8.4 45.5 0.0 11.6 53.3 0.0 25.6 14.6 0.1 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.7 0.7 7.1 0.1 23.7 0.2 0.0 0.0 1.8 0.0 0.1 0.3 8.5 0.0 2.1 16.8 0.0 3.6 2.9 17.8 10.3 8.7 0.0 0.1 8.4 0.0 9.8 0.1 13.5 0.0 10.9 1.3 14.8 0.2 6.8 9.1 15.5 9.4 0.0 0.0 0.0 4.2 1.1 0.0 0.0 6.5 7.7 5.2 1.4 0.0 0.0 0.0 8.8 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 44.0 39.7 85.4 56.3 38.8 65.3 50.3 51.2 48.5 49.2 71.1 45.5 24.8 0.0 1.5 141.0 0.2 5.2 5.9 0.0 4.6 222.9 51.5 29.6 1.1 5.7 0.0 14.7 4.2 0.1 1.4 6.6 9.8 0.4 20.1 0.6 15.0 9.4 65.9 0.0 414.9 0.4 0.0 188.8 0.5 0.2 0.0 18.2 38.6 0.5 0.2 136.3 203.5 7.1 0.0 0.6 10.5 16.5 150.4 2.1 3.6 93.7 0.0 32.3 0.0 1269.7 319.5 2.0 11.7 65.8 1.9 6.7 0.3 30.3 4.4 12.0 6.6 28.6 17.7 163.1 64.3 0.7 3.1 0.0 1.5 30.0 8.4 0.6 FOXG1 "BF1, FKH2, FKHL1, FKHL2, FKHL3, FKHL4, FOXG1A, FOXG1B, FOXG1C, HBF-3, HFK1, HFK2, HFK3, QIN" ENSG00000176165 "Forkhead box G1" P55316 14 28766787-28770277 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 25.3" "Cell type enhanced" "Detected in some" "Astrocytes: 69.5;Excitatory neurons: 35.9;Inhibitory neurons: 33.2;Oligodendrocyte precursor cells: 31.2;Spermatocytes: 15.4" "Cancer enriched" "Detected in some" 10 "glioma: 15.9" "Group enriched" "Detected in many" 37 "amygdala: 11.6;basal ganglia: 20.1;cerebral cortex: 25.3;hippocampal formation: 21.5;white matter: 8.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 15.6;SCLC-21H: 39.0;U-138 MG: 25.2;U-251 MG: 25.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 10: Non-specific - Unknown function" "unprognostic (2.92e-2)" "unprognostic (2.22e-1)" "unprognostic (1.92e-1)" "unprognostic (3.49e-1)" "unprognostic (1.17e-3)" "unprognostic (2.14e-2)" "unprognostic (1.27e-11)" "unprognostic (4.10e-2)" "unprognostic (1.08e-1)" "unprognostic (1.60e-2)" 0.0 0.0 11.6 0.0 20.1 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 21.5 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.2 3.1 0.2 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 7.6 6.0 4.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 3.4 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.0 0.1 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.0 0.0 0.0 0.1 0.0 2.3 0.0 0.1 0.1 25.2 0.0 2.0 25.2 0.0 0.0 0.0 8.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 20.1 0.0 25.3 21.5 0.4 0.0 0.0 0.0 0.0 0.2 8.9 0.0 0.0 0.0 69.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.1 0.0 0.0 35.9 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 33.2 0.0 0.0 0.0 0.0 3.4 0.3 0.0 0.0 4.7 0.0 1.4 0.0 31.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 9.5 15.4 2.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 PRKD1 "PKC-mu, PKCM, PKD, PRKCM" ENSG00000184304 "Protein kinase D1" Q15139 14 29576479-30191898 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Angiogenesis, Apoptosis, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 362.1;Excitatory neurons: 147.4;Inhibitory neurons: 171.1;Microglial cells: 89.0;Oligodendrocyte precursor cells: 390.6" "Cancer enhanced" "Detected in all" "prostate cancer: 10.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 21.6;fHDF/TERT166: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018367, HPA029834" Uncertain Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Cluster 21: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 68: Oligodendrocytes - Mixed function" "Plasma membrane" Cytosol "CAB018367: AB_2253119, HPA029834: AB_10602821" "unprognostic (5.35e-2)" "unprognostic (3.20e-1)" "unprognostic (2.27e-2)" "unprognostic (6.70e-2)" "unprognostic (2.37e-1)" "unprognostic (1.92e-1)" "unprognostic (1.08e-3)" "unprognostic (8.88e-2)" "unprognostic (2.37e-2)" "unprognostic (5.29e-2)" "unprognostic (7.08e-2)" "unprognostic (1.56e-1)" "prognostic favorable (2.44e-5)" "unprognostic (9.45e-4)" "unprognostic (1.99e-1)" "prognostic unfavorable (2.91e-4)" "unprognostic (3.89e-1)" 8.0 9.6 5.6 2.2 8.0 0.0 7.7 6.5 6.7 6.4 3.7 9.5 1.0 7.9 3.5 2.1 6.5 4.4 6.1 7.5 7.5 17.5 1.6 7.5 0.3 8.6 8.6 11.2 5.4 10.6 5.6 1.9 8.7 14.7 1.3 4.7 2.9 9.3 1.6 2.8 3.6 6.3 8.9 2.3 4.6 11.7 8.1 2.4 5.9 2.6 0.5 13.1 4.6 10.3 0.0 4.4 4.8 3.1 21.6 16.5 0.1 14.1 10.4 16.7 7.3 0.0 0.3 0.0 1.9 19.4 4.0 0.1 7.9 2.1 6.8 0.0 6.2 0.0 0.0 0.5 8.8 0.0 0.1 18.4 0.3 1.4 1.5 6.1 2.6 0.0 1.4 0.4 17.4 1.8 0.0 0.0 2.6 0.0 9.6 0.0 6.3 5.2 9.7 6.6 4.3 13.0 2.6 0.0 4.5 4.6 0.0 0.1 5.6 13.6 6.7 1.0 3.7 0.0 0.0 0.0 3.5 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 8.0 6.5 6.7 7.5 7.5 8.6 8.6 8.7 8.9 8.1 10.3 4.6 0.0 7.4 362.1 0.2 0.5 4.8 0.4 0.6 1.4 1.4 1.5 1.2 10.0 0.0 12.9 6.2 0.0 0.0 0.1 29.4 2.4 39.5 2.8 9.2 6.1 3.0 2.7 147.4 4.2 0.1 6.4 0.5 8.4 0.0 18.7 10.8 2.5 0.2 1.7 171.1 0.2 0.0 1.6 0.9 16.9 7.5 0.7 7.2 89.0 0.0 16.7 0.0 390.6 76.6 2.0 0.1 12.8 0.4 12.4 0.2 4.5 0.1 2.9 0.0 13.3 4.5 3.2 7.8 0.0 0.9 0.3 0.6 29.6 0.1 1.3 G2E3 "FLJ20333, KIAA1333, PHF7B" ENSG00000092140 "G2/M-phase specific E3 ubiquitin protein ligase" Q7L622 14 30559158-30620064 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 42.3" "Group enriched" "Detected in all" 6 "Early spermatids: 722.5;Late spermatids: 233.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001601 Uncertain Approved "Golgi apparatus,Vesicles,Cytosol" NA Yes "Cluster 18: Basophils - Vesicular transport" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" Cytosol "Golgi apparatus, Vesicles" "HPA001601: AB_1079198" "unprognostic (4.75e-2)" "unprognostic (6.31e-2)" "unprognostic (2.27e-2)" "unprognostic (4.86e-2)" "unprognostic (9.10e-2)" "unprognostic (3.99e-2)" "unprognostic (5.44e-6)" "unprognostic (1.17e-2)" "unprognostic (2.81e-2)" "unprognostic (1.86e-1)" "unprognostic (3.13e-2)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (1.67e-1)" "unprognostic (1.23e-1)" "unprognostic (2.32e-2)" "unprognostic (2.12e-2)" 4.8 3.2 2.1 6.4 7.0 10.0 6.4 11.6 5.5 6.4 0.7 5.6 5.0 6.3 3.7 6.2 4.8 3.8 4.8 2.4 5.6 4.5 5.2 4.5 9.1 3.1 2.5 6.1 5.2 5.6 2.7 6.3 2.7 5.1 5.3 13.8 4.9 4.6 3.0 5.9 4.9 6.2 1.0 6.3 5.3 42.3 7.0 14.3 6.6 3.9 8.9 4.9 3.9 9.6 37.9 15.6 33.7 16.1 11.2 15.0 30.5 31.9 12.9 20.2 22.9 17.1 20.5 32.9 10.9 18.4 15.9 29.7 36.4 18.8 42.2 25.7 15.7 19.6 17.1 31.0 10.3 34.0 22.5 8.1 7.4 15.1 34.9 18.3 22.9 22.5 21.2 24.2 29.0 21.9 22.6 9.6 31.2 27.5 32.7 21.4 0.0 8.2 10.5 22.3 28.4 19.9 27.7 16.0 7.9 20.5 19.1 12.5 17.3 19.7 21.9 16.9 21.9 14.1 47.7 38.8 5.4 16.6 29.2 20.2 6.5 12.9 7.6 8.5 10.1 9.2 7.4 6.3 5.6 9.9 9.2 7.8 5.9 6.5 11.3 6.8 6.6 4.1 2.1 7.0 11.6 5.5 2.4 5.6 3.1 2.5 2.7 1.0 7.0 9.6 22.6 19.2 9.0 17.9 32.9 21.9 22.5 11.8 26.7 34.9 13.0 10.8 10.0 12.8 13.6 5.5 25.0 17.8 23.0 9.0 9.8 8.9 722.5 13.9 26.6 17.0 13.8 42.7 45.3 7.1 22.7 20.6 14.3 14.1 17.1 23.3 13.2 7.5 14.2 35.3 38.4 14.7 14.2 13.9 12.4 233.9 16.4 16.5 8.8 24.4 16.2 15.5 32.0 41.7 43.1 10.7 9.4 14.3 14.4 22.5 5.6 12.0 10.9 33.4 52.6 18.0 18.6 69.8 42.7 20.7 25.4 10.0 24.9 11.9 12.4 20.6 SCFD1 "C14orf163, KIAA0917, RA410, SLY1, STXBP1L2" ENSG00000092108 "Sec1 family domain containing 1" Q8WVM8 14 30622291-30737694 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003579 Approved NA NA 120000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 55: Plasma cells - Humoral immune response" "HPA003579: AB_1079872" "unprognostic (2.33e-1)" "unprognostic (1.04e-1)" "unprognostic (1.07e-1)" "unprognostic (2.50e-1)" "unprognostic (1.81e-1)" "unprognostic (1.08e-2)" "unprognostic (1.24e-2)" "unprognostic (1.21e-1)" "unprognostic (3.21e-2)" "unprognostic (3.07e-2)" "unprognostic (8.35e-2)" "unprognostic (2.65e-1)" "unprognostic (7.52e-3)" "unprognostic (1.05e-1)" "unprognostic (3.08e-1)" "unprognostic (3.05e-1)" "unprognostic (6.32e-2)" 23.2 29.3 11.8 22.3 12.4 9.9 29.2 12.3 12.6 34.0 13.0 27.6 22.2 21.8 40.8 29.7 21.7 19.6 29.6 11.9 12.4 32.5 35.1 22.5 26.2 11.8 12.1 23.6 46.4 41.8 29.3 27.8 11.8 27.7 29.8 14.9 52.3 24.0 24.6 19.5 23.8 22.9 11.5 19.0 28.0 26.6 11.6 25.6 44.3 29.3 29.1 30.0 20.8 12.0 71.7 26.0 37.8 22.9 64.1 67.0 53.4 57.0 68.4 69.5 83.5 42.2 58.9 36.9 24.2 79.7 38.8 44.5 41.3 46.5 80.0 53.2 22.2 30.7 28.6 149.5 77.9 50.2 32.4 49.1 39.1 48.9 78.1 58.5 45.5 26.5 42.6 68.0 74.7 66.8 30.7 27.8 40.7 83.9 45.1 30.2 42.1 42.2 70.7 45.6 35.9 33.0 58.7 54.4 53.6 42.9 70.5 35.3 48.1 41.9 44.0 43.0 45.3 45.3 40.8 49.4 26.9 36.7 52.9 26.8 17.2 20.2 14.0 23.2 17.8 20.1 16.2 17.3 23.7 14.7 15.2 14.1 3.0 23.1 27.8 16.9 24.4 16.1 11.8 12.4 12.3 12.6 11.9 12.4 11.8 12.1 11.8 11.5 11.6 12.0 33.0 51.3 31.3 67.9 47.7 25.0 55.2 55.1 18.2 35.0 26.9 27.1 35.3 18.6 50.8 25.8 43.8 61.9 51.3 31.8 64.6 49.2 29.3 34.9 51.6 32.3 47.2 24.2 123.0 50.6 61.0 47.9 20.9 34.2 53.7 32.1 24.3 20.6 44.9 30.3 112.8 44.9 36.7 27.7 33.4 16.6 38.5 35.5 37.4 90.9 66.9 31.1 62.8 112.6 106.6 41.2 23.5 40.3 70.9 42.3 28.8 40.9 52.1 39.9 13.1 53.7 49.0 71.8 53.5 20.5 24.4 83.0 41.4 47.8 30.0 43.5 COCH "COCH-5B2, DFNA31, DFNA9" ENSG00000100473 Cochlin O43405 14 30874514-30895065 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" Hearing "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "pancreas: 502.0" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 63.0;Horizontal cells: 84.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 71.3" "Group enriched" "Detected in some" 12 "memory B-cell: 38.3;naive B-cell: 17.7" "Lineage enriched" "Detected in many" 17 "B-cells: 38.3" "Cell line enhanced" "Detected in many" "HEK 293: 95.7;Hep G2: 63.8;K-562: 129.1;NB-4: 105.5;SCLC-21H: 111.8" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 50.8" HPA065086 Supported Vesicles "Secreted in other tissues" NA NA 160000 "Cluster 19: B-cells - Humoral immune response" "Cluster 25: Pancreas - Digestion" "Cluster 1: K-562 - Erythropoiesis" "Cluster 48: Smooth muscle cells - ECM organization" Vesicles "HPA065086: " "unprognostic (8.36e-3)" "unprognostic (2.51e-2)" "unprognostic (8.61e-2)" "unprognostic (1.64e-2)" "unprognostic (6.48e-2)" "unprognostic (6.53e-2)" "unprognostic (9.61e-2)" "unprognostic (4.03e-1)" "unprognostic (2.11e-2)" "unprognostic (1.40e-1)" "unprognostic (1.27e-2)" "unprognostic (2.91e-3)" "unprognostic (5.42e-3)" "unprognostic (3.92e-2)" "unprognostic (2.80e-2)" "unprognostic (1.03e-1)" "unprognostic (1.72e-1)" 3.2 3.7 7.3 2.8 71.3 4.0 3.4 1.4 20.9 17.4 19.0 3.2 0.8 0.6 2.2 0.9 6.2 2.9 1.9 5.6 8.0 5.2 0.5 0.6 11.0 2.9 7.9 0.8 502.0 3.4 10.1 1.9 3.7 48.3 2.2 12.1 3.6 73.4 1.3 15.2 2.6 1.1 6.2 2.6 1.7 5.2 12.5 1.3 1.3 5.0 7.7 2.0 23.0 1.7 0.0 35.3 3.1 0.0 0.6 0.1 21.8 0.2 0.0 6.4 17.1 20.9 1.2 0.4 1.7 0.0 1.3 0.1 22.2 0.0 10.6 0.0 95.7 18.1 7.6 63.8 0.0 1.8 7.3 1.3 0.0 0.6 0.0 0.0 0.3 39.9 129.1 5.1 1.6 0.8 9.2 105.5 11.9 0.1 3.7 26.7 0.0 0.9 1.1 3.4 111.8 30.4 2.6 0.6 0.2 12.1 0.0 48.7 0.9 0.0 0.0 0.3 0.1 5.7 15.8 11.2 0.0 0.0 4.7 0.0 0.6 0.0 0.0 0.0 0.0 38.3 0.3 0.0 0.1 17.7 0.0 0.1 0.2 0.0 0.0 0.0 2.2 1.0 7.3 71.3 1.4 20.9 5.6 8.0 2.9 7.9 3.7 6.2 12.5 1.7 2.0 0.0 0.5 3.6 13.4 19.1 2.3 0.3 0.0 2.7 7.9 1.5 0.8 2.8 0.9 0.0 4.2 6.5 1.3 0.6 1.9 0.5 1.5 2.2 0.8 3.1 17.0 7.4 14.3 63.0 14.3 22.0 1.1 1.0 1.3 1.8 5.0 5.0 3.8 84.1 24.2 0.3 6.1 5.0 25.2 2.0 1.5 2.4 19.6 7.5 2.8 14.5 0.0 6.0 16.5 3.7 4.3 6.0 10.0 3.5 0.2 11.7 0.5 4.0 0.0 2.8 9.0 22.1 20.3 0.1 13.5 6.6 3.3 0.1 0.6 1.7 STRN3 "PPP2R6B, S/G2NA, SG2NA" ENSG00000196792 "Striatin 3" Q13033 14 30893799-31026401 "Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003392, HPA004636, CAB069925" Approved Supported "Nucleoplasm,Actin filaments,Cytosol" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 48: Smooth muscle cells - ECM organization" Cytosol "Nucleoplasm, Actin filaments" "CAB069925: AB_1146988, HPA003392: AB_1079942, HPA004636: AB_1079940" "unprognostic (4.08e-1)" "unprognostic (8.66e-2)" "unprognostic (8.08e-2)" "unprognostic (4.22e-2)" "unprognostic (3.06e-2)" "unprognostic (7.74e-3)" "unprognostic (3.37e-2)" "unprognostic (2.83e-1)" "unprognostic (3.05e-1)" "unprognostic (9.53e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "prognostic favorable (9.66e-4)" "unprognostic (8.74e-2)" "unprognostic (7.85e-2)" "unprognostic (4.83e-2)" "unprognostic (1.01e-2)" 18.9 13.4 8.4 9.3 8.3 10.0 11.6 14.9 11.2 14.0 8.9 16.1 7.3 12.4 13.8 15.3 9.9 12.4 18.5 7.5 16.4 13.9 21.5 10.0 7.5 7.7 9.8 10.1 12.6 13.9 9.3 11.9 7.5 13.7 12.6 14.2 10.3 14.1 39.2 11.7 9.7 18.0 6.0 10.4 11.2 20.9 10.7 9.4 13.7 28.5 9.0 14.7 11.6 10.6 33.7 29.2 31.0 22.0 27.4 20.4 25.8 33.0 23.2 24.9 26.3 37.7 22.4 18.4 22.0 23.2 12.6 18.2 33.5 18.1 37.7 17.5 12.3 19.2 19.6 73.6 28.8 15.6 19.8 19.9 20.8 19.5 24.8 23.9 21.5 16.7 22.8 17.8 25.4 21.5 21.3 16.3 15.3 24.1 25.5 15.0 35.5 4.9 39.2 47.7 19.1 15.5 32.8 23.6 17.7 28.4 27.7 14.5 28.0 24.8 21.3 14.7 12.4 15.7 21.4 17.8 12.7 11.2 20.5 4.1 3.5 4.7 3.3 4.3 4.4 3.4 4.2 3.7 3.1 3.2 4.1 4.8 4.3 4.2 3.5 5.7 3.6 1.3 8.4 8.3 14.9 11.2 7.5 16.4 7.7 9.8 7.5 6.0 10.7 10.6 37.1 22.4 22.4 82.3 19.5 98.1 57.5 17.9 23.9 27.2 37.1 25.1 51.7 28.6 22.1 31.3 27.1 22.1 17.5 34.1 11.7 38.9 21.8 32.7 48.0 36.0 31.9 43.8 110.9 26.3 19.9 39.6 20.4 46.9 8.8 21.7 35.0 43.1 12.8 37.0 119.0 18.8 16.2 23.9 45.7 13.4 26.8 22.9 44.4 92.8 18.9 24.6 11.3 102.1 139.2 40.3 13.2 27.8 31.3 49.6 13.2 43.3 25.2 30.2 26.3 52.3 51.9 59.8 53.6 31.4 96.5 33.2 21.4 26.1 16.3 53.6 AP4S1 "AP47B, CLA20, SPG52" ENSG00000100478 "Adaptor related protein complex 4 subunit sigma 1" Q9Y587 14 31025106-31130996 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 36.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039963 Approved Supported Vesicles NA NA "Cluster 15: NK-cells - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Vesicles "HPA039963: AB_10795240" "unprognostic (4.03e-2)" "unprognostic (1.42e-1)" "unprognostic (1.65e-1)" "unprognostic (2.43e-1)" "unprognostic (1.14e-1)" "unprognostic (8.00e-3)" "unprognostic (1.03e-1)" "prognostic favorable (7.44e-4)" "unprognostic (3.79e-2)" "unprognostic (8.62e-3)" "unprognostic (1.15e-2)" "unprognostic (3.02e-1)" "prognostic favorable (2.87e-6)" "unprognostic (2.20e-3)" "unprognostic (5.44e-2)" "unprognostic (7.75e-2)" "unprognostic (5.59e-2)" 4.8 6.3 9.8 6.6 10.6 6.0 5.7 14.1 12.8 6.5 5.6 8.6 3.9 7.7 7.0 4.9 7.3 5.4 8.7 9.5 10.2 7.8 6.2 5.4 8.1 6.3 6.5 10.7 7.9 6.5 8.5 6.7 6.1 6.2 4.1 11.9 5.2 6.7 12.6 4.6 4.4 7.9 5.4 8.0 4.3 18.4 9.0 6.6 8.8 7.2 7.7 6.2 4.8 10.1 9.0 12.6 11.0 3.2 4.4 7.9 8.5 6.0 10.4 9.6 9.5 12.2 14.5 10.6 5.5 7.3 7.2 9.7 7.6 9.4 15.9 9.1 4.4 16.4 5.5 19.0 9.5 14.1 9.2 6.3 5.9 9.6 12.0 6.4 11.7 8.0 8.4 7.0 10.3 12.5 9.7 7.8 13.1 10.5 10.9 10.3 9.8 1.4 10.5 12.4 6.1 6.1 10.7 5.1 16.3 7.3 10.8 6.5 8.8 7.3 6.5 5.0 5.2 8.6 17.0 15.9 4.2 4.4 5.7 3.4 1.3 2.4 2.5 3.5 3.7 3.3 3.8 3.0 1.2 3.4 3.7 4.5 2.6 5.8 2.8 3.3 6.6 1.7 9.8 10.6 14.1 12.8 9.5 10.2 6.3 6.5 6.1 5.4 9.0 10.1 7.1 9.6 7.7 10.7 8.1 3.4 6.5 6.5 1.2 12.1 4.0 4.3 16.5 4.3 3.1 5.5 31.3 9.1 7.6 3.9 5.9 7.6 21.9 5.2 8.8 6.7 6.0 3.8 29.4 4.8 5.3 6.2 7.1 5.8 7.6 7.8 10.8 4.0 7.4 6.7 24.9 3.8 4.1 5.4 4.1 17.0 6.8 6.0 3.6 12.2 7.5 9.3 5.2 25.1 16.4 2.8 6.2 8.6 4.2 4.0 5.0 7.7 8.1 24.4 6.6 8.5 8.1 36.0 8.3 3.0 2.8 11.5 7.3 8.2 4.0 5.2 HECTD1 KIAA1131 ENSG00000092148 "HECT domain E3 ubiquitin protein ligase 1" Q9ULT8 14 31100112-31207804 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 218.4" "Cell type enhanced" "Detected in all" "Urothelial cells: 302.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002929, HPA054461" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 46: Basophils - DNA binding" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Nucleoli" "HPA002929: AB_1850574, HPA054461: AB_2682496" "unprognostic (6.71e-2)" "unprognostic (4.86e-2)" "unprognostic (5.31e-2)" "unprognostic (1.25e-1)" "unprognostic (1.64e-1)" "unprognostic (6.99e-2)" "unprognostic (1.32e-1)" "unprognostic (7.03e-2)" "unprognostic (2.29e-2)" "unprognostic (3.13e-2)" "unprognostic (3.60e-3)" "unprognostic (1.51e-1)" "prognostic favorable (1.20e-6)" "unprognostic (6.53e-2)" "unprognostic (1.22e-1)" "unprognostic (1.07e-1)" "unprognostic (9.91e-3)" 43.0 48.6 27.8 23.1 33.6 54.0 37.6 58.6 33.7 43.5 34.0 38.3 25.1 37.0 30.7 74.6 33.8 26.7 47.2 27.2 30.9 37.0 74.3 32.9 28.7 30.2 30.1 38.5 34.7 56.5 34.4 35.5 32.5 30.7 31.2 66.9 42.6 31.0 218.4 50.8 33.6 30.8 28.0 30.4 43.7 42.7 31.3 26.3 51.3 133.6 37.3 39.8 51.5 36.6 95.1 54.6 49.2 30.4 144.0 77.2 44.7 54.8 54.1 47.4 39.7 41.0 47.8 72.1 57.8 97.3 34.0 62.6 63.2 47.7 69.6 44.5 24.9 75.6 44.3 163.9 66.9 81.8 52.7 66.3 64.4 52.2 80.9 63.6 87.5 42.2 54.4 32.1 72.8 72.4 31.8 31.7 36.0 76.6 47.5 53.6 58.0 30.4 71.3 93.2 36.2 40.8 79.8 54.5 49.0 56.3 58.7 49.5 93.4 56.6 42.9 41.9 49.0 34.3 52.9 79.0 28.0 37.3 49.7 9.1 5.7 8.3 4.5 4.8 5.2 4.8 5.2 4.1 6.4 6.3 4.2 4.3 3.0 6.3 3.8 5.3 5.6 2.4 27.8 33.6 58.6 33.7 27.2 30.9 30.2 30.1 32.5 28.0 31.3 36.6 63.4 48.1 80.8 84.5 60.7 86.7 93.5 61.2 48.3 98.9 40.8 28.6 108.1 25.8 94.8 71.7 98.0 70.2 72.1 40.9 11.7 44.2 3.6 101.6 83.0 60.0 48.7 41.2 89.9 36.1 42.9 59.9 96.8 118.1 32.9 81.6 46.4 84.7 29.0 65.6 101.1 33.0 63.1 43.9 34.5 8.7 69.0 54.0 33.8 90.9 65.1 40.9 78.2 100.0 127.9 52.6 33.9 74.4 71.1 106.3 37.1 22.4 148.4 194.5 46.0 77.4 78.9 50.6 100.0 83.7 114.9 140.0 61.4 97.0 44.5 302.9 HEATR5A "C14orf125, DKFZP434I1735" ENSG00000129493 "HEAT repeat containing 5A" Q86XA9 14 31291788-31420550 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 67.8;Oligodendrocytes: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 120.4" "Lineage enriched" "Detected in all" 7 "granulocytes: 120.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049539 Uncertain NA NA "Cluster 46: Basophils - DNA binding" "Cluster 80: Striated muscle - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA049539: AB_2680809" "unprognostic (2.63e-1)" "unprognostic (2.24e-1)" "unprognostic (1.75e-3)" "unprognostic (2.16e-2)" "unprognostic (2.42e-1)" "unprognostic (5.47e-3)" "unprognostic (3.97e-2)" "unprognostic (9.37e-2)" "unprognostic (8.02e-2)" "unprognostic (1.70e-1)" "unprognostic (1.84e-1)" "unprognostic (1.04e-1)" "prognostic favorable (1.11e-6)" "unprognostic (1.00e-1)" "unprognostic (5.93e-2)" "unprognostic (2.83e-2)" "unprognostic (6.00e-2)" 8.6 11.1 8.9 8.9 12.5 7.0 8.0 11.0 8.8 9.6 9.7 14.1 10.3 7.3 5.8 10.0 8.9 7.4 16.3 8.2 12.9 10.2 8.7 8.9 5.7 13.8 11.6 6.2 4.8 9.1 7.5 12.1 15.5 5.8 11.4 7.4 8.0 5.7 12.1 4.2 12.0 10.3 10.1 8.0 7.5 8.2 10.5 3.5 7.6 20.3 6.7 10.9 6.6 18.5 28.3 43.3 12.2 15.7 29.0 27.3 25.3 33.6 28.3 18.0 18.3 17.4 21.1 15.1 31.4 50.7 10.8 18.6 23.2 10.3 25.5 11.5 21.4 11.4 56.5 73.8 16.9 21.9 15.8 12.8 5.5 15.4 14.6 14.1 22.8 6.9 23.4 15.2 21.0 25.2 8.2 9.4 9.3 17.8 25.2 4.7 24.1 8.6 11.9 17.5 5.1 15.3 77.2 35.3 78.4 17.0 20.0 6.2 35.4 13.1 19.6 22.5 13.6 14.9 42.3 23.8 3.9 12.0 19.5 120.4 11.8 47.3 2.7 11.7 1.6 4.7 1.9 2.4 8.2 3.6 1.6 2.9 38.4 3.7 18.1 3.7 2.0 4.6 8.9 12.5 11.0 8.8 8.2 12.9 13.8 11.6 15.5 10.1 10.5 18.5 7.8 28.9 20.2 58.4 7.5 5.9 2.4 6.3 5.2 12.1 9.9 5.5 17.0 5.7 15.5 18.4 14.6 13.1 2.7 33.5 1.9 11.7 3.5 16.3 9.0 8.7 6.7 2.5 27.1 11.7 10.8 13.1 9.7 7.4 11.4 6.9 10.4 14.8 10.6 1.7 38.8 13.5 10.2 14.8 10.8 1.3 12.2 13.6 10.6 42.2 15.1 19.2 1.0 67.8 96.6 17.6 22.4 11.7 10.1 6.3 17.3 8.9 21.8 9.3 0.0 18.1 9.6 21.7 13.2 10.0 7.2 18.1 5.9 11.4 13.1 4.9 AL139353.1 ENSG00000203546 "Novel protein" 14 31334312-31457441 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 1.1;skeletal muscle: 1.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Breast glandular cells: 3.2;Breast myoepithelial cells: 5.8;Cytotrophoblasts: 4.6;Distal tubular cells: 3.9;Proximal tubular cells: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "NK-cell: 1.3" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 7: Non-specific - Mitochondria" "unprognostic (2.86e-4)" "unprognostic (3.48e-1)" "unprognostic (3.52e-1)" "unprognostic (2.21e-1)" "unprognostic (2.52e-1)" "unprognostic (4.35e-2)" "unprognostic (4.97e-2)" "unprognostic (1.18e-2)" "unprognostic (3.91e-2)" "unprognostic (3.13e-2)" "unprognostic (5.79e-3)" "unprognostic (1.47e-2)" "unprognostic (2.63e-3)" "unprognostic (8.26e-3)" "unprognostic (3.56e-2)" "unprognostic (4.57e-2)" "unprognostic (5.10e-2)" 1.1 0.1 0.2 0.0 0.3 0.0 0.2 0.3 0.6 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.3 0.3 0.3 0.3 0.1 0.1 0.1 0.3 0.3 0.1 0.1 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.1 0.0 1.1 0.1 0.0 0.0 0.3 0.1 0.1 0.3 0.3 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.3 0.1 0.0 0.1 0.7 0.2 0.1 0.0 1.3 0.0 0.6 0.5 0.0 0.2 0.3 0.3 0.6 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 1.2 3.2 2.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 3.2 5.8 0.0 0.0 0.6 1.8 0.0 4.6 0.4 0.0 3.9 1.5 0.0 2.5 1.6 0.6 0.0 0.0 0.0 1.3 1.6 1.1 0.0 0.7 0.0 1.9 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 6.5 2.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.5 0.3 1.1 0.0 0.0 DTD2 "C14orf126, MGC9912" ENSG00000129480 "D-aminoacyl-tRNA deacylase 2" Q96FN9 14 31446036-31457506 "Enzymes, Predicted intracellular proteins" "Hydrolase, RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 35.2;Oligodendrocytes: 40.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001117 Approved Approved Vesicles NA NA "Cluster 15: NK-cells - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles "HPA001117: AB_2666204" "unprognostic (2.56e-3)" "unprognostic (9.38e-2)" "unprognostic (1.27e-3)" "unprognostic (3.24e-2)" "unprognostic (8.45e-2)" "prognostic unfavorable (9.33e-4)" "unprognostic (3.04e-2)" "unprognostic (1.64e-1)" "unprognostic (8.74e-3)" "unprognostic (2.91e-1)" "unprognostic (5.28e-2)" "unprognostic (6.96e-2)" "unprognostic (1.24e-1)" "unprognostic (2.32e-1)" "unprognostic (3.06e-2)" "unprognostic (1.22e-2)" "prognostic unfavorable (5.74e-6)" 8.6 6.3 4.7 4.9 6.8 2.3 7.1 5.2 6.5 4.0 5.2 4.8 3.9 5.2 5.0 5.7 4.9 3.5 3.1 5.3 5.3 5.8 8.1 5.8 5.5 5.5 5.9 5.3 6.3 6.1 4.4 4.3 5.9 5.7 5.4 5.0 6.0 3.9 1.6 5.6 3.7 5.5 4.9 4.9 4.0 4.0 6.2 5.0 6.2 1.6 5.5 4.7 3.8 8.1 11.4 9.5 8.1 10.6 14.6 12.3 5.5 10.3 10.0 8.0 7.1 5.2 10.7 21.6 6.8 11.8 8.6 10.8 13.0 11.6 13.6 11.7 5.7 6.2 6.5 29.0 15.7 12.6 7.3 14.0 12.9 7.1 15.9 6.7 11.8 12.8 12.3 9.9 10.7 13.7 18.3 11.3 11.0 19.6 9.7 12.3 6.0 11.3 15.0 9.8 12.1 8.0 16.8 21.6 12.4 6.9 19.8 6.5 8.6 8.7 7.7 7.1 9.1 12.3 24.5 20.7 3.8 11.4 14.3 2.5 2.6 1.0 2.0 2.2 2.9 2.7 3.0 2.2 3.7 3.2 4.5 3.0 1.5 3.7 1.2 2.2 1.6 2.8 4.7 6.8 5.2 6.5 5.3 5.3 5.5 5.9 5.9 4.9 6.2 8.1 2.9 9.6 9.0 10.1 7.6 5.2 5.7 5.1 13.1 5.9 6.1 4.3 4.8 15.7 4.9 3.7 8.4 9.1 4.9 3.3 3.9 5.7 4.4 6.8 7.2 3.8 3.0 8.0 9.2 6.2 6.3 6.2 5.1 3.0 1.3 5.9 3.9 11.6 5.1 5.0 12.7 6.7 14.2 5.5 3.7 6.6 7.5 4.0 3.6 2.8 4.8 9.5 7.2 35.2 40.2 5.2 3.9 8.2 7.1 6.0 3.3 9.7 6.2 9.2 0.0 7.4 6.8 10.1 2.7 16.2 5.4 2.7 5.4 10.3 7.2 4.2 GPR33 ENSG00000214943 "G protein-coupled receptor 33" Q49SQ1 14 31482875-31488039 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "myeloid DC: 2.6" "Lineage enhanced" "Detected in single" "dendritic cells: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 28: Myeloid DCs - Unknown function" "unprognostic (1.20e-1)" "unprognostic (8.10e-3)" "unprognostic (6.53e-4)" "unprognostic (9.13e-2)" "unprognostic (2.55e-1)" "unprognostic (2.10e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NUBPL "C14orf127, FLJ12660, huInd1, IND1" ENSG00000151413 "Nucleotide binding protein like" Q8TB37 14 31489956-31861224 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 68.2;Inhibitory neurons: 74.8;Oligodendrocyte precursor cells: 87.9;Oligodendrocytes: 99.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029203 Approved Supported Mitochondria "Intracellular and membrane" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Mitochondria "HPA029203: AB_10602810" "unprognostic (1.49e-1)" "unprognostic (1.71e-2)" "unprognostic (5.21e-3)" "unprognostic (8.28e-2)" "unprognostic (8.25e-2)" "unprognostic (1.94e-3)" "unprognostic (1.67e-1)" "unprognostic (1.93e-2)" "unprognostic (1.15e-1)" "unprognostic (1.35e-1)" "unprognostic (2.15e-1)" "unprognostic (2.80e-1)" "prognostic favorable (3.64e-8)" "unprognostic (2.82e-2)" "unprognostic (6.60e-2)" "unprognostic (3.67e-3)" "unprognostic (1.56e-2)" 9.7 6.4 4.2 3.9 4.6 1.8 8.9 4.5 4.8 4.9 4.2 7.6 4.9 5.8 7.6 4.6 6.4 5.3 17.0 4.0 5.0 12.2 12.3 4.1 5.7 4.9 4.7 6.8 5.5 7.9 3.8 5.5 4.5 6.3 7.8 5.2 11.9 6.1 11.9 4.7 5.8 5.4 4.3 6.6 4.7 3.5 5.0 5.5 8.0 17.4 5.4 4.2 3.2 5.8 13.6 8.5 6.4 3.3 8.9 16.4 11.5 7.3 8.2 8.9 10.2 5.9 15.3 9.8 9.2 9.1 7.5 11.7 8.6 15.5 15.3 7.1 11.1 3.5 6.3 30.4 8.8 10.4 3.0 10.7 17.0 6.0 12.8 7.3 5.0 7.0 6.4 4.9 9.8 7.4 7.7 7.1 5.4 10.8 13.1 8.6 13.4 5.3 10.2 10.0 6.0 6.2 12.2 10.8 14.5 7.2 21.1 5.4 4.9 8.6 5.9 5.6 6.8 8.1 9.7 9.3 5.5 7.3 7.9 0.0 1.1 0.4 2.1 1.2 1.7 2.6 2.7 2.3 4.4 1.7 3.0 2.4 0.4 2.5 0.7 2.2 1.8 0.9 4.2 4.6 4.5 4.8 4.0 5.0 4.9 4.7 4.5 4.3 5.0 5.8 6.9 12.8 9.8 68.2 10.1 9.6 8.6 5.4 9.1 15.3 10.2 7.1 36.9 15.7 10.6 9.2 20.9 11.2 7.5 6.3 7.9 6.8 24.1 12.6 10.8 6.3 7.2 6.7 48.2 5.7 10.2 12.0 7.1 5.4 14.5 16.4 4.6 15.3 4.9 10.1 74.8 12.0 2.0 4.1 16.1 7.4 6.5 6.1 12.4 54.4 2.8 16.2 5.2 87.9 99.6 5.2 5.8 11.7 8.0 4.4 5.1 19.1 18.7 28.4 13.1 11.8 9.8 15.7 5.2 7.3 11.6 5.7 6.4 23.1 18.2 5.9 ARHGAP5 "GFI2, p190-B, p190BRhoGAP, RhoGAP5" ENSG00000100852 "Rho GTPase activating protein 5" Q13017 14 32076114-32159728 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 381.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046993, HPA056507" Approved Supported "Endoplasmic reticulum,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 15: RT4 - Unknown function" "Cluster 64: Astrocytes - Nervous system maintenance" "Endoplasmic reticulum, Cytosol" "HPA046993: AB_2679895, HPA056507: AB_2683158" "unprognostic (1.79e-1)" "unprognostic (2.03e-1)" "unprognostic (2.66e-3)" "unprognostic (6.77e-2)" "unprognostic (1.69e-1)" "unprognostic (3.75e-2)" "unprognostic (1.55e-2)" "unprognostic (6.23e-2)" "unprognostic (2.88e-1)" "unprognostic (2.18e-1)" "unprognostic (1.28e-2)" "unprognostic (6.63e-2)" "prognostic favorable (3.97e-8)" "unprognostic (9.79e-2)" "unprognostic (2.21e-1)" "unprognostic (2.13e-1)" "unprognostic (1.00e-2)" 23.7 27.3 54.3 19.8 55.5 10.9 27.3 66.4 53.6 26.2 12.1 29.5 35.3 28.0 24.7 66.5 23.2 32.7 62.8 47.5 52.7 43.0 31.8 28.0 14.6 42.9 52.0 47.3 29.7 48.1 10.0 37.1 43.2 30.5 26.3 57.8 59.8 29.3 14.0 30.8 38.9 23.4 45.6 42.9 29.4 46.5 50.6 18.3 68.5 24.7 18.5 32.8 15.7 80.4 61.0 48.5 47.3 69.8 60.7 42.4 27.3 37.1 45.6 22.1 32.9 62.2 58.0 17.9 32.1 47.0 37.2 63.3 46.0 39.9 42.7 18.0 26.6 26.9 30.1 91.2 41.5 16.5 15.5 47.5 78.8 20.7 77.1 54.3 27.4 33.3 24.3 51.8 36.3 31.9 36.4 0.8 23.7 67.1 57.7 38.9 58.2 3.5 48.4 159.5 73.2 28.6 99.6 52.7 74.6 52.5 54.8 1.1 44.6 40.8 60.6 33.9 27.6 19.7 41.5 2.8 20.5 17.5 113.1 2.2 1.4 0.0 3.1 0.7 3.8 6.1 5.5 3.0 5.3 5.3 5.7 3.5 0.5 5.9 1.2 7.6 5.0 2.0 54.3 55.5 66.4 53.6 47.5 52.7 42.9 52.0 43.2 45.6 50.6 80.4 50.9 192.3 71.9 381.9 40.7 94.2 144.2 52.1 130.9 97.2 52.8 53.3 301.2 58.6 70.2 58.8 114.7 27.5 27.0 85.0 54.8 50.2 42.0 92.1 77.9 42.9 61.8 28.6 81.7 46.1 14.5 65.1 59.7 136.3 5.1 30.0 37.5 51.1 19.0 65.6 140.7 56.8 46.8 19.0 45.4 66.8 104.4 44.2 67.6 65.6 18.6 103.3 14.4 139.7 205.6 75.0 93.5 100.4 35.7 104.2 89.6 60.1 78.4 92.7 59.2 103.1 65.9 128.5 75.6 94.0 70.3 13.4 29.2 77.3 51.1 180.9 AKAP6 "ADAP6, AKAP100, KIAA0311, mAKAP, PRKA6" ENSG00000151320 "A-kinase anchoring protein 6" Q13023 14 32329298-32837684 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 59.8;heart muscle: 54.6;skeletal muscle: 47.5;tongue: 50.7" "Group enriched" "Detected in many" 6 "Excitatory neurons: 601.6;Inhibitory neurons: 663.1;Oligodendrocyte precursor cells: 412.7;Oligodendrocytes: 1162.5" "Cancer enhanced" "Detected in many" "glioma: 2.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "naive B-cell: 3.5" "Lineage enriched" "Detected in single" 6 "B-cells: 3.5" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001983, HPA048741" Enhanced NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 80: Striated muscle - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "CAB001983: , HPA048741: AB_2680506" "unprognostic (1.99e-1)" "unprognostic (9.92e-2)" "unprognostic (1.88e-1)" "unprognostic (1.37e-1)" "unprognostic (2.52e-1)" "unprognostic (4.33e-2)" "unprognostic (1.41e-4)" "unprognostic (1.81e-3)" "unprognostic (1.93e-2)" "unprognostic (4.49e-3)" "unprognostic (1.24e-3)" "unprognostic (3.54e-1)" "unprognostic (3.33e-16)" "unprognostic (8.57e-2)" "unprognostic (1.27e-1)" "unprognostic (5.14e-3)" "unprognostic (1.79e-3)" 1.6 5.6 21.0 2.5 31.4 0.5 4.6 20.3 24.6 1.6 0.0 5.5 1.8 3.9 5.6 5.4 2.9 3.7 54.6 16.9 36.7 2.9 2.1 2.3 0.8 52.0 34.9 2.5 0.8 3.5 3.6 4.5 51.9 2.0 2.2 13.6 2.6 1.2 47.5 1.2 2.4 7.7 22.4 0.8 2.0 5.9 34.8 0.9 4.8 50.7 0.7 4.2 1.5 59.8 0.3 0.8 1.0 0.9 0.2 1.7 0.2 1.3 3.6 0.2 0.4 1.1 1.0 1.4 0.9 15.8 0.6 0.8 1.2 1.4 0.5 1.3 1.0 1.3 1.5 1.1 0.5 0.1 0.3 1.8 1.3 0.0 0.4 0.6 0.1 2.1 0.3 4.1 1.1 0.8 0.7 0.2 0.2 1.1 1.1 0.7 4.9 0.6 0.4 1.2 5.2 4.2 1.1 0.7 3.2 0.7 2.9 0.1 0.3 0.2 0.8 0.8 0.5 2.5 2.4 0.6 1.5 0.1 5.4 0.3 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.2 3.5 0.4 0.6 0.5 0.1 0.1 0.4 0.0 0.3 21.0 31.4 20.3 24.6 16.9 36.7 52.0 34.9 51.9 22.4 34.8 59.8 0.6 6.4 2.7 111.3 2.2 2.3 2.9 1.0 5.2 49.2 8.7 3.0 108.0 0.0 4.9 1.8 50.1 0.8 0.1 1.1 0.0 0.8 32.4 6.7 0.4 1.7 1.2 0.0 601.6 0.5 0.3 6.3 0.0 1.4 1.3 0.6 1.1 2.7 1.2 26.9 663.1 0.6 4.1 0.6 1.6 13.7 14.6 1.1 7.2 23.4 0.7 2.5 0.0 412.7 1162.5 0.3 0.1 33.1 2.0 1.1 1.9 1.5 23.6 21.5 19.7 25.8 14.3 25.9 1.3 1.1 1.6 0.4 0.6 3.4 0.9 0.9 NPAS3 "bHLHe12, MOP6, PASD6" ENSG00000151322 "Neuronal PAS domain protein 3" Q8IXF0 14 32934396-33820863 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.8" "Group enriched" "Detected in many" 6 "Astrocytes: 3405.1;Inhibitory neurons: 1408.3;Oligodendrocyte precursor cells: 1893.0;Oligodendrocytes: 1772.0" "Group enriched" "Detected in some" 4 "endometrial cancer: 6.4;glioma: 7.7;ovarian cancer: 3.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "AF22: 9.3;U-266/70: 23.6;U-266/84: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075337 Enhanced Supported Nucleoplasm NA NA "Cluster 70: Brain - Nervous system development" "Cluster 29: U-266 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA075337: " "unprognostic (6.02e-3)" "unprognostic (2.37e-1)" "unprognostic (1.75e-1)" "unprognostic (1.31e-2)" "unprognostic (3.24e-1)" "unprognostic (1.36e-1)" "unprognostic (1.14e-2)" "unprognostic (5.65e-2)" "unprognostic (2.74e-1)" "unprognostic (3.12e-3)" "unprognostic (5.29e-3)" "unprognostic (1.38e-1)" "unprognostic (3.18e-3)" "unprognostic (2.65e-3)" "unprognostic (1.50e-1)" "unprognostic (2.69e-3)" "unprognostic (3.27e-1)" 0.8 0.8 17.3 0.1 19.9 0.0 0.9 14.6 12.9 6.0 0.0 1.4 0.3 3.9 0.8 0.3 3.9 0.7 0.4 14.0 15.0 0.9 0.1 0.2 0.1 22.8 18.0 2.7 0.4 0.5 1.0 0.5 15.8 0.8 0.3 1.4 0.8 1.3 0.2 0.2 0.4 0.6 18.0 1.1 1.0 1.3 15.9 0.4 1.8 0.2 0.2 0.5 0.5 18.3 0.0 0.0 9.3 0.0 0.2 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.5 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.6 23.6 7.0 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 19.9 14.6 12.9 14.0 15.0 22.8 18.0 15.8 18.0 15.9 18.3 5.1 0.0 0.0 3405.1 0.1 1.0 1.0 0.0 0.6 8.9 3.8 5.1 2.1 0.0 0.1 1.8 0.0 1.5 0.1 0.1 1.9 0.1 22.2 24.6 5.7 3.2 1.2 0.0 341.9 0.0 0.1 3.5 0.0 72.3 0.0 0.7 4.2 0.1 0.5 10.1 1408.3 0.0 0.0 0.0 1.4 17.0 7.2 0.7 0.0 116.2 0.0 7.4 0.0 1893.0 1772.0 0.2 0.0 5.3 0.1 0.5 0.0 0.5 1.8 0.7 0.0 11.5 3.1 0.2 0.8 0.1 0.4 0.3 1.0 1.1 0.0 0.5 EGLN3 "HIFPH3, PHD3" ENSG00000129521 "Egl-9 family hypoxia inducible factor 3" Q9H6Z9 14 33924227-34462774 "Enzymes, Predicted intracellular proteins" "Apoptosis, DNA damage" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 110.3;skin 1: 118.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 213.7;Cardiomyocytes: 105.8;Distal enterocytes: 135.5;Extravillous trophoblasts: 115.9;Suprabasal keratinocytes: 231.6" "Cancer enhanced" "Detected in all" "renal cancer: 50.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 10 "plasmacytoid DC: 25.5" "Lineage enriched" "Detected in many" 14 "dendritic cells: 25.5" "Cell line enhanced" "Detected in many" "RH-30: 44.6;RPTEC TERT1: 38.2;RT4: 122.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064895 Supported Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "HPA064895: AB_2685384" "unprognostic (3.58e-2)" "unprognostic (4.76e-3)" "unprognostic (1.75e-1)" "unprognostic (8.87e-2)" "unprognostic (6.88e-2)" "unprognostic (1.38e-2)" "prognostic unfavorable (2.14e-5)" "unprognostic (1.39e-3)" "unprognostic (3.44e-2)" "unprognostic (1.79e-1)" "unprognostic (2.93e-2)" "unprognostic (2.90e-1)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.37e-1)" "unprognostic (5.21e-2)" "unprognostic (4.71e-2)" "unprognostic (6.30e-2)" 14.6 0.8 32.9 9.4 40.9 0.3 10.0 38.2 37.5 12.3 15.4 25.9 35.7 10.0 4.4 27.0 9.4 13.8 110.3 29.7 38.9 16.3 4.9 8.3 5.7 34.3 37.5 2.1 4.3 0.3 3.4 25.4 32.2 9.1 20.0 15.2 11.2 12.0 20.8 118.2 40.9 11.7 31.9 4.9 37.7 1.1 42.9 4.9 2.8 6.4 9.8 51.3 20.8 36.1 31.1 8.0 0.9 32.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 8.2 0.0 10.0 0.1 0.9 0.9 15.0 29.4 0.0 3.1 8.0 8.3 20.5 1.0 0.0 0.0 0.4 4.0 14.5 0.0 0.1 0.0 0.0 2.3 16.9 0.0 0.4 2.7 0.7 0.1 24.3 26.7 2.8 0.0 44.6 11.1 38.2 122.9 6.2 7.0 2.0 11.8 3.2 18.2 12.0 0.1 0.0 0.2 3.2 0.0 1.8 0.4 6.7 0.1 7.2 0.0 0.5 0.0 0.0 1.8 0.1 0.0 0.0 0.0 1.2 0.9 2.6 0.0 0.1 0.1 0.1 1.1 0.0 25.5 0.0 0.9 32.9 40.9 38.2 37.5 29.7 38.9 34.3 37.5 32.2 31.9 42.9 36.1 6.0 0.0 0.6 36.2 1.6 213.7 49.0 56.6 3.4 11.6 16.0 17.0 105.8 4.3 24.8 9.2 2.1 11.4 16.0 135.5 9.8 15.6 1.8 42.3 8.5 25.1 16.2 0.4 1.0 6.9 115.9 16.8 74.9 17.2 1.3 0.1 12.5 0.3 3.1 1.7 4.3 31.6 12.2 1.9 62.8 4.9 2.5 10.8 40.9 0.0 0.9 11.6 0.0 6.6 54.2 46.6 41.9 0.7 0.4 17.4 59.7 20.5 37.2 2.4 0.0 17.7 9.4 1.7 0.3 4.1 231.6 103.0 4.5 1.2 14.1 25.7 SPTSSA "C14orf147, ssSPTa" ENSG00000165389 "Serine palmitoyltransferase small subunit A" Q969W0 14 34432788-34462240 "Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 405.2;Melanocytes: 435.8;Suprabasal keratinocytes: 443.8;Syncytiotrophoblasts: 512.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 180.0" "Low region specificity" "Detected in all" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 47: Cytotrophoblasts - Unknown function" "unprognostic (1.16e-1)" "unprognostic (3.23e-3)" "unprognostic (1.40e-1)" "unprognostic (1.33e-1)" "unprognostic (3.43e-2)" "unprognostic (6.24e-3)" "unprognostic (1.05e-1)" "unprognostic (1.51e-1)" "unprognostic (4.00e-1)" "unprognostic (3.19e-2)" "unprognostic (2.44e-2)" "unprognostic (6.64e-2)" "unprognostic (1.19e-1)" "unprognostic (1.24e-2)" "unprognostic (2.40e-1)" "unprognostic (3.25e-1)" "unprognostic (5.86e-2)" 25.1 71.1 13.5 21.1 13.6 5.7 39.3 13.8 17.9 21.0 13.8 38.4 20.8 16.9 25.6 25.3 21.4 27.1 16.2 12.6 15.8 23.5 46.9 33.6 12.2 18.6 15.4 20.1 13.9 18.2 13.3 28.8 17.0 22.5 36.0 15.3 34.2 24.7 24.4 22.2 21.9 27.3 15.1 13.2 20.5 7.1 14.6 8.5 19.8 19.0 13.0 30.6 26.0 16.2 67.4 38.3 37.6 14.0 61.6 42.8 44.4 44.1 27.2 34.1 41.0 31.3 39.4 56.0 38.8 25.1 25.0 28.2 34.1 37.5 53.7 29.7 21.1 35.2 74.0 153.7 48.5 46.5 19.9 39.8 58.9 25.2 40.8 26.4 40.9 15.7 25.6 58.3 30.4 71.0 19.2 47.0 28.9 32.2 47.4 24.8 180.0 41.2 42.8 29.5 24.6 32.6 100.9 87.7 71.3 29.4 39.9 50.0 43.4 26.8 17.5 27.7 33.4 48.1 34.1 41.0 18.0 40.8 30.4 21.5 36.9 4.9 5.4 29.9 5.3 8.3 4.9 5.3 19.6 7.1 5.1 6.2 2.0 20.8 25.5 7.0 5.3 21.5 13.5 13.6 13.8 17.9 12.6 15.8 18.6 15.4 17.0 15.1 14.6 16.2 51.0 144.2 123.5 14.4 33.1 405.2 166.6 192.0 217.9 40.9 165.5 63.1 33.2 70.1 108.9 88.3 10.4 265.8 31.5 189.6 154.6 257.7 1.3 62.2 165.4 65.5 49.7 66.1 11.2 96.8 126.2 100.9 34.7 100.6 32.4 24.1 50.3 79.1 78.3 40.4 13.5 74.9 120.1 67.1 127.6 2.7 45.7 56.5 435.8 15.0 71.0 43.8 18.6 14.1 30.5 71.0 102.4 60.2 70.9 118.3 75.0 96.7 30.8 31.2 46.0 78.5 98.6 1.9 6.1 167.7 443.8 512.4 33.8 82.9 107.6 153.5 EAPP "BM036, C14orf11, FLJ20578" ENSG00000129518 "E2F associated phosphoprotein" Q56P03 14 34515938-34539711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002916 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 39: Non-specific - Basic cellular processes" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA002916: AB_1078715" "unprognostic (8.76e-3)" "unprognostic (1.27e-3)" "unprognostic (2.08e-3)" "unprognostic (1.94e-1)" "unprognostic (4.59e-2)" "unprognostic (1.64e-1)" "unprognostic (2.80e-1)" "prognostic favorable (9.34e-4)" "unprognostic (1.81e-1)" "unprognostic (6.38e-2)" "unprognostic (2.05e-1)" "unprognostic (7.80e-2)" "prognostic favorable (2.23e-6)" "unprognostic (2.64e-1)" "unprognostic (2.68e-1)" "prognostic favorable (2.96e-4)" "unprognostic (3.24e-2)" 37.3 35.8 26.3 24.6 27.0 89.2 51.0 29.7 35.5 33.3 27.1 50.8 35.7 35.0 44.7 29.0 39.4 28.1 29.0 27.1 28.6 42.4 50.2 29.5 37.2 25.9 26.5 49.7 26.7 54.7 21.6 35.2 26.3 33.7 51.7 37.1 36.4 31.2 37.0 46.9 45.6 29.2 28.1 31.3 29.3 23.5 27.1 49.1 45.5 29.3 37.1 31.1 30.0 30.0 37.7 45.1 41.3 24.4 47.8 48.7 64.1 33.8 51.6 41.5 43.1 21.6 48.6 39.1 46.6 41.5 24.7 34.5 30.8 45.1 48.3 49.1 27.1 28.7 31.6 91.7 65.1 51.5 30.4 56.3 56.7 23.8 60.9 54.6 41.7 54.1 28.9 42.0 39.1 88.0 71.4 41.5 24.3 69.4 50.0 44.8 49.5 39.5 50.2 50.3 33.1 36.5 47.8 45.6 76.4 39.4 79.7 32.3 45.2 21.4 18.1 28.1 22.0 52.8 63.1 41.5 20.1 28.0 27.6 139.9 61.9 134.3 65.3 57.8 79.1 107.7 81.9 75.0 54.9 101.0 82.7 75.8 140.2 100.6 80.9 47.8 124.4 80.0 26.3 27.0 29.7 35.5 27.1 28.6 25.9 26.5 26.3 28.1 27.1 30.0 59.8 22.4 53.3 17.0 78.6 46.4 67.2 145.0 74.6 75.6 60.0 70.1 35.4 60.1 78.8 82.8 31.3 125.3 76.3 91.8 174.1 86.6 20.9 82.0 59.6 57.8 66.0 66.7 20.5 84.5 76.5 67.6 26.5 54.8 73.5 98.7 57.5 109.0 58.8 25.2 21.3 112.8 87.5 50.6 33.9 14.9 89.5 47.5 90.7 16.9 71.3 122.0 87.6 17.6 23.1 59.8 102.5 94.4 46.8 61.4 131.5 164.8 102.0 75.7 72.3 69.9 78.7 103.3 38.3 63.8 66.5 189.4 74.2 101.2 98.0 58.2 SNX6 ENSG00000129515 "Sorting nexin 6" Q9UNH7 14 34561093-34630160 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049374 Approved Supported Endosomes,Lysosomes NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 10: Non-specific - Unknown function" "Endosomes, Lysosomes" "HPA049374: AB_2680734" "unprognostic (1.89e-1)" "unprognostic (6.49e-2)" "unprognostic (1.46e-1)" "unprognostic (3.06e-2)" "unprognostic (1.12e-1)" "unprognostic (2.36e-3)" "prognostic unfavorable (1.25e-4)" "unprognostic (1.23e-1)" "unprognostic (6.63e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (4.68e-4)" "unprognostic (1.91e-1)" "unprognostic (3.48e-2)" "unprognostic (1.40e-1)" "unprognostic (1.55e-1)" "unprognostic (8.82e-2)" "unprognostic (2.10e-2)" 50.0 36.5 38.0 46.8 44.4 42.0 36.7 41.2 62.9 40.4 40.2 50.4 74.2 33.6 30.1 40.0 31.2 39.7 33.7 35.4 41.0 44.4 38.9 33.4 56.5 45.4 42.9 31.3 25.1 78.3 14.9 74.5 44.9 25.8 49.1 14.8 27.2 29.5 30.5 30.3 49.1 43.9 44.8 49.2 39.6 36.0 42.1 45.1 34.1 29.2 47.8 50.2 29.6 51.4 112.3 65.3 73.5 48.9 114.5 224.7 99.4 113.1 124.0 110.4 95.4 61.6 115.4 73.2 79.0 153.2 44.1 67.8 81.1 85.8 187.9 93.5 31.7 44.6 34.9 115.9 108.5 77.2 46.8 154.1 98.9 80.7 109.7 100.4 151.7 53.3 48.8 56.3 146.9 68.4 69.9 41.4 40.2 97.7 73.0 74.3 84.4 64.1 135.2 84.6 56.7 61.1 89.9 72.9 94.6 65.0 77.6 47.5 150.8 74.6 52.6 67.8 72.0 55.9 95.9 82.9 37.6 41.6 86.1 73.5 74.2 93.4 73.1 97.4 95.8 71.5 97.0 84.8 66.5 68.0 73.3 79.2 126.5 74.0 101.3 47.6 102.0 109.0 38.0 44.4 41.2 62.9 35.4 41.0 45.4 42.9 44.9 44.8 42.1 51.4 130.2 86.6 49.7 17.6 77.5 51.4 63.0 109.7 69.4 43.4 51.1 67.8 73.4 27.1 87.2 80.9 22.9 166.7 108.9 73.0 125.2 88.1 6.6 74.9 110.1 87.5 52.0 55.5 25.5 64.7 126.3 88.0 68.8 114.3 85.4 93.5 124.6 36.8 251.1 21.9 31.2 62.7 67.1 196.1 73.0 15.3 64.3 155.7 62.2 26.2 155.4 69.6 88.6 21.1 52.5 74.1 77.9 94.8 51.2 84.0 54.8 127.0 73.3 39.4 59.2 74.2 133.8 164.6 167.9 90.0 65.8 254.6 109.4 346.2 82.0 76.8 CFL2 NEM7 ENSG00000165410 "Cofilin 2" Q9Y281 14 34709113-34714823 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease variant, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "heart muscle: 372.8;skeletal muscle: 719.9;tongue: 686.4" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 522.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037078, HPA045599" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 47000000 "Cluster 37: B-cells - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nucleoplasm, Cytosol" "Plasma membrane" "CAB037078: AB_259128, HPA045599: AB_2679383" "unprognostic (1.05e-1)" "unprognostic (1.28e-1)" "unprognostic (1.29e-2)" "unprognostic (1.59e-1)" "unprognostic (3.02e-2)" "unprognostic (2.80e-3)" "unprognostic (3.82e-1)" "unprognostic (2.02e-1)" "unprognostic (3.02e-1)" "unprognostic (2.92e-2)" "unprognostic (2.48e-2)" "unprognostic (1.27e-1)" "unprognostic (1.65e-2)" "unprognostic (3.13e-3)" "unprognostic (9.59e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (2.16e-5)" 48.7 52.5 71.7 28.6 98.7 18.1 24.6 90.3 116.1 39.8 53.9 92.5 14.3 73.4 19.5 69.0 42.6 24.1 372.8 69.4 85.0 31.4 125.9 24.9 10.7 85.7 83.6 41.2 9.4 24.4 10.9 35.3 88.7 75.4 28.1 41.0 17.1 107.3 719.9 8.2 24.0 115.0 74.7 12.7 36.1 21.7 81.2 10.4 29.4 686.4 9.9 56.8 24.3 130.5 87.1 77.7 49.5 32.0 51.1 185.6 27.9 146.6 170.5 145.6 151.4 61.9 38.5 30.6 58.5 245.2 104.9 17.1 107.4 32.5 268.6 4.2 45.0 6.6 87.4 144.5 81.6 8.2 5.3 139.3 12.4 122.2 67.7 96.8 145.9 4.5 9.9 26.8 186.9 25.5 6.3 4.3 16.3 15.4 118.9 5.4 158.1 4.7 55.1 17.7 10.3 41.7 96.6 21.5 51.2 36.2 47.8 7.5 124.6 140.9 93.0 66.1 72.9 34.3 22.8 11.7 51.7 11.4 34.5 1.8 1.0 1.3 1.9 1.0 3.1 4.9 2.2 2.1 1.6 3.0 1.7 1.8 0.3 1.8 0.4 1.6 2.1 0.9 71.7 98.7 90.3 116.1 69.4 85.0 85.7 83.6 88.7 74.7 81.2 130.5 39.6 105.8 41.6 6.2 17.0 20.0 88.6 31.3 23.9 62.8 19.6 16.6 522.2 22.8 26.3 22.0 20.9 32.2 11.5 0.9 60.7 45.2 2.6 40.3 60.5 45.1 9.5 11.4 9.6 39.7 60.5 69.9 6.1 56.2 5.7 25.8 47.2 112.0 15.6 77.4 14.2 2.4 57.0 15.7 14.4 10.1 57.2 10.6 30.2 11.2 5.7 112.9 15.5 8.0 93.8 24.7 4.0 98.6 60.4 84.0 1.0 101.9 24.7 57.8 32.9 83.9 115.8 49.3 51.9 16.1 19.5 21.3 21.1 47.9 4.6 58.5 BAZ1A "ACF1, hACF1, WALp1, WCRF180" ENSG00000198604 "Bromodomain adjacent to zinc finger domain 1A" Q9NRL2 14 34752731-34875647 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 74.6" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 428.6;Early spermatids: 555.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 29.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 29.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002730 Supported NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 22: Epithelial cell types - Mixed function" "HPA002730: AB_1078269" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "unprognostic (2.76e-2)" "unprognostic (1.84e-2)" "unprognostic (4.24e-2)" "unprognostic (2.64e-1)" "prognostic unfavorable (4.44e-4)" "unprognostic (4.11e-2)" "unprognostic (3.99e-3)" "unprognostic (1.01e-2)" "unprognostic (2.24e-3)" "unprognostic (9.02e-2)" "prognostic unfavorable (1.31e-7)" "unprognostic (2.44e-1)" "unprognostic (7.83e-2)" "unprognostic (2.90e-2)" "unprognostic (4.37e-2)" 14.4 6.0 4.7 22.5 5.8 74.6 11.7 4.5 6.4 8.5 5.0 12.5 10.4 7.6 7.3 16.6 8.9 13.5 5.7 4.8 5.6 6.8 11.9 19.3 25.2 6.3 5.6 7.8 7.1 6.2 3.6 12.7 5.9 8.8 12.9 1.7 11.5 5.8 9.7 21.6 12.4 9.0 5.1 20.2 13.1 30.8 6.6 21.7 7.7 6.4 20.7 27.9 11.2 7.0 46.4 24.1 39.7 30.5 16.9 19.6 49.2 36.7 20.0 33.6 33.6 23.9 32.8 92.1 28.0 26.3 18.7 47.0 68.4 23.8 58.2 33.4 29.5 60.0 22.6 66.9 19.9 99.6 69.8 18.2 24.2 36.3 48.1 13.5 49.3 41.2 56.4 23.0 28.5 52.9 95.3 31.3 19.1 36.4 34.1 72.4 40.9 25.7 21.0 44.2 50.4 41.2 49.6 67.4 20.2 13.5 34.5 68.7 44.6 31.0 22.7 33.6 37.2 12.7 13.5 77.1 10.0 45.9 36.0 7.6 5.7 7.7 3.5 6.2 2.5 5.3 3.6 3.9 3.4 4.7 3.6 2.9 29.3 2.7 7.1 4.2 4.2 1.5 4.7 5.8 4.5 6.4 4.8 5.6 6.3 5.6 5.9 5.1 6.6 7.0 68.5 60.9 77.9 24.5 103.5 428.6 237.6 96.9 174.2 2.6 79.7 54.0 14.7 28.6 82.8 16.5 2.1 68.6 135.4 89.2 0.0 86.8 555.2 87.5 72.3 103.8 30.5 85.2 12.2 74.7 118.0 76.1 66.3 112.1 101.6 33.1 27.8 28.6 87.9 0.0 9.4 69.9 77.3 96.7 263.7 373.0 40.4 158.7 72.9 47.8 165.8 2.4 129.8 26.7 35.8 121.7 133.6 13.5 90.5 213.2 51.6 15.3 89.2 2.0 6.6 106.8 76.1 199.9 38.7 141.8 389.6 196.9 152.1 23.8 62.1 372.5 SRP54 ENSG00000100883 "Signal recognition particle 54" P61011 14 34981957-35029686 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Hydrolase, Ribonucleoprotein, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 327.3;Late spermatids: 901.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048977, HPA062044" Approved Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 25: Spermatids - Spermatogenesis" Cytosol "HPA048977: AB_2680583, HPA062044: AB_2684668" "unprognostic (1.22e-3)" "unprognostic (6.04e-2)" "unprognostic (9.06e-2)" "unprognostic (1.72e-2)" "unprognostic (3.88e-1)" "unprognostic (2.67e-3)" "unprognostic (2.06e-3)" "unprognostic (6.44e-2)" "unprognostic (2.53e-1)" "unprognostic (1.88e-2)" "unprognostic (2.15e-1)" "unprognostic (1.66e-1)" "unprognostic (1.10e-3)" "unprognostic (1.81e-1)" "unprognostic (1.98e-1)" "unprognostic (2.86e-1)" "unprognostic (2.50e-3)" 22.8 33.1 17.1 30.2 18.1 17.4 28.7 19.3 22.5 32.5 20.9 28.1 25.8 23.3 35.8 28.5 22.0 23.2 32.1 17.6 21.3 35.3 61.9 25.0 34.6 19.8 19.2 22.7 55.0 39.7 36.2 29.5 20.5 31.2 29.5 24.2 60.3 28.7 39.8 26.1 26.8 23.5 20.0 28.4 30.4 44.0 18.1 35.5 30.9 33.7 42.6 34.8 23.1 21.4 59.3 66.9 56.7 54.9 62.8 61.3 67.8 83.2 78.3 87.3 107.0 71.3 62.8 75.8 77.5 81.4 75.8 56.1 79.0 66.7 125.6 87.5 37.8 70.9 54.6 184.6 92.7 70.5 65.4 51.5 64.8 63.5 102.3 66.1 88.8 64.9 61.7 82.7 93.1 98.8 81.9 42.4 45.0 96.1 61.3 58.5 72.2 67.4 104.9 89.3 48.9 59.4 59.3 76.7 74.6 71.4 99.4 49.7 66.6 48.7 51.0 62.8 57.1 73.2 108.3 101.1 36.8 45.9 63.5 23.8 27.4 39.2 31.0 35.0 39.6 25.6 31.4 34.0 32.8 25.8 28.7 28.3 27.1 42.1 47.0 21.9 48.2 30.5 17.1 18.1 19.3 22.5 17.6 21.3 19.8 19.2 20.5 20.0 18.1 21.4 40.8 12.8 49.3 25.5 63.2 40.0 56.0 74.6 37.5 37.5 40.7 29.0 41.0 34.3 81.2 40.5 58.4 67.3 59.6 39.4 64.6 73.2 327.3 53.1 43.9 40.7 44.9 36.2 25.4 79.8 75.6 45.8 38.7 64.3 47.5 37.3 36.4 110.0 49.7 26.9 26.8 48.7 87.5 39.0 43.6 901.8 38.5 47.4 28.4 24.4 56.1 44.3 41.2 27.6 54.6 55.1 34.0 37.6 133.1 60.7 39.0 79.2 93.0 50.1 26.3 38.3 46.1 95.4 76.0 36.0 50.3 94.0 64.7 43.0 31.6 64.5 FAM177A1 C14orf24 ENSG00000151327 "Family with sequence similarity 177 member A1" Q8N128 14 35044907-35113130 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 637.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053222, HPA055440" Uncertain Approved Nucleoplasm,Vesicles "Secreted to blood" NA NA 170000 "Cluster 1: Neutrophils - Mixed function" "Cluster 78: Testis - Spermatogenesis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 24: Non-specific - Transcription regulation" Vesicles Nucleoplasm "HPA053222: AB_2682083, HPA055440: AB_2682817" "unprognostic (6.86e-2)" "unprognostic (2.03e-1)" "unprognostic (2.12e-1)" "unprognostic (7.01e-2)" "unprognostic (1.91e-2)" "prognostic unfavorable (9.70e-4)" "unprognostic (4.64e-3)" "unprognostic (6.28e-2)" "unprognostic (7.79e-2)" "prognostic favorable (8.51e-5)" "unprognostic (1.12e-2)" "unprognostic (7.22e-3)" "unprognostic (1.04e-1)" "unprognostic (2.56e-1)" "unprognostic (1.69e-1)" "unprognostic (8.28e-2)" "unprognostic (1.91e-1)" 45.3 43.2 36.8 30.0 50.1 49.6 38.2 45.3 46.5 44.2 36.9 81.5 57.2 29.4 29.6 49.7 26.8 37.7 78.1 39.0 51.3 61.3 77.0 68.6 20.2 52.4 50.6 28.2 49.4 30.6 47.4 27.3 49.1 63.1 71.5 31.3 43.4 36.1 48.3 41.3 54.6 42.3 45.0 23.6 42.5 86.2 47.0 21.6 48.0 32.8 23.2 46.7 37.7 57.0 63.4 51.2 38.0 31.3 64.6 64.6 46.7 101.3 55.8 52.4 57.1 52.2 82.6 25.1 68.1 98.9 71.1 65.8 47.1 58.5 66.7 73.5 28.8 19.5 63.8 179.5 79.4 30.7 44.9 58.5 75.3 63.5 49.5 76.7 60.6 46.7 47.7 79.8 102.5 91.5 38.0 28.1 30.9 100.9 65.2 21.9 52.7 35.9 95.2 68.7 52.1 45.9 119.3 94.2 81.3 75.2 87.2 23.9 71.3 67.5 59.2 76.6 53.2 59.3 79.8 31.2 42.3 20.5 68.0 79.9 43.9 79.2 31.0 36.7 36.5 45.0 40.3 35.7 34.8 35.8 31.7 31.4 167.5 32.6 31.9 50.8 60.0 30.4 36.8 50.1 45.3 46.5 39.0 51.3 52.4 50.6 49.1 45.0 47.0 57.0 126.7 240.4 176.3 6.5 87.4 160.7 199.4 200.4 83.6 35.8 119.0 118.4 147.8 67.2 168.1 104.8 27.1 71.0 322.2 329.3 119.3 121.9 637.1 235.5 86.6 116.4 133.8 36.0 10.7 249.6 118.0 80.5 107.0 426.4 82.3 43.1 82.5 235.6 75.5 23.5 13.4 189.5 144.5 61.1 130.9 505.9 54.0 85.4 149.4 8.4 125.1 45.3 48.4 9.0 28.4 364.6 220.1 53.0 133.3 211.4 273.7 347.2 177.8 45.5 46.0 65.2 106.2 189.3 106.8 93.1 171.5 123.3 215.7 30.4 224.2 229.5 PPP2R3C "C14orf10, FLJ20644, G4-1, G5PR" ENSG00000092020 "Protein phosphatase 2 regulatory subunit B''gamma" Q969Q6 14 35085467-35122517 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cone-rod dystrophy, Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 489.7;Late spermatids: 233.5;Spermatocytes: 239.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040835, HPA058834" Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 10: Brain - Neuronal signaling" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "Golgi apparatus, Cytosol" "HPA040835: AB_10794152, HPA058834: AB_2683831" "unprognostic (1.41e-1)" "unprognostic (1.52e-1)" "unprognostic (1.15e-1)" "unprognostic (7.32e-3)" "unprognostic (5.33e-2)" "unprognostic (9.73e-2)" "unprognostic (1.10e-3)" "unprognostic (3.05e-1)" "unprognostic (7.85e-2)" "unprognostic (9.48e-3)" "unprognostic (1.17e-2)" "unprognostic (1.91e-1)" "unprognostic (2.18e-1)" "unprognostic (3.04e-2)" "unprognostic (3.15e-3)" "unprognostic (8.55e-2)" "unprognostic (8.29e-2)" 19.9 15.5 23.5 23.9 25.0 42.8 17.1 24.4 41.6 18.1 23.3 18.6 21.0 16.2 16.4 12.5 14.0 18.6 22.9 23.8 25.6 14.4 16.1 17.7 31.0 25.3 24.4 15.9 10.2 17.0 17.6 18.8 25.6 17.1 20.3 15.4 13.5 14.1 24.9 7.1 22.5 21.0 24.9 24.4 16.2 71.6 24.4 26.4 12.4 25.7 25.9 22.3 10.4 27.5 41.2 21.8 41.7 33.9 32.4 54.5 29.6 33.0 32.0 41.0 48.0 18.1 32.2 47.2 13.4 33.9 15.5 17.6 20.0 13.8 60.5 47.8 19.3 26.2 11.9 65.2 43.3 51.2 51.7 41.9 14.4 29.0 19.7 24.0 55.7 26.2 25.7 46.3 57.4 28.4 46.4 43.1 37.1 27.4 24.3 50.2 27.1 32.8 15.8 24.1 39.9 37.5 41.7 27.6 57.8 19.9 17.9 57.0 47.9 41.3 17.3 36.0 34.9 44.8 52.4 92.8 22.8 47.9 48.1 66.5 41.6 86.9 23.4 52.5 27.0 31.0 24.8 29.5 36.1 33.1 22.0 26.9 76.9 33.1 42.7 16.3 40.8 34.0 23.5 25.0 24.4 41.6 23.8 25.6 25.3 24.4 25.6 24.9 24.4 27.5 35.5 16.0 24.7 32.7 40.2 11.5 23.3 31.7 9.6 15.9 18.8 14.7 26.3 17.2 25.8 20.2 4.2 19.4 48.1 29.1 33.2 31.2 489.7 23.1 28.1 33.8 31.2 69.7 28.3 36.1 26.2 26.5 19.9 21.7 33.7 31.3 34.6 22.8 61.3 8.4 30.4 26.8 32.6 49.7 36.3 233.5 28.3 42.6 28.4 24.4 71.5 28.7 46.4 36.2 58.8 49.2 22.3 30.5 37.4 24.8 37.8 43.2 25.1 21.5 32.9 24.0 43.1 239.2 58.6 19.6 13.5 34.8 45.2 36.2 24.6 30.5 PRORP "KIAA0391, MRPP3" ENSG00000100890 "Protein only RNase P catalytic subunit" O15091 14 35121846-35277622 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.8;dendritic cells: 1.1;Hofbauer cells: 1.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA020459 Approved Supported Nucleoplasm,Mitochondria NA NA "Cluster 13: T-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 24: Non-specific - Transcription regulation" Mitochondria Nucleoplasm "HPA020459: AB_2670449" "unprognostic (6.44e-3)" "unprognostic (8.10e-2)" "unprognostic (7.71e-3)" "unprognostic (4.90e-2)" "unprognostic (3.42e-2)" "unprognostic (1.74e-1)" "unprognostic (2.76e-2)" "unprognostic (8.67e-2)" "unprognostic (1.94e-2)" "unprognostic (3.25e-4)" "unprognostic (1.75e-1)" "unprognostic (1.80e-1)" "unprognostic (9.67e-5)" "unprognostic (2.56e-1)" "unprognostic (1.67e-1)" "unprognostic (2.10e-2)" "unprognostic (6.65e-2)" 11.3 17.0 11.0 17.0 12.2 12.2 13.9 12.4 16.1 13.6 16.6 19.9 15.3 8.4 16.7 19.2 11.8 10.4 13.7 11.4 12.1 25.0 24.9 12.5 21.2 13.2 12.5 7.0 10.6 19.3 9.7 11.0 12.8 10.6 20.8 6.2 13.1 9.6 15.1 17.3 14.5 11.9 11.6 13.6 13.6 12.1 13.1 31.1 15.6 17.1 22.5 15.4 11.9 14.4 47.5 34.9 23.6 33.1 25.1 21.0 22.7 31.1 25.3 35.9 26.1 35.8 26.3 53.0 39.0 27.2 9.9 33.9 43.8 47.3 36.5 39.2 12.9 22.6 24.9 77.9 25.2 27.2 23.0 28.3 37.7 33.9 31.6 30.2 50.0 41.3 38.4 13.6 42.5 54.9 46.0 33.3 26.8 30.4 33.4 42.9 40.4 28.1 52.6 44.6 24.0 25.0 40.0 43.3 26.8 29.0 55.4 23.9 44.5 30.7 25.7 22.1 25.8 15.5 40.4 53.9 14.5 32.0 32.5 30.9 10.3 7.2 30.3 9.6 43.9 20.1 47.3 32.8 13.8 14.4 41.6 30.1 14.4 24.7 8.2 20.4 56.1 24.3 11.0 12.2 12.4 16.1 11.4 12.1 13.2 12.5 12.8 11.6 13.1 14.4 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 PSMA6 "IOTA, MGC22756, MGC2333, MGC23846, p27K, PROS27" ENSG00000100902 "Proteasome 20S subunit alpha 6" P60900 14 35278633-35317493 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 156.3;Late spermatids: 474.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003049 Approved Supported Nucleoplasm NA NA 18000000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 23: Testis - Cell cycle regulation" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "HPA003049: AB_1079703" "unprognostic (9.68e-3)" "unprognostic (5.91e-2)" "unprognostic (1.90e-2)" "unprognostic (8.07e-2)" "unprognostic (3.42e-2)" "unprognostic (4.11e-3)" "unprognostic (7.48e-2)" "unprognostic (1.25e-1)" "unprognostic (1.16e-1)" "prognostic favorable (3.27e-4)" "unprognostic (1.29e-3)" "unprognostic (2.63e-1)" "unprognostic (1.52e-2)" "unprognostic (2.05e-1)" "unprognostic (5.45e-2)" "unprognostic (3.49e-1)" "unprognostic (5.08e-2)" 118.4 141.3 88.3 117.3 92.4 155.5 131.1 88.9 140.7 81.3 86.6 128.6 115.1 82.4 98.7 126.0 84.0 69.7 169.1 92.2 97.6 98.0 172.8 123.6 137.6 92.6 90.5 71.3 91.9 82.8 83.2 120.7 96.0 74.7 130.0 63.9 87.8 81.1 350.1 107.5 114.8 94.4 92.8 114.4 95.9 247.9 94.7 290.1 82.3 203.9 139.7 132.6 85.7 92.4 502.2 367.2 257.6 264.9 209.8 214.5 523.1 252.2 300.3 368.2 329.0 338.8 341.7 322.9 492.1 244.4 220.4 337.5 306.6 280.0 434.5 337.9 170.1 257.6 233.6 1011.6 235.8 542.0 225.8 166.7 229.4 256.6 324.7 178.2 312.2 548.1 284.2 220.4 298.7 522.9 838.2 458.2 249.3 391.0 407.0 1249.4 261.3 256.9 312.8 634.9 275.1 230.8 285.5 402.2 274.7 211.9 473.8 351.4 267.1 235.8 231.8 245.7 283.6 234.0 576.3 605.9 192.4 335.7 272.0 232.1 364.6 242.2 241.0 344.8 243.0 212.8 230.9 248.9 373.6 171.5 182.5 217.5 131.9 300.6 343.7 385.3 317.0 711.5 88.3 92.4 88.9 140.7 92.2 97.6 92.6 90.5 96.0 92.8 94.7 92.4 20.8 44.8 40.7 20.2 37.7 33.3 14.9 37.2 69.4 13.7 16.5 15.0 1.4 22.8 45.7 14.7 25.0 32.2 24.8 22.4 21.5 34.2 156.3 21.2 14.9 30.5 18.0 56.8 32.7 36.7 26.0 28.4 46.4 28.2 54.5 10.1 29.6 20.0 22.6 25.2 31.2 18.3 22.4 36.7 89.5 474.9 22.7 62.2 24.9 22.5 34.1 8.6 34.0 20.6 29.4 32.8 19.5 17.3 114.6 15.9 43.1 25.4 59.5 19.4 13.1 17.8 31.3 35.1 20.0 89.8 33.1 41.3 53.7 9.2 22.2 17.1 NFKBIA "IkappaBalpha, IKBA, MAD-3, NFKBI" ENSG00000100906 "NFKB inhibitor alpha" P25963 14 35401513-35404749 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Host-virus interaction" "Cancer-related genes, Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 1114.7" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 4056.6;Langerhans cells: 4828.7;Suprabasal keratinocytes: 3420.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 391.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003815, HPA029207" Approved Enhanced Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 15: RT4 - Unknown function" "Cluster 41: Macrophages - Immune response" Cytosol "CAB003815: AB_344886, HPA029207: AB_10603122" "prognostic favorable (1.33e-5)" "unprognostic (3.39e-1)" "unprognostic (7.29e-2)" "unprognostic (7.24e-2)" "unprognostic (8.88e-2)" "unprognostic (1.62e-1)" "unprognostic (3.51e-1)" "unprognostic (2.46e-1)" "unprognostic (2.39e-1)" "unprognostic (2.46e-1)" "unprognostic (2.46e-1)" "unprognostic (7.19e-2)" "unprognostic (2.32e-2)" "unprognostic (3.69e-1)" "unprognostic (4.44e-2)" "unprognostic (9.74e-2)" "unprognostic (3.80e-2)" 281.0 171.3 75.6 150.7 78.0 1114.7 171.4 75.4 92.5 123.8 78.3 121.0 61.2 95.5 29.6 151.8 141.2 130.4 145.5 71.4 75.9 104.5 208.1 366.0 122.6 90.1 76.2 255.7 101.9 68.8 92.4 92.7 81.6 112.6 80.9 18.7 118.3 110.0 139.7 260.5 148.5 92.7 77.0 226.2 130.7 31.7 84.9 123.2 111.9 138.3 181.4 366.2 166.8 79.8 62.5 54.1 20.1 18.2 114.7 75.9 71.1 25.2 240.7 53.3 47.3 16.9 36.5 37.5 66.1 40.2 125.2 79.5 38.3 104.9 76.1 229.2 14.9 18.6 39.9 101.4 68.6 29.9 15.0 83.1 103.5 36.4 92.2 35.5 48.6 18.4 15.9 58.4 38.6 73.0 39.2 71.0 18.6 60.0 33.1 87.8 23.1 31.6 92.8 391.7 17.9 31.2 67.2 115.9 29.7 41.0 66.1 62.2 91.7 72.8 26.5 21.3 41.0 70.9 77.7 64.5 60.8 22.0 15.3 322.0 444.9 301.4 175.3 267.2 264.0 258.4 207.1 182.5 428.9 329.7 178.1 153.0 942.9 285.9 183.7 233.0 154.9 506.4 75.6 78.0 75.4 92.5 71.4 75.9 90.1 76.2 81.6 77.0 84.9 79.8 802.9 535.2 914.0 14.4 505.6 4056.6 1862.8 2061.4 1729.6 27.0 430.7 414.0 188.6 367.4 719.2 62.5 12.5 196.4 762.2 447.8 195.6 875.0 4.3 703.8 935.6 1079.8 203.5 87.8 7.1 394.8 174.9 1145.1 333.8 1440.1 906.1 68.2 313.4 147.2 791.2 48.8 5.1 453.0 634.7 491.4 4828.7 14.7 153.1 1609.0 1085.1 39.4 428.1 95.2 97.9 6.6 8.6 383.5 511.5 116.2 1039.4 1412.0 1051.6 115.9 298.2 37.4 203.8 956.9 847.2 3.3 26.4 1544.6 3420.6 660.0 838.4 91.8 346.0 1004.6 INSM2 "IA-6, Mlt1" ENSG00000168348 "INSM transcriptional repressor 2" Q96T92 14 35534164-35537054 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 3.6;retina: 2.7" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 2.1;Rod photoreceptor cells: 7.2;Spermatocytes: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 134 "SH-SY5Y: 114.0" "Region enhanced" "Detected in single" "hypothalamus: 1.1" "Low region specificity" "Detected in some" "HPA044885, HPA051925" Uncertain Approved Nucleoplasm NA NA "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm "HPA044885: AB_10794779, HPA051925: AB_2681664" "unprognostic (9.88e-2)" "unprognostic (8.74e-2)" "unprognostic (2.35e-1)" "unprognostic (1.08e-3)" "unprognostic (3.29e-3)" "unprognostic (1.72e-1)" "unprognostic (2.51e-1)" "unprognostic (2.26e-3)" "unprognostic (2.60e-3)" "unprognostic (7.51e-2)" "unprognostic (1.75e-2)" "unprognostic (2.36e-3)" "unprognostic (5.00e-1)" 0.0 0.3 0.9 0.0 1.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 3.6 0.0 0.0 0.0 0.0 1.9 0.8 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 114.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 0.1 2.2 0.9 3.6 1.9 0.8 2.1 0.3 1.5 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.4 0.4 0.0 0.0 0.0 2.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.1 4.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 RALGAPA1 "DKFZp667F074, GARNL1, GRIPE, KIAA0884, RalGAPalpha1, Tulip1" ENSG00000174373 "Ral GTPase activating protein catalytic subunit alpha 1" Q6GYQ0 14 35538352-35809304 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 394.0;Inhibitory neurons: 233.9;Oligodendrocyte precursor cells: 239.3;Oligodendrocytes: 412.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000851 Approved Approved Mitochondria,Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 21: Non-specific - Transcription" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 9: Photoreceptor cells - Phototransduction" Cytosol Mitochondria "HPA000851: AB_1078945" "unprognostic (1.26e-1)" "unprognostic (1.33e-1)" "unprognostic (8.90e-2)" "unprognostic (6.76e-2)" "unprognostic (1.85e-1)" "unprognostic (1.19e-2)" "unprognostic (7.65e-2)" "unprognostic (1.17e-2)" "unprognostic (2.88e-1)" "unprognostic (3.38e-2)" "unprognostic (1.25e-2)" "unprognostic (5.00e-2)" "prognostic favorable (9.76e-5)" "unprognostic (2.75e-1)" "unprognostic (2.46e-1)" "unprognostic (3.09e-2)" "unprognostic (1.46e-1)" 13.5 18.5 24.0 9.0 28.1 7.1 16.0 36.0 29.0 21.6 18.3 17.6 7.7 16.5 13.8 15.8 17.9 9.4 12.8 24.2 26.3 14.4 13.0 14.1 9.6 26.6 25.5 23.9 16.3 25.5 23.4 7.4 26.2 17.5 14.5 39.4 13.0 10.5 18.4 20.1 14.7 12.6 25.9 12.0 15.8 10.6 26.4 9.7 16.3 10.9 9.0 15.9 18.3 33.6 7.4 8.7 11.0 9.6 16.4 11.4 7.0 5.2 5.4 6.7 6.0 5.2 6.4 7.2 7.2 7.1 8.8 12.0 13.4 10.2 6.2 16.1 5.1 6.7 11.0 26.3 8.4 11.4 10.4 8.6 18.3 5.8 14.1 11.0 9.5 14.2 6.7 17.9 5.9 11.8 8.5 5.4 5.0 18.2 12.9 6.9 6.7 4.6 13.8 11.9 10.2 16.7 11.0 18.9 9.6 10.6 18.0 5.3 8.7 6.5 5.0 7.6 6.5 14.6 14.4 9.3 3.0 7.3 7.2 0.0 0.2 0.0 0.7 0.3 0.9 0.5 0.7 0.9 0.3 0.3 0.4 0.7 0.0 0.7 0.3 0.4 0.8 0.1 24.0 28.1 36.0 29.0 24.2 26.3 26.6 25.5 26.2 25.9 26.4 33.6 40.2 16.0 30.9 162.6 63.9 38.1 28.3 13.9 62.0 86.1 27.7 21.5 19.4 15.7 25.2 23.9 394.0 10.9 105.8 31.0 0.0 12.8 19.5 47.0 38.5 31.4 31.1 14.9 215.3 15.8 5.5 34.6 54.0 50.8 53.4 41.6 18.5 14.8 9.2 52.2 233.9 23.3 16.2 10.0 39.9 8.7 34.2 35.4 19.6 173.3 16.8 30.5 16.5 239.3 412.8 15.9 25.9 29.0 86.3 36.0 26.6 10.4 25.2 119.1 39.5 59.0 37.8 47.0 38.0 55.9 46.2 15.2 80.7 24.0 28.7 27.1 BRMS1L "BRMS1, FLJ39177, MGC11296" ENSG00000100916 "BRMS1 like transcriptional repressor" Q5PSV4 14 35826338-35932325 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046623 Uncertain Supported Nucleoplasm NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoplasm "HPA046623: AB_2679724" "prognostic unfavorable (5.78e-4)" "unprognostic (1.86e-1)" "unprognostic (2.03e-1)" "unprognostic (1.69e-3)" "unprognostic (2.66e-2)" "unprognostic (2.27e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (2.56e-2)" "unprognostic (2.02e-2)" "unprognostic (8.04e-2)" "unprognostic (6.50e-2)" "unprognostic (1.66e-1)" "prognostic favorable (6.55e-5)" "unprognostic (2.06e-2)" "unprognostic (1.98e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (6.87e-6)" 6.2 10.1 8.3 3.8 9.0 2.6 6.2 7.6 11.2 6.0 5.4 5.1 3.2 6.3 5.5 6.4 5.1 4.2 11.6 8.9 7.8 8.9 6.1 4.8 3.0 7.4 8.2 7.2 3.0 9.8 4.4 7.3 7.9 6.5 3.6 8.2 4.2 6.2 13.6 5.9 3.1 7.0 7.7 3.5 4.3 5.3 8.2 3.5 7.2 13.7 3.9 5.8 5.4 9.4 10.1 10.1 17.1 9.9 15.2 19.1 25.5 10.3 9.9 15.7 15.3 6.5 8.3 8.1 10.3 14.4 7.4 12.6 13.7 18.7 22.3 9.0 16.8 7.4 10.1 28.6 10.7 3.7 5.9 13.4 12.5 12.1 10.2 8.2 11.4 4.7 3.6 6.3 17.7 13.5 4.3 6.0 6.8 14.2 14.8 4.4 19.1 6.2 12.7 11.4 5.1 13.1 12.0 13.7 12.2 13.0 15.7 5.2 7.0 14.9 9.1 8.6 10.2 5.8 8.2 5.0 3.7 8.1 9.2 0.0 0.5 0.3 1.0 1.2 0.8 0.7 1.0 1.3 0.3 0.5 1.4 1.2 0.0 0.4 1.4 0.9 1.4 0.7 8.3 9.0 7.6 11.2 8.9 7.8 7.4 8.2 7.9 7.7 8.2 9.4 11.6 9.6 13.9 13.7 10.5 18.6 10.2 10.4 19.9 18.5 8.4 7.1 19.2 2.8 10.6 7.3 4.2 19.3 15.7 2.3 7.9 4.9 3.5 6.7 13.0 11.2 4.8 1.3 21.2 6.9 15.4 15.3 6.1 6.3 14.7 6.9 6.8 6.3 5.1 16.8 22.3 3.8 12.2 2.8 9.5 3.2 11.1 3.9 8.8 6.5 6.6 21.4 3.1 20.6 26.2 4.4 3.0 9.8 8.8 14.0 1.7 19.2 6.7 17.5 19.7 17.5 20.0 6.5 16.6 12.6 16.2 22.4 11.4 11.8 3.7 7.1 MBIP ENSG00000151332 "MAP3K12 binding inhibitory protein 1" Q9NS73 14 36298564-36320637 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 218.0;Alveolar cells type 2: 316.0" "Cancer enhanced" "Detected in all" "thyroid cancer: 30.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003388 Supported Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 1: Thyroid gland - Transcription" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 11: Alveolar cells - Smell perception" Cytosol "Nucleoplasm, Nucleoli" "HPA003388: AB_1079322" "unprognostic (8.79e-2)" "unprognostic (9.92e-2)" "unprognostic (5.07e-2)" "unprognostic (8.66e-2)" "unprognostic (9.85e-2)" "unprognostic (4.71e-2)" "unprognostic (2.71e-1)" "prognostic favorable (1.52e-4)" "unprognostic (5.24e-2)" "prognostic favorable (1.14e-4)" "unprognostic (4.65e-1)" "unprognostic (9.27e-2)" "prognostic favorable (1.25e-4)" "unprognostic (2.95e-1)" "unprognostic (1.12e-1)" "unprognostic (1.74e-3)" "unprognostic (1.09e-1)" 16.2 19.4 17.4 12.1 18.5 35.1 24.9 20.7 22.0 27.9 17.9 17.0 16.9 26.6 21.3 16.5 16.5 16.5 14.2 16.7 19.7 26.2 29.0 76.7 17.4 15.9 17.5 32.2 17.6 19.7 22.4 19.1 16.4 18.5 22.2 22.3 15.9 16.3 7.2 28.5 17.3 20.2 17.2 15.6 31.2 18.2 20.0 17.9 81.7 9.3 16.0 15.2 13.5 21.4 29.6 15.4 31.7 32.1 31.3 30.0 24.1 24.8 30.7 32.2 33.6 31.2 28.9 28.0 36.8 32.1 16.8 22.1 33.7 22.9 39.3 40.5 25.5 16.4 14.7 55.0 33.9 33.8 17.5 30.8 35.1 21.1 27.2 33.2 20.4 38.3 28.4 33.8 24.2 28.8 32.5 27.7 26.9 25.2 44.6 15.4 27.7 19.5 37.2 22.7 47.3 18.8 20.4 19.5 33.4 27.3 31.9 21.6 16.0 35.6 23.2 26.3 26.0 27.8 34.5 44.0 13.6 17.3 25.3 2.0 12.6 3.0 14.6 9.9 18.5 16.4 17.6 18.0 12.8 12.3 22.6 18.5 7.0 12.9 8.1 14.5 23.6 13.3 17.4 18.5 20.7 22.0 16.7 19.7 15.9 17.5 16.4 17.2 20.0 21.4 16.0 218.0 316.0 18.3 14.9 90.2 30.7 41.5 22.2 24.9 15.3 23.0 10.7 10.0 106.7 25.8 2.1 24.7 12.2 16.1 58.7 21.2 4.2 20.9 28.2 18.3 31.5 9.7 21.2 19.0 21.1 29.7 13.3 35.6 13.3 30.2 16.1 25.2 18.7 92.5 24.8 15.5 20.3 9.5 15.4 4.2 32.0 14.5 21.4 9.4 11.5 29.0 12.3 31.7 27.0 17.8 18.6 27.1 18.9 29.0 18.9 49.6 34.9 24.1 13.1 18.0 27.8 50.1 35.5 17.9 65.5 19.8 20.6 25.5 21.1 21.4 NKX2-1 "BCH, NKX2A, TITF1, TTF-1, TTF1" ENSG00000136352 "NK2 homeobox 1" P43699 14 36516392-36521149 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Congenital hypothyroidism, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "lung: 53.1;thyroid gland: 172.4" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 137.8;Alveolar cells type 2: 124.8" "Group enriched" "Detected in some" 39 "lung cancer: 30.9;thyroid cancer: 103.2" "Region enhanced" "Detected in many" "thalamus: 17.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SCLC-21H: 78.7" "Group enriched" "Detected in some" 5 "basal ganglia: 3.2;hypothalamus: 10.2" "Group enriched" "Detected in some" 13 "basal ganglia: 4.3;hypothalamus: 10.4" "CAB000078, CAB053633, HPA074316" Enhanced Uncertain "Golgi apparatus,Vesicles" NA NA "Cluster 1: Thyroid gland - Transcription" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 11: Alveolar cells - Smell perception" "Golgi apparatus, Vesicles" "CAB000078: , CAB053633: AB_442138, HPA074316: " "unprognostic (3.79e-1)" "unprognostic (4.25e-3)" "unprognostic (1.12e-1)" "unprognostic (1.79e-2)" "unprognostic (1.26e-2)" "unprognostic (2.23e-1)" "unprognostic (1.18e-1)" "unprognostic (1.29e-1)" "unprognostic (1.83e-2)" "unprognostic (4.18e-1)" 0.0 0.1 1.1 0.0 2.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 10.1 0.0 0.0 53.1 0.0 0.0 0.3 0.1 0.1 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 17.8 0.0 172.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 78.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.0 0.0 4.0 0.1 10.1 0.0 0.3 0.0 0.0 17.8 0.1 0.0 137.8 124.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.1 0.7 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 NKX2-8 "Nkx2-9, NKX2.8, NKX2H" ENSG00000136327 "NK2 homeobox 8" O15522 14 36580004-36582614 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.4;esophagus: 2.6;testis: 7.9" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 2.3;Basal squamous epithelial cells: 6.8;Late spermatids: 2.1;Oligodendrocytes: 2.6;Prostatic glandular cells: 2.1;Squamous epithelial cells: 3.4" "Cancer enhanced" "Detected in many" "thyroid cancer: 2.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 3.6;PC-3: 2.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA062879 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoplasm "Plasma membrane" "HPA062879: AB_2684892" "unprognostic (6.03e-2)" "unprognostic (1.75e-1)" "unprognostic (1.37e-3)" "unprognostic (2.27e-1)" "unprognostic (3.45e-4)" "unprognostic (2.36e-1)" "unprognostic (8.34e-2)" "unprognostic (7.80e-2)" "unprognostic (3.66e-1)" "unprognostic (3.11e-1)" "unprognostic (8.39e-3)" "unprognostic (4.60e-2)" "unprognostic (2.70e-1)" "unprognostic (6.13e-2)" 0.0 0.0 0.4 0.0 1.1 0.0 0.0 1.2 0.5 0.1 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.3 0.0 2.3 1.3 0.0 0.0 0.1 1.1 0.0 2.4 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 7.9 2.1 0.0 1.4 0.0 0.0 0.0 0.0 4.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 3.6 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 1.2 0.5 0.2 2.1 2.3 1.3 2.4 2.0 2.1 4.4 0.0 0.0 0.0 0.0 0.0 0.5 2.3 0.9 6.8 0.0 1.0 1.1 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 2.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.2 3.4 0.4 0.0 0.0 0.0 0.0 0.4 PAX9 ENSG00000198807 "Paired box 9" P55771 14 36657568-36679362 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "esophagus: 81.0;lymphoid tissue: 20.5;parathyroid gland: 43.0;salivary gland: 51.8" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 45.3;Basal squamous epithelial cells: 174.8;Ionocytes: 40.7;Squamous epithelial cells: 172.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 12.3;HDLM-2: 58.3;PC-3: 18.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA001572, CAB016239" Enhanced Supported Nucleoplasm,Nucleoli NA NA "Cluster 35: T-regs - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 44: HDLM-2 - Immune response" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoli Nucleoplasm "CAB016239: AB_2159984, HPA001572: " "unprognostic (3.09e-1)" "prognostic favorable (5.38e-4)" "unprognostic (1.56e-2)" "unprognostic (2.80e-2)" "unprognostic (1.40e-2)" "unprognostic (1.43e-2)" "unprognostic (5.93e-3)" "unprognostic (2.71e-3)" "unprognostic (2.96e-1)" "unprognostic (5.58e-2)" "unprognostic (2.41e-2)" "unprognostic (9.44e-2)" "unprognostic (2.31e-4)" "unprognostic (1.43e-1)" "unprognostic (1.20e-1)" "unprognostic (1.79e-1)" "unprognostic (1.17e-1)" 0.1 0.1 0.0 0.1 0.0 0.3 0.6 0.0 0.0 7.3 0.1 0.7 0.0 0.2 0.3 81.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.1 0.1 43.0 2.2 0.0 0.0 3.7 0.1 0.0 51.8 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.0 20.5 0.7 0.0 8.5 0.7 7.1 0.0 5.3 2.3 0.0 2.5 2.1 3.8 2.0 0.0 0.3 0.0 0.0 1.6 1.8 1.6 0.8 0.0 0.5 11.4 2.1 12.3 0.0 58.3 7.3 0.9 1.2 0.0 0.0 0.0 4.2 0.7 6.0 0.0 1.9 0.0 0.0 5.3 2.3 0.3 0.2 7.3 0.9 0.0 0.1 1.9 18.9 0.0 0.0 0.0 0.0 6.9 3.4 0.0 1.3 7.0 1.4 0.9 5.1 0.0 0.0 0.0 0.6 2.2 1.0 0.0 0.1 4.4 0.7 0.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 8.4 45.3 174.8 0.0 1.6 1.3 0.4 0.0 25.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.6 0.0 0.4 0.0 0.2 0.2 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 40.7 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 20.9 0.0 0.0 26.8 0.0 0.0 0.1 2.0 2.4 0.9 172.0 0.3 0.1 0.1 0.0 0.6 12.1 SLC25A21 "ODC, ODC1" ENSG00000183032 "Solute carrier family 25 member 21" Q9BQT8 14 36677921-37172606 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 6.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 27.8;Excitatory neurons: 14.1;Exocrine glandular cells: 10.0;Inhibitory neurons: 10.4;Oligodendrocyte precursor cells: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "K-562: 26.4;Karpas-707: 54.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000662 Uncertain NA NA "Cluster 23: Testis - Cell cycle regulation" "Cluster 2: Karpas-707 - Immune response" "Cluster 6: Erythroid cells - Oxygen transport" "HPA000662: AB_1080000" "unprognostic (6.81e-3)" "unprognostic (6.98e-2)" "unprognostic (7.21e-2)" "unprognostic (2.45e-1)" "unprognostic (2.78e-2)" "unprognostic (2.20e-1)" "unprognostic (2.44e-2)" "unprognostic (1.09e-1)" "unprognostic (7.32e-2)" "unprognostic (6.86e-2)" "unprognostic (9.16e-2)" "unprognostic (1.66e-1)" "unprognostic (6.70e-4)" "unprognostic (9.09e-3)" "unprognostic (1.95e-2)" "unprognostic (3.52e-1)" "unprognostic (1.07e-1)" 0.9 1.2 0.2 0.3 0.3 6.3 0.5 0.3 0.3 0.6 0.1 0.6 0.7 1.3 0.2 1.2 0.7 0.6 1.3 0.2 0.4 1.6 0.4 0.5 0.1 0.4 0.3 2.0 2.8 0.9 0.3 0.1 0.4 1.6 0.3 1.0 1.6 0.4 0.7 0.3 1.2 0.7 0.4 0.5 0.8 3.9 0.3 0.3 1.5 0.9 0.1 0.6 0.3 0.5 1.3 1.0 0.4 3.2 0.1 1.0 0.0 0.3 0.8 1.7 0.7 0.2 0.9 0.1 1.4 0.4 0.0 1.0 0.0 0.7 0.6 0.8 9.5 0.9 0.8 0.8 1.0 0.0 0.0 0.7 1.1 0.0 0.5 0.9 3.9 0.0 26.4 54.4 0.8 2.7 0.0 0.0 2.1 0.0 4.1 0.0 0.0 0.0 0.8 3.9 2.6 0.0 2.6 0.2 1.3 0.4 2.9 0.0 1.9 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.3 0.2 0.4 0.4 0.3 0.4 0.4 0.3 0.5 0.3 0.0 0.0 2.3 0.2 1.0 1.8 1.8 6.8 0.1 1.0 0.9 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.1 1.9 0.9 1.4 0.1 1.0 0.7 1.8 27.8 14.1 10.0 0.0 0.9 0.0 0.2 0.0 0.4 0.7 0.3 0.2 1.7 10.4 0.5 2.0 0.0 0.4 1.4 1.5 0.1 0.0 4.7 0.0 4.3 0.0 11.6 5.2 3.7 0.0 0.7 0.0 2.7 0.1 4.2 0.4 1.5 0.0 1.1 1.1 3.1 3.6 3.6 0.9 0.0 0.1 1.9 1.0 0.6 MIPOL1 CCDC193 ENSG00000151338 "Mirror-image polydactyly 1" Q8TD10 14 37197913-37552361 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 138.2;Excitatory neurons: 159.4;Inhibitory neurons: 141.1;Late spermatids: 129.2;Oligodendrocyte precursor cells: 91.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 25.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002893, HPA050179" Enhanced Approved Cytosol NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "HPA002893: AB_1079386, HPA050179: AB_2681043" "unprognostic (3.24e-1)" "unprognostic (1.33e-1)" "unprognostic (2.26e-1)" "unprognostic (4.30e-2)" "unprognostic (1.08e-1)" "unprognostic (6.29e-2)" "unprognostic (4.61e-4)" "unprognostic (2.37e-2)" "unprognostic (2.84e-2)" "unprognostic (2.39e-2)" "unprognostic (3.54e-2)" "unprognostic (8.73e-2)" "unprognostic (1.58e-1)" "unprognostic (3.17e-1)" "unprognostic (9.78e-3)" "unprognostic (3.41e-3)" "unprognostic (1.85e-2)" 2.5 2.7 1.8 1.2 1.6 0.4 4.0 1.0 1.6 4.7 1.8 2.7 1.3 4.4 2.2 3.4 3.4 3.3 2.8 1.4 1.7 4.0 1.9 2.4 0.3 1.9 1.7 6.2 4.5 6.5 2.8 1.4 1.8 5.5 2.1 2.9 3.4 3.3 2.0 1.8 1.2 3.5 1.8 1.2 3.5 7.9 1.8 0.9 5.3 2.8 0.6 3.4 3.5 1.9 5.3 2.2 0.8 7.4 5.3 8.7 0.0 4.8 3.2 4.0 5.9 2.9 3.2 0.0 4.6 4.0 1.6 6.1 0.0 6.6 5.4 0.0 7.8 0.0 3.6 12.8 3.4 0.0 0.1 5.5 6.6 1.1 12.8 4.9 25.2 0.0 10.5 0.1 6.0 5.3 0.0 0.0 3.1 3.5 16.3 0.0 0.7 0.0 5.8 5.9 6.2 0.0 6.2 5.3 5.5 5.4 6.6 0.0 13.4 0.0 3.9 0.0 5.5 0.0 0.0 0.0 0.0 0.0 9.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 1.8 1.6 1.0 1.6 1.4 1.7 1.9 1.7 1.8 1.8 1.8 1.9 7.9 76.9 59.2 41.4 1.2 4.2 15.7 5.8 18.2 13.8 8.0 6.6 14.3 11.5 55.8 9.2 52.1 0.1 0.7 1.6 9.8 4.9 138.2 5.6 13.8 10.4 9.1 1.3 159.4 7.4 0.1 16.2 14.3 6.0 46.7 10.8 3.9 3.0 0.1 11.8 141.1 1.9 6.1 1.6 5.7 129.2 8.4 5.2 7.2 45.0 0.2 6.0 1.0 91.0 24.9 11.3 0.8 9.1 0.1 16.2 0.9 4.0 70.0 23.0 0.0 19.9 16.7 36.2 15.1 6.3 6.3 0.0 4.7 16.2 3.5 8.6 FOXA1 HNF3A ENSG00000129514 "Forkhead box A1" P55317 14 37589552-37596059 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 74.7;stomach 1: 28.0" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 113.8;Basal squamous epithelial cells: 76.8;Breast glandular cells: 87.9;Enteroendocrine cells: 84.6;Prostatic glandular cells: 89.8;Respiratory ciliated cells: 66.7;Urothelial cells: 154.5" "Group enriched" "Detected in many" 5 "breast cancer: 80.0;prostate cancer: 127.0" "Region enriched" "Detected in single" 5 "midbrain: 3.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 48.9;MCF7: 105.3;PC-3: 69.5;RT4: 96.7;SK-BR-3: 97.0;T-47d: 135.9" "Region enhanced" "Detected in some" "midbrain: 1.1" "Region enriched" "Detected in single" 6 "midbrain: 5.4" "CAB011595, HPA050505" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 37: Intestine - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 35: Glandular cells - Unknown function" Nucleoplasm "Nucleoli fibrillar center" "CAB011595: AB_2104842, HPA050505: AB_2681148" "unprognostic (1.61e-1)" "unprognostic (8.80e-2)" "unprognostic (1.12e-1)" "unprognostic (4.65e-1)" "unprognostic (2.58e-1)" "unprognostic (1.51e-1)" "unprognostic (1.74e-1)" "unprognostic (1.78e-1)" "unprognostic (1.71e-1)" "unprognostic (3.01e-1)" "unprognostic (1.54e-2)" "unprognostic (6.30e-2)" "unprognostic (0.00e+0)" "unprognostic (3.67e-1)" "unprognostic (2.58e-1)" "unprognostic (1.69e-2)" "prognostic favorable (1.00e-4)" 0.2 0.1 0.0 1.6 0.0 0.0 22.3 0.0 0.0 1.5 0.0 12.4 8.4 0.1 0.6 11.9 2.4 2.3 0.0 0.0 0.3 0.1 26.9 7.5 0.0 0.1 3.5 0.0 0.5 0.0 0.7 0.0 0.2 74.7 10.4 0.0 19.3 0.3 0.0 1.3 4.8 0.2 0.2 0.0 28.0 0.4 0.7 0.0 0.0 0.0 2.3 20.5 4.4 0.0 4.9 4.4 0.0 2.8 0.0 0.0 0.5 0.0 0.4 0.0 0.0 21.3 2.7 0.0 1.4 0.0 0.1 23.4 13.2 3.3 0.1 0.0 23.4 0.0 4.1 48.9 0.0 0.0 0.2 0.0 0.7 0.0 0.4 1.9 0.0 0.4 0.9 0.0 0.0 105.3 0.1 0.3 0.0 32.0 69.5 0.0 1.1 0.4 9.9 96.7 11.8 0.0 4.8 97.0 0.0 0.0 135.9 0.4 0.0 0.9 0.1 0.4 3.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 3.5 0.2 0.2 0.7 0.0 0.3 28.9 43.5 0.0 0.1 1.0 113.8 47.8 76.8 0.0 87.9 34.8 1.3 30.0 52.3 3.7 0.0 0.0 0.5 27.5 0.0 1.5 0.4 2.7 0.2 1.2 84.6 0.0 0.0 2.4 0.0 1.0 35.7 4.4 2.5 0.0 1.1 31.7 0.0 0.0 0.0 34.9 42.7 0.9 0.3 0.9 0.0 0.7 3.6 0.0 1.0 0.0 0.0 0.0 0.0 4.3 27.2 0.0 1.2 89.8 4.9 0.0 66.7 0.0 0.0 0.0 2.3 0.9 1.2 62.9 0.1 0.0 1.4 0.1 27.9 154.5 TTC6 "C14orf25, NCRNA00291" ENSG00000139865 "Tetratricopeptide repeat domain 6" Q86TZ1 14 37595847-38041442 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 7.9;prostate: 17.5" "Cell type enhanced" "Detected in some" "Breast glandular cells: 13.8;Club cells: 11.1;Early spermatids: 39.1;Late spermatids: 18.1;Spermatocytes: 10.7" "Group enriched" "Detected in some" 7 "breast cancer: 2.2;prostate cancer: 3.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 8.4;MCF7: 12.2;RT4: 8.4;T-47d: 22.8" "Not detected" "Not detected" "Region enriched" "Detected in some" 7 "midbrain: 9.7" HPA069293 Approved Centrosome NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 6: T47d - Mammary gland" "Cluster 35: Glandular cells - Unknown function" Centrosome "HPA069293: AB_2686110" "unprognostic (7.92e-2)" "unprognostic (6.95e-2)" "unprognostic (9.22e-2)" "unprognostic (1.98e-1)" "unprognostic (7.06e-2)" "unprognostic (1.22e-2)" "unprognostic (1.68e-1)" "unprognostic (3.60e-4)" "unprognostic (6.75e-2)" "unprognostic (2.07e-2)" "unprognostic (4.08e-4)" "unprognostic (5.60e-2)" "unprognostic (8.91e-8)" "unprognostic (1.76e-1)" "unprognostic (2.58e-1)" "unprognostic (1.60e-1)" "unprognostic (6.07e-3)" 0.0 0.0 0.5 0.2 0.8 0.0 7.9 0.1 0.8 0.1 1.1 1.0 0.6 0.0 0.0 0.4 0.3 0.7 0.0 0.7 1.0 0.0 3.5 1.1 0.0 2.5 5.0 0.0 0.0 0.0 0.3 0.0 1.3 17.5 0.5 0.0 2.7 0.1 0.0 0.7 0.7 0.0 3.9 0.0 3.6 5.8 3.9 0.0 0.0 0.0 0.1 1.4 0.3 1.0 0.7 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 0.0 0.4 0.0 0.0 2.4 1.3 0.2 0.0 0.0 3.4 0.0 1.2 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 12.2 0.0 0.0 0.0 1.7 4.5 0.0 0.0 0.0 1.0 8.4 2.4 0.0 0.0 4.5 0.0 0.0 22.8 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.1 0.8 0.7 1.0 2.5 5.0 1.3 3.9 3.9 1.0 0.2 0.0 8.4 0.3 0.1 0.0 2.8 1.5 6.2 0.0 13.8 6.9 0.8 1.5 11.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 39.1 0.0 0.0 0.4 7.7 0.0 6.4 0.0 0.0 0.4 7.1 0.1 0.0 0.0 0.0 2.5 0.0 0.0 1.0 0.7 0.0 0.0 0.0 18.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.8 0.4 0.0 4.9 0.0 0.0 7.5 0.0 0.0 0.2 0.4 10.7 1.9 2.3 0.0 0.0 0.3 0.0 1.1 3.1 SSTR1 ENSG00000139874 "Somatostatin receptor 1" P30872 14 38207904-38213067 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.0;intestine: 13.8;stomach 1: 21.7" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 18.1;Gastric mucus-secreting cells: 16.8;Hepatic stellate cells: 27.1;Oligodendrocyte precursor cells: 24.1;Paneth cells: 10.7;Proximal enterocytes: 11.8" "Cancer enhanced" "Detected in many" "prostate cancer: 5.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 118.9;BJ hTERT+: 32.5;BJ hTERT+ SV40 Large T+: 21.4;fHDF/TERT166: 70.7;HeLa: 26.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003207, HPA031506" Approved Uncertain Vesicles NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 17: Intestinal endocrine cells - Hormone signaling" Vesicles "HPA003207: , HPA031506: AB_2673913" "unprognostic (1.40e-1)" "unprognostic (1.37e-1)" "unprognostic (3.36e-1)" "unprognostic (2.50e-3)" "unprognostic (4.34e-2)" "unprognostic (9.90e-2)" "unprognostic (3.66e-3)" "unprognostic (1.91e-1)" "unprognostic (6.16e-3)" "unprognostic (3.20e-2)" "unprognostic (1.72e-2)" "unprognostic (9.19e-2)" "prognostic favorable (4.28e-4)" "unprognostic (2.17e-1)" "unprognostic (1.67e-1)" "unprognostic (4.71e-2)" "unprognostic (3.28e-2)" 1.0 0.3 3.9 0.3 8.8 0.0 0.9 0.5 8.7 0.8 0.0 3.5 13.8 1.0 0.4 0.3 0.9 0.4 1.0 10.0 10.0 2.0 6.8 5.2 0.0 4.7 7.0 0.8 3.6 0.0 0.9 2.6 5.6 1.0 2.3 0.3 0.3 0.4 0.7 0.3 8.2 0.5 1.4 0.6 21.7 0.1 6.1 0.0 0.3 0.9 0.0 1.8 0.7 1.7 0.0 0.0 0.0 0.0 0.3 0.2 0.0 118.9 32.5 21.4 1.8 1.2 0.0 0.0 0.0 70.7 0.0 0.2 0.0 0.0 15.4 0.0 0.0 0.0 26.7 0.1 6.3 0.0 0.0 0.2 0.0 0.0 0.3 0.4 1.5 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.1 9.6 0.2 0.0 0.0 0.1 4.7 0.0 3.4 0.0 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 8.8 0.5 8.7 10.0 10.0 4.7 7.0 5.6 1.4 6.1 1.7 1.7 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 1.5 0.2 0.0 0.8 2.8 0.0 1.8 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 2.4 18.1 0.0 3.9 0.8 0.0 1.0 16.8 0.0 0.0 0.0 27.1 7.2 0.0 0.0 5.5 6.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.8 0.0 0.0 0.0 24.1 0.3 0.2 10.7 0.0 0.1 0.1 11.8 1.9 0.0 0.1 0.0 1.0 0.6 0.0 0.1 0.1 0.1 0.1 0.0 0.2 6.2 0.0 CLEC14A C14orf27 ENSG00000176435 "C-type lectin domain containing 14A" Q86T13 14 38254000-38256093 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 13 "Adipocytes: 396.6;Endothelial cells: 272.8;Hepatic stellate cells: 567.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 83.7;HUVEC TERT2: 451.8;TIME: 158.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039468, HPA048119" Uncertain Supported "Endoplasmic reticulum,Golgi apparatus" NA NA 4100000 "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Endoplasmic reticulum, Golgi apparatus" "HPA039468: AB_2676524, HPA048119: AB_2680270" "unprognostic (4.02e-1)" "unprognostic (4.26e-2)" "unprognostic (4.20e-3)" "unprognostic (9.44e-2)" "unprognostic (1.35e-1)" "prognostic favorable (4.13e-6)" "unprognostic (2.55e-3)" "unprognostic (2.69e-1)" "unprognostic (1.67e-1)" "unprognostic (6.90e-2)" "unprognostic (5.41e-2)" "unprognostic (1.26e-1)" "unprognostic (1.63e-2)" "unprognostic (1.75e-2)" "unprognostic (1.55e-1)" "unprognostic (4.97e-2)" "unprognostic (5.28e-2)" 67.1 9.5 13.6 7.9 13.4 0.1 50.6 13.8 15.2 24.8 10.9 15.2 10.1 31.2 7.6 11.1 22.6 19.0 65.1 11.5 13.3 15.9 9.4 55.5 6.6 15.0 13.9 9.5 7.8 10.5 6.1 25.0 15.4 14.5 7.2 0.8 13.6 9.8 33.2 15.8 18.8 19.8 13.1 16.7 13.8 3.5 14.9 4.6 31.4 43.3 4.2 19.2 16.8 15.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 451.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 158.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 13.4 13.8 15.2 11.5 13.3 15.0 13.9 15.4 13.1 14.9 15.6 396.6 0.0 3.2 0.0 0.9 3.4 0.2 0.0 1.8 0.1 1.5 2.5 6.4 1.5 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.1 1.1 0.2 0.5 272.8 0.0 0.0 0.4 0.2 0.1 31.0 0.0 0.3 1.3 0.1 567.2 2.1 0.4 0.0 0.2 0.0 0.0 6.4 3.1 1.0 0.6 1.1 5.4 15.0 0.0 0.2 0.0 4.0 2.9 0.0 0.0 0.4 1.4 0.2 0.0 0.0 0.0 0.5 0.0 14.1 7.5 1.6 0.9 0.9 3.1 0.1 1.3 6.7 0.0 0.3 SEC23A ENSG00000100934 "Sec23 homolog A, COPII coat complex component" Q15436 14 39031919-39109646 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 347.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043806, HPA069974" Uncertain Approved Nucleoplasm,Vesicles NA NA 83000 "Cluster 46: Basophils - DNA binding" "Cluster 8: Non-specific - Mitochondria" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Vesicles" "HPA043806: , HPA069974: AB_2686223" "unprognostic (2.40e-1)" "prognostic unfavorable (5.75e-4)" "prognostic favorable (3.56e-4)" "unprognostic (3.30e-2)" "unprognostic (1.18e-1)" "unprognostic (6.39e-2)" "unprognostic (1.15e-2)" "unprognostic (5.85e-2)" "unprognostic (1.71e-1)" "unprognostic (2.69e-1)" "unprognostic (1.28e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (1.69e-4)" "prognostic unfavorable (2.94e-4)" "unprognostic (1.16e-1)" "unprognostic (2.73e-1)" "unprognostic (1.41e-3)" 45.9 32.0 11.4 31.8 14.2 13.1 20.9 18.3 16.8 36.2 31.4 40.0 57.7 42.7 19.9 34.1 21.5 32.1 46.9 13.3 18.9 23.1 80.8 20.2 21.0 13.8 14.0 33.9 12.0 8.1 10.5 27.1 15.3 34.0 34.2 38.5 10.5 52.6 54.2 12.8 52.6 90.5 7.6 20.5 16.8 23.5 12.7 18.9 17.9 58.5 22.0 40.7 17.9 15.4 52.1 90.8 76.9 74.7 161.3 173.0 25.9 195.1 176.4 135.2 166.8 93.2 44.2 12.6 46.9 279.6 54.9 41.2 99.6 86.3 208.6 39.6 36.9 21.8 67.7 347.3 122.4 35.9 31.3 134.0 48.8 91.6 73.7 114.6 130.8 26.9 15.6 30.1 125.8 47.5 32.9 16.9 18.4 81.7 91.3 44.0 111.8 19.1 84.7 75.6 8.5 20.5 132.8 43.0 51.8 68.6 51.5 12.4 138.4 75.0 57.8 110.8 52.0 27.0 36.6 56.0 50.3 31.4 70.2 70.5 34.3 38.6 26.6 29.3 38.4 23.6 33.1 34.9 31.1 21.1 34.9 28.0 29.5 42.1 27.3 26.7 38.1 31.4 11.4 14.2 18.3 16.8 13.3 18.9 13.8 14.0 15.3 7.6 12.7 15.4 35.4 16.0 26.9 34.9 30.5 25.9 33.5 15.5 15.4 39.7 11.8 10.3 54.6 15.7 18.8 31.3 68.8 16.0 36.0 87.0 7.9 9.8 13.4 11.3 42.8 41.1 24.5 6.1 48.3 5.6 43.7 55.0 26.5 18.8 27.9 56.9 118.9 133.6 25.6 30.3 51.1 31.6 12.2 36.4 32.3 18.6 74.9 24.3 24.9 48.7 25.6 19.4 32.0 34.2 44.3 17.8 34.1 71.5 38.5 37.5 88.6 32.8 10.1 58.7 39.5 27.6 51.4 18.0 15.5 15.7 24.0 24.8 32.3 31.0 30.2 56.5 GEMIN2 SIP1 ENSG00000092208 "Gem nuclear organelle associated protein 2" O14893 14 39114223-39136973 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 45.8;Late spermatids: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015426, HPA046570, HPA057114" Enhanced Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 23: Testis - Cell cycle regulation" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nuclear bodies" Nucleoli "CAB015426: AB_629517, HPA046570: AB_2679703, HPA057114: AB_2683340" "unprognostic (4.53e-1)" "unprognostic (1.56e-1)" "unprognostic (1.52e-1)" "unprognostic (5.07e-3)" "unprognostic (1.04e-1)" "unprognostic (3.52e-2)" "prognostic unfavorable (3.88e-6)" "unprognostic (8.62e-3)" "unprognostic (3.05e-2)" "unprognostic (1.99e-3)" "unprognostic (3.08e-1)" "unprognostic (3.03e-1)" "unprognostic (4.53e-3)" "unprognostic (1.52e-1)" "unprognostic (1.58e-1)" "unprognostic (3.95e-1)" "unprognostic (6.78e-2)" 6.1 4.3 6.1 4.5 6.3 10.3 7.9 10.2 7.9 5.9 4.6 6.0 6.7 5.4 7.2 5.7 5.9 4.2 7.7 5.7 3.9 6.1 5.6 4.8 8.8 3.6 2.6 5.9 4.7 3.7 4.6 5.6 3.6 4.8 6.1 4.7 4.3 4.5 12.1 6.3 4.7 7.7 1.1 5.2 5.1 8.3 3.4 9.1 5.5 7.9 7.8 6.2 5.5 6.2 23.6 34.5 33.3 23.7 11.3 12.6 17.0 11.5 9.0 30.3 30.0 30.7 27.9 36.0 23.4 9.8 11.0 17.5 45.6 18.7 31.5 17.6 26.7 21.5 18.1 76.8 23.9 32.6 12.8 7.3 17.6 18.8 27.5 8.7 26.6 31.4 25.2 25.6 17.3 48.9 36.3 31.2 23.6 29.7 38.3 32.8 36.4 22.6 17.5 15.6 32.2 6.2 24.5 17.7 12.4 18.4 41.5 14.0 11.2 12.7 20.0 13.3 18.6 26.8 44.2 54.1 6.6 34.0 19.6 10.8 12.0 9.9 13.5 13.1 9.8 15.3 12.3 13.5 16.2 15.8 13.5 14.4 3.1 11.9 11.5 16.1 11.8 9.2 6.1 6.3 10.2 7.9 5.7 3.9 3.6 2.6 3.6 1.1 3.4 6.2 11.6 6.4 3.7 4.9 10.3 8.5 8.1 20.9 8.0 5.9 7.3 12.1 6.0 5.7 11.4 5.5 10.4 12.9 7.0 2.2 11.7 10.8 45.8 11.2 11.3 10.6 3.6 17.2 7.4 6.4 18.9 12.5 2.6 7.5 5.7 11.7 9.7 6.6 11.4 5.0 6.2 7.1 14.2 10.6 7.3 41.1 9.0 6.3 7.2 4.7 9.4 8.1 9.2 4.0 7.4 6.9 2.5 9.8 9.4 8.0 3.1 14.7 15.5 6.9 6.6 8.3 8.1 25.9 15.4 11.3 8.0 3.8 9.1 11.6 9.3 4.8 TRAPPC6B ENSG00000182400 "Trafficking protein particle complex 6B" Q86SZ2 14 39147811-39170532 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Neurogenesis "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047928 Uncertain Approved "Endoplasmic reticulum" NA NA "Cluster 42: Non-specific - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Endoplasmic reticulum" "HPA047928: AB_2680214" "unprognostic (3.89e-1)" "unprognostic (4.94e-3)" "unprognostic (1.80e-1)" "unprognostic (1.44e-1)" "unprognostic (7.60e-2)" "unprognostic (1.55e-2)" "unprognostic (3.79e-2)" "unprognostic (1.04e-2)" "unprognostic (3.09e-2)" "unprognostic (2.07e-2)" "unprognostic (4.57e-1)" "unprognostic (2.18e-2)" "prognostic favorable (1.76e-4)" "unprognostic (2.98e-2)" "unprognostic (3.41e-1)" "unprognostic (1.31e-1)" "unprognostic (1.90e-1)" 12.7 15.8 17.0 11.2 19.1 4.8 14.6 18.5 21.9 11.7 14.3 12.9 10.9 12.1 12.2 15.0 9.6 9.5 13.7 20.0 16.8 13.9 24.4 10.4 12.2 13.8 13.7 10.2 10.9 13.9 12.6 12.9 15.9 12.9 10.4 24.6 10.4 13.2 16.6 11.4 10.3 11.8 14.0 12.9 11.0 12.9 14.6 13.5 15.9 18.6 12.2 12.8 12.0 15.6 17.5 7.7 13.0 12.6 18.1 20.4 10.3 22.0 19.4 19.6 19.2 12.7 32.6 10.9 15.2 20.5 9.7 13.4 19.2 14.0 23.8 19.9 9.4 14.9 10.6 37.3 25.8 21.1 19.8 19.4 23.2 16.9 22.4 31.1 17.3 19.8 16.7 22.4 20.5 21.6 15.7 15.2 11.1 13.5 29.7 12.2 24.0 10.7 21.4 34.0 12.7 10.3 26.2 15.9 24.7 13.5 30.2 13.2 24.8 18.0 9.1 15.4 12.1 20.8 30.7 15.9 8.9 12.1 17.4 8.7 3.2 5.6 2.9 6.8 2.6 3.3 4.0 3.3 4.8 2.1 3.4 3.4 3.3 7.7 7.1 4.8 3.6 2.4 17.0 19.1 18.5 21.9 20.0 16.8 13.8 13.7 15.9 14.0 14.6 15.6 20.0 22.4 19.4 24.2 20.3 22.6 19.7 17.9 25.6 25.3 18.2 12.6 24.0 10.0 15.6 18.4 35.5 14.2 28.7 12.4 54.8 14.3 38.8 12.1 17.6 17.5 16.6 27.6 47.0 17.4 13.1 22.0 18.8 18.4 29.2 15.5 23.6 22.8 15.7 23.5 50.6 9.6 26.4 15.0 21.3 16.0 16.1 23.0 17.8 13.1 18.2 16.0 27.8 31.2 45.0 22.2 12.6 17.7 21.4 19.2 11.3 20.7 10.8 39.4 26.3 15.5 21.1 58.9 31.3 29.7 25.1 22.6 22.3 26.8 10.1 30.1 PNN memA ENSG00000100941 "Pinin, desmosome associated protein" Q9H307 14 39175183-39183220 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001378 Supported Supported "Nuclear speckles" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 18: Non-specific - Mitochondria" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA001378: AB_1079648" "unprognostic (9.28e-3)" "unprognostic (5.07e-2)" "unprognostic (5.46e-2)" "unprognostic (3.91e-1)" "unprognostic (7.38e-3)" "unprognostic (7.40e-2)" "prognostic unfavorable (5.79e-4)" "unprognostic (1.65e-2)" "unprognostic (1.67e-3)" "unprognostic (3.75e-2)" "unprognostic (3.70e-2)" "prognostic unfavorable (2.44e-4)" "unprognostic (1.51e-3)" "unprognostic (1.25e-1)" "unprognostic (1.53e-1)" "unprognostic (1.00e-1)" "unprognostic (4.30e-2)" 57.8 60.6 42.7 68.0 46.6 135.9 60.2 50.6 48.1 82.2 77.8 83.1 56.5 81.5 129.5 74.0 77.0 41.8 54.9 42.9 51.4 87.6 124.8 61.4 87.6 47.5 45.1 84.5 78.5 40.8 90.7 53.8 47.2 83.8 63.1 76.0 65.6 48.4 59.9 67.7 90.5 48.0 43.9 103.6 70.7 58.5 47.1 65.6 88.4 27.0 69.5 69.2 73.3 50.9 152.4 72.0 193.2 94.0 45.5 37.4 141.4 116.6 35.4 82.4 81.2 112.3 232.6 229.1 72.7 53.2 69.7 156.4 153.3 85.5 138.5 105.1 109.0 158.6 243.7 246.0 39.1 201.0 107.6 55.8 73.5 80.1 65.1 115.5 57.3 119.0 149.1 128.2 65.8 122.6 145.5 170.3 126.6 76.2 114.3 188.4 137.0 64.2 65.6 219.3 93.8 50.5 126.2 90.5 69.1 133.2 114.4 117.5 92.7 115.9 90.9 52.7 142.2 102.5 87.8 194.0 59.5 167.3 70.6 9.2 13.7 22.0 17.0 11.4 16.1 22.2 12.1 10.9 11.8 25.5 17.2 16.6 27.6 15.4 16.4 22.1 14.2 6.1 42.7 46.6 50.6 48.1 42.9 51.4 47.5 45.1 47.2 43.9 47.1 50.9 105.6 192.3 125.0 40.8 170.5 126.2 244.5 84.4 153.1 203.1 77.5 87.5 63.4 61.5 164.8 60.7 56.3 113.2 230.9 129.3 35.2 89.4 59.0 155.0 178.9 127.9 136.2 121.1 33.1 58.3 100.0 117.1 101.9 289.4 142.5 273.5 69.3 67.8 62.3 153.1 35.6 96.6 71.2 69.3 72.5 53.7 156.3 93.9 49.8 25.3 89.2 138.0 193.6 41.2 54.6 76.7 126.3 151.6 116.7 172.1 82.9 28.9 111.7 172.4 151.2 166.2 161.3 212.8 149.3 145.0 112.0 99.6 170.6 211.8 123.7 245.4 MIA2 "cTAGE-5A, cTAGE-5B, cTAGE-5C, cTAGE-5D, CTAGE5, FLJ22404, MEA6, MGEA, MGEA11, MGEA6, TALI" ENSG00000150527 "MIA SH3 domain ER export factor 2" Q96PC5 14 39230231-39388513 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 138.9" "Cell type enhanced" "Detected in many" "Collecting duct cells: 44.1;Ductal cells: 42.9;Endometrial ciliated cells: 78.7;Exocrine glandular cells: 42.7;Glandular and luminal cells: 93.5;Pancreatic endocrine cells: 41.3;Proximal tubular cells: 61.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 125.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000387, HPA000922, HPA054066, HPA055459" Approved Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 7: Non-specific - Mitochondria" "Endoplasmic reticulum" "HPA000387: AB_1078582, HPA000922: AB_1078581, HPA054066: AB_2682368, HPA055459: AB_2682819" "unprognostic (2.62e-1)" "unprognostic (7.17e-3)" "unprognostic (2.33e-1)" "unprognostic (5.27e-4)" "unprognostic (3.21e-4)" "unprognostic (2.63e-1)" "unprognostic (2.48e-1)" "unprognostic (7.18e-2)" "unprognostic (1.12e-1)" "unprognostic (1.21e-2)" "unprognostic (4.31e-2)" "unprognostic (1.78e-1)" "prognostic favorable (2.81e-4)" "unprognostic (6.93e-2)" "unprognostic (8.08e-2)" "unprognostic (2.91e-1)" "unprognostic (3.97e-2)" 12.1 26.6 5.6 16.8 6.9 23.6 22.1 5.8 7.9 29.7 58.0 30.8 80.4 15.7 40.2 26.9 22.2 30.3 16.6 9.4 6.5 78.4 138.9 15.5 16.2 5.6 4.7 9.6 43.6 40.5 15.5 11.2 6.4 21.1 34.6 12.8 52.5 19.2 54.5 9.9 78.4 12.3 4.1 14.5 45.3 21.0 5.1 14.3 46.7 20.7 19.8 16.2 17.2 7.1 23.0 25.1 10.4 18.5 20.6 23.2 14.5 13.3 13.9 9.3 9.6 19.7 125.4 27.5 40.1 15.0 18.9 34.1 12.7 15.0 11.0 21.4 10.6 17.2 11.5 106.1 48.2 23.2 30.7 14.4 83.7 9.2 69.2 59.0 15.3 31.8 16.6 68.3 14.0 22.1 14.9 18.9 12.0 87.2 20.8 15.2 18.3 34.9 42.7 24.7 8.7 5.1 31.0 32.5 20.4 13.1 31.2 24.8 24.3 14.1 9.2 10.4 8.8 38.7 35.7 27.2 7.9 14.5 12.0 40.9 16.3 25.9 15.4 18.0 14.0 11.7 11.6 14.4 17.8 13.1 14.2 13.2 34.5 14.6 21.0 12.3 11.8 11.8 5.6 6.9 5.8 7.9 9.4 6.5 5.6 4.7 6.4 4.1 5.1 7.1 26.7 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 33.1 19.9 0.0 5.7 0.0 44.1 0.0 5.6 35.9 0.8 7.9 42.9 0.5 78.7 30.7 7.1 0.0 0.0 0.1 42.7 5.0 4.6 0.0 93.5 0.0 10.3 0.0 3.8 7.6 0.0 0.1 1.8 0.0 0.0 0.0 0.6 0.0 12.7 0.0 0.0 23.8 0.0 1.0 0.0 0.0 41.3 0.0 0.0 8.1 0.0 6.6 61.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 7.0 13.6 20.0 0.2 0.0 FBXO33 Fbx33 ENSG00000165355 "F-box protein 33" Q7Z6M2 14 39397669-39432500 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 52.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 82.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046657 Approved Approved Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 3: HMC-1 - Innate immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA046657: AB_10960398" "unprognostic (8.84e-3)" "unprognostic (6.72e-2)" "unprognostic (3.65e-2)" "unprognostic (2.79e-1)" "unprognostic (1.08e-1)" "unprognostic (3.20e-2)" "unprognostic (1.19e-1)" "prognostic favorable (4.94e-4)" "unprognostic (1.24e-1)" "unprognostic (2.70e-2)" "unprognostic (1.17e-1)" "unprognostic (2.40e-1)" "prognostic favorable (4.58e-4)" "unprognostic (9.61e-2)" "unprognostic (4.54e-1)" "unprognostic (4.41e-2)" "unprognostic (8.58e-3)" 7.0 9.6 12.2 8.1 12.6 52.6 6.5 10.8 16.2 8.0 16.7 5.9 7.2 6.5 10.1 5.2 6.0 7.3 5.3 14.9 12.9 7.3 6.9 7.9 9.4 12.4 10.8 6.1 5.9 13.2 10.8 7.8 12.5 7.5 5.7 8.4 6.7 7.4 3.0 5.7 5.6 6.6 9.8 7.8 6.0 12.1 11.6 11.8 11.6 6.7 9.8 7.2 4.9 12.5 12.8 7.8 7.0 10.8 24.7 11.5 11.6 12.6 16.9 6.9 8.0 4.7 11.1 14.3 15.2 19.7 6.9 6.4 18.3 12.4 12.3 13.7 11.8 5.7 10.5 12.2 7.0 21.7 20.9 10.7 13.2 11.8 3.8 11.9 5.8 14.0 5.0 12.6 13.6 13.7 19.4 13.5 7.2 11.5 11.6 16.6 11.4 13.0 13.2 16.1 12.1 5.5 11.3 11.8 14.0 10.4 8.7 13.7 7.5 11.6 10.4 17.4 10.1 17.0 21.6 22.6 9.0 10.1 8.8 0.9 0.9 1.8 1.6 1.1 1.4 1.2 1.6 1.7 0.8 1.1 2.2 2.1 3.9 2.8 1.1 0.7 1.7 0.6 12.2 12.6 10.8 16.2 14.9 12.9 12.4 10.8 12.5 9.8 11.6 12.5 14.7 9.6 20.1 21.9 25.7 34.5 13.6 6.4 27.9 24.0 19.1 16.4 8.9 4.3 8.1 9.2 43.8 8.4 40.8 18.0 7.9 8.1 42.1 25.7 14.3 14.7 23.9 16.2 82.6 9.3 9.5 14.8 12.8 39.8 10.2 10.1 13.9 10.6 10.5 28.6 46.7 14.2 2.0 19.2 23.3 10.7 8.4 22.6 19.6 23.4 14.8 12.4 10.3 34.7 36.7 14.0 10.1 5.3 32.7 21.5 13.9 4.0 8.4 17.9 0.0 18.8 17.8 28.5 12.2 24.0 56.4 21.2 31.4 8.0 13.7 24.7 LRFN5 "C14orf146, FIGLER8, SALM5" ENSG00000165379 "Leucine rich repeat and fibronectin type III domain containing 5" Q96NI6 14 41606876-41904549 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.5;cervix: 10.1;parathyroid gland: 11.1" "Group enriched" "Detected in some" 19 "Excitatory neurons: 873.9;Inhibitory neurons: 581.5;Oligodendrocyte precursor cells: 296.1" "Cancer enhanced" "Detected in some" "testis cancer: 1.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 16.4;HSkMC: 3.1;RPTEC TERT1: 5.2;SCLC-21H: 8.8;U-138 MG: 10.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001177 Uncertain "Intracellular and membrane" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA001177: AB_1079274" "unprognostic (5.23e-3)" "unprognostic (1.37e-1)" "unprognostic (5.10e-1)" "unprognostic (6.24e-2)" "unprognostic (2.39e-1)" "unprognostic (3.54e-1)" "unprognostic (1.31e-1)" "unprognostic (6.38e-3)" "unprognostic (2.61e-2)" "unprognostic (5.78e-2)" "unprognostic (2.70e-2)" "unprognostic (9.27e-2)" "unprognostic (6.02e-3)" "unprognostic (3.79e-3)" "unprognostic (1.98e-1)" "unprognostic (6.07e-3)" "unprognostic (2.92e-3)" 1.4 2.2 5.3 1.0 7.5 0.0 1.4 0.0 16.5 10.1 0.0 2.0 0.2 2.5 0.6 0.5 3.3 1.0 0.6 7.9 5.9 0.2 0.3 0.7 0.0 0.8 1.4 1.6 0.3 11.1 0.8 1.1 4.9 2.4 1.0 2.6 0.3 6.4 0.2 0.6 0.4 1.5 0.8 0.6 0.7 0.9 2.0 0.3 0.5 0.5 0.2 6.1 5.2 4.3 0.0 0.0 1.7 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 8.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 10.7 0.1 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 7.5 0.0 16.5 7.9 5.9 0.8 1.4 4.9 0.8 2.0 4.3 0.5 0.0 0.0 29.7 0.0 0.3 0.0 0.0 0.0 8.2 0.1 0.6 1.0 2.8 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 3.2 0.3 7.8 0.9 0.0 0.0 873.9 0.0 0.1 7.9 0.0 0.6 0.0 0.2 0.0 0.5 0.1 0.0 581.5 0.0 0.0 0.0 0.8 1.7 8.4 0.1 1.8 24.4 0.0 0.4 0.0 296.1 11.8 0.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 1.4 1.5 0.0 2.1 0.0 0.3 0.1 0.2 2.1 0.0 0.1 FSCB "C14orf155, DKFZP434F1017" ENSG00000189139 "Fibrous sheath CABYR binding protein" Q5H9T9 14 44504149-44507283 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "testis: 32.5" "Group enriched" "Detected in some" 69 "Early spermatids: 339.4;Late spermatids: 655.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA003546 Supported NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 25: Spermatids - Spermatogenesis" "HPA003546: AB_1845561" "unprognostic (8.13e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 339.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 655.2 6.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 7.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C14orf28 "DRIP-1, DRIP1" ENSG00000179476 "Chromosome 14 open reading frame 28" Q4W4Y0 14 44897275-44907257 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Early spermatids: 184.9;Late spermatids: 127.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059635 Approved Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 44: HDLM-2 - Immune response" "Cluster 34: Spermatids - Unknown function" Cytosol "HPA059635: AB_2684091" "unprognostic (5.41e-2)" "unprognostic (1.21e-2)" "unprognostic (3.23e-1)" "unprognostic (3.06e-6)" "unprognostic (1.18e-1)" "unprognostic (6.64e-3)" "unprognostic (2.37e-2)" "unprognostic (1.90e-2)" "unprognostic (2.25e-1)" "unprognostic (5.35e-2)" "unprognostic (3.13e-3)" "unprognostic (7.33e-2)" "unprognostic (3.26e-2)" "unprognostic (2.43e-1)" "unprognostic (2.30e-1)" "unprognostic (4.68e-2)" "unprognostic (2.01e-1)" 5.4 2.4 2.4 2.4 2.8 1.0 3.5 2.5 3.5 3.8 2.5 5.3 4.1 6.1 3.7 3.1 4.5 2.6 5.0 2.4 2.5 2.8 4.8 2.8 2.7 2.8 2.6 6.5 3.5 2.5 2.1 2.8 2.8 3.9 3.1 2.3 3.6 4.5 4.6 3.3 4.2 4.5 2.5 3.0 3.8 8.6 2.6 1.4 3.6 4.6 2.9 5.3 2.5 3.1 1.9 1.3 2.5 4.3 4.9 2.6 5.6 3.7 4.1 1.8 2.8 0.1 2.4 2.5 2.2 2.6 4.0 1.0 0.6 1.8 3.1 9.3 0.5 1.2 0.5 2.6 1.4 1.1 2.8 2.0 3.0 0.5 2.9 3.4 1.0 3.0 0.6 3.4 1.4 3.7 1.1 2.2 0.4 3.6 1.4 1.8 3.0 1.0 2.5 2.4 0.5 0.7 1.5 3.0 1.7 2.0 5.4 1.1 1.5 6.8 3.3 1.1 0.7 4.8 4.2 1.6 1.9 0.6 2.2 1.1 1.1 4.6 2.6 1.7 2.9 4.8 2.5 3.3 1.2 3.1 5.4 3.2 2.3 2.5 2.3 2.1 3.1 1.4 2.4 2.8 2.5 3.5 2.4 2.5 2.8 2.6 2.8 2.5 2.6 3.1 5.9 3.2 2.7 1.6 8.8 3.1 9.4 10.3 10.8 3.2 6.5 7.2 12.1 5.7 4.7 5.5 0.0 5.6 6.0 6.7 9.8 8.4 184.9 1.6 4.8 5.3 3.0 2.1 4.0 8.7 4.9 8.9 5.6 2.8 1.3 2.9 5.3 11.5 4.6 3.3 3.8 7.0 8.2 5.4 3.1 127.9 10.5 3.8 5.4 6.5 4.4 3.4 5.2 9.0 9.5 5.9 4.9 16.1 5.5 14.2 15.8 16.0 1.8 2.9 19.7 3.6 11.2 18.5 10.2 5.4 4.4 6.6 6.5 3.3 5.2 7.6 KLHL28 "BTBD5, FLJ20081" ENSG00000179454 "Kelch like family member 28" Q9NXS3 14 44924324-45042322 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 27.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000988 Approved Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 2: Karpas-707 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "HPA000988: AB_1845480" "unprognostic (8.09e-2)" "unprognostic (1.02e-1)" "unprognostic (1.15e-1)" "unprognostic (1.37e-1)" "unprognostic (7.84e-3)" "unprognostic (9.20e-2)" "unprognostic (4.36e-3)" "unprognostic (4.92e-2)" "unprognostic (2.66e-1)" "unprognostic (2.14e-1)" "unprognostic (1.23e-1)" "unprognostic (1.53e-1)" "unprognostic (4.68e-2)" "unprognostic (7.55e-2)" "unprognostic (4.34e-1)" "unprognostic (1.75e-2)" "unprognostic (6.53e-2)" 4.6 4.8 2.6 6.5 3.4 27.0 5.7 9.0 3.6 5.2 3.3 5.0 5.1 5.3 5.0 6.5 5.4 5.5 4.1 2.9 3.9 4.6 6.4 5.6 8.7 3.2 2.9 7.8 3.8 4.2 3.0 5.6 3.5 5.5 6.0 8.1 4.3 3.9 4.7 5.1 5.0 5.8 3.3 5.8 5.0 7.3 3.3 9.2 7.6 8.0 7.4 5.6 3.5 6.4 4.5 6.7 8.6 5.6 7.7 6.8 6.5 5.8 6.4 8.4 7.1 3.0 6.8 6.6 6.2 10.1 2.2 7.6 7.7 6.1 9.2 12.3 4.2 5.7 6.9 3.4 6.9 9.2 12.0 5.3 8.6 5.4 8.6 4.8 6.8 10.2 5.1 16.0 4.9 6.5 7.4 4.7 5.3 5.0 6.3 6.3 9.6 3.7 4.8 8.0 9.8 6.0 7.5 5.0 8.1 5.5 9.4 3.9 8.7 7.5 8.6 5.3 3.3 9.4 11.0 9.2 2.6 4.1 4.6 31.5 7.3 18.3 17.0 10.2 31.5 14.9 17.0 18.0 6.4 13.0 20.0 17.2 16.8 20.3 11.2 8.7 14.2 6.9 2.6 3.4 9.0 3.6 2.9 3.9 3.2 2.9 3.5 3.3 3.3 6.4 15.7 16.0 9.4 17.0 30.1 24.5 16.4 20.1 27.9 24.8 12.9 10.4 12.1 11.5 17.6 18.4 35.5 7.7 27.5 14.9 7.9 10.0 40.2 20.0 13.6 15.4 13.9 27.8 32.6 5.6 8.3 18.0 17.3 9.7 19.0 10.2 16.8 13.1 9.2 15.2 30.0 12.1 6.1 15.8 23.6 62.8 21.8 19.1 23.2 16.9 15.7 23.2 23.7 36.7 40.4 10.3 12.7 17.7 27.0 12.6 13.1 8.5 32.3 23.4 13.1 14.6 19.8 10.8 5.1 19.4 30.1 14.1 38.6 7.7 9.5 15.8 TOGARAM1 "crescerin, Crescerin-1, FAM179B, KIAA0423" ENSG00000198718 "TOG array regulator of axonemal microtubules 1" Q9Y4F4 14 44962190-45074431 "Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 65.7;Endometrial stromal cells: 28.6;Granulosa cells: 30.1;Respiratory ciliated cells: 38.6;Theca cells: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "basophil: 4.8" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050849, HPA053559" Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 54: Non-specific - Microtubule organization" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA050849: AB_2681257, HPA053559: AB_2682190" "unprognostic (2.91e-1)" "unprognostic (4.07e-2)" "unprognostic (2.04e-2)" "unprognostic (1.05e-2)" "unprognostic (1.40e-1)" "unprognostic (1.17e-1)" "unprognostic (4.88e-2)" "unprognostic (2.67e-2)" "unprognostic (2.69e-1)" "unprognostic (1.21e-1)" "unprognostic (5.63e-2)" "unprognostic (6.49e-2)" "prognostic favorable (8.38e-4)" "unprognostic (1.62e-1)" "unprognostic (2.15e-1)" "unprognostic (3.02e-2)" "unprognostic (1.60e-1)" 4.5 6.6 9.6 2.9 13.4 3.9 5.2 10.1 13.0 6.7 9.6 4.5 2.7 6.0 5.2 4.6 10.4 4.7 8.3 11.2 8.9 7.9 4.6 3.9 3.9 7.2 8.0 7.6 6.3 8.5 7.1 5.8 8.7 5.5 3.7 16.8 4.8 6.4 12.4 4.2 3.8 5.4 7.5 4.3 4.3 6.5 9.3 8.4 9.0 12.1 3.9 5.4 4.3 19.9 3.5 5.7 5.3 1.4 12.2 14.2 3.8 4.9 10.4 9.1 10.8 2.3 3.7 3.3 5.6 7.9 4.9 6.4 9.8 3.3 10.0 3.0 3.6 2.7 2.8 2.7 8.6 4.6 2.7 8.3 5.6 5.2 8.8 10.8 7.4 1.8 1.9 3.7 9.2 5.0 5.9 2.5 1.8 5.2 4.3 2.9 12.9 2.2 8.6 12.0 5.5 2.1 5.8 8.4 9.1 5.5 6.2 3.6 5.5 6.1 4.9 7.8 3.7 3.8 3.0 3.7 3.5 0.9 5.2 4.8 0.4 1.0 0.4 0.4 0.5 0.4 0.6 0.4 0.6 0.6 0.5 0.3 0.0 0.8 0.4 0.7 0.6 0.3 9.6 13.4 10.1 13.0 11.2 8.9 7.2 8.0 8.7 7.5 9.3 19.9 15.8 16.0 14.9 0.0 4.5 0.0 0.0 0.0 0.0 0.0 15.2 10.9 0.0 0.0 20.4 16.5 0.0 11.9 13.2 0.0 1.9 10.2 0.0 65.7 28.6 6.6 0.0 0.0 0.0 5.6 8.1 8.8 0.0 16.0 10.1 30.1 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 6.7 0.0 0.0 0.0 0.0 8.6 0.0 0.0 3.8 0.0 0.0 10.4 38.6 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 9.9 6.3 34.4 0.0 0.0 PRPF39 "FLJ11128, FLJ20666" ENSG00000185246 "Pre-mRNA processing factor 39" Q86UA1 14 45084107-45116282 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001176, HPA078403" Approved Approved Nucleoplasm NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA001176: AB_2171026, HPA078403: " "unprognostic (1.79e-1)" "unprognostic (2.75e-1)" "unprognostic (1.03e-1)" "unprognostic (2.19e-1)" "unprognostic (1.91e-2)" "unprognostic (6.75e-3)" "prognostic unfavorable (3.84e-5)" "unprognostic (9.51e-3)" "prognostic unfavorable (6.51e-4)" "prognostic favorable (8.48e-4)" "unprognostic (4.34e-3)" "prognostic unfavorable (4.04e-4)" "unprognostic (5.02e-3)" "unprognostic (1.83e-1)" "unprognostic (9.04e-2)" "unprognostic (8.93e-2)" "prognostic favorable (2.99e-4)" 4.8 4.0 1.4 0.7 1.6 2.7 4.8 1.3 2.0 5.5 0.2 5.1 1.5 5.2 1.7 3.9 6.3 1.3 3.7 1.1 1.0 5.6 3.4 3.2 1.5 1.3 0.7 5.5 4.4 1.7 4.1 1.7 1.5 3.5 1.0 2.0 4.4 1.5 7.6 4.8 4.3 1.5 0.2 3.8 5.1 3.0 1.0 1.8 3.6 1.7 1.2 5.3 4.3 2.2 7.8 8.5 7.0 3.4 2.7 2.4 7.0 6.2 3.4 4.9 4.3 5.1 5.2 4.9 6.2 4.5 3.6 5.1 9.0 4.1 7.3 8.9 6.2 6.8 11.5 4.8 3.2 6.5 1.9 1.5 2.5 2.7 3.2 2.6 3.5 6.2 9.8 5.2 5.4 7.0 7.2 3.1 6.5 5.2 8.9 9.5 6.0 6.3 2.8 10.4 6.8 1.8 2.9 3.9 4.9 3.5 3.7 5.2 7.8 4.3 4.0 3.1 8.3 5.1 12.9 11.2 1.8 6.6 2.4 5.2 2.7 4.7 4.5 4.9 6.4 5.6 4.0 4.7 4.9 5.0 5.2 6.1 2.1 4.3 5.2 2.0 5.4 3.2 1.4 1.6 1.3 2.0 1.1 1.0 1.3 0.7 1.5 0.2 1.0 2.2 14.3 25.6 22.5 21.2 18.2 27.3 15.6 6.5 18.8 19.5 10.6 7.4 14.9 7.2 13.5 7.3 14.6 12.1 21.5 7.0 9.8 8.5 1.3 9.2 19.5 12.8 9.6 15.8 36.6 9.3 10.6 15.5 12.2 11.2 16.4 16.7 10.8 7.5 7.5 16.8 37.1 9.1 6.1 5.1 14.6 4.9 14.9 9.5 14.2 25.3 8.4 10.8 5.2 31.2 55.5 8.0 6.6 14.7 19.1 14.2 14.2 5.4 6.1 24.2 6.6 13.5 16.7 11.6 11.8 18.3 25.3 12.0 19.7 13.4 9.2 10.0 FKBP3 "FKBP-25, FKBP25" ENSG00000100442 "FKBP prolyl isomerase 3" Q00688 14 45115599-45135319 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 424.4;tongue: 372.0" "Cell type enhanced" "Detected in all" "Late spermatids: 377.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000864, CAB012232, CAB012520" Supported Supported Cytosol NA NA 1300000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 80: Striated muscle - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 10: Non-specific - Unknown function" Cytosol "CAB012232: , CAB012520: AB_873554, HPA000864: AB_1078873" "unprognostic (7.77e-2)" "unprognostic (1.47e-1)" "unprognostic (3.18e-1)" "unprognostic (9.72e-2)" "unprognostic (1.25e-1)" "unprognostic (9.82e-3)" "unprognostic (3.58e-3)" "unprognostic (2.28e-1)" "unprognostic (5.04e-3)" "unprognostic (1.22e-3)" "unprognostic (7.47e-2)" "unprognostic (6.92e-3)" "unprognostic (1.00e-1)" "unprognostic (3.07e-1)" "unprognostic (1.51e-1)" "unprognostic (1.00e-2)" "unprognostic (1.47e-1)" 40.9 46.8 100.3 35.8 102.3 38.4 50.0 110.1 122.1 38.1 91.8 49.4 44.7 31.4 64.8 54.7 31.4 29.8 109.5 101.9 100.6 66.5 69.7 27.6 53.7 100.7 99.3 35.3 32.8 55.5 56.6 46.9 100.1 57.7 49.1 82.3 37.1 37.9 424.4 38.3 47.8 39.2 99.8 39.9 38.0 52.9 101.4 59.6 40.1 372.0 57.7 43.3 38.6 105.8 161.0 175.3 249.0 132.4 109.0 117.8 98.3 96.2 110.3 149.3 163.5 154.8 134.1 85.1 98.9 110.0 84.1 130.0 188.4 124.8 211.7 123.7 111.0 69.8 138.8 202.6 107.1 122.2 72.8 112.0 127.5 87.2 80.1 136.8 198.0 131.9 102.9 62.1 179.9 196.9 197.5 163.0 126.7 178.3 164.5 187.0 183.7 102.9 242.2 183.7 151.2 59.2 154.8 94.5 156.0 186.4 222.6 89.9 128.7 113.0 195.6 59.9 75.1 104.0 198.8 132.5 68.3 83.0 108.1 23.4 22.4 22.1 18.7 27.3 22.8 29.7 25.0 25.7 33.3 21.8 23.4 26.7 3.6 24.2 29.4 43.0 30.8 20.2 100.3 102.3 110.1 122.1 101.9 100.6 100.7 99.3 100.1 99.8 101.4 105.8 48.3 41.7 46.6 25.8 45.3 47.8 94.4 205.5 45.5 79.3 39.9 46.7 202.5 48.6 101.4 93.8 10.4 320.9 51.2 56.4 252.4 131.1 212.7 55.0 83.3 58.5 56.1 50.9 49.7 73.0 135.4 70.0 36.7 68.1 53.7 75.6 38.2 91.1 131.1 40.4 44.5 71.2 124.1 39.9 43.0 377.4 80.8 53.7 69.4 17.8 110.7 80.7 50.4 21.1 34.3 88.4 53.7 97.8 58.0 76.4 91.8 220.1 73.5 67.4 105.2 71.3 118.5 154.0 111.2 65.0 47.9 165.0 48.8 84.1 96.1 77.6 FANCM "FAAP250, KIAA1596" ENSG00000187790 "FA complementation group M" Q8IYD8 14 45135930-45200890 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Disease variant, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Early spermatids: 65.5;Late spermatids: 206.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055144 Supported Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "HPA055144: AB_2682715" "unprognostic (8.40e-2)" "unprognostic (6.70e-2)" "unprognostic (3.99e-2)" "unprognostic (4.32e-2)" "unprognostic (2.15e-1)" "unprognostic (2.31e-3)" "unprognostic (2.66e-2)" "unprognostic (1.18e-1)" "unprognostic (1.57e-2)" "unprognostic (8.52e-2)" "unprognostic (1.14e-1)" "unprognostic (1.23e-2)" "unprognostic (7.55e-2)" "unprognostic (2.90e-1)" "unprognostic (1.71e-1)" "unprognostic (8.94e-2)" "unprognostic (1.13e-2)" 1.9 1.6 0.8 2.2 1.6 5.6 2.8 1.9 2.2 2.0 0.3 1.6 1.3 2.4 2.2 1.9 1.6 1.8 1.3 1.0 0.9 1.8 1.5 1.7 3.3 1.0 0.8 2.9 1.1 1.5 0.8 1.9 1.2 1.6 1.8 2.8 1.4 1.9 1.6 2.6 1.2 1.9 0.7 2.3 1.4 7.6 1.1 4.1 1.5 2.3 2.6 1.5 1.5 1.2 8.2 7.0 8.1 7.5 6.4 3.5 6.5 10.3 4.1 8.1 10.1 11.3 6.2 10.6 5.8 2.6 4.5 10.6 9.5 4.4 11.0 7.6 5.4 5.1 7.8 6.4 1.1 13.0 6.1 2.2 1.6 8.1 5.1 1.8 7.1 6.6 9.1 8.9 6.9 8.1 9.5 9.2 3.2 6.3 11.6 9.0 12.7 4.5 3.4 5.8 7.3 1.9 9.4 7.6 4.0 5.1 8.0 6.0 5.6 11.8 11.0 10.6 8.1 4.4 8.7 10.3 2.3 7.9 7.0 6.6 0.7 2.5 2.0 2.0 1.1 4.3 1.3 0.7 0.6 2.0 2.0 1.7 1.0 1.1 0.9 1.7 1.0 0.6 0.8 1.6 1.9 2.2 1.0 0.9 1.0 0.8 1.2 0.7 1.1 1.2 6.5 0.0 3.1 9.8 8.3 2.7 1.1 1.9 4.6 6.3 3.9 2.4 8.3 1.5 3.1 1.8 2.1 7.6 5.6 1.7 0.0 2.2 65.5 3.5 5.8 5.1 0.0 12.8 21.0 2.7 3.5 4.6 5.1 3.0 1.3 9.4 5.7 1.7 3.5 3.3 15.6 1.6 4.1 3.8 2.9 206.1 9.0 4.0 3.6 18.7 5.9 4.8 3.1 20.1 22.7 2.4 0.8 5.3 8.4 0.8 1.5 1.9 1.1 6.9 6.6 4.7 6.0 26.5 14.0 4.4 1.8 2.3 5.6 9.5 3.2 0.7 MIS18BP1 "C14orf106, FLJ11186, KIAA1903, KNL2, M18BP1" ENSG00000129534 "MIS18 binding protein 1" Q6P0N0 14 45203190-45253540 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 40.7" "Cell type enhanced" "Detected in many" "Granulosa cells: 145.1;monocytes: 150.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA006504 Approved Approved Nucleoli,Cytosol NA Yes "Cluster 14: Monocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 32: U-937 - Innate immune response" "Cluster 41: Macrophages - Immune response" Nucleoli Cytosol "HPA006504: AB_1078317" "unprognostic (2.12e-1)" "unprognostic (1.06e-1)" "unprognostic (2.58e-2)" "unprognostic (1.44e-2)" "unprognostic (1.51e-1)" "unprognostic (1.05e-2)" "prognostic unfavorable (3.83e-4)" "unprognostic (4.18e-1)" "unprognostic (1.36e-2)" "unprognostic (3.33e-1)" "unprognostic (3.32e-2)" "unprognostic (2.32e-3)" "unprognostic (3.31e-2)" "unprognostic (5.49e-2)" "unprognostic (2.30e-1)" "unprognostic (2.97e-1)" "unprognostic (2.21e-1)" 8.6 3.7 1.5 14.1 1.4 40.7 10.7 0.9 1.6 7.3 1.1 8.0 8.4 10.2 5.3 7.1 6.7 7.7 3.8 1.4 1.7 3.7 4.1 9.5 23.2 2.1 1.9 12.2 4.6 2.3 1.3 10.6 2.4 6.3 10.1 1.2 6.7 5.8 1.3 8.6 9.6 9.6 1.9 15.2 8.5 13.5 1.5 24.4 6.8 3.8 21.7 7.8 3.9 2.8 54.1 20.0 40.7 18.0 12.1 17.2 30.0 36.4 19.2 29.7 36.5 10.7 50.7 73.6 15.5 18.5 12.8 37.0 23.9 18.5 55.3 39.5 15.3 44.5 23.2 13.8 8.1 103.7 39.7 12.5 7.4 17.6 16.5 19.4 36.7 14.1 19.7 17.2 29.1 19.9 44.1 45.9 30.8 26.5 24.9 51.5 16.4 28.5 15.3 22.3 28.4 12.3 16.2 24.6 13.1 24.1 29.5 58.1 20.4 15.7 47.4 19.5 16.6 15.3 21.5 34.5 8.8 42.6 22.8 64.5 28.8 35.8 7.9 28.5 8.5 28.5 7.5 6.8 21.5 25.5 5.0 5.1 17.8 10.8 53.8 31.0 10.9 9.1 1.5 1.4 0.9 1.6 1.4 1.7 2.1 1.9 2.4 1.9 1.5 2.8 54.6 25.6 27.8 6.8 87.7 20.1 11.6 17.7 19.4 8.4 24.3 27.3 13.3 7.2 26.1 9.2 16.7 40.9 91.6 17.1 5.9 14.0 3.5 29.2 47.6 43.5 27.6 72.6 34.5 11.1 42.5 32.5 35.7 28.0 43.6 145.1 30.4 7.3 35.4 0.0 7.6 25.8 18.3 89.8 30.9 6.8 55.3 115.7 5.4 74.0 150.1 5.1 55.6 9.5 11.1 13.5 47.7 60.5 73.5 25.0 12.1 5.0 20.9 7.6 0.0 13.9 23.3 80.0 105.4 32.5 26.3 19.4 54.5 77.9 29.9 24.6 RPL10L ENSG00000165496 "Ribosomal protein L10 like" Q96L21 14 46651010-46651781 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "testis: 92.0" "Group enriched" "Detected in some" 17 "Early spermatids: 581.2;Late spermatids: 224.4;Spermatocytes: 310.1" "Cancer enriched" "Detected in single" 15 "testis cancer: 6.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 43 "U-2 OS: 41.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA011311 Uncertain Approved "Endoplasmic reticulum,Cytosol" NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 9: U-2 OS - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" "Endoplasmic reticulum, Cytosol" "HPA011311: AB_1856431" "unprognostic (7.36e-2)" "unprognostic (1.32e-1)" "unprognostic (1.92e-2)" "unprognostic (4.18e-2)" "unprognostic (6.67e-2)" "unprognostic (2.92e-1)" "unprognostic (8.70e-4)" "unprognostic (4.69e-2)" "unprognostic (5.27e-3)" "unprognostic (1.30e-1)" "unprognostic (2.36e-1)" "unprognostic (1.05e-1)" "unprognostic (1.70e-1)" "unprognostic (1.83e-1)" "unprognostic (4.40e-2)" "unprognostic (1.44e-2)" 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 92.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 41.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 10.4 0.3 0.0 0.0 0.0 0.1 1.3 0.0 0.2 0.0 0.0 0.2 0.0 2.2 0.0 0.0 581.2 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 1.5 0.0 0.3 19.2 224.4 6.2 0.9 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.2 0.0 6.6 0.1 0.1 0.1 0.0 6.6 2.9 20.8 310.1 14.7 0.0 18.8 0.3 2.4 0.2 2.0 4.3 MDGA2 MAMDC1 ENSG00000139915 "MAM domain containing glycosylphosphatidylinositol anchor 2" Q7Z553 14 46839629-47675605 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "brain: 8.0;retina: 4.4;testis: 3.8" "Group enriched" "Detected in some" 7 "Excitatory neurons: 1559.3;Inhibitory neurons: 1208.8;Oligodendrocyte precursor cells: 1972.9" "Cancer enhanced" "Detected in single" "melanoma: 0.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.1;T-47d: 2.5;U-138 MG: 5.6;U-2 OS: 4.0;U-87 MG: 2.1;WM-115: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003084 Uncertain NA NA "Cluster 65: Brain - Ion transport" "Cluster 17: WM-115 - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA003084: AB_1079302" "unprognostic (3.27e-1)" "unprognostic (5.38e-2)" "unprognostic (9.13e-2)" "unprognostic (8.92e-3)" "unprognostic (6.36e-2)" "unprognostic (2.14e-2)" "unprognostic (1.63e-1)" "unprognostic (2.49e-3)" "unprognostic (3.62e-3)" "unprognostic (3.06e-2)" "unprognostic (5.89e-1)" 0.1 0.2 5.4 0.0 6.3 0.0 0.0 0.1 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 6.4 0.1 0.1 0.0 0.0 7.0 2.7 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 4.4 0.1 0.0 0.0 0.3 0.0 0.0 4.9 0.0 0.2 3.8 3.1 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 2.5 0.0 0.0 5.6 4.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 6.3 0.1 6.1 6.1 6.4 7.0 2.7 8.0 4.9 3.1 5.1 0.0 0.0 0.0 24.2 0.1 0.4 0.0 0.0 0.0 50.6 3.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 50.9 0.0 0.0 0.1 0.0 0.0 1559.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1208.8 0.0 0.0 0.0 0.0 7.1 0.3 0.0 5.4 52.5 0.0 0.3 0.0 1972.9 209.4 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.2 4.4 6.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 RPS29 "S29, uS14" ENSG00000213741 "Ribosomal protein S29" P62273 14 49570984-49599164 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA004107 Enhanced Supported "Endoplasmic reticulum,Cytosol" NA NA "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Endoplasmic reticulum, Cytosol" "HPA004107: AB_1079848" "prognostic favorable (2.66e-4)" "unprognostic (1.38e-1)" "unprognostic (1.38e-1)" "unprognostic (1.28e-1)" "unprognostic (4.40e-3)" "unprognostic (4.13e-2)" "unprognostic (9.95e-2)" "unprognostic (4.21e-2)" "unprognostic (2.98e-2)" "unprognostic (1.12e-1)" "unprognostic (8.62e-2)" "unprognostic (1.18e-1)" "unprognostic (2.94e-1)" "unprognostic (3.18e-2)" "unprognostic (1.66e-1)" "unprognostic (7.48e-3)" "unprognostic (7.71e-2)" 2915.6 2346.5 1747.8 1549.0 1785.8 3286.7 3207.7 1739.1 2601.7 3116.1 1718.3 2990.1 1407.8 1886.3 910.5 3294.5 2641.4 401.1 2127.4 1719.9 1762.6 2371.4 2697.6 2200.4 2364.9 1769.5 1741.7 4756.3 4388.2 1049.0 1483.6 887.0 1779.0 2246.8 1122.6 586.1 2625.0 797.7 3625.5 4604.2 3272.8 594.9 1830.7 4088.6 2645.0 1036.8 1800.8 3083.3 1906.9 1770.0 2079.7 2435.8 2777.8 1817.5 3057.7 1984.5 2021.5 1823.8 2271.9 3830.2 2675.3 2042.2 1722.2 1821.1 1483.1 2020.7 2733.7 2772.5 2264.9 1729.0 895.7 2605.0 2373.0 2922.0 2014.3 1811.3 4267.9 2191.4 1630.4 3564.5 2776.6 5612.2 1803.4 4011.6 4623.6 1204.7 3464.6 3181.7 2623.2 4723.4 2489.2 3498.4 1791.5 4047.4 3845.0 3454.4 2484.9 5075.2 5572.2 3178.5 2521.0 3196.6 2248.6 2696.4 1527.3 1753.1 1455.4 2636.2 5088.5 1938.5 3444.4 4786.4 2459.7 1381.7 3726.2 1295.6 1836.9 4014.0 4872.1 3856.3 973.0 2256.8 1363.0 3144.8 4379.9 1967.1 6689.0 3436.4 8449.9 11659.9 12162.6 8749.3 5025.2 10334.9 13471.6 11360.1 968.3 5389.4 3185.1 6778.8 7617.0 26592.8 1747.8 1785.8 1739.1 2601.7 1719.9 1762.6 1769.5 1741.7 1779.0 1830.7 1800.8 1817.5 1348.6 1131.4 2051.0 7.8 5426.0 3418.6 1043.1 2689.6 672.1 235.2 4463.4 3147.6 609.1 2805.3 2104.4 1074.1 129.3 3390.8 4425.2 2370.0 2424.1 2731.6 1371.1 1272.1 2960.5 1727.4 2673.2 2790.5 10.7 7061.8 4966.0 1443.2 650.3 1997.1 3019.4 2592.2 4092.8 7356.4 3048.0 107.7 12.0 6874.6 769.0 5623.6 5164.4 3280.3 3747.1 2396.2 2002.8 10.3 4580.9 1122.2 5206.1 10.1 17.9 5207.4 5628.6 1617.8 1584.1 1084.2 4951.5 3523.5 985.2 355.1 1091.3 1292.9 1159.9 1090.2 994.1 1255.0 4894.6 3673.2 4742.9 954.8 6917.3 1177.5 LRR1 "LRR-1, MGC20689, PPIL5" ENSG00000165501 "Leucine rich repeat protein 1" Q96L50 14 49598761-49614672 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 29.1" "Cell type enhanced" "Detected in many" "Early spermatids: 129.5;Spermatocytes: 151.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA065703, HPA069364" Approved Approved "Nucleoplasm,Nuclear membrane,Vesicles" No No "Cluster 46: Basophils - DNA binding" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nuclear membrane" Vesicles "HPA065703: AB_2685537, HPA069364: AB_2686129" "unprognostic (2.73e-2)" "unprognostic (1.21e-2)" "unprognostic (3.17e-2)" "unprognostic (2.26e-2)" "unprognostic (2.85e-2)" "unprognostic (9.34e-2)" "prognostic unfavorable (2.97e-4)" "unprognostic (7.34e-2)" "unprognostic (2.50e-2)" "unprognostic (8.30e-2)" "unprognostic (4.64e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (4.90e-7)" "unprognostic (6.86e-2)" "unprognostic (1.21e-1)" "unprognostic (1.86e-1)" "unprognostic (4.04e-2)" 5.7 5.5 1.6 9.1 1.7 22.6 5.6 1.7 2.1 3.0 1.6 12.2 9.6 3.7 2.4 6.7 3.3 3.6 3.2 1.5 1.6 3.1 6.1 4.2 14.0 1.8 1.7 2.4 4.3 2.9 1.2 4.0 1.8 3.2 10.0 3.2 4.1 3.4 4.0 4.7 10.1 6.1 1.7 7.5 4.6 29.1 1.8 23.2 3.4 4.8 13.3 5.4 3.5 1.9 66.5 39.3 34.2 38.4 15.1 10.6 38.2 35.0 30.8 72.5 68.7 38.4 49.1 60.9 25.1 22.9 23.2 41.7 42.2 29.8 64.1 56.5 31.3 27.4 29.4 24.6 8.5 64.5 34.2 6.9 11.3 33.9 19.4 9.2 35.8 49.2 29.3 45.4 49.2 55.2 87.2 60.1 22.5 31.7 53.0 54.8 56.2 41.4 25.4 27.1 36.9 21.7 33.1 35.3 25.4 12.1 49.9 49.6 13.1 50.6 83.1 24.8 44.4 23.6 35.9 69.0 23.6 47.7 42.9 22.4 14.2 25.4 10.1 22.7 13.5 16.1 13.3 14.8 15.0 12.6 10.8 12.3 8.2 11.1 16.9 17.7 15.7 10.5 1.6 1.7 1.7 2.1 1.5 1.6 1.8 1.7 1.8 1.7 1.8 1.9 6.4 3.2 6.5 2.0 12.1 15.6 5.7 12.0 4.6 3.8 6.5 5.6 3.6 5.7 9.3 3.7 2.1 12.6 9.2 11.8 1.9 16.8 129.5 3.4 5.3 8.9 4.8 48.4 0.9 22.7 34.2 7.8 6.6 2.9 14.5 9.5 6.8 6.6 21.6 1.7 1.1 11.0 12.2 10.4 19.2 41.6 7.5 11.5 10.6 2.8 16.7 8.1 13.4 1.0 2.0 14.1 3.7 3.4 31.3 11.2 8.7 7.5 4.3 5.2 6.6 5.5 8.0 151.7 14.0 8.8 14.9 7.7 10.5 7.5 14.5 7.0 RPL36AL RPL36A ENSG00000165502 "Ribosomal protein L36a like" Q969Q0 14 49618530-49620626 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" HPA077586 Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" NA Yes "Cluster 12: Non-specific - Basic cellular processes" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Endoplasmic reticulum, Cytosol" "Plasma membrane" "HPA077586: AB_2686846" "unprognostic (1.55e-2)" "unprognostic (2.44e-2)" "unprognostic (8.73e-2)" "unprognostic (3.15e-3)" "unprognostic (1.52e-1)" "unprognostic (2.55e-2)" "unprognostic (1.31e-1)" "unprognostic (6.37e-2)" "unprognostic (4.18e-2)" "unprognostic (1.38e-3)" "unprognostic (2.29e-1)" "unprognostic (4.72e-1)" "unprognostic (1.16e-3)" "unprognostic (8.32e-2)" "unprognostic (2.80e-1)" "prognostic favorable (2.83e-4)" "unprognostic (1.00e-1)" 279.7 310.9 234.2 246.4 241.7 404.2 328.6 232.1 349.8 381.8 221.4 331.8 260.5 280.7 492.7 277.4 315.9 162.6 273.2 225.1 244.6 255.3 372.3 240.5 311.9 244.4 237.3 501.3 628.8 220.0 252.9 176.7 240.6 250.8 248.8 102.0 327.5 253.2 378.6 247.6 284.9 197.9 242.0 294.2 360.3 137.6 240.5 283.4 211.2 206.5 377.1 297.8 285.9 246.2 635.8 473.9 330.1 192.6 471.3 649.8 194.9 508.9 569.9 475.4 534.7 499.0 426.1 833.4 474.5 430.3 327.9 443.5 287.6 441.3 554.8 288.1 331.1 521.6 527.5 652.8 595.1 838.8 426.0 667.8 668.2 362.7 485.9 553.7 614.6 367.3 339.5 714.4 372.8 831.7 496.5 752.6 186.0 452.1 482.0 308.6 519.5 449.5 730.7 964.2 290.3 178.1 448.5 350.8 544.1 313.0 762.2 460.1 468.2 291.3 463.0 382.3 399.8 427.6 487.0 842.7 210.5 376.9 283.7 1308.9 603.0 935.1 823.8 582.2 1113.2 959.3 1070.1 1040.5 614.8 729.1 984.7 937.6 654.0 806.3 542.2 1008.3 1096.2 1506.1 234.2 241.7 232.1 349.8 225.1 244.6 244.4 237.3 240.6 242.0 240.5 246.2 453.2 307.7 395.4 11.4 666.4 945.7 1352.2 1151.7 422.3 110.9 674.6 1022.1 662.4 652.0 643.5 312.6 25.0 690.0 778.0 871.5 995.9 739.8 614.3 490.0 431.4 515.5 366.2 535.9 14.1 1371.2 720.9 523.6 381.3 543.7 716.4 369.2 591.8 920.1 778.5 80.8 16.0 793.7 520.8 814.1 1020.0 236.4 725.7 585.0 843.1 22.5 1045.3 368.1 930.0 11.6 22.9 1311.2 1063.8 534.1 853.2 1279.2 1151.2 1194.4 579.1 127.7 486.4 693.6 898.3 364.7 150.2 390.6 839.3 516.3 888.1 355.4 620.5 1412.3 MGAT2 GNT-II ENSG00000168282 "Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase" Q10469 14 49620799-49623481 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043721, HPA056824" Approved Supported "Golgi apparatus" NA Yes 5100000 "Cluster 44: Non-specific - Transcription" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA043721: AB_2678636, HPA056824: AB_2683248" "unprognostic (1.20e-2)" "prognostic unfavorable (3.22e-4)" "unprognostic (2.84e-1)" "unprognostic (5.49e-2)" "unprognostic (1.37e-1)" "unprognostic (1.70e-1)" "unprognostic (3.77e-1)" "unprognostic (1.92e-2)" "unprognostic (1.14e-1)" "unprognostic (7.44e-2)" "unprognostic (7.12e-2)" "unprognostic (5.63e-2)" "unprognostic (2.59e-3)" "unprognostic (9.14e-2)" "unprognostic (3.74e-2)" "unprognostic (4.72e-2)" "unprognostic (2.12e-2)" 16.8 17.6 5.9 24.3 5.8 10.3 13.3 6.9 6.8 17.4 9.0 23.6 23.1 12.7 21.7 11.8 11.9 15.2 11.7 5.6 6.7 14.2 40.7 13.8 25.3 6.4 6.3 13.1 23.8 8.2 7.9 22.0 6.6 14.1 21.9 8.2 15.8 13.7 5.0 9.3 22.5 16.0 6.9 20.2 21.0 24.3 7.2 16.4 13.3 5.6 25.1 20.9 8.8 7.3 63.5 30.7 23.2 39.2 53.6 51.7 15.1 68.6 67.7 62.2 55.8 37.5 47.1 63.7 56.9 62.9 36.0 49.5 32.9 39.7 66.7 65.5 29.1 40.7 21.7 37.2 42.3 94.5 91.2 39.8 31.2 36.8 51.8 45.5 75.5 31.4 31.7 170.4 66.3 24.2 32.9 60.1 23.8 22.2 49.1 36.7 67.1 55.6 49.3 36.2 24.0 25.6 49.3 12.9 39.8 22.2 39.1 63.6 78.9 56.1 60.8 41.1 49.6 182.8 94.6 56.7 27.3 46.5 38.6 49.4 38.6 39.3 36.6 34.1 39.3 25.1 33.3 33.1 39.9 15.9 19.3 26.8 11.6 22.3 39.8 47.2 31.6 44.8 5.9 5.8 6.9 6.8 5.6 6.7 6.4 6.3 6.6 6.9 7.2 7.3 17.4 12.8 8.6 2.0 31.7 15.7 25.7 28.8 14.2 13.7 15.5 8.9 0.1 24.3 18.0 11.0 4.2 26.4 46.9 34.6 9.8 31.0 7.9 12.5 20.7 20.8 12.1 19.0 3.0 34.4 40.3 24.3 13.7 11.7 17.1 27.7 27.1 63.0 37.2 18.5 4.3 20.5 40.7 34.5 28.8 6.0 17.4 26.3 21.4 2.8 40.6 16.7 63.8 6.0 4.5 36.5 25.1 22.2 77.1 27.0 26.7 15.2 23.5 15.8 6.6 15.8 34.6 56.4 13.0 15.2 14.1 5.3 31.5 23.2 20.0 25.5 DNAAF2 "C14orf104, CILD10, FLJ10563, KTU, PF13" ENSG00000165506 "Dynein axonemal assembly factor 2" Q9NVR5 14 49625174-49635244 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002894, HPA004113" Enhanced Supported Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 57: B-cells - Immune response" Cytosol "HPA002894: AB_1078316, HPA004113: AB_1078315" "unprognostic (3.88e-2)" "unprognostic (2.11e-1)" "unprognostic (7.57e-2)" "unprognostic (5.85e-2)" "unprognostic (1.19e-2)" "unprognostic (1.65e-1)" "unprognostic (9.50e-2)" "unprognostic (1.75e-2)" "unprognostic (2.53e-2)" "unprognostic (2.47e-1)" "unprognostic (4.51e-2)" "unprognostic (2.25e-2)" "prognostic favorable (6.74e-7)" "unprognostic (6.72e-2)" "unprognostic (2.54e-1)" "unprognostic (5.04e-2)" "unprognostic (3.44e-2)" 3.8 4.6 3.2 4.4 3.1 3.4 5.7 3.8 3.3 4.3 6.0 5.4 7.6 4.0 4.1 4.4 8.6 3.7 4.3 3.0 3.5 6.8 9.3 3.7 5.5 3.5 4.3 3.5 6.9 3.9 3.4 3.4 3.5 4.0 4.7 4.8 5.5 3.0 5.0 3.2 6.2 3.3 3.6 4.1 5.1 6.3 3.4 4.7 5.3 5.3 4.6 4.6 3.3 3.6 14.2 8.3 18.0 14.1 8.6 9.9 17.1 7.5 8.3 8.2 9.0 8.1 13.4 20.7 11.6 5.0 6.7 15.3 15.0 10.6 10.2 14.6 8.9 10.6 6.2 14.1 6.7 17.3 8.6 6.6 11.3 7.0 9.5 8.4 8.5 11.3 16.0 13.8 8.2 17.7 11.4 17.8 19.6 14.7 15.1 14.0 13.9 7.0 11.7 11.8 27.4 20.4 11.2 12.0 13.8 11.3 13.7 6.9 7.0 7.6 21.7 7.9 9.5 27.5 18.4 17.1 2.9 10.5 8.5 7.8 4.9 6.8 7.4 4.5 8.9 11.6 8.2 9.9 5.7 9.3 7.9 7.8 1.8 12.4 5.8 5.1 8.5 4.8 3.2 3.1 3.8 3.3 3.0 3.5 3.5 4.3 3.5 3.6 3.4 3.6 9.8 3.2 5.6 5.9 38.5 41.0 25.0 38.9 41.5 7.0 21.4 20.3 10.6 15.7 14.6 12.9 0.0 21.6 16.2 13.0 31.3 28.4 25.9 30.3 22.9 17.1 9.6 13.9 6.8 24.0 29.4 17.6 19.4 13.8 12.0 12.2 19.2 26.6 14.0 3.3 8.0 15.3 48.8 9.2 21.1 7.5 18.3 10.2 19.6 2.8 10.5 11.3 19.6 6.6 6.2 25.7 13.0 16.6 43.7 36.2 30.8 37.9 27.2 11.9 6.6 16.0 15.4 22.4 17.9 38.6 44.0 12.4 28.0 30.2 22.8 20.0 POLE2 DPE2 ENSG00000100479 "DNA polymerase epsilon 2, accessory subunit" P56282 14 49643555-49688422 "FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "DNA replication" DNA-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 18.2" "Cell type enhanced" "Detected in many" "Erythroid cells: 21.0;Spermatogonia: 24.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" HPA027555 Uncertain Supported "Nucleoplasm,Nuclear bodies,Vesicles" No No "Cluster 48: NK-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nuclear bodies" Vesicles "HPA027555: AB_10610282" "unprognostic (1.42e-1)" "unprognostic (6.57e-3)" "unprognostic (3.53e-2)" "unprognostic (7.44e-2)" "unprognostic (2.04e-2)" "unprognostic (4.99e-3)" "unprognostic (7.60e-3)" "unprognostic (2.32e-3)" "unprognostic (1.10e-3)" "unprognostic (2.69e-2)" "unprognostic (1.88e-2)" "unprognostic (1.37e-3)" "unprognostic (5.13e-11)" "unprognostic (9.97e-2)" "unprognostic (1.66e-1)" "unprognostic (1.27e-1)" "unprognostic (1.50e-3)" 0.9 0.9 0.5 5.1 0.3 18.2 3.0 0.5 0.6 2.1 0.0 3.8 2.5 2.5 0.7 3.7 1.0 0.9 0.6 0.2 0.2 0.7 3.1 1.2 5.1 0.2 0.4 1.0 0.8 0.7 0.5 3.0 0.2 1.4 4.5 3.0 1.0 0.7 0.5 3.5 3.6 2.3 0.3 1.5 2.1 4.1 0.2 5.5 0.9 0.9 6.2 1.4 1.9 0.6 37.2 18.6 34.3 16.3 1.7 9.9 18.2 20.4 10.4 31.9 36.7 19.3 27.5 23.6 11.6 11.6 17.5 22.3 35.3 12.8 36.9 27.4 19.6 35.4 20.6 23.9 0.8 41.2 14.6 2.8 0.8 18.5 2.9 4.1 19.0 30.5 30.9 14.3 31.6 32.7 43.6 28.4 20.2 30.9 42.6 35.9 31.7 21.0 11.6 20.6 24.8 14.3 20.5 11.9 6.7 16.5 24.5 15.8 6.7 5.3 38.5 21.4 16.9 10.7 22.7 52.7 9.8 30.1 20.9 0.0 0.0 0.2 0.2 0.0 0.1 0.3 0.2 0.4 0.1 0.2 0.0 0.2 0.0 0.9 0.0 0.2 0.7 0.1 0.5 0.3 0.5 0.6 0.2 0.2 0.2 0.4 0.2 0.3 0.2 0.6 2.0 3.2 0.5 4.2 2.4 4.8 2.1 1.9 2.2 0.8 1.5 1.1 1.2 1.5 1.3 0.0 0.0 9.1 1.0 2.2 0.0 1.3 1.2 0.8 2.6 1.5 1.2 21.0 9.5 1.5 10.6 2.7 1.1 1.5 0.0 4.3 5.0 5.5 5.5 0.0 11.9 2.8 0.0 1.9 1.6 0.8 1.5 1.1 1.8 7.5 1.0 2.0 4.1 12.1 11.5 0.8 0.5 3.0 5.7 1.9 1.1 1.2 0.9 3.1 0.0 2.1 7.4 5.3 24.4 6.0 3.7 3.4 1.7 1.8 4.7 1.5 KLHDC1 MST025 ENSG00000197776 "Kelch domain containing 1" Q8N7A1 14 49693105-49753150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 46.4;Excitatory neurons: 41.7;Inhibitory neurons: 51.1;Microglial cells: 49.6;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 90.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 5.7;ASC TERT1: 5.3;HSkMC: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020461 Approved Supported Cytosol No No "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "HPA020461: AB_1852556" "unprognostic (2.97e-2)" "unprognostic (6.30e-2)" "unprognostic (8.49e-3)" "unprognostic (1.26e-2)" "unprognostic (5.46e-2)" "unprognostic (1.32e-2)" "unprognostic (1.32e-1)" "unprognostic (1.95e-2)" "unprognostic (1.01e-1)" "unprognostic (2.53e-1)" "prognostic favorable (1.94e-4)" "unprognostic (3.42e-1)" "unprognostic (5.61e-2)" "unprognostic (3.14e-2)" "unprognostic (1.13e-1)" "unprognostic (8.45e-2)" "unprognostic (2.24e-1)" 5.2 4.2 3.3 2.3 5.1 1.4 4.8 4.5 6.0 6.2 1.5 5.5 1.9 6.0 5.7 2.2 5.8 3.1 4.6 2.8 5.4 3.1 3.5 3.1 3.6 5.0 4.2 9.3 3.8 4.1 6.2 2.6 4.3 4.6 2.3 6.0 3.3 4.3 7.2 5.1 3.8 3.5 3.1 3.8 3.9 4.8 4.0 1.9 5.6 4.7 2.6 4.4 4.8 7.4 0.7 0.3 0.6 0.3 5.7 5.3 0.0 1.5 2.1 0.5 0.3 0.0 1.8 0.3 0.3 0.6 0.5 0.5 0.1 0.0 0.4 1.5 0.5 0.2 0.1 0.0 2.9 0.1 0.7 4.5 0.2 0.2 0.2 2.9 1.2 1.0 0.3 0.0 2.2 0.2 0.4 0.8 0.0 0.2 0.2 0.4 0.5 0.0 1.1 0.2 0.2 1.5 0.2 0.0 0.6 0.7 0.6 1.2 1.7 1.3 1.4 0.5 0.1 0.5 0.0 0.4 1.2 0.2 0.7 0.5 0.4 1.0 0.7 0.8 1.4 1.2 1.0 0.9 0.4 0.8 1.7 1.4 0.0 0.6 0.4 1.4 0.3 0.7 3.3 5.1 4.5 6.0 2.8 5.4 5.0 4.2 4.3 3.1 4.0 7.4 7.6 22.4 6.5 46.4 6.1 3.6 3.4 1.5 4.0 10.4 3.3 2.3 10.1 5.7 5.7 0.0 4.2 1.5 2.7 1.7 9.8 0.8 2.1 3.5 5.4 5.7 1.8 5.2 41.7 0.8 0.8 7.3 2.6 1.9 1.3 4.5 4.6 3.2 2.6 13.5 51.1 2.4 2.0 2.2 3.3 3.3 18.0 2.9 5.4 49.6 2.2 15.0 4.1 45.2 90.5 0.4 2.7 10.1 2.9 1.6 4.2 2.5 3.1 15.8 0.0 9.5 6.1 17.9 7.6 1.3 3.3 0.3 3.7 4.2 1.2 1.8 KLHDC2 "HCLP-1, LCP" ENSG00000165516 "Kelch domain containing 2" Q9Y2U9 14 49768130-49786385 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000628 Approved Supported "Nucleoplasm,Nuclear membrane,Nuclear bodies" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 8: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nuclear membrane" "Nuclear bodies" "HPA000628: AB_2666051" "unprognostic (2.65e-1)" "unprognostic (8.29e-2)" "unprognostic (1.30e-2)" "unprognostic (9.01e-2)" "unprognostic (2.57e-2)" "unprognostic (5.52e-3)" "unprognostic (4.54e-2)" "unprognostic (9.72e-3)" "unprognostic (7.43e-2)" "unprognostic (1.24e-1)" "unprognostic (4.81e-3)" "unprognostic (6.77e-3)" "prognostic favorable (2.75e-10)" "unprognostic (2.20e-2)" "unprognostic (2.08e-1)" "unprognostic (1.32e-2)" "unprognostic (9.34e-2)" 21.5 22.3 12.8 8.6 13.3 10.1 19.6 13.7 16.1 18.8 15.0 23.8 18.4 20.7 14.8 15.0 17.0 13.8 38.0 14.4 14.0 34.1 49.1 14.5 10.9 12.4 12.3 25.1 30.3 16.8 17.7 12.7 13.9 18.5 18.0 23.9 20.1 20.1 53.0 18.8 21.6 14.1 13.3 12.3 24.4 23.3 12.6 15.2 28.2 38.2 10.5 22.3 16.2 14.9 14.7 12.2 22.5 11.0 31.7 27.5 23.7 15.0 28.8 18.8 19.0 7.1 19.6 29.1 20.4 27.4 10.8 12.8 13.9 13.9 15.9 20.1 14.7 9.1 8.6 17.0 23.1 19.6 7.8 28.6 23.5 8.6 16.9 23.1 17.4 24.6 11.8 21.5 15.1 17.3 20.1 8.6 16.6 17.0 34.8 15.3 24.0 18.1 8.6 31.2 27.4 22.0 25.1 46.4 17.1 17.2 17.8 7.4 14.9 17.2 13.3 13.7 7.8 29.0 19.7 17.1 9.7 10.0 9.2 12.3 9.1 19.9 11.1 6.1 13.8 18.2 16.8 17.4 9.0 19.0 23.5 15.8 8.4 16.8 5.8 6.8 18.0 12.3 12.8 13.3 13.7 16.1 14.4 14.0 12.4 12.3 13.9 13.3 12.6 14.9 40.6 41.7 52.4 30.3 42.1 48.9 53.5 64.8 53.5 65.1 48.6 40.9 9.3 77.2 53.9 47.8 50.1 102.5 40.7 68.9 107.6 59.8 96.8 44.8 41.9 36.4 57.2 47.8 30.6 85.8 68.6 51.2 67.2 38.7 30.4 62.8 45.3 91.8 33.2 65.6 35.4 75.3 63.1 28.7 33.6 27.1 81.4 26.5 39.2 18.7 36.3 73.9 54.6 28.1 33.1 54.8 78.9 77.5 74.5 53.9 143.9 170.1 27.8 98.1 65.7 46.3 90.5 238.7 93.2 42.7 66.3 82.4 44.9 54.7 78.9 55.5 NEMF "FLJ10051, NY-CO-1, SDCCAG1" ENSG00000165525 "Nuclear export mediator factor" O60524 14 49782083-49852821 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004160 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 830000 "Cluster 6: Non-specific - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA004160: AB_1079884" "unprognostic (9.92e-2)" "unprognostic (6.03e-2)" "unprognostic (4.44e-2)" "unprognostic (3.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.65e-1)" "unprognostic (9.15e-3)" "unprognostic (7.62e-2)" "unprognostic (1.21e-2)" "unprognostic (2.32e-1)" "unprognostic (2.50e-1)" "unprognostic (1.12e-1)" "prognostic favorable (2.85e-4)" "unprognostic (3.61e-1)" "unprognostic (2.36e-1)" "unprognostic (8.98e-2)" "unprognostic (1.81e-2)" 16.5 13.8 9.5 18.0 13.0 42.1 14.7 18.1 14.7 16.2 5.9 13.6 10.0 16.2 13.5 22.5 12.2 13.2 17.7 7.9 10.6 14.9 11.9 13.8 17.9 11.8 11.6 15.2 15.2 24.8 10.3 18.2 11.9 16.0 14.5 14.7 14.6 15.8 23.0 14.3 13.6 15.7 10.9 15.5 14.1 10.7 10.7 16.3 18.5 21.5 17.9 18.0 11.6 18.4 34.3 39.2 35.9 24.1 37.3 31.0 32.1 42.0 28.3 27.6 27.3 23.2 35.3 13.3 32.0 35.7 21.2 47.5 34.1 26.7 42.2 38.9 22.7 38.7 40.3 29.1 23.8 50.7 33.4 26.8 19.6 29.9 27.2 36.3 39.8 23.8 47.3 36.2 37.7 30.6 31.2 17.9 21.9 28.6 36.8 32.6 35.5 20.8 33.7 44.8 23.6 22.2 41.6 40.4 39.2 37.2 37.6 31.1 47.2 39.2 34.4 26.6 28.9 24.5 47.6 40.9 14.7 23.9 35.5 76.4 38.9 45.8 45.7 36.9 44.8 83.7 47.1 44.4 33.9 86.7 55.6 59.1 61.3 47.8 54.4 79.7 46.1 20.3 9.5 13.0 18.1 14.7 7.9 10.6 11.8 11.6 11.9 10.9 10.7 18.4 66.2 41.7 76.7 65.3 81.1 34.4 67.4 81.6 29.6 92.1 31.7 43.1 97.2 34.3 74.4 44.1 100.1 85.8 78.4 51.8 37.2 57.0 13.9 52.2 60.1 65.2 54.0 57.0 75.7 39.1 58.1 53.0 41.8 60.7 89.3 68.0 49.6 28.1 58.9 131.2 80.7 48.9 71.2 48.7 57.0 13.1 65.9 57.9 24.9 62.8 79.4 54.8 82.4 56.8 99.5 46.4 68.5 67.4 50.0 66.1 59.4 29.9 82.4 90.0 72.3 65.7 70.7 83.0 58.3 32.5 34.1 108.4 66.9 64.1 54.6 88.6 ARF6 ENSG00000165527 "ADP ribosylation factor 6" P62330 14 49893082-49897054 "Predicted intracellular proteins, RAS pathway related proteins" "Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 716.1;Suprabasal keratinocytes: 673.3;Urothelial cells: 703.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002778, CAB079914" Approved Supported Cytosol NA NA 310000 "Cluster 44: Non-specific - Transcription" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 2: Karpas-707 - Immune response" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "CAB002778: , CAB079914: AB_2539861" "unprognostic (1.21e-1)" "unprognostic (2.75e-3)" "unprognostic (1.80e-1)" "unprognostic (7.02e-2)" "unprognostic (2.85e-1)" "unprognostic (1.83e-1)" "unprognostic (4.12e-3)" "unprognostic (2.16e-1)" "unprognostic (1.23e-1)" "unprognostic (1.41e-1)" "prognostic unfavorable (3.10e-5)" "unprognostic (1.61e-1)" "unprognostic (1.67e-1)" "unprognostic (8.37e-3)" "unprognostic (1.22e-1)" "unprognostic (2.37e-1)" "unprognostic (1.49e-2)" 32.1 25.3 13.4 43.6 14.2 83.1 32.6 15.2 15.3 35.7 16.3 53.4 46.4 21.7 26.6 108.2 28.3 32.8 18.3 11.8 14.3 29.7 46.1 31.5 62.0 14.7 14.3 15.3 24.7 20.4 12.6 36.3 15.4 32.2 51.0 13.2 36.3 19.2 26.1 66.0 51.2 23.8 15.6 49.6 46.7 15.8 15.9 45.2 21.1 17.1 66.7 46.8 55.7 15.6 141.5 58.2 38.4 44.8 51.5 68.4 78.3 86.5 62.6 60.3 62.2 42.6 96.2 91.3 43.7 72.7 46.3 101.7 43.7 69.3 71.3 181.4 34.9 47.2 30.6 38.3 58.1 87.2 60.7 53.7 81.5 48.9 93.7 72.1 67.6 58.3 45.9 176.9 84.7 101.5 77.7 76.5 42.0 75.9 82.8 59.4 50.1 53.9 157.6 112.9 56.4 37.4 68.9 102.3 89.0 46.5 78.0 70.0 90.0 111.9 57.4 66.7 66.1 94.3 104.4 68.6 40.1 50.9 81.3 34.2 20.7 21.1 34.7 33.0 37.6 33.5 33.7 35.3 23.9 26.6 23.0 29.6 14.7 29.1 31.4 15.8 36.2 23.4 13.4 14.2 15.2 15.3 11.8 14.3 14.7 14.3 15.4 15.6 15.9 15.6 102.9 51.3 29.9 2.9 233.7 599.8 529.1 47.9 231.6 22.9 154.4 80.1 18.5 127.2 47.6 101.2 2.1 152.7 298.8 276.0 158.5 125.4 5.8 95.6 98.5 117.1 99.3 140.1 5.3 80.0 208.1 94.9 115.7 143.7 79.9 40.3 108.5 143.3 168.0 33.7 5.9 167.0 20.3 195.6 716.1 8.3 33.5 184.5 304.1 15.0 204.9 42.2 192.6 6.0 8.9 130.4 161.6 32.7 182.4 443.4 190.8 166.5 30.3 21.6 46.0 68.8 90.7 62.7 48.7 361.4 673.3 202.9 311.0 52.6 182.5 703.8 VCPKMT "C14orf138, METTL21D, VCP-KMT" ENSG00000100483 "Valosin containing protein lysine methyltransferase" Q9H867 14 50108632-50116600 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001146, HPA076561" Uncertain Supported Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" Cytosol "HPA001146: AB_1845558, HPA076561: AB_2732312" "unprognostic (1.58e-1)" "unprognostic (2.87e-2)" "unprognostic (5.05e-2)" "unprognostic (3.86e-1)" "unprognostic (3.54e-1)" "unprognostic (4.74e-2)" "unprognostic (9.97e-2)" "prognostic favorable (2.40e-4)" "unprognostic (8.20e-2)" "unprognostic (1.74e-1)" "unprognostic (4.90e-2)" "prognostic unfavorable (4.75e-4)" "prognostic unfavorable (6.79e-4)" "unprognostic (1.15e-1)" "unprognostic (1.48e-1)" "unprognostic (1.66e-1)" "unprognostic (6.27e-2)" 2.9 4.1 1.7 3.4 2.1 5.1 2.3 2.4 5.3 3.7 3.0 3.3 1.7 3.0 2.6 4.9 2.9 2.3 2.7 2.5 2.0 2.7 3.9 3.1 4.3 2.0 1.9 2.6 2.9 1.9 3.3 1.6 2.0 2.7 1.6 1.5 2.2 1.6 2.3 3.9 3.2 1.5 1.5 4.8 3.6 2.1 2.2 4.7 2.6 1.8 4.4 3.0 3.2 2.5 4.2 4.4 4.0 4.9 2.6 3.1 4.4 4.0 4.4 4.4 3.3 2.8 4.8 12.8 2.7 2.8 1.1 7.9 4.9 7.0 4.4 6.4 3.2 2.5 1.7 2.8 3.6 6.4 3.3 2.0 3.9 4.8 4.9 3.0 5.5 4.6 3.0 5.3 3.3 5.5 13.4 6.7 3.9 6.1 7.2 9.0 7.4 3.4 5.6 6.3 6.7 7.9 5.9 1.6 7.1 3.6 4.0 5.7 1.4 7.2 5.6 2.6 4.5 5.1 11.4 5.0 2.5 5.2 3.5 12.1 2.8 0.0 9.3 4.7 10.9 27.1 9.1 11.5 3.8 21.4 11.2 12.4 0.8 11.8 2.2 5.4 7.8 4.8 1.7 2.1 2.4 5.3 2.5 2.0 2.0 1.9 2.0 1.5 2.2 2.5 11.5 12.8 9.8 7.8 38.0 30.3 17.3 7.7 30.1 6.5 12.8 10.8 3.6 8.6 9.7 7.3 10.4 10.2 25.7 5.6 9.8 5.8 39.4 14.1 9.8 8.3 5.4 9.5 12.6 5.7 8.4 9.3 7.7 17.1 17.7 7.2 6.8 7.7 5.1 1.7 11.0 8.5 12.2 7.5 16.4 10.2 7.5 8.7 10.6 3.7 9.5 3.5 15.5 10.6 17.5 5.3 8.0 4.9 48.2 15.5 7.8 6.7 8.6 8.1 0.0 9.1 9.1 14.4 16.6 24.9 37.4 11.5 22.4 10.2 7.1 17.1 SOS2 ENSG00000100485 "SOS Ras/Rho guanine nucleotide exchange factor 2" Q07890 14 50117130-50231578 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 8.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004577, HPA047368, HPA052689" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 8: Non-specific - Mitochondria" "Cluster 2: Karpas-707 - Immune response" "Cluster 44: Endometrium - Transcription" Nucleoplasm Vesicles "CAB004577: AB_628270, HPA047368: AB_2680014, HPA052689: AB_2681917" "unprognostic (7.99e-2)" "unprognostic (6.17e-2)" "unprognostic (7.80e-2)" "unprognostic (4.93e-2)" "unprognostic (2.81e-2)" "unprognostic (7.64e-2)" "unprognostic (1.56e-1)" "unprognostic (3.08e-1)" "unprognostic (2.01e-1)" "unprognostic (3.88e-1)" "unprognostic (9.99e-2)" "unprognostic (8.21e-2)" "prognostic favorable (8.48e-8)" "unprognostic (2.47e-2)" "unprognostic (1.91e-1)" "unprognostic (1.01e-1)" "unprognostic (6.57e-2)" 23.8 14.9 15.3 15.3 21.4 39.5 17.9 18.2 19.5 14.3 13.5 17.4 21.5 15.2 22.4 16.4 12.7 12.9 21.5 14.0 16.8 24.5 13.2 15.8 14.4 19.7 18.6 15.3 15.9 39.3 9.1 17.0 19.1 15.4 17.3 14.0 14.5 18.7 57.6 17.9 24.5 18.0 16.8 17.8 13.7 27.9 19.6 16.5 25.1 63.8 13.5 14.8 10.5 23.9 15.3 11.1 22.1 14.9 16.6 18.0 10.4 13.5 14.8 10.0 12.5 4.9 19.8 16.0 11.9 17.3 17.3 13.8 12.1 10.2 17.7 26.9 4.4 16.1 8.5 8.5 18.3 19.1 16.6 18.8 24.6 9.3 21.6 25.2 21.8 13.1 12.5 39.0 24.2 12.7 15.9 15.1 6.9 11.4 9.6 17.0 30.8 12.1 16.1 14.4 16.0 18.7 15.0 17.5 17.8 15.9 19.4 23.0 24.1 27.3 17.8 12.5 8.9 27.3 31.7 19.6 7.1 10.5 16.4 8.0 1.1 2.8 1.1 0.9 0.9 0.6 0.7 0.8 0.8 0.7 0.8 0.7 4.6 1.7 2.0 1.4 0.0 0.4 15.3 21.4 18.2 19.5 14.0 16.8 19.7 18.6 19.1 16.8 19.6 23.9 34.1 9.6 26.3 59.4 18.4 35.7 20.9 10.5 10.2 17.2 23.8 15.6 43.7 17.2 18.2 18.4 16.7 8.2 46.3 36.0 7.9 11.3 17.0 18.7 30.4 23.5 20.4 6.3 71.5 10.7 8.0 22.2 12.8 29.8 20.3 37.4 22.9 13.8 8.8 25.2 89.6 18.5 12.2 33.3 17.5 8.6 12.5 29.0 17.8 80.6 29.0 17.6 21.6 100.5 104.8 14.5 24.6 13.5 28.6 27.3 28.6 15.8 14.3 22.5 19.7 43.4 30.8 54.3 12.3 17.7 39.6 13.0 24.2 17.4 14.9 30.6 L2HGDH "C14orf160, FLJ12618" ENSG00000087299 "L-2-hydroxyglutarate dehydrogenase" Q9H9P8 14 50237563-50312229 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 56.3;Excitatory neurons: 60.5;Inhibitory neurons: 61.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 8.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065409, HPA069708" Approved Enhanced Mitochondria NA NA "Cluster 46: Basophils - DNA binding" "Cluster 8: Non-specific - Mitochondria" "Cluster 36: HEL - Hemostasis" "Cluster 9: Photoreceptor cells - Phototransduction" Mitochondria "HPA065409: AB_2685485, HPA069708: AB_2686179" "unprognostic (1.74e-1)" "unprognostic (1.15e-2)" "unprognostic (1.13e-2)" "unprognostic (1.23e-3)" "unprognostic (1.04e-2)" "unprognostic (4.33e-2)" "unprognostic (8.84e-2)" "unprognostic (1.58e-2)" "unprognostic (4.17e-2)" "unprognostic (9.91e-2)" "unprognostic (2.84e-1)" "unprognostic (1.97e-1)" "prognostic favorable (9.75e-10)" "unprognostic (1.24e-2)" "unprognostic (5.88e-2)" "unprognostic (1.45e-1)" "unprognostic (1.02e-2)" 4.6 2.5 2.9 2.2 2.9 2.7 3.7 6.1 5.5 2.3 1.3 4.3 4.7 2.4 3.0 5.1 3.1 2.0 5.2 2.7 2.5 19.6 12.6 1.8 2.6 1.2 2.4 2.5 3.9 6.1 2.3 1.7 1.1 3.3 5.0 11.4 2.8 3.2 15.5 5.1 3.6 2.5 1.2 1.3 4.3 3.9 2.4 3.0 4.8 14.7 3.4 2.4 2.3 4.1 24.3 16.6 6.8 6.6 3.3 2.2 19.1 7.9 4.4 12.2 14.3 26.8 10.8 19.0 9.0 3.2 9.7 17.4 20.6 8.2 13.5 15.2 11.9 41.1 10.9 3.7 3.1 14.7 13.7 2.0 5.2 8.1 7.0 3.1 5.3 19.3 14.7 11.6 3.2 29.0 16.7 6.7 9.9 20.6 17.6 15.6 22.0 14.8 11.4 28.0 13.8 9.9 23.3 17.5 10.4 9.0 22.9 4.0 5.0 7.7 21.5 9.0 10.6 10.5 25.6 26.3 4.3 7.3 8.8 8.6 0.4 0.9 0.9 0.1 2.2 0.8 1.1 1.0 0.6 0.6 1.3 1.7 0.5 1.7 0.1 1.0 1.6 0.5 2.9 2.9 6.1 5.5 2.7 2.5 1.2 2.4 1.1 1.2 2.4 4.1 1.9 41.7 19.2 16.6 5.1 3.7 2.7 2.1 8.6 15.5 3.9 2.2 14.7 2.8 20.4 12.9 56.3 6.4 6.1 4.8 15.6 3.8 35.1 5.2 2.8 4.6 7.8 7.4 60.5 4.2 6.6 5.3 7.7 5.6 18.9 6.0 2.9 14.2 2.1 11.8 61.4 4.3 0.0 2.7 0.6 8.8 2.5 3.3 1.8 13.1 2.4 6.1 7.2 20.6 18.9 2.5 3.6 4.5 3.3 2.7 6.0 21.7 18.4 40.3 0.0 5.8 3.9 14.3 12.6 10.5 6.3 4.9 5.0 4.6 7.6 2.1 DMAC2L "ATP5S, ATPW, HSU79253" ENSG00000125375 "Distal membrane arm assembly complex 2 like" Q99766 14 50312324-50335558 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 60.5;Cytotrophoblasts: 36.6;Extravillous trophoblasts: 24.6;Hofbauer cells: 28.5;Syncytiotrophoblasts: 41.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062690 Approved Nucleoplasm,Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 2: Karpas-707 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Mitochondria" "HPA062690: AB_2684836" "unprognostic (2.24e-2)" "unprognostic (3.44e-3)" "unprognostic (7.85e-2)" "unprognostic (1.71e-1)" "unprognostic (8.53e-3)" "unprognostic (2.92e-2)" "unprognostic (2.21e-1)" "prognostic favorable (5.53e-4)" "unprognostic (5.73e-2)" "unprognostic (2.98e-1)" "unprognostic (1.02e-3)" "unprognostic (1.91e-1)" "prognostic favorable (2.37e-8)" "unprognostic (5.64e-2)" "unprognostic (1.67e-1)" "unprognostic (1.72e-1)" "unprognostic (2.95e-1)" 8.0 5.6 3.9 5.5 6.2 13.5 8.6 4.1 5.7 6.9 3.0 6.8 10.3 6.3 7.1 10.0 5.2 6.9 10.0 3.4 4.3 8.0 7.5 5.4 8.6 5.4 4.9 4.7 10.8 8.8 3.8 3.7 5.1 6.2 6.3 10.1 6.7 5.0 15.7 10.8 7.3 3.8 4.7 5.9 6.3 15.4 4.2 6.3 12.9 8.9 7.6 7.2 4.2 9.7 18.8 6.7 8.5 5.6 7.2 11.8 18.8 5.9 8.5 11.4 13.3 9.5 10.4 21.1 5.9 8.8 5.4 10.9 2.3 6.3 6.8 10.9 5.0 9.1 5.4 22.5 5.6 20.6 17.6 12.0 11.3 3.5 6.5 3.0 8.9 14.3 5.4 25.9 8.0 14.2 5.2 7.7 6.2 14.0 7.7 10.2 9.6 8.7 9.1 20.4 11.2 9.1 6.9 14.5 13.4 3.1 18.6 10.4 4.2 11.3 15.4 5.3 7.4 13.2 12.4 12.2 3.4 10.2 10.4 20.5 13.1 19.8 14.3 15.6 12.4 19.3 11.7 13.5 9.9 17.1 13.8 15.4 2.5 12.3 20.4 19.0 14.5 12.5 3.9 6.2 4.1 5.7 3.4 4.3 5.4 4.9 5.1 4.7 4.2 9.7 9.4 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.5 0.0 0.0 0.0 0.0 36.6 12.5 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 24.6 6.3 0.0 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 41.7 1.9 0.0 0.0 0.0 CDKL1 KKIALRE ENSG00000100490 "Cyclin dependent kinase like 1" Q00532 14 50326265-50416461 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 23.4;Excitatory neurons: 46.2;Oligodendrocyte precursor cells: 46.8;Oligodendrocytes: 25.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 18.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059605, HPA065919" Uncertain Enhanced Nucleoplasm,Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm Vesicles "HPA059605: AB_2684080, HPA065919: AB_2685578" "unprognostic (4.12e-3)" "unprognostic (3.22e-1)" "unprognostic (4.54e-2)" "unprognostic (8.04e-2)" "unprognostic (1.64e-2)" "unprognostic (1.02e-1)" "unprognostic (3.23e-3)" "unprognostic (9.36e-3)" "unprognostic (2.63e-1)" "unprognostic (9.99e-2)" "unprognostic (1.20e-1)" "unprognostic (9.36e-2)" "unprognostic (5.53e-8)" "unprognostic (1.21e-1)" "unprognostic (7.96e-2)" "unprognostic (9.39e-3)" "unprognostic (3.31e-3)" 13.5 3.6 3.4 4.9 4.4 3.6 3.5 1.4 9.0 13.9 3.7 8.8 13.2 13.9 3.2 5.2 15.4 5.2 2.3 5.5 2.3 19.4 1.6 6.5 6.5 2.0 2.1 13.8 1.3 1.2 0.6 6.5 2.9 5.9 6.6 20.2 2.8 9.0 7.1 13.5 6.9 8.5 2.9 7.0 4.9 2.0 1.8 1.9 7.9 1.0 2.6 6.9 6.6 8.1 7.7 4.9 3.5 4.3 5.3 6.1 2.3 2.2 3.2 1.9 2.0 4.0 5.9 6.1 2.8 3.2 3.2 5.9 0.8 0.3 1.9 8.9 3.1 12.2 4.6 3.9 6.2 9.7 5.3 1.5 3.0 3.2 8.0 2.4 6.7 10.3 3.3 4.8 1.1 2.5 2.8 4.7 1.9 2.6 3.9 3.3 3.8 3.1 5.3 6.6 4.6 3.4 4.2 18.3 2.1 1.3 2.4 6.2 4.0 6.7 4.1 7.1 5.0 2.4 1.8 2.9 1.7 8.7 7.6 3.2 1.4 2.6 3.5 1.4 3.1 2.6 2.3 3.2 0.8 3.0 1.9 1.9 0.7 2.3 0.2 0.8 2.4 1.3 3.4 4.4 1.4 9.0 5.5 2.3 2.0 2.1 2.9 2.9 1.8 8.1 3.2 19.2 9.9 6.5 3.0 3.1 4.1 0.2 3.4 0.7 0.4 0.5 0.5 0.0 2.6 11.0 0.0 0.1 2.3 7.2 5.9 1.4 0.4 23.4 9.6 3.3 1.8 6.1 46.2 1.8 0.1 7.6 1.1 4.9 1.3 3.2 6.4 0.3 0.4 0.0 20.6 2.1 2.0 0.9 1.5 1.5 9.0 1.5 0.0 7.5 0.8 0.9 2.1 46.8 25.4 1.9 4.8 3.4 0.2 3.1 4.9 8.0 20.4 0.7 0.0 4.0 4.6 0.0 0.3 4.7 2.7 0.3 4.2 3.6 5.2 2.2 MAP4K5 "GCKR, KHS, KHS1" ENSG00000012983 "Mitogen-activated protein kinase kinase kinase kinase 5" Q9Y4K4 14 50418501-50561126 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 332.7;Oligodendrocytes: 707.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 66.7;eosinophil: 26.3" "Lineage enriched" "Detected in all" 7 "granulocytes: 66.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036696, HPA078030" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 70: Brain - Nervous system development" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Cytosol "Plasma membrane" "HPA036696: AB_10672362, HPA078030: " "unprognostic (1.39e-1)" "unprognostic (1.00e-1)" "unprognostic (3.80e-1)" "unprognostic (1.66e-1)" "unprognostic (4.41e-2)" "unprognostic (1.43e-1)" "unprognostic (8.58e-3)" "unprognostic (4.13e-2)" "unprognostic (6.31e-2)" "unprognostic (2.24e-2)" "unprognostic (1.53e-3)" "unprognostic (7.34e-2)" "unprognostic (1.78e-2)" "unprognostic (3.71e-2)" "unprognostic (1.40e-1)" "unprognostic (9.58e-3)" "unprognostic (2.02e-2)" 20.5 12.8 16.2 13.2 31.1 22.1 22.2 20.7 21.5 30.6 3.9 20.8 13.1 33.4 12.9 20.5 19.0 21.5 10.9 18.3 23.9 11.9 10.0 17.1 12.4 28.4 22.0 32.4 14.2 14.8 11.8 19.8 24.8 17.9 16.6 18.6 18.0 21.1 12.3 28.5 14.7 24.7 17.6 15.7 16.8 7.9 23.8 11.6 17.0 14.2 13.2 20.2 23.8 58.1 51.7 15.2 36.5 31.5 33.0 34.5 35.6 59.2 53.0 39.4 34.9 19.3 35.2 35.3 34.3 54.6 20.9 36.1 34.3 31.9 59.7 29.4 24.8 21.7 27.1 17.5 27.9 19.6 33.0 25.2 25.7 34.8 36.1 63.0 52.6 31.7 20.8 22.5 58.6 19.4 26.6 18.7 17.7 16.6 29.5 31.8 55.4 13.5 39.2 39.5 11.7 26.5 33.5 23.0 23.4 29.3 25.8 14.7 53.8 50.9 35.7 35.2 28.2 16.3 18.0 23.6 19.2 13.5 37.2 66.7 2.8 26.3 6.7 3.3 3.8 6.1 4.2 5.9 3.0 9.7 4.4 4.6 1.0 10.1 2.2 4.9 1.0 1.9 16.2 31.1 20.7 21.5 18.3 23.9 28.4 22.0 24.8 17.6 23.8 58.1 40.5 41.7 20.8 135.2 29.9 70.0 42.9 21.4 56.3 56.7 32.6 26.5 10.5 30.0 27.4 27.6 47.9 11.4 30.6 27.5 19.6 29.5 3.7 25.7 52.2 40.4 23.4 46.7 144.2 20.9 19.5 50.1 43.8 49.1 29.8 37.8 38.6 9.0 8.1 33.7 144.1 16.4 8.2 12.3 24.8 3.7 42.6 25.1 23.2 101.2 18.3 19.5 18.6 332.7 707.2 25.9 20.2 51.1 27.0 57.4 10.9 12.0 25.6 33.1 13.1 49.7 41.7 10.6 14.1 54.9 86.1 6.6 31.5 22.4 18.6 61.7 ATL1 "AD-FSP, FSP1, SPG3, SPG3A" ENSG00000198513 "Atlastin GTPase 1" Q8WXF7 14 50532509-50634017 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hydrolase "Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 138.6;Inhibitory neurons: 95.5;Oligodendrocyte precursor cells: 81.4;Oligodendrocytes: 136.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 22.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 22.9" "Cell line enhanced" "Detected in many" "HDLM-2: 19.8;SCLC-21H: 17.1;SH-SY5Y: 15.4;SiHa: 18.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027550 Enhanced NA NA "Cluster 38: Basophils - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 44: HDLM-2 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA027550: AB_10600983" "unprognostic (2.06e-2)" "unprognostic (7.57e-3)" "unprognostic (1.82e-1)" "unprognostic (7.93e-2)" "unprognostic (2.44e-1)" "unprognostic (1.38e-1)" "unprognostic (2.29e-1)" "unprognostic (1.88e-1)" "unprognostic (7.31e-2)" "unprognostic (1.52e-1)" "unprognostic (1.09e-1)" "unprognostic (6.50e-2)" "unprognostic (1.22e-2)" "unprognostic (3.59e-2)" "unprognostic (2.39e-1)" "unprognostic (4.95e-2)" "unprognostic (1.23e-2)" 4.1 5.6 29.1 3.3 33.2 0.2 11.3 18.8 42.8 5.7 2.2 8.1 3.9 9.0 2.9 5.3 6.5 4.8 2.1 37.1 30.3 4.0 0.3 4.3 1.7 25.2 21.5 10.5 3.7 1.9 7.7 0.5 29.6 8.3 5.6 9.5 13.2 8.6 1.1 9.6 4.9 15.6 24.9 1.1 4.6 8.7 25.0 1.1 2.5 2.2 1.8 6.7 5.3 30.0 1.2 1.1 4.8 4.6 0.3 0.0 3.4 5.7 9.6 6.2 7.4 0.0 4.1 3.7 2.5 0.1 4.5 1.4 8.4 1.1 2.4 19.8 1.8 1.2 0.8 0.3 0.2 0.2 3.1 3.6 1.9 8.6 1.6 0.3 0.4 4.2 0.1 0.5 8.7 0.4 1.2 0.6 4.4 1.4 1.5 0.6 12.1 0.4 1.7 2.5 17.1 15.4 18.9 1.1 0.6 0.0 0.0 2.1 1.3 6.0 4.6 0.0 2.9 0.9 4.7 1.7 3.9 0.2 0.2 22.9 0.1 4.9 2.5 0.0 0.5 3.8 0.9 2.1 1.2 1.1 2.1 4.2 0.3 0.6 0.5 2.8 0.4 2.0 29.1 33.2 18.8 42.8 37.1 30.3 25.2 21.5 29.6 24.9 25.0 30.0 3.0 6.4 2.6 31.6 3.7 5.1 6.2 10.3 6.2 27.8 18.1 16.3 1.9 5.7 6.6 5.5 0.0 0.4 6.7 9.3 0.0 10.6 31.4 4.2 5.4 4.8 7.2 0.4 138.6 13.1 1.1 14.6 5.6 2.3 6.3 1.2 5.0 0.0 1.6 11.8 95.5 1.9 2.0 0.0 3.6 5.7 13.4 5.5 8.8 20.6 1.3 23.0 2.1 81.4 136.7 7.2 6.0 17.0 5.2 3.9 13.2 3.4 14.2 8.6 19.7 4.5 10.8 31.9 5.7 4.1 5.5 0.1 3.8 0.2 3.6 3.3 SAV1 "salvador, WW45, WWP4" ENSG00000151748 "Salvador family WW domain containing protein 1" Q9H4B6 14 50632058-50668306 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001808 Approved Supported Cytosol NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 50: Fibroblasts - ECM organization" Cytosol "HPA001808: AB_2666441" "prognostic favorable (2.92e-5)" "unprognostic (5.17e-2)" "unprognostic (1.24e-1)" "unprognostic (1.52e-2)" "unprognostic (4.38e-1)" "unprognostic (1.42e-1)" "unprognostic (1.44e-3)" "unprognostic (3.00e-2)" "unprognostic (1.82e-1)" "unprognostic (1.37e-1)" "unprognostic (1.41e-3)" "unprognostic (5.20e-2)" "prognostic favorable (3.83e-6)" "unprognostic (2.32e-1)" "unprognostic (2.05e-1)" "unprognostic (1.28e-2)" "unprognostic (1.90e-3)" 32.2 16.4 14.0 12.8 16.7 7.3 35.3 15.1 16.9 24.5 22.0 17.0 15.3 23.3 18.8 15.8 21.2 26.2 24.2 12.8 15.0 22.9 17.6 20.2 15.7 16.5 15.1 37.7 34.4 27.0 8.5 17.0 16.1 27.6 12.6 17.6 45.5 19.2 23.1 17.8 13.2 17.7 14.7 18.6 18.9 30.6 16.6 10.3 34.2 27.1 14.7 16.7 18.7 19.6 96.3 10.7 17.8 12.4 43.5 39.8 22.4 26.6 87.3 34.1 43.4 16.0 47.8 14.9 63.9 26.4 17.8 42.8 25.7 28.9 62.9 45.6 20.8 16.4 16.4 11.4 21.3 17.9 14.0 24.9 36.5 15.3 33.8 25.8 24.5 15.9 27.5 7.2 42.5 17.9 15.1 11.0 33.1 21.6 17.3 17.2 49.5 6.1 21.5 13.6 22.2 16.8 47.1 27.7 41.3 28.9 20.3 18.0 17.7 16.2 55.5 22.4 16.4 11.3 15.4 9.0 11.1 7.2 22.1 0.6 0.3 0.0 0.9 0.3 0.9 3.3 0.7 0.5 0.3 3.4 0.5 0.7 0.5 0.5 0.4 1.2 1.0 0.4 14.0 16.7 15.1 16.9 12.8 15.0 16.5 15.1 16.1 14.7 16.6 19.6 76.4 35.3 44.0 9.4 35.8 65.9 37.2 19.1 24.5 19.6 76.4 60.6 39.1 15.7 35.1 18.4 25.0 19.9 14.7 11.2 17.6 40.5 92.5 39.6 47.3 76.9 5.4 27.0 10.4 47.6 23.0 59.3 11.7 58.1 2.5 46.4 59.3 14.5 10.5 5.0 10.0 10.1 10.2 13.5 61.5 26.1 66.8 34.1 30.2 12.2 11.6 26.9 2.1 12.5 27.0 66.5 14.6 42.5 7.4 81.4 12.1 16.3 33.3 26.4 6.6 41.8 45.1 41.4 38.8 14.6 59.5 23.1 9.4 17.7 9.6 34.1 NIN ENSG00000100503 Ninein Q8N4C6 14 50719763-50831162 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 43.2" "Cell type enhanced" "Detected in many" "Excitatory neurons: 240.5;Muller glia cells: 150.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "basophil: 31.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005939, HPA070691" Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Centrosome" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoli, Nucleoli rim, Centrosome" Nucleoplasm "HPA005939: AB_2667474, HPA070691: AB_2686296" "unprognostic (1.98e-1)" "unprognostic (1.06e-1)" "unprognostic (3.54e-2)" "unprognostic (3.96e-1)" "unprognostic (1.52e-1)" "unprognostic (1.43e-2)" "unprognostic (3.41e-2)" "unprognostic (3.31e-1)" "unprognostic (5.81e-3)" "unprognostic (1.78e-2)" "unprognostic (2.07e-1)" "unprognostic (4.06e-1)" "unprognostic (2.46e-2)" "unprognostic (2.67e-1)" "unprognostic (1.28e-1)" "unprognostic (2.58e-2)" "unprognostic (7.66e-3)" 11.2 4.4 10.1 19.9 10.8 43.2 8.9 9.5 15.0 7.2 0.0 8.3 4.8 7.7 2.8 12.9 10.5 8.9 18.2 10.4 0.9 6.7 5.7 9.5 25.9 0.0 1.3 9.7 7.2 9.0 8.9 16.8 0.0 6.9 8.6 19.1 5.4 5.4 6.0 12.9 7.1 10.3 0.0 16.2 9.3 5.2 3.0 19.9 7.7 7.4 23.7 13.6 5.7 7.5 29.1 21.6 42.4 36.8 16.7 26.8 20.4 26.5 22.1 21.4 18.0 14.7 14.6 48.5 17.7 35.5 19.9 32.5 34.2 16.3 45.3 34.7 10.4 25.1 13.2 12.3 9.8 41.6 57.5 18.4 11.4 37.2 14.9 13.3 34.6 25.9 6.6 26.3 31.8 36.8 22.6 14.0 6.4 10.1 23.6 37.1 81.6 5.7 20.1 42.9 18.6 22.2 34.0 9.6 25.1 10.2 21.2 39.3 50.9 55.2 74.3 20.5 29.0 18.6 12.1 34.3 14.4 32.8 30.4 31.9 2.9 24.0 3.9 2.5 3.3 8.9 2.4 6.2 2.0 6.2 5.1 4.7 9.6 2.9 2.1 7.7 2.5 1.4 10.1 10.8 9.5 15.0 10.4 0.9 0.0 1.3 0.0 0.0 3.0 7.5 34.0 6.4 7.7 100.2 85.6 18.4 9.1 10.2 18.8 13.3 13.3 10.9 68.0 14.3 27.1 11.0 62.6 12.4 102.7 8.7 3.9 7.3 22.2 17.3 28.5 26.7 12.6 29.0 240.5 4.2 11.3 32.9 7.7 14.9 31.6 3.9 21.8 4.4 22.7 6.7 110.4 5.7 20.3 46.8 42.2 10.4 8.4 61.3 23.2 63.7 63.2 150.2 57.7 105.6 75.1 5.2 6.2 9.4 48.1 16.5 3.2 7.3 29.4 21.0 32.9 44.9 24.1 0.2 4.3 20.1 21.0 9.7 56.2 21.8 6.9 15.5 PYGL GSD6 ENSG00000100504 "Glycogen phosphorylase L" P06737 14 50857891-50944483 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Allosteric enzyme, Glycosyltransferase, Transferase" "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 145.6" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 151.2;Hofbauer cells: 177.6;Muller glia cells: 265.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 141.1;neutrophil: 153.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 279.1;HMC-1: 304.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000962, HPA004119" Enhanced Supported "Plasma membrane,Cytosol" NA NA 16000000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 5: Muller glia cells - Visual perception" "Plasma membrane, Cytosol" "HPA000962: AB_1079722, HPA004119: AB_1079723" "unprognostic (2.70e-2)" "unprognostic (8.64e-3)" "unprognostic (1.46e-2)" "unprognostic (8.55e-2)" "unprognostic (9.41e-2)" "prognostic unfavorable (5.97e-4)" "unprognostic (1.66e-1)" "unprognostic (1.34e-2)" "unprognostic (3.34e-1)" "unprognostic (1.94e-2)" "prognostic unfavorable (2.63e-4)" "unprognostic (4.45e-3)" "unprognostic (3.15e-3)" "unprognostic (1.95e-2)" "unprognostic (1.76e-1)" "unprognostic (9.72e-2)" "unprognostic (1.12e-3)" 110.1 21.0 5.9 24.1 6.6 108.9 36.4 5.0 8.4 33.6 10.4 19.0 3.7 20.7 6.4 55.8 19.1 13.0 14.9 5.2 6.2 10.2 145.6 26.1 6.3 10.7 17.6 18.2 5.7 21.1 7.5 49.3 8.7 13.0 24.0 78.2 26.8 29.7 5.1 37.0 8.4 26.7 8.6 49.4 9.6 5.2 9.0 4.8 10.2 5.8 6.8 41.7 38.1 10.3 145.7 40.8 10.1 64.3 47.0 56.2 114.5 28.6 24.1 77.4 117.3 107.4 18.3 0.1 54.4 171.7 91.2 279.1 107.0 144.8 132.0 0.5 46.8 28.0 60.5 82.4 83.8 106.9 304.4 119.4 56.8 104.1 43.6 75.4 69.3 0.8 11.6 0.5 55.4 144.7 0.4 141.7 39.3 12.8 152.0 2.7 36.2 6.1 104.7 95.1 4.5 4.4 131.0 43.3 1.7 38.6 20.6 200.4 3.2 29.7 49.6 56.0 92.9 1.2 0.3 0.5 27.3 107.7 15.9 50.2 55.9 141.1 0.0 24.2 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 153.7 0.6 15.7 1.2 0.2 24.8 5.9 6.6 5.0 8.4 5.2 6.2 10.7 17.6 8.7 8.6 9.0 10.3 6.7 22.4 6.3 1.3 1.8 30.7 10.5 40.5 6.8 4.6 7.0 3.8 3.4 5.7 35.4 7.3 0.0 28.9 0.2 11.2 3.9 10.9 1.0 35.4 18.9 7.8 1.2 9.0 1.8 2.1 151.2 18.8 6.6 62.6 6.3 9.3 8.2 65.4 177.6 1.7 2.2 7.1 14.2 56.7 7.9 1.5 14.3 54.6 19.6 15.9 52.4 265.1 2.1 14.1 0.6 7.4 5.2 21.8 1.8 9.7 0.0 6.4 24.5 11.9 6.6 15.4 8.8 0.7 1.4 22.4 22.3 21.1 2.3 4.0 14.0 9.2 ABHD12B "BEM46L3, C14orf29" ENSG00000131969 "Abhydrolase domain containing 12B" Q7Z5M8 14 50872053-50904970 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 6.8;retina: 15.6;skin 1: 10.5" "Cell type enriched" "Detected in some" 7 "Muller glia cells: 188.1" "Cancer enriched" "Detected in many" 5 "testis cancer: 7.6" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "eosinophil: 1.0;neutrophil: 2.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.1" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "thalamus: 2.1" "Low region specificity" "Detected in many" HPA002873 Uncertain Uncertain Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 5: Muller glia cells - Visual perception" Nucleoplasm "HPA002873: AB_2220573" "unprognostic (6.61e-2)" "unprognostic (3.49e-2)" "unprognostic (2.92e-3)" "unprognostic (1.99e-3)" "unprognostic (4.63e-2)" "unprognostic (1.17e-2)" "unprognostic (1.62e-2)" "unprognostic (2.09e-1)" "unprognostic (4.31e-2)" "unprognostic (6.27e-2)" "unprognostic (3.30e-1)" "unprognostic (3.35e-1)" "unprognostic (1.70e-3)" "unprognostic (3.16e-2)" "unprognostic (9.62e-2)" "unprognostic (3.18e-3)" "unprognostic (1.68e-1)" 0.5 0.0 2.7 0.1 6.5 1.6 1.3 0.0 2.6 0.0 0.9 0.7 0.0 0.3 0.0 0.2 1.0 0.1 0.1 1.4 1.7 0.2 0.0 0.3 0.1 0.2 5.0 0.0 0.0 0.2 0.1 0.1 1.4 0.0 1.0 15.6 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.6 6.8 0.3 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 2.7 6.5 0.0 2.6 1.4 1.7 0.2 5.0 1.4 0.0 6.8 1.0 2.4 0.0 0.0 0.3 0.1 0.4 0.1 1.5 0.0 3.4 0.1 0.1 1.9 0.0 5.0 1.8 2.1 0.1 0.0 2.2 0.0 0.0 7.7 2.5 0.2 0.7 0.0 0.0 9.9 0.0 0.0 0.7 0.0 0.6 1.3 0.0 0.0 0.0 0.1 0.0 0.7 1.0 4.1 0.0 0.0 5.8 1.2 0.1 0.0 0.0 0.0 188.1 0.0 1.0 4.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 26.4 18.1 0.0 0.1 1.2 0.3 0.2 0.0 1.4 0.3 0.1 0.0 1.8 0.2 TRIM9 "RNF91, SPRING" ENSG00000100505 "Tripartite motif containing 9" Q9C026 14 50975262-51096061 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.3;retina: 20.9" "Cell type enhanced" "Detected in some" "Astrocytes: 324.2;Excitatory neurons: 545.6;Inhibitory neurons: 381.1;Oligodendrocyte precursor cells: 582.1;Oligodendrocytes: 143.7" "Cancer enriched" "Detected in some" 8 "glioma: 25.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 32.2;HAP1: 23.0;HDLM-2: 36.5;SCLC-21H: 32.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 6: Brain - Smell perception" "Cluster 44: HDLM-2 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "unprognostic (1.22e-1)" "unprognostic (6.37e-2)" "unprognostic (1.17e-1)" "unprognostic (1.10e-3)" "unprognostic (6.67e-2)" "unprognostic (1.13e-2)" "unprognostic (2.24e-3)" "unprognostic (7.66e-2)" "unprognostic (1.88e-1)" "unprognostic (3.06e-2)" "unprognostic (2.38e-3)" "unprognostic (1.06e-1)" "unprognostic (1.20e-1)" "unprognostic (1.55e-1)" "unprognostic (9.00e-2)" "unprognostic (7.57e-6)" "unprognostic (1.85e-3)" 0.9 2.1 31.1 1.2 39.6 0.9 1.2 63.3 45.5 3.7 0.0 6.3 0.2 4.6 1.3 0.4 0.8 4.4 1.2 45.6 14.1 1.0 2.3 0.5 0.2 12.4 18.9 1.3 0.6 0.1 13.5 0.3 12.3 0.8 0.9 20.9 2.1 3.1 0.6 0.9 1.2 3.2 12.4 0.3 1.0 1.0 28.0 0.9 0.5 0.4 0.2 0.7 1.8 32.3 0.0 3.7 5.7 32.2 0.0 0.0 2.1 0.0 0.0 0.4 0.9 2.5 0.3 0.4 0.2 0.5 5.5 0.1 23.0 0.0 0.9 36.5 4.6 1.8 0.1 0.0 0.0 1.3 1.2 0.9 0.0 0.6 0.0 0.1 0.0 3.1 0.0 0.2 0.9 0.1 7.2 0.9 1.9 0.1 4.9 4.2 8.3 0.2 0.1 0.0 32.7 2.6 0.5 0.1 7.3 0.3 0.5 0.9 0.0 2.1 0.9 0.0 1.5 0.6 0.1 0.4 9.6 0.9 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.1 39.6 63.3 45.5 45.6 14.1 12.4 18.9 12.3 12.4 28.0 32.3 0.1 0.0 0.0 324.2 0.2 0.5 0.1 0.2 0.6 51.5 0.6 4.3 1.4 1.5 0.0 0.0 33.3 0.4 0.0 2.2 1.9 0.3 0.2 0.3 0.3 0.4 1.2 0.0 545.6 0.0 2.9 1.6 0.0 0.7 0.0 0.8 0.7 0.1 0.2 1.7 381.1 0.0 2.0 0.3 0.3 0.2 2.1 0.0 7.2 28.1 0.0 44.4 0.0 582.1 143.7 0.1 0.1 4.1 1.1 0.2 0.0 0.3 0.0 25.9 0.0 14.8 0.4 0.4 0.8 0.2 0.0 0.3 0.4 0.1 0.2 0.0 TMX1 "PDIA11, TMX, TXNDC, TXNDC1" ENSG00000139921 "Thioredoxin related transmembrane protein 1" Q9H3N1 14 51240162-51257655 "Predicted membrane proteins, Transporters" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003085 Approved Supported "Nucleoli,Endoplasmic reticulum" NA NA 26000 "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" "Endoplasmic reticulum" Nucleoli "HPA003085: AB_1080424" "unprognostic (1.83e-1)" "unprognostic (7.42e-2)" "unprognostic (6.97e-3)" "unprognostic (1.49e-2)" "unprognostic (2.63e-1)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.29e-6)" "unprognostic (3.70e-2)" "unprognostic (1.51e-1)" "unprognostic (6.84e-2)" "unprognostic (2.44e-3)" "unprognostic (5.07e-2)" "unprognostic (9.30e-2)" "unprognostic (1.85e-2)" "unprognostic (1.66e-1)" "unprognostic (1.18e-1)" "unprognostic (3.21e-3)" 11.0 8.8 5.8 10.8 6.3 10.7 11.3 6.7 8.7 7.8 7.4 12.3 10.6 8.1 10.8 9.1 6.6 8.5 4.8 5.4 6.6 10.2 12.6 9.3 12.4 6.5 6.8 6.6 9.1 9.4 5.5 13.2 7.0 7.9 12.2 6.8 8.3 9.2 5.2 9.8 9.3 9.9 6.9 10.7 10.4 5.0 7.0 11.6 11.4 4.4 10.5 13.0 6.6 7.0 27.0 23.8 33.8 18.4 26.0 20.3 35.5 33.5 26.8 33.2 42.2 24.9 49.0 38.8 30.0 22.6 15.6 26.1 60.3 21.5 60.4 38.6 19.6 28.4 19.4 24.7 22.4 66.2 27.4 24.4 19.5 22.2 16.3 24.0 29.7 31.2 23.6 25.9 32.1 32.6 29.7 35.5 38.3 42.2 28.5 30.9 60.9 23.4 32.2 34.8 21.1 15.5 26.6 17.8 24.6 22.2 25.8 28.6 19.0 34.9 32.2 24.8 30.9 22.4 23.9 31.4 15.4 36.6 33.5 10.5 12.2 6.2 8.6 14.7 10.6 7.7 8.8 9.0 13.6 6.3 8.5 10.1 4.3 11.5 11.0 15.7 11.0 12.4 5.8 6.3 6.7 8.7 5.4 6.6 6.5 6.8 7.0 6.9 7.0 7.0 43.0 38.5 29.1 24.5 55.9 108.6 63.1 80.5 71.2 13.7 40.7 20.8 9.2 44.3 55.7 35.0 12.5 73.9 82.6 38.2 9.8 62.1 2.5 22.0 42.2 47.5 17.4 81.2 8.9 67.6 149.3 48.4 32.1 28.0 43.6 24.4 43.2 44.0 73.2 10.1 11.2 29.2 63.1 61.1 84.3 4.3 24.8 65.7 55.2 18.7 70.0 27.0 46.4 22.1 25.2 50.3 44.0 28.6 79.2 58.4 29.3 32.4 42.2 32.6 59.2 37.3 49.4 59.5 68.7 79.0 97.3 57.7 62.5 58.7 46.5 59.5 FRMD6 "C14orf31, EX1, MGC17921, willin" ENSG00000139926 "FERM domain containing 6" Q96NE9 14 51489100-51730727 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 160.6;Early spermatids: 219.1;Late spermatids: 473.0;Suprabasal keratinocytes: 137.5;Urothelial cells: 130.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 351.1;fHDF/TERT166: 765.6;U-138 MG: 290.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001297 Uncertain Supported Approved Mitochondria NA NA "Cluster 10: Basophils - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 25: Spermatids - Spermatogenesis" Mitochondria "HPA001297: AB_1078913" "unprognostic (1.30e-1)" "unprognostic (1.09e-1)" "unprognostic (1.84e-1)" "unprognostic (2.29e-1)" "unprognostic (2.64e-2)" "unprognostic (8.05e-2)" "unprognostic (8.19e-2)" "unprognostic (3.55e-3)" "unprognostic (1.28e-1)" "unprognostic (2.45e-2)" "prognostic unfavorable (2.66e-4)" "unprognostic (3.18e-2)" "prognostic unfavorable (1.28e-4)" "prognostic unfavorable (3.50e-4)" "unprognostic (1.18e-1)" "unprognostic (2.11e-2)" "unprognostic (1.20e-2)" 12.1 13.4 5.2 9.5 5.2 1.2 27.1 12.6 6.7 28.1 8.4 16.0 5.2 53.6 11.3 59.8 13.4 33.0 7.3 6.4 4.5 4.2 10.4 8.6 5.5 5.7 8.1 25.9 5.0 2.4 3.4 14.1 4.9 27.7 10.8 1.5 21.5 30.7 7.4 43.2 7.5 46.8 5.4 12.0 7.2 31.0 5.8 12.6 6.6 6.8 12.7 31.5 30.1 5.6 71.4 14.1 20.1 42.1 40.1 67.6 8.8 351.1 163.2 169.5 146.0 51.9 16.4 1.9 10.6 765.6 47.6 82.8 5.7 113.8 200.3 1.1 8.6 0.3 7.6 2.2 46.8 0.2 4.2 58.8 40.9 152.0 200.5 77.8 52.6 3.7 0.7 24.6 181.8 12.2 7.1 0.2 3.9 0.2 27.4 0.8 79.1 0.7 33.4 113.7 4.1 44.9 27.8 3.9 31.3 37.7 3.0 1.0 242.6 290.7 97.6 73.3 73.5 18.9 17.3 0.2 19.3 0.3 114.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.1 0.0 0.0 0.1 5.2 5.2 12.6 6.7 6.4 4.5 5.7 8.1 4.9 5.4 5.8 5.6 6.9 3.2 1.5 34.6 0.8 111.4 160.6 42.4 41.5 0.4 40.5 49.4 2.9 8.6 11.6 0.0 0.0 40.1 1.5 0.0 0.0 16.9 219.1 2.0 41.1 14.4 0.0 2.5 45.2 2.9 4.8 57.8 1.1 3.6 1.3 0.9 9.3 4.2 3.8 0.0 22.5 0.3 10.2 0.3 21.1 473.0 17.7 1.5 32.0 68.4 0.7 8.2 0.0 74.9 5.9 64.0 0.0 22.2 3.7 52.0 0.1 0.4 2.7 0.5 6.6 24.5 28.0 10.2 9.8 115.7 137.5 39.0 3.3 0.9 0.1 130.7 GNG2 ENSG00000186469 "G protein subunit gamma 2" P59768 14 51826195-51979342 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 113.4" "Cell type enhanced" "Detected in many" "dendritic cells: 251.8;Early spermatids: 714.4;Late spermatids: 1146.4;NK-cells: 246.1" "Cancer enhanced" "Detected in all" "glioma: 15.4" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 77.2;fHDF/TERT166: 140.2;MOLT-4: 112.5;SH-SY5Y: 89.2;WM-115: 249.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003534, CAB018380" Uncertain Supported Approved "Vesicles,Plasma membrane" NA NA 170000 "Cluster 46: Basophils - DNA binding" "Cluster 65: Brain - Ion transport" "Cluster 17: WM-115 - Nervous system development" "Cluster 34: Spermatids - Unknown function" "Plasma membrane" Vesicles "CAB018380: AB_631547, HPA003534: AB_1079004" "unprognostic (6.11e-2)" "unprognostic (5.78e-3)" "unprognostic (2.06e-3)" "unprognostic (6.55e-2)" "unprognostic (1.33e-1)" "unprognostic (4.01e-2)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (5.72e-2)" "unprognostic (1.24e-1)" "prognostic favorable (1.64e-4)" "unprognostic (8.47e-2)" "prognostic unfavorable (3.90e-6)" "unprognostic (9.82e-2)" "unprognostic (1.29e-1)" "unprognostic (1.08e-1)" "unprognostic (3.59e-2)" 51.3 22.0 38.5 41.1 44.8 64.0 21.0 0.8 55.4 11.9 10.9 24.1 15.2 12.2 5.1 14.1 5.8 17.3 13.5 54.1 75.2 7.5 12.7 19.0 47.7 10.6 20.5 14.4 7.3 3.5 14.9 19.5 27.2 10.6 19.6 15.0 8.1 9.0 5.6 7.8 21.2 19.8 13.6 61.7 15.9 113.4 46.4 62.0 5.7 13.1 45.4 22.2 5.3 22.2 0.0 3.1 77.2 48.6 11.6 15.0 1.2 12.9 15.9 6.1 4.9 6.4 0.2 0.2 1.8 140.2 8.9 0.3 10.4 0.0 4.2 36.4 1.2 0.0 0.7 0.0 6.0 7.4 0.3 25.1 0.0 6.2 0.5 32.2 0.0 67.9 0.0 6.5 39.7 0.0 112.5 12.0 41.1 0.0 9.5 39.4 6.1 2.0 6.4 0.0 11.5 89.2 0.3 0.1 34.5 2.7 0.0 0.3 0.0 18.7 3.1 0.3 9.9 0.2 0.0 5.5 15.5 39.2 249.0 379.4 64.0 177.1 162.8 111.9 110.5 38.1 88.9 134.2 65.8 36.2 55.5 98.5 185.2 25.2 177.3 28.0 143.2 158.6 38.5 44.8 0.8 55.4 54.1 75.2 10.6 20.5 27.2 13.6 46.4 22.2 11.6 6.4 7.2 3.3 101.3 11.5 0.4 0.0 2.2 18.7 1.5 1.9 1.0 1.5 0.0 3.7 2.1 0.6 251.8 0.8 1.9 0.2 714.4 0.5 2.7 11.7 175.8 20.4 66.2 0.0 0.6 23.9 11.7 0.8 32.3 0.2 11.0 0.9 51.1 0.0 59.6 2.4 0.0 94.1 60.0 1146.4 9.9 84.0 55.2 24.4 33.3 0.7 246.1 96.0 3.2 0.5 0.1 6.0 62.7 0.2 0.1 0.9 0.0 2.2 39.5 10.2 12.2 11.2 4.6 1.3 6.7 0.7 191.5 2.2 0.5 0.2 RTRAF "C14orf166, CGI-99, CLE, CLE7, hCLE1, LCRP369, RLLM1" ENSG00000087302 "RNA transcription, translation and transport factor" Q9Y224 14 51989514-52010694 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 316.0;Distal tubular cells: 309.1;Exocrine glandular cells: 289.7;Extravillous trophoblasts: 349.6;Proximal tubular cells: 303.7;Syncytiotrophoblasts: 261.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039824 Supported Supported Nucleoplasm NA NA 48000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA039824: AB_10793922" "unprognostic (2.99e-2)" "unprognostic (2.90e-1)" "unprognostic (7.89e-2)" "unprognostic (2.28e-2)" "unprognostic (1.53e-1)" "unprognostic (6.08e-2)" "unprognostic (1.66e-3)" "unprognostic (1.46e-1)" "unprognostic (2.23e-2)" "unprognostic (6.50e-2)" "unprognostic (2.80e-1)" "unprognostic (2.07e-1)" "unprognostic (2.31e-2)" "unprognostic (3.34e-1)" "unprognostic (5.03e-2)" "unprognostic (5.74e-2)" "unprognostic (1.99e-1)" 92.9 92.7 47.2 73.7 48.9 138.9 87.2 50.8 60.3 69.3 52.5 93.5 61.3 71.1 87.0 79.1 64.5 67.8 151.6 46.6 50.9 77.3 78.9 64.0 105.5 50.4 48.6 96.5 114.0 74.1 65.6 68.2 49.4 66.6 88.7 56.3 76.8 58.7 155.8 79.6 67.3 76.9 51.4 61.2 98.9 142.2 49.0 107.0 81.2 102.2 105.3 87.9 62.8 54.6 214.6 142.1 239.8 233.7 157.7 208.3 228.8 166.9 183.6 180.9 203.1 153.2 184.0 290.8 174.0 139.5 142.2 167.1 226.2 152.6 234.7 158.0 126.5 113.3 287.8 206.7 252.1 243.8 125.0 158.5 155.6 136.6 223.5 210.1 207.2 269.6 118.8 135.1 177.3 237.6 310.8 306.3 187.1 247.8 238.1 278.6 228.0 138.0 176.1 245.2 169.0 171.6 211.0 376.7 274.7 301.3 252.8 190.4 146.0 196.6 216.4 167.2 212.7 50.5 76.2 295.7 96.9 189.3 228.7 54.8 93.3 58.7 73.5 104.7 91.1 108.8 102.0 88.6 117.6 90.9 93.2 95.2 19.2 96.1 112.5 107.9 144.0 126.6 47.2 48.9 50.8 60.3 46.6 50.9 50.4 48.6 49.4 51.4 49.0 54.6 168.6 44.8 67.2 0.0 39.2 0.0 0.0 0.0 0.0 0.0 181.7 232.8 0.0 0.0 39.0 73.5 0.0 316.0 83.1 0.0 309.1 226.6 0.0 164.3 108.1 77.5 0.0 0.0 0.0 289.7 349.6 77.4 0.0 103.6 61.8 242.8 0.0 0.0 240.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.5 0.0 0.0 154.5 0.0 0.0 0.0 0.0 232.4 0.0 0.0 13.0 0.0 0.0 303.7 49.6 0.0 0.0 0.0 95.2 0.0 0.0 0.0 0.0 261.6 53.6 233.9 0.0 0.0 NID2 ENSG00000087303 "Nidogen 2" Q14112 14 52004803-52069228 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 60.8" "Cell type enhanced" "Detected in many" "Adipocytes: 31.0;Endothelial cells: 19.7;Fibroblasts: 46.0;Microglial cells: 19.7;Smooth muscle cells: 22.6;Theca cells: 19.1" "Cancer enhanced" "Detected in all" "thyroid cancer: 15.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 285.4;ASC TERT1: 113.0;BJ: 152.1;BJ hTERT+: 131.8;HHSteC: 158.1;HSkMC: 591.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA052460, HPA058772" Enhanced Enhanced "Plasma membrane" "Secreted to extracellular matrix" NA NA 6300000 "Cluster 28: Placenta - Pregnancy" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Plasma membrane" "HPA052460: AB_2681840, HPA058772: AB_2683815" "unprognostic (6.51e-2)" "unprognostic (3.55e-3)" "unprognostic (3.73e-2)" "unprognostic (3.25e-2)" "unprognostic (2.04e-1)" "unprognostic (1.94e-1)" "unprognostic (5.37e-2)" "unprognostic (3.05e-3)" "unprognostic (2.52e-3)" "unprognostic (3.07e-2)" "unprognostic (4.85e-2)" "unprognostic (1.43e-1)" "unprognostic (1.48e-3)" "prognostic unfavorable (7.34e-4)" "unprognostic (4.58e-2)" "unprognostic (2.87e-2)" "prognostic unfavorable (2.78e-4)" 28.3 5.2 0.9 9.2 1.2 0.7 9.6 0.6 1.4 7.5 44.0 8.8 2.3 17.4 5.8 5.4 6.7 19.0 15.6 1.4 0.5 4.8 5.9 6.1 3.5 1.8 0.6 18.9 3.4 13.2 2.5 60.8 0.5 8.4 6.8 0.1 3.6 10.4 4.3 1.7 3.5 11.4 1.1 1.9 6.8 1.4 0.9 2.1 31.6 5.5 1.4 15.4 5.4 1.6 0.0 3.4 76.6 0.0 285.4 113.0 0.2 152.1 131.8 14.5 15.0 0.4 0.0 0.0 22.2 17.3 0.0 10.7 9.9 0.1 3.9 0.1 2.0 0.0 3.0 0.0 158.1 0.0 0.0 591.5 0.0 59.6 0.1 82.5 8.1 0.1 0.0 0.0 8.6 0.0 0.0 0.4 3.3 0.0 5.1 23.5 0.2 0.1 19.9 0.0 0.0 1.8 0.0 0.1 0.0 10.0 0.0 0.0 0.9 54.4 0.6 33.0 0.0 0.0 0.0 0.1 17.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.2 0.6 1.4 1.4 0.5 1.8 0.6 0.5 1.1 0.9 1.6 31.0 0.0 0.0 0.0 0.2 0.6 0.2 0.0 0.6 1.4 0.2 0.3 2.1 0.0 0.0 1.8 0.0 0.7 0.7 3.7 0.0 0.1 14.0 1.5 11.3 19.7 0.0 0.0 0.8 0.0 1.1 46.0 1.1 0.4 1.3 0.4 8.6 0.0 1.6 0.0 1.7 2.0 0.0 0.3 1.2 4.4 6.2 0.3 3.6 19.7 1.0 0.0 0.0 2.0 4.8 0.2 1.3 8.6 0.1 0.2 1.7 0.4 0.0 0.8 6.6 6.1 22.6 0.2 0.1 0.1 1.0 0.8 0.4 19.1 3.0 0.2 PTGDR "DP, DP1, PTGDR1" ENSG00000168229 "Prostaglandin D2 receptor" Q13258 14 52267698-52276724 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Mast cell degranulation" "G-protein coupled receptor, Receptor, Transducer" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 7.9;lymphoid tissue: 6.3" "Cell type enhanced" "Detected in some" "dendritic cells: 50.6;NK-cells: 187.4;T-cells: 31.4" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.0" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "gdT-cell: 68.0;NK-cell: 90.3" "Group enriched" "Detected in many" 33 "NK-cells: 90.3;T-cells: 68.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA049668 Enhanced NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "HPA049668: " "unprognostic (9.32e-3)" "unprognostic (3.31e-2)" "unprognostic (1.00e-2)" "unprognostic (2.04e-3)" "unprognostic (4.80e-2)" "unprognostic (2.70e-2)" "unprognostic (3.11e-3)" "unprognostic (5.00e-2)" "unprognostic (9.38e-3)" "unprognostic (4.94e-2)" "unprognostic (1.81e-2)" "unprognostic (1.54e-1)" "unprognostic (5.60e-8)" "unprognostic (1.14e-2)" "unprognostic (2.32e-1)" "unprognostic (4.02e-2)" "unprognostic (5.89e-2)" 2.0 0.5 0.2 2.1 1.7 1.4 1.2 0.8 0.7 2.1 2.6 5.6 0.7 1.5 1.0 0.4 1.3 1.6 1.9 0.1 0.3 0.5 1.1 1.7 3.2 2.4 0.6 0.8 0.3 0.4 2.1 0.2 0.4 0.8 7.9 0.0 1.1 0.4 0.6 0.6 1.4 0.8 1.5 6.3 1.3 0.2 0.4 0.9 1.1 0.4 1.1 0.9 1.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 68.0 0.0 33.5 0.1 9.0 40.9 0.1 0.0 1.4 22.5 2.3 90.3 0.4 0.2 0.2 12.9 0.2 1.7 0.8 0.7 0.1 0.3 2.4 0.6 0.4 1.5 0.4 0.1 2.9 3.2 0.0 0.0 0.9 0.5 0.0 0.0 0.6 0.0 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.0 50.6 3.2 0.0 0.0 0.0 0.2 0.1 2.0 1.2 2.7 0.2 0.0 0.0 1.5 1.1 0.1 1.3 0.2 2.2 0.5 0.1 0.0 0.2 7.5 0.0 1.9 0.4 0.0 0.0 4.6 1.8 1.0 0.4 0.0 187.4 0.0 0.1 0.0 2.8 0.0 4.0 0.0 0.2 0.1 0.0 0.0 0.0 0.8 5.5 0.0 0.0 0.1 0.1 0.0 31.4 2.2 14.6 0.0 PTGER2 EP2 ENSG00000125384 "Prostaglandin E receptor 2" P43116 14 52314305-52328598 "FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 38.4" "Cell type enhanced" "Detected in many" "dendritic cells: 55.6;Macrophages: 33.2;NK-cells: 177.1;T-cells: 63.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 26.1;ASC TERT1: 68.3;HHSteC: 43.8;HL-60: 25.2;HSkMC: 56.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 63: NK-cells & T-cells - Immune response" "unprognostic (1.48e-1)" "unprognostic (2.48e-2)" "unprognostic (1.36e-2)" "unprognostic (4.04e-3)" "unprognostic (1.55e-2)" "unprognostic (3.24e-1)" "unprognostic (3.11e-3)" "unprognostic (1.79e-1)" "unprognostic (2.42e-1)" "unprognostic (1.20e-3)" "unprognostic (1.18e-1)" "unprognostic (1.83e-1)" "prognostic unfavorable (4.16e-4)" "unprognostic (8.48e-3)" "unprognostic (5.26e-3)" "unprognostic (6.71e-2)" "unprognostic (5.74e-2)" 8.7 1.4 0.1 12.6 0.6 38.4 3.6 0.0 0.4 17.2 3.0 8.0 6.2 9.4 0.6 1.8 4.6 9.7 1.1 0.1 0.2 3.2 3.6 5.4 4.5 0.7 0.5 8.2 1.2 0.4 0.7 14.4 0.3 9.9 6.6 0.0 3.2 2.8 0.7 1.3 9.4 5.1 0.6 11.8 17.5 2.9 0.3 3.2 1.7 0.3 1.7 5.8 2.2 0.3 1.3 0.5 0.0 0.0 26.1 68.3 0.1 2.1 0.4 2.3 2.8 0.0 0.1 0.0 1.8 1.4 0.0 9.3 0.0 0.5 3.3 0.0 13.2 0.0 0.7 0.0 43.8 25.2 0.3 56.2 1.1 5.8 0.9 7.4 0.0 0.0 0.0 0.0 13.4 1.2 0.0 1.0 1.0 4.5 8.8 0.2 0.0 0.0 20.6 0.1 0.7 20.6 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.9 1.5 15.5 0.0 0.0 0.0 0.0 6.1 14.2 0.2 5.8 35.9 35.5 106.7 30.6 129.3 0.2 91.0 114.3 19.0 0.1 21.7 67.7 4.7 73.5 61.5 0.9 50.0 66.3 0.1 0.6 0.0 0.4 0.1 0.2 0.7 0.5 0.3 0.6 0.3 0.3 4.0 3.2 1.7 0.0 3.2 1.8 0.4 0.8 1.2 0.0 2.0 2.5 1.2 1.5 0.7 3.7 0.0 0.1 55.6 0.7 0.0 0.3 0.0 24.0 1.6 0.9 6.0 3.0 0.1 0.0 0.3 13.9 15.3 7.7 20.8 2.9 4.2 0.6 10.0 0.0 0.1 6.0 0.0 28.0 19.6 0.5 4.1 33.2 3.6 0.0 16.6 0.0 177.1 0.0 0.0 1.5 0.1 3.0 3.7 1.4 0.0 0.3 9.6 0.0 0.0 1.3 11.6 0.1 1.2 0.2 1.6 0.3 63.1 0.2 0.6 0.2 TXNDC16 KIAA1344 ENSG00000087301 "Thioredoxin domain containing 16" Q9P2K2 14 52430596-52552522 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 26.7" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 69.8;Glandular and luminal cells: 124.9;Inhibitory neurons: 88.8" "Cancer enhanced" "Detected in all" "prostate cancer: 18.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002543 Approved Approved Mitochondria "Secreted to blood" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 44: Endometrium - Transcription" Mitochondria "HPA002543: AB_1079199" "unprognostic (1.37e-1)" "unprognostic (7.79e-3)" "unprognostic (5.95e-3)" "unprognostic (2.36e-1)" "unprognostic (5.95e-3)" "unprognostic (9.73e-2)" "unprognostic (2.50e-1)" "unprognostic (1.43e-2)" "unprognostic (7.01e-2)" "unprognostic (1.49e-1)" "unprognostic (2.07e-2)" "unprognostic (1.21e-1)" "prognostic favorable (6.79e-4)" "unprognostic (1.39e-1)" "unprognostic (1.56e-1)" "unprognostic (3.55e-3)" "unprognostic (2.04e-1)" 6.2 4.0 4.6 3.5 4.6 5.1 6.9 10.1 6.0 9.3 0.6 5.8 4.1 6.9 14.6 3.7 4.1 5.2 3.7 4.9 4.3 5.0 7.4 4.4 4.5 3.9 4.0 10.3 6.4 7.0 3.8 5.8 4.3 26.7 5.9 9.1 4.0 13.0 2.0 4.6 4.8 4.3 4.0 10.2 6.3 7.1 4.1 5.9 4.0 4.0 3.9 3.4 3.8 6.7 8.3 0.8 8.9 5.0 6.5 4.7 7.0 2.7 3.6 4.5 8.7 3.0 6.6 13.5 8.9 2.2 2.8 7.7 10.3 3.7 6.9 5.7 13.5 6.2 6.2 2.8 4.7 7.4 2.9 8.8 3.4 5.8 4.2 4.0 5.1 5.8 8.0 20.4 3.9 4.0 9.3 5.1 9.9 5.5 4.9 18.4 16.9 12.4 5.7 8.4 29.0 10.0 13.2 13.5 3.9 7.5 8.6 5.4 2.7 6.0 3.0 6.9 4.6 5.6 8.0 13.5 1.7 7.7 3.5 1.3 3.0 1.2 1.3 2.4 1.3 0.5 1.3 0.9 2.6 0.3 0.6 0.6 1.7 0.6 2.9 1.0 2.4 1.0 4.6 4.6 10.1 6.0 4.9 4.3 3.9 4.0 4.3 4.0 4.1 6.7 9.1 9.6 6.4 23.2 6.1 6.6 6.0 2.5 9.6 42.3 26.6 19.0 10.1 8.6 5.0 7.3 8.4 2.3 15.1 8.8 1.9 5.2 4.0 69.8 9.6 7.4 18.5 21.8 61.0 3.9 1.6 7.2 13.3 124.9 2.5 13.9 15.4 14.1 3.3 10.1 88.8 17.9 0.0 18.8 8.6 4.2 27.7 13.0 1.8 24.4 5.9 7.3 7.2 45.8 51.5 1.3 8.5 52.3 11.3 19.0 5.9 2.8 4.4 44.8 0.0 11.1 11.2 12.0 9.5 8.1 8.4 1.1 7.7 5.7 10.9 4.5 GPR137C "DKFZp762F0713, TM7SF1L2" ENSG00000180998 "G protein-coupled receptor 137C" Q8N3F9 14 52552836-52637713 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 14.6;epididymis: 8.1;retina: 17.3" "Group enriched" "Detected in many" 5 "Excitatory neurons: 85.5;Inhibitory neurons: 125.4;Oligodendrocyte precursor cells: 101.6;Oligodendrocytes: 137.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 9 "NK-cells: 1.5;T-cells: 1.4" "Cell line enhanced" "Detected in many" "SH-SY5Y: 9.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003640, HPA030763" Uncertain Approved Vesicles NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "HPA003640: AB_2667025, HPA030763: AB_10602352" "unprognostic (1.39e-1)" "unprognostic (1.45e-1)" "unprognostic (1.23e-1)" "unprognostic (6.84e-2)" "unprognostic (8.50e-3)" "unprognostic (7.34e-3)" "unprognostic (5.95e-3)" "unprognostic (2.32e-2)" "unprognostic (4.41e-2)" "unprognostic (8.42e-4)" "unprognostic (2.20e-2)" "unprognostic (1.04e-1)" "unprognostic (7.88e-2)" "unprognostic (4.08e-1)" "unprognostic (1.38e-2)" "unprognostic (2.83e-1)" "unprognostic (2.60e-1)" 0.5 0.7 5.3 0.2 3.8 0.9 0.5 14.6 7.2 0.6 0.0 0.4 0.7 0.8 8.1 0.4 0.3 1.1 1.0 4.0 5.5 0.4 0.6 0.8 0.4 5.9 5.9 0.7 0.2 0.4 1.5 0.4 5.0 0.7 0.4 17.3 0.2 0.4 0.5 0.2 0.3 0.4 2.4 1.0 0.4 2.9 8.4 0.3 0.6 0.6 0.1 0.4 0.3 7.7 0.8 0.3 6.6 6.4 1.7 0.6 2.7 3.3 2.2 3.2 7.8 0.9 1.4 0.2 1.9 2.2 6.5 1.5 2.5 0.5 4.5 0.4 1.7 0.3 1.5 0.4 0.1 0.1 1.1 0.4 0.0 2.8 0.2 0.6 1.5 1.1 0.9 2.3 4.4 3.8 0.1 0.6 1.1 0.4 4.1 1.2 4.3 0.3 1.0 4.8 7.4 9.1 1.3 0.2 0.1 2.7 4.4 0.0 0.0 6.8 7.6 5.5 2.3 0.4 1.6 0.8 1.5 0.1 1.9 0.0 0.0 0.0 1.0 0.0 1.4 0.0 0.5 1.4 0.0 0.0 0.3 0.5 0.1 1.5 0.1 0.0 0.5 0.2 5.3 3.8 14.6 7.2 4.0 5.5 5.9 5.9 5.0 2.4 8.4 7.7 2.8 0.0 1.3 20.2 0.7 0.6 0.7 0.1 2.2 22.4 1.4 1.4 2.5 1.5 0.1 0.0 2.1 0.3 0.4 0.4 0.0 0.3 2.3 3.4 1.6 3.8 1.2 0.0 85.5 0.2 0.3 1.9 1.1 6.2 0.0 5.6 2.2 0.5 0.5 6.7 125.4 0.7 0.0 2.2 0.8 1.5 0.6 0.9 1.8 21.5 0.2 5.4 1.0 101.6 137.4 0.0 0.0 0.7 1.0 1.8 0.1 0.2 0.1 20.2 0.0 1.1 1.7 6.9 5.1 1.3 0.9 0.1 1.2 1.2 0.1 0.5 ERO1A "ERO1-alpha, Ero1alpha, ERO1L" ENSG00000197930 "Endoplasmic reticulum oxidoreductase 1 alpha" Q96HE7 14 52639915-52695900 "Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 172.5" "Cell type enhanced" "Detected in many" "Ductal cells: 221.3;Extravillous trophoblasts: 215.8;Pancreatic endocrine cells: 264.7;Prostatic glandular cells: 171.4;Urothelial cells: 145.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026653, HPA030053, CAB034294" Enhanced "Intracellular and membrane" NA NA 110000 "Cluster 38: Basophils - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "CAB034294: AB_2098744, HPA026653: AB_1848254, HPA030053: AB_10601467" "unprognostic (8.64e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (1.86e-2)" "unprognostic (5.89e-2)" "unprognostic (5.69e-3)" "unprognostic (4.23e-2)" "prognostic unfavorable (7.59e-4)" "prognostic unfavorable (1.10e-5)" "unprognostic (4.98e-2)" "unprognostic (4.95e-2)" "prognostic unfavorable (2.27e-4)" "unprognostic (3.17e-1)" "prognostic unfavorable (6.54e-9)" "unprognostic (9.19e-2)" "unprognostic (2.78e-2)" "unprognostic (4.58e-1)" "unprognostic (5.03e-2)" 17.9 8.6 12.2 20.4 11.7 47.0 16.4 11.8 12.9 59.0 11.3 18.5 17.9 12.0 15.1 172.5 10.0 18.9 15.5 12.1 16.6 14.6 31.2 15.2 14.9 11.7 13.3 8.5 18.9 11.1 12.6 44.4 12.8 9.6 17.8 30.6 37.4 14.0 9.1 18.9 16.5 12.0 9.9 14.6 29.0 5.4 15.1 8.3 13.4 8.2 30.4 32.6 62.4 10.9 100.6 24.2 19.9 21.4 54.4 61.3 38.0 42.4 52.7 34.1 56.9 33.4 158.0 26.3 50.7 28.3 42.0 61.1 27.1 84.1 84.9 22.0 14.5 3.6 25.1 42.1 46.2 60.2 72.1 54.5 54.2 43.9 44.5 79.9 48.2 32.3 18.1 50.8 46.2 15.8 36.0 37.8 11.8 46.5 15.5 21.5 59.8 38.1 52.3 97.1 18.5 49.6 28.9 17.8 39.4 25.7 24.8 22.3 40.0 60.7 29.5 49.6 37.4 26.9 28.8 22.7 88.0 30.3 28.7 20.6 5.9 11.7 5.0 6.9 11.0 4.6 9.4 6.3 4.9 3.1 5.5 5.5 14.7 6.7 9.4 3.7 11.9 2.5 12.2 11.7 11.8 12.9 12.1 16.6 11.7 13.3 12.8 9.9 15.1 10.9 33.8 16.0 27.6 0.0 18.8 0.0 79.2 0.0 19.4 23.4 29.7 11.8 0.0 38.6 15.5 38.6 16.7 24.3 23.3 33.4 3.9 221.3 0.6 32.4 23.8 32.6 10.9 9.9 0.0 130.6 215.8 20.5 56.1 64.0 6.3 10.9 21.0 62.5 42.9 42.1 0.0 10.7 0.0 42.7 0.0 1.6 6.2 49.7 0.0 0.0 45.0 12.2 15.5 0.0 0.0 264.7 18.1 12.8 60.0 171.4 29.0 15.1 13.1 26.4 19.7 14.6 20.9 0.6 3.6 25.7 0.0 91.4 32.1 10.4 20.3 145.8 PSMC6 p42 ENSG00000100519 "Proteasome 26S subunit, ATPase 6" P62333 14 52707178-52728590 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042823 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" No No 300000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042823: AB_2678188" "unprognostic (2.38e-2)" "unprognostic (2.72e-2)" "unprognostic (9.18e-2)" "unprognostic (1.29e-1)" "unprognostic (1.19e-2)" "unprognostic (4.26e-3)" "unprognostic (3.14e-3)" "unprognostic (6.30e-2)" "unprognostic (1.06e-1)" "unprognostic (2.79e-2)" "unprognostic (3.50e-2)" "unprognostic (1.00e-2)" "unprognostic (1.52e-2)" "unprognostic (5.00e-2)" "unprognostic (2.68e-1)" "unprognostic (4.13e-2)" "unprognostic (4.67e-1)" 43.4 48.4 38.8 47.3 39.2 44.1 58.1 41.2 54.0 44.0 37.4 52.2 50.0 47.6 49.2 65.1 49.2 36.5 78.7 39.8 42.1 65.9 87.1 39.6 55.4 41.1 41.0 51.0 43.7 59.9 5.5 54.9 42.0 45.3 54.3 60.1 37.9 45.6 118.1 44.6 46.6 56.8 41.5 38.8 46.5 31.4 41.0 56.3 54.3 106.7 67.0 57.2 7.9 44.1 182.0 115.0 135.4 99.0 92.4 95.8 146.0 139.3 133.1 220.8 165.1 142.6 143.5 156.8 169.8 121.6 111.5 134.0 173.9 121.9 230.6 151.2 74.5 115.0 91.3 153.5 111.0 164.9 106.8 71.8 118.4 112.1 111.6 120.1 141.2 77.4 174.2 64.7 161.8 163.2 129.5 111.8 108.7 170.1 153.8 108.4 237.2 70.7 144.6 178.5 96.0 71.2 123.8 76.5 122.3 120.8 156.4 117.0 108.9 121.2 171.0 95.8 145.2 45.6 127.0 175.8 79.1 110.5 112.9 77.5 62.4 67.0 51.2 71.9 59.5 63.4 62.7 56.4 73.9 56.4 59.6 59.0 52.7 55.6 73.0 38.5 85.4 75.4 38.8 39.2 41.2 54.0 39.8 42.1 41.1 41.0 42.0 41.5 41.0 44.1 81.2 70.5 58.9 23.5 74.2 86.2 141.9 187.1 50.1 65.5 55.3 51.3 76.6 62.9 140.6 57.0 68.8 162.2 69.4 73.5 135.0 131.0 30.4 92.8 75.3 78.2 70.4 85.2 37.4 106.9 139.9 72.1 38.7 96.3 67.7 68.7 50.0 84.4 92.1 62.2 39.0 58.9 109.9 71.3 67.9 19.9 67.1 61.4 80.0 20.6 90.9 64.6 52.5 38.2 46.7 116.2 46.2 65.5 64.0 85.2 72.5 140.2 116.4 107.6 72.3 66.5 130.6 63.4 82.8 48.9 72.0 237.5 65.0 79.7 73.4 116.6 STYX ENSG00000198252 "Serine/threonine/tyrosine interacting protein" Q8WUJ0 14 52730166-52774989 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 117.1;Late spermatids: 92.5;Spermatocytes: 73.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040290 Uncertain Approved Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 6: T47d - Mammary gland" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "HPA040290: AB_10963686" "unprognostic (5.24e-2)" "unprognostic (2.48e-1)" "unprognostic (2.22e-1)" "unprognostic (9.56e-2)" "unprognostic (2.43e-1)" "unprognostic (2.16e-1)" "unprognostic (2.81e-1)" "unprognostic (2.37e-1)" "unprognostic (3.00e-3)" "unprognostic (1.91e-2)" "unprognostic (3.21e-2)" "unprognostic (2.26e-1)" "unprognostic (1.57e-3)" "unprognostic (6.89e-2)" "unprognostic (6.82e-2)" "unprognostic (2.48e-2)" "unprognostic (6.84e-3)" 9.4 3.7 3.3 8.8 4.3 5.8 7.6 4.3 4.3 5.6 2.9 6.0 5.7 6.8 4.7 9.1 4.7 5.8 8.7 2.6 3.5 5.8 26.7 5.8 14.0 4.6 4.3 6.8 5.8 4.8 2.2 9.5 4.5 6.3 6.5 3.9 5.7 5.8 11.4 8.1 5.7 6.9 3.8 9.1 6.6 10.9 3.9 9.4 5.6 12.9 12.4 7.4 4.8 5.4 14.4 7.8 10.5 12.7 17.5 24.9 20.0 16.9 12.6 12.1 12.2 11.3 10.3 17.7 14.1 16.0 10.2 11.1 13.1 13.8 21.3 16.0 5.0 9.1 8.3 15.0 14.5 14.5 11.5 17.9 16.4 16.0 16.4 10.9 22.2 15.7 11.0 16.6 16.9 19.9 16.3 9.5 12.7 16.1 15.9 13.6 14.1 10.5 15.8 16.1 2.4 7.0 17.3 11.5 11.4 14.6 28.1 14.5 20.8 21.1 13.4 23.1 10.7 6.1 8.8 10.8 6.8 9.6 18.3 7.7 4.4 3.7 5.6 6.1 7.4 6.1 9.2 7.6 4.8 3.8 10.6 8.2 2.2 4.9 5.8 3.6 10.8 5.6 3.3 4.3 4.3 4.3 2.6 3.5 4.6 4.3 4.5 3.8 3.9 5.4 15.2 6.4 9.2 6.2 18.3 16.6 10.7 10.2 9.6 5.1 14.1 8.0 23.1 8.6 11.4 5.5 6.2 13.8 19.7 7.6 13.7 12.4 117.1 9.1 10.9 16.0 4.8 15.6 7.7 18.2 32.8 11.8 11.2 8.9 20.8 5.9 16.1 54.7 15.4 5.0 7.6 6.1 8.2 21.2 20.4 92.5 9.6 20.2 3.6 10.3 27.6 8.7 15.5 6.6 15.9 14.5 7.9 11.3 16.2 19.6 8.1 12.0 14.6 6.9 26.3 8.7 19.6 73.1 25.7 16.9 19.6 21.1 25.6 5.9 8.2 13.6 GNPNAT1 "FLJ10607, Gpnat1" ENSG00000100522 "Glucosamine-phosphate N-acetyltransferase 1" Q96EK6 14 52775193-52791668 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 77.1" "Cell type enhanced" "Detected in all" "Hepatocytes: 89.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044647 Approved NA NA 72000 "Cluster 27: Non-specific - Gene expression" "Cluster 85: Liver - Metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 55: Plasma cells - Humoral immune response" "HPA044647: AB_10795986" "unprognostic (4.55e-3)" "unprognostic (1.19e-2)" "unprognostic (4.47e-3)" "unprognostic (5.18e-3)" "unprognostic (4.23e-1)" "unprognostic (1.52e-2)" "unprognostic (1.21e-1)" "unprognostic (3.19e-3)" "unprognostic (1.03e-1)" "unprognostic (6.81e-2)" "prognostic unfavorable (8.52e-5)" "unprognostic (5.82e-2)" "unprognostic (3.22e-3)" "unprognostic (2.16e-2)" "unprognostic (1.68e-1)" "unprognostic (1.31e-1)" "unprognostic (4.05e-2)" 21.5 7.3 4.8 11.1 5.5 3.9 16.8 6.9 6.1 14.6 5.0 18.4 15.0 9.2 9.5 8.5 8.4 11.4 5.4 5.9 5.8 13.6 77.1 6.0 7.3 4.9 4.7 9.3 25.4 8.0 5.8 10.5 5.4 15.5 22.0 5.6 19.3 7.0 11.2 6.7 14.1 10.7 4.9 5.5 19.7 15.3 5.1 5.8 8.5 7.3 8.5 13.8 6.1 6.2 99.8 37.6 30.5 34.7 32.0 73.8 49.9 63.6 41.4 53.5 54.8 43.4 59.1 56.3 34.6 64.2 26.2 40.0 59.2 64.0 92.9 32.4 31.1 38.1 36.2 55.1 46.2 42.7 19.5 29.9 53.1 92.9 99.5 27.7 62.1 35.3 36.7 13.4 70.8 85.6 52.0 21.9 31.8 129.1 67.6 34.7 14.4 33.9 51.2 51.3 30.6 42.8 54.1 70.5 46.6 20.8 83.4 14.6 70.1 55.2 56.9 97.6 50.0 14.0 28.4 24.4 26.1 27.4 32.8 6.4 1.7 0.1 5.0 2.1 6.0 4.6 5.2 4.6 4.0 5.1 5.9 4.7 0.6 5.5 5.0 2.4 6.8 3.1 4.8 5.5 6.9 6.1 5.9 5.8 4.9 4.7 5.4 4.9 5.1 6.2 14.1 16.0 12.1 5.2 10.7 19.2 33.7 19.1 10.2 9.6 23.6 16.3 3.6 18.6 18.5 12.9 4.2 23.3 10.6 13.4 33.2 40.3 43.8 16.0 25.5 17.7 5.4 13.3 16.5 37.6 74.8 25.8 32.6 39.5 7.0 16.5 12.1 89.4 15.5 3.3 10.8 61.0 10.2 6.0 9.3 11.8 19.6 8.6 7.2 8.4 5.4 5.3 18.6 9.0 9.0 45.9 14.0 18.0 13.8 42.0 8.0 16.1 13.0 6.4 19.7 18.3 24.7 71.2 7.2 22.3 21.3 12.2 10.6 13.7 30.1 38.1 FERMT2 "KIND2, mig-2, PLEKHC1, UNC112B" ENSG00000073712 "Fermitin family member 2" Q96AC1 14 52857268-52952435 "Predicted intracellular proteins" "Cell adhesion, Cell shape, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040505, HPA072965" Uncertain Supported "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA 230000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" "Focal adhesion sites" "Nucleoplasm, Cytosol" "HPA040505: AB_10673300, HPA072965: " "unprognostic (4.38e-2)" "unprognostic (4.25e-2)" "unprognostic (8.00e-3)" "unprognostic (2.42e-2)" "unprognostic (2.51e-2)" "unprognostic (4.89e-3)" "unprognostic (2.50e-2)" "unprognostic (1.92e-1)" "unprognostic (4.21e-2)" "unprognostic (1.07e-1)" "unprognostic (3.58e-1)" "unprognostic (1.99e-1)" "unprognostic (3.87e-2)" "unprognostic (3.96e-3)" "unprognostic (7.69e-2)" "unprognostic (3.14e-1)" "unprognostic (1.73e-3)" 148.4 21.2 28.7 38.8 31.6 0.5 57.6 29.0 37.3 44.7 18.0 104.3 13.1 105.1 26.3 46.8 55.7 65.7 66.9 31.0 27.4 55.4 108.3 47.9 15.3 35.7 29.1 43.6 20.6 18.4 13.1 116.5 33.5 69.1 33.3 29.5 22.6 117.9 48.8 13.4 29.3 155.6 30.6 37.6 46.4 15.5 27.6 6.9 35.9 69.6 6.6 77.7 29.1 38.1 22.8 18.9 101.6 46.8 163.7 133.7 84.6 148.4 95.2 172.3 107.9 34.1 17.6 0.1 49.4 153.1 33.8 9.6 80.1 11.1 128.3 0.2 22.6 31.9 83.1 40.3 209.6 0.4 12.6 129.4 23.5 95.3 125.4 78.5 91.2 16.8 0.6 153.4 131.7 28.0 7.7 0.5 64.3 0.2 51.3 3.9 103.8 0.4 60.9 20.6 6.2 130.5 157.8 35.0 37.7 103.3 30.1 1.1 115.2 134.5 92.4 108.2 56.0 22.6 29.4 0.6 30.9 0.2 33.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.7 31.6 29.0 37.3 31.0 27.4 35.7 29.1 33.5 30.6 27.6 38.1 152.7 76.9 42.0 116.5 1.0 18.6 150.6 15.5 13.6 39.5 33.8 41.4 65.8 24.3 25.6 40.5 37.5 74.8 2.3 0.2 31.3 48.5 68.2 20.1 141.7 110.4 0.0 2.7 13.7 33.2 178.1 103.9 3.6 40.2 58.3 31.6 110.3 82.3 10.4 15.2 16.1 0.5 4.1 8.9 19.5 27.9 74.9 4.4 46.2 29.0 4.8 52.3 1.0 41.2 92.0 27.6 0.1 174.9 4.5 40.0 0.0 44.7 10.1 56.0 151.2 83.4 174.1 4.1 16.2 2.2 8.1 102.6 7.9 12.3 0.4 37.0 DDHD1 "KIAA1705, PA-PLA1, SPG28" ENSG00000100523 "DDHD domain containing 1" Q8NEL9 14 53036745-53153323 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 30.7" "Cell type enhanced" "Detected in many" "Early spermatids: 280.9;Excitatory neurons: 140.5;Late spermatids: 146.3;Oligodendrocytes: 177.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049870 Enhanced NA NA "Cluster 15: NK-cells - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA049870: AB_2680925" "unprognostic (2.48e-1)" "unprognostic (1.49e-2)" "unprognostic (1.39e-1)" "unprognostic (1.79e-1)" "unprognostic (8.14e-3)" "unprognostic (9.40e-2)" "unprognostic (4.91e-3)" "unprognostic (2.25e-2)" "unprognostic (8.07e-2)" "unprognostic (2.63e-1)" "unprognostic (3.24e-3)" "unprognostic (1.78e-1)" "unprognostic (4.67e-6)" "unprognostic (1.61e-1)" "unprognostic (1.92e-1)" "unprognostic (2.28e-1)" "unprognostic (1.11e-1)" 4.5 3.6 5.7 6.0 6.6 8.7 3.9 9.7 10.1 5.3 0.8 3.8 2.5 5.0 2.2 2.5 3.7 4.6 5.1 6.8 6.9 2.3 2.6 5.2 10.0 6.9 6.6 5.1 2.9 4.4 5.3 7.5 7.6 3.7 4.6 16.7 2.3 4.1 3.1 3.3 4.7 5.1 4.2 6.2 3.8 30.7 6.6 6.6 3.5 5.3 8.5 5.4 3.4 10.3 8.7 10.2 32.5 12.7 14.0 12.7 6.7 13.0 9.8 9.4 10.3 2.4 1.7 23.3 6.4 9.1 8.7 3.7 15.8 3.6 11.3 12.8 7.0 3.0 8.7 4.7 12.1 10.6 10.3 6.9 4.3 10.0 8.4 6.7 7.1 7.9 5.9 19.6 11.0 9.2 12.6 5.4 6.7 5.6 8.4 9.6 34.0 4.0 5.0 11.3 14.5 9.3 15.2 4.2 4.4 5.7 5.9 6.9 10.5 8.9 13.9 13.4 9.6 9.1 6.3 15.3 4.7 9.6 5.0 1.6 1.4 1.2 4.6 2.2 4.4 3.2 3.7 5.1 1.7 2.6 3.2 3.9 0.8 4.6 3.7 1.5 5.3 1.3 5.7 6.6 9.7 10.1 6.8 6.9 6.9 6.6 7.6 4.2 6.6 10.3 12.0 6.4 15.4 69.9 40.4 6.1 7.1 3.5 23.9 64.2 9.3 7.0 13.2 7.2 3.6 9.2 87.6 17.6 46.5 3.2 0.0 6.8 280.9 8.7 38.7 19.1 8.4 27.8 140.5 6.7 7.4 25.4 7.7 15.3 7.6 20.0 5.3 5.8 16.2 45.4 120.6 5.0 2.0 18.5 13.3 146.3 13.7 31.5 5.4 38.4 22.1 19.1 49.4 104.0 177.9 5.1 3.4 20.7 42.7 8.2 1.9 4.9 6.7 35.0 19.7 17.1 15.8 57.4 46.6 9.7 6.0 17.4 42.4 24.9 5.6 5.9 BMP4 BMP2B ENSG00000125378 "Bone morphogenetic protein 4" P12644 14 53949736-53958761 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Cancer-related genes, Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 47.3;Fibroblasts: 65.2;Hepatic stellate cells: 52.8;Pancreatic endocrine cells: 40.1;Skeletal myocytes: 51.0;Syncytiotrophoblasts: 34.8" "Cancer enhanced" "Detected in all" "colorectal cancer: 28.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 1.9" "Group enriched" "Detected in many" 12 "monocytes: 1.9;T-cells: 1.3" "Cell line enhanced" "Detected in many" "CACO-2: 120.1;CAPAN-2: 298.6;Hep G2: 326.0;OE19: 219.1;SuSa: 168.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006863, HPA066235" Uncertain "Secreted to blood" NA NA 162000000 "Cluster 7: Monocytes - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 50: Fibroblasts - ECM organization" "CAB006863: , HPA066235: AB_2685641" "unprognostic (1.30e-1)" "unprognostic (3.27e-2)" "unprognostic (1.29e-1)" "unprognostic (5.20e-3)" "unprognostic (3.39e-2)" "unprognostic (3.32e-1)" "unprognostic (2.78e-2)" "unprognostic (3.11e-1)" "unprognostic (3.45e-3)" "unprognostic (7.67e-2)" "unprognostic (2.45e-3)" "unprognostic (7.06e-2)" "unprognostic (1.58e-2)" "unprognostic (2.93e-3)" "unprognostic (1.37e-1)" "unprognostic (3.22e-1)" "unprognostic (1.24e-1)" 14.0 13.4 3.0 6.1 3.2 0.1 13.4 7.0 4.5 21.0 32.4 25.6 17.0 8.9 2.5 12.9 9.7 14.4 16.3 3.1 2.8 9.0 4.2 13.4 9.6 3.6 3.3 23.8 3.4 2.7 4.7 44.4 3.9 21.9 28.9 2.7 10.5 18.7 11.5 15.3 19.2 9.0 3.2 6.5 23.8 2.0 3.9 3.4 8.5 17.7 4.2 27.4 23.5 4.7 15.6 40.0 2.1 1.8 0.5 0.4 0.6 7.9 34.0 20.1 15.5 120.1 298.6 0.0 97.2 0.1 2.2 73.2 8.6 1.0 10.7 4.1 5.9 0.2 8.3 326.0 19.4 0.0 1.0 0.0 2.8 9.5 0.5 61.1 59.3 6.8 0.0 0.3 9.7 6.9 5.3 0.3 13.9 219.1 3.4 0.2 10.5 0.3 28.5 1.3 0.1 0.3 0.0 1.1 0.9 168.2 38.8 1.5 2.9 0.6 87.1 0.3 1.4 0.2 0.1 1.0 0.1 0.1 4.3 0.0 0.6 0.0 0.1 1.1 0.0 0.0 0.9 0.2 0.1 0.0 1.3 0.4 0.0 0.0 1.9 0.0 0.0 0.3 3.0 3.2 7.0 4.5 3.1 2.8 3.6 3.3 3.9 3.2 3.9 4.7 7.6 9.6 7.3 1.0 0.6 27.5 4.0 16.1 47.3 0.3 8.0 10.4 5.7 14.3 6.0 5.5 0.0 29.3 0.1 1.0 3.9 5.5 2.5 0.7 18.9 18.2 0.0 2.7 1.3 0.2 18.9 65.2 0.5 0.7 1.3 0.9 52.8 2.0 3.7 0.0 0.4 5.3 2.0 0.6 5.9 1.0 10.5 0.4 3.6 1.9 0.0 0.5 0.0 1.0 0.3 40.1 4.0 1.5 0.1 2.3 0.6 2.4 5.8 1.5 0.0 51.0 10.5 1.4 2.2 7.5 17.5 34.8 1.0 1.4 4.0 1.4 CDKN3 "CDI1, KAP" ENSG00000100526 "Cyclin dependent kinase inhibitor 3" Q16667 14 54396849-54420218 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Hydrolase, Protein phosphatase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 207.0" "Cell type enhanced" "Detected in many" "Early spermatids: 2630.9;Late spermatids: 659.4;Spermatocytes: 606.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 18.8" "Group enriched" "Detected in all" 6 "NK-cells: 6.4;T-cells: 18.8" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005285, HPA039311, HPA058874" Enhanced Cytosol NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" Cytosol "CAB005285: AB_2078884, HPA039311: , HPA058874: AB_2683842" "unprognostic (3.46e-2)" "unprognostic (9.95e-2)" "unprognostic (5.79e-2)" "unprognostic (6.78e-3)" "unprognostic (2.73e-1)" "unprognostic (6.08e-2)" "unprognostic (1.51e-3)" "prognostic unfavorable (4.52e-4)" "unprognostic (2.50e-3)" "unprognostic (2.85e-3)" "prognostic unfavorable (7.46e-4)" "unprognostic (5.89e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.71e-1)" "unprognostic (7.30e-2)" "unprognostic (7.92e-2)" "unprognostic (4.31e-2)" 3.4 1.6 2.8 12.2 2.7 43.4 3.4 5.0 4.2 2.2 3.4 13.9 12.4 2.8 0.4 10.2 1.3 2.9 5.3 2.9 3.1 2.0 2.4 2.1 28.4 2.5 2.7 1.3 1.1 0.5 1.6 6.7 3.3 1.6 16.9 2.6 3.3 0.7 3.0 5.9 12.6 7.4 2.1 4.9 5.0 207.0 3.5 30.9 1.7 4.1 30.0 5.8 4.1 2.6 276.7 102.5 74.0 78.2 12.5 15.3 46.5 63.1 97.0 135.8 146.9 81.8 136.5 139.9 44.4 96.7 135.9 195.9 114.6 78.3 245.6 169.5 59.3 65.8 69.0 126.8 10.1 86.2 47.6 5.4 4.9 84.3 138.3 44.4 88.4 129.8 36.1 162.2 159.8 186.9 118.1 67.9 27.9 254.7 216.4 72.7 66.6 29.7 70.5 56.9 30.6 42.0 118.7 67.4 52.5 54.6 142.9 69.4 33.0 59.2 195.8 91.7 155.0 38.6 47.4 91.4 98.6 120.4 110.9 0.0 1.3 1.3 1.6 1.7 0.7 2.1 5.5 4.8 1.8 0.9 2.9 2.3 1.0 6.4 1.2 1.5 18.8 3.1 2.8 2.7 5.0 4.2 2.9 3.1 2.5 2.7 3.3 2.1 3.5 2.6 1.4 0.0 0.0 0.7 10.5 9.3 4.3 9.7 4.6 3.2 6.4 11.6 9.7 0.0 2.4 1.8 2.1 42.6 2.7 7.3 0.0 3.5 2630.9 2.7 3.5 6.8 7.8 125.5 2.5 2.4 35.0 10.2 9.2 3.5 7.0 31.3 6.1 3.1 37.7 5.0 3.9 17.9 4.1 9.8 8.8 659.4 21.5 8.9 1.8 1.0 2.9 1.7 0.0 0.0 0.2 1.9 7.2 10.5 41.0 4.0 3.4 2.8 0.2 2.9 0.0 3.0 20.5 606.9 39.8 22.5 6.5 4.1 8.3 3.9 31.2 5.3 CNIH1 "CNIH, CNIL, TGAM77" ENSG00000100528 "Cornichon family AMPA receptor auxiliary protein 1" O95406 14 54423561-54441391 "Predicted membrane proteins, Transporters" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002544 Approved Uncertain Vesicles NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Vesicles "HPA002544: AB_2081856" "unprognostic (1.06e-1)" "unprognostic (1.18e-3)" "unprognostic (7.09e-2)" "unprognostic (5.06e-2)" "unprognostic (1.50e-1)" "unprognostic (8.93e-3)" "unprognostic (1.47e-1)" "unprognostic (2.71e-3)" "unprognostic (4.78e-2)" "unprognostic (4.62e-1)" "unprognostic (1.38e-2)" "unprognostic (1.79e-1)" "unprognostic (4.12e-2)" "unprognostic (1.28e-1)" "unprognostic (1.47e-1)" "unprognostic (1.71e-2)" "prognostic unfavorable (8.95e-4)" 73.2 61.7 40.2 50.9 42.1 37.2 73.6 45.2 49.5 59.8 58.5 86.9 99.4 49.6 50.8 72.5 67.0 74.4 84.6 42.8 47.2 79.9 232.9 46.7 61.2 44.3 43.4 44.0 41.8 59.8 41.2 58.4 44.8 57.2 95.1 60.3 49.7 57.1 58.9 36.0 85.4 68.2 49.1 33.8 45.4 37.1 41.3 56.2 65.0 95.5 79.0 95.1 39.4 50.7 233.4 141.3 113.8 129.2 301.0 380.9 107.8 276.8 348.6 232.0 264.4 86.5 316.4 289.7 180.2 209.2 141.6 226.5 208.3 200.3 287.5 111.9 124.5 112.1 80.9 152.8 303.6 136.5 90.2 314.4 244.3 217.1 304.0 236.8 221.3 117.7 111.5 95.5 262.4 138.4 151.5 102.9 84.2 266.3 281.3 114.8 191.8 97.3 264.2 171.4 95.5 106.3 163.4 127.8 316.7 104.8 197.5 144.9 143.7 194.7 192.9 165.4 167.8 59.7 138.8 141.2 235.9 115.3 176.5 5.3 84.6 10.7 32.5 66.8 54.8 64.3 57.3 47.0 86.0 55.2 75.1 52.1 20.9 44.0 53.7 48.4 65.1 96.6 40.2 42.1 45.2 49.5 42.8 47.2 44.3 43.4 44.8 49.1 41.3 50.7 41.1 35.3 60.6 14.7 64.9 105.7 86.2 186.1 141.7 41.9 69.2 64.0 85.6 50.1 79.8 46.0 20.9 95.7 48.1 98.8 90.1 89.3 44.4 54.8 57.9 72.3 104.4 65.0 26.9 62.3 123.4 90.3 52.5 32.8 197.3 32.4 70.3 140.0 115.5 67.3 34.8 91.5 99.7 102.8 80.0 17.0 60.0 73.5 83.6 9.4 110.3 59.9 35.0 17.6 22.5 65.6 96.6 65.8 84.0 92.0 149.9 164.7 79.9 45.1 46.0 60.5 68.1 68.7 64.1 144.9 110.0 70.9 69.3 68.4 123.0 91.4 GMFB GMF ENSG00000197045 "Glia maturation factor beta" P60983 14 54474484-54489026 "Plasma proteins, Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 90.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002954 Approved Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 240000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 45: Intestine - Brush border" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA002954: AB_1078997" "unprognostic (7.93e-2)" "unprognostic (7.69e-3)" "unprognostic (4.81e-3)" "unprognostic (2.99e-2)" "unprognostic (1.12e-2)" "unprognostic (2.06e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (1.48e-2)" "unprognostic (1.90e-1)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (4.29e-2)" "prognostic favorable (9.48e-5)" "unprognostic (1.80e-1)" "unprognostic (2.82e-1)" "unprognostic (1.23e-1)" "unprognostic (9.09e-2)" 25.2 21.8 62.8 23.5 68.8 28.8 26.0 61.6 90.4 18.6 39.8 35.0 33.5 19.3 14.0 15.8 14.2 16.5 17.2 61.4 75.6 33.6 25.8 24.2 25.3 73.0 64.5 16.1 12.8 20.1 12.3 26.5 71.4 14.8 35.2 18.4 10.7 12.9 7.0 13.7 29.5 18.2 84.0 18.4 19.0 11.1 71.9 16.2 21.9 10.2 24.4 22.3 11.4 85.3 92.7 36.9 71.8 53.2 75.8 94.5 53.9 93.2 67.9 66.2 82.1 42.6 79.4 85.2 42.4 92.0 39.5 33.4 73.7 64.0 104.4 30.9 25.4 42.5 37.4 39.9 64.7 59.9 35.5 72.0 58.8 57.1 56.0 67.9 60.8 38.4 31.4 28.8 106.1 45.7 36.8 22.9 46.4 52.1 38.9 36.9 84.7 24.4 84.4 86.3 42.4 65.5 64.6 54.4 71.4 59.0 59.8 46.4 48.1 94.9 71.9 48.7 58.4 10.4 19.4 52.0 80.0 36.3 61.5 6.8 10.2 9.1 5.0 13.3 7.0 6.6 5.9 5.1 12.6 7.8 6.2 6.6 16.1 8.0 14.0 4.4 8.5 6.2 62.8 68.8 61.6 90.4 61.4 75.6 73.0 64.5 71.4 84.0 71.9 85.3 23.3 25.6 16.2 8.1 39.3 59.9 50.2 33.6 48.9 18.4 28.0 18.0 17.3 20.0 22.6 25.8 4.2 39.3 33.7 61.8 21.5 38.7 27.3 21.5 29.5 22.2 29.9 14.5 16.8 23.3 84.5 35.1 23.9 36.1 21.6 25.4 16.8 24.5 45.4 21.9 13.6 33.6 26.4 34.6 36.4 7.5 20.2 43.0 46.2 8.4 37.8 25.7 25.7 14.1 16.5 37.3 32.1 15.8 16.9 56.0 26.0 60.5 16.4 15.4 13.1 77.0 54.5 16.0 11.4 33.5 43.8 58.3 26.2 18.8 36.2 56.2 CGRRF1 "CGR19, RNF197" ENSG00000100532 "Cell growth regulator with ring finger domain 1" Q99675 14 54509812-54539292 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 145.4;Spermatocytes: 112.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002930 Uncertain Supported Nucleoplasm,Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Vesicles "HPA002930: AB_1078507" "unprognostic (1.81e-1)" "unprognostic (3.76e-1)" "unprognostic (5.61e-2)" "unprognostic (4.38e-1)" "unprognostic (1.01e-1)" "unprognostic (3.21e-1)" "prognostic unfavorable (6.84e-4)" "unprognostic (2.25e-1)" "unprognostic (5.58e-2)" "unprognostic (2.63e-1)" "unprognostic (7.29e-2)" "unprognostic (2.64e-3)" "prognostic favorable (2.57e-8)" "unprognostic (2.94e-1)" "unprognostic (1.61e-1)" "unprognostic (1.48e-1)" "unprognostic (1.74e-1)" 9.9 9.2 20.5 3.9 21.1 7.9 11.9 22.2 25.8 9.6 21.2 11.7 5.3 11.0 13.8 5.9 11.2 5.9 12.3 20.2 21.2 14.5 7.8 7.5 6.0 21.2 21.4 10.0 13.1 12.8 12.7 7.0 21.2 11.3 6.9 13.6 8.5 10.9 19.3 4.2 8.5 8.6 22.1 8.5 9.7 22.3 20.9 5.6 12.7 12.5 5.3 10.1 7.5 22.3 10.4 8.6 9.7 8.6 16.7 10.6 7.3 9.5 10.2 14.6 15.2 8.7 11.7 5.9 11.9 8.2 15.8 9.1 10.8 8.4 18.5 11.9 8.7 8.3 1.7 10.6 20.1 4.6 4.4 10.9 16.7 11.0 18.1 9.6 10.6 9.3 3.3 7.6 13.6 19.0 4.9 7.2 6.0 9.5 15.3 10.8 12.3 2.9 11.8 13.3 6.4 6.3 8.3 3.9 16.1 8.7 11.3 4.2 9.3 18.2 14.3 7.2 8.7 5.0 6.4 8.5 10.0 5.6 12.0 61.9 12.4 22.6 19.1 15.4 18.7 18.2 19.9 20.2 10.4 19.4 20.0 18.6 12.5 20.3 19.0 9.0 22.3 19.7 20.5 21.1 22.2 25.8 20.2 21.2 21.2 21.4 21.2 22.1 20.9 22.3 20.3 9.6 11.5 21.5 22.6 7.6 17.4 26.7 16.5 18.6 18.3 18.7 22.1 14.3 17.3 16.5 10.4 14.7 21.8 17.5 23.5 21.6 145.4 13.7 15.1 20.3 10.7 4.2 14.2 16.9 11.5 22.3 5.6 13.1 29.2 12.7 18.9 10.6 17.0 11.8 13.8 9.1 28.5 14.8 10.3 41.5 16.8 24.8 16.0 12.2 15.5 29.4 16.5 17.1 24.3 17.7 13.1 22.6 11.5 16.8 15.6 27.3 22.6 15.9 19.7 17.0 25.0 112.2 36.0 10.0 3.4 12.0 24.0 12.3 11.0 14.0 SAMD4A "DKFZP434H0350, hSmaug1, KIAA1053, SAMD4, Smaug, SMG, SMGA" ENSG00000020577 "Sterile alpha motif domain containing 4A" Q9UPU9 14 54566117-54793315 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 94.3;testis: 107.9" "Group enriched" "Detected in many" 4 "Early spermatids: 1176.0;Late spermatids: 2275.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 1.2;non-classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043061, HPA065309" Approved Approved "Cell Junctions,Cytosol" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 34: Spermatids - Unknown function" "Cell Junctions" Cytosol "HPA043061: AB_2678299, HPA065309: AB_2685462" "unprognostic (1.46e-1)" "unprognostic (8.10e-3)" "unprognostic (9.66e-3)" "unprognostic (1.18e-4)" "unprognostic (2.79e-1)" "unprognostic (6.37e-2)" "unprognostic (1.46e-1)" "unprognostic (1.17e-1)" "unprognostic (1.13e-1)" "unprognostic (1.75e-1)" "unprognostic (1.98e-1)" "unprognostic (7.74e-2)" "unprognostic (1.09e-2)" "unprognostic (2.83e-2)" "unprognostic (8.27e-2)" "unprognostic (5.41e-2)" "unprognostic (1.51e-1)" 16.6 4.2 27.4 8.9 33.1 0.4 13.1 42.3 24.9 13.0 14.1 37.6 3.2 26.1 4.0 6.7 12.0 6.0 47.8 22.6 40.3 12.4 16.6 21.2 4.6 79.0 46.2 4.5 6.2 3.8 6.1 9.2 69.4 14.5 4.8 2.6 7.0 9.4 94.3 8.9 10.4 17.1 64.1 7.1 10.9 107.9 41.8 1.1 7.0 39.3 3.1 17.7 12.8 60.8 32.9 2.9 6.7 3.4 14.0 21.3 11.7 27.4 41.4 22.3 22.0 36.8 7.8 1.8 14.0 41.7 8.8 22.6 6.6 14.2 32.8 16.5 2.8 0.0 4.0 7.7 7.7 0.0 0.2 12.6 5.3 15.9 23.4 6.5 17.1 0.0 2.6 0.0 11.0 2.4 0.4 0.1 3.1 0.2 7.5 0.9 13.5 0.1 11.0 10.8 1.0 10.7 4.0 5.2 15.9 13.8 21.0 0.3 37.1 26.6 41.1 6.6 8.7 0.1 0.1 0.0 7.5 0.6 8.4 0.0 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.2 27.4 33.1 42.3 24.9 22.6 40.3 79.0 46.2 69.4 64.1 41.8 60.8 16.0 25.6 1.5 170.1 7.4 39.6 47.0 12.0 1.2 2.4 6.2 6.1 278.5 14.3 9.9 18.4 8.4 10.5 1.6 4.4 3.9 9.9 1176.0 13.7 45.3 30.9 6.0 5.7 64.6 8.0 1.8 47.3 1.5 29.3 22.8 0.8 10.8 62.6 11.6 10.1 173.7 1.5 6.1 15.3 28.9 2275.7 14.6 13.0 24.9 72.1 12.8 1.5 1.0 380.5 140.7 19.8 5.5 23.7 0.3 55.1 5.6 22.9 4.0 5.4 13.1 79.7 37.1 17.1 7.6 0.4 24.3 1.9 5.7 0.3 1.7 44.5 GCH1 "DYT14, DYT5, DYT5a, GCH, GTPCH1" ENSG00000131979 "GTP cyclohydrolase 1" P30793 14 54842008-54902826 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis" "Allosteric enzyme, Hydrolase" "Disease variant, Dystonia, Parkinsonism, Phenylketonuria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 31.4;liver: 36.7" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 212.5;Hepatocytes: 94.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 11.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 23.5;Daudi: 25.0;JURKAT: 23.0;SH-SY5Y: 50.9" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 12.7" HPA028612 Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" No No "Cluster 51: Monocytes - Innate immune response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 41: Macrophages - Immune response" Nucleoplasm "Nuclear membrane, Cytosol" "HPA028612: AB_10602135" "unprognostic (3.77e-2)" "unprognostic (2.67e-3)" "unprognostic (6.73e-2)" "unprognostic (2.39e-1)" "unprognostic (9.26e-2)" "unprognostic (1.27e-1)" "unprognostic (7.26e-2)" "unprognostic (1.75e-1)" "unprognostic (3.97e-1)" "prognostic favorable (8.69e-4)" "prognostic favorable (1.41e-4)" "unprognostic (1.23e-1)" "unprognostic (1.96e-2)" "unprognostic (7.22e-3)" "unprognostic (1.76e-2)" "unprognostic (2.23e-1)" "prognostic favorable (6.67e-4)" 2.4 6.0 2.1 8.1 3.0 31.4 1.8 1.1 2.0 0.4 1.5 2.4 9.4 0.4 0.2 3.5 1.2 0.4 1.9 1.9 4.8 4.6 36.7 4.1 7.0 3.5 16.1 0.5 2.6 0.9 1.8 0.3 8.4 1.5 2.4 0.1 1.7 1.0 0.4 2.2 7.5 1.1 2.4 6.9 2.8 1.2 7.8 3.8 0.8 0.2 2.0 3.3 1.4 2.0 4.7 0.6 1.3 7.1 0.0 0.0 23.5 0.0 2.0 2.4 2.9 1.4 1.0 25.0 6.9 0.2 5.8 4.0 4.9 1.5 0.1 10.9 5.2 0.6 0.3 3.1 8.4 0.0 1.9 0.3 0.7 1.2 0.1 0.0 0.7 23.0 2.8 0.0 0.0 5.0 15.1 0.3 0.4 6.5 8.2 9.6 2.8 0.0 2.9 1.6 11.6 50.9 3.3 2.4 1.6 0.4 2.9 1.5 0.3 0.1 4.0 9.9 3.8 10.5 8.4 7.8 3.1 8.4 0.0 0.0 2.6 0.2 2.8 5.3 2.1 0.7 1.0 1.5 2.8 1.9 2.5 1.3 0.3 1.8 11.1 0.1 2.1 1.2 2.1 3.0 1.1 2.0 1.9 4.8 3.5 16.1 8.4 2.4 7.8 2.0 19.2 3.2 4.8 0.7 33.4 74.6 30.9 23.6 17.6 0.0 19.4 13.2 6.5 4.3 13.6 5.5 2.1 1.9 50.9 21.8 7.9 8.7 0.5 16.8 5.8 19.8 212.5 10.1 3.8 9.4 44.3 15.3 43.8 29.3 0.0 0.3 6.8 94.6 6.1 0.0 5.9 22.7 4.1 28.0 33.3 0.6 0.3 55.8 10.6 15.9 29.5 0.7 29.9 0.5 0.8 11.0 13.6 4.9 14.4 20.5 17.1 48.6 6.9 0.4 0.0 12.5 7.5 2.2 6.7 20.8 76.1 4.2 41.8 11.9 12.2 39.0 WDHD1 "AND-1, CHTF4, CTF4" ENSG00000198554 "WD repeat and HMG-box DNA binding protein 1" O75717 14 54938949-55027105 "Predicted intracellular proteins, Predicted membrane proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 8.0" "Cell type enhanced" "Detected in many" "Erythroid cells: 15.5;Spermatocytes: 15.0;Spermatogonia: 19.3" "Cancer enhanced" "Detected in all" "testis cancer: 23.5" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000632, HPA001122" Enhanced Enhanced Nucleoplasm NA Yes "Cluster 40: NK-cells - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA000632: , HPA001122: AB_1080589" "unprognostic (1.88e-1)" "unprognostic (1.21e-1)" "unprognostic (1.98e-2)" "unprognostic (2.25e-3)" "unprognostic (1.20e-1)" "unprognostic (6.85e-3)" "unprognostic (2.33e-4)" "unprognostic (5.52e-3)" "unprognostic (7.28e-3)" "unprognostic (8.05e-3)" "prognostic unfavorable (9.24e-4)" "unprognostic (5.11e-2)" "unprognostic (2.67e-4)" "unprognostic (8.31e-3)" "unprognostic (1.50e-1)" "unprognostic (3.49e-2)" "unprognostic (2.36e-2)" 1.3 0.8 0.5 3.8 1.0 7.2 2.2 0.9 0.9 1.2 0.1 2.8 1.8 2.1 0.6 2.4 1.6 1.3 0.9 0.7 0.2 1.1 1.2 1.3 5.5 0.2 0.2 1.4 0.9 1.5 0.3 2.8 0.2 1.0 4.0 1.8 0.7 0.8 0.6 2.0 1.7 2.6 0.3 1.7 1.6 5.3 0.4 8.0 0.9 0.8 6.7 1.7 1.1 0.9 39.6 24.7 48.4 21.4 4.6 11.2 28.1 37.5 16.1 29.6 36.0 16.6 25.9 44.9 18.6 10.8 21.4 32.8 72.9 21.5 61.7 30.0 12.7 29.8 23.7 16.2 1.9 56.7 21.8 5.9 3.8 36.6 14.3 7.1 19.6 28.8 37.8 22.0 28.7 21.7 53.5 11.1 38.6 21.1 25.7 49.5 69.7 17.3 8.4 26.0 28.1 19.8 39.8 10.0 12.8 35.1 26.8 11.3 12.8 37.3 43.9 27.5 32.1 6.5 14.4 58.8 17.1 27.4 30.0 1.7 0.3 0.6 0.9 0.2 1.2 1.2 1.0 1.3 0.5 1.8 1.3 1.8 0.4 2.0 0.4 0.7 1.6 0.6 0.5 1.0 0.9 0.9 0.7 0.2 0.2 0.2 0.2 0.3 0.4 0.9 2.3 0.0 2.0 3.9 5.1 3.8 2.2 3.5 3.4 2.9 1.8 1.9 1.7 0.0 4.0 3.7 0.0 8.7 3.6 1.8 0.0 1.8 0.8 1.9 3.1 2.0 0.0 15.5 10.3 1.0 8.4 3.4 2.6 2.5 0.0 12.4 0.7 0.9 4.1 3.3 6.5 2.4 6.1 2.1 1.2 1.1 0.0 2.4 1.8 5.6 1.4 1.4 2.1 4.5 10.1 1.1 0.3 3.0 7.8 0.6 0.5 6.2 3.5 3.1 0.0 2.4 3.0 15.0 19.3 6.1 2.4 2.6 3.6 2.8 5.2 1.7 SOCS4 SOCS7 ENSG00000180008 "Suppressor of cytokine signaling 4" Q8WXH5 14 55027230-55049489 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "testis cancer: 17.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013478, HPA057961" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 11: Basophils - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Cytosol" "CAB013478: , HPA057961: AB_2683564" "unprognostic (7.18e-3)" "unprognostic (1.49e-1)" "unprognostic (9.74e-3)" "unprognostic (4.57e-2)" "unprognostic (3.36e-3)" "unprognostic (3.82e-3)" "unprognostic (3.69e-3)" "unprognostic (2.70e-1)" "unprognostic (9.70e-2)" "unprognostic (1.38e-1)" "unprognostic (1.21e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-2)" "unprognostic (4.56e-2)" "unprognostic (7.61e-2)" "unprognostic (4.35e-3)" "unprognostic (1.13e-1)" 6.6 4.9 6.1 7.9 6.7 6.8 5.7 6.7 6.7 4.7 5.6 5.2 5.3 5.8 4.2 5.1 5.2 6.6 5.6 5.9 8.7 6.3 4.9 6.7 8.9 8.1 7.1 3.8 4.1 5.5 4.5 5.7 8.2 4.8 5.6 10.8 4.5 4.5 4.9 5.1 5.3 6.0 8.1 7.6 7.0 4.3 7.0 8.0 6.9 5.1 7.6 6.5 4.2 8.8 14.2 11.0 16.2 18.9 11.0 12.2 12.0 16.4 12.1 9.9 16.0 9.6 15.2 20.8 11.3 12.4 9.7 19.1 21.4 13.5 23.1 20.8 8.8 12.8 16.3 6.1 11.1 14.3 20.9 9.9 14.4 17.6 13.0 11.5 18.5 22.0 7.4 19.2 19.3 14.6 21.9 11.6 12.7 11.7 12.0 20.3 24.5 8.5 15.2 15.0 21.1 18.5 16.6 9.8 16.8 14.8 14.0 11.2 19.3 25.5 23.9 13.1 14.0 7.4 8.3 19.6 17.2 11.8 20.2 0.9 1.2 1.2 0.8 1.3 1.3 0.8 1.0 0.8 0.9 1.1 0.6 0.6 0.7 1.8 1.8 1.2 1.0 0.5 6.1 6.7 6.7 6.7 5.9 8.7 8.1 7.1 8.2 8.1 7.0 8.8 30.7 6.4 12.4 9.8 22.3 24.0 10.8 10.7 14.8 13.6 14.7 12.3 20.2 11.5 15.8 14.7 20.9 5.2 27.5 14.7 13.7 9.4 7.4 36.8 22.5 20.9 20.4 16.8 14.3 8.7 6.2 14.8 29.0 20.6 32.9 11.8 15.0 9.4 7.4 37.0 13.6 8.3 8.2 13.3 21.8 2.6 7.2 15.6 3.6 11.2 17.3 21.0 13.4 4.5 20.4 15.6 9.6 10.1 19.4 8.1 6.7 14.6 19.7 17.4 0.0 15.8 21.5 20.7 10.9 14.7 23.2 4.9 21.7 13.7 8.1 11.5 MAPK1IP1L C14orf32 ENSG00000168175 "Mitogen-activated protein kinase 1 interacting protein 1 like" Q8NDC0 14 55051647-55070194 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034506 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Cytosol" "HPA034506: AB_10669784" "unprognostic (3.27e-2)" "unprognostic (1.30e-1)" "unprognostic (2.83e-1)" "unprognostic (2.68e-2)" "unprognostic (1.43e-1)" "unprognostic (1.28e-1)" "unprognostic (6.86e-3)" "unprognostic (8.17e-3)" "unprognostic (3.32e-1)" "unprognostic (2.91e-2)" "unprognostic (1.70e-1)" "unprognostic (4.65e-1)" "prognostic favorable (4.82e-5)" "unprognostic (7.96e-2)" "unprognostic (1.71e-1)" "unprognostic (2.45e-1)" "unprognostic (5.40e-2)" 31.2 26.3 15.6 27.5 16.5 83.2 26.5 16.7 22.3 26.0 15.4 24.4 18.9 30.2 29.4 27.6 28.9 26.4 33.3 16.0 19.6 42.0 27.3 25.7 29.5 18.0 17.8 34.6 21.9 23.4 22.3 30.2 17.5 24.6 24.8 19.1 30.2 24.6 25.7 27.0 21.2 35.6 17.0 24.2 23.1 21.6 18.0 23.9 25.8 19.9 36.5 34.2 21.8 18.1 49.0 42.3 73.1 46.8 57.8 56.6 56.5 53.7 56.8 65.2 75.2 34.1 42.2 56.3 44.4 72.0 39.2 52.5 79.3 81.3 90.7 51.4 50.6 54.3 39.4 51.7 63.0 67.3 57.4 73.6 60.0 54.5 85.9 47.5 87.9 35.4 51.2 48.7 95.6 59.0 56.9 51.7 53.1 46.2 70.4 48.1 80.4 34.0 89.9 54.1 47.5 55.0 51.9 36.7 51.6 65.1 65.5 38.4 66.8 66.6 87.0 41.7 48.6 29.9 46.3 73.3 53.3 34.7 49.0 44.1 26.7 32.1 24.2 37.4 32.0 31.8 28.3 26.3 29.0 27.4 26.0 26.1 19.7 26.0 36.4 37.2 37.9 25.1 15.6 16.5 16.7 22.3 16.0 19.6 18.0 17.8 17.5 17.0 18.0 18.1 73.5 70.5 66.9 25.5 106.3 71.9 164.0 77.3 53.5 22.9 44.1 36.2 71.2 40.0 66.3 47.8 37.5 121.2 78.0 60.3 70.5 65.0 28.5 73.7 57.1 69.5 57.9 57.7 34.3 69.4 112.3 60.7 70.3 86.2 83.1 41.5 43.2 51.5 75.1 38.7 32.2 54.8 50.8 64.4 88.4 14.1 51.3 72.9 49.8 28.1 65.0 60.0 49.4 27.2 38.1 94.4 44.2 54.2 109.5 104.8 44.1 103.4 39.6 24.9 32.9 59.1 66.5 81.1 60.6 53.6 71.6 151.3 86.4 40.5 46.9 145.3 LGALS3 "GALIG, LGALS2, MAC-2" ENSG00000131981 "Galectin 3" P17931 14 55124110-55145423 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Immunity, Innate immunity, mRNA processing, mRNA splicing" "IgE-binding protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 1194.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 4097.0;Paneth cells: 3445.9;Proximal enterocytes: 4397.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 651.4;intermediate monocyte: 544.6;myeloid DC: 397.8;non-classical monocyte: 441.2;T-reg: 251.9" "Group enriched" "Detected in all" 13 "dendritic cells: 397.8;monocytes: 651.4;T-cells: 251.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 1169.3;CAPAN-2: 968.0;OE19: 1613.0;SK-MEL-30: 2329.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003162, CAB005191, HPA076528" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA NA 1900000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 37: Intestine - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Cytosol" "Plasma membrane" "CAB005191: AB_2136784, HPA003162: AB_1078937, HPA076528: " "unprognostic (1.42e-1)" "unprognostic (9.79e-2)" "unprognostic (1.14e-1)" "unprognostic (3.15e-1)" "unprognostic (2.46e-2)" "unprognostic (3.34e-2)" "unprognostic (1.73e-3)" "unprognostic (1.00e-1)" "unprognostic (2.13e-2)" "unprognostic (1.28e-1)" "unprognostic (1.08e-3)" "unprognostic (5.97e-2)" "unprognostic (8.52e-2)" "unprognostic (1.44e-1)" "unprognostic (2.96e-2)" "unprognostic (2.65e-3)" "unprognostic (7.60e-3)" 404.5 72.0 111.4 219.8 111.8 346.9 323.1 110.7 148.1 331.4 104.3 1194.1 691.9 162.3 53.8 437.8 223.1 273.0 246.2 110.3 109.4 120.0 27.3 356.1 84.5 118.6 111.9 251.4 79.9 19.8 60.6 141.2 108.6 143.1 875.4 68.3 358.6 177.4 78.6 473.1 853.4 158.8 110.4 61.9 340.7 63.5 125.2 53.0 72.3 105.6 114.1 300.8 273.5 114.0 298.6 96.5 3.3 2.5 581.2 1169.3 344.9 226.7 496.2 64.0 113.2 225.4 968.0 0.7 121.3 272.8 114.6 289.0 6.1 245.4 37.5 357.1 4.4 1.0 104.7 103.8 446.8 1.0 1.1 363.4 375.2 73.9 152.8 145.1 101.5 0.7 1.4 283.1 148.8 218.5 1.3 74.4 5.6 1613.0 271.1 0.7 11.3 22.4 604.8 434.2 7.8 22.6 529.0 0.9 2329.1 16.2 242.8 31.4 180.5 297.8 41.5 112.0 4.4 154.0 535.6 2.8 426.8 18.6 31.8 18.5 651.4 32.4 15.7 544.6 99.7 11.5 58.4 44.2 397.8 4.7 2.5 8.3 28.7 24.2 441.2 9.6 251.9 449.6 111.4 111.8 110.7 148.1 110.3 109.4 118.6 111.9 108.6 110.4 125.2 114.0 1157.4 721.1 359.8 33.3 42.0 631.3 624.1 1278.9 241.9 2.9 307.3 478.7 218.2 258.7 1463.3 119.5 0.0 766.1 38.8 4097.0 673.1 605.9 21.7 636.2 742.7 397.8 173.4 578.1 0.2 1057.8 1051.7 666.3 281.4 846.8 580.5 6.3 64.6 2.3 1137.4 1.7 0.5 1733.8 1778.1 287.8 844.6 44.4 555.7 651.2 848.4 14.0 639.1 300.1 9.2 2.0 0.3 1289.6 3445.9 384.0 77.4 708.4 4397.2 81.3 1506.5 14.7 144.7 220.2 521.0 11.5 6.6 524.8 797.6 483.8 119.5 2.9 1880.1 1139.7 DLGAP5 "DLG1, DLG7, HURP, KIAA0008" ENSG00000126787 "DLG associated protein 5" Q15398 14 55148112-55191608 "Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 29.7;lymphoid tissue: 42.0;testis: 17.4" "Cell type enhanced" "Detected in many" "Erythroid cells: 92.6;Extravillous trophoblasts: 23.1;Plasma cells: 22.1;Spermatocytes: 68.1;Spermatogonia: 31.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "T-reg: 5.4" "Lineage enriched" "Detected in many" 5 "T-cells: 5.4" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA005546 Enhanced Supported "Centriolar satellite,Cytosol" Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Centriolar satellite, Cytosol" "HPA005546: AB_1078677" "unprognostic (2.24e-1)" "unprognostic (1.77e-1)" "unprognostic (1.19e-3)" "prognostic unfavorable (4.59e-4)" "unprognostic (1.42e-1)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.52e-6)" "prognostic unfavorable (7.85e-4)" "unprognostic (6.15e-3)" "unprognostic (3.55e-1)" "prognostic unfavorable (9.94e-6)" "unprognostic (4.69e-2)" "unprognostic (0.00e+0)" "unprognostic (1.06e-2)" "unprognostic (3.64e-1)" "unprognostic (1.29e-1)" "unprognostic (1.93e-2)" 0.8 0.3 1.4 8.1 0.9 29.7 1.4 0.4 1.8 0.8 0.6 5.5 5.0 1.3 0.1 5.2 0.4 0.8 0.2 1.0 1.7 0.2 0.7 0.7 17.9 0.7 1.0 0.2 0.1 0.2 0.0 4.1 0.8 0.2 6.7 0.1 0.8 0.1 0.1 3.1 4.6 2.7 0.3 2.6 3.0 17.4 1.1 42.0 0.4 0.0 18.7 2.0 1.5 3.8 144.8 56.8 140.6 63.7 3.3 13.4 43.8 80.3 52.7 115.3 109.3 45.9 75.8 82.1 44.2 46.9 47.4 85.6 91.5 64.0 150.5 101.9 45.7 84.4 49.9 39.3 0.4 82.7 49.3 2.8 2.2 54.8 27.0 18.9 129.0 82.5 70.5 79.8 109.3 69.2 105.0 42.7 72.6 63.3 57.3 80.8 137.9 39.0 37.9 45.2 71.7 40.7 84.8 31.7 30.8 60.6 71.6 31.6 49.6 52.4 133.3 50.6 94.6 19.4 44.9 108.9 35.9 59.6 83.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.9 1.4 0.3 0.0 0.2 0.1 0.2 1.0 0.0 0.0 5.4 0.7 1.4 0.9 0.4 1.8 1.0 1.7 0.7 1.0 0.8 0.3 1.1 3.8 0.1 0.0 0.5 0.0 4.4 1.1 0.7 3.3 0.0 0.0 1.2 0.9 0.4 0.0 1.3 0.0 0.0 11.6 1.4 3.2 0.0 0.4 19.7 7.2 2.6 2.4 0.0 92.6 0.3 0.0 23.1 4.2 7.7 4.5 0.0 15.8 3.9 0.5 10.5 0.0 0.3 3.6 8.2 4.1 1.6 6.0 0.9 3.7 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.2 0.2 1.2 22.1 0.6 0.3 0.1 1.3 0.0 6.6 0.0 3.8 68.1 31.7 11.6 0.4 1.9 4.0 0.9 6.9 1.4 FBXO34 "Fbx34, FLJ20725" ENSG00000178974 "F-box protein 34" Q9NWN3 14 55271344-55370053 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 165.2;Late spermatids: 219.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052592 Uncertain Approved "Nuclear speckles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 24: Non-specific - Transcription regulation" "Nuclear speckles" "HPA052592: AB_2681877" "unprognostic (6.19e-2)" "unprognostic (1.73e-1)" "unprognostic (5.47e-2)" "unprognostic (6.35e-2)" "unprognostic (1.60e-1)" "unprognostic (1.44e-2)" "unprognostic (1.18e-1)" "unprognostic (9.87e-3)" "unprognostic (3.07e-2)" "unprognostic (1.67e-1)" "unprognostic (1.04e-2)" "unprognostic (1.30e-1)" "prognostic favorable (1.20e-13)" "unprognostic (4.49e-2)" "unprognostic (3.14e-1)" "unprognostic (2.04e-1)" "unprognostic (1.23e-1)" 9.0 7.9 7.8 11.9 10.7 17.2 12.6 6.5 14.9 12.3 7.1 27.3 14.4 11.0 15.9 33.5 15.0 13.3 13.1 14.4 6.2 18.3 12.0 15.2 12.8 4.6 5.8 11.6 10.5 11.6 6.5 10.0 4.7 12.9 26.8 16.0 17.5 11.6 31.2 12.2 15.1 11.7 4.9 13.9 18.1 24.8 6.7 17.0 22.7 44.7 15.8 16.4 16.1 7.5 30.1 17.2 13.5 12.3 17.3 14.1 14.8 14.9 25.4 22.1 25.5 15.7 37.8 24.0 12.1 12.9 14.4 29.0 17.5 15.0 28.3 14.8 10.2 25.2 10.4 9.7 13.4 30.5 23.8 11.5 21.6 15.4 15.4 17.2 17.0 25.8 19.9 18.8 14.3 20.2 24.0 21.6 8.0 26.3 13.3 25.5 33.1 13.4 20.3 34.2 14.9 16.2 18.0 17.9 14.8 16.3 21.5 19.5 13.0 19.3 24.9 10.5 11.8 9.1 8.2 27.1 13.7 16.4 11.3 9.4 11.2 2.5 9.9 7.5 11.8 7.0 10.1 10.8 11.1 7.0 8.8 9.3 6.1 13.2 14.0 5.1 6.9 8.7 7.8 10.7 6.5 14.9 14.4 6.2 4.6 5.8 4.7 4.9 6.7 7.5 16.2 22.4 31.6 22.9 27.3 21.0 32.9 18.5 15.9 36.7 15.6 12.7 21.5 7.2 32.5 18.4 22.9 13.9 57.8 63.7 17.6 22.8 165.2 27.1 17.4 24.1 26.4 52.8 109.1 30.3 4.7 14.7 31.1 28.9 17.2 21.1 9.3 7.8 9.9 37.0 75.5 30.0 30.5 13.5 24.3 219.1 23.0 27.8 12.4 46.9 12.6 14.1 24.7 35.2 20.7 18.0 35.3 16.6 27.4 31.2 20.0 17.0 34.5 32.4 6.6 24.2 19.3 34.1 16.3 20.7 24.3 27.0 44.1 11.4 29.3 63.2 ATG14 "ATG14L, KIAA0831" ENSG00000126775 "Autophagy related 14" Q6ZNE5 14 55366391-55411830 "Predicted intracellular proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB037242 Uncertain NA NA "Cluster 15: NK-cells - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 24: Non-specific - Transcription regulation" "CAB037242: AB_1852353" "unprognostic (8.53e-2)" "unprognostic (1.84e-1)" "unprognostic (2.93e-2)" "unprognostic (5.83e-2)" "unprognostic (3.37e-2)" "unprognostic (2.80e-2)" "prognostic unfavorable (1.63e-4)" "unprognostic (1.61e-2)" "unprognostic (3.44e-2)" "unprognostic (2.92e-1)" "unprognostic (2.63e-1)" "unprognostic (8.49e-3)" "prognostic favorable (1.95e-4)" "unprognostic (1.70e-1)" "unprognostic (2.32e-1)" "unprognostic (1.28e-1)" "unprognostic (1.30e-1)" 6.1 6.7 5.3 4.6 6.6 28.9 6.4 6.9 6.7 7.3 4.8 6.8 5.3 7.7 2.0 7.0 5.6 5.7 8.0 5.7 5.4 6.2 4.8 5.3 4.5 5.8 5.7 8.0 4.9 8.0 3.4 6.2 5.7 5.6 3.8 8.9 6.0 6.5 16.0 8.7 5.0 6.1 5.8 5.6 4.8 7.7 5.8 5.1 6.4 10.4 5.4 6.4 6.6 8.5 8.2 5.7 4.8 7.0 8.3 9.9 10.4 7.5 13.1 7.1 8.5 5.1 9.6 3.2 6.3 7.3 3.6 8.7 5.6 2.9 10.2 5.2 3.7 4.7 7.5 6.7 8.4 5.8 6.4 6.8 8.7 6.0 5.4 11.3 6.7 5.6 4.8 7.1 6.7 6.5 4.0 6.7 8.8 3.6 7.4 4.0 12.3 2.4 3.4 5.3 5.8 6.5 11.2 6.5 7.8 5.7 6.4 2.3 8.0 11.1 8.3 5.6 3.8 4.1 4.7 3.5 6.9 3.2 5.9 2.7 2.5 1.1 2.4 1.8 2.0 2.5 2.4 2.4 1.6 2.8 2.6 2.7 0.8 5.9 1.6 2.4 2.0 1.7 5.3 6.6 6.9 6.7 5.7 5.4 5.8 5.7 5.7 5.8 5.8 8.5 22.5 19.2 27.6 17.3 20.0 17.5 7.3 7.5 30.7 14.9 27.3 22.0 39.1 11.5 15.8 11.0 8.4 10.0 17.3 15.2 19.6 11.6 7.5 21.8 30.0 19.0 19.7 49.9 28.0 7.9 7.8 22.6 12.2 35.1 25.9 16.1 15.7 12.7 7.2 3.3 27.8 10.8 8.2 12.2 9.2 5.8 14.3 14.4 14.2 12.2 14.1 12.6 16.5 24.1 44.5 11.9 12.4 16.6 16.9 9.8 10.3 17.2 10.2 23.1 13.1 22.5 21.2 21.3 53.2 20.8 26.0 14.4 17.2 11.4 8.3 11.2 TBPL2 "TBP2, TRF3" ENSG00000182521 "TATA-box binding protein like 2" Q6SJ96 14 55413541-55456726 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.7;skeletal muscle: 1.7" "Cell type enhanced" "Detected in some" "Microglial cells: 1.0;Smooth muscle cells: 2.0" "Cancer enriched" "Detected in single" 40 "testis cancer: 2.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 5.7;HMC-1: 2.7;U-2 OS: 2.5;U-937: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA056241 Uncertain NA NA "Cluster 45: Intestine - Brush border" "Cluster 44: HDLM-2 - Immune response" "Cluster 10: Non-specific - Unknown function" "HPA056241: AB_2683076" "unprognostic (3.42e-1)" "unprognostic (1.16e-1)" "unprognostic (1.50e-1)" "unprognostic (3.06e-4)" "unprognostic (1.43e-1)" "unprognostic (1.32e-1)" "unprognostic (1.76e-1)" 0.2 0.5 0.6 0.8 0.7 0.5 0.0 1.7 1.2 0.4 0.4 0.2 0.9 0.7 0.0 0.2 0.2 0.1 0.0 0.6 0.4 0.2 0.2 0.4 0.3 1.5 0.6 0.1 0.2 0.1 0.0 0.2 0.8 0.3 0.2 0.1 0.6 0.1 1.7 1.3 0.6 0.0 0.2 0.5 0.5 0.8 0.5 0.0 0.0 0.0 0.1 0.0 0.0 1.5 2.0 0.5 0.0 0.6 0.0 0.6 1.2 0.0 0.0 0.0 0.2 0.2 0.3 0.4 1.6 0.0 0.2 0.5 0.1 0.0 0.0 5.7 0.0 0.4 0.6 0.0 0.0 0.0 2.7 0.0 1.0 0.0 0.2 0.0 0.0 0.1 0.3 1.9 0.0 1.4 0.3 1.0 0.4 0.0 0.5 0.5 0.0 0.4 0.0 0.8 0.7 0.5 0.0 0.1 0.2 0.0 0.8 0.7 0.0 0.2 2.5 0.2 0.4 1.7 0.9 0.2 0.3 4.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.6 0.7 1.7 1.2 0.6 0.4 1.5 0.6 0.8 0.2 0.5 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.3 2.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 KTN1 "CG1, KIAA0004, KNT" ENSG00000126777 "Kinectin 1" Q86UP2 14 55559072-55701526 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003178, CAB015331, HPA017876" Enhanced Enhanced "Endoplasmic reticulum" NA NA 55000 "Cluster 6: Non-specific - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 54: Cardiomyocytes - Muscle contraction" "Endoplasmic reticulum" "CAB015331: , HPA003178: AB_1079218, HPA017876: AB_1852652" "unprognostic (7.00e-3)" "unprognostic (2.99e-2)" "unprognostic (8.60e-2)" "unprognostic (5.50e-2)" "unprognostic (2.49e-1)" "prognostic unfavorable (6.83e-5)" "prognostic unfavorable (3.76e-4)" "unprognostic (1.75e-1)" "unprognostic (1.21e-2)" "unprognostic (1.01e-1)" "unprognostic (9.08e-2)" "unprognostic (8.72e-2)" "prognostic favorable (1.01e-6)" "unprognostic (1.27e-1)" "unprognostic (2.75e-1)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" 81.6 77.7 90.8 52.8 98.9 36.1 81.6 92.8 106.3 61.4 165.0 97.4 43.4 58.1 97.1 72.7 53.2 58.6 134.6 81.0 94.2 104.0 106.6 67.0 61.8 100.2 95.3 63.9 67.2 143.0 67.4 69.4 100.7 77.5 90.8 127.9 73.5 73.5 378.2 137.6 53.2 60.3 95.2 53.4 61.1 145.1 99.4 54.7 107.7 281.6 61.0 113.1 55.2 110.3 200.5 133.4 100.3 106.5 132.8 127.3 140.2 159.7 127.3 97.2 85.2 89.4 233.9 152.8 213.4 166.7 102.7 347.2 122.5 138.2 162.7 251.9 65.2 109.1 223.0 174.4 126.3 160.3 83.3 119.1 124.6 122.1 208.4 208.3 161.9 122.2 107.4 88.1 189.0 154.6 141.3 95.0 76.8 91.1 194.3 109.6 258.2 73.5 244.8 307.0 122.4 100.0 245.8 113.2 143.2 201.7 115.3 101.7 230.0 193.9 250.4 100.0 151.2 38.9 55.9 110.4 229.4 93.4 109.5 117.0 42.7 48.0 56.2 40.3 54.7 95.6 69.4 65.8 44.0 106.6 71.1 62.1 29.6 64.9 52.6 185.8 48.4 16.0 90.8 98.9 92.8 106.3 81.0 94.2 100.2 95.3 100.7 95.2 99.4 110.3 363.1 307.7 239.8 72.5 171.7 654.5 285.8 215.6 270.9 206.5 460.6 348.7 852.7 270.2 214.7 428.6 360.7 155.1 194.9 575.2 31.3 249.7 721.9 351.3 186.6 345.0 224.0 165.3 93.9 304.0 199.1 211.9 95.3 298.1 134.9 384.5 295.9 401.7 116.8 326.4 112.1 226.4 207.5 181.3 261.6 377.9 248.5 168.9 172.5 104.9 194.3 449.2 142.2 90.0 139.8 341.2 325.7 441.6 184.6 283.5 152.6 109.3 319.3 400.9 335.2 333.5 292.1 694.3 386.4 217.8 723.0 164.7 168.3 162.4 282.4 328.0 PELI2 ENSG00000139946 "Pellino E3 ubiquitin protein ligase family member 2" Q9HAT8 14 56117814-56301524 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 114.3;Microglial cells: 100.2;Oligodendrocyte precursor cells: 150.8;Oligodendrocytes: 77.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 5.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 33.3;JURKAT: 43.8;MOLT-4: 39.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053182 Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoplasm, Nucleoli, Intermediate filaments" "HPA053182: AB_2682072" "unprognostic (3.26e-1)" "unprognostic (2.25e-1)" "unprognostic (9.21e-2)" "unprognostic (8.94e-3)" "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "unprognostic (2.53e-2)" "unprognostic (3.36e-3)" "unprognostic (1.81e-1)" "unprognostic (2.68e-2)" "unprognostic (1.18e-1)" "unprognostic (2.14e-1)" "prognostic favorable (1.53e-6)" "unprognostic (3.64e-1)" "unprognostic (2.15e-1)" "unprognostic (5.43e-2)" "unprognostic (2.22e-1)" 11.6 3.0 8.1 4.3 7.8 18.6 7.7 27.9 5.9 6.7 5.4 7.0 11.0 6.7 2.5 4.4 6.3 10.0 2.9 5.6 6.6 9.2 2.8 6.7 4.0 8.8 10.9 15.0 28.6 1.9 2.7 3.1 9.3 4.7 3.9 15.1 7.7 3.5 2.4 5.9 9.2 3.3 8.0 6.8 14.4 10.0 10.4 19.1 4.1 3.8 2.0 10.6 5.7 9.2 0.1 3.1 8.8 0.0 4.8 7.2 0.2 1.2 4.2 0.9 0.1 0.2 0.7 0.2 4.2 2.5 0.0 0.9 6.9 0.0 0.4 2.3 2.4 7.9 13.0 0.0 4.1 1.1 33.3 4.5 0.4 0.0 0.0 4.8 1.6 43.8 6.0 0.1 0.9 0.0 39.5 0.4 14.5 0.1 1.2 19.2 0.5 1.8 3.6 15.4 17.5 0.0 0.8 0.1 10.2 5.5 0.0 6.3 0.5 2.6 4.4 0.8 4.4 0.7 0.1 1.0 4.6 5.4 2.6 0.9 1.9 2.4 0.3 1.0 0.5 0.1 0.3 0.2 1.3 0.4 0.2 0.1 5.6 0.3 0.8 0.3 0.0 0.7 8.1 7.8 27.9 5.9 5.6 6.6 8.8 10.9 9.3 8.0 10.4 9.2 13.9 0.0 10.0 114.3 7.7 14.3 10.4 1.7 9.6 30.7 7.1 7.7 2.7 8.6 6.7 12.9 29.2 0.1 11.8 15.0 3.9 5.9 3.7 23.7 14.5 18.0 7.2 5.5 13.5 14.1 0.1 13.5 34.1 21.2 5.7 5.7 17.5 1.0 1.2 21.9 22.1 7.9 2.0 19.7 14.0 5.7 17.1 20.3 17.8 100.2 22.9 9.7 10.3 150.8 77.5 9.1 6.0 18.0 5.6 7.8 12.4 10.1 8.8 19.7 13.1 5.4 22.0 2.0 24.0 4.7 18.3 0.1 6.2 5.6 3.1 12.6 TMEM260 "C14orf101, FLJ20392" ENSG00000070269 "Transmembrane protein 260" Q9NX78 14 56488354-56650606 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix: 39.8" "Cell type enhanced" "Detected in many" "Early spermatids: 88.5;Excitatory neurons: 66.7;Inhibitory neurons: 62.8;Oligodendrocyte precursor cells: 69.9;Oligodendrocytes: 106.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003502 Uncertain Approved "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Cytosol" "Focal adhesion sites" "HPA003502: AB_1078314" "unprognostic (4.63e-2)" "unprognostic (2.41e-2)" "unprognostic (1.98e-1)" "unprognostic (1.73e-2)" "unprognostic (2.51e-1)" "unprognostic (3.58e-2)" "unprognostic (2.04e-1)" "prognostic favorable (7.11e-4)" "unprognostic (7.14e-2)" "unprognostic (1.89e-1)" "unprognostic (1.95e-3)" "unprognostic (3.22e-1)" "unprognostic (2.23e-3)" "unprognostic (5.81e-2)" "unprognostic (8.11e-2)" "unprognostic (1.32e-1)" "unprognostic (3.84e-2)" 4.6 4.3 4.5 4.0 5.4 2.1 5.5 4.7 4.9 39.8 12.4 5.8 5.2 6.2 7.8 3.4 7.4 5.9 2.5 4.4 4.5 6.8 5.6 4.4 4.7 4.6 4.4 9.3 4.5 7.3 3.7 5.7 4.5 5.2 5.8 6.9 3.8 4.5 2.2 5.6 5.7 3.9 4.4 4.0 5.5 5.2 4.5 5.8 8.4 2.2 3.8 4.7 3.6 7.3 8.0 5.5 4.2 8.9 14.5 11.9 8.2 8.4 9.2 5.4 6.4 2.6 5.8 6.5 8.0 6.2 6.1 9.1 9.7 6.1 8.4 8.1 4.9 4.2 2.7 3.6 10.2 5.9 9.6 14.6 10.7 3.0 10.3 9.8 7.1 4.9 5.2 6.8 7.1 5.3 3.1 2.2 3.9 13.0 8.6 4.3 6.7 2.2 9.0 11.7 8.8 4.3 9.4 6.7 5.5 7.8 8.6 9.0 10.0 10.9 4.1 8.2 4.2 4.1 3.5 3.8 6.8 4.3 5.5 0.0 1.1 1.2 1.3 0.8 0.9 0.7 0.8 0.7 0.9 0.7 1.2 0.8 0.5 2.5 0.7 1.9 1.3 0.8 4.5 5.4 4.7 4.9 4.4 4.5 4.6 4.4 4.5 4.4 4.5 7.3 12.2 19.2 17.2 39.8 13.0 5.4 7.1 5.9 5.7 14.6 8.0 7.7 3.7 2.8 8.5 22.0 4.2 10.2 9.8 9.4 1.9 8.1 88.5 22.8 17.6 8.3 18.0 7.6 66.7 3.8 7.7 10.4 9.2 29.1 12.0 20.0 8.9 13.3 6.5 6.7 62.8 10.0 6.1 12.8 5.0 31.5 15.2 8.7 1.8 39.4 11.1 5.2 14.4 69.9 106.0 5.6 7.6 10.9 9.3 9.3 9.5 4.8 14.2 16.4 0.0 7.0 8.0 9.3 11.0 10.0 5.5 11.1 8.9 14.5 12.1 8.0 OTX2 ENSG00000165588 "Orthodenticle homeobox 2" P32243 14 56799905-56816693 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "choroid plexus: 108.8;retina: 279.9" "Group enriched" "Detected in some" 11 "Bipolar cells: 170.6;Cone photoreceptor cells: 168.9;Rod photoreceptor cells: 202.5" "Cancer enriched" "Detected in single" 27 "testis cancer: 11.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 249.6;hTERT-RPE1: 57.0;NTERA-2: 199.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA000633, HPA001123" Uncertain Supported Nucleoplasm,Vesicles NA NA "Cluster 77: Retina - Visual perception" "Cluster 5: NTERA-2 - Transcription" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm Vesicles "HPA000633: AB_1079538, HPA001123: " "unprognostic (3.82e-1)" "unprognostic (2.56e-2)" "unprognostic (9.28e-2)" 0.0 0.0 4.1 0.0 1.3 0.0 0.0 8.5 0.5 0.0 108.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.9 2.6 0.0 0.0 0.0 0.0 0.2 8.7 0.0 0.0 0.0 2.5 0.0 2.0 0.0 0.0 279.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 12.8 0.0 0.0 0.8 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 249.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 57.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 199.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 1.3 8.5 0.5 5.9 2.6 0.2 8.7 2.0 0.1 12.8 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 170.6 0.0 0.0 0.3 0.0 0.0 0.0 168.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 202.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EXOC5 "SEC10, SEC10L1, SEC10P" ENSG00000070367 "Exocyst complex component 5" O00471 14 57200507-57268905 "Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 130.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060837 Approved NA NA "Cluster 44: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA060837: AB_2684375" "unprognostic (2.95e-2)" "unprognostic (5.92e-2)" "unprognostic (1.82e-2)" "unprognostic (6.84e-2)" "unprognostic (5.05e-2)" "unprognostic (3.38e-1)" "unprognostic (9.47e-3)" "unprognostic (2.82e-2)" "unprognostic (9.14e-2)" "unprognostic (4.42e-2)" "unprognostic (1.25e-1)" "unprognostic (1.34e-1)" "unprognostic (3.89e-2)" "unprognostic (1.49e-1)" "unprognostic (2.38e-1)" "unprognostic (7.92e-2)" "unprognostic (2.98e-2)" 9.0 6.3 4.9 6.6 6.2 5.1 5.1 6.4 6.5 4.5 7.5 4.8 5.6 4.7 4.9 6.5 4.5 4.7 5.2 5.3 6.4 7.7 8.4 6.6 7.2 6.2 7.5 4.6 3.7 6.9 3.4 7.7 7.4 5.6 4.5 9.8 5.4 4.9 5.7 5.6 5.9 6.4 5.5 7.9 5.7 11.1 6.0 8.7 7.4 5.9 6.6 5.7 3.7 8.4 21.7 13.4 26.3 13.4 17.4 17.1 20.1 33.1 15.6 12.3 14.3 12.6 13.4 31.9 19.6 17.9 12.5 17.3 16.3 13.5 19.1 37.7 9.6 20.4 9.9 9.6 16.1 25.2 25.7 10.3 14.0 12.1 13.5 16.2 22.6 22.4 19.9 23.5 25.0 9.8 34.2 5.7 14.2 12.4 23.8 23.9 38.7 11.8 15.4 17.7 20.4 17.5 26.8 10.7 16.4 22.1 19.9 12.2 24.9 26.7 29.9 17.1 16.5 12.0 15.9 26.7 24.5 14.1 17.5 6.8 5.1 6.1 4.8 5.5 5.9 5.6 4.9 5.2 6.3 5.8 5.4 4.7 2.8 6.3 5.2 3.2 6.3 6.8 4.9 6.2 6.4 6.5 5.3 6.4 6.2 7.5 7.4 5.5 6.0 8.4 32.1 25.6 18.6 34.3 26.7 22.6 23.1 18.8 22.2 32.2 23.4 13.2 28.3 21.5 24.2 14.7 29.2 17.4 24.2 17.1 17.6 18.6 130.7 29.4 32.5 35.7 34.6 34.7 56.2 17.3 19.4 27.5 21.9 23.2 34.9 20.6 45.0 38.6 21.6 63.9 56.5 17.0 32.6 31.5 34.1 108.6 23.6 31.4 21.4 38.4 34.3 28.6 23.7 49.3 71.9 25.2 10.8 35.7 27.7 24.7 11.1 41.1 29.4 30.2 19.7 31.1 33.9 128.6 53.2 32.8 30.0 18.7 26.0 34.6 15.3 20.1 AP5M1 "C14orf108, FLJ10813, mu5, MuD, MUDENG" ENSG00000053770 "Adaptor related protein complex 5 subunit mu 1" Q9H0R1 14 57268924-57298742 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 115.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055768, HPA057098" Approved NA NA "Cluster 15: NK-cells - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" "HPA055768: AB_2682913, HPA057098: AB_2683335" "unprognostic (7.95e-2)" "unprognostic (5.37e-2)" "prognostic favorable (7.91e-4)" "unprognostic (1.52e-1)" "unprognostic (2.68e-1)" "unprognostic (2.27e-2)" "unprognostic (1.86e-1)" "unprognostic (2.11e-1)" "unprognostic (2.27e-2)" "unprognostic (1.64e-1)" "unprognostic (5.51e-3)" "unprognostic (1.23e-1)" "prognostic favorable (1.11e-14)" "unprognostic (6.26e-2)" "unprognostic (1.38e-1)" "unprognostic (6.62e-2)" "unprognostic (1.60e-1)" 11.5 12.1 6.5 13.2 8.7 15.4 13.8 11.9 10.2 14.3 20.1 25.7 28.8 11.7 15.3 16.3 9.8 12.1 16.5 7.2 13.5 28.5 21.1 11.7 17.0 13.2 9.0 8.3 10.0 31.5 6.6 11.0 12.1 12.3 29.5 22.5 16.7 12.6 15.5 11.2 25.2 14.0 9.0 14.4 14.9 10.5 10.0 22.2 18.4 28.3 22.8 13.3 7.5 11.0 19.0 16.1 22.3 21.5 20.2 22.6 17.8 21.0 20.7 18.5 24.5 16.1 27.8 26.7 20.4 20.7 16.5 27.6 32.1 18.5 27.8 27.9 9.4 14.8 15.3 18.7 14.0 44.9 23.6 20.9 23.8 17.6 13.3 19.2 21.0 23.2 18.4 17.6 29.8 16.6 41.6 11.2 16.9 34.6 22.4 27.9 29.4 20.3 42.7 44.1 36.4 20.0 24.3 38.9 16.3 21.8 23.8 20.4 13.5 26.3 24.9 13.9 12.0 9.7 15.9 24.1 23.2 21.1 19.8 20.5 17.8 36.4 19.1 15.4 20.8 22.8 21.0 22.0 24.9 15.9 21.4 22.9 14.9 28.6 15.3 13.2 25.6 17.9 6.5 8.7 11.9 10.2 7.2 13.5 13.2 9.0 12.1 9.0 10.0 11.0 15.4 32.1 13.1 19.2 30.7 20.1 18.8 30.5 21.6 21.0 17.8 11.6 32.6 17.2 25.3 23.9 39.6 21.5 22.6 40.6 86.1 20.9 115.1 11.5 12.9 19.0 29.9 23.4 42.3 16.2 18.9 17.0 29.0 13.1 17.7 13.4 18.9 31.1 24.5 35.3 45.6 29.0 44.7 25.6 11.5 88.1 17.7 17.9 21.4 21.5 32.1 19.3 34.0 19.1 31.0 16.6 23.7 20.3 26.8 19.9 44.8 74.4 16.2 31.3 19.7 12.7 13.4 31.5 10.7 37.8 21.5 19.3 22.3 17.2 39.6 23.7 NAA30 "C14orf35, FLJ35355, MAK3, Mak3p, NAT12" ENSG00000139977 "N-alpha-acetyltransferase 30, NatC catalytic subunit" Q147X3 14 57390544-57415906 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 107.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057824 Uncertain Supported Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol "HPA057824: AB_2683539" "unprognostic (5.13e-2)" "unprognostic (7.59e-2)" "unprognostic (1.09e-1)" "unprognostic (1.52e-2)" "unprognostic (5.22e-2)" "unprognostic (6.31e-2)" "unprognostic (1.84e-2)" "unprognostic (5.44e-2)" "unprognostic (2.59e-1)" "unprognostic (1.12e-1)" "unprognostic (1.67e-1)" "unprognostic (5.21e-2)" "prognostic favorable (1.25e-8)" "unprognostic (1.77e-1)" "unprognostic (1.67e-1)" "unprognostic (5.75e-3)" "unprognostic (1.63e-1)" 9.6 7.7 9.7 7.2 11.3 15.0 9.6 10.6 11.8 7.8 6.5 8.4 9.9 9.1 7.1 11.3 7.4 7.1 14.2 11.6 11.6 12.4 16.7 6.4 9.0 8.6 9.3 14.9 9.0 12.5 5.7 13.4 9.2 10.1 7.9 12.0 8.0 10.1 31.8 8.3 8.7 10.1 9.3 8.3 7.0 18.5 12.4 9.0 10.6 27.3 9.1 8.2 6.0 9.4 19.4 18.2 10.2 16.7 16.8 21.9 17.1 22.1 21.3 16.5 15.0 16.5 13.9 14.1 19.0 18.4 12.5 20.1 18.5 14.3 27.4 24.7 9.4 11.4 10.1 14.5 17.5 23.1 12.8 15.0 20.7 15.0 24.9 18.4 25.8 17.3 11.3 13.6 22.1 22.1 19.5 13.4 11.0 17.8 20.0 15.3 29.4 11.0 16.9 17.4 21.8 11.5 18.7 18.3 23.0 18.2 23.6 11.9 22.7 25.7 27.0 14.2 14.3 10.1 13.2 16.9 17.1 11.5 18.7 0.8 0.4 0.2 1.2 0.9 1.2 1.0 1.1 1.8 0.3 1.1 1.2 1.2 0.2 2.4 2.8 0.6 1.7 0.4 9.7 11.3 10.6 11.8 11.6 11.6 8.6 9.3 9.2 9.3 12.4 9.4 11.8 9.6 6.3 10.1 16.7 41.0 11.8 8.6 25.0 13.5 16.5 10.9 34.9 17.2 8.0 3.7 18.8 18.3 20.1 11.6 9.8 12.5 107.1 9.0 13.1 17.0 21.0 9.0 20.3 11.6 15.6 13.1 12.8 10.8 7.0 14.9 11.0 25.5 9.9 10.1 20.3 13.7 6.1 13.2 12.1 37.6 13.7 8.2 23.2 10.3 9.9 13.3 8.2 16.6 18.9 14.5 13.8 13.5 18.1 18.9 13.6 17.9 9.5 15.3 19.7 13.3 15.4 69.2 20.5 25.5 41.2 22.2 17.0 13.3 12.6 16.7 CCDC198 "C14orf105, FLJ10650" ENSG00000100557 "Coiled-coil domain containing 198" Q9NVL8 14 57469300-57493867 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 27.5;kidney: 97.3;liver: 36.8;pancreas: 34.0" "Group enriched" "Detected in some" 4 "Collecting duct cells: 57.0;Distal tubular cells: 68.4;Proximal tubular cells: 191.8" "Cancer enriched" "Detected in many" 5 "renal cancer: 25.1" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "A549: 11.5;RPTEC TERT1: 34.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA029202 Uncertain Nucleoplasm,Cytosol NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol Nucleoplasm "HPA029202: AB_10600754" "unprognostic (1.45e-1)" "unprognostic (3.65e-1)" "unprognostic (2.38e-1)" "unprognostic (6.67e-2)" "prognostic unfavorable (5.61e-4)" "unprognostic (1.21e-1)" "unprognostic (5.45e-3)" "unprognostic (1.51e-1)" "prognostic favorable (1.92e-4)" "unprognostic (6.07e-2)" "unprognostic (2.77e-1)" "unprognostic (1.61e-3)" 0.1 0.1 0.5 0.5 0.7 0.6 0.0 1.0 0.6 1.3 0.0 0.2 1.5 0.5 1.9 0.1 27.5 16.8 0.2 0.4 0.4 97.3 36.8 0.1 0.1 0.7 0.5 0.1 34.0 0.0 0.0 0.0 0.8 0.1 0.1 0.1 0.0 1.5 0.2 0.6 0.2 0.0 0.4 0.1 0.4 0.1 0.8 0.0 0.2 0.0 0.0 0.2 0.0 1.6 0.0 11.5 0.0 0.0 0.0 0.6 0.2 0.1 0.1 0.0 0.0 1.1 0.9 0.1 2.9 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.4 0.3 0.2 0.2 0.0 0.2 0.1 0.0 0.2 34.3 0.4 0.1 0.0 0.1 0.1 0.0 0.3 0.2 0.5 0.3 0.4 0.5 0.1 0.0 0.3 0.3 0.3 1.6 0.4 0.0 1.7 0.3 0.2 0.7 0.1 0.9 0.6 1.4 1.0 0.0 1.2 1.2 1.9 1.5 1.0 0.3 0.5 2.2 1.9 0.5 0.7 1.0 0.6 0.4 0.4 0.7 0.5 0.8 0.4 0.8 1.6 0.0 3.2 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 57.0 0.0 0.0 0.1 0.0 68.4 22.2 0.0 19.7 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.1 0.0 0.0 191.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 SLC35F4 "C14orf36, FLJ37712" ENSG00000151812 "Solute carrier family 35 member F4" A4IF30 14 57563920-57982194 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.6;retina: 6.4;seminal vesicle: 3.5" "Cell type enriched" "Detected in some" 12 "Inhibitory neurons: 166.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "RPMI-8226: 1.5;U-87 MG: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043853 Uncertain Approved "Nucleoli fibrillar center" NA NA "Cluster 77: Retina - Visual perception" "Cluster 25: RPMI-8226 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoli fibrillar center" "HPA043853: AB_10963083" "unprognostic (2.37e-1)" "unprognostic (2.10e-1)" "unprognostic (3.56e-1)" "unprognostic (2.66e-4)" "unprognostic (4.88e-2)" "unprognostic (8.64e-2)" "unprognostic (1.38e-1)" "unprognostic (1.76e-2)" "unprognostic (3.94e-2)" "unprognostic (1.39e-1)" "unprognostic (4.03e-3)" "unprognostic (3.50e-2)" "unprognostic (1.05e-2)" "unprognostic (9.68e-3)" "unprognostic (9.23e-2)" 0.0 0.0 0.7 0.0 0.9 0.0 0.0 5.6 0.7 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.4 1.4 0.0 0.0 0.0 0.0 1.7 1.4 0.0 0.1 0.0 0.0 0.0 1.8 1.3 0.0 6.4 0.0 3.5 0.0 0.0 0.0 0.3 2.9 0.0 0.0 1.0 2.3 0.0 0.8 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 5.6 0.7 0.4 1.4 1.7 1.4 1.8 2.9 2.3 0.6 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.4 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.1 11.7 0.1 0.0 0.2 0.0 0.0 12.2 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 166.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 5.3 0.1 0.0 3.0 0.0 0.0 0.0 0.1 0.0 13.7 0.0 0.0 0.1 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARMH4 "C14orf37, UT2" ENSG00000139971 "Armadillo like helical domain containing 4" Q86TY3 14 57999735-58298139 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.8;kidney: 8.3" "Cell type enhanced" "Detected in some" "Adipocytes: 15.8;Collecting duct cells: 12.9;Endometrial ciliated cells: 10.2;Endometrial stromal cells: 7.7;Granulosa cells: 26.0;Theca cells: 44.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 9.7;AN3-CA: 6.1;fHDF/TERT166: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001580, HPA001789" Enhanced Approved "Plasma membrane" NA NA 1800000 "Cluster 21: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" "Plasma membrane" "HPA001580: AB_2666366, HPA001789: AB_1078328" "unprognostic (2.56e-2)" "unprognostic (2.04e-2)" "unprognostic (1.20e-3)" "unprognostic (8.56e-2)" "unprognostic (1.15e-1)" "unprognostic (6.97e-3)" "unprognostic (1.94e-1)" "unprognostic (7.84e-3)" "unprognostic (2.66e-1)" "unprognostic (2.32e-1)" "unprognostic (2.42e-1)" "unprognostic (1.01e-1)" "unprognostic (3.87e-8)" "unprognostic (5.22e-6)" "unprognostic (4.93e-2)" "unprognostic (8.74e-4)" "unprognostic (3.01e-4)" 1.2 2.5 2.3 0.6 3.6 0.7 0.8 8.5 3.5 1.8 0.0 0.7 0.5 3.0 1.8 0.8 2.1 1.8 3.1 2.6 2.1 8.3 0.8 0.7 0.4 11.5 5.1 4.3 1.0 3.6 1.3 0.4 12.8 1.6 1.0 1.2 0.7 1.4 0.2 1.0 0.7 2.3 1.0 0.5 1.4 2.2 1.6 0.2 1.5 1.9 0.3 1.2 0.9 0.7 0.0 0.0 9.7 6.1 4.7 1.7 0.0 1.9 1.5 0.3 0.3 0.5 0.1 0.0 0.6 10.8 1.2 0.0 2.9 0.0 0.4 0.1 1.0 0.0 0.0 0.5 0.2 0.0 4.8 1.8 0.0 0.2 0.2 2.7 0.5 0.8 0.1 0.3 1.2 0.3 0.0 0.0 4.5 0.0 2.0 1.4 0.3 2.5 3.9 0.3 1.1 0.0 0.1 0.0 0.3 2.7 0.2 0.2 0.1 1.3 3.5 0.5 2.6 0.3 0.2 0.0 3.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 3.6 8.5 3.5 2.6 2.1 11.5 5.1 12.8 1.0 1.6 0.7 15.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.0 0.0 12.9 0.0 0.2 0.7 0.0 0.0 2.1 0.0 10.2 7.7 2.3 0.0 0.0 0.0 1.3 0.4 3.0 0.0 2.4 0.0 26.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.3 0.3 44.5 0.0 0.0 ACTR10 "ACTR11, Arp10, Arp11, HARP11" ENSG00000131966 "Actin related protein 10" Q9NZ32 14 58200080-58235636 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000699 Approved "Vesicles,Plasma membrane,Focal adhesion sites" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 35: Non-specific - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Vesicles, Plasma membrane, Focal adhesion sites" "HPA000699: " "prognostic unfavorable (3.24e-4)" "unprognostic (4.61e-2)" "unprognostic (6.22e-3)" "unprognostic (2.03e-2)" "unprognostic (4.42e-1)" "unprognostic (1.36e-2)" "prognostic unfavorable (2.71e-5)" "unprognostic (3.20e-1)" "unprognostic (9.30e-2)" "unprognostic (1.53e-1)" "unprognostic (4.86e-1)" "unprognostic (2.36e-1)" "prognostic favorable (8.48e-8)" "unprognostic (1.01e-2)" "unprognostic (2.39e-1)" "unprognostic (2.43e-2)" "unprognostic (8.48e-2)" 12.6 18.0 22.4 3.1 22.4 5.4 12.5 23.4 41.5 15.9 24.5 13.5 2.7 10.2 5.0 16.4 12.7 4.2 22.9 22.2 22.9 18.0 18.5 10.8 4.2 22.3 22.4 15.8 17.4 8.7 20.3 6.4 22.5 14.5 4.4 5.5 10.3 4.7 10.2 13.2 11.3 6.1 22.1 14.7 13.2 10.8 23.0 5.3 13.6 4.1 4.3 12.0 13.9 22.9 4.1 2.6 4.6 1.8 15.3 7.3 2.3 3.1 3.6 4.9 6.1 3.5 4.8 6.3 4.5 6.7 3.0 4.2 6.2 4.5 7.2 3.3 15.3 2.4 4.6 6.9 13.0 4.3 3.4 9.7 6.8 4.5 8.5 4.3 6.7 3.6 2.1 5.0 10.3 11.3 5.7 16.2 2.3 4.0 20.8 4.0 8.0 3.7 9.1 5.2 2.6 2.9 5.9 4.9 16.9 5.2 8.4 7.1 5.4 5.3 11.3 4.9 2.8 2.9 2.0 7.1 5.8 3.3 3.2 15.7 5.4 8.6 6.2 7.3 9.2 6.1 7.0 6.2 4.3 4.1 7.2 7.5 7.8 5.9 8.5 4.8 5.5 4.0 22.4 22.4 23.4 41.5 22.2 22.9 22.3 22.4 22.5 22.1 23.0 22.9 68.3 60.9 44.2 28.7 39.9 53.3 66.4 125.7 34.1 71.4 35.8 43.3 77.0 42.9 75.1 51.5 29.2 110.1 46.4 59.6 125.2 81.2 8.7 40.3 46.7 54.4 33.6 60.0 48.6 59.6 76.9 73.4 32.1 29.7 43.7 49.6 47.8 31.8 77.8 57.2 47.3 48.1 105.8 32.0 38.4 11.6 88.3 47.2 74.7 23.4 52.8 101.4 35.0 40.2 54.6 75.0 29.1 80.1 34.7 59.1 56.3 111.7 67.7 72.0 78.9 54.5 96.6 116.4 60.4 45.7 64.4 156.0 46.1 81.3 41.3 54.6 PSMA3 HC8 ENSG00000100567 "Proteasome 20S subunit alpha 3" P25788 14 58244843-58272012 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000905 Approved NA NA 9700000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "HPA000905: AB_1079702" "unprognostic (3.60e-1)" "unprognostic (4.81e-3)" "unprognostic (1.17e-1)" "unprognostic (2.19e-2)" "unprognostic (4.91e-1)" "unprognostic (5.79e-2)" "unprognostic (1.97e-3)" "unprognostic (1.27e-1)" "unprognostic (7.92e-2)" "unprognostic (7.36e-3)" "unprognostic (1.65e-2)" "unprognostic (7.57e-2)" "unprognostic (1.83e-3)" "unprognostic (2.33e-2)" "unprognostic (6.47e-2)" "prognostic favorable (2.91e-4)" "unprognostic (2.16e-1)" 74.1 88.6 50.0 84.8 52.6 82.8 82.1 54.9 61.8 59.6 54.2 76.7 81.3 55.4 127.6 75.8 57.9 60.7 99.9 51.2 55.2 94.3 162.2 69.0 104.1 53.2 52.3 40.4 55.4 72.9 46.6 90.8 53.3 60.9 82.9 48.3 54.7 76.3 170.6 53.1 74.3 78.6 55.8 66.6 61.0 41.3 51.9 108.6 74.9 130.4 96.9 102.5 48.6 56.6 359.2 214.3 215.1 179.2 166.4 154.3 277.8 187.2 209.3 257.4 256.8 317.8 294.2 304.1 330.9 171.3 202.4 243.9 249.2 200.9 299.7 262.3 148.9 208.5 150.9 360.8 314.2 340.4 170.0 132.8 142.2 179.2 169.1 151.7 307.2 242.0 201.3 174.6 209.3 400.4 299.7 314.4 144.9 286.8 328.3 249.3 279.6 222.7 377.5 339.7 202.9 100.3 167.5 261.8 189.5 201.6 273.3 244.9 198.3 148.4 287.1 167.6 249.4 68.4 137.3 314.1 215.7 260.2 184.1 95.3 78.9 52.0 71.2 98.9 92.2 85.8 87.1 86.0 91.8 61.9 69.5 80.8 48.2 94.1 85.6 122.4 112.6 95.5 50.0 52.6 54.9 61.8 51.2 55.2 53.2 52.3 53.3 55.8 51.9 56.6 132.9 118.6 119.2 21.9 93.7 118.7 169.6 418.7 71.2 43.5 69.2 77.6 117.0 71.4 195.7 88.3 35.5 387.5 104.5 83.3 166.3 241.3 24.7 127.6 95.6 137.7 64.4 60.6 27.6 231.1 269.2 108.5 59.1 109.1 95.7 412.6 66.4 145.4 184.0 42.1 29.1 103.8 250.3 59.2 77.5 27.4 109.3 89.4 108.5 26.2 206.0 87.3 84.5 32.6 33.6 192.9 89.0 106.1 118.4 167.5 108.9 297.5 157.4 68.6 98.6 83.7 279.6 109.3 66.9 89.8 106.0 403.5 99.3 104.9 108.4 171.6 ARID4A "RBBP1, RBP-1, RBP1" ENSG00000032219 "AT-rich interaction domain 4A" P29374 14 58298504-58373887 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048899 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Plasma membrane, Cytosol" "HPA048899: " "unprognostic (1.57e-1)" "unprognostic (9.39e-2)" "unprognostic (5.17e-2)" "unprognostic (2.69e-1)" "unprognostic (3.70e-2)" "prognostic favorable (1.91e-4)" "unprognostic (2.71e-1)" "prognostic favorable (7.82e-4)" "unprognostic (2.08e-2)" "unprognostic (6.92e-2)" "unprognostic (3.27e-1)" "unprognostic (3.72e-2)" "unprognostic (9.32e-2)" "unprognostic (2.32e-1)" "unprognostic (2.64e-1)" "unprognostic (4.11e-2)" "unprognostic (3.52e-2)" 9.8 6.9 8.6 11.1 9.2 34.7 9.1 14.8 10.0 8.6 8.9 7.7 8.8 9.5 6.8 7.4 6.8 9.0 8.7 8.0 11.7 9.4 18.7 10.3 14.9 7.9 7.7 12.5 7.4 9.8 5.4 9.8 7.6 8.6 8.8 14.0 6.7 7.6 5.4 8.7 9.1 8.2 6.8 14.0 8.9 6.9 12.3 14.5 10.6 6.3 11.2 8.4 7.5 10.7 8.5 7.0 19.2 9.5 9.3 11.2 9.7 9.9 8.4 6.6 10.4 8.3 13.1 20.4 10.3 8.4 6.3 9.6 8.6 4.8 9.6 14.3 5.5 9.2 8.2 8.0 5.6 19.7 12.8 8.4 5.2 6.4 6.6 10.5 10.6 11.6 10.7 16.3 7.1 11.5 14.3 17.7 3.8 8.2 8.7 14.5 16.6 6.1 7.1 14.9 16.5 14.3 16.9 8.4 12.0 9.4 14.3 17.8 15.3 11.2 8.7 9.1 4.6 5.3 4.2 18.3 6.7 12.3 5.8 65.8 19.5 59.1 20.6 20.1 23.3 31.5 25.3 22.1 14.9 42.3 27.0 26.5 109.4 29.1 40.8 19.8 19.8 10.1 8.6 9.2 14.8 10.0 8.0 11.7 7.9 7.7 7.6 6.8 12.3 10.7 57.7 83.3 100.9 68.9 73.5 38.4 21.2 22.1 64.3 111.0 29.5 35.8 55.0 24.3 32.3 27.6 52.1 19.9 74.0 33.0 19.6 23.3 18.2 40.5 37.6 47.1 22.8 45.8 94.2 21.7 21.3 40.1 26.0 52.6 65.2 39.9 37.5 41.9 34.7 112.7 78.6 35.5 20.3 47.7 49.5 8.8 36.4 59.3 26.6 63.7 75.8 63.9 49.4 86.5 91.4 24.9 38.6 36.1 55.1 20.9 43.4 14.9 11.2 64.2 19.7 40.0 43.0 38.6 33.8 55.4 33.4 20.4 77.0 34.1 32.9 17.7 TOMM20L UNQ9438 ENSG00000196860 "Translocase of outer mitochondrial membrane 20 like" Q6UXN7 14 58395928-58408702 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 10.9" "Cell type enriched" "Detected in some" 5 "Early spermatids: 154.1" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA076397 Enhanced NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 44: HDLM-2 - Immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA076397: " "unprognostic (1.72e-1)" "unprognostic (2.34e-4)" "unprognostic (8.13e-2)" "unprognostic (7.80e-3)" "unprognostic (5.08e-2)" "unprognostic (2.15e-1)" "unprognostic (1.35e-1)" "unprognostic (4.28e-2)" "unprognostic (4.93e-1)" "unprognostic (1.37e-3)" "unprognostic (3.06e-2)" "unprognostic (5.66e-3)" "unprognostic (4.57e-6)" "unprognostic (8.75e-2)" "unprognostic (1.50e-1)" "unprognostic (1.32e-1)" "unprognostic (7.66e-3)" 0.3 0.1 0.2 0.1 0.1 0.1 0.3 0.3 0.1 0.0 0.0 0.3 0.0 0.1 1.0 0.0 0.2 0.0 0.2 0.1 0.1 0.4 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.5 0.1 0.2 0.1 0.4 0.3 0.4 0.2 0.3 0.0 0.2 0.3 0.1 0.1 0.2 0.4 10.9 0.1 0.0 0.6 0.0 0.1 0.1 0.0 0.2 0.5 0.0 0.1 0.5 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.1 0.0 0.1 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.3 0.4 0.1 0.2 0.1 0.4 0.5 0.2 0.1 0.1 0.1 1.0 0.7 0.1 0.1 0.2 0.3 0.4 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.0 1.3 0.2 0.0 0.2 0.0 0.0 0.0 0.6 0.9 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 154.1 0.8 0.2 0.1 0.0 0.0 2.5 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 2.6 0.1 0.0 0.0 0.0 28.6 0.9 0.2 0.0 0.0 0.0 0.8 0.0 4.5 2.1 0.1 0.3 0.7 0.0 0.2 0.1 0.8 0.0 0.0 0.0 0.4 0.1 27.6 1.6 0.0 0.4 0.0 0.1 0.2 0.2 0.2 TIMM9 TIM9A ENSG00000100575 "Translocase of inner mitochondrial membrane 9" Q9Y5J7 14 58408495-58427531 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002932 Approved Supported Mitochondria NA NA 78000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" Mitochondria "HPA002932: AB_1080287" "prognostic favorable (8.04e-4)" "unprognostic (8.05e-2)" "unprognostic (3.08e-1)" "unprognostic (1.02e-1)" "unprognostic (2.54e-1)" "unprognostic (3.11e-2)" "prognostic unfavorable (9.89e-5)" "unprognostic (1.51e-1)" "unprognostic (1.84e-1)" "prognostic favorable (6.39e-5)" "unprognostic (3.41e-1)" "unprognostic (7.32e-2)" "unprognostic (7.16e-2)" "unprognostic (4.13e-2)" "unprognostic (1.54e-1)" "unprognostic (1.20e-1)" "unprognostic (5.77e-2)" 42.4 35.8 22.6 18.1 25.1 21.3 40.5 26.9 39.7 37.1 25.7 45.1 23.0 33.6 35.6 29.9 36.1 24.0 34.9 24.0 24.7 46.4 31.8 24.0 28.4 23.8 24.6 48.3 75.7 21.2 27.7 22.3 24.3 32.2 18.0 28.2 35.8 20.5 66.1 33.2 26.8 26.8 24.2 26.1 37.1 22.4 23.3 18.8 30.2 23.6 25.1 39.2 31.4 28.0 71.0 56.7 45.8 46.6 53.0 99.6 63.0 67.6 38.3 55.0 48.7 60.3 74.3 100.4 73.1 38.8 45.2 48.0 63.9 67.0 76.3 68.0 38.5 53.0 36.2 68.8 129.1 78.5 45.6 77.1 86.5 51.4 100.4 80.2 54.4 47.2 82.0 57.8 53.9 120.3 75.5 101.0 38.2 106.2 98.8 63.3 73.8 58.9 70.3 63.1 60.3 34.3 44.6 109.7 126.7 55.2 78.0 45.1 57.4 63.0 87.0 41.4 73.8 40.4 43.1 91.8 50.0 79.1 76.8 8.8 14.8 4.0 14.3 17.0 26.3 28.5 22.5 21.4 21.4 22.3 28.5 27.3 1.6 27.8 19.2 23.2 25.2 12.5 22.6 25.1 26.9 39.7 24.0 24.7 23.8 24.6 24.3 24.2 23.3 28.0 26.8 32.1 20.0 12.7 40.5 35.3 46.4 47.6 38.7 15.9 44.2 55.2 20.7 32.9 26.0 14.7 22.9 80.1 30.7 12.2 72.4 39.1 36.7 21.4 38.5 33.6 25.2 35.3 14.2 54.1 92.9 32.2 25.5 21.9 36.8 36.6 39.7 33.0 61.2 5.0 15.4 43.2 24.4 47.9 29.9 32.7 74.3 30.0 33.8 3.7 47.6 31.6 39.1 8.5 12.2 38.2 30.5 51.6 33.8 57.3 35.3 117.7 15.0 24.0 19.7 49.7 32.3 78.8 22.1 39.2 39.6 73.5 29.9 56.9 53.4 42.8 KIAA0586 "JBTS23, Talpid3" ENSG00000100578 KIAA0586 Q9BVV6 14 58427385-58551297 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 81.3;Early spermatids: 142.0;Late spermatids: 108.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000846, HPA050249" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm Cytosol "HPA000846: AB_2234167, HPA050249: " "unprognostic (1.90e-1)" "unprognostic (7.85e-2)" "unprognostic (2.98e-2)" "unprognostic (6.88e-2)" "unprognostic (4.99e-2)" "unprognostic (1.76e-3)" "unprognostic (4.82e-3)" "unprognostic (1.13e-1)" "unprognostic (2.80e-1)" "unprognostic (2.39e-1)" "unprognostic (2.67e-2)" "unprognostic (5.65e-2)" "prognostic favorable (7.20e-4)" "unprognostic (8.10e-3)" "unprognostic (1.77e-1)" "unprognostic (3.41e-1)" "unprognostic (1.13e-1)" 5.0 5.1 4.6 4.8 4.9 5.4 5.7 6.0 7.1 5.1 4.5 4.9 3.3 4.3 6.2 5.0 4.3 4.9 4.7 4.3 4.9 4.0 6.5 4.2 7.4 4.9 5.1 6.0 4.0 6.1 7.1 3.7 5.0 5.1 6.0 7.9 4.2 4.6 5.8 5.2 4.4 6.3 4.7 5.4 3.9 16.4 4.7 12.4 4.9 6.1 7.1 5.6 4.8 6.5 21.1 14.0 20.2 9.7 16.4 15.6 8.7 17.3 16.3 15.1 15.7 6.0 11.3 23.4 11.4 14.8 6.2 12.3 19.1 10.9 24.8 16.8 6.9 17.9 11.1 18.2 11.2 27.6 15.3 10.5 4.6 11.2 17.7 7.2 19.9 22.3 18.0 12.4 28.4 13.5 16.9 11.4 8.7 10.7 22.8 20.5 23.5 14.6 10.9 8.8 11.1 8.4 18.4 12.3 8.9 10.8 14.7 14.4 18.8 23.4 18.4 12.9 14.5 7.4 9.5 19.0 16.2 21.8 13.7 13.2 2.0 5.0 7.0 2.1 5.6 6.3 6.6 5.3 2.6 6.8 8.5 6.1 2.0 9.7 3.2 3.3 7.1 2.6 4.6 4.9 6.0 7.1 4.3 4.9 4.9 5.1 5.0 4.7 4.7 6.5 17.9 12.8 14.5 29.4 20.9 3.2 6.1 6.2 12.5 30.5 10.1 9.8 14.1 7.2 9.3 9.2 81.3 7.5 20.1 5.9 5.9 6.5 142.0 18.5 19.6 13.9 10.7 22.1 52.0 5.2 8.4 14.5 16.8 11.0 21.5 15.2 9.3 4.7 9.5 32.0 56.7 8.5 10.2 7.9 2.8 108.1 10.2 10.8 8.8 27.2 10.6 17.0 14.4 47.3 73.9 5.9 3.0 12.0 20.6 4.3 4.3 7.7 20.0 51.0 0.0 19.7 12.3 61.6 23.9 12.4 4.5 4.8 24.4 15.7 7.3 3.3 DACT1 "DAPPER, DAPPER1, FRODO, HDPR1, THYEX3" ENSG00000165617 "Dishevelled binding antagonist of beta catenin 1" Q9NYF0 14 58633967-58648321 "Disease related genes, Predicted intracellular proteins" "Neurogenesis, Wnt signaling pathway" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 56.0;Late spermatids: 17.9;Peritubular cells: 27.8;Smooth muscle cells: 15.7" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 17.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-MEL-30: 13.5;SuSa: 17.2;U-138 MG: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003016, HPA074619" Enhanced Supported Nucleoplasm NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "HPA003016: AB_1078623, HPA074619: " "unprognostic (2.47e-2)" "unprognostic (2.72e-2)" "unprognostic (1.79e-2)" "unprognostic (1.22e-1)" "unprognostic (1.03e-2)" "unprognostic (3.55e-2)" "unprognostic (1.37e-1)" "unprognostic (1.17e-2)" "unprognostic (4.79e-2)" "unprognostic (1.93e-1)" "unprognostic (5.42e-2)" "unprognostic (6.54e-2)" "unprognostic (4.16e-2)" "unprognostic (1.64e-2)" "unprognostic (2.54e-1)" "unprognostic (1.37e-3)" "unprognostic (1.89e-3)" 8.6 7.9 5.2 4.1 4.2 1.5 6.5 17.4 3.3 12.0 0.6 6.3 5.9 7.6 5.8 2.9 5.9 24.9 8.0 3.6 2.5 5.5 2.7 9.3 4.1 1.6 3.2 24.4 2.3 8.0 3.8 12.1 2.0 11.8 6.7 2.0 3.5 13.1 2.4 2.7 3.9 8.9 2.0 7.2 6.9 9.8 2.4 3.6 10.7 4.4 2.3 14.0 6.6 3.4 0.0 0.0 4.0 0.1 4.5 5.0 0.1 2.3 2.9 2.4 2.1 0.3 0.2 0.0 0.1 6.9 4.0 3.6 11.5 0.0 1.3 2.7 2.4 0.0 0.1 0.0 8.2 0.0 1.3 5.9 0.3 9.0 0.0 9.0 0.1 0.8 0.0 0.0 1.6 0.0 0.9 0.1 3.8 0.2 0.9 4.9 5.6 0.0 0.0 0.0 0.1 0.0 6.5 0.0 13.5 17.2 0.0 0.4 0.0 31.7 10.8 0.5 8.5 4.4 1.8 0.0 3.4 1.4 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.2 4.2 17.4 3.3 3.6 2.5 1.6 3.2 2.0 2.0 2.4 3.4 1.1 0.0 0.0 0.3 1.0 0.8 1.2 0.0 1.2 0.4 0.3 1.5 3.9 7.2 0.0 1.8 0.0 0.2 0.2 0.3 0.0 1.7 56.0 0.4 9.3 1.4 0.0 0.0 2.7 2.3 0.8 11.7 2.0 0.3 0.0 2.3 4.2 0.0 1.2 0.0 4.0 1.0 0.0 2.9 2.1 17.9 12.2 0.6 1.8 6.5 0.0 4.5 0.0 1.5 0.8 3.1 0.0 27.8 0.6 0.4 0.0 1.0 0.0 0.5 0.0 2.9 15.7 12.6 8.6 0.3 1.3 0.1 0.5 3.6 0.5 0.4 DAAM1 KIAA0666 ENSG00000100592 "Dishevelled associated activator of morphogenesis 1" Q9Y4D1 14 59188646-59371405 "Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 467.3;Suprabasal keratinocytes: 332.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HaCaT: 39.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026605, HPA064789" Uncertain Approved "Plasma membrane,Cytosol" NA NA 9700 "Cluster 6: Non-specific - Transcription" "Cluster 31: Skin - Epidermis development" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 28: Keratinocytes - Keratinization" "Plasma membrane, Cytosol" "HPA026605: AB_1847464, HPA064789: AB_2685352" "unprognostic (2.81e-1)" "unprognostic (9.70e-2)" "unprognostic (3.85e-2)" "unprognostic (2.74e-1)" "unprognostic (2.32e-1)" "unprognostic (1.84e-1)" "unprognostic (1.76e-2)" "unprognostic (2.48e-1)" "unprognostic (2.02e-1)" "unprognostic (6.40e-2)" "unprognostic (1.98e-1)" "unprognostic (4.64e-2)" "prognostic favorable (3.77e-4)" "unprognostic (5.01e-2)" "unprognostic (3.29e-1)" "unprognostic (1.39e-1)" "unprognostic (3.15e-2)" 14.5 6.2 13.0 6.8 13.6 5.4 10.4 12.6 12.8 13.6 22.8 13.5 4.8 13.5 5.6 19.0 7.7 5.9 19.3 11.8 14.8 6.9 12.6 10.5 11.1 7.9 8.1 8.0 9.3 20.6 5.3 9.1 8.3 11.9 8.5 24.9 9.4 11.0 5.6 30.9 7.2 10.9 7.8 13.1 7.0 6.9 11.2 4.8 7.4 4.7 15.6 9.5 15.1 10.7 18.2 1.9 13.1 3.5 7.8 5.8 17.1 2.5 2.3 4.7 4.8 9.4 16.6 20.4 4.4 5.6 9.6 39.7 11.8 10.0 4.0 9.0 4.1 6.8 4.8 11.8 4.8 7.9 3.8 3.9 10.6 3.9 4.7 10.8 11.3 10.2 11.9 9.9 2.8 17.0 6.9 4.9 7.5 12.9 5.6 6.3 11.1 2.0 6.8 13.5 20.3 4.8 15.8 23.1 16.1 8.7 30.5 2.1 10.8 3.9 7.4 8.4 2.2 2.2 2.7 22.1 5.0 1.5 8.7 7.7 2.0 2.6 2.3 2.4 3.0 10.8 3.0 2.3 2.2 4.6 2.4 2.6 2.8 6.7 3.5 18.3 4.0 1.9 13.0 13.6 12.6 12.8 11.8 14.8 7.9 8.1 8.3 7.8 11.2 10.7 62.2 35.3 27.0 160.6 37.8 467.3 172.4 128.6 30.7 110.7 56.8 40.6 149.3 38.6 82.3 29.5 308.6 33.0 66.9 47.0 23.5 63.8 40.0 68.4 142.9 71.9 87.7 140.0 143.7 93.1 27.6 67.3 21.9 54.6 26.0 155.2 102.4 47.2 32.8 195.2 202.0 56.7 73.2 16.3 55.8 16.6 60.3 36.1 90.7 66.5 25.2 96.5 16.5 74.9 24.3 191.4 45.1 74.1 30.8 104.2 24.7 12.8 102.4 168.7 32.9 84.6 66.3 51.3 46.3 52.8 332.0 34.2 25.1 25.1 38.1 84.2 GPR135 "HUMNPIIY20, PAFR" ENSG00000181619 "G protein-coupled receptor 135" Q8IZ08 14 59429022-59465342 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 8 "Early spermatids: 150.0;Late spermatids: 215.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA045337 Uncertain NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 20: HeLa - Mitochondria" "Cluster 31: Spermatids - Spermatogenesis" "HPA045337: AB_10960528" "unprognostic (1.55e-1)" "unprognostic (3.00e-1)" "unprognostic (6.09e-3)" "unprognostic (1.14e-1)" "unprognostic (4.20e-2)" "unprognostic (8.47e-2)" "unprognostic (3.22e-1)" "unprognostic (3.91e-2)" "unprognostic (4.64e-2)" "unprognostic (1.09e-1)" "unprognostic (2.47e-2)" "unprognostic (1.55e-1)" "unprognostic (2.75e-5)" "unprognostic (1.33e-2)" "unprognostic (1.90e-1)" "unprognostic (2.71e-2)" "unprognostic (2.68e-3)" 1.2 1.7 1.3 0.6 1.1 0.2 0.9 3.3 1.5 2.2 3.5 1.5 0.2 2.0 1.1 0.6 3.1 0.8 2.1 0.9 1.7 0.9 0.6 0.9 0.3 1.5 1.5 2.5 0.9 2.5 3.4 0.6 0.8 1.9 0.5 0.8 0.6 2.7 0.8 0.6 0.9 1.2 0.8 0.5 1.0 6.0 1.3 0.2 1.4 0.3 0.3 2.1 1.5 1.2 0.4 0.5 0.8 1.0 0.7 1.0 0.7 0.9 0.5 0.6 0.6 0.2 0.9 0.4 0.6 1.1 0.2 0.5 0.4 0.3 0.8 0.9 0.3 0.3 2.8 0.3 0.6 0.5 0.4 0.6 0.6 0.9 0.4 1.3 0.4 0.4 0.5 0.6 0.8 0.3 0.1 1.2 0.6 0.0 1.8 0.6 0.6 0.4 0.6 0.4 1.1 1.3 2.1 0.3 0.1 0.4 0.4 0.2 1.5 1.5 1.2 0.4 1.0 0.1 0.0 0.3 0.5 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 1.1 3.3 1.5 0.9 1.7 1.5 1.5 0.8 0.8 1.3 1.2 1.0 0.0 0.5 9.1 1.1 0.3 0.8 0.4 0.0 5.0 0.5 0.4 2.6 1.5 2.7 3.7 2.1 0.4 0.3 0.0 0.0 0.6 150.0 9.7 4.5 0.7 3.0 0.8 21.3 0.7 0.3 2.4 0.5 0.5 0.0 7.0 1.1 0.2 0.1 1.7 20.6 0.2 0.0 0.0 0.5 215.5 3.1 0.6 0.0 3.7 0.4 4.3 1.0 7.5 13.3 0.5 0.0 3.8 0.4 1.1 0.4 1.1 7.6 2.4 0.0 3.6 2.8 22.7 1.8 0.2 0.1 0.1 0.5 5.4 0.7 0.2 L3HYPDH "C14orf149, FLJ25436" ENSG00000126790 "Trans-L-3-hydroxyproline dehydratase" Q96EM0 14 59460363-59484408 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 47.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056694 Approved Uncertain Vesicles NA NA 49000 "Cluster 48: NK-cells - Unknown function" "Cluster 1: Thyroid gland - Transcription" "Cluster 17: WM-115 - Nervous system development" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles "HPA056694: AB_2683210" "unprognostic (3.39e-2)" "unprognostic (5.55e-3)" "unprognostic (3.81e-2)" "unprognostic (5.86e-2)" "unprognostic (1.10e-1)" "unprognostic (5.06e-2)" "unprognostic (8.34e-2)" "unprognostic (1.16e-1)" "unprognostic (7.24e-2)" "unprognostic (9.50e-2)" "unprognostic (1.26e-3)" "unprognostic (6.60e-2)" "prognostic unfavorable (1.72e-9)" "unprognostic (1.16e-1)" "unprognostic (2.22e-1)" "unprognostic (1.05e-1)" "unprognostic (1.14e-1)" 18.1 14.0 4.8 12.5 5.2 4.8 16.3 9.9 6.6 15.9 10.0 10.6 11.0 16.0 8.5 9.2 15.4 11.5 14.8 5.0 5.8 17.4 17.3 11.2 17.5 7.9 5.8 18.0 12.6 12.2 14.8 10.4 7.4 13.5 10.2 5.2 13.0 11.9 8.9 9.7 13.8 11.9 5.6 13.0 10.5 17.1 4.8 4.3 16.6 5.6 13.7 13.4 14.5 8.3 12.0 31.8 6.8 16.2 14.4 37.6 9.5 31.7 25.1 17.9 17.4 6.4 21.1 4.1 13.0 17.7 31.8 31.8 11.1 17.0 17.7 7.0 14.4 11.0 30.1 23.7 16.2 10.0 7.6 27.3 11.4 18.0 27.6 27.8 22.3 11.3 14.8 18.4 18.8 14.3 3.8 16.4 10.9 4.7 28.5 5.5 11.1 16.6 28.7 6.8 6.9 9.9 29.8 12.2 11.9 5.6 12.8 6.4 31.3 20.9 25.6 16.4 37.5 4.7 2.3 4.0 35.9 8.3 41.7 0.0 3.5 0.5 3.2 5.1 2.4 1.5 1.7 2.0 5.7 1.4 2.5 0.9 0.0 5.6 2.4 3.2 0.8 1.8 4.8 5.2 9.9 6.6 5.0 5.8 7.9 5.8 7.4 5.6 4.8 8.3 11.2 3.2 6.1 11.1 10.9 5.2 5.4 4.2 6.2 2.9 5.6 8.6 8.7 5.7 4.3 3.7 2.1 13.7 3.5 1.0 7.9 7.7 12.2 6.8 17.5 8.1 3.0 5.5 26.7 2.5 11.4 16.0 4.6 2.3 14.0 6.5 11.0 16.8 8.3 1.7 18.9 4.3 4.1 4.6 2.9 7.4 19.3 4.9 3.6 10.3 3.5 4.6 4.1 10.6 17.1 4.4 1.0 12.0 5.5 6.6 3.4 47.0 17.3 2.7 13.1 17.4 11.6 14.1 5.7 7.5 3.4 4.9 6.0 11.9 3.5 2.0 JKAMP "C14orf100, CDA06, HSPC213, HSPC327, JAMP" ENSG00000050130 "JNK1/MAPK8 associated membrane protein" Q9P055 14 59484443-59505410 "Cancer-related genes, Predicted membrane proteins" "Unfolded protein response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 174.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031172, HPA071650" Supported Approved Nucleoplasm,Vesicles NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Vesicles Nucleoplasm "HPA031172: AB_10670563, HPA071650: AB_2686429" "unprognostic (1.48e-1)" "unprognostic (2.19e-2)" "unprognostic (4.95e-2)" "unprognostic (5.88e-2)" "unprognostic (2.54e-1)" "unprognostic (1.49e-3)" "prognostic unfavorable (3.09e-6)" "unprognostic (2.68e-1)" "unprognostic (3.52e-1)" "unprognostic (1.16e-1)" "unprognostic (3.09e-1)" "unprognostic (3.14e-1)" "prognostic favorable (1.36e-4)" "unprognostic (1.76e-1)" "unprognostic (2.27e-1)" "unprognostic (1.36e-1)" "unprognostic (1.73e-1)" 25.9 34.9 23.6 17.7 26.5 22.9 32.5 29.5 30.3 23.0 34.2 29.6 17.3 30.5 26.4 17.8 31.2 30.8 25.9 22.9 30.2 44.5 34.0 30.7 25.2 30.1 29.8 25.8 20.7 56.6 28.6 33.8 31.3 29.9 29.5 34.7 25.4 27.0 17.1 17.9 24.0 27.7 28.7 23.0 24.4 30.4 26.1 22.1 34.6 21.1 20.7 26.4 16.2 32.0 54.8 68.0 57.3 46.8 40.9 59.0 42.8 85.9 76.6 52.6 62.9 21.8 108.1 27.7 75.6 85.5 55.3 40.0 41.2 52.8 72.1 82.8 24.0 30.3 38.5 42.3 56.0 45.6 53.6 60.9 56.6 45.9 32.6 82.1 55.7 35.8 25.4 54.9 100.7 54.1 25.6 37.8 31.2 45.9 60.4 31.4 73.6 27.9 92.1 59.3 23.7 40.9 82.8 68.4 45.1 40.0 66.4 32.3 72.4 54.9 65.6 53.0 58.0 21.7 45.5 32.7 80.7 33.2 68.0 86.3 59.3 82.3 34.4 74.8 34.3 36.1 37.0 37.0 51.9 34.1 38.9 36.5 89.4 50.2 83.0 70.5 47.0 57.8 23.6 26.5 29.5 30.3 22.9 30.2 30.1 29.8 31.3 28.7 26.1 32.0 25.5 22.4 31.2 29.7 23.6 30.0 32.8 132.9 54.1 30.3 31.6 27.1 10.2 41.5 66.3 46.0 18.8 64.2 42.0 27.4 7.9 45.4 174.5 43.3 31.7 26.9 31.2 40.8 30.3 54.8 64.8 37.4 27.5 20.9 34.9 28.0 26.4 41.9 57.8 28.6 26.8 26.7 89.5 60.3 31.4 61.2 35.4 40.4 48.0 19.7 34.2 40.1 29.9 28.1 34.5 51.4 21.3 31.6 50.2 26.3 22.4 53.0 110.6 30.3 13.1 27.5 58.8 85.1 41.1 30.7 29.1 29.8 27.6 30.3 24.6 20.9 CCDC175 C14orf38 ENSG00000151838 "Coiled-coil domain containing 175" P0C221 14 59504539-59576812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 18.4" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 8.4;Early spermatids: 11.9;Excitatory neurons: 15.9;Respiratory ciliated cells: 7.4;Rod photoreceptor cells: 11.4;Spermatocytes: 17.7" "Not detected" "Not detected" "Region enriched" "Detected in single" 22 "cerebellum: 18.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA004200 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm "Nucleoli, Cytosol" "HPA004200: AB_1078743" "unprognostic (3.64e-3)" "unprognostic (8.05e-2)" "unprognostic (1.13e-1)" "unprognostic (2.21e-1)" "unprognostic (3.83e-1)" "unprognostic (2.02e-2)" "unprognostic (5.98e-2)" "unprognostic (1.27e-1)" 0.0 0.0 0.1 0.0 0.2 0.1 0.0 18.4 0.5 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 18.4 0.5 0.0 0.2 0.7 0.8 0.8 0.4 0.1 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.6 0.0 8.4 0.0 0.0 1.1 0.0 0.0 11.9 5.0 0.1 0.0 0.0 1.7 15.9 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.3 0.0 0.0 1.5 4.8 0.0 0.3 0.0 0.0 0.1 1.5 0.0 5.0 3.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 7.4 11.4 0.0 0.4 0.3 17.7 4.4 0.0 0.0 0.0 0.0 0.1 2.4 0.1 RTN1 NSP ENSG00000139970 "Reticulon 1" Q16799 14 59595976-59870776 "Plasma proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 160.6;pituitary gland: 60.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 495.8;Horizontal cells: 240.6;Inhibitory neurons: 394.3;Oligodendrocyte precursor cells: 188.0;Oligodendrocytes: 247.7" "Cancer enhanced" "Detected in many" "glioma: 19.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 2.9;intermediate monocyte: 3.1;myeloid DC: 5.4" "Group enriched" "Detected in many" 14 "dendritic cells: 5.4;monocytes: 3.1" "Group enriched" "Detected in some" 4 "HEL: 61.7;SCLC-21H: 71.8;SH-SY5Y: 115.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002745, HPA040945, HPA044249" Enhanced Supported "Nuclear bodies,Endoplasmic reticulum" NA NA 150000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Endoplasmic reticulum" "Nuclear bodies" "CAB002745: , HPA040945: AB_2677217, HPA044249: AB_2678874" "unprognostic (9.40e-3)" "unprognostic (1.43e-3)" "unprognostic (3.20e-2)" "unprognostic (2.61e-1)" "unprognostic (4.24e-2)" "unprognostic (3.04e-3)" "unprognostic (8.67e-2)" "unprognostic (1.23e-2)" "unprognostic (2.49e-1)" "unprognostic (2.79e-1)" "prognostic favorable (3.69e-4)" "unprognostic (5.79e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-2)" "unprognostic (1.75e-1)" "unprognostic (6.71e-2)" "unprognostic (1.62e-2)" 11.1 12.0 111.1 9.3 127.5 0.4 7.2 57.0 134.7 2.2 0.0 7.6 2.5 1.3 0.4 1.6 12.8 5.5 0.9 133.0 160.6 1.6 1.0 6.4 2.7 37.5 24.9 0.7 4.0 17.4 60.1 2.4 46.7 6.4 2.8 34.1 3.4 1.9 0.8 3.2 4.1 2.4 10.8 18.3 3.9 2.3 68.3 1.0 2.5 0.7 1.8 1.9 3.6 50.2 0.0 0.0 0.7 1.0 2.9 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.9 0.1 0.4 0.0 2.1 61.7 0.0 0.0 3.4 0.1 0.2 0.0 0.1 0.0 2.1 0.0 0.5 0.4 0.0 0.3 0.7 0.3 0.0 0.0 4.9 0.0 0.0 0.0 0.6 0.1 0.0 0.0 71.8 115.1 14.9 0.0 0.0 0.2 0.0 0.0 0.0 9.9 2.8 0.1 5.6 0.0 0.0 0.0 19.4 4.4 0.7 0.0 2.9 0.0 0.0 3.1 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.7 111.1 127.5 57.0 134.7 133.0 160.6 37.5 24.9 46.7 10.8 68.3 50.2 1.0 0.0 1.1 64.3 0.5 4.8 0.4 0.0 0.0 34.1 11.4 4.3 1.0 1.5 0.6 0.0 25.0 1.2 1.4 0.8 0.0 0.0 16.2 23.5 0.3 2.9 54.2 0.8 495.8 0.0 5.0 1.5 5.6 0.4 0.0 0.2 0.0 0.5 17.8 240.6 394.3 3.6 0.0 14.4 59.7 21.4 2.8 23.8 10.6 87.1 22.8 14.3 0.0 188.0 247.7 1.4 0.1 1.2 0.1 5.8 0.8 0.9 0.7 33.3 0.0 10.7 2.5 2.3 3.8 0.2 6.5 2.5 0.7 0.1 0.5 0.3 LRRC9 FLJ46156 ENSG00000131951 "Leucine rich repeat containing 9" Q6ZRR7 14 59919713-60063559 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 5.4;choroid plexus: 12.4;testis: 8.1" "Cell type enhanced" "Detected in some" "Early spermatids: 112.6;Excitatory neurons: 28.0;Inhibitory neurons: 18.0;Late spermatids: 75.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040965, HPA041381, HPA077675" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 5: NTERA-2 - Transcription" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane, Cell Junctions" "Nucleoplasm, Nuclear bodies" "HPA040965: AB_2677225, HPA041381: AB_2677444, HPA077675: " "unprognostic (1.01e-2)" "unprognostic (2.00e-1)" "unprognostic (4.45e-2)" "unprognostic (2.12e-3)" "unprognostic (2.80e-1)" "unprognostic (2.95e-3)" "unprognostic (1.93e-1)" "unprognostic (3.11e-2)" "unprognostic (1.91e-2)" "unprognostic (4.82e-2)" "unprognostic (3.45e-3)" "unprognostic (6.06e-2)" "unprognostic (2.62e-3)" "unprognostic (8.54e-3)" "unprognostic (8.30e-2)" "unprognostic (1.67e-2)" "unprognostic (2.29e-2)" 0.3 0.1 0.9 0.0 1.6 0.1 0.0 1.0 0.6 0.0 12.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 1.0 1.7 0.0 0.0 0.0 0.0 5.2 5.4 0.0 0.0 0.7 0.5 0.0 3.7 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 4.3 0.0 0.0 8.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.6 1.0 0.6 1.0 1.7 5.2 5.4 3.7 4.3 1.9 5.0 0.0 0.0 0.0 6.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 112.6 1.5 0.1 0.1 0.0 0.0 28.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.7 18.0 0.0 0.0 0.0 0.0 75.8 0.9 0.1 0.0 1.9 0.0 0.8 0.0 5.5 2.0 0.0 0.0 0.7 0.0 0.7 0.4 0.0 2.9 0.2 0.0 0.0 0.0 10.3 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 PCNX4 "C14orf135, PCNXL4" ENSG00000126773 "Pecanex 4" Q63HM2 14 60091911-60169133 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 42.8;Endometrial ciliated cells: 82.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002076, HPA003390" Uncertain Approved Cytosol NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA002076: AB_1078322, HPA003390: AB_2066703" "unprognostic (2.00e-1)" "unprognostic (1.45e-1)" "unprognostic (1.89e-1)" "unprognostic (9.87e-2)" "unprognostic (2.18e-1)" "unprognostic (2.94e-1)" "unprognostic (3.83e-3)" "unprognostic (2.01e-1)" "unprognostic (1.54e-1)" "unprognostic (3.28e-1)" "unprognostic (1.40e-1)" "unprognostic (1.81e-1)" "prognostic favorable (6.84e-5)" "unprognostic (2.13e-1)" "unprognostic (2.08e-1)" "unprognostic (4.14e-2)" "unprognostic (8.59e-2)" 7.8 9.2 4.1 6.3 4.8 7.4 8.1 7.0 4.4 10.1 12.1 6.3 5.0 12.5 7.1 5.6 13.1 8.3 11.1 3.9 6.1 12.3 6.7 7.2 7.1 5.0 6.0 16.3 6.5 11.4 11.9 8.5 4.7 11.7 6.7 18.2 7.1 8.5 12.3 7.4 6.1 10.2 4.9 7.4 6.2 11.0 5.7 11.6 9.7 5.7 7.0 6.6 7.8 6.2 85.2 14.3 25.2 17.3 19.2 22.2 11.1 28.5 44.1 31.2 38.3 15.0 26.1 14.8 11.6 23.7 26.0 11.1 16.6 16.2 51.7 20.8 7.9 25.0 10.1 9.7 39.7 25.0 17.7 18.5 10.2 23.0 38.3 24.3 14.9 34.8 12.5 21.2 48.2 11.5 35.9 8.0 12.7 9.7 17.4 20.9 31.8 6.4 15.8 11.7 17.9 21.8 25.5 9.2 18.2 13.4 22.7 11.1 30.7 66.4 52.8 16.7 20.5 7.1 7.4 19.6 26.1 8.5 33.2 3.4 4.1 3.3 4.8 4.3 6.5 4.1 3.4 4.2 4.4 2.8 3.7 4.4 2.1 8.4 5.2 4.4 3.8 3.4 4.1 4.8 7.0 4.4 3.9 6.1 5.0 6.0 4.7 4.9 5.7 6.2 22.3 16.0 29.9 0.0 18.2 0.0 0.0 0.0 0.0 0.0 19.9 17.5 0.0 0.0 19.2 25.8 0.0 18.3 42.8 0.0 17.6 18.4 0.0 82.0 37.4 14.0 0.0 0.0 0.0 13.1 8.3 13.6 0.0 27.0 15.2 33.9 0.0 0.0 18.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 10.3 0.0 0.0 0.0 0.0 20.4 0.0 0.0 18.5 0.0 0.0 14.4 34.2 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 19.4 14.5 33.8 0.0 0.0 DHRS7 "retDSR4, SDR34C1" ENSG00000100612 "Dehydrogenase/reductase 7" Q9Y394 14 60144119-60169856 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 615.8" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 840.4" "Cancer enriched" "Detected in all" 5 "prostate cancer: 199.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031121, HPA078401" Enhanced Approved Nucleoplasm,Mitochondria No No "Cluster 5: Granulocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 45: Enterocytes - Digestion" "Nucleoplasm, Mitochondria" "HPA031121: AB_10600803, HPA078401: " "prognostic favorable (6.42e-4)" "unprognostic (5.20e-2)" "unprognostic (6.70e-3)" "unprognostic (1.67e-1)" "unprognostic (2.69e-1)" "prognostic unfavorable (2.51e-4)" "unprognostic (4.65e-2)" "unprognostic (4.31e-2)" "unprognostic (2.62e-1)" "prognostic unfavorable (7.99e-4)" "unprognostic (1.73e-1)" "unprognostic (1.59e-1)" "prognostic favorable (1.92e-10)" "unprognostic (8.35e-3)" "unprognostic (1.48e-1)" "unprognostic (1.07e-1)" "unprognostic (3.61e-1)" 62.1 103.4 50.8 43.8 53.9 61.0 58.5 59.2 75.4 48.9 50.2 73.0 108.9 49.8 96.5 44.3 45.9 59.1 47.1 49.9 55.1 100.5 146.4 64.2 45.5 62.3 54.9 64.9 76.8 226.8 54.7 29.6 63.3 409.9 69.5 111.1 317.5 134.6 615.8 46.6 181.0 51.0 57.8 45.4 182.3 9.8 52.0 39.2 120.3 136.0 49.4 51.7 41.1 65.6 221.3 52.9 41.8 89.3 219.6 74.4 42.8 74.3 186.4 26.5 59.0 37.3 149.8 21.5 41.7 76.8 78.0 92.7 57.2 108.3 34.5 156.1 36.0 53.7 28.7 60.9 110.1 71.8 1.7 63.3 116.7 47.6 153.0 50.8 52.5 66.2 18.2 52.6 61.4 59.2 40.9 67.2 18.6 151.2 55.4 42.7 50.8 24.4 118.3 70.5 83.4 99.8 72.6 118.0 168.2 52.7 72.7 32.5 35.8 126.6 38.7 36.9 44.2 18.3 7.9 45.0 62.6 64.8 93.5 743.5 213.1 519.6 335.7 159.1 340.6 184.4 238.9 298.5 185.0 167.0 134.6 258.5 835.4 294.7 224.0 388.8 215.5 450.2 50.8 53.9 59.2 75.4 49.9 55.1 62.3 54.9 63.3 57.8 52.0 65.6 109.6 54.5 102.5 16.0 72.2 34.0 70.3 233.2 52.3 25.7 81.2 57.4 27.6 160.2 138.4 86.5 83.4 29.6 210.4 101.3 19.6 222.5 2.1 56.2 55.5 89.7 46.5 20.4 12.2 165.9 88.7 87.9 120.8 120.0 178.5 22.9 48.5 166.4 94.4 42.1 19.0 102.2 386.6 54.5 70.6 3.5 82.3 98.7 108.5 16.9 172.5 94.4 299.7 26.2 20.1 210.6 114.5 84.2 99.0 263.4 840.4 44.1 57.0 70.7 85.5 66.4 73.7 1.6 2.9 47.0 25.4 20.8 152.1 19.7 79.2 47.1 PPM1A "MGC9201, PP2CA, PP2Calpha" ENSG00000100614 "Protein phosphatase, Mg2+/Mn2+ dependent 1A" P35813 14 60245752-60299087 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 142.9" "Cell type enhanced" "Detected in all" "Early spermatids: 446.2;Late spermatids: 565.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029209 Approved Supported "Plasma membrane,Cytosol" NA NA 380000 "Cluster 34: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 51: Myeloid cells - Hemostasis" Cytosol "Plasma membrane" "HPA029209: AB_2672951" "unprognostic (3.14e-1)" "unprognostic (2.14e-1)" "unprognostic (5.64e-2)" "unprognostic (1.85e-1)" "unprognostic (4.00e-2)" "unprognostic (2.30e-2)" "unprognostic (4.50e-2)" "unprognostic (1.11e-1)" "unprognostic (3.43e-1)" "unprognostic (2.89e-2)" "unprognostic (7.96e-2)" "unprognostic (1.29e-1)" "prognostic favorable (1.57e-9)" "unprognostic (1.58e-2)" "unprognostic (1.12e-1)" "unprognostic (1.57e-2)" "unprognostic (1.37e-1)" 22.7 19.2 14.0 22.2 16.5 142.9 23.5 27.0 22.4 22.4 3.3 36.6 36.8 28.0 19.3 25.7 17.3 20.1 36.8 16.7 24.4 42.5 51.2 20.3 24.4 18.2 16.3 16.2 25.5 36.8 14.3 22.1 20.0 29.9 36.0 51.0 31.5 23.0 78.9 21.9 37.3 26.5 15.3 20.4 23.2 54.5 16.4 31.1 24.3 76.6 26.2 21.4 17.8 23.1 129.7 28.6 24.4 20.9 36.5 33.6 31.1 34.8 40.7 25.3 23.8 16.3 37.2 77.1 32.4 39.6 18.7 28.1 25.5 35.9 44.0 70.1 14.4 47.6 19.5 25.7 30.6 54.7 32.6 28.6 42.1 29.7 40.4 29.5 25.1 38.7 26.9 59.6 31.3 56.5 71.5 12.8 23.0 25.8 23.9 25.3 56.5 25.0 30.4 61.2 41.2 31.0 36.1 41.7 30.1 22.2 42.0 23.5 35.1 52.4 52.0 23.3 25.0 46.1 28.1 89.9 24.0 21.2 27.1 5.4 1.0 3.0 1.8 1.0 1.9 0.9 1.4 1.6 1.5 3.0 1.1 1.0 4.4 2.9 1.2 0.9 2.6 0.9 14.0 16.5 27.0 22.4 16.7 24.4 18.2 16.3 20.0 15.3 16.4 23.1 25.9 16.0 22.6 43.8 34.2 77.4 41.3 17.6 34.7 42.2 41.6 22.7 95.0 44.3 20.0 38.6 64.6 31.9 49.1 111.2 33.2 24.6 446.2 31.3 34.6 31.5 60.9 93.5 77.8 24.4 24.0 36.6 25.5 38.8 26.6 20.7 22.9 73.3 28.2 58.9 71.6 60.2 22.4 33.5 51.0 565.6 42.3 58.6 60.5 25.3 26.8 40.1 45.3 66.4 53.4 34.6 87.8 52.3 45.4 86.5 128.5 90.0 17.8 66.8 39.5 36.2 35.9 69.8 25.3 32.9 82.3 73.5 40.8 19.4 42.1 69.6 C14orf39 SIX6OS1 ENSG00000179008 "Chromosome 14 open reading frame 39" Q8N1H7 14 60396469-60515543 "Plasma proteins, Predicted intracellular proteins" "DNA recombination, Meiosis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 4.8;salivary gland: 4.6;testis: 10.8" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 92.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Group enriched" "Detected in some" 16 "hypothalamus: 2.9;thalamus: 2.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 6.2;JURKAT: 28.3;MOLT-4: 23.9;RH-30: 6.2;U-2 OS: 12.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA059518 Uncertain Approved Nucleoplasm,Nucleoli Yes No "Cluster 77: Retina - Visual perception" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA059518: AB_2684049" "unprognostic (6.17e-2)" "unprognostic (1.73e-3)" "unprognostic (3.00e-6)" "unprognostic (2.78e-1)" "unprognostic (6.97e-2)" "unprognostic (7.55e-4)" "unprognostic (2.12e-1)" "unprognostic (1.71e-1)" "unprognostic (2.17e-1)" "unprognostic (1.78e-1)" "unprognostic (7.46e-2)" "unprognostic (4.35e-1)" "unprognostic (1.50e-1)" "unprognostic (2.09e-1)" 0.3 1.8 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.8 0.4 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.1 0.1 1.2 0.0 0.5 4.8 0.0 0.0 1.1 0.0 2.7 4.6 0.1 3.0 0.0 0.1 0.1 0.0 0.0 0.3 10.8 2.4 0.1 0.2 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.8 6.2 0.0 0.0 0.0 0.0 0.3 4.5 0.0 0.7 0.0 0.1 0.0 28.3 0.0 0.0 2.0 0.0 23.9 0.3 3.0 0.0 1.4 0.0 6.2 0.0 0.4 1.7 0.1 2.6 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 12.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.9 0.1 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 0.5 0.0 0.9 0.0 0.1 0.7 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.3 0.9 0.0 0.0 0.0 0.0 6.8 0.3 0.0 0.0 1.0 0.0 12.3 0.0 1.0 0.7 0.0 0.0 0.7 0.0 0.8 0.0 0.0 1.2 1.1 0.0 10.0 0.2 92.5 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 SIX6 "OPTX2, Six9" ENSG00000184302 "SIX homeobox 6" O95475 14 60509146-60512850 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Cataract, Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "pituitary gland: 28.4" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 29.2;Horizontal cells: 48.8;Muller glia cells: 160.9" "Cancer enriched" "Detected in single" 8 "glioma: 1.0" "Group enriched" "Detected in some" 18 "hypothalamus: 3.9;thalamus: 2.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "JURKAT: 13.4;MOLT-4: 44.0" "Region enriched" "Detected in single" 14 "hypothalamus: 3.6" "Region enriched" "Detected in single" 12 "hypothalamus: 1.6" HPA001403 Approved Approved Nucleoplasm NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 5: Muller glia cells - Visual perception" Nucleoplasm "HPA001403: AB_1079993" "unprognostic (2.76e-1)" "unprognostic (6.14e-2)" "unprognostic (8.18e-2)" "unprognostic (5.75e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 0.0 0.1 0.0 6.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 44.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.3 0.0 0.0 1.3 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 160.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 1.7 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 SIX1 DFNA23 ENSG00000126778 "SIX homeobox 1" Q15475 14 60643421-60658259 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 47.8;salivary gland: 51.1;skeletal muscle: 119.4;tongue: 46.3" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 30.7;Basal respiratory cells: 30.8;Club cells: 33.9;Ionocytes: 30.5;Prostatic glandular cells: 27.4;Respiratory ciliated cells: 67.1;Skeletal myocytes: 77.3;Spermatogonia: 25.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 36.3;LHCN-M2: 142.2;RH-30: 71.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA001893, CAB058690" Enhanced Supported Nucleoplasm,Nucleoli No No "Cluster 13: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm Nucleoli "CAB058690: AB_2665581, HPA001893: AB_1079991" "unprognostic (3.62e-1)" "unprognostic (5.44e-2)" "unprognostic (5.09e-2)" "prognostic unfavorable (8.92e-6)" "unprognostic (1.33e-2)" "unprognostic (1.44e-2)" "unprognostic (2.04e-3)" "prognostic favorable (3.94e-4)" "unprognostic (1.40e-1)" "unprognostic (9.15e-2)" "unprognostic (6.45e-2)" "unprognostic (1.89e-1)" "unprognostic (3.06e-8)" "unprognostic (8.61e-2)" "unprognostic (2.13e-1)" "unprognostic (1.94e-1)" "unprognostic (3.86e-1)" 5.5 0.4 0.3 0.0 0.5 0.0 1.9 0.5 1.2 15.2 1.0 0.0 0.0 0.0 0.4 1.1 0.8 0.5 0.0 0.3 0.3 0.0 0.0 1.5 0.5 0.3 0.4 0.2 0.3 47.8 19.8 0.0 0.4 13.2 0.0 0.0 51.1 0.2 119.4 0.3 0.0 0.0 0.3 0.0 0.4 1.7 0.5 9.7 1.9 46.3 0.2 1.6 0.8 0.4 15.2 3.5 0.6 28.1 17.0 20.6 0.4 4.1 10.6 4.9 4.0 0.0 8.2 0.0 2.2 0.6 2.1 4.4 10.3 6.4 2.1 0.0 17.1 2.0 1.9 6.8 0.0 0.0 0.2 15.6 4.9 2.3 0.7 36.3 0.3 1.6 5.8 0.0 142.2 2.8 0.0 0.5 0.0 0.0 8.9 0.0 71.9 0.0 5.9 16.3 2.5 0.3 5.0 0.3 6.1 0.5 3.3 0.4 13.9 6.7 5.4 7.9 6.5 0.5 0.1 0.0 1.5 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.5 1.2 0.3 0.3 0.3 0.4 0.4 0.3 0.5 0.4 0.8 3.2 1.5 0.0 0.0 0.1 30.7 30.8 0.6 0.0 1.0 0.8 0.9 0.0 33.9 1.8 0.0 0.2 0.0 0.1 1.9 0.0 0.2 1.1 0.1 1.6 0.0 0.0 0.0 0.8 0.4 5.7 0.5 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 30.5 0.0 0.0 0.6 0.0 0.3 0.0 1.9 0.0 0.8 0.0 1.0 0.1 0.2 0.0 1.2 0.0 27.4 0.0 0.1 67.1 0.2 0.0 77.3 5.1 0.0 25.0 0.1 0.1 0.3 0.1 0.1 0.0 18.3 SIX4 AREC3 ENSG00000100625 "SIX homeobox 4" Q9UIU6 14 60709539-60724351 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "choroid plexus: 6.0;parathyroid gland: 15.1;salivary gland: 6.9;skeletal muscle: 14.4;tongue: 15.7" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 20.9;Endometrial ciliated cells: 36.1;Glandular and luminal cells: 37.8;Prostatic glandular cells: 23.8;Respiratory ciliated cells: 30.3;Urothelial cells: 17.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 32.1;hTERT-RPE1: 23.3;RH-30: 30.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA031794 Uncertain Approved Nucleoplasm NA NA "Cluster 8: Non-specific - Mitochondria" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA031794: AB_10602928" "unprognostic (2.23e-1)" "unprognostic (9.50e-2)" "unprognostic (2.63e-4)" "unprognostic (9.74e-2)" "unprognostic (2.69e-2)" "unprognostic (1.03e-1)" "unprognostic (5.39e-2)" "unprognostic (1.28e-2)" "unprognostic (8.13e-2)" "unprognostic (2.33e-2)" "unprognostic (4.39e-2)" "unprognostic (5.38e-2)" "unprognostic (1.01e-1)" "unprognostic (2.99e-2)" "unprognostic (2.11e-1)" "unprognostic (1.51e-3)" "unprognostic (1.08e-1)" 0.7 0.7 1.0 0.2 0.8 0.1 1.6 2.0 2.6 2.2 6.0 0.3 0.1 0.9 0.7 0.2 2.4 0.6 0.5 1.0 1.6 0.8 0.1 0.7 0.0 2.4 1.6 1.4 1.5 15.1 2.7 0.9 2.3 2.6 0.0 0.3 6.9 0.6 14.4 0.1 0.1 0.4 1.2 0.0 1.5 0.3 1.4 1.3 1.0 15.7 0.1 1.1 0.4 1.5 32.1 2.1 1.9 7.9 7.2 8.7 14.5 7.1 10.5 2.0 3.0 1.5 10.2 0.0 4.6 3.5 2.0 11.8 8.4 5.8 4.7 2.6 6.4 0.9 3.2 2.1 2.3 3.4 0.3 4.2 2.7 1.7 9.5 23.3 1.8 0.6 6.6 0.0 10.6 7.6 0.0 0.3 5.3 0.2 13.2 2.1 30.2 0.0 3.8 17.3 5.0 0.5 4.3 6.7 1.9 2.8 9.7 0.2 6.4 6.3 14.0 4.2 6.3 2.2 0.1 0.0 2.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 2.0 2.6 1.0 1.6 2.4 1.6 2.3 1.2 1.4 1.5 0.1 3.2 0.5 0.0 0.1 0.4 13.9 6.9 6.8 0.5 11.9 9.7 3.3 0.0 8.3 1.8 20.9 5.0 0.3 0.1 0.0 0.2 0.1 36.1 2.9 0.9 1.8 0.0 2.6 1.1 4.1 3.2 0.0 37.8 1.3 0.1 0.4 0.3 0.3 0.0 3.2 0.0 2.0 0.0 0.3 0.0 0.3 0.7 1.8 0.0 0.0 1.6 0.0 4.0 0.1 2.9 0.0 1.5 1.3 23.8 0.0 0.3 30.3 0.4 0.0 9.7 2.5 0.4 1.3 2.2 0.6 3.1 0.9 0.1 0.0 17.2 MNAT1 "MAT1, RNF66" ENSG00000020426 "MNAT1 component of CDK activating kinase" P51948 14 60734742-60969965 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 365.2;Inhibitory neurons: 223.4;Oligodendrocyte precursor cells: 196.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000701, HPA001154, CAB004495" Approved Enhanced Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "CAB004495: AB_670057, HPA000701: AB_1079400, HPA001154: AB_2666212" "unprognostic (4.10e-2)" "unprognostic (1.52e-1)" "unprognostic (1.39e-1)" "unprognostic (6.11e-2)" "unprognostic (2.05e-1)" "prognostic unfavorable (2.45e-4)" "unprognostic (1.17e-2)" "unprognostic (2.73e-1)" "unprognostic (2.62e-2)" "unprognostic (3.52e-2)" "unprognostic (3.48e-2)" "unprognostic (6.34e-2)" "prognostic favorable (3.46e-4)" "unprognostic (2.68e-1)" "unprognostic (1.53e-1)" "unprognostic (1.53e-1)" "unprognostic (7.14e-3)" 21.5 20.4 25.0 9.5 26.9 14.0 25.8 27.8 31.6 21.0 16.7 18.5 8.8 18.1 18.9 16.8 24.7 14.1 21.0 25.3 26.0 27.0 23.5 14.3 13.5 22.9 22.9 22.4 14.7 55.3 22.2 16.0 22.2 20.8 12.7 29.2 25.7 15.7 79.9 13.0 10.7 19.3 21.3 11.6 16.8 12.2 27.2 26.1 18.3 65.3 17.3 19.8 16.4 28.7 203.9 38.5 47.0 33.3 53.5 58.6 51.3 73.1 78.4 87.5 70.2 30.9 69.4 48.6 53.9 53.9 47.3 63.2 53.0 84.1 124.7 61.0 55.0 32.9 36.2 45.9 66.4 77.0 16.8 36.0 60.5 56.5 62.1 84.1 84.6 69.6 49.6 45.3 98.5 69.5 48.2 48.2 25.8 38.3 85.1 49.4 127.9 30.9 102.9 94.3 41.9 28.5 56.0 46.6 71.7 54.0 72.2 37.0 64.9 66.8 70.7 31.8 55.6 19.7 17.8 70.4 53.9 12.9 49.4 12.2 6.1 22.3 14.3 8.6 14.7 26.9 15.3 15.3 11.9 19.8 17.6 17.8 0.5 34.6 10.1 46.6 13.6 6.6 25.0 26.9 27.8 31.6 25.3 26.0 22.9 22.9 22.2 21.3 27.2 28.7 30.1 32.1 25.5 91.1 31.1 24.9 59.4 88.3 23.3 43.0 28.0 35.6 58.4 22.8 50.8 29.5 31.3 50.6 51.1 6.1 80.3 35.2 6.1 85.6 34.6 28.9 17.4 14.5 365.2 44.5 36.3 33.9 25.5 60.4 32.9 23.3 18.5 23.3 20.2 23.5 223.4 13.8 52.9 6.9 10.7 6.9 30.1 13.3 14.2 119.9 12.6 50.3 44.3 196.6 148.1 59.3 9.3 30.5 30.1 48.1 4.3 74.3 81.4 59.2 52.6 77.5 52.2 50.9 41.2 26.6 18.2 36.0 35.3 26.9 16.0 44.2 TRMT5 "KIAA1393, TRM5" ENSG00000126814 "TRNA methyltransferase 5" Q32P41 14 60971441-60981170 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Early spermatids: 221.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000943 Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 24: B-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA000943: AB_1080388" "unprognostic (1.58e-2)" "unprognostic (3.62e-2)" "unprognostic (6.63e-3)" "unprognostic (1.11e-2)" "unprognostic (7.70e-3)" "unprognostic (2.26e-2)" "unprognostic (7.82e-3)" "unprognostic (4.50e-2)" "unprognostic (3.95e-1)" "unprognostic (1.78e-1)" "unprognostic (1.47e-1)" "unprognostic (2.84e-2)" "unprognostic (1.60e-3)" "unprognostic (1.82e-1)" "unprognostic (1.97e-2)" "unprognostic (2.10e-2)" "unprognostic (1.40e-1)" 7.3 5.5 3.5 4.4 3.8 4.8 9.8 6.0 4.1 6.5 3.1 6.7 5.7 7.0 7.8 7.6 7.4 5.1 4.2 3.4 4.6 6.9 6.8 5.0 6.0 2.5 3.4 9.9 6.7 10.5 3.5 7.0 2.8 6.9 6.0 5.2 7.6 4.8 7.5 6.7 4.5 7.0 3.1 4.7 5.8 17.3 4.0 6.1 7.2 7.2 5.8 6.7 3.9 3.8 49.7 12.5 17.9 25.0 15.5 23.6 19.4 18.2 14.0 19.1 15.2 9.8 28.7 25.2 19.9 13.3 14.3 22.3 22.9 26.4 25.0 25.3 11.5 18.6 8.1 10.2 25.1 33.2 9.9 18.3 25.1 17.4 25.4 17.0 17.0 21.6 24.5 8.8 28.3 18.7 17.1 16.8 16.4 19.4 20.3 5.4 41.5 21.4 16.3 16.7 22.1 21.6 20.2 20.1 16.6 15.4 33.5 19.7 16.1 22.1 26.7 15.7 17.5 5.3 10.8 11.6 15.6 7.2 21.0 0.1 3.2 0.7 2.4 5.5 3.3 4.9 3.4 3.5 3.0 4.1 3.8 3.4 0.3 1.4 5.9 5.2 4.5 2.5 3.5 3.8 6.0 4.1 3.4 4.6 2.5 3.4 2.8 3.1 4.0 3.8 7.0 6.4 10.9 3.9 4.5 6.4 19.5 15.9 9.6 5.7 6.3 10.0 8.0 1.5 19.6 11.0 4.2 12.8 5.7 3.2 1.9 7.7 221.8 8.2 17.4 9.2 5.4 10.7 5.4 7.5 12.4 12.4 9.7 8.1 6.3 12.1 8.6 7.0 10.9 3.3 6.7 8.3 8.2 6.2 7.6 50.2 11.1 6.0 7.2 3.7 4.1 12.2 1.0 9.0 6.3 8.2 4.8 7.5 4.7 8.2 3.9 11.1 14.9 5.4 13.1 14.7 9.5 23.3 12.6 11.1 4.3 19.2 5.2 14.4 7.6 10.6 SLC38A6 NAT-1 ENSG00000139974 "Solute carrier family 38 member 6" Q8IZM9 14 60981114-61083733 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 178.2;Excitatory neurons: 98.8;Hofbauer cells: 100.3;Inhibitory neurons: 77.4;Late spermatids: 124.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "ASC diff: 68.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018508 Approved Approved "Plasma membrane,Cell Junctions,Microtubules" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 4: Macrophages - Innate immune response" "Cell Junctions" "Plasma membrane, Microtubules" "HPA018508: AB_2190518" "unprognostic (7.08e-2)" "unprognostic (4.14e-2)" "unprognostic (1.75e-1)" "unprognostic (3.49e-1)" "unprognostic (1.00e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (9.47e-6)" "unprognostic (9.89e-3)" "unprognostic (2.38e-1)" "unprognostic (2.18e-2)" "unprognostic (2.20e-1)" "unprognostic (5.13e-2)" "prognostic unfavorable (1.37e-5)" "unprognostic (1.73e-1)" "unprognostic (4.63e-2)" "unprognostic (1.47e-1)" "unprognostic (2.90e-1)" 7.6 9.1 6.0 4.7 6.6 2.9 7.4 6.1 9.5 7.3 8.9 4.8 3.1 5.1 13.2 3.3 5.6 9.9 3.7 6.9 6.5 12.0 6.3 8.6 7.8 5.4 6.0 5.8 3.4 21.3 7.2 9.6 6.0 5.1 6.6 7.5 5.9 3.9 2.1 2.9 3.5 5.3 5.0 6.6 3.8 5.0 7.4 5.0 6.3 3.0 4.8 7.0 5.0 6.7 16.2 21.5 6.8 12.3 68.7 25.3 4.9 11.6 34.5 10.7 10.2 5.4 41.0 4.0 19.2 10.6 22.5 13.5 6.8 11.9 9.8 6.0 3.2 6.7 8.6 14.2 22.7 3.7 12.1 19.9 4.9 10.5 12.2 43.2 14.3 6.8 9.3 8.4 37.5 9.2 6.6 8.4 4.0 9.5 14.3 1.6 20.1 11.9 30.7 8.5 3.3 3.0 9.9 7.0 19.1 9.3 10.4 5.8 15.6 16.4 7.1 20.0 6.5 1.6 4.9 1.6 34.0 3.0 13.1 0.0 6.6 0.1 1.7 7.1 2.2 2.2 3.1 2.4 3.6 2.0 2.7 3.4 0.2 0.8 4.5 4.4 4.5 2.8 6.0 6.6 6.1 9.5 6.9 6.5 5.4 6.0 6.0 5.0 7.4 6.7 6.8 22.4 6.7 31.6 6.0 5.2 11.4 14.6 8.0 19.7 7.2 7.5 4.3 7.2 10.0 5.5 22.9 5.6 4.9 2.6 1.9 5.3 178.2 13.0 11.0 7.2 4.2 3.4 98.8 2.8 9.4 11.2 5.1 6.2 6.3 7.3 4.2 4.6 100.3 5.0 77.4 3.1 6.1 24.8 10.0 124.4 10.8 26.2 5.4 20.6 6.4 11.7 2.1 54.3 30.8 7.4 1.9 6.0 5.8 6.6 3.3 23.1 40.4 24.9 0.0 12.3 9.1 16.6 11.5 6.4 2.8 6.7 7.8 5.0 2.8 6.9 PRKCH "PKC-L, PKCL, PRKCL" ENSG00000027075 "Protein kinase C eta" P24723 14 61187559-61550976 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Differentiation "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 128.4;Microglial cells: 267.9;NK-cells: 229.6;T-cells: 130.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 11 "gdT-cell: 116.5;MAIT T-cell: 91.3;memory CD4 T-cell: 88.0;memory CD8 T-cell: 137.0;naive CD4 T-cell: 106.9;naive CD8 T-cell: 105.5;NK-cell: 117.1;T-reg: 79.8" "Group enriched" "Detected in all" 14 "NK-cells: 117.1;T-cells: 137.0" "Cell line enhanced" "Detected in many" "BEWO: 81.8;HUVEC TERT2: 108.7;MOLT-4: 75.8;RT4: 46.4;TIME: 72.0" "Group enriched" "Detected in all" 6 "basal ganglia: 28.0;thalamus: 17.9" "Low region specificity" "Detected in all" "HPA026294, HPA053709" Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 3: T-cells - Adaptive immune response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "Plasma membrane" "HPA026294: AB_10603988, HPA053709: AB_2682237" "unprognostic (1.42e-1)" "unprognostic (3.89e-3)" "unprognostic (1.78e-1)" "unprognostic (1.96e-3)" "unprognostic (1.04e-1)" "prognostic favorable (8.55e-6)" "unprognostic (1.14e-2)" "unprognostic (2.97e-2)" "unprognostic (4.14e-1)" "unprognostic (1.94e-1)" "unprognostic (7.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.52e-3)" "unprognostic (1.13e-1)" "unprognostic (4.14e-2)" "unprognostic (6.98e-2)" "unprognostic (4.73e-3)" 26.6 7.8 21.1 21.9 30.2 24.2 21.9 12.4 15.7 20.6 9.5 8.9 9.5 14.5 10.9 30.0 13.6 19.7 19.2 13.2 13.9 14.5 10.3 35.3 55.2 19.3 21.7 5.9 8.4 14.2 15.0 32.5 19.4 15.8 8.8 3.1 28.3 11.4 14.2 23.7 16.6 18.1 18.6 38.5 9.6 7.5 29.9 65.8 21.1 18.1 38.5 25.3 21.7 15.5 18.1 6.3 0.8 4.9 2.8 0.6 81.8 0.3 1.5 0.8 0.8 1.9 10.5 0.3 12.4 0.1 1.6 12.3 0.6 13.5 1.4 2.2 7.9 0.1 2.0 0.7 1.2 0.0 2.4 2.2 13.8 0.7 9.4 1.2 108.7 35.4 0.2 0.4 6.2 32.7 75.8 0.7 1.4 12.9 8.4 6.3 3.2 0.2 0.2 46.4 3.2 5.1 2.1 16.2 10.2 14.5 15.9 1.4 72.0 2.1 14.0 2.1 0.9 1.4 0.2 0.6 3.1 1.1 3.6 0.8 3.0 2.4 116.5 1.9 91.3 2.2 88.0 137.0 9.2 1.4 106.9 105.5 5.9 117.1 1.1 3.0 79.8 84.0 21.1 30.2 12.4 15.7 13.2 13.9 19.3 21.7 19.4 18.6 29.9 15.5 59.7 6.4 11.4 2.0 6.6 18.7 16.4 8.3 15.9 0.4 15.0 9.3 9.0 10.0 15.5 0.0 0.0 27.6 128.4 0.6 3.9 6.0 32.6 10.3 2.1 70.8 11.9 18.1 1.7 6.8 21.2 5.0 7.1 20.9 1.3 15.4 68.9 2.0 6.0 0.0 3.1 2.7 2.0 14.4 6.9 6.0 1.8 15.4 16.0 267.9 8.9 7.0 229.6 4.5 1.8 5.4 4.3 6.8 26.6 14.7 4.6 1.2 9.2 0.5 0.0 4.4 5.2 0.1 2.4 18.1 26.7 48.3 130.5 1.6 1.3 26.0 TMEM30B CDC50B ENSG00000182107 "Transmembrane protein 30B" Q3MIR4 14 61277370-61281761 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 124.0;Prostatic glandular cells: 101.1;Urothelial cells: 131.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 68.7;CAPAN-2: 54.4;HaCaT: 31.7;HBEC3-KT: 39.0;hTCEpi: 29.1;MCF7: 44.6;RT4: 94.9;T-47d: 30.4" "Not detected" "Not detected" HPA043162 Uncertain NA NA "Cluster 32: T-cells - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 15: RT4 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" "HPA043162: AB_10796688" "unprognostic (4.06e-2)" "unprognostic (2.46e-1)" "unprognostic (1.72e-1)" "unprognostic (3.47e-2)" "unprognostic (2.01e-1)" "unprognostic (6.20e-2)" "unprognostic (2.45e-3)" "unprognostic (3.43e-2)" "unprognostic (9.10e-2)" "unprognostic (2.20e-1)" "unprognostic (5.10e-2)" "unprognostic (2.26e-1)" "prognostic favorable (5.89e-5)" "unprognostic (2.21e-1)" "unprognostic (2.89e-1)" "unprognostic (2.60e-1)" "unprognostic (1.85e-1)" 3.9 1.6 0.5 3.7 0.7 0.4 14.8 0.5 1.0 16.4 0.9 29.1 43.3 3.8 28.2 14.1 15.2 23.9 2.0 0.3 0.7 12.3 12.3 14.5 1.2 0.6 0.5 2.5 35.7 59.1 18.2 5.7 0.5 21.9 26.1 0.3 27.7 13.4 1.2 8.6 34.4 1.7 0.5 0.7 42.2 2.6 0.6 5.3 50.0 1.9 4.4 16.1 9.3 0.4 68.7 0.2 0.0 0.0 6.7 1.6 0.1 0.1 0.0 0.0 0.0 11.6 54.4 0.0 0.1 0.0 0.0 31.7 0.0 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 29.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 44.6 0.0 0.1 0.6 28.2 1.6 0.0 1.5 0.2 0.0 94.9 11.2 0.1 0.8 25.6 0.1 1.9 30.4 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.7 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.5 0.7 0.5 1.0 0.3 0.7 0.6 0.5 0.5 0.5 0.6 0.4 0.6 28.9 31.9 0.0 0.6 64.9 124.0 19.5 61.5 0.0 32.2 16.5 1.9 47.1 24.5 40.5 0.0 28.0 1.1 90.8 13.7 24.8 0.9 23.8 3.9 3.9 23.4 0.0 0.0 37.2 11.4 5.5 62.7 45.3 2.5 0.7 4.2 14.1 2.0 0.0 0.0 73.1 20.3 1.0 6.8 1.6 8.7 1.5 5.4 1.0 0.6 2.9 2.1 0.0 0.1 31.9 75.3 79.0 0.4 101.1 73.6 1.0 22.7 0.3 13.1 2.4 5.4 5.9 3.6 43.3 63.6 35.8 3.6 0.9 64.7 131.9 AL355916.3 ENSG00000258989 "Novel protein" 14 61529128-61657964 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 24.6" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 12.8;Alveolar cells type 2: 12.9;Club cells: 5.0;granulocytes: 6.3;Respiratory ciliated cells: 8.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 15.8;LHCN-M2: 17.9;U-2 OS: 28.1" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 6: Brain - Smell perception" "Cluster 9: U-2 OS - Unknown function" "Cluster 11: Alveolar cells - Smell perception" 2.0 1.4 6.9 1.6 9.6 7.8 1.1 24.0 23.9 1.4 5.4 1.0 3.2 1.8 7.6 0.8 1.5 1.3 0.7 9.2 4.5 1.7 1.4 1.4 1.6 6.1 5.0 1.7 1.4 1.1 0.0 2.0 9.2 1.7 1.1 9.6 2.6 1.5 3.3 2.4 1.6 0.8 1.9 2.2 1.7 3.2 11.1 1.7 1.1 1.4 1.3 0.6 0.0 24.6 2.8 0.0 1.5 1.7 0.6 0.5 3.1 2.1 0.3 0.8 0.6 0.1 1.7 1.5 15.8 0.6 9.2 1.8 0.3 0.4 0.6 1.7 1.6 1.7 3.5 3.0 0.8 2.0 1.4 1.5 0.3 1.7 1.6 3.9 0.2 1.8 1.1 2.3 17.9 1.8 3.0 3.2 3.1 1.1 1.7 1.8 4.9 2.0 0.8 3.3 7.7 3.4 9.7 6.1 1.7 2.4 5.1 3.4 2.8 2.0 28.1 13.2 2.6 3.5 2.7 1.2 5.3 1.1 2.4 0.8 0.4 1.6 1.6 0.2 0.7 0.3 1.1 1.4 0.2 0.4 1.4 1.8 1.5 1.3 0.2 0.4 1.4 0.5 6.9 9.6 24.0 23.9 9.2 4.5 6.1 5.0 9.2 1.9 11.1 24.6 0.0 12.8 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 HIF1A "bHLHe78, HIF-1alpha, HIF1, MOP1, PASD8" ENSG00000100644 "Hypoxia inducible factor 1 subunit alpha" Q16665 14 61695513-61748259 "Cancer-related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 448.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 155.0" "Lineage enriched" "Detected in all" 7 "granulocytes: 155.0" "Cell line enhanced" "Detected in many" "LHCN-M2: 941.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000907, HPA001275, CAB017442" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Nuclear bodies" "CAB017442: AB_10621732, HPA000907: AB_2666139, HPA001275: AB_1079057" "unprognostic (1.07e-2)" "unprognostic (1.13e-3)" "unprognostic (9.41e-2)" "unprognostic (1.07e-1)" "unprognostic (2.51e-2)" "unprognostic (1.90e-1)" "unprognostic (2.94e-3)" "unprognostic (3.40e-1)" "unprognostic (4.05e-1)" "unprognostic (1.39e-1)" "unprognostic (1.77e-2)" "unprognostic (8.39e-2)" "unprognostic (1.24e-1)" "unprognostic (3.23e-2)" "unprognostic (3.58e-1)" "unprognostic (7.35e-2)" "unprognostic (3.88e-2)" 64.9 133.7 22.1 146.6 24.0 448.3 36.2 28.2 26.1 132.9 24.7 42.8 33.6 52.4 74.8 62.1 41.1 145.4 36.5 21.1 28.4 104.2 51.6 75.7 71.4 29.7 29.7 35.3 36.0 91.7 30.7 77.6 33.3 46.9 41.7 35.5 45.3 67.2 12.1 34.2 37.3 59.1 27.2 72.4 37.6 32.4 38.5 55.8 49.5 17.6 88.2 169.9 43.1 26.5 313.6 123.6 112.7 344.7 185.2 297.1 161.5 253.8 270.1 288.7 258.9 54.1 100.3 75.8 186.2 293.0 73.6 71.8 71.0 416.1 352.5 33.7 41.0 46.5 105.3 93.1 414.8 20.1 49.3 523.4 129.2 216.5 225.6 408.6 198.1 44.4 32.3 0.4 941.4 65.6 59.2 24.3 108.9 49.6 159.7 4.3 269.1 22.8 400.2 204.3 100.3 111.9 472.5 67.0 170.7 148.9 70.6 36.3 119.2 700.2 157.3 235.9 215.2 39.1 61.2 84.1 369.9 38.5 194.7 43.8 22.3 155.0 11.5 18.0 14.4 19.5 15.0 13.3 19.6 19.0 22.6 15.6 56.3 19.7 19.4 9.2 11.0 18.4 22.1 24.0 28.2 26.1 21.1 28.4 29.7 29.7 33.3 27.2 38.5 26.5 93.3 70.5 116.0 69.2 157.3 106.4 101.8 102.6 97.9 54.1 38.5 30.1 43.5 87.2 69.0 261.1 50.1 24.8 65.1 44.1 103.7 278.5 3.6 95.6 131.3 152.3 66.4 35.3 45.6 251.6 67.1 81.4 49.5 272.3 223.6 339.7 176.0 30.7 136.4 156.5 39.3 39.0 57.0 145.9 111.7 6.2 24.2 240.2 103.2 53.4 87.1 134.0 26.8 78.9 35.8 236.9 21.9 48.5 60.0 59.3 20.2 192.1 37.7 54.8 52.6 75.8 136.9 80.5 44.2 128.7 87.9 25.4 91.6 92.2 51.8 116.0 SNAPC1 "PTFgamma, SNAP43" ENSG00000023608 "Small nuclear RNA activating complex polypeptide 1" Q16533 14 61762420-61796428 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 171.9;Spermatocytes: 215.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 153.7;hTERT-HME1: 153.7;U-2 OS: 207.6;U-251 MG: 146.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067076, HPA072276" Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 17: Basophils - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 9: U-2 OS - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoli Nucleoplasm "HPA067076: AB_2732757, HPA072276: AB_2732199" "unprognostic (7.40e-2)" "unprognostic (5.04e-2)" "unprognostic (3.09e-2)" "unprognostic (1.11e-1)" "unprognostic (2.94e-1)" "unprognostic (8.55e-2)" "unprognostic (1.68e-3)" "unprognostic (1.88e-1)" "unprognostic (4.01e-2)" "unprognostic (5.18e-2)" "unprognostic (1.58e-1)" "unprognostic (1.99e-1)" "unprognostic (2.47e-3)" "unprognostic (1.58e-1)" "unprognostic (1.07e-1)" "unprognostic (3.10e-1)" "unprognostic (2.26e-1)" 6.2 9.0 2.7 6.4 3.6 6.0 5.9 4.9 3.4 10.1 4.1 3.5 3.6 7.0 4.9 6.0 6.4 7.7 8.3 2.7 2.9 7.0 5.2 4.8 8.1 4.3 5.7 6.1 3.6 7.9 5.8 8.7 4.5 6.8 3.0 6.6 5.2 6.9 4.4 5.2 3.2 4.8 3.0 6.8 3.2 20.0 3.0 7.1 7.2 4.7 6.9 10.0 5.2 4.6 57.6 11.0 10.7 22.8 11.7 13.6 12.7 47.4 31.4 53.3 31.4 3.9 11.5 11.9 61.5 20.3 153.7 17.7 10.6 14.3 87.3 13.0 7.6 7.1 5.7 8.1 30.8 7.5 15.2 13.1 9.5 45.0 153.7 20.7 20.7 16.2 8.0 10.6 51.4 7.4 18.3 12.0 10.3 6.4 35.9 13.9 28.3 4.4 43.9 8.8 7.6 18.3 31.3 5.5 39.0 13.2 11.0 11.7 31.8 58.4 207.6 38.2 146.6 7.0 7.8 10.5 39.7 9.5 35.3 7.7 5.0 4.5 4.4 4.3 5.7 8.4 5.4 3.8 5.2 8.8 8.8 5.7 4.9 7.0 3.8 6.9 6.5 3.6 2.7 3.6 4.9 3.4 2.7 2.9 4.3 5.7 4.5 3.0 3.0 4.6 22.6 35.3 18.3 10.1 28.0 95.3 56.2 171.9 43.3 10.2 11.5 18.0 24.6 11.5 53.6 29.5 2.1 16.8 31.2 3.4 7.9 28.6 70.7 70.1 28.7 29.3 4.2 10.7 12.8 15.9 31.5 31.1 4.1 47.6 41.8 20.2 26.7 6.9 17.3 8.4 13.3 4.0 42.7 11.7 32.6 17.1 22.1 31.6 17.8 10.3 12.4 40.4 4.1 10.6 14.6 20.3 1.9 20.3 7.9 28.8 5.6 13.3 83.9 12.6 19.7 38.3 34.7 215.0 67.7 23.5 64.5 5.6 29.0 20.6 6.8 20.8 SYT16 "CHR14SYT, Strep14, SYT14L, yt14r" ENSG00000139973 "Synaptotagmin 16" Q17RD7 14 61811974-62112550 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 16.5" "Group enriched" "Detected in some" 5 "Excitatory neurons: 281.4;Inhibitory neurons: 279.7;Oligodendrocyte precursor cells: 127.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 10.8;hTERT-HME1: 4.1;PC-3: 5.4;RPTEC TERT1: 6.2;RT4: 17.0;U-2 OS: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004199, HPA076871" Enhanced Approved Cytosol NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 15: RT4 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "HPA004199: AB_1080156, HPA076871: AB_2732324" "unprognostic (2.55e-2)" "unprognostic (1.43e-2)" "unprognostic (4.12e-1)" "unprognostic (8.88e-4)" "unprognostic (1.41e-1)" "unprognostic (9.08e-2)" "unprognostic (9.57e-2)" "unprognostic (9.95e-3)" "unprognostic (1.02e-1)" "unprognostic (1.38e-1)" "unprognostic (1.34e-1)" "unprognostic (3.41e-2)" "unprognostic (1.61e-2)" "unprognostic (3.06e-2)" "unprognostic (1.53e-3)" "unprognostic (2.15e-1)" 0.0 0.4 7.5 0.0 11.0 0.1 0.1 0.0 16.5 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.1 0.0 0.1 12.7 8.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.1 1.1 0.4 0.0 2.2 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.2 3.8 3.8 0.0 0.0 0.0 0.0 0.3 0.2 0.4 10.8 0.2 0.3 0.0 0.0 0.0 0.1 0.7 1.0 1.0 0.6 0.0 0.0 0.1 0.2 0.0 0.6 0.6 0.0 1.0 1.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 5.4 0.0 0.0 0.0 6.2 17.0 0.3 2.8 0.5 0.7 0.0 1.0 0.0 0.0 0.0 2.7 6.6 0.0 1.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 11.0 0.0 16.5 12.7 8.0 0.0 0.0 0.0 0.1 3.8 0.4 0.0 0.0 0.0 8.8 0.1 0.0 0.1 0.0 0.0 2.0 0.0 0.0 1.3 0.0 0.0 3.7 2.1 0.7 0.0 0.0 0.0 0.3 45.0 0.1 0.4 0.1 0.0 0.0 281.4 0.0 0.6 0.1 3.1 0.3 0.0 3.4 0.0 0.0 0.1 0.0 279.7 0.0 0.0 0.0 0.0 17.1 0.3 0.0 0.0 8.4 0.0 0.7 0.0 127.2 13.9 0.1 0.0 0.0 0.3 1.7 0.0 0.2 0.1 0.1 0.0 0.0 0.4 3.8 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 KCNH5 "eag2, H-EAG2, hEAG2, Kv10.2" ENSG00000140015 "Potassium voltage-gated channel subfamily H member 5" Q8NCM2 14 62699464-63102037 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 8.5;retina: 4.5" "Group enriched" "Detected in some" 16 "Bipolar cells: 62.2;Excitatory neurons: 185.0;Inhibitory neurons: 74.4;Oligodendrocyte precursor cells: 65.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HeLa: 7.2;RT4: 10.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030487, HPA072351" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 58: Brain - Synaptic function" "Cluster 15: RT4 - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Centrosome "Nucleoplasm, Cytosol" "HPA030487: AB_10609995, HPA072351: " "unprognostic (1.16e-1)" "unprognostic (7.23e-2)" "unprognostic (1.25e-1)" "unprognostic (4.23e-2)" "unprognostic (2.70e-1)" "unprognostic (1.12e-1)" "unprognostic (1.50e-1)" "unprognostic (1.76e-2)" "unprognostic (8.45e-2)" "unprognostic (2.66e-1)" "unprognostic (1.70e-3)" "unprognostic (3.11e-1)" 0.2 1.0 2.4 0.0 2.1 0.0 0.0 0.0 5.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 1.8 0.0 0.0 0.0 0.0 2.9 3.3 0.0 0.0 0.0 0.3 0.2 3.0 0.1 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 8.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.8 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 1.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 2.1 0.0 5.9 4.5 1.8 2.9 3.3 3.0 0.8 8.5 1.2 0.1 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 62.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 5.8 0.1 0.2 0.2 0.0 0.0 185.0 0.0 1.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 74.4 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 2.8 0.0 0.5 0.0 65.9 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 4.6 0.0 0.0 0.1 1.6 1.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 RHOJ "ARHJ, FLJ14445, RASL7B, TCL" ENSG00000126785 "Ras homolog family member J" Q9H4E5 14 63204114-63293508 "Predicted intracellular proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 41.0;Astrocytes: 176.0;Endothelial cells: 72.5;Hepatic stellate cells: 41.4;Microglial cells: 35.6;Oligodendrocyte precursor cells: 43.2;Skeletal myocytes: 34.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 63.8;HUVEC TERT2: 375.4;TIME: 100.9;WM-115: 106.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003050 Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Cluster 46: Fibroblasts - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA003050: AB_1079812" "unprognostic (7.24e-2)" "unprognostic (1.72e-1)" "unprognostic (4.37e-2)" "unprognostic (2.42e-1)" "unprognostic (6.71e-2)" "unprognostic (1.77e-2)" "unprognostic (2.89e-1)" "unprognostic (2.33e-2)" "unprognostic (2.19e-1)" "unprognostic (3.04e-3)" "unprognostic (1.42e-2)" "unprognostic (7.07e-2)" "prognostic unfavorable (1.31e-4)" "unprognostic (3.50e-3)" "unprognostic (4.84e-2)" "unprognostic (1.86e-2)" "unprognostic (1.06e-3)" 19.6 3.3 12.5 8.5 14.6 0.1 17.4 10.8 16.9 12.9 8.5 14.2 7.5 27.9 17.3 15.5 18.5 25.3 17.9 14.0 11.1 11.7 4.2 21.5 9.6 10.9 11.0 14.2 4.4 3.5 6.4 9.3 11.0 11.8 10.7 5.5 8.4 13.8 7.9 7.6 9.8 31.4 8.3 12.6 9.3 2.8 14.5 3.1 13.8 13.4 4.9 19.7 9.4 13.0 0.0 0.0 63.8 0.0 0.0 0.0 0.0 10.6 42.6 3.6 6.2 0.0 0.0 0.0 5.9 0.8 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.1 0.3 0.0 0.1 8.0 35.8 375.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.0 5.1 0.0 0.4 0.0 0.1 0.1 0.0 0.0 14.6 1.1 0.1 0.0 100.9 0.1 1.1 0.8 6.1 0.0 0.0 0.0 0.0 0.0 106.5 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 12.5 14.6 10.8 16.9 14.0 11.1 10.9 11.0 11.0 8.3 14.5 13.0 41.0 0.0 1.3 176.0 0.3 5.9 0.3 0.1 0.0 0.3 1.2 5.2 3.8 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.5 0.3 6.7 72.5 0.0 0.0 11.1 0.9 0.0 31.0 0.0 0.3 0.0 0.5 41.4 0.5 0.1 0.0 2.2 0.0 0.0 1.9 7.7 1.6 11.8 1.0 3.6 35.6 0.0 11.1 0.0 43.2 0.4 0.1 0.0 16.1 2.5 0.6 0.0 0.0 0.0 0.4 6.6 34.6 17.0 0.1 0.4 0.9 4.8 0.1 0.6 6.9 0.0 1.4 GPHB5 "GPB5, ZLUT1" ENSG00000179600 "Glycoprotein hormone subunit beta 5" Q86YW7 14 63312835-63318935 "Predicted secreted proteins" Hormone "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPP2R5E "B56E, B56epsilon" ENSG00000154001 "Protein phosphatase 2 regulatory subunit B'epsilon" Q16537 14 63371364-63543377 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 283.4;Horizontal cells: 262.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006034, CAB072342" Approved Supported Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" Cytosol "CAB072342: , HPA006034: AB_1079670" "unprognostic (1.58e-1)" "unprognostic (1.65e-1)" "unprognostic (3.11e-2)" "unprognostic (1.45e-1)" "unprognostic (2.06e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (2.26e-1)" "unprognostic (2.91e-1)" "unprognostic (1.57e-2)" "unprognostic (1.70e-2)" "unprognostic (4.62e-2)" "prognostic favorable (4.16e-4)" "unprognostic (1.23e-1)" "unprognostic (9.51e-2)" "unprognostic (1.92e-1)" "unprognostic (8.22e-2)" 12.7 12.5 9.5 13.5 11.0 14.5 12.5 10.3 11.1 14.6 7.2 17.0 10.7 14.9 10.2 19.8 11.7 12.0 15.7 11.4 11.1 14.7 15.8 12.7 15.4 7.4 7.6 12.6 10.9 17.5 6.6 16.0 7.9 12.7 20.0 26.7 9.2 12.6 17.8 11.8 12.3 15.0 7.6 14.3 12.0 14.3 10.4 19.2 20.2 16.5 17.0 17.1 9.8 7.8 90.5 26.0 46.7 22.1 31.6 37.0 44.5 37.1 30.4 39.5 39.1 33.1 35.4 39.6 22.1 38.1 29.3 36.2 48.1 34.4 67.8 36.2 11.8 25.7 18.1 27.7 33.7 41.7 30.4 27.1 37.7 38.8 42.7 28.8 40.2 39.8 33.3 41.9 43.8 60.2 41.8 18.7 35.3 37.7 46.8 41.9 47.8 30.1 38.2 68.1 26.5 51.6 47.7 39.1 25.0 40.1 57.4 20.8 37.8 61.7 68.6 31.7 33.0 15.2 24.4 50.9 28.4 26.3 42.7 1.4 1.3 1.3 2.0 1.4 1.9 1.1 2.2 2.5 1.2 1.7 1.7 1.9 1.0 4.5 1.9 1.9 1.4 0.6 9.5 11.0 10.3 11.1 11.4 11.1 7.4 7.6 7.9 7.6 10.4 7.8 52.1 89.8 55.5 54.2 52.8 80.4 56.9 34.0 60.3 65.0 49.3 27.8 61.7 44.3 35.3 22.0 64.6 27.2 54.8 55.0 29.4 46.4 283.4 65.1 57.2 52.5 27.1 41.2 110.4 47.7 41.5 44.8 33.1 74.6 24.1 48.6 41.0 45.1 29.8 262.5 131.6 51.6 28.5 38.7 49.0 46.6 43.8 42.3 37.4 59.0 49.7 38.4 61.8 93.5 91.8 41.4 48.1 43.2 55.9 58.5 24.9 41.2 41.6 81.2 26.3 51.5 71.1 74.9 22.5 63.1 91.6 30.6 57.0 47.8 70.2 46.9 WDR89 "C14orf150, MGC9907" ENSG00000140006 "WD repeat domain 89" Q96FK6 14 63597039-63641871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000813 Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 58: T-cells - T-cell receptor" "Intermediate filaments, Cytosol" "HPA000813: AB_1078324" "prognostic favorable (3.37e-4)" "unprognostic (6.46e-2)" "unprognostic (5.40e-2)" "unprognostic (1.00e-1)" "unprognostic (6.05e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (3.26e-4)" "unprognostic (1.05e-1)" "unprognostic (3.08e-2)" "unprognostic (8.66e-3)" "unprognostic (3.63e-1)" "unprognostic (3.28e-1)" "unprognostic (1.86e-1)" "unprognostic (1.09e-2)" "unprognostic (3.08e-1)" "unprognostic (8.63e-2)" "unprognostic (3.29e-1)" 4.9 5.8 4.4 7.6 4.9 3.0 8.1 7.0 5.9 6.8 3.3 6.1 5.1 6.9 6.8 5.3 6.4 4.8 4.4 4.5 4.6 8.8 8.8 5.4 11.2 4.5 4.4 8.2 5.9 7.4 3.0 6.6 4.2 5.8 6.8 11.4 4.1 4.5 5.8 6.1 4.0 5.3 3.9 8.6 5.4 5.3 5.1 10.1 9.2 7.3 10.3 6.6 4.4 5.7 35.4 16.2 18.2 10.2 10.7 11.2 27.2 14.0 7.6 14.4 16.2 11.6 17.0 33.7 11.4 4.2 9.7 16.7 22.8 13.2 24.3 21.8 13.1 22.7 10.5 14.4 13.8 29.9 15.5 10.1 17.1 16.0 22.7 8.1 12.8 24.0 19.7 17.8 10.5 19.5 24.0 17.3 17.5 23.9 29.2 18.2 18.3 19.2 15.5 14.6 16.5 12.4 15.0 16.8 11.1 18.1 19.2 16.0 9.2 16.8 16.4 11.0 16.6 10.4 8.8 20.9 7.2 20.9 11.9 0.1 2.8 0.5 8.4 2.7 10.5 8.0 8.8 7.8 4.8 7.3 14.3 12.4 0.6 9.4 4.6 3.1 10.1 5.3 4.4 4.9 7.0 5.9 4.5 4.6 4.5 4.4 4.2 3.9 5.1 5.7 5.6 9.6 6.7 4.9 14.5 9.7 13.9 4.6 8.0 6.7 6.3 5.3 4.8 8.6 7.0 5.5 4.2 9.9 7.0 3.8 13.7 6.8 2.8 3.4 7.7 7.0 3.6 11.6 11.3 5.5 13.6 6.5 2.6 4.1 1.3 7.5 5.3 8.0 6.3 1.7 13.2 5.1 4.1 6.3 4.2 4.6 4.4 5.1 3.6 6.5 5.6 7.0 8.2 8.5 14.5 3.6 2.4 6.4 6.1 11.2 2.7 7.9 3.1 9.3 13.1 6.9 4.9 6.1 11.6 6.3 10.9 7.0 11.2 8.7 5.5 7.3 SGPP1 ENSG00000126821 "Sphingosine-1-phosphate phosphatase 1" Q9BX95 14 63684216-63728065 "Metabolic proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Kupffer cells: 61.8;Oligodendrocytes: 60.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 6.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 43.8;U-698: 57.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053149, HPA064908" Approved Supported Nucleoplasm NA NA "Cluster 38: Basophils - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" Nucleoplasm "HPA053149: AB_2682057, HPA064908: AB_2797270" "unprognostic (1.57e-2)" "unprognostic (1.04e-2)" "unprognostic (5.40e-3)" "unprognostic (7.82e-2)" "unprognostic (9.09e-2)" "unprognostic (4.30e-2)" "unprognostic (6.49e-3)" "unprognostic (1.35e-2)" "unprognostic (1.64e-1)" "unprognostic (7.41e-2)" "unprognostic (1.51e-1)" "unprognostic (3.27e-1)" "unprognostic (8.59e-2)" "unprognostic (1.41e-1)" "unprognostic (1.92e-1)" "unprognostic (1.03e-1)" "unprognostic (1.31e-3)" 7.9 10.6 5.3 6.0 6.0 3.0 6.4 5.8 7.9 6.4 3.6 7.0 3.8 7.4 6.2 4.9 5.7 5.5 4.9 5.3 5.9 15.9 19.5 6.9 13.3 6.6 6.2 5.8 12.7 10.2 5.6 12.0 6.6 7.4 5.3 4.1 4.8 4.0 4.2 3.8 8.8 4.8 7.3 9.3 5.5 5.4 5.8 5.8 5.8 2.6 12.9 5.8 6.8 8.0 19.7 6.2 3.0 8.6 10.7 9.9 35.9 15.7 10.9 9.6 10.7 2.7 10.9 43.8 4.5 8.0 8.0 20.3 4.8 9.3 15.3 17.3 5.7 4.0 3.4 4.4 13.1 7.3 12.2 7.3 14.7 8.4 13.2 9.7 4.6 8.2 2.3 1.2 14.1 7.3 8.6 0.1 2.1 3.2 13.1 2.1 8.4 3.5 15.2 9.7 1.8 5.0 11.0 10.2 8.4 9.2 13.3 2.6 5.2 13.2 9.1 9.5 7.9 10.1 6.5 57.4 9.7 0.0 5.8 6.9 0.2 1.7 0.5 1.4 0.5 1.8 0.5 0.3 0.3 0.4 0.8 0.6 0.2 0.3 2.1 0.1 1.3 0.3 5.3 6.0 5.8 7.9 5.3 5.9 6.6 6.2 6.6 7.3 5.8 8.0 5.3 12.8 16.2 22.2 22.6 9.7 6.1 4.1 8.0 4.0 9.4 5.2 3.8 24.3 3.2 51.5 0.0 23.4 10.9 11.9 0.0 6.0 2.4 6.3 12.1 6.5 18.6 9.7 32.6 9.1 27.0 12.8 3.1 10.1 11.4 5.0 6.1 43.6 23.7 10.1 38.5 10.2 2.0 61.8 20.1 1.2 6.2 18.6 17.8 21.5 6.8 8.2 2.1 31.7 60.0 13.2 13.5 17.0 5.7 8.1 3.2 22.7 2.6 5.4 6.6 8.1 11.3 7.4 3.5 4.6 13.5 33.0 10.4 10.3 10.3 5.6 SYNE2 "DKFZP434H2235, KIAA1011, Nesp2, Nesprin-2, NUA, NUANCE, SYNE-2" ENSG00000054654 "Spectrin repeat containing nuclear envelope protein 2" Q8WXH0 14 63761899-64226433 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Disease variant, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 198.5" "Cell type enhanced" "Detected in all" "Granulosa cells: 454.6;Rod photoreceptor cells: 568.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 73.8" "Group enriched" "Detected in many" 11 "granulocytes: 73.8;T-cells: 38.5" "Cell line enhanced" "Detected in many" "Daudi: 48.8;SiHa: 29.8;U-698: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003435, HPA050204" Enhanced Approved "Nuclear membrane,Intermediate filaments" No Yes "Cluster 45: Eosinophils - Innate immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" "Nuclear membrane, Intermediate filaments" "HPA003435: AB_1080162, HPA050204: AB_2681051" "unprognostic (1.93e-2)" "unprognostic (3.72e-2)" "unprognostic (1.91e-1)" "unprognostic (2.33e-1)" "unprognostic (2.64e-1)" "unprognostic (1.97e-3)" "unprognostic (9.04e-2)" "unprognostic (2.58e-3)" "unprognostic (1.99e-2)" "unprognostic (2.41e-2)" "unprognostic (1.25e-2)" "unprognostic (2.24e-1)" "prognostic favorable (3.56e-9)" "unprognostic (5.05e-3)" "unprognostic (3.14e-1)" "unprognostic (1.51e-2)" "unprognostic (4.80e-2)" 30.1 6.0 8.8 3.4 9.2 7.9 28.0 21.1 8.7 15.4 89.5 13.3 4.5 18.1 9.9 24.3 14.3 5.5 58.3 9.6 7.6 29.0 19.5 18.4 8.5 7.7 9.6 35.9 37.7 66.6 16.7 9.9 7.5 11.5 4.4 24.8 16.1 3.7 198.5 39.7 11.4 4.6 7.0 10.0 12.4 13.1 11.4 5.5 24.4 96.7 6.1 13.6 19.0 6.9 23.2 8.7 11.0 3.5 11.3 3.2 12.3 1.3 1.6 2.7 4.2 2.8 3.3 48.8 2.3 1.7 2.6 11.0 6.2 3.5 3.2 8.9 3.5 0.4 7.9 0.7 3.0 1.0 0.3 4.4 15.1 3.4 2.2 2.6 7.0 7.5 0.4 4.8 1.8 11.2 6.2 0.3 3.4 5.4 3.3 6.9 14.5 1.8 20.0 13.6 9.9 8.2 29.8 3.8 7.0 5.5 5.0 0.3 7.3 4.2 7.5 1.5 4.5 4.9 3.5 27.5 1.8 0.0 5.7 0.5 0.1 73.8 38.5 0.3 27.6 5.2 24.3 28.0 0.0 5.3 11.8 18.5 30.1 3.9 0.3 1.2 30.1 3.4 8.8 9.2 21.1 8.7 9.6 7.6 7.7 9.6 7.5 7.0 11.4 6.9 414.4 307.7 140.1 8.5 44.9 111.3 138.9 46.4 174.2 27.4 70.3 59.1 261.4 105.8 184.5 202.3 183.5 168.8 226.8 51.0 19.6 108.2 9.4 249.9 71.2 238.8 46.2 10.5 9.5 55.4 65.7 59.6 126.9 365.2 25.9 454.6 73.5 33.3 17.7 6.7 13.9 60.9 59.0 5.7 13.2 14.3 100.9 12.8 48.0 128.4 8.9 107.2 300.7 33.2 6.6 71.7 27.9 53.4 180.3 65.0 35.9 72.2 196.1 568.7 111.7 73.5 167.0 13.0 17.0 104.6 87.5 224.0 222.1 69.5 80.6 80.6 ESR2 "ER-beta, Erb, NR3A2" ENSG00000140009 "Estrogen receptor 2" Q92731 14 64084232-64338112 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 6.1" "Cell type enhanced" "Detected in many" "Early spermatids: 61.4;Granulosa cells: 26.6;Late spermatids: 93.7;Rod photoreceptor cells: 35.6;Spermatocytes: 28.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 4.2;U-266/70: 9.8;U-698: 16.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 6.1" "HPA068406, CAB079300" Enhanced Supported Nucleoplasm,Vesicles NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 71: Testis - DNA repair" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm Vesicles "CAB079300: , HPA068406: " "unprognostic (7.63e-3)" "unprognostic (2.28e-3)" "unprognostic (8.27e-3)" "unprognostic (5.41e-2)" "unprognostic (2.91e-2)" "unprognostic (1.06e-1)" "unprognostic (1.80e-1)" "unprognostic (4.38e-2)" "unprognostic (1.95e-1)" "unprognostic (8.75e-2)" "unprognostic (2.57e-2)" "unprognostic (1.65e-1)" "unprognostic (3.03e-5)" "unprognostic (1.57e-1)" "unprognostic (1.66e-1)" "unprognostic (4.21e-2)" "unprognostic (5.89e-2)" 1.5 6.1 1.2 1.2 0.6 1.0 0.9 3.0 0.8 1.4 3.5 0.9 1.0 1.2 0.4 0.7 1.0 0.5 0.6 0.5 0.9 1.5 0.7 0.6 2.1 0.7 0.6 5.4 2.1 0.1 0.8 0.2 1.0 1.5 1.0 2.0 0.8 0.2 1.4 1.0 1.3 0.3 0.3 1.8 1.0 5.7 1.7 2.5 0.6 0.2 1.6 1.1 0.6 0.9 0.8 0.4 0.7 0.6 0.0 0.1 1.5 0.2 0.0 0.1 0.1 0.3 0.9 3.1 0.1 0.1 0.4 1.0 0.8 0.0 0.1 0.7 0.4 0.3 1.0 0.1 0.1 0.1 0.3 0.0 0.0 0.1 0.2 0.2 0.3 1.1 0.5 4.2 0.2 0.8 0.5 0.2 0.7 0.6 0.4 0.5 0.4 0.3 0.1 1.3 2.2 0.6 0.4 0.2 1.1 0.4 0.7 0.1 0.5 0.4 1.0 0.2 0.1 9.8 3.1 16.4 0.2 0.1 0.8 0.3 0.1 0.5 0.3 0.2 0.2 0.5 0.2 0.4 0.0 0.7 0.4 0.3 0.6 0.2 0.3 1.1 0.2 0.1 1.2 0.6 3.0 0.8 0.5 0.9 0.7 0.6 1.0 0.3 1.7 0.9 0.9 6.4 0.0 6.8 5.5 0.3 2.2 0.4 2.8 1.6 0.3 0.1 0.9 4.3 0.9 0.0 6.2 0.7 5.2 0.1 0.0 0.3 61.4 3.5 0.9 3.0 0.0 0.4 12.4 0.7 0.5 2.2 0.0 4.9 1.3 26.6 1.1 0.1 0.1 0.0 17.9 0.8 0.0 0.0 0.3 93.7 0.9 0.2 1.8 7.5 0.1 0.9 6.2 10.6 7.6 0.5 0.1 1.2 16.6 3.8 0.4 0.1 1.7 35.6 0.0 1.5 1.4 28.0 1.4 0.5 0.1 1.1 3.0 16.4 0.8 1.8 MTHFD1 "MTHFC, MTHFD" ENSG00000100714 "Methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1" 14 64388031-64463457 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "liver: 356.9" "Cell type enhanced" "Detected in many" "Hepatocytes: 142.9;Proximal tubular cells: 75.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000704, HPA001290, HPA015006, HPA050052" Approved Enhanced Cytosol NA Yes "Cluster 43: B-cells - Humoral immune response" "Cluster 85: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "HPA000704: AB_1079424, HPA001290: AB_1854177, HPA015006: AB_1854178, HPA050052: AB_2680998" "unprognostic (3.58e-2)" "unprognostic (5.50e-3)" "unprognostic (1.24e-1)" "unprognostic (2.46e-2)" "unprognostic (1.37e-1)" "unprognostic (7.01e-2)" "unprognostic (8.85e-3)" "unprognostic (7.62e-3)" "unprognostic (1.28e-1)" "unprognostic (2.29e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.84e-1)" "prognostic favorable (5.93e-5)" "unprognostic (2.45e-2)" "unprognostic (1.75e-1)" "unprognostic (7.30e-2)" "unprognostic (2.29e-2)" 56.4 18.0 8.6 20.0 17.4 27.0 29.8 8.3 12.3 16.9 15.0 23.3 19.7 16.1 9.9 25.1 16.0 13.1 28.1 12.9 8.1 55.3 356.9 15.4 23.6 7.5 7.8 24.9 23.8 27.5 9.2 13.3 7.0 12.9 27.5 3.6 15.6 13.8 64.1 17.1 18.9 20.0 7.2 14.5 17.9 4.7 8.9 30.2 20.5 61.9 27.7 18.6 16.6 8.3 294.1 164.9 58.5 143.6 70.5 53.4 95.7 106.4 83.3 148.1 147.4 161.2 144.2 103.3 49.6 67.1 68.3 146.0 177.6 111.2 160.4 107.3 117.9 122.2 143.5 131.8 50.6 104.5 81.2 43.0 37.3 124.3 66.4 57.5 93.1 98.1 108.5 98.7 114.7 270.1 179.9 62.3 118.0 186.5 160.4 138.3 201.2 114.4 110.5 160.9 128.7 49.0 183.7 111.4 58.3 54.0 164.4 58.6 51.5 115.1 184.1 102.2 134.2 58.8 65.6 177.9 107.4 125.2 134.8 0.4 11.7 0.1 9.7 19.5 13.0 27.0 10.1 12.3 17.7 15.3 7.8 10.7 0.9 17.8 16.7 4.0 19.5 12.2 8.6 17.4 8.3 12.3 12.9 8.1 7.5 7.8 7.0 7.2 8.9 8.3 8.1 19.2 23.5 15.0 16.2 13.8 14.2 14.7 13.6 0.0 9.8 8.1 43.9 15.7 19.5 16.5 0.0 30.6 10.8 7.9 41.1 16.9 1.4 6.8 11.7 12.3 3.0 42.3 19.5 10.3 30.9 14.9 15.3 8.7 50.7 27.2 12.8 142.9 25.3 0.0 15.6 14.3 2.0 13.0 11.0 1.5 13.1 12.3 14.2 8.4 13.3 0.0 8.2 14.1 10.9 11.7 6.3 13.2 24.1 10.2 8.2 75.3 11.5 0.0 19.7 13.1 19.3 0.9 8.9 19.5 10.7 9.9 16.6 21.4 24.6 12.7 ZBTB25 "C14orf51, KUP, ZNF46" ENSG00000089775 "Zinc finger and BTB domain containing 25" P24278 14 64449106-64505213 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 54.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054699 Uncertain Enhanced Nucleoplasm NA NA "Cluster 32: T-cells - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "HPA054699: AB_2682579" "unprognostic (1.13e-2)" "unprognostic (1.86e-1)" "unprognostic (1.16e-1)" "unprognostic (1.64e-2)" "unprognostic (1.82e-2)" "unprognostic (1.11e-3)" "unprognostic (5.32e-3)" "unprognostic (4.21e-2)" "unprognostic (2.26e-1)" "unprognostic (7.33e-2)" "unprognostic (1.70e-3)" "unprognostic (2.48e-1)" "prognostic unfavorable (3.56e-6)" "unprognostic (3.29e-2)" "unprognostic (1.05e-1)" "unprognostic (4.62e-2)" "unprognostic (1.04e-1)" 6.6 6.1 6.5 8.3 7.9 7.6 6.1 8.8 8.5 7.3 6.5 7.4 3.6 6.1 8.3 4.1 8.4 5.4 11.0 7.1 6.2 4.8 6.9 6.9 11.1 8.7 7.3 8.0 6.7 6.2 9.0 4.3 8.0 6.7 4.9 11.1 4.7 4.8 11.2 7.7 7.8 5.6 7.3 8.4 5.1 6.4 8.8 12.7 8.8 8.9 11.1 7.6 6.5 11.0 20.2 8.7 5.6 5.4 8.0 10.0 11.2 3.4 6.1 5.5 7.2 4.0 13.8 14.9 3.9 5.7 6.9 18.1 5.7 5.7 6.7 15.6 1.8 3.4 14.1 1.9 9.2 2.3 7.6 12.8 5.5 5.4 10.7 11.7 5.1 14.0 2.1 23.7 6.6 8.7 8.5 3.5 2.9 7.1 8.9 6.5 6.2 6.4 6.3 9.4 5.5 6.0 7.1 5.3 4.5 5.2 6.8 1.8 5.5 7.5 11.2 3.5 5.2 20.9 5.1 6.7 11.1 3.0 5.7 3.8 2.4 1.6 6.5 1.6 8.6 6.6 9.3 6.4 1.7 3.9 10.7 10.8 2.4 7.0 1.4 2.9 8.9 7.5 6.5 7.9 8.8 8.5 7.1 6.2 8.7 7.3 8.0 7.3 8.8 11.0 7.2 6.4 13.0 15.3 25.1 7.9 8.4 13.9 12.5 19.4 7.1 7.6 19.2 8.6 7.8 7.3 18.8 7.1 19.3 2.3 9.8 8.5 47.9 15.6 9.4 8.7 3.5 14.1 23.1 6.6 9.8 10.8 6.1 7.6 6.3 11.9 7.1 10.9 10.8 8.4 28.1 2.6 8.2 11.1 19.1 54.1 13.4 12.6 17.8 15.9 10.5 7.5 27.8 26.7 37.0 7.2 3.7 10.9 19.3 6.3 3.8 7.7 15.4 22.4 0.0 12.5 10.2 11.9 11.8 7.7 8.4 4.0 33.2 8.7 4.6 5.9 AKAP5 "AKAP75, AKAP79" ENSG00000179841 "A-kinase anchoring protein 5" P24588 14 64465499-64474503 "Plasma proteins, Predicted intracellular proteins, Transporters" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 13.5;intestine: 3.8" "Cell type enhanced" "Detected in many" "dendritic cells: 15.6;Excitatory neurons: 17.2;granulocytes: 67.6;Intestinal goblet cells: 28.7;NK-cells: 16.5" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 29 "amygdala: 5.3;basal ganglia: 13.5;cerebral cortex: 8.5;hippocampal formation: 7.7" "Immune cell enriched" "Detected in single" 8 "basophil: 3.0" "Lineage enriched" "Detected in single" 8 "granulocytes: 3.0" "Cell line enhanced" "Detected in many" "CACO-2: 10.9" "Group enriched" "Detected in all" 5 "amygdala: 27.6;basal ganglia: 79.0;cerebral cortex: 29.4;hippocampal formation: 30.8" "Group enriched" "Detected in all" 5 "amygdala: 24.3;basal ganglia: 79.9;cerebral cortex: 44.9;hippocampal formation: 43.7" "CAB004308, HPA053891" Enhanced Supported Approved Nucleoplasm NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 10: Brain - Neuronal signaling" "Cluster 39: CACO-2 - Unknown function" "Cluster 60: Granulocytes - Receptor signaling" Nucleoplasm "CAB004308: AB_626655, HPA053891: AB_2682294" "unprognostic (4.29e-2)" "unprognostic (5.89e-3)" "unprognostic (3.44e-4)" "unprognostic (2.30e-1)" "unprognostic (1.73e-1)" "unprognostic (2.24e-3)" "unprognostic (1.08e-1)" "unprognostic (3.57e-1)" "unprognostic (6.92e-2)" "unprognostic (3.02e-3)" "unprognostic (8.23e-2)" "unprognostic (1.42e-1)" "unprognostic (5.44e-2)" "unprognostic (4.49e-4)" "unprognostic (2.11e-1)" "unprognostic (2.42e-1)" "unprognostic (7.45e-2)" 0.3 0.3 5.3 1.4 13.5 0.6 0.5 0.0 8.5 0.4 0.0 3.7 0.5 1.3 0.1 0.5 0.5 0.9 0.2 7.7 0.0 1.3 0.8 1.8 1.9 0.0 0.1 0.4 0.2 0.4 1.0 1.1 0.0 0.4 3.8 0.6 0.3 0.4 0.2 0.5 1.4 1.3 0.0 1.2 0.5 0.3 0.0 0.9 0.5 0.0 1.6 0.6 0.3 0.3 1.3 1.0 1.3 0.8 0.4 0.1 4.2 0.9 0.4 1.2 1.5 10.9 3.3 1.0 2.0 0.7 0.1 0.4 2.8 0.2 1.1 2.0 2.4 3.3 2.0 0.9 0.1 0.4 0.4 0.4 0.1 0.8 0.0 2.1 0.4 2.4 0.4 0.7 0.7 0.8 2.7 0.2 1.0 0.1 0.5 3.3 0.5 0.2 1.9 1.2 3.3 1.4 1.1 0.1 0.2 3.8 1.0 0.2 0.6 1.4 4.2 0.1 1.7 2.2 2.6 2.4 0.9 0.4 0.2 3.0 0.0 0.1 0.3 0.0 0.0 0.1 0.1 0.3 0.0 0.2 0.1 0.1 0.2 0.3 0.0 0.1 0.0 0.0 5.3 13.5 0.0 8.5 7.7 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 6.4 2.4 1.6 2.8 0.9 1.3 0.5 1.2 7.4 1.8 1.4 1.6 1.5 0.2 0.0 8.4 0.6 15.6 5.1 0.0 0.6 2.6 0.5 1.4 1.9 0.0 2.7 17.2 0.2 1.9 2.1 0.5 1.0 67.6 0.9 0.4 0.7 0.5 8.4 5.5 28.7 0.0 0.3 2.9 0.9 0.0 1.2 1.8 0.0 0.3 0.9 16.5 3.0 1.6 0.8 2.2 0.0 6.4 1.2 0.8 1.4 0.2 7.7 0.0 2.2 0.8 0.5 4.9 0.1 0.9 0.7 12.4 0.3 6.2 0.9 ZBTB1 "KIAA0997, ZNF909" ENSG00000126804 "Zinc finger and BTB domain containing 1" Q9Y2K1 14 64503712-64533690 "Predicted intracellular proteins, Transcription factors" "Differentiation, DNA damage, DNA repair, Immunity, Innate immunity, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "dendritic cells: 115.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050516, HPA054552, HPA075151" Approved Supported Nucleoplasm NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA050516: AB_2681153, HPA054552: , HPA075151: " "unprognostic (4.09e-1)" "unprognostic (3.68e-1)" "unprognostic (1.08e-1)" "unprognostic (9.51e-2)" "unprognostic (1.28e-1)" "prognostic favorable (4.92e-4)" "unprognostic (1.11e-3)" "unprognostic (9.43e-2)" "unprognostic (6.64e-2)" "unprognostic (2.00e-1)" "unprognostic (9.65e-2)" "unprognostic (6.63e-2)" "unprognostic (3.34e-2)" "unprognostic (6.26e-2)" "unprognostic (2.23e-1)" "unprognostic (2.58e-1)" "unprognostic (3.27e-2)" 24.0 15.2 14.2 28.9 17.1 83.1 25.8 15.8 16.6 21.1 17.8 21.4 16.9 20.5 26.9 15.9 24.8 21.2 16.9 15.0 14.2 17.9 22.1 22.3 44.1 16.5 15.6 21.5 17.8 20.8 18.0 24.0 16.8 24.2 22.2 20.8 18.5 17.9 22.6 34.7 23.9 19.3 16.3 34.8 21.0 12.4 17.7 38.5 27.9 21.3 35.8 21.9 20.2 19.8 56.2 18.4 40.5 25.4 41.1 49.3 41.5 23.8 35.4 22.0 27.9 17.9 38.7 53.5 23.2 33.8 17.2 38.4 19.9 23.6 30.0 79.7 13.5 26.1 35.9 15.1 25.8 21.9 36.7 63.7 40.6 15.3 22.6 48.3 25.8 33.8 13.1 35.7 41.2 42.5 38.0 22.0 16.9 28.8 27.5 33.7 25.0 20.7 38.3 67.1 28.2 22.6 38.9 29.0 32.7 39.0 27.9 27.9 34.4 36.6 24.7 17.7 16.7 44.6 20.6 59.6 36.9 20.6 24.5 42.5 13.6 23.1 18.8 13.1 21.4 14.8 16.6 20.9 14.6 14.3 16.8 20.8 10.4 19.9 19.1 9.1 25.6 16.4 14.2 17.1 15.8 16.6 15.0 14.2 16.5 15.6 16.8 16.3 17.7 19.8 19.8 16.0 12.7 65.6 56.9 31.7 17.0 29.7 40.9 11.5 14.4 13.7 11.9 8.6 22.3 9.2 12.5 8.0 115.7 9.2 9.8 13.2 83.0 40.0 41.5 24.7 22.1 20.8 40.6 8.6 13.7 26.5 19.9 30.2 28.5 18.8 19.2 8.4 15.2 6.7 58.1 12.1 30.5 23.0 73.5 38.0 15.8 50.5 30.2 58.1 13.8 7.7 22.6 40.2 96.3 16.2 8.3 18.4 48.3 15.2 6.0 6.6 27.8 8.4 6.6 20.4 27.9 2.2 4.5 23.7 24.2 7.8 78.7 23.5 10.9 19.2 HSPA2 ENSG00000126803 "Heat shock protein family A (Hsp70) member 2" P54652 14 64535905-64546173 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Stress response" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 320.2;skeletal muscle: 170.4" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 342.0;Distal tubular cells: 238.7;Extravillous trophoblasts: 509.9;Spermatocytes: 578.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A549: 75.4;BEWO: 114.4;BJ hTERT+: 99.0;CAPAN-2: 52.9;SCLC-21H: 101.4" "Low region specificity" "Detected in all" "HPA000798, HPA052504" Enhanced Supported Approved Nucleoplasm,Vesicles NA NA 63000000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 70: Brain - Nervous system development" "Cluster 28: BEWO - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Vesicles Nucleoplasm "HPA000798: AB_1079090, HPA052504: AB_2681854" "prognostic favorable (1.78e-4)" "unprognostic (1.72e-1)" "unprognostic (2.73e-1)" "unprognostic (1.08e-2)" "unprognostic (3.78e-2)" "unprognostic (2.90e-2)" "unprognostic (7.11e-2)" "prognostic unfavorable (9.11e-4)" "unprognostic (1.31e-1)" "unprognostic (3.14e-2)" "unprognostic (2.09e-1)" "unprognostic (2.60e-1)" "unprognostic (5.31e-2)" "unprognostic (1.14e-1)" "unprognostic (1.90e-1)" "unprognostic (8.36e-2)" "unprognostic (1.25e-1)" 9.8 6.5 83.9 7.5 161.2 0.7 6.4 148.0 116.3 12.5 84.2 94.1 5.5 51.6 18.6 42.3 17.0 5.3 39.7 88.5 96.0 73.0 4.2 14.2 3.8 170.1 122.9 5.6 8.8 7.8 15.2 61.5 174.9 10.8 9.5 1.2 16.4 4.5 170.4 31.7 29.6 28.7 128.5 20.2 18.5 121.0 125.3 3.0 2.7 60.6 5.0 42.9 16.0 320.2 30.4 75.4 11.4 0.2 8.1 0.7 114.4 42.3 99.0 16.6 27.3 2.9 52.9 7.4 16.8 46.4 3.6 33.6 0.0 2.2 10.1 4.3 5.8 0.1 4.0 0.2 7.9 0.2 10.0 3.7 1.7 2.4 0.1 4.1 1.1 0.5 0.0 6.0 8.4 13.5 0.5 0.4 8.4 11.7 9.1 6.0 0.0 0.1 26.1 4.6 101.4 5.8 1.8 3.7 0.1 3.9 2.9 3.1 1.6 0.3 0.2 3.7 0.2 7.6 0.2 0.2 9.2 0.1 11.4 0.3 0.0 0.0 0.5 0.1 0.0 0.2 0.4 0.2 0.0 0.1 0.1 0.1 0.6 0.2 0.1 0.0 1.0 0.1 83.9 161.2 148.0 116.3 88.5 96.0 170.1 122.9 174.9 128.5 125.3 320.2 74.7 0.0 5.2 18.6 21.1 54.0 31.2 35.1 342.0 1.9 37.5 57.1 39.1 5.7 8.8 132.4 0.0 42.5 30.8 29.2 238.7 8.3 35.7 56.4 63.8 59.6 28.1 0.0 0.5 5.6 509.9 40.7 83.6 54.5 13.3 1.4 32.2 0.8 15.7 0.0 1.1 63.4 24.4 3.1 25.7 27.3 8.7 24.0 30.2 6.5 0.0 14.2 0.0 2.5 157.4 5.5 15.6 7.5 7.1 7.5 8.5 1.5 4.6 2.4 26.3 48.6 66.2 578.6 77.1 175.8 42.3 75.9 29.8 4.5 12.9 11.3 PPP1R36 C14orf50 ENSG00000165807 "Protein phosphatase 1 regulatory subunit 36" Q96LQ0 14 64549920-64589381 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 12.5;testis: 37.1" "Group enriched" "Detected in many" 4 "Early spermatids: 350.6;Late spermatids: 791.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "CAPAN-2: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077492 Enhanced NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 22: Non-specific - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 25: Spermatids - Spermatogenesis" "HPA077492: AB_2732348" "unprognostic (3.43e-4)" "unprognostic (5.75e-2)" "unprognostic (4.48e-2)" "unprognostic (6.04e-4)" "unprognostic (1.12e-2)" "unprognostic (9.37e-2)" "unprognostic (1.52e-3)" "unprognostic (9.21e-2)" "unprognostic (2.32e-1)" "unprognostic (9.09e-2)" "unprognostic (2.42e-1)" "unprognostic (1.17e-1)" "unprognostic (4.80e-3)" "unprognostic (9.77e-3)" "unprognostic (3.53e-1)" "unprognostic (7.12e-2)" "unprognostic (5.46e-2)" 1.9 0.5 1.2 0.4 1.6 0.0 1.4 1.2 2.0 1.0 1.6 6.5 6.6 0.9 3.0 0.6 12.5 2.0 0.5 1.2 1.4 2.4 0.1 1.2 0.2 1.8 1.6 0.1 10.8 0.4 1.9 0.9 2.1 0.2 5.6 0.1 3.8 0.3 0.2 1.0 4.7 0.5 1.8 0.1 7.2 37.1 1.5 0.2 0.2 0.6 0.3 0.9 0.3 2.2 0.2 0.1 0.3 0.1 1.4 0.7 1.0 0.8 0.4 0.5 1.2 0.2 13.9 0.0 0.1 0.7 0.5 0.4 0.0 0.0 0.6 0.1 0.1 0.4 0.8 0.1 0.8 0.0 0.1 0.9 0.7 0.2 0.5 0.9 0.3 0.1 0.0 0.0 0.7 0.8 0.1 0.4 0.0 0.4 0.0 0.1 0.1 0.1 0.5 0.6 3.0 0.1 1.4 0.1 0.0 0.2 0.1 0.2 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.3 0.1 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.2 0.0 1.2 1.6 1.2 2.0 1.2 1.4 1.8 1.6 2.1 1.8 1.5 2.2 1.5 0.0 0.6 2.3 0.5 0.5 0.5 1.6 1.8 0.0 2.7 4.6 0.7 4.3 6.3 3.7 0.0 0.4 1.5 5.0 1.9 0.9 350.6 44.3 1.6 3.2 4.2 0.0 1.7 8.2 2.5 0.8 6.6 6.4 0.0 0.1 2.9 0.0 0.4 0.0 1.4 7.3 0.0 0.6 0.7 791.2 3.4 1.4 0.0 3.7 0.1 0.8 2.1 0.0 5.8 6.8 3.4 3.8 0.3 0.2 8.1 0.1 36.2 0.2 0.0 3.2 1.4 124.8 8.0 1.8 0.4 0.5 0.5 0.2 6.6 0.9 PLEKHG3 "ARHGEF43, KIAA0599" ENSG00000126822 "Pleckstrin homology and RhoGEF domain containing G3" A1L390 14 64704102-64750249 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 179.2" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 90.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 6 "granulocytes: 24.0;NK-cells: 9.4;T-cells: 16.2" "Cell line enhanced" "Detected in many" "A-431: 78.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063455, HPA065323, HPA073702, HPA074734" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytokinetic bridge,Centrosome,Cytosol" Yes No "Cluster 5: Granulocytes - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane, Cytosol" "Nucleoplasm, Cytokinetic bridge, Centrosome" "HPA063455: AB_2685015, HPA065323: AB_2685467, HPA073702: AB_2732238, HPA074734: AB_2732265" "unprognostic (8.71e-2)" "unprognostic (1.69e-1)" "unprognostic (4.38e-2)" "unprognostic (4.04e-2)" "unprognostic (2.18e-1)" "unprognostic (7.22e-2)" "unprognostic (7.21e-2)" "unprognostic (5.53e-3)" "unprognostic (1.49e-1)" "unprognostic (3.34e-3)" "unprognostic (3.63e-1)" "unprognostic (3.54e-2)" "prognostic favorable (7.39e-8)" "unprognostic (2.29e-1)" "unprognostic (2.67e-1)" "unprognostic (4.24e-2)" "unprognostic (2.67e-3)" 25.2 3.5 44.0 10.7 92.5 16.3 23.4 47.2 74.1 33.9 53.0 39.0 13.0 67.5 5.0 45.8 38.1 22.6 17.2 44.5 46.7 36.0 36.3 14.3 5.6 65.8 66.3 33.8 33.0 17.0 6.8 29.3 60.9 24.2 15.5 2.9 29.2 37.5 9.7 44.9 13.2 26.4 37.9 26.6 22.3 5.7 74.1 4.6 23.7 7.4 4.9 32.2 39.1 179.2 78.4 36.5 29.8 45.3 3.1 0.0 49.0 8.7 10.4 13.8 11.0 38.9 34.3 0.0 15.3 8.6 4.8 74.6 20.3 69.7 4.7 0.2 16.7 35.1 48.3 9.2 4.0 1.3 16.1 3.9 39.6 2.9 24.4 22.9 9.1 0.3 0.0 0.4 4.6 37.5 0.1 32.0 10.0 21.2 37.0 0.4 14.7 5.5 37.0 58.0 9.9 18.0 17.7 26.7 25.1 27.5 29.0 8.0 16.6 6.0 59.8 0.3 12.3 0.1 0.2 0.1 0.6 3.7 10.7 9.0 3.0 18.2 16.2 1.5 11.1 0.0 5.0 7.3 1.0 0.0 0.5 3.6 24.0 9.4 1.0 0.0 1.7 5.3 44.0 92.5 47.2 74.1 44.5 46.7 65.8 66.3 60.9 37.9 74.1 179.2 3.1 3.2 6.2 15.0 0.7 19.4 19.4 15.1 21.6 5.5 16.0 9.8 7.8 12.8 6.0 47.8 0.0 7.9 14.5 24.7 11.7 26.7 0.9 18.6 18.5 4.0 34.7 0.4 1.0 20.6 9.5 7.4 14.3 23.6 1.3 1.9 3.6 10.1 5.5 0.0 3.2 26.9 18.3 6.5 8.0 1.5 7.5 2.7 5.4 6.5 4.6 9.1 45.3 10.6 90.9 35.3 16.7 25.6 2.8 16.1 2.3 9.5 4.0 0.8 26.3 5.1 25.3 0.2 1.6 25.6 21.5 2.6 9.0 10.5 13.2 32.2 SPTB ENSG00000070182 "Spectrin beta, erythrocytic" P11277 14 64746283-64879907 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Disease variant, Elliptocytosis, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 62.5;skeletal muscle: 123.9;tongue: 69.8" "Cell type enhanced" "Detected in some" "Erythroid cells: 81.0;Excitatory neurons: 16.0;Horizontal cells: 16.8;Inhibitory neurons: 32.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEL: 39.2;K-562: 47.8;U-937: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003394, HPA003398, CAB015169, CAB016232" Enhanced Approved Cytosol NA NA 7800000 "Cluster 80: Striated muscle - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 37: Myocytes - Muscle contraction" Cytosol "CAB015169: AB_2194363, CAB016232: AB_785785, HPA003394: AB_1080076, HPA003398: AB_1080074" "unprognostic (2.69e-1)" "unprognostic (4.72e-1)" "unprognostic (3.04e-2)" "unprognostic (2.19e-3)" "unprognostic (1.71e-1)" "unprognostic (2.33e-2)" "unprognostic (1.49e-1)" "unprognostic (1.30e-3)" "unprognostic (2.66e-1)" "unprognostic (2.28e-2)" "unprognostic (1.55e-3)" "unprognostic (2.11e-1)" "unprognostic (2.65e-1)" "unprognostic (1.39e-2)" "unprognostic (2.97e-1)" "unprognostic (3.44e-2)" "unprognostic (2.18e-2)" 2.2 1.5 5.3 0.2 11.2 62.5 0.3 28.3 11.4 0.3 27.7 0.2 0.1 0.2 5.2 2.0 0.5 0.4 22.7 10.8 4.0 1.0 0.1 0.4 0.0 28.5 5.3 0.2 2.6 11.1 5.3 6.7 28.2 1.5 0.1 1.6 2.2 1.1 123.9 0.2 0.2 0.8 8.5 0.8 0.2 0.7 9.3 0.4 0.1 69.8 0.0 0.2 0.2 4.4 0.3 1.5 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.1 0.0 0.7 0.0 0.0 0.0 0.3 0.3 2.3 6.3 0.2 0.0 0.4 3.7 39.2 0.3 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 1.4 47.8 0.0 0.0 0.3 0.0 0.3 0.0 0.5 2.1 0.0 0.0 0.2 0.0 0.2 6.1 2.6 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.3 6.7 0.0 0.6 1.5 7.7 0.0 0.1 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 5.3 11.2 28.3 11.4 10.8 4.0 28.5 5.3 28.2 8.5 9.3 4.4 0.1 0.0 0.0 0.7 0.0 0.8 0.7 0.6 0.0 10.3 0.5 0.1 6.3 1.5 0.7 0.0 0.0 0.1 0.5 0.0 0.0 0.3 0.4 0.4 0.9 0.4 3.0 81.0 16.0 0.2 0.3 0.8 0.0 0.9 2.5 0.2 0.0 0.0 0.2 16.8 32.1 0.3 0.0 0.0 0.4 0.4 0.3 0.3 1.8 1.9 0.0 5.0 1.0 11.1 2.1 0.3 0.0 1.2 0.1 0.7 0.0 0.2 0.0 2.6 6.6 11.6 3.8 0.1 1.1 0.5 0.4 0.1 0.6 0.4 0.1 0.6 CHURC1 "C14orf52, FLJ33064, My015" ENSG00000258289 "Churchill domain containing 1" Q8WUH1 14 64914361-64944591 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040072 Approved Approved Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 8: Non-specific - Mitochondria" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 59: Non-specific - Transcription" Cytosol "HPA040072: AB_10963788" "unprognostic (2.94e-1)" "unprognostic (2.42e-1)" "unprognostic (1.59e-1)" "unprognostic (1.61e-1)" "unprognostic (1.80e-1)" "unprognostic (2.17e-1)" "unprognostic (2.19e-1)" "unprognostic (1.64e-2)" "unprognostic (4.64e-1)" "unprognostic (6.78e-3)" "unprognostic (2.12e-1)" "unprognostic (1.99e-1)" "unprognostic (3.51e-2)" "unprognostic (6.67e-2)" "unprognostic (3.04e-2)" "unprognostic (1.55e-1)" "unprognostic (1.26e-1)" 47.8 42.0 29.9 39.1 34.8 43.8 37.4 34.5 41.2 41.2 27.2 43.8 30.9 40.0 32.6 34.3 34.2 32.5 58.8 29.8 33.7 34.7 52.4 29.3 43.8 38.8 33.3 43.9 30.2 46.1 25.2 34.5 38.6 32.4 36.4 35.7 26.5 37.7 82.9 30.1 33.9 45.8 34.7 42.2 33.7 25.4 34.3 61.2 32.9 53.0 43.3 38.3 30.5 40.3 119.6 61.8 58.8 43.7 70.1 75.6 68.9 85.3 74.3 47.4 53.9 34.1 75.1 69.9 57.7 73.7 75.2 84.9 51.7 69.2 51.8 79.7 25.3 67.9 47.7 79.3 66.1 37.7 64.9 89.9 50.5 43.0 81.4 79.7 51.6 107.2 30.6 60.5 58.1 97.6 72.7 61.6 31.4 140.9 101.1 63.4 63.2 42.6 64.5 83.8 30.0 36.7 57.6 59.8 81.0 53.7 101.8 78.4 64.8 41.3 87.8 45.0 56.0 49.5 46.8 162.0 43.0 44.6 51.8 201.6 131.9 145.4 111.5 137.6 128.2 161.8 167.5 134.1 107.4 135.9 166.3 139.8 292.8 122.4 138.3 154.7 238.5 143.5 29.9 34.8 34.5 41.2 29.8 33.7 38.8 33.3 38.6 34.7 34.3 40.3 154.6 102.5 89.0 0.0 128.2 58.5 73.8 176.8 130.3 73.8 85.0 98.7 53.4 94.4 98.2 99.3 43.8 90.4 97.9 89.3 131.0 160.7 82.0 130.8 87.3 109.9 89.8 91.5 0.0 222.7 89.7 100.9 75.4 80.8 95.6 69.6 127.5 190.4 89.3 53.8 0.0 100.3 107.8 172.6 69.6 27.1 104.1 130.5 83.6 0.0 214.3 155.2 132.8 0.0 0.0 216.8 118.9 121.5 79.7 70.5 124.6 211.0 145.1 87.2 131.5 100.6 135.7 131.1 81.1 158.3 65.9 89.8 137.0 205.8 121.1 72.2 CHURC1-FNTB ENSG00000125954 "CHURC1-FNTB readthrough" 14 64914485-65061803 "Metabolic proteins, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Group enriched" "Detected in some" 5 "Astrocytes: 11.1;Excitatory neurons: 10.4;Inhibitory neurons: 8.1;Microglial cells: 10.3;Oligodendrocyte precursor cells: 18.6;Oligodendrocytes: 15.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-2 OS: 3.2" CAB009260 Uncertain NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 21: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 68: Oligodendrocytes - Mixed function" "CAB009260: AB_2294228" "unprognostic (9.48e-2)" "unprognostic (8.51e-2)" "unprognostic (4.96e-2)" "unprognostic (8.55e-3)" "unprognostic (1.48e-1)" "unprognostic (2.61e-1)" "unprognostic (5.74e-2)" "unprognostic (9.27e-3)" "unprognostic (9.98e-2)" "unprognostic (7.68e-5)" "unprognostic (2.90e-1)" "unprognostic (1.91e-1)" "unprognostic (1.35e-1)" 0.5 0.6 0.2 0.0 0.5 0.7 0.4 0.8 0.8 0.3 0.5 0.4 0.0 0.6 0.0 0.3 0.8 0.2 0.6 0.2 0.5 0.2 0.3 0.3 0.2 1.0 0.4 0.4 0.5 0.0 0.3 0.3 0.9 0.3 0.0 0.1 0.2 0.1 1.3 0.4 0.2 0.2 0.7 0.1 0.7 1.7 0.5 0.4 0.2 0.0 0.1 0.3 0.3 1.4 0.6 2.1 1.0 1.0 1.5 0.9 0.9 2.1 0.4 0.8 0.1 0.0 1.8 0.1 1.2 0.2 0.9 2.5 0.3 0.0 0.5 1.6 0.0 0.0 0.4 0.0 1.2 0.0 0.7 0.6 0.3 0.0 0.4 1.7 0.1 0.3 0.5 0.5 0.4 0.0 0.6 0.3 0.8 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.2 1.1 1.4 2.0 0.4 0.2 0.7 1.3 0.0 0.0 3.2 0.6 1.0 1.4 0.9 0.6 1.5 0.9 0.4 3.0 1.4 1.5 0.8 1.4 1.5 0.6 1.1 1.0 1.1 0.6 1.2 0.9 2.6 1.1 0.8 1.2 2.5 1.8 0.2 0.5 0.8 0.8 0.2 0.5 1.0 0.4 0.9 0.7 0.5 1.4 0.0 0.0 2.2 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.3 0.0 0.0 0.0 18.6 15.4 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 GPX2 GSHPX-GI ENSG00000176153 "Glutathione peroxidase 2" P18283 14 64939152-64942905 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Oxidoreductase, Peroxidase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 497.7;intestine: 453.8;liver: 634.0;stomach 1: 374.6;urinary bladder: 350.5" "Cell type enhanced" "Detected in many" "Cholangiocytes: 386.1;Distal enterocytes: 436.6;Gastric mucus-secreting cells: 912.3;Hepatocytes: 753.4;Intestinal goblet cells: 438.6;Paneth cells: 463.0;Undifferentiated cells: 776.8;Urothelial cells: 1062.0" "Cancer enhanced" "Detected in many" "colorectal cancer: 493.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "OE19: 4748.8" "Region enhanced" "Detected in single" "pons and medulla: 1.2" "Low region specificity" "Detected in some" HPA003545 Enhanced Approved Nucleoplasm,Cytosol NA NA 82000 "Cluster 48: NK-cells - Unknown function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Cytosol "HPA003545: AB_10962695" "unprognostic (3.54e-1)" "unprognostic (1.08e-2)" "unprognostic (1.51e-1)" "unprognostic (1.90e-3)" "unprognostic (4.75e-3)" "prognostic unfavorable (5.10e-4)" "unprognostic (2.96e-2)" "unprognostic (2.93e-2)" "unprognostic (7.87e-2)" "unprognostic (1.54e-2)" "unprognostic (8.45e-2)" "unprognostic (1.44e-1)" "unprognostic (2.77e-2)" "unprognostic (4.39e-2)" "unprognostic (3.39e-2)" "unprognostic (6.66e-4)" "unprognostic (1.73e-2)" 1.9 0.2 0.1 53.8 0.3 0.3 5.3 0.5 0.3 23.5 0.1 333.5 96.7 0.7 1.7 187.7 4.9 497.7 0.3 0.2 0.5 30.6 634.0 2.6 0.1 0.4 0.2 0.2 24.5 0.0 1.2 0.2 0.4 43.3 453.8 0.0 71.8 24.9 0.3 25.4 175.7 9.7 0.1 0.6 374.6 2.5 0.3 3.3 0.5 0.0 1.2 350.5 108.2 0.7 0.0 1152.6 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 36.9 9.6 0.0 6.0 0.0 1.9 303.7 0.6 4.8 0.0 0.2 0.1 0.1 1.1 1048.6 0.0 0.1 0.4 0.0 9.7 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 5.6 0.6 0.3 1.3 4748.8 0.2 0.5 0.2 0.2 0.1 727.5 324.2 0.2 0.1 13.4 0.0 0.6 0.5 0.0 0.0 0.0 0.8 0.1 0.3 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.3 0.5 0.3 0.2 0.5 0.4 0.2 0.4 0.1 0.3 0.7 0.1 0.0 0.0 0.3 6.9 9.9 169.4 104.5 42.1 0.2 0.6 4.1 0.4 386.1 17.1 23.9 0.0 0.1 0.0 436.6 11.7 272.8 13.8 3.8 0.5 3.5 115.2 50.8 0.2 260.6 0.1 2.1 912.3 2.8 13.4 0.1 17.5 753.4 0.0 0.0 0.2 438.6 36.7 26.1 0.8 66.6 0.9 3.5 0.0 1.9 3.2 0.0 0.0 0.0 0.4 163.7 463.0 0.0 2.4 100.7 68.1 31.4 9.0 0.7 0.0 0.0 3.6 0.4 0.0 315.5 9.7 0.0 5.9 0.1 776.8 1062.0 RAB15 ENSG00000139998 "RAB15, member RAS oncogene family" P59190 14 64945814-64973226 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 51.3;Inhibitory neurons: 28.0;Intestinal goblet cells: 35.2" "Cancer enhanced" "Detected in all" "testis cancer: 83.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.9" "Cell line enhanced" "Detected in many" "HAP1: 128.1;RH-30: 151.2;RT4: 116.1;SK-BR-3: 116.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041177 Uncertain Approved "Vesicles,Centriolar satellite" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Vesicles, Centriolar satellite" "HPA041177: AB_10794547" "unprognostic (9.80e-2)" "unprognostic (1.42e-2)" "unprognostic (1.53e-1)" "unprognostic (4.94e-2)" "unprognostic (6.29e-2)" "unprognostic (3.45e-1)" "prognostic unfavorable (4.68e-4)" "unprognostic (7.14e-2)" "unprognostic (3.12e-1)" "unprognostic (4.25e-2)" "unprognostic (2.79e-2)" "unprognostic (2.02e-1)" "unprognostic (1.98e-2)" "unprognostic (1.29e-2)" "unprognostic (1.63e-1)" "unprognostic (1.86e-2)" "unprognostic (2.82e-2)" 2.8 4.9 30.0 6.2 35.0 0.8 8.4 28.2 43.2 7.3 13.4 13.5 12.7 4.2 5.6 4.3 4.7 6.2 33.4 38.9 22.6 19.3 21.2 9.9 3.8 21.2 20.7 2.2 12.6 39.4 9.6 16.1 28.6 10.9 20.2 5.8 36.5 4.6 10.0 7.2 13.1 11.8 17.2 2.8 10.9 1.7 25.5 7.7 6.7 1.2 3.0 17.9 5.0 31.5 10.9 57.0 20.3 20.3 4.5 6.4 57.6 6.7 9.3 13.5 11.8 26.8 28.4 0.6 3.9 16.5 6.2 10.9 128.1 1.3 9.5 3.6 6.2 12.3 1.1 23.5 0.6 0.6 7.5 4.4 2.5 5.9 1.2 3.5 42.6 29.2 0.4 2.0 23.9 61.8 15.2 11.3 45.8 65.6 8.2 18.5 151.2 1.0 15.8 116.1 65.4 12.7 3.4 116.7 15.0 23.6 33.2 11.8 11.2 11.5 49.0 5.5 8.7 0.6 0.4 5.8 2.4 0.3 8.6 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 1.9 0.1 0.0 30.0 35.0 28.2 43.2 38.9 22.6 21.2 20.7 28.6 17.2 25.5 31.5 1.7 6.4 3.9 5.9 0.8 2.5 3.2 1.3 0.6 2.9 12.4 7.4 22.2 4.3 4.2 16.5 0.0 24.7 5.0 5.5 3.9 7.9 0.5 6.6 2.8 3.7 1.2 0.0 51.3 12.2 16.0 2.0 2.6 13.6 1.3 4.1 4.6 8.7 2.7 11.8 28.0 35.2 0.0 0.3 1.3 1.1 0.3 0.9 0.0 4.7 1.0 2.0 1.0 10.6 4.9 13.0 5.5 1.5 0.2 5.6 2.9 5.9 1.3 2.9 0.0 2.4 5.2 0.9 0.4 1.6 1.1 17.9 1.5 1.5 12.0 14.1 FNTB FPTB ENSG00000257365 "Farnesyltransferase, CAAX box, beta" P49356 14 64986895-65062652 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Prenyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 70.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA062743 Uncertain Approved Centrosome NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 70: Brain - Nervous system development" "Cluster 17: WM-115 - Nervous system development" "Cluster 51: Myeloid cells - Hemostasis" Centrosome "HPA062743: AB_2684861" "unprognostic (2.79e-1)" "unprognostic (1.50e-2)" "unprognostic (1.54e-1)" "unprognostic (8.57e-3)" "unprognostic (1.88e-1)" "unprognostic (6.88e-2)" "prognostic unfavorable (6.03e-4)" "unprognostic (6.21e-2)" "unprognostic (3.11e-2)" "unprognostic (1.46e-2)" "unprognostic (1.70e-2)" "unprognostic (2.11e-1)" "unprognostic (2.49e-3)" "unprognostic (2.36e-2)" "unprognostic (3.60e-1)" "unprognostic (5.56e-2)" "unprognostic (1.11e-3)" 8.7 8.7 15.9 5.1 30.2 2.9 7.8 40.7 20.1 7.7 13.5 6.5 5.9 6.6 8.4 13.3 9.5 5.9 12.9 14.5 20.7 8.2 5.8 6.7 5.7 55.0 34.2 7.3 5.6 13.0 7.0 8.7 46.5 9.1 7.7 6.1 9.2 9.3 18.1 11.8 5.2 11.6 36.7 4.7 5.5 9.5 30.7 6.5 5.8 19.7 8.3 7.6 8.9 70.0 37.1 31.9 20.4 12.5 13.9 11.9 14.6 20.2 14.7 22.4 23.0 15.9 14.6 6.0 12.0 21.1 13.2 24.1 47.5 15.1 18.3 9.0 15.9 23.2 8.0 28.1 9.0 8.3 32.2 9.7 14.3 9.4 5.7 22.4 19.1 10.9 13.7 8.4 13.1 30.9 13.3 22.6 8.4 23.1 29.9 12.2 17.6 7.6 16.2 15.7 12.0 13.5 11.9 24.4 30.2 15.9 22.7 14.0 15.2 16.2 34.7 8.4 14.2 5.7 5.6 6.6 18.3 10.3 39.4 21.9 12.8 11.5 3.8 9.9 9.6 2.5 6.2 5.1 7.4 1.7 4.7 3.7 3.4 4.0 5.1 5.8 6.2 7.4 15.9 30.2 40.7 20.1 14.5 20.7 55.0 34.2 46.5 36.7 30.7 70.0 3.9 12.8 2.2 0.0 1.6 2.4 3.5 4.3 2.8 4.6 6.2 6.6 8.3 2.8 5.6 3.7 2.1 15.9 2.4 4.3 0.0 6.6 9.2 3.9 3.0 4.5 7.7 7.8 0.0 4.8 15.3 4.9 4.1 4.8 0.0 12.7 5.0 8.0 8.1 5.0 0.0 5.9 6.1 8.1 2.5 6.0 5.6 15.7 5.4 0.0 7.5 7.6 2.1 0.0 0.0 4.2 1.9 8.6 2.1 4.7 4.0 6.0 4.0 4.1 19.7 5.1 5.5 2.7 4.7 6.7 3.7 8.2 2.5 7.3 5.3 3.3 MAX "bHLHd4, bHLHd5, bHLHd6, bHLHd7, bHLHd8" ENSG00000125952 "MYC associated factor X" P61244 14 65006174-65102695 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 390.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000328, HPA003474" Supported Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 3: HMC-1 - Innate immune response" "Cluster 51: Myeloid cells - Hemostasis" Nucleoplasm "Golgi apparatus, Vesicles" "CAB000328: AB_2281783, HPA003474: AB_1079317" "unprognostic (4.50e-3)" "unprognostic (1.51e-3)" "unprognostic (4.08e-2)" "unprognostic (2.87e-1)" "unprognostic (8.37e-2)" "unprognostic (2.42e-2)" "unprognostic (1.13e-3)" "unprognostic (1.30e-3)" "unprognostic (1.53e-2)" "unprognostic (7.36e-3)" "unprognostic (7.19e-2)" "unprognostic (1.66e-2)" "prognostic unfavorable (5.57e-4)" "unprognostic (2.99e-1)" "unprognostic (4.68e-2)" "prognostic favorable (2.12e-4)" "unprognostic (6.03e-2)" 48.1 36.3 57.4 43.5 63.2 105.1 41.2 74.6 62.9 61.0 44.8 51.1 41.3 51.1 29.2 75.8 67.2 36.2 52.8 55.0 59.4 39.5 36.8 51.6 63.7 65.5 61.8 56.2 29.3 31.3 32.5 39.8 65.0 52.2 31.8 23.6 43.5 38.7 43.8 55.3 51.7 39.5 59.4 66.3 39.4 21.5 62.1 63.7 42.7 54.0 55.1 51.3 68.7 65.3 117.1 40.4 27.8 44.6 73.4 58.0 35.4 39.9 62.3 47.5 58.4 29.1 86.7 88.1 33.1 48.8 45.0 60.4 63.4 52.7 37.3 84.5 40.5 143.4 29.9 32.0 90.9 56.2 390.3 67.6 43.5 42.7 54.9 71.9 54.9 71.8 66.8 42.4 53.1 63.9 140.1 217.6 36.3 71.3 70.6 75.2 42.7 47.3 49.2 38.8 61.8 38.2 49.6 60.6 60.4 25.1 58.0 71.6 69.7 47.8 55.8 42.0 33.6 50.7 43.6 61.7 56.9 56.1 46.0 667.6 141.9 540.8 125.7 126.4 140.1 115.7 147.5 130.5 119.9 114.9 151.1 127.9 305.1 126.9 120.3 114.6 194.0 314.2 57.4 63.2 74.6 62.9 55.0 59.4 65.5 61.8 65.0 59.4 62.1 65.3 45.8 28.9 27.4 31.0 74.5 170.2 66.0 63.3 126.3 28.2 59.8 43.1 27.4 32.9 42.0 18.4 20.9 38.4 79.1 116.3 52.8 38.8 45.5 38.1 43.6 59.9 44.3 40.4 50.7 31.4 43.4 46.7 32.6 36.0 62.8 38.2 71.0 23.8 59.9 47.1 43.3 49.7 38.7 81.8 66.7 115.6 77.9 147.2 56.9 32.8 67.1 47.3 69.0 28.1 60.4 61.6 96.7 60.2 58.0 80.3 100.6 66.4 32.9 16.9 138.1 47.4 76.3 43.2 28.4 84.8 180.6 54.0 83.9 25.4 29.7 76.2 FUT8 ENSG00000033170 "Fucosyltransferase 8" Q9BYC5 14 65410592-65744121 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 64.3" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 1019.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 15.6;NK-cells: 14.8;T-cells: 10.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017129, HPA043410" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 70: Brain - Nervous system development" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB017129: , HPA043410: AB_2678467" "unprognostic (1.67e-1)" "unprognostic (1.63e-1)" "unprognostic (3.28e-2)" "unprognostic (1.65e-3)" "unprognostic (2.10e-1)" "unprognostic (5.61e-2)" "unprognostic (1.41e-1)" "unprognostic (8.81e-2)" "unprognostic (2.00e-2)" "unprognostic (1.33e-3)" "unprognostic (8.09e-2)" "unprognostic (1.94e-1)" "unprognostic (1.04e-3)" "unprognostic (1.40e-1)" "unprognostic (2.94e-1)" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" 7.9 8.2 21.0 11.9 38.2 3.6 10.5 44.1 28.2 6.9 0.0 11.4 17.5 9.0 5.3 6.8 15.6 11.1 4.7 20.4 27.7 6.9 3.4 8.1 11.7 32.8 29.9 7.3 9.9 9.6 4.6 17.3 29.3 5.8 11.6 8.3 42.6 10.5 2.5 5.3 17.4 11.0 29.4 10.2 31.8 16.4 29.7 11.3 8.4 6.3 18.6 13.3 4.5 64.3 115.9 22.5 12.6 110.6 49.5 38.4 61.6 35.9 64.8 30.3 32.6 16.9 44.8 30.7 29.2 40.1 79.4 9.0 29.9 11.4 45.6 124.2 11.0 33.5 7.2 23.0 26.8 7.6 23.9 96.0 6.8 39.3 19.4 124.4 69.6 17.1 14.1 28.8 20.8 60.8 36.6 16.7 14.7 59.6 66.6 26.9 10.3 17.2 46.5 33.1 23.4 16.6 20.8 9.8 8.0 70.6 10.2 12.9 141.8 34.5 36.0 15.3 30.5 47.3 18.5 74.3 68.6 13.6 11.1 0.7 2.0 0.7 3.6 0.9 3.8 15.6 6.2 5.6 2.6 8.3 6.6 6.6 0.3 14.8 1.4 2.6 10.0 2.9 21.0 38.2 44.1 28.2 20.4 27.7 32.8 29.9 29.3 29.4 29.7 64.3 19.0 12.8 32.5 227.5 43.1 12.1 7.4 11.5 17.1 10.1 18.3 11.7 5.9 8.6 18.9 12.9 4.2 45.5 8.3 5.9 0.0 9.1 37.9 9.9 14.6 16.0 5.4 15.8 169.0 31.7 28.1 22.7 78.0 10.2 7.6 3.3 14.6 3.5 13.0 8.4 166.4 26.5 2.0 12.2 8.6 15.3 12.8 10.2 1.8 70.3 3.6 27.8 9.2 138.7 1019.1 54.7 10.3 13.5 124.3 8.8 24.5 8.4 15.3 9.1 0.0 14.3 13.2 34.6 26.8 7.4 9.8 14.1 18.9 10.6 21.7 7.2 CCDC196 "C14orf53, LINC00238, NCRNA00238" ENSG00000196553 "Coiled-coil domain containing 196" A0A1B0GTZ2 14 66411704-66498677 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 11 "testis: 5.4" "Cell type enhanced" "Detected in some" "Exocrine glandular cells: 1.0;Proximal tubular cells: 2.0" "Cancer enhanced" "Detected in single" "breast cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 30: Mammary glandular cells - Lactation" "unprognostic (2.96e-2)" "unprognostic (6.53e-2)" "unprognostic (6.56e-2)" "unprognostic (2.57e-2)" "unprognostic (2.53e-1)" "unprognostic (4.47e-1)" "unprognostic (7.20e-2)" "unprognostic (9.22e-2)" "unprognostic (3.60e-6)" "unprognostic (5.72e-2)" "unprognostic (7.10e-2)" "unprognostic (6.03e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPHN KIAA1385 ENSG00000171723 Gephyrin Q9NQX3 14 66507407-67181803 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis" "Multifunctional enzyme, Transferase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 62.4" "Group enriched" "Detected in many" 4 "Astrocytes: 493.0;Excitatory neurons: 686.5;Inhibitory neurons: 866.7;Oligodendrocyte precursor cells: 576.1;Oligodendrocytes: 597.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003116, CAB004419, HPA024694" Enhanced Approved Vesicles,Cytosol NA NA 6900 "Cluster 16: MAIT-cells - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles Cytosol "CAB004419: AB_627670, HPA003116: AB_1078963, HPA024694: AB_1849616" "unprognostic (8.37e-2)" "unprognostic (2.53e-2)" "unprognostic (2.42e-1)" "unprognostic (1.20e-1)" "unprognostic (5.14e-2)" "unprognostic (4.89e-3)" "unprognostic (8.29e-2)" "unprognostic (1.41e-2)" "unprognostic (1.42e-1)" "unprognostic (2.23e-1)" "unprognostic (2.49e-2)" "unprognostic (8.54e-2)" "prognostic favorable (5.25e-12)" "unprognostic (9.81e-2)" "unprognostic (2.27e-1)" "unprognostic (7.50e-2)" "prognostic unfavorable (4.61e-5)" 13.8 11.1 35.5 3.5 36.0 2.6 13.4 48.4 54.1 9.7 20.9 11.8 7.4 9.9 11.6 12.2 11.1 6.2 17.1 36.1 37.6 25.3 62.4 9.3 3.8 32.7 35.3 8.9 23.9 11.7 13.6 3.6 32.3 11.3 10.1 23.1 9.4 6.6 24.5 15.2 9.0 6.2 32.4 6.7 14.7 6.2 34.6 5.8 11.9 13.8 4.3 11.4 10.7 39.5 39.9 8.8 13.7 15.9 14.2 17.5 9.5 11.1 5.7 12.7 12.2 2.8 17.9 0.0 1.8 7.7 5.5 13.1 17.0 19.9 18.9 15.0 14.9 15.8 9.4 22.3 7.8 9.1 15.8 13.3 13.8 2.9 16.0 4.8 11.8 13.8 9.3 14.2 7.1 19.2 11.9 22.2 5.0 28.3 17.0 0.0 32.5 13.2 16.7 7.5 25.8 10.3 10.2 31.6 12.4 3.3 18.5 11.5 6.7 14.1 24.8 11.3 13.0 22.8 9.1 0.3 10.5 0.8 11.2 0.0 0.7 0.3 2.0 1.2 3.2 1.2 2.5 1.7 1.1 1.9 1.7 1.6 0.0 1.3 1.0 1.5 3.0 0.7 35.5 36.0 48.4 54.1 36.1 37.6 32.7 35.3 32.3 32.4 34.6 39.5 11.5 6.4 13.1 493.0 11.8 4.7 9.2 5.8 27.9 34.3 12.4 6.7 12.7 8.6 10.8 1.8 52.1 3.9 3.5 8.6 13.7 4.0 3.8 7.2 13.5 10.7 6.0 7.6 686.5 5.3 2.3 8.7 19.9 13.6 0.0 3.9 15.7 47.6 3.7 43.7 866.7 15.0 8.2 5.8 1.7 5.0 11.1 4.5 1.8 148.0 1.3 8.9 1.0 576.1 597.5 3.1 7.8 5.7 15.1 11.5 7.1 20.1 2.4 34.9 0.0 12.5 11.8 11.8 8.9 26.7 5.8 2.1 7.9 9.0 10.4 6.5 FAM71D C14orf54 ENSG00000172717 "Family with sequence similarity 71 member D" Q8N9W8 14 67189393-67228550 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 14.2" "Group enriched" "Detected in many" 21 "Early spermatids: 199.1;Late spermatids: 257.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 34: Spermatids - Unknown function" "unprognostic (1.58e-2)" "unprognostic (8.05e-4)" "unprognostic (2.34e-2)" "unprognostic (2.86e-1)" "unprognostic (5.80e-2)" "unprognostic (1.05e-1)" "unprognostic (2.44e-3)" "unprognostic (6.62e-2)" "unprognostic (5.01e-1)" "unprognostic (6.72e-2)" "unprognostic (4.52e-2)" "unprognostic (2.06e-1)" "unprognostic (2.96e-5)" "unprognostic (2.37e-1)" "unprognostic (7.40e-2)" "unprognostic (8.85e-2)" "unprognostic (5.01e-5)" 0.0 0.0 0.3 0.1 0.5 0.3 0.1 1.7 0.8 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.2 0.4 0.8 0.0 0.1 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.8 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 14.2 0.3 0.1 0.2 0.2 0.1 0.0 0.0 1.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.4 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 1.0 0.1 0.1 0.2 0.3 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.3 0.5 1.7 0.8 0.4 0.8 0.2 0.3 0.3 0.1 0.3 1.1 0.4 0.0 3.0 1.3 1.8 3.2 0.3 2.2 0.0 0.2 0.5 0.6 2.3 0.0 4.2 0.0 0.0 4.2 5.7 10.1 0.0 8.2 199.1 0.5 0.4 1.6 10.3 0.0 2.8 7.4 3.6 1.2 0.0 0.6 10.8 0.2 0.7 1.0 3.0 0.0 3.6 8.5 2.0 1.0 2.5 257.6 3.7 2.2 0.0 0.0 6.3 0.5 1.0 2.5 2.1 9.5 8.2 0.7 0.1 0.6 5.8 0.5 7.2 0.7 0.0 0.2 1.8 2.2 2.1 0.0 2.3 4.4 1.7 0.1 8.3 0.3 MPP5 "FLJ12615, PALS1" ENSG00000072415 "Membrane palmitoylated protein 5" Q8N3R9 14 67240713-67336061 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 129.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "A-431: 156.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000993, HPA063890" Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 7: Kidney - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 44: Endometrium - Transcription" Nucleoplasm "Plasma membrane, Cytosol" "HPA000993: AB_1079407, HPA063890: AB_2732707" "unprognostic (3.65e-1)" "unprognostic (3.82e-3)" "unprognostic (4.56e-2)" "unprognostic (9.20e-2)" "unprognostic (9.86e-2)" "unprognostic (1.36e-1)" "prognostic unfavorable (5.62e-4)" "unprognostic (1.48e-1)" "unprognostic (1.02e-1)" "unprognostic (1.37e-1)" "unprognostic (1.93e-3)" "unprognostic (9.89e-3)" "prognostic favorable (1.71e-12)" "unprognostic (2.28e-1)" "unprognostic (1.82e-1)" "unprognostic (6.90e-2)" "unprognostic (6.87e-2)" 7.4 8.7 13.9 6.3 20.9 5.6 10.6 17.6 16.5 8.8 26.6 12.7 20.4 6.3 21.1 13.6 7.3 7.9 7.4 11.9 17.4 31.4 19.6 12.3 4.8 18.2 18.2 6.1 8.7 19.6 7.2 9.8 18.3 16.2 12.0 17.2 18.4 12.7 18.0 8.4 20.7 7.2 18.1 6.6 9.4 8.8 17.5 10.3 25.1 13.6 6.1 9.0 8.4 27.5 156.4 24.4 24.1 18.5 13.3 12.3 20.6 46.4 23.6 33.2 21.6 23.8 45.9 12.7 21.5 37.8 11.0 31.0 13.9 26.1 50.2 5.5 9.5 11.8 23.6 16.8 15.5 4.5 8.5 13.1 10.0 17.9 23.7 24.2 19.0 13.5 12.6 4.7 53.9 20.4 14.4 5.0 7.7 22.2 16.2 12.2 37.1 15.2 30.1 36.8 13.2 9.4 28.2 27.0 15.5 21.1 28.6 9.2 29.2 41.4 87.2 13.8 19.9 7.8 7.6 19.3 27.2 10.1 14.7 0.1 0.5 0.8 0.4 1.0 0.3 1.1 0.5 0.6 0.8 0.4 1.1 0.6 0.0 2.2 0.7 0.6 0.3 0.4 13.9 20.9 17.6 16.5 11.9 17.4 18.2 18.2 18.3 18.1 17.5 27.5 13.2 64.1 28.9 37.2 8.8 21.0 26.0 14.6 22.2 8.5 22.4 12.8 24.7 11.5 21.1 22.0 43.8 23.1 5.2 47.2 13.7 21.7 5.9 29.5 15.0 17.7 5.4 6.7 24.8 26.9 11.3 17.3 18.3 46.2 5.1 15.8 17.2 20.7 17.6 3.3 34.7 21.2 12.2 11.9 13.4 4.5 8.1 9.2 3.6 22.5 6.6 23.4 3.1 41.2 129.8 26.7 32.5 11.3 13.1 30.1 54.3 33.5 14.9 34.3 6.6 17.7 22.2 22.4 36.1 29.2 17.3 17.5 7.7 7.5 22.4 38.7 ATP6V1D "ATP6M, VATD, VMA8" ENSG00000100554 "ATPase H+ transporting V1 subunit D" Q9Y5K8 14 67294371-67360265 "Metabolic proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 365.9;Proximal tubular cells: 365.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031515, HPA057316" Enhanced Approved Nucleoplasm Yes No 19000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA031515: AB_10600785, HPA057316: AB_2683409" "unprognostic (1.10e-1)" "unprognostic (7.35e-2)" "unprognostic (1.59e-1)" "unprognostic (7.10e-3)" "unprognostic (1.52e-1)" "unprognostic (7.64e-2)" "unprognostic (7.78e-3)" "unprognostic (1.19e-1)" "unprognostic (2.32e-1)" "unprognostic (3.05e-2)" "unprognostic (1.13e-2)" "unprognostic (3.08e-2)" "prognostic favorable (7.60e-13)" "unprognostic (2.78e-1)" "unprognostic (3.18e-2)" "unprognostic (1.41e-2)" "unprognostic (1.44e-2)" 43.4 116.2 98.0 32.2 103.2 28.8 43.8 91.8 119.7 40.3 101.8 52.9 40.4 34.3 72.5 96.7 48.1 38.7 136.6 107.2 103.5 129.8 51.7 37.5 33.3 96.1 98.4 26.1 36.2 88.8 65.8 43.4 106.7 55.7 57.5 78.0 45.1 49.8 78.5 40.4 41.7 46.4 95.1 24.3 43.8 42.5 99.7 52.4 89.5 108.5 46.3 54.5 54.1 99.6 242.5 64.7 96.2 62.4 80.2 82.8 73.5 199.1 109.4 145.8 109.1 76.2 85.2 24.8 73.9 155.1 105.3 89.2 72.6 117.9 195.7 82.5 50.8 23.4 74.5 51.0 144.0 24.9 64.8 65.1 77.7 105.4 73.1 131.4 97.6 58.6 50.2 55.3 206.6 78.5 66.5 46.2 60.7 104.6 83.3 48.8 84.2 32.8 171.2 104.3 120.2 49.8 122.9 65.4 145.6 96.2 98.3 53.4 123.8 162.4 121.6 77.6 120.1 55.8 46.1 33.4 150.2 44.1 96.1 106.7 77.5 92.8 48.5 78.8 40.8 39.9 53.2 52.7 83.4 42.0 41.6 41.7 94.0 48.9 83.5 73.9 78.8 65.0 98.0 103.2 91.8 119.7 107.2 103.5 96.1 98.4 106.7 95.1 99.7 99.6 31.3 54.5 63.0 13.4 27.6 96.2 66.6 112.3 26.2 60.0 44.8 41.8 160.8 55.8 85.0 82.8 54.2 92.3 51.4 91.6 365.9 125.9 190.3 120.8 44.1 40.7 54.4 78.1 22.7 48.9 85.5 51.5 42.3 71.8 41.2 39.8 27.5 45.8 132.0 87.5 21.0 49.4 175.0 44.6 61.0 97.9 32.9 62.2 80.0 6.5 58.5 89.4 47.4 9.5 22.1 121.5 78.7 50.8 21.3 65.9 80.9 365.5 184.1 94.2 13.1 44.5 64.1 100.1 61.5 78.4 138.4 205.9 40.8 71.6 40.6 113.8 EIF2S1 "EIF-2alpha, EIF2, EIF2A" ENSG00000134001 "Eukaryotic translation initiation factor 2 subunit alpha" P05198 14 67360328-67386516 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011663, HPA064885" Supported Enhanced Cytosol NA NA 210000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Cytosol "CAB011663: AB_2096478, HPA064885: AB_2685382" "unprognostic (1.86e-2)" "unprognostic (8.33e-2)" "unprognostic (4.31e-2)" "unprognostic (2.46e-2)" "unprognostic (3.78e-2)" "unprognostic (1.78e-3)" "prognostic unfavorable (4.73e-7)" "unprognostic (4.14e-3)" "unprognostic (4.49e-1)" "unprognostic (1.68e-2)" "prognostic unfavorable (4.97e-4)" "unprognostic (2.95e-1)" "unprognostic (1.21e-2)" "unprognostic (1.73e-1)" "unprognostic (4.65e-1)" "unprognostic (1.59e-2)" "prognostic unfavorable (7.11e-4)" 28.3 24.5 12.5 29.9 14.0 25.0 25.7 15.1 17.8 18.1 10.4 25.0 21.5 19.4 19.6 38.8 15.8 21.5 28.7 14.6 14.1 24.5 35.3 18.4 30.4 13.7 12.7 17.1 26.3 22.9 9.4 26.3 13.6 22.1 26.7 21.2 18.3 22.3 49.4 23.7 21.5 27.0 13.8 19.8 19.8 33.4 13.5 27.9 27.9 40.6 33.5 39.1 19.0 16.6 265.7 86.4 59.8 92.3 56.4 63.4 127.8 115.5 68.3 127.4 110.7 101.6 92.2 118.7 57.0 87.4 85.7 100.4 139.1 110.3 192.7 86.9 51.9 76.9 80.0 70.4 59.2 82.7 71.9 52.4 62.6 113.9 172.5 49.8 105.4 73.8 132.6 89.6 127.3 131.3 113.7 64.7 61.1 157.9 142.9 85.7 99.0 84.6 78.2 120.0 85.9 60.7 83.0 96.5 91.1 52.3 164.5 70.8 81.3 167.4 180.7 82.0 124.4 77.0 90.4 180.7 97.1 145.3 110.2 51.4 50.6 33.0 47.4 71.0 58.4 55.4 54.5 51.7 70.1 45.8 50.3 51.5 6.9 58.6 62.8 48.0 64.3 70.7 12.5 14.0 15.1 17.8 14.6 14.1 13.7 12.7 13.6 13.8 13.5 16.6 64.1 28.9 40.2 17.3 44.1 142.8 88.2 77.2 37.5 22.1 32.0 30.1 92.8 30.0 55.8 22.0 12.5 78.7 38.0 23.3 70.5 89.6 81.0 34.6 48.9 60.3 13.1 64.2 21.7 63.0 104.7 51.2 34.1 44.8 35.5 35.7 26.4 39.8 70.4 37.0 20.9 30.6 61.1 37.9 51.3 33.4 31.1 40.7 51.6 15.9 61.3 32.2 36.0 15.1 23.8 70.8 18.3 40.6 56.7 79.9 26.6 65.1 35.0 35.2 26.3 60.7 85.9 204.9 96.3 49.7 130.4 93.4 46.1 57.9 39.7 79.1 PLEK2 ENSG00000100558 "Pleckstrin 2" Q9NYT0 14 67386984-67412167 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 51.1" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 149.0;Pancreatic endocrine cells: 179.8;Suprabasal keratinocytes: 90.6;Theca cells: 107.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 2.0;naive CD4 T-cell: 3.1" "Lineage enriched" "Detected in single" 7 "T-cells: 3.1" "Cell line enhanced" "Detected in many" "A-431: 91.0;CAPAN-2: 94.4;HBEC3-KT: 177.4;PC-3: 64.1;TIME: 69.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA001208 Enhanced Uncertain Vesicles,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 16: Pancreatic endocrine cells - Mixed function" Vesicles Cytosol "HPA001208: AB_1079631" "unprognostic (4.41e-3)" "unprognostic (3.77e-1)" "unprognostic (1.15e-1)" "unprognostic (6.23e-2)" "unprognostic (6.88e-2)" "unprognostic (3.17e-3)" "unprognostic (1.18e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (1.97e-1)" "unprognostic (9.21e-3)" "prognostic unfavorable (8.26e-5)" "unprognostic (1.06e-1)" "unprognostic (3.09e-3)" "unprognostic (2.90e-1)" "unprognostic (1.29e-1)" "unprognostic (8.98e-2)" "unprognostic (4.59e-2)" 0.8 51.1 0.3 5.5 0.3 12.7 3.9 0.8 0.6 3.9 0.1 25.1 29.6 1.5 32.4 16.4 1.7 3.9 0.3 0.4 0.2 9.7 29.7 1.6 0.2 0.3 0.2 0.6 7.9 7.0 1.3 1.5 0.3 7.7 28.7 0.1 6.8 4.2 0.3 26.5 32.6 1.3 0.2 0.6 20.6 3.1 0.4 22.9 23.5 0.2 5.5 12.1 7.9 0.4 91.0 13.4 0.0 0.1 0.0 1.0 8.4 17.9 2.7 4.2 5.2 48.8 94.4 0.0 17.3 2.5 0.2 42.4 0.1 177.4 9.6 0.1 0.7 0.0 19.4 0.4 3.8 0.0 0.0 1.9 12.3 4.6 55.4 0.0 14.8 0.0 0.4 0.4 3.0 28.9 0.0 0.2 0.3 57.4 64.1 0.0 0.1 14.0 30.0 2.4 0.7 0.2 17.0 7.9 5.2 0.9 11.6 0.9 69.3 0.0 54.1 0.3 0.4 0.3 0.2 0.3 10.7 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.3 0.4 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.3 0.8 0.6 0.4 0.2 0.3 0.2 0.3 0.2 0.4 0.4 0.1 0.0 1.1 1.0 0.6 149.0 29.0 69.9 37.0 0.0 4.9 6.0 0.5 10.0 11.8 5.5 0.0 1.0 0.0 25.0 3.9 42.1 0.1 2.3 0.2 2.0 8.4 16.0 0.8 46.3 5.5 4.2 37.2 2.2 0.0 24.0 0.0 11.5 6.8 0.0 0.6 68.5 26.4 1.3 57.1 0.3 0.3 7.4 21.4 0.0 5.2 0.0 0.0 0.5 0.3 179.8 23.9 0.0 0.0 15.8 47.9 3.2 4.5 0.0 0.0 0.0 4.6 0.4 2.3 21.2 90.6 1.5 1.3 107.7 54.8 25.5 TMEM229B "C14orf83, FLJ33387" ENSG00000198133 "Transmembrane protein 229B" Q8NBD8 14 67447084-67533739 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 14.6;Late spermatids: 25.7;NK-cells: 15.5;Oligodendrocyte precursor cells: 19.1" "Cancer enhanced" "Detected in all" "melanoma: 12.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 12.9;MCF7: 13.6;SK-MEL-30: 11.6;U-937: 34.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046562 Approved NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 70: Brain - Nervous system development" "Cluster 32: U-937 - Innate immune response" "Cluster 34: Spermatids - Unknown function" "HPA046562: AB_10960265" "prognostic favorable (5.38e-4)" "unprognostic (6.55e-2)" "unprognostic (1.23e-1)" "prognostic favorable (1.21e-5)" "unprognostic (7.37e-2)" "unprognostic (1.08e-1)" "unprognostic (1.09e-1)" "unprognostic (2.01e-1)" "unprognostic (2.01e-2)" "unprognostic (1.12e-1)" "unprognostic (2.76e-3)" "unprognostic (1.95e-2)" "unprognostic (5.18e-1)" "unprognostic (8.66e-2)" "unprognostic (1.22e-1)" "unprognostic (8.20e-2)" "prognostic favorable (1.79e-5)" 1.5 15.3 10.1 5.6 8.7 1.8 3.7 21.2 15.8 10.8 0.0 4.3 15.7 1.4 10.9 1.3 2.0 4.1 1.3 10.9 10.7 2.0 1.1 3.5 9.1 25.8 10.9 1.1 5.0 12.5 6.9 0.8 27.6 2.7 3.3 5.4 4.0 10.4 0.5 1.4 14.2 3.2 10.4 9.8 4.2 6.1 15.4 11.8 8.3 0.9 6.1 5.0 1.5 11.5 3.2 0.4 0.0 0.8 0.3 0.0 1.2 0.5 0.7 0.8 3.3 0.0 10.1 12.9 0.1 0.3 2.8 0.0 0.2 0.7 0.1 4.2 1.0 7.8 0.0 0.0 1.0 8.5 1.5 0.2 0.4 0.1 0.0 0.2 0.0 0.8 0.1 0.5 0.0 13.6 5.2 3.2 0.1 6.7 0.6 4.7 0.1 1.9 0.1 6.7 1.9 0.4 0.0 4.9 11.6 0.5 10.3 8.1 0.0 0.1 0.5 0.1 0.2 0.0 0.0 0.0 0.6 34.5 7.0 5.8 5.7 9.1 9.9 6.5 9.5 1.3 5.9 8.0 2.7 0.9 5.0 6.5 0.1 5.5 6.9 1.5 2.5 5.8 10.1 8.7 21.2 15.8 10.9 10.7 25.8 10.9 27.6 10.4 15.4 11.5 1.2 0.0 0.5 1.3 2.6 0.3 0.3 3.6 0.0 4.8 3.5 2.5 1.8 2.8 2.5 0.0 14.6 0.1 8.3 3.6 0.0 2.0 12.6 2.3 0.3 1.4 2.4 0.4 7.1 3.6 0.0 0.6 1.1 0.3 0.0 11.0 2.9 0.2 1.8 0.0 10.6 5.3 0.0 6.2 1.0 25.7 0.0 2.6 7.2 3.7 5.5 0.3 15.5 19.1 6.1 0.5 5.7 0.7 0.4 0.4 11.3 2.2 2.4 4.1 0.0 0.2 0.7 0.7 0.3 0.1 0.1 0.1 4.1 4.9 3.9 1.1 PLEKHH1 KIAA1200 ENSG00000054690 "Pleckstrin homology, MyTH4 and FERM domain containing H1" Q9ULM0 14 67533290-67589612 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 158.0" "Cell type enriched" "Detected in many" 8 "Oligodendrocytes: 607.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 10.2;BEWO: 9.7;RT4: 10.2;SK-MEL-30: 12.0;T-47d: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047707, HPA051964" Uncertain Approved Centrosome NA NA "Cluster 70: Brain - Nervous system development" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Centrosome "HPA047707: AB_2680126, HPA051964: AB_2681675" "unprognostic (2.47e-2)" "unprognostic (9.57e-2)" "unprognostic (3.94e-2)" "prognostic favorable (8.03e-5)" "unprognostic (4.74e-1)" "unprognostic (9.15e-3)" "unprognostic (8.43e-5)" "unprognostic (1.54e-2)" "unprognostic (2.28e-1)" "unprognostic (4.14e-2)" "unprognostic (3.72e-2)" "unprognostic (1.85e-1)" "prognostic favorable (4.03e-7)" "unprognostic (1.49e-1)" "unprognostic (1.15e-2)" "unprognostic (1.13e-1)" "prognostic favorable (2.26e-4)" 0.9 4.0 20.9 1.3 72.6 0.0 2.5 44.6 51.6 2.9 0.0 6.7 11.7 1.4 8.3 1.2 3.4 2.1 0.7 24.9 31.9 2.1 0.4 0.7 0.1 78.9 59.7 0.2 7.7 9.5 4.3 1.1 71.2 10.3 6.7 7.3 22.8 2.3 0.9 4.3 9.3 0.8 36.8 0.9 6.3 1.8 59.7 1.1 38.9 0.4 0.3 1.4 0.9 158.0 5.3 1.2 2.0 10.2 0.2 0.0 9.7 0.0 0.0 0.1 0.1 3.2 1.6 0.0 1.6 0.0 0.9 2.3 3.6 0.9 0.1 0.3 3.5 0.0 1.8 2.1 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 1.3 4.0 0.0 0.0 7.6 0.0 0.2 3.0 6.0 0.6 0.1 0.3 1.5 1.1 10.2 2.7 2.5 0.9 1.9 12.0 4.7 9.7 2.1 0.0 0.8 3.6 1.0 0.6 0.0 0.0 0.0 0.5 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.9 72.6 44.6 51.6 24.9 31.9 78.9 59.7 71.2 36.8 59.7 158.0 0.1 3.2 6.4 19.9 0.7 0.1 0.7 3.1 1.2 16.7 5.8 6.0 3.6 2.8 3.4 9.2 39.6 3.0 1.4 21.2 3.9 2.2 0.6 19.1 2.0 0.7 7.3 0.0 13.4 4.0 0.3 0.6 29.0 18.0 0.0 67.7 0.0 0.2 0.8 3.3 21.9 16.9 0.0 0.6 0.3 0.7 0.3 1.5 3.6 12.2 0.0 4.6 0.0 34.2 607.7 2.9 7.7 0.4 0.0 4.1 12.8 1.7 3.9 36.6 0.0 1.5 1.0 0.7 1.6 2.3 2.3 10.7 0.3 2.0 16.4 1.2 PIGH GPI-H ENSG00000100564 "Phosphatidylinositol glycan anchor biosynthesis class H" Q14442 14 67581955-67600286 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Autism spectrum disorder, Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Muller glia cells: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031624 Approved NA NA "Cluster 24: B-cells - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 5: Muller glia cells - Visual perception" "HPA031624: AB_10601046" "unprognostic (1.59e-2)" "unprognostic (3.07e-2)" "unprognostic (1.08e-1)" "unprognostic (5.80e-2)" "unprognostic (3.47e-2)" "unprognostic (8.25e-3)" "unprognostic (8.69e-3)" "unprognostic (3.26e-3)" "unprognostic (1.19e-1)" "unprognostic (2.73e-1)" "unprognostic (6.17e-3)" "unprognostic (1.39e-1)" "prognostic favorable (2.68e-7)" "unprognostic (7.42e-2)" "unprognostic (1.42e-2)" "unprognostic (7.00e-2)" "unprognostic (3.73e-1)" 15.4 34.2 19.9 8.2 23.6 27.2 19.2 23.4 26.4 25.9 22.5 14.2 12.6 14.0 36.6 14.0 15.5 13.6 15.1 19.4 23.4 34.7 23.9 13.7 11.9 23.9 22.4 23.8 29.2 66.7 13.6 12.5 23.9 28.9 11.6 47.6 26.2 16.0 32.2 19.9 16.1 10.9 22.6 16.5 19.6 20.7 22.7 11.8 28.8 24.7 13.3 16.4 14.4 27.4 24.5 15.6 14.7 30.3 32.1 12.3 12.4 13.3 16.1 18.2 17.7 25.4 8.3 16.5 12.9 9.1 30.4 17.5 26.3 18.9 20.1 25.4 34.8 17.3 12.4 26.1 25.2 12.8 19.9 17.9 23.8 13.7 21.0 5.6 11.8 28.5 39.7 11.5 13.3 21.4 18.8 21.4 2.7 33.8 41.9 6.3 14.8 9.9 19.6 20.0 18.3 22.1 10.1 19.4 33.8 10.8 22.0 12.5 6.1 18.1 23.2 23.8 15.8 21.9 15.2 11.2 13.9 27.1 25.7 42.0 24.8 52.5 44.9 35.1 58.5 61.8 46.5 41.8 25.4 72.0 48.3 45.0 12.1 51.5 45.7 29.6 48.2 35.0 19.9 23.6 23.4 26.4 19.4 23.4 23.9 22.4 23.9 22.6 22.7 27.4 14.8 3.2 14.1 5.5 23.6 20.6 20.4 37.1 19.4 35.5 22.8 25.9 4.9 22.8 17.8 22.0 35.5 29.8 28.7 9.5 29.4 22.3 12.1 20.3 10.5 16.1 7.2 13.2 8.0 37.1 28.7 20.8 9.2 10.9 7.0 13.4 13.9 14.6 22.7 26.9 10.4 14.9 26.4 7.6 12.9 9.4 21.5 12.3 35.6 7.5 7.0 96.6 23.7 8.5 10.3 24.3 10.6 21.1 31.2 26.8 29.4 31.3 12.2 45.5 0.0 22.7 18.7 78.8 59.5 17.7 20.9 56.4 20.7 34.6 14.1 18.2 ARG2 ENSG00000081181 "Arginase 2" P78540 14 67619920-67651708 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 220.0;prostate: 108.5;thyroid gland: 105.0" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 190.1;Collecting duct cells: 165.5;Glandular and luminal cells: 145.2;Proximal tubular cells: 220.9;Syncytiotrophoblasts: 601.3;Urothelial cells: 165.2" "Cancer enhanced" "Detected in all" "prostate cancer: 49.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 58.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000663, CAB009435" Enhanced Supported Mitochondria NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 30: Epithelial cell lines - Translation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Mitochondria "CAB009435: AB_2059089, HPA000663: AB_1078192" "unprognostic (8.74e-3)" "unprognostic (3.06e-2)" "unprognostic (1.35e-2)" "unprognostic (2.29e-1)" "unprognostic (2.30e-1)" "unprognostic (9.13e-2)" "unprognostic (1.10e-2)" "unprognostic (3.43e-3)" "unprognostic (4.62e-3)" "unprognostic (5.37e-2)" "unprognostic (4.66e-3)" "unprognostic (1.72e-1)" "unprognostic (9.39e-2)" "unprognostic (4.26e-1)" "unprognostic (2.31e-1)" "unprognostic (4.34e-1)" "unprognostic (1.26e-1)" 2.8 7.3 5.6 2.9 6.1 0.5 4.8 6.9 13.9 17.0 7.9 2.7 3.7 7.0 3.6 16.3 1.8 9.3 3.4 6.3 11.6 64.0 3.8 3.8 0.5 6.4 7.7 18.7 5.0 220.0 45.6 8.8 9.2 108.5 1.4 22.3 17.0 5.8 35.7 2.1 15.3 3.7 5.1 0.9 3.2 3.4 6.5 3.0 105.0 52.6 1.7 17.8 9.9 5.6 8.9 1.5 14.4 9.4 2.1 0.1 20.1 6.7 17.4 20.6 34.5 36.3 4.5 14.6 1.9 4.3 9.4 2.1 58.2 26.8 24.9 0.7 14.6 6.7 2.6 41.9 6.2 1.8 37.8 1.1 33.6 10.2 49.7 1.6 35.4 37.7 19.4 0.1 1.4 4.4 2.5 1.4 27.2 4.0 0.5 0.8 2.0 16.8 16.8 14.3 31.5 12.2 4.2 4.2 6.4 32.9 15.1 1.2 7.3 6.4 15.9 0.7 5.0 1.3 2.4 4.9 12.8 7.5 10.9 0.1 0.4 0.7 0.3 0.1 0.1 0.2 0.1 0.3 0.5 0.7 0.2 0.2 0.6 0.1 0.4 0.0 0.9 1.0 5.6 6.1 6.9 13.9 6.3 11.6 6.4 7.7 9.2 5.1 6.5 5.6 3.9 0.0 5.8 5.5 8.4 8.8 190.1 17.0 7.4 5.2 41.6 28.7 6.3 4.3 20.3 165.5 10.4 86.5 14.6 9.0 37.2 8.4 16.5 75.1 18.7 5.9 36.8 8.8 20.3 3.3 6.2 5.6 37.8 145.2 7.0 23.9 2.9 1.3 14.7 10.1 41.8 24.5 12.2 0.6 3.6 3.2 0.3 9.3 10.6 7.5 0.9 40.5 1.0 9.0 9.2 5.0 5.0 0.4 5.7 95.4 72.8 220.9 3.0 17.6 6.6 6.2 8.9 8.4 3.4 9.7 5.4 601.3 15.1 2.2 8.7 165.2 VTI1B VTI2 ENSG00000100568 "Vesicle transport through interaction with t-SNAREs 1B" Q9UEU0 14 67647085-67674820 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 493.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044121, HPA048150, HPA060118" Approved Enhanced "Golgi apparatus,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" "HPA044121: AB_2678819, HPA048150: AB_2680288, HPA060118: AB_2684206" "unprognostic (2.26e-1)" "unprognostic (4.83e-2)" "unprognostic (8.09e-2)" "unprognostic (2.24e-1)" "unprognostic (3.00e-2)" "unprognostic (2.36e-3)" "unprognostic (3.25e-3)" "unprognostic (9.12e-2)" "unprognostic (1.90e-2)" "unprognostic (3.86e-1)" "unprognostic (2.60e-1)" "unprognostic (2.11e-2)" "prognostic favorable (3.53e-12)" "unprognostic (8.35e-3)" "unprognostic (1.53e-1)" "unprognostic (1.43e-1)" "unprognostic (8.02e-3)" 53.8 26.9 55.5 20.4 56.8 22.3 39.8 54.4 102.1 22.7 49.8 42.9 28.3 18.4 53.5 44.3 18.5 28.7 60.1 56.6 58.1 53.0 41.6 26.8 23.8 55.1 56.6 21.0 44.0 23.9 17.1 21.3 56.8 22.3 35.2 23.0 30.1 13.6 46.5 31.0 24.1 22.4 56.0 26.5 40.0 30.8 56.3 12.1 34.0 28.2 27.0 33.3 23.4 56.9 111.7 54.8 31.4 18.1 61.9 37.2 45.4 48.1 30.5 23.8 23.7 27.3 38.5 32.9 40.2 54.5 27.5 30.6 36.8 36.6 37.7 34.3 22.6 33.4 32.5 34.8 26.6 20.9 22.9 36.3 39.6 25.6 26.1 60.5 27.2 23.1 22.2 25.4 34.5 131.1 26.6 77.7 20.3 76.6 88.0 31.8 35.6 12.2 35.1 65.0 17.4 35.5 33.8 45.5 71.4 23.7 41.9 58.0 38.5 62.6 93.8 51.4 45.6 23.8 27.8 53.2 52.9 38.9 29.0 88.8 61.5 143.8 49.4 80.4 42.4 49.0 43.1 51.1 59.6 43.0 40.5 50.3 27.2 56.4 70.2 38.6 60.2 58.3 55.5 56.8 54.4 102.1 56.6 58.1 55.1 56.6 56.8 56.0 56.3 56.9 47.6 25.6 35.0 13.1 48.7 42.3 61.4 91.7 33.0 23.2 82.2 65.4 30.5 67.2 64.4 66.2 22.9 107.4 47.5 138.2 217.2 109.1 141.7 58.5 43.2 51.5 46.6 102.7 15.8 131.4 167.9 51.6 40.8 49.5 64.0 43.6 73.9 95.3 131.4 15.2 18.2 96.0 50.8 99.8 49.2 493.5 41.7 80.9 71.2 11.2 121.6 65.4 78.2 13.6 17.1 130.7 119.4 39.9 51.0 120.5 165.4 268.6 55.3 44.8 19.7 36.5 58.2 104.5 57.2 58.2 52.8 125.9 46.8 35.5 91.9 124.6 RDH11 "ARSDR1, MDT1, SDR7C1" ENSG00000072042 "Retinol dehydrogenase 11" Q8TC12 14 67676800-67695793 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Cataract, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 582.0" "Cell type enhanced" "Detected in all" "Hepatocytes: 241.8;Muller glia cells: 299.7;Prostatic glandular cells: 285.7" "Cancer enriched" "Detected in all" 13 "prostate cancer: 286.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB046011 Enhanced "Intracellular and membrane" NA NA 340000 "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 5: Muller glia cells - Visual perception" "CAB046011: AB_11129613" "unprognostic (1.38e-1)" "unprognostic (6.86e-3)" "unprognostic (1.77e-1)" "prognostic favorable (2.62e-4)" "unprognostic (6.06e-2)" "prognostic unfavorable (2.89e-5)" "unprognostic (9.29e-2)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (3.58e-2)" "unprognostic (2.91e-2)" "unprognostic (1.27e-1)" "prognostic favorable (1.30e-7)" "unprognostic (1.65e-1)" "unprognostic (1.68e-1)" "unprognostic (2.18e-1)" "unprognostic (4.74e-2)" 23.6 59.5 39.3 24.5 43.2 13.9 28.7 50.2 54.4 32.6 35.9 29.2 34.1 33.2 86.0 34.6 23.5 42.7 17.6 40.4 47.2 106.0 153.1 34.9 20.4 49.2 47.7 28.9 42.6 79.8 23.4 21.9 49.3 582.0 31.4 73.9 44.2 34.4 8.3 31.4 23.9 43.6 49.8 22.2 31.9 28.4 46.1 30.7 61.7 13.5 26.2 34.3 30.3 58.4 183.7 81.9 71.3 82.0 111.5 100.4 59.3 68.0 134.2 83.7 150.9 68.6 216.7 31.7 51.2 64.6 104.8 142.5 104.0 150.8 113.7 63.0 42.6 65.1 40.7 69.0 106.9 24.3 46.0 94.4 98.0 109.3 92.0 63.9 97.4 87.0 52.1 101.1 77.2 97.5 72.2 38.8 40.4 49.7 92.8 53.6 87.4 45.8 194.1 93.0 73.8 62.0 71.2 89.7 99.1 58.2 100.7 38.3 74.2 89.5 101.1 38.9 49.5 47.5 40.0 40.7 115.8 66.0 74.3 282.4 71.1 104.0 62.3 57.7 68.2 39.0 67.7 61.5 51.3 45.5 67.3 64.8 11.0 56.3 65.4 59.1 65.1 115.8 39.3 43.2 50.2 54.4 40.4 47.2 49.2 47.7 49.3 49.8 46.1 58.4 27.0 25.6 66.0 38.2 29.2 11.5 40.0 77.9 16.5 53.5 45.4 24.5 20.4 68.6 59.9 47.8 50.1 24.9 32.4 26.8 7.9 92.5 2.5 21.9 50.9 39.3 43.3 29.2 33.3 84.0 38.1 37.5 19.9 38.2 29.2 46.3 47.8 241.8 35.8 79.1 37.6 28.9 89.5 42.4 15.4 6.1 43.2 35.9 35.6 17.8 39.8 299.7 37.0 70.4 43.4 61.2 36.7 56.1 27.3 285.7 17.5 56.0 23.9 97.0 46.0 29.7 38.7 25.8 24.0 20.2 19.2 63.5 29.8 66.7 25.3 46.1 RDH12 "FLJ30273, LCA13, RP53, SDR7C2" ENSG00000139988 "Retinol dehydrogenase 12" Q96NR8 14 67701886-67734451 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Oxidoreductase "Disease variant, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "retina: 222.7;skin 1: 63.8" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 146.0;Rod photoreceptor cells: 453.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 5.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "Cluster 79: Retina - Phototransduction" "Cluster 46: Photoreceptor cells - Phototransduction" "unprognostic (4.25e-3)" "unprognostic (4.50e-3)" "unprognostic (1.16e-1)" "unprognostic (7.53e-2)" "unprognostic (2.99e-1)" "unprognostic (1.99e-1)" "unprognostic (6.70e-2)" "unprognostic (2.13e-1)" "unprognostic (1.69e-2)" "unprognostic (2.72e-3)" "unprognostic (7.59e-2)" "unprognostic (2.02e-1)" "unprognostic (1.42e-2)" "unprognostic (6.47e-2)" "unprognostic (7.83e-2)" "unprognostic (3.58e-1)" "unprognostic (3.92e-1)" 0.1 4.1 1.3 0.1 1.0 0.1 2.2 1.0 1.4 11.0 0.4 0.0 0.3 0.0 8.7 22.1 0.5 17.6 0.0 0.9 1.2 13.6 3.8 0.1 0.0 1.2 2.3 0.0 3.2 0.0 0.9 0.1 1.2 0.5 0.0 222.7 1.7 0.1 0.1 63.8 0.1 0.0 0.6 0.0 12.4 0.1 4.6 0.4 1.2 0.0 1.6 0.0 23.6 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.0 1.0 1.4 0.9 1.2 1.2 2.3 1.2 0.6 4.6 1.1 0.0 0.0 0.0 0.7 0.0 4.7 0.3 0.0 0.6 39.8 0.1 0.1 0.0 20.0 0.3 1.8 146.0 0.0 0.0 0.1 0.0 0.7 0.2 1.8 1.1 2.2 0.0 0.0 1.2 1.7 0.0 0.4 14.3 1.7 0.0 0.0 0.0 5.7 0.2 20.2 0.9 0.0 0.0 0.6 0.9 0.0 0.3 0.2 1.8 1.0 0.0 53.0 0.0 1.5 0.2 1.5 2.6 0.0 0.0 0.3 0.1 12.5 0.2 453.2 0.0 0.0 0.2 0.0 0.1 4.7 38.6 0.0 0.1 0.1 0.1 0.3 ZFYVE26 "KIAA0321, SPG15" ENSG00000072121 "Zinc finger FYVE-type containing 26" Q68DK2 14 67727374-67816590 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 50.1;Rod photoreceptor cells: 126.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 11 "plasmacytoid DC: 4.8" "Lineage enriched" "Detected in single" 11 "dendritic cells: 4.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055500 Approved NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 46: Photoreceptor cells - Phototransduction" "HPA055500: AB_2682837" "unprognostic (3.14e-2)" "unprognostic (1.12e-1)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (1.96e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (2.84e-6)" "unprognostic (6.87e-2)" "unprognostic (8.18e-2)" "unprognostic (2.97e-2)" "unprognostic (8.29e-3)" "unprognostic (3.71e-2)" "prognostic favorable (1.54e-6)" "unprognostic (1.61e-1)" "unprognostic (1.58e-1)" "unprognostic (6.69e-2)" "unprognostic (5.34e-2)" 5.3 6.4 4.8 5.4 6.3 5.9 5.3 5.8 5.5 5.6 6.8 5.7 4.1 5.7 4.0 5.5 4.5 4.4 5.1 4.5 5.1 4.9 4.4 6.6 7.0 6.4 6.1 6.6 4.9 7.3 5.5 5.9 5.9 4.8 4.7 6.3 4.8 4.6 8.7 7.1 5.8 6.0 5.0 7.3 5.2 2.7 7.8 6.9 5.2 9.6 6.6 5.2 4.8 6.5 12.1 6.9 7.3 7.8 15.2 6.8 10.7 5.8 9.1 13.0 14.9 7.2 7.3 6.7 3.0 7.4 10.8 7.2 10.1 6.9 10.6 6.9 5.6 5.1 8.4 6.7 8.4 3.1 8.3 8.3 9.1 10.1 8.1 6.4 14.6 7.4 7.6 5.3 8.9 9.2 5.1 4.6 3.8 4.8 7.8 4.5 12.1 3.5 5.6 12.2 7.3 4.7 9.0 6.8 8.0 7.1 9.8 4.0 12.9 11.3 9.2 6.9 4.7 4.5 3.3 8.2 9.3 5.6 5.5 0.0 0.2 0.4 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.1 0.0 0.3 0.0 4.8 0.4 0.2 4.8 6.3 5.8 5.5 4.5 5.1 6.4 6.1 5.9 5.0 7.8 6.5 4.4 0.0 9.0 19.9 4.6 2.8 1.8 3.1 6.8 11.6 4.6 3.6 5.8 7.2 4.1 3.7 50.1 2.8 9.6 6.1 0.0 3.9 2.0 4.2 3.7 5.0 3.5 3.8 20.5 2.8 2.4 4.0 5.1 5.2 0.0 6.5 7.1 4.9 9.7 16.8 19.0 3.4 2.0 6.3 6.1 3.1 2.8 8.0 3.6 8.4 7.5 6.9 7.2 16.6 22.1 4.0 6.2 2.2 7.3 2.5 5.0 2.7 4.1 126.3 6.6 7.5 4.0 1.2 1.6 6.9 7.2 4.0 3.8 3.6 3.4 1.9 RAD51B "hREC2, R51H2, RAD51L1, REC2" ENSG00000182185 "RAD51 paralog B" O15315 14 67819779-68730218 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 10 "Astrocytes: 150.8;Microglial cells: 263.3;Oligodendrocyte precursor cells: 157.3;Oligodendrocytes: 375.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB016191, HPA051869" Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nuclear bodies" Nucleoplasm "CAB016191: AB_2238209, HPA051869: AB_2681644" "unprognostic (9.10e-3)" "unprognostic (5.45e-2)" "unprognostic (4.92e-1)" "unprognostic (6.65e-2)" "unprognostic (2.38e-2)" "unprognostic (4.85e-2)" "unprognostic (6.42e-3)" "unprognostic (2.54e-2)" "unprognostic (1.06e-1)" "unprognostic (3.08e-1)" "unprognostic (6.80e-3)" "unprognostic (1.47e-1)" "unprognostic (6.25e-2)" "unprognostic (1.77e-1)" "unprognostic (2.49e-2)" "unprognostic (6.79e-2)" "unprognostic (8.13e-3)" 3.1 2.3 3.0 2.9 5.7 7.3 5.5 3.8 3.3 5.8 5.8 3.0 1.1 4.4 9.0 3.7 3.9 4.3 1.7 3.4 3.7 2.7 2.1 2.7 4.8 5.7 4.7 6.3 2.1 4.9 2.0 4.1 5.7 2.5 2.6 3.0 13.1 2.3 1.2 4.2 2.4 4.4 4.3 2.6 2.6 1.8 5.0 5.9 2.5 1.2 4.3 3.6 4.5 7.3 15.3 5.9 6.5 3.9 5.9 10.0 4.0 7.6 5.8 8.2 10.5 4.2 20.1 18.6 4.8 4.7 9.4 13.4 4.1 12.1 11.1 8.4 4.2 8.9 5.4 3.3 3.2 7.6 8.6 5.1 9.0 9.4 9.9 3.8 7.4 13.5 7.3 8.4 6.7 11.9 14.9 2.7 3.8 14.6 5.9 16.6 7.7 6.8 6.3 4.3 4.4 2.9 6.0 2.2 13.1 7.6 10.1 6.8 2.0 9.9 9.6 7.8 6.3 4.0 4.4 14.9 5.5 13.1 5.7 17.4 5.7 5.7 8.1 4.8 6.6 14.2 7.6 8.6 6.5 11.8 9.4 8.9 0.7 8.5 4.7 6.4 9.4 4.5 3.0 5.7 3.8 3.3 3.4 3.7 5.7 4.7 5.7 4.3 5.0 7.3 5.1 0.0 1.1 150.8 13.3 6.6 5.1 6.4 5.7 1.8 8.4 5.1 1.6 0.0 4.0 1.8 8.4 5.4 3.5 1.1 3.9 1.9 3.0 5.3 3.7 4.5 4.8 4.6 21.5 1.4 6.7 4.2 3.1 3.6 4.5 6.8 1.8 0.8 6.5 1.7 22.0 3.8 2.0 3.4 3.5 1.9 3.7 4.2 8.8 263.3 6.8 5.8 3.1 157.3 375.2 1.0 0.6 4.5 8.9 2.4 2.7 1.8 8.4 6.0 0.0 3.6 7.0 6.2 3.2 5.6 7.0 4.0 7.0 4.4 1.8 4.6 ZFP36L1 "Berg36, BRF1, cMG1, ERF1, RNF162B, TIS11B" ENSG00000185650 "ZFP36 ring finger protein like 1" Q07352 14 68787660-68796253 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA transport, Transport" "Developmental protein, DNA-binding, Ribonucleoprotein, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 1973.2;Squamous epithelial cells: 2019.8;Suprabasal keratinocytes: 3223.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 6 "neutrophil: 2901.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 2901.2" "Cell line enhanced" "Detected in all" "hTERT-HME1: 462.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001301 Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 61: Squamous epithelial cells - Keratinization" "HPA001301: AB_1080644" "unprognostic (1.18e-2)" "unprognostic (2.64e-1)" "unprognostic (1.28e-1)" "unprognostic (1.58e-1)" "unprognostic (7.00e-2)" "unprognostic (1.27e-1)" "unprognostic (1.64e-2)" "unprognostic (1.11e-1)" "unprognostic (2.17e-2)" "unprognostic (3.81e-3)" "unprognostic (1.13e-3)" "unprognostic (1.30e-1)" "unprognostic (1.11e-2)" "unprognostic (6.45e-3)" "unprognostic (5.77e-2)" "unprognostic (2.97e-1)" "unprognostic (5.68e-2)" 342.7 107.9 108.1 218.2 108.3 84.0 305.6 118.0 96.1 466.4 91.7 335.1 127.5 423.1 107.7 293.0 303.3 174.9 178.8 98.7 184.1 157.8 260.1 242.7 199.5 207.8 187.5 453.5 225.4 161.7 67.3 315.8 145.0 222.3 104.2 57.5 319.3 201.7 93.1 511.3 151.5 316.0 162.7 178.5 196.9 49.3 142.6 130.1 190.6 89.6 150.4 335.8 467.0 166.8 235.6 211.8 94.7 139.0 234.4 187.2 203.9 96.4 169.6 59.1 72.9 93.9 159.5 58.4 59.5 177.4 85.5 108.4 8.8 313.8 70.0 27.9 13.2 21.5 115.0 68.2 133.8 3.3 24.3 157.6 396.4 69.1 462.1 195.2 119.2 17.1 61.5 113.7 314.4 54.1 9.3 11.1 78.7 105.1 31.7 150.5 127.1 17.8 213.4 155.3 1.0 2.5 113.7 163.4 87.8 131.9 148.3 3.0 254.4 167.3 122.8 139.0 101.0 62.9 32.9 39.9 213.5 1.4 66.9 230.8 240.9 3.9 211.1 244.7 197.2 266.0 168.8 150.3 123.8 461.4 179.3 162.2 2901.2 154.3 176.1 16.2 174.5 257.5 108.1 108.3 118.0 96.1 98.7 184.1 207.8 187.5 145.0 162.7 142.6 166.8 830.2 477.5 415.6 172.7 513.8 1333.5 761.2 830.2 1973.2 4.6 750.7 504.4 84.2 420.4 523.9 364.1 0.0 442.1 276.5 164.4 84.1 575.8 97.0 434.6 479.6 571.0 20.4 87.7 1.5 573.1 476.6 894.3 218.6 656.2 200.8 21.1 292.7 595.6 548.3 0.0 0.7 225.3 215.7 613.9 1272.8 72.2 502.0 670.0 528.3 142.4 499.0 211.9 131.8 63.8 0.9 544.8 138.3 397.2 191.7 657.7 138.4 143.7 314.5 9.2 269.5 562.0 714.4 12.2 13.3 2019.8 3223.6 898.7 405.2 157.1 191.1 817.8 ACTN1 ENSG00000072110 "Actinin alpha 1" P12814 14 68874128-68979440 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 524.5" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 351.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 364.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004303, HPA006035" Approved Approved "Plasma membrane,Actin filaments,Focal adhesion sites" NA NA 210000000 "Cluster 5: Granulocytes - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 1: Pancreatic cells - Digestion" "Plasma membrane, Actin filaments, Focal adhesion sites" "CAB004303: AB_626633, HPA006035: AB_1078095" "unprognostic (4.40e-2)" "unprognostic (1.03e-3)" "unprognostic (2.49e-2)" "unprognostic (1.96e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (6.19e-3)" "prognostic unfavorable (7.63e-5)" "unprognostic (3.62e-1)" "unprognostic (3.23e-2)" "unprognostic (3.16e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (9.08e-10)" "unprognostic (2.87e-2)" "unprognostic (2.00e-1)" "unprognostic (6.05e-3)" "prognostic unfavorable (8.00e-4)" 117.4 40.7 27.3 149.5 55.8 149.3 103.5 0.1 32.0 118.4 20.1 449.8 49.8 313.1 60.3 154.4 152.1 143.9 121.4 29.7 14.7 46.7 61.8 100.0 47.5 24.5 11.0 61.8 46.8 9.1 27.3 96.1 7.3 174.3 109.0 28.2 116.4 295.1 21.7 59.3 106.9 524.5 4.2 55.9 171.7 21.2 32.9 32.6 35.0 13.3 50.7 305.9 83.3 28.8 871.9 262.3 158.6 121.4 275.2 180.5 592.4 749.3 712.0 770.0 571.1 211.8 196.6 0.7 256.5 744.7 310.4 370.9 126.8 790.3 965.2 4.6 38.5 118.2 133.5 179.0 494.0 85.4 14.3 231.7 152.1 479.8 540.3 551.6 428.6 48.2 56.9 1.4 612.0 246.9 10.1 181.1 124.7 217.9 198.1 59.3 294.1 32.6 292.0 225.6 57.0 68.7 649.9 96.8 177.1 474.8 146.0 170.9 546.0 1085.2 432.8 126.9 662.5 113.8 47.8 3.9 314.4 115.7 584.4 64.6 67.5 137.1 5.7 28.8 7.1 0.1 22.7 12.4 45.5 0.2 103.9 92.2 364.2 4.5 8.9 2.0 9.6 89.2 27.3 55.8 0.1 32.0 29.7 14.7 24.5 11.0 7.3 4.2 32.9 28.8 44.7 38.5 25.1 19.6 4.0 119.3 154.9 137.4 82.0 74.7 88.6 157.6 60.3 51.5 36.0 42.3 246.0 155.3 3.0 17.2 3.9 186.8 34.0 65.8 112.8 135.5 38.5 21.9 102.7 144.9 351.8 88.9 34.1 90.2 7.6 15.9 129.5 96.6 79.5 18.5 29.7 57.3 59.0 100.9 82.1 10.7 35.8 96.4 30.2 34.7 105.1 6.0 4.1 9.0 4.3 203.7 28.0 245.6 0.6 132.6 2.4 15.3 47.8 80.8 177.5 30.0 270.6 19.4 18.4 51.8 59.8 66.9 22.7 20.9 47.0 67.1 DCAF5 "BCRG2, BCRP2, D14S1461E, KIAA1824, WDR22" ENSG00000139990 "DDB1 and CUL4 associated factor 5" Q96JK2 14 69050881-69153150 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 149.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041575, HPA048098" Uncertain Approved Mitochondria NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 34: Spermatids - Unknown function" Mitochondria "HPA041575: AB_2677558, HPA048098: AB_2680263" "unprognostic (8.12e-2)" "unprognostic (3.28e-2)" "unprognostic (4.26e-3)" "unprognostic (3.30e-1)" "unprognostic (1.58e-1)" "unprognostic (3.44e-1)" "unprognostic (2.27e-2)" "unprognostic (3.13e-2)" "unprognostic (1.25e-1)" "unprognostic (2.43e-1)" "unprognostic (5.80e-2)" "unprognostic (1.02e-1)" "unprognostic (1.63e-2)" "unprognostic (2.80e-2)" "unprognostic (1.02e-1)" "unprognostic (1.30e-1)" "unprognostic (2.06e-1)" 30.0 22.5 16.1 23.4 15.9 30.2 27.2 16.4 16.5 29.3 17.0 34.0 21.6 28.3 22.3 30.9 28.8 24.4 31.3 16.5 16.6 24.6 31.4 31.0 27.6 15.8 15.0 28.5 22.0 36.4 28.8 25.4 16.0 29.8 21.2 20.8 27.2 25.1 74.3 30.5 25.9 32.7 14.1 27.7 26.2 60.5 17.2 39.4 30.1 51.7 25.6 29.2 28.3 14.5 48.3 15.0 34.7 32.5 37.7 32.9 22.7 22.2 32.1 24.9 31.2 19.4 29.9 26.4 19.9 34.7 18.8 23.0 24.7 33.2 23.2 36.0 13.7 28.4 15.8 14.0 28.6 10.9 33.2 37.3 34.0 22.3 31.1 43.0 37.7 31.1 22.4 21.6 25.1 28.6 34.7 19.0 15.6 22.6 23.7 22.8 32.9 10.6 33.1 37.0 24.7 27.8 29.7 30.7 19.4 29.7 37.5 22.0 34.4 42.2 39.4 19.6 13.2 28.4 9.9 23.9 28.1 13.0 13.0 21.1 4.3 16.4 31.0 4.0 26.3 8.2 16.7 23.0 5.7 8.6 15.7 19.7 5.4 32.3 3.0 6.0 8.2 13.1 16.1 15.9 16.4 16.5 16.5 16.6 15.8 15.0 16.0 14.1 17.2 14.5 28.8 44.8 57.8 71.8 24.9 26.3 19.1 21.4 38.1 18.5 23.3 19.0 58.8 32.9 39.4 14.7 27.1 19.4 43.6 20.9 1.9 25.1 149.9 28.7 30.6 32.1 23.4 25.6 88.8 24.9 19.3 27.2 32.1 31.9 37.2 28.0 26.0 33.2 19.6 18.5 85.6 22.0 22.4 19.7 23.7 89.3 31.1 24.3 10.6 74.9 21.8 22.3 52.5 76.9 61.6 29.2 16.0 34.3 35.8 19.9 20.9 14.0 41.2 24.9 46.0 29.1 26.6 75.2 19.8 37.9 19.9 15.3 38.0 31.2 21.3 23.5 EXD2 "C14orf114, EXDL2, FLJ10738" ENSG00000081177 "Exonuclease 3'-5' domain containing 2" Q9NVH0 14 69191511-69244020 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002906, HPA005848" Uncertain Approved "Intermediate filaments,Mitochondria" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 6: T47d - Mammary gland" "Cluster 66: Spermatocytes - Spermatogenesis" Mitochondria "Intermediate filaments" "HPA002906: AB_1078767, HPA005848: AB_1078768" "unprognostic (3.36e-2)" "unprognostic (1.61e-2)" "unprognostic (1.25e-1)" "unprognostic (1.71e-1)" "unprognostic (2.63e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (8.47e-4)" "unprognostic (9.91e-2)" "unprognostic (8.03e-2)" "unprognostic (2.46e-1)" "unprognostic (4.64e-2)" "unprognostic (8.97e-2)" "prognostic favorable (2.08e-9)" "unprognostic (1.16e-1)" "unprognostic (3.06e-2)" "unprognostic (8.75e-2)" "unprognostic (2.14e-2)" 8.0 6.9 16.0 5.0 17.2 2.5 9.7 16.7 18.8 13.6 15.0 9.5 6.8 9.6 12.1 10.4 13.1 8.1 8.7 15.8 15.7 10.4 5.9 8.6 4.2 17.3 16.4 11.0 18.1 16.0 10.0 7.5 17.4 10.2 9.2 13.0 15.4 10.5 11.0 6.6 6.5 10.1 17.1 5.8 9.7 19.9 16.2 7.2 11.5 9.7 4.5 8.4 7.4 18.9 29.6 13.6 10.3 15.3 6.2 7.4 13.0 14.4 12.1 13.1 17.3 11.6 20.3 0.0 10.4 15.1 8.0 16.4 11.5 14.5 14.7 7.4 13.7 8.6 5.2 6.8 24.2 6.4 7.9 15.1 23.5 13.4 8.7 8.1 18.9 7.4 5.5 11.0 12.7 14.8 3.6 9.6 11.2 15.8 13.5 0.0 9.9 10.4 19.5 10.8 20.0 17.8 10.8 22.2 10.6 11.0 29.8 5.5 15.0 12.2 8.5 9.9 7.5 8.3 12.0 0.1 0.1 6.9 9.3 12.2 2.5 2.2 2.2 1.4 4.2 2.9 2.3 2.3 5.4 1.5 2.8 4.1 0.3 2.9 1.4 4.2 1.8 2.3 16.0 17.2 16.7 18.8 15.8 15.7 17.3 16.4 17.4 17.1 16.2 18.9 7.2 12.8 10.9 15.7 4.3 3.2 4.9 6.2 14.2 9.9 9.9 7.2 12.1 7.2 9.0 0.0 8.4 8.5 2.5 4.7 5.9 10.7 3.2 7.7 8.4 6.0 6.1 7.8 27.4 8.8 4.4 6.5 8.2 11.1 1.3 9.6 10.8 5.4 6.8 10.1 22.6 8.4 8.2 6.3 2.2 2.3 6.2 3.3 3.6 11.2 6.8 7.5 2.1 21.6 19.1 8.8 6.2 12.0 5.6 5.6 3.6 4.8 11.0 9.3 0.0 7.2 7.4 36.1 8.1 12.6 4.3 2.9 2.6 6.1 7.9 4.3 GALNT16 "GalNAc-T16, GALNTL1, KIAA1130" ENSG00000100626 "Polypeptide N-acetylgalactosaminyltransferase 16" Q8N428 14 69259277-69357033 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.8;heart muscle: 45.0" "Cell type enhanced" "Detected in many" "Astrocytes: 16.6;Cardiomyocytes: 46.7;Excitatory neurons: 27.6;Fibroblasts: 24.0;Inhibitory neurons: 23.8;Smooth muscle cells: 14.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.5;ASC diff: 11.7;hTEC/SVTERT24-B: 17.0;hTERT-RPE1: 17.2;SCLC-21H: 8.7;U-2 OS: 19.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059136, HPA075325" Approved Approved Vesicles,Cytosol NA NA 370000 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Cytosol" "HPA059136: AB_2683919, HPA075325: " "unprognostic (9.71e-3)" "unprognostic (7.47e-2)" "unprognostic (4.02e-1)" "unprognostic (2.30e-2)" "unprognostic (6.71e-2)" "unprognostic (5.72e-3)" "unprognostic (3.18e-3)" "unprognostic (1.22e-1)" "unprognostic (1.02e-1)" "unprognostic (1.28e-2)" "unprognostic (3.62e-4)" "unprognostic (1.31e-2)" "prognostic favorable (5.23e-6)" "unprognostic (5.38e-3)" "unprognostic (3.34e-2)" "unprognostic (3.93e-2)" "unprognostic (7.96e-5)" 14.4 11.6 25.7 2.0 24.4 0.1 12.0 14.7 28.4 7.6 6.5 6.5 2.2 7.3 2.8 3.6 5.6 3.4 45.0 27.0 35.5 7.7 2.0 3.4 3.2 19.6 22.5 2.1 4.3 2.5 4.7 0.4 19.9 4.0 2.2 1.3 23.5 4.6 4.4 7.5 3.7 8.6 16.4 12.1 3.2 3.5 40.8 2.2 4.9 5.8 1.3 3.1 5.0 21.3 0.0 0.8 8.5 0.3 11.7 5.3 0.0 1.3 0.1 1.5 2.3 0.4 0.0 0.0 0.2 1.4 0.8 0.0 3.0 0.0 0.3 0.1 6.0 0.0 0.2 0.5 0.1 0.0 0.5 0.5 0.0 17.0 0.0 17.2 0.9 0.0 0.0 0.0 2.8 0.5 0.0 0.0 1.7 0.0 0.1 0.0 4.8 0.0 0.5 0.0 8.7 3.0 1.8 0.4 0.0 0.3 0.3 0.0 0.1 1.7 19.9 2.2 2.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.7 24.4 14.7 28.4 27.0 35.5 19.6 22.5 19.9 16.4 40.8 21.3 4.0 0.0 0.0 16.6 0.0 4.1 0.4 0.0 0.0 2.8 3.1 3.0 46.7 0.0 0.0 0.0 2.1 0.1 0.2 0.0 3.9 0.1 9.7 0.2 0.4 1.7 0.0 0.0 27.6 0.0 0.0 24.0 0.5 0.2 0.0 0.3 0.0 0.0 0.2 0.0 23.8 0.1 0.0 0.0 6.1 11.2 0.9 0.3 3.6 5.6 0.0 0.1 0.0 8.0 1.6 0.0 0.0 3.8 0.0 0.5 0.1 0.1 0.0 0.8 6.6 10.1 14.8 0.6 2.1 0.3 3.3 0.0 0.3 11.2 0.6 0.4 ERH DROER ENSG00000100632 "ERH mRNA splicing and mitosis factor" P84090 14 69380128-69398299 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002567 Approved Approved Nucleoplasm,Cytosol NA Yes 190000 "Cluster 44: Non-specific - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Cytosol "HPA002567: AB_1078749" "unprognostic (2.42e-2)" "unprognostic (1.69e-1)" "unprognostic (3.42e-1)" "unprognostic (4.78e-2)" "unprognostic (9.34e-2)" "unprognostic (8.61e-3)" "prognostic unfavorable (7.89e-5)" "unprognostic (1.93e-1)" "unprognostic (1.06e-1)" "unprognostic (8.83e-3)" "unprognostic (2.31e-1)" "unprognostic (9.24e-2)" "unprognostic (2.49e-1)" "unprognostic (1.12e-1)" "unprognostic (9.32e-2)" "unprognostic (4.31e-2)" "unprognostic (2.39e-1)" 107.7 113.7 143.3 119.0 146.2 144.4 119.3 145.1 186.7 97.0 146.9 110.5 110.0 111.9 150.3 75.5 112.8 70.1 100.2 145.4 159.1 118.3 142.5 76.3 147.1 142.8 146.8 107.0 66.7 128.2 58.3 98.1 147.6 87.0 122.9 116.7 110.0 84.3 107.0 58.1 99.1 114.8 153.7 96.5 88.7 91.1 149.6 212.2 97.6 85.8 168.4 117.0 51.2 154.5 972.7 574.9 704.6 409.1 271.8 201.1 356.9 450.7 261.3 401.3 372.0 598.5 403.1 879.9 224.3 305.3 340.3 296.1 563.4 376.9 484.2 437.9 428.3 441.4 366.1 731.8 419.6 389.3 334.6 227.1 203.0 355.9 317.2 239.2 337.8 584.5 454.0 301.6 335.7 1043.2 714.1 750.8 537.2 525.6 686.0 558.9 599.9 320.6 415.4 672.8 449.1 439.8 442.1 464.6 355.6 330.8 539.9 564.4 351.4 425.7 699.7 286.7 480.0 351.7 336.2 1096.1 345.1 417.5 442.4 76.6 101.4 80.9 76.6 98.9 77.5 122.2 100.0 88.0 107.4 94.3 92.7 88.2 45.3 121.5 95.1 122.8 116.5 147.0 143.3 146.2 145.1 186.7 145.4 159.1 142.8 146.8 147.6 153.7 149.6 154.5 231.2 60.9 54.3 22.2 189.1 273.1 225.0 702.7 180.4 126.4 244.2 314.2 118.9 181.6 282.2 253.8 37.5 455.3 179.4 117.5 673.1 363.8 100.4 238.1 198.9 211.9 188.5 252.6 23.9 275.3 560.3 237.0 120.3 158.7 127.6 186.7 169.6 239.9 341.5 74.0 23.1 244.0 510.6 147.5 215.2 51.3 270.9 162.5 307.7 16.9 302.3 350.3 174.0 19.6 34.6 289.8 183.9 259.2 237.9 288.9 203.9 508.5 278.4 119.8 190.7 177.7 273.8 321.5 230.9 251.0 318.8 279.9 165.3 281.4 265.9 230.6 SLC39A9 FLJ11274 ENSG00000029364 "Solute carrier family 39 member 9" Q9NUM3 14 69398015-69462390 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007921, HPA075390" Approved Approved "Endoplasmic reticulum" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 6: T47d - Mammary gland" "Cluster 27: Mucus-secreting cells - Mucin production" "Endoplasmic reticulum" "HPA007921: AB_1080007, HPA075390: AB_2686748" "unprognostic (2.37e-1)" "unprognostic (9.29e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-1)" "unprognostic (4.35e-2)" "unprognostic (1.10e-1)" "unprognostic (5.50e-2)" "unprognostic (1.71e-1)" "unprognostic (2.49e-1)" "unprognostic (2.75e-1)" "unprognostic (1.57e-1)" "unprognostic (1.92e-1)" "prognostic favorable (1.05e-6)" "unprognostic (1.20e-1)" "unprognostic (1.83e-1)" "unprognostic (1.09e-2)" "unprognostic (2.16e-2)" 15.2 21.6 17.3 12.1 17.5 10.7 24.4 17.7 24.6 18.2 20.9 20.3 21.5 14.8 25.6 23.1 15.6 14.3 12.2 17.4 18.9 29.8 43.0 15.6 12.7 17.0 17.3 13.7 28.5 26.4 22.8 17.7 17.0 19.0 21.5 12.7 33.8 15.1 7.9 18.3 19.4 15.5 18.7 16.0 21.8 8.9 18.3 18.0 22.2 11.6 17.8 15.3 15.3 20.1 55.0 46.3 26.9 28.7 46.2 34.6 25.1 31.9 40.2 30.7 34.8 35.4 49.7 49.3 23.8 39.8 14.2 45.3 30.9 30.5 37.4 31.9 17.0 28.9 23.0 24.8 36.0 20.9 38.1 30.3 50.3 27.1 40.5 30.6 30.8 38.1 22.2 44.2 32.5 33.6 33.0 26.1 20.9 47.7 31.2 32.8 37.6 30.3 40.9 56.1 28.3 46.1 32.2 55.1 22.2 20.2 76.9 37.8 30.4 50.8 36.2 22.1 24.6 48.8 27.4 36.6 47.1 25.4 42.0 11.2 10.3 9.4 7.9 9.7 8.1 6.9 6.8 7.7 11.3 4.8 6.7 7.0 8.7 6.8 9.4 5.9 5.5 6.8 17.3 17.5 17.7 24.6 17.4 18.9 17.0 17.3 17.0 18.7 18.3 20.1 13.3 19.2 12.6 37.9 13.4 12.1 8.0 19.2 17.1 8.4 27.7 14.1 7.9 18.6 18.0 16.5 6.2 14.1 7.3 42.8 5.9 15.0 16.2 16.0 16.1 17.0 29.4 15.4 31.0 25.1 17.3 14.3 22.4 17.8 12.0 13.8 22.1 67.7 15.9 10.1 30.9 30.3 14.2 24.5 8.7 22.4 13.1 13.8 7.2 24.4 16.4 9.5 12.3 30.2 37.0 28.6 22.4 12.8 18.6 18.7 34.6 15.8 24.6 11.2 6.6 12.6 12.0 13.9 9.2 18.3 12.5 17.8 9.2 14.2 25.7 20.2 PLEKHD1 UPF0639 ENSG00000175985 "Pleckstrin homology and coiled-coil domain containing D1" A6NEE1 14 69484692-69531551 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.1;parathyroid gland: 6.0;retina: 8.8" "Group enriched" "Detected in some" 13 "Bipolar cells: 60.9;Horizontal cells: 230.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 13 "plasmacytoid DC: 3.7" "Lineage enriched" "Detected in single" 13 "dendritic cells: 3.7" "Cell line enhanced" "Detected in some" "OE19: 1.1;SK-BR-3: 2.4;T-47d: 2.3;U-266/70: 1.0" "Region enhanced" "Detected in many" "cerebellum: 30.0" "Low region specificity" "Detected in many" HPA051875 Uncertain NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 62: Horizontal cells - Visual perception" "HPA051875: AB_2681648" "unprognostic (8.73e-2)" "unprognostic (4.64e-3)" "unprognostic (3.73e-2)" "unprognostic (4.03e-2)" "unprognostic (7.58e-2)" "unprognostic (3.15e-3)" "unprognostic (1.44e-1)" "unprognostic (1.64e-3)" "unprognostic (3.28e-1)" "unprognostic (1.83e-1)" "unprognostic (4.56e-3)" "unprognostic (1.22e-1)" "unprognostic (5.49e-2)" "unprognostic (8.08e-2)" "unprognostic (2.28e-1)" "unprognostic (2.74e-2)" "unprognostic (1.42e-2)" 0.1 0.2 1.2 0.1 0.5 0.5 0.6 8.1 2.4 0.3 0.0 0.0 0.2 0.1 1.6 0.1 0.1 0.1 0.1 0.3 1.4 1.4 0.0 0.2 0.9 1.4 3.2 0.1 0.2 6.0 0.3 0.1 1.6 0.1 0.0 8.8 1.6 0.3 0.1 1.5 0.1 0.0 0.4 0.2 0.2 1.2 4.5 0.1 2.2 0.0 0.2 0.0 0.0 1.1 0.1 0.1 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.4 0.1 0.1 0.2 1.1 0.0 0.1 0.0 0.1 0.2 0.2 0.3 0.7 0.0 2.4 0.0 0.0 2.3 0.0 0.0 0.1 0.3 0.1 0.1 1.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.0 1.2 0.5 8.1 2.4 0.3 1.4 1.4 3.2 1.6 0.4 4.5 1.1 0.5 0.0 7.3 0.3 0.0 0.4 1.8 0.1 0.0 60.9 0.6 0.4 1.3 0.0 2.0 0.0 4.2 0.1 11.2 0.1 3.9 0.1 0.5 0.4 0.2 1.0 0.0 0.0 6.3 0.2 0.1 0.6 0.0 0.6 1.3 0.1 0.4 0.0 0.1 230.5 3.3 0.0 0.0 0.0 0.6 0.1 0.0 1.0 0.0 0.0 0.6 1.7 1.0 0.0 0.1 0.3 0.0 0.0 0.0 1.4 0.2 0.5 0.9 5.9 0.0 1.4 0.6 0.8 0.3 0.0 0.3 0.1 2.3 0.2 0.1 0.7 CCDC177 "C14orf162, PLPL" ENSG00000267909 "Coiled-coil domain containing 177" Q9NQR7 14 69569799-69574871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 5.0;retina: 4.5" "Group enriched" "Detected in some" 5 "Bipolar cells: 14.7;Cone photoreceptor cells: 10.4;Horizontal cells: 5.0;Rod photoreceptor cells: 9.0" "Cancer enhanced" "Detected in single" "cervical cancer: 0.5" "Group enriched" "Detected in some" 5 "cerebellum: 5.0;cerebral cortex: 2.3;hippocampal formation: 1.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "Cluster 6: Brain - Smell perception" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 56: Bipolar cells - Visual perception" "unprognostic (2.21e-1)" "unprognostic (2.33e-2)" "unprognostic (6.94e-3)" "unprognostic (1.34e-2)" "unprognostic (2.64e-3)" "unprognostic (1.77e-3)" "unprognostic (6.34e-4)" "unprognostic (2.58e-2)" "unprognostic (1.19e-1)" "unprognostic (1.99e-2)" "unprognostic (3.16e-1)" "unprognostic (7.84e-5)" "unprognostic (2.15e-4)" "unprognostic (3.81e-1)" "unprognostic (1.45e-1)" 0.0 0.1 0.6 0.0 0.6 0.0 0.1 5.0 2.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 5.0 2.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 1.4 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.1 0.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 SUSD6 KIAA0247 ENSG00000100647 "Sushi domain containing 6" Q92537 14 69611596-69715144 "Predicted membrane proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 107.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030464 Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 3: HMC-1 - Innate immune response" "Cluster 41: Macrophages - Immune response" Nucleoplasm "Intermediate filaments" "HPA030464: AB_10601128" "unprognostic (1.04e-1)" "unprognostic (2.29e-1)" "unprognostic (7.34e-2)" "unprognostic (1.58e-2)" "unprognostic (6.94e-2)" "unprognostic (3.46e-2)" "unprognostic (2.17e-1)" "unprognostic (2.73e-2)" "unprognostic (1.57e-1)" "unprognostic (3.66e-3)" "unprognostic (1.10e-2)" "unprognostic (6.70e-2)" "prognostic favorable (2.16e-4)" "unprognostic (1.10e-2)" "unprognostic (5.35e-2)" "unprognostic (1.30e-2)" "unprognostic (2.34e-1)" 25.3 19.3 12.0 32.9 12.4 67.2 22.2 26.7 11.6 16.2 13.1 20.9 25.4 13.0 43.1 31.8 21.0 27.5 15.6 13.5 12.8 22.2 12.2 37.1 30.4 24.5 14.5 13.5 22.1 16.6 14.4 17.0 15.3 17.8 19.0 15.6 29.7 16.7 12.3 27.3 32.8 19.7 18.2 33.6 20.9 10.7 14.2 21.7 22.4 11.5 36.2 21.7 18.1 15.5 19.4 4.9 7.0 6.4 14.0 10.2 12.8 10.7 22.6 6.0 5.8 5.9 16.7 22.6 11.8 13.5 4.8 26.4 4.0 22.1 5.6 38.9 3.0 18.4 4.1 9.8 22.6 3.0 45.6 16.6 21.5 10.1 18.7 6.5 12.4 6.9 5.7 19.6 8.4 9.5 4.5 8.1 1.4 11.3 5.0 7.7 6.2 9.1 11.5 9.8 3.0 4.7 8.8 25.4 4.0 5.1 10.4 8.3 19.4 13.8 8.1 8.8 4.4 13.5 3.2 15.7 8.9 10.3 7.4 16.3 11.6 12.3 5.5 10.2 5.5 5.3 4.8 3.4 7.6 5.0 4.6 3.4 33.0 4.1 13.7 4.3 4.6 8.8 12.0 12.4 26.7 11.6 13.5 12.8 24.5 14.5 15.3 18.2 14.2 15.5 45.6 12.8 30.0 22.2 24.6 0.0 36.0 0.0 23.3 16.7 44.2 21.5 14.0 21.5 11.2 18.4 20.9 4.3 32.9 44.3 7.9 26.7 1.0 34.7 13.3 32.8 7.3 13.9 34.6 24.6 1.7 13.1 18.8 28.4 8.8 9.7 17.9 15.9 23.5 15.2 21.1 21.9 0.0 67.4 0.0 5.1 5.3 44.3 0.0 107.7 31.6 4.3 16.5 22.1 28.4 38.7 20.4 6.8 15.1 43.0 74.1 15.2 10.9 23.7 26.3 18.3 19.0 8.4 15.4 19.7 0.0 9.2 21.2 7.6 8.5 54.6 SRSF5 "HRS, SFRS5, SRP40" ENSG00000100650 "Serine and arginine rich splicing factor 5" Q13243 14 69726900-69772005 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043484, HPA056523" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA 23000 "Cluster 34: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm "Nucleoli, Cytosol" "HPA043484: AB_10797143, HPA056523: AB_2683164" "unprognostic (2.08e-3)" "prognostic favorable (7.91e-4)" "unprognostic (1.89e-1)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" "unprognostic (1.79e-2)" "unprognostic (1.86e-1)" "unprognostic (2.06e-2)" "unprognostic (3.32e-2)" "unprognostic (1.61e-1)" "unprognostic (9.30e-3)" "unprognostic (1.07e-3)" "unprognostic (2.37e-2)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (2.42e-1)" "unprognostic (1.00e-2)" 210.9 188.4 68.1 149.5 72.5 456.9 229.8 60.3 108.2 174.2 125.9 231.8 129.2 222.5 218.0 217.9 240.9 130.1 154.4 75.9 69.7 119.6 183.8 214.8 210.1 75.5 71.1 220.0 136.6 188.1 215.5 105.1 74.1 172.7 164.8 233.8 235.8 126.7 217.6 282.0 256.6 180.3 66.0 211.8 212.8 104.1 69.5 214.7 224.8 68.3 155.0 189.3 177.4 97.1 456.4 133.5 313.8 141.4 192.7 179.6 177.4 214.6 239.7 177.6 183.7 164.7 283.6 473.1 110.4 301.8 174.7 210.2 242.5 309.2 209.7 407.4 142.3 354.3 386.7 183.6 224.3 334.7 255.7 350.9 201.2 199.7 216.3 260.4 247.0 401.8 255.4 268.3 114.3 382.1 385.1 232.4 182.0 356.6 128.2 324.0 148.5 183.3 237.2 563.1 165.9 236.3 364.3 214.1 296.0 188.5 235.9 292.3 299.7 98.4 264.2 110.9 205.6 261.6 184.5 754.8 232.3 286.1 140.1 137.1 65.8 103.6 93.1 117.9 94.9 109.5 83.1 85.0 70.1 108.7 81.1 79.6 161.9 86.2 129.6 99.8 74.8 77.2 68.1 72.5 60.3 108.2 75.9 69.7 75.5 71.1 74.1 66.0 69.5 97.1 380.7 253.2 309.1 218.1 392.8 138.0 768.6 610.1 204.9 387.4 248.6 259.1 195.0 240.2 386.6 183.9 239.8 444.3 542.9 471.8 320.8 201.7 190.3 224.2 169.8 293.6 302.9 195.4 199.5 171.8 261.5 288.0 188.6 225.3 480.2 251.3 249.9 225.4 217.7 378.6 177.7 376.6 380.5 236.2 154.3 105.0 345.5 314.7 133.4 104.9 323.4 277.4 428.5 128.2 268.7 226.6 538.5 267.1 212.3 376.7 484.7 228.2 373.4 317.3 276.1 583.7 354.2 201.8 149.8 196.4 145.6 749.2 456.6 201.6 275.5 542.1 SLC10A1 NTCP ENSG00000100652 "Solute carrier family 10 member 1" Q14973 14 69775416-69797241 "Metabolic proteins, Predicted membrane proteins, Transporters" "Host-virus interaction, Ion transport, Sodium transport, Symport, Transport" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 164 "liver: 426.9" "Cell type enriched" "Detected in some" 25 "Hepatocytes: 147.2" "Cancer enriched" "Detected in some" 79 "liver cancer: 65.2" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042727 Approved NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 2: Hepatocytes - Metabolism" "HPA042727: AB_10960691" "unprognostic (3.42e-1)" "unprognostic (9.39e-2)" "unprognostic (1.51e-2)" "unprognostic (2.11e-2)" "unprognostic (1.93e-2)" "unprognostic (6.51e-3)" "prognostic favorable (9.53e-6)" "unprognostic (6.07e-3)" "unprognostic (8.95e-2)" "unprognostic (2.17e-1)" "unprognostic (5.75e-3)" "unprognostic (1.22e-1)" "unprognostic (1.71e-2)" "unprognostic (1.05e-1)" "unprognostic (3.21e-1)" "unprognostic (2.45e-1)" "unprognostic (5.69e-2)" 0.0 0.0 0.4 0.1 0.5 0.3 0.0 2.5 1.2 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.8 0.4 0.1 426.9 0.0 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.4 0.5 2.5 1.2 0.8 0.4 0.4 0.4 0.3 0.0 0.5 0.5 0.4 0.0 0.0 1.3 0.6 0.1 0.1 0.4 0.0 0.6 0.2 0.1 0.5 5.7 0.2 0.0 0.0 0.2 1.4 0.0 0.0 0.0 1.1 0.1 0.6 0.7 0.0 2.7 4.2 0.0 0.1 0.6 0.5 0.6 0.0 0.1 1.4 147.2 0.1 0.0 2.7 0.0 2.0 3.8 0.0 5.4 0.0 0.3 0.0 2.8 0.0 0.2 0.0 3.0 2.4 0.0 0.1 0.0 0.5 0.1 0.2 0.0 0.1 0.2 0.0 3.4 0.7 0.1 0.0 0.2 0.0 0.3 1.7 0.2 0.0 0.1 SMOC1 ENSG00000198732 "SPARC related modular calcium binding 1" Q9H4F8 14 69854131-70032366 "Disease related genes, Human disease related genes, Predicted secreted proteins" Differentiation "Developmental protein" "Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.2;liver: 67.9" "Cell type enhanced" "Detected in many" "Hepatocytes: 104.4;Oligodendrocyte precursor cells: 372.4;Oligodendrocytes: 81.1;Peritubular cells: 133.2" "Cancer enhanced" "Detected in many" "glioma: 27.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 11 "plasmacytoid DC: 1.3" "Lineage enriched" "Detected in single" 14 "dendritic cells: 1.3" "Cell line enhanced" "Detected in some" "AF22: 50.3;HeLa: 122.6;HSkMC: 38.3;SiHa: 72.1;SK-BR-3: 30.6;U-266/70: 42.3;U-87 MG: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004153, CAB034427" Approved Approved "Plasma membrane" "Secreted to extracellular matrix" NA NA 140000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 15: Liver - Metabolism" "Cluster 20: HeLa - Mitochondria" "Cluster 68: Oligodendrocytes - Mixed function" "Plasma membrane" "CAB034427: AB_2193382, HPA004153: AB_1080035" "unprognostic (3.31e-1)" "unprognostic (2.17e-3)" "unprognostic (8.17e-2)" "unprognostic (1.96e-2)" "unprognostic (1.89e-2)" "unprognostic (4.04e-1)" "unprognostic (6.75e-3)" "unprognostic (2.09e-3)" "unprognostic (4.76e-2)" "unprognostic (2.80e-2)" "unprognostic (5.10e-2)" "unprognostic (5.63e-2)" "unprognostic (4.09e-2)" "unprognostic (3.92e-1)" "unprognostic (2.57e-1)" "unprognostic (1.34e-1)" "unprognostic (1.87e-1)" 15.9 10.3 29.2 0.5 30.3 0.1 6.2 53.2 29.1 9.4 17.5 1.3 1.9 2.2 7.7 0.3 6.6 0.5 8.3 27.9 31.6 3.0 67.9 0.6 0.9 38.4 38.8 1.4 10.3 0.3 4.4 8.0 36.8 33.4 1.0 2.4 5.8 38.8 12.7 2.4 1.4 1.0 41.2 27.2 3.8 35.7 29.6 0.4 4.2 2.7 0.5 1.3 6.3 52.8 0.0 3.3 50.3 0.0 9.8 6.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 2.9 0.0 0.0 20.4 0.0 122.6 17.4 0.1 0.0 0.0 38.3 11.9 1.4 1.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 2.0 0.2 72.1 30.6 0.0 0.3 0.0 0.0 0.4 0.3 2.9 0.0 0.0 42.3 0.0 0.0 51.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 29.2 30.3 53.2 29.1 27.9 31.6 38.4 38.8 36.8 41.2 29.6 52.8 0.3 0.0 0.0 12.1 2.5 0.3 0.0 0.7 0.0 2.1 1.3 3.8 2.0 7.2 0.1 0.0 16.7 24.2 4.0 0.0 0.0 0.3 4.7 11.9 0.6 2.9 15.6 0.0 1.0 2.3 0.8 6.0 3.6 1.5 0.0 1.4 3.3 104.4 2.8 0.0 13.5 0.1 14.2 2.5 0.4 19.0 7.8 0.3 0.0 1.0 0.1 0.3 0.0 372.4 81.1 3.7 0.1 133.2 12.4 0.0 0.0 0.0 1.1 0.3 0.0 0.7 2.3 2.1 3.9 0.0 0.4 40.2 0.4 0.4 0.0 0.1 SLC8A3 NCX3 ENSG00000100678 "Solute carrier family 8 member A3" P57103 14 70044215-70189070 "Metabolic proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sodium transport, Transport" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 10.8;retina: 9.6;skeletal muscle: 20.6;tongue: 9.4" "Group enriched" "Detected in some" 9 "Bipolar cells: 32.8;Excitatory neurons: 80.5;Inhibitory neurons: 129.4;Oligodendrocyte precursor cells: 107.1" "Cancer enriched" "Detected in single" 8 "glioma: 1.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.2;LHCN-M2: 7.9;SH-SY5Y: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (1.65e-1)" "unprognostic (5.53e-2)" "unprognostic (1.18e-2)" "unprognostic (1.51e-2)" "unprognostic (2.41e-1)" "unprognostic (1.95e-1)" "unprognostic (1.69e-1)" "unprognostic (3.46e-3)" "unprognostic (4.74e-2)" "unprognostic (1.64e-1)" "unprognostic (1.45e-3)" "unprognostic (8.53e-2)" "unprognostic (5.86e-2)" "unprognostic (1.14e-3)" "unprognostic (1.48e-1)" "unprognostic (1.48e-1)" "unprognostic (3.38e-1)" 0.3 1.2 7.1 0.3 6.0 0.3 0.2 1.7 6.6 0.4 0.0 0.3 0.3 0.2 0.2 0.3 0.1 0.4 0.6 5.3 7.7 0.1 0.1 0.6 0.2 6.1 7.6 0.0 0.2 0.7 0.9 0.1 7.1 0.3 0.2 9.6 0.3 0.1 20.6 0.3 0.4 0.3 5.4 0.1 0.3 0.1 10.8 0.2 0.0 9.4 0.2 1.2 0.2 4.7 0.0 0.0 4.2 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 24.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 6.0 1.7 6.6 5.3 7.7 6.1 7.6 7.1 5.4 10.8 4.7 0.0 0.0 0.6 2.9 0.0 0.1 0.0 0.0 0.0 32.8 0.0 0.0 1.4 0.0 0.0 0.0 4.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 80.5 0.0 0.4 0.2 0.0 0.0 8.8 0.0 0.0 0.0 0.1 8.4 129.4 0.5 0.0 0.0 0.3 0.1 0.0 0.0 0.0 4.7 0.0 0.8 0.0 107.1 8.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 COX16 "C14orf112, HSPC203" ENSG00000133983 "Cytochrome c oxidase assembly factor COX16" Q9P0S2 14 70325081-70416984 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 302.9;Ionocytes: 187.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062659 Uncertain Supported Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Translation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Mitochondria "HPA062659: AB_2684823" "unprognostic (5.44e-2)" "unprognostic (1.31e-1)" "unprognostic (2.68e-1)" "unprognostic (1.21e-2)" "unprognostic (3.63e-1)" "unprognostic (6.37e-3)" "unprognostic (1.80e-2)" "unprognostic (8.22e-2)" "unprognostic (1.88e-1)" "unprognostic (1.73e-2)" "unprognostic (6.80e-2)" "unprognostic (7.44e-2)" "prognostic favorable (1.03e-12)" "unprognostic (4.08e-1)" "unprognostic (1.73e-1)" "unprognostic (3.97e-1)" "unprognostic (1.72e-1)" 19.4 27.1 20.2 18.2 19.9 22.8 27.8 20.4 29.2 16.5 22.9 26.6 30.2 12.8 27.1 17.1 17.3 19.4 24.4 20.1 20.7 29.3 40.5 16.7 21.7 21.0 20.1 17.2 43.5 26.9 12.7 14.3 20.5 20.7 22.1 24.3 21.9 13.7 84.0 17.5 26.7 10.5 20.2 18.9 33.4 17.7 20.2 20.8 23.3 44.5 19.0 19.3 12.6 22.5 100.2 31.2 65.9 56.0 26.7 36.0 48.3 55.0 37.1 38.9 34.7 19.2 93.5 26.2 36.6 33.8 33.5 41.8 27.6 35.5 48.9 18.9 27.5 36.9 31.3 22.1 16.1 35.9 48.7 36.1 25.1 24.0 23.0 41.5 34.2 69.2 20.8 54.6 39.0 49.6 85.4 43.8 68.3 83.3 44.5 57.6 53.2 37.0 46.2 49.0 57.8 46.0 46.2 102.4 53.9 42.2 87.4 69.1 42.5 50.2 111.6 55.4 40.6 57.6 38.9 48.2 75.4 19.1 61.1 48.6 33.8 8.0 24.2 38.0 29.2 45.7 34.5 29.1 36.3 39.8 32.3 34.8 2.5 45.6 38.3 55.7 43.6 44.0 20.2 19.9 20.4 29.2 20.1 20.7 21.0 20.1 20.5 20.2 20.2 22.5 22.0 51.3 53.9 0.0 45.0 84.4 9.4 302.9 70.6 8.2 29.7 18.8 7.1 32.9 162.2 23.9 2.1 14.8 22.9 23.8 52.8 47.1 2.7 43.6 21.3 28.5 31.2 46.0 0.0 64.8 20.2 36.0 99.4 62.1 33.5 7.4 31.8 57.7 18.2 1.7 0.0 35.8 187.2 34.6 89.3 4.6 18.3 40.0 96.0 0.0 26.3 25.2 25.7 0.0 0.0 59.1 27.0 15.8 99.3 11.2 42.5 48.6 137.1 10.0 6.6 13.6 27.5 15.4 21.0 125.7 100.7 10.9 39.8 7.3 39.4 14.4 SYNJ2BP-COX16 ENSG00000258644 "SYNJ2BP-COX16 readthrough" 14 70326064-70417074 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 11.3" "Cell type enhanced" "Detected in some" "Erythroid cells: 4.8;Excitatory neurons: 3.1;Inhibitory neurons: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 10.1;U-2 OS: 10.6" "Low region specificity" "Detected in all" "HPA000866, HPA062659" Approved Supported Approved Mitochondria NA NA "Cluster 15: NK-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 59: Non-specific - Transcription" Mitochondria "HPA000866: AB_2276678, HPA062659: AB_2684823" "unprognostic (9.44e-2)" "unprognostic (2.42e-1)" "unprognostic (4.33e-2)" "unprognostic (1.68e-2)" "unprognostic (1.06e-1)" "unprognostic (1.34e-1)" "unprognostic (8.70e-2)" "unprognostic (2.02e-1)" "unprognostic (1.96e-2)" "unprognostic (3.00e-1)" "unprognostic (2.21e-2)" "unprognostic (6.41e-2)" "unprognostic (6.73e-4)" "unprognostic (6.68e-2)" "unprognostic (6.93e-2)" "unprognostic (2.55e-1)" "unprognostic (2.12e-2)" 2.7 2.8 0.4 1.4 0.6 0.4 2.2 0.7 2.5 2.6 0.5 2.9 1.1 2.6 0.8 1.8 1.8 0.8 4.3 0.5 0.7 3.6 2.3 2.1 1.7 0.6 0.5 2.8 0.7 1.3 1.7 1.0 0.6 1.9 0.7 0.7 1.2 0.5 3.1 1.3 1.3 1.5 0.5 1.9 2.1 11.3 0.5 2.4 1.7 2.4 1.1 2.5 1.8 0.5 5.9 1.6 3.4 1.2 0.0 0.2 2.3 6.2 0.5 2.7 2.4 0.6 7.4 0.0 4.6 0.0 4.9 4.7 0.0 1.1 2.0 0.7 2.0 0.0 1.0 2.5 2.6 0.0 1.2 0.0 1.4 2.3 0.0 4.2 1.9 4.7 0.0 0.5 1.6 0.4 3.6 1.1 1.6 10.1 1.8 4.7 0.7 2.9 1.4 2.3 2.9 4.7 1.1 2.2 3.5 4.2 2.2 2.9 0.0 2.9 10.6 0.0 3.2 0.3 2.6 0.0 5.3 0.0 4.0 1.6 8.9 0.1 11.1 11.2 11.5 14.4 12.1 11.0 12.0 13.6 11.4 10.8 0.0 15.1 5.7 9.2 12.8 7.9 0.4 0.6 0.7 2.5 0.5 0.7 0.6 0.5 0.6 0.5 0.5 0.5 0.6 0.0 0.5 1.0 1.1 0.0 0.1 0.0 1.2 0.3 0.4 0.1 0.0 0.0 0.6 0.0 0.0 0.3 1.4 0.0 1.9 0.4 1.6 2.0 0.7 1.8 0.0 4.8 3.1 0.8 0.4 1.1 1.1 2.6 0.0 0.3 0.7 0.7 0.2 0.0 2.7 0.0 0.0 0.8 0.0 0.9 0.6 1.0 0.0 0.0 0.1 0.3 2.1 0.5 0.6 0.3 0.1 0.4 2.4 0.0 0.2 0.6 0.0 0.3 0.0 0.2 0.9 1.0 0.2 1.5 0.0 0.3 0.6 0.2 0.4 0.0 SYNJ2BP Arip2 ENSG00000213463 "Synaptojanin 2 binding protein" P57105 14 70366499-70417090 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 140.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000866 Approved Supported Approved Mitochondria NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 8: Non-specific - Mitochondria" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 44: Endometrium - Transcription" Mitochondria "HPA000866: AB_2276678" "unprognostic (2.68e-1)" "unprognostic (1.76e-1)" "unprognostic (2.67e-1)" "unprognostic (3.31e-1)" "unprognostic (1.28e-1)" "unprognostic (1.04e-1)" "unprognostic (1.65e-1)" "unprognostic (1.60e-2)" "unprognostic (5.70e-2)" "unprognostic (6.14e-2)" "unprognostic (6.35e-3)" "unprognostic (1.44e-2)" "prognostic favorable (1.11e-16)" "unprognostic (2.81e-1)" "unprognostic (1.38e-1)" "unprognostic (5.35e-3)" "unprognostic (1.14e-2)" 10.2 10.1 10.3 7.3 10.1 1.3 9.9 9.3 10.0 8.1 13.3 13.7 19.6 9.0 7.9 8.2 7.2 8.4 14.9 8.4 9.3 21.7 20.3 9.5 6.6 10.0 9.8 7.2 7.4 24.9 6.6 9.3 9.8 12.9 15.1 16.4 9.5 11.9 28.7 5.7 16.0 10.7 10.8 9.1 15.5 3.9 10.6 5.1 11.2 29.3 6.4 8.6 6.1 9.7 14.0 9.1 15.3 10.3 11.7 13.4 10.6 10.8 11.1 7.4 8.3 8.7 12.8 0.0 10.0 12.7 7.5 11.6 15.7 11.6 17.5 1.9 8.0 5.2 13.9 11.4 10.3 0.0 1.7 10.5 9.2 9.4 5.3 13.1 16.6 5.8 3.1 2.7 13.4 10.2 7.2 2.1 11.1 13.9 10.9 9.0 22.4 3.9 16.0 20.7 11.1 19.4 14.6 12.0 8.8 9.9 22.7 3.6 18.5 17.7 12.1 6.9 8.7 3.7 15.0 0.0 15.6 1.8 14.9 0.3 3.0 0.1 2.3 3.1 2.7 2.5 2.8 2.7 3.0 2.0 3.8 3.1 0.3 2.3 2.1 1.9 2.3 1.1 10.3 10.1 9.3 10.0 8.4 9.3 10.0 9.8 9.8 10.8 10.6 9.7 36.6 38.5 46.6 0.0 17.8 6.0 28.7 49.4 9.1 44.9 25.9 15.4 89.4 48.6 43.3 75.4 81.3 38.3 13.1 50.1 140.8 49.0 36.9 56.0 26.5 38.4 19.8 5.7 0.0 39.2 31.5 21.7 21.9 85.7 9.5 33.5 37.1 50.4 24.7 30.3 0.0 41.2 44.7 23.6 9.1 9.8 30.4 16.9 14.2 0.0 28.8 37.1 28.8 0.0 0.0 35.7 43.5 41.3 4.2 25.8 87.3 77.0 31.5 88.0 26.3 37.6 27.8 68.9 12.9 12.5 4.8 10.9 17.4 25.0 62.6 30.3 ADAM21 ADAM31 ENSG00000139985 "ADAM metallopeptidase domain 21" Q9UKJ8 14 70417107-70460427 "Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 8.6" "Group enriched" "Detected in some" 41 "Early spermatids: 69.5;Late spermatids: 131.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-138 MG: 1.3;U-251 MG: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA059016 Uncertain NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 25: Spermatids - Spermatogenesis" "HPA059016: AB_2683882" "unprognostic (7.85e-2)" "unprognostic (7.67e-3)" "unprognostic (4.20e-2)" "unprognostic (1.35e-2)" "unprognostic (5.12e-1)" "unprognostic (1.48e-1)" "unprognostic (5.98e-2)" "unprognostic (2.16e-1)" "unprognostic (3.30e-1)" "unprognostic (2.41e-1)" "unprognostic (1.16e-1)" "unprognostic (2.72e-1)" "unprognostic (6.78e-2)" "unprognostic (1.82e-2)" "unprognostic (1.52e-1)" "unprognostic (2.08e-1)" "unprognostic (2.72e-1)" 0.1 0.4 0.4 0.1 0.4 0.0 0.1 0.0 0.9 0.2 0.4 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.4 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 1.3 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.1 8.6 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.4 0.3 0.0 0.1 0.2 0.4 0.5 0.1 0.2 0.2 0.0 0.1 0.0 0.3 0.0 0.1 0.2 0.2 0.0 0.1 0.4 0.3 0.2 0.3 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.2 0.7 0.0 0.3 0.0 0.2 0.6 0.0 0.6 0.0 0.0 0.1 0.1 0.4 0.3 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.5 0.1 0.1 0.5 0.2 1.3 0.0 0.1 1.3 0.1 0.7 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.9 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 69.5 0.2 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 131.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.1 0.1 2.4 1.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 ADAM20 ENSG00000134007 "ADAM metallopeptidase domain 20" O43506 14 70522358-70535015 "Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 1.6;testis: 5.1" "Cell type enhanced" "Detected in some" "Astrocytes: 30.0;Early spermatids: 55.5;Excitatory neurons: 45.4;Inhibitory neurons: 37.4;Oligodendrocyte precursor cells: 23.1;Oligodendrocytes: 23.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059377 Enhanced NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 29: Early spermatids - Spermatogenesis" "HPA059377: AB_2683997" "unprognostic (4.13e-3)" "unprognostic (3.45e-2)" "unprognostic (1.14e-1)" "unprognostic (8.34e-2)" "unprognostic (2.06e-1)" "unprognostic (1.57e-2)" "unprognostic (5.61e-2)" "unprognostic (2.89e-2)" "unprognostic (1.58e-3)" "unprognostic (1.77e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-1)" "unprognostic (2.46e-3)" "unprognostic (2.64e-1)" "unprognostic (6.83e-2)" "unprognostic (5.06e-2)" "unprognostic (9.52e-3)" 0.1 0.0 0.8 0.0 0.6 0.0 0.1 1.6 1.3 0.2 0.5 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.5 0.5 0.1 0.1 0.1 0.0 0.2 0.3 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 5.1 0.5 0.0 0.1 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 1.6 1.3 0.5 0.5 0.2 0.3 0.1 0.0 0.5 0.5 0.2 0.0 0.0 30.0 0.0 0.3 0.1 0.1 0.0 4.1 0.3 0.3 0.5 0.0 0.1 0.0 4.2 0.1 0.3 0.2 0.0 0.3 55.5 0.2 0.2 0.4 0.0 0.0 45.4 0.0 0.1 0.2 0.0 0.3 0.0 0.1 0.0 0.1 0.1 3.3 37.4 0.0 0.0 0.0 0.0 8.2 0.3 0.1 0.0 12.2 0.1 0.3 0.0 23.1 23.9 0.2 0.0 0.7 0.1 0.5 0.0 0.0 0.4 3.5 0.0 0.5 0.3 5.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.6 MED6 NY-REN-28 ENSG00000133997 "Mediator complex subunit 6" O75586 14 70581257-70600690 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030764, HPA069039" Approved Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA030764: AB_2673601, HPA069039: AB_2686070" "unprognostic (1.65e-2)" "unprognostic (1.93e-1)" "unprognostic (1.09e-1)" "unprognostic (2.22e-3)" "unprognostic (1.04e-1)" "unprognostic (1.72e-2)" "prognostic unfavorable (1.04e-4)" "unprognostic (1.74e-1)" "prognostic unfavorable (2.75e-4)" "unprognostic (2.23e-2)" "unprognostic (1.54e-1)" "unprognostic (1.48e-1)" "unprognostic (6.93e-2)" "unprognostic (2.86e-1)" "unprognostic (3.32e-1)" "unprognostic (1.01e-1)" "unprognostic (3.15e-2)" 13.0 14.9 13.3 14.0 13.3 21.6 17.2 22.5 17.3 14.8 10.6 13.2 11.8 14.8 17.7 17.2 15.0 12.2 14.6 12.6 13.8 11.5 16.8 13.0 24.3 10.3 11.6 19.0 11.2 12.2 12.1 15.3 10.8 11.2 13.0 22.0 12.3 12.4 23.2 18.6 12.2 14.4 10.1 15.0 12.4 13.7 12.9 24.3 14.8 22.6 26.5 16.4 13.9 13.3 81.0 43.5 56.1 24.2 29.6 32.0 44.9 39.6 42.7 60.8 60.3 43.8 48.9 60.9 22.7 34.6 36.0 37.9 67.5 41.0 64.4 44.0 35.7 44.8 31.6 59.5 36.0 39.5 34.4 36.1 47.2 43.1 39.7 26.7 48.1 45.8 42.3 37.4 45.2 60.3 56.7 53.2 41.9 56.7 53.7 46.5 51.9 32.0 37.8 42.4 37.9 40.3 41.8 44.3 47.0 32.6 69.2 49.1 37.7 49.7 71.2 24.8 37.3 39.2 63.7 85.8 43.1 34.1 34.7 19.1 16.2 24.6 17.6 18.9 20.9 17.9 23.1 20.3 18.5 20.2 21.3 21.7 15.8 22.6 22.9 13.9 23.4 14.1 13.3 13.3 22.5 17.3 12.6 13.8 10.3 11.6 10.8 10.1 12.9 13.3 36.7 19.2 25.7 16.0 48.7 19.4 34.2 50.3 28.5 73.5 23.0 21.1 7.4 12.8 34.5 18.4 79.2 39.1 49.4 13.9 5.9 30.3 7.6 22.7 24.9 27.6 22.1 22.5 27.1 23.1 44.3 30.1 24.5 30.5 46.3 29.5 25.4 15.0 26.2 26.9 24.2 14.0 20.3 19.2 15.4 6.3 27.1 21.4 17.8 16.9 30.4 38.5 47.4 18.6 18.6 27.2 19.5 29.3 41.6 38.3 22.5 14.1 37.2 97.7 26.3 28.0 26.4 25.3 37.7 23.5 20.0 49.0 44.7 25.2 14.8 39.2 TTC9 "KIAA0227, TTC9A" ENSG00000133985 "Tetratricopeptide repeat domain 9" Q92623 14 70641916-70675366 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 60.1" "Cell type enhanced" "Detected in many" "Pancreatic endocrine cells: 36.0;Respiratory ciliated cells: 38.1;Urothelial cells: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 18.2;Daudi: 15.9;RH-30: 21.3;SK-BR-3: 36.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA079473 Approved "Nuclear bodies" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nuclear bodies" "HPA079473: " "unprognostic (2.37e-2)" "unprognostic (6.01e-2)" "unprognostic (9.29e-2)" "prognostic favorable (1.82e-5)" "unprognostic (3.81e-2)" "unprognostic (2.38e-2)" "unprognostic (2.53e-2)" "unprognostic (7.12e-2)" "unprognostic (2.34e-1)" "unprognostic (1.81e-2)" "unprognostic (1.18e-2)" "unprognostic (2.39e-1)" "prognostic favorable (2.10e-8)" "unprognostic (1.22e-2)" "unprognostic (1.01e-1)" "unprognostic (3.16e-2)" "unprognostic (9.38e-2)" 1.4 1.2 6.4 4.0 6.8 0.9 3.7 3.3 9.8 5.4 1.5 0.8 0.8 1.2 1.4 60.1 10.2 3.4 2.1 6.4 5.9 2.9 1.1 4.4 9.3 5.7 3.9 0.1 1.5 2.9 3.7 4.0 5.5 2.5 0.8 6.0 12.6 1.6 9.5 5.9 2.5 0.8 3.7 5.7 4.1 0.5 4.3 5.1 4.0 5.2 15.4 4.4 13.7 6.5 18.2 2.1 6.7 0.3 0.0 0.0 7.1 0.3 0.1 0.5 2.2 0.4 8.9 15.9 2.4 0.1 1.5 6.6 5.0 0.6 0.3 0.5 1.9 2.2 0.7 5.2 0.0 0.0 4.4 0.6 1.2 0.0 0.1 0.3 0.0 3.5 0.0 1.4 7.3 9.0 0.4 0.2 3.7 13.0 2.3 3.7 21.3 0.1 11.0 4.1 4.1 2.0 2.0 36.4 0.0 4.0 12.7 0.6 0.0 0.0 3.2 0.0 0.3 0.0 0.2 4.9 0.0 0.4 0.1 0.0 0.0 0.6 0.4 0.3 0.9 0.6 0.7 0.5 0.0 1.2 1.1 0.7 0.8 0.0 1.5 0.0 0.4 0.2 6.4 6.8 3.3 9.8 6.4 5.9 5.7 3.9 5.5 3.7 4.3 6.5 3.8 3.2 7.2 1.3 11.3 1.0 4.7 16.3 1.2 3.8 13.7 10.5 1.8 14.3 24.8 9.2 6.2 24.1 1.5 0.2 1.9 21.0 0.4 8.3 2.3 5.9 1.2 0.0 10.5 5.8 2.5 1.2 4.1 19.1 1.3 15.2 0.4 2.2 2.8 0.0 13.6 0.5 16.2 4.1 0.8 0.7 0.0 2.1 7.2 3.7 3.0 15.8 4.1 9.0 0.7 36.0 0.5 0.0 4.4 13.0 0.0 0.3 38.1 5.4 0.0 0.7 2.1 0.1 2.6 9.0 1.7 7.4 7.6 0.2 0.5 56.9 MAP3K9 "MEKK9, MLK1, PRKE1" ENSG00000006432 "Mitogen-activated protein kinase kinase kinase 9" P80192 14 70722526-70809534 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.7;retina: 9.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 49.6;Inhibitory neurons: 58.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 22.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000942 Approved Approved Nucleoplasm,Nucleoli "Intracellular and membrane" NA NA "Cluster 6: Brain - Smell perception" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Nucleoli" "HPA000942: AB_1079360" "unprognostic (1.20e-1)" "unprognostic (3.75e-1)" "unprognostic (4.01e-2)" "unprognostic (1.43e-2)" "unprognostic (3.16e-3)" "unprognostic (2.45e-2)" "unprognostic (3.75e-5)" "unprognostic (2.58e-1)" "unprognostic (4.20e-2)" "unprognostic (4.38e-2)" "unprognostic (1.53e-2)" "unprognostic (2.48e-2)" "unprognostic (4.23e-6)" "unprognostic (5.71e-3)" "unprognostic (6.86e-3)" "unprognostic (1.79e-1)" "unprognostic (2.35e-1)" 0.2 1.0 3.3 1.0 4.6 0.7 1.3 10.7 22.7 0.9 0.4 1.5 1.5 0.4 1.5 5.1 1.0 0.4 0.5 4.0 3.2 1.4 0.7 1.9 1.4 8.6 3.0 0.6 2.2 2.7 1.1 0.6 7.7 0.9 1.5 9.6 1.7 0.5 0.8 4.0 1.4 0.2 0.3 0.9 1.6 5.5 10.0 0.9 2.7 0.4 3.6 0.7 1.8 6.8 22.3 10.5 2.0 2.5 0.0 0.0 6.7 0.5 0.3 2.1 1.9 7.8 8.6 4.5 2.8 0.1 4.7 10.3 6.5 12.8 2.2 3.0 1.7 0.2 4.1 5.2 0.3 0.5 0.9 0.1 6.5 1.5 12.7 3.7 0.0 4.1 1.7 1.0 0.5 9.4 3.7 0.5 4.2 9.0 4.5 1.3 3.9 0.9 4.6 10.9 13.8 3.0 6.3 7.7 1.2 3.7 6.9 0.8 0.0 0.0 8.5 0.0 3.5 2.2 5.6 2.4 3.4 0.4 1.4 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.2 0.2 0.0 0.0 0.2 0.0 3.3 4.6 10.7 22.7 4.0 3.2 8.6 3.0 7.7 0.3 10.0 6.8 0.3 6.4 13.4 6.8 3.9 8.7 13.7 9.4 6.8 17.7 11.2 4.8 2.3 14.3 12.4 7.3 12.5 2.8 1.7 5.7 1.9 6.1 19.8 7.4 0.7 0.8 8.4 0.0 49.6 4.8 1.6 1.0 4.1 8.5 1.3 1.8 1.1 4.8 1.2 30.3 58.1 4.0 4.1 0.8 1.9 20.0 0.6 0.8 3.6 5.6 0.4 3.2 0.0 8.5 1.3 11.1 3.9 0.0 2.8 15.8 2.6 2.8 7.1 12.7 0.0 0.8 1.3 8.0 8.4 12.6 9.1 4.0 3.7 6.0 5.8 27.9 PCNX1 "KIAA0805, KIAA0995, PCNX, PCNXL1, pecanex" ENSG00000100731 "Pecanex 1" Q96RV3 14 70907405-71115382 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 31.5;Alveolar cells type 2: 27.9;dendritic cells: 31.6;Endometrial stromal cells: 35.3;Granulosa cells: 57.2;Theca cells: 50.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048970, HPA053532" Approved Approved Nucleoplasm NA NA "Cluster 35: T-regs - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 44: HDLM-2 - Immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA048970: , HPA053532: AB_2682180" "unprognostic (1.96e-1)" "unprognostic (2.46e-1)" "unprognostic (2.01e-1)" "unprognostic (2.62e-1)" "unprognostic (2.21e-1)" "unprognostic (1.12e-1)" "unprognostic (1.12e-1)" "unprognostic (1.77e-1)" "unprognostic (7.41e-2)" "unprognostic (1.04e-2)" "unprognostic (4.16e-2)" "unprognostic (5.56e-2)" "prognostic favorable (4.05e-5)" "unprognostic (9.01e-3)" "unprognostic (2.90e-1)" "unprognostic (8.11e-2)" "unprognostic (7.37e-2)" 14.1 20.0 8.1 15.3 10.4 17.5 10.7 8.2 9.9 9.6 11.1 11.5 7.9 11.0 5.1 7.8 10.5 10.0 11.5 9.5 8.3 11.8 11.5 12.8 14.4 5.7 6.3 20.0 7.0 15.8 8.2 9.0 7.1 9.1 7.6 16.6 6.7 8.8 15.2 7.3 11.8 13.2 6.2 13.4 8.2 20.7 9.0 16.9 12.3 21.8 12.5 15.5 7.4 8.8 22.3 15.5 17.4 10.9 28.7 19.3 9.6 23.3 23.2 17.9 24.9 15.4 9.8 15.8 7.8 24.0 14.0 21.9 18.8 18.8 26.8 49.0 7.3 3.0 9.7 17.0 17.4 24.5 8.0 20.0 16.4 17.8 31.9 22.0 18.0 16.1 1.3 22.5 20.9 18.0 11.6 22.0 8.8 9.9 8.4 10.5 20.0 4.7 12.2 16.3 7.2 11.3 17.6 10.5 13.0 17.7 9.5 22.7 21.5 32.7 36.5 10.7 17.1 13.5 7.4 13.4 20.2 19.7 11.6 3.3 1.8 1.7 3.4 1.0 4.6 1.3 5.9 3.6 0.4 2.8 2.5 4.0 9.8 1.9 0.7 3.7 10.3 1.7 8.1 10.4 8.2 9.9 9.5 8.3 5.7 6.3 7.1 6.2 9.0 8.8 31.5 16.0 27.9 0.0 8.3 0.0 0.0 0.0 0.0 0.0 11.4 19.7 0.0 0.0 6.2 9.2 0.0 5.9 31.6 0.0 1.9 8.2 0.0 14.1 35.3 9.2 0.0 0.0 0.0 5.3 6.9 9.6 0.0 14.1 15.2 57.2 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 4.2 0.0 0.0 0.0 0.0 8.4 0.0 0.0 24.3 0.0 0.0 7.5 9.5 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 5.1 24.0 50.0 0.0 0.0 SIPA1L1 "E6TP1, KIAA0440, SPAR1" ENSG00000197555 "Signal induced proliferation associated 1 like 1" O43166 14 71320449-71741229 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 575.1;Inhibitory neurons: 447.6;Oligodendrocyte precursor cells: 221.2;Oligodendrocytes: 251.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 22.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-138 MG: 101.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002875, HPA077689" Approved Enhanced "Plasma membrane,Actin filaments" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 65: Brain - Ion transport" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane" "Actin filaments" "HPA002875: AB_1079974, HPA077689: " "unprognostic (1.50e-3)" "unprognostic (2.99e-1)" "unprognostic (3.34e-2)" "unprognostic (5.64e-3)" "unprognostic (4.19e-2)" "unprognostic (4.14e-1)" "unprognostic (7.89e-2)" "unprognostic (4.86e-2)" "unprognostic (3.09e-1)" "unprognostic (8.62e-2)" "unprognostic (2.61e-1)" "unprognostic (5.27e-2)" "prognostic favorable (6.80e-8)" "unprognostic (1.02e-1)" "unprognostic (1.37e-1)" "unprognostic (1.42e-1)" "unprognostic (7.03e-2)" 6.2 14.5 29.7 11.6 33.4 11.7 9.0 6.1 27.8 9.4 31.3 12.1 10.3 7.1 11.0 14.4 13.8 15.5 3.3 30.9 4.5 14.9 12.3 11.5 11.0 2.7 0.5 4.7 12.7 19.2 16.0 5.1 1.4 7.9 11.7 13.3 10.7 8.5 3.0 8.7 11.1 10.5 0.6 25.3 18.1 19.8 10.1 12.5 14.3 2.8 15.8 12.7 6.1 11.3 27.0 8.3 18.9 14.2 5.6 16.0 34.2 35.9 42.4 14.3 18.1 48.1 14.8 12.6 9.1 59.1 12.9 26.1 13.9 32.3 27.1 11.4 6.5 26.5 55.3 11.3 46.3 3.2 9.8 11.7 26.7 22.1 52.0 16.3 15.5 17.5 11.8 30.7 19.8 40.5 10.8 3.0 10.8 24.6 22.4 15.7 20.4 13.4 10.2 41.1 23.2 61.9 36.8 28.6 2.6 12.1 17.0 1.4 43.3 101.4 37.2 11.6 20.8 25.0 30.3 18.3 17.3 8.6 34.6 6.9 5.2 1.1 1.7 5.8 3.8 3.2 1.5 2.4 1.3 7.4 1.0 1.1 22.9 2.2 7.1 0.4 1.6 2.3 29.7 33.4 6.1 27.8 30.9 4.5 2.7 0.5 1.4 0.6 10.1 11.3 14.4 67.3 30.5 163.9 53.8 11.9 15.2 20.2 30.7 19.6 13.0 21.2 5.3 21.5 23.6 14.7 18.8 7.8 23.9 19.3 13.7 24.6 74.4 28.8 18.8 12.9 32.4 1.3 575.1 19.9 8.5 11.3 46.9 35.3 13.9 26.4 5.0 17.5 5.1 58.9 447.6 16.8 10.2 21.4 67.2 31.2 7.8 49.2 5.4 120.9 34.6 58.2 9.2 221.2 251.3 23.0 15.5 35.3 24.9 16.2 18.3 28.4 34.4 15.9 0.0 5.4 18.2 22.4 36.8 17.3 8.4 9.4 24.3 102.0 22.5 27.2 RGS6 ENSG00000182732 "Regulator of G protein signaling 6" P49758 14 71932429-72566530 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.2" "Cell type enhanced" "Detected in many" "Astrocytes: 97.3;Early spermatids: 173.5;Excitatory neurons: 652.7;Inhibitory neurons: 256.1;Late spermatids: 298.0" "Group enriched" "Detected in some" 7 "glioma: 3.1;thyroid cancer: 1.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HEL: 11.5;Karpas-707: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003067 Uncertain Approved Nucleoplasm,Nucleoli,Vesicles NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 21: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "Nucleoli, Vesicles" "HPA003067: AB_1079807" "unprognostic (7.18e-2)" "unprognostic (7.78e-2)" "unprognostic (1.00e-1)" "unprognostic (6.85e-2)" "unprognostic (5.61e-2)" "unprognostic (3.80e-2)" "unprognostic (1.24e-4)" "unprognostic (7.83e-2)" "unprognostic (2.03e-1)" "unprognostic (8.17e-2)" "unprognostic (1.30e-1)" "unprognostic (2.06e-2)" "unprognostic (8.64e-2)" "unprognostic (5.11e-2)" "unprognostic (8.06e-3)" "unprognostic (2.10e-1)" "unprognostic (3.68e-2)" 4.7 0.2 1.1 0.6 2.2 1.4 4.0 0.6 8.6 4.9 0.0 1.0 0.3 1.4 2.6 0.4 2.2 1.2 11.2 3.5 2.8 2.6 0.1 0.9 0.1 19.2 16.0 1.2 0.2 8.1 1.7 3.0 20.2 0.4 1.0 1.7 0.8 1.4 1.1 0.9 0.8 1.3 5.4 0.9 0.4 10.6 6.4 0.3 5.7 0.8 0.5 0.7 0.9 3.4 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 11.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 40.1 0.0 0.7 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.5 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.1 0.3 1.2 1.1 2.2 0.6 8.6 3.5 2.8 19.2 16.0 20.2 5.4 6.4 3.4 5.8 0.0 0.0 97.3 0.2 0.3 0.0 0.0 0.0 2.2 2.1 2.4 22.6 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 173.5 2.8 0.9 2.6 0.0 5.3 652.7 0.2 0.1 3.1 0.0 7.1 0.0 0.4 0.0 0.0 0.2 0.0 256.1 0.0 0.0 0.0 0.0 298.0 1.8 8.3 0.0 44.0 5.1 0.0 0.0 36.2 8.9 0.0 0.0 7.5 0.2 0.0 0.0 0.4 0.0 0.4 13.1 0.4 18.6 2.3 1.3 0.2 0.1 0.8 0.5 0.1 0.0 0.7 DPF3 "BAF45c, cer-d4, Cerd4, FLJ14079" ENSG00000205683 "Double PHD fingers 3" Q92784 14 72619296-72894116 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.5;retina: 18.0;skeletal muscle: 26.5" "Cell type enhanced" "Detected in many" "Astrocytes: 104.5;Cone photoreceptor cells: 108.4;Early spermatids: 58.5;Oligodendrocyte precursor cells: 123.1;Oligodendrocytes: 115.7;Rod photoreceptor cells: 85.5" "Cancer enhanced" "Detected in some" "glioma: 3.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 17.7;BJ hTERT+ SV40 Large T+: 12.2;HEL: 31.5;Karpas-707: 12.4" "Region enhanced" "Detected in all" "cerebellum: 49.5" "Low region specificity" "Detected in all" "HPA066790, HPA070601" Enhanced Enhanced Nucleoplasm NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 54: Non-specific - Microtubule organization" "Cluster 36: HEL - Hemostasis" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm "HPA066790: AB_2685724, HPA070601: AB_2686284" "unprognostic (2.38e-2)" "unprognostic (2.96e-1)" "unprognostic (3.25e-1)" "unprognostic (1.56e-2)" "unprognostic (1.55e-1)" "unprognostic (9.98e-2)" "unprognostic (4.80e-2)" "unprognostic (1.19e-2)" "unprognostic (1.33e-1)" "unprognostic (3.54e-2)" "unprognostic (9.71e-3)" "unprognostic (1.02e-1)" "unprognostic (2.02e-1)" "unprognostic (3.85e-3)" "unprognostic (4.08e-2)" "unprognostic (4.80e-2)" "unprognostic (1.96e-1)" 0.3 1.4 2.8 0.5 6.7 2.6 0.4 35.5 5.1 0.4 0.0 2.0 0.2 0.2 0.0 0.6 0.3 0.3 14.2 10.2 3.8 1.4 3.0 0.2 0.8 12.0 5.9 13.7 0.3 5.1 0.6 0.3 12.6 0.1 1.5 18.0 0.4 0.2 26.5 0.5 1.3 0.5 4.4 1.0 0.5 3.5 5.7 0.3 0.4 9.1 1.0 0.2 0.2 7.7 2.1 0.0 1.6 0.1 0.2 2.9 17.7 5.4 5.1 12.2 4.7 0.1 0.2 0.2 0.3 1.7 0.2 0.1 1.7 0.8 7.4 0.3 0.6 31.5 0.2 0.0 0.5 0.2 0.5 0.7 0.3 2.8 2.0 2.0 4.0 3.4 2.8 12.4 3.9 0.1 2.7 0.3 0.0 0.0 1.8 6.9 0.8 0.4 2.1 0.0 1.2 0.7 0.0 0.1 0.0 0.5 0.0 0.0 8.7 6.0 0.0 2.2 0.6 4.3 1.2 0.4 0.5 1.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 6.7 35.5 5.1 10.2 3.8 12.0 5.9 12.6 4.4 5.7 7.7 0.8 0.0 0.0 104.5 6.0 0.6 0.1 0.0 0.0 10.5 1.1 0.9 38.4 1.5 0.0 0.0 108.4 2.6 2.6 7.5 1.9 0.1 58.5 0.1 0.8 2.9 0.0 8.6 17.7 0.4 1.3 2.8 0.0 0.1 4.5 43.2 1.1 4.4 0.4 6.7 21.7 3.4 0.0 0.8 0.7 34.3 0.3 1.7 0.0 8.4 0.1 8.6 2.1 123.1 115.7 0.7 5.1 4.9 2.6 0.1 2.7 10.7 0.0 85.5 0.0 2.6 3.5 4.5 1.2 0.3 0.3 0.1 3.8 14.5 7.4 0.0 DCAF4 "DKFZp434K114, WDR21, WDR21A" ENSG00000119599 "DDB1 and CUL4 associated factor 4" Q8WV16 14 72926377-72959703 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047276 Approved Approved Nucleoplasm NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 59: Non-specific - Translation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm "HPA047276: AB_10959615" "unprognostic (6.01e-2)" "unprognostic (1.96e-1)" "unprognostic (9.31e-2)" "unprognostic (1.78e-2)" "unprognostic (1.78e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (6.77e-4)" "unprognostic (3.93e-2)" "unprognostic (2.11e-1)" "unprognostic (1.38e-2)" "unprognostic (2.86e-1)" "unprognostic (7.56e-2)" "prognostic favorable (4.90e-4)" "unprognostic (6.80e-2)" "unprognostic (1.87e-1)" "unprognostic (9.96e-3)" "unprognostic (2.11e-2)" 6.8 7.9 5.9 4.8 6.0 4.9 7.1 5.2 6.6 7.8 4.6 7.9 4.1 7.0 5.3 7.6 5.6 3.7 5.5 6.5 6.6 9.1 7.4 4.5 6.5 7.4 6.2 9.1 12.5 5.5 3.7 9.3 7.6 6.9 6.5 2.6 6.8 5.2 12.8 12.8 6.9 6.0 5.2 6.7 8.0 7.0 6.1 3.9 11.4 5.1 7.4 8.1 7.5 6.6 20.7 9.4 2.3 10.8 9.9 12.5 19.0 11.6 11.6 14.9 17.4 11.3 8.9 26.0 8.5 21.9 13.6 15.6 16.0 18.2 25.5 13.2 8.9 10.8 4.4 15.1 13.9 7.4 17.8 21.9 17.4 15.5 29.1 10.0 5.2 25.1 16.2 16.1 12.1 35.3 12.7 18.4 6.3 20.2 20.3 8.9 12.2 15.2 22.5 12.3 12.5 4.9 7.0 37.4 14.1 10.4 12.5 9.9 7.8 8.0 18.5 22.6 5.7 22.8 23.5 17.7 11.0 6.1 4.9 0.4 1.6 0.3 4.1 2.5 6.1 11.6 5.0 4.6 3.3 8.7 5.7 6.0 0.9 9.1 5.4 2.5 7.2 3.0 5.9 6.0 5.2 6.6 6.5 6.6 7.4 6.2 7.6 5.2 6.1 6.6 2.9 6.4 5.3 3.3 10.8 6.1 7.3 5.8 8.0 3.4 5.8 5.1 4.0 2.8 8.3 3.7 4.2 20.9 4.4 4.3 3.9 6.7 3.8 4.3 6.6 4.4 4.2 4.2 5.7 5.6 15.3 4.9 12.8 7.5 0.0 10.9 1.1 4.7 5.8 0.0 4.7 4.3 6.1 2.2 4.2 2.6 3.7 1.9 1.8 3.7 4.1 2.1 4.1 3.5 5.8 4.4 7.0 5.7 4.7 4.0 2.9 6.6 2.6 3.5 0.0 4.4 4.0 7.5 18.6 6.4 6.7 5.6 5.3 11.8 7.1 3.3 ZFYVE1 "DFCP1, KIAA1589, PPP1R172, TAFF1, ZNFN2A1" ENSG00000165861 "Zinc finger FYVE-type containing 1" Q9HBF4 14 72969451-73027131 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 45.8;Late spermatids: 108.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002898 Approved Supported "Endoplasmic reticulum" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 78: Testis - Spermatogenesis" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 25: Spermatids - Spermatogenesis" "Endoplasmic reticulum" "HPA002898: AB_1080653" "unprognostic (2.19e-1)" "unprognostic (1.50e-1)" "unprognostic (4.65e-2)" "unprognostic (1.23e-1)" "unprognostic (3.47e-1)" "unprognostic (2.40e-2)" "unprognostic (7.42e-3)" "unprognostic (6.82e-2)" "unprognostic (1.05e-2)" "unprognostic (2.40e-2)" "unprognostic (1.83e-2)" "unprognostic (1.53e-1)" "prognostic favorable (5.07e-12)" "unprognostic (4.03e-2)" "unprognostic (1.67e-1)" "unprognostic (2.95e-1)" "unprognostic (7.48e-2)" 11.8 13.5 9.8 5.8 11.3 12.3 9.3 9.8 9.6 8.6 7.4 11.1 9.3 9.1 5.7 13.2 7.2 8.1 9.4 9.4 10.9 12.1 11.2 8.2 7.1 11.3 10.8 9.6 7.7 11.1 6.4 9.4 11.1 7.7 6.6 9.1 8.3 7.1 16.3 13.2 9.1 9.4 10.1 8.2 7.7 16.9 11.2 8.1 12.5 13.7 7.3 9.2 9.3 10.9 8.0 11.3 10.6 10.3 26.9 18.5 7.2 11.5 17.9 12.4 19.5 7.8 6.9 4.2 8.6 14.7 14.6 5.7 7.5 7.1 12.7 16.6 4.2 5.2 5.3 5.5 23.0 1.9 18.7 24.3 18.6 12.2 10.2 18.7 19.7 11.3 4.8 10.8 16.3 9.5 8.3 5.9 5.0 6.4 10.3 11.7 7.4 5.2 11.2 8.3 5.7 9.9 10.4 10.5 12.0 14.6 14.3 7.1 22.0 22.7 9.3 6.4 3.9 15.7 16.9 5.9 12.4 4.2 10.7 2.2 7.0 9.6 6.7 6.3 4.6 3.0 3.4 4.6 6.1 3.0 3.6 4.5 10.9 3.7 5.9 3.5 5.7 5.5 9.8 11.3 9.8 9.6 9.4 10.9 11.3 10.8 11.1 10.1 11.2 10.9 5.6 12.8 5.5 10.1 5.1 6.5 1.8 3.6 8.0 6.2 6.8 4.1 7.8 1.5 3.7 9.2 4.2 3.7 6.8 10.2 1.9 6.4 45.8 6.5 6.3 6.3 7.2 23.1 14.8 5.3 4.4 6.3 7.7 7.0 8.2 9.7 7.1 8.6 5.5 16.8 14.3 7.6 4.1 7.1 3.3 108.9 8.7 7.1 12.4 10.3 6.6 7.6 6.2 13.0 20.6 6.1 9.7 9.1 6.9 3.3 13.1 8.3 3.5 5.4 0.0 5.5 7.6 5.5 3.6 9.0 5.4 9.3 6.4 7.5 4.5 6.2 RBM25 "fSAP94, NET52, RNPC7, S164, Snu71" ENSG00000119707 "RNA binding motif protein 25" P49756 14 73058532-73123899 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003025, HPA070713" Supported Enhanced "Nuclear speckles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA003025: AB_1079748, HPA070713: AB_2686302" "unprognostic (1.15e-2)" "unprognostic (3.24e-1)" "unprognostic (1.42e-1)" "unprognostic (2.28e-1)" "unprognostic (4.85e-2)" "unprognostic (3.47e-2)" "prognostic unfavorable (1.42e-4)" "unprognostic (4.22e-2)" "unprognostic (3.32e-2)" "unprognostic (1.93e-2)" "unprognostic (1.40e-1)" "prognostic unfavorable (8.09e-4)" "prognostic unfavorable (4.26e-4)" "unprognostic (6.98e-2)" "unprognostic (2.58e-1)" "unprognostic (2.75e-1)" "unprognostic (1.73e-1)" 31.4 23.2 14.7 36.0 16.2 72.6 30.7 21.5 20.9 28.7 17.2 28.9 23.4 31.4 22.7 28.9 29.5 21.2 22.2 14.5 19.3 20.8 21.2 30.3 40.0 14.9 13.7 31.1 33.2 22.7 25.3 26.7 16.1 22.5 24.0 41.9 31.4 19.8 41.1 33.3 29.9 23.2 12.5 29.7 27.7 28.5 15.9 36.4 29.3 21.9 33.4 28.1 29.8 20.7 97.8 55.6 86.9 66.6 38.1 44.6 76.5 78.4 54.6 59.5 65.2 74.5 61.2 116.7 40.5 54.0 45.1 72.3 100.9 47.2 101.6 73.8 53.3 98.2 43.2 57.7 24.1 87.5 60.0 32.4 33.3 69.7 56.7 51.1 60.0 42.4 102.7 47.6 65.2 73.3 114.4 51.1 73.8 59.6 60.1 97.4 94.8 57.1 49.0 67.4 58.5 55.8 98.5 64.4 35.0 52.2 92.7 37.9 77.2 87.5 85.5 47.3 79.7 50.2 96.0 141.5 39.1 61.3 61.2 17.4 17.2 16.6 19.9 19.2 18.7 22.3 15.8 16.9 18.2 23.7 16.6 17.6 20.3 27.2 17.5 28.7 19.2 11.7 14.7 16.2 21.5 20.9 14.5 19.3 14.9 13.7 16.1 12.5 15.9 20.7 177.8 230.8 319.9 94.7 226.2 227.4 194.3 109.8 198.6 253.8 136.2 139.2 131.5 77.2 191.8 92.0 268.9 151.8 268.4 137.5 17.6 111.0 71.1 160.4 295.6 170.2 155.2 149.3 115.4 122.6 183.5 185.1 146.8 223.2 247.8 183.3 95.3 98.3 113.1 180.0 99.3 146.3 54.9 110.8 180.8 29.2 157.8 169.9 81.8 71.2 176.9 131.2 155.5 84.9 134.1 132.9 111.0 137.7 233.2 236.5 86.3 32.9 137.0 263.0 72.3 234.2 213.4 213.8 212.9 196.7 236.7 185.4 242.9 161.0 162.5 235.1 PSEN1 "AD3, FAD, PS1, S182" ENSG00000080815 "Presenilin 1" P49768 14 73136418-73223691 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell adhesion, Notch signaling pathway" "Hydrolase, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "Oligodendrocytes: 395.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006844, HPA030760, HPA067496" Approved Supported "Nucleoplasm,Golgi apparatus,Cell Junctions" Yes No "Cluster 31: Non-specific - Inflammatory response" "Cluster 45: Intestine - Brush border" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "Nucleoplasm, Cell Junctions" "CAB006844: , HPA030760: AB_10696211, HPA067496: AB_2685853" "unprognostic (1.67e-1)" "unprognostic (4.79e-2)" "unprognostic (7.39e-2)" "unprognostic (8.68e-3)" "unprognostic (3.84e-1)" "unprognostic (5.48e-3)" "prognostic unfavorable (1.99e-5)" "unprognostic (1.65e-1)" "unprognostic (8.99e-2)" "unprognostic (8.45e-2)" "unprognostic (1.76e-3)" "unprognostic (2.74e-1)" "prognostic favorable (1.52e-8)" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (7.12e-3)" "unprognostic (1.85e-1)" 25.1 22.6 44.3 26.5 80.7 39.6 28.2 62.4 56.0 28.1 48.9 49.5 50.2 25.3 26.9 35.2 22.9 31.7 18.0 47.4 51.6 35.5 31.9 32.1 22.4 73.0 63.8 22.0 22.9 35.1 11.6 43.1 71.5 24.3 46.3 23.4 22.9 23.4 18.4 38.2 49.0 27.1 55.7 22.6 31.0 32.5 60.8 26.2 36.9 23.3 30.7 35.0 19.2 119.1 37.1 55.9 50.6 20.0 68.9 49.9 46.7 52.5 60.1 52.6 66.7 69.9 88.9 23.7 34.1 50.5 43.0 94.9 43.2 40.1 57.3 54.6 26.7 27.1 35.1 34.4 63.8 27.7 50.7 50.4 71.9 44.3 54.4 48.5 43.2 26.2 31.0 46.6 50.0 72.8 21.0 35.7 22.0 64.5 40.4 26.4 42.7 30.2 73.7 76.5 28.1 38.3 57.4 53.0 47.1 45.4 66.3 60.7 45.7 53.1 43.5 44.1 25.3 30.3 47.9 23.7 44.9 32.8 33.3 126.8 94.5 96.3 23.1 106.0 22.6 23.1 22.3 19.0 83.4 31.8 20.7 20.1 129.3 42.8 125.0 43.6 37.0 70.3 44.3 80.7 62.4 56.0 47.4 51.6 73.0 63.8 71.5 55.7 60.8 119.1 22.2 28.9 30.5 35.9 25.8 28.6 24.6 24.7 12.0 17.1 25.0 17.7 12.5 15.7 30.2 23.9 39.6 27.1 30.7 79.1 5.9 27.1 22.9 26.3 26.4 22.3 16.2 12.0 38.9 26.7 29.2 23.7 32.1 47.4 18.3 29.6 15.7 24.6 30.5 13.5 40.2 39.5 24.4 50.5 40.8 12.9 16.4 52.3 16.0 39.4 51.8 13.8 14.4 48.7 395.8 38.2 58.8 15.4 23.6 38.8 76.2 13.0 29.0 28.0 26.3 20.0 19.0 40.2 14.4 20.4 33.0 49.9 21.6 18.6 41.3 51.5 PAPLN MGC50452 ENSG00000100767 "Papilin, proteoglycan like sulfated glycoprotein" O95428 14 73237497-73274640 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 119.8;Endometrial stromal cells: 37.9;Leydig cells: 34.5;Peritubular cells: 44.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "neutrophil: 2.5;plasmacytoid DC: 5.4" "Group enriched" "Detected in many" 7 "dendritic cells: 5.4;granulocytes: 2.5" "Cell line enhanced" "Detected in many" "HHSteC: 16.1;HSkMC: 30.6;hTCEpi: 11.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA048682, HPA053453" Uncertain Approved Nucleoplasm "Secreted - unknown location" NA NA 76000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 64: Astrocytes - Nervous system maintenance" Nucleoplasm "HPA048682: AB_2680492, HPA053453: AB_2682155" "unprognostic (1.97e-3)" "unprognostic (3.27e-2)" "unprognostic (1.88e-1)" "unprognostic (3.56e-3)" "unprognostic (7.42e-2)" "unprognostic (7.91e-3)" "unprognostic (2.01e-2)" "unprognostic (2.46e-3)" "unprognostic (9.13e-3)" "unprognostic (3.69e-2)" "unprognostic (1.41e-1)" "unprognostic (4.87e-2)" "unprognostic (1.89e-2)" "unprognostic (2.14e-2)" "unprognostic (3.05e-3)" "unprognostic (2.69e-2)" "unprognostic (5.58e-2)" 16.1 6.6 15.7 8.4 17.0 2.3 10.7 12.1 23.5 30.3 15.7 13.4 3.0 20.4 14.9 7.1 23.0 5.6 8.0 14.4 13.3 42.6 3.2 13.4 15.2 14.1 14.6 16.8 4.0 0.4 16.4 4.0 13.1 13.6 4.5 9.5 7.5 7.5 2.1 15.7 17.8 6.3 12.3 29.1 11.3 6.4 14.4 5.1 24.8 1.8 13.6 5.1 9.1 12.3 2.7 2.6 1.0 0.4 1.9 2.3 5.8 0.5 0.0 0.1 0.2 3.4 0.8 0.5 2.7 0.0 0.1 4.3 2.7 2.0 0.3 3.0 3.9 1.2 4.7 0.3 16.1 0.4 2.1 30.6 11.4 0.5 1.7 0.2 0.6 2.5 0.8 0.3 0.0 1.4 0.3 3.0 0.6 0.3 0.8 0.4 0.3 2.8 2.3 0.6 0.3 0.5 6.2 7.0 1.3 7.9 0.2 4.8 0.5 0.7 2.3 0.2 0.3 1.3 0.1 0.3 1.4 1.4 0.6 0.8 0.5 0.3 0.2 0.3 0.1 0.4 0.1 0.2 0.1 0.5 0.2 0.2 2.5 0.3 0.2 5.4 0.3 0.1 15.7 17.0 12.1 23.5 14.4 13.3 14.1 14.6 13.1 12.3 14.4 12.3 0.4 0.0 2.6 119.8 0.3 2.0 0.7 5.1 0.6 1.2 1.8 1.4 1.9 7.2 4.8 5.5 8.4 0.5 5.7 0.4 0.0 4.0 0.3 11.8 37.9 3.4 0.0 0.0 0.3 0.0 1.1 8.3 0.5 16.1 0.0 0.2 3.3 0.1 1.2 0.0 0.9 0.4 2.0 0.3 1.6 1.7 34.5 1.8 1.8 10.3 1.6 15.7 0.0 3.0 0.3 0.4 0.0 44.0 0.2 1.4 0.2 10.2 3.7 3.0 6.6 1.4 1.8 0.6 0.1 0.8 3.0 0.4 0.7 0.1 1.0 0.4 NUMB C14orf41 ENSG00000133961 "NUMB endocytic adaptor protein" P49757 14 73275107-73458617 "Cancer-related genes, Predicted intracellular proteins" Neurogenesis "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 290.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002874, CAB011478" Approved Enhanced "Cell Junctions" NA NA 12000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Cell Junctions" "CAB011478: AB_443023, HPA002874: " "unprognostic (5.28e-2)" "unprognostic (7.23e-2)" "unprognostic (1.32e-1)" "unprognostic (1.32e-3)" "unprognostic (2.02e-1)" "unprognostic (2.01e-1)" "unprognostic (2.43e-1)" "unprognostic (9.49e-2)" "unprognostic (1.33e-2)" "unprognostic (4.08e-3)" "unprognostic (2.65e-3)" "unprognostic (4.14e-2)" "prognostic favorable (2.32e-6)" "unprognostic (9.12e-2)" "unprognostic (1.63e-1)" "unprognostic (3.92e-2)" "unprognostic (2.87e-1)" 35.6 25.9 17.3 37.7 19.2 35.5 33.0 20.4 23.4 34.3 22.0 46.3 46.6 35.6 25.9 40.0 39.0 41.7 28.8 20.9 17.6 41.3 52.1 52.8 24.7 20.3 19.5 33.9 37.3 40.5 20.2 44.4 19.7 29.5 42.2 20.4 36.8 31.6 21.1 32.6 47.4 37.6 18.1 40.4 36.8 20.3 19.4 27.6 39.0 24.1 30.9 40.5 34.0 18.2 70.2 46.9 33.3 30.2 65.8 99.6 45.3 64.9 87.2 51.2 54.1 57.0 86.0 31.9 39.7 80.7 37.8 45.2 39.8 66.6 77.2 48.9 22.2 25.5 28.2 37.3 69.7 23.7 57.5 56.0 70.3 126.2 74.8 56.2 112.3 49.2 47.0 37.1 65.6 62.9 43.3 32.8 15.4 78.9 50.1 27.6 46.7 21.6 71.2 105.3 13.6 35.3 81.0 54.2 33.4 55.9 81.3 34.5 108.8 76.2 42.7 49.3 28.2 30.9 38.9 29.2 153.1 27.4 34.3 91.9 93.3 96.8 12.6 76.4 13.2 22.6 12.7 14.0 68.7 21.4 12.9 11.8 290.3 12.8 102.8 12.8 17.9 64.5 17.3 19.2 20.4 23.4 20.9 17.6 20.3 19.5 19.7 18.1 19.4 18.2 54.4 64.1 49.0 108.4 53.6 42.8 27.7 38.6 42.1 30.7 38.4 26.0 22.0 44.3 50.0 55.2 81.3 26.0 29.9 59.3 25.4 27.9 11.9 68.2 35.0 59.2 40.7 22.9 151.1 26.4 31.0 37.5 43.8 56.6 24.1 26.3 52.1 51.0 42.6 15.2 78.8 39.4 36.7 91.5 109.7 8.1 45.1 94.1 46.2 141.5 117.3 42.6 39.1 62.4 81.8 46.9 39.3 36.9 40.9 37.1 64.7 43.2 56.9 46.4 26.3 22.8 29.7 59.2 32.7 35.6 46.5 34.3 25.6 16.7 37.5 44.6 HEATR4 MGC48595 ENSG00000187105 "HEAT repeat containing 4" Q86WZ0 14 73478484-73558947 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.4;testis: 11.5" "Cell type enhanced" "Detected in some" "Astrocytes: 27.4;Early spermatids: 85.5;Excitatory neurons: 19.8;Inhibitory neurons: 16.9;Late spermatids: 29.3;Oligodendrocyte precursor cells: 13.0" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "cerebellum: 6.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 2.2;SCLC-21H: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA003642, HPA079348" Enhanced Approved Vesicles,Cytosol NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 21: Non-specific - Transcription" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 23: Spermatids - Flagellum & Golgi organization" Vesicles Cytosol "HPA003642: AB_1079376, HPA079348: " "unprognostic (5.25e-2)" "unprognostic (2.45e-3)" "unprognostic (2.85e-2)" "unprognostic (1.36e-2)" "unprognostic (2.53e-2)" "unprognostic (2.60e-2)" "unprognostic (3.50e-1)" "unprognostic (8.09e-2)" "unprognostic (3.13e-1)" "unprognostic (1.51e-1)" "unprognostic (4.49e-2)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (3.28e-1)" "unprognostic (5.50e-2)" "unprognostic (1.96e-1)" "unprognostic (4.82e-3)" 0.5 0.5 0.2 0.8 0.2 0.9 0.4 6.4 1.0 0.7 0.0 0.4 1.9 1.0 0.3 0.6 0.6 0.8 0.6 0.8 0.0 0.4 0.8 0.5 1.6 0.0 0.0 1.0 0.9 0.2 0.5 0.3 0.1 0.4 0.1 2.9 0.8 0.1 1.9 3.6 0.8 0.1 0.0 1.0 0.7 11.5 0.1 0.0 1.0 0.0 0.0 0.3 0.5 0.8 0.7 0.8 0.3 0.5 0.0 0.0 0.3 0.3 0.0 0.0 0.1 0.2 0.2 0.8 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.2 0.1 0.6 0.1 0.0 0.0 0.5 1.0 0.0 0.0 0.1 0.0 0.5 0.0 0.8 0.2 0.2 0.0 2.2 0.2 0.9 0.3 0.2 0.7 0.4 0.4 0.3 0.0 1.1 2.4 0.3 0.8 1.1 1.2 0.5 1.3 0.1 0.4 0.1 0.9 0.7 0.1 0.6 0.2 0.1 0.5 0.2 0.1 0.2 0.1 0.1 0.4 0.1 0.2 0.5 0.5 0.3 0.0 0.6 0.5 0.5 0.3 0.3 0.0 0.2 0.2 0.1 0.2 0.2 6.4 1.0 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.2 0.0 1.5 27.4 0.2 0.3 0.5 0.1 0.0 0.8 0.3 0.3 0.8 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 85.5 0.3 0.3 0.4 0.0 0.0 19.8 0.0 0.2 0.5 0.0 0.9 0.0 0.4 0.0 0.6 0.1 0.0 16.9 0.2 0.0 0.0 1.0 29.3 0.6 0.3 0.0 3.7 0.0 0.6 0.0 13.0 6.8 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.7 0.1 0.0 0.9 0.7 11.1 1.6 0.0 0.9 0.1 0.4 0.1 0.0 0.1 RIOX1 "C14orf169, FLJ21802, JMJD9, MAPJD, NO66" ENSG00000170468 "Ribosomal oxygenase 1" Q9H6W3 14 73490933-73493394 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 9.1;dendritic cells: 8.0;Extravillous trophoblasts: 6.9;Hofbauer cells: 8.2;monocytes: 7.2;Proximal tubular cells: 7.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003730 Supported "Nucleoli rim" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" "Nucleoli rim" "HPA003730: AB_2667040" "unprognostic (4.70e-3)" "unprognostic (1.94e-2)" "unprognostic (2.45e-1)" "unprognostic (2.32e-1)" "unprognostic (1.84e-3)" "unprognostic (1.73e-1)" "unprognostic (2.27e-2)" "unprognostic (1.48e-1)" "unprognostic (6.51e-2)" "unprognostic (5.36e-2)" "unprognostic (1.35e-3)" "unprognostic (4.55e-2)" "unprognostic (2.84e-3)" "unprognostic (1.05e-1)" "unprognostic (1.67e-1)" "unprognostic (7.97e-3)" "unprognostic (8.62e-2)" 3.8 4.2 5.1 5.1 4.5 7.8 3.7 6.5 5.0 3.7 4.6 4.5 3.9 5.3 4.8 5.5 4.4 2.4 4.9 4.5 4.9 4.2 6.8 3.9 6.7 4.3 4.1 3.8 6.4 5.4 3.5 2.8 4.1 3.3 3.7 1.9 4.6 3.8 3.6 4.0 5.1 4.0 3.7 5.6 4.9 13.6 4.9 9.4 3.4 3.0 6.9 4.5 3.3 5.7 17.5 15.5 9.9 15.3 12.5 7.0 19.0 11.7 8.5 11.8 10.6 13.5 8.8 29.7 8.4 10.1 9.9 20.4 19.1 11.6 9.8 19.0 21.0 18.7 9.0 9.0 6.9 0.0 24.1 7.6 10.6 11.4 5.2 7.5 10.8 17.0 13.8 10.7 10.7 27.6 33.1 21.4 10.8 15.1 26.0 26.1 15.4 9.0 11.8 12.9 20.5 14.8 19.4 34.4 12.7 9.8 34.4 18.6 15.6 0.0 19.5 10.2 0.1 14.6 16.9 10.2 5.2 15.3 11.8 0.1 1.3 3.4 3.7 2.3 4.3 2.3 3.6 2.9 1.8 1.6 3.3 2.5 0.5 3.2 1.4 3.1 1.7 0.8 5.1 4.5 6.5 5.0 4.5 4.9 4.3 4.1 4.1 3.7 4.9 5.7 2.9 3.2 1.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 5.4 3.2 0.0 0.0 3.1 5.5 0.0 9.1 8.0 0.0 5.9 3.8 0.0 4.2 4.0 2.1 0.0 0.0 0.0 5.7 6.9 1.5 0.0 4.7 2.5 5.2 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 7.2 0.0 0.0 0.0 0.0 3.4 0.0 0.0 1.2 0.0 0.0 7.6 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 1.4 3.4 3.5 0.0 0.0 ACOT1 "ACH2, CTE-1, LACH2" ENSG00000184227 "Acyl-CoA thioesterase 1" Q86TX2 14 73537143-73543796 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 44.4" "Cell type enhanced" "Detected in some" "Astrocytes: 10.7;Cardiomyocytes: 51.5;Excitatory neurons: 13.8;Inhibitory neurons: 12.0;Oligodendrocyte precursor cells: 8.5;Oligodendrocytes: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 30.5;T-47d: 49.8" HPA043705 Approved Approved Mitochondria NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 6: T47d - Mammary gland" "Cluster 54: Cardiomyocytes - Muscle contraction" Mitochondria "HPA043705: AB_2678626" "unprognostic (4.74e-3)" "unprognostic (3.81e-3)" "unprognostic (7.65e-2)" "unprognostic (8.66e-2)" "unprognostic (1.22e-1)" "unprognostic (1.29e-1)" "unprognostic (4.54e-2)" "unprognostic (1.29e-2)" "unprognostic (1.53e-1)" "unprognostic (1.73e-2)" "unprognostic (1.84e-1)" "unprognostic (4.16e-1)" "prognostic favorable (5.09e-8)" "unprognostic (1.35e-3)" "unprognostic (4.60e-2)" "unprognostic (1.75e-1)" "unprognostic (1.43e-1)" 15.1 12.9 10.4 3.6 10.2 2.4 13.0 9.3 11.3 5.7 8.4 12.9 10.8 13.2 11.6 3.4 7.3 3.5 18.6 10.1 9.7 25.9 44.4 7.3 2.3 9.2 10.1 3.5 3.0 2.2 2.0 2.9 9.6 5.6 5.4 2.9 5.1 9.3 19.6 8.9 11.8 20.9 9.5 2.6 6.4 4.2 11.1 2.5 3.6 29.3 2.1 9.5 4.0 9.6 10.7 9.0 3.3 0.7 15.2 9.1 0.1 2.9 8.5 7.0 12.6 3.9 6.9 0.0 0.4 5.8 0.9 6.0 0.0 1.4 3.4 4.5 2.8 4.6 2.8 30.5 14.4 0.1 5.1 12.0 0.6 5.6 0.0 0.7 3.2 0.0 0.0 0.0 5.5 4.7 0.6 1.0 3.4 1.4 4.9 9.5 6.8 0.2 6.9 8.7 4.9 6.4 9.0 20.2 12.2 0.9 49.8 9.9 4.2 5.2 7.5 4.2 0.7 0.1 0.0 2.6 6.2 0.0 6.8 0.7 0.9 0.7 4.1 1.1 3.5 2.6 3.9 3.4 3.8 1.9 3.5 3.9 0.1 3.5 1.1 2.2 5.1 2.6 10.4 10.2 9.3 11.3 10.1 9.7 9.2 10.1 9.6 9.5 11.1 9.6 0.2 0.0 3.2 10.7 0.0 0.0 0.1 0.6 1.8 0.0 0.4 0.4 51.5 0.0 0.4 0.0 0.0 0.7 1.3 0.2 0.0 0.4 0.6 0.3 0.3 0.7 0.0 2.7 13.8 8.0 0.3 2.6 0.0 0.3 0.0 0.1 0.0 1.1 0.9 0.0 12.0 0.0 2.0 0.3 0.0 0.0 0.0 0.5 1.8 3.7 0.0 0.0 0.0 8.5 15.1 2.6 0.0 0.4 0.3 0.0 0.0 3.7 0.3 0.0 0.0 0.0 3.6 0.1 0.2 0.6 0.0 0.8 0.2 0.0 0.2 0.0 ACOT2 "Mte1, ZAP128" ENSG00000119673 "Acyl-CoA thioesterase 2" P49753 14 73567620-73575658 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 118.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 50.0;Exocrine glandular cells: 33.2;Proximal tubular cells: 36.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 62.4" "HPA043705, HPA060170" Enhanced Approved Mitochondria NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 8: Non-specific - Mitochondria" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 59: Non-specific - Transcription" Mitochondria "HPA043705: AB_2678626, HPA060170: AB_2732642" "unprognostic (4.44e-3)" "unprognostic (1.68e-2)" "unprognostic (3.17e-1)" "unprognostic (8.66e-2)" "unprognostic (1.78e-1)" "unprognostic (1.55e-1)" "unprognostic (2.78e-2)" "unprognostic (6.61e-2)" "unprognostic (4.10e-2)" "unprognostic (9.21e-2)" "unprognostic (6.42e-2)" "unprognostic (1.64e-1)" "prognostic favorable (2.28e-6)" "unprognostic (1.66e-3)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" "unprognostic (4.35e-1)" 92.3 47.7 10.0 7.0 10.3 5.6 48.9 9.2 12.4 17.1 12.2 42.2 24.7 42.9 10.7 10.9 24.1 6.1 94.5 10.1 9.5 49.4 118.9 17.3 4.7 8.8 9.4 11.7 12.8 22.4 8.3 4.4 8.2 17.8 11.1 4.1 17.8 11.1 114.0 13.1 24.5 22.8 9.2 11.4 22.5 12.0 13.0 3.7 14.5 50.0 3.3 31.2 13.3 9.0 22.8 25.0 4.9 22.1 21.3 7.9 1.0 13.7 31.5 21.9 28.6 18.1 12.6 0.1 9.7 7.0 10.3 12.7 0.0 1.2 11.4 33.1 31.6 16.0 7.6 62.4 14.5 0.1 43.3 19.5 0.0 7.6 0.1 21.0 9.5 0.0 0.0 0.1 18.7 7.4 2.5 18.2 7.5 2.3 37.8 37.2 21.9 0.3 8.0 9.5 21.6 27.3 33.1 24.3 29.6 2.1 51.1 12.7 17.0 17.9 47.2 11.8 13.0 0.0 0.1 9.5 15.8 0.1 18.2 3.5 5.9 3.1 22.1 7.0 15.8 15.0 20.2 16.6 21.9 12.4 17.8 19.9 0.2 15.3 6.5 13.6 31.3 13.6 10.0 10.3 9.2 12.4 10.1 9.5 8.8 9.4 8.2 9.2 13.0 9.0 4.3 0.0 6.4 3.3 6.6 1.7 1.0 5.9 16.5 1.1 5.2 4.2 50.0 7.2 3.0 7.3 10.4 6.1 3.0 20.1 13.7 20.9 1.5 1.4 1.9 4.0 15.7 8.4 2.9 33.2 3.2 7.0 11.7 2.1 13.4 1.9 4.2 27.7 14.9 1.7 3.1 15.5 10.2 3.8 1.6 1.1 5.9 5.6 5.4 1.0 18.5 5.5 7.2 3.0 1.7 21.8 8.6 8.2 7.9 0.4 27.5 36.5 3.3 4.9 6.6 1.4 9.8 0.3 4.8 8.5 0.4 8.2 5.8 1.7 18.8 0.4 ACOT4 "FLJ31235, PTE-Ib, PTE2B" ENSG00000177465 "Acyl-CoA thioesterase 4" Q8N9L9 14 73591873-73595766 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 15.0;liver: 16.8" "Cell type enhanced" "Detected in many" "Hepatocytes: 26.4;Proximal tubular cells: 59.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 17.6;MCF7: 14.1;SK-BR-3: 27.9;T-47d: 69.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA000779 Enhanced NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 6: T47d - Mammary gland" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA000779: AB_1078093" "unprognostic (2.29e-3)" "unprognostic (2.53e-3)" "unprognostic (2.30e-1)" "unprognostic (2.29e-3)" "unprognostic (1.16e-1)" "unprognostic (2.11e-1)" "unprognostic (2.25e-2)" "unprognostic (3.10e-2)" "unprognostic (1.72e-2)" "unprognostic (9.56e-2)" "prognostic unfavorable (1.77e-4)" "unprognostic (3.95e-1)" "prognostic favorable (8.43e-5)" "unprognostic (2.47e-1)" "unprognostic (1.92e-1)" "unprognostic (7.31e-2)" "unprognostic (1.73e-1)" 4.9 1.4 3.7 1.1 3.7 0.6 4.6 4.2 4.3 3.9 2.4 3.0 4.3 0.8 2.6 1.5 0.9 0.9 0.9 3.6 2.9 15.0 16.8 3.6 1.3 3.1 2.7 0.9 1.5 1.0 0.4 1.8 3.3 1.4 3.4 0.8 1.7 1.8 0.6 0.6 3.3 1.5 2.5 1.5 2.0 2.2 2.9 1.0 1.3 0.6 1.3 1.2 0.9 3.2 10.7 2.9 0.3 0.1 1.3 0.6 0.0 0.6 0.0 0.7 1.2 0.3 17.6 0.0 0.6 1.0 0.0 1.1 0.0 0.1 0.1 5.8 0.1 0.0 3.5 0.0 2.0 0.0 9.5 0.8 1.3 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.6 14.1 0.3 1.9 0.9 3.7 2.8 0.0 0.0 0.0 0.4 5.2 1.5 0.3 6.9 27.9 2.1 0.1 69.7 10.5 0.2 0.0 6.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 11.5 0.0 1.4 14.7 0.6 7.3 2.1 6.9 8.4 0.4 3.3 4.0 8.5 0.0 7.2 0.2 0.9 7.2 5.3 3.7 3.7 4.2 4.3 3.6 2.9 3.1 2.7 3.3 2.5 2.9 3.2 0.4 0.0 2.7 1.0 1.0 0.3 1.1 3.8 1.2 0.2 5.5 4.2 1.7 7.2 2.8 11.0 0.0 15.9 3.6 8.3 15.6 4.2 1.8 4.1 1.1 0.5 0.0 0.0 1.4 9.2 13.8 1.5 3.1 5.6 5.7 4.1 0.0 26.4 11.2 1.7 0.8 3.2 8.2 3.0 0.3 5.3 0.3 2.1 0.0 1.9 1.0 0.7 11.3 0.5 0.3 6.2 2.6 0.4 1.5 1.1 15.7 59.8 2.9 0.5 0.0 1.5 1.1 3.2 15.8 2.6 0.3 4.5 5.1 0.4 2.6 1.3 ACOT6 C14orf42 ENSG00000205669 "Acyl-CoA thioesterase 6" Q3I5F7 14 73610945-73619888 "Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.0;kidney: 3.7;liver: 3.1;skeletal muscle: 4.0" "Cell type enhanced" "Detected in some" "Astrocytes: 2.3;Excitatory neurons: 2.7;Hepatocytes: 3.4;Inhibitory neurons: 2.8;Proximal tubular cells: 5.7" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 5.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "T-47d: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058258 Uncertain NA NA "Cluster 39: Non-specific - Mitochondria" "Cluster 6: T47d - Mammary gland" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA058258: AB_2683656" "unprognostic (1.88e-1)" "unprognostic (1.77e-1)" "unprognostic (5.17e-2)" "unprognostic (1.24e-1)" "unprognostic (3.15e-2)" "unprognostic (6.52e-2)" "unprognostic (1.25e-1)" "unprognostic (5.07e-2)" "unprognostic (2.28e-1)" "unprognostic (5.04e-1)" 1.7 0.6 0.8 0.1 1.3 0.0 0.1 5.0 2.5 0.0 2.1 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.8 1.2 0.0 3.7 3.1 0.1 0.1 0.6 0.3 0.5 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.2 0.0 4.0 0.0 0.1 0.0 0.4 0.2 0.0 0.5 0.5 0.0 0.8 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.6 1.8 0.1 0.0 10.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.3 5.0 2.5 1.2 0.0 0.6 0.3 1.0 0.4 0.5 0.8 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 2.8 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DNAL1 "1700010H15RiK, C14orf168, CILD16, MGC12435" ENSG00000119661 "Dynein axonemal light chain 1" Q4LDG9 14 73644875-73703732 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Motor protein" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 55.2" "Cell type enhanced" "Detected in all" "Early spermatids: 335.4;Endometrial ciliated cells: 104.0;Respiratory ciliated cells: 141.4;Spermatocytes: 187.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053129, HPA060974" Approved Approved "Nucleoplasm,Centriolar satellite" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Centriolar satellite" "HPA053129: AB_2682051, HPA060974: " "unprognostic (1.11e-1)" "unprognostic (1.13e-2)" "unprognostic (2.27e-2)" "unprognostic (4.31e-2)" "unprognostic (1.66e-1)" "unprognostic (4.34e-1)" "unprognostic (4.25e-3)" "unprognostic (2.80e-1)" "unprognostic (2.91e-1)" "unprognostic (2.36e-2)" "unprognostic (3.16e-2)" "unprognostic (1.06e-1)" "prognostic favorable (5.17e-8)" "unprognostic (9.18e-2)" "unprognostic (1.25e-1)" "unprognostic (1.86e-2)" "unprognostic (3.26e-1)" 7.5 6.2 8.3 6.2 11.0 6.1 5.1 12.2 10.0 5.9 18.5 4.7 2.7 7.9 12.2 4.6 23.7 9.3 9.2 13.0 9.6 11.2 3.7 7.7 5.2 8.8 11.0 7.5 6.1 14.7 8.4 4.7 8.9 5.7 5.5 18.1 4.4 7.0 5.2 3.0 3.0 9.5 7.6 4.7 5.6 55.2 11.2 6.1 16.4 5.9 4.5 6.1 3.3 8.8 15.4 11.2 13.5 12.3 9.3 11.8 10.7 15.2 11.6 19.3 20.0 11.7 23.9 6.1 11.1 16.2 18.4 9.2 12.8 11.7 28.0 9.0 5.3 5.1 16.7 4.3 9.7 5.9 5.8 9.0 9.0 21.3 15.2 14.8 12.7 9.7 5.8 13.7 23.8 25.2 15.4 7.0 6.3 12.7 10.9 10.7 20.2 2.6 16.1 16.1 20.7 9.8 25.0 4.8 12.2 10.3 26.7 3.9 12.0 24.1 43.8 18.2 14.3 7.8 18.2 13.4 19.9 3.1 17.2 4.3 2.3 2.5 2.7 2.5 3.8 2.7 2.6 2.7 2.1 4.1 2.3 2.6 2.1 2.1 2.1 5.9 2.6 1.3 8.3 11.0 12.2 10.0 13.0 9.6 8.8 11.0 8.9 7.6 11.2 8.8 10.8 19.2 14.9 11.4 6.3 3.2 7.4 19.8 2.2 16.0 9.4 5.7 14.4 15.7 23.1 18.4 60.5 5.4 5.4 5.7 9.8 15.5 335.4 104.0 20.4 11.2 10.2 4.8 21.7 14.0 9.3 12.9 7.7 16.4 10.1 11.8 11.0 5.3 8.4 15.2 15.5 6.1 18.3 6.7 7.9 57.8 17.4 6.9 12.4 6.5 6.5 19.9 12.3 10.1 5.8 12.3 4.1 16.6 5.8 5.9 1.7 24.9 141.4 40.2 13.1 21.6 12.4 187.7 24.7 2.1 2.0 2.5 6.2 11.9 5.6 5.0 PNMA1 MA1 ENSG00000176903 "PNMA family member 1" Q8ND90 14 73711783-73714384 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 84.2;Peritubular cells: 84.7;Spermatocytes: 87.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003817, HPA015007" Enhanced Supported "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 57: Non-specific - Angiogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol "Nucleoplasm, Focal adhesion sites" "HPA003817: AB_1079646, HPA015007: AB_1855502" "unprognostic (2.82e-2)" "unprognostic (3.26e-1)" "unprognostic (9.50e-2)" "unprognostic (1.10e-1)" "unprognostic (2.96e-1)" "prognostic unfavorable (7.49e-5)" "prognostic unfavorable (3.00e-5)" "unprognostic (2.90e-1)" "unprognostic (5.35e-2)" "unprognostic (3.63e-1)" "unprognostic (5.58e-2)" "unprognostic (4.58e-2)" "unprognostic (1.67e-3)" "unprognostic (2.04e-3)" "unprognostic (4.17e-2)" "unprognostic (2.23e-3)" "prognostic unfavorable (4.51e-5)" 35.5 30.2 75.0 20.3 80.5 8.8 20.6 55.5 85.6 37.6 34.7 56.7 13.9 46.3 54.6 23.4 38.1 24.6 23.3 77.3 90.0 27.8 4.9 15.5 16.4 62.1 62.5 53.4 9.2 8.0 53.1 21.4 62.9 48.8 16.5 59.9 10.9 89.3 12.0 9.8 24.9 52.3 66.9 19.2 26.0 71.0 78.4 19.0 18.5 10.4 12.5 41.7 26.6 70.3 48.2 42.8 72.3 54.1 53.1 56.0 29.9 49.8 27.8 44.5 32.5 40.6 29.2 1.1 33.8 60.7 42.4 31.6 56.0 29.4 45.7 45.7 34.7 27.2 35.8 30.7 56.8 15.3 41.6 49.8 35.1 53.4 33.5 87.4 68.1 28.7 23.9 29.3 61.2 117.6 30.5 37.1 21.8 24.6 149.0 47.5 45.0 1.1 58.8 1.5 85.4 65.5 87.5 19.9 40.4 43.6 97.0 25.6 66.5 89.3 71.7 54.9 41.1 25.7 42.9 14.2 88.3 21.4 30.3 2.9 1.8 4.7 8.5 3.5 5.8 2.8 10.9 8.7 3.9 3.1 10.4 10.0 1.6 5.6 5.3 0.6 14.2 7.3 75.0 80.5 55.5 85.6 77.3 90.0 62.1 62.5 62.9 66.9 78.4 70.3 13.1 6.4 3.0 21.9 8.8 3.8 6.8 5.0 6.2 48.6 7.0 7.5 19.9 2.8 4.1 14.7 12.5 7.5 10.4 6.7 15.6 10.1 84.2 32.2 30.6 13.5 18.7 3.0 31.4 6.7 11.3 20.5 14.3 10.2 16.5 16.6 20.0 1.6 15.6 58.9 28.9 5.4 14.2 6.8 25.9 57.6 32.6 18.8 19.6 12.2 14.1 65.2 10.3 17.1 21.7 30.2 1.4 84.7 10.9 7.4 1.6 26.6 23.1 49.1 72.3 31.2 44.1 87.2 44.4 4.7 3.8 6.0 20.0 43.8 2.5 3.7 MIDEAS "C14orf117, C14orf43, ELMSAN1, LSR68" ENSG00000156030 "Mitotic deacetylase associated SANT domain protein" Q6PJG2 14 73715122-73790285 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 59.4;Cardiomyocytes: 21.0;Cytotrophoblasts: 41.3;dendritic cells: 15.8;Extravillous trophoblasts: 32.5;Hofbauer cells: 25.8;Syncytiotrophoblasts: 29.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "HMC-1: 61.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003111 Approved Enhanced Nucleoplasm NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA003111: AB_1078329" "unprognostic (1.54e-3)" "unprognostic (2.69e-1)" "unprognostic (2.83e-1)" "unprognostic (9.69e-3)" "unprognostic (4.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.03e-2)" "unprognostic (1.12e-1)" "unprognostic (8.55e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (2.02e-1)" "unprognostic (2.89e-1)" "unprognostic (3.36e-3)" "unprognostic (7.35e-2)" "unprognostic (2.44e-1)" "unprognostic (1.11e-1)" "unprognostic (1.96e-1)" 9.0 5.0 4.1 9.3 4.2 14.5 6.6 5.1 5.2 6.4 0.4 7.1 7.7 7.3 1.3 9.3 6.7 9.2 6.7 2.6 4.0 3.0 4.7 6.9 9.3 5.3 2.3 11.3 5.9 9.7 2.6 8.8 1.6 5.7 3.9 2.9 7.8 5.8 10.1 11.8 8.8 6.5 0.4 13.7 7.5 5.4 5.5 5.8 6.2 5.9 5.6 5.7 6.2 7.9 12.8 14.1 5.0 9.4 4.6 7.8 9.6 5.1 8.7 7.0 6.3 12.5 14.8 18.5 5.6 7.0 7.3 19.3 8.3 14.5 2.8 24.6 5.1 29.7 12.8 4.5 7.4 5.2 61.9 10.4 8.8 6.1 7.6 6.1 11.2 6.4 15.5 16.7 3.4 29.7 12.0 8.3 1.6 6.4 11.7 13.8 27.0 4.9 10.4 13.5 6.4 5.3 19.3 26.4 10.3 2.8 20.3 10.8 22.6 14.3 16.3 10.8 5.6 13.0 6.7 20.4 11.7 6.3 17.0 0.6 0.5 0.2 0.3 0.2 0.4 0.4 0.1 0.3 0.6 0.7 0.2 0.2 0.8 0.5 0.3 1.2 0.4 0.4 4.1 4.2 5.1 5.2 2.6 4.0 5.3 2.3 1.6 0.4 5.5 7.9 59.4 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 41.3 15.8 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 32.5 9.4 0.0 0.0 0.0 0.0 0.0 0.0 25.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 29.4 3.6 0.0 0.0 0.0 PTGR2 "FLJ39091, ZADH1" ENSG00000140043 "Prostaglandin reductase 2" Q8N8N7 14 73851844-73886827 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 43.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 6.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 41.9" HPA001125 Approved Approved Vesicles NA NA 36000 "Cluster 34: Basophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 6: T47d - Mammary gland" "Cluster 39: Non-specific - Basic cellular processes" Vesicles "HPA001125: AB_2666207" "unprognostic (3.82e-2)" "unprognostic (2.79e-2)" "unprognostic (6.05e-2)" "unprognostic (3.26e-1)" "unprognostic (2.28e-1)" "unprognostic (1.40e-1)" "unprognostic (1.39e-1)" "unprognostic (1.96e-2)" "unprognostic (2.80e-1)" "unprognostic (8.10e-3)" "unprognostic (6.99e-3)" "unprognostic (5.96e-1)" "prognostic favorable (4.55e-12)" "unprognostic (4.42e-2)" "unprognostic (1.03e-1)" "unprognostic (1.33e-1)" "unprognostic (7.24e-2)" 6.9 12.2 10.4 2.8 11.5 0.9 9.1 11.1 12.1 4.8 11.6 7.2 12.1 4.6 17.2 5.0 12.0 5.2 27.1 9.9 11.7 18.9 19.1 5.6 3.1 11.8 11.9 7.4 5.3 10.6 7.6 2.4 12.1 9.1 5.7 10.7 6.7 5.4 32.8 6.9 8.9 2.6 11.3 3.4 6.2 6.2 10.6 3.0 12.6 32.1 2.6 4.2 4.1 13.9 8.9 11.9 9.6 4.7 7.6 16.3 7.6 3.0 4.1 3.6 5.6 6.8 21.2 0.9 6.8 3.0 8.4 8.8 8.7 6.5 6.6 6.7 4.1 6.2 5.5 3.0 3.8 2.3 2.2 7.7 15.1 5.5 4.4 7.8 1.8 6.1 8.3 1.8 8.2 12.7 6.2 5.9 10.7 11.9 11.6 7.6 3.7 1.5 19.7 8.6 12.7 11.0 7.7 8.1 9.8 9.1 41.9 3.7 2.7 5.3 10.0 3.9 6.6 10.2 4.7 2.8 8.3 5.5 7.2 6.7 1.1 0.9 0.6 0.4 0.6 1.0 1.1 0.5 1.3 1.0 1.8 1.5 0.8 1.3 1.2 1.5 1.1 1.0 10.4 11.5 11.1 12.1 9.9 11.7 11.8 11.9 12.1 11.3 10.6 13.9 4.5 19.2 13.0 10.7 2.9 6.8 12.8 16.7 6.2 8.9 8.4 5.5 43.2 8.6 12.9 18.4 14.6 6.3 2.0 8.6 25.4 11.7 2.4 21.5 5.8 5.2 4.8 4.2 8.0 8.7 2.5 6.1 5.1 7.3 3.8 9.3 3.3 14.3 7.4 33.7 10.3 10.0 10.2 5.5 3.1 2.0 7.2 4.3 8.8 5.6 4.0 22.3 6.2 7.1 20.4 8.7 11.1 6.8 2.9 7.2 24.8 18.4 31.6 20.8 6.6 9.9 6.1 42.1 18.8 3.5 6.7 4.0 2.9 17.3 11.7 7.7 ZNF410 "APA-1, APA1" ENSG00000119725 "Zinc finger protein 410" Q86VK4 14 73886617-73932521 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 27.7;Excitatory neurons: 22.7;Inhibitory neurons: 23.8;Oligodendrocytes: 31.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002871 Approved "Nuclear bodies" Yes No "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" "Nuclear bodies" "HPA002871: AB_1080712" "unprognostic (5.84e-2)" "unprognostic (5.04e-2)" "unprognostic (9.29e-2)" "unprognostic (6.36e-3)" "unprognostic (5.86e-4)" "unprognostic (4.91e-2)" "unprognostic (2.83e-3)" "unprognostic (2.10e-2)" "unprognostic (1.78e-1)" "unprognostic (1.81e-1)" "unprognostic (1.86e-3)" "unprognostic (1.29e-2)" "unprognostic (3.73e-2)" "unprognostic (2.79e-2)" "unprognostic (2.46e-1)" "unprognostic (3.21e-2)" "unprognostic (1.19e-1)" 29.0 33.0 26.8 18.7 30.4 57.7 29.4 30.9 33.9 30.0 28.9 30.6 19.0 27.5 43.7 33.4 28.1 22.6 21.0 26.3 28.0 33.0 28.8 27.6 25.6 29.1 27.5 38.7 20.6 27.1 27.0 32.2 29.6 29.5 24.4 22.8 24.4 27.3 21.1 37.6 25.2 28.4 26.7 26.1 25.7 44.7 28.3 29.9 24.6 18.3 30.7 29.1 28.7 37.0 46.7 35.8 42.4 45.2 44.8 39.8 52.4 51.4 56.9 88.2 82.0 37.6 40.1 38.4 21.7 65.7 28.2 42.1 42.9 52.8 83.2 56.2 26.9 36.2 31.6 29.9 67.4 30.6 45.6 37.0 72.4 44.5 83.1 39.5 47.5 43.9 38.2 33.0 43.3 88.6 45.8 51.2 15.5 56.3 41.7 40.7 48.5 24.7 57.0 43.7 39.0 50.3 57.2 52.5 54.6 35.5 48.3 52.2 30.7 62.7 59.0 37.1 47.2 45.2 83.4 48.0 40.1 34.1 53.7 65.9 45.3 74.8 47.5 43.1 51.9 37.7 49.0 49.0 45.6 43.0 42.3 43.5 34.4 60.5 50.1 30.8 46.7 55.9 26.8 30.4 30.9 33.9 26.3 28.0 29.1 27.5 29.6 26.7 28.3 37.0 4.3 0.0 3.1 27.7 10.8 0.6 1.5 1.0 10.8 1.5 2.2 1.7 1.1 0.0 2.9 0.0 4.2 1.8 5.0 1.7 0.0 1.0 3.8 4.7 5.6 2.6 0.0 5.9 22.7 0.9 1.5 5.3 10.7 6.7 10.8 2.9 1.8 0.4 1.2 1.7 23.8 1.1 0.0 2.2 3.1 1.1 1.2 5.4 1.8 18.7 1.1 2.4 2.1 18.1 31.0 1.3 1.4 0.4 13.4 1.0 2.4 0.7 0.2 4.7 0.0 4.0 5.1 3.3 1.9 10.1 1.1 2.6 10.5 4.1 0.8 1.4 FAM161B "C14orf44, FLJ31697" ENSG00000156050 "FAM161 centrosomal protein B" Q96MY7 14 73931501-73950414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 62.9;Late spermatids: 142.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019125 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 21: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Plasma membrane" "Vesicles, Cytosol" "HPA019125: AB_1845570" "unprognostic (1.50e-1)" "unprognostic (9.03e-2)" "unprognostic (6.35e-2)" "unprognostic (1.99e-1)" "unprognostic (9.51e-2)" "unprognostic (1.79e-2)" "unprognostic (1.76e-3)" "unprognostic (5.54e-2)" "unprognostic (1.81e-1)" "unprognostic (1.57e-1)" "unprognostic (7.83e-2)" "unprognostic (1.53e-1)" "prognostic favorable (6.78e-4)" "unprognostic (1.26e-1)" "unprognostic (1.37e-1)" "unprognostic (7.35e-2)" "unprognostic (1.60e-1)" 2.7 8.7 6.6 1.7 6.6 1.2 4.8 5.8 8.2 5.3 3.4 3.9 3.3 5.2 4.3 4.1 5.5 2.7 5.4 6.4 5.9 7.2 5.1 2.8 1.8 6.8 5.7 12.8 2.2 4.3 7.6 2.4 7.1 6.0 2.7 10.1 2.8 5.2 7.9 2.1 3.3 3.4 5.5 3.1 3.3 18.8 6.1 1.9 4.2 4.8 1.8 5.5 3.8 6.6 2.1 1.6 2.2 3.4 4.7 3.5 2.0 3.6 2.8 6.0 5.8 1.5 2.6 3.3 2.3 4.2 2.5 3.9 0.9 1.7 4.1 9.2 1.8 1.6 1.6 1.7 4.0 1.1 2.3 2.6 3.4 6.1 2.2 4.4 2.7 3.4 1.0 1.6 4.3 3.3 3.1 4.2 0.5 1.4 3.5 2.1 2.9 1.3 3.1 3.1 2.7 2.5 5.1 2.3 3.1 1.6 8.1 1.5 2.9 12.4 5.6 3.1 2.2 3.3 2.2 2.1 6.3 1.9 2.2 3.2 1.3 1.9 1.1 0.3 1.3 0.7 1.2 1.7 0.2 0.9 0.6 0.4 0.4 1.3 0.4 0.3 0.7 0.9 6.6 6.6 5.8 8.2 6.4 5.9 6.8 5.7 7.1 5.5 6.1 6.6 3.5 3.2 4.8 4.9 3.0 0.6 2.1 1.0 3.4 8.9 3.7 3.8 3.4 0.0 3.2 1.8 4.2 1.5 1.9 3.5 0.0 1.0 62.9 5.9 3.9 2.2 0.0 1.7 7.3 1.6 1.1 4.6 7.1 4.5 0.0 5.0 2.5 0.7 2.9 3.3 8.6 4.1 2.0 1.2 0.7 142.7 3.4 1.4 1.8 2.8 2.2 8.0 6.2 5.5 2.9 1.2 0.8 9.4 1.4 0.8 4.3 4.2 9.4 16.7 6.6 5.2 4.2 11.0 6.1 0.6 0.9 2.2 3.3 9.6 1.4 0.9 COQ6 CGI-10 ENSG00000119723 "Coenzyme Q6, monooxygenase" Q9Y2Z9 14 73949926-73963670 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Monooxygenase, Oxidoreductase" "Deafness, Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 167.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051371 Uncertain NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 6: T47d - Mammary gland" "Cluster 29: Early spermatids - Spermatogenesis" "HPA051371: AB_2681459" "unprognostic (1.41e-1)" "unprognostic (1.35e-2)" "unprognostic (2.26e-2)" "unprognostic (2.22e-1)" "unprognostic (1.12e-1)" "unprognostic (2.88e-1)" "unprognostic (1.75e-2)" "unprognostic (2.77e-1)" "unprognostic (1.21e-1)" "unprognostic (8.33e-3)" "unprognostic (9.45e-3)" "unprognostic (2.90e-1)" "prognostic favorable (1.05e-6)" "unprognostic (1.19e-1)" "unprognostic (1.94e-1)" "unprognostic (7.46e-2)" "unprognostic (1.89e-1)" 11.2 38.4 10.5 5.6 11.0 5.5 12.0 10.9 13.1 12.1 15.5 13.0 10.2 10.0 11.3 10.1 10.5 6.7 32.0 10.8 11.1 23.0 25.7 7.4 6.3 10.6 10.6 11.5 7.0 25.1 15.9 8.0 10.6 12.6 9.5 5.8 11.1 9.9 38.6 9.3 10.8 9.8 10.7 11.3 13.4 22.0 11.0 7.3 12.3 42.6 7.0 13.6 10.5 11.1 12.2 21.7 11.1 25.7 13.2 10.7 15.4 14.8 13.6 21.8 18.4 16.4 21.0 10.7 13.7 15.3 15.0 19.1 16.6 14.8 20.6 16.3 13.3 7.2 12.8 14.3 18.0 7.2 24.9 18.1 19.2 19.9 19.5 14.1 13.9 21.5 6.4 9.6 19.2 33.3 12.4 11.7 4.0 24.8 26.0 11.7 14.1 7.6 22.9 15.2 16.6 8.8 25.2 21.5 14.6 7.2 36.4 13.3 9.4 24.8 22.9 19.0 10.8 8.9 9.0 9.0 13.7 10.6 17.1 5.4 11.3 9.2 11.3 14.2 11.3 10.3 11.2 11.3 12.1 5.3 15.6 9.4 2.3 14.5 13.1 8.9 7.6 8.5 10.5 11.0 10.9 13.1 10.8 11.1 10.6 10.6 10.6 10.7 11.0 11.1 11.9 25.6 25.5 6.2 11.4 4.7 8.1 26.9 6.8 18.9 12.3 12.4 10.3 11.5 23.1 12.9 12.5 26.3 4.1 8.3 19.6 10.8 167.0 14.1 11.0 9.1 4.8 7.4 10.0 10.9 12.6 11.9 12.2 9.9 25.3 13.9 11.4 14.7 16.2 20.2 10.0 9.7 20.3 5.4 4.2 49.5 10.8 7.5 10.6 3.7 9.6 12.0 15.5 5.0 8.4 8.6 8.4 12.4 10.6 6.0 23.3 41.3 15.8 28.1 19.7 10.5 20.5 24.7 21.0 11.5 6.0 23.8 11.9 39.9 9.4 7.1 ENTPD5 "CD39L4, NTPDase-5, PCPH" ENSG00000187097 "Ectonucleoside triphosphate diphosphohydrolase 5 (inactive)" O75356 14 73958010-74019399 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Hydrolase Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 107.2;kidney: 95.2;liver: 263.7" "Cell type enhanced" "Detected in all" "Distal enterocytes: 209.3;Hepatocytes: 134.8;Intestinal goblet cells: 77.1;Proximal enterocytes: 87.0" "Group enriched" "Detected in all" 5 "liver cancer: 18.2;prostate cancer: 39.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 18.3;eosinophil: 9.4" "Lineage enriched" "Detected in many" 7 "granulocytes: 18.3" "Cell line enhanced" "Detected in all" "RT4: 57.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002927 Enhanced "Secreted to blood" NA NA 5900000 "Cluster 46: Basophils - DNA binding" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 15: RT4 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA002927: AB_1078744" "unprognostic (4.19e-1)" "unprognostic (9.63e-3)" "unprognostic (3.11e-2)" "unprognostic (2.06e-2)" "unprognostic (1.98e-1)" "unprognostic (3.87e-2)" "unprognostic (1.46e-1)" "unprognostic (1.19e-1)" "unprognostic (3.34e-1)" "unprognostic (6.01e-2)" "unprognostic (6.20e-2)" "unprognostic (2.55e-1)" "prognostic favorable (3.95e-5)" "unprognostic (1.25e-1)" "unprognostic (5.06e-2)" "unprognostic (1.76e-1)" "unprognostic (6.92e-3)" 8.2 7.7 5.0 11.4 7.3 8.0 12.4 7.1 6.7 7.3 7.1 94.6 72.1 6.3 7.7 11.3 5.7 12.1 7.7 5.1 6.3 95.2 263.7 6.5 5.5 7.6 7.3 6.7 4.9 7.7 5.0 5.6 7.8 37.7 107.2 9.4 10.7 4.4 15.0 8.1 68.4 9.7 6.5 6.0 42.3 8.6 7.3 4.6 6.1 9.1 5.6 16.9 7.2 9.0 9.5 7.8 8.2 15.1 16.5 15.5 9.4 9.6 7.9 6.4 7.1 5.6 10.9 10.6 4.7 12.8 6.0 10.8 8.5 14.1 7.2 8.8 4.0 7.9 5.7 30.9 15.5 4.7 8.8 12.9 14.0 8.7 18.2 8.8 13.1 17.1 8.8 15.4 9.7 13.6 5.4 5.6 2.5 8.5 15.7 6.0 8.0 5.2 11.4 57.1 5.8 6.0 16.6 12.9 9.2 6.4 18.7 4.1 10.8 12.6 12.7 7.5 7.2 10.1 16.9 8.3 8.0 8.8 11.5 18.3 1.2 9.4 2.5 2.3 1.3 1.4 1.3 1.8 1.7 1.5 2.1 2.1 0.1 0.5 1.4 0.9 1.6 1.3 5.0 7.3 7.1 6.7 5.1 6.3 7.6 7.3 7.8 6.5 7.3 9.0 8.0 16.0 6.7 8.1 4.9 3.7 6.2 8.9 5.2 6.6 15.0 7.9 5.2 10.0 11.3 7.3 4.2 8.2 4.3 209.3 25.4 6.9 19.5 10.0 13.6 7.0 16.2 36.6 5.9 12.9 6.7 7.9 23.0 25.8 1.3 9.6 9.7 134.8 6.2 10.1 8.2 77.1 14.2 9.7 1.9 12.7 2.8 5.2 5.4 11.2 5.4 4.9 8.2 2.0 11.3 9.1 58.4 5.7 3.6 28.5 87.0 63.1 6.4 12.2 13.1 6.0 5.9 27.2 19.1 8.5 3.4 3.3 4.9 10.3 60.9 39.0 BBOF1 "C14orf45, CCDC176, FBB10" ENSG00000119636 "Basal body orientation factor 1" Q8ND07 14 74019349-74082863 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 38.6" "Group enriched" "Detected in many" 4 "Early spermatids: 239.3;Endometrial ciliated cells: 166.4;Late spermatids: 111.3;Respiratory ciliated cells: 177.8;Spermatocytes: 149.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003090, HPA003136, HPA075108" Approved Approved "Nucleoplasm,Plasma membrane,Centriolar satellite" NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Plasma membrane" "Centriolar satellite" "HPA003090: AB_1845571, HPA003136: AB_1078330, HPA075108: " "unprognostic (1.84e-2)" "unprognostic (1.31e-1)" "unprognostic (5.71e-2)" "prognostic favorable (6.34e-4)" "unprognostic (1.11e-2)" "unprognostic (1.29e-2)" "unprognostic (1.28e-2)" "unprognostic (2.08e-1)" "unprognostic (1.85e-1)" "unprognostic (4.62e-2)" "unprognostic (1.01e-1)" "unprognostic (3.89e-1)" "unprognostic (1.40e-3)" "unprognostic (6.14e-2)" "unprognostic (2.57e-1)" "unprognostic (7.93e-2)" "unprognostic (6.04e-3)" 4.9 2.8 5.8 2.3 6.3 6.5 7.3 5.5 9.0 6.5 15.9 7.1 2.0 7.1 14.6 5.2 22.5 5.7 4.4 6.3 5.8 9.7 2.2 6.8 1.7 9.7 9.8 5.1 2.8 5.0 10.7 2.4 8.3 5.5 3.5 24.3 3.8 7.1 2.3 3.1 2.4 5.5 8.0 1.4 3.4 38.6 6.2 2.8 13.2 3.3 2.1 5.0 3.1 6.6 5.4 3.1 1.3 8.7 5.7 12.5 1.1 4.6 6.5 4.6 4.3 1.1 3.7 5.3 1.2 5.7 2.0 1.3 1.8 0.8 5.2 0.8 1.0 0.6 3.1 1.2 4.8 2.7 0.3 6.1 4.2 10.3 1.3 7.3 1.7 9.7 2.9 0.9 3.4 4.3 8.5 1.3 0.4 0.5 2.1 3.0 3.4 0.9 7.9 1.4 5.2 3.3 9.0 3.6 2.6 1.3 9.2 0.2 3.8 5.7 4.0 7.6 1.3 1.9 4.9 3.3 16.7 0.3 1.6 1.1 0.0 0.1 1.5 0.0 1.8 0.5 1.4 1.0 0.1 0.6 1.9 1.5 1.0 1.1 0.0 2.4 0.3 1.2 5.8 6.3 5.5 9.0 6.3 5.8 9.7 9.8 8.3 8.0 6.2 6.6 3.8 12.8 8.1 0.0 1.4 0.0 3.8 0.0 4.0 7.8 15.8 8.0 0.0 7.2 30.3 3.7 29.2 1.8 3.9 1.8 15.6 9.0 239.3 166.4 15.1 3.1 2.4 39.6 0.0 3.5 2.6 7.4 2.0 18.2 1.3 4.3 3.6 4.5 2.3 6.7 0.0 2.7 0.0 1.6 0.0 111.3 10.8 3.9 0.0 0.0 0.8 5.7 4.1 0.0 0.0 3.0 0.2 6.0 0.7 2.5 1.0 23.5 177.8 29.9 0.0 4.3 4.0 149.2 14.7 1.3 0.0 1.0 2.3 4.1 0.9 3.4 ALDH6A1 MMSDH ENSG00000119711 "Aldehyde dehydrogenase 6 family member A1" Q02252 14 74056847-74084492 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "kidney: 379.1;liver: 367.1" "Cell type enhanced" "Detected in all" "Distal tubular cells: 201.5;Hepatocytes: 523.6;Proximal tubular cells: 962.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 43.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 43.2" "Cell line enhanced" "Detected in all" "T-47d: 57.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029072, HPA029073, HPA029074, HPA029075" Enhanced Enhanced Mitochondria No No 37000 "Cluster 2: Granulocytes - Unknown function" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 6: T47d - Mammary gland" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria "HPA029072: AB_10599176, HPA029073: AB_10601877, HPA029074: AB_10601000, HPA029075: AB_10602005" "unprognostic (1.45e-1)" "unprognostic (5.38e-2)" "unprognostic (6.89e-2)" "unprognostic (6.95e-3)" "unprognostic (1.46e-1)" "unprognostic (7.93e-2)" "unprognostic (1.11e-3)" "prognostic favorable (4.22e-4)" "unprognostic (1.58e-1)" "unprognostic (9.10e-2)" "unprognostic (3.11e-2)" "unprognostic (2.13e-1)" "prognostic favorable (2.00e-15)" "unprognostic (4.59e-1)" "unprognostic (1.92e-1)" "unprognostic (6.05e-3)" "unprognostic (1.12e-1)" 38.7 14.7 58.6 4.8 66.0 3.3 14.4 58.8 59.3 17.3 61.4 15.2 26.6 11.4 9.8 9.8 12.8 9.4 40.3 51.0 54.0 379.1 367.1 9.4 5.1 63.3 54.0 28.3 23.4 37.0 6.6 7.6 55.6 25.4 15.8 15.2 19.8 16.1 27.5 6.2 23.4 9.0 56.4 5.4 24.0 17.1 69.8 5.7 28.3 34.8 5.3 11.4 7.0 62.6 8.9 7.8 11.0 23.5 39.3 19.2 17.5 6.3 11.8 6.8 11.5 17.3 10.2 10.5 13.6 13.5 5.3 4.8 24.9 7.0 14.5 9.5 3.5 5.1 8.0 19.2 45.0 2.7 2.4 28.2 12.0 8.7 20.7 17.0 12.0 23.7 8.1 14.7 4.6 36.2 7.6 4.0 8.7 32.6 5.2 15.1 11.2 14.6 9.2 5.8 4.4 7.0 21.0 21.9 5.7 18.0 57.5 9.6 3.8 7.4 9.0 11.7 2.4 9.3 18.9 10.2 9.9 3.2 7.3 29.1 6.2 43.2 6.9 4.8 10.6 7.2 7.8 8.4 9.2 6.1 9.9 7.0 2.4 9.7 4.2 5.3 6.1 4.9 58.6 66.0 58.8 59.3 51.0 54.0 63.3 54.0 55.6 56.4 69.8 62.6 15.4 38.5 60.4 24.5 11.8 9.2 26.8 10.0 20.5 20.6 28.4 18.9 81.4 67.2 22.9 66.2 4.2 31.0 7.1 18.9 201.5 11.6 23.4 26.2 27.5 27.0 16.9 28.6 5.5 3.1 14.8 25.9 34.7 90.2 7.6 27.1 87.4 523.6 17.7 11.8 10.0 39.3 8.2 26.5 8.9 19.0 28.9 13.4 24.9 1.9 15.8 98.5 9.2 12.5 23.4 4.1 16.3 48.2 8.0 27.6 55.3 962.4 15.4 17.0 13.1 25.6 16.9 11.0 4.2 25.2 7.4 30.6 11.0 10.2 35.7 17.2 LIN52 C14orf46 ENSG00000205659 "Lin-52 DREAM MuvB core complex component" Q52LA3 14 74084796-74201235 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 47.5;Inhibitory neurons: 65.4;Oligodendrocyte precursor cells: 60.3;Oligodendrocytes: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000900, HPA001777" Uncertain Approved "Nuclear speckles" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 44: HDLM-2 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nuclear speckles" "HPA000900: AB_2135058, HPA001777: AB_2666431" "unprognostic (2.34e-2)" "unprognostic (6.51e-3)" "unprognostic (1.86e-1)" "unprognostic (1.94e-1)" "unprognostic (7.90e-3)" "prognostic favorable (6.60e-4)" "prognostic unfavorable (6.08e-5)" "unprognostic (2.48e-3)" "unprognostic (9.34e-2)" "unprognostic (8.65e-2)" "unprognostic (1.39e-3)" "unprognostic (3.18e-1)" "unprognostic (1.74e-3)" "unprognostic (1.20e-2)" "unprognostic (8.28e-2)" "unprognostic (2.43e-2)" "unprognostic (1.04e-1)" 8.0 7.8 8.4 5.4 8.4 3.5 6.3 8.8 10.1 5.8 7.8 4.5 6.5 7.0 5.7 4.9 5.5 4.9 10.2 8.3 10.0 19.3 6.6 5.0 6.1 9.2 8.9 8.5 3.4 6.8 5.7 5.0 9.3 6.4 5.7 10.7 3.9 5.6 5.6 3.8 5.8 6.8 7.9 5.1 4.3 7.5 8.9 10.7 5.1 10.0 6.3 5.8 3.9 8.5 10.5 7.7 26.8 12.8 15.5 6.6 10.5 17.5 16.7 23.0 25.7 14.0 9.6 5.9 5.3 8.6 9.2 9.2 20.4 6.9 35.1 49.1 8.1 9.1 8.9 20.0 16.6 9.4 12.7 8.2 7.7 12.2 15.9 6.3 11.0 18.6 9.7 27.8 11.4 13.4 14.9 12.3 7.7 13.8 12.3 19.0 25.1 9.6 6.0 6.2 19.0 15.5 16.4 12.0 13.7 9.9 16.3 13.5 6.3 10.8 20.3 11.5 14.8 18.2 41.8 13.2 12.5 10.7 18.4 6.2 6.4 20.6 10.7 6.6 16.6 8.7 9.3 10.7 8.6 9.4 13.7 12.5 3.2 11.4 4.8 7.9 13.9 10.1 8.4 8.4 8.8 10.1 8.3 10.0 9.2 8.9 9.3 7.9 8.9 8.5 5.6 9.6 9.0 39.8 10.4 4.8 3.2 3.2 11.4 8.8 7.6 5.3 10.0 10.0 6.6 5.5 8.4 6.3 8.8 3.5 7.9 3.1 0.8 5.9 6.6 7.4 3.0 16.4 47.5 2.4 5.2 8.1 6.1 6.7 2.5 9.0 6.4 12.2 6.3 16.8 65.4 6.0 4.1 4.3 3.7 1.6 5.3 4.5 0.0 26.2 6.6 10.8 10.3 60.3 60.4 2.4 5.0 9.8 27.3 3.3 10.9 22.4 6.2 7.5 6.6 8.1 6.4 16.3 10.4 10.3 5.5 8.8 8.2 3.7 4.7 1.4 VSX2 "CHX10, HOX10, RET1" ENSG00000119614 "Visual system homeobox 2" P58304 14 74239449-74262738 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding, Repressor" "Cataract, Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 43 "retina: 73.6" "Group enriched" "Detected in some" 10 "Bipolar cells: 152.4;Muller glia cells: 86.0" "Cancer enriched" "Detected in single" 34 "testis cancer: 2.5" "Region enhanced" "Detected in some" "pons: 1.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "midbrain: 1.3;pons and medulla: 1.7" "Region enhanced" "Detected in single" "pons: 1.7" HPA003436 Enhanced NA NA "Cluster 79: Retina - Phototransduction" "Cluster 56: Bipolar cells - Visual perception" "HPA003436: AB_1078523" "unprognostic (2.87e-1)" "unprognostic (1.22e-1)" "unprognostic (2.79e-1)" "unprognostic (3.29e-1)" "unprognostic (3.21e-4)" "unprognostic (7.77e-2)" "unprognostic (8.39e-4)" "unprognostic (3.13e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 73.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.2 0.5 1.7 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 152.4 0.0 0.0 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.6 86.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ABCD4 "EST352188, P70R, PMP69, PXMP1L" ENSG00000119688 "ATP binding cassette subfamily D member 4" O14678 14 74285269-74303055 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003396 Approved NA NA "Cluster 35: T-regs - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 52: Non-specific - Transcription" "HPA003396: AB_1078078" "unprognostic (3.92e-2)" "unprognostic (3.02e-1)" "unprognostic (3.01e-3)" "unprognostic (5.86e-2)" "unprognostic (3.69e-1)" "unprognostic (1.67e-1)" "unprognostic (5.72e-2)" "unprognostic (4.34e-2)" "unprognostic (3.46e-2)" "unprognostic (4.63e-2)" "unprognostic (2.21e-3)" "unprognostic (5.26e-2)" "unprognostic (2.35e-2)" "unprognostic (1.25e-1)" "unprognostic (6.69e-2)" "unprognostic (7.45e-3)" "unprognostic (7.93e-3)" 6.6 4.7 3.0 3.9 3.4 4.6 6.4 4.0 5.4 5.8 2.9 5.4 8.8 4.9 2.1 4.8 8.5 7.7 6.0 3.0 3.3 5.4 7.7 5.8 6.6 4.2 3.4 6.9 6.0 3.8 3.9 7.4 3.7 3.6 4.0 3.3 4.0 3.5 3.9 4.1 8.7 5.2 2.8 6.2 4.5 3.4 3.6 5.5 7.2 2.0 3.8 4.5 4.3 4.5 2.6 3.1 7.9 6.2 6.4 4.3 9.8 3.9 5.6 5.8 6.0 6.5 13.7 4.3 7.4 5.9 3.2 9.2 6.0 5.4 3.0 3.9 3.8 2.3 5.1 5.2 2.1 2.9 4.4 10.4 2.4 4.1 2.8 3.0 9.9 5.4 4.3 1.9 4.5 4.3 7.1 5.6 3.0 5.0 5.9 9.7 11.4 6.3 8.6 8.5 3.7 7.3 5.4 5.3 5.5 3.7 12.3 1.7 9.7 3.6 7.0 3.2 2.5 4.4 4.5 3.3 5.1 4.3 4.5 6.0 1.3 1.8 2.6 1.2 1.7 1.9 2.2 2.9 2.1 1.8 1.2 1.8 1.1 2.6 1.0 4.0 5.2 1.4 3.0 3.4 4.0 5.4 3.0 3.3 4.2 3.4 3.7 2.8 3.6 4.5 50.0 28.9 18.6 32.3 16.7 15.6 14.8 23.0 12.0 46.5 21.4 14.2 9.7 34.3 21.2 20.2 64.6 51.6 28.9 31.4 9.8 25.3 10.3 27.9 23.5 50.2 12.0 9.9 29.6 11.3 19.9 23.0 13.7 20.1 20.3 43.2 44.6 23.3 51.1 32.0 34.7 15.7 18.3 24.8 27.1 7.7 40.4 19.5 21.4 20.6 22.8 36.4 32.0 23.6 38.1 17.9 19.4 25.2 13.3 12.6 60.1 23.9 19.5 55.5 32.9 23.3 19.1 35.8 27.2 10.6 10.7 28.5 23.4 27.9 22.9 16.7 VRTN "C14orf115, FLJ10811, vertnin" ENSG00000133980 "Vertebrae development associated" Q9H8Y1 14 74303069-74360008 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 1.5;testis: 1.7" "Cell type enhanced" "Detected in single" "Spermatocytes: 2.7" "Cancer enriched" "Detected in single" 40 "testis cancer: 15.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "NTERA-2: 50.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA001460 Uncertain Approved Nucleoplasm NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "HPA001460: AB_1078318" "unprognostic (1.20e-1)" "unprognostic (4.31e-2)" "unprognostic (1.37e-1)" "unprognostic (5.98e-2)" "unprognostic (1.35e-1)" "unprognostic (3.78e-2)" "unprognostic (1.66e-1)" "unprognostic (1.77e-1)" 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 1.7 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.5 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 2.7 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 SYNDIG1L "capucin, DSPC1, IFITMD4, TMEM90A" ENSG00000183379 "Synapse differentiation inducing 1 like" A6NDD5 14 74405894-74426210 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 42 "brain: 468.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 2.7;Bipolar cells: 10.9;Inhibitory neurons: 4.8" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.1" "Region enriched" "Detected in all" 5 "basal ganglia: 468.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in all" 8 "basal ganglia: 280.7" "Region enriched" "Detected in many" 7 "basal ganglia: 125.1" "HPA042594, HPA048487" Uncertain NA NA "Cluster 65: Brain - Ion transport" "Cluster 56: Bipolar cells - Visual perception" "HPA042594: AB_2678069, HPA048487: AB_2680416" "unprognostic (5.75e-2)" "unprognostic (9.96e-3)" "unprognostic (2.25e-2)" "unprognostic (5.51e-2)" "unprognostic (3.08e-3)" "unprognostic (5.72e-2)" "unprognostic (5.83e-2)" "unprognostic (4.51e-2)" "unprognostic (2.83e-2)" "unprognostic (5.74e-2)" "unprognostic (8.85e-2)" "unprognostic (1.63e-1)" "unprognostic (3.85e-2)" "unprognostic (8.56e-2)" "unprognostic (1.50e-1)" "unprognostic (5.22e-2)" "unprognostic (7.34e-2)" 0.5 0.1 42.9 0.0 468.2 0.0 0.3 1.2 65.4 0.3 0.5 0.4 0.0 0.3 11.0 0.1 0.2 0.2 0.2 3.4 30.8 0.3 0.1 1.4 0.1 16.7 50.9 0.2 0.2 0.0 0.7 0.0 12.9 0.3 0.2 4.6 0.2 0.2 0.2 0.4 0.5 0.3 19.6 0.2 0.2 0.2 100.2 0.0 0.3 0.0 0.0 0.2 0.3 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.9 468.2 1.2 65.4 3.4 30.8 16.7 50.9 12.9 19.6 100.2 7.5 0.1 0.0 2.7 1.0 0.0 0.4 0.0 0.0 0.0 10.9 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 NPC2 "EDDM1, HE1, NP-C2" ENSG00000119655 "NPC intracellular cholesterol transporter 2" P61916 14 74476192-74494177 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Disease variant, Niemann-Pick disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 21 "epididymis: 16783.1" "Cell type enhanced" "Detected in all" "Alveolar cells type 2: 2034.2;Hofbauer cells: 2898.5;Kupffer cells: 2035.4" "Cancer enriched" "Detected in all" 5 "thyroid cancer: 769.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 668.7;classical monocyte: 1300.7;intermediate monocyte: 1772.7;myeloid DC: 587.8;neutrophil: 674.2;non-classical monocyte: 1252.1;plasmacytoid DC: 2113.2" "Group enriched" "Detected in all" 5 "dendritic cells: 2113.2;granulocytes: 674.2;monocytes: 1772.7" "Cell line enhanced" "Detected in all" "ASC diff: 1619.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000835, CAB032888" Enhanced "Secreted to blood" NA NA 53000000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 4: Macrophages - Innate immune response" "CAB032888: AB_2157036, HPA000835: AB_1079499" "unprognostic (1.27e-3)" "unprognostic (1.69e-2)" "prognostic unfavorable (4.83e-5)" "unprognostic (1.17e-1)" "unprognostic (1.82e-2)" "unprognostic (3.72e-2)" "prognostic unfavorable (3.13e-4)" "unprognostic (6.67e-3)" "unprognostic (3.26e-2)" "unprognostic (1.04e-1)" "unprognostic (9.15e-2)" "unprognostic (1.32e-1)" "unprognostic (3.11e-3)" "prognostic unfavorable (2.66e-4)" "unprognostic (1.97e-1)" "prognostic favorable (6.55e-4)" "unprognostic (1.42e-1)" 260.1 297.0 127.1 261.3 145.4 305.3 221.3 152.2 190.6 284.5 434.0 259.7 201.7 196.7 16783.1 185.0 170.0 356.0 215.1 118.1 156.9 322.4 202.4 786.0 360.3 185.7 145.6 283.1 219.9 241.3 197.5 263.1 179.2 164.2 220.8 48.6 221.9 261.3 58.7 181.6 193.3 180.5 151.1 305.6 206.8 156.8 172.1 134.4 444.7 114.7 241.9 347.4 187.9 195.5 297.2 199.3 124.8 179.4 1619.3 498.6 404.8 194.1 707.1 200.9 398.9 351.7 420.3 78.6 141.6 181.9 372.6 595.9 170.0 405.5 188.6 120.4 126.3 29.6 96.7 296.2 348.6 51.0 548.4 467.7 388.9 173.7 336.9 930.2 298.1 87.0 32.9 601.4 224.0 106.9 70.1 75.9 52.9 489.0 307.9 39.5 219.1 281.6 511.1 735.0 5.5 91.3 296.3 120.3 298.0 359.6 205.2 225.7 268.9 291.9 342.0 396.1 188.2 253.7 452.5 24.2 292.1 168.4 163.4 668.7 1300.7 274.1 92.2 1772.7 87.9 295.2 126.5 92.3 587.8 241.8 120.9 100.5 674.2 99.5 1252.1 2113.2 187.8 1304.5 127.1 145.4 152.2 190.6 118.1 156.9 185.7 145.6 179.2 151.1 172.1 195.5 154.9 381.4 2034.2 11.1 160.2 374.9 557.8 1074.2 170.2 9.9 138.6 220.5 55.4 163.0 626.9 331.1 22.9 228.3 664.0 301.0 305.2 500.4 90.9 123.8 168.5 276.5 119.7 65.4 2.1 279.4 803.3 318.1 61.7 161.0 341.4 104.2 447.3 195.6 2898.5 8.4 3.8 264.8 832.1 2035.4 750.9 69.6 566.7 1462.6 602.9 6.5 790.5 167.4 117.4 7.5 24.4 368.3 405.1 291.9 287.4 357.9 298.1 969.0 393.3 25.1 131.5 118.3 155.9 268.1 166.7 182.6 320.7 210.4 109.9 330.0 298.5 521.6 ISCA2 "HBLD1, ISA2" ENSG00000165898 "Iron-sulfur cluster assembly 2" Q86U28 14 74493756-74497106 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030492 Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 39: Non-specific - Basic cellular processes" "HPA030492: AB_10603772" "unprognostic (3.16e-2)" "unprognostic (2.44e-1)" "unprognostic (5.73e-2)" "unprognostic (5.62e-2)" "unprognostic (2.51e-1)" "unprognostic (5.89e-3)" "unprognostic (6.03e-3)" "unprognostic (7.98e-2)" "unprognostic (1.66e-1)" "unprognostic (2.59e-2)" "unprognostic (1.31e-2)" "unprognostic (2.21e-1)" "prognostic favorable (1.68e-7)" "unprognostic (3.98e-2)" "unprognostic (1.47e-1)" "prognostic favorable (8.98e-5)" "unprognostic (5.23e-2)" 15.1 33.9 20.3 9.7 20.6 15.5 16.9 22.4 23.9 13.7 27.4 16.9 14.2 11.0 46.4 15.4 19.5 7.6 34.3 19.5 21.2 30.6 22.0 12.9 17.0 21.2 21.1 18.1 18.1 12.9 23.4 12.8 21.3 18.5 17.5 19.1 17.8 12.1 38.3 13.3 16.0 8.4 21.1 20.0 18.1 20.6 22.6 18.5 26.0 29.2 17.4 13.7 13.4 21.5 43.4 30.7 28.4 18.1 25.5 37.2 35.9 19.7 26.3 30.2 36.3 36.3 39.3 21.8 25.3 16.6 38.2 30.7 27.8 25.9 40.7 30.7 20.2 13.7 13.1 39.6 38.3 17.7 30.2 31.2 29.0 18.2 20.6 28.0 30.8 44.4 18.2 25.5 32.7 51.0 42.9 34.5 21.0 60.2 28.3 29.8 31.9 21.8 42.6 34.1 19.1 19.6 20.8 24.4 31.8 30.5 60.2 20.9 16.9 17.1 39.5 25.3 17.7 43.3 60.3 40.2 28.0 20.6 25.4 130.8 109.1 159.0 91.8 108.0 93.5 172.3 127.6 111.6 111.0 165.4 148.5 122.1 87.5 101.5 106.6 218.1 157.4 161.3 20.3 20.6 22.4 23.9 19.5 21.2 21.2 21.1 21.3 21.1 22.6 21.5 25.2 19.2 20.4 7.2 36.2 15.4 27.2 74.9 13.6 22.1 36.2 38.2 113.3 22.8 42.7 33.1 12.5 70.8 28.8 45.5 146.8 62.0 41.0 38.3 17.6 27.2 29.3 73.2 4.4 55.0 70.1 28.8 24.5 18.1 12.6 31.8 28.9 42.4 81.5 28.6 5.5 36.3 63.1 33.2 18.3 19.3 33.5 30.4 8.8 2.8 49.0 69.8 41.2 3.0 7.2 59.5 50.8 18.0 25.0 40.2 51.4 133.5 78.6 31.6 13.1 15.1 25.1 107.2 63.7 25.4 13.2 25.4 30.7 43.1 42.3 27.6 LTBP2 "C14orf141, LTBP3" ENSG00000119681 "Latent transforming growth factor beta binding protein 2" Q14767 14 74498183-74612378 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor binding, Heparin-binding" "Disease variant, Dwarfism, Glaucoma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 60.6;Fibroblasts: 59.5;Peritubular cells: 82.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 240.8;HUVEC TERT2: 129.1;LHCN-M2: 129.4;TIME: 564.5" "Group enriched" "Detected in some" 10 "cerebellum: 5.3;olfactory bulb: 2.4" "Region enhanced" "Detected in many" "olfactory bulb: 15.4" HPA003415 Approved Approved Nucleoplasm "Secreted to extracellular matrix" NA NA 14000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "HPA003415: AB_1079284" "unprognostic (1.24e-1)" "unprognostic (3.09e-2)" "unprognostic (5.10e-2)" "unprognostic (3.92e-3)" "unprognostic (2.08e-3)" "unprognostic (2.10e-1)" "unprognostic (2.69e-1)" "unprognostic (4.43e-2)" "unprognostic (1.08e-1)" "unprognostic (1.61e-1)" "unprognostic (2.80e-2)" "unprognostic (3.77e-1)" "unprognostic (1.98e-3)" "unprognostic (2.22e-3)" "unprognostic (1.11e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (3.94e-4)" 34.2 4.0 1.1 15.2 2.9 0.6 24.4 4.1 5.6 66.2 9.5 6.6 3.1 22.5 23.9 10.7 11.7 33.1 45.4 1.2 1.1 4.1 2.1 64.9 8.3 2.2 1.1 39.4 8.7 9.6 7.3 28.0 1.4 15.7 2.6 2.3 26.7 19.6 13.6 12.6 6.9 16.0 2.2 3.9 8.5 5.4 1.9 3.1 53.0 21.4 6.1 14.2 21.6 1.0 2.5 4.9 1.2 0.2 36.9 67.7 0.2 47.4 16.2 9.2 5.7 0.0 17.4 0.4 13.8 240.8 4.1 4.8 0.2 17.7 3.8 0.2 0.8 0.8 2.2 2.1 8.8 0.1 0.6 70.2 7.7 50.7 29.1 68.9 129.1 0.1 0.2 0.1 129.4 1.1 0.1 0.3 0.3 0.2 4.5 0.5 1.1 0.1 11.3 6.7 1.0 3.3 33.1 0.1 1.1 3.4 1.1 0.2 564.5 3.3 54.0 17.0 18.0 0.7 0.7 0.1 13.1 0.3 1.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 2.9 4.1 5.6 1.2 1.1 2.2 1.1 1.4 2.2 1.9 1.0 3.8 0.0 2.2 2.3 0.1 5.6 15.1 13.0 13.1 2.1 1.9 60.6 6.4 0.0 6.1 0.0 0.0 0.5 1.2 0.1 5.9 1.4 1.2 0.5 7.9 6.5 0.0 5.7 1.1 0.4 0.3 59.5 1.5 0.9 1.3 1.9 9.3 0.4 4.2 3.3 0.7 0.0 20.3 0.3 5.8 5.8 16.4 3.7 0.0 22.5 0.1 0.4 0.0 1.0 0.3 4.4 0.0 82.4 0.3 10.7 0.0 0.0 0.3 1.0 6.6 3.2 10.8 2.8 3.8 5.2 1.0 1.2 0.9 2.2 0.1 2.1 AREL1 "FIEL1, KIAA0317" ENSG00000119682 "Apoptosis resistant E3 ubiquitin protein ligase 1" O15033 14 74653437-74713117 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051306 Uncertain NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "HPA051306: AB_2681433" "unprognostic (1.92e-1)" "unprognostic (1.34e-1)" "unprognostic (1.76e-1)" "unprognostic (1.92e-3)" "unprognostic (1.29e-1)" "unprognostic (2.49e-2)" "unprognostic (1.58e-3)" "unprognostic (9.32e-2)" "unprognostic (1.09e-1)" "unprognostic (1.32e-1)" "unprognostic (2.24e-1)" "unprognostic (2.12e-1)" "prognostic favorable (4.67e-6)" "unprognostic (6.73e-2)" "unprognostic (3.14e-1)" "unprognostic (1.52e-1)" "unprognostic (7.18e-2)" 6.2 6.9 4.3 10.4 4.7 16.9 6.7 3.1 4.8 7.8 3.3 10.4 11.8 6.5 7.1 10.0 10.4 6.7 10.6 6.7 5.0 14.6 5.3 9.0 10.0 3.1 4.1 6.8 9.5 15.4 4.5 8.3 2.6 8.4 12.3 13.3 9.7 7.7 9.9 7.8 12.7 8.4 3.7 8.5 9.8 17.1 5.6 13.1 15.5 13.1 13.3 10.0 5.6 3.5 19.2 24.6 25.1 23.6 21.3 14.1 19.3 20.7 23.5 25.2 25.1 19.2 22.2 16.4 10.8 26.6 22.9 25.3 26.9 23.2 32.4 30.4 12.7 25.5 14.5 13.7 14.2 18.5 23.9 18.4 15.8 18.6 20.0 31.6 25.0 23.5 20.3 17.1 32.9 25.8 19.2 7.8 15.4 26.0 24.2 19.5 28.4 10.2 20.5 42.6 24.6 33.0 18.1 23.9 13.4 16.6 21.0 18.5 34.6 23.8 28.5 14.3 24.3 22.6 32.8 32.2 28.8 14.0 18.8 2.2 3.5 7.1 4.6 5.1 3.3 2.1 2.8 4.2 4.5 1.4 2.9 2.6 6.8 3.4 2.7 2.1 2.6 3.4 4.3 4.7 3.1 4.8 6.7 5.0 3.1 4.1 2.6 3.7 5.6 3.5 3.7 12.8 4.6 23.2 6.5 3.6 3.4 6.0 7.4 12.3 7.0 3.7 11.1 5.7 7.5 11.0 27.1 4.2 11.2 18.3 1.9 6.6 3.1 7.2 7.1 5.0 14.9 21.0 24.8 9.2 3.3 4.6 12.8 10.5 1.3 10.3 6.4 12.9 8.0 16.8 24.1 11.6 8.2 15.0 5.3 4.6 8.7 9.6 5.4 23.4 13.9 5.2 11.3 22.6 32.5 11.2 6.5 6.8 9.1 6.8 11.8 5.1 7.3 11.7 0.0 4.4 4.9 6.7 11.1 10.5 3.3 5.9 8.4 6.4 11.5 6.3 FCF1 "Bka, C14orf111, CGI-35, UTP24" ENSG00000119616 "FCF1 rRNA-processing protein" Q9Y324 14 74713144-74738620 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 104.7;Smooth muscle cells: 67.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA046681 Approved Approved Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA046681: AB_10960541" "unprognostic (1.39e-2)" "unprognostic (1.54e-1)" "unprognostic (5.74e-2)" "unprognostic (1.01e-2)" "unprognostic (1.18e-1)" "unprognostic (7.94e-3)" "prognostic unfavorable (5.54e-6)" "unprognostic (3.17e-1)" "unprognostic (3.43e-2)" "unprognostic (7.36e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (7.79e-2)" "prognostic favorable (2.26e-4)" "unprognostic (3.30e-1)" "unprognostic (1.46e-1)" "unprognostic (3.03e-1)" "unprognostic (1.47e-1)" 32.5 23.1 9.9 25.4 12.7 27.0 34.9 12.7 13.0 30.5 11.5 28.6 18.9 29.2 20.9 24.9 38.4 22.0 26.8 9.4 12.1 30.1 32.8 27.9 34.4 12.5 12.7 39.9 16.5 26.6 12.9 32.1 12.8 28.2 29.3 13.2 19.9 30.6 25.3 17.3 20.5 30.2 11.3 23.5 23.0 18.4 11.4 33.2 43.3 22.4 41.3 29.2 19.0 17.4 109.3 78.7 55.8 63.5 86.8 76.3 73.5 93.6 71.7 91.4 81.2 88.1 87.3 97.2 59.6 82.1 44.2 78.5 94.1 88.5 160.7 90.6 40.8 67.4 46.4 57.9 62.6 83.1 59.5 60.3 76.6 97.3 101.4 72.4 86.6 82.7 82.2 56.9 83.3 77.5 97.0 29.6 75.0 63.2 90.5 72.9 109.5 46.3 46.4 88.1 39.1 56.9 120.1 62.8 55.0 61.4 80.7 57.0 79.9 72.7 77.6 69.5 108.3 49.9 140.7 147.7 69.2 77.5 82.5 13.5 17.0 20.5 19.1 15.3 21.0 24.3 18.4 16.6 13.9 21.2 19.5 20.5 14.7 15.3 18.8 31.3 19.6 9.2 9.9 12.7 12.7 13.0 9.4 12.1 12.5 12.7 12.8 11.3 11.4 17.4 11.9 6.4 18.3 7.5 18.8 3.1 7.6 10.5 11.4 7.5 12.2 7.5 24.0 34.3 14.9 12.9 6.2 11.8 26.6 16.3 15.6 17.4 23.8 28.0 18.5 13.7 10.2 36.2 11.6 19.0 14.7 13.3 6.1 13.5 26.0 9.3 28.5 104.7 12.8 11.8 11.7 15.9 8.2 33.6 4.3 11.9 15.5 12.6 0.0 7.5 16.4 13.5 24.7 11.6 17.5 17.4 10.3 17.0 12.0 6.1 13.1 18.4 45.4 7.2 13.1 12.5 67.7 12.4 12.3 11.1 4.8 8.8 14.3 8.2 15.6 6.7 YLPM1 "C14orf170, PPP1R169, ZAP" ENSG00000119596 "YLP motif containing 1" P49750 14 74763316-74859435 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048070, HPA061123" Uncertain Supported "Nucleoplasm,Nuclear speckles" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear speckles" "HPA048070: AB_2680247, HPA061123: AB_2684435" "unprognostic (2.17e-1)" "unprognostic (3.32e-2)" "unprognostic (3.95e-1)" "unprognostic (2.98e-1)" "unprognostic (3.79e-2)" "unprognostic (7.64e-2)" "unprognostic (3.22e-3)" "unprognostic (8.74e-2)" "unprognostic (3.60e-2)" "unprognostic (2.56e-1)" "unprognostic (7.83e-3)" "unprognostic (6.63e-2)" "prognostic favorable (6.08e-7)" "unprognostic (1.09e-2)" "unprognostic (2.41e-1)" "unprognostic (1.87e-1)" "unprognostic (1.60e-1)" 13.3 13.0 12.5 10.4 12.8 17.6 13.8 18.1 15.6 18.0 2.8 12.9 7.0 16.1 12.9 12.7 15.9 8.5 11.4 10.9 16.4 10.6 8.5 11.2 13.1 9.5 10.0 22.1 13.1 12.1 15.6 11.2 9.3 14.0 9.2 17.6 15.0 10.3 15.0 15.3 13.4 9.4 4.8 13.4 11.9 18.5 12.3 14.9 16.8 7.4 11.9 14.0 15.0 12.8 28.3 28.9 31.8 7.1 25.2 20.8 18.0 18.3 18.7 18.9 18.9 25.8 19.6 40.9 13.4 20.8 13.7 26.1 28.6 19.6 30.2 24.6 17.3 29.4 19.8 20.0 12.2 22.3 21.9 19.0 13.5 20.9 16.5 23.3 25.3 22.9 24.1 18.9 23.5 29.9 26.4 24.4 20.0 19.2 26.1 40.5 31.8 14.3 16.5 37.2 24.2 23.8 29.4 20.2 8.3 21.8 22.9 17.4 37.0 22.6 28.3 15.6 23.9 23.3 24.8 43.6 19.3 17.3 17.2 0.3 1.4 1.5 1.5 1.6 1.7 1.9 1.3 1.3 1.1 1.9 1.8 1.8 1.0 2.3 1.5 3.4 1.1 1.4 12.5 12.8 18.1 15.6 10.9 16.4 9.5 10.0 9.3 4.8 12.3 12.8 26.8 25.6 34.3 54.2 32.7 19.9 11.2 13.3 27.9 42.0 27.7 25.3 45.9 14.3 25.0 9.2 41.7 19.7 32.4 15.7 1.9 15.7 35.4 26.8 36.0 29.7 20.4 23.5 86.7 15.5 13.5 24.4 23.0 28.6 17.7 54.1 21.8 16.8 19.1 52.2 84.3 18.9 12.2 22.6 12.3 17.7 33.8 19.5 5.4 51.5 28.6 24.6 32.0 68.9 76.5 18.0 13.3 48.5 30.3 18.9 14.0 14.7 33.0 30.8 19.7 35.5 24.8 62.8 49.0 29.2 23.3 15.7 29.3 32.5 21.6 13.2 PROX2 FLJ36749 ENSG00000119608 "Prospero homeobox 2" Q3B8N5 14 74852871-74876154 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.9;Excitatory neurons: 1.6;granulocytes: 1.3;Inhibitory neurons: 1.1;Late spermatids: 1.0;Microglial cells: 1.0;Oligodendrocyte precursor cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "neutrophil: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 1.6;CACO-2: 1.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA045057 Uncertain NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 60: Granulocytes - Receptor signaling" "HPA045057: AB_10960259" "unprognostic (4.38e-2)" "unprognostic (1.40e-2)" "unprognostic (1.58e-1)" "unprognostic (1.43e-1)" "unprognostic (2.57e-1)" "unprognostic (1.36e-2)" "unprognostic (1.31e-2)" "unprognostic (3.95e-3)" "unprognostic (2.48e-1)" "unprognostic (2.55e-1)" "unprognostic (5.98e-3)" "unprognostic (2.98e-1)" "unprognostic (1.22e-2)" "unprognostic (9.87e-2)" "unprognostic (1.26e-1)" "unprognostic (3.59e-2)" "unprognostic (1.73e-4)" 0.3 0.2 0.5 0.4 0.4 1.2 0.3 1.5 0.6 0.8 1.3 0.3 0.2 0.4 0.6 0.2 0.5 0.1 0.3 0.4 0.3 0.3 0.2 0.3 0.6 0.3 0.9 0.9 0.3 0.1 0.5 0.2 0.4 0.5 0.3 1.2 0.4 0.3 0.2 1.1 0.5 0.1 0.1 0.5 0.2 0.3 0.3 0.2 0.6 0.0 0.3 0.3 0.5 0.6 0.0 0.1 1.6 0.6 0.5 0.2 0.4 0.1 0.0 0.0 0.1 1.4 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.5 0.5 0.2 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.2 0.1 0.0 0.1 0.3 0.3 0.0 0.0 0.2 0.4 0.1 0.0 0.1 0.0 0.1 0.1 0.3 0.1 0.3 0.1 0.1 0.0 0.2 0.1 0.9 0.0 0.2 0.0 0.0 0.2 1.1 0.1 0.2 0.2 0.2 0.0 0.0 0.1 0.1 0.1 0.1 1.4 1.1 0.1 0.3 0.0 0.0 0.5 0.4 1.5 0.6 0.4 0.3 0.3 0.9 0.4 0.1 0.3 0.6 0.0 0.0 1.9 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 DLST "DLTS, KGD2, OGDC-E2" ENSG00000119689 "Dihydrolipoamide S-succinyltransferase" P36957 14 74881891-74903743 "Citric acid cycle related proteins, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Acyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003010 Supported Supported Nucleoplasm,Mitochondria,Cytosol NA NA 70000 "Cluster 15: NK-cells - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "Mitochondria, Cytosol" "HPA003010: AB_1078679" "unprognostic (1.62e-1)" "unprognostic (3.01e-1)" "unprognostic (2.45e-3)" "unprognostic (6.36e-2)" "unprognostic (1.29e-1)" "unprognostic (1.21e-2)" "unprognostic (1.16e-1)" "unprognostic (5.83e-2)" "unprognostic (3.03e-1)" "unprognostic (1.37e-1)" "unprognostic (2.12e-2)" "unprognostic (1.18e-1)" "prognostic favorable (1.13e-12)" "unprognostic (3.29e-2)" "unprognostic (1.08e-1)" "unprognostic (1.66e-1)" "unprognostic (4.55e-3)" 64.5 85.5 33.5 32.3 34.7 75.0 59.6 35.8 34.7 62.1 43.8 63.3 58.7 47.5 43.2 62.9 46.1 36.2 129.0 30.8 35.1 100.4 78.4 48.5 36.9 35.8 34.5 45.8 44.8 78.8 35.4 44.8 34.3 41.3 59.3 37.1 46.5 43.5 144.7 64.3 58.3 52.1 33.6 46.1 57.7 29.3 37.3 42.5 42.9 224.2 45.7 58.0 49.7 32.5 79.1 81.1 63.7 45.4 98.1 110.6 97.5 106.3 107.8 106.8 99.0 80.9 88.1 81.0 44.3 118.1 48.1 87.8 109.0 105.6 112.0 61.5 43.3 68.4 66.3 74.8 101.4 49.5 45.4 114.0 90.5 103.8 126.7 95.5 106.1 36.6 53.4 55.6 110.3 112.0 59.0 69.7 55.0 146.6 79.0 73.8 93.8 46.7 125.8 100.8 75.5 64.1 100.6 129.4 71.3 54.2 121.7 70.5 90.8 63.8 83.2 79.5 74.0 38.7 43.7 73.4 93.9 47.9 68.8 3.0 1.3 2.3 2.1 2.0 1.8 1.6 1.9 1.6 2.1 1.0 1.5 2.2 1.3 3.5 1.8 2.8 2.0 1.5 33.5 34.7 35.8 34.7 30.8 35.1 35.8 34.5 34.3 33.6 37.3 32.5 24.2 6.4 4.8 14.0 22.7 26.4 23.5 19.7 21.6 19.1 25.1 20.4 28.5 21.5 10.1 20.2 31.3 41.0 27.7 41.9 56.7 37.8 7.3 10.9 20.4 19.8 14.8 22.5 21.9 25.7 38.8 25.6 30.5 18.9 21.0 19.4 23.2 43.6 32.1 13.5 24.6 31.8 12.2 20.9 19.0 6.2 18.0 18.8 23.2 13.1 27.1 10.0 20.6 18.6 18.5 44.3 28.0 20.7 20.0 28.2 49.8 73.3 8.7 20.8 26.3 18.3 24.0 12.1 15.3 34.2 28.4 79.5 23.1 19.3 40.5 27.7 RPS6KL1 "MGC11287, RSKL2" ENSG00000198208 "Ribosomal protein S6 kinase like 1" Q9Y6S9 14 74903951-74923302 "Enzymes, Predicted intracellular proteins" "Kinase, Ribonucleoprotein, Ribosomal protein, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 72.3;Cone photoreceptor cells: 83.4;Horizontal cells: 40.4;Rod photoreceptor cells: 73.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HMC-1: 17.5;SCLC-21H: 25.1;SK-BR-3: 19.7;U-266/70: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027451, HPA027794" Approved Approved Nucleoplasm NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 54: Non-specific - Microtubule organization" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm "HPA027451: AB_10599304, HPA027794: AB_10602098" "unprognostic (2.71e-2)" "unprognostic (9.33e-3)" "unprognostic (3.36e-1)" "unprognostic (1.13e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-2)" "unprognostic (1.44e-2)" "unprognostic (7.49e-4)" "unprognostic (2.06e-1)" "unprognostic (1.54e-1)" "unprognostic (4.09e-3)" "unprognostic (2.91e-1)" "unprognostic (1.11e-1)" "unprognostic (1.33e-2)" "unprognostic (1.14e-1)" "unprognostic (7.03e-2)" "unprognostic (7.52e-2)" 3.7 4.5 22.4 1.1 23.1 3.0 4.1 21.6 29.4 1.9 17.6 6.7 2.2 4.1 4.8 2.9 2.5 1.8 13.7 23.4 21.2 4.8 4.2 2.5 1.4 20.8 21.3 0.9 7.9 1.3 18.8 0.5 20.5 3.8 3.2 20.6 3.1 3.0 19.1 2.3 3.1 4.0 19.3 3.2 2.5 13.9 21.7 0.6 4.3 4.2 1.1 3.4 1.7 22.9 3.3 0.5 1.3 4.4 0.2 0.0 6.3 0.7 0.2 1.6 0.4 5.8 2.4 0.1 4.5 1.1 0.7 0.4 1.9 0.1 1.6 0.0 0.6 2.7 1.2 4.8 5.7 3.2 17.5 0.5 3.5 2.3 0.0 0.0 7.9 0.0 3.2 0.9 0.1 10.7 0.1 1.1 1.3 1.0 5.1 2.0 0.1 9.7 2.3 0.0 25.1 3.8 0.4 19.7 3.4 2.7 1.5 2.1 5.8 0.1 0.2 4.0 0.0 13.8 8.1 6.9 1.8 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.1 0.0 0.0 0.3 0.7 0.8 0.0 0.0 0.0 2.3 0.0 0.1 22.4 23.1 21.6 29.4 23.4 21.2 20.8 21.3 20.5 19.3 21.7 22.9 2.6 0.0 0.0 10.4 0.9 0.8 2.7 1.2 0.6 72.3 4.3 3.9 6.1 0.0 0.8 3.7 83.4 1.7 2.0 2.4 1.9 1.3 7.7 0.8 0.6 2.6 6.7 5.2 24.5 6.2 1.7 1.0 0.5 0.7 0.0 0.7 1.1 2.6 3.7 40.4 19.7 2.1 4.1 0.3 1.3 7.4 2.1 1.0 3.6 3.7 0.0 5.0 3.1 15.6 15.1 3.8 1.6 2.6 0.5 2.1 1.5 1.9 4.5 73.6 6.6 3.8 3.1 27.0 22.9 1.2 1.3 1.4 1.0 1.5 3.1 1.6 PGF "D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760" ENSG00000119630 "Placental growth factor" P49763 14 74941834-74955626 "Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 50.5;thyroid gland: 52.5" "Group enriched" "Detected in many" 11 "Extravillous trophoblasts: 1604.4;Syncytiotrophoblasts: 2122.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "BEWO: 422.4;HUVEC TERT2: 199.1" "Low region specificity" "Detected in all" HPA041624 Approved Nucleoplasm,Mitochondria,Cytosol "Secreted to blood" No No 20800 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 28: BEWO - Transcription regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "Mitochondria, Cytosol" "HPA041624: AB_10794522" "unprognostic (1.67e-2)" "unprognostic (4.62e-2)" "unprognostic (9.25e-3)" "unprognostic (1.34e-3)" "unprognostic (8.67e-3)" "unprognostic (2.41e-1)" "prognostic unfavorable (1.40e-4)" "unprognostic (7.26e-2)" "unprognostic (1.48e-1)" "unprognostic (4.45e-1)" "unprognostic (1.45e-2)" "unprognostic (3.51e-3)" "prognostic unfavorable (1.33e-6)" "unprognostic (2.52e-3)" "unprognostic (1.20e-1)" "unprognostic (3.49e-2)" "unprognostic (1.14e-1)" 11.8 4.9 7.4 7.8 7.6 0.1 11.3 7.3 11.7 22.4 20.2 7.0 2.4 7.6 1.4 10.0 21.8 5.9 18.8 8.7 20.6 8.1 6.0 7.2 6.4 9.5 15.7 6.4 4.9 8.4 5.5 50.5 9.3 19.3 2.0 1.2 10.5 10.3 9.9 15.7 12.5 7.8 7.0 3.3 4.8 3.2 8.6 3.9 52.5 5.9 3.3 13.6 14.8 7.8 1.4 1.5 1.3 1.3 2.0 0.2 422.4 4.0 3.6 1.8 2.2 10.9 0.6 0.3 9.1 2.8 0.2 0.5 1.8 19.2 1.6 0.2 2.4 0.0 0.1 11.3 1.5 0.2 11.0 4.7 4.5 7.5 1.8 0.5 199.1 0.0 0.0 0.1 55.6 0.9 0.0 0.5 2.1 0.1 3.4 0.2 51.3 0.0 0.5 1.0 31.0 17.0 0.0 0.8 7.7 25.0 0.1 0.5 40.6 0.3 10.2 0.1 17.0 0.4 0.2 0.7 6.3 0.5 0.5 0.0 0.0 0.2 0.4 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 7.4 7.6 7.3 11.7 8.7 20.6 9.5 15.7 9.3 7.0 8.6 7.8 32.4 9.6 4.6 1.0 1.0 24.6 10.3 111.4 34.7 1.3 8.9 16.0 3.6 0.0 26.0 0.0 14.6 83.8 2.4 2.0 0.0 2.7 0.1 1.1 3.3 169.4 7.1 2.7 0.1 0.5 1604.4 30.8 1.1 0.8 6.3 0.2 5.3 0.3 37.4 0.0 0.2 2.1 18.3 0.6 8.9 0.8 13.1 2.1 21.4 0.0 0.0 1.9 0.0 0.0 0.2 0.5 1.2 19.5 0.2 3.2 0.6 1.1 12.1 7.8 105.2 7.1 86.4 0.2 6.8 8.1 19.6 2122.6 3.0 3.0 2.3 5.8 EIF2B2 "EIF-2Bbeta, EIF2B" ENSG00000119718 "Eukaryotic translation initiation factor 2B subunit beta" P49770 14 75002921-75012366 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 165.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005841, CAB037105, HPA048028" Enhanced Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA 12000 "Cluster 44: Non-specific - Transcription" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Plasma membrane, Focal adhesion sites" Nucleoplasm "CAB037105: AB_1840834, HPA005841: AB_1078725, HPA048028: AB_2680235" "unprognostic (1.10e-1)" "unprognostic (4.41e-2)" "unprognostic (5.70e-2)" "unprognostic (6.71e-2)" "unprognostic (7.64e-2)" "unprognostic (3.45e-3)" "prognostic unfavorable (2.26e-6)" "unprognostic (1.48e-1)" "unprognostic (1.23e-1)" "unprognostic (1.65e-2)" "unprognostic (4.95e-2)" "unprognostic (1.01e-1)" "prognostic favorable (2.95e-4)" "unprognostic (4.15e-2)" "unprognostic (2.74e-1)" "unprognostic (1.44e-1)" "unprognostic (3.28e-2)" 2.7 5.3 4.0 2.9 4.5 3.2 3.6 8.7 4.8 3.9 2.2 3.0 3.0 3.6 4.9 3.8 3.1 4.0 3.9 3.6 6.1 4.9 3.3 2.7 4.0 4.5 4.2 2.9 4.0 8.5 3.5 4.8 4.5 4.1 3.8 6.8 2.8 4.5 5.5 4.0 2.8 3.4 2.9 2.7 2.6 3.9 4.8 3.9 11.5 7.1 4.2 4.0 2.6 6.9 5.9 7.0 5.6 6.4 6.3 5.2 7.4 3.7 6.1 7.1 8.2 9.0 5.9 5.2 2.3 5.8 4.5 4.4 8.8 8.7 10.6 3.2 6.5 4.6 6.3 6.2 8.2 3.4 5.3 4.8 8.2 9.1 9.3 6.1 24.8 4.5 4.2 4.9 15.5 17.4 5.5 4.3 4.0 7.3 10.3 3.4 6.6 4.3 10.1 7.0 6.0 4.8 3.9 5.5 8.4 6.9 9.0 3.2 6.4 5.4 5.2 2.4 4.8 8.4 7.5 6.2 5.9 4.3 4.2 4.2 1.8 1.4 3.0 1.9 2.5 2.1 2.6 2.5 2.4 2.0 1.9 2.0 1.0 3.3 1.8 2.0 4.0 2.5 4.0 4.5 8.7 4.8 3.6 6.1 4.5 4.2 4.5 2.9 4.8 6.9 18.9 19.2 11.5 6.2 14.1 17.7 19.5 28.9 18.2 28.2 15.4 17.0 18.2 22.8 21.5 25.8 45.9 51.5 16.1 15.3 41.1 36.2 12.1 17.0 14.5 32.1 15.6 20.8 5.3 33.1 56.5 18.3 12.8 12.8 21.5 17.5 13.2 11.9 33.7 28.6 5.4 9.0 20.3 19.1 11.9 12.7 15.8 18.8 14.2 1.9 28.0 27.3 28.8 2.5 8.5 28.1 11.7 16.1 11.3 17.5 19.0 50.8 17.2 29.4 26.3 16.9 27.9 84.2 27.4 27.3 21.9 165.5 14.9 30.5 19.7 19.2 MLH3 ENSG00000119684 "MutL homolog 3" Q9UHC1 14 75013769-75051532 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Disease variant, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 106.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060570 Approved Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 51: Myeloid cells - Hemostasis" Nucleoplasm "HPA060570: AB_2684323" "unprognostic (2.94e-1)" "unprognostic (6.70e-3)" "unprognostic (7.14e-3)" "unprognostic (7.35e-2)" "unprognostic (7.38e-2)" "unprognostic (1.55e-1)" "unprognostic (1.49e-2)" "unprognostic (1.62e-2)" "unprognostic (3.77e-2)" "unprognostic (6.68e-2)" "unprognostic (1.93e-2)" "unprognostic (8.42e-2)" "unprognostic (3.53e-1)" "unprognostic (2.89e-1)" "unprognostic (1.68e-1)" "unprognostic (1.64e-1)" "unprognostic (7.11e-2)" 4.3 9.4 7.2 5.6 11.7 2.3 7.9 12.7 8.6 7.2 5.8 5.8 5.3 7.4 7.5 5.3 6.5 6.1 6.0 6.3 9.3 7.5 7.3 5.2 6.6 8.1 8.8 8.1 5.3 12.6 5.1 5.8 9.3 7.6 6.6 8.5 5.4 8.6 6.6 4.7 4.8 5.5 7.9 6.4 4.5 6.7 9.0 6.4 11.1 7.8 7.7 5.3 3.2 19.8 13.1 13.5 10.3 1.7 10.6 17.0 10.4 4.5 4.2 7.0 6.3 11.7 16.5 14.2 3.7 5.5 9.2 9.2 0.2 4.3 10.4 14.1 0.2 9.3 8.7 7.1 8.6 4.0 6.3 6.3 10.4 7.2 0.5 8.7 12.0 0.1 8.8 11.4 15.8 11.3 6.3 4.5 8.7 10.6 7.6 11.3 6.3 3.1 17.4 13.4 14.9 10.5 14.4 9.9 0.9 10.3 13.1 9.0 6.1 2.9 5.9 4.3 4.5 14.4 15.0 15.4 10.7 0.4 13.2 5.1 2.6 1.7 4.6 2.1 3.5 3.0 2.5 4.2 2.9 5.9 4.1 3.3 1.1 6.3 1.5 2.4 3.1 5.9 7.2 11.7 12.7 8.6 6.3 9.3 8.1 8.8 9.3 7.9 9.0 19.8 19.4 25.6 17.3 47.3 16.6 7.9 23.3 14.3 8.6 49.8 11.6 11.0 19.5 27.1 15.6 36.8 43.8 16.2 15.0 8.5 7.9 16.4 6.0 13.6 35.3 18.5 13.1 6.7 43.4 11.1 6.8 25.8 6.6 10.8 23.5 40.8 13.6 15.6 10.3 35.3 52.9 12.4 12.2 9.1 6.1 7.9 39.7 47.7 16.0 31.9 14.6 28.5 29.9 51.8 106.7 12.3 12.0 51.1 8.7 16.9 29.2 17.1 17.6 59.3 46.0 29.7 23.3 54.4 10.8 7.9 8.7 10.1 13.6 31.0 18.9 12.2 ACYP1 ENSG00000119640 "Acylphosphatase 1" P07311 14 75053237-75069483 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Respiratory ciliated cells: 137.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034944 Approved Approved Nucleoplasm,Cytosol NA NA 89000 "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 49: Ciliated cells - Cilium organization" Cytosol Nucleoplasm "HPA034944: AB_10669898" "prognostic favorable (1.17e-4)" "unprognostic (3.83e-3)" "unprognostic (1.92e-1)" "unprognostic (5.90e-2)" "unprognostic (1.26e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (6.14e-7)" "unprognostic (5.48e-2)" "unprognostic (4.40e-1)" "unprognostic (1.64e-2)" "unprognostic (1.37e-3)" "unprognostic (3.56e-2)" "unprognostic (4.74e-2)" "unprognostic (6.69e-3)" "unprognostic (9.39e-2)" "unprognostic (1.07e-1)" "unprognostic (5.32e-3)" 13.7 38.4 46.2 15.2 48.6 21.1 22.1 49.9 65.5 17.3 50.8 21.5 15.6 14.4 36.7 20.8 29.6 10.2 17.0 45.0 54.0 29.1 9.6 19.7 27.7 50.7 49.7 13.6 12.4 21.1 36.5 15.3 51.8 17.3 26.9 44.0 15.8 15.0 34.0 35.0 21.1 15.6 46.6 16.5 19.3 26.9 50.4 39.7 30.1 21.1 28.1 16.1 17.6 56.0 78.9 43.1 60.9 37.4 24.5 26.6 32.6 44.7 17.2 45.5 63.5 42.8 86.9 86.5 26.4 18.2 25.7 68.1 39.9 19.1 73.8 127.8 49.3 57.6 123.6 32.1 14.3 36.6 56.8 14.9 27.7 61.5 30.0 28.8 60.0 80.9 45.2 103.0 60.0 52.3 82.7 67.7 18.6 67.6 40.8 64.7 80.8 41.2 62.2 39.0 112.0 44.5 29.5 20.8 74.2 29.1 44.5 35.4 27.3 29.5 55.6 61.3 48.4 23.8 52.4 94.6 46.1 42.5 32.8 5.3 2.8 17.5 10.9 6.2 12.7 13.7 18.3 12.9 5.1 14.1 15.4 14.5 1.2 14.0 10.5 10.3 24.6 6.7 46.2 48.6 49.9 65.5 45.0 54.0 50.7 49.7 51.8 46.6 50.4 56.0 18.5 6.4 9.1 17.0 18.2 28.7 44.4 54.1 30.1 38.6 20.8 24.0 21.2 31.5 28.9 66.2 12.5 27.3 18.7 24.5 39.2 20.6 31.6 89.2 18.4 26.5 30.1 47.5 17.8 18.7 33.7 22.7 13.7 17.8 12.0 19.8 10.4 5.7 22.3 43.7 25.0 25.2 73.2 6.6 11.7 11.0 16.8 12.3 39.2 15.9 10.1 23.2 16.5 16.1 44.4 20.2 20.6 16.6 16.9 20.2 16.7 22.3 137.9 32.4 26.3 11.1 31.5 89.8 14.1 23.8 24.0 13.7 22.3 20.4 33.8 34.4 ZC2HC1C "C14orf140, FAM164C" ENSG00000119703 "Zinc finger C2HC-type containing 1C" Q53FD0 14 75064109-75119502 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 23.9;testis: 55.3" "Group enriched" "Detected in many" 5 "Early spermatids: 165.2;Late spermatids: 195.1;Spermatocytes: 198.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CAPAN-2: 6.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA050928, HPA065062" Enhanced Approved "Nuclear speckles,Mitochondria" No No "Cluster 22: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear speckles" Mitochondria "HPA050928: AB_2681277, HPA065062: AB_2732728" "unprognostic (8.01e-2)" "unprognostic (2.01e-2)" "unprognostic (9.61e-2)" "unprognostic (8.01e-2)" "unprognostic (1.97e-3)" "unprognostic (6.00e-2)" "unprognostic (8.94e-2)" "unprognostic (1.20e-2)" "unprognostic (3.71e-3)" "unprognostic (3.22e-2)" "unprognostic (1.09e-3)" "unprognostic (2.26e-1)" "prognostic favorable (4.63e-13)" "unprognostic (4.69e-3)" "unprognostic (7.37e-2)" "unprognostic (3.12e-1)" "unprognostic (1.81e-1)" 1.1 2.5 2.5 0.6 2.7 0.4 1.7 2.8 2.9 1.8 5.1 2.7 3.1 1.3 23.9 1.3 11.0 1.6 5.2 2.4 2.9 5.5 8.4 2.5 0.2 3.1 3.7 0.6 5.1 6.9 6.1 0.8 2.9 1.3 2.4 2.6 2.9 3.4 4.7 1.6 2.4 1.0 2.8 0.8 1.6 55.3 2.9 2.3 7.0 1.5 0.5 1.4 0.6 3.3 3.8 2.8 0.3 3.3 0.2 0.0 1.8 0.3 1.1 1.4 0.8 4.8 6.9 3.3 2.6 0.4 2.6 1.0 0.0 0.0 1.2 3.9 0.3 0.6 1.0 2.3 2.5 0.0 1.8 0.3 0.4 1.6 0.0 1.7 1.1 0.2 5.8 1.0 0.7 0.6 0.4 0.3 0.7 2.4 1.8 0.0 0.2 0.7 4.3 0.3 5.7 1.3 2.4 2.0 1.5 0.6 2.9 0.9 0.7 0.9 0.9 1.0 0.8 4.0 4.9 1.1 1.4 0.4 0.6 0.3 0.0 0.2 0.6 0.0 0.1 0.4 0.3 0.1 0.1 0.2 0.1 0.1 0.1 1.2 0.1 0.2 0.9 0.1 2.5 2.7 2.8 2.9 2.4 2.9 3.1 3.7 2.9 2.8 2.9 3.3 0.8 6.4 9.7 2.0 0.9 1.8 1.9 1.3 4.6 4.5 7.9 5.1 7.0 2.8 6.6 11.0 10.4 2.3 1.6 2.5 3.9 4.6 165.2 21.0 2.1 2.0 5.3 0.4 2.4 1.4 1.1 2.5 1.1 1.9 1.3 1.1 2.9 4.7 1.7 11.8 2.1 2.3 0.0 1.0 0.7 195.1 3.1 1.0 3.6 1.0 0.9 3.0 8.2 0.5 1.0 1.6 0.6 2.6 0.6 2.8 4.2 7.4 32.5 8.5 6.6 5.2 2.0 198.5 5.5 1.9 0.9 5.1 0.9 2.3 3.9 1.3 NEK9 "DKFZp434D0935, MGC16714, Nek8, NERCC, NERCC1" ENSG00000119638 "NIMA related kinase 9" Q8TD19 14 75079353-75127344 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001405 Approved NA NA "Cluster 44: Non-specific - Transcription" "Cluster 52: Non-specific - Ribosome" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 59: Non-specific - Transcription" "HPA001405: AB_1079467" "unprognostic (1.00e-1)" "unprognostic (5.37e-2)" "unprognostic (9.97e-3)" "unprognostic (2.64e-2)" "unprognostic (3.86e-1)" "unprognostic (2.77e-1)" "unprognostic (1.12e-1)" "unprognostic (5.60e-3)" "unprognostic (2.81e-1)" "unprognostic (1.15e-1)" "prognostic favorable (5.63e-4)" "unprognostic (8.58e-2)" "unprognostic (1.36e-2)" "unprognostic (4.54e-2)" "unprognostic (9.22e-2)" "unprognostic (2.61e-1)" "unprognostic (1.57e-2)" 24.2 18.5 6.7 18.6 8.4 11.8 17.3 7.5 7.9 24.3 9.0 14.3 15.5 26.0 10.5 17.8 25.2 17.9 37.2 6.1 7.8 18.4 21.0 18.8 21.0 8.2 7.7 35.8 16.0 34.2 3.1 21.2 7.9 23.5 16.3 16.5 12.4 28.1 43.6 8.1 16.9 32.2 7.5 19.7 13.1 20.4 7.7 28.3 19.7 36.9 23.5 16.3 2.9 9.1 21.3 30.8 44.8 45.4 86.3 88.8 37.9 32.4 54.6 29.7 29.4 25.5 24.7 52.7 0.1 54.2 23.1 31.8 45.0 27.0 38.5 38.2 16.8 23.0 27.3 17.3 48.6 10.8 26.8 76.6 32.8 31.8 26.7 71.6 46.1 36.2 23.8 31.4 40.2 4.8 35.5 11.5 21.9 43.3 18.8 53.5 49.4 23.9 21.3 28.2 19.5 41.3 39.5 19.3 30.0 50.4 41.7 37.6 46.3 30.2 12.7 31.5 15.8 34.3 36.5 49.6 24.9 24.8 26.4 3.4 3.5 3.1 2.5 3.4 4.0 1.3 2.4 2.3 5.0 1.9 3.1 2.8 1.2 3.3 2.5 1.1 1.5 2.9 6.7 8.4 7.5 7.9 6.1 7.8 8.2 7.7 7.9 7.5 7.7 9.1 15.3 12.8 30.2 49.3 21.2 8.8 7.7 6.6 21.1 16.8 14.5 12.4 55.7 12.8 14.8 11.0 35.5 17.4 11.1 10.2 7.9 6.9 11.9 13.3 23.1 17.6 5.4 16.2 31.3 4.9 16.2 18.1 10.7 10.4 16.4 36.8 17.9 30.3 13.9 13.5 35.9 10.7 6.1 18.6 11.8 8.3 24.8 17.0 3.6 30.9 16.0 12.0 15.5 41.2 59.5 5.3 11.7 26.4 14.7 7.4 13.1 8.4 17.4 23.1 0.0 18.9 16.7 28.8 13.9 17.4 10.2 14.0 16.5 20.8 10.5 5.6 TMED10 "p23, P24(DELTA), p24d1, p24delta1, TMP21" ENSG00000170348 "Transmembrane p24 trafficking protein 10" P49755 14 75131469-75176612 "Predicted membrane proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034442, CAB037251, HPA047139, HPA050539" Enhanced Supported "Golgi apparatus" NA NA 220000 "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "CAB034442: AB_2204336, CAB037251: AB_1841216, HPA047139: AB_2679951, HPA050539: AB_2681163" "unprognostic (2.00e-1)" "unprognostic (1.73e-2)" "unprognostic (2.02e-1)" "unprognostic (2.51e-3)" "unprognostic (4.06e-1)" "unprognostic (1.17e-3)" "unprognostic (5.88e-2)" "unprognostic (1.21e-1)" "unprognostic (3.68e-2)" "unprognostic (6.46e-3)" "unprognostic (1.01e-2)" "unprognostic (1.27e-2)" "unprognostic (1.36e-2)" "unprognostic (1.43e-1)" "unprognostic (2.82e-1)" "prognostic unfavorable (8.67e-4)" "unprognostic (2.06e-2)" 68.0 70.3 51.8 55.2 55.8 18.0 93.2 52.6 60.7 137.9 61.2 77.0 62.3 92.6 133.1 59.9 100.6 69.2 82.3 49.5 66.1 62.7 126.9 68.0 61.0 65.8 54.3 99.7 131.9 91.4 53.6 76.3 63.2 91.0 82.3 48.8 130.7 85.9 73.7 56.0 58.8 78.9 57.5 54.6 78.3 40.0 58.2 73.7 146.0 61.0 65.9 66.9 59.7 69.6 93.3 52.2 85.5 142.5 197.5 183.7 110.9 96.5 159.5 99.5 111.2 51.8 161.2 82.5 80.6 167.5 56.8 90.8 80.4 140.6 160.5 43.7 36.2 50.5 31.1 79.2 167.1 101.7 50.2 135.1 221.5 77.0 220.1 196.0 176.9 91.7 44.6 177.8 145.0 104.6 71.0 80.7 51.9 145.2 55.8 70.6 55.3 116.6 119.7 94.8 82.9 87.1 89.0 147.0 175.9 81.0 138.3 163.3 122.3 97.0 62.9 65.9 50.7 98.9 99.3 91.3 177.0 88.3 95.8 107.4 46.4 28.9 60.8 39.4 93.8 39.7 58.7 59.3 62.9 30.3 51.9 55.9 20.4 101.8 42.6 70.9 38.2 91.4 51.8 55.8 52.6 60.7 49.5 66.1 65.8 54.3 63.2 57.5 58.2 69.6 80.8 64.1 106.3 32.0 141.8 114.2 180.4 488.1 107.0 55.6 182.5 130.6 155.3 187.3 279.9 200.5 27.1 181.0 186.7 186.2 62.6 319.1 14.5 147.7 177.5 107.3 140.7 75.5 26.9 385.7 609.9 164.4 145.8 172.0 100.1 170.9 123.1 339.7 255.0 77.4 30.0 276.2 272.6 159.4 166.3 31.5 179.3 151.6 297.1 38.4 129.5 137.9 130.7 50.8 84.2 225.8 148.9 209.9 538.8 218.7 120.3 138.9 304.8 63.1 78.9 112.7 132.2 317.7 116.5 151.7 135.1 309.2 122.1 145.8 161.9 207.7 FOS "AP-1, c-fos" ENSG00000170345 "Fos proto-oncogene, AP-1 transcription factor subunit" P01100 14 75278826-75282230 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "neutrophil: 504.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 504.8" "Cell line enhanced" "Detected in many" "hTCEpi: 453.1;OE19: 170.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "cerebellum: 80.9;spinal cord: 235.3" HPA018531 Approved Supported Nucleoplasm Yes No "Cluster 50: Neutrophils - Cellular senescence" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 30: Epithelial cell lines - Translation" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "HPA018531: AB_1846576" "unprognostic (1.18e-2)" "unprognostic (8.70e-2)" "unprognostic (1.61e-1)" "unprognostic (3.80e-1)" "unprognostic (3.08e-2)" "unprognostic (4.82e-2)" "unprognostic (2.09e-1)" "unprognostic (3.30e-1)" "unprognostic (9.55e-3)" "unprognostic (4.20e-3)" "unprognostic (1.04e-1)" "prognostic favorable (7.81e-4)" "unprognostic (3.20e-2)" "unprognostic (1.52e-2)" "unprognostic (3.22e-1)" "unprognostic (1.43e-1)" "unprognostic (2.66e-2)" 1136.1 735.7 62.9 576.0 87.2 2270.6 477.4 184.8 113.1 700.5 111.5 479.5 235.3 410.4 58.4 1250.8 1777.3 1160.0 513.1 58.9 190.7 266.1 308.8 486.9 449.9 145.1 84.0 1188.7 298.4 264.7 452.3 417.4 92.0 791.1 627.4 233.3 555.6 462.3 99.1 1645.4 584.5 964.3 100.6 178.0 525.6 87.2 104.4 424.2 1007.6 1014.2 26.8 946.5 346.6 121.7 2.2 1.4 7.1 10.4 59.9 18.3 42.1 6.4 2.4 4.5 3.2 4.4 12.6 0.6 1.8 43.5 42.6 3.0 3.6 74.7 1.1 1.2 1.1 1.0 21.9 1.9 27.6 2.6 42.8 44.3 453.1 3.9 27.4 6.2 2.7 9.2 2.0 19.7 1.2 26.1 0.9 12.9 7.4 170.9 2.5 2.0 1.4 23.8 18.8 20.4 52.4 3.6 9.8 85.9 39.8 21.8 1.4 9.2 6.3 0.4 5.7 3.7 2.0 52.4 61.2 9.6 2.9 8.0 5.7 38.3 81.0 89.5 0.3 20.1 0.4 0.3 0.2 0.7 69.6 0.2 0.2 0.1 504.8 4.6 2.5 1.5 0.4 27.7 62.9 87.2 184.8 113.1 58.9 190.7 145.1 84.0 92.0 100.6 104.4 121.7 3911.0 1102.6 1859.4 137.1 1015.9 859.7 1644.7 1577.5 4336.7 106.1 3184.1 2874.6 1027.6 1416.9 752.7 191.3 129.3 1506.7 1323.5 1648.6 17.6 690.9 17.4 1834.4 3720.3 1624.0 1628.0 290.5 4.9 528.1 2694.6 4146.8 2049.5 3656.5 1630.6 751.3 1317.2 207.2 1693.8 35.3 3.0 1967.2 793.5 2600.2 1540.4 53.5 943.8 2910.7 855.6 58.1 269.5 1119.5 10.3 6.0 1.8 383.5 1507.8 178.3 1256.1 1115.7 1675.1 20.0 354.4 406.9 1209.6 3390.9 2705.7 10.0 10.5 2438.0 1092.4 2283.3 1497.0 417.4 1366.2 298.4 JDP2 JUNDM2 ENSG00000140044 "Jun dimerization protein 2" Q8WYK2 14 75427716-75474111 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 70.7;Kupffer cells: 87.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 11.8;granulocytes: 7.7;monocytes: 13.2" "Cell line enhanced" "Detected in many" "HHSteC: 167.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059511 Supported Approved "Nucleoplasm,Nuclear speckles" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 50: Fibroblasts - ECM organization" "Nucleoplasm, Nuclear speckles" "HPA059511: AB_2684046" "unprognostic (3.19e-2)" "unprognostic (5.58e-2)" "prognostic unfavorable (8.58e-5)" "unprognostic (1.64e-2)" "unprognostic (2.13e-1)" "unprognostic (1.20e-1)" "unprognostic (2.99e-2)" "unprognostic (2.81e-1)" "unprognostic (5.06e-2)" "unprognostic (1.91e-1)" "unprognostic (3.25e-2)" "unprognostic (1.86e-1)" "unprognostic (8.11e-3)" "unprognostic (2.20e-1)" "unprognostic (1.92e-1)" "unprognostic (2.13e-1)" "unprognostic (9.30e-3)" 53.5 20.0 23.2 29.3 22.0 78.6 40.2 22.8 28.2 31.6 22.0 31.6 22.5 22.7 3.7 25.4 28.5 27.7 39.1 23.5 24.2 18.9 20.5 47.2 13.1 24.6 22.9 21.6 23.1 8.1 17.3 17.5 22.6 21.8 11.3 16.4 24.2 15.0 21.9 29.1 30.1 20.9 22.6 66.8 23.3 4.7 25.4 4.8 25.1 16.7 10.6 25.3 31.6 21.8 15.5 13.5 2.5 26.8 81.5 60.2 90.5 47.5 51.0 30.4 38.1 33.0 13.5 12.4 23.5 90.7 5.6 59.5 16.7 16.2 13.1 16.7 1.9 17.0 26.0 11.9 167.1 24.1 1.3 106.5 95.2 12.4 30.6 11.9 1.5 13.8 2.2 23.0 27.7 76.4 1.4 39.8 9.1 30.4 8.7 8.2 0.3 34.0 14.8 8.6 2.1 10.4 48.9 69.4 55.1 29.7 66.4 52.1 6.2 38.1 57.5 2.4 7.0 18.7 6.0 28.8 11.5 90.0 19.1 0.1 4.5 4.4 0.0 8.1 0.0 11.8 0.2 0.0 2.4 5.1 0.0 0.0 7.7 0.1 13.2 2.1 0.2 1.4 23.2 22.0 22.8 28.2 23.5 24.2 24.6 22.9 22.6 22.6 25.4 21.8 70.7 12.8 33.5 26.8 9.9 16.4 6.0 5.8 19.9 21.8 26.2 18.2 17.7 12.8 8.1 9.2 10.4 1.4 1.2 20.0 0.0 2.4 0.3 21.6 18.4 21.2 5.4 0.8 18.9 6.6 5.6 49.5 10.2 23.9 2.5 10.1 10.4 8.5 9.7 8.4 20.8 14.9 4.1 87.7 25.7 1.5 18.0 47.3 12.4 14.0 13.8 38.6 2.1 18.1 3.0 8.5 8.2 16.6 9.8 2.6 17.7 3.0 7.4 31.1 6.6 47.2 19.5 0.1 0.9 19.7 8.9 0.3 2.2 5.3 8.7 11.5 BATF "B-ATF, BATF1, SFA-2" ENSG00000156127 "Basic leucine zipper ATF-like transcription factor" Q16520 14 75522455-75546993 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 21.7;lymphoid tissue: 30.6" "Cell type enhanced" "Detected in many" "Breast glandular cells: 105.4;Breast myoepithelial cells: 73.9;granulocytes: 243.7;NK-cells: 103.0;T-cells: 116.5;Urothelial cells: 74.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Lineage enriched" "Detected in all" 5 "T-cells: 130.3" "Cell line enhanced" "Detected in many" "HDLM-2: 368.9;MCF7: 134.7;RT4: 83.3;SK-BR-3: 64.8;U-937: 101.6" "Not detected" "Not detected" "HPA059588, HPA064962" Approved Enhanced Nucleoplasm NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 16: Immune cells - Immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA059588: AB_2684074, HPA064962: AB_2685392" "unprognostic (3.33e-3)" "unprognostic (4.87e-3)" "prognostic unfavorable (8.30e-4)" "prognostic favorable (5.35e-6)" "unprognostic (3.02e-2)" "prognostic favorable (7.91e-5)" "unprognostic (1.14e-2)" "unprognostic (1.39e-1)" "unprognostic (2.94e-1)" "unprognostic (6.72e-2)" "unprognostic (7.17e-2)" "unprognostic (8.90e-2)" "prognostic unfavorable (3.74e-9)" "unprognostic (4.74e-2)" "unprognostic (1.90e-1)" "unprognostic (1.41e-1)" "prognostic favorable (4.30e-4)" 5.5 1.3 1.0 20.5 1.8 21.7 7.8 1.0 1.4 2.2 1.1 3.0 2.6 1.3 1.1 2.9 1.9 5.8 2.4 1.0 1.2 1.4 2.9 8.0 30.6 1.5 1.4 0.5 0.9 8.0 0.5 4.1 1.7 5.5 1.4 0.0 6.5 1.8 0.4 2.9 9.7 2.3 1.2 26.9 7.8 0.6 2.2 7.2 1.9 1.0 20.4 18.2 2.9 1.5 4.7 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 368.9 0.0 7.5 0.0 1.6 11.5 10.0 36.3 0.1 0.0 0.0 0.0 0.0 0.0 8.1 2.0 10.3 0.0 134.7 4.7 30.8 0.2 54.9 0.0 1.1 0.0 6.3 0.0 83.3 0.1 0.0 0.0 64.8 2.7 0.0 6.1 18.7 0.0 0.0 0.0 4.4 0.3 32.8 36.9 0.3 0.0 101.6 0.1 3.6 25.5 8.2 55.0 13.7 43.4 21.3 59.7 74.2 25.2 17.5 23.1 50.4 14.4 21.3 13.2 2.9 130.3 27.8 1.0 1.8 1.0 1.4 1.0 1.2 1.5 1.4 1.7 1.2 2.2 1.5 2.9 9.6 29.3 0.0 17.1 5.4 50.8 5.7 0.6 0.0 105.4 73.9 0.3 1.5 13.5 3.7 0.0 0.4 36.9 0.0 0.0 0.8 0.5 0.9 0.6 5.0 0.0 7.2 0.2 2.5 0.4 4.4 10.2 1.9 243.7 0.0 2.5 0.7 61.3 0.0 0.1 0.0 34.6 15.4 10.7 0.6 0.0 21.7 5.4 1.0 16.7 0.0 103.0 0.0 0.1 11.0 0.1 0.0 29.9 22.1 0.0 0.2 12.8 0.0 0.0 1.0 2.0 0.0 0.1 0.4 3.4 1.1 116.5 0.2 0.5 74.3 FLVCR2 "C14orf58, CCT, FLJ20371, MFSD7C, SLC49A2" ENSG00000119686 "FLVCR heme transporter 2" Q9UPI3 14 75578620-75663214 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 75.6;Kupffer cells: 44.9;Late spermatids: 142.5;Microglial cells: 41.2;Proximal enterocytes: 50.4;Syncytiotrophoblasts: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 14.0;intermediate monocyte: 14.6;myeloid DC: 7.6;non-classical monocyte: 11.8" "Group enriched" "Detected in many" 7 "dendritic cells: 7.6;monocytes: 14.6" "Cell line enhanced" "Detected in many" "ASC diff: 53.8;ASC TERT1: 23.2;BEWO: 73.5;MCF7: 26.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037984 Enhanced NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 14: B-cells - Humoral immune response" "Cluster 28: BEWO - Transcription regulation" "Cluster 25: Spermatids - Spermatogenesis" "HPA037984: AB_10672733" "unprognostic (2.42e-1)" "unprognostic (4.85e-2)" "unprognostic (4.19e-2)" "unprognostic (2.32e-1)" "unprognostic (1.24e-1)" "unprognostic (4.44e-2)" "unprognostic (8.72e-2)" "unprognostic (2.78e-1)" "unprognostic (3.64e-1)" "unprognostic (1.91e-1)" "unprognostic (2.22e-1)" "unprognostic (4.80e-2)" "prognostic favorable (2.53e-5)" "unprognostic (6.69e-2)" "unprognostic (9.94e-2)" "unprognostic (9.38e-2)" "unprognostic (1.16e-1)" 5.1 13.6 3.5 9.3 3.7 5.4 2.5 3.2 3.8 2.1 16.2 8.4 17.4 1.0 1.4 2.9 1.9 3.5 2.2 2.9 2.7 11.3 20.5 16.2 5.3 4.7 3.7 2.2 0.6 2.1 3.4 10.3 3.9 2.3 7.1 0.7 12.7 1.7 8.3 5.7 24.4 4.2 5.2 13.8 0.9 21.1 4.8 1.2 3.2 1.6 5.0 4.9 2.6 5.5 3.7 2.8 0.8 4.0 53.8 23.2 73.5 0.7 3.1 3.3 2.6 6.2 0.4 0.0 0.2 0.2 5.4 0.4 9.8 0.2 1.3 19.3 0.6 0.1 2.8 13.3 4.3 0.1 0.6 10.9 7.7 4.0 2.4 0.1 0.8 0.3 0.2 0.5 10.1 26.4 0.2 1.9 1.6 1.1 4.4 0.1 2.6 0.0 3.5 5.1 0.0 0.1 2.0 8.1 1.6 4.6 4.5 10.1 8.8 4.0 1.4 2.0 0.1 0.6 1.1 0.0 11.4 2.5 0.7 0.0 14.0 0.7 0.4 14.6 1.1 0.0 1.1 0.3 7.6 0.1 0.8 0.2 0.5 0.5 11.8 0.1 1.6 4.1 3.5 3.7 3.2 3.8 2.9 2.7 4.7 3.7 3.9 5.2 4.8 5.5 0.3 6.4 6.4 2.6 0.5 0.6 0.3 0.4 0.6 0.0 1.5 0.6 0.8 0.0 3.2 3.7 0.0 23.2 1.7 14.0 0.0 0.1 75.6 2.1 3.9 2.5 0.0 0.0 0.2 0.2 31.0 2.2 0.0 2.7 1.3 0.2 1.8 21.1 16.4 0.0 0.2 2.2 4.1 44.9 5.6 142.5 3.4 19.0 0.0 41.2 10.1 1.3 2.1 0.0 0.2 0.1 3.2 1.9 0.5 0.8 50.4 7.0 0.3 0.3 0.0 0.4 0.3 2.4 1.3 0.2 0.9 54.5 1.2 2.3 5.5 0.2 TTLL5 KIAA0998 ENSG00000119685 "Tubulin tyrosine ligase like 5" Q6EMB2 14 75633625-75955079 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Transcription Ligase "Cone-rod dystrophy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 57.4" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 127.2;Early spermatids: 111.0;Excitatory neurons: 134.3;Inhibitory neurons: 114.2;Oligodendrocytes: 242.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032128 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 77: Retina - Visual perception" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Plasma membrane, Cytosol" "HPA032128: AB_10600835" "unprognostic (7.35e-2)" "unprognostic (7.29e-2)" "unprognostic (7.73e-2)" "unprognostic (1.10e-1)" "unprognostic (1.33e-1)" "unprognostic (5.96e-2)" "unprognostic (7.21e-5)" "unprognostic (1.26e-1)" "unprognostic (1.70e-1)" "unprognostic (7.93e-2)" "unprognostic (1.10e-2)" "unprognostic (3.43e-1)" "unprognostic (5.67e-3)" "unprognostic (1.70e-1)" "unprognostic (1.57e-1)" "unprognostic (8.97e-2)" "unprognostic (2.15e-2)" 5.5 5.5 3.7 6.0 6.0 11.7 7.1 7.1 7.2 7.3 15.0 6.2 4.7 8.0 7.2 7.8 11.6 6.5 5.8 3.8 6.6 6.2 4.1 6.5 5.1 10.5 6.4 7.1 4.9 11.1 5.4 7.5 10.6 6.9 7.3 23.9 6.5 6.9 4.7 7.1 4.5 8.6 6.4 4.1 5.9 57.4 6.4 10.1 7.8 5.8 7.5 6.1 6.4 12.0 22.8 16.2 13.9 14.5 10.9 16.8 12.9 13.1 15.9 15.4 19.9 10.3 20.8 6.4 7.2 13.9 11.3 21.3 12.3 21.7 29.3 7.6 7.3 12.5 16.8 11.3 9.3 9.2 11.5 13.1 10.6 19.4 21.5 16.8 33.8 17.5 7.2 10.5 15.7 32.1 15.6 12.6 9.9 18.0 16.6 9.5 19.6 8.8 15.0 22.2 18.4 11.6 27.5 20.2 6.8 11.0 27.6 9.8 38.1 20.5 18.0 18.5 12.2 8.8 13.5 14.6 20.7 10.4 13.9 11.6 2.0 1.7 2.6 2.0 2.4 2.3 2.5 2.7 3.2 1.8 2.9 2.7 2.4 2.3 2.5 3.4 2.2 1.4 3.7 6.0 7.1 7.2 3.8 6.6 10.5 6.4 10.6 6.4 6.4 12.0 7.1 3.2 10.1 71.8 6.1 5.0 5.5 5.4 8.0 10.9 17.3 11.6 8.7 17.2 10.2 11.0 127.2 8.1 8.5 7.6 3.9 7.1 111.0 37.4 11.9 10.7 7.7 5.0 134.3 5.3 13.2 9.3 8.6 10.8 12.6 11.7 19.6 7.4 5.6 0.0 114.2 6.5 16.2 5.8 5.1 93.1 12.5 6.6 5.4 82.4 8.5 10.0 6.2 78.4 242.9 6.1 11.9 11.7 7.6 6.2 6.0 2.4 40.1 80.1 13.1 9.5 6.0 37.7 16.4 9.0 6.3 6.0 8.3 9.1 8.0 4.6 ERG28 "C14orf1, NET51" ENSG00000133935 "Ergosterol biosynthesis 28 homolog" Q9UKR5 14 75649791-75660876 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 152.0;Ductal cells: 95.4;Exocrine glandular cells: 110.3;Extravillous trophoblasts: 154.2;Syncytiotrophoblasts: 116.3;Theca cells: 121.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043172 Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 68: Epididymis - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 7: Non-specific - Mitochondria" "HPA043172: AB_10793942" "unprognostic (2.68e-3)" "unprognostic (2.11e-2)" "unprognostic (4.55e-1)" "unprognostic (2.05e-1)" "unprognostic (1.75e-1)" "unprognostic (1.34e-3)" "unprognostic (6.25e-2)" "unprognostic (7.66e-2)" "unprognostic (4.64e-1)" "unprognostic (2.66e-2)" "unprognostic (2.47e-1)" "unprognostic (3.01e-2)" "prognostic favorable (4.30e-5)" "unprognostic (1.28e-1)" "unprognostic (2.77e-1)" "unprognostic (9.58e-3)" "unprognostic (2.20e-1)" 9.8 27.7 24.0 9.1 23.3 13.2 17.3 24.6 26.2 16.9 25.1 16.5 21.6 14.9 40.6 34.6 16.9 11.9 13.6 24.6 25.0 18.5 70.2 22.6 11.5 26.2 25.2 20.0 16.1 29.7 17.4 14.9 25.4 21.2 15.5 19.4 19.9 13.8 10.3 24.8 14.5 14.6 25.4 8.3 13.6 47.1 25.8 10.2 21.5 11.3 14.6 12.5 20.1 27.5 39.2 21.6 42.7 33.5 28.6 53.1 26.6 15.6 48.2 29.9 51.0 33.8 91.4 16.6 22.3 19.6 59.7 42.4 38.5 67.0 34.0 31.2 25.4 17.8 20.5 48.4 41.4 19.7 25.5 66.5 56.7 42.9 23.8 24.0 35.3 44.7 16.0 39.3 20.9 77.7 30.2 21.8 41.8 62.5 34.7 23.9 28.7 33.0 99.8 50.5 36.6 20.1 39.2 33.5 24.1 37.8 56.1 28.3 25.1 16.1 32.0 15.8 15.8 25.3 32.5 36.1 25.7 28.5 27.7 33.5 12.3 20.0 40.0 12.7 39.5 39.4 43.1 41.8 29.8 34.5 39.1 38.5 6.6 31.8 13.2 38.4 42.7 31.9 24.0 23.3 24.6 26.2 24.6 25.0 26.2 25.2 25.4 25.4 25.8 27.5 18.8 22.4 57.5 0.0 9.3 0.0 0.0 0.0 0.0 0.0 74.7 57.7 0.0 0.0 11.2 60.7 0.0 152.0 23.6 0.0 49.0 95.4 0.0 43.4 11.5 18.0 0.0 0.0 0.0 110.3 154.2 21.4 0.0 30.3 5.1 63.2 0.0 0.0 64.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 37.7 0.0 0.0 0.0 0.0 76.9 0.0 0.0 3.5 0.0 0.0 47.1 18.2 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 116.3 12.4 121.2 0.0 0.0 IFT43 "C14orf179, FLJ32173, MGC16028" ENSG00000119650 "Intraflagellar transport 43" Q96FT9 14 75902136-76084585 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Ectodermal dysplasia, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Respiratory ciliated cells: 305.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003438 Approved Supported "Microtubules,Centriolar satellite" NA NA "Cluster 37: B-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" Microtubules "Centriolar satellite" "HPA003438: AB_1078327" "unprognostic (1.64e-2)" "unprognostic (5.75e-3)" "unprognostic (2.10e-1)" "unprognostic (1.81e-3)" "unprognostic (1.48e-1)" "unprognostic (8.73e-2)" "unprognostic (1.53e-2)" "unprognostic (5.27e-2)" "unprognostic (8.87e-2)" "unprognostic (1.26e-2)" "unprognostic (2.32e-2)" "unprognostic (9.78e-2)" "unprognostic (4.43e-2)" "unprognostic (2.51e-1)" "unprognostic (2.70e-2)" "unprognostic (1.75e-1)" "unprognostic (1.07e-2)" 21.5 24.0 29.2 12.2 29.5 5.4 25.1 28.9 31.4 24.6 38.7 27.5 23.0 24.6 49.6 18.0 64.5 18.2 43.2 28.7 29.7 38.9 41.5 20.6 11.6 29.5 31.2 16.2 22.6 27.1 32.8 21.5 30.9 26.9 19.4 25.1 16.1 30.5 13.9 15.4 19.3 27.7 29.8 15.5 21.6 40.5 29.4 15.9 33.0 8.8 17.0 25.5 18.4 29.8 34.8 38.2 27.5 42.7 33.9 54.3 19.5 22.3 42.7 33.6 33.5 14.6 34.9 3.9 23.8 39.5 30.4 36.2 26.7 41.3 37.6 18.3 25.6 1.8 22.3 0.1 94.9 3.8 8.0 48.6 44.4 37.1 48.3 48.6 52.1 38.5 9.6 15.2 40.8 69.7 14.3 6.0 14.2 42.7 48.9 9.1 22.2 10.9 77.0 30.0 26.7 31.9 43.9 29.8 31.5 36.9 77.4 10.2 24.3 19.7 24.7 28.9 19.6 20.1 18.8 4.4 76.9 1.6 20.6 34.5 11.6 19.7 13.8 16.4 17.6 33.8 14.9 14.4 15.7 23.1 24.3 23.4 5.8 15.4 16.4 20.2 19.6 13.4 29.2 29.5 28.9 31.4 28.7 29.7 29.5 31.2 30.9 29.8 29.4 29.8 40.9 12.8 27.4 50.3 14.8 18.6 44.1 103.7 38.1 27.8 36.0 45.6 43.8 42.9 66.1 64.4 66.7 41.9 8.7 24.7 64.6 53.8 147.5 171.0 54.5 35.3 15.7 5.9 46.4 38.7 14.7 39.4 38.2 33.2 26.6 28.7 38.6 32.9 22.4 10.1 55.0 30.2 61.1 7.6 20.0 33.2 33.8 11.5 26.6 14.0 32.0 49.8 14.4 38.2 38.5 33.5 18.7 35.0 13.7 25.8 45.1 160.2 305.8 87.7 32.9 31.2 63.5 124.4 37.2 24.6 21.6 41.9 16.2 32.8 26.1 34.5 TGFB3 "ARVD, ARVD1" ENSG00000119699 "Transforming growth factor beta 3" P10600 14 75958097-75983011 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins" "Growth factor, Mitogen" "Cancer-related genes, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Fibroblasts: 28.8;Late spermatids: 48.9;Leydig cells: 27.1;Sertoli cells: 32.9;Smooth muscle cells: 24.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "SK-BR-3: 104.6;T-47d: 75.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA063582 Approved Vesicles "Secreted to blood" NA NA 44800 "Cluster 57: Non-specific - Angiogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 33: Fibroblasts - ECM organization" Vesicles "HPA063582: AB_2685049" "unprognostic (7.84e-2)" "unprognostic (1.89e-1)" "unprognostic (4.32e-3)" "unprognostic (1.29e-1)" "unprognostic (3.27e-2)" "unprognostic (1.58e-1)" "unprognostic (1.24e-1)" "unprognostic (9.79e-2)" "unprognostic (2.83e-2)" "unprognostic (1.51e-2)" "unprognostic (5.63e-2)" "unprognostic (4.10e-1)" "prognostic unfavorable (4.01e-7)" "unprognostic (6.38e-3)" "unprognostic (1.10e-1)" "unprognostic (1.22e-2)" "unprognostic (3.27e-3)" 22.2 13.0 43.4 15.8 45.8 1.0 15.6 33.5 58.4 46.6 18.4 12.8 4.1 25.5 9.6 7.7 14.5 36.6 27.9 31.2 38.4 20.5 17.6 25.7 7.2 40.9 42.3 8.0 27.7 9.9 8.3 55.4 40.0 43.6 4.8 1.8 10.8 17.9 38.6 5.0 6.6 34.3 38.9 5.3 14.1 4.5 42.2 6.5 12.3 11.0 8.8 45.8 16.2 70.1 1.1 1.5 1.1 13.4 2.1 4.3 0.4 1.0 1.5 0.7 0.7 0.8 3.4 0.1 1.0 2.8 0.4 0.9 2.9 0.7 0.3 0.8 1.5 0.1 3.5 1.5 2.7 0.6 0.9 10.2 0.4 1.0 0.4 2.3 3.2 2.7 1.5 6.3 0.8 7.0 0.8 0.8 0.4 0.8 5.3 3.3 4.2 0.7 1.2 0.6 21.9 6.3 4.3 104.6 0.8 1.5 75.2 0.5 0.8 2.0 4.5 2.1 5.8 0.8 1.3 0.4 3.6 1.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.4 45.8 33.5 58.4 31.2 38.4 40.9 42.3 40.0 38.9 42.2 70.1 8.6 0.0 2.8 5.5 0.8 4.5 1.2 2.1 1.2 0.7 15.1 6.1 3.6 0.0 3.3 1.8 4.2 0.5 1.2 1.3 0.0 0.5 16.4 2.6 9.9 10.2 0.0 0.0 1.3 1.3 0.4 28.8 0.0 2.4 0.0 0.5 7.9 0.8 0.9 0.0 3.0 2.6 6.1 0.6 4.4 48.9 27.1 0.9 10.6 1.0 0.7 2.1 3.1 5.5 4.7 0.4 0.1 12.8 0.5 20.6 1.4 0.4 4.2 3.9 32.9 13.9 24.4 0.4 1.4 2.4 3.1 1.4 1.3 1.6 0.4 0.8 GPATCH2L "C14orf118, FLJ10033, FLJ20689" ENSG00000089916 "G-patch domain containing 2 like" Q9NWQ4 14 76151916-76254342 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018856 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA018856: AB_1845553" "unprognostic (5.98e-2)" "unprognostic (1.44e-2)" "unprognostic (7.07e-2)" "unprognostic (1.26e-2)" "unprognostic (1.51e-2)" "unprognostic (5.59e-2)" "unprognostic (6.63e-3)" "unprognostic (1.81e-2)" "unprognostic (2.89e-2)" "unprognostic (2.70e-1)" "unprognostic (2.05e-2)" "unprognostic (5.60e-2)" "unprognostic (5.81e-2)" "unprognostic (7.79e-2)" "unprognostic (2.14e-1)" "unprognostic (8.09e-2)" "unprognostic (1.81e-1)" 9.9 8.9 7.5 12.1 10.1 37.5 9.7 10.7 9.7 8.9 11.4 9.9 8.5 10.5 9.5 11.3 8.0 12.2 13.3 7.8 10.2 8.9 6.8 10.7 12.1 9.9 8.9 10.4 8.7 9.2 6.9 11.3 9.4 9.8 10.8 15.5 8.2 9.8 12.1 9.0 9.2 11.9 9.9 10.8 9.3 13.8 8.8 11.6 9.7 14.0 12.1 10.5 9.3 12.8 18.7 24.0 19.2 15.3 11.0 17.0 15.7 21.7 15.0 20.7 20.1 16.0 30.8 22.2 12.6 16.8 16.8 22.0 23.4 14.2 36.6 24.7 12.9 19.5 26.1 10.1 14.2 13.7 27.6 17.6 12.6 17.8 23.0 16.2 21.9 18.1 20.6 30.6 18.6 30.6 18.3 17.7 24.2 11.1 17.5 20.3 23.2 11.5 14.7 37.0 15.5 19.2 24.5 21.6 12.0 19.7 25.2 21.2 24.0 26.7 15.3 14.9 16.5 30.7 31.3 29.2 21.4 18.4 28.0 5.3 7.3 7.9 3.5 6.6 3.0 6.3 1.9 5.2 7.2 5.3 4.2 3.0 5.6 5.6 4.8 5.6 4.5 3.7 7.5 10.1 10.7 9.7 7.8 10.2 9.9 8.9 9.4 9.9 8.8 12.8 35.3 16.0 18.2 48.0 30.2 23.3 37.4 26.0 22.2 100.0 19.9 21.2 46.3 18.6 25.2 18.4 104.3 16.2 36.8 18.8 3.9 20.0 151.4 28.9 46.2 38.2 47.8 17.1 76.0 13.3 12.7 36.6 21.9 54.5 43.7 48.2 29.3 11.6 25.2 158.2 67.0 19.3 24.4 43.0 48.9 138.9 24.8 43.5 23.2 59.0 47.7 42.3 43.3 82.0 75.0 30.4 29.4 37.6 24.6 56.9 40.2 13.5 24.4 122.7 26.3 55.0 41.7 56.6 27.2 18.7 27.3 17.4 31.2 34.9 20.6 42.6 ESRRB "DFNB35, ERR2, ERRb, ERRbeta, ESRL2, NR3B2" ENSG00000119715 "Estrogen related receptor beta" O95718 14 76310712-76501837 "Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "retina: 36.5" "Cell type enhanced" "Detected in some" "Distal tubular cells: 13.7;Early spermatids: 14.1;Horizontal cells: 55.5;Late spermatids: 37.6;Rod photoreceptor cells: 40.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.3;K-562: 5.0;U-266/70: 2.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA074772 Supported Nucleoplasm,Cytosol NA NA "Cluster 77: Retina - Visual perception" "Cluster 1: K-562 - Erythropoiesis" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm Cytosol "HPA074772: " "unprognostic (1.12e-1)" "unprognostic (1.34e-2)" "unprognostic (6.28e-2)" "unprognostic (3.92e-5)" "unprognostic (5.18e-2)" "unprognostic (3.15e-2)" "unprognostic (2.14e-1)" "unprognostic (1.48e-1)" "unprognostic (2.28e-2)" "unprognostic (2.24e-2)" "unprognostic (2.16e-2)" "unprognostic (4.11e-2)" "unprognostic (2.68e-1)" "unprognostic (3.46e-1)" "unprognostic (1.89e-1)" "unprognostic (2.12e-4)" "unprognostic (4.40e-2)" 0.0 0.0 0.4 0.0 0.4 0.0 0.3 0.4 0.4 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 4.9 0.3 0.6 6.6 0.0 0.0 0.0 1.5 1.2 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 36.5 0.0 0.0 6.5 0.0 0.0 0.0 0.6 0.1 2.4 1.2 0.9 0.1 0.0 1.6 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.0 0.2 0.0 0.6 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.4 0.0 0.2 2.3 0.7 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.3 0.6 1.5 1.2 0.7 0.6 0.9 0.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.4 1.0 0.4 5.8 0.0 0.0 0.0 2.1 0.0 0.0 0.0 13.7 0.0 14.1 0.0 0.0 0.8 0.0 0.0 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.5 2.0 0.0 0.0 0.0 0.0 37.6 0.0 0.1 0.0 3.7 0.0 4.6 0.0 1.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 40.3 0.0 0.1 0.8 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VASH1 KIAA1036 ENSG00000071246 "Vasohibin 1" Q7L8A9 14 76761468-76783015 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Cell cycle, Growth arrest" "Carboxypeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 67.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 139.7;Early spermatids: 72.8;Late spermatids: 95.3;Microglial cells: 53.4;Rod photoreceptor cells: 98.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 46.1;HEL: 35.1;HUVEC TERT2: 85.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000653 Uncertain "Secreted to blood" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 77: Retina - Visual perception" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA000653: AB_1080551" "unprognostic (1.47e-1)" "unprognostic (9.13e-2)" "unprognostic (2.56e-2)" "unprognostic (7.29e-2)" "unprognostic (1.93e-1)" "unprognostic (2.53e-3)" "unprognostic (2.88e-3)" "unprognostic (1.62e-1)" "unprognostic (9.23e-2)" "unprognostic (6.94e-2)" "prognostic favorable (6.56e-6)" "unprognostic (8.84e-2)" "unprognostic (6.44e-3)" "unprognostic (2.69e-1)" "unprognostic (1.92e-1)" "unprognostic (5.06e-2)" "unprognostic (1.73e-1)" 12.1 18.5 33.2 12.3 34.0 3.0 7.4 30.8 28.8 9.2 21.3 7.9 5.6 11.9 4.2 4.3 8.7 9.0 36.0 28.1 30.8 8.1 3.8 16.0 7.8 38.7 36.3 13.4 5.7 3.9 13.7 19.9 36.6 6.5 5.2 67.6 5.6 4.5 7.5 4.6 8.2 11.5 37.1 18.3 5.1 13.2 36.1 3.2 6.1 7.0 6.6 8.5 6.6 36.4 1.1 5.6 46.1 13.8 11.6 8.4 2.3 4.0 1.3 3.4 1.4 1.5 3.1 2.1 2.8 3.2 4.2 1.3 7.3 1.5 1.0 25.0 5.3 35.1 3.4 1.5 6.9 1.5 3.5 4.5 0.3 1.3 0.2 10.4 85.0 6.2 1.6 0.4 1.1 7.1 1.3 3.0 4.7 1.4 2.8 1.3 4.6 1.0 0.9 2.6 19.1 14.8 4.6 1.8 2.2 9.1 7.8 7.4 24.2 4.3 9.6 5.2 2.0 2.0 1.1 1.2 6.1 11.2 8.3 0.0 0.8 0.0 0.6 2.0 0.5 0.1 0.3 0.3 1.3 0.3 0.2 0.3 0.0 0.2 2.7 2.4 0.1 0.5 33.2 34.0 30.8 28.8 28.1 30.8 38.7 36.3 36.6 37.1 36.1 36.4 17.3 0.0 2.3 7.2 2.7 0.6 0.0 0.3 0.0 9.4 0.9 2.4 10.9 1.5 0.7 1.8 139.7 0.4 11.1 0.0 0.0 0.9 72.8 0.8 7.7 27.5 6.7 0.0 13.4 0.0 0.3 7.6 1.5 0.6 12.0 18.1 31.8 1.2 14.8 0.0 11.9 0.4 2.0 14.2 9.3 95.3 1.8 23.6 1.8 53.4 7.6 15.2 3.1 21.6 21.8 0.3 0.0 3.0 0.4 0.0 0.0 0.2 0.0 98.8 13.1 5.5 10.0 0.8 2.3 0.4 0.1 0.3 1.8 5.7 0.2 0.1 ANGEL1 "Ccr4e, KIAA0759" ENSG00000013523 "Angel homolog 1" Q9UNK9 14 76786009-76826246 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 64.3;Late spermatids: 75.1;Oligodendrocyte precursor cells: 64.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000948 Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 22: Non-specific - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "HPA000948: AB_2227189" "unprognostic (4.81e-2)" "unprognostic (2.37e-2)" "unprognostic (2.67e-1)" "unprognostic (2.46e-3)" "unprognostic (1.42e-1)" "unprognostic (3.15e-1)" "unprognostic (7.33e-2)" "prognostic favorable (3.43e-4)" "unprognostic (9.24e-2)" "unprognostic (1.01e-1)" "prognostic favorable (5.46e-4)" "unprognostic (3.03e-1)" "unprognostic (6.92e-3)" "unprognostic (1.42e-1)" "unprognostic (2.22e-1)" "unprognostic (1.53e-1)" "unprognostic (6.32e-2)" 11.3 18.5 18.3 11.8 19.7 6.8 12.7 16.7 21.2 12.8 15.6 10.0 9.2 14.8 23.8 7.0 12.2 11.4 15.7 19.2 21.1 11.6 19.3 14.0 12.2 22.5 19.6 19.3 50.8 17.2 21.1 10.4 21.5 9.3 10.9 26.4 15.8 8.4 12.2 6.4 10.3 12.3 18.1 29.3 15.8 52.4 20.1 8.1 13.7 9.8 10.9 9.5 8.5 23.8 13.1 14.0 15.2 13.6 12.2 11.1 14.1 7.7 11.0 7.8 9.9 13.5 18.2 23.8 11.1 6.7 10.6 16.2 14.6 13.7 13.1 10.1 13.1 14.8 9.7 10.3 7.9 7.8 8.7 11.8 16.8 7.3 14.5 11.3 20.0 24.8 14.5 6.2 8.2 25.3 14.0 11.6 17.5 20.7 18.4 17.0 10.4 14.1 11.8 18.4 21.5 9.6 11.6 15.8 7.1 13.8 31.1 8.4 9.6 9.1 8.0 6.9 6.4 15.9 12.9 14.7 7.7 13.7 11.8 0.8 4.8 1.6 5.9 5.5 7.2 6.8 5.3 5.6 7.5 5.5 7.5 5.6 1.4 5.5 7.1 4.9 4.5 5.9 18.3 19.7 16.7 21.2 19.2 21.1 22.5 19.6 21.5 18.1 20.1 23.8 7.4 6.4 10.5 17.6 4.7 1.1 1.8 1.5 2.2 2.4 5.7 5.0 6.7 5.7 2.2 3.7 10.4 1.5 1.5 2.1 0.0 3.3 64.3 3.7 3.9 10.0 4.2 4.2 18.3 3.2 2.8 4.3 1.5 3.3 1.3 15.9 7.1 9.5 7.2 0.0 19.7 4.4 4.1 5.7 2.0 75.1 2.1 5.5 1.8 23.4 1.4 4.9 1.0 64.8 30.2 2.5 1.0 4.9 8.9 3.4 1.7 1.3 1.4 8.9 6.6 5.1 2.4 15.9 4.9 2.8 0.4 1.2 3.0 12.9 4.6 1.5 LRRC74A "C14orf166B, LRRC74" ENSG00000100565 "Leucine rich repeat containing 74A" Q0VAA2 14 76826372-76870302 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 4 "testis: 3.9" "Group enriched" "Detected in some" 84 "Early spermatids: 58.0;Late spermatids: 111.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA035094 Uncertain NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" "HPA035094: AB_10600793" "unprognostic (7.71e-3)" "unprognostic (1.77e-1)" "unprognostic (2.77e-1)" "unprognostic (6.38e-2)" "unprognostic (3.44e-1)" "unprognostic (5.29e-3)" "unprognostic (3.22e-1)" "unprognostic (1.11e-2)" "unprognostic (1.16e-1)" "unprognostic (3.30e-1)" "unprognostic (5.49e-3)" "unprognostic (1.11e-2)" "unprognostic (5.21e-4)" "unprognostic (1.72e-1)" "unprognostic (9.96e-2)" "unprognostic (6.36e-2)" "unprognostic (1.09e-1)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 3.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 111.9 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 IRF2BPL "C14orf4, EAP1, KIAA1865" ENSG00000119669 "Interferon regulatory factor 2 binding protein like" Q9H1B7 14 77024543-77028708 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050862, HPA061333" Approved Enhanced Nucleoplasm NA Yes "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA050862: AB_2681258, HPA061333: AB_2684481" "unprognostic (5.58e-2)" "unprognostic (6.48e-2)" "unprognostic (1.99e-3)" "prognostic unfavorable (5.52e-4)" "unprognostic (8.78e-3)" "unprognostic (1.57e-2)" "unprognostic (2.70e-1)" "unprognostic (1.81e-1)" "unprognostic (5.74e-2)" "unprognostic (2.53e-2)" "unprognostic (2.51e-3)" "unprognostic (5.39e-2)" "unprognostic (1.03e-3)" "unprognostic (2.55e-1)" "unprognostic (9.33e-2)" "unprognostic (1.14e-1)" "unprognostic (1.58e-2)" 26.1 25.3 12.2 9.2 13.9 5.6 28.5 13.4 12.0 20.1 12.8 32.4 6.9 25.8 5.1 13.3 33.7 6.5 22.6 14.1 21.1 28.7 19.1 20.9 6.2 15.2 14.8 32.4 17.5 19.8 22.6 7.9 10.9 18.4 3.3 7.3 19.2 10.1 16.8 25.2 15.1 8.0 12.6 19.0 18.8 13.5 19.0 9.7 18.7 4.2 3.3 26.4 18.2 9.4 15.4 13.2 32.2 36.3 9.6 8.8 45.8 15.9 13.0 4.4 5.9 6.2 24.8 5.4 11.3 13.6 12.4 23.6 5.6 11.8 3.7 25.8 19.1 6.9 13.0 8.5 12.5 1.9 29.7 11.8 9.1 7.8 6.8 34.8 6.0 10.9 10.4 59.4 5.7 42.2 21.0 14.5 14.5 6.6 68.2 4.4 9.1 13.0 15.6 22.4 24.9 36.0 22.5 23.2 42.5 8.6 16.1 3.4 10.4 20.2 19.5 6.8 10.3 22.9 26.3 9.0 31.3 4.7 25.8 1.7 1.4 1.3 2.8 1.9 2.7 1.4 2.5 2.6 1.3 1.6 2.0 2.3 9.0 5.9 2.3 10.7 2.6 0.8 12.2 13.9 13.4 12.0 14.1 21.1 15.2 14.8 10.9 12.6 19.0 9.4 71.4 22.4 14.3 5.9 40.2 73.7 32.5 22.5 115.5 57.1 54.6 41.5 19.5 32.9 11.6 64.4 29.2 22.8 58.9 10.8 37.2 19.6 1.3 25.3 26.0 44.0 47.6 10.8 8.2 19.0 49.7 47.8 12.2 25.6 26.6 15.2 55.6 60.5 33.3 10.1 8.6 14.7 16.2 54.7 78.9 4.0 30.1 26.6 35.6 9.4 10.0 57.8 38.1 8.5 4.8 17.8 7.0 34.3 21.1 30.0 6.7 23.1 13.8 10.4 39.5 56.4 83.2 1.6 50.5 54.2 50.6 46.0 39.0 27.5 12.8 20.6 CIPC KIAA1737 ENSG00000198894 "CLOCK interacting pacemaker" Q9C0C6 14 77098126-77117287 "Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 132.1" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 58.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000644 Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 80: Striated muscle - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Cytosol" Nucleoli "HPA000644: AB_1079206" "unprognostic (3.93e-2)" "unprognostic (6.71e-2)" "unprognostic (2.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.55e-1)" "unprognostic (1.85e-1)" "unprognostic (2.41e-1)" "unprognostic (6.67e-3)" "unprognostic (3.73e-2)" "unprognostic (1.74e-1)" "unprognostic (2.31e-2)" "unprognostic (3.20e-1)" "prognostic favorable (1.77e-10)" "unprognostic (2.28e-1)" "unprognostic (2.32e-1)" "unprognostic (1.13e-1)" "unprognostic (1.21e-1)" 13.2 9.6 41.3 8.4 53.0 4.2 15.8 48.0 41.1 16.8 24.7 26.8 10.3 14.6 13.5 22.1 30.4 9.0 39.8 46.5 44.1 14.2 15.4 11.1 8.4 47.5 48.2 9.1 9.7 29.5 13.5 9.0 43.9 25.5 19.9 41.2 20.5 24.8 132.1 15.4 11.4 16.5 42.3 9.1 11.4 11.7 53.3 10.3 20.4 82.4 10.1 17.2 15.5 49.6 9.4 12.6 25.4 16.8 10.1 8.0 15.4 6.0 9.4 10.9 9.8 10.3 19.4 23.3 5.9 9.7 9.6 14.3 23.7 9.4 14.3 12.3 6.4 14.9 9.8 9.5 9.7 8.4 10.7 9.4 17.9 10.6 6.5 14.1 12.7 19.2 14.0 8.8 8.1 21.4 20.2 10.2 10.6 21.3 10.9 20.2 11.3 14.0 11.0 16.1 35.9 13.4 11.0 17.4 14.9 10.7 27.2 8.6 14.9 7.0 15.1 10.0 7.6 8.4 7.1 11.1 13.2 7.1 14.8 4.3 4.5 1.6 2.6 5.1 4.1 7.9 3.6 2.7 5.4 7.1 3.8 2.8 5.5 5.5 3.8 2.0 4.1 3.6 41.3 53.0 48.0 41.1 46.5 44.1 47.5 48.2 43.9 42.3 53.3 49.6 8.5 16.0 18.4 33.6 4.7 9.1 8.2 5.3 12.5 29.3 18.3 12.6 49.9 8.6 12.6 11.0 58.4 7.4 5.5 43.5 9.8 4.2 11.0 39.8 9.2 7.0 17.4 6.5 16.4 5.6 5.0 5.6 9.2 20.3 1.3 5.8 7.1 29.5 15.2 11.8 20.2 14.8 30.5 16.0 6.6 15.8 4.1 7.2 8.8 9.4 5.8 22.8 2.1 21.1 58.7 5.1 12.4 14.3 4.2 8.3 18.1 6.0 30.5 36.4 13.1 7.9 9.3 19.9 9.1 10.4 9.8 13.5 3.1 7.1 13.7 7.1 TMEM63C "C14orf171, CSC1, DKFZp434P0111, hsCSC1" ENSG00000165548 "Transmembrane protein 63C" Q9P1W3 14 77116568-77259495 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.7;pituitary gland: 41.9" "Cell type enhanced" "Detected in some" "Early spermatids: 9.5;Enteroendocrine cells: 19.2;Excitatory neurons: 25.8;Inhibitory neurons: 22.2;Oligodendrocyte precursor cells: 16.1" "Cancer enhanced" "Detected in many" "breast cancer: 5.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 18.5;Karpas-707: 24.1;RPMI-8226: 12.7;SCLC-21H: 32.5;SK-BR-3: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030657 Uncertain Approved Centrosome NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Centrosome "HPA030657: AB_10601699" "unprognostic (2.74e-1)" "unprognostic (1.79e-2)" "unprognostic (2.30e-1)" "unprognostic (4.30e-8)" "unprognostic (2.85e-1)" "unprognostic (5.26e-2)" "unprognostic (2.68e-3)" "unprognostic (1.61e-3)" "unprognostic (2.51e-1)" "unprognostic (1.71e-1)" "unprognostic (1.21e-2)" "unprognostic (1.14e-1)" "unprognostic (2.90e-2)" "unprognostic (1.35e-3)" "unprognostic (3.72e-2)" "unprognostic (1.34e-7)" "unprognostic (5.90e-3)" 0.2 9.6 9.2 0.6 5.9 0.8 3.3 28.7 10.5 2.6 0.0 4.5 1.2 0.1 4.5 6.4 0.2 0.2 0.9 5.6 24.6 0.5 0.1 0.5 0.3 4.5 8.3 0.1 4.8 1.5 41.9 0.7 16.9 0.2 3.0 2.4 2.7 0.0 0.5 9.7 2.7 0.6 4.2 3.3 1.9 11.3 18.2 0.1 2.2 0.4 0.3 0.0 7.1 4.3 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 18.5 3.4 0.0 3.0 2.5 3.8 1.5 0.0 1.2 1.4 0.3 1.8 0.0 0.0 3.2 0.1 0.0 7.5 0.0 0.2 0.0 0.0 8.7 0.0 24.1 0.0 9.3 2.6 0.1 0.8 0.0 0.0 0.0 1.2 12.7 0.3 0.0 32.5 4.9 0.4 29.1 0.0 0.6 2.8 1.6 0.0 0.0 5.9 0.0 0.0 1.9 0.1 0.7 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.3 0.3 0.0 0.0 0.1 9.2 5.9 28.7 10.5 5.6 24.6 4.5 8.3 16.9 4.2 18.2 4.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.0 3.3 2.2 0.8 0.7 0.0 1.7 0.0 2.1 0.0 1.5 3.8 1.9 0.0 9.5 0.3 0.4 0.1 19.2 0.0 25.8 0.2 0.1 0.3 0.0 2.4 0.0 0.2 0.0 0.0 2.7 3.3 22.2 3.0 4.1 0.0 0.0 6.2 0.0 0.2 0.0 3.7 0.6 0.3 0.0 16.1 1.1 0.2 7.0 0.4 0.1 0.0 0.5 0.2 0.1 0.6 0.0 0.0 0.3 0.6 0.1 2.4 0.0 0.0 0.2 0.7 0.7 0.1 ZDHHC22 C14orf59 ENSG00000177108 "Zinc finger DHHC-type palmitoyltransferase 22" Q8N966 14 77131270-77142734 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 51.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 17.3;Excitatory neurons: 8.8;Inhibitory neurons: 13.4;Late spermatids: 5.0;Oligodendrocyte precursor cells: 24.6" "Cancer enriched" "Detected in single" 40 "glioma: 7.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 3.6;NTERA-2: 3.8;RH-30: 6.4;SCLC-21H: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049471, HPA072213" Enhanced "Plasma membrane" NA NA "Cluster 6: Brain - Smell perception" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 56: Bipolar cells - Visual perception" "Plasma membrane" "HPA049471: AB_2732553, HPA072213: AB_2686496" "unprognostic (1.02e-1)" "unprognostic (3.42e-1)" "unprognostic (1.22e-4)" "unprognostic (1.66e-1)" "unprognostic (8.86e-2)" "unprognostic (2.68e-1)" "unprognostic (3.41e-1)" "unprognostic (1.87e-1)" "unprognostic (6.94e-4)" "unprognostic (3.05e-1)" "unprognostic (6.30e-2)" "unprognostic (1.16e-1)" "unprognostic (4.02e-1)" "unprognostic (1.95e-1)" "unprognostic (4.79e-1)" 0.0 0.2 14.9 0.0 15.3 0.0 0.0 25.9 33.8 0.1 0.0 0.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 21.2 12.8 0.0 0.0 0.0 0.0 1.2 22.7 0.0 0.0 0.0 4.7 0.0 1.0 0.0 0.1 7.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.5 51.3 0.0 0.1 0.4 0.0 0.1 0.0 13.9 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 3.8 0.0 0.5 0.0 6.4 0.0 0.0 0.0 7.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 15.3 25.9 33.8 21.2 12.8 1.2 22.7 1.0 0.0 51.3 13.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.3 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 24.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NGB ENSG00000165553 Neuroglobin Q9NPG2 14 77265483-77271312 "Predicted intracellular proteins, Transporters" "Apoptosis, Oxygen transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 57.9;pituitary gland: 16.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 1.0;Excitatory neurons: 1.6;Inhibitory neurons: 1.7;Oligodendrocyte precursor cells: 3.5;Spermatogonia: 1.8" "Cancer enhanced" "Detected in some" "cervical cancer: 2.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 29 "RPMI-8226: 6.1;SCLC-21H: 12.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA042615, HPA058596" Enhanced NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA042615: AB_2678079, HPA058596: AB_2683769" "unprognostic (1.02e-1)" "unprognostic (3.55e-2)" "unprognostic (8.86e-2)" "unprognostic (1.03e-1)" "unprognostic (9.29e-2)" "unprognostic (3.14e-1)" "unprognostic (4.08e-2)" "unprognostic (6.65e-2)" "unprognostic (6.58e-2)" "unprognostic (3.37e-4)" "unprognostic (1.80e-1)" "unprognostic (3.12e-1)" 0.1 7.5 20.6 0.2 17.2 0.0 0.0 11.8 26.8 0.0 10.7 5.5 0.2 0.0 0.1 0.1 1.3 0.0 0.0 15.2 57.9 0.0 0.0 0.0 0.0 24.8 29.0 0.0 5.0 0.0 16.9 0.0 29.9 0.0 0.5 0.5 0.0 0.0 0.0 0.0 1.0 0.1 15.5 0.0 1.0 0.5 40.9 0.2 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.1 0.0 0.0 12.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.6 17.2 11.8 26.8 15.2 57.9 24.8 29.0 29.9 15.5 40.9 15.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 1.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 POMT2 LGMD2N ENSG00000009830 "Protein O-mannosyltransferase 2" Q9UKY4 14 77274956-77320883 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 37.5" "Cell type enhanced" "Detected in many" "Astrocytes: 27.1;Oligodendrocytes: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003663 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 43: Testis - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nucleoli, Cytosol" "HPA003663: AB_1079655" "unprognostic (2.15e-1)" "unprognostic (1.07e-2)" "unprognostic (7.92e-2)" "unprognostic (3.37e-2)" "unprognostic (1.48e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.40e-4)" "unprognostic (7.10e-3)" "unprognostic (1.17e-1)" "unprognostic (1.68e-1)" "unprognostic (6.89e-3)" "unprognostic (1.94e-3)" "unprognostic (8.50e-3)" "unprognostic (1.37e-1)" "unprognostic (2.44e-1)" "unprognostic (6.75e-3)" "unprognostic (3.46e-2)" 5.8 12.4 13.2 4.1 14.9 2.5 5.7 13.5 13.4 8.0 12.5 6.7 2.6 6.7 9.8 5.5 5.8 4.0 7.9 12.7 13.1 10.8 9.3 5.6 1.8 14.6 14.6 6.1 8.8 8.6 12.6 7.0 13.4 7.8 3.3 5.6 6.3 6.9 19.1 4.7 4.9 4.6 13.7 5.6 5.9 37.5 14.4 2.9 10.9 8.4 1.9 7.9 5.3 15.4 15.6 19.4 18.6 21.1 13.0 10.3 14.8 13.4 10.8 19.3 16.6 9.6 13.6 4.6 10.6 12.6 27.1 17.1 8.8 13.3 13.5 6.9 12.1 2.8 8.9 7.9 15.8 3.2 8.9 10.5 13.9 18.3 17.8 13.6 11.5 4.5 7.4 10.5 13.0 30.7 5.4 15.0 5.3 21.4 16.2 5.3 18.0 4.1 20.4 11.3 15.6 15.2 8.7 14.6 11.3 12.0 15.1 6.5 9.6 14.6 22.8 17.1 12.0 6.8 14.5 2.1 7.4 4.8 13.2 0.0 0.0 0.0 0.4 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.1 13.2 14.9 13.5 13.4 12.7 13.1 14.6 14.6 13.4 13.7 14.4 15.4 3.2 6.4 2.8 27.1 2.0 3.1 2.7 3.4 2.8 7.5 7.2 7.6 4.3 4.3 1.6 1.8 16.7 6.0 1.2 6.5 0.0 7.6 14.3 5.8 6.7 3.1 18.0 0.0 12.9 7.5 10.2 6.1 4.1 7.0 2.5 6.4 2.5 5.7 5.5 8.4 14.5 3.2 2.0 2.2 2.6 17.2 1.8 2.4 1.8 9.4 2.3 5.9 0.0 20.1 30.5 5.5 3.2 4.1 2.1 5.2 2.5 3.6 5.1 15.1 0.0 6.2 5.0 11.3 8.2 5.2 1.8 5.7 1.2 13.9 3.6 1.9 GSTZ1 "GSTZ1-1, MAAI, MAI" ENSG00000100577 "Glutathione S-transferase zeta 1" O43708 14 77320996-77331597 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" "Isomerase, Multifunctional enzyme, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 263.1" "Cell type enhanced" "Detected in many" "Hepatocytes: 373.2;Late spermatids: 398.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 182.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004701 Approved Approved Nucleoplasm,Cytosol NA NA 340000 "Cluster 18: Basophils - Vesicular transport" "Cluster 62: Liver - Hemostasis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 2: Hepatocytes - Metabolism" Cytosol Nucleoplasm "HPA004701: AB_1078990" "prognostic favorable (4.93e-4)" "unprognostic (1.08e-1)" "unprognostic (2.56e-1)" "unprognostic (2.16e-3)" "unprognostic (4.55e-1)" "unprognostic (3.03e-2)" "unprognostic (8.03e-3)" "unprognostic (1.98e-1)" "unprognostic (2.18e-1)" "prognostic favorable (3.73e-4)" "unprognostic (7.90e-2)" "unprognostic (1.73e-1)" "prognostic favorable (1.12e-7)" "unprognostic (1.00e-1)" "unprognostic (1.11e-1)" "unprognostic (4.12e-1)" "unprognostic (4.92e-2)" 13.9 34.7 11.1 9.7 12.5 9.3 23.2 13.2 16.3 12.7 10.5 21.9 22.5 10.8 22.1 26.9 14.9 11.9 14.3 10.5 12.3 24.5 263.1 7.8 13.5 12.6 11.7 6.5 20.1 26.4 13.3 11.2 12.8 21.1 21.7 5.1 24.1 9.6 47.4 22.1 15.6 7.9 12.3 12.1 18.9 57.8 11.9 14.0 19.5 37.3 17.4 11.9 13.8 14.0 18.8 39.0 27.6 19.9 17.1 23.9 45.8 11.4 11.9 21.6 30.9 13.0 45.2 43.5 14.9 13.6 13.4 24.1 18.9 22.5 20.7 23.2 21.0 20.8 13.3 26.9 26.3 7.8 15.8 22.1 24.0 12.4 20.8 12.0 18.6 24.7 17.5 37.0 14.5 182.1 12.2 16.4 8.2 64.1 30.3 20.2 29.5 34.2 32.5 24.0 30.2 26.2 26.0 49.1 35.6 15.5 81.2 11.1 13.8 17.0 52.5 18.9 8.6 28.2 32.7 35.2 41.9 11.3 20.8 13.4 15.5 9.9 2.6 22.2 2.4 8.2 4.6 3.7 20.7 10.4 3.9 3.1 1.6 5.1 20.1 15.0 7.9 7.4 11.1 12.5 13.2 16.3 10.5 12.3 12.6 11.7 12.8 12.3 11.9 14.0 6.1 6.4 9.6 6.5 13.5 13.4 19.8 26.2 15.9 7.3 36.1 34.2 13.0 47.1 19.0 9.2 4.2 91.4 7.5 34.9 46.9 45.0 125.8 19.4 15.6 11.1 28.8 30.3 2.9 68.0 62.5 15.0 33.1 27.0 3.8 25.7 15.4 373.2 44.6 16.8 3.3 45.7 20.3 38.1 10.9 398.1 11.8 19.0 17.8 3.7 30.4 26.4 4.1 2.0 9.2 41.8 37.4 6.0 13.2 19.8 72.9 77.8 15.0 11.9 0.0 12.3 13.2 51.3 29.4 38.0 14.1 76.2 6.7 55.8 50.3 30.3 TMED8 FAM15B ENSG00000100580 "Transmembrane p24 trafficking protein family member 8" Q6PL24 14 77335029-77377094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 62.7;Cone photoreceptor cells: 108.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Daudi: 58.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001205 Approved Approved "Vesicles,Plasma membrane" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 57: B-cells - Immune response" "Plasma membrane" Vesicles "HPA001205: AB_2204460" "unprognostic (1.07e-1)" "unprognostic (4.70e-2)" "unprognostic (4.85e-2)" "unprognostic (2.39e-1)" "unprognostic (1.13e-1)" "unprognostic (7.82e-2)" "unprognostic (1.68e-2)" "unprognostic (3.74e-2)" "unprognostic (1.22e-1)" "unprognostic (2.01e-1)" "unprognostic (2.81e-2)" "unprognostic (1.04e-1)" "unprognostic (1.03e-3)" "unprognostic (2.23e-3)" "unprognostic (1.12e-1)" "unprognostic (5.88e-2)" "unprognostic (2.77e-1)" 5.5 8.3 8.2 8.6 9.6 7.7 5.7 4.7 8.4 5.9 4.1 4.4 3.3 6.7 5.1 3.6 5.4 4.1 3.4 7.5 16.6 10.4 3.4 4.6 17.5 7.9 10.5 7.3 5.6 11.1 9.2 4.4 11.2 5.9 4.8 24.2 4.4 5.9 2.3 4.9 5.5 5.6 6.9 8.0 6.2 6.8 12.8 9.8 10.9 2.4 19.5 4.7 3.5 5.9 14.7 12.0 13.9 12.4 8.5 7.6 11.8 9.2 6.0 9.4 10.1 7.5 8.1 58.7 7.5 7.5 7.7 10.0 10.4 10.5 14.6 18.6 6.3 19.6 9.5 7.9 5.9 9.6 51.8 8.0 7.4 12.3 11.0 9.5 13.5 47.7 10.1 15.4 9.5 14.4 15.2 14.2 6.9 10.7 12.0 12.2 12.7 4.7 9.9 9.0 17.2 10.4 15.9 9.4 11.8 10.6 15.2 15.9 9.7 9.7 6.2 17.5 10.7 12.3 25.2 28.9 11.1 17.7 14.3 2.3 0.7 2.2 0.3 0.9 0.4 2.1 0.5 0.4 0.6 2.1 0.3 0.5 1.0 0.5 0.8 1.0 0.7 0.5 8.2 9.6 4.7 8.4 7.5 16.6 7.9 10.5 11.2 6.9 12.8 5.9 6.6 3.2 7.8 62.7 33.9 6.6 4.9 7.7 2.8 33.4 12.5 8.3 16.8 8.6 5.3 22.0 108.4 10.5 7.9 6.5 5.9 6.4 4.8 9.8 15.5 10.4 44.3 15.4 44.7 4.7 10.0 8.4 7.1 9.0 0.0 9.1 8.9 9.8 7.8 28.6 40.7 6.3 10.2 24.8 7.7 6.9 14.6 19.8 5.4 21.5 16.8 14.9 6.2 39.7 24.2 6.8 3.3 14.3 19.9 7.5 3.2 22.2 20.9 39.3 13.1 7.1 8.4 6.8 15.7 8.2 8.9 4.1 10.3 19.8 6.7 4.3 SAMD15 "C14orf174, FAM15A, FLJ35963" ENSG00000100583 "Sterile alpha motif domain containing 15" Q9P1V8 14 77376689-77391497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 15.3;testis: 17.7" "Group enriched" "Detected in many" 6 "Cone photoreceptor cells: 62.6;Early spermatids: 81.8;Endometrial ciliated cells: 38.8;Late spermatids: 111.7;Respiratory ciliated cells: 41.5;Rod photoreceptor cells: 75.7;Spermatocytes: 59.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA030673, HPA030677" Enhanced Approved "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 77: Retina - Visual perception" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 9: Photoreceptor cells - Phototransduction" "Nucleoplasm, Nuclear membrane, Nucleoli" "HPA030673: AB_10600655, HPA030677: AB_10599938" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (3.76e-2)" "unprognostic (1.15e-1)" "unprognostic (1.02e-2)" "unprognostic (1.38e-2)" "unprognostic (3.70e-3)" "unprognostic (5.20e-2)" "unprognostic (5.76e-2)" "unprognostic (1.11e-1)" "unprognostic (3.83e-3)" "unprognostic (6.19e-2)" "unprognostic (2.53e-3)" "unprognostic (6.87e-3)" "unprognostic (9.90e-2)" "unprognostic (3.73e-3)" "unprognostic (1.76e-2)" 0.5 0.8 1.7 0.3 2.8 0.6 1.0 0.7 1.5 0.7 7.7 0.2 0.3 1.0 5.3 0.2 4.5 1.1 0.1 1.7 3.4 1.9 0.1 0.8 1.4 2.8 3.5 0.7 2.0 2.4 2.4 0.3 2.0 0.7 0.3 15.3 0.3 0.7 0.2 0.5 0.2 0.3 1.4 0.2 0.4 17.7 2.7 0.4 3.9 0.0 1.4 0.8 0.2 0.8 2.5 3.4 1.3 2.7 0.3 1.4 1.2 1.0 0.9 2.6 2.3 2.5 2.2 2.8 1.1 1.0 2.3 2.4 0.9 1.4 3.7 0.2 0.5 0.4 1.0 0.6 0.1 0.5 2.9 1.3 0.9 2.3 0.2 1.1 1.8 1.4 0.3 0.7 1.1 7.6 0.6 0.2 0.5 0.6 1.0 1.2 1.2 0.1 4.6 1.4 2.8 1.8 3.5 0.5 0.5 0.5 4.3 0.8 0.7 2.5 1.4 2.6 1.3 0.4 2.4 1.8 3.1 0.1 1.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.7 2.8 0.7 1.5 1.7 3.4 2.8 3.5 2.0 1.4 2.7 0.8 0.7 0.0 0.0 1.0 0.3 0.3 0.5 0.6 0.0 11.2 0.9 0.9 1.9 2.8 1.8 0.0 62.6 0.3 0.8 0.7 1.9 2.8 81.8 38.8 4.6 0.5 3.6 0.0 1.3 0.6 0.2 1.0 0.0 1.4 0.0 1.3 0.4 0.0 0.1 3.3 0.6 0.5 0.0 0.0 0.0 111.7 1.5 0.3 0.0 0.0 0.1 5.5 0.0 0.5 0.4 0.9 0.1 0.0 0.0 0.2 0.0 3.5 41.5 75.7 0.0 1.0 1.0 59.3 7.3 0.0 0.0 0.3 0.3 6.0 0.1 0.3 NOXRED1 "C14orf148, FLJ32809" ENSG00000165555 "NADP dependent oxidoreductase domain containing 1" Q6NXP6 14 77394021-77423517 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 5.9;testis: 6.9" "Group enriched" "Detected in some" 25 "Early spermatids: 137.8;Late spermatids: 125.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA055658, HPA060408" Approved Approved "Vesicles,Plasma membrane" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 34: Spermatids - Unknown function" Vesicles "Plasma membrane" "HPA055658: AB_2682878, HPA060408: " "unprognostic (1.92e-2)" "unprognostic (4.83e-2)" "unprognostic (1.14e-1)" "unprognostic (1.55e-1)" "unprognostic (2.49e-2)" "unprognostic (9.87e-2)" "unprognostic (1.92e-2)" "unprognostic (1.36e-1)" "unprognostic (2.39e-2)" "unprognostic (2.61e-1)" "unprognostic (1.08e-3)" "unprognostic (1.24e-2)" "unprognostic (1.29e-2)" "unprognostic (2.60e-1)" "unprognostic (5.70e-2)" "unprognostic (1.70e-3)" "unprognostic (1.07e-3)" 0.2 0.6 0.5 0.1 0.6 0.2 0.5 0.2 0.5 0.2 1.7 0.5 0.5 0.5 0.5 0.3 0.5 0.6 0.1 0.5 0.6 0.5 0.3 0.3 0.6 0.8 1.0 0.3 0.4 0.2 0.7 0.3 0.7 0.3 0.5 5.9 0.2 0.4 0.1 1.1 0.3 0.4 0.9 0.5 0.2 6.9 0.5 0.5 0.9 0.0 0.4 0.2 0.2 0.7 0.3 0.7 0.3 0.4 0.1 0.7 0.5 0.3 0.5 0.3 0.2 0.4 0.3 0.7 0.1 0.6 0.1 0.2 0.1 0.1 0.4 0.3 0.2 0.4 0.0 0.7 0.2 0.1 0.6 0.4 0.9 0.3 0.5 0.4 0.2 0.8 0.1 0.5 0.1 0.8 0.2 0.2 0.0 0.2 0.6 0.2 0.1 0.0 0.3 0.1 0.7 0.5 0.4 0.1 0.1 0.7 0.7 0.4 0.9 0.2 0.2 0.4 0.1 0.7 0.7 0.4 0.3 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.6 0.2 0.5 0.5 0.6 0.8 1.0 0.7 0.9 0.5 0.7 0.2 0.0 0.0 5.2 0.2 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.1 0.0 0.1 0.0 4.2 0.0 0.0 0.3 0.0 0.0 137.8 0.6 0.1 0.2 1.8 0.0 4.1 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.1 0.0 3.0 0.0 0.0 0.3 0.2 125.8 0.9 0.3 0.0 0.0 0.0 0.4 0.0 3.0 4.4 0.1 0.0 1.2 0.1 0.1 0.3 0.1 0.2 1.5 0.0 0.0 0.1 4.1 2.2 0.0 0.0 0.0 0.0 0.2 0.1 0.1 VIPAS39 "C14orf133, hSPE-39, SPE-39, SPE39, VIPAR, VPS16B" ENSG00000151445 "VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog" Q9H9C1 14 77426675-77457952 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Protein transport, Spermatogenesis, Transcription, Transcription regulation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003589, HPA003593" Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 47: Cytotrophoblasts - Unknown function" "HPA003589: AB_10599707, HPA003593: AB_10601879" "unprognostic (1.30e-1)" "unprognostic (7.56e-2)" "unprognostic (3.41e-2)" "unprognostic (1.04e-1)" "unprognostic (5.79e-3)" "unprognostic (5.76e-2)" "prognostic unfavorable (1.06e-6)" "unprognostic (2.53e-2)" "unprognostic (1.67e-1)" "unprognostic (5.77e-2)" "unprognostic (1.57e-1)" "unprognostic (1.36e-1)" "unprognostic (1.56e-3)" "unprognostic (5.31e-3)" "unprognostic (3.48e-1)" "unprognostic (5.91e-2)" "unprognostic (1.09e-2)" 12.4 11.8 15.3 9.4 16.0 9.1 12.2 15.4 17.9 12.1 15.6 14.3 10.1 12.1 14.7 13.2 10.8 9.1 14.8 15.7 15.6 11.2 13.6 9.9 12.4 15.2 15.3 18.5 11.9 14.6 13.4 15.5 15.6 11.8 12.7 14.4 10.0 13.7 13.7 13.7 11.1 14.6 15.6 13.2 11.6 15.9 15.9 16.5 11.7 15.0 14.7 13.9 11.6 17.7 10.6 17.8 18.3 26.6 32.5 26.5 18.3 17.5 16.1 20.8 20.2 11.9 24.7 18.4 15.1 14.3 10.8 20.4 17.0 15.5 24.9 15.8 5.8 13.7 10.7 14.7 26.3 8.6 23.2 25.4 24.2 17.8 24.2 27.7 36.3 25.5 10.9 17.4 19.9 25.1 17.7 18.4 16.5 31.0 19.3 17.6 23.0 12.7 20.9 15.3 13.0 15.0 22.7 16.7 20.2 21.7 39.1 18.1 25.9 14.1 12.5 15.5 9.8 14.8 15.1 14.6 15.3 15.9 17.0 1.8 9.4 17.6 5.0 15.6 6.5 4.8 6.5 5.6 10.8 5.6 5.7 5.6 7.8 13.0 20.3 5.5 7.8 6.1 15.3 16.0 15.4 17.9 15.7 15.6 15.2 15.3 15.6 15.6 15.9 17.7 6.0 3.2 1.5 16.0 6.3 3.2 3.0 4.7 2.8 8.5 5.3 5.3 9.0 4.3 3.4 9.2 20.9 20.7 6.3 7.2 7.9 9.3 5.7 4.0 7.4 6.8 5.4 11.2 14.6 6.3 16.6 8.2 5.1 6.2 2.5 12.2 8.2 6.6 13.3 10.1 14.4 5.4 2.0 17.6 3.8 3.8 11.5 8.3 0.0 13.1 17.6 7.4 9.2 15.1 17.2 9.1 9.4 15.4 4.0 2.5 10.7 5.8 3.6 13.3 6.6 5.5 6.8 11.0 9.2 6.3 4.3 19.2 6.3 15.5 7.2 2.8 AHSA1 "Aha1, C14orf3, hAha1, p38" ENSG00000100591 "Activator of HSP90 ATPase activity 1" O95433 14 77457870-77469472 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 345.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000903, CAB006244" Supported Supported Cytosol NA NA 120000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "CAB006244: AB_425858, HPA000903: AB_1078112" "unprognostic (3.91e-1)" "unprognostic (1.92e-1)" "unprognostic (1.06e-1)" "unprognostic (2.69e-1)" "unprognostic (3.48e-1)" "unprognostic (1.49e-3)" "prognostic unfavorable (5.04e-6)" "unprognostic (3.63e-2)" "unprognostic (1.54e-1)" "unprognostic (1.06e-1)" "unprognostic (2.88e-1)" "unprognostic (2.63e-2)" "unprognostic (2.16e-2)" "unprognostic (1.33e-1)" "unprognostic (3.06e-2)" "unprognostic (1.44e-2)" "unprognostic (3.01e-1)" 70.9 99.1 134.7 51.8 136.1 51.0 55.4 142.0 345.7 63.9 135.3 82.4 44.8 80.1 72.3 72.6 120.9 39.4 116.7 134.9 139.1 73.2 71.8 60.8 71.6 141.8 139.3 69.8 50.3 65.5 66.7 76.5 144.0 64.4 71.8 39.1 56.7 70.3 140.2 59.8 54.9 85.0 139.4 55.7 61.9 99.4 142.5 65.2 47.1 118.3 91.4 76.9 61.1 156.2 185.0 356.7 103.1 131.9 159.1 110.3 175.1 131.2 111.6 223.0 165.3 277.0 163.4 361.3 103.0 145.1 258.4 204.7 386.2 186.5 231.8 131.8 207.5 156.1 181.6 343.3 113.7 102.6 230.8 98.3 244.9 150.7 72.2 133.1 209.9 225.3 205.5 115.6 138.5 522.6 278.6 207.8 170.6 347.7 372.9 210.2 110.3 178.1 178.2 187.1 155.0 161.4 119.2 302.9 115.8 154.4 174.4 152.6 100.3 115.3 162.1 126.2 198.7 103.7 241.6 273.8 169.1 211.3 131.1 82.7 51.5 67.9 66.4 74.0 76.9 81.0 59.8 68.0 67.2 63.7 69.0 70.6 39.8 88.7 92.5 66.4 77.2 52.2 134.7 136.1 142.0 345.7 134.9 139.1 141.8 139.3 144.0 139.4 142.5 156.2 46.6 35.3 21.6 10.1 59.4 156.0 208.2 82.8 74.0 36.0 49.9 46.6 92.2 42.9 57.0 27.6 85.5 153.4 66.8 60.0 74.3 74.2 40.6 112.6 60.8 54.9 78.3 55.8 14.6 48.8 113.3 68.3 25.5 59.6 76.2 55.2 28.9 41.0 93.5 18.5 14.7 70.5 65.1 26.7 117.5 34.2 67.7 52.6 90.7 12.2 58.5 46.6 61.8 10.1 23.6 67.8 65.6 66.5 54.1 145.4 56.4 87.0 132.2 54.1 98.6 46.9 135.0 92.0 57.3 67.7 140.1 136.7 92.3 86.0 85.2 120.1 ISM2 "FLJ32147, TAIL1, THSD3" ENSG00000100593 "Isthmin 2" Q6H9L7 14 77474394-77498816 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 58 "placenta: 213.4" "Group enriched" "Detected in some" 10 "Cytotrophoblasts: 291.0;Extravillous trophoblasts: 617.2;Syncytiotrophoblasts: 177.5" "Cancer enhanced" "Detected in some" "testis cancer: 1.4" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "BEWO: 386.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039314, HPA039742" Supported Supported Nucleoplasm "Secreted in female reproductive system" NA NA 1100000 "Cluster 28: Placenta - Pregnancy" "Cluster 28: BEWO - Transcription regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "HPA039314: AB_10673239, HPA039742: AB_10673427" "unprognostic (5.69e-2)" "unprognostic (9.17e-3)" "unprognostic (2.58e-2)" "unprognostic (1.41e-3)" "unprognostic (3.73e-2)" "unprognostic (2.34e-1)" "unprognostic (2.16e-2)" "unprognostic (3.09e-3)" "unprognostic (2.11e-1)" "unprognostic (4.13e-1)" "unprognostic (8.10e-2)" "unprognostic (1.42e-2)" "unprognostic (9.36e-2)" "unprognostic (1.83e-1)" "unprognostic (5.67e-2)" "unprognostic (3.95e-1)" 0.6 0.0 0.3 0.1 1.2 0.0 0.0 0.0 0.7 0.8 0.8 0.2 0.1 1.2 3.7 0.2 0.4 0.1 0.1 0.2 0.6 0.7 0.0 0.0 0.0 0.1 0.3 0.1 0.6 0.4 0.5 213.4 0.2 1.8 0.0 0.1 0.1 1.4 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.6 0.8 0.0 0.2 0.0 0.0 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 386.3 0.0 0.0 0.1 0.0 6.1 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.4 0.0 0.0 25.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.3 0.5 0.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.7 0.2 0.6 0.1 0.3 0.2 0.1 0.8 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 291.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.4 0.0 617.2 2.1 0.0 0.0 0.0 0.1 0.0 0.0 33.4 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.7 1.7 0.0 0.0 177.5 0.0 0.0 0.0 0.0 SPTLC2 "hLCB2a, KIAA0526, LCB2, LCB2A" ENSG00000100596 "Serine palmitoyltransferase long chain base subunit 2" O15270 14 77505997-77616637 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Acyltransferase, Transferase" "Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 164.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA No "Cluster 14: Monocytes - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 36: HEL - Hemostasis" "Cluster 10: Non-specific - Unknown function" "unprognostic (3.16e-1)" "unprognostic (2.82e-2)" "unprognostic (1.24e-1)" "unprognostic (4.41e-2)" "unprognostic (2.12e-1)" "unprognostic (1.42e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (1.46e-2)" "unprognostic (3.09e-1)" "unprognostic (4.05e-1)" "unprognostic (1.98e-2)" "unprognostic (2.51e-1)" "prognostic favorable (6.69e-8)" "unprognostic (1.29e-2)" "unprognostic (2.35e-1)" "unprognostic (4.94e-2)" "unprognostic (1.32e-1)" 17.6 12.2 14.6 12.6 26.7 33.7 18.3 24.0 19.4 15.2 9.9 18.5 14.5 10.5 7.6 22.8 14.2 11.8 6.7 15.3 18.1 17.6 7.7 13.1 12.0 30.7 21.5 10.4 5.7 10.7 6.2 20.4 31.5 8.4 19.8 14.2 13.7 8.8 3.9 12.2 17.4 11.6 25.3 19.6 20.4 5.0 21.7 10.3 10.9 6.1 13.3 15.0 10.8 52.7 28.9 18.5 14.1 15.5 14.3 17.8 23.7 41.7 30.8 28.2 29.3 23.7 62.3 28.8 10.4 42.7 14.5 34.7 38.1 23.7 42.5 12.6 11.0 82.5 13.4 14.3 12.1 8.4 25.8 11.7 11.4 18.4 20.4 16.3 40.6 19.4 16.2 13.5 16.2 24.9 22.2 28.7 9.2 45.4 16.8 23.5 14.3 10.0 32.9 63.4 13.6 17.1 15.0 50.3 15.8 24.7 61.8 15.3 25.9 25.7 18.2 9.6 9.7 7.6 13.4 19.1 17.3 29.4 14.8 18.3 31.3 27.1 6.1 24.2 5.7 6.7 5.1 6.8 31.2 7.9 3.5 5.8 19.1 17.7 31.8 11.1 6.0 13.4 14.6 26.7 24.0 19.4 15.3 18.1 30.7 21.5 31.5 25.3 21.7 52.7 125.1 28.9 27.3 24.8 27.3 32.4 28.3 27.0 15.4 15.7 24.3 18.4 8.9 15.7 30.7 47.8 35.5 11.9 28.3 37.6 1.9 24.0 1.6 44.1 36.0 53.1 13.2 51.3 31.2 16.1 12.3 18.9 43.3 36.0 51.3 37.2 68.2 7.2 25.1 5.0 29.5 39.3 20.3 75.9 19.8 1.7 14.6 66.2 19.6 83.4 51.3 8.8 32.0 59.3 164.0 35.0 30.4 15.8 11.0 27.0 28.4 8.8 33.5 20.0 32.9 10.5 25.5 7.3 19.0 37.7 29.1 6.6 23.3 14.6 33.0 60.0 ALKBH1 "ABH, alkB, ALKBH, hABH" ENSG00000100601 "AlkB homolog 1, histone H2A dioxygenase" Q13686 14 77672404-77708023 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, RNA repair, Translation regulation" "Dioxygenase, Lyase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044087, HPA060061" Approved Supported "Nucleoplasm,Endoplasmic reticulum" "Intracellular and membrane" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "Endoplasmic reticulum" "HPA044087: AB_2678803, HPA060061: " "unprognostic (1.92e-2)" "unprognostic (8.38e-2)" "unprognostic (1.32e-1)" "unprognostic (1.37e-3)" "unprognostic (3.41e-2)" "unprognostic (5.03e-2)" "unprognostic (3.74e-3)" "unprognostic (7.45e-3)" "unprognostic (2.68e-2)" "unprognostic (3.95e-2)" "unprognostic (5.05e-3)" "unprognostic (2.16e-2)" "prognostic favorable (1.80e-4)" "unprognostic (1.65e-3)" "unprognostic (1.46e-1)" "unprognostic (2.63e-1)" "unprognostic (2.44e-2)" 2.7 2.7 2.8 1.8 3.2 1.2 3.5 3.9 3.5 3.4 2.7 2.8 2.5 2.3 2.1 2.6 2.9 2.2 4.1 3.0 3.5 3.0 3.6 2.2 3.5 2.8 3.2 2.9 2.6 3.3 1.5 3.9 2.9 3.1 3.4 2.9 2.1 3.1 5.7 2.6 2.1 2.9 3.0 2.3 2.5 3.0 3.2 4.4 3.1 7.4 4.1 3.1 2.2 3.3 5.2 7.5 6.0 4.1 6.3 6.8 7.4 5.3 6.8 11.3 12.7 7.7 3.1 7.9 2.9 4.8 5.3 4.5 13.2 5.7 13.2 5.4 5.1 4.2 4.0 6.4 8.9 4.5 2.6 5.8 9.2 6.6 10.5 5.0 9.4 6.1 6.6 4.4 6.1 8.1 6.0 5.7 6.6 7.7 9.6 6.0 6.0 5.3 6.4 4.5 7.6 5.7 4.3 4.5 5.7 4.9 10.9 4.5 4.3 4.7 4.7 5.2 4.3 5.4 9.4 7.6 3.2 6.3 4.7 10.7 3.0 1.4 2.9 3.5 2.4 3.4 2.7 2.8 3.0 2.7 2.8 2.2 0.8 3.6 2.4 1.6 3.3 2.2 2.8 3.2 3.9 3.5 3.0 3.5 2.8 3.2 2.9 3.0 3.2 3.3 6.5 0.0 3.9 13.1 7.3 8.4 5.7 6.2 6.8 4.1 5.4 4.4 7.5 1.5 4.5 1.8 2.1 9.9 3.5 4.2 9.8 6.2 4.8 4.4 4.5 5.7 2.4 4.2 15.9 7.0 8.8 5.5 2.6 3.8 9.5 6.1 2.2 3.9 7.6 0.0 15.8 4.9 6.1 5.2 5.0 4.2 6.5 7.7 5.4 5.6 6.6 7.8 4.1 16.1 19.4 6.8 1.5 5.3 4.9 4.5 7.0 6.5 5.5 5.3 6.6 4.2 5.6 21.1 15.9 4.4 5.4 12.2 5.6 5.1 4.8 3.7 SLIRP "C14orf156, DC50" ENSG00000119705 "SRA stem-loop interacting RNA binding protein" Q9GZT3 14 77708071-77761104 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 1099.6;Proximal tubular cells: 1027.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020291 Approved Supported Mitochondria No Yes 32000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA020291: AB_1845563" "unprognostic (9.28e-2)" "unprognostic (4.88e-2)" "unprognostic (1.87e-1)" "unprognostic (3.62e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (4.88e-4)" "unprognostic (1.18e-1)" "unprognostic (8.23e-2)" "unprognostic (2.19e-1)" "unprognostic (1.14e-2)" "unprognostic (1.92e-2)" "unprognostic (1.35e-1)" "unprognostic (9.95e-3)" "unprognostic (1.52e-1)" "unprognostic (2.39e-1)" "unprognostic (3.60e-2)" "unprognostic (1.37e-1)" 121.9 131.0 241.0 80.4 251.7 122.7 155.0 250.5 391.0 92.8 228.9 161.3 112.5 91.5 196.3 163.7 89.6 68.3 336.8 249.8 251.6 203.0 211.2 81.1 82.8 251.4 247.5 82.0 110.5 145.2 120.2 91.9 248.6 95.7 141.3 109.9 105.0 90.3 364.5 92.1 107.6 97.0 248.2 92.9 140.2 122.9 245.9 97.4 94.6 442.3 113.5 123.8 101.8 261.2 422.5 867.3 340.9 330.8 226.0 227.7 441.2 240.0 234.8 484.1 419.6 1187.1 387.1 314.2 238.9 284.7 295.6 415.7 645.4 508.0 647.3 166.5 717.2 316.3 816.1 1199.5 343.4 211.8 216.6 242.5 332.3 387.3 428.2 232.4 408.7 403.2 321.2 172.8 430.0 1442.6 325.3 562.2 525.1 938.0 1211.5 294.8 282.9 345.6 508.8 840.3 425.5 274.1 253.3 533.0 360.3 373.7 555.7 360.9 227.0 237.1 422.5 254.0 416.9 184.8 374.7 605.0 325.7 407.2 309.6 88.9 276.1 103.9 105.2 275.3 112.0 169.4 139.0 104.6 239.8 143.1 143.4 120.3 87.8 93.3 288.8 247.4 154.9 216.2 241.0 251.7 250.5 391.0 249.8 251.6 251.4 247.5 248.6 248.2 245.9 261.2 130.4 109.0 140.0 8.5 112.3 178.8 164.5 542.9 92.8 68.8 168.8 154.3 1099.6 270.2 303.9 264.8 47.9 393.0 82.7 330.9 770.9 405.1 548.5 163.7 141.9 169.0 246.8 203.2 10.8 530.1 382.3 166.0 119.3 123.7 171.5 73.1 179.2 793.4 313.6 43.7 9.6 373.1 388.6 202.8 119.5 123.0 168.0 135.2 250.8 2.8 211.4 206.4 93.7 8.5 16.7 440.6 334.4 170.0 136.9 190.5 563.3 1027.1 254.5 126.8 170.9 178.6 202.7 382.6 210.3 178.5 214.4 240.5 80.6 84.7 404.0 163.8 SNW1 "Bx42, FUN20, NCoA-62, Prp45, PRPF45, SKIIP, SKIP, SKIP1" ENSG00000100603 "SNW domain containing 1" Q13573 14 77717599-77761207 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 300.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002457, CAB009931, HPA017370" Supported Enhanced Nucleoplasm,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 6: T47d - Mammary gland" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Cytosol "CAB009931: AB_2302187, HPA002457: AB_1080047, HPA017370: AB_1857339" "unprognostic (1.24e-3)" "unprognostic (2.02e-1)" "unprognostic (2.40e-1)" "unprognostic (6.43e-2)" "unprognostic (3.04e-1)" "unprognostic (4.27e-3)" "prognostic unfavorable (1.96e-4)" "unprognostic (1.07e-1)" "unprognostic (8.09e-3)" "unprognostic (2.88e-2)" "unprognostic (3.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.67e-1)" "unprognostic (2.47e-1)" "unprognostic (1.55e-1)" "unprognostic (4.45e-3)" "unprognostic (1.22e-2)" 47.1 33.3 27.6 33.6 29.5 91.2 42.7 30.6 35.9 39.2 29.1 38.4 32.6 39.0 28.4 38.4 38.3 26.7 39.5 27.0 29.0 38.7 33.6 37.1 46.2 29.5 28.6 41.4 38.6 31.3 30.3 33.0 29.8 32.2 32.1 43.3 34.0 21.9 64.8 50.7 38.5 30.9 28.6 44.6 36.6 48.5 28.4 49.0 33.9 35.9 41.9 38.8 38.0 32.9 91.0 66.6 67.0 70.8 54.5 60.6 76.5 61.3 54.6 66.8 61.2 66.0 81.0 88.3 54.5 46.1 50.8 88.2 81.8 58.9 90.3 71.1 63.5 71.8 59.1 66.7 77.7 50.5 81.0 46.8 76.1 60.0 82.8 71.5 65.8 83.7 103.9 64.7 51.9 93.1 90.7 85.4 74.2 103.1 87.8 97.3 85.5 61.7 61.4 82.6 71.2 76.5 84.7 73.6 87.3 68.1 106.6 95.5 69.9 71.6 81.7 64.9 73.9 62.9 95.5 98.7 65.5 79.8 80.9 94.5 71.0 95.6 57.5 76.9 65.5 59.2 64.5 65.9 72.6 67.0 67.6 63.9 67.8 94.5 92.1 43.2 94.5 76.1 27.6 29.5 30.6 35.9 27.0 29.0 29.5 28.6 29.8 28.6 28.4 32.9 86.5 93.0 49.3 13.1 64.2 56.5 80.4 89.1 33.6 56.0 40.1 50.0 49.9 47.1 77.9 53.3 35.5 79.4 75.4 38.0 76.3 79.0 43.5 97.2 81.3 69.9 43.6 85.0 17.9 70.1 100.1 64.9 26.5 80.5 92.3 61.5 55.6 33.7 76.4 38.7 18.6 50.8 54.9 53.6 52.0 24.0 77.9 70.7 39.2 30.0 95.6 66.7 65.9 15.6 31.9 71.3 43.8 74.1 46.3 48.9 48.8 57.3 88.1 72.2 65.7 60.9 89.5 300.5 140.7 39.7 54.3 109.0 76.8 54.4 47.9 70.9 ADCK1 FLJ39600 ENSG00000063761 "AarF domain containing kinase 1" Q86TW2 14 77800109-77935014 "Enzymes, Predicted secreted proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 20.9;Oligodendrocytes: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051012, HPA055014" Uncertain Uncertain Nucleoplasm "Secreted - unknown location" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA051012: AB_2681310, HPA055014: AB_2682672" "unprognostic (6.36e-2)" "unprognostic (7.09e-2)" "unprognostic (6.00e-2)" "unprognostic (1.76e-1)" "unprognostic (2.24e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (1.70e-4)" "prognostic favorable (4.11e-5)" "unprognostic (2.33e-1)" "unprognostic (1.64e-1)" "unprognostic (4.57e-3)" "unprognostic (1.38e-1)" "prognostic favorable (5.82e-6)" "unprognostic (6.30e-3)" "unprognostic (2.06e-1)" "unprognostic (9.57e-2)" "unprognostic (4.06e-1)" 4.4 8.1 7.3 3.7 7.8 5.3 4.2 7.3 10.3 4.3 8.2 6.7 7.4 4.8 5.1 6.1 4.4 3.8 9.0 7.8 7.2 7.0 8.6 4.0 4.1 7.8 7.4 4.7 6.7 6.5 8.3 5.1 8.2 6.5 5.8 3.8 6.7 5.4 8.9 6.3 5.6 6.4 7.1 7.3 6.1 4.6 7.9 5.2 5.9 5.2 4.8 5.1 4.0 10.2 5.5 9.1 4.4 17.4 13.0 6.5 6.2 5.7 7.9 4.5 5.6 4.7 12.4 12.0 8.5 9.5 7.5 10.2 27.0 9.3 2.9 6.3 9.1 2.8 4.9 7.5 12.2 4.5 6.6 7.7 16.2 1.9 5.7 4.4 7.1 10.1 11.4 7.4 5.9 24.5 5.8 7.6 9.6 17.5 10.2 9.1 0.7 9.0 6.6 13.9 10.4 6.0 10.6 14.7 5.9 6.8 20.9 9.4 6.8 4.6 3.4 8.9 4.6 6.4 7.7 6.3 6.6 7.7 5.8 1.3 4.0 1.4 4.2 6.0 2.9 1.4 1.6 2.4 7.4 3.0 1.9 3.4 0.3 3.2 2.5 5.5 3.1 2.5 7.3 7.8 7.3 10.3 7.8 7.2 7.8 7.4 8.2 7.1 7.9 10.2 1.9 0.0 3.7 10.1 1.8 0.9 1.8 3.9 2.8 5.9 2.9 3.0 5.7 4.3 2.8 0.0 20.9 8.2 4.2 4.0 3.9 4.4 1.5 2.0 2.4 1.4 1.8 2.1 10.3 5.1 4.2 2.4 6.6 2.4 1.3 5.0 1.8 6.6 9.6 8.4 11.7 4.0 4.1 4.4 1.5 0.8 1.5 5.1 0.0 5.6 2.5 4.0 3.1 11.6 29.0 2.8 1.3 1.9 3.2 1.5 3.0 3.8 2.4 9.3 0.0 2.1 1.6 1.8 9.9 4.3 1.4 5.3 2.2 4.6 5.4 1.2 NRXN3 "C14orf60, KIAA0743" ENSG00000021645 "Neurexin 3" "Q9HDB5, Q9Y4C0" 14 78170373-79868291 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 106.8;retina: 42.9" "Group enriched" "Detected in many" 10 "Excitatory neurons: 3526.5;Inhibitory neurons: 5083.8;Oligodendrocytes: 2145.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 106.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 9.7;RT4: 24.7;SK-BR-3: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002727 Approved NA NA 710000 "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 15: RT4 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA002727: AB_1079468" "unprognostic (7.96e-2)" "unprognostic (5.70e-4)" "unprognostic (8.18e-3)" "unprognostic (2.19e-2)" "unprognostic (2.31e-4)" "unprognostic (9.56e-2)" "unprognostic (2.80e-1)" "unprognostic (2.99e-3)" "unprognostic (1.12e-2)" "unprognostic (7.91e-2)" "unprognostic (2.40e-2)" "unprognostic (2.61e-1)" "prognostic favorable (1.83e-7)" "unprognostic (4.81e-2)" "unprognostic (2.61e-1)" "unprognostic (3.61e-2)" "unprognostic (2.91e-1)" 0.8 5.9 13.4 2.8 17.0 0.1 1.6 106.8 48.3 3.9 0.0 23.0 2.3 5.4 1.7 4.7 5.0 2.5 3.0 23.6 21.3 1.7 0.4 2.6 0.4 8.6 24.2 0.7 3.1 8.8 4.9 1.3 7.2 6.7 4.1 42.9 2.8 11.3 0.3 1.8 8.4 21.1 0.0 5.8 9.3 7.5 4.2 1.0 0.5 0.5 0.4 4.4 2.7 21.5 0.0 0.0 7.6 0.0 0.2 0.3 0.0 3.0 2.2 9.7 7.3 2.6 0.0 0.1 0.0 0.3 0.0 2.8 0.1 0.3 6.8 3.0 6.0 0.0 0.2 0.0 0.7 0.0 0.0 1.8 0.3 4.3 1.4 4.6 2.5 0.0 0.0 0.2 0.1 0.1 0.2 0.2 1.6 0.0 0.0 0.2 0.0 0.0 5.2 24.7 1.3 0.0 0.0 9.3 0.5 3.1 0.0 0.0 0.0 0.1 6.2 0.0 3.2 0.0 0.0 0.0 1.8 0.3 5.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 13.4 17.0 106.8 48.3 23.6 21.3 8.6 24.2 7.2 0.0 4.2 21.5 0.2 12.8 5.5 100.2 0.0 4.6 7.0 0.4 0.6 180.7 3.2 3.0 3.9 1.5 3.4 3.7 12.5 9.2 0.0 1.1 0.0 2.2 15.9 36.3 2.2 0.8 6.0 0.0 3526.5 3.1 0.5 1.8 0.0 31.5 0.0 0.8 1.4 0.1 0.7 116.1 5083.8 0.6 4.1 0.0 0.3 18.9 7.5 0.3 17.8 88.1 0.0 54.3 0.0 328.2 2145.0 0.7 0.2 6.4 1.2 7.5 0.0 0.1 9.3 10.7 0.0 0.4 2.2 2.1 0.8 0.1 0.9 37.9 0.6 0.0 1.0 3.0 DIO2 "SelY, TXDI2" ENSG00000211448 "Iodothyronine deiodinase 2" Q92813 14 80197526-80387757 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Thyroid hormones biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 163.9;thyroid gland: 355.8" "Cell type enhanced" "Detected in many" "Breast glandular cells: 150.7;Endometrial stromal cells: 158.3;Extravillous trophoblasts: 523.3;Muller glia cells: 246.4" "Cancer enriched" "Detected in many" 5 "thyroid cancer: 34.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 80.8;fHDF/TERT166: 41.8;HeLa: 95.4;HHSteC: 44.2;SiHa: 168.1;SK-BR-3: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048002 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Cluster 1: Thyroid gland - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 38: Extravillous trophoblasts - Unknown function" "Nucleoplasm, Vesicles" "Plasma membrane" "HPA048002: AB_2680230" "unprognostic (1.22e-1)" "unprognostic (1.69e-1)" "prognostic favorable (1.67e-4)" "prognostic favorable (4.62e-6)" "unprognostic (2.76e-1)" "unprognostic (1.22e-1)" "unprognostic (2.22e-1)" "unprognostic (2.17e-1)" "unprognostic (2.07e-1)" "unprognostic (8.78e-2)" "unprognostic (3.68e-2)" "unprognostic (2.48e-1)" "unprognostic (1.00e-3)" "unprognostic (5.08e-2)" "unprognostic (3.43e-1)" "unprognostic (8.40e-2)" "unprognostic (7.15e-2)" 1.5 3.0 18.0 0.6 15.3 0.1 15.3 15.0 24.6 163.9 5.9 1.3 1.3 40.2 0.5 58.9 0.7 5.1 11.9 17.1 13.0 5.0 0.1 1.6 0.8 13.6 19.2 0.2 1.8 6.6 31.6 14.5 17.4 9.0 1.7 7.4 33.3 30.4 6.5 7.1 1.5 4.5 5.5 0.6 5.3 4.7 13.3 1.2 355.8 70.7 33.1 6.0 25.0 16.6 0.2 9.5 0.0 0.0 0.5 1.4 0.3 80.8 16.6 6.2 0.9 0.0 0.3 0.2 0.2 41.8 0.3 1.7 2.9 0.0 6.1 0.0 0.2 0.0 95.4 0.0 44.2 0.0 0.2 5.1 0.0 1.2 0.0 3.9 1.4 0.0 0.0 0.8 0.5 1.9 0.1 0.1 1.7 0.0 0.5 0.8 3.9 0.1 0.0 0.8 0.0 0.2 168.1 35.3 0.3 7.1 0.1 0.0 0.8 0.3 7.0 17.4 20.1 2.8 0.0 0.0 7.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 15.3 15.0 24.6 17.1 13.0 13.6 19.2 17.4 5.5 13.3 16.6 0.1 0.0 0.5 52.9 0.3 2.9 0.1 0.0 2.2 3.3 150.7 34.4 1.9 0.0 0.0 0.0 0.0 4.8 0.5 0.2 0.0 0.0 29.5 14.2 158.3 2.3 0.0 0.0 1.0 0.0 523.3 24.6 0.0 15.6 0.0 0.1 0.7 0.2 9.2 1.7 1.0 0.5 0.0 1.3 5.7 12.5 3.4 1.3 5.4 4.7 0.0 246.4 0.0 8.5 1.4 1.0 0.0 4.1 0.3 0.3 0.0 0.0 0.0 7.8 0.0 69.1 6.5 9.7 0.7 8.9 3.0 28.2 1.7 0.9 0.1 0.1 CEP128 "C14orf145, C14orf61" ENSG00000100629 "Centrosomal protein 128" Q6ZU80 14 80476983-80959517 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 24.9" "Cell type enhanced" "Detected in many" "Astrocytes: 40.1;Microglial cells: 46.9;Oligodendrocyte precursor cells: 37.7;Oligodendrocytes: 71.0;Plasma cells: 81.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 7.8" "Group enriched" "Detected in many" 4 "dendritic cells: 6.8;T-cells: 7.8" "Cell line enhanced" "Detected in many" "Karpas-707: 59.9;MOLT-4: 55.7;U-266/70: 110.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001116, HPA018498, HPA077688" Uncertain Supported Centrosome NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 63: T-cells - Adaptive immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" Centrosome "HPA001116: AB_1078323, HPA018498: AB_1845560, HPA077688: " "unprognostic (6.13e-3)" "unprognostic (5.82e-2)" "unprognostic (1.65e-2)" "unprognostic (3.49e-2)" "unprognostic (4.32e-2)" "unprognostic (5.93e-2)" "unprognostic (2.64e-2)" "unprognostic (1.66e-1)" "unprognostic (3.89e-1)" "unprognostic (1.87e-1)" "unprognostic (3.42e-1)" "unprognostic (1.94e-2)" "unprognostic (2.60e-3)" "unprognostic (1.21e-1)" "unprognostic (3.37e-1)" "unprognostic (2.45e-1)" "unprognostic (1.48e-1)" 2.0 0.8 1.4 2.5 2.5 6.2 3.8 4.1 1.5 1.2 1.1 2.0 1.4 2.0 0.6 1.7 2.5 1.0 1.2 1.1 1.3 0.9 0.9 1.4 4.7 2.1 1.4 1.5 0.6 1.7 0.9 1.0 1.7 1.2 1.7 1.6 1.7 1.0 1.8 2.4 1.0 1.9 1.4 2.4 1.7 5.2 1.1 24.9 1.7 0.9 5.2 2.2 1.3 3.0 14.8 7.9 6.8 5.6 1.6 2.6 3.6 15.5 4.8 9.5 9.3 5.3 8.4 34.5 2.8 4.8 6.2 7.8 7.4 4.9 18.0 19.5 4.7 6.7 9.8 2.7 0.8 6.6 8.6 0.6 1.2 13.6 7.3 1.8 7.3 17.0 8.5 59.9 9.1 9.4 55.7 3.7 5.3 4.0 9.4 9.8 16.8 26.7 2.0 7.7 8.6 4.1 13.1 5.4 2.8 6.5 6.0 5.1 6.7 20.5 11.2 5.7 16.4 110.1 4.8 15.2 5.8 9.1 7.3 0.0 0.6 1.3 2.2 0.2 1.7 1.6 2.3 1.6 2.0 0.6 2.0 0.9 0.1 0.9 0.4 6.8 7.8 0.7 1.4 2.5 4.1 1.5 1.1 1.3 2.1 1.4 1.7 1.4 1.1 3.0 2.3 3.2 2.8 40.1 7.5 4.0 2.6 1.1 1.2 6.6 3.2 3.0 3.8 2.8 5.7 3.7 2.1 2.4 12.7 0.6 0.0 1.6 8.5 14.8 3.2 2.7 1.2 7.4 27.3 1.2 9.0 3.5 3.1 2.8 2.5 7.8 3.3 0.3 2.5 6.7 25.5 1.0 2.0 0.0 4.6 5.1 1.5 4.8 3.6 46.9 10.3 4.8 1.0 37.7 71.0 1.2 0.3 1.5 81.1 0.9 0.1 0.5 17.2 13.8 6.6 6.6 2.5 16.7 3.8 4.1 1.7 2.3 8.8 2.3 1.5 1.6 TSHR LGR3 ENSG00000165409 "Thyroid stimulating hormone receptor" P16473 14 80954989-81146306 "Cancer-related genes, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, Congenital hypothyroidism, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "thyroid gland: 273.9" "Group enriched" "Detected in some" 4 "Astrocytes: 5.5;Excitatory neurons: 7.0;Inhibitory neurons: 12.3;Microglial cells: 6.5;Oligodendrocyte precursor cells: 6.6;Oligodendrocytes: 9.5;Plasma cells: 11.7;Skeletal myocytes: 4.1" "Cancer enriched" "Detected in some" 116 "thyroid cancer: 100.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "naive B-cell: 1.7;T-reg: 6.9" "Group enriched" "Detected in many" 5 "B-cells: 1.7;T-cells: 6.9" "Cell line enhanced" "Detected in some" "JURKAT: 58.4;MOLT-4: 23.8;SCLC-21H: 23.0;U-266/70: 11.3" "Low region specificity" "Detected in some" "Region enhanced" "Detected in single" "hypothalamus: 1.3" CAB000473 Approved "Intracellular and membrane" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 1: Thyroid gland - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "CAB000473: AB_2303782" "unprognostic (3.36e-3)" "unprognostic (1.31e-3)" "unprognostic (1.02e-2)" "unprognostic (4.17e-6)" "unprognostic (3.01e-3)" "unprognostic (1.85e-3)" "unprognostic (1.83e-1)" "unprognostic (2.66e-2)" "unprognostic (3.39e-2)" "unprognostic (2.60e-2)" "unprognostic (1.70e-1)" "unprognostic (7.11e-3)" "unprognostic (5.08e-7)" "unprognostic (1.32e-1)" "unprognostic (7.40e-2)" "unprognostic (1.19e-1)" "unprognostic (1.66e-1)" 0.5 0.6 1.6 0.8 1.8 1.2 0.8 4.0 2.3 0.2 0.2 0.5 0.3 0.6 0.5 0.2 0.8 0.5 0.3 1.3 0.5 0.3 0.4 0.2 1.9 0.8 0.3 0.3 0.4 0.3 0.2 0.4 0.5 0.5 0.3 2.3 0.6 0.2 0.8 1.1 0.4 0.2 0.1 0.8 0.5 0.7 1.2 20.8 273.9 0.2 0.8 0.3 0.1 1.8 0.4 0.2 0.7 0.4 0.1 0.1 0.3 0.2 0.0 0.0 0.1 0.4 0.5 0.7 0.2 0.1 0.5 0.3 0.3 0.0 0.1 0.3 0.1 0.3 0.8 0.4 0.0 0.2 0.4 0.3 0.1 0.1 0.3 0.1 0.0 58.4 0.3 0.7 0.1 0.4 23.8 0.5 0.4 0.1 0.2 0.8 0.2 0.9 0.0 0.5 23.0 0.4 0.2 0.2 0.3 0.5 0.3 0.1 0.2 0.7 0.5 0.6 0.3 11.3 6.3 0.6 0.3 0.3 0.5 0.5 0.1 0.1 0.1 0.1 0.1 0.6 0.5 0.3 0.1 1.7 0.2 0.1 0.9 0.1 0.2 0.5 6.9 0.1 1.6 1.8 4.0 2.3 1.3 0.5 0.8 0.3 0.5 0.1 1.2 1.8 0.2 0.0 0.5 5.5 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.8 0.0 1.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.1 0.2 0.3 1.8 0.0 7.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 12.3 0.2 0.0 0.0 0.0 1.1 0.0 0.1 0.0 6.5 0.0 0.1 0.0 6.6 9.5 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.6 0.0 4.1 1.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 GTF2A1 TFIIA ENSG00000165417 "General transcription factor IIA subunit 1" P52655 14 81175452-81221377 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 7.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000869 Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 23: Testis - Cell cycle regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA000869: AB_1080253" "unprognostic (1.93e-1)" "unprognostic (1.31e-1)" "unprognostic (7.98e-3)" "unprognostic (1.40e-1)" "unprognostic (1.50e-2)" "unprognostic (1.20e-1)" "unprognostic (6.04e-3)" "unprognostic (1.65e-1)" "unprognostic (1.14e-1)" "unprognostic (1.85e-1)" "unprognostic (7.49e-2)" "unprognostic (2.76e-1)" "unprognostic (3.87e-2)" "unprognostic (4.04e-2)" "unprognostic (2.44e-1)" "unprognostic (2.11e-1)" "unprognostic (5.88e-2)" 10.4 10.1 3.0 12.9 4.3 7.4 13.0 12.3 11.1 11.0 0.1 10.1 9.6 12.0 14.7 13.2 8.7 9.9 10.2 4.6 4.3 11.4 14.5 9.0 16.2 2.3 2.8 13.0 9.8 14.5 5.7 13.2 2.7 10.8 11.0 13.5 8.3 9.0 10.7 11.3 9.1 10.4 2.4 12.6 10.6 19.6 3.3 21.1 23.2 15.5 14.7 10.7 7.4 5.3 20.5 20.0 41.0 27.8 22.8 19.0 15.7 25.9 24.7 21.6 19.4 30.0 20.1 33.9 20.5 20.1 15.9 15.5 28.7 18.2 38.0 31.1 9.0 31.4 21.5 17.9 22.5 21.6 30.6 17.9 13.6 29.8 38.4 22.5 22.4 27.1 19.5 44.0 27.9 34.0 54.9 12.5 22.9 15.5 19.8 30.0 36.6 20.8 14.4 41.2 40.2 23.7 59.8 22.8 25.6 19.6 34.6 17.8 29.4 21.9 17.0 30.7 25.9 35.9 42.2 34.5 17.5 24.6 35.8 7.3 0.7 1.3 1.3 0.5 1.0 0.7 1.2 0.7 0.4 0.6 1.0 1.2 1.2 1.0 2.6 1.9 0.7 0.5 3.0 4.3 12.3 11.1 4.6 4.3 2.3 2.8 2.7 2.4 3.3 5.3 27.0 19.2 13.6 25.5 22.3 18.0 8.6 11.9 10.8 24.9 18.4 19.7 26.5 5.7 14.0 23.9 35.5 15.1 21.4 21.2 1.9 12.0 59.4 14.5 26.5 20.7 18.6 32.0 32.9 13.0 14.4 20.0 17.9 18.9 30.4 37.2 16.8 25.9 17.0 40.4 33.4 17.5 10.2 25.2 22.1 8.0 12.8 25.0 10.6 29.0 30.9 22.0 18.6 26.7 26.4 12.4 15.8 13.5 56.2 16.6 13.0 15.0 11.4 15.8 26.3 22.0 23.7 28.6 26.5 23.9 24.4 26.0 21.7 16.2 11.6 12.0 STON2 "STN2, STNB2" ENSG00000140022 "Stonin 2" Q8WXE9 14 81260656-81436465 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 79.8" "Cell type enriched" "Detected in many" 4 "Astrocytes: 253.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "intermediate monocyte: 1.2" "Lineage enriched" "Detected in single" 4 "monocytes: 1.2" "Cell line enhanced" "Detected in many" "HEL: 113.4;HMC-1: 60.9;Karpas-707: 58.3;RT4: 46.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003086 Enhanced Approved Nucleoli,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 36: HEL - Hemostasis" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoli, Cytosol" "HPA003086: AB_2302748" "unprognostic (5.28e-2)" "unprognostic (9.83e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (4.96e-4)" "unprognostic (2.50e-1)" "unprognostic (1.11e-1)" "unprognostic (1.73e-2)" "unprognostic (3.55e-2)" "unprognostic (1.30e-1)" "unprognostic (1.38e-1)" "unprognostic (3.30e-1)" "unprognostic (9.88e-2)" "unprognostic (9.19e-2)" "unprognostic (5.82e-3)" "unprognostic (1.37e-1)" "unprognostic (6.15e-2)" "unprognostic (1.44e-1)" 3.4 0.8 65.6 1.2 64.8 5.5 9.6 31.2 44.7 4.6 14.1 4.4 4.0 1.2 5.1 14.3 10.7 5.9 3.0 60.1 79.8 14.3 3.0 5.0 1.0 36.5 68.3 2.8 0.9 0.3 10.0 2.5 39.5 2.1 5.0 10.2 5.6 2.7 13.2 8.0 4.3 1.7 27.0 16.3 5.7 3.3 60.9 2.5 10.8 17.4 2.9 6.3 9.5 53.7 4.7 3.1 12.1 0.2 0.0 0.1 13.4 0.0 0.1 0.0 0.3 10.0 4.2 0.0 5.5 0.0 3.4 30.6 16.5 39.8 0.0 0.8 5.5 113.4 19.9 4.2 0.0 0.0 60.9 1.7 33.5 0.0 11.0 0.0 0.0 6.1 40.2 58.3 1.2 6.8 5.4 0.0 11.9 11.5 2.4 0.1 17.6 3.4 8.4 46.0 28.1 1.7 13.7 0.6 0.0 9.9 1.7 0.3 0.3 2.4 8.8 9.7 2.6 6.0 11.9 0.1 8.4 0.4 2.6 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.1 65.6 64.8 31.2 44.7 60.1 79.8 36.5 68.3 39.5 27.0 60.9 53.7 6.3 3.2 0.5 253.4 0.1 13.6 13.2 20.5 30.7 0.6 11.8 8.1 1.1 2.8 6.8 18.4 12.5 1.4 0.1 4.8 7.9 0.6 0.4 56.0 1.2 5.0 0.0 12.2 0.9 0.5 0.4 8.3 7.1 16.1 0.0 12.5 4.2 0.9 3.4 3.3 4.4 3.2 14.2 18.0 6.1 1.6 10.2 13.5 1.8 23.4 2.3 23.9 0.0 12.1 15.2 3.2 2.7 8.6 1.0 6.8 4.6 20.6 5.8 6.1 0.0 36.1 3.2 1.0 5.9 24.3 8.8 15.5 0.9 6.3 2.7 33.2 SEL1L "Hrd3, IBD2, SEL1L1" ENSG00000071537 "SEL1L adaptor subunit of ERAD E3 ubiquitin ligase" Q9UBV2 14 81471547-81533853 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "pancreas: 403.4" "Cell type enhanced" "Detected in all" "Plasma cells: 238.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 339.5;U-266/84: 313.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024267 Enhanced "Intracellular and membrane" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 25: Pancreas - Digestion" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA024267: AB_1856659" "unprognostic (4.94e-1)" "unprognostic (8.69e-2)" "unprognostic (1.09e-2)" "unprognostic (1.91e-1)" "unprognostic (5.93e-2)" "unprognostic (1.16e-1)" "unprognostic (3.29e-1)" "unprognostic (2.78e-1)" "unprognostic (9.97e-2)" "unprognostic (2.58e-2)" "unprognostic (2.76e-3)" "unprognostic (4.86e-1)" "unprognostic (3.31e-2)" "unprognostic (1.30e-1)" "unprognostic (4.96e-2)" "unprognostic (1.83e-2)" "unprognostic (1.25e-2)" 30.6 19.1 13.9 31.1 17.8 17.7 25.2 17.0 17.0 21.4 11.5 35.7 36.7 24.2 18.1 16.8 17.1 22.0 22.8 14.5 17.4 28.8 66.6 27.6 21.6 18.9 16.7 17.1 403.4 29.9 8.7 38.4 19.3 31.6 31.8 15.7 19.6 22.8 22.2 15.5 32.5 28.1 18.4 30.6 35.0 11.2 17.6 17.8 54.3 21.1 29.3 29.0 12.1 25.9 35.3 69.3 27.4 35.5 60.2 58.6 48.5 54.6 52.3 31.2 33.0 26.6 53.7 36.0 58.8 63.2 38.1 32.8 19.2 30.6 56.1 56.0 13.6 26.3 21.7 33.2 86.0 53.6 60.3 47.8 72.0 31.4 68.0 45.9 51.7 29.5 16.2 195.2 38.6 42.7 30.6 15.1 8.7 58.7 29.6 21.2 38.9 28.4 24.0 54.1 15.5 25.7 42.7 39.4 44.9 23.5 68.5 35.5 86.8 87.7 49.0 49.2 34.1 339.5 313.1 35.4 96.5 24.1 34.4 31.5 19.7 24.8 16.8 25.6 13.7 14.2 12.9 13.4 18.9 13.1 12.0 12.9 45.7 16.7 22.5 13.7 14.0 14.5 13.9 17.8 17.0 17.0 14.5 17.4 18.9 16.7 19.3 18.4 17.6 25.9 51.6 12.8 35.2 27.1 44.8 26.8 19.0 27.1 15.9 23.5 31.5 18.9 67.0 32.9 24.9 27.6 31.3 23.5 44.1 48.8 5.9 24.1 3.5 21.1 48.9 40.0 21.6 15.4 35.9 45.6 21.9 44.7 37.8 28.0 34.2 32.0 38.9 125.7 31.9 30.3 35.2 38.9 50.8 58.1 40.4 5.4 23.6 47.6 53.4 29.0 39.7 18.3 30.9 42.3 70.7 40.1 33.1 28.2 238.9 40.0 34.8 20.2 27.8 18.3 46.0 28.5 51.8 14.0 18.8 16.0 26.1 41.9 32.9 38.9 32.0 33.9 FLRT2 ENSG00000185070 "Fibronectin leucine rich transmembrane protein 2" O43155 14 85530144-85654428 "Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 29.6" "Cell type enhanced" "Detected in many" "Astrocytes: 279.5;Excitatory neurons: 549.6;Inhibitory neurons: 321.3;Leydig cells: 219.0;Microglial cells: 432.8;Oligodendrocyte precursor cells: 212.1" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in some" 6 "basal ganglia: 2.1;cerebral cortex: 8.2;hippocampal formation: 4.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 60.1;HUVEC TERT2: 38.7;TIME: 55.3;U-138 MG: 58.8;U-2197: 43.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 17000 "Cluster 2: Granulocytes - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (2.11e-1)" "unprognostic (8.13e-3)" "unprognostic (4.59e-3)" "unprognostic (3.57e-2)" "unprognostic (1.46e-2)" "unprognostic (4.75e-2)" "unprognostic (9.46e-2)" "unprognostic (1.32e-1)" "unprognostic (2.59e-1)" "unprognostic (5.34e-2)" "unprognostic (8.02e-6)" "unprognostic (1.98e-3)" "unprognostic (8.03e-2)" "unprognostic (1.50e-2)" "unprognostic (1.50e-5)" 9.2 4.5 0.8 4.5 2.1 0.1 2.9 0.0 8.2 11.0 2.3 2.7 0.9 6.1 3.0 3.5 6.4 9.1 3.8 4.7 0.0 1.4 1.2 2.3 3.5 0.0 0.0 29.6 21.7 1.3 1.9 1.2 0.0 5.1 3.1 3.1 1.9 3.3 7.3 6.1 1.7 5.2 0.0 3.0 2.2 4.6 0.2 1.2 4.9 3.1 2.6 5.3 4.2 0.0 0.0 0.2 8.9 0.0 7.9 14.5 0.0 9.7 6.3 9.0 8.4 0.0 0.0 0.0 0.0 28.5 0.9 2.0 13.6 18.6 21.8 0.0 7.8 0.0 5.3 0.0 25.2 2.1 0.0 8.0 10.6 7.5 60.1 2.7 38.7 0.0 0.0 0.0 21.8 0.0 0.0 0.0 4.2 0.0 0.2 0.0 10.8 0.0 0.0 0.0 2.1 0.0 2.3 0.0 3.2 11.8 0.0 0.1 55.3 58.8 9.9 43.0 17.8 0.0 0.0 0.0 18.5 0.0 5.8 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 2.1 0.0 8.2 4.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.9 0.0 1.3 279.5 0.1 21.4 1.7 5.2 6.2 7.0 3.9 4.4 4.0 10.0 0.4 1.8 0.0 0.4 0.1 0.1 0.0 66.2 3.1 2.2 65.1 15.9 0.0 0.0 549.6 42.8 0.2 34.3 0.5 1.6 0.0 39.9 66.0 0.2 2.4 10.1 321.3 0.0 0.0 1.3 6.6 7.7 219.0 1.2 1.8 432.8 0.6 13.2 0.0 212.1 9.0 20.4 0.0 124.8 0.0 1.1 0.0 0.2 1.7 1.4 13.1 3.2 8.5 1.1 0.6 1.0 24.0 0.8 0.8 32.3 0.0 0.2 GALC ENSG00000054983 Galactosylceramidase P54803 14 87837820-87993665 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism, Sphingolipid metabolism" "Glycosidase, Hydrolase" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "granulocytes: 68.4;Kupffer cells: 72.1;Late spermatids: 77.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 84.3;HMC-1: 78.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022196 Approved "Intracellular and membrane" NA NA 53000 "Cluster 2: Granulocytes - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 3: HMC-1 - Innate immune response" "Cluster 24: Non-specific - Transcription regulation" "CAB022196: " "unprognostic (1.27e-1)" "unprognostic (1.40e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-1)" "unprognostic (2.16e-2)" "unprognostic (9.39e-2)" "unprognostic (3.08e-1)" "unprognostic (9.70e-2)" "unprognostic (1.73e-1)" "unprognostic (6.56e-2)" "unprognostic (8.44e-3)" "unprognostic (8.08e-2)" "unprognostic (1.84e-2)" "unprognostic (6.00e-2)" "unprognostic (2.13e-1)" "unprognostic (6.80e-2)" "unprognostic (2.72e-2)" 15.0 17.2 20.0 14.9 23.3 23.2 13.3 22.1 26.1 12.0 20.8 15.1 33.3 11.1 12.2 6.6 20.7 18.4 13.5 18.5 21.6 21.3 12.1 23.9 11.7 23.0 22.6 15.8 10.8 9.4 9.8 16.8 23.9 14.3 17.3 18.4 8.1 9.3 8.0 9.1 34.4 9.6 22.3 15.4 16.4 24.0 20.8 9.7 24.5 12.9 7.9 13.6 7.5 30.6 0.0 19.5 7.2 0.0 23.8 21.3 0.0 9.1 17.9 8.3 9.9 10.8 84.3 5.3 26.4 8.7 0.0 1.3 0.0 1.0 10.2 2.7 0.6 29.8 0.7 0.0 19.5 0.1 78.4 20.7 6.6 5.6 0.0 3.4 22.6 0.0 10.0 3.9 14.4 1.9 0.0 4.5 6.5 35.4 2.2 0.0 0.5 0.3 13.4 7.8 6.7 15.6 24.6 4.0 0.2 17.2 20.4 20.5 19.7 0.0 12.9 5.6 0.2 4.2 8.0 0.0 2.3 6.8 19.2 25.3 15.2 34.2 11.1 16.6 24.0 2.5 8.3 10.8 8.9 1.2 6.0 7.0 11.9 16.3 13.4 1.6 5.3 11.7 20.0 23.3 22.1 26.1 18.5 21.6 23.0 22.6 23.9 22.3 20.8 30.6 11.3 25.6 19.0 26.8 8.0 8.4 5.6 9.4 3.4 10.1 9.1 5.2 9.2 10.0 8.9 14.7 12.5 6.2 27.6 15.3 3.9 9.8 51.6 17.3 10.9 11.4 6.1 13.7 17.8 11.4 12.7 15.2 7.7 5.8 68.4 15.9 18.2 6.1 26.6 3.3 21.2 10.2 4.1 72.1 11.8 77.9 16.1 25.0 10.6 8.4 26.7 7.3 40.2 33.2 42.6 14.1 20.0 10.1 9.3 6.1 15.9 6.7 22.1 10.4 0.0 9.8 10.6 14.9 10.0 3.5 11.5 6.6 21.2 12.9 16.7 7.9 GPR65 "hTDAG8, TDAG8" ENSG00000140030 "G protein-coupled receptor 65" Q8IYL9 14 88005135-88014811 "G-protein coupled receptors, Predicted membrane proteins" Apoptosis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 12.6;lymphoid tissue: 9.6" "Cell type enhanced" "Detected in many" "dendritic cells: 256.1;granulocytes: 317.8;Kupffer cells: 112.5;monocytes: 90.9;NK-cells: 319.3;T-cells: 192.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 5.7;HEL: 6.2;HL-60: 7.5;HMC-1: 9.0;RH-30: 11.5" "Not detected" "Not detected" "HPA072624, HPA077397" Enhanced Approved Nucleoli,Vesicles,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "Nucleoli, Cytosol" "HPA072624: , HPA077397: " "unprognostic (8.56e-2)" "unprognostic (8.65e-3)" "unprognostic (1.98e-3)" "unprognostic (3.59e-3)" "unprognostic (3.10e-1)" "unprognostic (3.55e-3)" "unprognostic (1.15e-1)" "unprognostic (3.01e-2)" "unprognostic (3.62e-2)" "unprognostic (1.35e-1)" "unprognostic (1.08e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (4.99e-4)" "unprognostic (3.79e-1)" "unprognostic (4.46e-3)" "unprognostic (9.03e-2)" "unprognostic (3.80e-1)" 2.0 1.1 0.5 9.1 0.6 12.6 0.9 0.5 0.8 1.1 0.6 1.2 1.6 0.7 0.4 0.9 0.7 2.8 0.6 0.4 1.0 0.8 2.7 4.3 8.8 1.9 1.0 0.3 0.4 0.4 0.4 1.7 1.6 0.8 1.5 0.1 0.7 0.5 0.2 0.3 2.4 2.3 1.0 9.6 1.6 0.6 1.2 4.2 0.4 0.5 6.6 3.4 0.5 2.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.2 0.0 0.0 0.2 7.5 9.0 0.3 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.2 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 39.0 19.8 43.6 33.8 28.4 62.4 9.3 16.9 26.2 13.0 8.1 8.6 19.4 15.2 49.1 32.1 5.9 9.0 24.5 0.5 0.6 0.5 0.8 0.4 1.0 1.9 1.0 1.6 1.0 1.2 2.3 2.9 3.2 21.6 0.3 77.8 4.2 0.5 0.0 0.0 0.2 1.9 3.2 0.4 7.2 1.3 0.0 0.0 0.2 256.1 0.5 0.0 0.0 9.1 0.2 0.4 2.1 0.0 6.6 0.0 0.0 0.3 2.3 6.6 0.5 317.8 0.0 3.9 1.4 62.8 0.0 0.0 0.6 0.0 112.5 73.1 1.4 0.6 88.6 3.6 4.7 90.9 0.0 319.3 0.0 0.1 0.0 0.0 0.0 25.6 0.2 0.1 0.3 0.7 0.2 0.0 0.9 2.0 0.1 0.1 0.7 5.3 0.4 192.8 0.9 0.4 0.2 KCNK10 "K2p10.1, PPP1R97, TREK-2, TREK2" ENSG00000100433 "Potassium two pore domain channel subfamily K member 10" P57789 14 88180103-88326907 "Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.1;intestine: 5.1;stomach 1: 2.6" "Group enriched" "Detected in some" 4 "dendritic cells: 12.5;Excitatory neurons: 43.8;Inhibitory neurons: 17.0;Oligodendrocyte precursor cells: 37.7;Oligodendrocytes: 11.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 62 "plasmacytoid DC: 10.0" "Lineage enriched" "Detected in single" 100 "dendritic cells: 10.0" "Cell line enhanced" "Detected in some" "OE19: 1.5;REH: 1.7;SCLC-21H: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030462 Approved NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA030462: AB_10601919" "unprognostic (9.52e-3)" "unprognostic (1.17e-1)" "unprognostic (1.94e-2)" "unprognostic (1.08e-1)" "unprognostic (8.20e-2)" "unprognostic (1.45e-1)" "unprognostic (1.18e-1)" "unprognostic (2.25e-1)" "unprognostic (4.58e-1)" "unprognostic (1.23e-2)" "unprognostic (2.70e-1)" "unprognostic (2.45e-1)" "unprognostic (6.97e-2)" "unprognostic (1.92e-1)" "unprognostic (3.21e-2)" "unprognostic (1.29e-1)" "unprognostic (4.26e-3)" 0.0 0.3 4.0 0.4 3.6 0.2 0.0 5.1 4.1 0.2 0.0 1.3 5.1 0.0 0.0 1.1 0.0 0.0 0.0 4.4 2.9 2.4 0.0 0.1 0.1 4.2 2.9 0.0 1.4 0.0 0.5 0.0 3.5 0.0 0.7 0.1 0.2 0.0 0.0 0.0 2.6 0.1 2.3 0.1 2.6 0.5 2.4 0.0 0.0 0.0 0.4 0.0 0.2 4.6 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.5 0.1 1.7 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.1 4.0 3.6 5.1 4.1 4.4 2.9 4.2 2.9 3.5 2.3 2.4 4.6 0.0 0.0 0.0 0.7 0.1 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 12.5 2.1 0.0 0.0 0.7 0.0 0.0 0.1 1.8 0.0 43.8 0.6 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 17.0 1.6 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 37.7 11.9 0.1 0.3 0.0 0.0 0.0 1.5 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.2 0.0 0.0 0.1 0.0 1.6 0.1 SPATA7 "HSD3, LCA3" ENSG00000042317 "Spermatogenesis associated 7" Q9P0W8 14 88384924-88470350 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 57.0" "Group enriched" "Detected in many" 9 "Early spermatids: 946.9;Late spermatids: 1152.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038082, HPA038083" Enhanced Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Mitochondria, Cytosol" "HPA038082: AB_10671738, HPA038083: AB_10671519" "unprognostic (2.09e-2)" "unprognostic (6.72e-2)" "unprognostic (1.10e-1)" "unprognostic (6.50e-3)" "unprognostic (3.22e-2)" "unprognostic (6.75e-2)" "unprognostic (1.29e-3)" "unprognostic (4.70e-2)" "unprognostic (1.70e-1)" "unprognostic (5.45e-3)" "prognostic favorable (4.16e-5)" "unprognostic (2.88e-1)" "prognostic favorable (2.50e-5)" "unprognostic (8.41e-2)" "unprognostic (1.29e-2)" "unprognostic (6.09e-2)" "unprognostic (2.81e-2)" 5.8 6.0 8.6 1.6 10.4 1.7 6.0 28.4 9.5 7.2 6.7 5.8 2.2 6.6 7.0 2.8 8.3 5.5 5.4 8.6 10.4 9.5 5.1 4.6 1.8 8.6 9.2 12.3 7.9 7.6 11.1 2.8 8.6 6.6 3.1 10.2 4.1 4.6 5.0 5.6 3.2 4.7 8.9 3.6 5.0 57.0 9.2 3.0 12.1 4.5 1.2 5.4 4.9 11.2 2.3 3.7 5.5 7.5 8.8 16.5 6.0 5.2 9.3 5.1 3.4 1.2 4.5 2.2 2.5 5.7 3.8 2.3 2.5 4.0 4.8 3.2 1.8 0.5 1.9 2.1 12.7 3.9 0.5 7.8 6.6 2.1 3.9 16.8 9.4 5.0 1.3 2.7 4.8 2.8 2.8 3.7 1.4 2.9 4.6 3.9 5.6 1.3 8.1 1.9 3.9 4.9 5.1 6.7 5.0 6.5 6.0 4.2 4.9 3.7 4.0 5.2 2.9 2.6 2.1 1.3 6.2 1.1 2.6 0.0 1.0 0.2 2.1 1.4 2.5 1.9 1.7 1.0 2.1 0.4 1.0 1.8 0.8 0.4 0.9 2.1 0.7 1.0 8.6 10.4 28.4 9.5 8.6 10.4 8.6 9.2 8.6 8.9 9.2 11.2 7.8 12.8 7.3 38.5 1.5 2.4 7.6 9.8 7.4 10.8 6.3 8.5 12.0 7.2 8.8 3.7 20.9 2.6 5.3 1.1 9.8 11.0 946.9 22.3 13.2 6.8 16.3 1.3 113.0 7.2 3.6 11.8 4.1 4.2 1.3 19.4 7.9 4.5 5.7 15.2 91.6 4.0 12.2 17.2 2.8 1152.6 20.5 6.7 8.8 25.3 4.0 12.5 2.1 49.8 54.7 5.6 4.3 17.0 0.9 3.0 1.4 26.0 32.7 20.5 6.6 15.0 7.9 37.5 14.7 3.0 2.0 1.1 3.3 20.5 4.5 3.3 PTPN21 "PTPD1, PTPRL10" ENSG00000070778 "Protein tyrosine phosphatase non-receptor type 21" Q16825 14 88465778-88555007 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 57.7;Syncytiotrophoblasts: 101.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RH-30: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011468, HPA073999" Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 61: Skin - Cornification" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Cytosol "Golgi apparatus" "CAB011468: AB_442979, HPA073999: AB_2732247" "unprognostic (2.18e-1)" "unprognostic (4.21e-2)" "unprognostic (7.60e-2)" "unprognostic (3.09e-2)" "unprognostic (4.60e-2)" "unprognostic (5.71e-2)" "unprognostic (6.55e-2)" "unprognostic (5.19e-3)" "unprognostic (6.62e-2)" "unprognostic (1.02e-2)" "unprognostic (8.71e-3)" "unprognostic (3.04e-3)" "prognostic favorable (3.16e-9)" "unprognostic (6.52e-2)" "unprognostic (2.69e-1)" "unprognostic (2.56e-1)" "unprognostic (7.67e-2)" 10.0 5.4 6.7 4.1 7.2 0.0 9.2 6.4 6.6 11.5 10.1 11.9 6.0 12.0 5.9 10.3 10.1 8.7 21.3 6.2 8.0 7.8 7.7 17.9 2.1 9.7 7.8 17.5 9.4 8.3 4.5 10.3 7.2 9.3 7.6 9.1 7.4 9.5 11.8 29.0 8.2 10.4 7.9 4.0 9.0 20.2 7.4 1.1 18.7 9.8 1.9 10.1 9.8 7.4 5.8 4.6 11.8 4.6 12.3 10.6 12.1 15.2 11.6 8.8 12.2 8.1 10.2 0.0 3.6 19.6 7.9 5.4 1.7 5.4 12.9 0.3 2.7 0.0 5.6 3.4 13.6 0.1 0.2 7.1 10.4 7.4 8.8 11.4 7.2 0.0 1.8 0.2 22.9 4.7 0.0 0.3 3.5 6.2 8.7 0.1 35.3 0.1 7.7 4.1 0.8 13.6 8.7 21.6 5.2 10.0 10.7 2.3 14.5 16.3 12.8 6.7 10.6 0.5 1.9 0.0 6.0 0.2 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 7.2 6.4 6.6 6.2 8.0 9.7 7.8 7.2 7.9 7.4 7.4 7.2 57.7 6.0 14.4 0.0 10.5 6.3 4.0 4.0 7.2 7.1 5.8 34.9 5.7 7.1 7.3 35.5 10.3 0.1 18.1 0.0 5.0 19.1 10.2 11.4 6.0 4.8 8.0 12.8 8.4 5.4 12.0 7.1 7.1 2.5 9.2 6.1 9.7 1.9 1.7 14.4 15.0 8.2 1.3 3.9 5.3 17.1 0.4 0.0 13.1 0.0 4.7 1.0 28.1 20.3 10.7 6.1 27.1 0.0 8.8 6.7 3.5 10.3 9.4 0.0 12.7 10.5 20.2 6.6 3.5 11.9 101.9 0.6 7.4 6.2 4.7 ZC3H14 "FLJ11806, NY-REN-37, UKp68" ENSG00000100722 "Zinc finger CCCH-type containing 14" Q6PJT7 14 88562970-88627596 "Disease related genes, Human disease related genes, Predicted intracellular proteins" RNA-binding "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "testis: 173.6" "Cell type enhanced" "Detected in all" "Early spermatids: 1282.6;Late spermatids: 460.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049798, HPA053510" Enhanced Enhanced "Nucleoli,Nucleoli rim,Nuclear speckles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 77: Retina - Visual perception" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 29: Early spermatids - Spermatogenesis" "Nuclear speckles" "Nucleoli, Nucleoli rim" "HPA049798: AB_2680888, HPA053510: AB_2682174" "unprognostic (5.80e-3)" "unprognostic (2.25e-1)" "unprognostic (1.35e-2)" "unprognostic (7.39e-2)" "unprognostic (2.06e-1)" "unprognostic (1.91e-1)" "unprognostic (6.47e-3)" "unprognostic (9.57e-2)" "unprognostic (7.21e-3)" "unprognostic (2.77e-3)" "unprognostic (4.83e-2)" "unprognostic (1.50e-2)" "prognostic favorable (7.08e-4)" "unprognostic (2.09e-1)" "unprognostic (8.23e-2)" "unprognostic (3.71e-1)" "unprognostic (4.25e-2)" 20.9 21.0 9.5 16.3 10.7 23.6 22.5 26.9 14.9 23.7 38.3 26.9 19.7 25.7 25.1 20.2 27.7 18.7 24.7 10.8 8.1 24.3 43.3 24.2 18.2 5.5 5.1 26.1 37.4 33.2 24.3 23.0 6.8 23.6 31.2 41.1 31.4 23.6 30.2 21.4 21.2 28.2 4.4 15.7 21.6 173.6 9.0 20.0 32.2 25.1 23.6 22.1 19.5 13.1 39.5 75.4 64.7 54.8 50.8 48.6 68.3 58.6 54.2 85.2 74.7 55.3 63.2 55.1 41.9 61.4 46.3 44.4 46.8 55.7 115.9 43.4 34.7 26.7 51.6 42.5 51.2 57.3 34.3 39.2 65.2 68.2 66.9 53.3 56.7 47.2 54.2 21.0 75.8 86.3 52.8 28.1 39.9 60.8 64.1 46.1 83.9 23.1 54.3 68.2 45.6 37.0 75.2 75.4 37.3 54.3 75.3 36.3 39.2 101.3 65.1 43.1 59.2 29.3 30.0 61.7 49.0 27.1 48.0 19.1 20.7 29.4 18.9 25.3 20.4 16.8 18.0 20.8 22.1 15.4 17.2 16.9 3.8 25.9 29.6 12.5 17.2 17.4 9.5 10.7 26.9 14.9 10.8 8.1 5.5 5.1 6.8 4.4 9.0 13.1 25.2 121.8 57.0 38.2 18.1 22.7 24.5 25.2 21.1 61.2 27.0 24.9 22.6 28.6 37.6 20.2 77.2 49.2 25.4 28.4 35.2 25.6 1282.6 53.0 46.6 28.7 31.8 17.1 88.8 23.0 27.4 30.5 20.9 34.3 45.6 51.8 24.3 38.1 20.3 65.6 65.5 31.4 34.6 14.9 16.3 460.1 39.4 19.6 5.4 34.7 20.0 33.6 18.6 64.3 62.9 22.0 16.4 47.4 18.6 26.0 27.4 32.4 53.0 78.9 13.1 46.6 35.4 217.9 81.5 23.0 19.7 40.6 20.1 39.2 32.8 16.3 EML5 "EMAP-2, FAP16, HuEMAP-2" ENSG00000165521 "EMAP like 5" Q05BV3 14 88612431-88792752 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.7;ovary: 17.4;retina: 9.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 60.5;Excitatory neurons: 79.5;Granulosa cells: 98.7;Inhibitory neurons: 106.8;Oligodendrocyte precursor cells: 98.0" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 17.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 11.5;SH-SY5Y: 23.8" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "olfactory bulb: 41.5" "HPA054019, HPA055379" Uncertain NA NA "Cluster 21: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "HPA054019: AB_2682345, HPA055379: AB_2682799" "unprognostic (2.28e-1)" "unprognostic (1.80e-1)" "unprognostic (2.49e-1)" "unprognostic (8.68e-2)" "unprognostic (1.15e-1)" "unprognostic (4.67e-4)" "unprognostic (3.42e-2)" "unprognostic (4.50e-2)" "unprognostic (1.63e-1)" "unprognostic (1.92e-1)" "unprognostic (1.20e-3)" "unprognostic (1.36e-1)" "unprognostic (1.11e-4)" "unprognostic (1.21e-2)" "unprognostic (1.05e-1)" "unprognostic (3.82e-1)" "unprognostic (1.53e-3)" 0.4 3.8 3.3 0.7 2.8 0.3 0.8 17.7 2.8 0.7 0.0 1.3 0.2 0.4 0.2 0.8 1.1 0.1 0.2 3.4 2.4 1.4 1.6 0.6 0.2 0.5 5.5 17.4 0.9 2.4 3.9 0.0 1.5 4.4 0.3 9.5 0.8 0.2 0.1 0.5 0.8 0.2 0.3 0.9 0.6 2.7 2.7 0.7 1.6 0.1 0.6 0.8 0.5 1.1 1.3 0.5 0.0 1.0 0.0 0.0 2.6 0.4 0.3 0.2 0.1 0.0 0.9 0.1 0.0 0.0 0.2 3.5 4.1 0.1 0.1 2.2 2.2 1.1 0.5 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.5 11.5 0.1 1.2 2.9 0.0 0.2 0.4 1.0 1.4 0.0 0.4 0.1 3.1 3.9 23.8 1.1 1.3 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 1.7 4.7 1.0 3.7 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 2.8 17.7 2.8 3.4 2.4 0.5 5.5 1.5 0.3 2.7 1.1 0.2 0.0 5.8 31.3 3.5 0.5 1.0 0.0 0.6 28.2 2.0 0.9 1.5 1.5 1.3 0.0 60.5 0.2 0.7 1.2 0.0 0.9 3.1 2.0 1.2 0.8 10.7 2.1 79.5 0.4 0.1 1.2 3.1 1.9 1.3 98.7 0.0 0.1 0.0 20.2 106.8 0.3 0.0 0.0 0.0 2.9 0.6 0.3 3.6 17.8 0.2 3.6 0.0 98.0 34.5 0.3 1.1 1.2 4.5 5.7 0.0 0.4 4.6 30.1 0.0 1.9 7.4 13.6 8.1 1.5 0.4 0.1 1.7 5.1 0.1 0.6 TTC8 "BBS8, RP51" ENSG00000165533 "Tetratricopeptide repeat domain 8" Q8TAM2 14 88824153-88881078 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 66.8;Theca cells: 69.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 13.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 13.8" "Cell line enhanced" "Detected in all" "SH-SY5Y: 118.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (1.19e-2)" "unprognostic (1.08e-1)" "unprognostic (5.47e-2)" "prognostic favorable (1.69e-5)" "unprognostic (1.49e-1)" "unprognostic (7.10e-2)" "unprognostic (5.00e-3)" "unprognostic (1.54e-1)" "unprognostic (2.19e-1)" "prognostic favorable (7.77e-4)" "unprognostic (3.54e-2)" "unprognostic (2.51e-1)" "prognostic favorable (4.89e-4)" "unprognostic (1.65e-2)" "unprognostic (1.84e-1)" "unprognostic (2.44e-1)" "unprognostic (3.80e-2)" 8.3 38.9 13.9 6.6 14.6 9.3 18.6 11.8 14.2 15.5 20.4 9.4 6.0 13.5 35.9 13.0 23.2 15.5 11.5 14.9 19.3 13.6 13.2 8.9 4.3 14.0 14.4 68.9 12.0 22.5 22.4 6.8 12.7 23.6 9.9 37.4 10.0 18.6 2.6 8.8 5.8 14.4 13.3 6.8 8.4 23.7 16.5 5.9 37.1 4.2 5.0 16.4 5.0 13.4 19.8 28.1 16.7 16.2 35.1 43.5 14.0 24.0 37.6 31.8 21.5 7.9 37.2 8.7 20.6 30.3 19.3 28.5 18.1 19.4 32.2 6.6 7.3 5.5 9.1 11.1 25.4 10.6 1.9 27.3 23.9 23.0 19.9 30.4 19.3 11.6 20.5 9.8 27.3 33.9 10.9 10.2 8.9 10.3 27.0 3.3 23.0 5.2 31.3 30.6 19.6 118.5 38.0 21.3 22.4 11.5 52.6 8.3 11.7 22.6 11.9 20.2 16.6 1.2 6.8 3.8 33.3 2.8 9.9 13.8 0.7 3.8 0.4 0.9 0.6 0.4 0.5 0.5 1.9 2.2 0.2 0.4 0.7 1.7 1.5 0.7 0.0 0.5 13.9 14.6 11.8 14.2 14.9 19.3 14.0 14.4 12.7 13.3 16.5 13.4 3.7 3.2 9.0 38.8 2.1 8.8 8.0 12.3 19.4 17.0 11.7 9.1 6.0 10.0 11.2 9.2 39.6 10.2 0.6 4.3 13.7 13.5 8.1 24.1 10.6 4.9 10.8 4.8 51.1 6.2 9.7 12.8 6.1 11.7 0.0 66.8 5.3 8.0 6.7 20.2 53.4 6.1 6.1 3.5 6.6 7.4 19.6 4.4 7.2 14.0 0.4 12.5 1.0 51.3 21.3 7.8 2.4 25.2 3.7 4.9 2.3 15.5 28.3 41.7 19.7 5.8 12.2 14.6 6.9 8.3 6.5 1.8 1.2 69.0 6.6 4.7 FOXN3 "C14orf116, CHES1" ENSG00000053254 "Forkhead box N3" O00409 14 89124871-89619149 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 517.2;Oligodendrocyte precursor cells: 291.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 109.2;U-266/84: 112.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059209 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 44: HDLM-2 - Immune response" "Cluster 44: Endometrium - Transcription" Nucleoplasm "Plasma membrane" "HPA059209: AB_2683949" "unprognostic (1.69e-1)" "unprognostic (6.13e-3)" "unprognostic (2.08e-1)" "unprognostic (1.84e-1)" "unprognostic (4.09e-2)" "unprognostic (2.03e-1)" "unprognostic (3.03e-1)" "unprognostic (1.34e-2)" "unprognostic (8.75e-2)" "unprognostic (1.09e-1)" "unprognostic (2.64e-1)" "unprognostic (1.19e-1)" "prognostic favorable (9.58e-5)" "unprognostic (2.22e-2)" "unprognostic (1.88e-1)" "unprognostic (5.53e-2)" "unprognostic (2.11e-1)" 46.5 27.0 17.8 23.6 17.9 83.7 22.8 76.2 15.1 24.9 33.4 28.8 36.7 26.5 9.2 39.4 23.2 22.9 38.2 12.2 15.8 12.8 30.8 23.9 29.1 20.5 18.3 50.6 24.8 46.9 5.1 22.7 21.5 20.2 21.8 16.5 18.4 22.1 79.6 41.4 35.2 35.1 19.3 21.6 29.0 16.8 21.5 41.6 9.5 72.6 30.9 25.5 20.6 18.3 0.5 7.7 19.7 11.3 78.1 24.8 14.2 15.7 15.4 13.8 22.7 7.8 6.3 24.0 7.8 25.0 9.5 5.6 33.5 22.3 20.4 109.2 6.2 8.3 14.6 25.0 25.3 16.6 14.1 59.4 12.6 1.3 9.4 16.6 30.2 34.1 10.0 69.0 22.9 9.4 32.2 16.6 21.2 14.2 13.8 51.4 67.0 22.8 1.7 26.6 10.7 35.1 23.0 21.9 6.4 64.8 12.8 45.3 55.0 23.5 32.1 23.6 23.6 58.4 112.6 44.6 8.5 28.2 13.8 48.8 23.8 35.8 41.9 25.7 33.3 13.5 27.8 35.9 35.2 16.4 35.8 34.6 9.6 32.2 17.3 7.9 35.9 31.2 17.8 17.9 76.2 15.1 12.2 15.8 20.5 18.3 21.5 19.3 21.5 18.3 108.7 32.1 33.9 229.5 65.4 89.3 22.4 27.4 41.5 123.2 21.0 21.7 103.2 47.1 53.4 9.2 0.0 36.9 105.9 37.2 21.5 11.5 86.2 38.8 36.3 67.3 59.3 52.5 125.6 20.9 21.3 75.2 45.9 36.4 12.7 112.4 55.6 92.9 43.5 79.1 195.2 37.5 30.5 100.3 174.9 38.5 96.3 87.9 32.0 517.2 65.3 38.6 94.7 291.6 143.8 15.5 32.1 85.4 71.3 16.8 77.4 12.2 16.0 9.9 39.5 133.6 57.9 4.3 11.6 51.4 147.6 29.6 85.0 37.2 46.6 29.1 EFCAB11 C14orf143 ENSG00000140025 "EF-hand calcium binding domain 11" Q9BUY7 14 89794669-89954777 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 36.8" "Group enriched" "Detected in many" 5 "Early spermatids: 557.0;Late spermatids: 363.3;Oligodendrocytes: 139.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 14.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA051209 Approved "Cell Junctions,Cytosol" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 34: Spermatids - Unknown function" "Cell Junctions, Cytosol" "HPA051209: AB_2681389" "unprognostic (1.03e-1)" "unprognostic (6.10e-3)" "unprognostic (2.36e-2)" "unprognostic (2.00e-3)" "unprognostic (2.39e-1)" "unprognostic (3.74e-3)" "unprognostic (1.38e-1)" "unprognostic (2.77e-1)" "unprognostic (1.00e-2)" "unprognostic (3.37e-2)" "unprognostic (1.77e-1)" "unprognostic (2.24e-1)" "unprognostic (3.84e-7)" "unprognostic (4.16e-2)" "unprognostic (1.95e-1)" "unprognostic (9.82e-2)" "unprognostic (8.45e-2)" 5.0 4.1 8.5 3.2 8.1 6.1 9.1 8.2 10.6 5.3 9.9 5.4 5.1 3.8 6.4 4.8 11.0 3.4 2.6 7.3 7.2 7.6 6.0 3.2 3.7 8.1 8.3 4.8 4.8 8.2 3.3 6.4 7.6 5.2 5.4 6.2 4.7 5.0 2.0 3.3 3.8 3.8 7.6 3.5 4.6 36.8 8.3 4.4 7.8 2.4 4.8 4.7 3.0 8.6 8.4 12.7 11.0 13.5 6.5 7.1 30.5 12.1 10.9 16.1 11.2 15.2 29.1 13.1 22.4 8.1 11.4 17.9 9.3 24.2 23.1 14.9 6.1 9.4 11.0 24.6 1.5 12.1 22.0 4.9 5.9 10.5 11.9 9.2 13.6 13.8 10.0 12.5 19.3 43.4 9.0 16.3 4.7 34.3 22.7 10.3 17.1 9.6 15.2 23.0 4.5 7.7 15.3 27.9 14.5 22.4 22.7 8.6 11.5 8.7 11.9 9.3 12.0 7.6 23.2 23.0 12.7 5.7 16.1 14.9 1.1 3.0 0.4 2.5 0.2 2.2 0.7 0.8 1.8 2.4 1.1 1.1 2.7 2.9 5.0 1.6 1.0 0.6 8.5 8.1 8.2 10.6 7.3 7.2 8.1 8.3 7.6 7.6 8.3 8.6 5.8 0.0 1.1 30.3 6.2 5.1 7.0 14.2 2.2 8.6 8.8 7.9 4.2 11.5 9.7 18.4 2.1 15.7 3.0 3.3 9.8 12.1 557.0 37.7 6.3 7.4 0.0 9.5 16.8 16.9 28.9 6.3 1.5 10.5 5.1 8.0 6.4 6.3 11.7 3.3 19.1 6.1 10.2 4.0 6.6 363.3 5.6 5.7 3.6 18.7 8.0 6.8 2.1 40.2 139.9 6.5 9.7 7.5 6.4 2.6 3.6 20.4 47.7 13.2 0.0 5.3 6.0 62.8 14.7 5.4 3.3 7.7 2.5 10.2 12.2 5.9 TDP1 "FLJ11090, SCAN1" ENSG00000042088 "Tyrosyl-DNA phosphodiesterase 1" Q9NUW8 14 89954939-90044764 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 123.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071317 Approved Supported "Nucleoplasm,Plasma membrane" No No "Cluster 44: Non-specific - Transcription" "Cluster 3: T-cells - Adaptive immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "Plasma membrane" "HPA071317: AB_2686388" "unprognostic (5.60e-3)" "unprognostic (3.53e-1)" "unprognostic (7.03e-3)" "unprognostic (1.34e-1)" "unprognostic (7.45e-2)" "unprognostic (7.22e-2)" "prognostic unfavorable (8.99e-5)" "unprognostic (2.61e-1)" "unprognostic (1.46e-2)" "unprognostic (5.84e-3)" "unprognostic (2.51e-1)" "unprognostic (6.46e-2)" "unprognostic (1.10e-1)" "unprognostic (3.41e-1)" "unprognostic (1.64e-1)" "unprognostic (2.91e-2)" "unprognostic (1.26e-1)" 5.5 3.9 4.8 11.8 4.5 13.9 8.9 6.6 4.9 6.6 7.1 7.8 6.5 5.9 5.8 8.2 9.2 6.6 2.6 4.1 5.3 7.0 6.5 4.7 19.0 3.8 3.6 6.4 4.8 5.1 4.6 8.2 3.9 5.0 10.1 4.9 5.5 4.3 2.1 6.4 7.0 6.3 2.8 10.6 7.9 22.3 4.6 28.3 4.9 1.7 23.7 8.1 5.0 4.2 33.8 18.6 40.9 37.5 10.1 14.0 32.7 31.7 25.9 38.4 34.6 13.6 35.5 42.9 23.3 21.7 12.9 33.9 18.2 29.5 55.2 44.1 19.6 43.9 16.7 16.6 8.7 73.2 24.1 10.1 12.9 26.9 24.9 21.9 49.5 57.3 30.6 43.5 45.9 35.0 56.3 39.2 10.0 39.8 43.7 42.3 77.3 34.0 24.6 27.3 30.7 20.9 26.9 77.6 10.1 27.0 31.0 30.8 39.9 16.5 15.7 23.0 28.7 31.8 60.4 52.3 35.5 32.3 24.6 28.7 8.9 15.1 18.8 14.6 18.3 21.1 19.8 20.8 14.2 20.0 21.7 23.1 5.7 23.8 14.1 15.0 32.2 14.8 4.8 4.5 6.6 4.9 4.1 5.3 3.8 3.6 3.9 2.8 4.6 4.2 2.9 0.0 1.1 4.2 15.2 4.7 4.9 7.4 4.0 3.0 6.4 7.1 1.4 1.5 5.0 14.7 8.4 11.4 14.6 3.8 5.9 9.2 123.5 13.2 6.1 3.6 3.6 12.8 13.4 5.6 14.9 4.3 7.7 9.2 2.5 8.9 3.9 4.2 8.8 3.3 13.9 4.9 0.0 6.8 10.2 36.7 2.8 7.8 1.8 1.9 8.0 1.5 8.2 8.0 24.2 6.4 4.8 3.0 16.9 5.7 2.9 7.8 11.0 2.7 0.0 3.4 5.4 33.7 22.8 8.7 4.5 10.1 15.0 10.3 7.9 4.0 KCNK13 "K2p13.1, THIK-1, THIK1" ENSG00000152315 "Potassium two pore domain channel subfamily K member 13" Q9HB14 14 90061994-90185853 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 5.6;parathyroid gland: 6.0;testis: 9.2" "Cell type enriched" "Detected in some" 4 "Microglial cells: 41.2" "Cancer enhanced" "Detected in many" "testis cancer: 5.3" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "myeloid DC: 1.2" "Lineage enhanced" "Detected in single" "dendritic cells: 1.2" "Cell line enhanced" "Detected in some" "GAMG: 1.0;RT4: 1.9;SuSa: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA003514 Approved Approved "Nuclear speckles,Cell Junctions" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 15: RT4 - Unknown function" "Cluster 10: Non-specific - Unknown function" "Nuclear speckles, Cell Junctions" "HPA003514: AB_2666978" "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (6.17e-2)" "unprognostic (6.31e-2)" "unprognostic (2.56e-1)" "unprognostic (5.55e-2)" "unprognostic (3.56e-2)" "unprognostic (3.98e-2)" "unprognostic (2.40e-1)" "unprognostic (2.34e-1)" "unprognostic (1.85e-1)" "unprognostic (3.45e-2)" "unprognostic (1.97e-1)" "unprognostic (2.04e-2)" "unprognostic (6.32e-2)" "unprognostic (1.46e-1)" "unprognostic (5.65e-2)" 0.3 0.8 1.7 1.7 1.5 0.0 0.2 0.9 1.9 0.1 5.6 0.4 0.5 0.2 1.0 0.2 0.3 0.4 1.6 1.6 1.4 3.9 0.5 0.4 0.6 1.6 2.3 0.1 0.3 6.0 0.3 0.2 1.8 0.1 0.5 0.0 0.2 0.4 0.0 0.1 0.5 0.3 1.8 0.6 0.4 9.2 2.2 1.1 1.9 0.0 0.5 0.5 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.4 0.0 0.0 0.3 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.1 1.9 0.7 0.2 0.0 0.7 0.5 2.9 0.0 0.7 0.0 0.0 0.8 0.0 0.3 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 1.7 1.5 0.9 1.9 1.6 1.4 1.6 2.3 1.8 1.8 2.2 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.8 0.4 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 6.3 0.0 0.4 0.0 0.0 6.0 0.0 4.4 0.0 0.0 4.0 8.1 0.6 0.0 3.2 0.0 41.2 9.0 0.0 0.0 3.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.6 0.0 0.3 0.1 0.1 0.4 0.0 0.1 PSMC1 "p56, S4" ENSG00000100764 "Proteasome 26S subunit, ATPase 1" P62191 14 90256527-90275429 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 308.0" "Cell type enhanced" "Detected in all" "Early spermatids: 593.2;Late spermatids: 549.5;Syncytiotrophoblasts: 469.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000872, HPA016885" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 110000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Cytosol" "HPA000872: AB_1079705, HPA016885: " "unprognostic (4.10e-1)" "unprognostic (9.70e-2)" "unprognostic (8.17e-2)" "unprognostic (1.29e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (1.23e-2)" "unprognostic (1.00e-2)" "unprognostic (1.58e-1)" "unprognostic (1.03e-3)" "unprognostic (1.12e-2)" "unprognostic (1.10e-2)" "unprognostic (1.14e-2)" "unprognostic (1.28e-1)" "unprognostic (1.03e-1)" "unprognostic (2.85e-1)" "unprognostic (1.11e-2)" 76.7 61.3 47.6 48.0 50.3 86.3 64.9 50.8 63.3 51.7 47.6 72.4 35.7 67.3 71.6 71.5 53.4 37.5 114.9 49.5 53.6 62.2 83.3 55.0 49.5 50.5 51.3 45.6 52.7 69.3 37.0 69.6 53.0 49.7 60.4 40.1 55.3 57.5 308.0 74.1 54.5 61.5 49.4 57.5 61.1 82.2 50.3 62.5 48.1 142.5 72.2 64.7 54.1 50.8 141.6 131.1 147.5 154.8 126.6 115.4 154.9 133.5 185.7 287.9 215.4 122.3 154.7 119.4 198.4 162.3 132.2 142.8 182.2 155.8 334.2 143.9 80.0 93.8 84.6 105.9 109.1 143.7 120.4 104.3 120.7 187.9 137.1 120.2 176.2 130.3 134.8 69.9 200.6 267.9 108.0 186.7 130.6 180.7 160.4 127.5 190.8 97.6 163.0 144.6 154.6 103.2 109.0 279.6 118.0 121.8 175.9 125.2 134.9 110.1 98.8 119.6 196.3 120.0 204.3 178.3 159.8 129.1 172.1 95.1 101.4 160.1 67.1 93.7 66.4 57.7 68.5 69.0 101.1 56.8 62.5 60.7 109.9 82.0 110.7 70.8 101.2 116.5 47.6 50.3 50.8 63.3 49.5 53.6 50.5 51.3 53.0 49.4 50.3 50.8 63.1 102.5 80.4 11.4 51.4 65.0 90.3 175.3 30.1 51.3 48.6 45.7 39.2 88.6 136.0 55.2 52.1 304.2 48.2 91.2 119.3 180.8 593.2 68.9 56.1 90.1 57.0 80.6 21.0 197.7 178.9 71.4 30.1 70.1 98.2 82.4 75.7 196.6 150.2 79.1 21.2 68.7 111.9 91.8 82.2 549.5 76.4 74.7 67.6 14.0 146.0 88.1 72.1 10.6 22.3 210.3 71.5 82.0 50.7 75.5 104.2 160.4 123.9 65.8 85.5 67.5 139.5 198.1 48.7 44.1 50.2 469.4 55.4 82.5 74.4 92.7 NRDE2 "C14orf102, FLJ14051" ENSG00000119720 "NRDE-2, necessary for RNA interference, domain containing" Q9H7Z3 14 90267860-90331969 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, DNA damage, Mitosis, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.3" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 111.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047050, HPA050583" Uncertain Supported Nucleoplasm,Mitochondria NA NA "Cluster 11: Basophils - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Mitochondria" "HPA047050: AB_2679917, HPA050583: AB_2681182" "unprognostic (1.24e-2)" "unprognostic (3.58e-1)" "unprognostic (1.24e-1)" "unprognostic (3.02e-1)" "unprognostic (4.51e-2)" "unprognostic (1.08e-2)" "unprognostic (9.60e-2)" "unprognostic (8.91e-3)" "unprognostic (1.10e-1)" "unprognostic (4.88e-3)" "unprognostic (3.26e-3)" "unprognostic (1.35e-2)" "unprognostic (2.31e-3)" "unprognostic (8.27e-2)" "unprognostic (6.56e-2)" "unprognostic (3.13e-2)" "unprognostic (3.49e-2)" 1.0 1.0 2.1 1.4 3.0 3.5 1.2 7.3 2.9 1.3 2.3 1.3 2.5 1.6 1.3 1.1 1.2 0.9 1.2 2.1 2.8 1.1 1.7 1.2 1.2 2.5 2.1 1.5 1.2 1.4 1.8 1.1 2.4 1.3 1.0 3.1 1.4 0.9 1.6 2.0 1.5 1.1 1.8 1.6 1.3 0.9 2.8 1.7 1.7 1.0 1.1 1.1 1.2 3.6 0.7 1.4 2.0 1.2 0.3 1.0 1.4 1.4 0.9 1.0 1.1 1.8 1.3 1.3 0.7 1.4 1.3 1.9 1.1 1.9 1.9 2.5 1.7 1.7 5.0 1.3 0.5 4.6 2.2 1.8 1.3 1.0 0.6 2.1 0.9 3.3 0.8 2.0 0.9 1.4 2.1 1.9 0.7 0.6 1.1 1.8 2.9 0.5 0.6 2.9 1.8 2.1 0.6 3.8 1.0 0.7 1.7 1.9 1.2 1.5 0.7 0.9 0.6 1.6 1.9 1.3 1.4 0.8 1.8 1.6 0.8 1.0 0.8 0.5 0.6 0.8 0.5 0.6 0.4 1.0 0.5 0.6 1.3 0.7 0.4 1.1 0.5 0.2 2.1 3.0 7.3 2.9 2.1 2.8 2.5 2.1 2.4 1.8 2.8 3.6 18.2 35.3 29.7 11.4 21.6 5.9 7.0 13.3 17.1 79.4 19.7 14.9 13.2 37.1 18.8 18.4 87.6 19.1 26.4 23.3 7.9 16.6 8.6 15.2 23.8 20.8 24.7 13.7 10.0 14.6 13.0 16.7 18.8 18.0 38.6 24.7 28.2 42.1 11.8 53.8 12.2 24.2 14.2 17.6 6.7 9.7 23.6 12.8 8.8 4.7 25.1 30.4 30.9 15.1 18.8 14.0 17.7 33.1 9.4 8.0 36.5 18.6 11.4 111.3 0.0 26.6 16.5 24.3 39.4 9.3 6.3 25.2 18.6 18.3 23.7 5.5 CALM1 "CALML2, CAMI, DD132, PHKD" ENSG00000198668 "Calmodulin 1" P0DP23 14 90396502-90408268 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction" "Disease variant, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018558, HPA044999" Supported Supported Cytosol NA NA 75000000 "Cluster 44: Non-specific - Transcription" "Cluster 10: Brain - Neuronal signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 7: Non-specific - Mitochondria" Cytosol "CAB018558: AB_2069454, HPA044999: AB_2679177" "unprognostic (5.35e-3)" "unprognostic (3.96e-1)" "unprognostic (4.99e-3)" "unprognostic (2.91e-2)" "unprognostic (1.07e-1)" "unprognostic (2.87e-2)" "unprognostic (1.99e-3)" "unprognostic (1.52e-1)" "unprognostic (6.44e-2)" "unprognostic (1.16e-3)" "prognostic favorable (5.62e-4)" "unprognostic (2.77e-1)" "prognostic favorable (6.49e-4)" "unprognostic (2.66e-1)" "unprognostic (2.68e-1)" "unprognostic (1.11e-2)" "prognostic unfavorable (2.38e-5)" 264.2 143.5 429.9 152.3 537.5 349.1 123.1 442.8 839.7 134.2 259.8 332.9 289.6 105.1 209.7 304.6 251.4 153.8 287.0 635.9 371.6 326.3 210.9 209.1 165.7 466.2 374.6 104.4 121.7 225.5 143.9 207.4 447.5 169.5 312.2 241.6 188.0 215.3 588.9 104.0 279.2 227.2 328.7 166.6 202.2 123.6 443.5 146.5 118.0 185.6 210.5 191.6 125.2 527.2 189.3 256.3 308.0 115.7 332.2 286.5 256.9 347.4 295.3 260.0 283.2 278.1 320.9 200.8 171.1 413.0 123.4 309.4 194.6 490.1 431.0 398.3 119.7 212.4 211.0 264.1 185.9 327.6 167.2 188.0 232.7 261.6 93.1 173.6 592.9 140.3 101.3 270.0 353.9 653.7 112.4 316.2 178.4 521.1 351.6 216.9 264.9 134.4 215.3 574.5 621.2 259.1 292.3 507.7 195.5 254.0 335.6 112.0 363.1 212.9 137.7 224.8 289.0 149.5 371.0 222.2 335.9 267.6 301.5 1289.6 356.8 826.7 1005.3 420.4 1230.3 496.8 1039.1 1079.6 483.1 400.2 745.7 882.7 513.3 1036.9 647.3 453.3 1168.3 1477.9 429.9 537.5 442.8 839.7 635.9 371.6 466.2 374.6 447.5 328.7 443.5 527.2 1812.3 387.8 374.4 119.8 573.2 567.1 572.2 604.2 543.5 1729.1 343.7 514.8 867.5 346.0 523.1 399.1 123.0 427.7 1471.8 828.8 459.7 550.8 154.9 1026.1 249.0 996.0 599.8 143.5 367.6 444.7 984.2 521.4 317.0 377.6 490.3 148.5 652.5 333.7 795.1 604.0 258.9 513.9 730.4 286.5 837.4 101.5 210.6 639.9 627.9 131.2 856.3 1061.8 1100.9 108.0 188.9 534.2 615.8 500.2 591.8 287.7 1637.2 1430.5 1618.4 321.1 315.5 387.5 901.6 128.8 199.8 553.8 580.4 1147.6 1139.3 247.8 666.6 458.5 TTC7B TTC7L1 ENSG00000165914 "Tetratricopeptide repeat domain 7B" Q86TV6 14 90524564-90816479 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 88.8;Excitatory neurons: 116.7;Inhibitory neurons: 132.8;Oligodendrocyte precursor cells: 69.9;Oligodendrocytes: 70.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 5.6;eosinophil: 8.0" "Lineage enriched" "Detected in single" 9 "granulocytes: 8.0" "Cell line enhanced" "Detected in many" "HMC-1: 72.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058363, HPA059577" Enhanced Supported "Plasma membrane" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 47: Non-specific - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane" "HPA058363: AB_2683692, HPA059577: AB_2684069" "unprognostic (9.37e-2)" "unprognostic (4.20e-2)" "unprognostic (1.01e-2)" "unprognostic (2.41e-2)" "unprognostic (2.58e-1)" "unprognostic (2.67e-4)" "unprognostic (9.42e-2)" "unprognostic (2.17e-1)" "unprognostic (5.38e-2)" "unprognostic (7.60e-2)" "unprognostic (2.75e-3)" "unprognostic (2.87e-2)" "prognostic favorable (3.20e-6)" "unprognostic (2.74e-2)" "unprognostic (7.41e-2)" "unprognostic (4.48e-2)" "unprognostic (1.07e-2)" 23.7 11.6 42.9 9.1 43.4 10.2 18.1 47.1 57.2 20.1 0.7 37.9 5.0 24.2 6.1 15.5 18.0 9.2 33.2 51.0 18.7 16.9 17.6 18.5 4.1 35.7 32.2 15.8 24.7 15.7 18.2 18.4 38.7 16.1 4.4 14.4 12.8 13.9 60.9 9.3 11.0 17.6 14.6 15.4 22.4 4.2 45.2 3.5 9.5 27.9 2.7 25.4 13.1 39.6 19.4 17.2 20.0 14.8 18.2 21.5 65.5 15.5 13.2 20.2 21.7 4.5 5.1 0.2 23.6 17.4 23.9 0.4 13.1 10.8 19.6 35.3 14.1 43.6 8.9 4.1 18.3 1.0 72.8 16.1 7.1 10.9 13.2 18.5 29.4 16.9 24.7 35.3 19.7 20.5 0.5 17.2 11.4 1.1 14.8 37.8 33.0 6.6 6.6 14.4 30.5 20.9 15.4 6.3 33.3 12.7 9.0 13.3 33.7 20.6 16.1 15.2 25.4 12.0 6.3 0.2 29.6 4.1 20.6 5.6 0.2 8.0 0.1 0.5 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.1 1.0 0.3 0.1 0.5 0.9 0.5 42.9 43.4 47.1 57.2 51.0 18.7 35.7 32.2 38.7 14.6 45.2 39.6 13.1 3.2 1.1 88.8 0.5 2.8 2.1 1.1 0.6 13.4 2.7 2.8 21.6 2.8 0.4 5.5 16.7 13.1 0.6 0.1 1.9 2.3 5.9 1.3 5.2 7.9 1.2 2.5 116.7 2.4 7.4 7.3 0.5 2.0 7.6 20.0 10.8 9.9 8.1 30.3 132.8 0.1 4.1 5.6 4.3 3.2 6.8 7.2 12.4 36.5 2.7 6.0 0.0 69.9 70.7 0.8 0.1 7.2 0.4 3.0 0.3 4.0 5.5 17.8 26.3 9.9 9.2 1.7 1.6 0.7 2.0 30.1 1.1 2.1 0.0 1.2 RPS6KA5 "MSK1, RLPK" ENSG00000100784 "Ribosomal protein S6 kinase A5" O75582 14 90847861-91060641 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Inflammatory response, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 162.0;Oligodendrocytes: 156.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 31.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001274, HPA001780, CAB025458" Approved Enhanced Nucleoplasm NA NA "Cluster 38: Basophils - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 3: HMC-1 - Innate immune response" "Cluster 44: Endometrium - Transcription" Nucleoplasm "CAB025458: , HPA001274: AB_1079417, HPA001780: AB_2666432" "unprognostic (3.05e-2)" "unprognostic (2.19e-3)" "unprognostic (4.27e-4)" "unprognostic (1.98e-3)" "unprognostic (4.79e-2)" "unprognostic (4.20e-4)" "unprognostic (3.70e-2)" "unprognostic (5.80e-4)" "unprognostic (6.70e-2)" "unprognostic (8.39e-2)" "unprognostic (1.84e-1)" "unprognostic (1.97e-1)" "unprognostic (1.38e-4)" "unprognostic (5.73e-3)" "unprognostic (1.07e-1)" "unprognostic (2.42e-1)" "unprognostic (1.75e-1)" 2.6 0.9 2.4 2.9 7.8 3.3 7.5 14.7 3.7 3.1 1.0 6.6 3.7 4.9 0.3 5.3 4.1 2.8 2.6 1.6 3.0 1.9 1.7 2.8 3.4 4.1 3.8 4.6 1.5 3.0 2.6 3.4 4.1 3.1 5.1 3.0 4.9 4.3 9.0 3.7 4.9 3.9 2.9 3.1 5.4 2.4 4.5 5.0 4.0 9.9 3.5 5.4 4.1 8.0 1.3 2.1 2.7 1.4 0.0 0.5 9.4 0.9 1.3 2.9 4.1 1.2 2.7 6.7 2.8 2.8 1.8 4.7 2.2 1.8 5.1 1.0 3.5 7.5 1.8 0.4 0.0 7.1 31.8 0.8 4.3 1.7 1.3 0.7 3.2 5.1 0.7 7.1 2.9 3.1 2.0 2.2 0.9 4.6 3.4 3.3 11.2 3.2 3.2 2.9 10.4 3.2 2.7 14.8 8.1 1.8 3.0 1.9 0.6 0.8 1.5 0.6 3.4 2.8 3.5 5.9 1.7 5.0 10.6 16.9 3.0 9.0 3.7 2.5 6.1 4.5 4.6 3.5 2.7 5.8 5.5 3.0 19.8 10.4 3.5 1.2 7.9 2.6 2.4 7.8 14.7 3.7 1.6 3.0 4.1 3.8 4.1 2.9 4.5 8.0 13.2 19.2 26.5 80.3 53.7 40.4 45.2 20.4 53.5 32.9 41.4 42.9 20.7 14.3 22.7 7.3 16.7 43.7 21.0 36.7 0.0 11.1 9.1 96.2 19.0 21.4 16.3 22.5 65.4 5.1 6.5 21.8 13.3 162.0 92.2 32.5 20.3 6.5 7.1 26.9 32.5 17.3 4.1 17.6 13.4 3.1 14.0 21.8 19.6 53.4 21.2 10.5 23.7 36.7 156.1 3.5 13.0 11.7 26.0 29.3 41.9 3.7 31.3 32.1 13.1 51.9 22.3 21.2 23.7 35.5 46.3 111.8 48.6 7.2 20.8 52.7 DGLUCY "C14orf159, FLJ39975" ENSG00000133943 "D-glutamate cyclase" Q7Z3D6 14 91060333-91225632 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 163.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 28.9;Collecting duct cells: 29.5;Cytotrophoblasts: 30.9;Endometrial ciliated cells: 29.4;Granulosa cells: 49.8;Hofbauer cells: 31.7;Theca cells: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 200.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041423, HPA052932" Approved Supported Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 39: Non-specific - Mitochondria" "Cluster 2: Karpas-707 - Immune response" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA041423: AB_10795540, HPA052932: AB_2681991" "unprognostic (5.02e-2)" "unprognostic (1.01e-2)" "unprognostic (1.56e-1)" "prognostic favorable (4.28e-4)" "unprognostic (1.28e-1)" "unprognostic (2.26e-1)" "unprognostic (3.58e-2)" "prognostic favorable (9.48e-5)" "unprognostic (3.56e-1)" "prognostic favorable (7.28e-4)" "unprognostic (2.30e-1)" "unprognostic (1.74e-1)" "prognostic favorable (3.77e-15)" "unprognostic (1.50e-1)" "unprognostic (9.51e-2)" "unprognostic (2.75e-2)" "unprognostic (2.57e-3)" 23.9 32.2 38.5 21.4 46.0 21.7 16.7 53.5 49.2 25.0 76.1 33.5 25.1 26.0 17.2 28.4 38.6 22.6 122.3 36.6 39.8 35.6 24.9 25.0 21.6 45.5 51.3 22.9 16.8 47.9 21.5 16.6 42.1 22.8 30.4 8.3 32.2 34.1 143.0 25.6 23.7 32.0 38.0 33.6 38.1 19.0 45.4 27.3 30.1 163.6 19.9 31.9 20.2 45.2 6.2 16.4 8.0 20.1 32.8 30.6 21.0 6.6 17.7 19.3 19.6 10.9 46.7 41.3 46.0 18.8 24.9 18.0 23.0 24.7 7.9 22.8 9.5 27.7 9.1 13.8 47.8 28.5 38.2 47.5 10.5 10.6 4.0 25.3 34.6 22.8 14.0 54.4 18.4 1.4 22.7 27.0 16.4 0.8 1.4 38.2 15.7 30.9 32.7 25.9 22.4 11.2 10.4 17.8 7.3 8.4 32.0 24.5 24.7 5.7 4.8 17.1 5.9 30.9 23.8 14.0 29.6 36.8 3.8 67.5 48.8 30.8 30.1 69.4 30.3 34.0 19.3 24.5 72.9 22.4 15.9 20.0 200.5 21.0 60.7 22.0 45.2 29.0 38.5 46.0 53.5 49.2 36.6 39.8 45.5 51.3 42.1 38.0 45.4 45.2 19.2 28.9 16.4 0.0 4.3 0.0 0.0 0.0 0.0 0.0 11.5 13.2 0.0 0.0 5.6 29.5 0.0 30.9 12.5 0.0 21.5 17.6 0.0 29.4 14.8 6.2 0.0 0.0 0.0 5.8 15.8 7.4 0.0 25.0 7.6 49.8 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 7.2 0.0 0.0 0.0 0.0 6.3 0.0 0.0 2.7 0.0 0.0 17.0 5.1 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 16.8 8.7 35.6 0.0 0.0 GPR68 OGR1 ENSG00000119714 "G protein-coupled receptor 68" Q15743 14 91232532-91253925 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Amelogenesis imperfecta, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 12.2" "Cell type enhanced" "Detected in many" "dendritic cells: 8.0;Hofbauer cells: 17.3;Langerhans cells: 22.6;NK-cells: 12.3;T-cells: 13.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "gdT-cell: 22.9" "Group enriched" "Detected in many" 9 "NK-cells: 20.2;T-cells: 22.9" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 9.0;U-87 MG: 28.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 64: Macrophages - Immune response" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 63: NK-cells & T-cells - Immune response" "unprognostic (3.44e-1)" "unprognostic (1.01e-1)" "unprognostic (3.64e-1)" "prognostic favorable (3.06e-5)" "unprognostic (3.20e-2)" "unprognostic (1.43e-1)" "unprognostic (9.10e-2)" "unprognostic (1.58e-1)" "unprognostic (6.84e-2)" "unprognostic (9.63e-2)" "unprognostic (9.42e-2)" "unprognostic (3.73e-1)" "unprognostic (8.31e-9)" "unprognostic (1.70e-2)" "unprognostic (3.19e-2)" "unprognostic (9.44e-2)" "unprognostic (2.78e-3)" 3.7 1.0 2.5 5.7 1.9 1.4 2.3 3.6 4.9 2.2 0.8 3.1 1.8 1.3 0.5 8.7 1.0 3.7 2.4 1.8 3.3 3.1 1.0 4.9 5.9 2.2 2.6 0.3 0.7 0.9 12.2 3.1 3.7 2.7 1.5 0.2 3.8 0.4 0.7 6.2 2.9 2.0 0.2 4.2 5.7 2.1 2.7 1.2 1.7 0.2 2.8 7.5 3.9 1.4 0.2 0.1 0.6 0.0 0.0 0.9 0.6 1.1 0.6 0.0 0.0 0.2 1.0 0.9 0.4 9.0 0.0 1.0 0.0 0.1 0.2 0.3 0.1 0.0 0.1 0.2 0.0 0.6 4.1 0.4 0.1 4.8 0.0 4.4 0.4 2.9 5.8 0.8 3.9 1.2 0.8 6.4 0.1 0.0 0.1 0.3 0.3 0.2 0.1 0.3 3.1 4.4 0.1 0.1 0.0 0.2 1.5 0.4 2.8 6.1 0.1 1.1 0.4 1.0 1.3 0.2 28.6 1.1 0.1 0.0 0.1 0.1 22.9 0.0 13.8 0.5 5.0 13.5 0.2 0.4 0.6 4.5 2.3 20.2 0.0 0.0 8.7 4.1 2.5 1.9 3.6 4.9 1.8 3.3 2.2 2.6 3.7 0.2 2.7 1.4 1.1 0.0 4.8 0.3 0.7 3.6 0.2 4.2 0.6 0.5 0.8 0.8 1.7 0.0 1.0 0.0 0.0 0.1 8.0 0.1 0.0 0.0 5.4 0.5 0.2 6.9 0.0 2.7 4.1 0.2 0.1 4.3 0.0 0.3 0.0 0.1 0.4 0.0 17.3 0.0 2.1 0.0 0.0 0.0 22.6 1.6 0.3 3.0 3.6 0.0 0.6 0.0 12.3 1.0 0.3 2.9 0.0 4.5 1.3 0.1 0.0 0.4 0.4 0.2 0.0 0.1 1.1 3.4 0.4 0.9 3.0 0.7 13.1 0.2 0.0 0.3 CCDC88C "DAPLE, HkRP2, KIAA1509, SCA40" ENSG00000015133 "Coiled-coil domain containing 88C" Q9P219 14 91271323-91417844 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Guanine-nucleotide releasing factor" "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 33.9" "Cell type enhanced" "Detected in many" "dendritic cells: 80.1;NK-cells: 142.2;Plasma cells: 93.2;Respiratory ciliated cells: 112.5;T-cells: 89.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 55.6;Karpas-707: 50.1;SCLC-21H: 53.6;U-266/70: 58.5;U-266/84: 76.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 5 "basal ganglia: 37.0" HPA005832 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 16: U-266 - Nucleosome" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Nucleoli fibrillar center" "HPA005832: AB_1079202" "unprognostic (7.28e-2)" "unprognostic (2.33e-3)" "unprognostic (7.23e-2)" "unprognostic (5.06e-2)" "unprognostic (1.00e-1)" "prognostic favorable (3.47e-4)" "unprognostic (3.07e-2)" "prognostic favorable (2.90e-4)" "unprognostic (1.48e-1)" "unprognostic (2.13e-1)" "unprognostic (4.77e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.80e-4)" "unprognostic (7.48e-2)" "unprognostic (2.22e-1)" "unprognostic (2.15e-2)" "unprognostic (4.35e-2)" 4.5 1.4 5.9 19.4 23.9 31.2 6.9 3.2 7.1 4.0 2.5 9.4 13.3 3.1 1.6 12.5 12.2 6.2 4.0 3.6 3.9 6.8 3.6 9.7 33.9 5.6 6.7 1.0 8.3 5.3 5.2 2.4 4.6 9.4 7.0 1.0 10.1 3.9 2.3 7.0 11.7 2.3 4.3 21.7 12.4 8.0 7.8 20.4 2.5 2.7 20.4 8.1 7.6 3.2 8.5 6.9 7.5 9.5 0.0 0.0 34.9 0.0 0.0 0.0 0.0 6.8 13.4 45.1 6.1 0.0 0.4 0.4 11.3 6.4 0.0 28.8 4.7 10.0 4.8 9.9 0.7 23.0 8.4 0.0 11.4 0.0 0.0 0.7 8.6 55.6 11.2 50.1 0.1 24.9 24.2 29.6 7.1 6.2 11.5 19.5 0.2 14.2 2.6 10.2 53.6 11.6 4.6 16.9 4.6 5.6 10.2 20.7 2.6 0.0 0.2 0.1 0.1 58.5 76.2 22.8 0.0 20.1 0.1 7.8 3.3 1.3 9.4 1.9 8.8 2.5 6.0 9.2 1.8 2.1 3.8 5.8 2.3 4.0 3.0 2.0 10.7 4.1 5.9 23.9 3.2 7.1 3.6 3.9 5.6 6.7 4.6 4.3 7.8 3.2 26.6 3.2 28.8 7.8 54.1 9.3 15.9 19.0 27.9 0.0 15.3 7.6 19.8 10.0 22.1 14.7 0.0 3.6 80.1 29.6 0.0 4.4 9.6 62.6 1.4 17.3 23.9 20.6 7.1 5.9 2.2 4.2 20.4 12.1 2.5 1.3 20.3 1.6 6.3 0.0 2.5 15.3 22.4 21.0 12.4 18.7 4.1 18.9 1.8 9.4 20.1 8.0 142.2 8.0 5.2 7.8 18.2 3.0 93.2 16.8 13.1 13.2 112.5 0.1 0.0 2.9 4.4 4.7 17.4 31.2 9.5 1.8 89.2 3.3 19.4 19.8 PPP4R3A "FLFL1, FLJ20707, KIAA2010, MSTP033, PP4R3, SMEK1, smk-1, smk1" ENSG00000100796 "Protein phosphatase 4 regulatory subunit 3A" Q6IN85 14 91457508-91510554 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002568, HPA063917" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 59: Non-specific - Transcription" Nucleoplasm "Nuclear speckles, Cytosol" "HPA002568: AB_1079207, HPA063917: AB_2685153" "unprognostic (5.51e-2)" "unprognostic (2.93e-2)" "unprognostic (3.26e-1)" "unprognostic (1.40e-1)" "unprognostic (4.40e-2)" "unprognostic (9.95e-3)" "unprognostic (4.10e-2)" "unprognostic (5.71e-3)" "unprognostic (1.05e-1)" "unprognostic (8.34e-3)" "unprognostic (1.33e-1)" "unprognostic (3.85e-2)" "unprognostic (3.07e-1)" "unprognostic (1.13e-1)" "unprognostic (2.57e-1)" "unprognostic (1.57e-1)" "unprognostic (4.53e-2)" 19.3 13.5 14.4 18.2 14.5 50.0 19.6 16.6 15.2 19.1 16.2 21.2 17.2 20.0 15.9 21.4 20.4 12.3 16.2 12.6 13.3 18.3 23.7 20.2 28.3 13.6 14.2 22.0 19.8 16.8 14.8 17.5 13.7 18.4 18.5 10.9 20.8 13.1 24.5 25.4 24.4 15.0 12.7 24.1 20.6 22.3 14.5 27.4 17.7 16.7 25.4 19.5 19.4 16.9 24.5 41.4 34.1 27.1 22.5 20.9 60.9 23.2 21.4 24.5 24.6 35.2 32.1 63.1 30.2 19.2 15.0 27.8 36.6 28.9 39.8 52.0 19.7 32.5 25.7 24.5 26.3 59.1 33.1 15.1 50.4 19.7 31.1 20.1 26.7 29.4 33.5 36.2 33.1 52.1 42.8 38.0 31.2 46.5 29.8 54.0 40.6 26.5 30.3 41.5 41.6 25.4 35.3 77.0 32.5 33.6 39.4 37.8 28.0 19.2 20.6 21.1 26.8 36.0 67.0 69.3 25.2 31.8 34.7 6.2 1.9 2.9 4.9 2.6 6.6 4.6 4.5 4.4 2.1 7.4 5.6 4.8 2.5 9.0 3.7 5.0 6.9 2.6 14.4 14.5 16.6 15.2 12.6 13.3 13.6 14.2 13.7 12.7 14.5 16.9 44.1 32.1 48.3 0.0 83.0 0.0 46.7 0.0 58.1 27.9 35.9 23.5 0.0 32.9 30.3 46.0 20.9 33.9 91.8 21.1 29.4 21.2 13.0 86.9 46.5 33.3 13.3 47.5 0.0 25.1 29.0 27.3 45.3 70.7 20.2 39.8 28.9 51.8 25.8 32.0 0.0 28.2 0.0 48.7 0.0 8.5 37.6 70.7 0.0 0.0 41.8 21.0 44.3 0.0 0.0 27.8 25.7 42.5 75.8 56.6 37.3 23.5 16.8 27.3 26.3 45.9 27.1 91.0 59.9 58.0 0.0 44.3 80.1 33.0 25.8 75.2 CATSPERB "C14orf161, FLJ14298" ENSG00000133962 "Cation channel sperm associated auxiliary subunit beta" Q9H7T0 14 91580696-91780707 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "pancreas: 10.7" "Cell type enhanced" "Detected in some" "Early spermatids: 22.9;Exocrine glandular cells: 10.9;Gastric mucus-secreting cells: 11.7;Glandular and luminal cells: 6.2;Pancreatic endocrine cells: 7.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.2;OE19: 1.3;U-937: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA035134 Uncertain Vesicles NA NA "Cluster 38: Basophils - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 32: U-937 - Innate immune response" "Cluster 29: Early spermatids - Spermatogenesis" Vesicles "HPA035134: AB_10671510" "unprognostic (2.69e-2)" "unprognostic (1.95e-1)" "unprognostic (1.16e-3)" "unprognostic (1.93e-1)" "unprognostic (7.04e-3)" "unprognostic (2.72e-5)" "unprognostic (1.81e-1)" "unprognostic (5.01e-3)" "unprognostic (1.81e-3)" "unprognostic (3.52e-3)" "unprognostic (2.30e-2)" "unprognostic (4.34e-1)" "unprognostic (8.99e-3)" "unprognostic (6.85e-2)" "unprognostic (8.31e-2)" "unprognostic (8.88e-2)" "unprognostic (2.71e-3)" 0.5 0.2 0.5 0.6 0.5 0.3 0.8 1.0 0.5 0.4 0.1 0.6 0.4 0.2 0.4 0.5 0.4 0.8 0.4 0.3 0.2 0.2 0.1 0.6 0.9 0.3 0.1 0.3 10.7 0.3 0.2 0.2 0.3 0.6 0.5 0.8 2.5 0.2 1.2 2.3 0.9 0.2 0.1 0.6 1.4 1.1 0.2 0.3 0.5 0.0 0.5 0.2 0.2 0.8 0.2 0.0 0.2 0.5 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.7 1.2 0.4 0.3 0.0 0.0 0.2 0.0 0.1 0.2 0.4 0.6 0.1 0.4 0.7 0.0 0.5 0.2 0.1 0.2 0.1 0.1 0.5 0.0 0.3 0.1 0.0 0.1 0.7 0.2 0.2 0.0 1.3 0.1 0.1 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.2 0.5 0.5 0.1 0.7 0.3 0.0 0.0 0.0 0.1 0.2 0.3 0.1 0.0 1.2 0.3 0.3 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.5 1.0 0.5 0.3 0.2 0.3 0.1 0.3 0.1 0.2 0.8 0.1 3.2 1.5 0.3 0.1 0.1 0.3 0.2 0.0 0.0 3.3 1.0 0.2 0.0 2.1 0.0 0.0 0.1 0.3 2.2 0.0 2.7 22.9 1.6 0.9 0.6 0.0 0.0 4.9 10.9 0.1 0.6 11.7 6.2 0.0 0.1 0.0 0.1 0.0 0.0 1.3 3.0 0.0 0.3 0.3 3.2 0.6 0.1 0.0 1.9 0.6 0.0 1.0 0.5 1.8 7.5 2.5 0.0 0.4 0.9 0.1 0.5 1.5 0.0 0.0 0.9 0.3 4.5 0.2 0.8 0.0 0.3 0.7 0.1 1.4 0.8 TC2N "C14orf47, C2CD1, FLJ36557, MTAC2D1, Tac2-N" ENSG00000165929 "Tandem C2 domains, nuclear" Q8N9U0 14 91779746-91867536 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 103.0" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 211.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 84.6" "Group enriched" "Detected in many" 47 "NK-cells: 39.2;T-cells: 84.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 19.1;OE19: 63.8;RT4: 37.3;SK-BR-3: 43.9;T-47d: 22.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA027549 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 21: OE19 - Mitochondria" "Cluster 58: T-cells - T-cell receptor" "Nucleoplasm, Nuclear bodies" "HPA027549: AB_10603346" "unprognostic (5.36e-2)" "unprognostic (1.95e-1)" "unprognostic (4.70e-2)" "unprognostic (1.51e-1)" "unprognostic (7.17e-3)" "unprognostic (3.34e-2)" "unprognostic (2.38e-1)" "unprognostic (2.78e-2)" "unprognostic (3.44e-1)" "unprognostic (8.56e-2)" "prognostic unfavorable (9.86e-4)" "unprognostic (3.00e-1)" "prognostic favorable (4.13e-5)" "unprognostic (6.82e-2)" "unprognostic (1.65e-1)" "unprognostic (3.01e-1)" "unprognostic (1.09e-2)" 14.3 2.3 0.1 14.2 0.7 5.1 27.7 0.2 0.5 9.5 1.4 16.5 12.1 11.4 5.1 21.6 11.8 25.2 8.5 0.2 0.3 6.9 2.9 14.4 22.0 3.1 0.5 6.5 103.0 19.8 6.9 1.5 1.6 17.2 15.2 0.5 46.5 7.8 3.1 13.7 14.5 5.8 1.4 11.1 24.9 5.9 0.7 11.5 12.5 1.2 24.5 18.4 13.9 0.7 9.2 1.5 0.0 0.0 1.6 0.0 12.2 0.0 0.2 0.0 0.0 6.5 19.1 6.0 0.4 0.1 0.2 1.0 9.0 9.0 0.0 0.1 4.7 0.0 2.4 0.0 0.0 0.0 0.0 0.2 9.3 0.0 0.5 0.0 0.0 0.5 0.1 4.7 0.0 16.3 0.0 0.0 1.3 63.8 0.0 0.1 0.0 0.0 4.3 37.3 7.0 0.0 0.8 43.9 0.0 2.4 22.4 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.3 38.4 0.1 84.6 0.7 42.0 49.0 0.1 0.2 33.6 28.7 1.3 39.2 0.2 0.2 14.8 22.5 0.1 0.7 0.2 0.5 0.2 0.3 3.1 0.5 1.6 1.4 0.7 0.7 10.0 41.7 79.6 0.7 12.4 53.4 31.3 38.1 33.6 0.4 94.3 34.3 0.9 48.6 73.1 25.8 0.0 1.0 39.6 50.2 1.9 73.3 18.5 51.4 13.6 10.9 31.8 1.7 14.4 211.7 3.6 21.2 124.4 118.6 7.0 2.5 5.7 0.6 0.3 0.0 1.8 58.5 48.8 3.0 12.7 32.7 56.8 4.0 60.5 10.3 3.1 3.5 53.5 0.5 1.6 91.7 40.0 12.8 15.6 49.1 13.6 7.5 81.0 0.1 0.0 13.2 4.5 33.8 11.8 45.4 82.5 5.5 111.0 0.1 51.7 86.8 FBLN5 "ARMD3, DANCE, EVEC, UP50" ENSG00000140092 "Fibulin 5" Q9UBX5 14 91869411-91947987 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Age-related macular degeneration, Charcot-Marie-Tooth disease, Disease variant, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Fibroblasts: 209.4;Leydig cells: 626.6;Peritubular cells: 794.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 6.6" "Group enriched" "Detected in many" 19 "granulocytes: 6.6;T-cells: 1.8" "Cell line enhanced" "Detected in many" "ASC diff: 457.1;ASC TERT1: 234.6;BJ: 202.0;BJ hTERT+: 202.5;fHDF/TERT166: 394.6;HSkMC: 216.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000848, HPA000868, CAB025843" Supported Uncertain "Plasma membrane" "Secreted to extracellular matrix" NA NA 12000000 "Cluster 46: Basophils - DNA binding" "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" "CAB025843: , HPA000848: AB_1078620, HPA000868: AB_1078619" "unprognostic (5.53e-3)" "unprognostic (1.14e-1)" "unprognostic (7.78e-2)" "unprognostic (9.29e-2)" "unprognostic (5.55e-3)" "unprognostic (4.73e-2)" "prognostic favorable (6.75e-4)" "unprognostic (5.21e-3)" "unprognostic (4.76e-2)" "unprognostic (1.25e-2)" "unprognostic (3.74e-2)" "unprognostic (1.90e-1)" "unprognostic (7.26e-2)" "unprognostic (1.56e-3)" "unprognostic (1.73e-1)" "unprognostic (5.18e-2)" "unprognostic (3.17e-3)" 182.2 73.4 10.7 17.7 12.8 7.5 110.4 7.4 12.5 124.9 15.7 80.3 19.1 178.4 40.0 26.8 143.0 130.2 211.1 9.4 8.6 108.4 29.3 164.8 25.5 15.5 10.9 107.3 46.4 16.8 14.5 67.0 14.2 49.0 20.6 0.6 55.8 70.9 30.4 66.9 52.7 88.7 13.1 130.9 68.9 35.6 12.7 21.8 79.5 36.0 15.7 117.5 93.3 7.5 0.0 1.6 0.2 0.0 457.1 234.6 22.5 202.0 202.5 5.8 4.5 4.7 0.0 0.0 4.2 394.6 0.6 0.1 9.8 1.0 1.0 0.0 2.3 0.4 4.7 0.0 74.2 0.0 0.1 216.6 0.4 3.9 14.1 2.8 10.4 0.1 0.0 0.1 25.3 0.4 0.5 0.5 0.5 0.0 0.5 0.4 30.2 0.2 1.2 0.1 0.2 0.1 12.3 0.7 2.6 7.0 2.9 0.3 1.9 3.2 6.6 3.8 0.1 0.1 0.0 0.2 0.4 0.0 0.0 6.6 0.1 2.2 0.8 0.2 0.5 0.0 0.3 0.1 0.0 0.1 1.1 1.8 2.5 0.0 0.2 0.0 0.1 0.4 10.7 12.8 7.4 12.5 9.4 8.6 15.5 10.9 14.2 13.1 12.7 7.5 31.4 83.3 13.1 0.0 2.1 9.2 2.4 7.1 1.8 0.0 11.2 9.3 5.2 0.0 11.5 5.5 0.0 2.5 2.5 0.1 5.9 4.7 5.9 13.3 67.4 15.2 0.0 0.4 2.6 4.7 2.5 209.4 2.0 12.0 2.5 1.8 34.2 0.4 7.8 0.0 3.6 0.1 18.3 2.5 18.4 27.5 626.6 5.8 21.4 15.9 1.6 0.0 8.2 5.0 2.3 2.2 0.0 794.8 0.7 1.3 0.0 32.5 21.4 0.0 6.6 28.0 14.5 3.0 2.8 1.3 8.7 3.7 15.5 3.5 0.4 1.2 TRIP11 "CEV14, GMAP-210, GMAP210, Trip230" ENSG00000100815 "Thyroid hormone receptor interactor 11" Q15643 14 91965991-92040896 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002570, HPA070684" Supported Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" Nucleoplasm "HPA002570: AB_1078995, HPA070684: AB_2686295" "unprognostic (1.65e-1)" "unprognostic (2.81e-2)" "unprognostic (7.14e-2)" "unprognostic (1.12e-1)" "unprognostic (6.89e-2)" "unprognostic (1.39e-1)" "unprognostic (3.49e-3)" "unprognostic (1.60e-1)" "unprognostic (1.46e-1)" "unprognostic (7.33e-3)" "unprognostic (2.04e-1)" "unprognostic (1.21e-1)" "prognostic favorable (1.78e-6)" "unprognostic (1.78e-1)" "unprognostic (5.08e-1)" "unprognostic (7.74e-2)" "unprognostic (5.55e-2)" 10.4 10.5 4.7 8.6 8.8 7.6 10.5 10.8 7.4 11.6 13.5 10.1 10.4 9.7 6.7 12.1 7.7 10.1 10.6 3.5 5.4 13.5 12.9 8.0 9.4 6.2 7.3 11.0 25.5 19.2 4.8 11.6 6.8 9.6 9.8 10.6 11.0 8.5 11.8 8.9 7.9 10.2 6.2 8.6 15.3 13.6 6.5 11.2 16.7 15.6 11.4 10.4 5.8 10.7 22.8 22.5 14.4 15.2 24.8 38.1 21.8 35.3 27.0 17.1 19.5 13.8 36.0 15.8 25.3 31.3 13.3 29.1 19.1 17.1 37.0 24.1 5.8 17.9 20.4 13.1 18.9 21.2 17.1 14.7 20.4 30.3 25.8 18.9 27.8 8.7 11.9 17.8 27.0 31.7 12.2 5.2 6.6 22.1 16.0 14.8 27.5 8.0 15.3 36.5 10.5 9.5 28.5 16.6 11.0 14.5 36.2 10.5 36.9 19.8 13.8 20.8 16.1 15.7 25.9 14.2 23.2 11.7 25.3 9.3 9.7 20.2 13.9 9.0 13.6 13.0 14.7 13.1 7.9 23.7 14.2 14.9 9.6 14.8 16.1 14.3 14.5 4.3 4.7 8.8 10.8 7.4 3.5 5.4 6.2 7.3 6.8 6.2 6.5 10.7 66.8 54.5 79.8 57.5 32.5 16.6 30.7 31.7 21.6 61.1 39.9 40.0 115.7 34.3 54.0 38.6 73.0 44.2 41.4 29.8 17.6 72.5 13.6 58.2 81.2 53.9 32.2 30.7 58.1 46.2 32.0 51.7 39.8 56.5 37.9 68.7 32.9 37.5 24.4 43.7 74.7 40.4 32.6 25.7 11.2 14.7 62.1 30.4 7.2 51.5 41.6 56.5 47.4 66.9 92.4 44.7 29.5 54.2 26.3 39.0 31.6 23.4 56.4 70.4 59.2 76.6 50.4 105.0 65.8 19.5 17.0 72.5 30.2 79.8 32.9 35.1 ATXN3 "ATX3, JOS, MJD, SCA3" ENSG00000066427 "Ataxin 3" P54252 14 92044496-92106621 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021976, HPA024123, HPA069338" Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 28: BEWO - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli" "Plasma membrane" "CAB021976: , HPA024123: AB_1845133, HPA069338: AB_2686124" "unprognostic (1.06e-2)" "unprognostic (2.93e-1)" "unprognostic (1.22e-1)" "unprognostic (3.67e-2)" "unprognostic (5.76e-2)" "unprognostic (1.57e-1)" "unprognostic (1.42e-1)" "unprognostic (9.85e-3)" "unprognostic (1.69e-1)" "unprognostic (6.75e-2)" "unprognostic (1.04e-2)" "unprognostic (3.06e-2)" "unprognostic (2.03e-2)" "unprognostic (8.94e-3)" "unprognostic (4.22e-1)" "unprognostic (1.64e-1)" "unprognostic (1.11e-1)" 9.0 5.9 3.8 5.7 4.2 9.9 6.8 4.9 5.0 7.5 3.3 7.3 3.7 6.4 4.3 10.3 6.0 6.5 5.3 3.6 5.0 5.6 9.6 6.8 7.7 6.2 5.7 7.1 4.5 6.4 4.0 7.0 6.2 6.0 6.8 3.9 5.8 5.5 3.3 12.9 4.8 8.6 4.3 5.6 5.2 9.3 4.3 8.0 5.9 5.9 9.8 9.0 8.0 4.9 8.6 16.7 14.6 13.6 20.9 20.1 28.4 9.7 15.4 11.9 16.5 12.3 23.2 17.6 18.5 15.8 14.1 14.6 11.6 21.0 26.3 20.0 3.5 7.4 8.0 18.2 17.3 13.5 12.6 16.5 18.1 20.9 21.8 15.9 18.7 19.4 10.1 12.5 18.2 33.1 14.0 11.9 10.4 28.5 13.6 11.0 27.0 9.9 15.3 19.4 5.3 8.8 23.1 9.5 13.3 19.6 18.1 9.1 10.0 11.7 17.0 7.5 5.2 10.8 19.8 16.2 8.3 12.9 6.9 13.5 14.3 10.8 6.1 16.5 7.4 7.7 7.0 6.9 16.2 10.6 7.8 8.8 12.2 8.7 23.0 9.3 8.1 6.3 3.8 4.2 4.9 5.0 3.6 5.0 6.2 5.7 6.2 4.3 4.3 4.9 55.0 16.0 12.4 33.6 27.6 25.4 28.6 29.8 19.4 35.4 16.9 18.4 19.3 15.7 20.0 42.3 50.1 20.3 31.5 13.8 15.6 25.8 19.8 20.3 34.9 53.0 16.1 30.3 36.1 17.3 29.8 34.6 18.3 22.5 24.6 25.9 49.6 21.1 22.4 26.9 28.6 16.4 12.2 35.1 27.2 26.8 67.7 30.0 23.2 28.1 48.0 20.4 29.9 39.2 51.5 19.6 16.1 65.1 20.1 31.9 16.6 17.7 16.0 46.7 46.0 51.9 38.2 39.1 57.2 21.6 30.3 25.3 28.8 24.8 18.9 28.2 NDUFB1 "CI-MNLL, MNLL" ENSG00000183648 "NADH:ubiquinone oxidoreductase subunit B1" O75438 14 92116122-92121917 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 2435.4;Hepatocytes: 1690.0;Proximal tubular cells: 1614.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063737 Supported Supported "Nuclear speckles,Mitochondria" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 54: Cardiomyocytes - Muscle contraction" Mitochondria "Nuclear speckles" "HPA063737: AB_2685109" "unprognostic (1.12e-2)" "unprognostic (1.31e-3)" "unprognostic (6.70e-2)" "unprognostic (2.67e-2)" "unprognostic (1.28e-1)" "unprognostic (2.54e-2)" "unprognostic (6.91e-2)" "unprognostic (3.74e-3)" "unprognostic (5.35e-3)" "unprognostic (4.55e-3)" "unprognostic (1.18e-2)" "unprognostic (4.15e-2)" "prognostic favorable (1.31e-5)" "unprognostic (7.35e-2)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (5.05e-3)" 260.8 396.4 370.4 109.0 381.4 167.4 231.8 388.5 588.6 178.3 409.2 313.4 165.7 164.9 178.3 281.5 177.1 61.2 1221.5 381.0 401.1 512.7 503.2 182.3 118.4 379.8 374.6 162.7 206.3 373.5 314.7 61.1 383.2 221.5 122.4 260.9 233.5 59.5 862.6 153.6 225.9 69.4 381.2 214.0 292.4 112.3 376.4 230.6 250.4 1053.8 106.1 192.1 202.4 391.0 198.3 388.3 332.5 208.4 219.1 160.7 143.0 243.2 143.7 147.5 135.4 236.9 341.0 187.0 215.7 151.3 205.8 249.6 198.4 212.3 133.9 280.8 425.1 361.3 665.8 308.5 178.2 290.4 196.4 202.5 132.0 159.5 140.7 334.8 136.7 353.7 199.0 370.1 211.8 759.0 286.6 250.0 166.4 779.6 492.1 253.3 309.7 274.2 397.7 491.3 210.8 152.8 486.6 289.7 338.3 277.7 432.0 435.0 291.8 89.3 173.0 181.3 161.7 288.4 477.2 422.0 278.4 208.5 187.9 456.1 566.8 447.5 247.4 409.6 288.5 373.7 361.5 286.0 508.6 306.8 355.4 343.9 721.3 296.6 386.6 604.6 438.9 653.6 370.4 381.4 388.5 588.6 381.0 401.1 379.8 374.6 383.2 381.2 376.4 391.0 158.5 166.7 227.4 11.4 187.4 128.7 102.1 334.5 96.8 84.6 328.2 353.6 2435.4 467.5 237.0 389.9 39.6 260.3 170.4 627.2 1166.1 245.4 175.8 326.0 208.6 188.2 317.4 256.1 18.4 427.7 118.8 203.6 189.6 225.8 215.8 96.2 397.3 1690.0 422.3 55.5 21.7 515.9 268.5 619.8 179.3 57.3 262.5 281.7 332.6 10.3 478.1 223.3 241.0 11.1 15.0 294.4 628.7 241.1 201.6 97.9 845.2 1614.3 337.6 183.3 223.5 172.4 188.2 138.8 151.5 204.5 176.2 205.8 163.7 97.4 540.6 116.3 CPSF2 "CPSF100, KIAA1367" ENSG00000165934 "Cleavage and polyadenylation specific factor 2" Q9P2I0 14 92121969-92172145 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024238 Supported Approved Nucleoplasm,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Vesicles "HPA024238: AB_1847200" "unprognostic (2.31e-1)" "unprognostic (9.80e-2)" "unprognostic (3.73e-2)" "unprognostic (1.77e-2)" "unprognostic (4.95e-2)" "unprognostic (2.14e-2)" "prognostic unfavorable (4.35e-7)" "unprognostic (1.34e-1)" "unprognostic (2.94e-1)" "unprognostic (1.78e-2)" "unprognostic (2.33e-2)" "unprognostic (6.68e-2)" "unprognostic (8.78e-3)" "unprognostic (2.44e-1)" "unprognostic (2.91e-1)" "unprognostic (8.75e-2)" "unprognostic (4.90e-2)" 14.8 14.5 7.3 24.9 9.7 11.5 11.8 9.3 10.1 13.7 13.0 16.1 14.7 15.0 15.0 18.3 11.7 15.0 13.1 6.8 8.9 13.6 19.7 14.7 21.0 9.5 9.2 12.6 14.9 18.2 10.7 16.7 10.6 15.6 16.8 13.9 13.6 14.1 27.1 11.1 14.4 17.8 8.5 18.6 17.4 26.0 8.5 27.3 18.3 25.6 24.8 16.6 12.3 12.2 48.1 46.9 47.0 48.6 23.9 21.1 69.5 60.7 59.0 55.1 54.3 41.4 64.9 51.3 38.9 65.1 37.2 69.2 65.2 55.2 79.2 83.3 22.4 75.4 46.1 39.5 70.5 76.3 60.6 34.7 46.2 52.5 93.8 36.5 52.2 54.5 68.8 62.9 62.1 69.6 88.3 26.8 53.3 76.8 42.3 86.0 72.7 45.9 37.5 67.1 51.7 34.7 71.7 39.9 51.1 41.9 82.9 47.4 56.3 43.9 27.7 33.4 52.4 37.6 66.2 103.0 53.0 58.9 69.7 16.6 12.9 9.3 7.8 11.7 10.4 7.6 6.9 8.4 11.3 4.0 6.1 8.6 4.4 11.1 9.8 7.3 12.1 9.5 7.3 9.7 9.3 10.1 6.8 8.9 9.5 9.2 10.6 8.5 8.5 12.2 14.2 28.9 31.8 23.2 22.9 10.3 15.2 15.1 15.9 12.7 13.4 9.5 27.1 10.0 25.5 7.3 29.2 24.0 19.8 14.6 13.7 18.0 28.2 24.3 30.0 22.9 13.8 33.0 13.6 24.0 22.7 20.0 17.3 16.8 30.4 26.2 20.7 27.2 24.8 11.8 17.5 17.3 12.2 32.9 8.8 11.2 19.0 31.1 3.6 19.7 41.2 16.9 27.8 18.6 27.9 23.8 14.0 23.0 35.4 29.9 12.5 16.3 34.1 22.7 32.9 19.6 23.2 61.7 41.3 27.2 12.8 25.3 22.8 26.6 18.2 20.2 SLC24A4 NCKX4 ENSG00000140090 "Solute carrier family 24 member 4" Q8NFF2 14 92322581-92501481 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Olfaction, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport" "Amelogenesis imperfecta, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "choroid plexus: 92.6" "Group enriched" "Detected in some" 4 "Bipolar cells: 251.6;Cone photoreceptor cells: 200.1" "Group enriched" "Detected in some" 5 "glioma: 0.5;melanoma: 0.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 11.1;intermediate monocyte: 14.7;non-classical monocyte: 11.6" "Lineage enriched" "Detected in many" 5 "monocytes: 14.7" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063206 Approved "Plasma membrane" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 56: Bipolar cells - Visual perception" "Plasma membrane" "HPA063206: " "unprognostic (1.53e-1)" "unprognostic (1.41e-1)" "unprognostic (2.22e-1)" "unprognostic (1.18e-1)" "unprognostic (1.06e-1)" "unprognostic (3.43e-3)" "unprognostic (1.34e-1)" "unprognostic (2.04e-3)" "unprognostic (3.40e-2)" "unprognostic (1.32e-1)" "unprognostic (2.48e-3)" "unprognostic (3.21e-1)" "unprognostic (1.48e-3)" "unprognostic (1.25e-1)" "unprognostic (1.08e-1)" "unprognostic (1.90e-2)" "unprognostic (1.58e-2)" 0.5 0.2 7.1 1.4 10.3 3.5 0.1 17.5 8.1 0.2 92.6 0.2 0.2 0.1 0.1 0.2 0.2 0.6 0.2 7.2 5.3 0.0 0.1 0.8 1.2 22.7 14.1 0.2 0.1 0.0 1.4 0.3 19.1 0.2 0.2 12.3 0.1 0.3 0.8 0.1 0.3 0.4 14.7 2.7 0.1 1.1 16.5 0.4 0.1 1.0 0.4 0.3 0.2 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 11.1 0.0 0.0 14.7 0.2 0.0 0.0 0.0 3.0 0.1 0.0 0.0 1.5 0.1 11.6 0.5 0.0 2.7 7.1 10.3 17.5 8.1 7.2 5.3 22.7 14.1 19.1 14.7 16.5 12.9 0.8 0.0 1.9 47.0 0.4 0.0 0.1 0.0 0.0 251.6 0.3 0.1 1.8 0.0 0.0 0.0 200.1 0.0 0.1 0.0 0.0 0.0 4.0 0.5 0.1 0.9 0.0 0.8 19.9 0.0 0.1 0.5 0.0 0.8 0.0 0.0 1.1 0.0 4.0 0.0 28.5 0.0 0.0 22.2 1.8 5.6 0.3 16.6 0.0 2.8 44.3 4.1 1.0 10.1 1.3 0.1 0.0 0.4 0.1 0.2 0.0 0.2 0.7 10.6 0.0 9.9 0.2 0.1 1.6 0.0 0.0 0.3 0.3 0.0 0.0 0.1 RIN3 FLJ22439 ENSG00000100599 "Ras and Rab interactor 3" Q8TB24 14 92513781-92688994 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 46.3" "Cell type enhanced" "Detected in many" "Kupffer cells: 125.1;Macrophages: 78.7;Microglial cells: 100.2;monocytes: 109.8;NK-cells: 114.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 35.7;classical monocyte: 43.4;eosinophil: 54.1;intermediate monocyte: 40.4;myeloid DC: 41.6;neutrophil: 40.2;NK-cell: 21.5;non-classical monocyte: 50.8" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "HMC-1: 108.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA079218 Approved NA NA 7400 "Cluster 52: Eosinophils - Transcription" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "HPA079218: " "unprognostic (1.06e-1)" "unprognostic (1.33e-1)" "unprognostic (1.93e-1)" "unprognostic (1.87e-1)" "unprognostic (7.18e-2)" "unprognostic (6.40e-2)" "unprognostic (2.44e-1)" "unprognostic (1.14e-1)" "unprognostic (1.32e-1)" "unprognostic (3.07e-3)" "unprognostic (5.69e-3)" "unprognostic (5.13e-2)" "unprognostic (5.90e-3)" "unprognostic (2.88e-2)" "unprognostic (6.95e-2)" "unprognostic (1.20e-1)" "unprognostic (1.33e-1)" 10.5 13.6 4.3 9.6 3.6 46.3 8.1 4.1 5.3 7.3 2.8 19.1 6.6 15.4 1.6 6.7 8.7 8.1 8.6 4.4 6.6 4.5 12.4 16.3 6.1 9.6 5.9 6.7 2.2 5.4 2.7 6.4 7.0 7.0 4.8 0.2 5.1 5.1 3.2 5.3 9.7 10.2 7.5 22.8 6.4 5.2 9.1 10.9 5.0 2.9 5.3 10.6 8.6 8.6 10.3 19.8 4.4 1.7 1.7 14.3 15.0 12.9 14.0 12.0 8.0 7.5 17.5 0.0 12.1 19.1 8.2 22.0 3.1 0.1 5.5 10.6 3.9 21.4 1.5 8.1 8.7 6.9 108.1 8.1 7.7 11.5 4.8 4.7 7.1 2.6 3.1 0.5 5.0 6.5 3.3 16.3 2.7 1.1 6.0 2.7 2.1 0.2 4.9 6.9 1.0 0.0 6.2 2.1 9.5 4.3 0.1 2.5 12.5 13.8 10.8 20.1 10.9 3.1 0.0 0.2 13.5 0.3 18.1 35.7 43.4 54.1 10.1 40.4 3.4 7.8 4.7 4.9 41.6 8.5 6.8 7.7 40.2 21.5 50.8 1.8 3.0 24.5 4.3 3.6 4.1 5.3 4.4 6.6 9.6 5.9 7.0 7.5 9.1 8.6 19.2 0.0 8.9 18.3 28.2 3.8 2.0 3.4 0.6 2.2 3.7 5.5 4.7 1.5 2.2 0.0 0.0 5.1 44.0 9.2 0.0 1.6 10.2 2.2 3.5 15.4 0.0 12.6 6.9 1.4 3.1 4.2 1.1 2.6 51.4 5.4 8.2 14.9 49.3 0.0 5.2 7.3 4.1 125.1 50.8 6.6 5.3 78.7 12.4 100.2 109.8 0.0 114.4 20.6 0.9 10.1 3.8 18.8 9.7 3.8 9.5 6.2 2.5 0.3 13.1 10.1 4.6 19.1 4.0 1.1 2.7 12.7 32.5 1.9 8.9 3.6 LGMN "LGMN1, PRSC1" ENSG00000100600 Legumain Q99538 14 92703807-92748679 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 1448.9;Macrophages: 346.1;Syncytiotrophoblasts: 416.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 11 "plasmacytoid DC: 209.2" "Lineage enriched" "Detected in all" 12 "dendritic cells: 209.2" "Cell line enhanced" "Detected in many" "RPMI-8226: 898.6;U-266/70: 462.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001426 Enhanced Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 2000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 1: Thyroid gland - Transcription" "Cluster 25: RPMI-8226 - Immune response" "Cluster 4: Macrophages - Innate immune response" Vesicles Nucleoplasm "HPA001426: AB_1079247" "unprognostic (1.19e-1)" "unprognostic (1.16e-1)" "unprognostic (2.37e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (3.29e-2)" "unprognostic (4.52e-2)" "unprognostic (1.31e-1)" "unprognostic (5.03e-2)" "unprognostic (3.50e-2)" "unprognostic (4.70e-2)" "unprognostic (2.47e-1)" "prognostic favorable (4.70e-4)" "unprognostic (8.06e-2)" "unprognostic (3.64e-2)" "unprognostic (7.18e-3)" "unprognostic (7.24e-2)" 173.7 44.4 37.6 82.2 38.6 20.6 69.7 31.7 60.8 52.6 51.2 102.5 110.4 30.8 36.8 64.5 36.6 145.8 85.3 40.0 40.3 205.9 111.1 107.3 177.0 35.6 37.3 33.0 37.9 247.0 24.9 262.1 42.4 51.9 105.9 19.7 56.4 32.2 50.4 32.7 97.6 65.0 35.9 202.2 107.0 29.8 62.8 52.8 93.2 50.4 54.9 144.7 52.1 49.4 33.2 47.5 30.8 57.4 94.3 76.0 108.4 70.3 67.0 71.7 84.2 36.9 58.6 18.2 101.5 116.5 44.3 81.5 0.0 60.8 33.7 1.6 36.2 1.2 24.4 42.8 27.7 1.0 2.7 54.2 29.1 68.4 39.4 21.3 82.1 33.7 7.4 150.9 5.2 45.2 8.9 1.2 15.1 208.2 32.1 8.4 27.1 898.6 59.2 129.1 33.6 23.2 97.9 59.4 53.0 66.8 43.9 0.6 47.2 35.3 44.8 64.5 21.8 462.5 58.0 25.0 20.0 0.2 69.1 1.9 1.6 0.1 0.8 3.1 1.6 17.0 5.1 1.3 19.3 14.5 15.2 9.0 1.6 3.7 1.0 209.2 9.7 7.0 37.6 38.6 31.7 60.8 40.0 40.3 35.6 37.3 42.4 35.9 62.8 49.4 34.9 57.7 128.0 8.8 33.9 23.1 37.5 36.0 22.2 10.6 31.2 37.6 29.8 42.9 48.1 31.3 93.8 181.8 24.5 64.2 9.8 61.3 1.3 79.4 23.5 38.3 36.5 22.7 19.2 50.6 140.2 63.8 73.4 177.7 8.8 17.6 276.3 46.4 1448.9 13.5 41.0 31.1 95.6 317.6 89.0 3.3 30.4 346.1 48.0 27.2 37.5 23.6 2.1 10.6 15.2 50.5 57.1 57.9 24.7 44.6 163.4 220.4 20.9 19.8 19.7 40.4 62.1 19.9 17.6 22.3 17.5 416.3 8.2 15.1 48.3 44.7 GOLGA5 "golgin-84, GOLIM5, ret-II, rfg5" ENSG00000066455 "Golgin A5" Q8TBA6 14 92794305-92839947 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000992, HPA063876" Enhanced Supported Supported "Golgi apparatus" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA000992: AB_1079009, HPA063876: AB_2685140" "unprognostic (2.06e-1)" "unprognostic (1.76e-1)" "unprognostic (1.57e-1)" "unprognostic (2.64e-1)" "unprognostic (1.73e-1)" "unprognostic (2.77e-2)" "unprognostic (1.68e-1)" "unprognostic (3.15e-1)" "unprognostic (1.78e-1)" "unprognostic (5.02e-2)" "unprognostic (1.15e-2)" "unprognostic (2.83e-2)" "unprognostic (7.67e-2)" "unprognostic (6.44e-2)" "unprognostic (1.76e-1)" "unprognostic (1.06e-2)" "unprognostic (2.49e-2)" 26.0 23.3 21.4 18.2 23.7 10.4 33.1 22.4 26.4 32.2 23.9 26.4 23.3 21.9 54.2 25.0 19.2 24.0 21.5 20.8 22.3 25.5 54.3 22.4 18.8 22.6 22.4 20.6 32.2 33.6 23.5 28.2 23.1 31.2 32.5 15.8 32.4 25.8 26.9 23.3 22.9 26.0 22.6 19.1 32.9 34.3 22.1 16.9 33.2 20.0 23.3 24.1 19.6 25.9 32.4 29.4 25.9 23.7 53.1 71.4 44.3 43.9 80.4 41.9 49.2 21.8 43.4 21.0 35.1 70.2 29.2 33.4 23.1 35.9 56.6 25.8 11.2 19.9 14.0 29.3 61.5 23.3 31.8 55.1 63.7 29.5 60.6 46.2 42.0 21.8 17.7 27.3 46.5 60.1 18.1 19.6 16.1 70.2 31.0 13.9 37.9 21.1 42.8 38.9 18.4 26.0 40.0 29.6 45.7 35.7 51.0 25.6 35.0 23.9 15.6 31.3 22.2 33.3 27.6 18.2 54.9 18.2 40.8 10.4 10.0 23.6 10.3 13.0 11.8 9.5 10.4 10.6 9.9 9.5 9.2 8.1 8.8 8.7 11.9 9.1 12.9 6.7 21.4 23.7 22.4 26.4 20.8 22.3 22.6 22.4 23.1 22.6 22.1 25.9 18.7 28.9 26.3 8.8 15.7 7.8 11.2 17.9 16.5 7.5 16.2 11.9 26.8 8.6 19.6 14.7 12.5 23.7 17.2 23.8 29.4 25.3 31.6 17.6 24.6 16.7 22.3 15.8 17.6 32.7 32.0 21.7 33.1 25.7 9.5 29.7 13.9 33.5 15.4 25.2 15.6 31.6 4.1 14.7 10.3 18.5 23.0 14.6 12.4 15.0 18.2 15.6 16.5 14.6 21.9 28.9 12.0 25.2 29.2 19.4 19.9 24.2 18.7 10.7 26.3 18.0 19.3 34.1 37.0 16.5 11.4 50.3 15.9 15.6 16.5 16.5 CHGA ENSG00000100604 "Chromogranin A" P10645 14 92923150-92935285 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, Fungicide" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "parathyroid gland: 6568.4" "Cell type enriched" "Detected in many" 7 "Enteroendocrine cells: 6553.1" "Cancer enhanced" "Detected in many" "pancreatic cancer: 114.8" "Group enriched" "Detected in many" 16 "cerebral cortex: 326.0;white matter: 124.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 151 "SCLC-21H: 489.5;SH-SY5Y: 1339.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000023, HPA017369, CAB040544, CAB055506, CAB058688" Enhanced Supported Vesicles "Intracellular and membrane" NA NA 295000000 100000000 "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 17: Intestinal endocrine cells - Hormone signaling" Vesicles "CAB000023: , CAB040544: , CAB055506: AB_2081135, CAB058688: AB_2665574, HPA017369: AB_1846698" "prognostic favorable (7.85e-5)" "unprognostic (4.89e-2)" "unprognostic (5.96e-2)" "unprognostic (1.17e-1)" "unprognostic (1.43e-2)" "unprognostic (5.95e-2)" "prognostic unfavorable (2.40e-4)" "unprognostic (1.74e-1)" "unprognostic (2.23e-1)" "unprognostic (4.56e-2)" "prognostic favorable (4.07e-4)" "unprognostic (1.85e-1)" "unprognostic (8.81e-13)" "unprognostic (1.07e-2)" "unprognostic (1.77e-1)" "unprognostic (9.17e-2)" "prognostic unfavorable (3.99e-4)" 14.5 1248.5 8.6 9.4 11.4 0.2 0.3 0.0 326.0 8.3 0.0 92.0 242.7 0.4 0.3 1.0 1.1 0.2 0.2 4.4 1.7 1.0 0.4 1.6 0.1 14.4 0.0 0.2 102.5 6568.4 446.2 0.0 4.1 12.2 105.2 11.0 0.2 0.3 0.1 0.6 179.9 0.9 0.0 0.1 364.5 77.7 4.3 0.6 24.6 0.0 0.0 1.3 1.2 124.4 0.0 0.5 2.4 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.8 2.7 0.0 0.0 0.2 0.0 1.4 0.0 0.0 489.5 1339.4 0.0 0.4 0.1 0.0 0.1 0.1 0.0 0.0 4.2 0.3 0.4 0.0 0.0 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 11.4 0.0 326.0 4.4 1.7 14.4 0.0 4.1 0.0 4.3 124.4 0.1 0.0 0.0 11.1 1.0 0.9 0.4 0.0 0.0 17.3 0.2 0.3 2.9 0.0 0.0 0.0 29.2 0.3 0.0 9.8 0.0 0.1 1.3 6.0 2.3 0.8 6553.1 0.0 59.5 0.4 0.1 4.1 195.7 0.5 0.0 0.5 0.0 0.0 1.5 16.8 37.7 820.4 14.2 0.0 0.0 7.9 39.7 0.1 7.2 15.9 2.0 3.7 0.0 10.6 12.8 46.5 137.8 137.3 0.0 6.6 36.7 0.0 0.0 16.2 0.0 0.0 0.2 4.7 2.2 0.0 0.0 0.3 0.2 0.4 25.9 5.1 ITPK1 ENSG00000100605 "Inositol-tetrakisphosphate 1-kinase" Q13572 14 92936914-93116320 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Isomerase, Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 106.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 42.9" "Group enriched" "Detected in all" 5 "granulocytes: 42.9;monocytes: 25.9" "Cell line enhanced" "Detected in all" "WM-115: 110.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055230 Approved Approved Mitochondria NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 17: WM-115 - Nervous system development" "Cluster 45: Enterocytes - Digestion" Mitochondria "HPA055230: AB_2682748" "unprognostic (1.93e-3)" "unprognostic (2.50e-1)" "unprognostic (2.15e-1)" "prognostic favorable (8.56e-4)" "unprognostic (4.27e-1)" "unprognostic (2.04e-2)" "unprognostic (6.97e-2)" "unprognostic (1.32e-1)" "unprognostic (1.24e-2)" "unprognostic (2.86e-2)" "unprognostic (8.14e-2)" "unprognostic (2.27e-1)" "unprognostic (1.37e-3)" "unprognostic (2.39e-1)" "unprognostic (2.02e-1)" "unprognostic (4.20e-1)" "unprognostic (7.25e-3)" 60.0 27.2 88.3 15.5 105.9 17.3 45.3 84.7 92.7 57.0 57.2 60.1 44.4 66.8 11.6 24.8 30.3 19.4 59.2 92.5 80.7 35.6 48.3 31.6 9.0 90.2 95.8 27.1 30.7 14.8 20.6 6.8 83.0 38.8 16.4 9.3 21.0 21.7 40.9 22.2 58.5 23.4 83.2 38.1 34.2 29.5 100.4 6.9 25.4 16.1 6.6 62.5 35.0 100.7 28.1 56.6 10.3 26.3 22.5 12.6 27.8 11.8 17.5 22.9 13.8 32.8 48.9 17.7 57.4 18.6 8.7 32.5 29.6 50.3 7.2 65.9 13.1 39.2 14.6 28.5 16.8 17.9 41.5 8.2 29.5 11.6 26.3 9.9 22.8 18.0 21.9 19.8 11.3 74.6 15.5 25.5 22.0 36.4 25.5 29.1 15.1 26.3 15.5 46.3 28.0 35.5 29.6 59.0 49.5 7.8 79.5 21.7 18.0 15.9 17.3 27.0 18.9 19.3 19.1 11.4 14.6 13.8 110.8 5.3 9.8 18.2 3.2 15.4 1.9 3.3 2.0 2.1 7.0 1.0 1.2 2.2 42.9 2.4 25.9 3.5 3.0 5.1 88.3 105.9 84.7 92.7 92.5 80.7 90.2 95.8 83.0 83.2 100.4 100.7 11.8 12.8 11.1 32.0 10.8 7.4 7.5 8.3 2.8 10.2 11.8 7.6 24.3 17.2 5.1 29.5 18.8 9.7 12.9 73.5 13.7 19.2 12.7 18.1 12.5 12.4 28.8 5.9 45.1 27.3 10.0 8.9 13.3 21.2 16.5 9.2 13.9 31.3 19.4 6.7 21.6 24.8 4.1 44.7 11.8 30.3 14.9 30.5 26.6 16.9 23.2 17.2 18.6 31.7 46.5 44.6 38.7 48.2 13.2 15.2 106.6 23.0 3.3 13.7 19.7 7.4 17.8 4.3 14.3 7.0 4.4 6.8 12.7 10.3 34.5 11.0 MOAP1 "MAP-1, PNMA4" ENSG00000165943 "Modulator of apoptosis 1" Q96BY2 14 93182199-93184923 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000939, HPA076948" Enhanced Approved "Nucleoplasm,Cell Junctions" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 58: Brain - Synaptic function" "Cluster 21: OE19 - Mitochondria" "Cluster 56: Bipolar cells - Visual perception" Nucleoplasm "Cell Junctions" "HPA000939: AB_1079402, HPA076948: " "unprognostic (9.40e-3)" "unprognostic (1.26e-1)" "unprognostic (1.57e-1)" "unprognostic (7.52e-2)" "unprognostic (1.21e-1)" "unprognostic (8.75e-2)" "unprognostic (1.01e-1)" "prognostic favorable (7.37e-9)" "unprognostic (1.98e-1)" "unprognostic (6.52e-2)" "unprognostic (1.05e-3)" "unprognostic (1.58e-2)" "prognostic favorable (3.15e-6)" "unprognostic (6.93e-2)" "unprognostic (1.21e-1)" "unprognostic (1.61e-1)" "unprognostic (9.27e-2)" 17.7 32.2 39.9 11.3 39.8 40.5 19.0 17.8 54.6 25.8 9.4 36.2 13.9 20.9 26.8 17.4 24.0 17.1 55.8 46.4 59.2 30.8 20.3 21.5 19.4 30.1 25.1 19.1 19.3 45.7 37.0 16.2 39.9 32.4 15.9 92.4 20.9 30.6 44.2 17.5 22.2 22.3 22.1 19.2 26.6 10.3 33.7 23.2 24.1 34.6 17.6 24.1 12.3 38.8 9.8 8.2 19.1 25.0 16.3 6.4 11.1 10.2 14.4 12.4 11.5 8.4 8.9 30.4 19.7 14.6 8.5 16.5 13.9 12.7 13.9 10.7 15.8 16.2 17.4 11.5 19.7 15.8 25.0 9.3 18.4 7.6 13.4 30.3 15.9 35.6 6.2 15.6 11.5 40.4 24.1 10.8 7.5 20.8 8.6 12.7 23.3 14.7 29.4 28.7 36.7 31.0 9.1 16.4 48.4 14.8 25.3 12.1 14.6 4.1 5.6 9.9 5.1 30.9 31.3 15.1 12.8 10.2 7.5 53.5 5.9 19.6 15.5 6.9 19.8 6.8 19.1 19.4 6.2 11.9 23.1 21.1 6.1 16.1 8.8 5.4 16.6 12.1 39.9 39.8 17.8 54.6 46.4 59.2 30.1 25.1 39.9 22.1 33.7 38.8 20.4 32.1 32.1 11.8 21.8 16.2 18.2 11.4 13.1 91.8 18.7 12.4 71.9 24.3 13.9 20.2 50.1 28.9 33.7 10.2 41.1 36.2 4.7 26.5 15.3 18.2 48.5 9.9 37.4 15.1 5.7 16.3 12.2 60.6 27.8 36.0 16.8 8.2 16.5 84.1 35.0 21.0 34.6 13.7 9.8 1.7 17.7 15.9 12.4 12.2 16.1 85.4 50.4 18.1 16.3 22.3 7.5 27.4 15.8 21.2 15.7 19.4 7.5 96.0 19.7 15.5 21.8 27.9 22.2 10.5 15.5 47.7 28.2 23.7 16.2 23.9 TMEM251 "C14orf109, DKFZP564F1123" ENSG00000153485 "Transmembrane protein 251" Q8N6I4 14 93184951-93188463 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 113.5;Hofbauer cells: 110.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048559 Uncertain Approved "Golgi apparatus,Cell Junctions" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 4: Macrophages - Innate immune response" "Cell Junctions" "Golgi apparatus" "HPA048559: AB_2680441" "unprognostic (1.21e-2)" "unprognostic (4.56e-2)" "unprognostic (4.61e-3)" "unprognostic (3.37e-2)" "unprognostic (2.14e-1)" "unprognostic (4.03e-2)" "prognostic unfavorable (6.14e-7)" "unprognostic (1.67e-2)" "unprognostic (1.88e-1)" "unprognostic (9.99e-3)" "unprognostic (5.80e-3)" "unprognostic (1.58e-1)" "prognostic favorable (1.10e-4)" "unprognostic (5.17e-2)" "unprognostic (1.61e-1)" "unprognostic (7.47e-2)" "unprognostic (6.17e-2)" 16.6 22.9 7.3 6.4 7.8 2.7 16.9 7.9 10.0 15.5 8.2 22.9 10.3 14.2 16.5 13.1 14.7 6.7 25.6 7.6 7.6 33.2 17.2 17.1 8.0 7.7 7.8 14.2 21.2 10.3 19.8 6.9 7.8 25.7 12.5 20.7 19.6 9.2 30.6 13.7 18.1 6.8 7.4 15.9 21.8 8.4 8.1 8.6 17.6 12.4 6.9 17.2 12.8 9.0 11.0 12.1 15.3 16.1 17.2 7.3 9.4 7.9 8.2 12.7 16.2 7.8 11.1 12.1 12.9 7.9 15.9 15.9 17.8 12.6 17.7 9.3 13.4 10.9 8.8 18.3 15.2 16.0 14.7 9.3 14.6 10.0 16.2 6.8 12.2 13.5 9.3 12.0 11.6 52.5 10.2 12.8 8.3 28.0 11.6 4.7 16.0 11.3 16.6 23.6 12.9 13.4 11.7 6.0 36.9 12.4 17.7 11.4 5.0 6.1 10.8 14.6 9.4 9.3 16.0 11.8 11.4 6.1 9.1 6.8 9.7 13.6 3.9 9.4 2.9 4.7 4.6 4.4 8.0 5.5 5.2 5.9 10.5 5.3 13.0 7.3 4.1 4.2 7.3 7.8 7.9 10.0 7.6 7.6 7.7 7.8 7.8 7.4 8.1 9.0 13.4 3.2 14.4 5.2 22.4 23.2 37.9 33.6 13.1 14.8 41.1 39.1 22.5 32.9 22.0 31.3 27.1 36.6 16.5 44.8 113.5 30.3 1.8 33.1 16.3 11.9 15.0 11.3 5.9 26.6 21.1 16.6 20.9 35.7 17.2 15.2 8.9 19.2 110.1 13.5 7.8 36.1 26.4 28.4 20.0 2.3 11.8 39.6 32.0 2.8 16.2 34.8 12.3 5.0 13.8 17.7 23.8 10.9 13.1 43.3 31.7 69.6 17.2 30.6 39.5 13.9 23.2 4.5 17.8 18.1 31.1 27.4 16.1 17.6 30.9 36.4 AL110118.1 ENSG00000259066 "Novel protein" 14 93184973-93218586 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 6: Non-specific - Transcription" "unprognostic (5.50e-2)" "unprognostic (9.26e-2)" "unprognostic (2.37e-1)" "unprognostic (4.03e-1)" "unprognostic (2.81e-2)" "unprognostic (1.75e-1)" "unprognostic (2.62e-1)" "unprognostic (2.69e-2)" "unprognostic (3.48e-1)" "unprognostic (1.13e-1)" "unprognostic (3.26e-2)" "unprognostic (3.51e-2)" "unprognostic (5.61e-3)" "unprognostic (1.08e-1)" "unprognostic (5.86e-2)" "unprognostic (1.18e-3)" "unprognostic (6.11e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GON7 C14orf142 ENSG00000170270 "GON7 subunit of KEOPS complex" Q9BXV9 14 93202894-93207065 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 68.4;Endometrial ciliated cells: 187.5;Proximal tubular cells: 51.8;Respiratory ciliated cells: 94.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 6.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051832 Approved Supported "Nucleoplasm,Nucleoli rim" NA NA 41000 "Cluster 41: Basophils - Cellular respiration" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Nucleoli rim" "HPA051832: AB_2681628" "unprognostic (2.28e-2)" "unprognostic (1.96e-3)" "unprognostic (2.79e-2)" "unprognostic (1.45e-3)" "unprognostic (3.43e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.53e-5)" "unprognostic (3.40e-3)" "unprognostic (8.82e-2)" "unprognostic (1.45e-3)" "unprognostic (2.47e-3)" "unprognostic (7.37e-2)" "prognostic favorable (3.08e-4)" "unprognostic (2.96e-1)" "unprognostic (1.17e-1)" "unprognostic (2.67e-1)" "unprognostic (2.77e-1)" 6.9 13.2 9.0 5.8 8.8 0.4 8.3 8.6 11.5 12.1 15.8 13.9 13.2 5.4 23.3 6.8 35.4 7.2 14.7 9.0 10.1 17.8 12.9 8.8 1.9 9.8 9.4 5.6 10.4 12.6 12.8 5.6 10.2 7.9 12.0 13.4 7.9 5.7 13.4 4.9 10.2 5.2 8.6 8.8 9.1 8.7 9.6 3.7 8.7 12.9 9.9 6.9 5.7 9.1 11.6 9.2 13.3 8.9 9.2 21.4 9.3 11.0 6.2 21.6 17.5 9.1 18.1 4.7 7.2 7.0 12.6 18.2 18.3 9.2 25.1 0.1 0.0 4.6 22.5 22.6 4.7 9.7 19.6 4.1 11.9 15.1 9.7 6.0 13.3 5.5 16.7 1.5 9.3 26.8 11.3 23.4 3.4 49.6 4.3 20.0 12.9 21.4 23.4 12.9 15.8 19.8 8.2 20.4 24.8 11.8 16.8 19.9 13.6 7.6 15.1 16.5 6.2 10.0 29.6 3.1 23.2 10.8 13.2 6.2 0.9 0.4 0.8 1.7 0.1 0.0 0.5 0.6 1.5 0.7 0.2 0.4 0.9 0.3 0.8 0.2 0.8 0.5 9.0 8.8 8.6 11.5 9.0 10.1 9.8 9.4 10.2 8.6 9.6 9.1 17.2 6.4 13.6 0.0 7.2 0.0 0.0 0.0 0.0 0.0 19.7 23.9 0.0 0.0 9.9 14.7 0.0 19.6 12.7 0.0 68.4 27.7 0.0 187.5 15.8 7.3 0.0 0.0 0.0 21.7 18.1 5.8 0.0 27.4 10.1 9.4 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 17.5 0.0 0.0 1.4 0.0 0.0 51.8 94.7 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 7.7 7.0 21.3 0.0 0.0 UBR7 C14orf130 ENSG00000012963 "Ubiquitin protein ligase E3 component n-recognin 7" Q8N806 14 93207241-93229215 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 8 "Early spermatids: 300.9;Late spermatids: 372.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000861 Approved Approved Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 63: T-cells - Adaptive immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "HPA000861: AB_1078321" "unprognostic (9.60e-2)" "unprognostic (5.12e-3)" "unprognostic (1.11e-1)" "unprognostic (9.20e-2)" "unprognostic (3.30e-1)" "unprognostic (2.12e-1)" "prognostic unfavorable (8.12e-5)" "unprognostic (1.14e-1)" "unprognostic (9.83e-2)" "unprognostic (1.04e-2)" "unprognostic (4.30e-2)" "unprognostic (5.94e-2)" "prognostic favorable (9.76e-5)" "unprognostic (3.61e-2)" "unprognostic (2.91e-1)" "unprognostic (2.86e-1)" "unprognostic (1.78e-1)" 12.7 10.4 16.9 13.2 19.1 21.1 19.1 16.3 20.2 17.6 17.7 16.9 11.8 14.4 14.0 13.0 14.4 13.1 22.0 18.8 15.9 16.6 15.1 12.7 22.2 15.3 16.1 17.6 22.9 25.7 8.9 10.3 16.0 14.6 18.3 24.3 12.7 15.3 17.5 15.7 13.2 15.3 17.1 14.1 14.2 19.0 17.3 34.0 16.8 25.9 27.3 13.6 10.9 18.8 26.1 33.0 52.2 44.2 24.2 24.0 18.6 54.0 38.6 57.1 43.9 23.5 28.2 60.9 42.6 28.3 26.0 30.7 55.8 30.1 60.7 46.4 29.2 45.7 33.1 23.7 11.2 65.7 47.5 15.5 20.7 33.8 21.2 21.7 33.1 54.8 41.5 60.5 57.7 77.3 104.5 35.7 24.1 69.4 61.9 81.9 92.9 33.6 20.6 42.0 65.3 45.4 39.5 32.1 16.3 31.1 58.4 44.6 24.0 43.1 23.0 37.0 56.3 69.0 103.4 61.1 37.0 49.8 38.7 34.5 11.3 18.2 17.8 14.2 19.5 26.4 16.4 16.4 11.4 20.4 13.6 15.1 16.6 18.1 18.3 15.0 26.7 13.4 16.9 19.1 16.3 20.2 18.8 15.9 15.3 16.1 16.0 17.1 17.3 18.8 13.8 16.0 6.4 9.4 16.1 19.9 8.3 8.0 6.8 6.1 11.6 11.0 19.7 11.5 8.5 11.0 10.4 12.3 15.1 15.6 11.7 9.9 300.9 8.2 8.5 11.0 5.4 20.2 16.3 12.9 15.2 12.0 9.7 9.1 5.1 8.8 12.8 11.3 14.0 3.3 12.7 8.4 12.2 10.7 10.9 372.2 9.3 9.0 14.2 7.5 9.3 13.5 13.4 10.6 13.9 8.9 5.4 12.4 26.0 4.7 10.3 9.3 5.5 13.9 6.6 11.2 10.1 38.7 23.2 10.7 13.5 6.6 12.4 6.2 12.4 6.0 BTBD7 "FLJ10648, FUP1" ENSG00000011114 "BTB domain containing 7" Q9P203 14 93237550-93333092 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 175.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049926, HPA053406" Uncertain Approved "Focal adhesion sites" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 23: Testis - Cell cycle regulation" "Cluster 15: RT4 - Unknown function" "Cluster 44: Endometrium - Transcription" "Focal adhesion sites" "HPA049926: AB_2680956, HPA053406: AB_2682137" "unprognostic (3.36e-1)" "unprognostic (4.36e-2)" "unprognostic (1.04e-2)" "unprognostic (1.01e-1)" "unprognostic (7.74e-2)" "unprognostic (1.16e-1)" "unprognostic (1.67e-2)" "unprognostic (2.69e-1)" "unprognostic (6.55e-2)" "unprognostic (1.31e-1)" "unprognostic (8.97e-3)" "unprognostic (4.34e-2)" "prognostic favorable (1.69e-6)" "unprognostic (7.27e-2)" "unprognostic (1.97e-1)" "unprognostic (4.72e-2)" "unprognostic (9.52e-2)" 3.9 2.7 1.2 2.2 2.1 5.6 3.4 3.6 1.8 3.4 0.0 3.3 1.8 3.5 1.5 4.5 3.4 2.0 3.1 1.2 2.7 3.9 2.9 3.8 1.2 3.0 3.1 3.5 3.4 4.0 1.9 2.6 2.6 2.9 2.3 2.5 3.6 1.7 4.7 4.1 3.3 2.1 1.7 2.3 3.0 8.0 3.6 1.2 3.5 1.6 1.4 3.5 3.9 4.1 6.6 4.0 5.2 1.8 2.9 2.5 9.0 6.0 3.8 5.0 3.0 4.5 4.9 4.3 4.9 6.5 3.6 6.1 4.6 10.4 7.7 5.1 3.5 2.9 2.5 3.3 1.7 7.6 3.6 3.6 2.0 5.1 7.3 3.8 7.5 1.7 3.1 3.5 5.2 7.2 2.0 2.9 3.2 3.3 11.2 5.9 7.6 0.9 6.1 15.5 6.7 6.2 7.9 3.0 2.1 5.6 5.3 5.4 8.9 4.2 4.3 3.0 5.3 2.5 3.5 3.9 2.1 2.1 3.0 0.8 0.1 1.3 0.3 0.2 0.1 0.6 0.2 0.3 0.1 0.4 0.1 0.2 0.5 0.1 0.3 0.4 0.4 0.0 1.2 2.1 3.6 1.8 1.2 2.7 3.0 3.1 2.6 1.7 3.6 4.1 53.6 51.3 27.7 76.4 29.0 32.4 29.0 18.1 26.7 27.9 31.9 23.9 20.9 30.0 19.6 55.2 37.5 24.2 31.6 34.5 13.7 32.3 47.9 58.2 55.7 48.5 28.8 23.4 80.2 24.6 22.5 35.6 29.0 75.5 24.7 33.3 51.4 18.6 17.8 26.9 81.6 26.2 14.2 27.7 39.5 45.7 23.6 36.1 10.6 99.3 39.5 23.9 26.8 89.0 175.7 45.2 22.0 39.5 36.0 45.8 22.1 39.3 22.9 30.4 13.1 58.3 56.4 23.7 36.6 32.9 36.9 30.6 28.2 33.1 27.7 64.5 UNC79 KIAA1409 ENSG00000133958 "Unc-79 homolog, NALCN channel complex subunit" Q9P2D8 14 93333219-93707876 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.1;pituitary gland: 11.7" "Group enriched" "Detected in some" 4 "Excitatory neurons: 524.0;Inhibitory neurons: 463.6;Oligodendrocyte precursor cells: 270.4;Oligodendrocytes: 202.6" "Cancer enhanced" "Detected in some" "glioma: 0.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "REH: 4.3;SCLC-21H: 3.0;SH-SY5Y: 1.9;U-937: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071881 Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 58: Brain - Synaptic function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane" Nucleoplasm "HPA071881: AB_2732189" "unprognostic (8.42e-2)" "unprognostic (2.07e-1)" "unprognostic (6.70e-2)" "unprognostic (6.91e-2)" "unprognostic (1.06e-1)" "unprognostic (7.73e-2)" "unprognostic (2.99e-2)" "unprognostic (1.17e-1)" "unprognostic (2.31e-1)" "unprognostic (5.73e-3)" "unprognostic (8.03e-3)" "unprognostic (2.87e-1)" "unprognostic (3.39e-2)" "unprognostic (2.66e-2)" "unprognostic (5.57e-2)" "unprognostic (3.03e-2)" "unprognostic (7.47e-2)" 0.0 0.7 2.2 0.0 2.8 0.0 0.0 5.1 4.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 2.1 1.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.2 11.7 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.3 2.5 0.4 0.0 0.1 0.3 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 4.3 0.0 0.0 0.1 0.1 3.0 1.9 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.8 5.1 4.7 2.1 1.9 0.0 0.1 0.0 0.0 0.4 2.3 0.3 0.0 0.0 89.8 0.4 0.3 0.3 0.5 0.0 41.9 0.3 0.3 2.8 0.0 0.1 0.0 10.4 0.1 0.3 0.7 0.0 0.3 36.9 4.8 0.9 0.6 0.0 0.4 524.0 0.2 0.1 0.6 1.1 0.8 0.0 0.3 0.4 0.2 0.3 40.4 463.6 0.3 0.0 0.6 0.4 16.4 0.6 0.4 0.0 23.4 0.1 2.1 0.0 270.4 202.6 0.4 0.1 0.4 0.0 0.3 0.6 1.9 0.9 5.7 0.0 0.5 0.8 3.4 2.5 0.2 0.3 0.7 0.2 0.5 0.2 0.3 COX8C COX8-3 ENSG00000187581 "Cytochrome c oxidase subunit 8C" Q7Z4L0 14 93347182-93348356 "Metabolic proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 51 "testis: 76.2" "Cell type enhanced" "Detected in some" "Early spermatids: 865.6;Late spermatids: 1864.6;Spermatocytes: 424.3" "Group enriched" "Detected in some" 8 "ovarian cancer: 2.9;testis cancer: 6.7" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "U-937: 27.4" "Low region specificity" "Detected in many" HPA003127 Approved NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 32: U-937 - Innate immune response" "Cluster 34: Spermatids - Unknown function" "HPA003127: AB_1078560" "unprognostic (1.29e-1)" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (3.76e-3)" "unprognostic (2.11e-1)" "unprognostic (2.77e-2)" "unprognostic (7.71e-2)" "unprognostic (3.83e-1)" "unprognostic (1.99e-2)" "unprognostic (8.28e-2)" "unprognostic (6.33e-2)" "unprognostic (2.64e-2)" "unprognostic (9.15e-2)" 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.5 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.2 0.3 0.2 0.1 0.0 0.0 0.5 0.4 0.1 0.1 0.0 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 76.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.5 0.5 0.2 0.3 0.5 0.4 0.5 0.1 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 1.6 0.0 0.1 0.0 0.0 5.2 0.0 0.0 0.0 0.0 865.6 1.2 0.0 0.8 0.0 0.0 0.0 0.0 14.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1864.6 11.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.1 0.0 0.3 1.2 0.0 19.7 0.0 0.1 424.3 124.5 0.0 0.1 3.4 0.0 0.1 0.0 0.1 PRIMA1 PRIMA ENSG00000175785 "Proline rich membrane anchor 1" Q86XR5 14 93718298-93788485 "Predicted membrane proteins" "Neurotransmitter degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 53.7" "Group enriched" "Detected in some" 9 "Muller glia cells: 35.5;Oligodendrocytes: 54.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 11.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HAP1: 5.2;Hep G2: 3.3;NTERA-2: 2.3;SCLC-21H: 8.3;SH-SY5Y: 8.2" "Region enhanced" "Detected in many" "basal ganglia: 18.1" "Low region specificity" "Detected in all" "HPA046671, HPA060047" Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 5: Muller glia cells - Visual perception" "Plasma membrane" "Nucleoli, Cytosol" "HPA046671: AB_2679744, HPA060047: AB_2684194" "unprognostic (3.60e-2)" "unprognostic (1.97e-1)" "unprognostic (7.54e-2)" "prognostic unfavorable (6.99e-5)" "unprognostic (1.03e-2)" "unprognostic (3.73e-2)" "unprognostic (1.07e-1)" "unprognostic (5.81e-2)" "unprognostic (2.93e-1)" "unprognostic (1.05e-1)" "unprognostic (8.94e-2)" "unprognostic (6.61e-3)" "prognostic unfavorable (2.62e-7)" "unprognostic (2.33e-2)" "unprognostic (2.67e-1)" "unprognostic (7.94e-4)" "unprognostic (4.57e-3)" 5.8 3.0 6.1 2.9 11.3 0.0 3.8 10.8 12.3 17.5 2.5 53.7 2.1 13.9 2.1 8.0 18.3 1.6 8.8 5.2 7.9 2.5 0.8 1.0 0.1 17.1 11.3 5.4 1.3 0.0 0.7 1.0 14.7 15.6 3.7 5.7 5.0 5.0 0.9 3.4 21.6 8.1 12.7 0.2 20.0 1.7 9.1 0.2 1.7 1.4 2.3 11.0 14.4 18.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 5.2 0.0 0.0 0.1 0.3 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.3 8.2 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 11.3 10.8 12.3 5.2 7.9 17.1 11.3 14.7 12.7 9.1 18.4 0.2 0.0 0.0 1.3 0.0 0.5 1.0 0.3 0.6 2.6 0.4 1.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.4 0.2 0.0 0.0 0.2 0.0 0.0 3.4 2.6 0.6 0.0 0.0 1.8 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.0 1.2 2.8 0.1 0.0 0.0 0.0 35.5 0.0 2.0 54.7 0.1 0.0 0.0 1.2 0.7 0.0 0.1 0.0 0.3 0.0 4.9 0.3 0.7 1.4 0.6 0.3 0.0 0.0 0.0 0.0 0.1 FAM181A C14orf152 ENSG00000140067 "Family with sequence similarity 181 member A" Q8N9Y4 14 93918894-93929608 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 32.5" "Group enriched" "Detected in some" 4 "Early spermatids: 48.9;Spermatocytes: 35.4" "Group enriched" "Detected in some" 6 "endometrial cancer: 3.1;glioma: 9.7;ovarian cancer: 5.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "AF22: 4.3" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 31.9" HPA001603 Enhanced NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 12: NES - Nervous system development" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA001603: AB_1078326" "unprognostic (8.19e-2)" "unprognostic (6.78e-2)" "unprognostic (1.28e-2)" "unprognostic (1.31e-1)" "unprognostic (2.05e-2)" "unprognostic (1.84e-2)" "unprognostic (6.27e-2)" "unprognostic (4.44e-2)" "unprognostic (5.37e-2)" 0.0 0.0 6.3 0.0 6.0 0.0 0.0 6.0 7.5 0.1 4.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 5.8 6.8 0.0 0.0 0.9 0.0 7.7 7.0 0.0 0.0 0.0 2.2 0.0 6.8 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 6.9 0.0 0.0 32.5 6.4 0.0 1.2 0.0 0.0 0.0 0.0 6.4 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 6.0 6.0 7.5 5.8 6.8 7.7 7.0 6.8 6.9 6.4 6.4 0.0 3.2 3.1 8.8 0.0 0.0 0.0 1.6 0.0 0.1 0.1 0.4 0.4 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.9 6.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 8.7 0.6 0.1 0.0 0.0 0.0 0.9 0.0 0.5 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.7 0.2 0.0 0.0 0.1 35.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ASB2 ASB-2 ENSG00000100628 "Ankyrin repeat and SOCS box containing 2" Q96Q27 14 93934166-93976739 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "skeletal muscle: 522.2;tongue: 157.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 51.1;Early spermatids: 26.4;Late spermatids: 29.9;Skeletal myocytes: 27.6;T-cells: 14.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in many" 7 "eosinophil: 50.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 50.8" "Cell line enhanced" "Detected in some" "Karpas-707: 12.8;RPMI-8226: 12.4;SK-MEL-30: 5.9;U-266/70: 42.1;U-266/84: 8.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001546 Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA001546: AB_1078224" "unprognostic (5.65e-4)" "unprognostic (8.19e-2)" "unprognostic (1.31e-1)" "prognostic favorable (3.62e-6)" "unprognostic (4.11e-2)" "unprognostic (1.61e-1)" "unprognostic (5.29e-2)" "unprognostic (1.05e-3)" "unprognostic (4.25e-2)" "unprognostic (1.48e-2)" "unprognostic (2.51e-2)" "unprognostic (1.89e-1)" "unprognostic (2.49e-7)" "unprognostic (2.51e-3)" "unprognostic (2.12e-1)" "unprognostic (2.01e-2)" "unprognostic (2.27e-1)" 2.9 0.8 0.8 5.6 2.1 0.5 1.5 0.0 1.9 12.0 0.0 66.5 4.0 31.6 0.3 4.0 26.6 0.5 78.5 0.6 0.0 0.5 0.5 3.0 7.4 0.1 0.0 2.9 0.3 0.2 0.2 0.2 0.3 14.4 0.4 0.0 6.6 0.9 522.2 2.3 18.3 1.6 0.0 4.2 17.2 0.4 0.3 0.4 1.2 157.6 3.2 30.4 8.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 1.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.4 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.1 0.0 12.4 0.0 0.2 0.1 0.0 0.0 0.0 5.9 0.0 0.0 2.9 0.0 0.0 0.0 0.2 0.0 42.1 8.6 1.7 0.5 2.6 0.5 0.0 0.2 50.8 1.9 2.7 0.3 1.9 1.7 3.8 4.2 0.4 0.2 0.5 0.1 0.0 7.8 0.4 2.3 1.3 0.8 2.1 0.0 1.9 0.6 0.0 0.1 0.0 0.3 0.0 0.3 0.1 0.2 0.0 0.0 0.3 3.3 0.4 0.1 8.4 0.0 0.2 0.2 0.9 51.1 0.0 2.9 0.0 0.0 0.1 3.0 0.0 0.0 1.4 26.4 1.7 0.3 0.5 0.0 2.7 4.7 0.0 0.5 1.9 1.1 2.5 0.0 0.0 0.0 0.0 0.6 0.0 1.9 0.0 0.0 0.0 0.3 29.9 0.3 5.3 1.8 1.9 5.8 0.8 2.1 0.0 0.7 0.2 0.0 0.4 10.7 0.1 0.0 0.0 0.4 1.1 0.0 27.6 5.0 0.8 8.4 0.1 0.1 2.9 14.5 0.1 0.1 0.3 CCDC197 "C14orf48, LINC00521" ENSG00000175699 "Coiled-coil domain containing 197" 14 93987225-94008863 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.3" "Not detected" "Not detected" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "unprognostic (5.01e-1)" "unprognostic (1.09e-1)" 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 8.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.1 0.1 0.0 0.6 0.0 0.6 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OTUB2 "C14orf137, FLJ21916, MGC3102" ENSG00000089723 "OTU deubiquitinase, ubiquitin aldehyde binding 2" Q96DC9 14 94026340-94048930 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 7.3;testis: 14.4" "Group enriched" "Detected in many" 8 "Early spermatids: 641.1;Late spermatids: 1415.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 16.5;Karpas-707: 18.0;OE19: 18.1;RPTEC TERT1: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002329, HPA075090" Enhanced NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 34: Spermatids - Unknown function" "HPA002329: AB_1079537, HPA075090: AB_2686734" "unprognostic (6.80e-3)" "unprognostic (1.39e-3)" "unprognostic (3.68e-3)" "unprognostic (4.82e-3)" "unprognostic (1.66e-1)" "unprognostic (2.20e-1)" "unprognostic (2.30e-3)" "unprognostic (1.18e-2)" "unprognostic (2.55e-1)" "unprognostic (3.09e-3)" "unprognostic (2.80e-2)" "unprognostic (1.16e-2)" "unprognostic (6.25e-3)" "unprognostic (1.15e-1)" "unprognostic (2.06e-2)" "unprognostic (1.02e-4)" "unprognostic (3.16e-1)" 0.3 0.6 1.2 0.2 1.1 0.2 0.8 1.3 1.3 1.3 0.1 0.5 0.3 0.8 0.3 3.8 0.6 0.4 0.1 1.0 0.8 0.6 0.8 0.4 0.3 0.1 1.3 0.7 0.7 1.9 0.2 1.8 0.1 0.6 0.8 0.6 0.7 0.2 0.1 7.3 0.3 0.3 0.1 0.2 0.5 14.4 2.5 0.1 0.2 0.0 0.8 0.9 1.5 0.5 1.3 3.7 2.4 2.3 0.9 0.7 2.6 0.5 0.3 1.4 2.1 0.8 5.9 0.3 2.2 0.6 16.5 0.3 3.2 1.7 1.1 0.9 1.5 0.1 0.4 3.9 1.3 0.0 0.6 0.6 2.1 0.5 0.9 1.8 1.6 3.3 0.1 18.0 0.7 1.3 0.1 0.4 0.7 18.1 3.1 0.1 0.2 1.0 11.2 1.7 1.8 1.3 0.7 0.8 1.9 1.6 6.3 0.8 1.7 0.9 2.8 0.7 1.0 3.0 2.2 0.0 1.7 0.9 1.4 0.0 0.6 0.0 0.0 0.8 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 1.2 1.1 1.3 1.3 1.0 0.8 0.1 1.3 0.1 0.1 2.5 0.5 0.5 0.0 0.5 0.7 0.2 0.1 0.7 4.0 0.6 1.5 1.1 1.1 0.5 0.0 2.4 0.0 0.0 4.2 0.1 1.9 1.9 4.3 641.1 6.4 2.8 0.9 0.0 2.7 1.9 1.6 1.5 0.6 4.6 24.8 0.0 2.2 0.4 0.9 1.4 0.0 1.3 1.4 2.0 1.2 1.3 1415.3 6.8 2.4 0.0 0.0 0.4 0.5 0.0 0.5 0.6 5.2 1.3 3.4 0.1 0.3 0.5 1.5 1.8 1.4 6.6 0.6 0.6 9.2 4.3 2.0 2.3 117.5 1.0 2.2 1.0 2.4 DDX24 ENSG00000089737 "DEAD-box helicase 24" Q9GZR7 14 94048287-94081212 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002554 Uncertain Approved Nucleoli,Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoli, Cytosol" "HPA002554: AB_1078631" "unprognostic (7.48e-2)" "unprognostic (3.02e-2)" "unprognostic (8.95e-2)" "unprognostic (2.12e-1)" "unprognostic (2.31e-1)" "unprognostic (4.06e-3)" "unprognostic (8.81e-2)" "unprognostic (2.66e-3)" "unprognostic (2.77e-1)" "unprognostic (2.28e-2)" "unprognostic (1.60e-3)" "unprognostic (4.13e-2)" "prognostic favorable (3.06e-9)" "prognostic unfavorable (2.89e-4)" "unprognostic (6.15e-2)" "unprognostic (1.23e-1)" "unprognostic (5.66e-2)" 80.7 130.5 23.3 3.9 24.2 23.5 75.2 25.9 29.7 80.0 24.5 85.8 3.7 93.1 37.2 48.9 81.4 6.7 114.3 24.3 23.9 61.2 43.4 69.4 10.4 31.2 25.2 87.3 49.8 7.0 109.0 2.8 25.4 69.9 3.8 8.0 53.9 4.9 123.9 67.4 59.6 4.1 23.9 75.9 66.1 114.3 25.2 8.0 73.5 4.2 9.1 80.2 65.9 26.2 6.5 1.8 11.5 7.5 6.8 8.8 2.7 17.6 14.5 22.4 20.0 2.2 4.0 29.8 6.4 3.9 6.7 4.1 11.9 1.1 24.5 13.0 0.7 15.8 4.3 9.9 5.7 23.0 6.8 1.4 6.6 4.1 3.9 7.5 3.7 5.6 8.5 8.2 9.6 18.2 7.0 19.6 7.6 1.9 0.2 9.3 26.6 3.5 17.0 2.4 9.1 8.4 17.3 4.2 8.5 1.8 6.8 8.1 11.3 6.4 4.4 8.2 5.3 3.4 24.8 31.5 9.2 12.3 5.1 9.5 2.1 1.7 3.0 1.7 0.8 1.7 1.6 1.8 1.2 2.3 3.0 3.0 1.5 3.8 1.8 1.9 2.1 3.0 23.3 24.2 25.9 29.7 24.3 23.9 31.2 25.2 25.4 23.9 25.2 26.2 164.7 169.9 160.6 45.4 245.9 182.8 186.6 147.4 171.4 184.7 86.6 94.7 228.3 64.3 146.4 147.1 131.3 94.0 332.8 74.1 272.0 147.0 98.2 244.0 248.2 142.2 97.5 75.5 62.9 98.9 72.6 189.0 95.8 201.0 154.9 251.5 109.6 103.4 85.1 232.2 73.6 89.0 118.0 92.1 147.4 67.4 231.5 143.5 99.6 45.0 158.0 133.4 122.6 31.7 56.1 91.0 67.4 244.8 225.6 116.4 70.7 242.3 160.4 200.5 164.3 185.0 198.0 506.5 435.9 127.6 145.6 157.1 342.1 305.9 74.9 123.7 IFI27L1 FAM14B ENSG00000165948 "Interferon alpha inducible protein 27 like 1" Q96BM0 14 94081301-94103846 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 97.6" "Cell type enhanced" "Detected in all" "Early spermatids: 328.4;Late spermatids: 160.8;Theca cells: 125.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 16.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 202.4" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (7.89e-3)" "unprognostic (1.47e-1)" "unprognostic (6.31e-2)" "unprognostic (8.54e-3)" "unprognostic (2.53e-1)" "unprognostic (4.81e-2)" "unprognostic (1.84e-2)" "unprognostic (2.63e-1)" "unprognostic (3.68e-1)" "unprognostic (7.63e-3)" "unprognostic (2.50e-1)" "unprognostic (2.00e-1)" "unprognostic (3.90e-2)" "unprognostic (3.50e-2)" "unprognostic (1.71e-1)" "unprognostic (5.93e-3)" "unprognostic (2.92e-1)" 15.7 51.0 28.6 6.6 28.3 20.0 13.1 28.6 31.6 11.3 33.4 14.0 11.9 10.2 23.0 11.5 11.3 9.5 17.1 28.4 30.5 14.3 10.6 13.9 6.8 29.6 30.0 28.5 9.5 12.8 13.3 4.5 30.2 7.5 13.8 17.2 11.8 7.2 20.1 13.1 12.6 9.6 28.6 12.6 16.5 97.6 30.2 12.9 9.2 14.4 10.2 6.6 11.0 29.8 16.8 16.3 23.9 23.7 29.6 27.2 10.9 20.2 21.8 19.5 47.0 5.5 38.1 16.1 31.5 16.5 20.4 17.7 3.5 12.0 13.9 43.0 20.0 14.1 34.4 10.9 14.4 16.9 15.6 25.3 14.0 22.0 15.6 33.0 15.7 70.8 28.8 202.4 32.3 14.6 18.5 16.0 8.1 32.3 13.9 33.6 21.1 25.4 23.4 3.1 20.7 11.3 35.1 15.8 29.4 16.0 22.4 27.3 17.4 9.6 7.4 19.0 15.2 43.6 46.3 24.4 31.4 18.4 12.3 16.2 1.6 2.3 2.3 1.8 2.1 2.4 4.0 3.2 1.5 2.8 2.7 3.3 0.8 3.9 1.6 4.6 5.4 1.6 28.6 28.3 28.6 31.6 28.4 30.5 29.6 30.0 30.2 28.6 30.2 29.8 28.7 28.9 13.7 15.7 15.3 17.1 22.9 34.4 18.2 17.9 20.7 21.5 18.8 14.3 23.0 20.2 10.4 19.3 11.1 53.5 27.4 27.4 328.4 33.7 14.4 20.1 15.5 12.8 4.6 26.7 14.0 26.5 23.4 18.8 5.7 72.2 30.4 14.3 35.7 13.5 5.5 59.4 44.7 10.0 12.2 160.8 42.6 11.8 26.6 3.7 5.5 44.6 14.4 6.0 7.5 26.2 43.5 57.2 44.7 13.6 88.1 33.5 20.0 30.1 13.1 11.7 17.6 30.0 39.0 21.6 14.2 7.1 14.0 125.3 31.6 23.8 IFI27 "FAM14D, ISG12, P27" ENSG00000165949 "Interferon alpha inducible protein 27" P40305 14 94104836-94116698 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 3792.9;Distal enterocytes: 2150.5;Endothelial cells: 1972.1;Exocrine glandular cells: 1603.8;Intestinal goblet cells: 1638.8;Pancreatic endocrine cells: 1678.1;Paneth cells: 2179.2;Proximal enterocytes: 3048.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 7.0" "Group enriched" "Detected in many" 6 "monocytes: 7.0;T-cells: 2.6" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 2026.8;BJ hTERT+ SV40 Large T+ RasG12V: 1782.5;EFO-21: 547.7;Karpas-707: 501.5;SK-MEL-30: 607.2" HPA028875 Uncertain NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 16: Pancreatic endocrine cells - Mixed function" "HPA028875: AB_10601434" "unprognostic (1.15e-1)" "unprognostic (1.19e-1)" "unprognostic (2.43e-2)" "unprognostic (6.68e-2)" "unprognostic (4.74e-2)" "unprognostic (1.59e-2)" "unprognostic (6.78e-3)" "unprognostic (5.26e-2)" "unprognostic (2.10e-1)" "prognostic favorable (8.80e-4)" "unprognostic (1.13e-3)" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (1.53e-1)" "unprognostic (1.18e-1)" "unprognostic (1.41e-1)" "unprognostic (1.65e-1)" 470.3 323.3 178.3 115.7 177.4 162.8 410.3 180.9 232.6 351.4 162.7 374.4 129.2 137.8 39.9 310.4 163.2 344.1 471.5 174.5 182.4 217.9 150.4 608.2 48.3 203.8 187.7 75.6 39.3 30.3 65.3 183.8 215.0 85.0 221.4 6.1 156.9 47.0 113.1 129.8 256.2 117.4 194.9 797.8 697.0 140.2 194.1 202.8 149.8 152.4 54.2 116.9 213.7 190.8 181.3 0.4 1.3 0.4 0.5 21.7 1.7 2.8 8.8 2026.8 1782.5 3.8 146.8 1.5 547.7 115.3 33.8 5.7 1.1 0.2 79.7 2.1 3.7 1.0 1.4 0.9 13.7 0.6 1.1 2.0 2.0 353.8 0.1 1.1 284.0 1.3 1.1 501.5 0.1 0.5 1.7 1.1 0.5 0.5 24.7 1.8 0.5 0.6 1.2 0.6 0.4 1.1 0.0 0.1 607.2 1.4 0.9 3.0 0.3 0.2 2.7 325.8 1.0 9.4 14.6 3.9 0.9 0.5 1.4 0.0 1.3 0.5 0.3 7.0 0.3 0.0 2.6 0.7 0.8 0.1 0.0 0.4 0.0 0.4 2.1 0.1 2.5 2.1 178.3 177.4 180.9 232.6 174.5 182.4 203.8 187.7 215.0 194.9 194.1 190.8 3792.9 391.0 82.7 1.3 26.8 171.2 6.5 126.9 91.6 4.9 23.4 38.2 45.9 151.5 237.4 12.9 8.4 7.3 14.9 2150.5 1.9 50.6 13.6 1035.5 188.3 1972.1 267.8 42.3 0.6 1603.8 221.2 330.8 892.5 838.5 45.1 1174.4 742.5 5.8 158.3 5.0 0.4 1638.8 107.8 106.9 163.5 36.7 172.1 59.6 350.4 84.3 26.1 8.3 0.0 0.0 0.7 1678.1 2179.2 417.5 6.3 11.1 3048.1 23.7 548.1 20.5 276.1 45.2 295.8 20.3 12.1 151.9 140.4 5.2 34.1 302.4 523.4 80.4 IFI27L2 "FAM14A, TLH29" ENSG00000119632 "Interferon alpha inducible protein 27 like 2" Q9H2X8 14 94127779-94130253 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 446.8" HPA049588 Approved Nucleoli,Cytosol "Intracellular and membrane" No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 48: Smooth muscle cells - ECM organization" Cytosol Nucleoli "HPA049588: " "unprognostic (9.70e-3)" "unprognostic (2.71e-1)" "unprognostic (2.16e-1)" "unprognostic (1.76e-1)" "unprognostic (2.45e-1)" "unprognostic (2.80e-2)" "unprognostic (7.46e-3)" "unprognostic (4.76e-2)" "unprognostic (4.69e-2)" "unprognostic (1.58e-2)" "unprognostic (4.79e-3)" "unprognostic (3.96e-2)" "unprognostic (8.13e-2)" "unprognostic (2.03e-1)" "unprognostic (3.88e-1)" "unprognostic (5.09e-2)" "unprognostic (3.52e-2)" 47.8 114.5 148.9 42.4 157.0 46.6 43.1 159.2 207.3 76.4 142.8 57.3 22.5 51.5 14.5 73.9 54.1 46.4 108.2 149.3 169.0 68.2 10.2 60.0 57.9 162.6 152.7 78.8 27.8 55.0 83.3 10.7 162.3 35.8 20.4 51.6 26.7 21.6 8.8 52.5 52.8 25.6 160.9 72.2 35.5 31.1 160.1 46.9 35.1 9.9 50.5 41.6 72.1 171.9 61.5 39.3 10.8 90.8 70.1 166.5 7.6 118.1 129.9 92.3 99.6 12.1 28.0 29.0 128.3 134.2 59.1 81.6 8.8 150.5 36.8 185.4 3.0 44.0 41.0 4.6 98.5 53.2 116.7 163.1 55.8 50.5 39.0 162.6 49.1 108.5 3.8 446.8 107.5 128.3 32.3 33.9 16.4 41.9 49.2 1.9 40.2 42.2 137.8 25.2 24.1 28.7 3.8 0.0 78.4 22.9 146.4 87.6 65.9 61.5 35.0 79.5 30.1 171.8 164.4 10.4 201.7 124.1 39.2 167.4 238.3 48.0 153.4 167.9 99.4 214.2 140.6 168.4 184.2 201.3 104.2 134.9 37.6 44.3 121.5 153.5 203.5 217.4 148.9 157.0 159.2 207.3 149.3 169.0 162.6 152.7 162.3 160.9 160.1 171.9 86.5 38.5 50.9 10.1 71.8 92.8 73.1 218.3 111.0 27.2 47.9 103.6 162.8 50.1 55.8 178.4 20.9 2.3 79.3 58.2 178.1 159.2 8.2 78.1 113.7 70.1 99.6 20.6 1.6 29.1 2.7 133.0 43.8 11.6 90.7 64.8 121.1 4.2 190.8 23.5 3.6 193.8 57.0 163.7 107.6 31.1 183.0 119.1 236.5 0.0 134.7 181.0 137.0 5.5 13.9 68.1 150.2 115.5 104.4 23.7 125.6 113.3 61.8 113.3 124.9 70.4 87.7 8.3 22.1 105.2 66.9 2.9 92.2 92.7 82.8 55.9 PPP4R4 "CFAP14, KIAA1622, PP4R4" ENSG00000119698 "Protein phosphatase 4 regulatory subunit 4" Q6NUP7 14 94146128-94279734 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 7.9" "Cell type enhanced" "Detected in many" "Astrocytes: 44.4;Cone photoreceptor cells: 75.0;Excitatory neurons: 63.1;Inhibitory neurons: 63.0;Spermatocytes: 33.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-HME1: 6.7;RH-30: 19.4;T-47d: 23.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041866, HPA050321" Approved Supported Cytosol NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 15: Liver - Metabolism" "Cluster 6: T47d - Mammary gland" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Cytosol "HPA041866: AB_10804120, HPA050321: AB_2681086" "unprognostic (2.65e-3)" "unprognostic (3.06e-1)" "unprognostic (9.07e-2)" "unprognostic (9.49e-3)" "unprognostic (2.48e-2)" "unprognostic (1.59e-1)" "unprognostic (3.88e-2)" "unprognostic (2.45e-1)" "unprognostic (1.25e-1)" "unprognostic (8.85e-2)" "unprognostic (6.91e-3)" "unprognostic (1.72e-2)" "unprognostic (8.95e-2)" "unprognostic (7.53e-2)" "unprognostic (3.35e-2)" "unprognostic (1.77e-1)" "unprognostic (6.24e-2)" 0.2 0.4 2.7 0.3 3.0 0.1 0.5 2.2 4.0 4.3 1.0 0.1 0.0 0.8 0.0 0.3 1.6 0.3 0.2 3.3 3.6 0.3 3.0 1.5 0.2 2.8 2.7 5.1 0.4 0.9 2.6 0.5 2.4 0.4 0.1 5.4 0.3 0.6 0.1 0.6 0.1 0.3 1.8 0.0 0.7 7.9 3.4 0.1 0.2 0.0 0.6 0.2 1.2 4.2 0.8 0.1 3.5 0.9 0.8 0.0 0.9 0.4 3.1 1.0 0.9 0.2 0.9 0.0 0.0 0.0 2.5 0.1 4.5 4.7 0.6 0.3 0.7 0.0 0.0 1.9 0.3 0.0 0.6 0.0 0.9 0.1 6.7 0.0 0.0 2.1 0.0 0.3 0.6 1.0 0.0 0.1 1.8 0.0 0.1 0.2 19.4 0.1 0.2 0.9 0.4 0.1 0.1 0.1 0.1 1.3 23.6 0.0 0.0 3.0 2.9 0.2 0.3 0.9 0.1 0.6 1.8 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.7 3.0 2.2 4.0 3.3 3.6 2.8 2.7 2.4 1.8 3.4 4.2 0.1 3.2 9.5 44.4 0.1 4.8 4.9 4.9 5.7 1.4 3.6 0.8 0.4 0.0 2.9 0.0 75.0 0.0 0.0 0.0 0.0 2.4 17.9 3.5 0.2 0.6 0.0 0.0 63.1 0.4 0.2 0.5 2.0 3.1 0.0 19.5 6.4 1.0 0.1 1.7 63.0 0.0 2.0 1.3 0.7 18.0 5.9 0.2 0.0 1.9 0.0 6.0 0.0 17.6 3.7 0.2 0.0 5.7 0.1 17.8 0.0 0.2 14.5 0.8 0.0 0.6 1.6 33.7 9.2 1.6 2.6 0.0 0.4 1.2 0.0 7.2 SERPINA10 "PZI, ZPI" ENSG00000140093 "Serpin family A member 10" Q9UK55 14 94280460-94293268 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 104 "liver: 346.9" "Cell type enriched" "Detected in some" 17 "Hepatocytes: 259.1" "Cancer enriched" "Detected in some" 51 "liver cancer: 40.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "Hep G2: 21.2" "Not detected" "Not detected" HPA048739 Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 3960000000 4700000000 "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 15: Hepatocytes - Hemostasis" Nucleoplasm Cytosol "HPA048739: AB_2797237" "unprognostic (7.14e-2)" "unprognostic (2.03e-1)" "unprognostic (2.69e-2)" "unprognostic (2.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.45e-1)" "prognostic favorable (9.00e-4)" "unprognostic (6.11e-2)" "unprognostic (2.81e-4)" "unprognostic (2.31e-4)" "unprognostic (2.77e-2)" "unprognostic (2.91e-3)" "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (1.11e-1)" "unprognostic (7.93e-3)" 0.4 0.4 0.4 0.6 0.7 3.3 0.6 3.2 1.4 0.6 0.4 0.7 0.7 0.7 0.5 0.4 0.3 0.5 0.6 0.4 0.4 0.5 346.9 0.4 0.8 1.5 0.5 0.9 0.5 0.2 0.2 0.5 0.8 0.4 0.7 3.1 0.4 0.4 0.5 1.7 0.7 0.6 0.4 0.7 0.7 0.6 0.7 1.3 0.7 0.4 0.4 0.2 0.1 2.5 0.6 0.2 1.8 0.7 0.7 0.6 0.4 0.5 0.5 0.9 0.8 2.7 0.6 2.1 0.3 0.4 0.2 0.4 2.2 0.5 1.3 0.8 1.4 2.0 0.8 21.2 0.4 1.6 1.1 0.6 0.5 0.3 0.7 1.1 1.0 1.1 0.5 1.3 1.0 0.3 1.4 0.8 0.8 0.2 0.6 0.9 1.2 0.9 0.5 0.7 0.9 0.8 0.4 0.4 0.2 1.0 0.9 0.9 0.6 0.7 0.4 0.7 0.6 1.1 0.5 0.9 0.9 1.9 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 3.2 1.4 0.4 0.4 1.5 0.5 0.8 0.4 0.7 2.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.8 2.8 0.0 0.0 14.6 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 6.6 8.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 3.3 259.1 0.0 0.0 0.0 0.4 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 SERPINA6 CBG ENSG00000170099 "Serpin family A member 6" P08185 14 94304248-94323389 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" Transport "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "liver: 776.6" "Group enriched" "Detected in some" 4 "Cholangiocytes: 204.5;Hepatocytes: 390.8" "Cancer enriched" "Detected in many" 9 "liver cancer: 244.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "T-47d: 961.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA017864 Approved "Secreted to blood" NA NA 60800000000 37000000000 "Cluster 62: Liver - Hemostasis" "Cluster 6: T47d - Mammary gland" "Cluster 15: Hepatocytes - Hemostasis" "HPA017864: AB_1856721" "unprognostic (2.82e-2)" "unprognostic (1.67e-1)" "unprognostic (1.02e-3)" "prognostic favorable (6.96e-5)" "unprognostic (2.93e-3)" "unprognostic (9.98e-3)" "unprognostic (4.43e-2)" "unprognostic (3.11e-1)" "unprognostic (4.80e-3)" "unprognostic (2.94e-1)" "unprognostic (2.47e-2)" "unprognostic (4.54e-2)" "unprognostic (1.43e-1)" "unprognostic (2.14e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 1.9 0.0 3.5 0.1 0.5 0.0 0.0 12.6 35.1 0.0 0.0 0.0 43.5 776.6 0.1 0.0 0.0 0.0 0.3 17.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 114.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.2 0.4 0.4 4.5 0.1 0.4 0.0 0.1 0.7 0.0 0.0 961.9 0.0 0.0 0.5 0.0 0.6 0.0 0.3 0.0 0.5 1.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.1 0.1 0.1 0.7 0.0 0.0 4.4 0.0 0.4 204.5 0.3 0.0 0.0 0.3 0.0 0.4 1.9 33.1 0.0 62.6 0.3 0.4 9.0 16.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.2 9.7 390.8 0.0 0.0 0.0 0.8 2.0 8.7 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.1 1.0 1.2 0.0 0.0 0.0 0.1 43.0 2.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.8 0.1 SERPINA1 "A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1" ENSG00000197249 "Serpin family A member 1" P01009 14 94376747-94390693 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase, Blood coagulation, Hemostasis" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 45 "liver: 34022.4" "Cell type enriched" "Detected in many" 8 "Hepatocytes: 42919.3" "Cancer enriched" "Detected in all" 10 "liver cancer: 3850.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 2482.1;intermediate monocyte: 3411.9;neutrophil: 2823.2;non-classical monocyte: 4518.8" "Group enriched" "Detected in all" 5 "granulocytes: 2823.2;monocytes: 4518.8" "Cell line enriched" "Detected in many" 10 "Hep G2: 4769.1" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "cerebellum: 130.6" "HPA000927, HPA001292, CAB013211, CAB016648, CAB073396" Enhanced Enhanced Vesicles "Secreted to blood" NA NA 2070000000000 140000000000 "Cluster 51: Monocytes - Innate immune response" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 15: Hepatocytes - Hemostasis" Vesicles "CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762" "prognostic favorable (1.61e-5)" "unprognostic (3.37e-1)" "prognostic favorable (5.86e-4)" "unprognostic (1.38e-2)" "unprognostic (1.98e-2)" "unprognostic (5.50e-3)" "unprognostic (3.81e-2)" "unprognostic (6.78e-2)" "unprognostic (2.54e-2)" "unprognostic (7.96e-2)" "unprognostic (1.08e-1)" "unprognostic (4.54e-1)" "unprognostic (1.23e-2)" "unprognostic (1.89e-1)" "unprognostic (1.30e-2)" "unprognostic (1.17e-2)" "unprognostic (1.96e-1)" 49.1 9.7 7.3 225.0 7.1 157.1 100.6 9.1 21.3 105.7 11.1 151.0 278.6 42.3 5.3 10.1 22.4 352.3 12.5 7.3 11.1 621.2 34022.4 570.7 37.0 20.9 14.4 5.4 201.0 5.2 9.1 26.6 15.8 12.6 178.8 2.6 33.6 140.5 3.7 8.2 760.9 75.7 12.2 313.6 282.5 3.0 16.2 15.0 23.0 11.9 25.2 55.8 9.1 16.9 25.9 0.3 0.0 0.5 1.0 0.0 1.5 0.6 1.7 0.6 1.1 187.8 500.8 2.6 15.6 0.0 1.4 1.9 0.0 10.9 1.2 70.1 0.0 4.3 2.0 4769.1 0.3 16.8 2.3 4.1 5.4 0.3 18.5 1.9 0.0 0.0 3.2 0.4 0.0 0.8 1.1 12.1 2.0 5.5 8.0 1.9 16.7 2.4 300.8 3.0 0.6 1.3 6.4 1.6 1.4 0.4 262.1 2.7 1.6 2.1 59.4 1.9 7.1 3.3 1.8 7.0 4.4 41.8 0.6 10.6 2482.1 634.3 5.5 3411.9 6.8 7.7 3.6 4.1 683.6 3.6 4.3 3.6 2823.2 5.3 4518.8 14.9 4.5 2770.7 7.3 7.1 9.1 21.3 7.3 11.1 20.9 14.4 15.8 12.2 16.2 16.9 2.2 35.3 285.9 0.0 137.4 2.3 1.0 36.3 0.0 0.2 100.8 31.5 5.3 4520.9 165.5 150.8 0.0 1.6 3.9 52.0 68.4 3787.9 0.2 70.0 2.8 57.0 12.1 1227.4 0.0 225.8 4.5 3.6 36.2 51.3 1.3 0.1 938.8 42919.3 167.6 0.0 0.0 742.4 30.5 1454.0 74.1 1.1 0.0 413.3 1.8 1.0 291.7 0.3 9.2 0.0 0.0 2161.6 137.0 0.0 1.5 6.8 5270.0 745.9 108.3 0.2 0.0 0.6 17.4 0.0 0.2 0.6 1.7 6.4 75.5 0.0 83.2 6.7 SERPINA11 ENSG00000186910 "Serpin family A member 11" Q86U17 14 94442464-94452800 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 92 "liver: 490.6" "Cell type enriched" "Detected in some" 46 "Hepatocytes: 278.7" "Cancer enriched" "Detected in some" 9 "liver cancer: 94.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "Hep G2: 17.2" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 230000000 "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 15: Hepatocytes - Hemostasis" "unprognostic (2.50e-2)" "unprognostic (3.26e-1)" "unprognostic (9.00e-2)" "prognostic favorable (6.30e-4)" "unprognostic (7.44e-2)" "unprognostic (2.02e-2)" "unprognostic (1.70e-1)" "unprognostic (3.44e-1)" "unprognostic (5.14e-2)" "unprognostic (1.53e-1)" "unprognostic (1.64e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.1 5.3 0.0 0.0 0.0 0.5 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 490.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 3.9 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.3 0.0 0.0 4.3 1.8 0.0 4.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.6 278.7 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.2 SERPINA9 "CENTERIN, GCET1, SERPINA11b" ENSG00000170054 "Serpin family A member 9" Q86WD7 14 94462717-94479689 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "lymphoid tissue: 72.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 4 "stomach cancer: 2.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 66 "Daudi: 69.5" "Region enriched" "Detected in many" 16 "basal ganglia: 71.8" "Secreted to blood" NA NA "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "unprognostic (1.32e-2)" "unprognostic (1.05e-1)" "unprognostic (1.94e-2)" "unprognostic (3.89e-3)" "unprognostic (6.10e-2)" "unprognostic (6.67e-2)" "unprognostic (1.38e-2)" "unprognostic (1.16e-1)" 0.0 0.0 0.0 13.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 41.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 1.7 0.8 0.1 0.0 0.3 0.2 0.0 0.0 1.4 0.0 0.0 72.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 69.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SERPINA12 "OL-64, Vaspin" ENSG00000165953 "Serpin family A member 12" Q8IW75 14 94487274-94517844 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "skin 1: 396.4" "Cell type enriched" "Detected in some" 4 "Suprabasal keratinocytes: 20.9" "Group enriched" "Detected in some" 5 "liver cancer: 1.8;melanoma: 2.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "Hep G2: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA 6500000 "Cluster 61: Skin - Cornification" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 28: Keratinocytes - Keratinization" "unprognostic (1.82e-3)" "unprognostic (6.44e-2)" "unprognostic (3.25e-1)" "unprognostic (1.00e-2)" "unprognostic (5.98e-2)" "unprognostic (2.97e-2)" "unprognostic (7.64e-3)" "unprognostic (6.67e-2)" 0.3 0.0 0.0 0.0 0.0 0.1 27.7 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 4.3 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 396.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 SERPINA4 "KAL, kallistatin, KLST, KST, PI4" ENSG00000100665 "Serpin family A member 4" P29622 14 94561442-94569913 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 550.0" "Cell type enhanced" "Detected in some" "Cholangiocytes: 245.9;Exocrine glandular cells: 93.8;Hepatocytes: 478.5;Pancreatic endocrine cells: 62.1" "Cancer enriched" "Detected in many" 4 "liver cancer: 94.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "Hep G2: 28.4" "Not detected" "Not detected" "HPA003607, HPA068939" Approved Uncertain Vesicles "Secreted to blood" NA NA 14500000000 14000000000 "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" Vesicles "HPA003607: AB_1079914, HPA068939: " "unprognostic (1.65e-3)" "unprognostic (4.13e-2)" "prognostic favorable (2.95e-4)" "unprognostic (2.09e-3)" "unprognostic (1.99e-3)" "unprognostic (2.82e-1)" "unprognostic (4.03e-3)" "unprognostic (1.02e-2)" "unprognostic (2.24e-4)" "unprognostic (1.08e-1)" "unprognostic (5.45e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 2.8 0.4 41.0 0.0 1.5 53.4 0.0 0.0 0.0 7.3 550.0 0.0 0.0 0.0 0.0 0.0 116.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.5 0.0 0.0 0.3 0.0 0.0 0.0 27.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 245.9 0.0 3.7 0.0 0.0 0.0 0.0 11.7 30.0 0.0 3.3 0.3 0.3 0.0 2.7 0.0 93.8 0.0 0.0 5.1 4.5 0.0 0.2 5.3 478.5 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 62.1 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 SERPINA5 "PAI3, PCI, PLANH3, PROCI" ENSG00000188488 "Serpin family A member 5" P05154 14 94561442-94593118 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Fertilization, Lipid transport, Transport" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 484.5;liver: 785.6;testis: 432.4" "Cell type enhanced" "Detected in many" "Cholangiocytes: 400.4;Endometrial ciliated cells: 175.2;Glandular and luminal cells: 345.3;Hepatocytes: 198.2;Late spermatids: 277.8;Peritubular cells: 144.4" "Cancer enhanced" "Detected in many" "liver cancer: 121.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "Hep G2: 261.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA078846 Enhanced "Secreted to blood" NA NA 2100000000 "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 44: Endometrium - Transcription" "HPA078846: " "unprognostic (5.94e-3)" "unprognostic (2.64e-4)" "unprognostic (1.13e-1)" "prognostic favorable (7.72e-4)" "unprognostic (3.34e-3)" "unprognostic (6.10e-3)" "unprognostic (3.94e-2)" "unprognostic (1.39e-3)" "unprognostic (5.36e-1)" "unprognostic (1.50e-1)" "unprognostic (6.16e-2)" "unprognostic (1.87e-2)" "unprognostic (8.39e-3)" "unprognostic (3.38e-3)" "unprognostic (9.92e-2)" "unprognostic (8.08e-2)" "unprognostic (3.23e-1)" 5.1 484.5 1.8 3.3 2.4 0.0 19.6 2.2 1.7 29.6 3.0 5.3 5.5 31.8 1.2 0.8 26.3 160.5 19.0 1.6 7.2 151.4 785.6 1.0 3.6 3.5 3.8 30.1 173.9 0.2 3.2 0.1 5.3 6.8 1.9 14.0 9.4 153.3 46.4 3.3 3.6 2.1 1.7 112.2 12.1 432.4 2.8 0.9 4.1 152.6 4.7 2.3 4.0 3.7 0.8 0.1 2.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 12.0 12.2 0.0 8.3 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 261.3 0.3 0.4 0.0 1.7 0.3 0.1 0.0 2.3 4.9 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.7 0.2 0.0 0.1 0.5 0.2 3.9 0.1 0.4 17.4 0.2 0.1 7.9 0.9 0.1 0.0 0.5 0.0 0.6 0.4 1.5 0.2 0.1 0.2 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.4 2.2 1.7 1.6 7.2 3.5 3.8 5.3 1.7 2.8 3.7 0.9 0.0 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.2 18.9 14.1 0.8 400.4 0.1 33.1 2.1 0.0 0.1 0.0 64.6 103.2 78.7 175.2 19.7 40.3 0.0 2.7 0.0 122.2 0.0 18.2 0.5 345.3 0.0 78.2 2.5 198.2 0.0 8.4 0.0 0.0 0.0 3.2 0.7 277.8 57.2 1.9 0.0 0.0 0.6 5.4 0.0 0.0 0.2 18.3 0.0 144.4 0.0 0.1 0.0 7.5 0.0 1.4 6.6 11.6 1.5 11.1 2.9 0.0 0.6 0.3 1.8 58.7 0.0 0.1 SERPINA3 "AACT, ACT" ENSG00000196136 "Serpin family A member 3" P01011 14 94612384-94624055 "Cancer-related genes, Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "liver: 9176.5;pancreas: 4910.2" "Cell type enhanced" "Detected in some" "Ductal cells: 20.9;Exocrine glandular cells: 33.0;Fibroblasts: 68.6;Late spermatids: 12.2;Pancreatic endocrine cells: 18.7" "Cancer enhanced" "Detected in many" "liver cancer: 4.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 7 "Hep G2: 449.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000893, HPA002560, CAB016647" Enhanced "Secreted to blood" NA NA 697000000000 94000000000 "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 50: Fibroblasts - ECM organization" "CAB016647: AB_1611882, HPA000893: AB_10794315, HPA002560: AB_1856717" "prognostic favorable (8.92e-4)" "unprognostic (3.33e-3)" "unprognostic (9.21e-2)" "unprognostic (1.53e-2)" "unprognostic (1.05e-1)" "unprognostic (1.72e-1)" "unprognostic (2.00e-2)" "unprognostic (1.00e-2)" "unprognostic (2.23e-1)" "unprognostic (9.60e-2)" "unprognostic (1.20e-2)" "unprognostic (9.92e-2)" "unprognostic (3.74e-12)" "unprognostic (6.47e-2)" "unprognostic (1.33e-2)" "unprognostic (2.02e-2)" 91.8 58.0 100.4 43.4 116.5 2.1 371.0 117.7 293.8 368.8 110.3 79.5 11.7 44.9 11.5 42.5 116.6 146.0 311.7 103.6 320.0 215.5 9176.5 169.9 5.0 196.3 183.1 181.5 4910.2 1.0 271.2 14.6 138.3 580.5 13.3 131.5 1505.8 54.9 177.8 55.7 91.6 83.1 141.4 31.7 290.5 66.9 176.3 2.6 72.6 38.9 6.4 207.4 70.4 173.0 0.2 0.5 0.0 0.3 0.2 0.8 0.3 0.1 0.1 0.0 0.0 1.2 4.9 0.6 4.5 0.0 3.3 0.9 0.0 4.4 0.0 2.7 0.0 1.0 0.2 449.9 56.9 1.9 0.7 52.0 63.9 0.0 2.5 5.4 0.0 0.0 0.3 0.2 0.0 17.1 0.5 0.5 0.8 1.6 0.0 0.6 2.2 0.2 3.8 0.2 0.1 0.0 1.8 2.5 65.6 0.4 2.4 0.0 0.6 0.0 8.5 0.1 19.4 1.1 2.0 2.1 0.4 0.8 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 100.4 116.5 117.7 293.8 103.6 320.0 196.3 183.1 138.3 141.4 176.3 173.0 0.1 0.0 0.0 1.0 0.0 0.0 0.1 0.5 1.8 0.0 5.6 2.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 20.9 3.7 0.2 0.1 0.3 0.0 0.0 0.0 33.0 0.0 68.6 9.7 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.3 0.0 0.0 1.0 0.2 0.0 0.0 0.0 18.7 0.0 0.4 0.3 0.5 0.0 0.1 1.5 0.0 0.0 1.7 0.8 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 GSC ENSG00000133937 "Goosecoid homeobox" P56915 14 94768223-94770113 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 3.8;breast: 6.8" "Cell type enhanced" "Detected in some" "Adipocytes: 3.5;Breast myoepithelial cells: 2.2;Ductal cells: 3.0;Exocrine glandular cells: 2.4;Fibroblasts: 9.2;Langerhans cells: 2.3;Skeletal myocytes: 2.6;Smooth muscle cells: 4.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 9 "hypothalamus: 1.4" "Immune cell enriched" "Detected in single" 8 "gdT-cell: 3.6" "Lineage enriched" "Detected in single" 18 "T-cells: 3.6" "Cell line enhanced" "Detected in some" "AN3-CA: 1.3;HEK 293: 2.0;MCF7: 3.2;REH: 3.3;SH-SY5Y: 3.5;T-47d: 2.5;U-251 MG: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB079923, CAB079924" Supported "Nucleoplasm,Nuclear speckles,Actin filaments" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 14: REH - Unknown function" "Cluster 50: Fibroblasts - ECM organization" "Nucleoplasm, Nuclear speckles" "Actin filaments" "CAB079923: , CAB079924: " "unprognostic (2.11e-2)" "unprognostic (1.04e-1)" "unprognostic (3.15e-2)" "unprognostic (5.11e-2)" "unprognostic (2.49e-1)" "unprognostic (3.70e-3)" "unprognostic (1.82e-3)" "unprognostic (3.87e-2)" "unprognostic (3.41e-1)" "unprognostic (2.74e-1)" "unprognostic (1.39e-1)" "unprognostic (2.28e-1)" "unprognostic (5.18e-10)" "unprognostic (4.96e-2)" "unprognostic (1.31e-1)" "unprognostic (1.52e-1)" "unprognostic (1.16e-1)" 3.8 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.1 0.4 0.1 0.1 0.2 0.0 0.1 0.4 0.0 0.5 0.0 1.4 0.1 0.0 0.0 0.3 0.1 0.1 0.1 0.6 0.1 0.4 0.0 0.0 0.7 0.0 0.0 0.9 0.5 1.2 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 1.6 2.2 0.1 0.3 0.2 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.3 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.6 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.1 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.1 0.6 0.3 0.0 0.0 0.0 1.0 2.2 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 3.0 0.1 0.3 0.1 0.4 0.0 0.0 0.0 2.4 0.0 9.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.2 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.7 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 2.6 4.6 0.0 1.2 0.0 0.9 0.0 0.4 0.0 0.0 0.1 DICER1 "Dicer, HERNA, K12H4.8-LIKE, KIAA0928, MNG1" ENSG00000100697 "Dicer 1, ribonuclease III" Q9UPY3 14 95086228-95158010 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction, RNA-mediated gene silencing" "Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 418.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000694, CAB068185" Approved Supported Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol "CAB068185: AB_2665650, HPA000694: AB_1078661" "unprognostic (2.97e-1)" "unprognostic (2.70e-2)" "unprognostic (1.21e-1)" "unprognostic (1.72e-1)" "unprognostic (6.75e-2)" "unprognostic (9.62e-2)" "unprognostic (1.96e-2)" "unprognostic (7.73e-2)" "unprognostic (1.21e-1)" "unprognostic (8.52e-3)" "unprognostic (5.73e-2)" "unprognostic (9.22e-2)" "unprognostic (4.22e-2)" "unprognostic (9.07e-2)" "unprognostic (2.58e-1)" "unprognostic (6.04e-3)" "unprognostic (3.74e-2)" 15.6 7.9 6.7 14.0 22.5 10.8 15.1 12.3 11.4 13.3 7.4 13.0 7.5 12.7 8.3 15.0 12.4 8.7 9.9 7.2 14.0 10.7 12.8 14.9 11.0 19.1 16.0 14.3 12.6 11.5 10.6 18.7 18.5 12.5 10.9 19.3 12.4 10.1 19.2 13.0 11.6 11.5 11.6 12.1 10.1 13.2 20.3 8.5 14.7 16.2 12.0 12.7 14.5 39.4 18.6 19.4 40.7 12.0 7.2 14.5 26.4 15.5 10.7 11.3 11.1 25.4 12.5 20.9 16.1 16.0 10.4 21.2 31.6 13.9 20.5 35.9 14.6 36.5 10.1 16.0 6.7 22.6 18.0 12.2 10.1 12.3 20.8 8.0 16.1 15.7 15.7 16.6 16.9 21.8 24.1 6.8 9.3 11.0 10.2 16.0 31.9 12.2 8.2 30.9 31.9 16.4 16.2 13.4 15.2 19.2 18.0 12.4 16.4 8.1 14.4 14.0 16.9 18.9 31.7 31.4 8.0 14.5 13.1 1.4 1.1 0.8 0.3 1.4 0.7 0.7 0.6 0.4 0.8 0.7 0.5 0.3 3.9 0.5 3.2 0.4 0.7 0.4 6.7 22.5 12.3 11.4 7.2 14.0 19.1 16.0 18.5 11.6 20.3 39.4 69.4 54.5 53.7 88.8 45.7 27.4 49.5 29.9 40.5 98.2 50.7 29.1 36.4 41.5 47.3 46.0 56.3 46.6 36.9 44.0 5.9 33.4 23.3 37.4 54.2 52.0 46.1 33.4 99.7 23.1 22.8 45.6 33.1 50.1 12.0 35.5 42.1 60.1 48.8 107.7 112.2 29.7 24.4 104.2 24.8 15.5 54.3 82.3 23.2 81.5 84.6 33.5 33.0 109.1 418.6 33.2 28.0 52.6 39.2 62.5 27.1 25.9 38.6 73.8 32.9 64.3 41.9 45.5 56.1 63.0 27.6 25.7 31.7 35.9 33.9 62.1 CLMN "FLJ12383, KIAA0500, KIAA1188" ENSG00000165959 Calmin Q96JQ2 14 95181940-95319908 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 67.0" "Cell type enhanced" "Detected in many" "Early spermatids: 161.8;Late spermatids: 313.5;Oligodendrocytes: 418.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 13.8;SK-BR-3: 16.0;T-47d: 13.5;WM-115: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012634 Enhanced Approved "Nuclear bodies,Cytosol" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nuclear bodies" Cytosol "HPA012634: AB_1846973" "unprognostic (5.31e-2)" "unprognostic (2.12e-1)" "unprognostic (4.20e-2)" "unprognostic (6.07e-2)" "unprognostic (8.88e-2)" "unprognostic (4.31e-1)" "unprognostic (4.18e-2)" "unprognostic (7.24e-2)" "unprognostic (8.31e-2)" "unprognostic (2.64e-1)" "unprognostic (1.29e-3)" "unprognostic (3.09e-2)" "prognostic favorable (2.68e-7)" "unprognostic (8.27e-2)" "unprognostic (1.33e-1)" "unprognostic (1.45e-2)" "unprognostic (9.91e-3)" 11.1 1.1 16.6 4.2 38.9 1.1 10.9 11.4 28.1 7.5 6.9 11.5 3.0 4.9 7.4 2.9 9.2 5.8 5.3 15.5 12.2 13.3 14.1 4.9 1.3 21.5 25.7 2.9 17.3 1.7 2.9 2.3 23.3 6.9 12.8 9.8 9.2 5.0 3.8 3.2 6.7 2.8 7.3 3.0 7.2 32.8 42.9 1.0 5.9 5.5 1.6 4.7 6.9 67.0 6.3 8.4 1.3 0.2 4.9 2.2 0.5 0.1 0.0 0.4 0.3 0.7 10.5 0.0 0.9 0.0 13.8 5.5 0.6 3.7 0.0 4.3 1.5 0.2 0.3 5.0 0.5 0.0 0.1 2.4 3.6 1.6 5.8 1.9 4.2 2.3 0.0 1.2 3.0 5.6 0.3 0.5 0.5 7.7 2.0 4.8 4.4 2.8 3.9 10.3 1.7 1.6 2.1 16.0 8.2 1.2 13.5 0.4 1.2 0.1 3.6 0.0 0.3 1.6 0.1 5.8 2.9 2.5 15.5 7.3 6.9 0.6 0.0 2.4 0.0 3.0 0.0 0.0 1.4 1.5 0.0 0.1 5.7 0.0 1.5 2.4 0.0 2.1 16.6 38.9 11.4 28.1 15.5 12.2 21.5 25.7 23.3 7.3 42.9 67.0 12.9 16.0 3.4 21.9 18.0 6.2 39.2 11.7 37.0 61.8 39.0 22.2 58.6 42.9 17.3 58.8 14.6 2.5 3.5 93.1 27.4 53.1 161.8 76.7 16.9 11.4 23.4 0.4 9.3 47.5 1.8 12.2 33.6 37.3 4.5 0.4 2.2 81.9 7.3 38.7 11.5 72.5 8.2 11.9 7.2 313.5 22.4 15.6 3.6 1.0 17.1 3.5 0.0 5.0 418.6 40.1 44.1 10.9 21.9 62.3 15.9 21.0 115.6 28.2 105.2 4.8 100.6 4.2 15.3 7.1 2.6 2.9 2.8 0.2 50.2 51.5 SYNE3 "C14orf139, C14orf49, FLJ25605, LINC00341, NCRNA00341, Nesp3, Nesprin-3, NET53" ENSG00000176438 "Spectrin repeat containing nuclear envelope family member 3" Q6ZMZ3 14 95407266-95475836 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 19.1" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 70.2;Cone photoreceptor cells: 62.6;Rod photoreceptor cells: 103.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 46.5;ASC TERT1: 36.2;Karpas-707: 42.3;REH: 34.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA055227, HPA077140" Approved Supported "Nuclear membrane" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 46: Photoreceptor cells - Phototransduction" "Nuclear membrane" "HPA055227: AB_2682747, HPA077140: AB_2686826" "unprognostic (4.63e-2)" "unprognostic (6.99e-3)" "unprognostic (3.79e-1)" "unprognostic (1.48e-3)" "unprognostic (7.15e-2)" "unprognostic (2.12e-3)" "unprognostic (2.45e-1)" "unprognostic (2.61e-2)" "unprognostic (4.92e-1)" "unprognostic (2.87e-1)" "unprognostic (8.50e-2)" "unprognostic (3.32e-1)" "unprognostic (7.41e-6)" "unprognostic (1.31e-1)" "unprognostic (1.42e-1)" "unprognostic (6.95e-2)" "unprognostic (7.19e-2)" 19.1 3.4 5.1 4.3 9.5 13.7 12.6 5.8 6.7 4.0 8.7 2.8 1.5 2.3 1.4 2.0 4.5 2.1 4.3 4.5 5.5 1.1 3.0 4.4 6.0 10.0 8.0 4.0 0.9 0.4 1.7 3.4 7.4 1.6 2.6 11.9 3.2 1.1 2.2 4.3 3.8 2.2 5.6 5.0 2.1 2.7 8.3 2.4 2.9 3.3 6.0 3.2 4.1 12.3 1.2 0.1 0.7 1.1 46.5 36.2 14.3 5.4 9.4 5.1 4.0 7.8 1.3 6.3 0.9 2.6 1.6 0.3 1.1 4.0 2.3 20.9 0.9 4.3 0.9 2.1 6.0 6.6 10.4 10.2 1.4 6.4 3.7 0.4 9.0 1.9 0.3 42.3 3.9 1.5 3.9 7.3 0.1 0.2 2.6 34.8 23.2 13.5 0.6 0.7 1.0 5.1 0.2 0.1 2.5 0.6 2.0 9.6 8.2 3.7 2.2 5.0 0.7 5.0 11.1 5.9 7.4 14.6 28.2 2.2 1.9 0.1 0.7 1.5 0.9 1.2 1.0 0.8 0.8 1.0 1.2 1.0 0.9 0.3 1.6 1.0 0.9 1.0 5.1 9.5 5.8 6.7 4.5 5.5 10.0 8.0 7.4 5.6 8.3 12.3 12.4 9.6 18.3 3.3 19.7 2.3 0.4 0.1 0.6 5.1 1.0 1.3 70.2 0.0 0.7 0.0 62.6 2.2 16.1 4.9 0.0 0.0 3.9 6.5 5.1 14.7 1.2 4.0 2.5 0.4 15.0 22.3 1.1 1.4 12.0 0.2 5.0 6.8 4.3 6.7 3.3 5.0 0.0 17.6 14.8 2.4 13.1 20.3 5.4 3.7 27.8 5.3 9.2 14.1 20.8 0.5 6.2 0.4 20.6 1.9 2.9 0.4 6.6 103.7 6.6 19.1 12.1 0.6 1.1 0.3 1.0 1.9 14.0 0.0 1.9 0.5 GLRX5 "C14orf87, GRX5, PR01238" ENSG00000182512 "Glutaredoxin 5" Q86SX6 14 95533503-95544724 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 195.0" "Cell type enhanced" "Detected in all" "Distal tubular cells: 518.5;Erythroid cells: 1134.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042465, HPA063716" Approved Supported Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 6: Erythroid cells - Oxygen transport" Mitochondria "HPA042465: AB_10794048, HPA063716: AB_2685102" "unprognostic (2.57e-1)" "unprognostic (6.76e-2)" "unprognostic (1.60e-2)" "unprognostic (2.69e-2)" "unprognostic (3.72e-2)" "unprognostic (2.43e-3)" "unprognostic (1.29e-1)" "unprognostic (5.41e-2)" "unprognostic (8.28e-2)" "prognostic favorable (1.08e-5)" "unprognostic (1.85e-1)" "unprognostic (1.02e-1)" "prognostic favorable (7.83e-10)" "unprognostic (1.44e-1)" "unprognostic (3.81e-2)" "unprognostic (2.66e-2)" "unprognostic (8.91e-2)" 37.2 52.1 44.1 17.6 44.9 178.8 27.2 43.8 50.2 22.3 46.7 44.8 46.2 19.2 39.0 24.5 23.6 17.5 76.9 46.6 45.8 74.5 105.5 18.3 23.1 43.3 44.5 32.8 31.5 46.3 18.9 37.8 44.3 26.8 37.3 10.1 29.3 29.6 195.0 18.3 33.2 24.4 42.9 20.8 34.2 35.7 46.2 40.3 26.7 168.9 27.0 24.5 15.0 42.9 77.1 92.7 61.4 68.0 74.2 57.5 202.0 54.9 56.1 69.4 69.1 124.8 87.5 111.7 77.4 42.8 39.2 75.5 116.5 79.6 71.5 68.5 94.4 100.3 63.4 202.2 73.5 160.9 96.5 55.4 74.1 49.9 81.1 28.1 76.1 94.4 115.7 88.3 61.2 205.5 133.6 165.9 81.5 89.7 107.8 220.8 184.3 67.8 93.3 89.3 127.9 75.2 54.8 81.3 87.7 59.9 107.7 72.6 55.6 30.5 65.0 77.6 85.7 41.7 57.9 92.0 67.2 99.8 72.2 0.4 2.9 4.8 3.4 4.3 4.9 4.6 4.6 6.0 4.7 5.4 3.7 3.9 1.3 3.9 2.7 9.0 6.2 1.8 44.1 44.9 43.8 50.2 46.6 45.8 43.3 44.5 44.3 42.9 46.2 42.9 78.7 28.9 30.0 7.8 41.1 108.5 58.7 7.5 61.5 38.5 112.8 135.9 150.0 64.3 10.4 95.6 33.3 97.8 66.5 76.3 518.5 15.2 312.0 49.7 61.5 58.9 54.0 1134.9 15.0 15.6 164.9 66.2 46.4 48.3 14.7 110.3 47.2 147.2 58.7 50.5 16.4 72.1 4.1 41.7 58.7 90.2 54.3 50.7 87.2 7.5 21.3 128.1 52.5 12.5 15.2 15.2 39.5 73.7 75.2 108.2 51.8 281.4 9.1 43.0 59.2 61.1 92.7 115.4 79.0 102.2 124.9 53.8 48.8 169.0 88.0 76.6 TCL1B TML1 ENSG00000213231 "TCL1 family AKT coactivator B" O95988 14 95686426-95692628 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 1.2;lymphoid tissue: 2.5;testis: 2.5" "Cell type enriched" "Detected in some" 8 "Syncytiotrophoblasts: 72.7" "Cancer enriched" "Detected in single" 72 "testis cancer: 8.3" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 24 "naive B-cell: 11.7;plasmacytoid DC: 6.2" "Group enriched" "Detected in many" 24 "B-cells: 11.7;dendritic cells: 6.2" "Cell line enriched" "Detected in some" 7 "U-698: 511.8" "Not detected" "Not detected" HPA053163 Uncertain Approved Cytosol NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Cytosol "HPA053163: AB_2682064" "unprognostic (1.55e-1)" 0.1 0.0 0.1 0.4 0.7 1.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 2.2 0.6 0.4 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.7 0.0 2.5 0.4 0.2 0.0 0.0 2.5 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 73.5 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.5 0.0 2.5 0.6 0.4 0.0 0.0 1.3 0.0 0.2 0.2 0.4 511.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.3 0.3 0.0 6.2 0.0 0.3 0.1 0.7 0.1 0.2 0.1 0.2 0.6 0.4 0.5 0.1 0.4 1.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.1 9.0 0.0 0.0 72.7 0.0 0.1 0.0 0.1 TCL1A TCL1 ENSG00000100721 "TCL1 family AKT coactivator A" P56279 14 95709947-95714196 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "lymphoid tissue: 267.6" "Group enriched" "Detected in some" 4 "B-cells: 282.5;dendritic cells: 210.3" "Cancer enriched" "Detected in many" 18 "testis cancer: 64.4" "Not detected" "Not detected" "Group enriched" "Detected in many" 296 "memory B-cell: 874.7;naive B-cell: 2160.3;plasmacytoid DC: 1099.9" "Group enriched" "Detected in all" 350 "B-cells: 2160.3;dendritic cells: 1099.9" "Group enriched" "Detected in some" 142 "Daudi: 459.4;REH: 599.4;U-698: 616.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB004045, HPA016604" Enhanced Enhanced "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA "Cluster 37: B-cells - Transcription" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" "Endoplasmic reticulum, Cytosol" Nucleoplasm "CAB004045: AB_2179419, HPA016604: AB_1857859" "unprognostic (1.27e-3)" "unprognostic (3.12e-4)" "unprognostic (2.61e-4)" "unprognostic (2.01e-2)" "unprognostic (1.27e-1)" "unprognostic (4.75e-4)" "unprognostic (7.70e-2)" "unprognostic (9.67e-3)" "unprognostic (1.03e-1)" "unprognostic (3.35e-1)" "unprognostic (1.14e-1)" "unprognostic (2.14e-2)" "unprognostic (2.64e-2)" "unprognostic (1.87e-1)" "unprognostic (3.94e-1)" "unprognostic (2.06e-1)" "unprognostic (4.55e-1)" 1.0 0.1 0.1 34.4 0.1 20.3 0.2 0.1 0.1 0.1 0.0 2.4 0.8 0.8 0.6 0.5 0.1 3.6 0.6 0.1 0.1 0.4 0.4 1.0 267.6 0.1 0.1 0.1 0.3 0.0 0.0 0.8 0.2 0.3 2.0 0.0 4.0 0.0 0.1 0.4 14.2 0.3 0.0 56.7 3.4 7.7 0.1 19.1 1.1 0.0 216.0 2.7 0.1 0.3 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 459.4 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.6 0.3 0.0 0.0 0.4 0.3 0.0 0.0 0.0 599.4 0.3 0.8 0.0 0.0 0.2 0.2 0.4 0.7 0.1 0.3 0.1 1.0 1.0 0.2 2.8 0.6 0.2 0.5 3.9 616.2 0.2 0.1 0.1 4.6 1.4 1.8 0.5 0.5 1.3 874.7 0.9 0.4 2.2 2160.3 1.5 0.5 3.3 1.3 1.6 1099.9 1.2 92.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.3 0.0 0.0 1.3 0.0 282.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 210.3 0.6 0.0 0.0 0.9 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.2 0.5 0.0 0.0 0.0 0.4 0.2 0.3 0.0 0.0 0.2 0.0 0.3 0.0 0.9 0.6 2.8 0.0 0.0 2.7 0.0 3.1 0.0 0.0 0.0 0.2 0.4 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 28.7 60.2 0.0 0.0 0.0 2.7 0.0 0.3 0.0 TUNAR "HI-LNC78, LINC00617, TUNA" ENSG00000250366 "TCL1 upstream neural differentiation-associated RNA" 14 95876392-95925663 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 42.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 4.1;Endometrial ciliated cells: 11.5;Endometrial stromal cells: 8.9;Excitatory neurons: 4.6;Glandular and luminal cells: 16.8;Spermatogonia: 3.5" "Cancer enhanced" "Detected in many" "testis cancer: 3.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 16.3;HAP1: 7.0;NTERA-2: 11.8;SCLC-21H: 16.1;SuSa: 4.6" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 12: NES - Nervous system development" "Cluster 44: Endometrium - Transcription" "unprognostic (1.28e-3)" "unprognostic (3.94e-1)" "unprognostic (4.10e-2)" "unprognostic (1.69e-1)" "unprognostic (1.41e-2)" "unprognostic (1.34e-1)" "prognostic favorable (1.55e-4)" "unprognostic (5.33e-2)" "unprognostic (2.92e-2)" "unprognostic (1.18e-1)" 0.0 0.1 6.3 0.1 42.5 0.3 0.4 5.6 10.8 0.3 0.0 0.0 0.1 6.5 0.1 0.0 8.5 0.1 0.0 9.5 9.6 0.2 0.0 0.0 0.3 30.8 12.0 0.1 2.7 0.0 1.2 0.0 30.5 0.0 0.0 8.5 0.0 3.5 0.0 0.1 0.0 0.0 11.6 0.1 0.5 1.3 23.0 0.1 1.1 0.0 0.2 0.0 0.0 3.9 0.0 0.1 16.3 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 7.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 11.8 0.0 0.1 0.7 0.0 0.0 0.4 0.1 16.1 1.3 0.0 0.1 0.0 4.6 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 42.5 5.6 10.8 9.5 9.6 30.8 12.0 30.5 11.6 23.0 3.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.3 0.0 0.0 0.0 2.1 0.0 1.3 0.0 0.0 0.0 2.8 11.5 8.9 0.1 0.0 0.0 4.6 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.1 0.1 3.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 C14orf132 C14orf88 ENSG00000227051 "Chromosome 14 open reading frame 132" Q9NPU4 14 96039362-96093971 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 74.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 38.5;Bipolar cells: 57.8;Endometrial ciliated cells: 55.2;Horizontal cells: 63.9;Skeletal myocytes: 44.9" "Cancer enhanced" "Detected in many" "glioma: 12.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 49.9;SCLC-21H: 52.5;SH-SY5Y: 52.0;U-87 MG: 46.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 56: Bipolar cells - Visual perception" "unprognostic (1.82e-1)" "unprognostic (1.18e-1)" "unprognostic (1.40e-2)" "unprognostic (1.53e-1)" "unprognostic (2.07e-1)" "unprognostic (5.47e-2)" "unprognostic (2.50e-2)" "unprognostic (1.27e-1)" "unprognostic (1.82e-1)" "unprognostic (4.42e-2)" "prognostic favorable (3.54e-4)" "unprognostic (2.51e-2)" "unprognostic (5.55e-3)" "unprognostic (1.47e-2)" "unprognostic (3.09e-2)" "unprognostic (1.33e-5)" "prognostic unfavorable (4.95e-4)" 5.9 14.0 57.3 3.2 58.1 0.1 6.9 62.8 69.1 23.3 20.5 23.8 2.1 26.2 14.2 7.1 22.5 5.0 4.1 74.7 52.5 9.9 4.1 18.4 0.8 53.6 49.8 5.2 3.2 0.1 38.8 0.8 50.9 9.5 4.4 12.8 3.0 19.8 3.0 13.8 14.2 22.3 51.2 6.2 15.7 1.3 55.8 3.1 2.4 6.6 1.2 8.5 11.9 56.1 0.0 6.4 30.8 9.7 22.0 22.0 0.1 10.6 23.8 13.6 8.3 0.1 0.1 0.0 2.4 23.8 9.0 0.7 3.7 0.8 11.7 0.0 1.4 0.1 1.2 0.1 2.7 0.0 0.2 12.0 1.2 12.7 1.0 0.0 0.2 3.0 0.0 0.1 6.3 49.9 0.8 0.1 15.0 0.0 0.0 28.5 5.0 0.1 11.0 22.4 52.5 52.0 8.3 1.0 1.5 8.3 28.9 1.4 0.0 10.8 6.5 18.0 0.0 0.0 0.0 0.1 46.1 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.9 0.1 0.0 0.0 0.0 0.1 0.1 0.2 57.3 58.1 62.8 69.1 74.7 52.5 53.6 49.8 50.9 51.2 55.8 56.1 4.8 38.5 10.6 14.7 0.4 2.7 3.7 5.9 5.2 57.8 0.7 7.1 1.9 1.5 3.9 7.3 20.9 0.3 0.2 0.0 5.9 5.8 3.0 55.2 23.8 8.6 9.0 0.0 20.3 0.2 1.0 16.6 2.0 6.8 1.3 5.4 19.2 4.0 0.3 63.9 11.2 0.1 4.1 0.6 7.1 3.0 15.8 0.5 8.8 7.5 0.1 4.0 0.0 11.1 24.7 1.2 0.1 13.5 0.1 2.1 0.0 0.0 13.6 6.1 0.0 44.9 4.4 0.3 0.6 6.8 7.7 0.3 1.0 0.6 0.1 2.3 BDKRB2 BK-2 ENSG00000168398 "Bradykinin receptor B2" P30411 14 96204679-96244166 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 41.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 19.3;Endothelial cells: 18.2;Fibroblasts: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 49.2;BJ hTERT+: 94.5;U-87 MG: 39.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA003551, HPA050841" Approved Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" "Golgi apparatus, Vesicles" "HPA003551: , HPA050841: AB_2681254" "unprognostic (1.03e-1)" "unprognostic (7.90e-2)" "unprognostic (1.12e-1)" "unprognostic (1.83e-1)" "unprognostic (8.79e-3)" "unprognostic (2.68e-2)" "unprognostic (1.93e-1)" "unprognostic (4.66e-2)" "unprognostic (1.94e-1)" "unprognostic (2.84e-2)" "unprognostic (3.19e-1)" "unprognostic (1.72e-1)" "unprognostic (3.32e-3)" "unprognostic (3.11e-2)" "unprognostic (9.40e-2)" "unprognostic (9.90e-2)" "unprognostic (1.49e-2)" 14.0 1.4 0.8 5.5 1.0 0.0 5.8 3.8 1.1 15.6 0.9 12.4 7.9 6.7 2.4 17.2 7.2 20.8 1.2 0.9 0.8 13.4 0.7 2.5 0.3 4.9 1.3 1.0 9.4 0.9 0.8 1.3 5.0 4.8 12.2 0.0 3.5 6.2 0.9 5.4 9.7 10.2 1.0 0.1 4.9 0.2 1.5 0.9 3.6 1.8 1.7 41.1 15.4 1.2 1.7 6.1 0.1 11.0 16.2 49.2 0.0 5.5 94.5 3.2 3.7 0.3 10.4 0.0 0.2 8.7 3.7 14.8 0.0 2.4 2.8 1.2 0.1 0.0 1.1 0.0 7.8 0.0 0.0 15.1 7.5 9.4 4.7 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.1 0.1 20.4 0.0 0.0 2.2 0.0 3.2 0.0 3.4 1.1 1.8 15.6 0.1 2.1 1.0 0.0 0.0 0.3 0.3 3.3 0.1 0.2 0.0 0.0 39.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 1.0 3.8 1.1 0.9 0.8 4.9 1.3 5.0 1.0 1.5 1.2 8.2 3.2 3.1 0.0 0.0 9.2 0.7 5.3 6.8 0.0 0.2 0.5 0.6 10.0 11.6 9.2 0.0 1.2 0.0 19.3 7.9 11.5 0.0 7.5 16.1 18.2 7.1 0.0 1.8 3.8 3.6 25.8 1.1 4.6 0.0 0.0 3.3 0.2 0.2 0.0 0.4 7.2 8.2 0.0 15.2 0.0 0.9 0.4 5.4 0.0 0.0 0.0 0.0 1.0 1.9 6.9 6.2 1.2 0.0 1.0 10.6 0.2 12.5 0.0 0.0 4.5 1.2 0.0 0.0 15.3 5.8 4.0 0.3 0.1 0.9 2.9 AL355102.2 ENSG00000258691 "Novel protein" 14 96204844-96263929 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 2.4;kidney: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.0;HaCaT: 2.8;hTCEpi: 1.9" NA NA "Cluster 37: Intestine - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "unprognostic (6.82e-2)" "unprognostic (4.35e-2)" "unprognostic (6.28e-2)" "unprognostic (6.16e-3)" "unprognostic (7.02e-2)" "unprognostic (5.97e-2)" "unprognostic (4.71e-2)" "unprognostic (2.46e-1)" "unprognostic (3.57e-3)" "unprognostic (9.07e-2)" 0.9 0.0 0.1 0.1 0.3 0.0 0.3 0.6 0.5 1.3 0.0 0.9 0.2 0.2 0.0 2.4 0.4 0.6 0.1 0.1 0.1 2.1 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.7 0.0 0.4 0.1 0.2 0.6 0.6 0.6 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.4 1.5 1.6 0.5 0.2 1.0 0.0 0.0 0.0 1.7 0.0 1.3 5.0 0.1 0.8 0.0 0.1 0.0 0.0 0.5 0.5 2.8 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.6 1.9 1.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.9 0.0 0.0 1.1 0.0 0.5 0.0 0.2 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.6 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BDKRB1 "B1BKR, BKR1, bradyb1" ENSG00000100739 "Bradykinin receptor B1" P46663 14 96256210-96268967 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 23.4" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 40.8;Basal squamous epithelial cells: 41.5;Fibroblasts: 17.0;Squamous epithelial cells: 22.5;Suprabasal keratinocytes: 17.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 32.0;fHDF/TERT166: 18.8;HHSteC: 29.2;hTEC/SVTERT24-B: 29.2;U-2197: 27.9;U-87 MG: 90.1" "Low region specificity" "Detected in single" HPA002935 Approved NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 61: Squamous epithelial cells - Keratinization" "HPA002935: AB_1078274" "unprognostic (6.15e-2)" "unprognostic (2.78e-2)" "unprognostic (9.40e-2)" "unprognostic (3.06e-3)" "unprognostic (6.76e-2)" "unprognostic (1.11e-2)" "unprognostic (3.31e-2)" "unprognostic (2.34e-3)" "unprognostic (2.23e-2)" "unprognostic (2.96e-2)" "unprognostic (4.80e-3)" "unprognostic (2.36e-1)" "unprognostic (9.96e-6)" "unprognostic (2.33e-1)" "unprognostic (8.82e-2)" "unprognostic (2.33e-3)" "unprognostic (4.66e-2)" 10.7 0.2 0.4 5.2 0.7 0.0 1.2 1.3 0.9 6.9 0.3 4.2 1.8 0.9 0.6 13.4 5.1 14.1 1.6 0.5 0.3 8.3 0.2 1.3 0.1 0.5 0.4 0.4 6.5 0.0 0.2 0.7 0.5 1.5 2.7 0.2 1.9 0.2 0.1 3.3 3.6 6.0 0.3 0.1 4.5 2.3 0.4 0.1 1.1 0.5 0.4 23.4 7.4 0.6 0.5 1.4 0.0 1.2 2.9 9.9 0.1 2.3 32.0 3.1 0.5 0.0 0.6 0.0 0.1 18.8 1.4 2.4 0.0 0.4 5.0 0.3 0.1 0.0 2.7 0.0 29.2 0.0 0.1 1.0 2.4 29.2 0.6 0.2 0.0 0.0 0.0 0.1 4.2 0.4 0.0 0.0 0.0 1.7 0.2 0.0 7.2 0.2 0.2 0.1 0.7 0.0 8.2 2.4 0.0 0.3 0.0 0.0 0.0 9.5 0.6 27.9 1.8 4.6 9.3 0.0 90.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.7 1.3 0.9 0.5 0.3 0.5 0.4 0.5 0.3 0.4 0.6 1.4 0.0 0.5 0.0 0.0 40.8 2.9 9.0 41.5 1.7 0.0 0.3 0.8 0.0 3.2 0.0 0.0 0.3 0.0 5.5 7.9 2.3 1.1 0.9 3.7 5.0 0.0 0.0 0.4 1.2 1.4 17.0 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.1 8.2 0.0 6.1 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.3 4.9 0.4 0.0 1.6 2.3 0.1 3.3 0.1 0.0 1.6 2.5 0.9 1.3 22.5 17.2 1.5 0.2 0.0 0.4 2.8 ATG2B "C14orf103, FLJ10242" ENSG00000066739 "Autophagy related 2B" Q96BY7 14 96279195-96363341 "Predicted intracellular proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 84.5;Oligodendrocyte precursor cells: 105.6;Oligodendrocytes: 84.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001427, HPA019665" Approved NA NA "Cluster 15: NK-cells - Transcription" "Cluster 54: Non-specific - Microtubule organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 44: Endometrium - Transcription" "HPA001427: AB_1845551, HPA019665: AB_2274278" "unprognostic (9.39e-2)" "unprognostic (1.01e-1)" "unprognostic (7.28e-2)" "unprognostic (1.07e-1)" "unprognostic (1.02e-1)" "unprognostic (6.01e-2)" "unprognostic (3.19e-1)" "unprognostic (9.29e-3)" "unprognostic (1.47e-1)" "unprognostic (1.21e-1)" "unprognostic (3.75e-3)" "unprognostic (1.45e-2)" "unprognostic (7.60e-3)" "unprognostic (6.66e-2)" "unprognostic (3.08e-1)" "unprognostic (3.90e-2)" "unprognostic (8.49e-2)" 6.4 6.2 5.8 3.9 6.8 6.7 6.5 8.6 7.9 7.2 5.8 6.3 4.4 7.4 5.5 5.2 6.9 4.2 4.9 6.2 5.4 5.6 9.8 6.0 4.7 8.1 5.4 7.2 12.1 8.2 6.8 4.0 8.2 5.9 4.3 12.1 5.4 4.0 8.6 11.4 7.3 5.0 5.0 6.4 6.4 8.6 5.9 6.9 7.3 7.2 4.9 5.7 6.3 9.0 3.8 4.8 5.8 4.5 9.9 9.1 4.6 5.5 7.8 5.9 6.7 2.6 2.6 8.5 5.1 9.1 3.9 5.1 8.0 5.4 9.5 7.9 4.0 3.7 5.2 2.3 6.5 6.9 3.9 7.6 5.4 8.0 6.3 6.3 7.6 6.3 4.3 7.5 4.8 6.2 6.2 5.9 2.8 4.5 4.8 5.6 13.0 5.7 6.7 4.6 5.6 6.4 8.4 3.4 4.0 5.9 5.3 3.9 10.2 3.3 1.5 8.1 3.5 7.4 6.5 7.7 6.7 4.7 3.2 0.1 0.2 0.4 0.3 0.1 0.5 0.2 0.3 0.3 0.2 0.2 0.3 0.3 0.4 0.5 0.2 0.3 0.5 0.1 5.8 6.8 8.6 7.9 6.2 5.4 8.1 5.4 8.2 5.0 5.9 9.0 15.8 12.8 12.3 47.3 11.0 13.8 3.7 4.4 21.6 24.8 12.2 7.7 14.2 12.8 6.3 9.2 27.1 5.8 12.3 9.5 3.9 5.8 41.0 20.8 16.9 12.9 8.3 21.8 84.5 6.1 3.2 14.0 10.7 26.9 7.0 10.9 14.6 27.2 4.2 32.0 66.3 13.3 2.0 12.6 10.7 48.9 12.8 8.9 1.8 36.5 6.4 7.9 6.2 105.6 84.2 5.3 10.7 10.5 27.2 9.0 12.5 8.9 7.0 19.4 6.6 13.8 12.6 17.7 14.9 19.6 28.1 15.7 13.0 8.7 9.4 3.7 GSKIP C14orf129 ENSG00000100744 "GSK3B interacting protein" Q9P0R6 14 96363452-96387288 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 166.1;Early spermatids: 384.9;Late spermatids: 321.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043054, HPA046782" Approved Approved "Nucleoli,Golgi apparatus,Vesicles" No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 45: Intestine - Brush border" "Cluster 15: RT4 - Unknown function" "Cluster 34: Spermatids - Unknown function" "Golgi apparatus, Vesicles" Nucleoli "HPA043054: AB_2678293, HPA046782: AB_2679803" "unprognostic (3.48e-1)" "unprognostic (1.16e-1)" "unprognostic (1.68e-2)" "unprognostic (5.08e-2)" "unprognostic (1.58e-1)" "unprognostic (1.04e-1)" "unprognostic (6.23e-3)" "unprognostic (1.11e-1)" "unprognostic (9.35e-2)" "unprognostic (1.16e-3)" "unprognostic (6.82e-2)" "unprognostic (2.84e-1)" "unprognostic (8.74e-3)" "unprognostic (4.67e-2)" "unprognostic (1.52e-1)" "unprognostic (1.48e-2)" "unprognostic (2.30e-1)" 11.4 13.1 13.6 17.5 16.7 16.2 13.2 14.7 16.7 10.4 10.9 60.4 48.3 10.6 11.3 41.0 10.9 14.2 11.0 15.7 14.8 16.4 23.3 9.7 19.6 12.9 12.0 6.7 9.9 9.5 8.1 13.8 13.3 13.9 54.6 67.8 12.1 9.9 12.7 14.5 56.6 15.9 13.9 11.8 23.3 48.7 13.7 11.1 10.3 10.6 22.4 21.1 16.2 14.9 21.9 30.5 33.6 23.1 25.2 29.1 56.6 39.7 30.7 26.2 28.8 22.7 36.6 20.9 23.6 30.4 15.9 23.8 22.1 24.2 37.9 49.9 21.1 8.8 16.1 17.5 23.4 23.1 14.5 23.2 37.7 33.1 32.7 20.1 34.6 23.5 19.2 18.7 33.6 53.5 17.0 18.6 37.3 33.9 38.3 16.7 31.4 19.3 61.5 79.9 11.8 38.4 44.8 41.6 34.9 33.7 31.9 14.3 37.8 12.0 15.1 25.6 12.8 21.7 67.0 17.8 30.6 16.4 19.6 64.4 20.9 47.0 27.7 24.3 42.8 38.3 37.6 32.4 21.2 33.1 37.0 34.5 40.9 37.5 33.6 17.9 66.6 28.6 13.6 16.7 14.7 16.7 15.7 14.8 12.9 12.0 13.3 13.9 13.7 14.9 12.6 12.8 7.4 5.9 24.8 45.2 24.2 27.6 19.9 26.8 18.4 14.5 18.9 14.3 21.7 20.2 41.7 42.7 17.9 166.1 72.4 34.1 384.9 32.3 11.1 17.4 28.1 24.0 14.3 39.4 43.3 12.1 41.8 32.2 19.7 6.6 17.9 17.3 23.6 23.5 10.8 73.0 52.9 19.8 19.6 321.7 8.1 16.8 19.6 5.6 25.2 22.3 16.5 10.6 17.9 39.9 102.9 7.9 22.6 37.4 81.8 47.4 28.6 104.0 19.7 6.5 16.5 40.0 34.1 35.7 65.9 119.6 24.4 7.9 69.1 43.7 AK7 "CFAP75, FAP75, FLJ32864" ENSG00000140057 "Adenylate kinase 7" Q96M32 14 96392128-96489427 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 24.3" "Group enriched" "Detected in many" 4 "Endometrial ciliated cells: 97.9;Respiratory ciliated cells: 137.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 23 "basophil: 9.0" "Lineage enriched" "Detected in single" 29 "granulocytes: 9.0" "Cell line enhanced" "Detected in many" "BEWO: 17.0;CAPAN-2: 15.1;MCF7: 49.5;REH: 35.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003543 Enhanced NA NA "Cluster 38: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" "HPA003543: AB_1078117" "unprognostic (4.18e-3)" "unprognostic (1.14e-1)" "unprognostic (9.40e-3)" "prognostic favorable (3.18e-4)" "unprognostic (4.98e-5)" "unprognostic (8.41e-2)" "unprognostic (9.81e-3)" "unprognostic (1.29e-1)" "unprognostic (9.02e-2)" "unprognostic (3.65e-4)" "unprognostic (8.64e-2)" "unprognostic (1.89e-1)" "prognostic favorable (1.14e-4)" "unprognostic (2.00e-2)" "unprognostic (1.23e-2)" "unprognostic (4.01e-2)" "unprognostic (2.25e-3)" 0.7 2.6 2.0 0.6 3.1 1.5 1.4 1.1 1.7 1.7 13.2 2.1 1.9 2.1 3.9 1.5 24.3 2.6 0.7 2.2 5.2 4.5 1.6 4.2 0.6 6.9 9.4 0.4 2.2 6.9 5.1 0.5 5.6 0.9 1.6 3.0 1.0 1.3 0.3 6.1 1.2 1.1 4.4 3.3 2.8 7.6 5.0 0.5 2.7 0.0 0.4 0.5 1.0 4.2 0.2 4.9 2.0 1.5 0.8 2.6 17.0 0.3 0.6 0.3 0.3 0.5 15.1 0.4 0.3 0.0 0.3 1.9 4.7 0.2 0.1 2.2 0.4 0.4 2.4 0.2 0.8 0.1 0.3 0.2 0.6 2.5 0.1 0.8 0.2 1.4 0.2 0.3 0.3 49.5 0.3 0.3 0.8 2.2 1.0 35.2 0.3 0.4 7.6 0.3 3.1 6.7 1.9 0.6 0.1 1.8 4.2 0.2 0.1 0.4 0.2 0.6 0.2 0.6 2.3 0.2 0.2 0.0 0.7 9.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.2 0.1 0.1 0.3 0.2 0.2 0.0 0.0 0.1 2.0 3.1 1.1 1.7 2.2 5.2 6.9 9.4 5.6 4.4 5.0 4.2 1.6 6.4 4.1 0.7 0.8 1.8 0.9 3.6 1.8 0.2 0.9 0.3 0.4 4.3 12.3 7.3 2.1 0.7 0.1 1.4 3.9 3.2 18.7 97.9 1.7 1.9 1.2 6.9 2.0 1.1 1.7 0.8 5.1 11.6 0.0 0.1 0.7 2.4 0.2 0.0 2.4 0.3 4.1 0.3 0.4 4.1 0.0 0.5 1.8 0.0 0.0 0.6 0.0 0.5 3.7 0.5 0.1 0.0 0.0 0.5 1.0 3.4 137.1 1.8 0.0 0.4 1.6 25.4 9.1 0.7 3.0 2.9 0.2 1.5 1.2 0.6 PAPOLA PAP ENSG00000090060 "Poly(A) polymerase alpha" P51003 14 96501433-96567111 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 1036.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001788 Supported Supported Nucleoplasm NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA001788: AB_1079564" "unprognostic (3.18e-1)" "unprognostic (1.30e-1)" "unprognostic (9.69e-2)" "unprognostic (7.26e-2)" "unprognostic (9.10e-2)" "unprognostic (5.10e-3)" "prognostic unfavorable (2.41e-5)" "unprognostic (2.12e-2)" "unprognostic (2.82e-2)" "unprognostic (1.38e-3)" "unprognostic (3.13e-1)" "unprognostic (1.22e-3)" "unprognostic (3.37e-1)" "unprognostic (1.65e-1)" "unprognostic (1.77e-1)" "unprognostic (1.08e-2)" "unprognostic (4.05e-1)" 52.6 60.5 62.7 66.6 65.1 96.9 62.7 71.7 87.4 61.7 70.1 70.5 57.1 68.5 72.5 59.6 57.9 56.1 61.0 59.9 64.4 60.7 81.6 50.0 77.8 63.0 61.7 76.1 71.6 73.2 53.0 85.3 64.3 54.2 71.8 92.4 63.8 54.0 46.7 57.9 67.6 61.6 62.8 69.3 65.9 75.8 62.1 93.0 68.9 56.4 82.8 66.4 53.5 80.7 126.6 119.4 150.5 152.6 107.2 119.4 331.6 112.9 120.4 132.1 125.8 132.9 125.6 170.9 125.3 134.1 115.2 104.4 50.1 156.9 235.0 141.1 81.1 131.9 88.9 138.5 110.6 166.2 133.4 110.6 134.1 148.0 131.1 127.8 150.5 79.5 128.2 146.5 128.9 184.6 140.5 91.1 102.9 205.0 135.3 146.7 183.5 98.7 132.0 192.7 154.0 102.0 151.4 115.8 111.6 167.9 165.3 158.3 119.0 91.3 72.6 104.1 140.7 114.3 186.7 138.6 144.5 137.5 158.9 73.5 32.0 56.1 23.8 39.3 29.0 38.9 30.2 34.2 38.8 42.7 35.3 33.9 41.3 41.3 37.7 25.1 32.7 36.6 62.7 65.1 71.7 87.4 59.9 64.4 63.0 61.7 64.3 62.8 62.1 80.7 126.3 80.1 122.4 64.6 171.4 229.7 406.3 196.6 126.9 78.2 140.0 101.6 157.2 88.6 160.1 84.6 95.9 346.2 139.6 124.1 183.9 121.4 634.7 326.1 145.4 150.7 117.2 126.8 87.9 137.0 440.7 129.9 95.3 371.7 136.4 113.8 85.6 112.3 155.6 63.9 111.5 154.9 168.9 141.3 239.4 275.3 96.3 153.2 168.9 104.9 171.8 93.4 135.9 105.1 115.2 129.6 118.9 80.5 197.4 373.0 122.5 136.5 253.1 107.2 105.2 131.6 185.0 256.8 203.0 146.0 247.6 1036.0 167.8 131.2 166.1 540.3 VRK1 ENSG00000100749 "VRK serine/threonine kinase 1" Q99986 14 96797304-96954846 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 50.4;testis: 37.1" "Cell type enhanced" "Detected in all" "Spermatocytes: 198.9;Spermatogonia: 110.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000660, HPA017929" Enhanced Supported Nucleoplasm,Cytosol Yes No "Cluster 15: NK-cells - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Cytosol "HPA000660: AB_1080579, HPA017929: AB_1858770" "unprognostic (1.03e-1)" "unprognostic (1.17e-2)" "unprognostic (1.84e-2)" "unprognostic (2.24e-3)" "unprognostic (5.42e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (4.15e-4)" "unprognostic (4.20e-2)" "unprognostic (2.11e-2)" "unprognostic (5.47e-2)" "unprognostic (5.14e-2)" "unprognostic (1.60e-1)" "unprognostic (2.53e-2)" "unprognostic (6.70e-2)" "unprognostic (4.56e-2)" "unprognostic (3.36e-2)" "unprognostic (1.58e-1)" 5.9 5.2 5.9 12.8 7.1 50.4 11.5 6.0 7.9 5.2 4.3 10.8 6.5 6.5 6.9 8.9 9.2 4.4 5.2 5.9 5.1 4.9 5.5 4.9 27.1 5.3 5.5 6.0 3.2 5.4 3.1 7.6 5.4 5.0 12.3 4.4 4.3 5.0 4.7 7.4 7.2 6.7 4.8 11.3 6.5 37.1 5.9 35.5 5.9 4.6 27.9 7.7 5.4 7.0 52.4 27.0 78.5 30.2 9.2 14.9 44.8 42.8 34.4 67.1 65.4 36.0 54.7 139.2 22.4 24.3 39.2 56.5 75.5 54.4 90.5 73.4 36.4 90.5 18.7 39.3 10.2 168.5 49.2 8.5 9.7 50.4 32.6 12.8 47.0 104.8 76.6 79.0 56.9 65.5 137.1 76.5 47.8 39.9 59.3 124.5 134.2 48.6 32.3 59.3 53.2 28.0 34.2 36.4 30.8 36.0 39.3 66.6 24.4 27.9 22.8 47.7 37.3 37.7 53.5 124.8 44.7 74.6 34.8 42.7 12.3 26.2 21.5 15.5 29.0 31.3 24.9 26.4 15.7 32.7 27.1 27.3 6.5 45.6 15.2 21.4 34.9 19.4 5.9 7.1 6.0 7.9 5.9 5.1 5.3 5.5 5.4 4.8 5.9 7.0 15.3 3.2 4.6 6.8 30.6 16.8 13.8 23.3 6.2 12.4 9.3 11.3 11.8 12.8 16.7 14.7 8.4 34.8 24.8 6.3 11.7 13.5 21.3 21.1 8.3 12.4 3.0 76.2 42.0 19.4 48.3 11.4 14.8 10.8 28.5 20.0 7.1 3.3 19.2 10.1 36.2 10.4 20.3 11.8 14.9 11.5 5.6 12.0 12.4 19.7 14.2 6.2 27.8 12.1 19.8 10.3 2.2 9.8 25.4 6.1 3.0 11.2 37.6 9.6 19.7 14.3 15.1 198.9 110.9 14.1 13.9 15.1 26.8 9.2 18.1 10.4 BCL11B "CTIP-2, CTIP2, hRIT1-alpha, ZNF856B" ENSG00000127152 "BAF chromatin remodeling complex subunit BCL11B" Q9C0K0 14 99169287-99272197 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Cancer-related genes, Disease variant, Mental retardation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 21.2;lymphoid tissue: 36.6;skin 1: 15.0" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 62.8;Basal squamous epithelial cells: 73.4;Excitatory neurons: 57.5;Inhibitory neurons: 105.7;NK-cells: 51.5;Suprabasal keratinocytes: 71.3;T-cells: 133.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 8.0;basal ganglia: 21.2;cerebral cortex: 17.2;hippocampal formation: 18.9" "Group enriched" "Detected in many" 8 "gdT-cell: 2.0;MAIT T-cell: 1.8;memory CD4 T-cell: 2.8;memory CD8 T-cell: 2.4;naive CD4 T-cell: 4.6;naive CD8 T-cell: 3.1;T-reg: 2.0" "Lineage enriched" "Detected in single" 14 "T-cells: 4.6" "Group enriched" "Detected in some" 6 "JURKAT: 38.3;MOLT-4: 47.3" "Region enhanced" "Detected in many" "basal ganglia: 64.3" "Region enhanced" "Detected in many" "basal ganglia: 30.0" HPA049117 Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "Nucleoli fibrillar center" "HPA049117: AB_2680639" "unprognostic (1.64e-5)" "unprognostic (4.66e-2)" "unprognostic (2.35e-2)" "unprognostic (1.87e-2)" "unprognostic (9.37e-2)" "unprognostic (5.97e-2)" "unprognostic (4.75e-2)" "unprognostic (6.07e-2)" "unprognostic (1.74e-1)" "unprognostic (1.40e-2)" "unprognostic (1.90e-1)" "unprognostic (1.12e-1)" "unprognostic (1.60e-6)" "unprognostic (1.07e-3)" "unprognostic (1.61e-1)" "unprognostic (3.31e-3)" "prognostic favorable (7.48e-4)" 0.4 0.3 8.0 5.1 21.2 4.9 1.1 0.0 17.2 0.9 0.0 1.2 2.0 0.2 0.5 4.3 0.3 0.9 0.1 18.9 1.1 0.3 0.4 1.1 10.2 0.3 0.8 0.2 0.1 0.0 0.2 0.1 0.0 0.5 1.4 0.0 1.7 0.3 0.2 15.0 3.5 0.2 1.5 4.4 1.9 0.5 2.0 36.6 0.8 0.0 7.5 1.3 2.9 3.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 1.7 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.9 0.0 0.2 0.0 0.0 38.3 0.0 4.1 0.0 2.8 47.3 0.8 0.5 3.6 0.0 7.0 0.0 0.0 0.0 2.6 3.7 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.7 0.2 0.0 2.6 0.1 0.0 2.0 0.7 0.0 0.0 0.0 0.1 2.0 0.0 1.8 0.0 2.8 2.4 0.0 0.0 4.6 3.1 0.0 0.3 0.0 0.0 2.0 0.8 8.0 21.2 0.0 17.2 18.9 1.1 0.3 0.8 0.0 1.5 2.0 3.9 1.3 3.2 0.0 1.3 6.4 62.8 1.6 6.3 73.4 0.4 4.3 4.4 3.8 4.3 1.3 0.0 0.0 0.1 44.2 3.8 1.9 0.2 0.2 0.2 0.2 1.2 1.2 5.3 57.5 0.5 0.0 3.3 2.0 0.3 5.1 0.2 3.3 0.3 0.3 0.0 105.7 4.9 2.0 1.0 11.4 0.4 0.6 4.0 5.4 1.0 4.9 0.0 51.5 32.2 2.0 1.1 5.4 0.0 24.4 0.6 10.1 0.5 0.3 0.1 0.0 0.5 1.9 1.6 5.8 42.7 71.3 0.0 133.4 0.1 9.7 0.6 SETD3 "C14orf154, FLJ23027" ENSG00000183576 "SET domain containing 3, actin histidine methyltransferase" Q86TU7 14 99397748-99480889 "Enzymes, Predicted intracellular proteins" "Actin-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 206.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003591, HPA003639" Approved Approved Mitochondria NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 66: Spermatocytes - Spermatogenesis" Mitochondria "HPA003591: AB_1079930, HPA003639: AB_1079931" "unprognostic (6.82e-2)" "unprognostic (2.66e-2)" "unprognostic (8.07e-2)" "unprognostic (2.16e-2)" "unprognostic (2.42e-1)" "prognostic unfavorable (6.46e-4)" "unprognostic (1.04e-2)" "unprognostic (3.24e-2)" "unprognostic (3.29e-1)" "unprognostic (2.73e-2)" "unprognostic (2.01e-1)" "unprognostic (4.42e-1)" "prognostic favorable (1.89e-15)" "unprognostic (6.81e-2)" "unprognostic (3.21e-1)" "unprognostic (2.20e-1)" "unprognostic (2.62e-3)" 38.8 26.6 49.6 25.2 50.6 23.5 30.1 46.9 59.2 29.2 45.1 49.5 36.3 26.2 83.5 36.6 46.6 29.4 79.0 48.1 47.8 96.1 47.2 37.4 24.1 46.4 45.5 22.0 37.6 40.1 21.6 42.6 45.9 35.9 37.9 64.5 57.8 41.6 174.0 31.6 37.4 39.4 46.2 28.4 29.1 85.0 52.2 24.5 53.4 118.2 24.8 36.3 24.4 52.1 39.9 44.6 33.1 31.7 37.6 42.0 117.1 49.4 37.4 50.3 51.1 43.5 65.7 38.8 39.5 55.6 39.5 50.4 40.8 55.2 79.6 38.5 22.0 35.3 27.8 40.2 46.9 53.6 51.2 29.6 71.3 44.7 64.8 37.9 63.4 57.2 28.3 56.9 56.3 74.7 56.6 57.9 19.9 98.5 50.7 34.1 67.8 32.0 72.6 48.4 58.9 27.4 44.3 45.4 38.4 59.7 61.6 46.2 56.6 22.6 31.5 153.8 38.2 40.6 49.3 42.1 42.6 52.5 35.3 7.6 18.1 24.9 17.7 21.5 20.6 11.4 15.0 16.6 22.4 8.9 12.3 15.4 10.8 20.6 19.2 14.1 12.2 14.8 49.6 50.6 46.9 59.2 48.1 47.8 46.4 45.5 45.9 46.2 52.2 52.1 31.1 25.6 44.5 43.1 16.9 24.3 18.6 14.4 21.6 26.0 22.8 17.1 83.0 18.6 24.8 25.8 27.1 61.9 37.3 37.2 33.2 24.7 206.6 29.9 24.9 29.1 21.7 11.3 47.7 28.0 45.4 22.2 17.3 30.7 32.9 7.5 22.9 27.5 35.8 18.5 43.6 28.2 14.2 29.7 23.2 121.0 19.0 35.9 10.6 52.5 27.9 47.6 60.8 38.2 36.8 25.7 20.3 21.1 23.6 26.1 30.1 101.5 28.1 39.5 6.6 25.3 23.0 130.4 73.0 25.0 32.4 30.0 27.9 9.2 30.5 20.8 CCNK CPR4 ENSG00000090061 "Cyclin K" O75909 14 99481169-99535044 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" Cyclin "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 102.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000645, HPA077073" Supported Enhanced Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 18: U-2197 - ECM organization" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA000645: AB_1078606, HPA077073: AB_2732331" "unprognostic (8.07e-2)" "unprognostic (9.32e-3)" "unprognostic (9.52e-2)" "unprognostic (1.52e-2)" "unprognostic (5.83e-2)" "unprognostic (6.71e-2)" "unprognostic (9.22e-4)" "unprognostic (1.50e-2)" "unprognostic (2.06e-1)" "unprognostic (1.64e-1)" "unprognostic (4.78e-3)" "unprognostic (8.94e-3)" "unprognostic (7.74e-2)" "unprognostic (3.93e-1)" "unprognostic (2.73e-1)" "unprognostic (1.06e-1)" "unprognostic (6.21e-2)" 20.7 18.0 8.8 26.6 10.2 102.1 16.9 11.5 12.8 17.9 10.5 26.3 25.5 18.9 18.8 25.5 22.1 18.5 19.3 9.8 11.8 16.6 17.9 21.7 28.4 11.9 10.8 25.8 16.7 13.5 19.7 19.8 10.9 17.0 28.0 16.3 20.7 16.2 39.2 22.1 27.7 19.8 9.1 24.9 25.0 45.4 10.6 33.3 20.0 22.4 34.1 21.5 19.1 12.9 53.9 59.3 59.7 50.2 47.5 49.4 109.3 69.9 62.2 71.4 82.3 86.3 69.7 84.3 47.7 75.9 53.1 59.9 64.3 89.9 99.5 83.0 33.7 78.1 38.6 75.2 62.4 111.1 85.6 53.7 68.2 71.1 81.4 33.8 54.4 82.9 72.1 72.8 62.7 115.1 85.9 44.6 59.0 66.2 52.1 76.5 80.2 44.7 39.8 101.1 49.1 36.5 62.7 31.9 28.6 57.7 87.4 49.6 66.5 25.6 40.7 226.1 63.3 61.7 86.6 101.5 65.5 50.9 53.4 5.3 5.3 12.6 7.2 5.7 6.3 5.4 5.6 6.4 4.7 4.9 6.5 6.0 12.8 5.1 6.2 5.0 6.3 3.4 8.8 10.2 11.5 12.8 9.8 11.8 11.9 10.8 10.9 9.1 10.6 12.9 29.6 12.8 37.9 13.7 41.8 36.8 48.6 31.3 33.6 16.9 29.5 23.6 11.5 14.3 37.7 22.0 20.9 23.5 52.7 36.0 13.7 20.1 51.5 39.2 39.6 24.1 19.7 39.2 13.7 24.7 29.3 27.6 49.5 56.7 20.3 29.3 25.7 18.7 24.2 18.5 14.0 34.2 30.5 32.7 32.1 22.0 22.4 41.1 17.8 16.9 38.0 13.4 47.4 14.1 18.5 31.8 26.4 18.0 44.9 42.1 26.2 17.2 43.4 28.8 0.0 40.1 23.0 78.9 64.3 35.7 45.3 27.2 46.5 24.9 32.4 70.2 CCDC85C ENSG00000205476 "Coiled-coil domain containing 85C" A6NKD9 14 99500190-99604207 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 72.9" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 62.6;Rod photoreceptor cells: 51.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058346, HPA061922" Uncertain Approved "Nucleoplasm,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Cell Junctions" Yes No "Cluster 20: T-cells - T-cell receptor" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 44: HDLM-2 - Immune response" "Cluster 44: Endometrium - Transcription" "Nucleoli rim, Cell Junctions" "Nucleoplasm, Nuclear bodies, Mitotic chromosome" "HPA058346: AB_2683686, HPA061922: " "unprognostic (7.17e-2)" "unprognostic (2.23e-2)" "unprognostic (3.64e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (5.70e-2)" "unprognostic (2.61e-1)" "unprognostic (1.68e-3)" "unprognostic (4.80e-2)" "unprognostic (1.45e-2)" "unprognostic (8.75e-2)" "unprognostic (3.30e-1)" "unprognostic (1.68e-3)" "prognostic favorable (2.60e-5)" "unprognostic (4.14e-2)" "unprognostic (1.95e-1)" "unprognostic (8.74e-3)" "unprognostic (9.81e-3)" 5.2 22.0 26.4 4.3 32.9 9.7 7.1 72.9 27.1 5.8 20.6 31.3 18.7 15.4 14.3 28.3 11.3 5.4 19.6 24.8 20.9 14.4 18.2 8.1 2.5 30.8 24.1 5.1 18.5 16.4 17.0 8.6 27.0 15.0 11.1 34.7 26.4 16.2 20.7 19.4 17.7 13.1 24.5 3.6 19.2 8.5 28.6 5.0 9.3 5.6 7.5 16.1 8.9 21.0 48.4 43.4 52.7 31.7 0.7 0.2 48.9 16.0 16.2 31.4 18.1 52.9 49.8 0.3 61.7 18.2 8.6 63.3 39.2 38.4 19.5 79.2 23.3 2.5 43.6 36.1 4.2 0.5 4.9 0.1 19.9 9.0 25.9 18.6 9.9 27.9 11.8 7.2 3.9 80.3 21.8 6.6 19.3 55.4 44.7 32.1 22.1 10.8 22.3 18.8 26.0 32.6 40.7 21.5 9.5 19.9 46.9 9.8 22.6 6.2 51.5 22.4 16.2 11.2 15.8 0.4 1.0 4.3 4.5 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.4 0.1 26.4 32.9 72.9 27.1 24.8 20.9 30.8 24.1 27.0 24.5 28.6 21.0 8.5 22.4 5.6 15.7 6.7 8.8 8.7 4.0 13.6 35.2 12.1 9.3 3.0 5.7 7.3 1.8 62.6 6.3 3.9 21.2 0.0 7.6 3.1 18.8 8.1 9.2 9.6 3.4 2.8 9.4 4.5 6.2 17.3 35.6 6.3 14.1 5.3 16.7 1.8 1.7 5.4 9.6 6.1 1.6 1.2 2.1 0.6 5.0 8.8 4.7 0.4 30.6 1.0 1.5 11.7 17.4 13.2 0.7 10.4 11.0 23.3 6.5 3.0 51.7 0.0 5.7 4.1 1.4 3.5 20.4 14.1 4.9 8.3 2.3 13.0 12.0 HHIPL1 KIAA1822 ENSG00000182218 "HHIP like 1" Q96JK4 14 99645129-99680569 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.7" "Cell type enhanced" "Detected in some" "Astrocytes: 33.3;Bipolar cells: 10.5;Excitatory neurons: 8.3;Inhibitory neurons: 12.2;Muller glia cells: 13.1;Oligodendrocyte precursor cells: 13.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 3.1;fHDF/TERT166: 5.6;SiHa: 3.7;THP-1: 3.9" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA 120000 "Cluster 10: Brain - Neuronal signaling" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 64: Astrocytes - Nervous system maintenance" "unprognostic (6.16e-2)" "unprognostic (3.44e-2)" "unprognostic (3.43e-2)" "unprognostic (1.59e-2)" "unprognostic (1.30e-1)" "unprognostic (2.31e-1)" "unprognostic (2.75e-2)" "unprognostic (4.70e-3)" "unprognostic (6.68e-2)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" "unprognostic (1.35e-3)" "unprognostic (8.49e-6)" "unprognostic (2.52e-2)" "unprognostic (2.97e-1)" "unprognostic (2.70e-2)" "unprognostic (7.12e-6)" 1.6 0.3 7.0 1.1 8.7 0.1 0.8 4.1 8.4 1.5 3.0 2.0 0.5 2.5 0.4 0.8 1.3 1.2 1.6 7.2 4.6 0.7 0.6 0.7 1.0 4.9 4.7 1.0 0.2 0.3 0.9 0.6 4.5 1.7 0.3 2.1 0.8 0.9 0.3 0.5 0.9 1.8 4.0 0.9 0.8 0.4 6.3 0.1 0.5 0.4 0.6 1.3 1.1 4.2 0.0 0.2 0.4 0.1 0.1 0.0 1.7 1.6 0.4 0.3 0.1 0.1 0.5 0.1 3.1 5.6 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 1.7 0.0 0.0 0.9 0.1 1.2 0.2 0.1 1.4 0.1 0.0 0.1 0.9 0.2 0.0 0.2 1.2 0.0 0.0 0.5 0.0 0.2 0.0 0.1 0.1 0.6 3.7 0.0 0.0 0.6 0.0 3.9 1.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.0 8.7 4.1 8.4 7.2 4.6 4.9 4.7 4.5 4.0 6.3 4.2 1.6 0.0 0.0 33.3 0.1 0.0 0.0 0.0 0.0 10.5 0.3 0.8 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 2.0 1.7 0.0 0.0 8.3 0.0 0.1 2.6 0.0 0.0 0.0 0.9 0.7 0.3 1.9 0.0 12.2 0.0 0.0 2.1 0.7 0.2 0.3 0.3 3.6 6.5 0.0 13.1 0.0 13.0 6.2 0.0 1.4 1.9 0.0 0.1 0.1 0.0 0.0 1.7 0.0 0.9 0.9 0.3 0.4 0.0 0.0 0.1 0.0 0.7 0.0 0.1 CYP46A1 CYP46 ENSG00000036530 "Cytochrome P450 family 46 subfamily A member 1" Q9Y6A2 14 99684298-99727301 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 96.2" "Cell type enhanced" "Detected in many" "Astrocytes: 58.1;Cone photoreceptor cells: 66.7;Excitatory neurons: 53.0;Inhibitory neurons: 41.6;Rod photoreceptor cells: 28.4" "Cancer enriched" "Detected in single" 5 "glioma: 1.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 23 "plasmacytoid DC: 3.4" "Lineage enriched" "Detected in single" 23 "dendritic cells: 3.4" "Group enriched" "Detected in some" 4 "AF22: 2.4;U-937: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 32: U-937 - Innate immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "unprognostic (2.16e-1)" "unprognostic (4.30e-1)" "unprognostic (2.50e-5)" "unprognostic (9.48e-5)" "unprognostic (1.15e-1)" "unprognostic (5.92e-2)" "unprognostic (3.45e-2)" "unprognostic (1.06e-1)" "unprognostic (5.37e-2)" "unprognostic (4.01e-2)" "unprognostic (1.32e-5)" "unprognostic (5.21e-2)" "unprognostic (2.44e-4)" "unprognostic (5.97e-4)" "unprognostic (1.59e-1)" "unprognostic (1.15e-2)" "unprognostic (3.88e-3)" 1.9 2.0 45.7 0.3 96.2 0.0 0.8 20.1 66.7 1.4 17.5 0.7 0.2 1.5 0.9 0.2 1.0 0.4 4.7 52.7 34.0 1.4 1.3 0.6 0.6 25.3 32.0 1.6 2.1 1.9 16.6 0.0 26.2 1.4 0.2 5.1 1.4 0.6 1.1 0.4 0.5 0.8 23.5 0.2 0.7 2.5 38.2 0.4 1.7 0.5 0.1 0.9 0.7 39.0 0.0 0.0 2.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.8 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.8 0.0 1.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.1 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 45.7 96.2 20.1 66.7 52.7 34.0 25.3 32.0 26.2 23.5 38.2 39.0 3.5 3.2 6.0 58.1 0.7 1.7 6.4 0.0 1.2 11.5 1.8 3.3 7.0 2.8 1.8 1.8 66.7 0.2 8.7 0.0 1.9 0.2 0.7 0.9 5.0 7.6 0.0 0.0 53.0 1.1 0.3 4.0 0.5 0.6 1.3 2.1 2.9 3.4 0.6 8.4 41.6 0.0 0.0 2.1 3.0 1.3 4.7 0.9 3.6 6.5 1.1 20.8 0.0 23.6 11.8 0.1 0.1 4.1 2.2 4.1 0.0 7.4 0.9 28.4 0.0 8.1 3.9 9.4 5.3 0.0 1.4 0.1 1.5 2.7 0.1 3.5 EML1 "ELP79, EMAP, EMAPL, HuEMAP" ENSG00000066629 "EMAP like 1" O00423 14 99737693-99942060 "Disease related genes, Predicted intracellular proteins" "Disease variant, Epilepsy, Lissencephaly, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 158.4;Excitatory neurons: 57.5;Late spermatids: 61.3;Microglial cells: 69.3;Oligodendrocytes: 61.8;Rod photoreceptor cells: 113.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 67.3;HDLM-2: 89.5;U-2197: 104.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033137, HPA049105" Uncertain NA NA "Cluster 13: Striated muscle - Muscle contraction" "Cluster 18: U-2197 - ECM organization" "Cluster 9: Photoreceptor cells - Phototransduction" "CAB033137: AB_2098052, HPA049105: AB_2680633" "unprognostic (9.86e-3)" "unprognostic (2.54e-1)" "unprognostic (8.18e-2)" "unprognostic (2.77e-2)" "unprognostic (2.56e-1)" "unprognostic (4.08e-2)" "unprognostic (2.68e-2)" "unprognostic (8.09e-3)" "unprognostic (7.83e-2)" "unprognostic (3.06e-3)" "unprognostic (1.89e-2)" "unprognostic (9.98e-2)" "unprognostic (4.09e-3)" "unprognostic (1.37e-2)" "unprognostic (1.25e-1)" "unprognostic (7.81e-3)" "unprognostic (7.03e-3)" 15.5 6.4 8.6 9.1 25.5 0.3 9.7 7.3 12.7 13.2 15.0 35.5 6.8 16.1 10.8 24.1 15.1 18.6 17.2 8.6 7.9 8.6 5.5 13.2 3.3 9.2 9.0 3.8 8.7 28.3 9.2 27.2 10.7 9.6 14.9 50.1 5.0 16.9 47.5 9.4 10.1 31.0 9.4 3.9 14.9 8.0 8.9 1.3 14.8 34.4 4.4 17.1 10.3 22.8 0.0 44.9 36.8 12.9 20.1 39.5 0.3 35.9 67.3 25.2 8.4 5.1 0.9 0.0 22.2 22.6 30.3 0.2 26.7 3.1 11.5 89.5 13.6 0.0 7.9 0.8 4.8 0.1 0.9 11.6 4.9 31.0 11.7 16.0 44.5 0.7 0.1 0.0 10.4 21.3 0.1 0.1 14.5 0.1 17.2 5.4 13.5 0.2 56.2 0.6 14.1 20.9 11.8 1.8 0.0 24.1 13.7 1.2 42.3 22.8 4.1 104.3 14.9 0.5 0.0 0.3 57.3 0.1 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 25.5 7.3 12.7 8.6 7.9 9.2 9.0 10.7 9.4 8.9 22.8 22.8 16.0 7.0 17.3 0.3 2.8 1.2 0.4 1.2 9.2 1.0 1.3 15.0 1.5 4.5 3.7 158.4 2.7 0.1 0.1 0.0 4.6 29.1 15.9 14.2 30.1 0.0 0.0 57.5 4.9 0.6 20.6 4.1 4.7 0.0 1.6 40.0 1.3 1.3 1.7 29.9 0.6 0.0 2.5 4.7 61.3 7.2 1.9 7.2 69.3 0.6 8.8 1.0 17.6 61.8 0.8 0.0 6.0 1.2 1.4 0.0 2.5 11.8 113.6 0.0 20.8 8.7 4.8 11.3 0.4 4.0 2.9 0.7 1.2 0.0 0.7 EVL RNB6 ENSG00000196405 Enah/Vasp-like Q9UI08 14 99971449-100144236 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 402.4;NK-cells: 591.2;Rod photoreceptor cells: 438.0;T-cells: 373.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 291.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018849, HPA019536, CAB033987" Enhanced Approved Vesicles,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Vesicles, Cytosol" "CAB033987: AB_2101264, HPA018849: AB_1848310, HPA019536: AB_2670180" "unprognostic (1.12e-3)" "unprognostic (5.03e-3)" "unprognostic (6.46e-3)" "unprognostic (2.70e-1)" "unprognostic (2.65e-1)" "unprognostic (2.27e-3)" "unprognostic (3.65e-2)" "unprognostic (2.35e-1)" "unprognostic (2.06e-1)" "unprognostic (6.35e-3)" "prognostic favorable (4.07e-6)" "unprognostic (3.50e-3)" "prognostic unfavorable (4.14e-6)" "unprognostic (7.97e-2)" "unprognostic (1.58e-1)" "unprognostic (8.69e-3)" "unprognostic (2.43e-1)" 38.8 31.3 130.5 91.9 135.1 50.1 58.1 105.0 185.5 44.4 66.3 46.6 29.2 64.8 49.5 30.6 63.7 42.0 53.0 136.9 108.8 42.6 90.3 63.2 159.0 103.1 110.1 51.6 40.8 19.7 98.6 29.1 106.1 52.1 24.2 204.6 41.2 32.0 33.2 41.0 69.9 62.0 92.5 107.7 43.3 31.6 115.5 179.4 37.9 28.8 126.2 43.1 32.8 121.2 15.2 14.2 107.1 30.3 22.4 58.5 59.7 18.9 26.5 14.2 18.7 0.8 11.4 30.9 24.9 19.2 10.5 0.4 49.0 36.3 16.8 30.4 32.6 51.9 11.5 8.4 18.0 16.2 116.7 31.6 18.9 9.1 35.8 29.3 38.3 117.3 25.5 2.3 15.7 22.7 291.7 89.6 19.7 13.1 21.8 65.4 58.7 5.5 17.2 0.6 120.8 73.1 14.3 22.0 7.2 24.6 17.7 47.4 27.7 11.2 16.5 66.9 12.8 55.3 44.1 87.9 14.9 27.1 19.7 2.3 2.6 27.4 20.2 13.9 15.1 9.6 22.6 19.2 4.3 13.2 26.3 24.4 0.6 18.0 16.5 0.8 41.4 10.6 130.5 135.1 105.0 185.5 136.9 108.8 103.1 110.1 106.1 92.5 115.5 121.2 26.4 28.9 42.3 45.1 155.2 20.8 22.2 10.8 12.0 125.4 70.4 50.5 4.7 22.8 14.2 12.9 402.4 22.6 215.3 1.0 31.3 12.9 4.2 40.1 51.9 47.5 8.4 31.1 119.9 14.0 12.0 30.5 20.4 26.2 17.1 45.1 39.3 102.2 144.8 77.4 121.1 3.7 8.2 82.5 76.6 12.0 24.8 92.5 26.6 100.2 42.0 89.1 591.2 86.0 66.1 11.6 2.9 49.7 53.3 17.4 2.6 14.2 41.9 438.0 6.6 29.8 33.9 14.1 28.4 8.7 31.4 14.6 373.3 13.5 3.8 15.9 DEGS2 "C14orf66, DES2, FADS8" ENSG00000168350 "Delta 4-desaturase, sphingolipid 2" Q6QHC5 14 100143957-100159645 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 37.0;intestine: 34.8;skin 1: 54.2" "Cell type enhanced" "Detected in many" "Collecting duct cells: 82.8;Paneth cells: 77.0;Proximal enterocytes: 298.9;Respiratory ciliated cells: 144.8;Squamous epithelial cells: 86.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 3.5;eosinophil: 6.6;memory B-cell: 10.9;naive B-cell: 6.8" "Group enriched" "Detected in many" 5 "B-cells: 10.9;granulocytes: 6.6" "Group enriched" "Detected in some" 16 "OE19: 69.3;T-47d: 104.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046644 Approved Nucleoplasm,Nucleoli NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 31: Skin - Epidermis development" "Cluster 6: T47d - Mammary gland" "Cluster 45: Enterocytes - Digestion" "Nucleoplasm, Nucleoli" "HPA046644: AB_2797231" "unprognostic (8.18e-2)" "unprognostic (3.83e-3)" "unprognostic (2.33e-1)" "unprognostic (1.32e-2)" "unprognostic (3.55e-1)" "unprognostic (4.91e-2)" "unprognostic (1.53e-1)" "unprognostic (1.13e-2)" "unprognostic (2.43e-1)" "unprognostic (1.20e-1)" "unprognostic (1.64e-1)" "unprognostic (1.38e-1)" "prognostic favorable (7.94e-7)" "unprognostic (1.03e-3)" "unprognostic (1.26e-1)" "unprognostic (1.14e-1)" "prognostic favorable (1.66e-4)" 0.4 0.1 6.4 1.0 7.2 0.2 6.1 18.3 7.1 4.8 3.6 8.9 24.7 3.3 0.5 37.0 2.0 6.5 0.2 5.1 4.5 10.8 0.9 1.6 0.6 5.9 5.3 1.0 6.9 0.4 3.3 0.4 6.0 2.3 4.5 0.2 8.6 2.1 0.3 54.2 34.8 0.5 4.8 0.8 20.1 1.1 5.3 0.1 2.4 0.0 1.8 6.5 10.1 4.9 0.0 0.3 0.0 0.3 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.5 2.4 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.5 0.8 0.1 0.3 0.0 0.0 0.0 0.0 1.1 1.6 0.0 0.0 4.2 0.4 0.3 0.1 69.3 0.0 0.4 0.0 3.6 0.0 1.6 5.2 0.1 0.0 3.1 0.0 0.1 104.4 1.1 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.5 0.4 6.6 1.6 0.0 0.0 10.9 0.1 0.7 0.7 6.8 0.0 1.0 0.2 0.2 0.0 0.1 0.0 0.7 6.4 7.2 18.3 7.1 5.1 4.5 5.9 5.3 6.0 4.8 5.3 4.9 0.7 3.2 5.0 5.2 3.7 1.8 3.3 22.9 1.2 4.6 24.2 15.2 0.6 37.1 34.8 82.8 0.0 7.7 3.3 24.2 1.9 19.0 1.2 15.3 4.3 3.8 55.3 1.3 0.5 1.5 4.9 1.3 54.6 28.9 9.5 0.9 0.4 0.3 1.6 0.0 0.4 53.5 34.6 0.9 0.6 1.6 0.3 1.5 0.0 3.7 0.5 1.2 12.3 0.0 1.5 2.4 77.0 0.0 3.7 1.7 298.9 0.4 144.8 22.0 0.0 1.1 3.1 3.2 4.0 86.9 15.3 37.4 2.5 0.2 69.6 21.0 YY1 "DELTA, INO80S, NF-E1, UCRBP, YIN-YANG-1" ENSG00000100811 "YY1 transcription factor" P25490 14 100238298-100282788 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, DNA damage, DNA recombination, DNA repair, Spermatogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001119, CAB009392" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Nucleoli fibrillar center, Vesicles" "CAB009392: AB_2218501, HPA001119: AB_1858930" "unprognostic (7.67e-2)" "unprognostic (8.08e-2)" "unprognostic (2.57e-2)" "prognostic unfavorable (6.13e-4)" "unprognostic (6.75e-3)" "unprognostic (8.31e-3)" "prognostic unfavorable (3.44e-4)" "unprognostic (1.09e-1)" "unprognostic (4.26e-2)" "unprognostic (7.68e-3)" "unprognostic (1.40e-1)" "unprognostic (1.51e-1)" "unprognostic (3.72e-2)" "unprognostic (4.36e-2)" "unprognostic (1.66e-1)" "unprognostic (2.30e-1)" "unprognostic (4.30e-1)" 27.2 26.2 20.9 28.9 22.1 56.4 27.0 27.0 24.2 24.6 18.5 30.7 27.9 24.8 34.0 28.9 21.7 22.7 22.8 22.7 20.2 32.9 46.8 24.0 36.0 20.4 20.4 21.6 24.4 32.5 17.4 34.2 20.3 25.2 28.7 20.1 25.1 23.6 36.8 29.0 29.7 24.8 20.1 31.9 26.2 23.8 21.5 52.3 37.2 27.2 38.2 31.9 21.0 26.2 62.0 30.7 64.2 51.5 51.8 65.9 68.1 60.0 55.1 64.7 66.0 38.6 97.7 94.0 82.3 54.5 37.1 64.0 72.6 64.1 88.3 70.8 60.9 86.8 34.6 50.0 48.4 103.8 73.2 38.7 76.4 45.4 61.4 58.6 63.9 67.3 69.9 61.8 63.7 74.5 113.5 61.8 68.7 98.0 56.0 93.9 88.9 50.7 75.8 58.3 68.2 53.3 79.2 57.8 85.1 54.0 86.6 100.1 57.4 39.4 48.3 97.6 53.8 68.3 72.0 126.6 56.4 68.6 52.5 4.8 5.7 11.9 4.3 4.8 5.6 5.3 5.7 5.9 4.9 8.3 5.4 5.4 9.8 9.5 3.8 5.3 7.7 2.7 20.9 22.1 27.0 24.2 22.7 20.2 20.4 20.4 20.3 20.1 21.5 26.2 116.0 54.5 66.8 23.8 102.4 238.0 101.1 49.9 211.7 80.5 129.8 98.2 91.5 92.9 50.0 68.0 81.3 118.6 147.4 122.8 72.4 68.7 10.3 118.7 133.8 115.7 110.1 125.4 28.2 82.0 123.6 106.7 58.1 153.6 71.7 99.4 103.5 119.4 81.3 127.9 26.5 108.8 48.8 111.8 225.8 15.7 94.8 121.6 76.5 30.0 117.8 82.0 114.4 20.6 40.7 80.0 95.5 100.8 125.0 168.9 90.0 104.6 47.6 74.9 92.1 106.5 124.3 86.0 67.0 192.1 243.1 175.5 124.8 124.1 118.7 153.5 SLC25A29 "C14orf69, FLJ38975" ENSG00000197119 "Solute carrier family 25 member 29" Q8N8R3 14 100291116-100306547 "Metabolic proteins, Predicted intracellular proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 419.6" "Cell type enhanced" "Detected in many" "Astrocytes: 108.7;Collecting duct cells: 123.2;Endometrial ciliated cells: 136.7;Glandular and luminal cells: 136.0" "Cancer enhanced" "Detected in all" "thyroid cancer: 47.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030781 Uncertain NA NA "Cluster 10: Basophils - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 44: Endometrium - Transcription" "HPA030781: AB_10603029" "unprognostic (8.64e-3)" "unprognostic (1.20e-3)" "unprognostic (2.39e-2)" "unprognostic (1.32e-1)" "unprognostic (2.23e-1)" "unprognostic (3.63e-3)" "unprognostic (3.39e-3)" "unprognostic (2.10e-3)" "unprognostic (1.81e-1)" "unprognostic (4.00e-1)" "prognostic favorable (2.90e-4)" "unprognostic (1.32e-3)" "unprognostic (1.17e-1)" "unprognostic (2.97e-2)" "unprognostic (1.21e-1)" "unprognostic (1.21e-1)" "prognostic favorable (5.26e-4)" 28.0 44.6 57.6 5.3 66.1 13.5 34.4 71.1 74.2 46.8 72.2 20.2 8.1 32.1 37.5 36.3 84.4 12.2 30.5 56.9 57.8 124.5 35.9 44.1 8.1 91.8 69.3 49.9 22.2 6.6 62.8 6.6 83.8 69.1 5.3 47.4 45.5 12.6 11.9 42.4 18.5 8.2 68.7 20.5 26.6 44.8 66.8 8.8 419.6 6.0 5.7 26.9 27.0 94.9 11.0 23.2 29.7 39.0 6.8 2.5 17.4 8.2 8.9 16.8 9.9 5.4 6.7 0.0 20.4 2.8 8.6 11.5 12.7 4.2 5.6 4.2 5.4 10.4 35.8 9.9 16.1 6.1 13.0 7.4 12.9 7.7 7.1 25.5 23.3 35.7 3.4 1.2 4.9 34.8 37.9 33.6 14.8 9.7 22.5 49.1 12.4 0.8 55.5 7.7 42.9 52.8 19.3 13.2 15.4 12.5 33.0 10.2 24.5 6.1 11.7 8.6 12.9 2.9 1.3 1.4 6.9 14.9 7.6 1.5 1.1 2.1 0.9 0.2 0.0 0.1 0.4 0.9 1.2 0.5 0.1 0.6 1.2 0.1 0.0 0.5 0.6 0.2 57.6 66.1 71.1 74.2 56.9 57.8 91.8 69.3 83.8 68.7 66.8 94.9 23.5 9.6 26.5 108.7 5.8 6.5 16.3 14.8 22.8 17.9 57.1 38.5 1.4 11.5 23.3 123.2 75.0 6.2 17.8 9.4 17.6 31.4 19.7 136.7 24.8 20.9 20.9 3.8 26.4 11.8 0.7 10.9 12.2 136.0 14.5 22.6 31.8 9.5 7.4 21.9 22.4 8.8 12.2 2.8 30.0 62.4 2.5 11.7 10.6 30.9 8.8 21.0 12.3 42.7 78.5 14.2 17.0 6.0 4.1 39.6 4.6 13.1 45.1 82.7 13.1 7.0 12.6 4.2 5.0 24.5 6.5 18.6 6.4 6.3 14.3 13.8 SLC25A47 C14orf68 ENSG00000140107 "Solute carrier family 25 member 47" Q6Q0C1 14 100323339-100330421 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 355 "liver: 534.7" "Cell type enriched" "Detected in some" 40 "Hepatocytes: 270.2" "Cancer enriched" "Detected in single" 273 "liver cancer: 56.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Hep G2: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" NA NA "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "unprognostic (2.54e-3)" "unprognostic (2.57e-3)" "unprognostic (5.12e-2)" "unprognostic (2.27e-2)" "unprognostic (6.07e-2)" "unprognostic (1.30e-2)" "unprognostic (4.25e-2)" "unprognostic (1.14e-1)" "unprognostic (2.89e-2)" "unprognostic (2.50e-1)" "unprognostic (1.96e-3)" "unprognostic (4.46e-1)" "unprognostic (1.44e-1)" "unprognostic (4.50e-1)" "unprognostic (5.64e-2)" "unprognostic (1.02e-2)" "unprognostic (1.94e-1)" 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 534.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.5 0.0 1.8 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.2 0.0 0.1 0.0 2.7 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 2.9 270.2 0.0 0.0 0.0 0.6 0.0 6.7 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.8 0.0 0.0 0.0 3.5 3.5 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.7 0.0 0.0 0.4 0.1 WARS1 "IFI53, IFP53, WARS" ENSG00000140105 "Tryptophanyl-tRNA synthetase 1" P23381 14 100333790-100376805 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Angiogenesis, Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 324.4" "Cell type enhanced" "Detected in some" "Adipocytes: 66.4;Cytotrophoblasts: 16.5;Endothelial cells: 38.5;Hofbauer cells: 43.1;Syncytiotrophoblasts: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "intermediate monocyte: 1345.3;non-classical monocyte: 1608.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 908.5;SK-MEL-30: 1012.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005573, HPA018944" Enhanced Enhanced Cytosol No No 49000000 "Cluster 51: Monocytes - Innate immune response" "Cluster 28: Placenta - Pregnancy" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 41: Macrophages - Immune response" Cytosol "HPA005573: AB_2667366, HPA018944: AB_2669986" "unprognostic (5.36e-2)" "unprognostic (5.98e-2)" "unprognostic (3.99e-2)" "unprognostic (1.54e-1)" "unprognostic (2.30e-1)" "unprognostic (9.25e-2)" "prognostic unfavorable (7.88e-4)" "unprognostic (5.14e-2)" "unprognostic (4.26e-2)" "prognostic favorable (1.94e-4)" "unprognostic (4.84e-2)" "unprognostic (3.21e-1)" "unprognostic (3.53e-3)" "unprognostic (1.37e-1)" "unprognostic (9.45e-2)" "unprognostic (1.62e-1)" "unprognostic (5.92e-3)" 100.7 67.9 40.3 185.6 44.4 70.5 65.4 40.1 45.5 35.9 45.2 67.8 44.8 39.6 70.3 54.4 50.8 48.7 157.6 44.2 56.0 83.6 47.9 207.5 139.0 72.0 52.6 21.2 47.5 39.2 63.4 324.4 65.3 49.1 72.0 37.8 49.5 38.3 74.7 28.4 67.7 76.2 47.6 110.6 70.1 67.7 55.0 61.7 159.9 67.0 86.2 107.7 30.7 44.9 91.2 85.7 54.6 319.1 78.7 110.7 87.3 117.4 220.7 232.1 301.4 57.4 80.2 101.7 105.5 277.4 59.7 151.1 158.8 130.3 153.1 154.4 48.3 64.1 60.9 72.3 908.5 184.9 101.6 126.9 186.9 141.3 290.1 74.5 225.0 66.1 202.8 255.0 107.5 178.0 64.3 87.1 55.4 94.1 152.2 51.4 86.5 64.9 119.3 80.8 145.7 84.9 69.4 58.7 1012.4 70.5 153.6 234.7 153.1 25.7 58.9 269.2 61.3 446.4 277.1 191.9 295.0 144.2 205.5 96.5 471.7 610.4 41.5 1345.3 38.4 71.4 34.5 38.4 337.9 68.0 24.8 28.6 170.9 44.5 1608.2 54.7 44.8 672.7 40.3 44.4 40.1 45.5 44.2 56.0 72.0 52.6 65.3 47.6 55.0 44.9 66.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 16.5 3.7 0.0 0.0 0.0 0.0 0.0 0.0 38.5 0.0 0.0 0.0 0.0 11.5 5.5 0.0 0.0 0.0 0.0 0.0 0.0 43.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 16.6 0.5 0.0 0.0 0.0 WDR25 "C14orf67, MGC4645" ENSG00000176473 "WD repeat domain 25" Q64LD2 14 100376418-100530303 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 33.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003113 Uncertain Approved Nucleoplasm "Secreted to blood" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "HPA003113: AB_2215263" "unprognostic (5.31e-2)" "unprognostic (5.76e-3)" "unprognostic (2.28e-2)" "unprognostic (1.24e-1)" "unprognostic (1.11e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (7.36e-4)" "unprognostic (1.79e-2)" "unprognostic (6.62e-2)" "unprognostic (3.94e-3)" "unprognostic (2.44e-2)" "unprognostic (1.37e-2)" "prognostic favorable (3.89e-5)" "unprognostic (1.01e-2)" "unprognostic (1.73e-1)" "unprognostic (7.30e-2)" "unprognostic (7.51e-2)" 6.4 10.0 7.6 2.5 7.8 4.1 6.5 8.0 9.5 8.1 8.1 6.7 3.2 7.9 4.2 4.5 6.8 3.0 6.6 7.4 7.5 7.0 8.6 5.8 3.6 7.6 7.6 6.6 12.9 3.5 11.3 3.3 8.5 7.9 2.5 4.5 5.7 3.6 10.7 5.7 4.8 2.7 7.0 5.7 6.5 7.4 7.3 5.6 9.1 4.5 2.3 7.9 5.4 7.8 3.5 6.1 4.2 15.6 6.7 6.2 3.5 6.4 10.2 7.3 7.4 2.9 6.5 5.1 7.9 5.0 2.0 6.2 4.0 7.8 3.8 5.0 2.9 3.4 6.9 4.9 12.2 4.0 3.8 9.3 9.2 5.3 7.9 6.4 5.3 5.9 4.2 7.3 4.8 13.5 6.0 4.4 3.2 4.2 10.7 4.3 5.9 3.6 5.6 2.8 9.8 10.3 5.2 1.9 9.0 4.0 7.2 1.4 9.2 2.8 3.2 10.8 3.7 4.9 2.6 2.5 9.7 3.0 5.4 34.0 16.4 24.6 8.6 14.6 8.7 13.0 11.1 9.1 14.3 8.5 11.7 8.6 8.7 5.6 16.3 11.0 12.0 12.2 7.6 7.8 8.0 9.5 7.4 7.5 7.6 7.6 8.5 7.0 7.3 7.8 7.1 0.0 6.4 12.1 5.1 3.2 4.3 8.6 0.6 8.8 5.5 6.1 2.6 0.0 6.9 3.7 10.4 8.4 6.7 6.3 9.8 12.7 9.2 13.8 6.7 8.8 5.4 11.0 17.8 33.6 4.7 6.2 8.2 8.5 3.8 3.9 5.0 8.7 6.9 5.0 16.9 9.0 14.2 5.6 4.0 6.3 6.8 3.7 5.4 16.9 5.4 14.0 5.2 14.6 19.1 13.3 3.8 11.3 6.3 3.3 7.5 17.9 11.8 16.2 13.1 4.5 7.2 15.6 17.0 2.8 3.0 7.0 5.0 9.2 7.1 3.0 BEGAIN KIAA1446 ENSG00000183092 "Brain enriched guanylate kinase associated" Q9BUH8 14 100537147-100587413 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.2;pancreas: 23.8;pituitary gland: 19.6" "Cell type enriched" "Detected in many" 7 "Horizontal cells: 143.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "eosinophil: 3.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.4" "Group enriched" "Detected in some" 7 "HeLa: 56.6;SH-SY5Y: 129.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002899 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "Golgi apparatus, Cytosol" "HPA002899: AB_1078277" "unprognostic (2.98e-4)" "unprognostic (2.75e-3)" "unprognostic (2.66e-2)" "unprognostic (2.66e-4)" "unprognostic (2.77e-3)" "unprognostic (1.93e-2)" "unprognostic (5.16e-2)" "unprognostic (6.35e-2)" "unprognostic (3.83e-1)" "unprognostic (4.33e-2)" "unprognostic (4.15e-2)" "unprognostic (5.47e-2)" "unprognostic (1.59e-1)" "unprognostic (9.01e-2)" "unprognostic (3.11e-1)" "unprognostic (2.75e-1)" "unprognostic (2.60e-1)" 1.9 3.2 15.3 0.4 14.9 4.0 1.7 16.4 27.2 3.4 0.0 1.2 2.6 2.4 0.8 1.0 6.0 1.2 2.6 22.0 5.1 1.0 0.7 1.4 0.5 6.4 1.5 4.8 23.8 4.6 19.6 1.6 6.6 4.1 0.2 2.1 1.5 1.3 0.7 1.2 2.7 0.8 1.0 5.8 1.2 2.8 3.2 1.0 1.0 0.1 0.5 1.5 1.3 11.9 0.8 3.3 1.8 11.1 0.0 0.0 0.3 0.3 0.0 0.5 0.1 0.0 1.1 0.3 0.5 0.5 2.5 0.4 0.5 0.0 0.0 0.0 1.1 5.1 56.6 0.0 0.1 0.2 0.3 0.3 0.2 0.9 1.2 0.0 0.1 0.7 0.6 0.1 0.0 4.4 0.4 1.6 1.3 0.3 1.9 0.1 0.3 7.0 0.0 0.2 2.9 129.7 3.0 0.1 3.0 0.0 0.9 13.7 0.0 0.4 3.8 0.1 0.0 0.0 0.0 0.2 9.2 2.5 0.3 0.8 0.1 3.4 0.0 0.7 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.4 0.0 0.1 15.3 14.9 16.4 27.2 22.0 5.1 6.4 1.5 6.6 1.0 3.2 11.9 0.8 0.0 0.6 18.6 0.3 2.4 1.8 0.3 0.0 3.7 0.5 1.1 2.3 0.0 0.7 0.0 0.0 0.1 0.2 0.3 0.0 1.4 0.4 0.1 0.1 0.6 0.0 0.0 18.4 8.0 0.2 1.5 0.0 0.1 9.5 0.1 1.4 0.0 0.3 143.0 10.9 0.0 0.0 0.0 0.8 0.8 1.8 0.3 1.8 4.7 1.1 0.8 0.0 15.6 0.8 2.9 1.1 6.8 0.3 1.6 2.7 0.1 0.1 2.3 0.0 1.7 0.7 0.9 1.5 0.3 2.0 0.1 0.3 0.4 0.4 0.4 DLK1 "Delta1, FA1, pG2, Pref-1, ZOG" ENSG00000185559 "Delta like non-canonical Notch ligand 1" P80370 14 100725705-100738224 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 1330.8;pituitary gland: 772.9;placenta: 1631.2" "Cell type enhanced" "Detected in some" "Exocrine glandular cells: 576.5;Fibroblasts: 699.3;Leydig cells: 1357.0;Skeletal myocytes: 2360.1" "Cancer enhanced" "Detected in many" "liver cancer: 28.1;testis cancer: 25.4" "Region enhanced" "Detected in many" "hypothalamus: 163.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 120.0;Hep G2: 419.1;SH-SY5Y: 473.8" "Region enhanced" "Detected in many" "hypothalamus: 111.7" "Group enriched" "Detected in many" 5 "hypothalamus: 41.2;midbrain: 156.8" "CAB005872, HPA062262" Enhanced Approved "Golgi apparatus" NA NA 2600000 "Cluster 28: Placenta - Pregnancy" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "CAB005872: AB_731965, HPA062262: AB_2684729" "unprognostic (2.16e-2)" "prognostic unfavorable (2.31e-4)" "unprognostic (1.49e-1)" "unprognostic (1.14e-1)" "unprognostic (4.89e-3)" "unprognostic (5.75e-2)" "unprognostic (1.87e-2)" "unprognostic (1.12e-1)" "unprognostic (5.24e-1)" "unprognostic (3.11e-2)" "unprognostic (6.57e-2)" 3.1 1330.8 3.4 6.1 1.9 0.1 7.1 0.0 0.8 9.4 0.3 0.2 1.8 0.7 0.2 2.6 3.1 2.2 45.7 0.5 163.3 0.6 1.8 0.8 0.5 15.4 38.7 277.2 21.2 0.0 772.9 1631.2 81.7 1.4 0.0 0.0 26.9 0.0 17.5 1.2 1.3 0.2 2.1 1.1 1.0 40.9 14.7 1.7 0.2 83.1 0.0 1.0 1.5 0.9 0.0 0.0 120.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 12.6 0.3 419.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 60.6 0.0 0.0 0.0 0.0 0.3 3.4 0.0 0.0 0.0 1.4 0.1 0.0 0.5 33.7 473.8 0.0 0.1 0.0 2.9 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 35.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 1.9 0.0 0.8 0.5 163.3 15.4 38.7 81.7 2.1 14.7 0.9 0.4 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 1.3 1.0 2.6 0.0 0.0 0.0 0.0 55.2 0.2 0.0 0.0 4.8 7.1 0.0 0.0 6.7 0.0 0.0 0.0 576.5 45.3 699.3 0.0 0.0 0.0 0.8 0.0 0.0 84.3 0.0 0.0 0.0 0.0 0.0 0.3 35.0 1357.0 4.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.0 0.0 172.6 0.0 1.3 0.0 0.2 0.0 0.0 59.2 2360.1 3.0 13.5 69.9 0.0 0.4 105.8 0.8 63.2 0.0 0.2 RTL1 "HUR1, Mar1, MART1, PEG11, SIRH2" ENSG00000254656 "Retrotransposon Gag like 1" A6NKG5 14 100879753-100903722 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 1.6;brain: 7.7;placenta: 2.9" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "melanoma: 1.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 30 "SH-SY5Y: 572.5" "Low region specificity" "Detected in many" "HPA066979, HPA077601" Enhanced Approved Cytosol No NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" Cytosol "HPA066979: AB_2685759, HPA077601: " "unprognostic (1.61e-1)" "unprognostic (3.30e-1)" "unprognostic (1.26e-1)" "unprognostic (1.42e-3)" "unprognostic (2.10e-1)" 0.1 1.6 1.6 0.0 0.7 0.0 0.0 0.9 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 7.7 0.0 0.0 0.0 0.0 3.4 4.2 0.6 0.1 0.0 0.2 2.9 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 18.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 572.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.7 0.9 1.3 1.2 7.7 3.4 4.2 7.7 0.2 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 DIO3 TXDI3 ENSG00000197406 "Iodothyronine deiodinase 3" P55073 14 101561351-101563452 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins" "Thyroid hormones biosynthesis" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 25.0;placenta: 17.8" "Cell type enhanced" "Detected in some" "Endothelial cells: 7.8;Fibroblasts: 27.9;Leydig cells: 10.8;Muller glia cells: 8.1;Peritubular cells: 7.5;Skeletal myocytes: 16.3;Syncytiotrophoblasts: 28.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "AF22: 54.2" "Low region specificity" "Detected in many" "Region enhanced" "Detected in some" "amygdala: 4.4;hippocampal formation: 5.6" HPA073684 Supported Vesicles NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 12: NES - Nervous system development" "Cluster 33: Fibroblasts - ECM organization" Vesicles "HPA073684: " "unprognostic (4.52e-3)" "unprognostic (1.80e-1)" "unprognostic (3.04e-3)" "unprognostic (3.48e-1)" "unprognostic (5.16e-2)" "unprognostic (1.50e-1)" "unprognostic (4.24e-2)" "unprognostic (8.11e-2)" "unprognostic (2.58e-1)" "unprognostic (6.24e-2)" "unprognostic (2.34e-1)" "unprognostic (2.52e-1)" "unprognostic (7.46e-5)" "unprognostic (4.82e-3)" "unprognostic (2.43e-1)" "unprognostic (1.11e-4)" "unprognostic (9.80e-3)" 5.0 0.4 0.5 1.8 1.2 0.0 3.2 0.2 1.2 25.0 0.2 1.7 0.0 6.5 0.6 1.8 6.7 3.0 0.6 0.6 0.2 0.3 3.9 2.6 1.3 1.3 0.3 13.6 1.5 0.0 0.7 17.8 0.3 3.2 0.4 0.7 1.7 2.2 1.6 3.5 1.7 0.9 0.4 0.6 1.6 1.3 3.3 0.2 4.1 3.0 0.1 5.2 15.4 0.4 0.0 0.2 54.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.1 0.0 0.0 1.0 1.3 0.8 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 0.2 1.2 0.6 0.2 1.3 0.3 0.3 0.4 3.3 0.4 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.6 0.4 0.0 0.0 0.0 0.0 1.9 0.0 5.9 0.0 0.6 0.3 0.4 4.9 7.8 0.0 0.0 0.1 0.0 2.5 27.9 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.5 0.0 0.0 0.7 0.6 10.8 0.1 0.0 0.0 0.6 8.1 0.0 0.0 0.0 0.9 1.1 7.5 0.0 0.8 0.0 0.0 0.0 0.2 0.0 16.3 0.7 0.1 0.2 0.2 0.1 28.3 0.2 0.1 0.3 0.4 PPP2R5C "B56G, B56gamma, PR61G" ENSG00000078304 "Protein phosphatase 2 regulatory subunit B'gamma" Q13362 14 101761798-101927989 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "dendritic cells: 525.3;T-cells: 323.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027553 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA027553: AB_10602081" "unprognostic (3.28e-1)" "unprognostic (1.66e-1)" "unprognostic (2.19e-1)" "unprognostic (3.24e-2)" "unprognostic (1.36e-1)" "unprognostic (1.10e-1)" "unprognostic (2.78e-1)" "unprognostic (1.23e-1)" "unprognostic (1.99e-1)" "unprognostic (1.31e-3)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" "unprognostic (2.33e-3)" "unprognostic (1.17e-1)" "unprognostic (3.09e-1)" "unprognostic (4.49e-1)" "unprognostic (1.72e-1)" 54.7 58.4 72.7 77.6 75.1 129.2 62.0 67.3 81.2 59.2 55.1 70.7 52.4 53.8 63.5 73.8 49.2 57.7 112.6 89.3 72.5 58.6 89.3 66.8 136.9 73.1 71.1 61.2 59.6 64.1 43.2 45.6 72.4 50.5 74.4 56.2 69.2 55.8 79.2 67.3 57.3 60.8 74.2 72.0 53.8 66.5 71.9 114.4 66.5 73.0 124.6 67.3 44.1 72.8 100.6 67.4 111.8 108.6 99.5 138.8 107.9 92.7 121.5 113.5 107.9 68.2 169.8 272.1 86.9 120.8 79.7 102.7 103.6 98.2 146.6 123.2 48.3 79.0 74.8 66.7 73.3 122.7 162.4 91.9 124.4 78.2 72.1 100.7 103.3 145.3 167.5 111.7 109.7 153.2 124.1 135.1 65.0 200.7 111.2 103.7 125.8 67.8 109.3 112.1 87.2 163.3 125.6 82.2 161.1 78.0 150.2 92.9 103.0 71.1 67.3 276.4 93.0 154.8 249.3 449.4 106.6 89.5 81.0 97.5 72.7 72.6 217.2 94.3 140.0 74.8 139.8 172.3 65.4 68.8 98.4 153.5 133.7 68.2 104.6 95.8 156.2 91.3 72.7 75.1 67.3 81.2 89.3 72.5 73.1 71.1 72.4 74.2 71.9 72.8 51.0 83.3 93.9 61.4 94.4 58.6 45.7 35.0 26.2 30.8 51.7 35.8 133.9 47.1 52.4 36.8 58.4 49.8 525.3 69.3 46.9 38.3 79.6 104.2 39.2 45.9 47.4 45.3 124.6 46.9 46.6 43.4 33.6 54.9 69.6 38.7 59.3 78.5 73.2 26.9 92.2 78.9 38.7 122.9 84.5 69.5 52.5 78.4 85.4 84.3 128.2 49.9 280.2 71.4 89.8 50.6 69.7 45.5 193.9 48.9 51.0 62.8 76.5 43.3 39.5 34.3 54.1 47.1 27.5 36.2 70.3 52.4 323.4 42.7 62.6 71.6 DYNC1H1 "CMT2O, DHC1, DNCH1, Dnchc1, DNCL, DNECL, HL-3, p22" ENSG00000197102 "Dynein cytoplasmic 1 heavy chain 1" Q14204 14 101964573-102056443 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transport" "Motor protein" "Charcot-Marie-Tooth disease, Disease variant, Mental retardation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003742, CAB010443" Enhanced Supported Centrosome,Cytosol NA NA 490000 "Cluster 11: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Centrosome, Cytosol" "CAB010443: AB_2093483, HPA003742: AB_1078713" "unprognostic (2.58e-1)" "unprognostic (6.77e-2)" "unprognostic (1.68e-1)" "unprognostic (4.65e-2)" "unprognostic (4.66e-2)" "unprognostic (5.49e-2)" "prognostic unfavorable (3.03e-7)" "unprognostic (8.93e-2)" "unprognostic (1.23e-2)" "unprognostic (1.92e-1)" "unprognostic (2.38e-1)" "unprognostic (2.31e-1)" "prognostic favorable (1.09e-6)" "unprognostic (1.63e-2)" "unprognostic (8.73e-2)" "unprognostic (1.93e-1)" "unprognostic (4.52e-3)" 22.4 19.3 7.8 4.9 7.2 9.2 18.2 16.1 10.9 17.2 0.0 29.1 3.6 24.6 5.0 18.5 17.5 4.0 29.7 9.2 1.1 12.6 9.4 19.9 4.4 5.2 4.3 21.0 15.8 2.0 20.9 3.0 9.0 14.5 3.1 13.2 19.9 2.9 53.1 27.6 19.2 3.1 0.6 14.2 19.7 13.0 2.1 2.0 17.6 1.2 2.4 23.4 18.0 9.2 3.3 6.6 5.0 4.6 3.0 5.0 3.2 3.0 1.8 5.1 4.5 2.6 4.5 4.2 3.4 5.4 4.9 4.0 8.2 5.3 3.6 3.4 3.5 4.1 15.1 3.3 2.7 3.6 6.4 6.4 6.3 14.1 4.9 3.2 3.9 8.0 3.0 8.9 4.5 4.2 5.6 4.1 5.1 2.1 10.2 4.6 3.3 1.6 5.2 7.6 8.4 2.8 3.2 2.2 3.4 4.9 2.5 1.5 11.5 6.8 4.1 11.5 5.1 4.3 7.6 4.9 9.1 2.9 3.0 1.3 0.6 0.8 0.6 0.4 0.5 0.4 0.4 0.4 0.6 0.5 0.3 0.5 1.2 0.4 0.6 0.6 0.4 0.3 7.8 7.2 16.1 10.9 9.2 1.1 5.2 4.3 9.0 0.6 2.1 9.2 102.1 125.0 84.7 83.9 55.9 52.4 46.4 75.0 51.2 126.4 63.1 55.5 182.9 31.5 89.1 77.3 139.7 49.6 106.3 94.2 13.7 112.6 14.8 123.6 131.0 93.7 71.3 38.1 127.3 81.2 42.9 86.5 86.6 134.6 33.5 117.9 46.1 36.7 40.2 183.4 131.0 68.0 75.3 52.7 123.6 16.8 70.5 90.7 71.2 51.5 99.2 63.3 73.2 51.8 93.3 131.3 73.6 71.5 100.0 47.6 82.6 48.5 90.7 115.4 85.5 81.4 106.1 87.1 72.2 59.2 64.1 37.4 91.3 86.1 64.4 46.5 HSP90AA1 "FLJ31884, Hsp89, Hsp90, HSP90N, HSPC1, HSPCA" ENSG00000080824 "Heat shock protein 90 alpha family class A member 1" P07900 14 102080742-102139699 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Stress response" "Chaperone, Hydrolase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 2527.6" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 12150.7;Urothelial cells: 5781.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB002058 Approved Supported Cytosol NA NA 71000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "CAB002058: " "prognostic unfavorable (5.59e-4)" "unprognostic (3.77e-2)" "unprognostic (1.78e-2)" "unprognostic (9.25e-2)" "unprognostic (2.53e-1)" "unprognostic (1.05e-3)" "prognostic unfavorable (3.09e-5)" "unprognostic (7.79e-3)" "unprognostic (5.71e-2)" "unprognostic (7.81e-3)" "unprognostic (3.68e-2)" "unprognostic (1.65e-2)" "prognostic favorable (1.18e-5)" "unprognostic (1.04e-1)" "unprognostic (2.54e-1)" "unprognostic (1.43e-1)" "unprognostic (1.12e-1)" 362.9 439.5 1188.2 299.3 1221.3 459.2 438.6 1272.5 2527.6 282.1 1284.0 289.7 191.3 239.6 318.6 262.0 560.3 363.7 460.6 1213.8 1334.7 452.4 380.5 376.1 321.9 1283.8 1324.0 350.4 273.5 421.8 355.5 420.6 1351.6 348.4 311.1 1127.6 371.1 319.5 405.8 224.8 244.2 306.2 1216.2 217.6 297.5 541.9 1274.3 404.8 223.3 434.9 376.7 406.5 232.8 1639.1 1348.6 1832.2 1142.0 794.2 678.0 567.7 1512.1 1466.0 709.0 1779.5 994.1 1123.6 1245.6 1671.5 1323.1 960.7 1164.7 1471.2 3319.0 1452.5 3215.8 1227.4 1091.9 1291.8 1029.3 1444.3 334.9 1936.9 950.0 539.4 604.6 1140.3 416.2 1107.1 998.6 1764.9 1818.9 838.8 1634.1 1850.8 2087.7 891.1 1191.0 2500.5 1709.3 1968.2 1550.2 715.1 1030.3 1738.2 1497.0 1077.2 1860.4 1389.6 848.2 1903.9 1790.2 765.2 708.2 1234.6 786.5 1860.0 2826.4 783.5 2534.1 2402.7 1167.3 1182.5 1521.0 184.4 87.6 112.1 195.4 128.5 254.9 128.4 162.4 202.2 104.9 127.8 119.2 174.8 57.5 252.6 124.9 208.0 177.8 113.5 1188.2 1221.3 1272.5 2527.6 1213.8 1334.7 1283.8 1324.0 1351.6 1216.2 1274.3 1639.1 1571.4 1137.8 696.7 255.6 934.0 1340.7 12150.7 814.1 748.4 1185.6 1215.2 1173.1 2257.3 684.9 1020.6 513.1 2103.8 1415.1 1091.2 905.8 342.4 1210.5 662.9 2972.0 1350.8 1163.8 947.3 1502.3 158.9 867.6 1909.7 1632.5 788.5 2209.5 916.4 1026.8 341.3 554.4 1348.0 723.5 216.2 992.2 703.9 618.8 3110.7 442.6 732.0 2305.3 1300.2 267.0 773.6 1548.1 356.3 96.5 435.3 779.9 1021.6 722.9 1227.4 3791.1 552.2 896.4 2827.3 3623.6 618.0 1112.4 1974.9 3800.9 2142.4 830.1 1113.7 2050.2 3196.2 972.6 1028.8 5781.1 WDR20 "DMR, FLJ33659, MGC33177" ENSG00000140153 "WD repeat domain 20" Q8TBZ3 14 102139503-102224847 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 241.9;Late spermatids: 250.6;Oligodendrocytes: 201.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 34: Spermatids - Unknown function" "unprognostic (5.59e-2)" "unprognostic (1.00e-1)" "unprognostic (8.45e-2)" "unprognostic (7.70e-2)" "unprognostic (5.48e-2)" "unprognostic (5.14e-2)" "unprognostic (2.43e-2)" "unprognostic (3.96e-2)" "unprognostic (1.78e-1)" "unprognostic (5.04e-2)" "unprognostic (1.19e-2)" "unprognostic (3.26e-2)" "prognostic favorable (3.26e-9)" "unprognostic (6.62e-2)" "unprognostic (2.01e-1)" "unprognostic (2.68e-2)" "unprognostic (1.41e-2)" 12.2 17.0 11.2 9.4 16.3 10.7 11.7 18.7 15.6 11.5 13.3 10.8 16.0 10.3 12.0 13.5 10.7 8.9 10.0 12.3 15.0 12.5 10.9 8.8 11.5 16.5 14.0 12.3 12.3 11.9 10.5 9.9 16.1 10.2 10.5 29.9 11.4 7.4 11.8 16.0 13.1 9.1 11.6 10.4 10.6 23.9 14.3 12.3 14.1 13.0 10.8 10.4 12.1 28.7 16.2 20.6 14.6 13.0 16.4 14.3 19.2 19.8 16.4 21.9 17.7 17.6 15.2 17.7 12.9 18.6 11.9 19.3 21.6 17.8 27.7 25.0 9.8 9.3 14.8 19.4 12.6 14.4 16.1 11.2 16.7 15.8 15.5 22.0 15.4 14.2 12.3 18.6 23.9 37.2 13.3 21.8 13.0 22.3 22.7 13.3 14.5 11.9 31.8 25.4 18.4 20.8 17.3 22.2 13.9 16.2 24.1 13.8 17.0 20.3 9.3 32.2 18.7 14.6 21.9 18.8 18.5 11.7 22.2 28.5 20.7 37.7 25.8 21.2 27.0 27.6 28.4 24.2 21.0 19.9 28.9 27.4 40.2 30.4 21.4 12.4 33.6 21.0 11.2 16.3 18.7 15.6 12.3 15.0 16.5 14.0 16.1 11.6 14.3 28.7 17.5 9.6 14.5 48.6 21.0 25.1 15.4 19.6 16.5 20.5 16.3 12.7 10.4 10.0 16.7 11.0 16.7 25.6 22.8 19.6 21.5 17.9 241.9 20.1 14.5 12.9 11.4 25.0 43.3 17.3 19.4 15.6 14.3 21.1 22.9 15.0 15.0 12.7 13.4 33.7 42.9 12.8 18.3 10.4 13.8 250.6 13.1 12.9 21.4 48.7 15.6 23.8 22.6 68.9 201.5 18.9 17.6 15.1 17.4 19.0 27.5 25.1 15.6 54.6 13.1 18.6 17.4 43.0 25.3 16.4 27.4 34.9 22.3 8.7 12.1 21.7 MOK "RAGE, RAGE1, STK30" ENSG00000080823 "MOK protein kinase" Q9UQ07 14 102224500-102305190 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 125.8;testis: 54.0" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 185.6;Early spermatids: 212.8;Late spermatids: 185.8;Respiratory ciliated cells: 156.9;Rod photoreceptor cells: 465.7" "Cancer enriched" "Detected in many" 4 "melanoma: 7.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 8.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBF TERT88: 149.0;hTEC/SVTERT24-B: 383.5;NB-4: 499.1;U-138 MG: 200.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027292 Supported "Endoplasmic reticulum" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 24: NB-4 - Immune response" "Cluster 46: Photoreceptor cells - Phototransduction" "Endoplasmic reticulum" "HPA027292: AB_10600989" "unprognostic (8.16e-2)" "unprognostic (1.82e-1)" "unprognostic (6.68e-2)" "unprognostic (6.05e-3)" "unprognostic (1.34e-2)" "unprognostic (1.81e-2)" "unprognostic (4.43e-2)" "unprognostic (3.49e-4)" "unprognostic (2.19e-1)" "unprognostic (2.03e-2)" "unprognostic (2.93e-1)" "unprognostic (3.01e-3)" "unprognostic (5.97e-2)" "unprognostic (1.81e-1)" "unprognostic (2.17e-1)" "unprognostic (1.26e-2)" "unprognostic (2.48e-1)" 9.2 11.2 15.7 1.8 16.0 3.0 6.8 14.8 18.6 8.9 26.9 5.3 3.4 7.8 7.3 4.3 21.2 4.6 13.0 17.2 16.9 12.6 5.8 5.3 1.7 16.2 17.2 12.9 9.7 7.1 18.6 2.4 15.9 7.6 1.8 125.8 6.3 3.5 2.2 6.8 3.0 3.9 15.0 4.7 9.3 54.0 17.1 1.7 14.8 0.7 1.3 8.4 5.5 15.6 18.9 16.5 2.2 9.5 3.8 13.1 4.2 37.7 11.0 53.4 63.7 1.5 45.4 14.5 3.1 7.2 11.5 4.1 3.3 19.4 149.0 16.2 14.1 3.4 2.3 12.7 15.9 1.6 17.9 11.1 4.9 383.5 35.3 41.3 2.0 2.9 3.4 1.0 35.3 12.5 1.2 499.1 0.7 8.3 39.4 2.2 1.0 0.3 21.9 0.8 6.0 3.9 6.8 2.6 109.4 0.8 11.2 1.5 1.4 200.4 10.4 7.7 12.1 1.3 2.4 1.2 40.2 1.2 93.1 0.0 0.7 0.0 0.5 0.6 0.8 0.0 0.4 1.4 3.0 0.5 0.7 1.7 0.5 8.0 0.1 0.0 0.0 0.9 15.7 16.0 14.8 18.6 17.2 16.9 16.2 17.2 15.9 15.0 17.1 15.6 5.8 19.2 17.5 68.6 1.0 10.7 6.3 12.0 7.4 40.9 19.1 17.3 12.3 10.0 27.5 12.9 185.6 1.4 2.4 6.1 5.9 8.3 212.8 122.1 16.9 7.2 4.8 3.6 54.7 16.0 2.6 17.6 12.2 10.7 3.8 12.2 8.6 2.0 2.1 16.8 37.5 2.4 6.1 1.3 5.3 185.8 30.4 2.5 80.0 7.5 0.5 59.5 1.0 16.1 6.8 6.5 1.2 16.1 1.1 2.7 3.5 11.1 156.9 465.7 26.3 22.4 13.4 121.4 32.0 5.4 5.8 1.2 4.2 13.4 4.2 3.8 ZNF839 C14orf131 ENSG00000022976 "Zinc finger protein 839" A8K0R7 14 102317377-102342702 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 27.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020434 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 14: REH - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" "Plasma membrane" Nucleoplasm "HPA020434: AB_10669862" "unprognostic (7.83e-2)" "unprognostic (1.96e-1)" "unprognostic (2.28e-1)" "unprognostic (8.81e-2)" "unprognostic (1.49e-1)" "unprognostic (2.33e-1)" "unprognostic (6.73e-2)" "unprognostic (5.69e-2)" "unprognostic (1.85e-1)" "unprognostic (7.10e-3)" "prognostic favorable (4.57e-4)" "unprognostic (2.40e-2)" "prognostic favorable (5.00e-4)" "unprognostic (1.32e-1)" "unprognostic (2.17e-2)" "unprognostic (1.08e-1)" "unprognostic (8.21e-2)" 7.6 9.3 9.7 6.8 8.9 11.5 13.7 6.2 9.5 9.2 7.9 7.8 7.1 8.1 9.3 7.2 17.0 6.8 8.7 8.9 11.0 11.3 14.6 6.1 10.8 8.7 8.6 10.9 12.1 10.8 9.2 5.6 8.1 9.0 8.1 8.0 10.5 9.5 18.5 19.4 9.8 5.2 6.7 15.1 8.0 31.3 9.3 12.2 11.2 12.1 8.8 7.0 6.0 8.7 13.5 12.1 15.4 27.8 7.0 11.8 26.2 10.3 8.4 12.6 10.3 4.6 11.2 13.8 8.3 7.0 5.2 13.0 10.0 25.9 9.7 18.6 19.1 9.6 12.7 7.7 6.3 9.1 8.1 9.5 18.9 24.4 22.6 19.1 17.0 19.3 21.0 17.6 17.9 25.1 13.9 14.6 20.6 7.3 12.0 29.7 9.4 8.8 11.2 10.9 8.2 25.7 8.5 10.7 9.6 14.5 24.5 14.7 6.7 8.1 7.3 11.3 9.3 17.3 13.5 16.2 6.3 10.7 13.6 0.0 0.2 0.7 0.6 0.6 0.7 0.5 0.4 0.4 0.3 0.4 0.7 0.6 1.0 0.1 0.1 0.6 0.6 0.1 9.7 8.9 6.2 9.5 8.9 11.0 8.7 8.6 8.1 6.7 9.3 8.7 4.6 0.0 10.0 12.1 4.1 3.1 2.6 2.2 2.8 7.6 6.7 7.1 1.9 7.2 3.7 11.0 8.4 6.3 6.5 3.3 11.7 2.9 27.4 6.1 4.3 3.5 1.2 7.4 7.9 2.8 3.1 4.0 5.6 4.5 3.8 10.6 4.6 4.7 3.1 3.3 7.8 5.7 4.1 2.2 1.5 3.8 5.0 3.5 3.6 3.7 1.9 6.9 1.0 5.0 8.2 2.8 1.6 4.1 4.5 2.5 5.3 7.0 7.9 9.6 0.0 3.6 3.3 19.9 11.6 3.7 2.6 5.6 4.5 5.7 5.4 1.5 CINP MGC849 ENSG00000100865 "Cyclin dependent kinase 2 interacting protein" Q9BW66 14 102341102-102362916 "Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, DNA replication" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (3.47e-1)" "unprognostic (2.84e-1)" "unprognostic (1.50e-2)" "unprognostic (8.07e-2)" "unprognostic (2.19e-1)" "unprognostic (2.17e-3)" "unprognostic (1.44e-2)" "unprognostic (2.45e-1)" "unprognostic (3.91e-2)" "unprognostic (2.61e-2)" "unprognostic (3.41e-2)" "unprognostic (2.55e-1)" "unprognostic (1.46e-3)" "unprognostic (1.85e-1)" "unprognostic (1.46e-1)" "unprognostic (2.40e-1)" "unprognostic (2.71e-1)" 20.9 23.9 27.4 13.3 30.5 28.8 19.8 31.1 32.2 14.3 23.1 18.0 13.6 11.5 21.9 25.2 14.3 15.0 27.8 25.7 28.4 22.6 33.5 15.7 20.3 30.0 28.7 13.7 44.1 19.3 12.6 15.0 30.0 15.9 15.9 4.5 29.8 13.7 31.9 16.9 15.1 17.1 30.3 17.1 23.6 29.2 28.7 19.5 18.3 27.0 17.8 18.2 14.4 33.3 32.1 75.1 29.1 33.3 54.5 71.6 33.4 47.0 61.1 63.3 52.3 50.8 49.6 36.3 45.8 59.4 31.6 52.7 52.0 64.7 57.6 41.6 40.2 26.2 48.0 60.4 46.7 67.2 25.7 54.7 47.5 46.1 52.6 41.9 67.7 34.2 38.5 44.0 57.9 161.2 39.8 36.4 31.2 90.2 74.5 26.2 41.3 47.8 61.5 73.2 30.9 30.2 36.6 60.0 33.6 25.7 71.3 31.5 47.3 36.1 22.0 108.7 42.1 84.9 70.9 63.3 60.4 42.5 41.9 46.1 58.3 55.0 37.5 58.4 34.4 44.1 33.4 35.1 54.3 37.6 31.9 31.5 49.8 38.0 50.8 50.7 41.6 46.4 27.4 30.5 31.1 32.2 25.7 28.4 30.0 28.7 30.0 30.3 28.7 33.3 27.5 28.9 16.2 3.3 19.1 14.0 26.0 37.5 14.2 18.2 25.2 28.1 39.7 15.7 29.0 20.2 12.5 48.5 18.4 19.1 56.7 39.6 59.4 15.4 24.9 28.8 19.7 29.5 4.1 45.2 53.7 27.8 16.3 16.7 19.6 25.8 28.5 43.9 59.8 15.2 3.6 27.1 18.3 25.5 22.2 111.2 29.8 28.1 17.8 0.0 65.8 25.2 35.0 4.0 10.0 42.6 21.9 20.3 36.5 25.9 43.9 82.2 19.8 20.1 32.9 18.0 21.4 90.1 16.1 33.6 15.8 37.1 20.5 33.9 32.9 25.4 TECPR2 KIAA0329 ENSG00000196663 "Tectonin beta-propeller repeat containing 2" O15040 14 102362941-102502477 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Autophagy "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 57.5;Excitatory neurons: 59.1;Oligodendrocytes: 150.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "neutrophil: 7.3" "Lineage enriched" "Detected in single" 13 "granulocytes: 7.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000658 Enhanced Approved Nucleoplasm,Nucleoli,Centrosome NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 21: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 51: Myeloid cells - Hemostasis" Nucleoplasm "Nucleoli, Centrosome" "HPA000658: AB_1079191" "unprognostic (6.81e-2)" "unprognostic (1.21e-1)" "unprognostic (3.77e-2)" "unprognostic (2.62e-1)" "unprognostic (4.46e-1)" "unprognostic (1.63e-3)" "prognostic unfavorable (5.66e-5)" "unprognostic (1.17e-1)" "unprognostic (3.22e-2)" "unprognostic (1.64e-1)" "unprognostic (5.76e-3)" "unprognostic (3.78e-2)" "prognostic favorable (6.53e-9)" "unprognostic (1.39e-2)" "unprognostic (1.48e-1)" "unprognostic (1.91e-1)" "unprognostic (1.56e-3)" 5.4 5.1 12.4 5.4 18.8 5.7 5.4 12.1 13.9 6.0 5.6 8.3 3.8 7.9 6.7 4.9 6.4 4.5 7.5 12.9 10.5 4.4 4.1 5.1 2.7 13.0 14.7 5.9 4.5 9.0 7.2 5.7 12.2 6.4 3.2 9.7 10.1 7.2 11.1 5.6 4.7 8.7 10.4 5.7 5.4 10.9 15.4 5.5 5.7 7.8 2.9 7.2 5.0 21.5 4.7 9.4 8.9 7.4 18.0 13.6 4.9 10.4 12.0 10.3 8.6 2.0 3.4 3.5 6.4 10.9 7.6 8.4 6.2 7.8 8.6 13.0 4.1 4.2 4.9 4.1 8.5 2.3 3.9 9.0 6.8 9.3 6.1 9.7 10.2 3.9 2.1 7.8 9.6 8.9 2.1 2.5 3.4 4.9 9.7 5.0 6.2 1.1 5.2 7.8 7.1 6.6 9.0 2.3 5.7 5.7 10.5 3.1 10.6 7.9 2.0 21.4 4.4 8.0 5.1 0.7 7.6 6.1 8.3 0.3 0.5 0.9 0.2 0.3 0.2 0.0 0.2 0.1 0.2 0.1 0.3 0.1 7.3 0.1 0.1 0.1 0.4 0.4 12.4 18.8 12.1 13.9 12.9 10.5 13.0 14.7 12.2 10.4 15.4 21.5 9.1 9.6 6.9 57.5 3.5 2.0 3.1 4.7 8.0 17.0 10.1 8.0 13.0 4.3 5.6 3.7 50.1 7.1 5.7 7.2 5.9 8.2 31.2 7.4 10.3 8.7 4.2 5.7 59.1 7.1 5.7 8.4 5.6 6.3 0.0 8.6 8.2 6.1 4.9 13.5 34.4 3.8 10.2 4.7 3.4 27.9 14.3 12.7 3.6 26.2 8.5 21.6 5.2 28.6 150.4 6.8 2.5 18.8 8.0 4.0 5.9 6.0 7.0 44.7 19.7 9.1 8.3 24.6 15.0 7.7 1.6 6.0 4.6 8.4 4.6 3.2 ANKRD9 ENSG00000156381 "Ankyrin repeat domain 9" Q96BM1 14 102501767-102509799 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 112.0;skeletal muscle: 154.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 198.8;Early spermatids: 161.0;Erythroid cells: 146.5;Proximal enterocytes: 129.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055985 Uncertain NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 18: U-2197 - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA055985: AB_2682996" "unprognostic (1.34e-1)" "unprognostic (1.43e-1)" "unprognostic (3.05e-2)" "unprognostic (1.26e-2)" "unprognostic (7.76e-2)" "unprognostic (7.31e-3)" "unprognostic (6.78e-2)" "unprognostic (3.97e-2)" "unprognostic (3.35e-1)" "unprognostic (2.99e-1)" "unprognostic (3.68e-1)" "unprognostic (1.17e-1)" "prognostic favorable (1.17e-7)" "unprognostic (3.89e-1)" "unprognostic (4.74e-1)" "unprognostic (1.32e-2)" "unprognostic (1.15e-1)" 12.1 21.1 29.0 3.0 20.8 18.1 10.4 22.2 43.1 10.5 27.4 30.7 50.3 7.6 1.9 19.5 6.9 4.6 112.0 19.0 17.5 24.2 16.0 15.9 0.8 36.4 24.3 10.2 11.4 8.8 7.4 5.0 27.4 20.1 10.0 2.4 26.1 4.1 154.7 25.6 32.7 2.4 27.4 9.2 22.5 40.6 37.3 0.4 11.2 26.4 1.7 12.9 15.0 15.3 16.0 7.5 13.3 12.6 13.6 5.6 20.8 18.7 7.0 8.3 8.1 1.9 10.5 0.0 20.5 5.2 9.2 25.8 6.5 3.8 4.2 11.3 26.7 4.2 14.7 3.6 7.0 1.5 13.5 2.8 22.6 4.5 4.5 5.4 3.6 2.1 8.2 1.4 4.0 14.0 2.2 4.4 6.3 24.6 33.5 21.5 12.5 1.0 8.5 16.2 10.8 11.5 13.3 8.6 24.4 7.8 13.1 6.0 8.3 8.4 10.9 41.4 14.7 11.9 6.9 0.5 9.9 2.9 8.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 29.0 20.8 22.2 43.1 19.0 17.5 36.4 24.3 27.4 27.4 37.3 15.3 10.8 19.2 4.5 41.4 2.7 13.0 37.5 1.5 6.8 11.0 32.3 22.5 40.3 15.7 5.0 14.7 2.1 9.7 30.4 198.8 92.0 3.9 161.0 11.4 6.4 9.8 16.7 146.5 12.6 4.8 30.5 13.5 34.7 21.5 31.8 20.1 8.6 11.8 29.5 16.8 14.1 42.5 2.0 7.5 7.8 23.9 5.6 25.4 10.6 5.6 0.7 16.8 2.1 4.0 3.4 5.3 73.7 9.8 10.2 37.8 129.2 16.7 1.1 7.7 13.1 26.8 10.8 6.6 6.7 14.1 20.2 18.3 9.3 18.3 56.7 54.8 RCOR1 "COREST, KIAA0071, RCOR" ENSG00000089902 "REST corepressor 1" Q9UKL0 14 102592649-102730561 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Suprabasal keratinocytes: 117.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001956, HPA049327, HPA054241" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoplasm "CAB001956: , HPA049327: AB_2680715, HPA054241: AB_2682426" "unprognostic (1.98e-1)" "unprognostic (6.00e-2)" "unprognostic (1.17e-1)" "unprognostic (4.01e-3)" "unprognostic (1.25e-1)" "unprognostic (2.18e-1)" "unprognostic (9.96e-3)" "unprognostic (1.72e-2)" "unprognostic (1.87e-2)" "unprognostic (4.98e-2)" "unprognostic (1.46e-2)" "unprognostic (6.05e-3)" "unprognostic (7.23e-2)" "unprognostic (1.39e-1)" "unprognostic (2.02e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (3.72e-4)" 11.2 5.8 3.3 11.2 3.1 46.1 9.0 4.6 4.1 14.2 3.3 11.0 12.0 9.5 13.3 33.2 9.5 8.7 6.7 5.0 3.6 6.7 9.4 12.9 11.9 3.4 3.5 9.0 7.9 10.4 5.2 20.8 3.6 8.8 11.1 6.3 10.2 5.8 11.8 16.6 12.6 8.8 3.5 8.6 13.4 13.7 4.3 14.5 6.3 10.6 14.7 10.2 19.1 4.2 21.3 19.5 17.2 19.0 13.5 18.6 36.1 21.5 15.2 19.7 18.7 18.0 25.2 23.8 17.1 18.7 9.9 32.6 26.2 15.4 29.4 10.1 9.6 44.2 17.4 17.6 18.4 44.3 38.2 13.1 23.6 17.4 26.5 21.1 21.8 22.1 35.7 17.5 20.1 34.6 27.8 29.9 8.5 23.2 33.1 70.4 17.4 10.6 24.1 25.9 22.2 13.8 48.1 21.9 13.9 21.5 30.0 34.6 23.8 13.6 10.2 43.8 14.2 12.9 16.6 25.0 16.3 32.0 14.6 3.1 1.4 2.2 0.2 1.5 0.3 0.3 0.3 0.6 1.5 0.3 0.3 0.3 3.7 0.7 1.8 0.6 0.5 0.5 3.3 3.1 4.6 4.1 5.0 3.6 3.4 3.5 3.6 3.5 4.3 4.2 15.8 48.1 40.0 32.3 27.3 57.6 27.7 12.0 30.7 8.4 25.6 20.7 16.7 10.0 19.7 3.7 2.1 31.1 39.1 31.5 5.9 6.7 5.1 55.7 36.1 15.9 21.0 32.2 39.3 7.4 20.4 20.2 32.6 58.3 24.1 18.0 11.0 11.7 15.1 10.1 33.8 16.8 10.2 38.8 65.6 4.9 24.2 43.6 24.9 52.5 33.1 9.5 12.3 22.1 23.5 16.7 15.2 21.1 14.8 25.4 18.2 8.0 16.3 5.4 0.0 18.9 19.6 22.5 18.6 46.9 117.6 43.1 26.2 20.3 22.8 72.3 TRAF3 "CAP-1, CD40bp, CRAF1, LAP1, RNF118" ENSG00000131323 "TNF receptor associated factor 3" Q13114 14 102777449-102911500 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Immunity, Ubl conjugation pathway" Transferase "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 108.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002933 Uncertain NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA002933: AB_1080352" "unprognostic (4.06e-2)" "unprognostic (1.75e-2)" "unprognostic (2.08e-2)" "unprognostic (4.49e-3)" "unprognostic (5.25e-2)" "unprognostic (4.17e-2)" "prognostic unfavorable (1.02e-5)" "unprognostic (1.31e-1)" "unprognostic (7.24e-2)" "unprognostic (1.16e-1)" "prognostic favorable (2.42e-5)" "unprognostic (1.29e-1)" "unprognostic (2.29e-2)" "unprognostic (1.28e-1)" "unprognostic (1.71e-1)" "unprognostic (3.13e-2)" "unprognostic (2.12e-1)" 6.6 4.2 8.3 18.8 8.7 20.5 4.8 6.3 14.5 3.9 7.6 7.9 7.7 5.8 2.3 6.6 6.8 6.2 6.3 15.6 12.1 5.4 6.4 7.3 20.9 9.8 9.9 3.3 4.5 7.2 8.4 3.9 9.5 5.0 6.3 4.4 4.8 5.7 5.6 6.8 10.7 6.4 8.1 12.0 6.7 10.7 12.8 9.4 6.1 3.3 15.9 8.8 4.7 8.0 25.3 26.4 14.8 9.7 7.5 11.4 23.4 19.1 19.0 19.1 16.7 13.3 36.7 18.6 22.5 19.2 25.8 14.9 20.4 20.4 19.1 50.2 13.9 18.2 11.7 10.3 12.0 21.4 54.5 11.4 13.9 13.1 18.3 10.9 13.9 27.8 18.2 57.4 11.8 23.6 46.2 12.6 8.0 10.7 19.2 25.5 19.8 11.7 16.8 29.3 38.3 13.8 19.8 14.1 13.0 6.6 13.1 24.2 29.9 18.0 14.8 48.0 27.8 42.2 51.7 36.0 20.5 10.8 21.8 3.3 5.1 1.8 2.9 4.0 2.4 10.0 4.2 2.6 3.6 9.5 3.0 2.1 3.8 2.4 2.5 5.9 3.8 5.0 8.3 8.7 6.3 14.5 15.6 12.1 9.8 9.9 9.5 8.1 12.8 8.0 4.2 6.4 8.9 54.5 43.3 12.2 20.4 20.0 18.2 42.6 9.1 6.9 8.0 10.0 13.8 0.0 6.2 5.3 12.8 14.9 3.9 15.8 9.7 20.2 13.5 8.6 17.4 2.1 108.3 17.8 11.7 11.2 8.6 12.2 8.2 3.5 1.4 5.3 12.9 15.2 63.1 15.8 10.2 8.7 29.5 7.6 1.8 20.3 17.8 23.4 18.1 5.4 8.2 63.8 43.6 22.6 5.9 6.4 42.1 28.8 16.9 8.3 19.2 11.0 0.0 12.2 8.4 14.2 33.2 12.7 12.6 3.4 21.9 1.5 11.3 24.9 AMN amnionless ENSG00000166126 "Amnion associated transmembrane protein" Q9BXJ7 14 102922663-102933596 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Protein transport, Transport" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "intestine: 83.5;kidney: 39.8;liver: 37.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 672.6;Intestinal goblet cells: 283.9;Paneth cells: 724.4;Proximal enterocytes: 2014.8;Proximal tubular cells: 348.9;Undifferentiated cells: 272.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.2;CACO-2: 8.1;Hep G2: 9.9;U-698: 3.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA000817 Approved "Secreted in other tissues" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 39: CACO-2 - Unknown function" "Cluster 45: Enterocytes - Digestion" "HPA000817: AB_1078146" "unprognostic (2.02e-2)" "unprognostic (1.67e-1)" "unprognostic (3.94e-3)" "unprognostic (7.39e-3)" "unprognostic (9.32e-2)" "unprognostic (1.88e-3)" "unprognostic (8.68e-2)" "unprognostic (1.62e-1)" "unprognostic (4.37e-2)" "unprognostic (2.97e-2)" "unprognostic (7.57e-2)" "unprognostic (2.43e-2)" "prognostic favorable (9.62e-5)" "unprognostic (8.02e-2)" "unprognostic (1.58e-1)" "unprognostic (1.83e-1)" "unprognostic (1.66e-1)" 1.4 0.0 0.1 1.1 0.2 0.1 0.5 0.1 0.2 1.5 0.0 33.0 43.5 0.1 0.0 5.6 1.1 1.9 0.0 0.2 0.1 39.8 37.8 1.7 0.1 0.3 0.1 0.1 0.7 0.0 0.5 0.0 0.3 0.7 3.0 0.0 1.2 0.0 0.0 2.3 83.5 0.1 0.1 0.5 8.0 0.8 0.1 0.1 0.8 0.0 0.0 0.3 2.5 0.3 0.3 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 8.1 0.1 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 9.9 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.1 0.7 1.2 0.0 1.1 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.1 0.7 0.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.2 0.2 0.1 0.3 0.1 0.3 0.1 0.1 0.3 0.2 9.6 0.5 0.7 18.0 13.4 23.4 1.3 12.0 3.3 13.1 2.0 1.5 140.2 6.1 20.2 0.0 2.7 4.7 672.6 33.2 1.8 4.8 8.2 1.1 0.6 19.2 0.8 0.1 0.7 4.1 0.9 61.7 10.5 4.5 1.9 0.4 52.6 0.6 1.7 0.1 283.9 6.1 1.6 2.3 6.3 0.6 3.1 7.2 0.0 0.1 0.2 1.0 0.0 0.1 11.1 724.4 0.7 4.5 28.1 2014.8 348.9 4.5 1.2 0.0 0.5 0.9 21.2 25.7 17.1 20.9 1.4 5.2 0.4 272.4 65.7 CDC42BPB "KIAA1124, MRCKB" ENSG00000198752 "CDC42 binding protein kinase beta" Q9Y5S2 14 102932380-103057549 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022821 Approved NA NA 12000 "Cluster 7: Monocytes - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 44: Endometrium - Transcription" "HPA022821: AB_1846376" "unprognostic (6.73e-2)" "unprognostic (2.19e-2)" "unprognostic (6.99e-2)" "unprognostic (5.67e-2)" "unprognostic (1.41e-2)" "unprognostic (2.19e-1)" "unprognostic (2.90e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (2.71e-1)" "unprognostic (1.24e-1)" "unprognostic (3.46e-2)" "unprognostic (2.28e-1)" "prognostic favorable (8.67e-10)" "unprognostic (2.11e-1)" "unprognostic (1.86e-1)" "unprognostic (8.59e-2)" "unprognostic (7.56e-2)" 38.7 31.3 42.7 17.8 42.5 3.6 31.2 31.2 40.2 33.5 21.0 35.8 30.2 38.0 17.9 37.8 31.3 29.5 36.3 44.3 36.4 32.3 28.9 32.9 9.8 38.6 40.2 33.4 33.1 34.2 32.5 29.5 35.7 28.7 20.2 24.1 27.9 30.4 27.2 33.0 34.9 32.3 38.5 22.2 32.0 25.2 40.8 8.6 29.6 24.2 12.6 35.0 33.2 46.1 42.8 83.8 52.7 38.7 57.3 65.1 53.0 47.9 50.3 49.7 45.4 28.8 49.0 0.0 51.1 93.7 37.7 53.0 54.9 57.2 52.3 52.2 24.8 23.4 68.0 29.0 62.2 0.2 24.1 56.7 57.6 51.0 48.5 52.2 97.7 9.8 19.3 11.7 48.3 89.2 0.4 5.4 25.3 66.5 68.4 0.2 44.3 1.2 63.1 82.6 38.2 41.6 85.1 31.6 35.8 55.7 48.7 14.9 125.3 47.3 31.6 105.8 45.3 15.1 17.4 12.4 53.2 5.2 46.9 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.7 42.5 31.2 40.2 44.3 36.4 38.6 40.2 35.7 38.5 40.8 46.1 57.1 57.7 35.8 37.5 7.8 14.5 16.5 14.5 17.6 45.8 19.1 15.4 28.8 28.6 27.4 55.2 33.3 12.6 0.5 35.4 3.9 29.8 14.2 35.8 55.0 46.3 25.2 11.0 40.3 21.8 11.1 25.7 32.1 59.4 13.3 37.8 36.0 20.5 12.8 57.2 33.1 16.1 30.5 13.5 14.7 7.9 32.3 21.7 12.4 31.9 11.1 29.3 0.0 31.7 74.6 44.2 15.4 55.3 3.5 26.1 28.2 15.4 28.1 42.3 6.6 38.6 29.3 15.5 17.0 27.2 18.3 16.8 3.2 37.3 27.5 32.4 LBHD2 ENSG00000283071 "LBH domain containing 2" A0A0U1RRK4 14 103084210-103090027 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 11.9;testis: 3.0" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 1.3;Proximal tubular cells: 1.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 33: Fibroblasts - ECM organization" 1.7 0.0 1.9 0.2 3.6 0.0 0.5 0.8 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 4.4 0.3 0.0 0.0 0.1 3.6 1.6 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.1 3.0 11.9 0.0 0.0 0.0 0.0 0.4 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 3.6 0.8 2.1 3.1 4.4 3.6 1.6 3.9 0.9 11.9 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 EXOC3L4 C14orf73 ENSG00000205436 "Exocyst complex component 3 like 4" Q17RC7 14 103100144-103110559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 19.1;liver: 41.1" "Cell type enhanced" "Detected in some" "Cholangiocytes: 8.6;Gastric mucus-secreting cells: 21.9;Hepatocytes: 25.1;Proximal enterocytes: 30.2;Proximal tubular cells: 12.3" "Cancer enhanced" "Detected in many" "liver cancer: 7.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 3.4;HEL: 3.8;Hep G2: 2.7;RPMI-8226: 2.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA043661 Approved NA NA "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 36: HEL - Hemostasis" "Cluster 45: Enterocytes - Digestion" "HPA043661: AB_10965693" "unprognostic (8.71e-2)" "unprognostic (7.42e-3)" "prognostic unfavorable (1.43e-5)" "unprognostic (8.20e-2)" "unprognostic (1.06e-1)" "unprognostic (1.79e-1)" "unprognostic (9.53e-3)" "unprognostic (6.64e-2)" "unprognostic (1.49e-1)" "unprognostic (6.98e-2)" "unprognostic (3.12e-1)" "unprognostic (8.96e-2)" "unprognostic (2.22e-1)" "unprognostic (1.32e-2)" "unprognostic (5.21e-2)" "unprognostic (2.22e-1)" "unprognostic (2.81e-4)" 0.7 0.3 0.0 2.7 0.0 0.2 0.2 0.0 0.1 0.5 0.1 2.8 19.1 0.2 0.0 0.5 0.4 3.0 0.8 0.0 0.0 3.9 41.1 1.7 6.5 0.0 0.0 0.3 1.5 0.0 0.2 0.9 0.0 1.3 1.3 0.0 0.7 0.3 0.3 0.1 9.7 0.2 0.0 5.1 4.6 0.2 0.0 3.7 0.3 0.0 2.8 0.8 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.6 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 3.4 0.0 3.8 0.0 2.7 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.2 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.2 1.3 0.0 0.0 0.2 0.1 1.1 8.6 0.6 0.0 0.0 0.0 0.0 6.3 0.0 2.3 0.1 0.3 0.2 0.3 1.2 0.0 0.0 4.1 3.2 2.2 21.9 0.3 0.0 0.8 0.4 25.1 0.2 0.0 0.0 5.3 0.0 0.8 0.3 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.6 1.5 2.1 0.2 30.2 12.3 1.5 0.0 0.0 6.4 0.8 0.1 2.0 0.0 0.4 0.3 0.2 2.2 5.1 0.7 TNFAIP2 "B94, EXOC3L3" ENSG00000185215 "TNF alpha induced protein 2" Q03169 14 103121476-103137439 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Angiogenesis, Differentiation" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "urinary bladder: 277.5" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 295.5;Langerhans cells: 198.7;monocytes: 351.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 48.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "RT4: 785.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB004598, HPA030624" Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 15: RT4 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus, Cytosol" "Nucleoplasm, Nuclear membrane" "CAB004598: AB_628370, HPA030624: AB_2673552" "unprognostic (5.01e-3)" "unprognostic (4.93e-2)" "unprognostic (1.56e-3)" "unprognostic (8.02e-3)" "unprognostic (3.39e-2)" "unprognostic (2.98e-2)" "unprognostic (5.52e-3)" "unprognostic (5.97e-2)" "unprognostic (1.94e-1)" "unprognostic (7.02e-2)" "unprognostic (1.22e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (4.10e-4)" "prognostic favorable (2.79e-5)" "unprognostic (1.75e-2)" "unprognostic (3.83e-2)" "prognostic favorable (7.17e-5)" 119.9 76.8 9.0 103.6 11.5 106.8 78.4 6.7 12.2 53.8 12.1 39.8 38.0 50.9 6.6 88.3 57.1 102.2 48.3 8.0 9.7 67.7 61.6 142.4 87.4 17.1 10.4 16.9 33.6 66.8 16.6 48.4 16.2 73.6 26.8 1.6 84.0 14.9 35.0 53.3 52.5 24.8 13.6 147.9 37.4 37.1 21.4 39.5 36.8 32.5 80.3 277.5 74.6 16.1 34.7 156.3 1.1 0.6 10.1 45.9 54.5 9.7 43.2 26.4 8.9 1.6 148.7 0.3 120.3 48.5 142.5 104.2 11.6 0.0 11.9 6.1 0.6 15.4 120.0 0.7 19.2 7.7 20.0 17.8 1.6 8.4 0.1 10.5 14.2 7.7 15.5 35.3 3.6 3.4 0.4 11.6 9.7 19.6 13.4 6.8 18.9 24.9 80.8 785.1 1.3 2.3 150.2 52.4 1.9 5.6 83.8 50.4 28.4 5.1 13.5 30.3 31.5 31.4 2.4 0.9 38.1 34.0 16.1 5.9 16.8 9.0 0.1 18.6 0.1 0.1 0.1 0.0 9.4 0.2 0.1 0.1 48.4 0.2 15.0 0.5 0.0 4.5 9.0 11.5 6.7 12.2 8.0 9.7 17.1 10.4 16.2 13.6 21.4 16.1 45.8 0.0 25.1 2.3 8.2 28.3 41.8 295.5 6.8 1.1 24.2 11.4 14.1 51.5 126.1 27.6 0.0 1.2 1.3 1.0 0.0 160.9 36.8 92.4 122.2 47.1 17.3 1.7 2.5 44.7 61.2 123.3 5.6 172.8 33.7 4.5 18.9 8.0 54.1 0.0 5.7 0.3 85.5 151.2 198.7 48.8 8.4 163.3 30.2 25.3 351.9 5.9 5.2 1.0 0.9 122.1 18.3 2.2 11.7 186.0 0.7 14.4 121.5 0.7 19.7 104.9 39.7 2.1 4.6 20.7 33.4 4.8 8.3 1.1 1.9 138.6 EIF5 ENSG00000100664 "Eukaryotic translation initiation factor 5" P55010 14 103333544-103345025 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 787.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA000867, CAB004226" Supported Enhanced Cytosol NA NA 77000 "Cluster 6: Non-specific - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 16: U-266 - Nucleosome" "Cluster 7: Non-specific - Mitochondria" Cytosol "CAB004226: AB_627507, HPA000867: AB_1078731" "unprognostic (1.39e-1)" "unprognostic (3.13e-1)" "unprognostic (4.02e-2)" "unprognostic (6.47e-3)" "unprognostic (6.33e-2)" "unprognostic (3.02e-1)" "unprognostic (2.01e-1)" "unprognostic (5.59e-2)" "unprognostic (7.82e-2)" "unprognostic (3.92e-3)" "unprognostic (1.08e-1)" "unprognostic (2.70e-2)" "prognostic favorable (5.67e-7)" "unprognostic (2.76e-1)" "unprognostic (8.41e-2)" "unprognostic (5.43e-3)" "unprognostic (3.14e-2)" 90.5 60.4 82.6 54.5 86.9 194.4 72.1 89.7 90.9 48.7 73.7 81.6 79.5 56.3 54.9 74.4 66.2 63.3 85.2 87.8 92.7 92.4 151.4 64.6 62.3 88.1 93.0 45.6 78.1 81.7 40.8 66.3 93.4 54.9 77.9 50.4 63.5 75.1 163.6 56.8 67.4 71.0 96.3 55.3 65.3 94.9 87.4 61.6 93.4 144.5 80.1 62.9 46.0 103.2 132.9 149.4 174.0 79.1 147.0 129.1 182.3 190.7 205.1 192.5 145.3 223.7 137.3 136.4 117.2 172.4 165.0 173.3 220.9 193.3 325.6 111.9 87.4 121.9 76.3 119.6 152.8 222.1 100.6 139.7 127.0 170.8 230.6 160.2 196.9 98.9 255.8 126.7 161.3 188.7 152.7 73.4 90.5 251.7 285.8 127.4 226.1 85.1 112.8 423.7 153.7 107.7 191.6 141.3 155.9 161.0 135.5 100.8 149.7 152.8 103.3 196.3 201.5 376.2 787.9 287.4 150.5 154.3 182.4 356.8 245.1 323.9 235.1 249.1 265.2 335.0 239.4 224.3 241.5 334.1 283.0 236.8 266.1 315.1 273.0 329.2 221.1 401.0 82.6 86.9 89.7 90.9 87.8 92.7 88.1 93.0 93.4 96.3 87.4 103.2 282.4 144.2 158.6 56.5 269.5 340.1 346.0 216.0 362.0 196.8 260.5 252.3 307.3 101.5 172.4 73.5 185.6 233.0 298.1 221.9 215.2 243.8 280.6 182.0 162.9 227.9 199.6 408.1 47.3 282.3 212.1 267.6 137.1 252.4 278.7 218.7 134.6 255.5 173.1 176.7 40.9 220.3 187.2 158.4 313.2 683.5 128.0 282.5 152.9 30.9 238.7 167.7 129.8 24.6 60.6 247.8 161.7 173.8 414.4 260.4 233.7 272.3 179.8 212.9 118.3 460.0 372.7 507.8 367.8 323.2 265.2 493.8 281.7 213.1 232.0 254.0 MARK3 "CTAK1, KP78, PAR-1A" ENSG00000075413 "Microtubule affinity regulating kinase 3" P27448 14 103385377-103503831 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 32 "eosinophil: 101.5" "Lineage enriched" "Detected in all" 32 "granulocytes: 101.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024652 Approved NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "HPA024652: AB_1853582" "unprognostic (6.86e-2)" "unprognostic (2.93e-1)" "unprognostic (7.70e-2)" "unprognostic (3.48e-2)" "unprognostic (8.41e-2)" "unprognostic (1.50e-1)" "unprognostic (2.31e-3)" "unprognostic (2.21e-1)" "prognostic unfavorable (1.14e-4)" "unprognostic (2.29e-3)" "unprognostic (3.66e-2)" "unprognostic (1.55e-2)" "unprognostic (1.13e-1)" "unprognostic (4.71e-2)" "unprognostic (1.34e-1)" "unprognostic (1.33e-2)" "unprognostic (1.60e-1)" 34.6 52.5 14.9 23.0 15.9 53.2 27.5 16.0 22.1 29.8 15.1 34.8 20.4 31.3 26.7 39.8 36.8 20.8 71.5 14.5 14.8 38.7 30.8 38.3 24.9 15.1 15.0 33.7 46.7 33.8 32.0 22.8 16.2 30.5 21.3 23.2 29.2 24.2 71.0 27.3 31.8 30.8 15.0 42.6 46.5 38.4 14.7 31.0 33.2 42.7 26.2 32.1 28.5 15.6 28.1 33.3 52.8 34.7 64.3 43.6 40.9 54.9 56.8 66.3 62.4 23.3 46.2 36.3 31.9 52.5 27.0 51.5 58.3 56.6 81.2 39.4 28.0 46.8 34.9 30.8 123.5 53.4 27.2 56.1 51.5 53.1 105.0 51.9 61.0 33.0 45.4 77.1 51.2 61.6 34.9 38.4 42.0 57.7 56.0 44.9 56.2 30.1 54.1 52.3 44.5 43.1 59.0 36.6 52.1 58.7 50.8 47.1 50.2 34.8 23.4 62.1 48.4 44.4 67.0 42.1 41.5 40.8 48.0 0.3 1.5 101.5 1.4 1.1 0.9 1.5 2.2 2.8 1.8 0.6 2.4 1.6 2.3 1.4 1.1 1.2 3.1 0.7 14.9 15.9 16.0 22.1 14.5 14.8 15.1 15.0 16.2 15.0 14.7 15.6 38.0 57.7 79.1 154.1 43.6 44.2 57.2 28.7 33.0 78.7 26.3 21.7 74.6 47.1 45.2 38.6 162.6 33.3 47.9 36.6 11.7 46.8 38.0 47.5 63.7 50.9 31.2 187.1 153.5 42.0 31.0 47.3 52.0 62.1 48.2 128.7 63.9 30.1 30.2 58.9 145.0 32.3 30.5 40.4 63.0 52.4 60.9 42.6 37.4 70.3 57.5 34.4 61.8 138.2 172.3 60.4 34.0 59.0 55.9 67.4 34.6 21.5 36.8 86.7 32.9 38.9 44.1 74.6 72.4 36.1 52.1 49.1 54.8 98.9 33.7 114.6 CKB CKBB ENSG00000166165 "Creatine kinase B" P12277 14 103519667-103522833 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 694.7;intestine: 653.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 2767.4;Distal enterocytes: 4691.8;Distal tubular cells: 2281.3;Horizontal cells: 5042.4;Muller glia cells: 3639.8;Rod photoreceptor cells: 3789.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 10 "non-classical monocyte: 290.8" "Lineage enriched" "Detected in many" 18 "monocytes: 290.8" "Cell line enhanced" "Detected in many" "CACO-2: 455.8;HEK 293: 1399.8;SCLC-21H: 792.2;SH-SY5Y: 352.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001254, CAB047313" Enhanced Supported Cytosol No No 38000000 "Cluster 51: Monocytes - Innate immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "CAB047313: , HPA001254: AB_1078528" "unprognostic (9.97e-2)" "unprognostic (1.33e-3)" "unprognostic (4.25e-3)" "unprognostic (1.10e-1)" "unprognostic (7.63e-2)" "unprognostic (3.62e-2)" "unprognostic (1.64e-1)" "unprognostic (1.30e-1)" "unprognostic (4.24e-1)" "unprognostic (4.60e-2)" "unprognostic (2.68e-3)" "unprognostic (9.89e-3)" "prognostic favorable (4.02e-8)" "unprognostic (2.62e-1)" "unprognostic (1.10e-1)" "unprognostic (1.67e-2)" "unprognostic (2.13e-1)" 90.7 60.0 471.6 25.8 627.0 3.2 47.2 641.1 694.7 105.2 192.7 653.4 36.0 222.6 16.0 54.5 197.9 17.9 269.8 428.7 482.3 161.0 9.0 60.3 4.0 427.5 440.4 58.8 27.7 108.2 74.0 4.7 345.1 301.8 151.9 471.3 37.9 208.3 80.0 76.5 120.8 113.8 434.5 6.8 479.9 97.6 596.2 2.8 87.9 47.1 5.1 298.4 101.6 383.6 2.4 54.5 321.1 14.7 4.4 2.3 6.3 37.5 0.3 2.4 1.4 455.8 7.3 0.4 36.9 29.1 9.9 70.2 109.9 1.5 0.2 9.6 1399.8 111.0 242.1 165.4 16.6 0.7 87.9 14.7 0.6 3.9 0.8 3.3 0.0 5.1 198.7 3.7 4.8 20.0 2.3 3.9 109.1 48.3 213.6 13.9 6.8 275.9 65.9 2.5 792.2 352.2 65.3 10.6 25.2 21.6 21.1 40.9 2.2 1.5 56.3 4.7 147.3 21.1 2.7 7.2 6.4 2.1 14.1 2.4 0.5 14.6 0.3 28.5 0.4 0.0 0.2 0.1 16.4 0.2 0.1 0.5 1.0 0.2 290.8 0.0 0.7 6.0 471.6 627.0 641.1 694.7 428.7 482.3 427.5 440.4 345.1 434.5 596.2 383.6 14.8 195.5 103.5 515.8 13.5 153.7 296.2 257.6 56.3 2767.4 41.5 48.9 553.5 145.8 117.9 114.0 1909.9 4.4 3.4 4691.8 2281.3 127.6 445.8 773.2 205.7 60.8 467.1 9.9 178.0 42.5 11.7 96.6 359.4 408.5 28.6 476.1 74.6 9.2 8.2 5042.4 147.0 726.0 187.2 2.8 44.9 147.4 304.1 39.8 181.5 88.1 74.2 3639.8 0.0 93.5 161.2 131.4 1996.9 1089.3 6.6 279.8 9.5 118.0 456.1 3789.9 59.2 15.4 222.6 127.3 97.4 22.1 175.2 41.6 19.1 12.2 755.6 220.1 TRMT61A "C14orf172, FLJ40452, GCD14, Gcd14p, hTRM61" ENSG00000166166 "TRNA methyltransferase 61A" Q96FX7 14 103529196-103537073 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 62.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 10.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024269 Approved Mitochondria NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 43: Cardiomyocytes - Nuclear processes" Mitochondria "HPA024269: " "unprognostic (5.12e-2)" "unprognostic (2.73e-2)" "unprognostic (1.36e-1)" "unprognostic (5.59e-3)" "unprognostic (1.49e-1)" "unprognostic (3.70e-2)" "prognostic unfavorable (1.60e-4)" "unprognostic (1.94e-1)" "unprognostic (3.29e-1)" "unprognostic (2.20e-1)" "unprognostic (3.70e-2)" "unprognostic (9.86e-3)" "unprognostic (2.88e-3)" "unprognostic (4.16e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-1)" "unprognostic (1.28e-1)" 10.5 10.0 11.2 4.5 13.6 4.5 9.6 11.2 14.4 15.2 8.1 24.3 4.4 18.7 2.3 9.7 18.9 2.4 7.5 10.9 10.0 13.9 11.6 8.1 3.7 11.9 11.6 10.8 11.0 3.0 7.5 2.7 11.0 17.1 1.7 1.5 7.4 7.0 9.9 10.8 9.6 4.3 10.7 7.6 12.4 8.3 11.7 2.3 15.3 2.6 1.8 21.3 11.2 12.8 10.0 24.4 3.7 7.6 3.8 3.9 15.1 10.8 4.8 13.3 7.2 33.4 16.8 16.1 13.3 5.7 7.8 25.2 8.0 8.3 3.7 11.0 15.0 12.3 9.6 18.0 6.7 15.9 9.2 4.4 10.4 11.6 4.7 3.1 2.3 11.4 18.5 7.6 4.5 28.9 19.6 12.2 12.9 20.7 48.8 24.0 11.6 13.9 5.4 14.5 19.4 12.2 12.4 11.5 14.7 1.4 21.5 9.3 4.6 12.0 12.8 31.9 22.4 10.2 7.0 20.2 12.8 12.7 23.3 0.0 2.1 0.3 2.6 5.4 1.9 2.5 2.1 2.8 3.3 2.6 2.3 2.3 0.0 2.7 10.8 2.2 1.6 2.2 11.2 13.6 11.2 14.4 10.9 10.0 11.9 11.6 11.0 10.7 11.7 12.8 9.8 0.0 6.0 4.9 11.0 26.1 19.9 7.7 6.8 13.7 11.5 13.5 62.7 7.2 4.7 7.3 4.2 13.0 7.2 19.2 17.6 19.4 4.0 6.0 15.7 10.6 10.7 2.5 4.1 12.2 15.5 13.6 8.2 7.2 2.5 12.6 3.9 9.9 12.3 30.3 3.2 10.4 4.1 7.8 7.8 18.9 11.1 6.6 10.6 2.8 12.8 9.4 4.1 0.5 4.8 19.7 9.3 18.4 6.3 22.8 6.3 15.7 5.0 11.2 0.0 12.5 15.4 6.9 12.5 8.5 30.0 12.0 7.0 10.7 19.4 13.6 BAG5 ENSG00000166170 "BAG cochaperone 5" Q9UL15 14 103556545-103562657 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 127.7" "Group enriched" "Detected in all" 13 "Early spermatids: 1734.2;Late spermatids: 1796.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016429 Enhanced Approved Vesicles NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 83: Testis - Spermatogenesis" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 34: Spermatids - Unknown function" Vesicles "HPA016429: AB_1845261" "unprognostic (3.02e-2)" "unprognostic (2.98e-2)" "unprognostic (1.05e-2)" "unprognostic (6.26e-2)" "unprognostic (2.54e-1)" "unprognostic (5.22e-2)" "unprognostic (1.99e-3)" "unprognostic (2.78e-1)" "unprognostic (1.04e-1)" "unprognostic (4.77e-3)" "unprognostic (2.34e-1)" "unprognostic (3.80e-2)" "prognostic favorable (1.58e-8)" "unprognostic (2.51e-1)" "unprognostic (1.52e-1)" "unprognostic (3.69e-2)" "unprognostic (2.53e-1)" 24.6 11.4 12.7 15.1 13.0 27.8 18.7 15.9 16.7 14.7 15.6 14.8 12.3 16.1 12.6 21.8 16.0 12.9 13.3 13.5 13.2 15.9 11.9 15.5 17.1 12.6 12.4 12.1 12.2 14.0 10.8 14.4 12.8 14.0 14.6 18.4 16.5 14.2 13.1 19.3 12.1 15.1 12.4 18.3 14.9 127.7 12.2 14.9 23.7 13.5 19.1 15.3 12.6 14.3 26.2 22.1 30.0 27.1 27.5 26.5 33.1 26.0 22.6 22.6 19.9 18.0 32.7 47.3 24.5 30.2 20.6 38.4 24.2 34.7 35.6 19.9 15.8 31.3 25.3 16.2 17.4 42.7 31.3 19.3 43.7 23.2 29.3 20.7 24.0 34.4 25.2 34.8 31.2 35.1 37.4 19.9 17.8 43.8 27.4 40.1 34.4 21.6 37.3 58.3 33.0 22.3 34.9 30.3 23.6 20.1 38.9 21.8 28.4 24.4 19.9 37.9 31.2 21.4 34.4 52.7 27.5 22.9 30.9 28.7 13.4 11.9 9.3 14.8 11.9 6.8 11.0 9.0 14.1 7.8 12.8 11.1 9.0 13.0 21.4 5.9 10.6 12.7 12.7 13.0 15.9 16.7 13.5 13.2 12.6 12.4 12.8 12.4 12.2 14.3 51.5 44.8 24.3 10.4 29.4 69.0 44.8 33.3 47.8 37.9 32.9 28.8 21.8 17.2 44.5 35.0 27.1 25.4 40.0 26.5 66.5 24.7 1734.2 78.6 43.7 41.2 31.7 29.5 18.9 19.1 17.7 31.7 26.0 89.5 32.3 19.3 52.5 25.6 22.1 75.7 14.7 25.0 32.6 29.2 26.4 1796.9 49.7 24.4 32.0 11.2 23.6 49.6 36.0 9.0 20.3 27.1 15.2 67.0 18.5 45.2 18.4 31.7 43.3 36.2 32.9 30.3 27.0 129.7 40.4 60.5 89.8 40.8 33.3 33.1 24.3 62.1 KLC1 "hKLC1B, hKLC1G, hKLC1J, hKLC1N, hKLC1P, hKLC1R, hKLC1S, KLC, KNS2, KNS2A" ENSG00000126214 "Kinesin light chain 1" Q07866 14 103561896-103714249 "Predicted intracellular proteins" "Host-virus interaction" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 397.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009798, HPA044617, HPA052450" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 14000 "Cluster 26: Non-specific - Mitochondria" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 62: Horizontal cells - Visual perception" "Plasma membrane" "Nucleoplasm, Cytosol" "CAB009798: AB_2280879, HPA044617: AB_2679024, HPA052450: AB_2681838" "unprognostic (6.93e-3)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (7.94e-2)" "unprognostic (2.60e-1)" "unprognostic (1.19e-1)" "unprognostic (1.21e-3)" "unprognostic (2.67e-2)" "unprognostic (9.21e-2)" "unprognostic (5.62e-2)" "prognostic favorable (6.75e-4)" "unprognostic (6.84e-3)" "prognostic unfavorable (7.17e-4)" "unprognostic (6.58e-2)" "unprognostic (8.69e-2)" "unprognostic (4.05e-1)" "unprognostic (1.49e-1)" 70.8 49.4 282.9 42.2 302.0 50.3 63.0 273.5 358.7 74.8 220.4 89.9 26.2 71.5 43.9 66.0 65.0 38.4 100.0 310.6 299.8 35.6 29.9 66.0 44.2 378.9 305.0 62.8 43.0 48.5 86.7 45.9 397.0 47.1 34.3 158.6 54.2 47.1 123.4 68.2 48.7 58.0 300.0 49.0 53.9 45.6 301.7 40.2 48.6 71.5 47.4 66.5 69.8 304.0 57.0 74.2 138.6 76.3 92.6 102.8 65.5 129.5 105.4 118.6 81.7 64.0 60.8 75.8 65.2 139.3 53.2 93.0 85.8 69.6 112.0 89.9 43.9 41.6 92.8 66.1 106.8 83.4 79.5 73.4 109.3 89.6 112.1 126.5 104.2 52.8 63.5 83.7 104.4 94.6 56.9 74.0 45.6 90.1 140.4 53.0 60.6 38.2 74.7 122.5 165.1 93.5 105.7 52.7 90.2 85.9 47.9 40.1 152.7 88.4 43.5 123.1 74.1 65.9 50.0 83.3 101.7 47.7 97.0 5.5 4.6 9.8 7.3 4.6 6.6 5.0 6.5 7.8 5.1 6.8 5.7 5.0 5.0 3.1 6.5 7.6 7.0 2.9 282.9 302.0 273.5 358.7 310.6 299.8 378.9 305.0 397.0 300.0 301.7 304.0 45.2 44.8 32.6 92.4 24.3 26.0 45.1 30.1 13.6 140.8 18.7 19.7 39.3 15.7 21.5 20.2 52.1 22.6 29.5 17.9 9.8 42.9 8.0 30.8 41.8 45.5 44.9 13.2 84.1 30.7 30.6 37.4 27.0 43.2 33.6 31.5 39.3 18.9 30.5 138.0 80.8 24.3 28.5 19.9 23.8 17.0 38.5 24.4 39.2 73.1 36.3 45.4 20.6 57.3 89.8 71.2 17.3 48.2 26.2 46.6 15.8 5.1 23.8 106.1 26.3 46.4 46.8 64.8 83.3 20.1 17.6 42.1 30.8 17.1 17.5 38.4 COA8 "APOP-1, APOPT1, C14orf153, MGC2562" ENSG00000256053 "Cytochrome c oxidase assembly factor 8" Q96IL0 14 103562960-103607523 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Apoptosis "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 122.2" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 62.6;Cytotrophoblasts: 75.7;Extravillous trophoblasts: 54.9;Hofbauer cells: 85.8;Syncytiotrophoblasts: 69.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 24: Non-specific - Transcription regulation" "unprognostic (1.28e-1)" "unprognostic (1.76e-1)" "unprognostic (1.46e-1)" "unprognostic (4.06e-1)" "unprognostic (1.93e-1)" "unprognostic (6.74e-3)" "prognostic unfavorable (6.34e-5)" "unprognostic (1.83e-1)" "unprognostic (7.59e-2)" "prognostic favorable (4.78e-4)" "unprognostic (2.24e-1)" "unprognostic (2.26e-1)" "unprognostic (1.43e-2)" "unprognostic (5.55e-2)" "unprognostic (2.98e-2)" "unprognostic (3.14e-1)" "unprognostic (3.99e-1)" 21.1 13.4 21.9 12.5 21.9 12.1 19.8 23.0 25.5 17.6 22.3 26.9 19.3 15.8 18.5 20.3 13.8 15.4 32.0 22.6 21.8 22.8 18.5 14.6 17.0 22.9 22.0 14.8 24.2 14.8 11.3 16.3 22.7 15.4 19.1 9.5 24.8 15.4 122.2 21.2 16.4 16.4 21.4 12.0 20.1 56.2 21.6 11.3 25.7 77.0 16.9 20.5 15.2 24.6 27.5 19.2 17.1 36.5 39.6 45.2 32.2 29.3 31.7 34.7 41.5 23.3 43.9 24.2 29.6 38.7 33.0 37.9 14.6 33.2 46.4 36.8 19.5 9.9 19.3 18.5 47.8 22.0 21.6 33.9 56.4 22.9 53.6 39.3 38.3 26.8 22.2 34.8 37.9 37.8 21.2 28.8 24.9 66.4 71.9 18.3 19.0 22.8 49.1 26.5 34.1 18.1 21.3 26.8 60.0 23.9 41.1 25.6 28.2 30.6 19.9 46.0 40.7 15.3 31.7 30.3 41.9 22.2 33.0 45.6 25.9 34.3 23.4 24.9 21.8 29.5 22.5 24.0 20.8 30.2 20.8 23.2 15.2 31.4 23.3 20.0 30.4 23.7 21.9 21.9 23.0 25.5 22.6 21.8 22.9 22.0 22.7 21.4 21.6 24.6 15.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.6 0.0 0.0 0.0 0.0 75.7 8.4 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 54.9 11.0 0.0 0.0 0.0 0.0 0.0 0.0 85.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 69.4 1.4 0.0 0.0 0.0 AL139300.1 ENSG00000256500 "Novel protein" 14 103562962-103685924 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 31.7;tongue: 16.5" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;granulocytes: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA044617, HPA052450" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 60: Granulocytes - Receptor signaling" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA044617: AB_2679024, HPA052450: AB_2681838" "unprognostic (1.56e-1)" 4.3 2.6 0.9 2.9 1.0 0.8 1.3 0.9 5.2 1.2 0.2 1.4 0.0 0.8 0.2 1.6 0.9 0.1 12.8 1.4 1.6 0.5 0.5 1.0 1.6 1.0 1.7 1.0 2.5 7.5 3.8 0.1 1.6 1.4 0.0 3.5 1.6 1.1 31.7 0.6 0.7 3.1 0.7 0.4 0.7 9.4 1.1 2.9 0.1 16.5 1.7 3.4 0.5 1.2 8.1 15.9 18.5 0.6 8.2 7.8 5.6 25.7 19.7 29.3 17.0 9.5 12.1 22.0 17.2 19.2 19.3 5.5 12.4 13.3 17.4 6.7 0.0 8.7 6.1 8.7 9.7 10.8 3.4 8.6 0.6 13.5 11.0 14.5 15.2 13.7 11.6 3.4 21.4 15.4 18.9 1.2 12.1 19.5 13.9 7.7 12.1 11.4 13.6 9.0 22.1 12.2 14.6 5.7 12.1 6.2 13.0 6.6 8.4 11.3 9.2 16.9 10.4 6.4 8.6 25.6 19.6 3.4 9.8 0.2 0.8 1.1 0.5 1.3 0.7 0.3 0.7 0.9 0.4 1.3 1.0 0.4 0.7 0.6 1.6 1.5 1.4 0.3 0.9 1.0 0.9 5.2 1.4 1.6 1.0 1.7 1.6 0.7 1.1 1.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 XRCC3 ENSG00000126215 "X-ray repair cross complementing 3" O43542 14 103697609-103715504 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 10.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA062422, HPA068953" Enhanced Nucleoplasm NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA062422: AB_2684757, HPA068953: AB_2686062" "unprognostic (2.52e-2)" "unprognostic (1.81e-3)" "unprognostic (6.75e-2)" "unprognostic (4.01e-2)" "unprognostic (4.29e-1)" "unprognostic (1.83e-1)" "unprognostic (2.53e-4)" "unprognostic (2.93e-2)" "unprognostic (4.67e-2)" "unprognostic (1.58e-2)" "unprognostic (4.46e-2)" "unprognostic (2.53e-2)" "unprognostic (3.52e-7)" "unprognostic (1.27e-1)" "unprognostic (1.57e-1)" "unprognostic (8.84e-2)" "unprognostic (3.72e-2)" 9.8 6.0 8.7 8.7 12.5 31.9 9.3 7.2 10.3 13.7 11.9 11.1 6.9 10.4 1.7 13.9 10.9 6.6 8.3 6.6 5.8 7.9 7.7 12.1 15.4 13.6 9.7 12.7 9.8 1.7 8.6 5.2 9.7 13.4 7.5 4.5 12.7 3.3 12.4 39.0 12.6 2.8 7.7 21.3 9.1 13.8 9.7 10.0 10.5 2.5 11.0 9.6 12.4 14.3 32.4 58.4 31.5 38.5 2.8 7.9 57.0 35.5 11.6 48.9 52.3 32.4 50.3 51.8 29.5 7.5 38.4 50.3 34.6 52.4 29.9 31.3 36.1 50.6 31.6 30.4 4.9 45.3 30.8 6.0 5.2 43.2 26.7 10.4 20.2 51.3 31.8 30.4 25.2 70.7 79.6 35.8 26.4 47.1 42.0 63.7 45.7 19.8 10.5 44.2 31.1 25.7 41.3 21.7 14.3 17.4 34.6 35.0 17.5 25.1 28.9 80.0 38.8 26.2 25.8 63.7 15.6 36.9 38.4 0.7 0.5 0.9 1.0 0.9 1.0 1.1 0.8 0.8 0.5 0.9 0.8 0.5 0.3 0.7 0.7 0.4 0.6 1.3 8.7 12.5 7.2 10.3 6.6 5.8 13.6 9.7 9.7 7.7 9.7 14.3 2.2 0.0 0.0 2.6 2.5 1.5 1.9 2.1 1.8 1.7 3.2 3.6 0.2 2.8 2.5 0.0 2.1 10.2 1.8 6.9 1.9 1.5 0.7 1.9 2.2 2.0 1.2 7.4 2.6 1.8 6.1 1.2 0.5 2.0 0.0 4.7 0.4 0.3 4.4 3.3 1.0 7.4 0.0 0.0 2.0 1.8 0.3 1.5 0.0 1.0 1.5 1.7 2.1 1.5 1.4 1.7 2.6 1.2 4.4 1.6 0.7 0.2 1.7 2.3 0.0 2.6 1.2 3.1 5.8 2.8 1.3 3.1 2.0 4.2 8.3 1.2 ZFYVE21 "MGC2550, ZF21" ENSG00000100711 "Zinc finger FYVE-type containing 21" Q9BQ24 14 103715730-103733668 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 165.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055721 Uncertain NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA055721: AB_2682896" "unprognostic (1.10e-2)" "unprognostic (3.35e-1)" "unprognostic (8.89e-2)" "unprognostic (7.54e-3)" "unprognostic (1.96e-1)" "unprognostic (8.32e-2)" "unprognostic (4.74e-2)" "unprognostic (1.16e-1)" "unprognostic (1.04e-2)" "unprognostic (5.11e-3)" "unprognostic (5.02e-2)" "unprognostic (9.13e-2)" "prognostic favorable (2.58e-6)" "unprognostic (2.30e-3)" "unprognostic (1.71e-1)" "unprognostic (7.18e-2)" "unprognostic (2.06e-1)" 57.4 28.9 117.0 14.2 121.0 11.9 54.0 115.6 143.1 69.3 113.2 52.3 18.2 70.8 50.3 68.4 71.8 28.4 51.6 112.8 116.0 37.0 34.7 31.6 16.5 121.3 114.4 56.1 26.7 34.1 32.0 30.1 118.0 41.0 25.7 15.2 61.5 53.3 22.0 73.2 31.0 45.6 123.6 28.1 44.9 35.5 120.0 19.3 50.3 29.9 17.5 65.1 67.8 127.4 27.1 34.1 29.1 26.7 76.9 61.6 48.2 49.8 35.2 41.5 36.2 40.2 34.3 6.0 31.5 53.2 29.9 45.4 25.3 59.4 37.3 11.5 30.9 33.5 23.0 55.3 60.8 8.6 21.4 42.1 61.6 18.4 29.8 37.4 51.0 19.6 13.0 11.4 29.9 165.5 23.3 26.8 13.4 41.3 47.9 12.6 21.6 9.2 81.5 95.5 16.6 11.5 35.2 44.3 26.2 32.2 56.6 22.3 44.7 20.1 16.3 68.4 25.6 12.8 13.8 9.2 22.7 18.7 19.5 28.3 36.2 42.1 20.0 57.6 19.8 18.1 18.7 20.1 23.9 24.7 19.4 18.5 29.6 16.3 47.8 19.4 21.7 24.6 117.0 121.0 115.6 143.1 112.8 116.0 121.3 114.4 118.0 123.6 120.0 127.4 68.0 19.2 23.9 61.7 9.5 45.5 83.5 161.9 59.2 27.8 58.8 68.6 36.0 41.5 83.1 80.9 33.3 115.7 20.9 33.6 121.3 56.4 14.2 25.3 54.7 71.0 19.3 76.2 30.9 54.5 40.0 65.3 12.2 30.3 19.7 22.0 66.4 26.9 55.4 20.2 11.8 34.2 81.4 22.6 29.5 23.0 109.6 28.4 103.2 19.7 32.3 91.6 24.7 11.6 21.8 79.3 51.9 197.1 7.4 87.7 31.5 98.9 47.1 29.6 65.7 57.2 60.7 46.3 78.4 50.9 60.2 101.5 13.4 36.3 32.4 81.9 PPP1R13B "ASPP1, KIAA0771, p53BP2-like, p85" ENSG00000088808 "Protein phosphatase 1 regulatory subunit 13B" Q96KQ4 14 103733195-103847575 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 106.1;Granulosa cells: 83.4;Inhibitory neurons: 105.9;Late spermatids: 78.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006394, CAB015454" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 14: REH - Unknown function" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm Cytosol "CAB015454: AB_2252775, HPA006394: AB_1079668" "unprognostic (1.20e-1)" "unprognostic (8.61e-2)" "unprognostic (6.65e-2)" "unprognostic (1.45e-1)" "unprognostic (2.12e-1)" "unprognostic (1.37e-1)" "unprognostic (1.25e-2)" "prognostic favorable (1.41e-4)" "unprognostic (3.22e-3)" "unprognostic (5.13e-2)" "unprognostic (5.39e-2)" "unprognostic (1.62e-3)" "prognostic favorable (3.28e-11)" "unprognostic (1.68e-1)" "unprognostic (1.69e-1)" "unprognostic (1.97e-2)" "unprognostic (2.23e-1)" 7.0 4.7 3.4 3.2 4.2 0.7 7.4 6.6 8.5 6.8 4.0 7.7 7.1 7.6 2.1 11.6 9.8 4.7 21.2 7.6 3.9 6.9 5.0 9.9 2.7 1.2 2.0 10.9 8.3 7.8 6.5 6.0 1.7 10.7 5.6 8.0 10.2 5.3 7.5 12.5 7.6 5.2 0.3 11.3 10.1 19.1 3.8 2.0 23.4 6.2 5.1 8.0 7.1 4.2 4.9 4.2 0.5 5.4 0.9 0.4 1.9 3.2 2.3 4.0 1.8 3.3 4.4 1.1 11.7 2.2 4.9 9.8 5.8 3.7 3.5 2.2 4.0 0.0 1.3 5.7 3.6 0.5 4.4 1.0 4.4 0.3 4.7 1.7 7.9 2.8 0.7 1.7 2.7 20.3 0.0 0.5 1.0 12.3 5.1 11.3 3.2 2.7 7.8 12.7 6.6 16.9 9.9 7.3 2.5 2.6 18.4 0.7 7.1 2.9 4.0 2.4 3.0 4.0 5.8 8.4 1.8 2.9 1.4 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 4.2 6.6 8.5 7.6 3.9 1.2 2.0 1.7 0.3 3.8 4.2 35.1 19.2 39.5 31.0 7.1 13.5 16.6 6.9 18.8 15.8 31.3 20.6 45.4 14.3 11.8 7.3 12.5 2.9 11.9 26.9 3.9 7.9 58.0 37.9 7.9 30.3 15.6 2.7 106.1 6.4 1.0 7.7 37.8 48.5 0.0 83.4 14.3 9.0 2.9 15.2 105.9 14.2 6.1 1.6 5.7 78.4 4.4 3.0 3.6 49.6 0.4 5.8 1.0 31.7 33.2 6.8 18.7 20.3 6.3 13.1 14.6 7.8 8.3 12.9 6.6 10.9 6.7 17.8 15.1 24.1 12.9 2.2 9.0 8.7 15.8 13.7 ATP5MPL "6.8PL, C14orf2, MLQ, MP68" ENSG00000156411 "ATP synthase membrane subunit 6.8PL" P56378 14 103912288-103928269 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 1602.3;Extravillous trophoblasts: 671.4;Hofbauer cells: 920.9;Proximal tubular cells: 1883.7;Syncytiotrophoblasts: 710.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058978, HPA060520" Approved Supported "Nucleoli fibrillar center,Mitochondria" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Mitochondria "Nucleoli fibrillar center" "HPA058978: AB_2683867, HPA060520: AB_2684302" "unprognostic (1.37e-1)" "unprognostic (1.42e-3)" "unprognostic (1.55e-1)" "unprognostic (2.30e-1)" "unprognostic (2.11e-1)" "unprognostic (1.20e-2)" "unprognostic (1.75e-2)" "unprognostic (1.69e-1)" "unprognostic (1.62e-1)" "prognostic favorable (6.80e-4)" "unprognostic (1.34e-2)" "unprognostic (5.48e-2)" "unprognostic (1.34e-3)" "unprognostic (9.26e-2)" "unprognostic (1.50e-1)" "unprognostic (1.57e-1)" "unprognostic (4.14e-2)" 107.8 166.9 304.6 75.7 318.3 177.4 127.5 305.8 446.6 94.9 306.0 165.2 165.1 80.5 139.6 159.4 87.0 48.8 548.2 321.9 313.4 205.2 181.9 79.9 94.4 301.2 297.7 98.3 113.8 257.3 159.9 77.1 302.4 108.5 167.5 169.9 100.9 87.8 489.6 106.1 128.9 78.9 303.1 108.7 135.6 83.4 305.5 135.0 111.5 471.6 122.5 103.0 101.1 304.1 244.6 278.5 233.6 222.8 275.0 284.2 228.5 185.2 211.7 228.6 199.5 240.6 167.4 254.4 187.9 191.2 183.4 201.1 306.4 225.3 310.0 207.9 306.8 280.4 227.5 380.4 180.4 346.2 188.4 298.6 301.5 155.7 164.2 260.8 264.4 330.6 176.7 264.7 253.7 730.8 333.1 493.9 182.1 560.5 523.7 211.5 202.7 231.2 358.4 345.0 201.2 238.4 155.9 289.0 371.4 256.2 355.3 401.7 142.7 87.9 137.9 242.0 153.2 199.3 372.5 360.2 207.8 195.7 152.3 405.1 512.8 336.0 204.9 409.1 232.9 309.5 261.1 234.1 367.0 261.9 295.5 260.0 517.5 206.2 401.4 355.4 282.2 656.9 304.6 318.3 305.8 446.6 321.9 313.4 301.2 297.7 302.4 303.1 305.5 304.1 88.0 221.2 225.1 0.0 47.9 0.0 0.0 0.0 0.0 0.0 369.7 334.4 0.0 0.0 92.2 413.8 0.0 609.1 63.1 0.0 1602.3 504.6 0.0 341.3 245.9 104.1 0.0 0.0 0.0 572.6 671.4 113.8 0.0 297.7 93.4 207.9 0.0 0.0 920.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 210.3 0.0 0.0 335.5 0.0 0.0 0.0 0.0 570.5 0.0 0.0 0.0 0.0 0.0 1883.7 146.5 0.0 0.0 0.0 104.8 0.0 0.0 0.0 0.0 710.1 70.2 228.6 0.0 0.0 TDRD9 "C14orf75, DKFZp434N0820, FLJ36164, NET54" ENSG00000156414 "Tudor domain containing 9" Q8NDG6 14 103928456-104052667 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "parathyroid gland: 30.6;testis: 40.7" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 43.2;Spermatocytes: 63.2;Spermatogonia: 38.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "classical monocyte: 1.6" "Lineage enriched" "Detected in single" 6 "monocytes: 1.6" "Cell line enhanced" "Detected in some" "HDLM-2: 24.4;HeLa: 21.5;HMC-1: 94.2;RPTEC TERT1: 25.5;SK-MEL-30: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 3: HMC-1 - Innate immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "unprognostic (3.71e-1)" "unprognostic (3.02e-1)" "unprognostic (1.59e-1)" "unprognostic (1.89e-1)" "unprognostic (1.91e-1)" "unprognostic (1.55e-1)" "unprognostic (2.74e-1)" "unprognostic (3.74e-1)" "unprognostic (1.55e-1)" "unprognostic (1.61e-1)" "unprognostic (2.13e-4)" "unprognostic (1.60e-2)" "unprognostic (4.57e-3)" "unprognostic (8.97e-2)" "unprognostic (3.34e-1)" "prognostic unfavorable (5.52e-4)" "unprognostic (2.41e-2)" 0.4 0.5 0.9 0.6 0.8 1.7 0.5 1.3 0.9 0.4 1.2 0.3 0.1 0.4 0.4 0.2 0.9 0.9 0.6 0.8 0.8 2.1 0.3 1.0 0.5 1.7 1.0 0.2 0.5 30.6 1.0 0.5 2.0 0.3 0.2 3.5 0.3 0.5 0.1 0.1 0.3 0.5 1.1 3.0 0.8 40.7 1.1 0.3 5.4 0.5 0.5 0.4 0.2 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 21.5 0.0 0.0 0.0 94.2 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 25.5 0.0 8.7 0.0 0.0 0.6 13.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.8 1.3 0.9 0.8 0.8 1.7 1.0 2.0 1.1 1.1 1.3 0.9 6.4 2.0 2.3 0.0 0.0 0.1 0.1 0.0 4.3 1.0 0.4 12.4 0.0 0.7 0.0 4.2 0.0 0.5 0.0 1.9 0.6 13.1 43.2 1.5 0.9 0.0 1.3 9.1 0.0 0.0 0.7 0.0 3.7 0.0 0.3 0.4 0.1 1.9 6.7 4.6 0.0 2.0 1.8 0.0 7.3 0.9 1.5 0.0 2.8 2.9 0.6 0.0 1.0 4.6 0.5 0.0 2.2 0.3 0.5 0.0 2.5 0.2 2.3 6.6 0.9 0.8 63.2 38.6 0.0 0.0 0.0 0.3 11.7 0.0 0.1 RD3L "TDRD9-AS1, TDRD9AS1" ENSG00000227729 "Retinal degeneration 3 like" P0DJH9 14 103940426-103942561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 26 "heart muscle: 23.3;retina: 13.3" "Group enriched" "Detected in some" 9 "Bipolar cells: 78.5;Cardiomyocytes: 40.8;Cone photoreceptor cells: 29.2;Horizontal cells: 26.9;Rod photoreceptor cells: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "olfactory bulb: 10.4" "Low region specificity" "Detected in all" HPA067971 Enhanced Approved "Cell Junctions" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 56: Bipolar cells - Visual perception" "Cell Junctions" "HPA067971: AB_2685935" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.5 0.0 0.0 40.8 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ASPG C14orf76 ENSG00000166183 Asparaginase Q86U10 14 104085686-104115582 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 102.4;liver: 151.1" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 21.4;Distal enterocytes: 21.2;Granulosa cells: 66.8;Hepatocytes: 93.9;Proximal tubular cells: 49.7" "Cancer enhanced" "Detected in many" "liver cancer: 4.4" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA069761 Enhanced NA NA "Cluster 85: Liver - Metabolism" "Cluster 40: Granulosa cells - Unknown function" "HPA069761: AB_2686191" "unprognostic (1.45e-2)" "unprognostic (7.43e-3)" "unprognostic (2.38e-3)" "unprognostic (1.30e-1)" "unprognostic (7.23e-2)" "unprognostic (1.74e-2)" "unprognostic (1.72e-2)" "unprognostic (3.47e-2)" "unprognostic (1.98e-1)" "unprognostic (2.20e-1)" "unprognostic (2.50e-1)" "unprognostic (1.10e-1)" "unprognostic (8.75e-2)" "unprognostic (7.98e-2)" "unprognostic (3.85e-1)" "unprognostic (1.52e-2)" "unprognostic (2.32e-2)" 1.1 1.4 0.1 0.2 0.2 0.0 0.7 0.0 0.4 5.4 0.2 4.7 1.5 2.2 1.1 34.0 6.2 0.1 102.4 0.3 0.3 12.8 151.1 2.3 0.0 0.4 0.6 11.4 0.2 0.8 2.3 1.8 0.2 0.3 1.9 0.3 2.8 0.1 0.5 9.9 0.5 1.2 0.0 0.2 3.1 1.1 1.1 0.1 5.9 0.0 3.7 2.3 9.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.5 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.2 0.0 0.2 0.1 0.6 0.5 0.4 0.3 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.3 0.3 0.4 0.6 0.2 0.0 1.1 0.0 0.0 6.4 1.7 0.3 0.5 1.8 0.2 0.7 0.0 1.1 0.6 0.8 21.4 2.8 2.4 0.0 0.0 0.2 0.0 21.2 3.9 0.0 0.4 0.7 0.1 0.5 1.8 0.0 0.1 0.2 0.2 4.3 4.6 0.7 0.0 66.8 3.6 93.9 0.2 5.0 0.1 16.0 0.0 1.6 0.3 0.7 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.4 7.6 1.2 0.0 0.1 0.9 49.7 1.6 0.3 0.0 0.0 0.6 0.3 1.5 8.4 9.1 0.5 0.3 3.9 5.4 3.0 KIF26A "DKFZP434N178, KIAA1236" ENSG00000066735 "Kinesin family member 26A" Q9ULI4 14 104138723-104180894 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 22.4;Endothelial cells: 11.9;Enteroendocrine cells: 7.7;Hepatic stellate cells: 13.9;Horizontal cells: 18.5;Spermatogonia: 8.1" "Group enriched" "Detected in many" 5 "stomach cancer: 3.8;testis cancer: 14.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 30.6;MCF7: 24.9;NTERA-2: 20.8;REH: 18.8;SCLC-21H: 19.2;SH-SY5Y: 39.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA046882, HPA060346" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Plasma membrane, Cytosol" "HPA046882: AB_2679856, HPA060346: AB_2684259" "unprognostic (3.01e-1)" "unprognostic (3.20e-1)" "unprognostic (3.95e-1)" "unprognostic (1.77e-2)" "unprognostic (2.79e-1)" "unprognostic (1.12e-1)" "unprognostic (5.49e-3)" "unprognostic (1.69e-1)" "unprognostic (1.21e-2)" "unprognostic (3.31e-3)" "unprognostic (5.24e-3)" "unprognostic (7.01e-2)" "prognostic unfavorable (7.78e-4)" "unprognostic (7.96e-2)" "unprognostic (1.72e-1)" "unprognostic (9.12e-2)" "unprognostic (4.68e-3)" 5.0 2.3 2.1 0.7 1.3 2.0 4.6 0.5 1.5 5.0 3.0 2.6 0.4 2.4 0.2 1.4 2.6 0.4 5.7 0.8 1.4 3.8 0.6 2.2 0.3 1.3 1.3 4.1 5.7 0.3 2.9 1.8 1.4 0.8 0.4 0.1 1.0 0.8 2.9 2.8 1.9 0.4 0.9 4.2 1.8 2.8 1.8 0.2 1.5 1.0 0.1 2.0 2.1 0.5 0.0 1.7 1.0 3.9 0.0 0.0 6.7 0.3 0.0 0.0 0.0 3.1 0.0 0.0 5.3 0.0 0.7 2.5 3.1 0.0 0.0 0.0 4.9 0.0 30.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 6.7 0.0 0.0 0.0 24.9 0.0 0.0 20.8 0.2 2.0 18.8 7.9 2.0 0.0 0.0 19.2 39.3 4.4 0.6 0.0 2.5 0.4 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.3 0.5 1.5 0.8 1.4 1.3 1.3 1.4 0.9 1.8 0.5 22.4 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.1 0.3 0.1 3.2 0.0 0.0 1.8 0.0 1.0 0.0 1.3 1.9 0.7 0.4 0.2 4.4 11.9 7.7 4.8 0.5 0.2 0.8 2.1 0.0 0.2 0.0 0.4 13.9 0.2 2.6 18.5 0.7 2.6 0.0 0.3 1.1 0.1 0.0 0.1 1.8 3.7 0.0 0.2 0.0 0.0 0.1 0.2 1.0 0.7 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.7 0.7 0.2 8.1 1.2 1.7 0.4 0.1 0.3 2.8 0.0 TMEM179 "C14orf90, FLJ42486, TMEM179A" ENSG00000258986 "Transmembrane protein 179" Q6ZVK1 14 104474678-104605647 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 31.5;pituitary gland: 88.1" "Group enriched" "Detected in some" 5 "Bipolar cells: 58.1;Horizontal cells: 65.6" "Group enriched" "Detected in some" 4 "glioma: 2.7;pancreatic cancer: 3.1;testis cancer: 2.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 8.8;SCLC-21H: 37.3;SH-SY5Y: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002942 Uncertain Mitochondria NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 62: Horizontal cells - Visual perception" Mitochondria "HPA002942: AB_1078113" "unprognostic (8.65e-2)" "unprognostic (8.24e-2)" "unprognostic (3.10e-2)" "unprognostic (1.29e-2)" "unprognostic (1.90e-2)" "unprognostic (1.08e-2)" "unprognostic (3.46e-2)" "unprognostic (2.69e-1)" "unprognostic (1.31e-1)" "unprognostic (2.09e-1)" "unprognostic (2.82e-3)" "unprognostic (1.09e-1)" "unprognostic (1.89e-4)" "unprognostic (8.68e-3)" "unprognostic (1.56e-1)" "unprognostic (9.71e-6)" "unprognostic (1.70e-2)" 0.2 11.4 18.9 0.3 19.3 0.0 0.1 12.0 29.7 0.1 4.6 3.8 0.2 0.1 0.4 0.1 0.3 0.1 1.0 17.8 24.6 0.5 0.5 0.1 0.0 25.9 24.9 0.1 4.0 0.1 88.1 0.8 31.5 0.8 0.2 6.2 0.1 0.1 0.1 0.0 1.4 0.3 12.5 0.0 1.3 5.2 18.8 0.0 0.1 0.0 0.0 0.1 0.7 20.5 0.0 0.5 0.3 0.8 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 37.3 11.6 0.0 0.3 0.0 0.1 0.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 19.3 12.0 29.7 17.8 24.6 25.9 24.9 31.5 12.5 18.8 20.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 58.1 0.0 0.0 1.2 0.0 0.0 0.0 4.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 12.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.1 65.6 12.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 1.5 0.0 7.5 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.1 0.7 3.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 C14orf180 "C14orf77, NRAC" ENSG00000184601 "Chromosome 14 open reading frame 180" Q8N912 14 104579764-104590515 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 40.8;breast: 26.7;heart muscle: 109.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 2.7;Cardiomyocytes: 7.6;Fibroblasts: 2.0;Hepatic stellate cells: 3.3;Horizontal cells: 3.3;Smooth muscle cells: 1.4" "Cancer enhanced" "Detected in single" "renal cancer: 0.7" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "ASC diff: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "unprognostic (2.48e-2)" "unprognostic (1.55e-1)" "unprognostic (1.53e-1)" "unprognostic (1.57e-1)" "unprognostic (1.60e-1)" "unprognostic (3.19e-3)" "unprognostic (1.89e-1)" "unprognostic (3.12e-2)" "unprognostic (3.89e-2)" "unprognostic (2.32e-1)" "unprognostic (9.80e-2)" 40.8 3.1 0.0 0.1 0.2 0.0 26.7 0.2 0.2 0.9 13.5 0.9 0.3 1.1 0.0 0.0 1.8 0.2 109.5 1.5 0.0 1.8 4.1 0.4 0.0 0.5 0.8 0.8 0.8 0.0 1.8 0.8 0.5 0.6 0.0 0.1 0.9 0.4 5.7 0.6 1.4 0.0 0.0 0.5 2.2 0.1 0.4 0.0 0.9 0.7 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 1.5 0.0 0.5 0.8 0.5 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.4 7.6 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 1.1 0.0 2.0 0.0 0.0 0.0 0.0 3.3 0.0 0.3 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 INF2 "C14orf151, C14orf173, MGC13251" ENSG00000203485 "Inverted formin 2" Q27J81 14 104681146-104722535 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Actin-binding "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 229.3;Gastric mucus-secreting cells: 183.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 100.8" "Region enhanced" "Detected in all" "basal ganglia: 224.1" "Low region specificity" "Detected in all" HPA000724 Approved Approved "Nuclear bodies,Endoplasmic reticulum" NA NA 3000000 "Cluster 35: T-regs - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 28: BEWO - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Endoplasmic reticulum" "Nuclear bodies" "HPA000724: AB_1078325" "unprognostic (1.42e-1)" "unprognostic (9.18e-2)" "unprognostic (2.57e-2)" "unprognostic (1.00e-2)" "unprognostic (1.49e-2)" "unprognostic (5.90e-3)" "prognostic unfavorable (8.18e-4)" "unprognostic (1.13e-2)" "unprognostic (9.55e-2)" "unprognostic (1.18e-1)" "unprognostic (1.26e-2)" "unprognostic (1.36e-3)" "unprognostic (7.24e-2)" "unprognostic (4.01e-1)" "unprognostic (2.36e-1)" "unprognostic (5.80e-2)" "unprognostic (7.70e-2)" 42.8 21.4 14.0 8.4 29.6 7.5 35.2 18.3 29.5 28.7 1.4 40.4 21.2 24.3 2.3 20.4 20.9 8.9 24.1 14.7 14.7 27.3 30.2 34.3 6.9 30.7 25.5 13.6 15.7 2.0 8.3 11.7 27.5 23.2 4.7 3.3 17.9 7.5 13.7 26.9 31.7 4.4 12.2 31.4 34.7 32.2 26.3 2.1 20.8 1.5 3.4 30.2 28.5 71.2 26.3 92.1 9.9 16.0 7.6 12.2 84.2 49.0 14.5 21.9 14.0 35.5 40.2 3.7 46.6 17.9 17.0 43.3 9.4 22.7 9.5 18.5 26.6 22.0 59.9 23.9 16.5 6.8 21.0 11.4 14.5 15.8 6.8 15.0 24.1 9.1 10.7 10.5 18.0 30.0 10.2 17.9 17.1 18.3 100.8 29.8 19.2 9.4 12.6 38.0 20.5 12.8 26.4 36.7 11.7 8.0 8.0 4.9 49.9 29.4 22.1 45.7 22.5 6.9 3.7 3.7 41.2 12.1 25.1 0.5 2.1 0.1 0.9 0.7 0.7 1.6 3.2 0.6 2.4 1.5 2.5 1.6 1.6 1.2 0.1 5.1 4.0 3.2 14.0 29.6 18.3 29.5 14.7 14.7 30.7 25.5 27.5 12.2 26.3 71.2 48.8 64.1 13.4 10.1 22.5 22.7 17.5 19.0 17.1 0.3 16.5 14.6 14.3 28.6 15.0 3.7 0.0 54.8 5.2 229.3 5.9 24.1 1.2 7.8 8.6 29.8 17.4 17.2 16.7 25.5 87.8 17.9 183.0 18.2 14.7 8.4 25.4 29.8 32.6 0.0 1.9 86.2 12.2 21.8 35.6 2.1 5.6 25.5 8.8 20.6 14.0 55.3 1.0 11.1 89.6 58.1 110.7 4.5 7.8 26.6 90.4 7.3 9.4 2.0 32.9 5.7 36.1 1.1 4.5 8.5 18.8 31.6 9.3 12.9 66.9 38.2 ADSS1 "ADSSL1, FLJ38602" ENSG00000185100 "Adenylosuccinate synthase 1" Q8N142 14 104724229-104747325 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Purine biosynthesis" Ligase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "skeletal muscle: 1273.1;tongue: 609.8" "Cell type enriched" "Detected in some" 20 "Cardiomyocytes: 137.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 15.2;MCF7: 14.2;OE19: 23.2;SiHa: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052621 Enhanced NA NA 290000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 21: OE19 - Mitochondria" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA052621: " "unprognostic (2.23e-2)" "unprognostic (3.15e-1)" "unprognostic (1.72e-3)" "unprognostic (5.14e-2)" "unprognostic (2.81e-3)" "unprognostic (3.46e-1)" "unprognostic (1.70e-2)" "unprognostic (1.15e-2)" "unprognostic (1.06e-1)" "unprognostic (1.58e-2)" "unprognostic (2.26e-1)" "unprognostic (3.35e-1)" "prognostic unfavorable (4.99e-4)" "unprognostic (2.33e-1)" "unprognostic (2.35e-1)" "unprognostic (2.18e-2)" "unprognostic (2.78e-2)" 8.1 5.1 3.8 1.0 6.8 0.9 4.4 6.6 5.6 4.1 7.6 3.0 2.7 3.3 4.5 18.5 6.5 5.7 100.2 3.7 6.7 14.8 28.8 3.1 1.1 6.0 6.0 2.7 7.9 7.3 10.0 7.3 6.1 7.6 1.4 10.1 10.7 4.0 1273.1 5.5 2.8 2.3 5.2 2.0 6.5 18.5 5.5 1.0 7.4 609.8 0.8 6.5 5.4 7.7 0.1 3.2 2.4 7.1 1.7 1.1 0.8 0.9 1.3 0.2 0.7 0.2 2.5 0.0 15.2 0.8 0.5 1.3 0.2 0.5 0.6 1.0 0.5 0.1 7.9 1.1 1.8 0.0 6.0 3.2 2.3 0.0 2.6 2.7 0.4 0.3 2.9 0.1 1.2 14.2 0.0 0.7 2.1 23.2 1.3 0.2 0.3 0.9 0.5 1.7 2.0 4.2 23.1 1.0 3.3 1.8 7.1 2.1 0.8 0.1 0.6 1.6 0.1 4.4 3.5 0.0 2.2 1.0 1.5 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.8 6.8 6.6 5.6 3.7 6.7 6.0 6.0 6.1 5.2 5.5 7.7 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 137.4 0.0 0.0 0.0 0.0 3.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.7 6.6 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 SIVA1 "CD27BP, SIVA, Siva-1, Siva-2" ENSG00000184990 "SIVA1 apoptosis inducing factor" O15304 14 104753147-104768494 "Predicted intracellular proteins" "Apoptosis, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 506.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065398, HPA066693" Supported Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA065398: AB_2685484, HPA066693: AB_2685703" "unprognostic (1.86e-1)" "prognostic favorable (5.95e-4)" "unprognostic (1.61e-1)" "unprognostic (1.51e-1)" "unprognostic (6.89e-2)" "unprognostic (2.27e-1)" "unprognostic (4.77e-3)" "unprognostic (2.89e-1)" "unprognostic (2.17e-2)" "unprognostic (7.19e-3)" "unprognostic (5.85e-3)" "unprognostic (3.21e-2)" "unprognostic (4.94e-2)" "unprognostic (3.06e-2)" "unprognostic (4.08e-1)" "unprognostic (3.51e-1)" "unprognostic (7.43e-2)" 79.8 64.3 36.0 28.4 37.7 102.2 80.8 36.1 60.4 95.9 43.3 108.3 39.8 78.5 9.0 76.1 86.2 24.2 104.6 35.0 36.8 79.6 155.7 65.1 39.6 39.0 36.5 94.4 103.9 16.0 94.2 27.5 36.5 87.8 7.1 3.1 63.2 37.0 168.8 65.5 73.8 10.5 38.3 83.3 91.1 102.7 40.8 69.7 82.9 35.5 12.7 85.4 78.0 38.9 143.3 233.6 58.9 94.8 19.4 24.7 157.8 76.5 41.5 92.2 80.3 179.8 124.1 135.9 109.6 27.5 60.3 138.4 23.2 77.2 7.9 106.6 230.9 56.5 129.5 214.6 48.4 98.8 95.3 29.9 34.5 42.1 13.5 13.6 53.8 382.9 57.7 76.1 22.2 506.6 319.6 225.9 85.9 94.1 317.9 186.6 117.8 107.8 20.7 133.3 151.6 76.2 107.3 63.1 106.4 9.4 123.5 103.0 58.6 74.4 92.8 176.4 124.8 61.0 71.0 161.9 85.6 112.3 84.7 210.7 139.5 255.0 140.4 171.6 159.5 205.1 167.3 154.6 107.5 195.3 182.3 156.1 134.0 102.7 188.2 502.3 195.3 193.9 36.0 37.7 36.1 60.4 35.0 36.8 39.0 36.5 36.5 38.3 40.8 38.9 127.0 60.9 126.7 8.1 109.3 116.5 213.0 188.9 92.8 38.7 178.1 261.1 54.6 107.2 130.2 103.0 12.5 297.4 147.9 145.0 138.9 91.2 241.3 103.3 88.9 109.6 91.1 148.5 6.3 170.9 345.1 139.8 63.7 74.3 145.1 127.9 163.1 221.0 180.6 38.7 6.3 194.0 103.7 89.7 106.5 54.1 140.8 98.0 108.5 5.6 119.6 143.9 84.5 4.5 9.9 113.2 131.8 124.1 131.3 162.4 201.4 180.2 176.5 45.3 111.7 126.2 143.1 368.9 325.2 112.8 116.9 278.4 115.2 136.3 198.7 218.8 AKT1 "AKT, PKB, PRKBA, RAC, RAC-alpha" ENSG00000142208 "AKT serine/threonine kinase 1" P31749 14 104769349-104795751 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters" "Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Neurogenesis, Sugar transport, Translation regulation, Transport" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 61.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 61.5" "Cell line enhanced" "Detected in all" "MCF7: 558.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002891, CAB003765" Supported Supported Nucleoplasm,Microtubules NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 30: Mammary glandular cells - Lactation" Nucleoplasm Microtubules "CAB003765: AB_562035, HPA002891: AB_1078123" "unprognostic (3.30e-2)" "unprognostic (4.27e-2)" "unprognostic (1.98e-1)" "unprognostic (1.84e-1)" "unprognostic (3.70e-1)" "unprognostic (9.17e-3)" "unprognostic (1.55e-3)" "unprognostic (1.21e-1)" "unprognostic (1.47e-1)" "prognostic favorable (4.83e-4)" "unprognostic (3.58e-2)" "unprognostic (1.90e-2)" "prognostic favorable (2.12e-4)" "unprognostic (7.14e-2)" "unprognostic (1.28e-1)" "unprognostic (1.06e-1)" "unprognostic (2.41e-1)" 71.5 102.7 45.9 57.7 45.5 51.2 61.2 43.7 53.2 52.0 50.4 85.0 50.8 59.5 23.2 70.7 53.7 50.0 105.9 45.2 44.3 54.3 97.3 69.2 51.9 50.5 45.7 43.7 94.3 53.0 35.9 55.4 45.0 67.2 39.6 25.1 67.7 73.0 58.1 45.0 53.3 63.4 47.4 63.7 77.8 23.9 48.0 52.4 52.3 64.9 40.3 72.6 48.4 43.3 77.3 150.5 124.6 186.9 95.2 97.7 136.9 142.3 171.5 204.6 163.6 96.8 92.8 91.2 105.5 196.6 102.8 99.4 89.5 131.9 90.1 214.3 36.2 70.6 90.4 103.2 104.6 117.5 178.0 140.0 109.1 102.9 68.1 98.2 154.4 87.5 62.1 102.2 134.1 558.3 145.3 146.8 32.6 153.5 107.2 137.5 111.9 60.5 94.8 189.5 141.2 117.2 117.3 152.2 88.9 56.8 195.7 170.2 123.5 133.2 63.2 192.3 145.1 105.4 52.6 80.7 113.7 96.7 162.0 6.4 9.9 61.5 10.0 10.3 7.2 5.5 8.7 11.4 7.0 7.2 4.6 10.1 22.6 11.0 12.4 10.0 9.0 6.3 45.9 45.5 43.7 53.2 45.2 44.3 50.5 45.7 45.0 47.4 48.0 43.3 45.8 16.0 27.4 16.6 13.7 12.4 20.0 17.3 15.9 26.3 58.0 39.9 16.1 32.9 17.7 22.0 12.5 19.4 54.2 40.9 13.7 23.6 1.9 17.9 28.1 27.5 30.0 11.3 8.2 35.2 31.8 24.0 26.0 24.8 2.5 40.4 23.2 42.9 23.2 42.1 13.0 37.3 22.4 23.3 21.4 3.3 28.6 28.0 10.6 6.5 23.1 51.2 24.7 8.0 9.6 53.3 22.1 30.9 10.3 38.8 23.5 17.9 14.2 26.6 26.3 24.9 29.1 1.8 5.3 16.2 13.9 23.4 23.3 34.0 33.7 33.4 ZBTB42 ZNF925 ENSG00000179627 "Zinc finger and BTB domain containing 42" B2RXF5 14 104800596-104804712 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 11.7;Exocrine glandular cells: 13.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 10 "eosinophil: 5.4" "Lineage enriched" "Detected in single" 10 "granulocytes: 5.4" "Cell line enhanced" "Detected in many" "HDLM-2: 19.3;MCF7: 33.7;T-47d: 26.9" "Not detected" "Not detected" HPA066961 Approved Supported Nucleoplasm NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 6: T47d - Mammary gland" "Cluster 35: Glandular cells - Unknown function" Nucleoplasm "HPA066961: AB_2685756" "unprognostic (1.23e-1)" "unprognostic (1.84e-1)" "unprognostic (8.68e-2)" "unprognostic (1.59e-1)" "unprognostic (6.99e-2)" "unprognostic (6.67e-2)" "unprognostic (6.17e-3)" "unprognostic (2.56e-1)" "unprognostic (4.35e-1)" "unprognostic (2.70e-2)" "unprognostic (1.63e-1)" "unprognostic (3.42e-1)" "prognostic favorable (2.30e-9)" "unprognostic (1.34e-1)" "unprognostic (2.75e-1)" "unprognostic (1.58e-3)" "unprognostic (5.45e-2)" 2.3 3.5 1.1 1.7 1.1 0.3 3.3 1.0 0.9 1.7 1.5 3.0 3.2 2.2 1.8 4.8 4.5 1.8 4.5 0.9 1.2 4.1 5.5 4.3 1.4 1.8 1.4 1.1 11.5 2.2 1.0 1.1 1.3 6.2 1.8 0.4 6.3 3.3 6.5 2.6 2.9 1.4 1.4 2.2 6.5 2.4 1.2 1.4 4.7 2.6 1.3 2.3 2.2 1.0 1.3 4.4 1.3 5.3 1.0 1.1 5.4 1.9 2.0 3.4 3.0 2.8 5.1 0.4 3.7 1.9 2.3 5.8 1.1 1.8 0.5 19.3 1.3 1.8 2.3 3.3 1.6 0.4 10.3 2.0 2.1 1.4 0.7 2.4 1.5 3.8 3.0 2.9 0.6 33.7 3.6 2.8 0.8 8.9 4.0 5.0 0.3 2.7 2.5 8.6 5.9 2.5 1.5 7.9 3.4 1.2 26.9 2.1 2.4 1.3 3.0 0.3 0.6 3.1 1.8 0.3 4.3 1.8 2.8 0.0 0.1 5.4 0.3 0.0 0.5 0.4 0.4 0.1 0.0 0.4 0.3 0.4 0.0 0.1 0.0 0.4 0.3 0.2 1.1 1.1 1.0 0.9 0.9 1.2 1.8 1.4 1.3 1.4 1.2 1.0 3.1 3.2 11.7 0.3 1.2 0.4 5.0 1.9 1.2 0.3 8.1 3.4 4.4 5.7 8.2 0.0 0.0 1.2 1.1 4.3 3.9 4.2 2.6 2.3 1.2 2.6 5.4 4.4 0.0 13.5 1.9 1.1 3.1 3.9 0.0 2.3 2.5 7.3 1.1 0.0 0.0 6.4 2.0 2.5 0.6 0.9 0.6 0.9 1.8 0.0 0.8 2.8 5.2 0.5 0.0 7.5 3.2 0.4 0.7 6.9 3.4 4.3 3.1 0.4 0.0 1.5 1.6 8.4 3.4 3.4 0.1 0.8 1.8 0.5 4.9 5.1 CEP170B "Cep170R, FAM68C, KIAA0284" ENSG00000099814 "Centrosomal protein 170B" Q9Y4F5 14 104865268-104896770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 229.4;Distal enterocytes: 81.2;Rod photoreceptor cells: 112.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000871, HPA059017" Enhanced Approved Microtubules,Centrosome,Cytosol NA NA "Cluster 18: Non-specific - Mitochondria" "Cluster 20: HeLa - Mitochondria" "Cluster 9: Photoreceptor cells - Phototransduction" Cytosol "Microtubules, Centrosome" "HPA000871: AB_2666124, HPA059017: AB_2683883" "unprognostic (1.09e-1)" "unprognostic (1.60e-2)" "unprognostic (1.30e-1)" "unprognostic (1.50e-1)" "unprognostic (2.38e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (6.12e-4)" "unprognostic (5.40e-2)" "unprognostic (1.84e-1)" "unprognostic (4.96e-2)" "unprognostic (2.68e-1)" "prognostic unfavorable (4.41e-4)" "prognostic favorable (3.26e-4)" "unprognostic (1.62e-1)" "unprognostic (1.00e-1)" "unprognostic (8.17e-2)" "unprognostic (1.17e-2)" 13.0 12.8 13.0 4.9 14.1 0.2 13.2 0.0 27.6 11.9 0.0 27.8 17.9 14.8 2.6 31.3 14.7 6.0 9.9 16.6 1.7 29.2 20.2 14.9 0.8 12.3 4.4 6.3 27.7 6.1 21.1 2.7 10.6 19.5 5.7 10.2 18.5 7.7 6.5 36.2 21.1 4.1 0.0 4.5 24.3 15.4 5.1 1.0 20.7 1.4 1.9 16.1 16.4 10.3 23.4 19.1 1.4 17.8 7.4 5.3 41.3 18.0 7.0 8.9 5.9 20.3 14.0 0.0 21.5 13.8 6.1 50.7 4.2 21.1 2.3 8.6 8.8 0.0 22.9 13.4 14.9 0.1 18.2 5.2 26.2 9.3 13.5 7.0 9.0 0.1 6.0 0.2 7.7 49.4 0.1 0.3 5.9 33.2 16.3 7.7 0.1 5.6 8.9 39.1 4.8 5.0 26.7 15.5 24.2 3.0 27.1 3.4 20.0 14.0 15.3 39.0 12.3 0.8 0.1 0.1 11.1 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 14.1 0.0 27.6 16.6 1.7 12.3 4.4 10.6 0.0 5.1 10.3 1.7 9.6 15.3 5.2 0.8 23.8 12.6 12.8 10.2 18.0 15.2 11.4 3.7 22.8 10.0 18.4 229.4 3.6 0.2 81.2 1.9 12.2 0.8 16.2 6.3 4.4 22.1 0.0 17.7 24.0 7.6 5.4 48.4 18.2 5.7 5.7 8.6 12.8 1.4 40.4 14.9 41.0 8.2 0.8 5.2 1.7 3.7 1.3 8.8 2.8 1.0 11.1 0.0 5.5 5.9 31.8 42.9 8.6 0.7 30.3 27.5 5.0 20.1 112.6 6.6 6.8 7.8 1.7 5.2 13.9 24.6 6.7 1.9 0.0 35.6 24.5 PLD4 C14orf175 ENSG00000166428 "Phospholipase D family member 4" Q96BZ4 14 104924713-104937761 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.4;brain: 16.7;lymphoid tissue: 11.3" "Cell type enriched" "Detected in many" 7 "dendritic cells: 284.8" "Cancer enhanced" "Detected in many" "glioma: 4.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "plasmacytoid DC: 3621.6" "Lineage enriched" "Detected in all" 5 "dendritic cells: 3621.6" "Group enriched" "Detected in some" 4 "HMC-1: 127.3;RPMI-8226: 85.5;THP-1: 191.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051512 Uncertain NA NA 2900000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA051512: AB_2681515" "unprognostic (4.50e-3)" "unprognostic (1.78e-4)" "unprognostic (7.12e-2)" "unprognostic (5.30e-3)" "unprognostic (5.54e-2)" "unprognostic (2.91e-3)" "unprognostic (2.56e-1)" "unprognostic (4.76e-3)" "unprognostic (1.45e-3)" "unprognostic (1.19e-3)" "unprognostic (3.45e-3)" "unprognostic (3.89e-1)" "unprognostic (6.90e-3)" "unprognostic (8.94e-2)" "unprognostic (2.83e-1)" "unprognostic (1.28e-2)" "unprognostic (2.41e-1)" 0.4 1.0 5.1 5.7 4.7 13.4 1.5 7.0 7.1 1.0 0.4 0.8 3.8 1.0 0.2 0.6 1.8 2.4 0.5 4.5 7.3 0.8 0.5 1.8 11.3 15.7 6.8 0.5 1.1 1.2 2.1 0.8 10.3 1.7 0.5 0.5 3.5 1.8 0.3 0.6 5.1 0.5 13.9 10.4 2.8 0.6 9.4 2.8 0.6 0.0 9.4 1.9 0.4 16.7 0.1 0.2 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.1 0.0 9.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 127.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.1 10.7 0.1 0.0 0.1 30.0 0.1 85.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 191.5 0.0 0.1 0.3 0.1 0.2 0.4 0.0 0.1 0.2 1.6 0.3 4.6 43.0 699.5 1.0 188.4 1.9 222.7 0.8 1.2 545.8 198.4 1.7 0.4 9.8 25.4 297.9 3621.6 1.0 72.9 5.1 4.7 7.0 7.1 4.5 7.3 15.7 6.8 10.3 13.9 9.4 16.7 0.8 0.0 0.0 0.3 34.7 0.4 0.1 0.0 0.0 2.7 0.6 2.8 1.4 0.0 0.0 0.0 0.0 0.2 284.8 0.0 0.0 0.0 0.7 0.1 0.3 2.7 0.0 5.5 0.1 0.0 0.4 1.1 1.1 0.4 3.8 0.0 0.0 0.0 30.6 1.7 0.1 0.0 0.0 1.3 32.0 4.7 0.0 38.0 5.4 22.5 11.3 0.1 2.1 0.5 0.1 0.0 0.0 0.0 2.3 0.1 0.0 0.1 0.0 1.1 6.6 1.6 0.3 1.6 1.6 0.0 0.4 0.3 2.2 0.0 0.1 0.0 AHNAK2 C14orf78 ENSG00000185567 "AHNAK nucleoprotein 2" Q8IVF2 14 104937244-104978374 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 305.9" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 114.3;Basal respiratory cells: 83.8;Horizontal cells: 60.6;Ionocytes: 61.1;Pancreatic endocrine cells: 68.2;Respiratory ciliated cells: 66.8;Squamous epithelial cells: 63.7;Suprabasal keratinocytes: 164.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 24.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 135.1;HBEC3-KT: 124.9;hTCEpi: 308.7;hTERT-HME1: 130.3;TIME: 138.4" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 7 "medulla oblongata: 11.3;midbrain: 10.6;pons: 13.2;spinal cord: 38.9;thalamus: 15.0" "HPA000878, HPA002940, HPA004145, HPA020111" Enhanced Enhanced "Plasma membrane,Cytosol" No No 40000 "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Cytosol "Plasma membrane" "HPA000878: AB_2666127, HPA002940: AB_1859547, HPA004145: AB_1859546, HPA020111: AB_2670371" "unprognostic (3.56e-1)" "unprognostic (6.04e-2)" "unprognostic (6.19e-3)" "unprognostic (1.31e-3)" "unprognostic (9.55e-4)" "unprognostic (1.76e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (2.79e-5)" "unprognostic (3.43e-1)" "unprognostic (3.06e-3)" "prognostic unfavorable (4.05e-6)" "unprognostic (1.48e-1)" "unprognostic (1.17e-2)" "unprognostic (1.39e-2)" "unprognostic (6.97e-2)" "unprognostic (2.05e-1)" "prognostic unfavorable (2.23e-5)" 30.4 2.3 9.8 2.4 9.9 0.0 16.4 9.3 15.9 84.5 4.6 105.3 1.4 64.3 2.9 114.1 29.2 5.1 4.5 9.7 16.0 3.5 6.2 5.1 0.1 38.1 15.3 3.5 1.6 0.7 3.4 1.8 40.8 18.6 8.6 19.0 24.0 28.6 3.6 305.9 20.2 31.6 12.4 0.9 25.2 7.7 18.1 0.4 2.8 4.5 4.7 49.4 86.6 18.5 2.9 107.6 0.1 6.0 120.0 135.1 0.2 10.5 22.3 3.8 1.9 0.3 38.9 0.1 14.5 82.9 85.3 62.9 0.3 124.9 1.7 0.0 0.4 0.0 67.5 0.5 11.0 0.0 3.8 17.6 308.7 12.1 130.3 52.3 54.7 0.0 0.0 0.2 62.8 8.0 0.0 0.0 0.3 9.5 42.9 0.3 5.7 0.1 84.4 0.0 0.6 0.6 46.2 0.1 2.3 2.8 6.0 0.0 138.4 29.3 17.9 33.8 9.9 0.0 0.0 0.0 88.4 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 9.8 9.9 9.3 15.9 9.7 16.0 38.1 15.3 40.8 12.4 18.1 18.5 3.8 12.8 1.1 0.3 0.0 114.3 4.9 83.8 13.1 8.9 2.2 1.3 1.5 0.0 38.2 1.8 2.1 0.2 0.3 0.4 0.0 11.9 24.2 16.0 10.5 13.0 0.0 0.0 8.2 8.7 0.5 31.9 0.0 18.9 17.1 0.1 3.6 2.1 1.0 60.6 5.1 0.0 61.1 0.3 12.7 3.1 0.6 0.7 32.0 3.7 0.0 3.2 0.0 1.5 3.3 68.2 0.0 0.4 0.0 4.5 0.0 0.3 66.8 13.9 0.0 13.1 8.6 0.4 4.3 63.7 164.7 0.1 0.9 0.1 0.2 6.2 CLBA1 C14orf79 ENSG00000140104 "Clathrin binding box of aftiphilin containing 1" Q96F83 14 104985775-105010482 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 16.0;Collecting duct cells: 16.5;Endometrial ciliated cells: 29.9;Respiratory ciliated cells: 19.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042052, HPA061117" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA042052: AB_2677822, HPA061117: AB_2684434" "unprognostic (1.49e-2)" "unprognostic (4.04e-2)" "unprognostic (4.84e-2)" "unprognostic (2.88e-2)" "unprognostic (5.51e-2)" "unprognostic (1.49e-1)" "unprognostic (5.77e-2)" "unprognostic (9.43e-3)" "unprognostic (1.78e-1)" "unprognostic (8.21e-2)" "unprognostic (3.50e-2)" "unprognostic (2.30e-1)" "unprognostic (4.39e-3)" "unprognostic (3.12e-2)" "unprognostic (1.11e-2)" "unprognostic (9.30e-2)" "unprognostic (2.95e-1)" 3.6 7.8 5.7 1.3 6.0 1.6 5.8 3.7 6.4 8.0 11.1 5.6 1.7 7.6 11.5 7.8 14.9 3.4 3.0 6.2 7.5 15.9 6.9 5.8 1.5 5.5 6.5 7.1 14.4 9.3 21.7 1.8 4.4 9.6 2.6 3.1 8.1 6.1 1.8 7.6 3.1 3.3 5.0 3.2 5.9 23.9 7.0 1.3 18.2 1.2 1.2 6.0 5.4 4.2 5.1 8.9 2.7 8.3 2.6 3.8 4.1 4.0 3.7 4.7 2.1 0.8 8.7 0.5 8.3 4.0 2.5 10.9 1.0 6.0 3.0 4.2 3.2 0.3 8.9 0.4 9.2 2.3 2.2 2.3 13.6 5.1 10.1 8.0 2.7 4.2 3.1 1.4 2.8 17.5 0.9 6.6 3.4 5.0 8.5 3.2 1.5 2.9 10.4 2.9 17.1 8.9 5.7 2.5 5.0 1.7 18.0 3.1 3.0 5.9 2.7 12.0 3.1 1.6 1.1 0.5 7.6 0.7 4.2 0.4 0.2 0.0 0.2 0.2 0.0 0.2 0.2 0.0 0.1 0.2 0.1 0.2 0.3 0.2 0.1 0.4 0.1 0.1 5.7 6.0 3.7 6.4 6.2 7.5 5.5 6.5 4.4 5.0 7.0 4.2 1.0 16.0 3.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 7.4 7.4 0.0 0.0 2.5 16.5 0.0 1.8 0.4 0.0 3.9 7.9 0.0 29.9 8.1 0.9 0.0 0.0 0.0 1.3 0.8 1.3 0.0 8.8 2.5 3.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 6.5 19.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.7 0.4 6.5 0.0 0.0 CDCA4 "FLJ20764, Hepp" ENSG00000170779 "Cell division cycle associated 4" Q9BXL8 14 105009573-105021083 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 55.8" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 64.2;Cytotrophoblasts: 84.5;Extravillous trophoblasts: 154.5;Spermatogonia: 69.9;Suprabasal keratinocytes: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA064971 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA Yes "Cluster 16: MAIT-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "Plasma membrane, Cytosol" "HPA064971: AB_2685395" "unprognostic (2.22e-3)" "unprognostic (1.84e-1)" "unprognostic (2.69e-1)" "unprognostic (9.93e-3)" "unprognostic (1.42e-1)" "unprognostic (8.36e-2)" "prognostic unfavorable (4.19e-4)" "prognostic unfavorable (7.94e-4)" "unprognostic (4.20e-2)" "unprognostic (8.54e-2)" "prognostic unfavorable (6.67e-4)" "unprognostic (6.73e-2)" "prognostic unfavorable (1.47e-6)" "unprognostic (2.15e-1)" "unprognostic (1.55e-1)" "unprognostic (7.50e-2)" "unprognostic (1.24e-2)" 3.9 2.6 1.9 7.4 2.0 55.8 4.2 3.0 2.1 8.7 2.1 4.6 4.7 5.4 1.8 18.6 4.1 2.6 2.7 1.7 1.8 3.4 2.7 3.6 11.6 2.1 1.9 4.1 3.2 1.8 1.7 9.2 2.1 3.8 2.9 1.3 5.5 2.2 1.4 24.7 4.9 3.5 1.9 6.6 3.8 11.6 2.0 14.6 3.3 1.5 8.5 4.2 10.2 2.0 40.6 41.3 46.7 35.6 7.9 13.2 61.1 59.0 18.0 45.2 39.7 50.9 50.2 52.9 31.5 20.9 34.5 63.5 32.9 68.0 27.1 58.2 26.1 33.4 33.9 43.2 9.7 59.8 27.0 9.4 20.8 35.2 32.7 15.1 31.4 45.0 37.5 53.0 32.1 98.8 56.2 40.1 34.8 35.1 94.0 53.6 68.1 19.7 15.9 46.2 27.2 33.5 56.6 22.3 46.8 20.5 44.0 39.8 48.8 39.9 50.5 55.3 79.5 19.5 25.9 54.4 33.5 30.2 67.5 1.1 4.3 10.6 11.9 4.9 14.8 8.4 12.7 16.7 4.7 5.4 7.4 8.9 1.6 12.9 5.6 5.1 11.1 7.0 1.9 2.0 3.0 2.1 1.7 1.8 2.1 1.9 2.1 1.9 2.0 2.0 5.4 0.0 2.2 0.7 7.4 64.2 26.5 36.6 13.1 3.4 8.7 8.3 0.6 0.0 9.0 1.8 0.0 84.5 11.5 4.3 3.9 12.7 8.1 9.0 9.0 10.9 3.0 53.0 1.8 7.0 154.5 10.2 3.1 12.5 28.6 15.1 7.9 2.2 24.3 13.5 1.3 6.6 6.1 5.9 22.6 6.8 8.4 8.4 17.8 2.8 9.3 4.6 9.2 1.0 1.8 12.3 3.3 6.0 11.8 16.1 1.9 1.8 7.7 2.6 6.6 4.6 12.5 43.0 69.9 21.3 67.1 25.9 17.7 3.6 9.5 43.2 GPR132 G2A ENSG00000183484 "G protein-coupled receptor 132" Q9UNW8 14 105049395-105065445 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Stress response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 8.0;lymphoid tissue: 7.8" "Cell type enhanced" "Detected in some" "B-cells: 23.6;Langerhans cells: 45.5;Macrophages: 30.2;monocytes: 19.1;NK-cells: 15.5;T-cells: 20.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "HDLM-2: 26.9;Karpas-707: 26.6;THP-1: 8.2" "HPA029694, HPA029695" Supported NA NA "Cluster 34: Basophils - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 41: Macrophages - Immune response" "HPA029694: AB_10600213, HPA029695: AB_10601984" "unprognostic (2.71e-3)" "prognostic favorable (3.21e-4)" "unprognostic (1.68e-2)" "unprognostic (1.07e-3)" "unprognostic (1.16e-1)" "prognostic favorable (6.44e-4)" "unprognostic (1.82e-1)" "unprognostic (1.28e-1)" "unprognostic (3.35e-2)" "unprognostic (8.54e-2)" "unprognostic (1.10e-1)" "unprognostic (4.18e-1)" "prognostic unfavorable (1.71e-5)" "unprognostic (6.71e-2)" "unprognostic (4.60e-2)" "unprognostic (1.23e-3)" "unprognostic (2.72e-1)" 2.1 0.7 0.9 7.0 0.7 8.0 0.9 0.7 0.9 0.9 1.0 1.3 1.0 0.6 0.4 0.8 1.6 1.4 0.8 0.8 1.0 5.4 0.5 2.7 7.7 1.6 1.1 0.3 0.7 0.3 0.5 1.5 1.2 0.8 0.9 0.3 0.9 0.3 0.5 2.6 4.3 0.8 1.0 7.8 1.7 0.3 1.2 1.9 4.6 0.6 4.5 2.4 1.1 1.3 0.0 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.5 3.5 0.6 0.0 0.0 0.7 0.0 0.0 0.0 26.9 0.3 0.6 0.1 0.0 0.1 2.1 0.5 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 26.6 0.0 0.8 0.0 2.7 0.1 0.0 0.0 2.1 0.2 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.8 8.2 0.4 0.1 0.1 0.0 0.3 0.7 2.6 0.3 0.0 2.4 0.0 9.6 6.0 5.5 6.1 7.7 5.9 4.2 4.8 5.5 5.7 4.5 4.8 5.3 4.7 5.8 9.1 3.1 3.6 5.0 0.9 0.7 0.7 0.9 0.8 1.0 1.6 1.1 1.2 1.0 1.2 1.3 0.6 0.0 1.9 0.7 23.6 1.7 0.1 1.0 0.0 0.0 0.3 0.3 0.8 0.0 0.7 1.8 0.0 0.1 12.2 0.0 1.9 0.4 0.0 2.2 0.8 0.9 0.0 4.0 0.7 0.6 0.3 0.4 1.1 5.2 12.7 0.0 0.0 0.0 3.9 0.0 0.6 0.0 0.0 7.1 45.5 0.2 0.0 30.2 5.4 7.5 19.1 0.0 15.5 0.0 0.1 1.2 0.0 0.0 11.7 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.0 1.6 0.0 20.7 0.0 0.0 0.9 JAG2 ENSG00000184916 "Jagged canonical Notch ligand 2" Q9Y219 14 105140982-105168824 "Predicted membrane proteins" "Notch signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 56.1;Basal respiratory cells: 30.9;Basal squamous epithelial cells: 27.3;Breast myoepithelial cells: 26.4;Endothelial cells: 34.2;Horizontal cells: 26.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 62.6;HBEC3-KT: 21.0;SCLC-21H: 31.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025481, HPA030636, HPA050567" Approved Supported Vesicles,Cytosol NA NA 370000 "Cluster 31: Skin - Epidermis development" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Vesicles Cytosol "CAB025481: , HPA030636: AB_10602607, HPA050567: AB_2681178" "unprognostic (6.74e-2)" "unprognostic (4.49e-2)" "unprognostic (4.28e-2)" "unprognostic (6.97e-3)" "unprognostic (3.50e-1)" "unprognostic (2.13e-2)" "unprognostic (1.01e-1)" "unprognostic (6.84e-2)" "unprognostic (1.18e-2)" "unprognostic (2.62e-1)" "unprognostic (1.67e-2)" "unprognostic (9.19e-2)" "unprognostic (8.47e-3)" "unprognostic (1.46e-1)" "unprognostic (2.58e-1)" "unprognostic (2.39e-1)" "unprognostic (2.17e-1)" 7.2 1.0 4.0 1.3 3.6 0.1 9.6 0.9 5.0 4.6 0.5 3.1 1.1 5.3 0.4 8.8 5.3 1.8 12.8 3.5 7.4 4.3 0.9 5.1 0.7 4.6 4.4 1.5 6.8 1.5 17.4 3.0 6.8 8.1 0.2 0.8 7.8 2.8 9.7 19.5 4.0 1.1 2.5 2.0 3.0 3.2 6.5 1.6 4.7 2.8 0.6 5.2 6.8 1.6 16.8 6.7 0.4 1.7 0.0 0.0 20.0 0.2 0.1 0.0 0.0 5.6 20.1 0.0 13.8 0.0 0.1 62.6 4.0 21.0 0.0 2.3 9.7 0.0 20.0 0.0 0.2 0.1 3.9 0.2 9.9 0.0 2.3 0.2 5.1 0.9 4.1 0.0 0.0 7.6 0.0 0.0 2.0 2.1 2.3 5.3 3.9 7.2 0.1 4.4 31.4 1.0 5.6 1.3 0.2 0.3 15.8 2.5 17.2 0.1 1.7 0.0 0.2 0.9 0.1 0.1 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 3.6 0.9 5.0 3.5 7.4 4.6 4.4 6.8 2.5 6.5 1.6 56.1 6.4 3.2 1.0 0.2 23.3 7.6 30.9 27.3 2.7 3.8 26.4 6.7 2.8 7.6 0.0 25.0 2.2 2.2 2.7 0.0 3.9 0.1 16.5 0.9 34.2 0.0 0.0 12.1 2.7 1.0 1.8 2.0 7.4 0.0 1.1 7.9 0.6 0.7 26.9 9.9 3.6 4.1 0.8 2.9 1.0 1.5 1.1 7.2 15.0 1.3 0.6 1.0 0.5 1.1 3.3 2.1 0.7 0.9 4.4 8.2 0.3 11.5 4.8 0.0 3.7 3.7 0.8 13.5 6.0 6.8 1.4 3.4 0.3 2.7 1.5 NUDT14 UGPP ENSG00000183828 "Nudix hydrolase 14" O95848 14 105172938-105181323 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 176.1;Proximal enterocytes: 206.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046755, HPA058759" Approved Approved Nucleoli,Microtubules NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 39: Non-specific - Basic cellular processes" Microtubules Nucleoli "HPA046755: AB_10963433, HPA058759: AB_2683809" "unprognostic (1.05e-2)" "unprognostic (6.01e-2)" "unprognostic (1.89e-1)" "unprognostic (2.44e-1)" "unprognostic (1.91e-1)" "unprognostic (3.55e-1)" "unprognostic (1.05e-3)" "unprognostic (9.17e-3)" "unprognostic (2.02e-1)" "prognostic favorable (1.66e-4)" "unprognostic (3.16e-3)" "unprognostic (3.13e-1)" "prognostic favorable (1.18e-5)" "unprognostic (1.89e-1)" "unprognostic (1.02e-1)" "unprognostic (7.21e-3)" "unprognostic (2.38e-1)" 16.5 23.9 17.4 3.5 20.1 2.1 19.3 19.9 28.4 9.0 27.5 14.5 12.5 6.4 3.5 17.5 8.9 6.4 27.5 19.9 21.5 28.8 19.5 20.1 5.9 19.0 17.4 6.4 40.4 16.0 61.1 3.2 19.1 18.6 2.9 4.7 17.2 2.9 31.6 14.1 16.3 1.8 17.9 12.5 17.6 13.9 17.2 3.6 22.1 12.7 2.1 8.4 11.3 21.1 18.1 24.2 2.1 9.4 2.8 3.3 38.1 5.0 6.5 8.0 11.5 17.5 18.7 1.3 24.4 2.6 17.8 22.7 1.1 13.6 0.7 9.5 17.7 4.0 10.4 12.2 19.9 4.8 46.7 4.7 16.7 1.9 1.4 3.4 15.9 8.8 6.4 2.9 2.8 52.5 0.6 0.0 12.6 42.7 33.5 9.4 21.9 10.8 8.8 51.2 32.8 4.8 9.0 0.2 21.7 3.9 18.8 23.1 38.3 13.2 5.8 9.5 5.1 1.4 1.0 2.2 19.4 5.5 4.9 6.2 40.5 1.2 12.6 40.8 7.5 12.8 9.6 8.0 33.5 10.2 9.4 10.8 1.3 15.2 68.6 17.0 6.0 19.2 17.4 20.1 19.9 28.4 19.9 21.5 19.0 17.4 19.1 17.9 17.2 21.1 66.1 12.8 28.5 5.2 12.4 38.9 101.7 123.4 52.9 12.1 46.8 78.5 54.5 40.0 41.2 35.0 18.8 44.7 16.1 88.2 176.1 94.1 3.1 59.3 8.0 61.6 37.3 10.1 5.9 30.8 18.2 14.7 30.5 31.0 38.8 11.9 27.1 28.0 137.0 35.3 3.0 62.6 73.2 27.4 27.1 9.8 11.5 33.9 46.2 12.2 35.6 38.3 22.6 0.5 5.8 51.2 132.4 3.8 7.7 51.9 206.9 169.1 65.7 19.1 0.0 39.0 11.4 12.4 48.5 30.4 19.0 38.2 26.8 5.2 75.4 82.2 BRF1 "BRF, GTF3B, hBRF, TAF3B2, TAF3C, TFIIIB90" ENSG00000185024 "BRF1 RNA polymerase III transcription initiation factor subunit" Q92994 14 105209286-105315589 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051918, HPA074990" Approved Approved "Nucleoplasm,Nuclear bodies" Yes No "Cluster 40: NK-cells - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Nuclear bodies" "HPA051918: AB_2681663, HPA074990: " "unprognostic (1.98e-1)" "unprognostic (4.45e-2)" "unprognostic (1.46e-2)" "unprognostic (2.51e-2)" "unprognostic (1.07e-1)" "unprognostic (7.52e-2)" "unprognostic (1.52e-4)" "unprognostic (2.67e-2)" "unprognostic (3.25e-1)" "unprognostic (2.26e-1)" "prognostic favorable (7.25e-6)" "unprognostic (8.83e-2)" "prognostic favorable (1.13e-4)" "unprognostic (1.85e-1)" "unprognostic (2.70e-1)" "unprognostic (5.39e-2)" "unprognostic (2.52e-1)" 10.5 11.4 19.7 5.5 22.2 6.5 10.5 23.1 23.6 12.5 12.9 11.1 7.6 12.1 4.2 10.4 12.8 6.0 12.2 17.1 19.2 11.6 13.1 8.4 8.1 31.8 24.9 13.0 15.1 10.3 20.4 6.0 29.7 12.0 4.2 7.5 10.1 6.3 17.7 11.2 10.3 4.6 18.7 12.6 11.2 14.6 25.4 7.3 10.5 9.6 5.8 11.5 9.9 37.4 12.6 28.0 11.8 25.3 10.3 11.4 11.9 17.4 11.2 15.4 12.2 20.2 18.8 9.4 16.9 12.0 7.5 24.2 14.4 11.7 8.4 25.2 14.2 11.5 15.1 9.9 11.5 13.7 24.3 11.3 10.1 9.3 11.5 7.8 11.3 19.7 13.1 7.5 7.6 40.9 16.2 17.1 8.6 20.7 27.7 28.2 8.1 9.6 7.6 29.9 37.5 27.8 18.4 14.0 16.0 5.4 33.4 18.9 16.8 12.1 9.6 22.7 14.2 13.8 11.5 8.9 14.5 11.3 16.9 0.4 1.2 2.0 1.6 1.0 1.1 1.5 1.1 1.6 1.2 1.4 1.4 1.3 0.5 2.5 4.0 3.1 1.6 1.6 19.7 22.2 23.1 23.6 17.1 19.2 31.8 24.9 29.7 18.7 25.4 37.4 11.5 3.2 5.9 17.6 11.4 7.5 7.1 4.5 8.6 18.8 10.7 9.0 8.5 2.8 6.3 3.7 16.7 11.4 15.5 16.2 3.9 5.8 2.3 26.5 10.9 9.5 9.6 6.3 18.3 7.1 8.9 7.7 14.8 16.5 2.5 16.0 8.9 11.3 7.2 30.3 20.8 11.7 4.1 6.7 10.3 1.4 6.5 7.8 8.8 10.3 5.3 7.1 4.1 15.1 34.2 4.8 6.5 4.5 13.4 7.7 8.9 6.1 12.4 20.0 0.0 9.6 8.2 9.2 12.7 7.7 8.8 9.3 11.6 13.2 12.5 5.1 BTBD6 BDPL ENSG00000184887 "BTB domain containing 6" Q96KE9 14 105248490-105251093 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031355 Approved Approved Nucleoplasm NA NA "Cluster 35: T-regs - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA031355: AB_10611812" "prognostic favorable (1.11e-4)" "unprognostic (2.01e-2)" "unprognostic (2.65e-1)" "unprognostic (1.97e-2)" "unprognostic (2.69e-1)" "unprognostic (2.58e-1)" "unprognostic (2.23e-2)" "unprognostic (4.83e-2)" "unprognostic (2.58e-1)" "unprognostic (1.44e-1)" "prognostic favorable (2.25e-4)" "unprognostic (8.48e-3)" "prognostic favorable (6.51e-5)" "unprognostic (6.55e-2)" "unprognostic (3.22e-1)" "unprognostic (6.86e-2)" "unprognostic (9.85e-2)" 69.4 26.3 52.1 20.4 52.6 28.2 56.6 48.3 60.3 32.6 48.1 43.8 28.8 31.4 28.1 50.9 30.8 20.5 52.1 54.2 51.7 34.5 44.2 34.7 22.0 49.7 51.0 36.7 13.2 12.6 39.9 15.6 49.9 43.6 23.1 14.6 42.8 23.5 169.4 48.5 39.5 18.8 48.4 31.4 46.9 79.3 52.1 18.4 30.4 144.6 19.0 38.9 37.7 51.3 50.8 39.8 21.4 56.8 66.8 46.2 0.1 45.6 41.1 69.2 46.9 31.3 45.2 15.9 27.4 67.0 14.5 66.2 41.3 43.9 34.0 41.2 33.5 11.7 58.6 0.0 45.6 35.8 21.7 48.3 59.6 31.9 25.7 26.9 55.9 52.2 0.0 0.3 37.3 71.8 37.8 14.5 9.1 47.6 67.6 40.3 0.1 14.9 26.5 55.0 34.8 14.8 42.9 34.3 35.0 14.7 69.9 45.3 37.9 55.5 1.5 82.1 57.8 10.2 14.7 7.8 57.2 16.4 44.1 0.5 0.6 2.9 2.3 1.0 2.2 1.3 2.4 2.3 0.7 0.7 1.8 1.2 0.3 0.4 0.8 1.5 5.3 0.6 52.1 52.6 48.3 60.3 54.2 51.7 49.7 51.0 49.9 48.4 52.1 51.3 31.5 25.6 24.3 3.9 5.4 11.7 25.7 6.5 6.2 23.1 24.0 23.4 22.0 14.3 15.3 11.0 6.2 2.8 25.3 31.0 21.5 5.7 15.0 25.6 19.5 17.8 20.4 5.2 12.4 0.0 3.8 17.3 10.2 34.9 24.7 22.2 17.9 15.4 7.8 20.2 12.5 31.2 10.2 9.8 10.0 35.2 9.3 10.3 12.4 8.4 3.6 19.1 5.2 5.0 3.7 1.0 11.6 7.5 7.6 16.3 20.5 11.6 15.5 18.8 13.1 15.7 13.0 7.8 8.3 9.6 12.6 2.2 16.4 15.2 21.9 19.5 PACS2 "KIAA0602, PACS1L" ENSG00000179364 "Phosphofurin acidic cluster sorting protein 2" Q86VP3 14 105300563-105398147 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Apoptosis, Host-virus interaction" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 136.6;skeletal muscle: 98.5" "Cell type enhanced" "Detected in all" "Horizontal cells: 97.6;Oligodendrocytes: 169.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077892 Approved Mitochondria NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 70: Brain - Nervous system development" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Mitochondria "HPA077892: AB_2686865" "unprognostic (4.31e-2)" "unprognostic (2.61e-1)" "unprognostic (4.53e-2)" "unprognostic (1.24e-1)" "unprognostic (3.09e-2)" "unprognostic (4.08e-2)" "prognostic unfavorable (3.11e-5)" "unprognostic (1.18e-2)" "unprognostic (1.37e-1)" "unprognostic (1.90e-1)" "prognostic favorable (2.95e-4)" "unprognostic (1.49e-1)" "prognostic favorable (1.56e-4)" "unprognostic (2.08e-1)" "unprognostic (3.80e-1)" "unprognostic (2.58e-1)" "unprognostic (1.30e-1)" 22.4 16.1 48.4 10.6 101.5 9.0 18.7 104.4 61.3 18.1 4.7 24.6 10.9 21.0 5.4 11.2 19.0 11.2 23.8 43.2 58.0 12.4 6.9 16.1 8.5 136.6 110.6 20.0 28.8 11.7 21.6 8.8 119.6 15.0 6.6 12.2 16.3 11.5 98.5 12.6 14.2 10.0 80.8 16.0 17.4 19.8 106.1 9.4 14.1 46.1 5.5 19.3 14.1 126.8 17.5 23.8 21.9 20.7 21.5 20.6 25.9 13.0 15.0 11.0 9.6 10.4 32.5 19.0 21.5 20.0 14.1 19.7 13.5 18.7 7.9 23.7 11.0 8.7 10.0 15.6 28.1 7.1 15.0 24.1 17.5 7.7 17.7 13.9 20.1 18.9 5.4 17.2 9.7 54.9 12.1 9.5 8.5 22.1 19.4 26.5 13.3 12.1 9.3 39.7 49.0 25.8 12.4 11.1 19.4 13.7 28.1 13.2 30.8 16.2 7.2 25.6 13.1 22.3 15.6 7.2 24.6 12.8 16.1 0.0 0.6 0.1 0.3 1.1 0.6 0.0 0.3 0.4 1.1 0.2 0.1 0.4 0.1 1.0 1.9 2.3 0.8 0.4 48.4 101.5 104.4 61.3 43.2 58.0 136.6 110.6 119.6 80.8 106.1 126.8 28.3 9.6 14.7 41.1 3.3 9.1 7.5 7.1 8.0 30.5 15.1 14.4 21.4 8.6 12.6 5.5 12.5 4.3 15.1 21.5 13.7 13.9 77.1 13.8 15.7 21.1 13.1 4.2 29.7 23.0 3.2 15.5 20.4 18.3 1.3 28.8 19.2 10.8 17.6 97.6 41.0 14.6 8.2 15.7 23.0 78.7 17.4 17.1 26.6 30.9 8.4 17.0 7.2 23.1 169.3 14.2 12.6 16.6 7.1 9.0 19.3 12.3 7.7 23.4 6.6 20.6 14.2 18.3 14.6 8.1 8.4 3.4 8.0 30.6 19.5 8.0 TEX22 ENSG00000226174 "Testis expressed 22" C9J3V5 14 105398538-105450106 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 5.0" "Group enriched" "Detected in some" 8 "Early spermatids: 290.6;Late spermatids: 614.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 3.2;U-266/70: 2.3;U-937: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA065576 Enhanced NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 44: HDLM-2 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" "HPA065576: AB_2685513" "unprognostic (3.99e-2)" "unprognostic (6.00e-2)" "unprognostic (1.30e-3)" "unprognostic (2.06e-1)" "unprognostic (3.36e-1)" "unprognostic (1.62e-2)" "unprognostic (7.48e-2)" "unprognostic (1.52e-2)" "unprognostic (3.95e-2)" "unprognostic (1.53e-5)" "unprognostic (1.42e-4)" "unprognostic (8.13e-2)" "unprognostic (5.96e-2)" "unprognostic (2.18e-2)" "unprognostic (5.25e-2)" "unprognostic (1.68e-2)" "unprognostic (5.91e-3)" 0.2 0.0 0.7 0.2 0.8 0.4 0.3 1.1 0.7 0.3 0.3 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.6 0.5 0.6 0.1 0.1 0.5 0.9 0.8 0.6 0.3 0.2 0.1 0.1 0.8 0.4 0.0 0.1 0.2 0.1 0.1 0.2 0.4 0.0 0.7 0.7 0.2 5.0 0.7 1.0 0.3 0.0 0.2 0.1 0.2 1.2 0.2 0.3 0.3 1.4 0.4 0.0 0.3 0.1 0.0 0.0 0.2 0.1 0.2 0.8 0.1 0.0 0.0 0.2 0.2 0.0 0.0 3.2 0.2 0.1 0.5 0.0 0.1 0.2 0.8 0.2 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.9 0.0 1.0 0.1 0.1 0.1 0.0 0.1 0.8 0.0 0.0 0.1 0.2 0.2 0.3 0.0 0.0 0.1 0.2 0.2 0.3 0.0 0.1 0.1 0.3 0.0 2.3 0.3 0.3 0.1 1.7 1.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.7 0.8 1.1 0.7 0.6 0.5 0.9 0.8 0.8 0.7 0.7 1.2 0.3 0.0 0.0 6.2 1.1 0.4 0.4 0.2 0.6 0.1 1.0 0.9 0.4 0.0 0.1 0.0 0.0 0.2 0.3 0.2 1.9 0.6 290.6 1.3 0.5 0.4 0.0 0.8 3.2 0.6 0.1 0.4 0.0 0.4 4.5 2.2 0.0 0.1 1.0 0.0 4.8 0.2 0.0 1.9 0.3 614.3 4.1 1.0 1.8 1.0 1.2 0.3 0.0 6.6 5.8 0.6 0.1 2.2 0.3 0.5 0.8 0.5 0.4 0.2 6.6 0.9 0.6 54.2 3.0 0.4 0.1 0.1 0.6 0.4 0.2 0.2 MTA1 ENSG00000182979 "Metastasis associated 1" Q13330 14 105419820-105470729 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004508, HPA005544" Supported Enhanced Nucleoplasm,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 30: Mammary glandular cells - Lactation" Nucleoplasm Cytosol "CAB004508: AB_627969, HPA005544: AB_1079420" "unprognostic (6.79e-3)" "unprognostic (4.22e-2)" "unprognostic (1.06e-1)" "unprognostic (6.36e-2)" "unprognostic (2.91e-2)" "unprognostic (7.74e-2)" "prognostic unfavorable (4.62e-4)" "unprognostic (6.59e-2)" "unprognostic (1.47e-1)" "unprognostic (6.72e-3)" "prognostic favorable (9.48e-5)" "unprognostic (4.57e-3)" "unprognostic (1.39e-2)" "unprognostic (2.88e-2)" "unprognostic (1.48e-1)" "unprognostic (1.75e-1)" "unprognostic (1.18e-1)" 23.1 23.8 24.1 10.8 23.4 15.4 24.6 23.7 31.0 31.7 19.4 31.2 13.1 29.9 11.6 22.6 31.8 6.2 39.2 24.1 20.1 24.7 24.1 19.6 12.1 22.2 21.5 38.6 30.1 9.4 36.9 9.2 20.1 31.8 5.6 8.3 23.6 12.7 25.6 21.1 22.1 9.0 20.0 26.7 22.5 37.6 22.5 16.5 30.4 7.7 9.1 29.2 24.4 22.3 33.6 26.3 47.9 48.2 18.0 30.5 42.3 26.2 19.9 25.4 24.3 34.4 44.1 65.4 26.7 19.3 17.9 45.3 35.1 25.0 17.1 43.2 59.0 34.1 25.2 35.5 39.6 43.2 25.3 34.4 30.9 18.0 41.1 35.5 36.4 48.0 39.3 27.7 13.4 60.4 78.3 85.2 69.1 47.7 55.1 73.1 29.1 21.5 20.6 26.0 76.9 80.1 35.5 40.5 40.8 24.3 36.7 40.7 26.6 20.4 21.6 34.1 27.8 55.9 28.9 41.3 25.6 28.7 36.6 0.1 0.2 0.8 0.3 0.2 0.3 0.3 0.2 0.2 0.2 0.3 0.3 0.4 0.0 0.4 0.1 0.9 0.2 0.2 24.1 23.4 23.7 31.0 24.1 20.1 22.2 21.5 20.1 20.0 22.5 22.3 32.1 3.2 16.0 37.9 20.9 15.6 28.8 14.6 13.1 0.0 64.8 38.6 9.2 27.1 15.2 35.0 0.0 11.6 17.7 17.2 17.6 13.2 32.8 25.0 28.4 20.4 18.6 25.4 17.2 19.6 8.0 21.8 28.1 23.9 5.7 47.6 18.2 15.5 11.0 0.0 16.1 21.6 10.2 18.5 13.5 11.3 36.1 15.7 12.4 21.5 13.8 0.0 20.6 32.6 27.0 16.3 11.5 32.0 17.8 45.4 18.5 8.8 27.0 0.0 19.7 30.5 25.4 21.5 13.3 16.8 19.0 9.3 18.7 27.1 24.9 46.2 CRIP2 "CRP2, ESP1" ENSG00000182809 "Cysteine rich protein 2" P52943 14 105472962-105480162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "heart muscle: 1113.7" "Cell type enhanced" "Detected in many" "Adipocytes: 459.4;Cardiomyocytes: 863.3;Endothelial cells: 510.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 52.1;memory CD4 T-cell: 80.4;naive B-cell: 109.9;T-reg: 115.6" "Group enriched" "Detected in all" 30 "B-cells: 109.9;T-cells: 115.6" "Cell line enhanced" "Detected in many" "EFO-21: 321.9;MCF7: 306.5;SK-BR-3: 303.7;T-47d: 266.4;TIME: 259.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042664 Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA 160000 "Cluster 26: Non-specific - Mitochondria" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 38: EFO-21 - Unknown function" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoli "Nucleoplasm, Plasma membrane" "HPA042664: AB_10797017" "unprognostic (2.68e-1)" "unprognostic (6.53e-3)" "unprognostic (2.11e-3)" "unprognostic (2.19e-1)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.63e-2)" "unprognostic (2.56e-1)" "unprognostic (3.20e-3)" "unprognostic (9.68e-2)" "unprognostic (6.96e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-2)" "unprognostic (6.25e-2)" "unprognostic (2.35e-2)" "unprognostic (2.39e-2)" "unprognostic (8.26e-3)" 177.6 44.7 160.4 31.3 172.0 1.5 162.5 137.7 259.5 101.6 124.2 101.9 27.0 138.1 36.4 127.3 130.0 47.9 1113.7 172.7 186.4 205.1 52.7 185.7 30.0 157.3 158.7 51.2 46.1 19.2 175.0 49.6 158.6 89.0 8.3 4.1 100.0 72.9 52.5 128.9 82.8 32.0 145.0 104.1 66.1 92.8 191.9 10.4 155.6 42.7 16.5 121.4 100.4 140.8 2.5 201.2 37.9 98.3 4.3 19.9 10.0 17.5 1.9 2.8 1.0 7.1 44.2 0.2 321.9 73.8 4.5 166.8 3.6 50.8 0.1 2.3 1.9 0.2 132.5 73.8 24.3 0.0 25.5 10.5 4.4 5.2 26.2 38.4 192.7 0.2 0.5 1.4 26.8 306.5 0.5 0.6 10.0 45.7 143.4 0.4 7.7 9.9 140.1 0.6 61.6 175.3 30.0 303.7 1.9 4.9 266.4 0.1 259.3 82.7 38.8 2.3 50.5 0.7 0.6 0.9 24.3 0.3 179.3 0.2 1.9 0.0 7.5 0.9 6.8 52.1 80.4 17.2 3.6 109.9 17.8 4.5 1.0 3.7 0.5 0.5 115.6 10.4 160.4 172.0 137.7 259.5 172.7 186.4 157.3 158.7 158.6 145.0 191.9 140.8 459.4 157.0 33.7 17.9 15.0 153.2 96.7 206.4 29.0 2.7 110.0 140.7 863.3 107.2 127.1 189.4 4.2 2.6 8.2 0.9 154.6 106.8 37.9 125.1 28.8 510.4 25.2 9.7 16.4 87.6 30.5 132.9 32.1 126.6 7.6 0.4 346.3 30.4 3.0 94.2 3.0 0.3 81.4 11.8 92.6 84.0 28.0 9.3 156.5 27.2 2.5 57.2 1.0 4.5 3.1 48.9 0.1 14.7 7.0 37.4 0.2 17.0 155.7 4.0 276.1 108.1 339.5 27.8 46.1 20.1 196.8 32.0 32.5 5.9 0.2 103.2 CRIP1 CRIP ENSG00000213145 "Cysteine rich protein 1" P50238 14 105486317-105488947 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 980.8;Endometrial ciliated cells: 1761.1;Proximal enterocytes: 2548.8;Respiratory ciliated cells: 1702.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 699.8;CAPAN-2: 415.5;HaCaT: 464.1;HDLM-2: 329.5;OE19: 1305.8;T-47d: 586.0" HPA042462 Approved Approved "Nuclear speckles,Plasma membrane,Centrosome,Cytosol" NA NA 29000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 31: Skin - Epidermis development" "Cluster 21: OE19 - Mitochondria" "Cluster 11: Alveolar cells - Smell perception" "Nuclear speckles, Cytosol" "Plasma membrane, Centrosome" "HPA042462: AB_10794277" "unprognostic (2.97e-3)" "unprognostic (1.27e-3)" "unprognostic (1.34e-2)" "unprognostic (1.17e-2)" "unprognostic (2.39e-1)" "unprognostic (2.93e-3)" "unprognostic (4.33e-1)" "unprognostic (3.33e-1)" "unprognostic (3.20e-2)" "unprognostic (2.60e-2)" "unprognostic (2.87e-1)" "unprognostic (9.16e-2)" "unprognostic (3.26e-3)" "unprognostic (5.10e-2)" "unprognostic (2.66e-1)" "unprognostic (7.51e-3)" "unprognostic (2.14e-1)" 265.2 21.7 19.2 61.1 19.7 29.4 180.8 20.0 36.4 147.4 20.3 133.9 121.7 108.0 206.6 118.7 118.2 28.1 262.6 18.5 20.3 109.7 17.8 254.6 83.9 26.9 29.1 49.8 18.3 21.2 41.5 28.3 24.6 49.6 55.4 0.2 135.7 87.9 44.7 301.1 312.5 42.4 24.7 94.5 94.2 14.3 21.0 79.6 182.1 50.2 135.7 113.7 98.9 20.3 0.0 699.8 4.8 0.6 12.1 8.3 66.8 1.3 0.4 9.0 0.1 21.0 415.5 228.0 2.4 191.0 2.6 464.1 0.1 0.0 0.0 329.5 0.0 17.7 294.7 116.3 1.8 0.1 0.2 3.8 0.0 23.1 0.0 0.9 0.5 64.6 0.5 0.9 0.0 3.7 8.1 1.6 7.4 1305.8 36.4 181.3 0.0 45.5 0.0 0.0 18.5 1.3 2.6 1.2 0.0 0.5 586.0 106.4 1.5 0.4 0.4 5.5 0.0 0.3 0.2 17.9 0.0 0.0 0.6 121.8 218.6 313.1 209.2 214.4 135.1 697.0 442.0 222.1 442.9 384.2 85.4 100.2 13.9 323.5 283.9 291.3 694.8 465.6 19.2 19.7 20.0 36.4 18.5 20.3 26.9 29.1 24.6 24.7 21.0 20.3 50.2 980.8 256.2 0.3 350.7 186.5 1.2 79.5 67.2 0.0 88.1 18.3 1.0 2.8 501.3 51.5 0.0 2.1 287.8 360.4 1.9 20.5 3.6 1761.1 124.5 86.4 76.5 27.3 0.0 3.1 4.3 313.3 210.0 491.9 521.5 0.1 24.7 1.3 52.2 0.0 0.0 243.1 30.5 168.0 577.3 26.2 25.1 523.7 370.0 1.9 461.4 0.2 83.4 0.0 0.1 34.2 659.2 9.4 584.3 0.7 2548.8 2.5 1702.1 0.0 223.5 8.2 448.0 1.0 11.4 29.4 251.6 1.5 524.7 0.1 190.7 3.0 TEDC1 C14orf80 ENSG00000185347 "Tubulin epsilon and delta complex 1" Q86SX3 14 105489855-105499575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Ductal cells: 11.6;Endometrial ciliated cells: 12.0;Exocrine glandular cells: 12.7;Extravillous trophoblasts: 26.6;Hofbauer cells: 14.6;monocytes: 11.9;Pancreatic endocrine cells: 14.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 66.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA039049, HPA039050" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" No No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 6: Brain - Smell perception" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039049: AB_2676320, HPA039050: AB_10670918" "unprognostic (8.06e-2)" "unprognostic (1.06e-2)" "unprognostic (9.17e-2)" "unprognostic (1.65e-1)" "unprognostic (3.06e-1)" "unprognostic (1.57e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (5.19e-2)" "unprognostic (1.49e-1)" "unprognostic (3.12e-1)" "unprognostic (3.81e-2)" "unprognostic (2.91e-2)" "unprognostic (1.12e-3)" "unprognostic (8.73e-3)" "unprognostic (2.88e-1)" "unprognostic (1.17e-1)" "unprognostic (6.18e-3)" 5.1 1.6 5.2 4.9 5.5 6.8 4.7 4.1 7.8 4.3 0.5 5.5 5.1 3.8 1.0 6.8 4.6 1.8 4.3 5.8 3.0 4.0 5.4 4.9 5.4 7.0 3.5 2.5 3.0 1.0 5.3 1.6 4.2 4.2 1.6 0.5 4.3 2.3 2.3 8.2 5.4 1.0 3.1 6.8 5.9 4.9 3.6 4.5 5.7 0.5 3.1 3.9 4.5 5.3 17.2 38.9 9.2 13.5 0.8 1.5 24.5 13.4 5.0 15.9 14.7 14.0 31.2 25.6 27.2 2.2 6.2 43.5 3.2 14.0 3.0 29.0 16.0 6.5 22.8 13.3 0.6 12.9 17.9 0.3 4.6 10.6 3.5 2.0 6.4 23.2 10.5 31.2 2.5 66.7 26.9 29.6 11.9 14.6 41.8 21.9 13.8 17.9 4.5 14.3 25.7 15.5 13.7 15.8 9.8 2.0 26.0 12.6 7.8 10.9 18.4 33.4 22.4 17.8 8.2 15.7 13.9 14.8 18.0 0.0 0.5 0.6 0.5 0.9 0.4 0.1 0.8 1.4 0.7 0.3 0.6 0.1 0.1 0.0 0.8 2.4 0.6 0.2 5.2 5.5 4.1 7.8 5.8 3.0 7.0 3.5 4.2 3.1 3.6 5.3 4.8 3.2 2.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 5.9 5.3 0.0 0.0 0.6 1.8 0.0 8.0 10.1 0.0 3.9 11.6 0.0 12.0 3.0 4.0 0.0 0.0 0.0 12.7 26.6 3.4 0.0 7.2 0.0 8.1 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 11.9 0.0 0.0 0.0 0.0 14.7 0.0 0.0 4.7 0.0 0.0 2.0 3.6 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 4.0 4.2 2.5 0.0 0.0 TMEM121 "hole, MGC4659, TMEM121A" ENSG00000184986 "Transmembrane protein 121" Q9BTD3 14 105526583-105530202 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 31.2;Muller glia cells: 14.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 8.1;MCF7: 8.1;PC-3: 10.2;REH: 6.7;SCLC-21H: 5.3;WM-115: 5.4" "Low region specificity" "Detected in all" HPA049857 Uncertain Approved Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA049857: AB_2680917" "unprognostic (4.25e-2)" "unprognostic (3.34e-1)" "unprognostic (2.05e-3)" "unprognostic (2.20e-2)" "unprognostic (1.31e-1)" "unprognostic (9.50e-2)" "unprognostic (1.88e-3)" "unprognostic (9.54e-2)" "unprognostic (3.47e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-3)" "unprognostic (5.31e-2)" "unprognostic (5.48e-4)" "unprognostic (2.83e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (5.87e-4)" "unprognostic (5.90e-2)" 2.0 1.0 4.8 0.5 5.0 0.2 2.4 2.9 6.4 4.6 0.4 2.4 0.2 4.3 0.1 1.0 4.6 0.1 2.3 5.7 3.1 2.6 2.6 1.7 0.3 5.8 4.8 2.4 2.4 0.6 5.1 0.2 3.8 3.7 0.0 0.0 1.4 0.4 0.3 1.5 1.8 0.2 2.6 3.4 1.8 1.2 3.3 0.1 2.6 0.0 0.0 2.1 2.1 3.9 0.0 4.0 0.4 3.6 0.0 0.2 0.7 2.4 0.5 0.4 0.0 0.0 1.3 1.2 8.1 0.0 0.7 0.4 0.4 0.1 0.0 0.5 1.9 0.0 0.4 1.4 0.6 0.0 1.4 0.2 0.0 0.1 0.0 0.2 0.4 0.5 0.1 0.0 0.2 8.1 0.2 0.0 1.2 0.1 10.2 6.7 0.0 0.1 0.1 0.0 5.3 2.0 0.4 0.0 2.0 0.0 2.4 0.3 1.4 1.1 2.1 0.2 0.4 0.6 0.0 0.0 0.1 0.5 5.4 0.0 0.0 0.0 0.6 0.0 1.0 2.1 1.2 0.6 0.2 0.6 0.7 0.4 0.0 0.8 0.0 0.0 0.0 0.2 4.8 5.0 2.9 6.4 5.7 3.1 5.8 4.8 3.8 2.6 3.3 3.9 10.6 0.0 0.5 2.3 2.8 4.6 2.6 0.1 2.2 5.1 8.9 10.8 1.5 1.5 0.7 5.5 0.0 0.2 0.7 0.0 0.0 1.0 1.7 5.4 5.5 9.5 0.0 3.4 5.7 0.2 2.2 4.6 1.1 1.4 0.0 31.2 10.8 2.3 0.4 10.1 4.8 0.0 0.0 0.6 4.8 2.2 4.4 0.4 7.2 2.8 0.0 14.4 1.0 12.1 11.5 0.0 0.0 6.4 0.5 1.8 0.0 0.1 1.6 1.6 0.0 4.0 3.2 0.7 3.1 0.4 2.6 0.3 3.2 1.8 0.2 0.6 IGHA2 ENSG00000211890 "Immunoglobulin heavy constant alpha 2 (A2m marker)" P01877 14 105583731-105588395 "Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "intestine: 5017.7;salivary gland: 3728.4" "Group enriched" "Detected in many" 22 "B-cells: 3713.4;Plasma cells: 10918.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 876 "memory B-cell: 279.6;naive B-cell: 123.8" "Lineage enriched" "Detected in single" 1214 "B-cells: 279.6" "Group enriched" "Detected in some" 42 "U-266/70: 181.9;U-266/84: 63.9" "Not detected" "Not detected" "HPA001217, HPA006013" Approved "Immunoglobulin genes" NA NA 67000000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA001217: AB_1079120, HPA006013: AB_1079119" "prognostic favorable (1.98e-9)" "unprognostic (3.20e-2)" "unprognostic (2.23e-2)" "unprognostic (1.53e-2)" "unprognostic (1.93e-2)" "prognostic favorable (8.40e-5)" "unprognostic (4.56e-2)" "unprognostic (2.59e-1)" "unprognostic (3.17e-1)" "unprognostic (3.69e-2)" "unprognostic (1.20e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (7.50e-6)" "unprognostic (2.12e-1)" "unprognostic (3.28e-2)" "unprognostic (9.70e-2)" "unprognostic (4.47e-1)" 24.3 3.7 0.0 14.2 0.0 12.4 329.7 0.0 0.0 47.6 0.0 5017.7 15.3 8.9 0.0 219.7 35.0 0.9 4.8 0.0 0.0 49.7 35.1 134.2 6.8 0.0 0.0 5.3 30.3 0.0 4.9 0.3 0.0 37.7 8.8 0.0 3728.4 0.1 2.1 17.8 2261.3 1.0 0.0 700.9 670.1 1.1 0.0 22.4 59.8 0.0 13.0 93.4 67.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 2.8 2.8 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.1 0.0 0.9 181.9 63.9 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 279.6 0.0 0.1 0.1 123.8 0.0 0.1 0.2 0.0 0.1 0.1 0.1 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.2 12.4 0.0 3713.4 0.0 2.4 0.0 2.8 0.0 1.4 0.3 1.2 5.7 0.6 0.0 0.0 0.1 3.2 3.7 0.0 0.0 0.0 0.0 0.0 15.6 8.5 56.2 0.0 0.0 0.0 8.0 10.7 0.0 15.2 0.0 78.9 6.0 0.3 0.0 0.0 2.9 0.0 10.8 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.3 0.0 10918.5 0.3 0.0 0.1 0.0 0.0 0.0 0.1 23.6 0.0 0.0 12.3 0.0 0.4 325.4 0.0 4.8 0.2 IGHE ENSG00000211891 "Immunoglobulin heavy constant epsilon" P01854 14 105597691-105601728 "Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 1.9;lymphoid tissue: 4.6;thyroid gland: 2.6" "Cell type enriched" "Detected in some" 50 "Plasma cells: 462.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "U-266/70: 3818.2" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 77000000 "Cluster 64: Macrophages - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "unprognostic (3.18e-2)" "unprognostic (1.28e-2)" "unprognostic (1.54e-3)" "unprognostic (4.99e-1)" "unprognostic (4.87e-3)" "unprognostic (1.51e-1)" "unprognostic (1.13e-1)" "unprognostic (5.36e-2)" "unprognostic (2.40e-2)" "unprognostic (8.04e-2)" "unprognostic (3.88e-2)" "unprognostic (3.01e-3)" "unprognostic (1.07e-2)" "unprognostic (3.98e-1)" "unprognostic (2.17e-1)" "unprognostic (1.63e-1)" 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 1.9 0.0 0.0 4.6 1.4 0.0 0.0 0.2 2.6 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.6 0.0 0.0 0.6 0.0 0.6 3818.2 371.6 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 462.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 IGHG4 ENSG00000211892 "Immunoglobulin heavy constant gamma 4 (G4m marker)" P01861 14 105620506-105626066 "FDA approved drug targets, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 2478.2" "Group enriched" "Detected in some" 10 "B-cells: 964.5;Plasma cells: 2099.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 457 "memory B-cell: 122.7;naive B-cell: 73.7" "Lineage enriched" "Detected in single" 571 "B-cells: 122.7" "Cell line enriched" "Detected in some" 6 "RPMI-8226: 339.7" HPA001245 Approved "Immunoglobulin genes" NA NA 170000000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA001245: AB_1079121" "unprognostic (7.29e-3)" "unprognostic (5.20e-2)" "unprognostic (1.32e-2)" "unprognostic (3.16e-2)" "unprognostic (1.16e-2)" "prognostic favorable (1.16e-4)" "unprognostic (4.58e-1)" "unprognostic (1.92e-2)" "unprognostic (3.49e-1)" "unprognostic (8.63e-2)" "unprognostic (4.74e-2)" "unprognostic (6.71e-2)" "prognostic unfavorable (9.09e-8)" "unprognostic (2.84e-2)" "unprognostic (4.23e-1)" "unprognostic (9.24e-2)" "unprognostic (7.72e-2)" 80.0 2.1 0.4 2478.2 0.6 42.2 5.8 0.5 1.0 33.9 0.3 40.6 85.5 10.8 0.2 401.2 28.5 101.3 19.2 0.3 0.4 44.0 43.7 49.4 136.5 0.6 0.4 3.9 4.2 0.5 1.9 0.2 1.3 31.2 44.3 0.1 16.4 4.1 0.8 4.7 186.2 1.8 1.1 831.6 57.4 2.2 0.4 49.9 108.3 0.0 872.5 588.7 29.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.0 0.3 0.0 0.0 0.0 2.7 0.0 0.5 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 43.2 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.3 0.6 339.7 0.0 0.0 3.5 3.7 0.3 0.2 0.0 0.0 0.1 0.0 1.0 0.0 0.9 0.3 1.5 0.6 0.1 57.5 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 122.7 0.0 0.0 0.1 73.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 19.6 0.4 0.6 0.5 1.0 0.3 0.4 0.6 0.4 1.3 1.1 0.4 0.3 1.3 6.4 118.8 0.0 964.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 7.0 8.6 3.7 0.0 0.0 0.0 0.3 11.5 0.0 0.0 0.2 0.0 0.4 2.5 27.8 26.7 0.0 0.0 0.0 4.3 0.0 0.0 50.4 0.0 16.4 36.7 0.0 0.0 0.0 10.5 0.0 51.9 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.3 0.0 2099.3 0.2 0.0 10.6 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 152.3 0.0 12.8 0.1 IGHG2 ENSG00000211893 "Immunoglobulin heavy constant gamma 2 (G2m marker)" P01859 14 105639559-105644790 "FDA approved drug targets, Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "lymphoid tissue: 4319.4" "Group enriched" "Detected in some" 8 "B-cells: 2050.1;Plasma cells: 2918.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 447 "memory B-cell: 339.0;naive B-cell: 119.3" "Lineage enriched" "Detected in single" 661 "B-cells: 339.0" "Group enriched" "Detected in some" 4 "RH-30: 9.6;RPMI-8226: 25.1" HPA001245 Approved "Immunoglobulin genes" NA NA 250000000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA001245: AB_1079121" "prognostic favorable (3.53e-4)" "unprognostic (6.88e-3)" "unprognostic (2.40e-2)" "unprognostic (1.55e-2)" "unprognostic (2.40e-2)" "prognostic favorable (3.30e-6)" "unprognostic (1.06e-1)" "unprognostic (6.67e-2)" "unprognostic (1.74e-1)" "unprognostic (7.59e-2)" "unprognostic (1.80e-1)" "unprognostic (1.41e-1)" "prognostic unfavorable (4.30e-8)" "unprognostic (4.72e-2)" "unprognostic (3.32e-2)" "unprognostic (1.05e-1)" "unprognostic (7.40e-2)" 109.5 11.0 1.3 170.0 1.4 34.8 56.0 0.2 4.1 59.9 0.8 202.8 7.5 55.8 0.8 90.2 51.5 20.7 15.2 0.2 1.1 157.5 98.2 171.0 65.4 0.9 0.2 16.3 8.0 0.1 8.2 0.0 0.5 64.2 9.4 0.0 201.2 1.2 3.5 13.3 330.7 1.0 1.5 4319.4 87.2 2.3 0.3 16.7 134.4 0.0 226.0 100.4 104.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 25.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.1 0.0 1.5 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.4 339.0 0.5 0.0 0.3 119.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 34.5 1.3 1.4 0.2 4.1 0.2 1.1 0.9 0.2 0.5 1.5 0.3 1.8 0.2 54.5 305.3 0.0 2050.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.9 2.8 13.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.2 4.1 0.0 32.5 0.0 0.0 0.0 3.1 0.0 0.0 126.1 0.0 8.2 5.1 0.1 0.0 0.0 0.9 0.0 12.4 0.0 0.2 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 2918.6 0.7 0.0 3.5 0.0 0.0 0.0 0.3 0.9 0.1 0.0 0.0 0.0 0.1 305.5 0.0 0.7 0.0 IGHA1 ENSG00000211895 "Immunoglobulin heavy constant alpha 1" P01876 14 105703995-105708665 "Disease related genes, Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 7411.2;lymphoid tissue: 6397.6;salivary gland: 8904.9;stomach 1: 6664.9" "Group enriched" "Detected in many" 10 "B-cells: 17763.5;Plasma cells: 34095.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 203 "memory B-cell: 2571.8;naive B-cell: 1114.6" "Lineage enriched" "Detected in many" 284 "B-cells: 2571.8" "Cell line enhanced" "Detected in many" "HDLM-2: 17.4;RPMI-8226: 34.7;SH-SY5Y: 22.3;U-266/70: 78.2;U-266/84: 24.0" "HPA001217, HPA006013" Approved "Immunoglobulin genes" NA NA 130000000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA001217: AB_1079120, HPA006013: AB_1079119" "prognostic favorable (8.87e-5)" "unprognostic (5.36e-3)" "unprognostic (2.10e-2)" "unprognostic (1.59e-2)" "unprognostic (3.75e-2)" "prognostic favorable (3.81e-5)" "unprognostic (1.17e-1)" "unprognostic (3.86e-1)" "unprognostic (2.62e-1)" "unprognostic (3.26e-2)" "unprognostic (1.66e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (1.83e-7)" "unprognostic (8.10e-2)" "unprognostic (5.08e-2)" "unprognostic (1.16e-1)" "unprognostic (2.99e-2)" 200.6 41.7 1.4 1121.1 1.0 918.5 953.5 0.7 6.5 214.3 4.2 5973.6 7411.2 79.9 3.5 641.9 203.5 662.9 73.8 0.6 1.3 278.5 327.7 1305.3 1420.6 3.5 1.1 40.6 115.1 3.5 38.3 6.7 1.1 202.5 1338.5 0.0 8904.9 69.0 10.8 56.7 3788.8 69.5 1.4 6397.6 6664.9 23.2 1.0 131.0 447.3 0.4 1949.0 1616.2 302.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.8 0.0 0.0 3.6 0.0 0.0 0.0 17.4 0.0 3.7 0.0 0.0 0.0 5.4 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.1 0.0 0.0 4.1 14.4 5.5 0.0 0.0 3.8 4.3 34.7 0.0 0.0 9.7 22.3 2.6 0.0 0.0 0.0 0.0 1.6 5.1 0.0 3.9 4.2 3.2 78.2 24.0 2.2 0.0 2.4 0.0 3.8 3.0 0.6 1.3 0.3 1.0 2571.8 0.7 1.1 1.5 1114.6 0.4 1.0 9.0 0.9 0.9 1.7 1.0 508.3 1.4 1.0 0.7 6.5 0.6 1.3 3.5 1.1 1.1 1.4 1.0 1.9 11.8 131.4 783.5 0.0 17763.5 0.0 26.0 0.0 1.2 0.0 22.4 4.6 4.7 22.8 46.4 0.0 0.0 0.7 55.5 20.8 0.0 0.0 0.0 0.1 0.1 26.5 28.4 167.0 0.0 0.0 0.5 56.5 99.4 0.1 584.8 0.0 353.8 225.1 1.6 0.0 0.0 13.6 0.0 57.8 0.0 0.0 0.0 34.6 0.0 0.0 6.7 0.0 11.3 0.0 0.0 0.0 12.8 0.0 34095.8 33.2 0.0 1.4 16.0 0.0 0.0 2.0 13.6 0.0 0.0 0.8 0.0 6.0 2514.2 0.0 27.9 1.2 IGHG1 ENSG00000211896 "Immunoglobulin heavy constant gamma 1 (G1m marker)" P01857 14 105736343-105743071 "Disease related genes, FDA approved drug targets, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 11451.9;urinary bladder: 3998.0" "Group enriched" "Detected in many" 16 "B-cells: 3900.5;Plasma cells: 9883.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "spinal cord: 12.7" "Immune cell enriched" "Detected in some" 6 "memory B-cell: 766.8" "Lineage enriched" "Detected in many" 123 "B-cells: 766.8" "Group enriched" "Detected in many" 9 "Karpas-707: 157.8;U-698: 392.7" "HPA001245, CAB008642" Supported "Immunoglobulin genes" NA NA 230000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "CAB008642: AB_1617595, HPA001245: AB_1079121" "unprognostic (6.47e-3)" "unprognostic (4.39e-3)" "unprognostic (2.91e-2)" "unprognostic (2.32e-3)" "unprognostic (1.55e-2)" "prognostic favorable (2.67e-4)" "unprognostic (3.90e-2)" "unprognostic (3.25e-1)" "unprognostic (7.52e-2)" "unprognostic (5.36e-3)" "unprognostic (8.06e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.49e-9)" "unprognostic (3.12e-1)" "unprognostic (3.52e-1)" "unprognostic (8.96e-2)" "unprognostic (7.61e-2)" 526.0 696.8 0.7 1661.1 0.6 681.1 203.2 0.5 4.5 518.2 2.8 302.1 103.7 210.6 18.4 334.4 661.5 312.9 143.2 0.4 2.2 491.7 356.1 962.4 3281.1 4.7 3.2 407.0 38.5 7.9 35.8 2.3 2.3 209.8 85.1 0.3 391.6 250.8 13.1 28.5 1008.8 27.6 12.7 11451.9 608.9 172.8 1.2 1773.7 1277.9 0.1 5826.8 3998.0 267.2 1.8 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.7 0.0 0.0 2.3 0.0 0.0 0.0 8.4 0.0 5.3 0.0 0.0 0.0 22.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 157.8 0.0 0.0 1.7 2.1 2.6 0.0 0.0 2.9 15.1 3.7 0.0 0.0 18.2 17.0 3.1 0.0 0.0 0.0 0.0 0.2 10.8 0.0 3.2 3.3 4.5 4.9 0.3 392.7 0.1 3.7 0.0 0.2 0.3 0.1 0.3 0.0 0.2 766.8 0.6 0.3 0.4 134.9 0.0 0.1 6.2 0.1 0.1 0.1 0.2 96.2 0.7 0.6 0.5 4.5 0.4 2.2 4.7 3.2 2.3 12.7 1.2 1.8 2.9 73.7 378.5 0.0 3900.5 0.0 8.1 0.0 0.0 0.0 0.5 0.0 2.8 22.8 9.3 0.0 0.0 0.0 0.4 7.0 0.0 0.0 0.5 0.0 0.1 8.5 13.9 83.4 0.0 0.0 0.0 13.6 8.2 0.0 209.4 0.0 46.1 52.9 0.1 0.0 0.0 5.0 0.0 62.8 0.0 0.9 0.0 9.7 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 5.4 0.0 9883.3 9.1 0.0 10.9 1.5 0.1 0.0 0.0 1.5 1.9 1.0 0.0 0.0 0.0 415.6 0.0 13.6 0.1 IGHG3 ENSG00000211897 "Immunoglobulin heavy constant gamma 3 (G3m marker)" 14 105764503-105771405 "Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "lymphoid tissue: 1289.1" "Group enriched" "Detected in many" 7 "B-cells: 2548.4;Plasma cells: 4543.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 415 "memory B-cell: 211.0;naive B-cell: 64.4" "Lineage enriched" "Detected in single" 636 "B-cells: 211.0" "Group enriched" "Detected in some" 5 "HDLM-2: 23.8;Karpas-707: 18.7;U-698: 49.1" "Immunoglobulin genes" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (8.49e-3)" "unprognostic (3.93e-3)" "unprognostic (1.57e-1)" "unprognostic (5.50e-2)" "unprognostic (1.71e-2)" "prognostic favorable (4.00e-5)" "unprognostic (1.92e-2)" "unprognostic (6.65e-2)" "unprognostic (2.33e-2)" "unprognostic (1.99e-2)" "unprognostic (8.36e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (8.46e-11)" "unprognostic (9.05e-2)" "unprognostic (1.18e-1)" "unprognostic (9.80e-2)" "unprognostic (6.79e-2)" 63.6 17.6 0.1 90.8 0.3 65.4 23.8 0.1 1.5 37.9 1.0 30.0 11.6 22.8 0.3 32.2 104.4 8.4 6.7 0.1 0.6 72.8 42.4 194.9 346.3 2.8 0.1 13.4 6.3 0.1 6.8 0.1 0.4 41.4 8.8 0.0 69.9 12.7 1.9 2.3 100.9 1.6 1.2 1289.1 65.4 31.7 0.1 27.1 87.6 0.0 929.0 87.3 29.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 6.0 3.9 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.1 0.0 49.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 211.0 0.0 0.0 0.0 64.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 20.7 0.1 0.3 0.1 1.5 0.1 0.6 2.8 0.1 0.4 1.2 0.1 1.0 1.9 57.7 363.7 0.0 2548.4 0.0 9.7 0.0 0.0 0.0 0.5 0.1 1.9 18.6 11.2 0.0 0.0 0.0 2.0 7.0 0.0 0.0 6.5 0.1 0.2 5.3 13.2 24.5 0.0 0.0 0.0 9.1 2.6 0.0 195.5 0.0 22.9 64.2 0.1 0.0 0.0 7.4 0.0 62.8 0.0 16.4 0.0 7.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.6 0.0 4543.8 13.3 0.0 0.5 2.2 0.0 0.0 0.0 0.7 4.7 0.7 0.0 0.0 0.0 467.3 0.0 13.5 0.1 IGHD "FLJ00382, FLJ46727, MGC29633" ENSG00000211898 "Immunoglobulin heavy constant delta" P01880 14 105836765-105845678 "Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 330.9" "Group enriched" "Detected in some" 47 "B-cells: 261.8;Plasma cells: 588.1;T-cells: 474.2" "Cancer enhanced" "Detected in many" "lung cancer: 58.7" "Not detected" "Not detected" "Group enriched" "Detected in many" 63 "memory B-cell: 279.1;naive B-cell: 815.9" "Lineage enriched" "Detected in many" 93 "B-cells: 815.9" "Group enriched" "Detected in some" 7 "Daudi: 82.3;U-698: 95.8" CAB012703 Approved "Immunoglobulin genes" NA NA 14000000000 "Cluster 21: B-cells - Adaptive immune response" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 22: Epithelial cell types - Mixed function" "CAB012703: AB_10554307" "prognostic favorable (1.49e-6)" "unprognostic (1.84e-2)" "unprognostic (3.99e-2)" "unprognostic (9.54e-2)" "unprognostic (3.06e-2)" "unprognostic (2.08e-3)" "unprognostic (4.63e-2)" "unprognostic (3.28e-1)" "unprognostic (8.18e-2)" "unprognostic (6.16e-2)" "unprognostic (1.75e-1)" "unprognostic (1.25e-1)" "unprognostic (2.13e-3)" "unprognostic (5.76e-2)" "unprognostic (2.64e-1)" "unprognostic (3.82e-3)" "unprognostic (4.30e-2)" 2.8 0.4 0.0 35.4 0.0 39.2 9.3 0.0 0.4 0.9 0.0 2.2 3.4 5.0 0.2 2.8 0.6 19.0 5.7 0.0 0.0 2.1 3.5 34.1 111.6 0.2 0.0 0.3 0.4 0.2 0.0 0.3 0.0 6.4 1.9 0.0 67.1 1.2 0.4 1.5 17.6 0.9 0.0 146.7 43.3 0.3 0.1 8.3 1.3 0.0 330.9 20.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 82.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 12.4 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 95.8 0.0 0.0 0.0 2.7 0.5 0.3 0.4 0.3 0.2 279.1 0.3 0.8 0.7 815.9 1.0 0.3 3.3 0.3 0.5 8.7 0.4 39.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 261.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.6 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.3 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 1.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.7 0.0 9.2 0.0 0.0 0.0 0.0 0.0 588.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 474.2 0.0 0.0 0.0 IGHM ENSG00000211899 "Immunoglobulin heavy constant mu" P01871 14 105851705-105856218 "Disease related genes, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 1315.0;lymphoid tissue: 4112.3" "Group enriched" "Detected in many" 14 "B-cells: 3757.1;Plasma cells: 9906.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in all" 16 "memory B-cell: 4278.4;naive B-cell: 6731.2" "Lineage enriched" "Detected in all" 19 "B-cells: 6731.2" "Group enriched" "Detected in many" 9 "Daudi: 4983.6;U-698: 4905.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" CAB008643 Uncertain "Immunoglobulin genes" NA NA 110000000000 "Cluster 21: B-cells - Adaptive immune response" "Cluster 64: Macrophages - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "CAB008643: AB_1617732" "unprognostic (2.91e-3)" "prognostic favorable (6.49e-4)" "unprognostic (9.30e-3)" "unprognostic (9.90e-3)" "unprognostic (2.05e-1)" "prognostic favorable (3.70e-6)" "unprognostic (9.61e-3)" "unprognostic (1.01e-1)" "unprognostic (1.52e-2)" "unprognostic (3.23e-3)" "unprognostic (2.46e-2)" "unprognostic (7.13e-2)" "prognostic unfavorable (5.20e-5)" "unprognostic (3.01e-1)" "unprognostic (1.76e-1)" "unprognostic (3.24e-2)" "unprognostic (6.28e-3)" 52.0 9.0 0.4 373.7 0.4 395.3 56.6 0.2 1.7 67.9 1.8 446.8 1204.9 11.1 10.2 66.8 38.5 141.7 50.5 0.2 0.4 48.4 84.7 180.6 3192.1 1.9 0.3 9.7 44.5 0.6 8.7 3.6 0.7 15.1 201.4 0.0 325.1 6.1 2.7 1.7 1315.0 7.9 1.0 4112.3 528.9 70.9 0.7 117.3 37.0 0.7 497.1 128.0 10.5 0.5 4.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 4983.6 2.9 0.0 0.0 0.8 0.0 0.0 0.0 21.6 0.0 3.0 0.0 0.0 0.0 2.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 1.7 28.7 1.2 0.0 0.0 580.2 2.2 6.9 0.0 0.0 4.0 5.8 3.0 0.5 1.2 0.0 0.2 3.8 6.5 0.0 13.8 1.2 2.5 1.5 1.5 4905.9 0.0 2.4 0.0 10.8 5.4 5.6 3.1 1.2 2.3 4278.4 5.5 6.8 5.4 6731.2 4.5 3.8 25.4 11.4 4.5 346.1 11.4 815.2 0.4 0.4 0.2 1.7 0.2 0.4 1.9 0.3 0.7 1.0 0.7 0.5 1.0 38.5 254.5 0.0 3757.1 0.0 0.2 0.0 1.2 0.0 2.2 0.8 0.3 31.5 14.2 0.0 0.0 0.0 63.8 1.8 0.0 0.0 0.0 0.0 0.1 4.2 6.7 474.1 0.0 0.0 0.0 10.8 27.5 0.0 152.6 0.0 56.7 147.9 0.1 0.0 0.0 2.2 0.0 158.1 0.0 0.0 0.0 12.4 0.0 0.0 5.2 0.0 11.3 0.0 0.0 0.0 1.2 0.0 9906.5 0.3 0.0 2.2 1.5 0.0 0.0 0.4 16.8 0.0 0.0 0.2 0.0 0.0 415.0 0.3 4.1 0.1 IGHJ6 ENSG00000211900 "Immunoglobulin heavy joining 6" 14 105863198-105863258 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "cervix: 142.4;intestine: 38.6;lung: 47.0;testis: 151.4;urinary bladder: 113.5" "Cell type enriched" "Detected in single" 56 "Plasma cells: 39.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 14 "memory B-cell: 316.2;naive B-cell: 112.7" "Lineage enriched" "Detected in many" 21 "B-cells: 316.2" "Cell line enhanced" "Detected in some" "U-266/84: 1.3;U-937: 1.2" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 71: Testis - DNA repair" "Cluster 16: U-266 - Nucleosome" "Cluster 55: Plasma cells - Humoral immune response" 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.1 0.9 142.4 0.0 2.6 38.6 1.0 0.0 0.0 2.1 0.5 0.9 0.3 0.0 3.0 2.4 47.0 0.4 0.4 0.1 0.0 0.0 3.7 0.0 0.0 0.3 3.6 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.6 0.7 151.4 0.3 0.0 0.7 0.0 10.7 113.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.2 0.0 3.5 3.5 0.8 0.3 0.0 0.2 316.2 0.5 0.6 0.5 112.7 0.6 0.3 14.8 0.2 1.0 0.0 0.1 89.2 0.0 0.0 0.1 0.9 0.3 0.0 0.4 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHJ5 ENSG00000242472 "Immunoglobulin heavy joining 5" 14 105863814-105863862 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 33.5;breast: 73.2;intestine: 72.3;prostate: 32.7" "Cell type enriched" "Detected in single" 397 "Plasma cells: 39.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 263 "memory B-cell: 1081.0" "Lineage enriched" "Detected in many" 263 "B-cells: 1081.0" "Group enriched" "Detected in some" 11 "HL-60: 10.5;REH: 14.0;RH-30: 18.0" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 85: Liver - Metabolism" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 55: Plasma cells - Humoral immune response" 33.5 0.0 0.7 0.0 3.7 0.0 73.2 0.7 2.0 0.0 2.0 72.3 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.9 4.2 4.5 29.4 17.1 0.0 3.1 1.0 0.0 4.7 0.0 0.0 0.0 1.9 32.7 0.2 0.2 0.0 0.0 0.0 7.9 0.0 0.0 1.6 0.0 0.0 0.4 1.3 0.0 4.8 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.6 2.1 1.2 0.7 1081.0 0.4 0.6 4.1 0.0 2.6 0.9 2.3 0.7 0.6 0.0 1.1 316.0 0.7 3.7 0.7 2.0 0.9 4.2 3.1 1.0 1.9 1.6 1.3 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHJ4 ENSG00000240041 "Immunoglobulin heavy joining 4" 14 105864215-105864260 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 416.7;lymphoid tissue: 1568.0;urinary bladder: 551.2" "Cell type enriched" "Detected in single" 148 "Plasma cells: 103.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 187 "memory B-cell: 6029.7;naive B-cell: 2618.0" "Lineage enriched" "Detected in all" 261 "B-cells: 6029.7" "Cell line enriched" "Detected in some" 87 "U-698: 3990.3" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" 0.0 0.0 7.2 0.0 2.9 0.0 240.0 0.9 10.8 0.0 3.6 377.5 0.0 0.0 0.0 200.2 7.4 4.1 12.3 0.9 2.5 0.0 39.1 0.0 0.0 8.9 30.7 0.0 0.0 13.6 0.0 2.5 22.3 7.0 416.7 0.0 0.0 0.0 0.0 20.7 0.0 0.0 2.0 45.4 7.3 3.7 3.1 32.3 3.9 0.0 1568.0 551.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 19.9 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 14.0 17.5 0.0 0.0 0.0 0.0 6.8 3.6 0.0 0.0 0.0 0.0 0.0 8.9 0.0 45.8 0.0 0.0 6.2 0.0 3990.3 0.0 12.2 0.0 13.9 3.6 5.4 5.0 1.3 3.0 6029.7 13.2 4.0 23.1 2618.0 1.5 6.0 20.1 3.3 6.0 0.0 6.6 1048.2 7.2 2.9 0.9 10.8 0.9 2.5 8.9 30.7 22.3 2.0 3.1 1.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHJ3 ENSG00000242887 "Immunoglobulin heavy joining 3" 14 105864587-105864635 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 36.4;intestine: 57.9;pancreas: 61.6" "Cell type enriched" "Detected in single" 48 "Plasma cells: 24.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "basophil: 9.0;naive B-cell: 29.1" "Group enriched" "Detected in many" 7 "B-cells: 29.1;granulocytes: 9.0" "Cell line enhanced" "Detected in some" "Daudi: 1.5;RPMI-8226: 6.1;TIME: 8.0;U-251 MG: 2.6" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (8.67e-4)" "unprognostic (8.67e-3)" "unprognostic (1.12e-1)" "unprognostic (2.42e-2)" "prognostic favorable (3.86e-5)" "unprognostic (3.12e-1)" "unprognostic (2.21e-1)" "unprognostic (2.82e-1)" "unprognostic (4.22e-2)" "unprognostic (2.03e-1)" "unprognostic (5.70e-2)" "prognostic unfavorable (3.24e-4)" "unprognostic (8.47e-2)" "unprognostic (2.54e-1)" "unprognostic (9.62e-2)" "unprognostic (1.30e-1)" 16.2 3.0 0.6 0.0 0.9 0.0 0.0 0.2 2.5 1.9 0.5 0.0 0.0 0.0 0.0 36.4 0.7 9.1 0.0 0.6 0.9 0.9 10.2 17.3 0.0 1.5 0.4 11.3 61.6 0.0 0.0 0.0 1.7 7.5 57.9 0.1 0.0 4.3 0.0 2.4 0.0 0.0 1.4 0.0 0.0 0.3 0.7 0.0 2.4 0.0 0.0 5.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.4 0.2 0.0 0.9 0.0 0.7 1.1 2.6 29.1 1.5 1.2 0.0 0.4 0.7 0.0 1.2 0.0 0.6 0.9 0.2 2.5 0.6 0.9 1.5 0.4 1.7 1.4 0.7 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 IGHJ2 ENSG00000211904 "Immunoglobulin heavy joining 2" 14 105865199-105865250 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "cervix: 48.7;intestine: 127.5;lymphoid tissue: 174.5" "Cell type enriched" "Detected in single" 6 "Plasma cells: 3.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "medulla oblongata: 3.8" "Group enriched" "Detected in some" 18 "MAIT T-cell: 49.0;naive B-cell: 12.6" "Group enriched" "Detected in many" 45 "B-cells: 12.6;T-cells: 49.0" "Group enriched" "Detected in some" 25 "Daudi: 3.8;K-562: 1.1" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.03e-3)" "unprognostic (2.87e-2)" "unprognostic (1.81e-2)" "unprognostic (1.27e-2)" "prognostic favorable (1.05e-4)" "unprognostic (7.40e-2)" "unprognostic (6.38e-2)" "unprognostic (1.82e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (5.33e-6)" "unprognostic (4.31e-2)" "unprognostic (1.68e-1)" "unprognostic (5.48e-2)" "unprognostic (4.60e-1)" 2.0 0.0 0.2 0.0 0.5 13.3 20.5 0.2 2.0 48.7 0.1 87.2 0.0 5.4 17.9 18.0 2.1 0.8 0.1 0.2 0.4 1.2 12.0 0.0 7.6 3.8 0.8 7.7 18.9 0.6 0.0 0.0 0.5 15.0 127.5 0.0 0.0 7.1 0.0 0.0 0.0 5.8 0.6 18.8 18.2 0.1 0.5 19.6 5.1 0.0 174.5 6.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 49.0 1.3 0.4 1.6 0.4 12.6 0.0 0.2 0.2 0.0 0.6 0.0 0.0 17.1 0.2 0.5 0.2 2.0 0.2 0.4 3.8 0.8 0.5 0.6 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHJ1 ENSG00000211905 "Immunoglobulin heavy joining 1" A0A0C4DH62 14 105865407-105865458 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "intestine: 354.8;lymphoid tissue: 414.0;salivary gland: 120.1;stomach 1: 305.5" "Cell type enriched" "Detected in single" 18 "Plasma cells: 1.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebral cortex: 1.9" "Group enriched" "Detected in some" 72 "memory B-cell: 276.3;naive B-cell: 180.8;plasmacytoid DC: 99.0" "Group enriched" "Detected in many" 73 "B-cells: 276.3;dendritic cells: 99.0" "Cell line enhanced" "Detected in some" "SCLC-21H: 2.7;U-698: 1.8" "Immunoglobulin genes" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (5.28e-3)" "unprognostic (2.05e-2)" "unprognostic (6.81e-2)" "unprognostic (9.53e-2)" "prognostic favorable (3.55e-4)" "unprognostic (2.51e-1)" "unprognostic (2.45e-1)" "unprognostic (3.00e-2)" "unprognostic (2.90e-2)" 8.6 5.3 0.1 196.9 0.1 35.6 72.8 0.0 1.9 18.6 0.2 260.2 354.8 3.3 0.0 15.7 5.2 12.6 1.4 0.1 0.1 2.3 6.1 28.5 46.8 1.3 0.0 8.2 3.1 0.4 0.0 0.7 0.5 4.3 182.6 0.0 120.1 0.5 0.0 0.0 171.1 12.0 0.3 100.2 305.5 1.0 0.2 14.6 2.9 0.0 414.0 61.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.0 0.2 276.3 0.6 2.5 0.2 180.8 0.3 0.3 0.0 0.1 0.1 99.0 0.2 29.1 0.1 0.1 0.0 1.9 0.1 0.1 1.3 0.0 0.5 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD7-27 "DHQ52, IGHD727" ENSG00000236597 "Immunoglobulin heavy diversity 7-27" 14 105865551-105865561 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 4 "endometrial cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD1-26 IGHD126 ENSG00000211907 "Immunoglobulin heavy diversity 1-26" 14 105881034-105881053 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD6-25 IGHD625 ENSG00000225825 "Immunoglobulin heavy diversity 6-25" 14 105881539-105881556 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.69e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD5-24 IGHD524 ENSG00000211909 "Immunoglobulin heavy diversity 5-24 (non-functional)" 14 105883903-105883922 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD4-23 IGHD423 ENSG00000227196 "Immunoglobulin heavy diversity 4-23 (non-functional)" 14 105884870-105884888 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD3-22 IGHD322 ENSG00000211911 "Immunoglobulin heavy diversity 3-22" 14 105886031-105886061 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 1.6;lymphoid tissue: 2.7;stomach 1: 3.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 5 "naive B-cell: 48.9" "Lineage enriched" "Detected in many" 7 "B-cells: 48.9" "Cell line enriched" "Detected in single" 13 "SH-SY5Y: 1.3" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 13: SH-SY5Y - Nervous system development" "unprognostic (4.12e-1)" "unprognostic (1.53e-1)" 0.0 0.0 0.1 0.9 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 1.2 3.1 0.0 0.0 0.7 0.0 0.0 2.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 48.9 0.0 0.0 6.9 0.0 0.0 0.0 0.0 8.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD2-21 IGHD221 ENSG00000211912 "Immunoglobulin heavy diversity 2-21" 14 105888551-105888578 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD1-20 IGHD120 ENSG00000237020 "Immunoglobulin heavy diversity 1-20" 14 105891191-105891207 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD6-19 IGHD619 ENSG00000211914 "Immunoglobulin heavy diversity 6-19" 14 105891699-105891719 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD5-18 IGHD518 ENSG00000211915 "Immunoglobulin heavy diversity 5-18" 14 105893542-105893561 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD4-17 IGHD417 ENSG00000227800 "Immunoglobulin heavy diversity 4-17" 14 105894508-105894523 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "cervical cancer: 7.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD3-16 IGHD316 ENSG00000211917 "Immunoglobulin heavy diversity 3-16" 14 105895634-105895670 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "bone marrow: 4.0;intestine: 2.6;lymphoid tissue: 4.1" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 7 "naive B-cell: 27.0" "Lineage enriched" "Detected in many" 12 "B-cells: 27.0" "Group enriched" "Detected in some" 16 "HEL: 2.4;HMC-1: 1.3;NB-4: 1.0" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" 0.0 0.0 0.0 1.7 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.8 0.0 0.0 0.0 2.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 27.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD2-15 "D2, IGHD215" ENSG00000211918 "Immunoglobulin heavy diversity 2-15" 14 105897957-105897987 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "bone marrow: 2.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "endometrial cancer: 3.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 8 "naive B-cell: 39.9" "Lineage enriched" "Detected in single" 400 "B-cells: 39.9" "Cell line enriched" "Detected in single" 28 "HEL: 2.7" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 36: HEL - Hemostasis" 0.2 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 39.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD1-14 "DM2, IGHD114" ENSG00000227108 "Immunoglobulin heavy diversity 1-14 (non-functional)" 14 105900638-105900654 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD6-13 "DN1, IGHD613" ENSG00000211920 "Immunoglobulin heavy diversity 6-13" 14 105901142-105901162 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD5-12 "DK1, IGHD512" ENSG00000211921 "Immunoglobulin heavy diversity 5-12" 14 105902649-105902671 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "stomach cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD4-11 "DA1, IGHD411" ENSG00000232543 "Immunoglobulin heavy diversity 4-11 (non-functional)" 14 105903616-105903631 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD3-10 "DXP'1, IGHD310" ENSG00000211923 "Immunoglobulin heavy diversity 3-10" 14 105904497-105904527 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "bone marrow: 1.3;intestine: 3.7;lymphoid tissue: 4.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "cervical cancer: 5.2" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 7 "naive B-cell: 5.4" "Lineage enriched" "Detected in single" 55 "B-cells: 5.4" "Cell line enriched" "Detected in single" 12 "NB-4: 1.1" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" 0.0 0.0 0.0 1.1 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 4.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD3-9 "DXP1, IGHD39" ENSG00000211924 "Immunoglobulin heavy diversity 3-9" 14 105904681-105904711 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 11.9;stomach 1: 4.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 214 "memory B-cell: 8.9;naive B-cell: 33.8" "Lineage enriched" "Detected in single" 339 "B-cells: 33.8" "Cell line enriched" "Detected in some" 5 "HEL: 5.5" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 16: Immune cells - Immune response" "Cluster 36: HEL - Hemostasis" "unprognostic (1.74e-1)" "unprognostic (1.50e-1)" "unprognostic (9.31e-2)" 0.0 0.0 0.0 2.8 0.0 0.5 0.0 0.0 0.1 0.0 0.0 2.1 1.6 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.9 0.4 0.0 0.0 2.0 0.0 0.1 2.8 4.8 0.0 0.1 2.2 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 33.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD2-8 "DLR1, IGHD28" ENSG00000211925 "Immunoglobulin heavy diversity 2-8" 14 105907211-105907241 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.7;lymphoid tissue: 1.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 33 "naive B-cell: 3.2" "Lineage enriched" "Detected in single" 33 "B-cells: 3.2" "Not detected" "Not detected" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 40: Neutrophils - Inflammatory response" 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD1-7 "DM1, IGHD17" ENSG00000237197 "Immunoglobulin heavy diversity 1-7" 14 105909907-105909923 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD6-6 "D(N4), IGHD66" ENSG00000228131 "Immunoglobulin heavy diversity 6-6" 14 105910410-105910427 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD5-5 "DK4, IGHD55" ENSG00000211928 "Immunoglobulin heavy diversity 5-5" 14 105912257-105912276 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD4-4 "DA4, IGHD44" ENSG00000233655 "Immunoglobulin heavy diversity 4-4" 14 105913222-105913237 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD3-3 "DXP4, IGHD33" ENSG00000211930 "Immunoglobulin heavy diversity 3-3" 14 105914359-105914389 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 4.3;lymphoid tissue: 2.6;salivary gland: 3.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 5 "naive B-cell: 62.6" "Lineage enriched" "Detected in single" 626 "B-cells: 62.6" "Group enriched" "Detected in some" 48 "NB-4: 6.9;SH-SY5Y: 2.6" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 24: NB-4 - Immune response" "unprognostic (1.34e-1)" "unprognostic (1.69e-1)" "unprognostic (3.13e-1)" "unprognostic (1.75e-1)" 0.0 0.0 0.0 0.9 0.1 4.3 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.5 0.0 0.0 0.0 1.0 0.0 0.0 1.9 1.6 0.1 0.0 0.1 0.0 0.0 0.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 62.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD2-2 IGHD22 ENSG00000211931 "Immunoglobulin heavy diversity 2-2" 14 105916826-105916856 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 14 "bone marrow: 2.9;intestine: 2.5;lymphoid tissue: 2.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "naive B-cell: 3.0" "Lineage enriched" "Detected in single" 31 "B-cells: 3.0" "Cell line enriched" "Detected in single" 23 "NB-4: 2.3" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 2: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "unprognostic (3.23e-3)" "unprognostic (1.40e-1)" 0.0 0.0 0.0 0.9 0.0 2.9 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 2.1 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD1-1 IGHD11 ENSG00000236170 "Immunoglobulin heavy diversity 1-1" P0DOY5 14 105919502-105919518 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV6-1 ENSG00000211933 "Immunoglobulin heavy variable 6-1" A0A0B4J1U7 14 105939756-105940253 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 441.3;lymphoid tissue: 159.0" "Cell type enriched" "Detected in some" 175 "Plasma cells: 2295.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 6 "naive B-cell: 19.7" "Lineage enriched" "Detected in single" 53 "B-cells: 19.7" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 930000000 "Cluster 24: B-cells - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (1.35e-4)" "unprognostic (9.66e-2)" "unprognostic (4.55e-3)" "unprognostic (1.26e-1)" "prognostic favorable (1.85e-5)" "unprognostic (1.84e-1)" "unprognostic (2.13e-2)" "unprognostic (1.89e-3)" "unprognostic (1.41e-1)" "unprognostic (3.95e-1)" "prognostic unfavorable (2.48e-6)" "unprognostic (3.69e-2)" "unprognostic (6.93e-2)" "unprognostic (1.70e-1)" "unprognostic (1.30e-1)" 13.0 2.1 0.3 0.0 0.1 0.0 7.5 0.0 0.4 4.2 0.2 441.3 0.0 1.2 0.0 17.9 4.3 1.5 2.7 0.0 0.1 3.2 6.2 13.6 0.0 0.3 0.1 0.9 11.5 0.0 0.3 0.0 0.1 1.6 0.0 0.0 56.7 8.6 0.1 2.0 40.9 11.2 0.3 159.0 19.5 0.3 0.2 0.0 6.8 0.0 0.0 3.7 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.7 0.7 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.1 19.7 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.0 0.1 0.3 0.1 0.1 0.3 0.2 0.2 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.1 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2295.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 IGHV1-2 V35 ENSG00000211934 "Immunoglobulin heavy variable 1-2" P23083 14 105986582-105987083 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 462.7;lymphoid tissue: 1157.3" "Cell type enriched" "Detected in some" 38 "Plasma cells: 609.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 52 "memory B-cell: 285.2;naive B-cell: 347.4" "Lineage enriched" "Detected in many" 57 "B-cells: 347.4" "Cell line enriched" "Detected in some" 8 "U-266/70: 14302.7" "Immunoglobulin genes" NA NA 4000000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.63e-3)" "unprognostic (1.09e-3)" "unprognostic (1.88e-1)" "unprognostic (9.46e-2)" "unprognostic (5.78e-2)" "prognostic favorable (1.67e-5)" "unprognostic (9.05e-2)" "unprognostic (1.10e-1)" "unprognostic (1.38e-1)" "unprognostic (2.37e-1)" "unprognostic (1.99e-1)" "unprognostic (4.20e-2)" "prognostic unfavorable (2.02e-4)" "unprognostic (2.17e-2)" "unprognostic (8.59e-2)" "unprognostic (3.19e-1)" "unprognostic (1.17e-2)" 16.7 43.1 0.3 364.1 0.2 76.0 84.1 0.0 1.2 41.5 0.5 462.7 223.7 13.1 1.3 34.5 58.5 54.4 26.2 0.0 0.1 13.7 18.9 60.7 404.9 0.4 0.0 36.5 3.0 0.6 1.3 0.6 0.2 23.2 283.8 0.0 222.4 52.5 0.4 4.5 121.9 7.5 0.2 393.2 216.1 35.0 0.1 72.1 33.7 0.0 1157.3 255.5 8.9 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 4.3 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.8 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 2.6 0.0 0.0 2.3 0.4 2.8 0.0 0.0 3.1 0.6 0.5 0.0 0.0 1.3 1.8 0.1 0.0 0.6 0.0 0.0 0.2 0.3 0.0 1.5 0.0 1.3 14302.7 1755.5 0.5 0.0 0.4 0.0 0.3 0.6 0.1 0.3 0.0 0.2 285.2 1.6 0.7 0.2 347.4 1.5 0.6 6.1 0.2 0.3 0.5 1.1 34.0 0.3 0.2 0.0 1.2 0.0 0.1 0.4 0.0 0.2 0.2 0.1 0.6 0.0 0.0 1.3 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 4.6 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 609.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 IGHV1-3 VI-3B ENSG00000211935 "Immunoglobulin heavy variable 1-3" A0A0C4DH29 14 106005095-106005574 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 223.2;lymphoid tissue: 629.4" "Cell type enriched" "Detected in some" 335 "Plasma cells: 13473.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "memory B-cell: 52.8;naive B-cell: 27.8" "Lineage enriched" "Detected in many" 9 "B-cells: 52.8" "Cell line enriched" "Detected in some" 11 "Karpas-707: 148.5" "Immunoglobulin genes" NA NA 2600000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.39e-2)" "unprognostic (3.81e-3)" "unprognostic (2.96e-2)" "unprognostic (4.93e-2)" "unprognostic (7.41e-3)" "unprognostic (2.42e-1)" "unprognostic (7.85e-2)" "unprognostic (5.60e-2)" "unprognostic (3.07e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (5.67e-7)" "unprognostic (7.02e-2)" "unprognostic (4.31e-1)" "unprognostic (1.75e-1)" "unprognostic (3.26e-1)" 10.6 59.3 0.0 207.8 0.0 36.4 46.7 0.0 0.5 41.6 0.3 193.3 218.5 4.8 15.3 45.5 6.5 85.4 3.2 0.0 0.1 8.2 8.9 40.9 171.8 0.2 0.0 8.4 7.0 0.3 0.6 0.1 0.1 6.0 223.2 0.0 120.6 23.5 0.6 0.9 140.9 11.2 0.0 246.6 189.1 0.4 0.1 57.8 24.2 0.0 629.4 92.1 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 14.1 1.0 148.5 0.0 0.0 0.8 1.1 0.1 0.0 0.0 0.0 0.7 0.7 0.0 0.0 10.0 8.9 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.7 0.0 2.8 1.4 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 52.8 0.6 0.2 0.0 27.8 1.6 0.5 0.0 0.0 0.0 5.8 1.7 6.1 0.0 0.0 0.0 0.5 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 40.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13473.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 4.5 0.0 0.0 0.0 IGHV4-4 ENSG00000276775 "Immunoglobulin heavy variable 4-4" A0A075B6R2 14 106011922-106012420 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 567.7;urinary bladder: 768.4" "Cell type enriched" "Detected in some" 285 "Plasma cells: 2624.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 10 "midbrain: 4.8" "Group enriched" "Detected in some" 23 "memory B-cell: 56.6;naive B-cell: 31.2" "Lineage enriched" "Detected in many" 30 "B-cells: 56.6" "Cell line enriched" "Detected in some" 18 "Karpas-707: 34.5" "Immunoglobulin genes" NA NA 3800000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.03e-3)" "unprognostic (1.93e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.60e-6)" "unprognostic (2.24e-1)" "unprognostic (6.27e-2)" "unprognostic (1.30e-1)" "unprognostic (2.10e-1)" "unprognostic (7.45e-2)" "prognostic unfavorable (1.69e-5)" "unprognostic (3.16e-1)" "unprognostic (2.59e-1)" "unprognostic (1.55e-1)" "unprognostic (2.05e-1)" 9.4 2.5 0.0 131.4 0.0 17.8 63.6 0.0 0.2 37.5 0.1 205.2 159.9 3.8 0.8 59.8 53.4 104.9 0.9 0.0 0.1 5.5 6.6 36.9 173.2 0.3 4.8 10.0 6.0 0.4 0.4 0.0 0.1 4.0 140.2 0.0 78.2 15.0 0.3 3.8 78.6 13.4 0.4 186.4 175.0 1.6 0.1 31.8 16.7 0.0 567.7 768.4 5.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.5 34.5 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 56.6 0.2 0.2 0.0 31.2 0.6 0.0 0.0 0.0 0.0 1.9 0.6 4.1 0.0 0.0 0.0 0.2 0.0 0.1 0.3 4.8 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2624.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 IGHV7-4-1 ENSG00000282122 "Immunoglobulin heavy variable 7-4-1" A0A0J9YVY3 14 106025145-106025630 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 97.4;lymphoid tissue: 133.9" "Cell type enriched" "Detected in some" 4 "Plasma cells: 4.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 109 "memory B-cell: 8.3;naive B-cell: 13.5" "Lineage enriched" "Detected in single" 136 "B-cells: 13.5" "Cell line enriched" "Detected in some" 5 "Karpas-707: 5.4" "Immunoglobulin genes" NA NA 560000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 50: Fibroblasts - ECM organization" 3.9 2.9 0.3 58.3 0.0 39.0 21.1 0.0 0.6 7.7 0.2 60.8 8.3 0.5 0.0 4.7 0.8 3.1 0.8 0.0 0.0 2.1 2.8 49.1 7.5 0.0 0.0 0.9 0.7 0.0 0.2 0.0 0.0 2.6 97.4 0.0 42.2 8.7 0.3 0.2 42.9 0.2 0.1 68.5 24.2 0.2 0.0 45.6 5.9 0.0 133.9 10.4 2.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV2-5 ENSG00000211937 "Immunoglobulin heavy variable 2-5" P01817 14 106037902-106038365 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 465.8;lymphoid tissue: 1426.6;stomach 1: 707.9" "Cell type enriched" "Detected in some" 333 "Plasma cells: 9414.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "memory B-cell: 66.7;naive B-cell: 67.3" "Lineage enriched" "Detected in many" 22 "B-cells: 67.3" "Cell line enriched" "Detected in some" 5 "Karpas-707: 8.8" "Immunoglobulin genes" NA NA 700000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.38e-2)" "unprognostic (4.10e-3)" "unprognostic (2.51e-2)" "unprognostic (6.62e-3)" "prognostic favorable (1.41e-4)" "unprognostic (1.66e-1)" "unprognostic (1.35e-1)" "unprognostic (3.63e-1)" "unprognostic (1.47e-1)" "unprognostic (8.45e-2)" "unprognostic (3.38e-1)" "prognostic unfavorable (2.09e-6)" "unprognostic (2.74e-2)" "unprognostic (1.69e-1)" "unprognostic (4.15e-1)" "unprognostic (1.56e-1)" 16.9 5.0 0.0 183.0 0.2 112.8 106.0 0.0 0.5 45.0 0.2 465.8 266.6 7.5 2.5 27.9 10.7 65.0 5.8 0.0 0.1 20.9 16.4 83.9 188.0 0.5 0.2 13.8 9.3 1.0 1.1 0.3 0.7 9.4 296.3 0.0 201.4 8.8 0.4 2.9 177.0 17.4 0.3 351.0 707.9 2.3 0.0 121.5 27.6 0.0 1426.6 249.3 12.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.8 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 1.6 0.4 0.0 0.1 1.2 1.8 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.4 0.6 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 66.7 0.0 0.0 0.1 67.3 0.1 0.1 3.0 0.0 0.0 0.0 0.0 10.5 0.0 0.2 0.0 0.5 0.0 0.1 0.5 0.2 0.7 0.3 0.0 0.4 0.0 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.1 27.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9414.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 IGHV3-7 ENSG00000211938 "Immunoglobulin heavy variable 3-7" P01780 14 106062151-106062683 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 461.3;lymphoid tissue: 971.3" "Cell type enriched" "Detected in some" 255 "Plasma cells: 20463.1" "Cancer enhanced" "Detected in many" "stomach cancer: 18.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 147 "memory B-cell: 134.0;naive B-cell: 107.0" "Lineage enriched" "Detected in single" 163 "B-cells: 134.0" "Cell line enhanced" "Detected in some" "Daudi: 7.6;HL-60: 3.1;K-562: 3.0;NB-4: 3.0;RPMI-8226: 5.8;SH-SY5Y: 4.8;TIME: 2.9" "Immunoglobulin genes" NA NA 39000000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.29e-2)" "unprognostic (5.57e-3)" "unprognostic (1.37e-2)" "prognostic favorable (1.47e-6)" "unprognostic (1.00e-2)" "unprognostic (2.74e-1)" "unprognostic (1.28e-1)" "unprognostic (5.46e-2)" "unprognostic (1.37e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (4.35e-5)" "unprognostic (5.18e-2)" "unprognostic (8.50e-2)" "unprognostic (1.63e-1)" "unprognostic (7.70e-2)" 47.8 10.1 0.7 50.1 1.0 71.1 202.7 0.3 0.8 87.4 0.6 461.3 154.1 37.7 8.2 17.8 13.4 37.0 2.2 0.2 0.4 17.6 20.3 56.4 102.5 1.6 2.8 24.7 4.8 2.9 1.8 0.3 2.3 9.2 303.5 0.0 265.5 22.9 1.3 9.6 206.0 3.6 3.9 610.4 230.4 13.2 0.4 0.0 21.1 0.1 971.3 42.9 14.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 3.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.0 0.0 0.0 0.0 0.0 3.0 0.5 0.0 0.0 0.4 2.6 5.8 0.0 0.0 2.3 4.8 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.7 0.0 1.2 1.6 0.0 0.1 0.0 0.6 0.0 0.4 0.8 0.2 0.1 0.0 0.2 134.0 0.2 0.2 0.3 107.0 0.1 0.1 0.1 0.1 0.2 0.6 0.2 12.6 0.7 1.0 0.3 0.8 0.2 0.4 1.6 2.8 2.3 3.9 0.4 1.3 0.0 0.0 0.0 0.0 80.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 30.5 0.0 5.3 0.0 0.0 0.0 4.4 31.1 0.0 0.0 0.0 2.2 1.9 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20463.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.0 0.0 0.0 7.4 0.0 0.5 0.0 IGHV3-64D ENSG00000282639 "Immunoglobulin heavy variable 3-64D" A0A0J9YX35 14 106088122-106088573 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 145.2;lymphoid tissue: 272.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 301 "memory B-cell: 43.3;naive B-cell: 18.7" "Lineage enriched" "Detected in single" 420 "B-cells: 43.3" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 2500000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 7: Non-specific - Mitochondria" 8.3 0.5 0.2 140.3 0.1 10.9 84.2 0.0 0.8 12.9 0.3 130.9 20.4 3.3 1.4 35.4 7.8 46.3 4.8 0.5 0.0 1.5 4.2 36.7 48.8 0.1 0.0 5.1 8.1 0.1 0.1 0.1 0.0 4.1 145.2 0.0 28.9 11.5 0.0 3.8 68.8 3.6 0.1 67.4 74.8 0.5 0.0 16.5 2.9 0.0 272.7 40.5 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.3 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.7 0.2 0.1 0.0 0.8 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV5-10-1 IGHV5-A ENSG00000282651 "Immunoglobulin heavy variable 5-10-1" A0A0J9YXX1 14 106107972-106108464 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 316.6;lymphoid tissue: 568.1" "Cell type enriched" "Detected in single" 36 "B-cells: 3.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "memory B-cell: 74.8;naive B-cell: 66.7" "Lineage enriched" "Detected in many" 16 "B-cells: 74.8" "Group enriched" "Detected in some" 6 "Daudi: 9.4;U-698: 4.8" HPA006014 Approved "Immunoglobulin genes" NA NA 1200000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "HPA006014: " 4.5 28.4 0.0 229.8 0.0 38.7 102.0 0.0 0.9 68.9 0.1 274.0 0.9 10.8 0.0 111.5 20.0 92.5 6.2 0.0 0.0 5.5 7.3 128.3 121.2 0.1 0.0 54.0 5.7 0.4 0.3 0.2 0.2 6.9 316.6 0.0 75.5 19.0 0.1 1.6 51.6 10.9 0.0 203.8 148.3 0.1 0.0 39.3 7.3 0.0 568.1 196.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.4 0.0 4.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.8 0.0 0.0 0.0 66.7 0.0 0.0 4.6 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV3-11 ENSG00000211941 "Immunoglobulin heavy variable 3-11" P01762 14 106116635-106117204 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 220.1;lymphoid tissue: 613.1;stomach 1: 206.7" "Cell type enriched" "Detected in some" 142 "Plasma cells: 1655.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 445 "memory B-cell: 43.1;naive B-cell: 45.7" "Lineage enriched" "Detected in single" 458 "B-cells: 45.7" "Cell line enhanced" "Detected in some" "Daudi: 1.1;SH-SY5Y: 1.2" "Immunoglobulin genes" NA NA 18000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (2.07e-3)" "unprognostic (4.84e-2)" "unprognostic (5.81e-3)" "unprognostic (1.07e-2)" "unprognostic (1.04e-2)" "prognostic favorable (3.42e-5)" "unprognostic (4.12e-1)" "unprognostic (6.50e-2)" "unprognostic (2.37e-1)" "unprognostic (3.44e-2)" "unprognostic (3.51e-1)" "unprognostic (2.83e-1)" "prognostic unfavorable (1.52e-5)" "unprognostic (1.43e-1)" "unprognostic (2.97e-1)" "unprognostic (1.86e-1)" "unprognostic (1.30e-1)" 9.3 25.9 0.0 175.0 0.0 38.0 66.0 0.0 0.5 34.7 0.2 220.1 193.4 6.8 12.3 38.6 6.6 43.7 8.6 0.0 0.0 6.8 10.5 29.1 123.7 0.8 0.0 7.8 2.0 0.2 0.8 0.0 0.1 4.0 167.9 0.0 119.7 3.7 0.3 0.7 116.8 11.2 0.1 219.2 206.7 1.3 0.4 44.9 17.0 0.0 613.1 109.4 8.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.7 0.7 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.1 0.0 0.0 0.0 45.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.6 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1655.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 IGHV3-13 ENSG00000211942 "Immunoglobulin heavy variable 3-13" P01766 14 106129540-106130072 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 67.5;lymphoid tissue: 137.3;urinary bladder: 90.5" "Group enriched" "Detected in some" 6 "B-cells: 6.7;Plasma cells: 13.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 193 "memory B-cell: 18.8;naive B-cell: 19.6" "Lineage enriched" "Detected in single" 197 "B-cells: 19.6" "Cell line enhanced" "Detected in some" "MOLT-4: 1.8;U-266/70: 1.0" "Immunoglobulin genes" NA NA 33000000000 "Cluster 21: B-cells - Adaptive immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 57: B-cells - Immune response" "prognostic favorable (3.24e-4)" "unprognostic (7.42e-2)" "unprognostic (1.96e-2)" "unprognostic (5.03e-2)" "prognostic favorable (6.67e-6)" "unprognostic (5.44e-2)" "unprognostic (1.23e-2)" "unprognostic (1.53e-1)" "unprognostic (5.31e-2)" "unprognostic (8.27e-2)" "unprognostic (2.45e-1)" "prognostic unfavorable (7.21e-5)" "unprognostic (6.79e-2)" "unprognostic (3.21e-1)" "unprognostic (4.45e-1)" "unprognostic (7.87e-2)" 1.3 36.6 0.0 24.1 0.0 6.9 17.2 0.0 0.1 1.9 0.0 67.5 49.5 1.5 0.0 15.4 4.3 9.7 1.8 0.0 0.0 1.1 1.5 7.2 39.5 0.0 0.1 1.5 0.7 0.0 0.1 0.0 0.0 1.1 36.1 0.0 30.9 1.4 0.0 0.1 22.8 5.6 0.1 56.5 42.9 0.9 0.0 9.3 2.8 0.0 137.3 90.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 IGHV3-15 ENSG00000211943 "Immunoglobulin heavy variable 3-15" A0A0B4J1V0 14 106153624-106154163 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 183.3;lymphoid tissue: 380.2;salivary gland: 177.7;stomach 1: 112.8;urinary bladder: 172.6" "Cell type enriched" "Detected in some" 112 "Plasma cells: 6281.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 9 "MAIT T-cell: 21.6;memory B-cell: 24.4" "Group enriched" "Detected in many" 9 "B-cells: 24.4;T-cells: 21.6" "Cell line enhanced" "Detected in some" "BEWO: 2.2;Daudi: 1.9;HL-60: 2.1;K-562: 2.0;NB-4: 2.4;RH-30: 1.9;RPMI-8226: 4.1;SH-SY5Y: 3.7" "Immunoglobulin genes" NA NA 20000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (8.85e-5)" "unprognostic (2.07e-1)" "unprognostic (1.94e-2)" "unprognostic (1.41e-2)" "unprognostic (1.62e-2)" "prognostic favorable (3.34e-5)" "unprognostic (5.20e-2)" "unprognostic (2.44e-1)" "unprognostic (9.67e-2)" "unprognostic (3.24e-2)" "unprognostic (2.53e-1)" "unprognostic (2.19e-1)" "prognostic unfavorable (1.49e-7)" "unprognostic (6.85e-2)" "unprognostic (6.92e-2)" "unprognostic (7.12e-2)" "unprognostic (3.63e-1)" 12.2 36.8 0.0 24.7 0.5 1.8 23.2 0.0 1.2 13.0 0.1 183.3 4.5 5.0 0.9 11.7 16.3 29.6 1.4 0.0 0.2 9.1 10.6 40.0 0.0 1.0 0.0 5.8 19.1 0.4 1.3 0.4 0.3 9.5 14.6 0.0 177.7 23.0 0.8 4.2 107.2 0.3 0.0 380.2 112.8 0.5 0.0 0.0 14.9 0.0 10.4 172.6 9.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.8 2.4 0.7 0.0 0.0 0.0 1.9 4.1 0.0 0.0 0.0 3.7 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.6 0.1 0.4 1.6 0.0 0.2 0.0 0.3 0.0 0.2 0.2 0.1 0.1 0.0 21.6 24.4 0.1 0.2 0.2 0.0 0.2 0.1 2.5 0.0 0.0 0.2 0.1 1.8 0.0 0.5 0.0 1.2 0.0 0.2 1.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 56.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 1.1 8.2 0.0 0.0 0.1 1.1 0.6 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6281.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.0 IGHV3-16 ENSG00000211944 "Immunoglobulin heavy variable 3-16 (non-functional)" A0A0C4DH30 14 106165205-106165730 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 3200000000 "Cluster 43: B-cells - Humoral immune response" "unprognostic (1.04e-1)" "unprognostic (1.04e-1)" 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV1-18 ENSG00000211945 "Immunoglobulin heavy variable 1-18" A0A0C4DH31 14 106184901-106185394 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 223.2;lymphoid tissue: 486.7;salivary gland: 234.3" "Cell type enriched" "Detected in some" 259 "Plasma cells: 13773.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 21 "memory B-cell: 73.2" "Lineage enriched" "Detected in many" 21 "B-cells: 73.2" "Cell line enhanced" "Detected in some" "Daudi: 1.6;HL-60: 3.0;RPMI-8226: 2.9;TIME: 1.6" "Immunoglobulin genes" NA NA 4700000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (3.47e-4)" "unprognostic (2.53e-2)" "unprognostic (8.73e-3)" "unprognostic (2.56e-2)" "unprognostic (9.67e-3)" "prognostic favorable (8.27e-4)" "unprognostic (5.47e-2)" "unprognostic (3.52e-1)" "unprognostic (2.65e-1)" "unprognostic (3.50e-2)" "unprognostic (3.60e-1)" "unprognostic (4.26e-1)" "prognostic unfavorable (5.84e-7)" "unprognostic (3.22e-1)" "unprognostic (2.62e-1)" "unprognostic (2.87e-1)" "unprognostic (2.44e-2)" 22.0 3.5 0.0 0.0 0.3 0.0 22.9 0.0 0.6 54.6 0.0 223.2 0.0 8.9 4.5 162.5 24.3 7.7 2.3 0.0 0.0 16.2 14.3 58.3 0.0 0.6 0.1 8.5 3.2 1.9 1.3 0.2 0.4 10.8 0.0 0.0 234.3 0.0 0.4 1.3 103.2 2.6 0.0 486.7 84.0 0.5 0.1 0.0 33.9 0.2 0.0 156.1 12.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 3.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.9 0.0 0.0 0.0 0.6 0.5 0.8 0.0 0.0 1.1 1.2 2.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.5 0.4 1.0 0.5 0.0 0.3 0.0 1.4 0.0 3.4 0.0 0.1 0.0 0.0 0.1 73.2 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.6 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 50.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.5 53.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 13773.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 3.2 0.0 0.1 0.0 IGHV3-20 ENSG00000211946 "Immunoglobulin heavy variable 3-20" A0A0C4DH32 14 106210936-106211453 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 99.2;lymphoid tissue: 216.6;stomach 1: 122.5;urinary bladder: 81.9" "Cell type enriched" "Detected in some" 24 "Plasma cells: 142.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 242 "memory B-cell: 28.5;naive B-cell: 19.8" "Lineage enriched" "Detected in single" 286 "B-cells: 28.5" "Cell line enhanced" "Detected in single" "Daudi: 1.2" "Immunoglobulin genes" NA NA 2200000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (2.56e-5)" "unprognostic (2.30e-1)" "unprognostic (9.51e-2)" "unprognostic (1.45e-2)" "prognostic favorable (2.93e-4)" "unprognostic (1.35e-2)" "unprognostic (2.37e-1)" "unprognostic (2.45e-1)" "unprognostic (2.62e-1)" "unprognostic (2.42e-1)" "unprognostic (2.93e-1)" "prognostic unfavorable (2.10e-4)" "unprognostic (2.09e-1)" "unprognostic (1.87e-1)" "unprognostic (1.19e-1)" "unprognostic (1.76e-1)" 2.8 2.1 0.0 36.3 0.2 22.6 23.7 0.0 0.1 17.4 0.2 64.8 99.2 1.8 0.0 10.1 2.2 20.7 3.1 0.0 0.0 1.5 4.7 10.5 58.0 0.1 0.0 2.7 0.4 0.1 0.2 0.0 0.0 1.2 62.5 0.0 43.1 1.4 0.0 0.3 37.7 2.0 0.0 59.6 122.5 1.1 0.0 16.6 2.8 0.0 216.6 81.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 142.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 IGHV3-21 ENSG00000211947 "Immunoglobulin heavy variable 3-21" A0A0B4J1V1 14 106235064-106235594 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 209.7;lymphoid tissue: 398.1;salivary gland: 213.2" "Cell type enriched" "Detected in some" 86 "Plasma cells: 3885.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.1;NB-4: 2.1;NTERA-2: 1.2;RH-30: 2.3;TIME: 1.9" "Immunoglobulin genes" NA NA 37000000000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 64: Macrophages - Immune response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (1.30e-4)" "unprognostic (1.21e-2)" "unprognostic (7.19e-3)" "unprognostic (1.51e-2)" "unprognostic (9.16e-3)" "prognostic favorable (9.34e-4)" "unprognostic (3.15e-2)" "unprognostic (1.76e-1)" "unprognostic (4.42e-2)" "unprognostic (3.03e-2)" "unprognostic (2.48e-1)" "unprognostic (4.05e-1)" "prognostic unfavorable (9.31e-8)" "unprognostic (1.73e-1)" "unprognostic (3.19e-1)" "unprognostic (1.35e-1)" "unprognostic (1.77e-1)" 18.1 2.7 0.3 0.0 0.3 0.0 24.8 0.2 1.1 16.8 0.3 209.7 0.0 7.1 0.9 17.4 30.9 0.0 2.0 0.2 0.3 15.4 10.7 55.3 0.0 0.4 0.3 2.9 16.2 2.3 1.3 0.6 0.4 7.2 0.0 0.0 213.2 0.3 0.4 4.3 111.3 0.8 0.4 398.1 83.0 0.4 0.3 0.0 25.6 0.0 0.0 27.7 10.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 2.1 1.2 0.0 0.0 0.7 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.3 0.2 1.1 0.2 0.3 0.4 0.3 0.4 0.4 0.3 1.0 0.0 0.0 0.0 0.0 44.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.0 21.4 0.0 0.0 0.1 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3885.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.2 0.0 IGHV3-23 ENSG00000211949 "Immunoglobulin heavy variable 3-23" P01764 14 106268606-106269140 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1683.1;lymphoid tissue: 2989.8" "Cell type enriched" "Detected in some" 139 "Plasma cells: 15979.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 406 "memory B-cell: 548.5;naive B-cell: 336.7" "Lineage enriched" "Detected in many" 503 "B-cells: 548.5" "Cell line enhanced" "Detected in some" "BEWO: 4.4;HL-60: 3.3;NB-4: 4.1;RH-30: 3.0;RPMI-8226: 9.0;SH-SY5Y: 5.8" "Immunoglobulin genes" NA NA 42000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.17e-3)" "unprognostic (5.43e-2)" "unprognostic (9.68e-3)" "unprognostic (3.31e-3)" "unprognostic (1.34e-2)" "prognostic favorable (3.85e-4)" "unprognostic (3.26e-1)" "unprognostic (4.79e-1)" "unprognostic (7.26e-2)" "unprognostic (6.52e-3)" "unprognostic (1.72e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.79e-7)" "unprognostic (6.22e-2)" "unprognostic (1.84e-1)" "unprognostic (1.36e-1)" "unprognostic (6.42e-2)" 66.5 189.3 0.4 912.2 0.4 185.5 343.1 0.1 2.1 80.1 1.5 1683.1 1640.8 37.0 9.8 342.6 30.1 231.2 46.4 0.1 0.3 27.3 56.4 248.7 859.5 0.8 0.1 42.6 31.0 1.5 2.7 0.9 0.4 35.3 1087.1 0.1 697.8 53.4 0.9 15.0 886.8 40.0 0.8 802.7 1058.8 35.0 0.2 197.5 52.3 0.1 2989.8 993.6 27.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.2 4.1 0.7 0.0 0.0 0.6 3.0 9.0 0.0 0.0 2.7 5.8 0.8 0.1 0.0 0.0 0.0 0.0 1.8 0.0 1.3 1.3 1.1 1.5 0.0 0.3 0.0 0.9 0.0 0.4 0.4 0.1 0.2 0.0 0.1 548.5 0.2 0.3 0.3 336.7 0.1 0.2 1.0 0.2 0.2 0.2 0.8 62.4 0.4 0.4 0.1 2.1 0.1 0.3 0.8 0.1 0.4 0.8 0.2 1.4 0.1 0.0 0.0 0.0 114.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 12.0 0.0 0.0 0.0 1.6 19.4 0.0 1.3 0.0 1.8 2.0 0.2 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 3.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15979.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.9 0.0 0.1 0.0 IGHV1-24 ENSG00000211950 "Immunoglobulin heavy variable 1-24" A0A0C4DH33 14 106276548-106277043 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 186.8;salivary gland: 76.3" "Cell type enriched" "Detected in some" 4 "Plasma cells: 231.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "medulla oblongata: 1.2" "Immune cell enhanced" "Detected in single" "naive B-cell: 2.8" "Lineage enriched" "Detected in single" 9 "B-cells: 2.8" "Cell line enhanced" "Detected in some" "Daudi: 1.0;HL-60: 1.8;JURKAT: 1.3;RH-30: 1.4" "Immunoglobulin genes" NA NA 3100000000 "Cluster 24: B-cells - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (9.01e-4)" "unprognostic (2.67e-2)" "unprognostic (1.66e-2)" "unprognostic (1.93e-3)" "prognostic favorable (3.61e-4)" "unprognostic (1.28e-1)" "unprognostic (1.08e-2)" "unprognostic (1.02e-1)" "unprognostic (1.62e-1)" "unprognostic (1.59e-1)" "unprognostic (4.10e-1)" "prognostic unfavorable (2.07e-7)" "unprognostic (5.43e-2)" "unprognostic (3.14e-2)" "unprognostic (3.17e-1)" "unprognostic (4.78e-2)" 6.8 1.4 0.1 33.7 0.0 0.0 8.5 0.0 0.3 56.3 0.1 30.5 0.0 5.7 0.0 46.2 6.5 4.6 1.8 0.0 0.1 7.0 6.4 17.7 0.0 1.2 0.1 19.6 1.4 0.1 0.4 0.3 0.0 3.1 14.0 0.0 76.3 0.0 0.1 0.8 24.0 2.1 0.0 186.8 37.0 14.2 0.0 0.4 14.5 0.0 18.4 63.3 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.8 0.1 0.0 0.0 2.8 0.1 0.2 0.0 0.0 0.0 0.0 0.1 3.6 0.1 0.0 0.0 0.3 0.0 0.1 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 19.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 231.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 5.7 0.0 0.0 0.0 0.2 0.0 0.2 0.0 IGHV2-26 ENSG00000211951 "Immunoglobulin heavy variable 2-26" A0A0B4J1V2 14 106301396-106301862 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 128.8;lymphoid tissue: 98.5;urinary bladder: 227.1" "Group enriched" "Detected in some" 39 "B-cells: 8.3;Plasma cells: 7.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in some" 14 "memory B-cell: 13.9" "Lineage enriched" "Detected in single" 140 "B-cells: 13.9" "Cell line enhanced" "Detected in some" "HL-60: 1.3;RH-30: 1.4" "Immunoglobulin genes" NA NA 190000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 57: B-cells - Immune response" "unprognostic (9.39e-3)" "unprognostic (4.50e-2)" "unprognostic (7.66e-3)" "unprognostic (2.94e-2)" "prognostic favorable (6.05e-4)" "unprognostic (4.59e-2)" "unprognostic (1.18e-1)" "unprognostic (1.67e-1)" "unprognostic (1.72e-1)" "unprognostic (2.13e-2)" "unprognostic (4.99e-1)" "prognostic unfavorable (4.99e-5)" "unprognostic (6.68e-2)" "unprognostic (2.61e-1)" "unprognostic (2.24e-1)" "unprognostic (8.09e-2)" 6.2 7.7 0.0 59.0 0.0 21.6 14.0 0.0 0.3 15.5 0.2 35.0 61.5 4.2 0.0 31.5 3.8 128.8 5.6 0.0 0.4 2.3 6.0 20.7 3.5 0.2 0.6 0.5 1.6 0.0 0.3 0.0 0.1 6.3 86.5 0.0 44.2 0.9 0.1 0.5 55.1 4.4 0.2 98.5 65.1 0.0 1.1 0.0 6.8 0.0 21.8 227.1 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.4 0.2 0.6 0.1 0.2 1.1 0.2 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 IGHV4-28 ENSG00000211952 "Immunoglobulin heavy variable 4-28" A0A0C4DH34 14 106324254-106324760 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 44.8;lymphoid tissue: 87.4;salivary gland: 39.9;stomach 1: 30.7;urinary bladder: 122.6" "Cell type enriched" "Detected in some" 230 "Plasma cells: 346.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "spinal cord: 1.3" "Group enriched" "Detected in some" 206 "memory B-cell: 28.7;naive B-cell: 12.5" "Lineage enriched" "Detected in single" 288 "B-cells: 28.7" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 2500000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (3.14e-3)" "unprognostic (1.32e-2)" "unprognostic (8.05e-2)" "unprognostic (6.64e-3)" "prognostic favorable (2.63e-4)" "unprognostic (1.58e-2)" "unprognostic (7.52e-2)" "unprognostic (1.03e-1)" "unprognostic (5.74e-2)" "unprognostic (4.76e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (4.79e-6)" "unprognostic (1.45e-1)" "unprognostic (1.28e-1)" "unprognostic (2.72e-1)" "unprognostic (1.75e-1)" 1.8 11.3 0.0 40.9 0.0 6.0 12.9 0.0 0.2 3.3 0.1 44.8 44.8 1.0 0.0 12.5 1.9 7.7 1.2 0.0 0.0 1.8 2.4 8.9 10.0 0.0 0.0 3.5 0.4 0.0 0.2 0.0 0.0 0.8 44.1 0.0 39.9 1.7 0.0 0.5 30.2 2.0 1.3 42.3 30.7 0.5 0.0 5.8 4.3 0.0 87.4 122.6 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 346.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 IGHV3-30 ENSG00000270550 "Immunoglobulin heavy variable 3-30" "P01768, P0DP03" 14 106335082-106335613 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 534.0;lymphoid tissue: 1294.8;salivary gland: 459.9;stomach 1: 572.6;urinary bladder: 378.9" "Cell type enriched" "Detected in some" 184 "Plasma cells: 14426.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 409 "memory B-cell: 164.0;naive B-cell: 136.6" "Lineage enriched" "Detected in single" 446 "B-cells: 164.0" "Cell line enhanced" "Detected in some" "BEWO: 2.1;Daudi: 1.7;NB-4: 2.3;RPMI-8226: 1.7;SCLC-21H: 1.7;SH-SY5Y: 3.0;U-266/70: 1.3" "Immunoglobulin genes" NA NA 8500000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (2.12e-3)" "unprognostic (5.51e-2)" "unprognostic (1.05e-1)" "unprognostic (1.81e-3)" "unprognostic (1.72e-2)" "prognostic favorable (3.23e-5)" "unprognostic (7.43e-2)" "unprognostic (2.09e-1)" "unprognostic (1.95e-2)" "unprognostic (2.94e-2)" "unprognostic (2.94e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (1.65e-7)" "unprognostic (1.32e-1)" "unprognostic (2.16e-1)" "unprognostic (2.01e-1)" "unprognostic (6.96e-2)" 25.3 38.5 0.1 320.5 0.2 119.7 143.9 0.0 0.4 49.3 0.5 534.0 265.5 13.3 0.0 134.6 44.8 146.5 30.3 0.4 0.2 29.2 25.1 128.2 374.9 0.6 0.2 23.0 12.3 0.7 3.3 0.7 0.2 18.6 254.9 0.0 459.9 20.4 0.9 3.5 296.1 23.6 0.1 797.4 572.6 5.9 0.1 158.2 76.6 0.1 1294.8 378.9 34.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.0 0.0 1.0 1.7 0.0 0.0 1.7 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 1.3 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 164.0 0.2 0.0 0.1 136.6 0.3 0.1 0.3 0.0 0.0 0.2 0.0 24.4 0.1 0.2 0.0 0.4 0.4 0.2 0.6 0.2 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 78.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 5.4 16.3 0.0 1.3 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14426.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.4 0.0 IGHV4-31 ENSG00000231475 "Immunoglobulin heavy variable 4-31" A0A087WSY4 14 106349283-106349792 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 467.7;urinary bladder: 190.8" "Cell type enriched" "Detected in some" 183 "Plasma cells: 1651.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in single" "spinal cord: 1.6" "Group enriched" "Detected in some" 48 "memory B-cell: 43.6;naive B-cell: 19.4" "Lineage enriched" "Detected in single" 66 "B-cells: 43.6" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.4;SH-SY5Y: 1.0" "Immunoglobulin genes" NA NA 710000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.53e-3)" "unprognostic (9.05e-2)" "unprognostic (1.12e-1)" "prognostic favorable (5.74e-4)" "prognostic favorable (4.64e-5)" "unprognostic (1.16e-2)" "unprognostic (2.22e-1)" "unprognostic (1.04e-1)" "unprognostic (5.05e-2)" "unprognostic (1.72e-2)" "unprognostic (9.75e-2)" "prognostic unfavorable (6.38e-6)" "unprognostic (2.00e-1)" "unprognostic (1.48e-1)" "unprognostic (3.63e-1)" "unprognostic (1.09e-1)" 4.3 1.7 0.0 48.0 0.0 5.4 37.6 0.0 0.3 15.4 0.0 103.8 72.1 6.5 1.5 32.2 5.3 105.2 11.7 0.0 0.7 3.9 6.3 19.1 104.0 0.2 0.2 58.0 4.7 0.2 0.5 0.0 0.1 11.4 24.9 0.0 53.2 8.4 0.1 1.3 90.4 3.1 1.6 138.6 87.8 1.3 0.2 76.0 15.7 0.0 467.7 190.8 4.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.6 0.1 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.7 0.2 0.2 0.1 1.6 0.2 0.1 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1651.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 IGHV3-33 ENSG00000211955 "Immunoglobulin heavy variable 3-33" P01772 14 106359793-106360324 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1066.7;lymphoid tissue: 2371.2;stomach 1: 1778.8" "Cell type enriched" "Detected in some" 26 "Plasma cells: 556.5" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in some" "cerebral cortex: 4.0" "Group enriched" "Detected in many" 101 "memory B-cell: 378.9;naive B-cell: 364.1" "Lineage enriched" "Detected in many" 103 "B-cells: 378.9" "Cell line enhanced" "Detected in some" "HDLM-2: 5.4;HL-60: 5.3;RPMI-8226: 7.7;SH-SY5Y: 3.8;U-266/70: 8.1" "Immunoglobulin genes" NA NA 7500000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.04e-3)" "unprognostic (2.38e-2)" "unprognostic (8.95e-3)" "prognostic favorable (6.36e-4)" "unprognostic (6.84e-2)" "prognostic favorable (7.19e-5)" "unprognostic (1.80e-1)" "unprognostic (1.95e-1)" "unprognostic (7.31e-2)" "unprognostic (3.82e-2)" "unprognostic (1.70e-1)" "unprognostic (5.18e-1)" "prognostic unfavorable (4.10e-6)" "unprognostic (6.23e-2)" "unprognostic (1.69e-1)" "unprognostic (3.26e-1)" "unprognostic (5.92e-2)" 27.9 67.4 1.0 513.8 0.8 117.8 289.5 0.2 4.0 53.6 2.4 1066.7 882.1 16.2 14.5 127.5 18.9 141.9 32.9 0.2 0.4 15.7 41.8 210.1 795.2 1.4 0.2 110.0 29.4 1.9 1.7 0.8 0.4 23.2 775.6 0.0 619.6 39.5 0.5 3.6 343.9 37.3 0.5 476.1 1778.8 29.4 0.7 296.8 42.2 0.1 2371.2 379.8 18.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 5.4 0.0 0.5 0.0 0.0 0.0 5.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.1 0.8 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.8 2.9 7.7 0.0 0.0 1.4 3.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.3 0.7 8.1 0.0 0.2 0.0 0.8 0.0 0.2 0.6 0.1 1.1 0.0 1.9 378.9 3.6 0.9 0.3 364.1 1.4 0.6 1.0 0.2 0.1 0.2 0.5 44.6 1.0 0.8 0.2 4.0 0.2 0.4 1.4 0.2 0.4 0.5 0.7 0.7 0.0 0.0 0.6 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 10.0 2.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 556.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 IGHV4-34 ENSG00000211956 "Immunoglobulin heavy variable 4-34" P06331 14 106373663-106374145 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 283.3;urinary bladder: 278.5" "Cell type enriched" "Detected in some" 197 "Plasma cells: 15696.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 602 "U-698: 5353.4" "Immunoglobulin genes" NA NA 4300000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (5.34e-3)" "unprognostic (1.32e-1)" "unprognostic (2.25e-2)" "unprognostic (5.34e-3)" "unprognostic (6.12e-2)" "prognostic favorable (2.77e-4)" "unprognostic (8.06e-2)" "unprognostic (3.89e-1)" "unprognostic (1.23e-1)" "unprognostic (4.27e-2)" "unprognostic (2.68e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (2.55e-6)" "unprognostic (2.61e-1)" "unprognostic (1.01e-1)" "unprognostic (1.75e-1)" "unprognostic (7.51e-2)" 7.9 3.0 0.0 0.0 0.3 0.0 9.8 0.1 1.5 12.0 0.1 83.5 0.0 5.5 0.9 7.3 22.5 0.0 2.3 0.0 0.2 7.2 7.0 33.4 0.0 0.6 0.2 22.0 1.3 0.4 0.9 0.3 0.3 3.8 2.2 0.0 82.1 0.0 0.3 2.8 54.2 0.3 0.1 283.3 48.0 0.3 0.1 0.0 19.3 0.0 0.0 278.5 4.0 1.4 3.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.5 2.6 3.2 0.0 0.0 1.4 0.0 4.1 0.0 0.3 0.0 0.6 3.7 0.0 0.1 8.8 0.4 1.8 0.0 0.8 5353.4 0.0 3.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.1 0.5 0.0 0.8 0.0 0.3 0.1 1.5 0.0 0.2 0.6 0.2 0.3 0.1 0.1 1.4 0.0 0.0 0.0 0.0 79.4 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 53.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15696.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 5.6 0.0 0.0 0.0 IGHV3-35 ENSG00000211957 "Immunoglobulin heavy variable 3-35 (non-functional)" A0A0C4DH35 14 106389392-106389858 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 14.1;lymphoid tissue: 12.8;salivary gland: 7.6;stomach 1: 16.7;urinary bladder: 20.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 16 "memory B-cell: 3.7" "Lineage enriched" "Detected in single" 35 "B-cells: 3.7" "Cell line enriched" "Detected in single" 6 "MOLT-4: 1.3" "Immunoglobulin genes" NA NA 19000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.39e-3)" "unprognostic (9.98e-2)" "unprognostic (1.16e-2)" "unprognostic (1.60e-2)" "prognostic favorable (2.53e-4)" "unprognostic (1.06e-1)" "unprognostic (4.74e-1)" "unprognostic (3.44e-1)" "unprognostic (2.37e-1)" "unprognostic (3.21e-1)" "unprognostic (4.29e-6)" "unprognostic (4.60e-2)" "unprognostic (1.60e-1)" "unprognostic (1.33e-1)" "unprognostic (8.59e-2)" 0.1 0.1 0.0 12.8 0.0 3.3 1.1 0.0 0.0 2.8 0.0 10.3 14.1 0.4 0.0 0.5 1.1 1.1 0.5 0.0 0.0 0.1 0.7 2.4 1.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 11.1 0.0 7.6 0.5 0.0 0.2 6.0 0.6 0.0 5.3 16.7 0.0 0.0 0.0 0.0 0.0 2.2 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV3-38 ENSG00000211958 "Immunoglobulin heavy variable 3-38 (non-functional)" A0A0C4DH36 14 106410493-106411021 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 9.9;lymphoid tissue: 10.4;stomach 1: 5.9;urinary bladder: 7.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "memory B-cell: 3.4;naive B-cell: 1.5" "Lineage enriched" "Detected in single" 34 "B-cells: 3.4" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 2900000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "unprognostic (1.03e-5)" "unprognostic (5.11e-2)" "unprognostic (3.29e-3)" "unprognostic (1.02e-1)" "unprognostic (1.31e-3)" "unprognostic (8.40e-2)" "unprognostic (3.54e-2)" "unprognostic (2.05e-1)" "unprognostic (1.98e-1)" "unprognostic (1.75e-8)" "unprognostic (6.25e-2)" "unprognostic (1.92e-1)" "unprognostic (2.99e-1)" "unprognostic (2.52e-1)" 0.3 0.1 0.0 5.9 0.0 1.6 3.3 0.0 0.0 1.4 0.0 7.7 9.9 0.1 0.0 0.9 0.1 0.9 0.2 0.0 0.0 0.1 0.4 1.8 2.2 0.0 0.0 0.6 0.4 0.0 0.0 0.2 0.0 0.2 7.0 0.0 4.1 0.0 0.0 0.2 5.8 0.0 0.0 4.4 5.9 0.7 0.0 0.0 0.0 0.0 10.4 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV4-39 ENSG00000211959 "Immunoglobulin heavy variable 4-39" P01824 14 106421711-106422218 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 251.6;lymphoid tissue: 474.9;salivary gland: 247.1;urinary bladder: 541.3" "Cell type enriched" "Detected in some" 432 "Plasma cells: 48104.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.6;naive B-cell: 1.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 2.3;Daudi: 1.8;HL-60: 2.4;NB-4: 2.2;RH-30: 2.1;RPMI-8226: 1.4;U-266/70: 2.1;U-698: 2.0" "Immunoglobulin genes" NA NA 5000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.18e-3)" "unprognostic (2.99e-3)" "unprognostic (5.95e-3)" "unprognostic (1.46e-2)" "unprognostic (5.65e-2)" "unprognostic (2.38e-3)" "unprognostic (4.48e-2)" "unprognostic (2.63e-1)" "unprognostic (1.77e-1)" "unprognostic (2.23e-2)" "unprognostic (2.35e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (2.60e-6)" "unprognostic (2.04e-2)" "unprognostic (2.77e-1)" "unprognostic (7.68e-2)" "unprognostic (8.33e-2)" 17.8 6.5 0.5 378.0 0.5 14.5 33.2 0.1 0.8 24.0 1.5 251.6 4.4 12.5 2.5 19.1 17.7 0.0 11.4 0.1 0.2 13.8 13.8 54.9 0.0 0.8 1.2 17.6 3.7 1.2 1.4 0.0 0.6 7.1 5.0 0.0 247.1 9.5 0.5 12.1 143.6 2.0 0.1 474.9 108.1 1.3 0.4 2.8 37.2 0.0 5.3 541.3 13.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 1.1 2.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.2 0.2 0.0 2.1 0.0 2.0 0.0 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.2 1.6 0.1 0.1 0.1 1.7 0.5 0.1 1.1 0.1 0.1 0.2 0.1 0.0 0.5 0.5 0.1 0.8 0.1 0.2 0.8 1.2 0.6 0.1 0.4 0.3 0.0 0.0 0.0 0.0 89.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 111.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48104.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.3 0.0 0.3 0.0 IGHV3-43 ENSG00000232216 "Immunoglobulin heavy variable 3-43" A0A0B4J1X8 14 106470264-106470800 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 211.9;stomach 1: 312.2;urinary bladder: 153.0" "Cell type enriched" "Detected in some" 28 "Plasma cells: 557.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 321 "memory B-cell: 29.4;naive B-cell: 39.0" "Lineage enriched" "Detected in single" 366 "B-cells: 39.0" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.8;SH-SY5Y: 2.3" "Immunoglobulin genes" NA NA 4000000000 "Cluster 24: B-cells - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (2.31e-4)" "unprognostic (2.22e-2)" "prognostic favorable (1.46e-4)" "unprognostic (4.87e-3)" "prognostic favorable (8.20e-4)" "unprognostic (2.36e-1)" "unprognostic (1.34e-1)" "unprognostic (4.63e-1)" "unprognostic (7.27e-3)" "unprognostic (4.50e-2)" "unprognostic (8.73e-2)" "prognostic unfavorable (2.40e-5)" "unprognostic (1.60e-1)" "unprognostic (1.74e-1)" "unprognostic (1.29e-1)" "unprognostic (1.75e-2)" 9.3 2.3 0.0 23.7 0.3 11.5 43.7 0.0 0.3 46.0 0.0 101.8 102.5 2.0 0.0 10.2 3.5 10.7 0.4 0.0 0.0 2.7 9.8 10.8 4.3 0.7 0.0 4.2 2.2 1.0 0.3 0.1 0.2 2.7 66.1 0.0 58.1 5.4 0.1 1.0 48.3 4.4 0.0 83.7 312.2 0.2 0.1 0.0 3.8 0.0 211.9 153.0 4.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.5 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 29.4 0.0 0.0 0.0 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.3 0.0 0.3 0.0 0.0 0.7 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 557.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 IGHV1-45 ENSG00000211961 "Immunoglobulin heavy variable 1-45" A0A0A0MS14 14 106506996-106507491 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 18.9;lymphoid tissue: 30.3;stomach 1: 17.5" "Cell type enriched" "Detected in single" 20 "Plasma cells: 2.0" "Cancer enriched" "Detected in many" 7 "lung cancer: 15.4" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-266/70: 1.2;U-266/84: 1.3" "Immunoglobulin genes" NA NA 380000000 "Cluster 32: T-cells - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (5.57e-4)" "unprognostic (5.07e-3)" "unprognostic (2.12e-3)" "unprognostic (1.46e-1)" "unprognostic (7.64e-3)" "unprognostic (2.90e-1)" "unprognostic (3.50e-2)" "unprognostic (3.16e-1)" "unprognostic (1.48e-1)" "unprognostic (1.05e-1)" "unprognostic (4.05e-1)" "unprognostic (1.28e-3)" "unprognostic (2.94e-2)" "unprognostic (2.87e-1)" "unprognostic (2.32e-1)" "unprognostic (3.16e-1)" 0.2 0.1 0.0 3.7 0.0 1.8 18.9 0.0 0.0 0.3 0.0 4.5 1.1 0.5 0.0 6.4 0.2 0.6 0.1 0.0 0.0 0.2 0.2 3.5 7.6 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.3 6.1 0.0 11.5 0.0 0.0 0.1 2.3 0.7 0.0 6.9 17.5 0.1 0.0 2.9 0.3 0.0 30.3 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 1.1 0.6 0.3 0.0 1.1 0.7 0.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV1-46 ENSG00000211962 "Immunoglobulin heavy variable 1-46" P01743 14 106511117-106511856 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 67.9;lymphoid tissue: 125.7;salivary gland: 67.4" "Cell type enriched" "Detected in some" 201 "Plasma cells: 8432.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.7;RPMI-8226: 1.2;SH-SY5Y: 1.2;TIME: 2.3;U-266/70: 1.1;U-266/84: 1.2" "Immunoglobulin genes" NA NA 2900000000 "Cluster 24: B-cells - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (6.28e-4)" "unprognostic (2.49e-2)" "prognostic favorable (7.34e-4)" "unprognostic (1.10e-2)" "unprognostic (3.53e-2)" "unprognostic (1.80e-3)" "unprognostic (1.87e-1)" "unprognostic (6.76e-2)" "unprognostic (8.11e-2)" "unprognostic (2.57e-2)" "unprognostic (1.25e-1)" "unprognostic (3.27e-1)" "prognostic unfavorable (1.56e-6)" "unprognostic (6.19e-2)" "unprognostic (2.52e-1)" "unprognostic (2.27e-1)" "unprognostic (5.13e-1)" 5.1 1.3 0.0 0.0 0.0 0.0 7.2 0.0 0.1 6.2 0.0 67.9 0.0 2.5 1.0 4.9 3.5 0.7 5.0 0.0 0.0 3.2 4.2 15.3 0.0 0.1 0.0 3.0 5.3 0.1 0.3 0.3 0.1 1.9 45.1 0.0 67.4 0.0 0.1 0.7 34.2 0.0 0.0 125.7 25.1 0.2 0.0 0.0 10.5 0.2 0.0 5.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.3 1.2 0.0 0.0 0.5 1.2 0.2 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.3 0.0 0.1 1.1 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.7 0.0 0.0 0.0 1.9 41.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8432.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 IGHV3-48 ENSG00000211964 "Immunoglobulin heavy variable 3-48" P01763 14 106537810-106538344 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 516.4;lymphoid tissue: 858.8;stomach 1: 404.9" "Cell type enriched" "Detected in some" 100 "Plasma cells: 5878.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 1.3" "Group enriched" "Detected in some" 527 "memory B-cell: 187.1;naive B-cell: 97.5" "Lineage enriched" "Detected in single" 693 "B-cells: 187.1" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.5;SH-SY5Y: 1.6" "Immunoglobulin genes" NA NA 49000000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (9.19e-3)" "unprognostic (1.87e-2)" "unprognostic (5.12e-2)" "unprognostic (9.07e-3)" "unprognostic (1.77e-1)" "prognostic favorable (1.56e-5)" "unprognostic (1.23e-1)" "unprognostic (9.59e-2)" "unprognostic (2.65e-1)" "unprognostic (4.02e-2)" "unprognostic (2.64e-1)" "unprognostic (2.44e-1)" "prognostic unfavorable (4.88e-8)" "unprognostic (1.89e-1)" "unprognostic (1.25e-1)" "unprognostic (1.35e-1)" "unprognostic (2.15e-1)" 8.7 22.9 0.0 232.6 0.0 81.2 56.4 0.0 1.3 25.9 0.2 434.1 516.4 8.1 0.1 33.4 12.1 38.6 6.9 0.0 0.0 10.8 18.6 32.3 125.3 0.3 0.0 12.2 8.8 0.9 0.9 0.1 0.7 6.8 253.2 0.0 164.6 16.0 0.6 1.6 134.4 17.7 0.1 271.1 404.9 27.9 0.0 36.3 16.0 0.0 858.8 248.6 7.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.9 0.4 0.0 0.0 0.0 0.8 0.9 0.0 0.0 1.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 187.1 0.0 0.0 0.1 97.5 0.0 0.1 0.1 0.0 0.0 0.0 0.2 22.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 58.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.7 17.9 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5878.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 IGHV3-49 ENSG00000211965 "Immunoglobulin heavy variable 3-49" A0A0A0MS15 14 106556936-106557477 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 210.7;lymphoid tissue: 373.5;stomach 1: 182.3" "Cell type enriched" "Detected in some" 46 "Plasma cells: 717.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 187 "memory B-cell: 59.4;naive B-cell: 42.2" "Lineage enriched" "Detected in single" 219 "B-cells: 59.4" "Cell line enhanced" "Detected in single" "RPMI-8226: 1.0" "Immunoglobulin genes" NA NA 1600000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (7.16e-4)" "unprognostic (7.91e-3)" "unprognostic (2.50e-2)" "unprognostic (1.66e-2)" "unprognostic (2.12e-1)" "prognostic favorable (2.34e-6)" "unprognostic (4.47e-2)" "unprognostic (4.30e-2)" "unprognostic (7.00e-3)" "unprognostic (9.17e-2)" "unprognostic (2.18e-1)" "unprognostic (4.20e-2)" "prognostic unfavorable (1.43e-6)" "unprognostic (7.42e-2)" "unprognostic (2.79e-1)" "unprognostic (8.96e-2)" "unprognostic (3.00e-1)" 20.8 7.1 0.0 112.3 0.0 45.7 42.5 0.0 0.5 11.5 0.3 210.7 184.4 4.6 3.9 20.0 5.1 10.9 9.4 0.0 0.2 5.0 12.8 43.2 108.6 0.7 0.0 26.5 1.7 0.2 0.4 0.0 0.3 3.0 139.3 0.0 88.5 12.1 0.2 0.4 88.2 11.5 0.1 183.1 182.3 1.8 0.1 21.4 9.7 0.0 373.5 100.0 3.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.4 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.4 0.0 0.0 0.0 42.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.5 0.0 0.2 0.7 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 717.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 IGHV5-51 ENSG00000211966 "Immunoglobulin heavy variable 5-51" A0A0C4DH38 14 106578744-106579236 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 245.7;lymphoid tissue: 547.1;salivary gland: 224.5;urinary bladder: 353.3" "Cell type enriched" "Detected in some" 87 "Plasma cells: 5993.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.8;Daudi: 3.7;K-562: 2.4;NB-4: 1.7;TIME: 3.3" HPA006014 Approved "Immunoglobulin genes" NA NA 2700000000 "Cluster 41: Basophils - Cellular respiration" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA006014: " "unprognostic (2.03e-3)" "unprognostic (1.00e-1)" "unprognostic (3.21e-2)" "unprognostic (7.65e-3)" "unprognostic (1.80e-2)" "prognostic favorable (5.47e-4)" "unprognostic (2.40e-2)" "unprognostic (1.15e-1)" "unprognostic (3.92e-2)" "unprognostic (6.47e-2)" "unprognostic (2.49e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.31e-7)" "unprognostic (1.11e-1)" "unprognostic (1.05e-1)" "unprognostic (3.70e-1)" "unprognostic (1.17e-1)" 20.0 4.8 0.3 0.0 0.0 0.0 25.9 0.1 1.7 17.8 0.7 245.7 0.0 8.6 6.3 19.1 15.2 27.1 2.1 0.1 0.7 15.4 15.0 56.2 0.0 0.9 0.0 8.8 17.1 1.0 2.2 0.6 0.2 11.2 0.0 0.0 224.5 0.0 0.7 3.2 144.8 1.7 0.6 547.1 99.9 4.8 0.1 0.0 25.6 0.0 0.0 353.3 14.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 1.3 0.8 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.3 1.3 1.2 0.8 0.0 0.1 0.0 0.7 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.1 1.7 0.1 0.7 0.9 0.0 0.2 0.6 0.1 1.3 0.0 0.0 0.0 0.0 68.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 1.8 44.9 0.0 0.0 0.0 0.7 1.0 0.1 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5993.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 IGHV8-51-1 "IGHV(III)-51-1, IGHVIII-51-1" ENSG00000254167 "Immunoglobulin heavy variable IGHV8-51-1 (non-functional)" 14 106583501-106583807 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "lymphoid tissue: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "MOLT-4: 10.8" "Immunoglobulin genes" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "unprognostic (2.16e-1)" "unprognostic (4.58e-2)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV3-53 ENSG00000211967 "Immunoglobulin heavy variable 3-53" P01767 14 106592676-106593347 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 81.5;lymphoid tissue: 129.5;stomach 1: 43.3" "Cell type enriched" "Detected in some" 22 "Plasma cells: 176.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 99 "memory B-cell: 54.7;naive B-cell: 52.7" "Lineage enriched" "Detected in single" 101 "B-cells: 54.7" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 4300000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.41e-3)" "unprognostic (1.12e-1)" "unprognostic (2.46e-3)" "prognostic favorable (5.66e-4)" "prognostic favorable (3.95e-4)" "unprognostic (3.91e-2)" "unprognostic (1.12e-1)" "unprognostic (2.51e-1)" "unprognostic (6.82e-2)" "unprognostic (1.19e-1)" "unprognostic (3.36e-2)" "prognostic unfavorable (2.04e-5)" "unprognostic (1.79e-1)" "unprognostic (8.26e-2)" "unprognostic (2.64e-1)" "unprognostic (3.72e-1)" 2.9 0.8 0.0 37.1 0.0 7.9 15.5 0.0 0.1 4.7 0.0 66.5 81.5 1.0 0.3 4.1 1.9 6.7 1.4 0.0 0.0 1.8 2.8 7.7 38.5 0.1 0.0 3.2 1.3 0.1 0.1 0.0 0.0 1.1 74.0 0.0 32.2 1.9 0.0 0.3 33.9 2.3 0.0 66.9 43.3 1.6 0.0 8.2 4.6 0.0 129.5 10.2 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 54.7 0.0 0.0 0.0 52.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 176.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 IGHV1-58 ENSG00000211968 "Immunoglobulin heavy variable 1-58" A0A0C4DH39 14 106622357-106622855 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "urinary bladder: 204.7" "Group enriched" "Detected in some" 17 "B-cells: 2.4;Plasma cells: 1.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 49 "memory B-cell: 8.7;naive B-cell: 12.7" "Lineage enriched" "Detected in single" 58 "B-cells: 12.7" "Cell line enhanced" "Detected in single" "MOLT-4: 1.5" "Immunoglobulin genes" NA NA 120000000 "Cluster 21: B-cells - Adaptive immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 57: B-cells - Immune response" "unprognostic (9.63e-3)" "unprognostic (6.78e-2)" "unprognostic (5.64e-2)" "unprognostic (4.04e-2)" "prognostic favorable (7.25e-4)" "unprognostic (4.56e-2)" "unprognostic (1.21e-1)" "unprognostic (4.62e-1)" "unprognostic (1.46e-2)" "unprognostic (4.89e-2)" "unprognostic (2.58e-1)" "prognostic unfavorable (8.28e-5)" "unprognostic (3.24e-2)" "unprognostic (5.28e-2)" "unprognostic (6.79e-2)" "unprognostic (1.36e-1)" 8.1 3.4 0.0 13.8 0.0 5.9 3.8 0.0 0.0 0.8 0.0 19.5 15.7 0.4 0.0 8.3 1.1 4.7 1.0 0.0 0.0 1.5 1.4 5.4 41.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.4 27.8 0.0 23.5 1.9 0.0 0.2 9.8 0.1 0.0 26.2 13.1 0.5 0.0 10.3 1.1 0.0 51.1 204.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV4-59 ENSG00000224373 "Immunoglobulin heavy variable 4-59" P01825 14 106627249-106627825 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 525.9;lymphoid tissue: 911.2;urinary bladder: 702.5" "Cell type enriched" "Detected in some" 301 "Plasma cells: 12374.9" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in some" "spinal cord: 2.0" "Group enriched" "Detected in some" 37 "memory B-cell: 169.0;naive B-cell: 77.2" "Lineage enriched" "Detected in many" 51 "B-cells: 169.0" "Cell line enhanced" "Detected in some" "MOLT-4: 8.1;SCLC-21H: 2.0;SH-SY5Y: 4.2" "Immunoglobulin genes" NA NA 5500000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (1.62e-5)" "unprognostic (3.95e-2)" "unprognostic (7.25e-3)" "unprognostic (9.13e-2)" "unprognostic (1.13e-2)" "prognostic favorable (9.18e-5)" "unprognostic (2.88e-2)" "unprognostic (3.55e-1)" "unprognostic (2.16e-1)" "unprognostic (3.22e-2)" "unprognostic (2.22e-1)" "unprognostic (3.68e-1)" "prognostic unfavorable (1.41e-7)" "unprognostic (6.04e-2)" "unprognostic (2.24e-1)" "unprognostic (1.94e-1)" "unprognostic (1.76e-1)" 23.9 3.2 0.0 260.5 0.3 95.5 89.3 0.0 1.1 40.4 0.8 525.9 301.0 12.1 2.7 89.6 17.9 168.0 27.9 0.0 0.6 13.8 20.6 89.9 148.0 0.3 0.1 23.5 10.3 1.7 1.5 0.3 0.2 12.6 456.0 0.0 225.7 8.8 0.5 3.6 222.6 19.5 2.0 465.3 260.5 15.0 0.2 86.4 44.1 0.0 911.2 702.5 10.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 0.0 0.0 0.0 8.1 1.0 0.3 0.3 0.0 0.8 1.0 0.7 0.0 0.0 2.0 4.2 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.4 0.4 0.1 1.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 169.0 0.0 0.2 1.4 77.2 0.1 0.0 0.0 0.0 0.1 3.3 0.1 11.9 0.0 0.3 0.0 1.1 0.0 0.6 0.3 0.1 0.2 2.0 0.2 0.3 0.0 0.0 0.6 0.0 41.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 11.2 0.0 0.0 0.0 0.7 1.2 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12374.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 3.6 0.0 0.5 0.0 IGHV4-61 ENSG00000211970 "Immunoglobulin heavy variable 4-61" A0A0C4DH41 14 106639119-106639657 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 206.7;lymphoid tissue: 385.2;stomach 1: 143.1" "Cell type enriched" "Detected in some" 98 "Plasma cells: 2432.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 43 "memory B-cell: 39.0;naive B-cell: 25.5" "Lineage enriched" "Detected in single" 52 "B-cells: 39.0" "Cell line enriched" "Detected in single" 11 "MOLT-4: 8.7" "Immunoglobulin genes" NA NA 4400000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (2.11e-3)" "unprognostic (6.59e-2)" "unprognostic (4.92e-2)" "unprognostic (1.12e-2)" "prognostic favorable (3.71e-6)" "unprognostic (6.96e-2)" "unprognostic (5.98e-2)" "unprognostic (1.26e-1)" "unprognostic (1.72e-2)" "unprognostic (9.95e-2)" "unprognostic (9.02e-2)" "prognostic unfavorable (4.13e-6)" "unprognostic (3.55e-2)" "unprognostic (3.10e-1)" "unprognostic (4.24e-1)" "unprognostic (2.32e-2)" 6.4 44.4 0.0 97.5 0.1 30.8 56.0 0.0 0.2 10.1 0.1 206.7 185.7 5.8 0.0 15.5 5.0 22.4 3.1 0.0 0.1 5.5 10.5 28.2 54.4 0.3 0.1 10.4 1.3 0.2 0.7 0.0 0.3 4.1 121.8 0.0 104.3 7.0 0.2 0.7 86.5 8.0 0.3 181.3 143.1 0.9 0.0 30.1 23.0 0.0 385.2 43.9 5.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.4 0.0 0.0 8.7 0.8 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 39.0 0.0 0.1 0.0 25.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 4.6 0.0 0.1 0.0 0.2 0.0 0.1 0.3 0.1 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2432.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 IGHV3-64 ENSG00000223648 "Immunoglobulin heavy variable 3-64" A0A075B6Q5 14 106657725-106658258 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 17.9;lymphoid tissue: 32.1;salivary gland: 21.0" "Cell type enriched" "Detected in some" 38 "Plasma cells: 88.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 19 "memory B-cell: 11.1" "Lineage enriched" "Detected in single" 111 "B-cells: 11.1" "Cell line enhanced" "Detected in single" "HL-60: 1.1" "Immunoglobulin genes" NA NA 4300000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (6.09e-6)" "unprognostic (6.52e-2)" "unprognostic (2.11e-3)" "unprognostic (3.10e-2)" "unprognostic (1.39e-3)" "unprognostic (1.40e-1)" "unprognostic (2.06e-1)" "unprognostic (8.01e-2)" "unprognostic (2.13e-2)" "unprognostic (2.33e-1)" "unprognostic (2.52e-1)" "prognostic unfavorable (3.93e-5)" "unprognostic (1.58e-1)" "unprognostic (1.85e-1)" "unprognostic (3.86e-2)" "unprognostic (1.07e-2)" 1.7 0.1 0.0 2.0 0.0 8.6 7.2 0.0 0.4 0.7 0.0 17.9 6.9 0.9 0.0 1.2 1.9 4.1 1.2 0.0 0.0 0.8 2.2 4.3 0.0 0.1 0.0 3.3 3.6 0.0 0.1 0.0 0.0 0.5 1.2 0.0 21.0 0.4 0.0 0.1 11.3 1.3 0.0 32.1 6.0 0.0 0.0 0.0 1.5 0.0 0.0 3.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 IGHV3-66 ENSG00000211972 "Immunoglobulin heavy variable 3-66" A0A0C4DH42 14 106675017-106675544 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 47.3;intestine: 59.5;urinary bladder: 103.9" "Cell type enriched" "Detected in some" 107 "Plasma cells: 958.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 137 "memory B-cell: 39.7" "Lineage enriched" "Detected in single" 137 "B-cells: 39.7" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.7;U-2 OS: 2.3" "Immunoglobulin genes" NA NA 7200000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (2.43e-6)" "unprognostic (2.48e-2)" "unprognostic (5.05e-3)" "unprognostic (1.31e-3)" "unprognostic (2.20e-3)" "unprognostic (8.65e-2)" "unprognostic (1.59e-1)" "unprognostic (4.83e-2)" "unprognostic (1.87e-2)" "unprognostic (6.95e-2)" "unprognostic (2.85e-1)" "prognostic unfavorable (2.89e-6)" "unprognostic (3.87e-1)" "unprognostic (1.21e-1)" "unprognostic (2.84e-1)" "unprognostic (1.19e-1)" 3.8 0.9 0.0 0.0 0.1 11.1 3.9 0.0 0.4 15.3 0.3 59.5 0.0 1.4 1.2 27.0 3.2 47.3 0.3 0.0 0.0 1.3 3.5 13.1 41.1 0.2 0.0 5.6 0.4 0.0 0.1 0.0 0.0 3.9 32.3 0.0 16.1 5.7 0.0 1.5 10.1 1.3 0.0 31.8 6.3 0.6 0.0 0.0 2.5 0.0 39.7 103.9 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 39.7 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 958.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 IGHV1-69 IGHV1-E ENSG00000211973 "Immunoglobulin heavy variable 1-69" P01742 14 106714684-106715181 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 139.1;lymphoid tissue: 170.2;urinary bladder: 162.6" "Cell type enriched" "Detected in some" 85 "Plasma cells: 231.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 22 "medulla oblongata: 2.5;pons: 3.0" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.5;plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 1.4;HMC-1: 1.0;MOLT-4: 6.2;SCLC-21H: 1.1;U-698: 1.9" "Immunoglobulin genes" NA NA 2700000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (3.51e-3)" "unprognostic (7.03e-2)" "prognostic favorable (9.56e-5)" "prognostic favorable (8.32e-4)" "unprognostic (1.06e-2)" "unprognostic (1.69e-1)" "unprognostic (1.82e-1)" "unprognostic (3.64e-1)" "unprognostic (1.64e-2)" "unprognostic (1.70e-1)" "unprognostic (3.91e-1)" "prognostic unfavorable (2.77e-7)" "unprognostic (1.28e-1)" "unprognostic (2.95e-1)" "unprognostic (8.20e-2)" "unprognostic (6.82e-2)" 7.7 1.4 0.0 0.0 0.1 0.1 6.5 0.0 0.0 21.4 0.1 56.9 0.0 6.9 0.0 7.0 5.7 77.4 0.7 0.0 0.1 7.0 4.8 18.0 0.0 2.5 0.0 2.0 0.8 1.8 0.5 0.0 3.0 4.6 139.1 0.0 55.9 13.0 0.1 0.5 31.7 6.8 0.0 170.2 31.0 0.1 0.0 0.0 25.2 0.0 0.0 162.6 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.1 0.1 0.9 0.0 0.0 1.3 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 2.5 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 231.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 IGHV2-70D ENSG00000211974 "Immunoglobulin heavy variable 2-70D" A0A0C4DH43 14 106723574-106724093 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 36.8;lymphoid tissue: 90.8;stomach 1: 47.0" "Cell type enriched" "Detected in single" 10 "B-cells: 1.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 68 "memory B-cell: 9.7;naive B-cell: 3.7" "Lineage enriched" "Detected in single" 97 "B-cells: 9.7" "Cell line enriched" "Detected in single" 7 "MOLT-4: 1.7" "Immunoglobulin genes" NA NA 110000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "unprognostic (5.57e-2)" "unprognostic (9.48e-3)" "prognostic favorable (3.34e-4)" "unprognostic (4.34e-2)" "unprognostic (8.37e-3)" "unprognostic (2.34e-2)" "unprognostic (1.22e-1)" "unprognostic (1.04e-1)" "unprognostic (2.13e-2)" "unprognostic (6.01e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (6.70e-2)" "unprognostic (3.83e-1)" "unprognostic (3.66e-2)" "unprognostic (8.11e-2)" 1.7 0.7 0.0 16.6 0.0 4.1 7.1 0.0 0.0 5.6 0.1 36.8 14.2 1.9 0.0 5.2 4.5 20.9 1.7 0.0 0.0 2.5 2.3 6.2 4.6 0.0 0.0 0.8 0.3 0.1 0.1 0.0 0.0 0.7 33.1 0.0 30.3 0.1 0.0 0.1 21.7 0.6 0.0 41.4 47.0 0.0 0.0 4.5 2.5 0.0 90.8 3.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV1-69-2 IGHV1-F ENSG00000281990 "Immunoglobulin heavy variable 1-69-2" A0A0G2JMI3 14 106737110-106737547 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 22.1;lymphoid tissue: 47.1" "Cell type enriched" "Detected in some" 226 "Plasma cells: 10423.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 6.7;naive B-cell: 5.5" "Lineage enriched" "Detected in many" 6 "B-cells: 6.7" "Cell line enriched" "Detected in some" 6 "MOLT-4: 11.2" "Immunoglobulin genes" NA NA 1100000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" 6.3 0.3 0.0 5.8 0.0 2.5 3.6 0.0 0.0 1.5 0.0 12.0 22.1 1.1 0.2 2.1 1.2 14.5 1.6 0.0 0.0 2.7 0.9 4.5 13.5 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.5 14.4 0.0 16.4 0.9 0.0 0.0 18.0 0.2 0.0 47.1 9.9 0.2 0.0 3.7 1.1 0.0 36.5 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 6.7 0.5 0.9 0.0 5.5 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 1.4 23.0 0.0 0.0 0.0 1.1 1.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10423.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 IGHV1-69D ENSG00000280411 "Immunoglobulin heavy variable 1-69D" A0A0B4J2H0 14 106762092-106762588 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 2878.6;stomach 1: 989.1" "Group enriched" "Detected in some" 6 "Plasma cells: 5.8;T-cells: 1.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 225 "memory B-cell: 184.5;naive B-cell: 433.4" "Lineage enriched" "Detected in many" 316 "B-cells: 433.4" "Cell line enhanced" "Detected in some" "Daudi: 2.8;HL-60: 2.3;MOLT-4: 4.2;RPMI-8226: 2.5;U-266/70: 3.3;U-698: 7.9" "Immunoglobulin genes" NA NA 1200000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 11: Alveolar cells - Smell perception" "unprognostic (3.32e-3)" "unprognostic (1.75e-2)" "unprognostic (3.87e-2)" "unprognostic (3.77e-2)" "unprognostic (2.49e-4)" "prognostic favorable (2.88e-4)" "unprognostic (1.66e-2)" "unprognostic (1.76e-1)" "unprognostic (1.01e-1)" "unprognostic (1.88e-2)" "unprognostic (1.62e-1)" "unprognostic (3.01e-1)" "prognostic unfavorable (2.72e-8)" "unprognostic (5.14e-2)" "unprognostic (9.96e-2)" "unprognostic (2.84e-2)" "unprognostic (2.08e-2)" 26.1 95.3 0.1 462.7 0.1 113.1 146.7 0.0 0.7 37.5 1.0 628.2 491.2 15.0 16.8 98.6 16.0 78.0 20.2 0.0 0.1 17.5 46.6 149.6 2878.6 1.1 0.0 35.9 3.3 0.6 1.1 0.4 0.1 16.5 406.2 0.0 385.0 100.0 0.5 5.2 121.3 43.8 0.2 452.7 989.1 6.8 0.0 135.7 38.3 0.0 2219.2 295.4 11.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 4.2 0.3 1.3 0.0 0.0 0.9 0.8 2.5 0.0 0.0 0.8 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.6 0.4 3.3 0.1 7.9 0.0 0.7 0.0 0.8 0.3 0.1 0.0 0.0 0.2 184.5 0.3 0.0 0.2 433.4 0.4 0.1 0.4 0.2 0.4 1.3 0.2 33.5 0.1 0.1 0.0 0.7 0.0 0.1 1.1 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 IGHV2-70 ENSG00000274576 "Immunoglobulin heavy variable 2-70" P01814 14 106770577-106771020 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "lymphoid tissue: 727.6;stomach 1: 502.1" "Cell type enriched" "Detected in single" 5 "Plasma cells: 2.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 5.2" "Group enriched" "Detected in some" 241 "memory B-cell: 24.6;naive B-cell: 23.5" "Lineage enriched" "Detected in single" 247 "B-cells: 24.6" "Cell line enriched" "Detected in some" 8 "U-698: 12.4" "Immunoglobulin genes" NA NA 170000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (8.01e-3)" "unprognostic (2.93e-2)" "unprognostic (3.56e-3)" "unprognostic (2.38e-2)" "unprognostic (1.12e-2)" "unprognostic (2.30e-1)" "unprognostic (1.76e-1)" "unprognostic (3.14e-1)" "unprognostic (8.29e-2)" "unprognostic (1.49e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (9.44e-6)" "unprognostic (9.10e-2)" "unprognostic (2.50e-1)" "unprognostic (8.93e-2)" "unprognostic (2.91e-1)" 7.3 25.7 0.0 96.2 0.0 69.2 86.1 0.0 5.2 62.3 0.0 86.7 53.2 4.1 0.0 44.3 8.1 37.5 2.5 0.0 1.4 4.8 13.2 69.9 82.7 0.1 1.1 5.0 1.0 0.9 0.3 0.2 0.1 6.8 82.8 0.0 94.5 14.1 0.1 0.9 42.1 2.5 2.2 156.4 502.1 1.2 0.0 59.5 8.5 0.0 727.6 50.4 4.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.4 0.8 0.0 0.0 0.8 0.6 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.1 0.7 0.0 0.1 0.0 12.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.6 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 5.2 0.0 1.4 0.1 1.1 0.1 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV3-72 ENSG00000225698 "Immunoglobulin heavy variable 3-72" A0A0B4J1Y9 14 106790691-106791233 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 75.7;lymphoid tissue: 121.6;urinary bladder: 101.3" "Cell type enriched" "Detected in some" 271 "Plasma cells: 3507.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 5 "memory B-cell: 52.4" "Lineage enriched" "Detected in many" 50 "B-cells: 52.4" "Cell line enhanced" "Detected in some" "NB-4: 1.3;RH-30: 1.3;RPMI-8226: 1.2;TIME: 2.2;U-698: 5.8" "Immunoglobulin genes" NA NA 9600000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (9.10e-6)" "unprognostic (2.18e-2)" "unprognostic (1.32e-2)" "unprognostic (2.93e-2)" "prognostic favorable (8.57e-5)" "unprognostic (9.14e-3)" "unprognostic (3.98e-2)" "unprognostic (1.86e-1)" "unprognostic (9.20e-2)" "unprognostic (1.12e-1)" "unprognostic (6.27e-2)" "prognostic unfavorable (4.40e-4)" "unprognostic (9.29e-2)" "unprognostic (1.29e-1)" "unprognostic (8.81e-2)" "unprognostic (1.32e-1)" 4.8 2.6 0.1 18.4 0.1 15.5 7.0 0.0 0.6 5.2 0.1 75.7 28.4 3.0 2.9 17.4 3.4 0.3 0.3 0.0 0.0 1.9 5.3 8.6 2.7 0.5 0.0 2.3 3.4 0.1 0.2 0.1 0.1 1.9 47.6 0.0 46.6 0.9 0.1 0.3 58.2 5.4 0.1 121.6 29.4 0.0 0.0 2.6 2.2 0.5 12.1 101.3 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 1.3 0.2 0.0 0.0 0.1 1.3 1.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.1 0.0 0.3 0.0 5.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 52.4 0.1 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.1 0.1 0.0 0.6 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.1 7.1 0.0 0.0 0.0 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3507.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 IGHV3-73 ENSG00000211976 "Immunoglobulin heavy variable 3-73" A0A0B4J1V6 14 106802694-106803233 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 141.8;lymphoid tissue: 83.0;urinary bladder: 81.7" "Cell type enhanced" "Detected in some" "B-cells: 6.1;Cholangiocytes: 1.5;Erythroid cells: 5.3;Plasma cells: 3.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 86 "memory B-cell: 69.9;naive B-cell: 42.9" "Lineage enriched" "Detected in single" 107 "B-cells: 69.9" "Cell line enhanced" "Detected in some" "Daudi: 1.4;HEL: 1.1;HL-60: 1.1;K-562: 1.7" "Immunoglobulin genes" NA NA 3200000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 57: B-cells - Immune response" "prognostic favorable (7.89e-4)" "unprognostic (3.61e-2)" "unprognostic (1.55e-2)" "unprognostic (8.79e-2)" "prognostic favorable (7.25e-7)" "unprognostic (4.23e-2)" "unprognostic (4.32e-2)" "unprognostic (5.40e-1)" "unprognostic (1.57e-2)" "unprognostic (2.27e-2)" "unprognostic (5.37e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (4.45e-1)" "unprognostic (2.52e-1)" "unprognostic (5.25e-2)" "unprognostic (4.37e-2)" 4.4 13.3 0.0 9.4 0.0 15.8 10.5 0.0 0.5 4.7 0.3 76.9 141.8 5.1 0.0 4.0 3.9 19.1 10.4 0.0 0.0 3.0 9.8 12.3 0.0 0.1 0.0 1.5 5.9 0.0 0.5 0.1 0.2 4.3 58.0 0.0 30.6 3.9 0.4 0.2 23.6 0.4 0.1 83.0 47.5 0.4 0.0 0.0 4.1 0.0 0.2 81.7 2.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 69.9 0.1 0.0 0.0 42.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 IGHV3-74 ENSG00000224650 "Immunoglobulin heavy variable 3-74" A0A0B4J1X5 14 106810442-106811131 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 103.9;lymphoid tissue: 327.0;salivary gland: 102.6" "Cell type enriched" "Detected in some" 454 "Plasma cells: 19404.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in single" "cerebral cortex: 1.5" "Immune cell enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 861 "Daudi: 2948.0" "Immunoglobulin genes" NA NA 27000000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 64: Macrophages - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (2.47e-4)" "unprognostic (9.70e-2)" "prognostic favorable (8.33e-4)" "unprognostic (6.96e-3)" "unprognostic (1.42e-1)" "prognostic favorable (7.79e-4)" "unprognostic (1.06e-1)" "unprognostic (7.06e-2)" "unprognostic (3.94e-1)" "unprognostic (3.07e-2)" "unprognostic (2.42e-1)" "unprognostic (9.85e-2)" "prognostic unfavorable (4.70e-6)" "unprognostic (1.14e-1)" "unprognostic (2.54e-1)" "unprognostic (1.04e-1)" "unprognostic (1.12e-1)" 11.3 1.2 0.1 0.0 0.2 0.0 12.6 0.0 1.5 9.3 0.0 103.9 0.0 2.1 1.9 87.3 2.6 1.3 0.7 0.0 0.3 4.7 6.6 22.2 0.0 0.6 0.0 2.5 1.9 0.6 0.8 0.1 0.2 6.5 0.0 0.0 102.6 0.0 0.5 3.2 74.1 0.0 0.3 327.0 27.5 0.2 0.1 0.0 7.7 0.0 0.0 46.4 5.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 2948.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.1 1.1 0.2 0.0 0.0 0.1 1.2 0.0 0.1 0.1 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.1 0.7 0.3 0.4 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.9 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 1.5 0.0 0.3 0.6 0.0 0.2 0.3 0.1 0.2 0.0 0.0 0.0 0.0 42.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 1.4 27.5 0.2 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 19404.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 2.3 0.0 0.1 0.3 IGHV7-81 ENSG00000211979 "Immunoglobulin heavy variable 7-81 (non-functional)" A0A0B4J1V7 14 106874583-106875071 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 12.7;lymphoid tissue: 18.3;stomach 1: 12.3" "Group enriched" "Detected in some" 12 "B-cells: 1.5;Plasma cells: 1.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "memory B-cell: 5.5;naive B-cell: 3.9" "Lineage enriched" "Detected in single" 14 "B-cells: 5.5" "Cell line enhanced" "Detected in some" "A549: 1.1;Daudi: 6.1;OE19: 1.2;U-698: 2.0" "Immunoglobulin genes" NA NA 270000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" "unprognostic (5.71e-4)" "unprognostic (3.87e-1)" "unprognostic (1.06e-1)" "unprognostic (6.85e-2)" "unprognostic (2.67e-3)" "unprognostic (2.24e-1)" "unprognostic (2.07e-1)" "unprognostic (1.14e-2)" "unprognostic (6.16e-5)" "unprognostic (1.69e-3)" "unprognostic (1.78e-2)" "unprognostic (1.08e-1)" "unprognostic (5.63e-2)" "unprognostic (3.44e-1)" "unprognostic (3.63e-2)" 0.1 0.1 0.0 8.4 0.0 4.6 3.6 0.0 0.0 0.3 0.0 7.6 6.4 0.4 0.0 0.6 0.3 7.9 0.2 0.0 0.0 0.3 0.2 1.8 4.2 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 2.3 12.7 0.0 5.0 0.1 0.0 0.2 6.2 0.4 0.0 2.3 12.3 0.1 0.0 1.4 0.0 0.0 18.3 1.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.2 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.5 0.3 0.1 0.0 3.9 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0